PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Yang, ZS; Aderemi, OA; Zhao, QW; Edsall, PR; Simovic, MO; Lund, BJ; Espinoza, MD; Woodson, AM; Li, YS; Cancio, LC				Yang, Zhangsheng; Aderemi, Olawale A.; Zhao, Qingwei; Edsall, Peter R.; Simovic, Milomir O.; Lund, Brian J.; Espinoza, Mark D.; Woodson, Amber M.; Li, Yansong; Cancio, Leopoldo C.			Early Complement and Fibrinolytic Activation in a Rat Model of Blast-Induced Multi-Organ Damage	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			Blast injury; Complement; Fibrinolysis; Multi-Organ Failure; Rat	SYSTEMIC INFLAMMATORY RESPONSE; MULTIPLE ORGAN FAILURE; TRAUMATIC BRAIN-INJURY; PLASMINOGEN-ACTIVATOR; C1 INHIBITOR; COAGULATION; COMPONENT; HEMORRHAGE; C3	Objective Blast injury is associated with multi-organ failure (MOF), causing significant morbidity and mortality in trauma patients. However, the pathogenesis of blast-induced MOF still remains obscure. In this study, we evaluate the pathophysiological changes related to blast-induced MOF in a clinically relevant rat model of blast injury. Methods A moderate blast overpressure was applied to induce injury in anesthetized rats. Pathological changes were evaluated by H&E staining. Complement activation, plasminogen, and myeloperoxidase levels were analyzed by complement hemolytic assay (CH50) and/or ELISA in blood samples. Results Analysis of lung, brain, and liver tissue at 24 hour after blast overpressure revealed severe injuries. The level of complement components C3 and C1q decreased in parallel with the reduction of CH50 level in injured animals at 1, 3, and 6 hours after blast. Consumption of plasminogen was also detected as early as 1 hour post-injury. Myeloperoxidase levels were elevated within 1 hour of blast injury. Conclusion Our data reveal that blast injury triggers the complement and fibrinolytic systems, which likely contribute to blast-induced MOF. Conceivably, therapies that target these systems early may improve clinical outcomes in blast patients.	[Yang, Zhangsheng; Aderemi, Olawale A.; Zhao, Qingwei; Edsall, Peter R.; Simovic, Milomir O.; Lund, Brian J.; Espinoza, Mark D.; Woodson, Amber M.; Li, Yansong; Cancio, Leopoldo C.] US Army Inst Surg Res, 3698 Chambers Pass Rd, Ft Sam Houston, TX 78234 USA		Yang, ZS (corresponding author), US Army Inst Surg Res, 3698 Chambers Pass Rd, Ft Sam Houston, TX 78234 USA.				DHP [BA150301]; Office of the Secretary of Defense for Health Affairs	This study was supported by DHP (BA150301), and is strategically aligned with CCCRP. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Campbell JC, 2016, SHOCK, V46, P177, DOI 10.1097/SHK.0000000000000677; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Ciraulo DL, 2006, J AM COLL SURGEONS, V203, P942, DOI 10.1016/j.jamcollsurg.2006.07.028; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Duehrkop C, 2014, BIOCHEM PHARMACOL, V88, P12, DOI 10.1016/j.bcp.2013.12.013; Eftaxiopoulou T, 2016, INJURY, V47, P625, DOI 10.1016/j.injury.2016.01.017; Fan KH, 2017, CHEM-BIOL INTERACT, V271, P15, DOI 10.1016/j.cbi.2017.04.021; Foley JH, 2015, J THROMB HAEMOST, V13, P610, DOI 10.1111/jth.12837; Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302; Foley JH, 2016, EBIOMEDICINE, V5, P175, DOI 10.1016/j.ebiom.2016.02.011; Howes JM, 2012, DIABETES VASC DIS RE, V9, P216, DOI 10.1177/1479164111432788; Hubbard William Brad, 2014, Biomed Sci Instrum, V50, P92; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Kastl SP, 2006, J THROMB HAEMOST, V4, P1790, DOI 10.1111/j.1538-7836.2006.02046.x; Kirkman E, 2011, PHILOS T R SOC B, V366, P144, DOI 10.1098/rstb.2010.0240; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lee DH, 2018, EUR J TRAUMA EMERG S, V44, P291, DOI 10.1007/s00068-017-0844-0; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Liu HZ, 2015, FRONT BIOSCI-LANDMRK, V20, P927, DOI 10.2741/4347; Lucca JJD, 2013, J SURG RES, V179, P153, DOI 10.1016/j.jss.2012.10.017; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Lucca JJD, 2012, SHOCK, V38, P82, DOI 10.1097/SHK.0b013e31825a3522; Lupu F, 2014, THROMB RES, V133, pS28, DOI 10.1016/j.thromres.2014.03.014; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Madurska MJ, 2017, EUR J TRAUMA EMERG S; Mellor S G, 1988, Br J Hosp Med, V39, P536; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Prat NJ, 2015, SHOCK, V43, P598, DOI 10.1097/SHK.0000000000000346; Ramsey MT, 2016, J TRAUMA ACUTE CARE, V80, P726, DOI 10.1097/TA.0000000000001017; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; REINARTZ J, 1995, J IMMUNOL, V154, P844; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Siva Sai Sujith Sajja Benkata, 2014, Biomed Sci Instrum, V50, P375; Tsukamoto T, 2010, INJURY, V41, P21, DOI 10.1016/j.injury.2009.07.010; Volpin G, 2014, INT ORTHOP, V38, P1303, DOI 10.1007/s00264-013-2261-2; WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189; Wojta J, 2002, BLOOD, V100, P517, DOI 10.1182/blood.V100.2.517; Wu XW, 2017, SHOCK, V47, P500, DOI 10.1097/SHK.0000000000000758	49	3	4	2	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			282	290		10.1093/milmed/usy412			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100041	30901474	Bronze			2022-02-06	
J	Zhang, GL; Zha, JP; Liu, JC; Di, J				Zhang, Guolei; Zha, Junpu; Liu, Junchuan; Di, Jun			Minocycline impedes mitochondrial-dependent cell death and stabilizes expression of hypoxia inducible factor-1 alpha in spinal cord injury	ARCHIVES OF MEDICAL SCIENCE			English	Article						minocycline; mitochondrial proteins; apoptosis; HIF-1 alpha; spinal cord injury	CYTOCHROME-C RELEASE; MEDIATED APOPTOSIS; BRAIN; NEUROPROTECTION; INVOLVEMENT; ACTIVATION; PATHWAYS; CAPACITY; HIF-1	Introduction: One of the crucial mechanisms following spinal cord injury is mitochondria-associated cell death. Minocycline, an anti-inflammatory drug, is well known to impede mitochondrial cell death. However, there has been no study on the effect of minocycline linking Fas cell surface death receptor (FAS)-mediated cell death and hypoxia inducible factor (HIF-1 alpha), the targets involved in mitochondrial cell death. Material and methods: Male Sprague Dawley rats (N = 15, divided into three groups) were subjected to traumatic spinal cord injury and were injected with minocycline (n = 5) (90 mg/kg and later a 45 mg/kg dose twice a day (every 12 h)). Injection with sterile PBS in injured animals served as the vehicle (n = 5) and another group comprised healthy animals (n = 5). TUNEL assay was used to quantify cell death. The release of Smac/Diablo, cytochrome-c (cyt-c), HIF-1 alpha, FAS ligand (FASL) and tumour necrosis factor-alpha (TNF-alpha) was measured using ELISA. Expression of HIF-1 alpha, FASL and other cell death associated factors was quantified at the mRNA and protein level and confirmed with immunohistochemistry. Results: There was a marked reduction in the HIF-1 alpha and FASL expression levels in the minocycline-treated group compared to the vehicle. The reduction of HIF-1 alpha and FASL was associated with other factors linked to cell death (Smac/Diablo, cyt-c, TNF-alpha, p53, caspase-8 and BH3 interacting domain death agonist (BID)) (p < 0.5; *p < 0.05 vs. vehicle group, **p < 0.01 vs. vehicle group). Conclusions: The present study focuses on the investigation of minocycline in inhibiting mitochondria-associated cell death by modulating FASL and HIF-1 alpha expression, which are seemingly interlinked mechanisms contributing to cell death.	[Zhang, Guolei; Zha, Junpu; Liu, Junchuan; Di, Jun] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, 139 Ziqiang Rd, Shijiazhuang 050000, Hebei, Peoples R China		Di, J (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, 139 Ziqiang Rd, Shijiazhuang 050000, Hebei, Peoples R China.	jundi1974@hotmail.com					ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Elzey BD, 2001, J IMMUNOL, V167, P3049, DOI 10.4049/jimmunol.167.6.3049; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Fernandez-Gomez FJ, 2005, NEUROSCIENCE, V133, P959, DOI 10.1016/j.neuroscience.2005.03.019; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Jia L, 2011, NEUROCHEM RES, V36, P419, DOI 10.1007/s11064-010-0357-2; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Lopez-Hernandez B, 2012, EXP NEUROL, V233, P543, DOI 10.1016/j.expneurol.2011.11.040; Maier K, 2007, NEUROBIOL DIS, V25, P514, DOI 10.1016/j.nbd.2006.10.022; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morota S, 2007, J NEUROCHEM, V103, P2066, DOI 10.1111/j.1471-4159.2007.04912.x; Nikolic I, 2017, ARCH MED SCI, V13, P293, DOI 10.5114/aoms.2016.59874; Redin G S, 1966, Antimicrob Agents Chemother (Bethesda), V6, P371; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Volm M, 2000, ANTICANCER RES, V20, P1527; Wang L, 2014, J MED HYPOTHESES IDE, V8, P27, DOI 10.1016/j.jmhi.2013.07.003; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Xiaowei H, 2006, SPINAL CORD, V44, P35, DOI 10.1038/sj.sc.3101813; Xue MZ, 2010, AM J PATHOL, V176, P1193, DOI 10.2353/ajpath.2010.090361; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zhu TN, 2014, J NEUROPATH EXP NEUR, V73, P975, DOI 10.1097/NEN.0000000000000118	33	3	4	1	3	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.	MAR	2019	15	2					475	483		10.5114/aoms.2018.73520			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN4QK	WOS:000460168400022	30899301	gold, Green Published, Green Submitted			2022-02-06	
J	Wu, RH; Ye, Y; Ma, T; Jia, G; Qin, HP				Wu, Ruhong; Ye, Yun; Ma, Tao; Jia, Geng; Qin, Huaping			Management of subdural effusion and hydrocephalus following decompressive craniectomy for posttraumatic cerebral infarction in a patient with traumatic brain injury: a case report	BMC SURGERY			English	Article						Decompressive craniectomy; Hydrocephalus; Posttraumatic cerebral infarction; Subdural effusion; Subdural effusion with hydrocephalus	EXTERNAL HYDROCEPHALUS; HYGROMA; HEMICRANIECTOMY; SECONDARY	BackgroundSubdural effusion with hydrocephalus (SDEH) is a rare complication of traumatic brain injury, especially following decompressive craniectomy (DC) for posttraumatic cerebral infarction. The diagnosis and treatment are still difficult and controversial for neurosurgeons.Case presentationA 45-year-old man developed traumatic cerebral infarction after traumatic brain injury and underwent DC because of the mass effect of cerebral infarction. Unfortunately, the complications of traumatic subdural effusion (SDE) and hydrocephalus occurred in succession following DC. Burr-hole drainage and subdural peritoneal shunt were performed in sequence because of the mass effect of SDE, which only temporarily improved the symptoms of the patient. Cranioplasty and ventriculoperitoneal shunt were performed ultimately, after which SDE disappeared completely. However, the patient remains severely disabled, with a Glasgow Outcome Scale of 3.ConclusionsIt is important for neurosurgeons to consider the presence of accompanying hydrocephalus when treating patients with SDE. Once the diagnosis of SDEH is established and the SDE has no mass effect, timely ventriculoperitoneal shunt may be needed to avoid multiple surgical procedures, which is a safe and effective surgical method to treat SDEH.	[Wu, Ruhong; Ye, Yun; Ma, Tao; Jia, Geng; Qin, Huaping] Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, 185 Juqian Rd, Changzhou City 213003, Peoples R China		Qin, HP (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, 185 Juqian Rd, Changzhou City 213003, Peoples R China.	qhp197708@163.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bae Dong-Hyeon, 2014, Korean J Neurotrauma, V10, P35, DOI 10.13004/kjnt.2014.10.2.35; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Escosa-Bage M, 2002, REV NEUROLOGIA, V35, P141, DOI 10.33588/rn.3502.2001269; Ham HY, 2011, J KOREAN NEUROSURG S, V50, P370, DOI 10.3340/jkns.2011.50.4.370; Herold TJS, 2004, J EMERG MED, V27, P361, DOI 10.1016/j.jemermed.2004.03.018; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kawaguchi T, 1998, NEUROSURGERY, V43, P1033, DOI 10.1097/00006123-199811000-00017; Kilincer C, 2010, ACTA NEUROCHIR, V152, P557, DOI 10.1007/s00701-009-0476-1; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Mori K, 2000, SURG NEUROL, V53, P303, DOI 10.1016/S0090-3019(00)00199-3; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; Rossini Z, 2017, WORLD NEUROSURG, V106, DOI 10.1016/J.WNEU.2017.07.112; Server A, 2001, ACTA RADIOL, V42, P254; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Tsuang FY, 2012, J NEUROSURG, V116, P558, DOI 10.3171/2011.10.JNS11711; Tzerakis N, 2010, CASE REP MED, V2010, DOI 10.1155/2010/743784; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Yang XF, 2010, ACTA NEUROCHIR, V152, P555, DOI 10.1007/s00701-009-0475-2; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc	34	3	5	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2482			BMC SURG	BMC Surg.	FEB 27	2019	19								26	10.1186/s12893-019-0489-5			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HN3VE	WOS:000460111600001	30813919	gold, Green Published			2022-02-06	
J	Geraldo, A; Azeredo, A; Pasion, R; Dores, AR; Barbosa, F				Geraldo, Andreia; Azeredo, Andreia; Pasion, Rita; Dores, Artemisa Rocha; Barbosa, Fernando			Fostering advances to neuropsychological assessment based on the Research Domain Criteria: The bridge between cognitive functioning and physiology	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Research Domain Criteria; physiology	EVENT-RELATED POTENTIALS; ERROR-RELATED NEGATIVITY; TRAUMATIC BRAIN-INJURY; GAMMA-BAND ACTIVITY; SHORT-TERM-MEMORY; NEURAL MECHANISMS; ALZHEIMERS-DISEASE; THETA OSCILLATIONS; DUAL-TASK; PSYCHOMETRIC PROPERTIES	Objectives: The current review aimed to explore the advances in neuropsychological assessment in light of a recent research framework designed to improve our knowledge on mental health - the Research Domain Criteria (RDoC). Methods: RDoC proposals on neuropsychological tests were reviewed across the RDoC cognitive systems domain. The focus is on the physiological unit of analysis and the potential applications are illustrated given the functional relevance of RDoC constructs to psychopathological and neurological conditions. Results: The advances in neuropsychology anchored in RDoC are not observable in terms of innovative paradigms, but rather in the neurobiological correlates that may be obtained from the classical neuropsychological tasks. The behavior unit of analysis may be integrated with physiological outcomes while mapping distinct cognitive constructs simultaneously. Conclusions: Under the aegis of RDoC, the integration of multiple levels of analysis allows to obtain a more detailed and complete neuropsychological characterization with high potential to be translated into better intervention strategies.	[Geraldo, Andreia; Azeredo, Andreia; Pasion, Rita; Dores, Artemisa Rocha; Barbosa, Fernando] Univ Porto, Fac Psychol & Educ Sci, Porto, Portugal		Geraldo, A (corresponding author), Univ Porto, Fac Psychol & Educ Sci, Lab Neuropsychophysiol, Rua Alfredo Allen, P-4200135 Porto, Portugal.	g.andreia9@gmail.com	Barbosa, Fernando/L-3836-2014	Barbosa, Fernando/0000-0002-3310-5613; Pasion, Rita/0000-0002-1568-7541	Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission	Fundacao para a Ciencia e a Tecnologia.	Aftanas LI, 2002, INT J PSYCHOPHYSIOL, V44, P67, DOI 10.1016/S0167-8760(01)00194-5; ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; American Psychological Association, 2010, CLIN NEUROPSYCHOLOGY; Guevara MA, 2018, BRAIN RES, V1683, P86, DOI 10.1016/j.brainres.2018.02.004; Babiloni C, 2004, NEUROPSYCHOLOGY, V18, P719, DOI 10.1037/0894-4105.18.4.719; Babiloni C, 2004, BEHAV NEUROSCI, V118, P687, DOI 10.1037/0735-7044.118.4.687; Baddeley A.D., 2007, COMMUNICATION 0913; Baez S, 2019, NEUROPSYCHOLOGIA, V126, P159, DOI 10.1016/j.neuropsychologia.2017.02.012; Balconi M, 2007, J PSYCHOPHYSIOL, V21, P100, DOI 10.1027/0269-8803.21.2.100; Balconi M, 2009, PHYSIOL BEHAV, V97, P455, DOI 10.1016/j.physbeh.2009.03.023; Barbieri E., 2016, FRONT PSYCH C 54 ANN, DOI [10.3389/conf.fpsyg.2016.68.00089, DOI 10.3389/CONF.FPSYG.2016.68.00089]; Barr MS, 2010, SCHIZOPHR RES, V121, P146, DOI 10.1016/j.schres.2010.05.023; Barr MS, 2014, BRAIN RES, V1576, P43, DOI 10.1016/j.brainres.2014.05.043; Barwood CHS, 2012, APHASIOLOGY, V26, P103, DOI 10.1080/02687038.2011.617812; Barwood CHS, 2011, BRAIN LANG, V116, P125, DOI 10.1016/j.bandl.2010.07.004; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P197, DOI 10.1016/S0167-8760(00)00141-0; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Berry AS, 2016, J NEUROSCI, V36, P12559, DOI 10.1523/JNEUROSCI.0626-16.2016; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; BOBINSKI M, 1995, DEMENTIA, V6, P205, DOI 10.1159/000106948; Bonnefond A, 2008, J PSYCHOPHYSIOL, V22, P100, DOI 10.1027/0269-8803.22.2.100; Bonnefond M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0153-16.2017; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Casaletto KB, 2017, J INT NEUROPSYCH SOC, V23, P778, DOI 10.1017/S1355617717001060; Chan CC, 2015, CLIN NEUROPHYSIOL, V126, P1717, DOI 10.1016/j.clinph.2014.11.016; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Clawson A, 2013, PSYCHOPHYSIOLOGY, V50, P711, DOI 10.1111/psyp.12066; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P1209, DOI 10.1111/psyp.12138; Clementz BA, 2016, AM J PSYCHIAT, V173, P373, DOI 10.1176/appi.ajp.2015.14091200; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Connell AM, 2018, AM J DRUG ALCOHOL AB, V44, P263, DOI 10.1080/00952990.2017.1343340; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Cook IA, 1998, ELECTROEN CLIN NEURO, V107, P408, DOI 10.1016/S0013-4694(98)00092-3; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; DAVIDSON RJ, 1990, PSYCHOPHYSIOLOGY, V27, P528, DOI 10.1111/j.1469-8986.1990.tb01970.x; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ellis AJ, 2017, NEUROPSYCHOLOGIA, V102, P45, DOI 10.1016/j.neuropsychologia.2017.06.003; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FERNANDEZ T, 1995, ELECTROEN CLIN NEURO, V94, P175, DOI 10.1016/0013-4694(94)00262-J; Filipovic SR, 2001, CLIN NEUROPHYSIOL, V112, P1307, DOI 10.1016/S1388-2457(01)00558-2; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Geburek AJ, 2013, INT J PSYCHOPHYSIOL, V87, P349, DOI 10.1016/j.ijpsycho.2012.08.006; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gonzalez-Villar AJ, 2017, BRAIN TOPOGR, V30, P539, DOI 10.1007/s10548-017-0561-3; GRAFFRADFORD NR, 1990, BRAIN, V113, P1, DOI 10.1093/brain/113.1.1; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; GROTHMARNAT G, 2003, HDB PSYCHOL ASSESSME; Gruber T, 2006, EUR J NEUROSCI, V24, P2654, DOI 10.1111/j.1460-9568.2006.05130.x; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2002, J PERS SOC PSYCHOL, V82, P610, DOI 10.1037//0022-3514.82.4.610; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harmony T, 1996, INT J PSYCHOPHYSIOL, V24, P161, DOI 10.1016/S0167-8760(96)00053-0; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hileman CM, 2011, DEV NEUROPSYCHOL, V36, P214, DOI 10.1080/87565641.2010.549870; Hogan MJ, 2003, INT J PSYCHOPHYSIOL, V49, P147, DOI 10.1016/S0167-8760(03)00118-1; Hurley RS, 2012, J NEUROSCI, V32, P4848, DOI 10.1523/JNEUROSCI.5984-11.2012; Hurley RS, 2009, J NEUROSCI, V29, P15762, DOI 10.1523/JNEUROSCI.2912-09.2009; Huster RJ, 2014, NEUROIMAGE, V94, P120, DOI 10.1016/j.neuroimage.2014.02.034; Inzlicht M, 2015, TRENDS COGN SCI, V19, P126, DOI 10.1016/j.tics.2015.01.004; Isquith PK, 2004, DEV NEUROPSYCHOL, V26, P403, DOI 10.1207/s15326942dn2601_3; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Ivanova MV, 2015, APHASIOLOGY, V29, P645, DOI 10.1080/02687038.2014.975182; JARVIS PE, 1984, HALSTEAD REITAN TEST; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kawohl W, 2010, NEUROREHAB NEURAL RE, V24, P282, DOI 10.1177/1545968309348311; Kielar A, 2012, NEUROPSYCHOLOGIA, V50, P3320, DOI 10.1016/j.neuropsychologia.2012.09.013; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; Kitade Shuko, 1999, Journal of Medical Investigation, V46, P87; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Kozak MJ, 2016, PSYCHOPHYSIOLOGY, V53, P286, DOI 10.1111/psyp.12518; Kropotov J. D., 2016, FUNCTIONAL NEUROMARK; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lange F, 2017, NEUROSCI BIOBEHAV R, V83, P496, DOI 10.1016/j.neubiorev.2017.09.011; Lange F, 2016, NEUROPSYCHOLOGIA, V93, P142, DOI 10.1016/j.neuropsychologia.2016.09.021; Langer N, 2013, CORTEX, V49, P2424, DOI 10.1016/j.cortex.2013.01.008; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Light Gregory A, 2010, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0625s52; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Llorens A, 2014, BRAIN LANG, V133, P47, DOI 10.1016/j.bandl.2014.03.010; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Maguire MJ, 2013, DEV COGN NEUROS-NETH, V6, P125, DOI 10.1016/j.dcn.2013.08.002; MALAMUT BL, 1992, NEUROLOGY, V42, P163, DOI 10.1212/WNL.42.1.163; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; Marshall AC, 2015, NEUROBIOL AGING, V36, P2136, DOI 10.1016/j.neurobiolaging.2015.02.026; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Maurage P, 2007, CLIN NEUROPHYSIOL, V118, P633, DOI 10.1016/j.clinph.2006.11.007; McNeil M.R, 1991, CLIN APHASIOLOGY C; Meyer A, 2014, PSYCHOPHYSIOLOGY, V51, P602, DOI 10.1111/psyp.12208; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Missonnier P, 2012, J PSYCHIATR NEUROSCI, V37, P95, DOI 10.1503/jpn.110033; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Nemeth K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101393; NICHELLI P, 1988, BRAIN, V111, P1337, DOI 10.1093/brain/111.6.1337; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Ors M, 2001, BRAIN LANG, V77, P60, DOI 10.1006/brln.2000.2423; Parra Mario A, 2012, Front Neurol, V3, P172, DOI 10.3389/fneur.2012.00172; Pasion R, 2018, NEUROSCI BIOBEHAV R, V91, P170, DOI 10.1016/j.neubiorev.2017.03.012; Pasion R, 2016, J NEUROSCI METH, V267, P126, DOI 10.1016/j.jneumeth.2016.04.009; Pasion R, 2016, PERS INDIV DIFFER, V95, P6, DOI 10.1016/j.paid.2016.02.017; Patrick CJ, 2013, J ABNORM PSYCHOL, V122, P902, DOI 10.1037/a0032807; PEPIN EP, 1993, NEUROLOGY, V43, P733, DOI 10.1212/WNL.43.4.733; Perri R, 2013, J ALZHEIMERS DIS, V37, P99, DOI 10.3233/JAD-130347; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Popescu M, 2009, NEUROREPORT, V20, P1104, DOI 10.1097/WNR.0b013e32832e9c97; Prinz P., 1989, ELECTROENCEPHALOGR C, V73, P27, DOI [10.1016/0013-4694(89)90092-8, DOI 10.1016/0013-4694(89)90092-8]; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Rey A, 1999, FIGURAS COMPLEXAS RE; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Rietdijk WJR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102672; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Sabisch B, 2006, NEUROREPORT, V17, P1511, DOI 10.1097/01.wnr.0000236850.61306.91; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Scharinger C, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00006; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Seer C, 2016, NEUROSCI BIOBEHAV R, V71, P691, DOI 10.1016/j.neubiorev.2016.08.003; Shariff AF, 2011, CURR DIR PSYCHOL SCI, V20, P395, DOI 10.1177/0963721411424739; Singhal A, 2002, PSYCHOPHYSIOLOGY, V39, P236, DOI 10.1017/S0048577201392156; SOININEN H, 1992, ACTA NEUROL SCAND, V85, P36, DOI 10.1111/j.1600-0404.1992.tb04452.x; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; SPEEDIE LJ, 1982, NEUROPSYCHOLOGIA, V20, P597, DOI 10.1016/0028-3932(82)90033-1; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Styles E. A., 2006, PSYCHOL ATTENTION; Swanston M.T., 2001, VISUAL PERCEPTION IN; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TEUBER HL, 1968, NEUROPSYCHOLOGIA, V6, P267, DOI 10.1016/0028-3932(68)90025-0; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; VANDERMEERE J, 1995, PERCEPT MOTOR SKILL, V81, P259, DOI 10.2466/pms.1995.81.1.259; Vecchio F, 2014, J COGNITIVE NEUROSCI, V26, P1883, DOI 10.1162/jocn_a_00615; Vila-Ballo A, 2014, BIOL PSYCHOL, V102, P141, DOI 10.1016/j.biopsycho.2014.07.021; von Bastian CC, 2017, J EXP PSYCHOL GEN, V146, P1266, DOI 10.1037/xge0000333; Wacker J, 2010, EUR J PERSONALITY, V24, P85, DOI 10.1002/per.740; Walhovd KB, 2003, BIOL PSYCHOL, V62, P65, DOI 10.1016/S0301-0511(02)00093-5; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; West R, 2000, PSYCHOPHYSIOLOGY, V37, P179, DOI 10.1111/1469-8986.3720179; West R, 2012, PSYCHOPHYSIOLOGY, V49, P1309, DOI 10.1111/j.1469-8986.2012.01464.x; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Wickens CD, 1977, P HUM FACT SOC 21 AN, P282, DOI [10.1177/107118137702100404, DOI 10.1177/107118137702100404]; Wiener DA, 2004, APHASIOLOGY, V18, P599, DOI 10.1080/02687030444000228; Wostmann NM, 2013, BRAIN COGNITION, V81, P82, DOI 10.1016/j.bandc.2012.09.010; Yeung MK, 2016, NEUROPSYCHOLOGY, V30, P281, DOI 10.1037/neu0000231; Yu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137649; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	177	3	3	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2019	33	2			SI		327	356		10.1080/13854046.2018.1523467			30	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HP2MG	WOS:000461507800009	30394184	Green Submitted			2022-02-06	
J	Hasan, O; Sheikh, S; Fatima, A; Abbas, A; Zahid, N; Baloch, N				Hasan, Obada; Sheikh, Sadaf; Fatima, Anam; Abbas, Asad; Zahid, Nida; Baloch, Naveed			Motor-vehicle Crash Patient Injury Patterns from a Level One Trauma Center in a Metropolitan City: A Cross-Sectional Study	CUREUS			English	Article						motorcycle accidents; injury pattern; orthopedic; emergency medicine	HELMET USE	Introduction Motorcycles are an inexpensive and popular mode of transportation in Karachi, Pakistan, despite the increasing number of motor vehicle injuries. Although motorcycle-related injuries have been studied previously, to our knowledge, there are no published reports on the orthopedic injuries associated with motorcycles crashes. Methods We conducted a cross-sectional study of medical records of patients with motorcycle-related injuries in 2015, at the Aga Khan University in Karachi, Pakistan. We reviewed the patient demographic and medical data, helmet use, the Glasgow coma score, the spectrum of injuries, length of stay, specific injury diagnosis, and final disposition of patients. Data were analyzed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp., Armonk, NY). Results We identified 450 motorcycle crash injuries. Ninety percent of these victims were males, and 81% were driving at the time of the crash. More than 50% of crashes involved patients age under 29 years, and most crashes (35%) involved patients in the third decade of life. We observed that 6.8% of accidents involved patients younger than 10 years of age. For all the motorcycle-related injuries, 45% occurred during the weekend (Saturday and Sunday). Helmets were worn by only 7% of patients. The most common types of collisions were motorcycle versus car followed by lone motorcycle fall. Of the injuries sustained, the cumulative frequency of orthopedic injuries was the highest (63%), of which 34% were lower limb injuries and 29% were upper limb injuries. The second highest frequency of injuries were head injuries (46%). We also found that 85% motorcycle injury victims sustained fractures. Conclusion The frequency of motorcycle-related injuries was high among young adults, and closed fractures of the lower limbs were the most common orthopedic injuries related to motorcycle crashes. Use of helmets among motorcyclists needs to be reinforced to prevent head injuries. We suggest motorcyclists to use protective clothes and motorcycle sidebars to prevent fractures of the lower limb. Further research is needed to determine the type of fractures, type of head injuries, surgical interventions required, and morbidity and mortality in motorcycle-related injuries and whether designing separate lanes for motorcycles will reduce the burden of these injuries on the healthcare system.	[Hasan, Obada] Aga Khan Univ Hosp, Orthoped Surg, Karachi, Pakistan; [Sheikh, Sadaf] Aga Khan Univ Hosp, Emergency Med, Karachi, Pakistan; [Abbas, Asad] Aga Khan Univ Hosp, Surg Ex Intern, Karachi, Pakistan; [Zahid, Nida] Aga Khan Univ Hosp, Epidemiol & Publ Hlth, Karachi, Pakistan; [Baloch, Naveed] Aga Khan Univ Hosp, Surg, Karachi, Pakistan		Hasan, O (corresponding author), Aga Khan Univ Hosp, Orthoped Surg, Karachi, Pakistan.	obada.husseinali@aku.edu	Hasan, Obada/ABA-8347-2020; Zahid, Nida/M-2696-2019	Hasan, Obada/0000-0003-3654-4854; Zahid, Nida/0000-0001-8812-9463			Bjornskau T, 2012, ACCIDENT ANAL PREV, V49, P50, DOI 10.1016/j.aap.2011.09.051; Conrad P, 1996, ACCIDENT ANAL PREV, V28, P193, DOI 10.1016/0001-4575(95)00056-9; HOFLING I, 2006, FINN J ORTHOP TRAUMA, V29, P243; Mackay M, 2000, J CRASH PREV INJ CON, V2, P11, DOI [10.1080/10286580008902549, DOI 10.1080/10286580008902549]; Monk JP, 2009, CAN J SURG, V52, pE235; Peek-Asa C, 1999, ACCIDENT ANAL PREV, V31, P229, DOI 10.1016/S0001-4575(98)00071-2; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Talving P, 2010, J TRAUMA, V68, P441, DOI [10.1097/TA.0b013e3181cbf303, 10.1097/TA.0b013e3181bb80bf]; Tsai M C, 1999, Inj Prev, V5, P290; WATSON GS, 1980, AM J PUBLIC HEALTH, V70, P579, DOI 10.2105/AJPH.70.6.579	10	3	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 14	2019	11	2							e4073	10.7759/cureus.4073			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HP6YN	WOS:000461833500002	31019851	gold, Green Published, Green Submitted			2022-02-06	
J	Soendergaard, PL; Siert, L; Poulsen, I; Wood, RL; Norup, A				Soendergaard, Pernille Langer; Siert, Lars; Poulsen, Ingrid; Wood, Rodger Ll; Norup, Anne			Measuring Neurobehavioral Disabilities Among Severe Brain Injury Survivors: Reports of Survivors and Proxies in the Chronic Phase	FRONTIERS IN NEUROLOGY			English	Article						neurobehavioral disability; traumatic brain injury; acquired brain injury; SASNOS; chronic phase; proxy ratings	PERSONALITY-CHANGE; NEUROPSYCHOLOGY BEHAVIOR; SOCIAL-ADJUSTMENT; OUTCOME SCALE; HEAD-INJURY; FOLLOW-UP; REHABILITATION; VALIDITY; SYMPTOMS; IMPACT	Background: Neurobehavioral disability (NBD) has a major influence on long-term psychosocial outcome following acquired brain injury, as it affects not only the survivor of the brain injury, but the whole family. Objectives: To investigate (1) the frequency of NBD among survivors of severe brain injury measured by the Danish version of the St Andrew's-Swansea Neurobehavioural Outcome Scale (SASNOS) rated by patients and proxies, (2) factors associated with NBD, and (3) concordance between reports of NBD completed by patients and proxies. Methods: SASNOS was administered at an outpatient unit as a part of a follow-up assessment after discharge from intensive neurorehabilitation. SASNOS consists of five factors describing the following domains: Interpersonal Behavior, Cognition, Aggression, Inhibition and Communication, and both the patient and a proxy were asked to complete the questionnaire. Data collection was conducted over a period of 2 years, and 32 patients and 31 proxies completed the questionnaire. Mean time since injury was 19.4 months (10.0 SD). Most patients were male (68.8%), and most proxies were female (58.1%). Most of the patients had suffered a traumatic brain injury (68.8%). Results: A fourth of this patient group reported themselves below the normal range on the major domains of Interpersonal Behavior and Cognition. Significant associations between proxies' reports and time since injury, cohabitant status, and the patient's score on the Extended Glasgow Outcome Scale were found. Furthermore, significant differences were found between patient and proxy ratings. Proxies rated patients as having fewer problems on the Interpersonal Behavior domain, and more problems in relation to Cognition. Cognition was the only domain, where patients rated themselves higher indicating fewer problems, compared with their proxies. On both the Aggression and Communication domains, proxies rated patients higher indicating fewer problems than the patients themselves. Conclusion: Danish brain injury survivors experienced NBD as measured by SASNOS. Differences were found between patient and proxy ratings in relation to Cognition and Interpersonal Behavior. The NBDs identified can affect the survivor's ability to reintegrate and participate in activities of daily living, emphasizing how a systematic assessment is required.	[Soendergaard, Pernille Langer; Norup, Anne] Rigshosp, Dept Neurol, Glostrup, Denmark; [Soendergaard, Pernille Langer; Norup, Anne] Univ Southern Denmark, Dept Psychol, Odense, Denmark; [Siert, Lars; Poulsen, Ingrid] Copenhagen Univ Hosp, Rigshosp, RUBRIC Res Unit Brain Injury Rehabil Copenhagen, Dept Neurorehabil,TBI Unit, Hvidovre, Denmark; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Hlth, Aarhus, Denmark; [Wood, Rodger Ll] Swansea Univ, Inst Life Sci, Coll Med, Swansea, W Glam, Wales		Soendergaard, PL (corresponding author), Rigshosp, Dept Neurol, Glostrup, Denmark.; Soendergaard, PL (corresponding author), Univ Southern Denmark, Dept Psychol, Odense, Denmark.	pernille.langer.soendergaard@regionh.dk	Poulsen, ingrid/AAH-2052-2019; Soendergaard, Pernille Langer/C-6149-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116; Soendergaard, Pernille Langer/0000-0002-5347-8898			Alderman N, 2018, BRAIN INJURY, V32, P218, DOI 10.1080/02699052.2017.1406989; Alderman N, 2017, ARCH CLIN NEUROPSYCH, V32, P951, DOI 10.1093/arclin/acx026; Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McMillan TM, 2013, NEUROREHABILITATION, V32, P791, DOI 10.3233/NRE-130903; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Norup A, 2018, REV IBEROAM NEUROPSI, V1, P17; Norup A, 2019, NEUROPSYCHOL REHABIL, V29, P1113, DOI 10.1080/09602011.2017.1371045; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2013, NEUROREHABILITATION, V32, P751, DOI 10.3233/NRE-130899; Satz P, 1996, PSYCHOL ASSESSMENT, V8, P115; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weddell RA, 2018, BRAIN INJURY, V32, P442, DOI 10.1080/02699052.2018.1429657; Weddell RA, 2016, BRAIN INJURY, V30, P1362, DOI 10.1080/02699052.2016.1195921; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler D, 2006, 8 21FROM SCH PRIMARY; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Wood RL, 2013, NEUROREHABILITATION, V32, P699, DOI 10.3233/NRE-130895	43	3	3	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 5	2019	10								51	10.3389/fneur.2019.00051			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HK3HO	WOS:000457804800002	30804873	Green Published, gold			2022-02-06	
J	Bangirana, P; Giordani, B; Kobusingye, O; Murungyi, L; Mock, C; John, CC; Idro, R				Bangirana, Paul; Giordani, Bruno; Kobusingye, Olive; Murungyi, Letisia; Mock, Charles; John, Chandy C.; Idro, Richard			Patterns of traumatic brain injury and six-month neuropsychological outcomes in Uganda	BMC NEUROLOGY			English	Article						Cognition; Brain injury; Anxiety; Depression; Physical disability; Traffic crashes	COMPUTERIZED COGNITIVE REHABILITATION; RECOVERY 10 YEARS; FUNCTIONAL RECOVERY; IMPAIRMENT; VALIDITY; MODERATE; DEPRESSION; PREDICTION; DISORDER; BENEFITS	BackgroundTraumatic brain injuries in Uganda are on the increase, however little is known about the neuropsychological outcomes in survivors. This study characterized patients with traumatic brain injury (TBI) and the associated six-month neuropsychological outcomes in a Ugandan tertiary hospital.MethodsPatients admitted at Mulago Hospital with head injury from November 2015 to April 2016 were prospectively enrolled during admission and followed up at six months after discharge to assess cognition, posttraumatic stress symptoms (PTSS), depression symptoms and physical disability. The outcomes were compared to a non-head-injury group recruited from among the caretakers, siblings and neighbours of the patients with age and sex entered as covariates.ResultsOne hundred and seventy-one patients and 145 non-head injury participants were enrolled. The age range for the whole sample was 1 to 69years with the non-head injury group being older (mean age (SD) 33.34 (13.35) vs 29.34 (14.13) years of age, p=0.01). Overall, motorcycle crashes (36/171, 38.6%) and being hit by an object (58/171, 33.9%) were the leading causes of TBI. Head injury from falls occurred more frequently in children <18years (13.8% vs 2.8%, p=0.03). In adults 18years and older, patients had higher rates of neurocognitive impairment (28.4% vs 6.6%, p<0.0001), PTSS (43.9% vs 7.9%, p<0.0001), depression symptoms (55.4% vs 10%, p<0.0001) and physical disability (7.2% vs 0%, p=0.002). Lower Glasgow Coma Score (GCS) on admission was associated with neurocognitive impairment (11.6 vs 13.1, p=0.04) and physical disability (10 vs 12.9, p=0.01) six months later.ConclusionThis first such study in the East-African region shows that depth of coma on admission in TBI is associated with neurocognitive impairment and physical disability.	[Bangirana, Paul] Makerere Univ, Dept Psychiat, Kampala, Uganda; [Giordani, Bruno] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kobusingye, Olive] Makerere Univ, Trauma Injury & Disabil Track, Sch Publ Hlth, Kampala, Uganda; [Murungyi, Letisia] Global Hlth Uganda, Kampala, Uganda; [Mock, Charles] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [John, Chandy C.] Indiana Univ, Dept Paediat, Indianapolis, IN 46204 USA; [Idro, Richard] Makerere Univ, Dept Paediat & Child Hlth, Kampala, Uganda		Bangirana, P (corresponding author), Makerere Univ, Dept Psychiat, Kampala, Uganda.	pbangirana@yahoo.com	Giordani, Bruno/AAR-1910-2021; , Ridro/ABD-3556-2020	Giordani, Bruno/0000-0001-5921-3455; Kobusingye, Olive/0000-0003-2413-599X; Bangirana, Paul/0000-0002-7136-0594	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25 TW009345]; Office of The Director, National Institutes of Health (OD), National Institute of Dental Craniofacial Research (NIDCR), National Institute of Neurological Disorders and Stroke (NINDS), National Heart, Lung, and Blood Institute (NHLBI), Fogarty Internatio [D43TW010132]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW010132] Funding Source: NIH RePORTER	Funding for this study was made possible by a grant of the National Institutes of Health under award number [R25 TW009345] and by a D43TW010132 supported by Office of The Director, National Institutes of Health (OD), National Institute of Dental & Craniofacial Research (NIDCR), National Institute of Neurological Disorders and Stroke (NINDS), National Heart, Lung, and Blood Institute (NHLBI), Fogarty International Center (FIC), National Institute on Minority Health and Health Disparities (NIMHD). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funding body had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; [Anonymous], 2013, ANN CRIM TRAFF ROAD; Bangirana P, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0063-6; Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Department of State U, 2017, UG 2017 CRIM SAF REP; Erem G, 2012, CRANIAL COMPUTED TOM; Faul M, 2010, PREV CONTROL; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gill IJ, 2014, BRAIN INJURY, V28, P1, DOI 10.3109/02699052.2013.851416; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Jayaraman Sudha, 2009, World J Surg, V33, P2512, DOI 10.1007/s00268-009-0180-6; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kamulegeya A, 2009, CLINICS, V64, P843, DOI 10.1590/S1807-59322009000900004; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kigera J, 2010, ANN AFRICAN SURG, V5; Kituuka O, 2005, SHORT TERM OUTCOME H; Maas AI, 2017, LANCET NEUROLOGY; Mamman JI., 1979, PATTERN ACUTE HEAD I; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Ministry of Health M, 2014, UG HOSP HLTH CTR 4 C; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naddumba E. K., 2004, East and Central African Journal of Surgery, V9, P44; Nakimuli-Mpungu E, 2012, HIV AIDS-RES PALLIAT, V4, P51, DOI 10.2147/HIV.S29818; Pietrzak RH, 2008, ARCH CLIN NEUROPSYCH, V23, P433, DOI 10.1016/j.acn.2008.03.002; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Statistics UBo ICF, 2018, ICF UG DEM HLTH SURV; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Westerman R., 2001, ADF HLTH, V2, P29; WHO, 1994, US GUID SELF REP QUE, P1; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; World Health Organization, 2015, GLOB STAT REP ROAD S	51	3	3	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	FEB 4	2019	19								18	10.1186/s12883-019-1246-1			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HK1ZH	WOS:000457705400001	30717695	Green Published, gold			2022-02-06	
J	Deng, Z; Liu, DH; Fu, TP; Jiang, WQ; Qiu, M; Xiao, XY; Xu, J; Feng, YW; Li, DH; Zeng, HK				Deng, Zhe; Liu, Dehong; Fu, Tingping; Jiang, Wenqiang; Qiu, Min; Xiao, Xiaoyong; Xu, Ji; Feng, Yongwen; Li, Danhui; Zeng, Hongke			NF-kappa B mediates early blood-brain barrier disruption in a rat model of traumatic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Blood-brain barrier; traumatic shock; NF-kappa B; pyrrolidinedithiocarbamate	HYPERTONIC SALINE RESUSCITATION; VIVO NEUTROPHIL INTERACTIONS; HEMORRHAGIC-SHOCK; GROWTH-FACTOR; LUNG INJURY; OXIDATIVE STRESS; DAMAGE; INHIBITION; HYPOXIA; EXPRESSION	BACKGROUND Blood-brain barrier (BBB) disruption is associated with a large number of central nervous system and systemic disorders. The aim of the present study was to investigate the dynamic change of BBB changes during traumatic shock and resuscitation as well as the mechanisms involved. METHODS The experiments were performed on male Sprague-Dawley rats anesthetized with pentobarbital sodium. To produce traumatic shock, the rats were subjected to bilateral femoral traumatic fracture and blood withdrawal from the femoral artery to decrease mean arterial pressure (MAP) to 35 mm Hg. Hypovolemic status (at a MAP of 35 to 40 mm Hg) was sustained for 1 hour followed by fluid resuscitation with shed blood and 20 mL/kg of lactated Ringer's solution. RESULTS The rats were sacrificed at 1 hour, 2 hours, or 6 hours after fluid resuscitation. Blood-brain barrier permeability studies showed that traumatic shock significantly increased brain water contents and sodium fluorescein leakage, which was aggravated by fluid resuscitation. Real-time reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analyses revealed that Na+-K+-Cl- cotransporter-1 and vascular endothelial growth factor (VEGF) expression were upregulated in cortical brain tissue of traumatic shock rats, and this change was accompanied by downregulation of occludin and claudin-5. Traumatic shock also significantly increased the protein levels of NF-kappa B-p65 subunit. Of note, administration of NF-kappa B inhibitor PDTC effectively attenuated augmentation of the above changes. CONCLUSION Our results suggest that traumatic shock is associated with early BBB disruption, and inhibition of NF-kappa B may be an effective therapeutic strategy in protecting the BBB under traumatic shock conditions.	[Deng, Zhe; Jiang, Wenqiang; Zeng, Hongke] Southern Med Univ, Sch Clin Med 2, 1063 Shatai Nan Rd, Guangzhou 510515, Guangdong, Peoples R China; [Deng, Zhe; Jiang, Wenqiang; Zeng, Hongke] Guangdong Acad Med Sci Guangdong, Guangdong Gen Hosp, Dept Emergency & Crit Care Med, Guangzhou, Guangdong, Peoples R China; [Deng, Zhe; Liu, Dehong; Fu, Tingping; Qiu, Min; Xiao, Xiaoyong; Feng, Yongwen; Li, Danhui] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Hlth Sci Ctr,Dept Emergency Med, Shenzhen, Guangdong, Peoples R China; [Xu, Ji] Shenzhen Univ, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Hlth Sci Ctr,Cent Lab, Shenzhen, Guangdong, Peoples R China		Zeng, HK (corresponding author), Southern Med Univ, Sch Clin Med 2, 1063 Shatai Nan Rd, Guangzhou 510515, Guangdong, Peoples R China.; Zeng, HK (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Emergency & Crit Care Med, 106 Zhongshan Er Rd, Guangzhou 510080, Guangdong, Peoples R China.	zenghongke@vip.163.com			Basic Research Project of Knowledge Program of Shenzhen Science and Technology Innovation Commission [JCYJ20130401112547042]; Rui E (Rui Yi) Specialized Research Funds for Emergency Medical Research [R2014008]	This work was supported by grants from Rui E (Rui Yi) Specialized Research Funds for Emergency Medical Research (R2014008) and the Basic Research Project of Knowledge Program of Shenzhen Science and Technology Innovation Commission (JCYJ20130401112547042).	Adams CA, 2002, SHOCK, V18, P513, DOI 10.1097/00024382-200212000-00005; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Begum G, 2015, STROKE, V46, P1956, DOI 10.1161/STROKEAHA.115.008939; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; [邓哲 Deng Zhe], 2012, [中华创伤杂志, Chinese Journal of Trauma], V28, P556; Dhanasekar C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145093; Foroutan S, 2005, AM J PHYSIOL-CELL PH, V289, pC1492, DOI 10.1152/ajpcell.00257.2005; Funk K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-32; Gong WF, 2011, J TRAUMA, V71, P275, DOI 10.1097/TA.0b013e318226eb51; Grist JJ, 2018, CLIN IMMUNOL, V189, P52, DOI 10.1016/j.clim.2016.05.009; GUNNAR W, 1988, SURGERY, V103, P398; Hardaway RM, 2006, MIL MED, V171, P278, DOI 10.7205/MILMED.171.4.278; Hardaway RM, 2001, AM J MED SCI, V322, P222, DOI 10.1097/00000441-200110000-00013; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Jin XC, 2014, CURR NEUROVASC RES, V11, P254, DOI 10.2174/1567202611666140530145643; Jin XC, 2012, NEUROBIOL DIS, V48, P309, DOI 10.1016/j.nbd.2012.07.007; Jumnongprakhon P, 2016, BRAIN RES, V1646, P182, DOI [10.1016/j.brainres.2016.05.049, 10.1016/j.brainres.2016.06.014]; Klettner A, 2015, MOL VIS, V21, P736; KOZHURA VL, 1990, RESUSCITATION, V19, P89, DOI 10.1016/0300-9572(90)90032-A; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Liu YW, 2016, MOL NEUROBIOL; Morales-Aza BM, 2004, NEUROBIOL DIS, V17, P62, DOI 10.1016/j.nbd.2004.05.010; Morishita K, 2014, J TRAUMA ACUTE CARE, V76, P610, DOI 10.1097/TA.0000000000000137; Nagy B, 2015, J CRIT CARE, V30, P162, DOI 10.1016/j.jcrc.2014.07.008; Natah SS, 2009, J APPL PHYSIOL, V107, P1348, DOI 10.1152/japplphysiol.91484.2008; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ott M, 2007, J TRAUMA, V63, P591, DOI 10.1097/TA.0b013e31812e51c7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qi J, 2015, AM J TRANSL RES, V7, P1826; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Shapiro ML, 2011, J TRAUMA, V71, P281; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Song J, 2008, J MED POSTGRAD, V21, P255; Song Z, 2015, INT J EXP PATHOL, V96, P406, DOI 10.1111/iep.12160; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; [孙英刚 Sun Yinggang], 2002, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V27, P1086; Tsai YF, 2015, FREE RADICAL BIO MED, V89, P387, DOI 10.1016/j.freeradbiomed.2015.08.008; Varatharaj A, 2016, BRAIN BEHAV IMMUN; Wang SF, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00148; Wang Z, 2011, CELL PHYSIOL BIOCHEM, V28, P703, DOI 10.1159/000335764; Winderlich JN, 2016, J CEREBR BLOOD F MET, V36, P1087, DOI 10.1177/0271678X15608392; Yan YP, 2003, BRAIN RES, V961, P22, DOI 10.1016/S0006-8993(02)03832-5; Yuen N, 2014, AM J PHYSIOL-CELL PH, V306, pC931, DOI 10.1152/ajpcell.00021.2013; Zhang JQ, 2016, ONCOL REP, V36, P705, DOI 10.3892/or.2016.4888; Zhao H, 2016, J CEREB BLOOD FLOW M; Zhao HF, 2015, NEUROSCIENCE, V310, P641, DOI 10.1016/j.neuroscience.2015.10.006	51	3	4	2	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2019	86	2					240	249		10.1097/TA.0000000000002124			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HK0GN	WOS:000457577100010	30399134				2022-02-06	
J	Fisher, AFW				Fisher, Allison F. Winters			Dance/movement therapy & warrior wellness: A pilot case study	ARTS IN PSYCHOTHERAPY			English	Article						Dance/movement therapy; Military; Veterans; Mind-body; Wellness; Integrative health	DANCE MOVEMENT THERAPY; TREATMENT PREFERENCES; COMPLEMENTARY; INTERVENTION; SYMPTOMS	Dance/movement therapy (DMT) is "the psychotherapeutic use of movement to further the emotional, cognitive, physical, and social integration of the individual" (American Dance Therapy Association, 2016), has been researched as a therapeutic intervention for various diagnoses and disorders, and exists in many healthcare settings across the United States. Despite its presence, dance is still widely misunderstood and undervalued as a therapy. The need for integrative mental health services has given rise to an interest in non-pharmacological approaches for treating various conditions, specifically within the veteran and military population. Arts-based methods in particular are being explored on the levels of practice, policy, and research in response to this need. This pilot case study is an analysis of an existing dance/movement therapy-based mind-body wellness program that is part of a larger integrative program for military service members with traumatic brain injury (TBI) and psychological health conditions. Data has been triangulated from patient surveys, clinical notes, the researcher practitioner's embodied observations, and historical programmatic data. The results of the analysis indicate potential increase in mind-body awareness for patients as well as a possible shift in movement flow. Inconsistencies in organization/internal messaging suggest further exploration of the critical tenets of integrative medicine.	[Fisher, Allison F. Winters] Saybrook Univ, 475 14th St,9th Floor, Oakland, CA 94612 USA; [Fisher, Allison F. Winters] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA		Fisher, AFW (corresponding author), 4860 South Palmer Rd, Bethesda, MD 20889 USA.	allison.f.winters.civ@mail.mil					American Dance Therapy Association, 2016, DANC MOV THER; Americans for the Arts, 2013, ARTS HLTH WELL BEING; Bartenieff I, 1980, BODY MOVEMENT COPING; Bentz V. M., 1998, MINDFUL INQUIRY SOCI; Brauninger I, 2012, ART PSYCHOTHER, V39, P443, DOI 10.1016/j.aip.2012.07.002; Brauninger I, 2012, ART PSYCHOTHER, V39, P296, DOI 10.1016/j.aip.2012.03.008; Crawford EF, 2015, J TRAUMA STRESS, V28, P118, DOI 10.1002/jts.21993; Department of Veterans Affairs Veterans Health Administration, 2014, VA MENT HLTH SERV PU; Goertz C, 2013, J ALTERN COMPLEM MED, V19, P509, DOI 10.1089/acm.2012.0108; Goodill S. W., 2010, CREATIVE ARTS THERAP; GORDONCOHEN N, 1987, AM J DANCE THER, V10, P95, DOI 10.1007/BF02251791; Hanna J. L., 2012, DANCE MOVEMENT THERA, P167; Hay-Smith EJC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0203-6; Hays D. G., 2011, QUALITATIVE INQUIRY; Horrigan B, 2012, INTEGRATIVE MED AM I; Jacobson IG, 2009, ANN EPIDEMIOL, V19, P613, DOI 10.1016/j.annepidem.2009.05.001; Janesick V., 2016, STRETCHING; Koch S, 2014, ART PSYCHOTHER, V41, P46, DOI 10.1016/j.aip.2013.10.004; Koch SC, 2007, ART PSYCHOTHER, V34, P340, DOI 10.1016/j.aip.2007.07.001; MacDonald J, 2006, DANCE MOVEMENT THERA, P49; National Center for Complementary and Integrative Health, 2017, NCCIH CLIN DIG HLTH; National Center for Complementary and Integrative Health, 2016, COMPL ALT INT HLTH W; Phillips M. M., 2014, WALL STREET J; Ritter M, 1996, ART PSYCHOTHER, V23, P249, DOI 10.1016/0197-4556(96)00027-5; Saldana J, 2013, CODING MANUAL QUALIT; Samueli Institute, 2013, ALT MED US RIS MIL; Schumm JA, 2015, BEHAV RES THER, V69, P75, DOI 10.1016/j.brat.2015.04.006; Tantia JF, 2012, AM J DANCE THER, V34, P53, DOI 10.1007/s10465-012-9131-0; The National Intrepid Center of Excellence, 2016, NAT INTR CTR EXC HOP; The National Intrepid Center of Excellence, 2017, MISS VIS GUID PRINC; Todres L, 2007, EMBODIED ENQUIRY: PHENOMENOLOGICAL TOUCHSTONES FOR RESEARCH, PSYCHOTHERAPY AND SPIRITUALITY, P1, DOI 10.1057/9780230598850; Winters AF, 2008, AM J DANCE THER, V30, P84, DOI 10.1007/s10465-008-9054-y; Yin R., 1994, CASE STUDY RES DESIG, V2; [No title captured]	34	3	3	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2019	62				SI		52	60		10.1016/j.aip.2018.11.010			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IG5IR	WOS:000473837200010					2022-02-06	
J	Fragata, I; Alves, M; Papoila, AL; Ferreira, P; Nunes, AP; Moreira, NC; Canhao, P				Fragata, Isabel; Alves, Marta; Papoila, Ana Luisa; Ferreira, Patricia; Nunes, Ana Paiva; Moreira, Nuno Canto; Canhao, Patricia			Prediction of clinical outcome in subacute subarachnoid hemorrhage using diffusion tensor imaging	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; diffusion tensor imaging; clinical outcome; vascular disorders	TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; CEREBRAL VASOSPASM; WHITE-MATTER; BLOOD; ISCHEMIA; IMPACT; EDEMA; RISK; TIME	OBJECTIVE Clinical outcome in nontraumatic subarachnoid hemorrhage (SAH) is multifactorial and difficult to predict. Diffusion tensor imaging (DTI) findings are a prognostic marker in some diseases such as traumatic brain injury. The authors hypothesized that DTI parameters measured in the subacute phase of SAH can be associated with a poor clinical outcome. METHODS Diffusion tensor imaging was prospectively performed in 54 patients at 8-10 days after nontraumatic SAH. Logistic regression analysis was performed to evaluate the association of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values with a poor clinical outcome (modified Rankin Scale score >= 3) at 3 months. RESULTS At 8-10 days post-SAH, after adjusting for other variables associated with a poor outcome, an increased ADC at the frontal centrum semiovale was associated with a poor prognosis (OR estimate 1.29, 95% CI 1.04-1.60, p = 0.020). Moreover, an increase of 0.1 in the FA value at the corpus callosum at 8-10 days after SAH corresponded to 66% lower odds of having a poor outcome (p = 0.002). CONCLUSIONS Decreased FA and increased ADC values in specific brain regions were independently associated with a poor clinical outcome after SAH. This preliminary exploratory study supports a potential role for DTI in predicting the outcome of SAH.	[Fragata, Isabel] Ctr Hosp Lisboa Cent, Neuroradiol Dept, Lisbon, Portugal; [Alves, Marta; Papoila, Ana Luisa] Ctr Hosp Lisboa Cent, Ctr Invest, Lisbon, Portugal; [Ferreira, Patricia; Nunes, Ana Paiva] Ctr Hosp Lisboa Cent, Cerebrovasc Unit, Lisbon, Portugal; [Papoila, Ana Luisa] Univ Nova Lisboa, Fac Ciencias Med, Biostat Dept, Lisbon, Portugal; [Fragata, Isabel] Univ Nova Lisboa, Fac Ciencias Med, Nova Med Sch, Lisbon, Portugal; [Canhao, Patricia] Ctr Hosp Lisboa Norte, Neurol Dept, Lisbon, Portugal; [Canhao, Patricia] Univ Lisbon, Fac Med, Lisbon, Portugal; [Moreira, Nuno Canto] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden		Fragata, I (corresponding author), Ctr Hosp Lisboa Cent, Lisbon, Portugal.	isabelfragata@gmail.com	Alves, Marta MA/P-2486-2016; Nunes, Ana Paiva/A-5086-2012; Fragata, Isabel/AAB-5687-2022; Papoila, Ana/S-2164-2019	Alves, Marta MA/0000-0002-7421-8550; Papoila, Ana/0000-0002-2918-8364; Fragata, Isabel/0000-0002-7037-7458; Paiva Nunes, Ana/0000-0002-5573-1551	Sociedade Portuguesa de AVC/Tecnifar	Dr. Fragata was supported by a grant from the Sociedade Portuguesa de AVC/Tecnifar.	Bendel P, 2010, AM J NEURORADIOL, V31, P370, DOI 10.3174/ajnr.A1804; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Condette-Auliac S, 2001, STROKE, V32, P1818, DOI 10.1161/01.STR.32.8.1818; De Marchis GM, 2015, NEUROCRIT CARE, V22, P74, DOI 10.1007/s12028-014-0008-6; DRAKE CG, 1988, J NEUROSURG, V68, P985; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fragata I, 2017, STROKE, V48, P2091, DOI 10.1161/STROKEAHA.117.016811; Fragata I, 2017, NEURORADIOLOGY, V59, P13, DOI 10.1007/s00234-016-1774-y; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Frontera JA, 2015, J NEUROL NEUROSUR PS, V86, P71, DOI 10.1136/jnnp-2013-307313; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Germano A, 2000, ACTA NEUROCHIR, V142, P575, DOI 10.1007/s007010050472; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Helbok R, 2013, J NEUROL NEUROSUR PS, V84, P266, DOI 10.1136/jnnp-2012-302804; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; KISTLER JP, 1983, NEUROLOGY, V33, P424, DOI 10.1212/WNL.33.4.424; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Liu YW, 2007, RADIOLOGY, V242, P518, DOI 10.1148/radiol.2422051698; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nitkunan A, 2008, STROKE, V39, P1999, DOI 10.1161/STROKEAHA.107.507475; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; TEASDALE G, 1974, LANCET, V2, P81; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wartenberg KE, 2011, NEUROCRIT CARE, V14, P407, DOI 10.1007/s12028-010-9488-1; Weimer JM, 2017, AM J NEURORADIOL, V38, P928, DOI 10.3174/ajnr.A5181; Witsch J, 2016, ANN NEUROL, V80, P46, DOI 10.1002/ana.24675; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	40	3	3	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2019	130	2					550	558		10.3171/2017.10.JNS171793			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HO6AP	WOS:000461011200025	29652228	Bronze			2022-02-06	
J	Franz, HM; Corbo, V; Fonda, JR; Levin, LK; Milberg, WP; McGlinchey, RE				Franz, Hannah M.; Corbo, Vincent; Fonda, Jennifer R.; Levin, Laura K.; Milberg, William P.; McGlinchey, Regina E.			The Impact of Interpersonal Early Life Trauma on Cardio-Metabolic Health in Post-9/11 Veterans	HEALTH PSYCHOLOGY			English	Article						PTSD; MetS; veterans; childhood trauma; triglycerides	POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD TRAUMA; CARDIOVASCULAR-DISEASE; HEART-DISEASE; SEXUAL-ABUSE; RISK-FACTOR; MALTREATMENT; DEPRESSION; NEUROBIOLOGY; PSYCHOPATHOLOGY	Objective: This study examined the impact of early life trauma (ELT) on cardio-metabolic health in veterans from post-9/11 conflicts who experience significant stress from deployment and reintegration. Method: Three hundred thirty-seven veterans from the Translational Research Center for Traumatic Brain Injury and Stress Disorders study underwent physiological assessments, including blood pressure and waist circumference. Fasting blood samples were collected to measure metabolic syndrome (MetS; cholesterol/triglycerides/glucose). ELT history was determined using the Traumatic Life Events Questionnaire. Posttraumatic stress disorder (PTSD) symptoms were assessed using the Clinician-Administered PTSD Scale. Logistic regression models examined the association of ELT and MetS diagnostic criteria while controlling for confounders. Results: The adjusted logistic regression showed a significant relationship between interpersonal ELT (IP ELT) and risk of MetS, with IP ELT having an approximately 3-fold increase in the risk of cardio-metabolic syndrome compared with those with no trauma (odds ratio [OR] = 3.06, p < .05). IP ELT was associated with over a 2-fold increased risk of elevated triglycerides compared with those with no trauma (OR = 2.06, p < .05). PTSD symptoms also explained in part the IP-ELT/MetS relationship. Veterans with any ELT were significantly more likely to meet for a current diagnosis of PTSD. Conclusions: Our findings suggest that veterans with IP ELT are more likely to meet MetS and PTSD diagnostic criteria than veterans without IP ELT. This is concerning considering the young age of the sample and stresses the importance of an integrated and holistic approach in the assessment of physical and mental health in returning veterans.	[Franz, Hannah M.; Corbo, Vincent; Fonda, Jennifer R.; Levin, Laura K.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, 11D-132,150 South Huntington Ave,Jamaica Plain, Boston, MA 02130 USA; [Corbo, Vincent] Southern New Hampshire Univ, Dept Psychol, Manchester, NH USA; [Fonda, Jennifer R.; Milberg, William P.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Fonda, Jennifer R.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		McGlinchey, RE (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, 11D-132,150 South Huntington Ave,Jamaica Plain, Boston, MA 02130 USA.	Regina_McGlinchey@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021	Fonda, Jennifer R./0000-0001-9482-2918; McGlinchey, Regina/0000-0003-4809-1194	U.S. Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center [B9254-C]; Veterans AffairsUS Department of Veterans Affairs [I50RX003001, I01CX001327] Funding Source: NIH RePORTER	This research was supported by the U.S. Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center (B9254-C). All procedures were approved by the VA Boston Healthcare System Institutional Review Board and Research and Development Committee.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Amstadter Ananda B, 2008, J Aggress Maltreat Trauma, V16, P391; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Brown GR, 2005, J AFFECT DISORDERS, V89, P57, DOI 10.1016/j.jad.2005.06.012; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Corbo V, 2016, J PSYCHIATR RES, V79, P70, DOI 10.1016/j.jpsychires.2016.05.001; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dortland AKBV, 2012, PROG NEURO-PSYCHOPH, V36, P85, DOI 10.1016/j.pnpbp.2011.10.001; Ehring T, 2010, BEHAV THER, V41, P587, DOI 10.1016/j.beth.2010.04.004; Fortenbaugh FC, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.684; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Heppner PS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-1; Hudson JI, 2010, AM J CLIN NUTR, V91, P1568, DOI 10.3945/ajcn.2010.29203; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lee C, 2014, SOC SCI MED, V105, P122, DOI 10.1016/j.socscimed.2014.01.017; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McLaughlin Katie A, 2010, Depress Anxiety, V27, P1087, DOI 10.1002/da.20762; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Pickering TG, 2005, HYPERTENSION, V45, P142, DOI 10.1161/01.HYP.0000150859.47929.8e; Purnell JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE351, DOI 10.1152/ajpendo.90769.2008; Rasmusson AM, 2010, EXP BIOL MED, V235, P1150, DOI 10.1258/ebm.2010.009334; Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007; Roy A, 2010, PSYCHOSOM MED, V72, P833, DOI 10.1097/PSY.0b013e3181eafc2d; Sachs-Ericsson N, 2010, AGING MENT HEALTH, V14, P489, DOI 10.1080/13607860903191382; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Slagter SN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-195; Stevens J. S., 2016, BEHAV NEUROBIOLOGY P, V38; Tarullo AR, 2006, HORM BEHAV, V50, P632, DOI 10.1016/j.yhbeh.2006.06.010; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; van der Kolk BA, 2003, CHILD ADOL PSYCH CL, V12, P293, DOI 10.1016/S1056-4993(03)00003-8; van Rooij SJH, 2017, SOC NEUROSCI-UK, V12, P22, DOI 10.1080/17470919.2016.1164244; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023	55	3	3	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	FEB	2019	38	2					113	121		10.1037/hea0000706			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HH8KW	WOS:000455981900002	30652910	Green Accepted, Bronze			2022-02-06	
J	Jang, SH; Seo, YS				Jang, Sung Ho; Seo, You Sung			Headache due to spinothalamic tract injury in patients with mild traumatic brain injury: Two case reports	MEDICINE			English	Article						central pain; diffusion tensor imaging; mild traumatic brain injury; spinothalamic tract	AXONAL INJURY; PATHOPHYSIOLOGY	Rationale:Headache is the most common physical complaint reported by the following traumatic brain injury (TBI). Several studies using diffusion tensor tractography (DTT) have demonstrated that injury of the spinothalamic tract (STT) is a pathogenetic mechanism of central pain following TBI. However, no study of headache due to injury of the STT has been reported.Patient concerns:Patient 1 was a 52-year-old female who suffered head trauma resulting from an in-car traffic crash. While sitting in a passenger seat in a moving vehicle, another vehicle suddenly hit the car from the right side. Her head hit the door and she suffered a flexion-hyperextension-rotation injury. She began to feel headaches in both fronto-parieto-occipital areas approximately 2weeks after the crash. The characteristics and severity of pain were as follows: constant tingling and intermittent stabbing pain without allodynia or hyperalgesia (visual analogue scale score: 7). Patient 2 was a 50-year-old male who suffered head trauma from a flexion-hyperextension injury that occurred after being hit from behind by a vehicle while driving his car. He began to feel headache in both fronto-parieto-occipital areas the day after the crash: constant tingling pain without allodynia or hyperalgesia (visual analogue scale score: 6).Diagnoses:The patient 1 was diagnosed as mild TBI due to head flexion-hyperextension-rotation injury. The patient 2 was diagnosed as mild TBI due to head flexion-hyperextension injury.Interventions:Clinical assessment and DTT were performed at 5months (patient 1) and 10months (patient 2) after the initial injury.Outcomes:On DTTs of patient 1 and 2, the STTs showed narrowing in both hemispheres. In addition, discontinuations at the subcortical white matter were observed in both hemispheres in patient 2.Lessons:Headache due to injury of the STT was diagnosed in patients with mild TBI. Precise diagnosis of central pain from other types of pain is clinically important because the management of central pain is quite different from those for other types of pain. Our results suggest that headache might be ascribed to the injury of the STT in patients with mild TBI. Therefore, we recommend evaluation of the STT using DTT in patients with mild TBI who complain of headache having the characteristics of neuropathic pain.	[Jang, Sung Ho; Seo, You Sung] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea		Seo, YS (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea.	yousung1008@daum.net			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2018R1A2B6000996]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (No. 2018R1A2B6000996).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Jang SH, 2014, SOMATOSENS MOT RES, V31, P7, DOI 10.3109/08990220.2013.813843; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Miller M D, 1993, Fam Pract Res J, V13, P15; Nathan D, 2013, BRAIN INJURY MED, P932; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051	18	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2019	98	6							e14306	10.1097/MD.0000000000014306			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ6ZR	WOS:000462569300030	30732149	gold, Green Published			2022-02-06	
J	Kane, AW; Diaz, DS; Moore, C				Kane, Ashley W.; Diaz, Deborah S.; Moore, Carolyn			Physical Therapy Management of Adults with Mild Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						postconcussion syndrome; postural instability; gaze stability; benign paroxysmal positional vertigo; cervicogenic dizziness; graduated exertion	CONCUSSION ASSESSMENT; HIGH-SCHOOL; REHABILITATION; RELIABILITY; DIZZINESS; IMPAIRMENT; RETURN	Rehabilitation for individuals after mild traumatic brain injury (mTBI) or concussion requires emphasis on both cognitive and physical rest, with a gradual return to activity including sports. As the client becomes more active, the rehabilitation professional should pay close attention to symptoms associated with mTBI, such as headache, dizziness, nausea, and difficulty concentrating. The systematic approach to return to play provided by the Berlin Consensus Statement on Concussion in Sport can apply to adults with mTBI. This protocol calls for gradually increasing the intensity of physical activity while attending to postconcussion symptoms. During the incident that led to an mTBI, the injured individual may incur injuries to the vestibular and balance system that are best addressed by professionals with specific training in vestibular rehabilitation, most commonly physical therapists. Benign paroxysmal positional vertigo is a condition in which otoconia particles in the inner ear dislodge into the semicircular canals, resulting in severe vertigo and imbalance. This condition frequently resolves in a few sessions with a vestibular physical therapist. In conditions such as gaze instability, motion sensitivity, impaired postural control, and cervicogenic dizziness, improvement is more gradual and requires longer follow-up with a physical therapist and a home exercise program. In all of the above-stated conditions, it is essential to consider that a patient with protracted symptoms of mTBI or postconcussion syndrome will recover more slowly than others and should be monitored for symptoms throughout the intervention.	[Kane, Ashley W.] Augusta Hlth, Outpatient Phys Therapy Dept, POB 1000,107 Med Ctr Circle, Fishersville, VA 22939 USA; [Diaz, Deborah S.; Moore, Carolyn] Mary Baldwin Univ, Phys Therapy Program, Staunton, VA USA		Kane, AW (corresponding author), Augusta Hlth, Outpatient Phys Therapy Dept, POB 1000,107 Med Ctr Circle, Fishersville, VA 22939 USA.	ashleywkane@gmail.com					Adams J, 2017, PHYSIOTHER CAN, V69, P249, DOI [10.3138/ptc.2015-81ep, 10.3138/ptc.2015-81EP]; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control, 2015, NAT CTR INJ PREV CON; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Danna-Dos-Santos A, 2018, SCI REP, V8, P1; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Foushee JP, 2017, RADIOL TECHNOL, V89, P83; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Journal of Neurosurgery Publishing Group, 2018, SCIENCEDAILY; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Klatt BN, 2015, PHYS MED REHABIL INT, V2, P4; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morris L, 2014, VESTIBULAR REHABILIT, p[511, 517]; National Institute of Neurological Disorders and Stroke (NINDS), TRAUM BRAIN INJ HOP; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Reiley A. S., 2017, ARCH PHYSIOTHER, V7, P12, DOI DOI 10.1180/S40945-017-0040-X; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598	39	3	3	1	15	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2019	40	1					36	47		10.1055/s-0038-1676652			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HG5OT	WOS:000455027900005	30616293				2022-02-06	
J	Kowalski, RG; Weintraub, AH; Rubin, BA; Gerber, DJ; Olsen, AJ				Kowalski, Robert G.; Weintraub, Alan H.; Rubin, Benjamin A.; Gerber, Donald J.; Olsen, Andrew J.			Impact of timing of ventriculoperitoneal shunt placement on outcome in posttraumatic hydrocephalus	JOURNAL OF NEUROSURGERY			English	Article						posttraumatic hydrocephalus; traumatic brain injury; ventriculoperitoneal shunt	NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; VENTRICULAR SIZE; RISK-FACTORS; EVANS INDEX; REHABILITATION; IMPLANTATION; CRANIOPLASTY; ORIENTATION	OBJECTIVE Posttraumatic hydrocephalus (PTH) is a frequent sequela of traumatic brain injury (TBI) and complication of related cranial surgery. The roles of PTH and the timing of cerebrospinal fluid (CSF) shunt placement in TBI outcome have not been well described. The goal of this study was to assess the impact of hydrocephalus and timing of ventriculoperitoneal (VP) shunt placement on outcome during inpatient rehabilitation after TBI. METHODS In this cohort study, all TBI patients admitted to Craig Hospital between 2009 and 2013 were evaluated for PTH, defined as ventriculomegaly, and hydrocephalus symptoms, delayed or deteriorating recovery, or elevated opening pressure on lumbar puncture. Extent of ventriculomegaly was quantified by the Evans index from CT scans. Outcome measures were emergence from and duration of posttraumatic amnesia (PTA) and functional status as assessed by means of the Functional Independence Measure (FIM). Findings in this group were compared to findings in a group of TBI patients without PTH (controls) who were admitted for inpatient rehabilitation during the same study period and met specific criteria for inclusion. RESULTS A total of 701 patients were admitted with TBI during the study period. Of these patients, 59 (8%) were diagnosed with PTH and were included in this study as the PTH group, and 204 who were admitted for rehabilitation and met the criteria for inclusion as controls constituted the comparison group (no-PTH group). PTH was associated with initial postinjury failure to follow commands, midline shift or cistern compression, subcortical contusion, and craniotomy or craniectomy. In multivariable analyses, independent predictors of longer PTA duration and lower FIM score at rehabilitation discharge were PTH, emergency department Glasgow Coma Scale motor score < 6, and longer time from injury to rehabilitation admission. PTH accounted for a 51-day increase in PTA duration and a 29-point reduction in discharge FIM score. In 40% of PTH patients with preshunt CT brain imaging analyzed, ventriculomegaly (Evans index > 0.3) was observed 3 or more days before VP shunt placement (median 10 days, range 3-102 days). Among PTH patients who received a VP shunt, earlier placement was associated with better outcome by all measures assessed and independently predicted better FIM total score and shorter PTA duration. CONCLUSIONS Posttraumatic hydrocephalus predicts worse outcome during inpatient rehabilitation, with poorer functional outcomes and longer duration of PTA. In shunt-treated PTH patients, earlier CSF shunting predicted improved recovery. These results suggest that clinical vigilance for PTH onset and additional studies on timing of CSF diversion are warranted.	[Kowalski, Robert G.; Weintraub, Alan H.; Gerber, Donald J.] Craig Hosp, Res Dept, Englewood, CO USA; [Kowalski, Robert G.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Weintraub, Alan H.] CNS Med Grp, Englewood, CO USA; [Rubin, Benjamin A.] Colorado Brain & Spine Inst, Englewood, CO USA; [Olsen, Andrew J.] Radiol Imaging Associates, Englewood, CO USA		Kowalski, RG (corresponding author), Univ Colorado, Sch Med, Aurora, CO 80045 USA.	robert.g.kowalski@ucdenver.edu			Craig Hospital; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) research grant; Rocky Mountain Regional Brain Injury System [90DP0034-01-00]	This work was supported by Craig Hospital; a National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) research grant; and the Rocky Mountain Regional Brain Injury System (grant no. 90DP0034-01-00).	Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; FLEISCHER AS, 1988, ANN EMERG MED, V17, P165, DOI 10.1016/S0196-0644(88)80305-6; Guyot LL, 2000, NEUROL RES, V22, P25; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kwon HG, 2012, EUR NEUROL, V67, P63, DOI 10.1159/000334729; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lesniak MS, 2002, BRIT J NEUROSURG, V16, P555; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li G, 2008, BRAIN INJURY, V22, P333, DOI 10.1080/02699050801958353; Licata C, 2001, J Neurosurg Sci, V45, P141; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Sim J, 2005, PHYS THER, V85, P257; SYNEK V, 1976, NEUROLOGY, V26, P231, DOI 10.1212/WNL.26.3.231; Tarnaris A, 2009, J NEUROSURG, V110, P837, DOI 10.3171/2007.9.17572; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Toma AK, 2011, NEUROSURGERY, V68, P939, DOI 10.1227/NEU.0b013e318208f5e0; Tribl G, 2000, BRAIN INJURY, V14, P345; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wee HY, 2014, INT MED CASE REP J, V7, P67, DOI 10.2147/IMCRJ.S59410; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265	40	3	3	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2019	130	2					406	417		10.3171/2017.7.JNS17555			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	HO6AP	WOS:000461011200009		Bronze			2022-02-06	
J	Nelson, NR; Morbitzer, KA; Jordan, JD; Rhoney, DH				Nelson, Nicholas R.; Morbitzer, Kathryn A.; Jordan, J. Dedrick; Rhoney, Denise H.			The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Vancomycin; Creatinine clearance; Pharmacokinetics; Traumatic brain injury; Infection	AUGMENTED RENAL CLEARANCE; PHARMACOKINETIC PARAMETERS; ACCURACY	BackgroundTraumatic brain injury (TBI) is associated with secondary complications, including infection, and patients with TBI often exhibit augmented renal clearance (ARC). This phenomenon has been associated with subtherapeutic levels of renally cleared drugs such as vancomycin, which is dosed based on body weight and creatinine clearance (CrCl). Many clinicians, however, cap CrCl at 120mL/min/1.73m(2) when calculating vancomycin dosing regimens. We hypothesize that capping patient CrCl, as opposed to utilizing the non-capped CrCl, when determining vancomycin dosing schemes results in subtherapeutic serum trough concentrations in patients with TBI.MethodsThis was a retrospective study of adult patients with TBI admitted between April 2014 and December 2015 who received vancomycin. Population-based pharmacokinetic (PK) parameters using non-capped calculated CrCl and capped CrCl were compared with patient-specific PK parameters based on serum trough concentrations.ResultsThirty-two patients with TBI were included in the study. ARC was suspected in 24 (75%) patients due to a median estimated CrCl at serum trough concentration of 167.3 (127.7-197.7) mL/min. The mean dosing regimen was 17.1 (13.2-19.2) mg/kg every 8 (8-8) h. There was no difference between the median measured trough concentration and predicted value using non-capped CrCl [10.4 (7.1-15.0) vs. 11.5 (7.8-13.7) mcg/mL; p=0.7986]. The median measured trough concentration was significantly lower than the predicted trough concentration when calculated based on capping the CrCl at 120mL/min/1.73m(2) [16.3 (15.3-22.0) vs. 11.5 (7.8-13.7) mcg/mL; p<0.0001].ConclusionsPatients with traumatic brain injury appeared to exhibit augmented renal clearance, leading to subtherapeutic vancomycin serum trough concentrations when doses were calculated using the traditional method of capping creatinine clearance at 120mL/min/1.73m(2). Instead, utilizing patients' non-capped creatinine clearance when determining a vancomycin dosing regimen is more accurate and provides a better estimation of vancomycin pharmacokinetics and could be applied to other renally excreted medications.	[Nelson, Nicholas R.; Morbitzer, Kathryn A.; Rhoney, Denise H.] Univ N Carolina, Div Practice Adv & Clin Educ, Eshelman Sch Pharm, 115 Beard Hall,Campus Box 7574, Chapel Hill, NC 27599 USA; [Jordan, J. Dedrick] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27514 USA		Rhoney, DH (corresponding author), Univ N Carolina, Div Practice Adv & Clin Educ, Eshelman Sch Pharm, 115 Beard Hall,Campus Box 7574, Chapel Hill, NC 27599 USA.	drhoney@unc.edu		Jordan, Dedrick/0000-0002-0706-9583; Nelson, Nicholas/0000-0002-5503-4043			Ambrose P, 2004, WINTER MES BASIC CLI, P451; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carrie C, 2018, ANAESTH CRIT CARE PA, V37, P35, DOI 10.1016/j.accpm.2017.06.006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Dooley MJ, 2004, BRIT J CANCER, V90, P991, DOI 10.1038/sj.bjc.6601641; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Evidence-based Medicine Consult, AD CREAT CLEAR CRCL; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Llopis-Salvia P, 2006, J CLIN PHARM THER, V31, P447, DOI 10.1111/j.1365-2710.2006.00762.x; MATZKE GR, 1984, ANTIMICROB AGENTS CH, V25, P433, DOI 10.1128/AAC.25.4.433; McAuley D, GLOBALRPH; Michaud L, 2010, HEMONC TODAY; Morbitzer KA, 2015, NEUROCRIT CARE, V22, P258, DOI 10.1007/s12028-014-0079-4; Oswalt A, 2017, J PHARM PRACT; SAWYER WT, 1983, AM J HOSP PHARM, V40, P2175, DOI 10.1093/ajhp/40.12.2175; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Wilhelm SM, 2011, PHARMACOTHERAPY, V31, P658, DOI 10.1592/phco.31.7.658; Winter MA, 2012, PHARMACOTHERAPY, V32, P604, DOI 10.1002/j.1875-9114.2012.01098.x; Wurtz R, 1997, CLIN INFECT DIS, V25, P112, DOI 10.1086/514505	26	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					126	131		10.1007/s12028-018-0583-z			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700015	30051194				2022-02-06	
J	Ning, YL; Yang, N; Chen, X; Tian, HK; Zhao, ZA; Zhang, XZ; Liu, D; Li, P; Zhao, Y; Peng, Y; Wang, ZG; Chen, JF; Zhou, YG				Ning, Ya-Lei; Yang, Nan; Chen, Xing; Tian, Hua-Ke; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Liu, Dong; Li, Ping; Zhao, Yan; Peng, Yan; Wang, Zheng-Guo; Chen, Jiang-Fan; Zhou, Yuan-Guo			Caffeine attenuates brain injury but increases mortality induced by high-intensity blast wave exposure	TOXICOLOGY LETTERS			English	Article						Caffeine; Mortality; Blast-induced traumatic brain injury; Major trauma; Severe blast injury; Lung injury	LUNG INJURY; SHOCK-TUBES; COFFEE; CONSUMPTION; DAMAGE; HEALTH; MOUSE; MODEL; MICE	Caffeine is a substance that is consumed worldwide, and it may exert neuroprotective effects against various cerebral insults, including neurotrauma, which is the most prevalent injury among military personnel. To investigate the effects of caffeine on high-intensity blast wave-induced severe blast injury in mice, three different paradigms of caffeine were applied to male C57BL/6 mice with severe whole body blast injury (WBBI). The results demonstrated that chronic caffeine treatment alleviated blast-induced traumatic brain injury (bTBI); however, both chronic and acute caffeine treatments exacerbated blast-induced lung injuries and, more importantly, increased both the cumulative and time-segmented mortalities postinjury. Interestingly, withdrawing caffeine intake preinjury resulted in favorable outcomes in mortality and lung injury, similar to the findings in water-treated mice, and had the trend to attenuate brain injury. These findings demonstrated that although drinking coffee or caffeine preparations attenuated blast-induced brain trauma, these beverages may place personnel in the battlefield at high risk of casualties, which will help us re-evaluate the therapeutic strategy of caffeine application, particularly in multiple-organ-trauma settings. Furthermore, these findings provided possible strategies for reducing the risk of casualties with caffeine consumption, which may help to change the coffee-drinking habits of military personnel.	[Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Li, Ping; Zhao, Yan; Peng, Yan; Zhou, Yuan-Guo] Army Med Univ, Res Inst Surg, Mol Biol Ctr, Chongqing 400042, Peoples R China; [Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Liu, Dong; Li, Ping; Zhao, Yan; Peng, Yan; Wang, Zheng-Guo; Zhou, Yuan-Guo] Army Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Ning, Ya-Lei; Li, Ping; Zhao, Yan; Wang, Zheng-Guo; Zhou, Yuan-Guo] Army Med Univ, State Key Lab Trauma Burn & Combined Injury, Chongqing 400038, Peoples R China; [Ning, Ya-Lei; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo] Army Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing 400038, Peoples R China; [Tian, Hua-Ke] PLA 324 Hosp, Dept Trauma & Microsurg, Chongqing 400020, Peoples R China; [Zhang, Xiu-Zhu; Liu, Dong] Army Med Univ, Res Inst Surg, Trauma Ctr, Chongqing 400042, Peoples R China; [Wang, Zheng-Guo] Army Med Univ, Res Inst Surg, Dept 4, Chongqing 400042, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Army Med Univ, Res Inst Surg, Mol Biol Ctr, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Army Med Univ, Daping Hosp, Chongqing 400042, Peoples R China.	ygzhou@tmmu.edu.cn		Li, Ping/0000-0002-4926-3835	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571888]; Foundational and Cuttingedge Research Plan of Chongqing [cstc2014jcyjA10072]; Key Project of Medicine Health of PLA [08G098]	This work was supported by the National Natural Science Foundation of China (No. 81571888), the Foundational and Cuttingedge Research Plan of Chongqing (No. cstc2014jcyjA10072), and the Key Project of Medicine & Health of PLA (No. 08G098).	Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425; Boison Detlev, 2011, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-13443-2_9; Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Comer A M, 2001, Paediatr Drugs, V3, P61, DOI 10.2165/00128072-200103010-00005; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cunha RA, 2010, J ALZHEIMERS DIS, V20, pS95, DOI 10.3233/JAD-2010-1408; Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341; Donadieu E, 2007, ACTA HISTOCHEM, V109, P177, DOI 10.1016/j.acthis.2007.01.004; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; DVBIC, 2016, DOD TBI WORLDW NUMB; Espinosa J, 2013, J ALZHEIMERS DIS, V34, P509, DOI 10.3233/JAD-111982; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm Bertil B, 2004, Lakartidningen, V101, P2552; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945; Hosny EN, 2019, NUTR NEUROSCI, V22, P789, DOI 10.1080/1028415X.2018.1446812; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Kumral A, 2012, ACTA PAEDIATR, V101, pe299, DOI 10.1111/j.1651-2227.2012.02664.x; Lean MEJ, 2012, MATURITAS, V72, P171, DOI 10.1016/j.maturitas.2012.04.005; Li J, 2011, EUR J PHARMACOL, V654, P295, DOI 10.1016/j.ejphar.2010.12.040; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Ning YL, 2015, CHIN J TRAUMATOL, V18, P204, DOI 10.1016/j.cjtee.2015.10.003; Ning YL, 2015, CHIN J TRAUMATOL, V18, P187, DOI 10.1016/j.cjtee.2015.04.005; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Oboh G, 2017, METAB BRAIN DIS, V32, P629, DOI 10.1007/s11011-017-9951-1; Ohta A, 2007, J IMMUNOL, V179, P7431, DOI 10.4049/jimmunol.179.11.7431; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Souza MA, 2013, NEUROCHEM INT, V62, P821, DOI 10.1016/j.neuint.2013.02.021; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109; Zhao Y, 2015, CHIN J TRAUMATOL, V18, P201, DOI 10.1016/j.cjtee.2015.10.002; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98	57	3	4	1	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-4274	1879-3169		TOXICOL LETT	Toxicol. Lett.	FEB	2019	301						90	97		10.1016/j.toxlet.2018.11.004			8	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	HD9JW	WOS:000452879300011	30423366				2022-02-06	
J	Polis, B; Polis, L; Nowoslawska, E				Polis, Bartosz; Polis, Lech; Nowoslawska, Emilia			Surgical treatment of post-inflammatory hydrocephalus. Analysis of 101 cases	CHILDS NERVOUS SYSTEM			English	Article						Hydrocephalus; Post-inflammatory; Multiloculated; Shunt; Neuroendoscopy; NOSIC	TRAUMATIC BRAIN-INJURY; CHILDREN; INFECTIONS; PLACEMENT; INFANTS	ObjectiveThe aim of this paper was to evaluate the outcomes of surgical treatment for post-inflammatory hydrocephalus in pediatric patients. The patient's age, surgical technique and type of implants, revision rate (depending on the cause for revision and shunt type), and final outcome measured with Neurologic Outcome Scale for Infants and Children (NOSIC) scale were evaluated.MethodsWe performed a retrospective analysis of 101 patients with post-inflammatory hydrocephalus, treated in Polish Mother's Memorial Hospital Research Institute since 2005. Children with comorbidities (e.g., tumors or hemorrhages) were excluded from the study. The assessment included patient age, surgical technique (ventriculoperitoneal shunt (VPS) or neuroendoscopy) and type of implant, revision rate (considering its cause), and final outcome measured in Neurologic Outcome Scale for Infants and Children (NOSIC) scale.ResultsVPS implantation was the most common surgical technique. It was performed in 66.33% (n=67) of cases. Neuroendoscopic procedure was used in 33.66% of cases (n=34). Revision rate of VPS was 52.23% (n=35). Endoscopic third ventricle ventriculostomy (ETV) was efficient only in 5 cases (14.7%), whereas in 29 cases (85.3%), it was followed by VPS implantation. Revision rate in VPS implantation after ETV reached 55.17% (n=16). In all age groups, VPS implantation was the most frequently used procedure. Revisions of the shunt systems occurred most frequently in the 1-3 (n=21 41.18%) and <1 (n=12, 23.53%) age ranges. The type of valve that most often underwent dysfunction was flow-regulated type (n=23, 62.16%). The type of valve that was the least frequently revised was differential pressure type (n=11, 17.18%). In all age groups, mechanical dysfunction was the most frequent cause of shunt disability. Average NOSIC score ranged from 39 to 98 (average 80.58, standard deviation 13.34). NOSIC result relative to individual operational techniques was as follows: ETV + VPS80.17 (n=29, standard deviation +/- 11.44), VPS80.44 (n=67, standard deviation +/- 14.30), and ETV80.80 (n=5, standard deviation +/- 11.62). There was no difference between the outcome of the NOSIC and the type of implanted valve or its dysfunction.Conclusions In our analysis, post-inflammatory hydrocephalus accounts for 11.7% of all hydrocephalus types. Of post-inflammatory hydrocephalus, multiloculated type accounts for 14.9%. The most common type of surgery in these patients is implantation of the ventriculoperitoneal system. The most frequent revisions of the VPS system occur in the group of the younger children (<3). The most common type of a dysfunction shunt is the differential pressure valve, and the rarest type the flow-regulated type. In the case of mechanical dysfunction, occlusion of the intraventricular catheter is the most common reason. ETV does not affect the frequency of VPS revisions. The average NOSIC score in children treated with hydrocephalus is below normal, and the best results are observed in the youngest children.	[Polis, Bartosz; Polis, Lech; Nowoslawska, Emilia] Polish Mothers Mem Hosp Res Inst, Dept Neurosurg & Neurotraumatol, 281-289 Rzgowska St, PL-93338 Lodz, Poland		Polis, B (corresponding author), Polish Mothers Mem Hosp Res Inst, Dept Neurosurg & Neurotraumatol, 281-289 Rzgowska St, PL-93338 Lodz, Poland.	jezza@post.pl		Nowoslawska, Emilia/0000-0002-2024-8906	National Science Grant [N N403 2424 40]	The work was funded by The National Science Grant No. N N403 2424 40.	Algin O, 2013, AM J NEURORADIOL, V34, P14, DOI 10.3174/ajnr.A2899; AMACHER AL, 1984, CHILD BRAIN, V11, P217; AMMIRATI M, 1987, CHILD NERV SYST, V3, P106, DOI 10.1007/BF00271135; Barszcz S, 1991, SURG CHILD INT, V5, P211; Bech RA, 1999, CHILD NERV SYST, V15, P213, DOI 10.1007/s003810050374; Bonetti MG, 2006, EMERGENCY NEURORADIOLOGY, P195, DOI 10.1007/3-540-29941-6_15; BROOKSHIRE BL, 1995, J PEDIATR PSYCHOL, V20, P785, DOI 10.1093/jpepsy/20.6.785; Candy AI, 1995, OPERATIVE NEUROSURGI; Chang CJ, 2004, BRAIN DEV-JPN, V26, P168, DOI 10.1016/S0387-7604(03)00122-0; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875; COHEN AR, 1993, PEDIATR NEUROSURG, V19, P127, DOI 10.1159/000120717; DAMATO RC, 1994, PERCEPT MOTOR SKILL, V78, P701, DOI 10.2466/pms.1994.78.2.701; DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P593, DOI 10.1080/01688638708410771; DONDERS J, 1992, J CLIN PSYCHOL, V48, P364, DOI 10.1002/1097-4679(199205)48:3<364::AID-JCLP2270480315>3.0.CO;2-A; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; HANDLER LC, 1978, NEURORADIOLOGY, V16, P31, DOI 10.1007/BF00395195; Hingwala Divyata, 2011, Indian J Radiol Imaging, V21, P90, DOI 10.4103/0971-3026.82283; HIRSCH JF, 1994, CHILD NERV SYST, V10, P64, DOI 10.1007/BF00313587; Hodel J, 2013, WORLD NEUROSURG S, V79; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; RAIMONDI AJ, 1974, AM J DIS CHILD, V127, P664, DOI 10.1001/archpedi.1974.02110240050005; Rekate HL, 2012, ACTA NEUROCHIR SUPPL, V113, P1, DOI 10.1007/978-3-7091-0923-6_1; Rekate HL, 2001, PEDIAT NEUROSURGERY, P457; RIVA D, 1994, CHILD NERV SYST, V10, P70, DOI 10.1007/BF00313588; Squier MV, 1997, J CLIN PATHOL, V50, P181, DOI 10.1136/jcp.50.3.181; Sverre M, 2017, PEDIATR NEUROL, V73, P36, DOI [10.1016/j.pediatrneurol.2017.04.018, DOI 10.1016/J.PEDIATRNEUROL.2017.04.018]; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Wong GKC, 2010, J NEUROL NEUROSUR PS, V81, P1064, DOI 10.1136/jnnp.2009.198523; Zahl SM, 2008, PEDIATRICS, V121, pE416, DOI 10.1542/peds.2007-1598; ZEINER HK, 1985, CHILD NERV SYST, V1, P115, DOI 10.1007/BF00706692	34	3	3	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2019	35	2					237	243		10.1007/s00381-018-4022-4			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HJ4HU	WOS:000457135900007	30564912	Green Published, hybrid			2022-02-06	
J	Poritz, JMP; Vos, L; Ngan, E; Leon-Novelo, L; Sherer, M				Poritz, Julia M. P.; Vos, Leia; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			Gender Differences in Employment and Economic Quality of Life Following Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; employment; economic quality of life	OUTCOMES; WOMEN; PARTICIPATION; INDIVIDUALS; IMPACT; RETURN; WORK	Objective: Due to limited systematic research on gender differences in health and quality of life outcomes following traumatic brain injury (TBI), the present study sought to contribute to the growing literature on gender differences in postinjury employment while also adding an examination of postinjury economic quality of life, an emerging area in disability research. Method: Independent variables included demographic and injury characteristics. Outcome variables included postinjury employment and economic quality of life, measured by the Participation Assessment With Recombined Tools-Objective and the Economic QOL, respectively. Hypotheses that women would experience poorer outcomes in postinjury employment and economic quality of life were tested with logistic and linear regression models. Results: Postinjury employment was associated with gender, higher educational attainment, and preinjury employment. Those with greater injury severity and those identifying as Black or African American were less likely to be employed postinjury. For men and women who were unemployed prior to injury, the odds of postinjury employment for men were 184% higher than for women. Men reported significantly greater economic quality of life. Contrary to hypotheses, postinjury employment was inversely related to economic quality of life in the final model. Conclusion: The results suggest that if unemployed prior to injury, women with TBI are less likely to be employed postinjury and also experience decreased economic quality of life postinjury, regardless of employment status. Although further research is needed to determine which strategies will improve economic quality of life for women with TBI, clinicians may utilize these preliminary findings to guide treatment and advocacy efforts. Impact and Implications This study contributes to the literature on gender disparities following traumatic brain injury; provides support for clinical practice, such as career counseling and advocacy; and reinforces preexisting policy proposals for workplace gender equality.	[Poritz, Julia M. P.; Vos, Leia; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Vos, Leia; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Dept Biostat & Data Sci, Sch Publ Hlth, Houston, TX 77030 USA		Poritz, JMP (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	jmporitz@utmb.edu	Vos, Leia/AAJ-8364-2020		National Institute on Disability, Independent Living, and Rehabilitation Research (NI-DILRR) Grants [90RT5007, 90DP0028]	The contents of this article were developed under National Institute on Disability, Independent Living, and Rehabilitation Research (NI-DILRR) Grants 90RT5007 and 90DP0028. NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policies of the NIDILRR, ACL, or HHS, and endorsement by the federal government should not be assumed.	Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Clark E, 2009, ISSUES DIVERS CLIN N, P69, DOI 10.1007/978-0-387-76908-0_4; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Erickson W., 2017, DISABILITY STAT AM C; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; Livermore GA, 2015, J DISABIL POLICY STU, V26, P70, DOI 10.1177/1044207315583875; Lynch JW, 1997, NEW ENGL J MED, V337, P1889, DOI 10.1056/NEJM199712253372606; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, pE17, DOI 10.1097/HTR.0000000000000290; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Tulsky D. S, 2018, IMPROVING MEAS UNPUB; Tulsky DS, 2015, ARCH PHYS MED REHAB, V96, P604, DOI 10.1016/j.apmr.2014.02.030; U. S. Bureau of Labor Statistics, 2015, LAB FORC PART RAT SE; U. S. Bureau of Labor Statistics, 2017, WOM MED EARN 82 PERC; U. S. Department of Defense, 2017, ACT DUT FEM RANK GRA; U. S. Department of Education, 2012, GEND EQ ED; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	29	3	3	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2019	64	1					65	71		10.1037/rep0000234			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	HK5TA	WOS:000458029100006	30346201	Bronze			2022-02-06	
J	Poritz, JMP; Harik, LM; Vos, L; Ngan, E; Leon-Novelo, L; Sherer, M				Poritz, Julia M. P.; Harik, Lindsey M.; Vos, Leia; Ngan, Esther; Leon-Novelo, Luis; Sherer, Mark			Perceived Stigma and Its Association With Participation Following Traumatic Brain Injury	STIGMA AND HEALTH			English	Article						traumatic brain injury; perceived stigma; community participation		Individuals with traumatic brain injury (TBI) may experience stigma in the form of negative attitudes or discriminatory behaviors, which are external actions directed toward the individual with the disability. Awareness of these negative attitudes, behaviors, and stereotypes related to one's condition is known as perceived stigma. Perceived stigma has been shown to be problematic in other populations because of its association with various negative mental and physical health outcomes. However, further research is needed on the factors related to perceived stigma in individuals with TBI as well as its association with community participation. The present study explored the associations of experiential and affective factors with perceived stigma in a sample of 504 individuals with TBI as well as the association of perceived stigma with community participation. Independent variables included experiential factors (preinjury years of education, preinjury occupation) and postinjury affective factors (depression, anxiety); demographic characteristics (age, gender, race/ethnicity) and injury severity served as covariates. Outcome variables included perceived stigma and community participation. Results of structural regression modeling revealed that affective factors were associated with perceived stigma, which was associated with community participation. Affective factors were associated with community participation only when perceived stigma was removed from the model. The findings of this research hold significant treatment implications for individuals with TBI such that modifying evidence-based practices to include consideration of perceived stigma may increase community participation for individuals with TBI.	[Poritz, Julia M. P.; Harik, Lindsey M.; Vos, Leia; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, 1333 Moursund St, Houston, TX 77030 USA; [Harik, Lindsey M.; Vos, Leia; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Ngan, Esther; Leon-Novelo, Luis] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX USA		Poritz, JMP (corresponding author), TIRR Mem Hermann, Brain Injury Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	Julia.Poritz@memorialhermann.org					Ali A, 2016, SOC PSYCH PSYCH EPID, V51, P465, DOI 10.1007/s00127-015-1133-z; Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown Robyn Lewis, 2017, Stigma Health, V2, P98, DOI 10.1037/sah0000042; Brown RL, 2015, RES AGING, V37, P335, DOI 10.1177/0164027514533133; Burgener SC, 2015, DEMENTIA-LONDON, V14, P609, DOI 10.1177/1471301213504202; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Clogg C.C., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Cook JE, 2014, SOC SCI MED, V103, P101, DOI 10.1016/j.socscimed.2013.09.023; Corrigan PW, 2006, J SOC CLIN PSYCHOL, V25, P875, DOI 10.1521/jscp.2006.25.8.875; Curvis W, 2018, NEUROPSYCHOL REHABIL, V28, P527, DOI 10.1080/09602011.2016.1175359; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gonzalez BD, 2012, PSYCHO-ONCOLOGY, V21, P239, DOI 10.1002/pon.1882; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee GH, 2016, EPILEPSY BEHAV, V54, P1, DOI 10.1016/j.yebeh.2015.10.024; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Liu HX, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3486-5; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor Kyrie., 2016, HOUSTON CHRONICLE; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Rafael F, 2010, EPILEPSIA, V51, P1061, DOI 10.1111/j.1528-1167.2009.02511.x; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sehlo MG, 2013, J PSYCHOSOM RES, V74, P248, DOI 10.1016/j.jpsychores.2012.09.023; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SWEENEY PD, 1986, J PERS SOC PSYCHOL, V50, P974, DOI 10.1037/0022-3514.50.5.974; Taft TH, 2014, NEUROGASTROENT MOTIL, V26, P1026, DOI 10.1111/nmo.12357; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilson MH, 2016, LANCET PUBLIC HEALTH, V1, pE44, DOI 10.1016/S2468-2667(16)30022-6	57	3	3	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2376-6972	2376-6964		STIGMA HEALTH	Stigma Health	FEB	2019	4	1					107	115		10.1037/sah0000122			9	Public, Environmental & Occupational Health; Psychology, Social	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health; Psychology	VJ9VW	WOS:000648757000011					2022-02-06	
J	Ritter, KG; Hussey, MJ; McLeod, TCV				Ritter, Katrina G.; Hussey, Matthew J.; McLeod, Tamara C. Valovich			Subsymptomatic Aerobic Exercise for Patients With Postconcussion Syndrome: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						rehabilitation; brain concussion; exercise training; return to play; persistent symptoms	CONCUSSION; ADOLESCENTS; ZURICH; RETURN; SPORT; REST	Clinical Scenario: Patients who experience prolonged concussion symptoms can be diagnosed with postconcussion syndrome (PCS) when those symptoms persist longer than 4 weeks. Aerobic exercise protocols have been shown to be effective in improving physical and mental aspects of health. Emerging research suggests that aerobic exercise may be useful as a treatment for PCS, where exercise allows patients to feel less isolated and more active during the recovery process. Clinical Question: Is aerobic exercise more beneficial in reducing symptoms than current standard care in patients with prolonged symptoms or PCS lasting longer than 4 weeks? Summary of Key Findings: After a thorough literature search. 4 studies relevant to the clinical question were selected. Of the 4 studies, 1 study was a randomized control trial and 3 studies were case series. All 4 studies investigated aerobic exercise protocol as treatment for PCS. Three studies demonstrated a greater rate of symptom improvement from baseline assessment to follow-up after a controlled subsymptomatic aerobic exercise program. One study showed a decrease in symptoms in the aerobic exercise group compared with the full-body stretching group. Clinical Bottom Line: There is moderate evidence to support subsymptomatic aerobic exercise as a treatment of PCS; therefore, it should be considered as a clinical option for reducing PCS and prolonged concussion symptoms. A previously validated protocol, such as the Buffalo Concussion Treadmill test, Balke protocol, or rating of perceived exertion, as mentioned in this critically appraised topic, should be used to measure baseline values and treatment progression. Strength of Recommendation: Level C evidence exists that the aerobic exercise protocol is more effective than the current standard of care in treating PCS.	[Ritter, Katrina G.; Hussey, Matthew J.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA; [Ritter, Katrina G.] AT Still Univ, Arizona Sch Heath Sci, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA		Ritter, KG (corresponding author), AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA.	kritter@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Hogan CL, 2015, PSYCHOL HEALTH, V30, P354, DOI 10.1080/08870446.2014.973410; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; OCEBM Levels of Evidence Working Group, 2011, OXFORD CTR EVIDENCE; Rasmussen L, 2013, PM&R, V5, P924, DOI 10.1016/j.pmrj.2013.06.003; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658	20	3	3	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2019	28	2					211	216		10.1123/jsr.2017-0159			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HI8TK	WOS:000456728600015	28952858	Bronze			2022-02-06	
J	Ross, PT; Lypson, ML				Ross, Paula T.; Lypson, Monica L.			Veteran-centred content in medical education	CLINICAL TEACHER			English	Article							MILITARY	Background Veterans have unique experiences that warrant special consideration in health care. Unfortunately, training in veteran-centred care has not been a clear focus of medical education, and only a very small proportion of medical schools include military cultural competency in their curricula. Methods We conducted an 80-minute focus group with six US veterans. Open-ended questions were used to elicit their perceptions of the health care that they receive, and how it can be improved. The audio-recording was transcribed verbatim and coded for thematic content. A phenomenological analytic approach was used to analyse the 31-page transcript and arrive at the final themes. Results Former service members from various periods of conflict (e.g. World War II, Vietnam, Persian Gulf) offered key insights about how to improve veterans' health care experiences. Veterans suggested that consideration of their previous military service would improve care. They lamented that the lack of military consciousness is a barrier to care. Finally, they suggested that clinicians pay close attention to the transition from service member to civilian, as reintegration to civilian life is a critical life experience. Training in veteran-centred care has not been a clear focus of medical education Discussion Veteran-centred care ensures optimal health care through ease of access to services, and through positive patient-provider interactions. Being aware of military culture can help providers to contextualise veterans' experiences and beliefs about health care seeking and illness management, particularly for invisible wounds of war, including traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD).	[Ross, Paula T.; Lypson, Monica L.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Lypson, Monica L.] Off Acad Affiliat, Dept Vet Affairs Cent Off, Washington, DC USA		Ross, PT (corresponding author), Univ Michigan, Sch Med, Off Med Student Educ, 5100-C3 Taubman Hlth Sci Lib,1135 E Catherine, Ann Arbor, MI 48109 USA.	paulat@umich.edu			University of Michigan Medical School, Graduate Medical Education Innovations Grant	University of Michigan Medical School, Graduate Medical Education Innovations Grant.	Association of American Medical Colleges (AAMC), 2012, SERV THOS WHO SERV A; Austrialian Government Department of Veteran Affairs, 2017, PENS SUMM; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Colaizzi P., 1978, EXISTENTIAL PHENOMEN; Convoy S, 2013, J EMERG NURS, V39, P591, DOI 10.1016/j.jen.2013.08.010; Hamm WG, 2008, YELLOW RIBBONS PROVI; Kumagai AK, 2009, ACAD MED, V84, P782, DOI 10.1097/ACM.0b013e3181a42398; Lee J, 2014, ACAD MED, V89, P1198, DOI 10.1097/ACM.0000000000000367; Lincoln A, 1865, 2 PRESIDENTIAL INAUG; Lypson M, 2016, VETERAN INTERACTIVE; Lypson ML, 2016, INTEGRATING VETERAN, V3, P9; Lypson ML, 2016, ACAD MED, V91, P1379, DOI 10.1097/ACM.0000000000001162; Meyer Eric, 2013, Mil Med, V178, pe848, DOI 10.7205/MILMED-D-13-00027; Ministry of Defence, 2016, ANN POP SURV UK ARM; Ramchand R, 2008, INVISIBLE WOUNDS WAR, P35; Ross Paula T, 2015, J Grad Med Educ, V7, P519, DOI 10.4300/JGME-D-14-00568.1; US Department of Veterans Affairs: National Center for VeteransAnalysis and Statistics, PROF VET 2015 DAT AM; Veteran Affairs Canada, WAR SERV CAN ARM FOR; Veterans Affairs Canada, 2009, COMP OTH COUNTR	19	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-4971	1743-498X		CLIN TEACH	Clin. Teach.	FEB	2019	16	1					53	57		10.1111/tct.12775			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	HJ8JD	WOS:000457443900010	29600591	Green Published			2022-02-06	
J	Ruslin, M; Wolff, J; Yusuf, HY; Arifin, MZ; Boffano, P; Forouzanfar, T				Ruslin, Muhammad; Wolff, Jan; Yusuf, Harmas Yazid; Arifin, Muhammad Zaifullah; Boffano, Paolo; Forouzanfar, Tymour			Use of neuron-specific enolase to predict mild brain injury in motorcycle crash patients with maxillofacial fractures: A pilot study	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Neuron-specific enolase; Serum; Maxillofacial fractures; Mild brain injuries	FACIAL FRACTURES; BIOMARKERS; IDENTIFICATION	Purpose: Mild traumatic brain injury (TBI) is common but accurate diagnosis and its clinical consequences have been a problem. Maxillofacial trauma does have an association with TBI. Neuron-specific enolase (NSE) has been developed to evaluate neuronal damage. The objective of this study was to investigate the accuracy of NSE serum levels to detect mild brain injury of patients with sustained maxillofacial fractures during motor vehicle accidents. Methods: Blood samples were drawn from 40 healthy people (control group) and 48 trauma patients who had sustained isolated maxillofacial fractures and mild brain injury in motor vehicle accidents. Brain injuries were graded by Glasgow Coma Scale. In the trauma group, correlations between the NSE serum value and different facial fracture sites were also assessed. Results: The NSE serum level (mean +/- SD, ng/ml) in the 48 patients with maxillofacial fractures and mild TBI was 13.12 +/- 9.68, significantly higher than that measured in the healthy control group (7.72 +/- 1.82, p < 0.001). The mean NSE serum level (ng/ml) in the lower part of the facial skeleton (15.44 with SD 15.34) was higher than that in the upper facial part (12.42 with SD 7.68); and the mean NSE level (ng/ml) in the middle-and lower part (11.97 with SD 5.63) was higher than in the middle part (7.88 with SD 2.64). Conclusion: An increase in NSE serum levels can be observed in patients sustained maxillofacial fractures and mild brain injury. (C) 2019 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Ruslin, Muhammad] Hasanuddin Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Makassar, Indonesia; [Ruslin, Muhammad; Wolff, Jan; Boffano, Paolo; Forouzanfar, Tymour] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam ACTA, Dept Oral & Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands; [Yusuf, Harmas Yazid] Univ Padjadjaran, Dept Oral & Maxillofacial Surg, Fac Dent, Bandung, Indonesia; [Arifin, Muhammad Zaifullah] Univ Padjadjaran, Fac Med, Dept Neurosurg, Bandung, Indonesia		Ruslin, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	m.ruslin@vumc.nl	Ruslin, M./AAE-3703-2021	Wolff, Jan/0000-0002-6269-4373; Ruslin, Muhammad/0000-0003-0943-4000			Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; Bazarian JJ, 2014, JAMA NEUROL, V71, P925, DOI 10.1001/jamaneurol.2014.1082; Ergun R, 1998, NEUROL RES, V20, P418; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Hayes RL, BIOCH MARKERS BRAIN; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Plaisier BR, 2000, J ORAL MAXIL SURG, V58, P708, DOI 10.1053/joms.2000.7250; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; Shankar AN, 2012, J CRANIO MAXILL SURG, V40, P675, DOI 10.1016/j.jcms.2011.11.004; TEASDALE G, 1974, LANCET, V2, P81; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wu Y. C., 2004, Hong Kong Medical Journal, V10, P251; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	21	3	5	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2019	22	1					47	50		10.1016/j.cjtee.2018.12.004			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	HR3SZ	WOS:000463061200008	30837107	gold, Green Published			2022-02-06	
J	Schellenberg, M; Inaba, K; Chen, J; Bardes, JM; Crow, E; Lam, L; Benjamin, E; Demetriades, D				Schellenberg, Morgan; Inaba, Kenji; Chen, Jessica; Bardes, James M.; Crow, Elizabeth; Lam, Lydia; Benjamin, Elizabeth; Demetriades, Demetrios			Falls in the Bathroom: A Mechanism of Injury for All Ages	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Ground-level falls; Accidental falls; Bathroom falls; Elderly		Background: When ground-level falls occur in the bathroom, there is particular potential for morbidity and mortality given the high density of hard surfaces. Risk factors are not clearly defined by the existing literature. The objective of this study was to define the epidemiology, injury patterns, and outcomes after falls in the bathroom. Materials and methods: All patients presenting to LAC+USC Medical Center (01/2008-05/2015) after a fall in the bathroom (ICD-9 code E884.6) were included. Demographics, injury data, investigations, procedures, and outcomes were collected. Results: Fifty-seven patients were included, with mean age 45 y (range 0-92). All ages were affected, with ages 41-60 y at highest risk. Common comorbidities included cardiovascular disease (n = 23, 40%), neuromuscular disorders (n = 13, 23%), and diabetes (n = 9, 16%). Ten patients (18%) were intoxicated. Home medications included antihypertensives (n = 18, 32%), antipsychotics (n = 9, 16%), and anticoagulants (n = 8, 14%). Common investigations included X-rays (n = 41, 72%) and CT scans of the head (n = 20, 35%). The most frequent injuries were contusion/laceration (n = 45, 79%), fracture (n = 12, 21%), and traumatic brain injury (n = 7, 12%). Most patients did not require hospital admission (n = 46, 81%), although 4 (7%) needed intensive care unit care and operative intervention (ORIF [n = 2, 4%] or craniectomy [n = 2, 4%]). Mortality was low (n = 1, 2%). Most patients were discharged home (n = 40, 70%). Conclusions: All ages, especially 41-60 y, are susceptible to falls in the bathroom. Despite the potential for serious injury, most do not require hospital admission. Risk factors include drugs/alcohol, cardiovascular disease, neuromuscular disorders, and diabetes. Efforts to minimize fall risk should be directed toward these individuals. (C) 2018 Elsevier Inc. All rights reserved.	[Schellenberg, Morgan; Inaba, Kenji; Bardes, James M.; Lam, Lydia; Benjamin, Elizabeth; Demetriades, Demetrios] Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA; [Chen, Jessica] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Crow, Elizabeth] Univ Southern Calif, Dept Emergency Med, LAC USC Med Ctr, Los Angeles, CA 90033 USA		Inaba, K (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	Benjamin, Elizabeth/AAD-2457-2020	Bardes, James/0000-0002-9361-6263; Inaba, Kenji/0000-0002-5191-596X			Abdelrahman H, 2018, J FAM COMMUNITY MED, V25, P48, DOI 10.4103/jfcm.JFCM_148_16; Carling A, 2018, CLIN REHABIL, V32, P526, DOI 10.1177/0269215517730597; DEVITO CA, 1988, J AM GERIATR SOC, V36, P1029, DOI 10.1111/j.1532-5415.1988.tb04371.x; Head EN, 2013, INJURY PREV, V19, P316, DOI 10.1136/injuryprev-2012-040600; Jensen J, 2002, SCAND J PUBLIC HEALT, V30, P54, DOI 10.1177/14034948020300011201; Phelan KJ, 2009, INJURY PREV, V15, P300, DOI 10.1136/ip.2008.020958; Romli MH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012048; Sauter T.C., 2015, PLOS ONE, V10, P1; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stevens Judy A, 2014, Inj Epidemiol, V1, P5, DOI 10.1186/2197-1714-1-5; Stevens JA, 2011, J SAFETY RES, V42, P311, DOI 10.1016/j.jsr.2011.07.001; Sung J, 2017, DISABIL REHABIL, V41, P1	12	3	3	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2019	234						283	286		10.1016/j.jss.2018.09.044			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	HD5BL	WOS:000452542500040	30527486				2022-02-06	
J	Suehiro, E; Fujiyama, Y; Kiyohira, M; Motoki, Y; Nojima, J; Suzuki, M				Suehiro, Eiichi; Fujiyama, Yuichi; Kiyohira, Miwa; Motoki, Yukari; Nojima, Junzo; Suzuki, Michiyasu			Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						biomarker; D-dimer; neuron specific enolase; tissue factor; traumatic brain injury	PRINCIPAL COMPONENT ANALYSIS; HEAD-INJURY; COAGULOPATHY; COAGULATION; PRODUCTS; PREDICT; FIBRIN; DAMAGE	D-dimer is a potential biomarker for the detection of traumatic brain injury (TBI). However, the mechanisms that trigger elevation of D-dimer in TBI remain unclear. The purpose of this study was to evaluate the reliability of D-dimer in blood as a biomarker for TBI and to determine the mechanisms involved in regulating its blood levels. Nine patients with moderate to severe isolated TBI (Glasgow Coma Scale [GCS] score 7-13) were admitted to our hospital from May 2013 to June 2014. Blood samples were collected from systemic arteries on arrival and at 1, 3, 5, and 7 days after injury. Blood levels of neuron specific enolase (NSE), D-dimer, and soluble tissue factor (sTF) were measured. NSE (33.4 ng/ml: normal <12.0 ng/ml) and D-dimer (56.1 mu g/ml: normal <1.0 mu g/ml) were elevated at admission and declined on day 1 after injury. At admission, there were significant correlations of D-dimer levels with NSE (R = 0.727, P = 0.026) and sTF (R = 0.803, P = 0.009) levels. The blood level of D-dimer accurately reflects the degree of brain tissue damage indicated by NSE levels. Our data suggest that release of sTF induced by brain tissue damage may activate the coagulation cascade, leading to elevation of D-dimer.	[Suehiro, Eiichi; Fujiyama, Yuichi; Kiyohira, Miwa; Suzuki, Michiyasu] Yamaguchi Univ, Grad Sch Med, Dept Neurosurg, Ube, Yamaguchi, Japan; [Motoki, Yukari; Nojima, Junzo] Yamaguchi Univ, Grad Sch Med, Fac Hlth Sci, Dept Lab Sci, Ube, Yamaguchi, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogishi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp			JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K10725]; ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives)	This work was supported by research funds from JSPS KAKENHI Grant Number 16K10725 and ZENKYOREN (National Mutual Insurance Federation of Agricultural Cooperatives).	BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Geeraedts LMG, 2007, RESUSCITATION, V73, P382, DOI 10.1016/j.resuscitation.2006.10.005; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hagiwara S, 2013, J TRAUMA ACUTE CARE, V74, P1275, DOI 10.1097/TA.0b013e31828cc967; Hayakawa M, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1811-1; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Sugimoto K, 2017, J NEUROTRAUM, V34, P3245, DOI 10.1089/neu.2017.5240; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	26	3	4	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	FEB	2019	59	2					63	67		10.2176/nmc.oa.2018-0254			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HL4TF	WOS:000458715300004	30674749	Green Submitted, gold, Green Published			2022-02-06	
J	Vander Vegt, CB; Register-Mihalik, JK; Ford, CB; Rodrigo, CJ; Guskiewicz, KM; Mihalik, JP				Vander Vegt, Christina B.; Register-Mihalik, Johna K.; Ford, Cassie B.; Rodrigo, Corey J.; Guskiewicz, Kevin M.; Mihalik, Jason P.			Baseline Concussion Clinical Measures Are Related to Sensory Organization and Balance	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						POSTURAL CONTROL; SENSORY INTEGRATION; CLINICAL ASSESSMENT; BALANCE PERFORMANCE	SPORTS-RELATED CONCUSSION; POSTURAL STABILITY; NEUROCOGNITIVE PERFORMANCE; EXECUTIVE FUNCTION; SYMPTOMS; INJURY; MANAGEMENT; RELIABILITY; HISTORY; ADULTS	Purpose This study aimed to examine relationships among baseline demographics, symptom severity, computerized neurocognitive outcomes, and balance performance in collegiate athletes. Methods Collegiate varsity athletes (N = 207, age = 19.3 +/- 1.0 yr) participating in an ongoing clinical research program who completed concussion baseline assessments including a demographic questionnaire, a graded symptom checklist, a neurocognitive assessment, and the Sensory Organization Test (SOT) were included in this study. The SOT composite equilibrium score (COMP) and three sensory ratio scores-vestibular (VEST), visual (VIS), and somatosensory (SOM)-were used to describe athletes' overall sensory organization and ability to use input from each sensory system to maintain balance. Separate stepwise multiple linear regression models were performed for each SOT outcome. Total symptom severity level and CNS Vital Signs domain scores served as predictor variables. Results Stepwise regression models for COMP (R-2 = 0.18, F-4,F-201 = 11.29, P < 0.001), VEST (R-2 = 0.14, F-4,F-201 = 8.16, P < 0.001), and VIS (R-2 = 0.10, F-4,F-201 = 5.52, P < 0.001) were all significant. Faster reaction times and higher executive function scores were associated with higher COMP and VEST scores in separate models. Those with faster reaction times also had significantly higher VIS scores. Conclusion Reaction time and executive function demonstrated significant relationships with SOT balance performance. These cognitive processes may influence athletes' ability to organize and process higher-order information and generate appropriate responses to changes in their environment, with respect to balance and injury risk. Future investigations should consider these relationships after injury, and clinicians should be mindful of this relationship when considering concussion management strategies.	[Vander Vegt, Christina B.; Register-Mihalik, Johna K.; Ford, Cassie B.; Rodrigo, Corey J.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Vander Vegt, Christina B.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 125 Fetzer Hall,Campus Box 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu					Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bruce JM, 2004, NEUROLOGY, V63, P1516; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T., 2014, ATHL TRAIN SPORT HLT, DOI [10.3928/19425864-20140916-01, DOI 10.3928/19425864-20140916-01]; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis M, 2018, J NEUROSURG-PEDIATR, V21, P401, DOI 10.3171/2017.9.PEDS17392; Ford C, 2017, NAT ATHL TRAIN ASS S; Gaerlan MG, 2012, J AM ACAD NURSE PRAC, V24, P375, DOI 10.1111/j.1745-7599.2012.00699.x; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kearney FC, 2013, DEMENT GERIATR COGN, V36, P20, DOI 10.1159/000350031; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; MANCHESTER D, 1989, J GERONTOL, V44, pM118; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parsons JT, 2014, NCAA SPORTS MED HDB; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Richardson JK, 2017, AM J PHYS MED REHAB, V96, P8, DOI 10.1097/PHM.0000000000000604; Romero-Franco N, 2014, J PHYS THER SCI, V26, P683, DOI 10.1589/jpts.26.683; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	40	3	3	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	FEB	2019	51	2					264	270		10.1249/MSS.0000000000001789			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HH7FU	WOS:000455896900006	30239494	Bronze			2022-02-06	
J	Wayment, HA; Craig, DI; Huffman, AH; Lininger, MR				Wayment, Heidi A.; Craig, Debbie, I; Huffman, Ann H.; Lininger, Monica R.			A Simple Field-Based Tool to Assess Concussion Symptom Reporting Behavior	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							DISCLOSURE	Introduction: Prevention and treatment of sport-related concussions is an important public health issue and has led to increased research on concussion symptom reporting behavior. To date, there is neither a common understanding of what constitutes concussion symptom reporting behavior nor measures that capture key features of concussion symptom reporting behavior. Concussion symptom reporting behavior can be initiated by an athlete, an athletic trainer, coach, or teammate and can occur in competition, practice, or days after symptoms appear. Follow-up diagnostics range from asking athletes initial questions about their symptoms to conducting rapid standardized sideline assessments to conducting full comprehensive concussion screens. Currently, for athletes who are not formally diagnosed with concussion, no information about concussion symptom reporting behavior sources, screening methods, or context is collected. Methods: Pilot data were collected from four National Collegiate Athletic Association Division I football programs. Athletic trainers recorded data about key concussion symptom reporting behavior features during the 2016 and 2017 football seasons. The 2016 data were analyzed in Spring 2017 and the reporting form was adapted for the Fall 2017 season. Two programs completed records during the 2017 season. These records were analyzed in Spring 2018. Results: Concussion symptom reporting behavior is most often initiated by athletes in practice contexts, followed by athletic trainers in game contexts. The 2017 data revealed that, regardless of source, 45% of initial screens received a comprehensive screen and about 25% of comprehensive screens originated by athlete or athletic trainer concussion symptom reporting behavior resulted in concussion diagnosis. Results led to development of a brief concussion symptom reporting behavior recording tool that can be used in practice, game, and athletic training room settings. Conclusions: The smartphone-supported Concussion Symptom Reporting Tool provides a rapid and easy way to record concussion symptom reporting behavior as well as estimate program-specific data for stakeholders interested in understanding concussion symptom reporting behavior. (C) 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.	[Wayment, Heidi A.; Huffman, Ann H.] No Arizona Univ, Dept Psychol Sci, Box 15106, Flagstaff, AZ 86011 USA; [Craig, Debbie, I; Lininger, Monica R.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Huffman, Ann H.] No Arizona Univ, WA Franke Coll Business, Flagstaff, AZ 86011 USA		Wayment, HA (corresponding author), No Arizona Univ, Dept Psychol Sci, Box 15106, Flagstaff, AZ 86011 USA.	heidi.wayment@nau.edu		Wayment, Heidi/0000-0001-5287-5966	NCAA; DoD programmatic research project investigating NCAA football programs' efforts to increase concussion-reporting behavior (Mind Matters)	The views expressed in this article are those of the authors and do not necessarily represent the official policy or position of the National Collegiate Athletic Association (NCAA) or the U.S. Department of Defense (DoD). This research was supported by the NCAA and DoD programmatic research project investigating NCAA football programs' efforts to increase concussion-reporting behavior (Mind Matters). This project was approved by the IRB at Northern Arizona University (Number 868162-1, dated March 1, 2016), with agreement from each of four participating university IRB offices that only Northern Arizona University official IRB review/approval was necessary (memos available upon request). All authors were principal investigators on the parent study and responsible for the implementation of concussion symptom reporting behavior reporting tool at each site. H.A. Wayment was responsible for leading manuscript preparation, including data interpretation and development of Concussion Symptom Reporting Tool and Excel-based calculator. D.I. Craig, M.R. Lininger, and A.H. Huffman contributed to the design and execution of study procedures, data interpretation, and manuscript preparation.	Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lininger M, J ATHL TRAIN; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Sefton J. M., 2004, J ATHL TRAINING, V39, pS52; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Yang Jingzhen, 2018, Inj Epidemiol, V5, P2, DOI 10.1186/s40621-018-0132-4	19	3	3	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	FEB	2019	56	2					323	330		10.1016/j.amepre.2018.10.007			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	HH7RE	WOS:000455927400021	30554973				2022-02-06	
J	Yun, YC; Yoon, YS; Kim, ES; Lee, YJ; Lee, JG; Jo, WJ; Lee, KJ				Yun, Young-Cheol; Yoon, Yong-Soon; Kim, Eun-Sil; Lee, Young-Jae; Lee, Jin-Gyeong; Jo, Won-Jae; Lee, Kwang Jae			Transabdominal Functional Magnetic Stimulation for the Treatment of Constipation in Brain-Injured Patients: A Randomized Controlled Trial	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Brain injuries; Stroke; Traumatic brain injuries; Constipation; Magnetic stimulation	COLON	Objective To investigate the effects of the transabdominal functional magnetic stimulation (A-FMS) for constipation in stroke or brain-injured patients. Methods Twenty-four brain-injured patients (11 males and 13 females; median age, 65 years; 22 cases of stroke and 2 cases of traumatic brain injury) with constipation, who were admitted to the rehabilitation department, were enrolled and randomly divided into magnetic stimulation (MS) group and sham stimulation (Sham) group. Several parameters related with constipation such as total and segmental colon transit time (CTT), defecation frequency, and Bristol Stool Scale (BSS) before and after 2 weeks of A-FMS (5 times per week, total 10 times of A-FMS) were evaluated. The Korean version of the Modified Barthel Index (K-MBI) was also evaluated. Results A significant decrease in segmental CTT in the left colon (-8.2 +/- 3.9 vs. 4.1 +/- 2.5 hours; p<0.05 by paired sample t-test) and a significant increase in the frequency of defecation (1.5 +/- 0.2 vs 0.7 +/- 0.3; p<0.05 by paired sample t-test) were observed in the MS group compared with the Sham group. Stool hardness became significantly softer in the MS group compared with the Sham group (2.3-3.5 in the MS and 2.6-3.1 in the Sham; p<0.05 by chi-square test) as evaluated by BSS. No difference in the K-MBI was observed between the two groups. Conclusion The present study suggests that A-FMS can be an additional therapeutic tool for managing constipation in brain-injured patients with abnormal bowel movement, defecation frequency, and stool hardness.	[Yun, Young-Cheol; Yoon, Yong-Soon; Kim, Eun-Sil; Lee, Jin-Gyeong; Jo, Won-Jae; Lee, Kwang Jae] Presbyterian Med Ctr, Dept Phys Med & Rehabil, 365 Seowon Ro, Jeonju 54987, South Korea; [Yoon, Yong-Soon; Lee, Kwang Jae] Presbyterian Med Ctr, Med Device Clin Trial Ctr, 365 Seowon Ro, Jeonju 54987, South Korea; [Lee, Young-Jae] Presbyterian Med Ctr, Dept Internal Med, Jeonju, South Korea		Lee, KJ (corresponding author), Presbyterian Med Ctr, Dept Phys Med & Rehabil, 365 Seowon Ro, Jeonju 54987, South Korea.; Lee, KJ (corresponding author), Presbyterian Med Ctr, Med Device Clin Trial Ctr, 365 Seowon Ro, Jeonju 54987, South Korea.	rytt@naver.com		LEE, Kwang Jae/0000-0001-7148-3765; Yun, Young Cheol/0000-0003-4970-1767; Lee, Young-Jae/0000-0002-3933-7343; Yoon, YongSoon/0000-0003-4709-3964			Camara-Lemarroy CR, 2014, J NEUROL SCI, V346, P20, DOI 10.1016/j.jns.2014.08.027; Chiu CM, 2009, J REHABIL MED, V41, P1085, DOI 10.2340/16501977-0456; DAVEY K, 1994, IEEE T BIO-MED ENG, V41, P1024, DOI 10.1109/10.335840; Dinning PG, 2007, COLORECTAL DIS, V9, P123, DOI 10.1111/j.1463-1318.2006.01096.x; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Govaert B, 2012, DIS COLON RECTUM, V55, P26, DOI 10.1097/DCR.0b013e31823898a5; Hollerbach S, 1998, Z GASTROENTEROL, V36, P313; Karakula-Juchnowicz H, 2016, PSYCHIATR POL, V50, P747, DOI 10.12740/PP/OnlineFirst/45053; Lee KJ, 2006, J GASTROEN HEPATOL, V21, P47, DOI 10.1111/j.1440-1746.2005.04134.x; Li JX, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007225; Lim YH, 2012, ANN REHABIL MED-ARM, V36, P371, DOI 10.5535/arm.2012.36.3.371; Lin CJ, 2013, SINGAP MED J, V54, P624; Lin VM, 1994, MUSCLE NERVE, V17, P1098; Lin VW, 2001, ARCH PHYS MED REHAB, V82, P167, DOI 10.1053/apmr.2001.18215; Lin VWH, 1998, J APPL PHYSIOL, V84, P1144, DOI 10.1152/jappl.1998.84.4.1144; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Robinson LR, 2002, ELECTRODIAGNOSTIC ME, P415; Sohn MK, 2007, ANN REHABIL MED-ARM, V31, P48; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Wang CP, 2012, J CHIN MED ASSOC, V75, P127, DOI 10.1016/j.jcma.2012.02.004; Yoon YS, 2016, GAZZ MED ITAL, V175, P421	21	3	3	0	3	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	FEB	2019	43	1					19	26		10.5535/arm.2019.43.1.19			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HN1HL	WOS:000459938000003	30852867	gold, Green Published, Green Submitted			2022-02-06	
J	He, XY; Dan, QQ; Wang, F; Li, YK; Fu, SJ; Zhao, N; Wang, TH				He, Xiu-Ying; Dan, Qi-Qin; Wang, Fang; Li, Yu-Kai; Fu, Song-Jun; Zhao, Nan; Wang, Ting-Hua			Protein Network Analysis of the Serum and Their Functional Implication in Patients Subjected to Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						protein network analysis; the serum; ELISA; patients; traumatic brain injury	CEREBROSPINAL-FLUID; NEURAL BEHAVIOR; ALPHA-SYNUCLEIN; EXPRESSION; CORTEX; BDNF; EPIDEMIOLOGY; INHIBITION; RECOVERY; RATS	Traumatic brain injury (TBI) often leads to severe neurobehavioral impairment, but the underlying molecular mechanism remains to be elucidated. Here, we collected the sera from 23 patients (aged from 19 to 81 years old, third day after TBI as TBI-third group) subjected to TBI from The First Hospital of Kunming City, and the sera from 22 healthy donors (aged from 18 to 81 years old and as control group). Then, three samples from TBI-third group and three samples from control group were subjected to the protein microarray detection, and bioinformatics analysis. Then, enzyme-linked immunosorbent assay (ELISA) was used to verify significantly altered protein levels. Results showed that, when compared with the control group, all significantly differentially expressed proteins [DEPs, P < 0.05, FDR < 0.05, fold change (FC) > 2] contained 172 molecules in the TBI-third group, in which 65 proteins were upregulated, while 107 proteins were downregulated. The biological processes of these DEPs, mostly happened in the extracellular region and the extracellular region parts, are mainly involved in the regulation of cellular process, signaling and signal transduction, cell communication, response to stimuli, the immune system process and multicellular organismal development. Moreover, the essential molecular functions of them are cytokine activity, growth factor activity and morphogen activity. Additionally, the most significant pathways are enriched in cytokine-cytokine receptor interaction and PI3K-Akt signaling pathways among downregulated proteins, and pathways in cancer and cytokine-cytokine receptor interaction among upregulated proteins. Of these, we focused on the NGF, NT-3, IGF-2, HGF, NPY, CRP, MMP-9, and ICAM-2 with a high number of interactors in Protein Protein Interaction (PPI) Network indicated by bioinformatics report. Furthermore, using ELISA test, we confirmed that all increase in the levels of NGF, NT-3, IGF-2, HGF, NPY, CRP, MMP-9, and ICAM-2 in the serum from TBI patients. Together, we determined the screened protein expressional profiles in serum for TBI patients, in which the cross-network between inflammatory factors and growth factors may play a crucial role in TBI damage and repair. Our findings could contribute to indication for the diagnosis and treatment of TBI in future translational medicine and clinical practice.	[He, Xiu-Ying; Dan, Qi-Qin; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Dept Anesthesiol,Inst Neurol Dis, Chengdu, Sichuan, Peoples R China; [Wang, Fang; Li, Yu-Kai; Fu, Song-Jun; Wang, Ting-Hua] Kunming Med Univ, Lab Zool Dept, Inst Neurosci, Kunming, Yunnan, Peoples R China; [Zhao, Nan] First Hosp Kunming, Dept Neurosurg, Kunming, Yunnan, Peoples R China		Wang, TH (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Dept Anesthesiol,Inst Neurol Dis, Chengdu, Sichuan, Peoples R China.; Wang, TH (corresponding author), Kunming Med Univ, Lab Zool Dept, Inst Neurosci, Kunming, Yunnan, Peoples R China.; Zhao, N (corresponding author), First Hosp Kunming, Dept Neurosurg, Kunming, Yunnan, Peoples R China.	zhao-nan@163.com; tinghua_neuron@263.net			Program Innovative Research Team in Science and Technology in Yunnan Province [2017HC007]	This study was supported by the Program Innovative Research Team in Science and Technology in Yunnan Province (Grant No. 2017HC007).	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; ALVES OL, 2001, MO CL BI CC, V2, P1; Becker A, 2018, CHIN J TRAUMATOL, V21, P152, DOI 10.1016/j.cjtee.2018.01.004; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Chen MR, 2016, NEUROCHEM RES, V41, P2585, DOI 10.1007/s11064-016-1970-5; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Feng GY, 2017, CELL MOL NEUROBIOL, V37, P817, DOI 10.1007/s10571-016-0420-x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gao L, 2012, GROWTH FACTORS, V30, P167, DOI 10.3109/08977194.2012.678842; Hannay H. J., 2004, NEUROPSYCHOLOGICAL A; Hauer AD, 2009, ATHEROSCLEROSIS, V204, P365, DOI 10.1016/j.atherosclerosis.2008.09.039; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lamprecht MR, 2017, J NEUROTRAUM, V34, P97, DOI 10.1089/neu.2015.4306; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Ou S, 2014, EUR REV MED PHARMACO, V18, P101; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Porth C. M, 2014, ESSENTIALS PATHOPHYS; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Qiu DL, 2016, IRAN J BASIC MED SCI, V19, P970; Qu BX, 2016, J NEUROTRAUM, V33, pA19; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SCALEA TM, 2005, NEUROTRAUMA EVIDENCE, P3; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Wang YC, 2016, APOPTOSIS, V21, P404, DOI 10.1007/s10495-016-1218-5; Whigham K. B, 2011, ENCY CLIN NEUROPSYCH, P1707, DOI [10.1007/978-0-387-79948-3_642, DOI 10.1007/978-0-387-79948-3_642]; Xiong LL, 2016, SPINAL CORD, V54, P1088, DOI 10.1038/sc.2016.55; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yang HJ, 2009, GROWTH FACTORS, V27, P237, DOI 10.1080/08977190903024298	47	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 31	2019	12								1049	10.3389/fnins.2018.01049			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ7PZ	WOS:000457391100001	30766469	Green Published, gold			2022-02-06	
J	Jang, SH; Bae, CH; Seo, JP				Jang, Sung Ho; Bae, Chang Hoon; Seo, Jeong Pyo			Injury of auditory radiation and sensorineural hearing loss from mild traumatic brain injury	BRAIN INJURY			English	Article						Diffusion tensor tractography; auditory radiation; traumatic axonal injury; mild traumatic brain injury	OPTIC RADIATION; AXONAL INJURY; HEAD-INJURY; TRACT; RECOVERY; PATIENT; PATHWAY	Objectives: We report on a patient with sensorineural hearing loss from injury of the auditory radiation following mild TBI, diagnosed by diffusion tensor tractography (DTT). Method: A 35-year-old female patient suffered head trauma. While walking in a crosswalk, her left lumbar area was hit by a turning car and she fell to the ground. She was pulled behind the car for several meters while her occipital area repeatedly hit the ground. She complained that she began to feel hearing impairment approximately two weeks after the head trauma, that aggravated over time. Approximately 1.5 years after head trauma, when she visited a university hospital for evaluation of the brain, she complained of severe hearing impairment. To characterize the patient's hearing loss, pure tone audiometry was evaluated in a sound proof room to screen her hearing status for the frequencies 250-8000 Hz. A pure tone threshold in the range of 41-60 dB HL was considered moderate sensorineural hearing loss and 61-80 dB HL severe. However, no abnormality was observed in either ear on physical examination. The patient was diagnosed with bilateral moderate sensorineural hearing loss. Results: On 1.5 year DTT, the auditory radiation was narrowed in both hemispheres. Conclusion: Neural injury of the auditory radiation was demonstrated in a patient with sensorineural hearing loss following mild TBI, using DTT.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea; [Bae, Chang Hoon] Yeungnam Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea		Seo, JP (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	raphael0905@hanmail.net		Bae, Chang Hoon/0000-0002-0835-4060	DGIST R&D Program of the Ministry of Science, ICT and Future Planning [18-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (18-BD-0401).	Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; BROWNING GG, 1982, ARCH OTOLARYNGOL, V108, P474; Brusis T, 2011, LARYNGO RHINO OTOL, V90, P73, DOI 10.1055/s-0030-1267938; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Caplan L., 2001, STROKE SYNDROMES; DORMAN EB, 1982, NEW ZEAL MED J, V95, P454; Flint PW., 2010, CUMMINGS OTOLARYNGOL, V5th ed.; Glass HC, 2010, AM J NEURORADIOL, V31, P1424, DOI 10.3174/ajnr.A2110; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Jang SH, 2017, CLIN MED, V17, P584, DOI 10.7861/clinmedicine.17-6-584; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Javad F, 2014, NEUROIMAGE, V84, P562, DOI 10.1016/j.neuroimage.2013.09.007; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Kwon HG, 2011, NEURORADIOLOGY, V53, P787, DOI 10.1007/s00234-011-0878-7; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Profant O, 2014, NEUROSCIENCE, V260, P87, DOI 10.1016/j.neuroscience.2013.12.010; Scholer W, 1990, Z Unfallchir Versicherungsmed, V83, P237; Segal S, 2003, OTOL NEUROTOL, V24, P734, DOI 10.1097/00129492-200309000-00007; Seo JP, 2014, NEURAL REGEN RES, V9, P1231, DOI 10.4103/1673-5374.135331; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	27	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					249	252		10.1080/02699052.2018.1539243			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300017	30359139				2022-02-06	
J	Jourdan, C; Bahrami, S; Azouvi, P; Tenovuo, O				Jourdan, Claire; Bahrami, Stephane; Azouvi, Philippe; Tenovuo, Olli			Practitioners' opinions on traumatic brain injury care pathways in Finland and France: different organizations, common issues	BRAIN INJURY			English	Article						Brain injuries; quality of health care; patient care; qualitative research	QUALITY-OF-CARE; REHABILITATION	Objective: In traumatic brain injury (TBI), differences in health-care contexts have profound effects on care pathways. Objectives were to compare TBI pathways of care and practitioners' views on quality of care issues in two large European areas: Varsinais-Suomi, Finland and Ile-de-France, France. Methods: Thematic analysis of semi-structured interviews was conducted with TBI practitioners (n = 10) from all stages of TBI care. Interviews addressed organization and financing of care, decision-making on care transitions, and perceived issues. The structure-process-outcome model of Donabedian was used to classify findings related to quality of care issues. Results: Main differences in organization of care pathways for people with TBI were related to financing modalities, number of pathway alternatives, inpatient versus outpatient rehabilitation, and indirect versus direct referrals to rehabilitation. Similar categories of issues were raised in the two settings. Issues in structures involved availability of services, financial access, and heterogeneity of expertise. Issues in processes involved diagnosis and follow-up, training regarding cognitive impairments, decision-making for referrals, transition delays, and care pathways of very severely affected patients. Conclusions: These findings provide clues to address care pathways in further comparative studies. Determinants of care pathway quality could be classified as direct or indirect, binding or adaptive organizational factors.	[Jourdan, Claire] CHU Montpellier, Dept Phys Med & Rehabil, Montpellier, France; [Jourdan, Claire; Bahrami, Stephane; Azouvi, Philippe] Univ Versailles St Quentin, UFR Sci Sante Simone Veil, HANDIReSP EA 4047, Montigny Le Bretonneux, France; [Bahrami, Stephane] Hop Raymond Poincare, AP HP, Publ Hlth Unit, Garches, France; [Bahrami, Stephane] Hop Raymond Poincare, AP HP, CIC Inserm 1429, Garches, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland		Jourdan, C (corresponding author), CHRU Montpellier, Dept Med Phys & Readaptat, Site Lapeyronie,371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.	cl-jourdan@chu-montpellier.fr			Societe Francaise de Medecine Physique et de Readaptation under grant SOFMER-IPSEN	This work was supported by the Societe Francaise de Medecine Physique et de Readaptation under grant SOFMER-IPSEN.	Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Chevreul Karine, 2010, Health Syst Transit, V12, P1; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Duncan PW, 2007, ARCH PHYS MED REHAB, V88, P1482, DOI 10.1016/j.apmr.2007.08.118; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Hoenig H, 2002, MED CARE, V40, P1036, DOI 10.1097/00005650-200211000-00005; Katz DI, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P2; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Pradat-Diehl P., 2012, Annals of Physical and Rehabilitation Medicine, V55, P546, DOI 10.1016/j.rehab.2012.07.002; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vuorenkoski Lauri, 2008, HLTH SYSTEMS TRANSIT, V10; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	19	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					205	211		10.1080/02699052.2018.1539869			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300011	30449182				2022-02-06	
J	Abbasivash, R; Hasanloei, MAV; Kazempour, A; Mandkhah, A; Ghoreishi, MMS; Masoumi, GA				Abbasivash, Rahman; Hasanloei, Mohammad Amin Valizade; Kazempour, Aidin; Mandkhah, Ata; Ghoreishi, Mir Mehdi Shaaf; Masoumi, Ghazal Akhavan			The Effect of Oral Administration of Amantadine on Neurological Outcome of Patients With Diffuse Axonal Injury in ICU	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; consciousness level; Glasgow Coma Scale; Glasgow Outcome Scale	TRAUMATIC BRAIN-INJURY; DOPAMINE; NEUROPROTECTION	Traumatic brain injury is a major cause of death and disability in adults. This study investigated the effect of oral administration of amantadine on the neurological outcomes of patients with diffuse axonal injury (DAI) in the intensive care unit (ICU). This double-blind clinical trial was conducted in the ICU of Imam Hospital in Urmia. Patients with DAI were intubated and received mechanical ventilation in the ICU. They were divided into 2 groups: patients receiving amantadine (A) and placebo (P). The acquired data were analyzed using SPSS, P<.05 significant level. Findings showed no significant difference between the 2 groups in age and sex. There was no significant difference between the mean Glasgow Coma Scale (GCS) at the time of admission and discharge, and the mean Glasgow Outcome Scale (GOS) of the patients in 2 groups. No significant difference was observed in the duration of mechanical ventilation, hospitalization, and mortality in both groups (P>.05) in ICU. However, there was a significant difference between the mean GCS at the time of admission and discharge and death. Also, significant differences existed between the mean GOS in discharged and deceased patients (P=.001). This study showed no significant difference between the mean GCS at the time of admission and discharge and the mean GOS of the discharged patients and the mortality rate in the 2 groups. However, there were clear statistical differences between these variables in discharged and deceased patients. It is recommended that further studies are conducted with a larger sample size.	[Abbasivash, Rahman; Hasanloei, Mohammad Amin Valizade; Ghoreishi, Mir Mehdi Shaaf] Urmia Univ Med Sci, Dept Anesthesiol, Orumiyeh, Iran; [Kazempour, Aidin; Mandkhah, Ata] Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran; [Masoumi, Ghazal Akhavan] Urmia Univ Med Sci, Imam Khomeini Hosp, Clin Res Dev Unit, Orumiyeh, Iran		Hasanloei, MAV (corresponding author), Urmia Univ Med Sci, Imam Khomeini Hosp, Clin Res Dev Unit, Emam Hosp, Ershad Blv,Postal Box 57157-81351, Orumiyeh, Iran.	aminvalizade@yahoo.com					Archer DP, 2018, BRIT J ANAESTH, V121, P1272, DOI 10.1016/j.bja.2018.07.024; Bi M, 2011, NEUROSCI LETT, V501, P35, DOI 10.1016/j.neulet.2011.06.036; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; Ito Y, 2008, CNS NEUROSCI THER, V14, P192, DOI 10.1111/j.1755-5949.2008.00050.x; Kelly ERP., 2012, PARKINSONS DIS, P1278; Kim YW, 2010, ANN NUCL MED, V24, P363, DOI 10.1007/s12149-010-0360-3; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; Pallan Tony V, 2014, J Vasc Interv Neurol, V7, P23; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Tbeadom A, 2017, YOUMANS WINN NEUROLO, V8th, P2748; Warner DS, 2017, ANESTHESIOLOGY, V126, P579, DOI 10.1097/ALN.0000000000001535	20	3	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	JAN 27	2019	13								1179069518824851	10.1177/1179069518824851			5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HM6CA	WOS:000459560400001	30728726	Green Published, gold			2022-02-06	
J	Plourde, V; Daya, H; Low, TA; Barlow, KM; Brooks, BL				Plourde, Vickie; Daya, Hussain; Low, Trevor A.; Barlow, Karen M.; Brooks, Brian L.			Evaluating anxiety and depression symptoms in children and adolescents with prior mild traumatic brain injury: Agreement between methods and respondents	CHILD NEUROPSYCHOLOGY			English	Article						Pediatric; head injury; anxiety; depression; assessment	CLOSED-HEAD INJURY; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; MULTIPLE INFORMANTS; OUTCOMES; YOUTH; PSYCHOPATHOLOGY; RELIABILITY; CONCUSSIONS; DISORDERS	Psychological functioning can be adversely impacted after a mild traumatic brain injury (mTBI) and may be a potential target for intervention. Despite the use of symptom ratings or structured diagnostic interview to assess long-term anxiety and depression symptoms in children and adolescents post-injury, no known studies have considered the agreement between different assessment methods and between respondents. The objectives of this study were to investigate the agreement between symptom ratings and structured diagnostic interview and between children and parents' symptom reporting. Participants (N = 33; 9-18 years old) were recruited from the Emergency Department and assessed on average 22.8 months (SD = 5.6) after their mTBI. Anxiety and depression symptoms were evaluated via subscales of a questionnaire (Behavior Assessment System for Children) and parts of a computerized structured diagnostic interview (generalized anxiety disorder and major depressive episode; Diagnostic Interview Schedule for Children - C-DISC-IV) administered individually to children and their parents. Results showed that the inter-method agreement to identify high levels of anxiety and depression was moderate to perfect in children while it was lower in parents. Although a similar percentage of participants with elevated anxiety or depression were identified by both children and parents, the agreement between youth and parents was variable, ranging from poor to good for anxiety and poor to moderate for depression. These results highlight the importance of collecting youth and parents' reports of anxiety and depression symptoms and considering potential discrepancies between informants' answers.	[Plourde, Vickie] Univ Alberta, Fac St Jean, 8406 Rue Marie Anne Gaboury Northwest, Edmonton, AB T6C 4G9, Canada; [Daya, Hussain] Univ Lethbridge, Dept Psychol, Lethbridge, AB, Canada; [Low, Trevor A.] Univ Calgary, Cumming Sch Med, Dept Neurosci, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Fac Med, Child Hlth Res Ctr, Dr Paul Hopkins Chair Paediat Rehabil, Brisbane, Australia; [Barlow, Karen M.; Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada		Plourde, V (corresponding author), Univ Alberta, Fac St Jean, 8406 Rue Marie Anne Gaboury Northwest, Edmonton, AB T6C 4G9, Canada.	plourde@ualberta.ca	Barlow, Karen/C-1323-2014; Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Plourde, Vickie/0000-0002-0098-5431; Low, Trevor/0000-0002-8564-845X	Alberta Innovates Health Solutions (AIHS); Alberta Children's Hospital Research Institute (ACHRI); Integrated Concussion Research Program (ICRP) at the University of Calgary; Cumming School of Medicine, University of Calgary	The authors would like to thank the families who participated in this research. The authors thank Angela Villavicencio and Brenda Turley for their assistance in the early stages of the project. Vickie Plourde PhD was supported by the Alberta Innovates Health Solutions (AIHS), the Alberta Children's Hospital Research Institute (ACHRI), the Integrated Concussion Research Program (ICRP) at the University of Calgary, and the Cumming School of Medicine, University of Calgary. Brian Brooks PhD receives salary support from a Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary award.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Becker EM, 2016, J PSYCHOPATHOL BEHAV, V38, P528, DOI 10.1007/s10862-016-9544-z; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Boyle MH, 1997, ARCH GEN PSYCHIAT, V54, P793; Boyle MH, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1544; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; De Los Reyes A, 2013, ANNU REV CLIN PSYCHO, V9, P123, DOI 10.1146/annurev-clinpsy-050212-185617; Dexheimer JW, 2017, INT J MED INFORM, V97, P163, DOI 10.1016/j.ijmedinf.2016.10.007; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hamblin RJ, 2016, PSYCHIAT RES, V245, P303, DOI 10.1016/j.psychres.2016.07.041; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; HODGES K, 1990, PSYCHOL ASSESSMENT, V0002, P00376, DOI DOI 10.1037/1040-3590.2.4.376; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P1569, DOI 10.1097/00004583-199912000-00019; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Liu J, 2013, DISASTER ADV, V6, P11; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Martel MM, 2017, J CHILD PSYCHOL PSYC, V58, P116, DOI 10.1111/jcpp.12611; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Rettew DC, 2009, INT J METH PSYCH RES, V18, P169, DOI 10.1002/mpr.289; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Ridge NW, 2009, J CLIN PSYCHOL, V65, P1115, DOI 10.1002/jclp.20620; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Smith SR, 2007, J PSYCHOEDUC ASSESS, V25, P139, DOI 10.1177/0734282906296233; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	53	3	3	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2019	25	1					44	59		10.1080/09297049.2018.1432585			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HB2IN	WOS:000450863500003	29382257				2022-02-06	
J	Abrahamson, EE; Poloyac, SM; Dixon, CE; Dekosky, ST; Ikonomovic, MD				Abrahamson, Eric E.; Poloyac, Samuel M.; Dixon, C. Edward; Dekosky, Steven T.; Ikonomovic, Milos D.			Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Excitotoxicity; glutamate; hippocampus; NMDA; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NMDA RECEPTOR ANTAGONISTS; FOCAL CEREBRAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; ALZHEIMERS-DISEASE; HEAD TRAUMA; COMBINATION THERAPY; MEMORY DEFICITS; CLINICAL-TRIALS; TIME-COURSE	Background: Altered glutamatergic neurotransmission after traumatic brain injury (TBI) contributes to excitotoxic cell damage and death. Prevention or suppression of such changes is a desirable goal for treatment of TBI. Memantine (3,5-dimethyl-1-adamantanamine), an uncompetitive NMDA receptor antagonist with voltage-dependent open channel blocking kinetics, was reported to be neuroprotective in preclinical models of excitotoxicity, brain ischemia, and in TBI when administered prophylactically, immediately, or within minutes after injury. Methods: The current study examined effects of memantine administered by single intraperitoneal injection to adult male rats at a more clinically relevant delay of one hour after moderate-severe controlled cortical impact (CCI) injury or sham surgery. Histopathology was assessed on days 1, 7, 21, and 90, vestibulomotor function (beam balance and beam walk) was assessed on days 1-5 and 71-75, and spatial memory (Morris water maze test, MWM) was assessed on days 14-21 and 83-90 after CCI injury or sham surgery. Results: When administered at 10 mg/kg, but not 2.5 or 5 mg/kg, memantine preserved cortical tissue and reduced neuronal degeneration 1 day after injury, and attenuated loss of synaptophysin immunoreactivity in the hippocampus 7 days after injury. No effects of 10 mg/kg memantine were observed on histopathology at 21 and 90 days after CCI injury or sham surgery, or on vestibulomotor function and spatial memory acquisition assessed during any of the testing periods. However, 10 mg/kg memantine resulted in trends for improved search strategy in the MWM memory retention probe trial. Conclusions: Administration of memantine at a clinically-relevant delay after moderate-severe CCI injury has beneficial effects on acute outcomes, while more significant improvement on subacute and chronic outcomes may require repeated drug administration or its combination with another therapy.	[Abrahamson, Eric E.; Dixon, C. Edward; Ikonomovic, Milos D.] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15213 USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol, Thomas Detre Hall WPIC,Room 1421,3811 Ohara St, Pittsburgh, PA 15213 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Dekosky, Steven T.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Dekosky, Steven T.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA		Ikonomovic, MD (corresponding author), Univ Pittsburgh, Dept Neurol, Thomas Detre Hall WPIC,Room 1421,3811 Ohara St, Pittsburgh, PA 15213 USA.	ikonomovicmd@upmc.edu			United States Department of Veterans Affairs, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I01 RX000511]; Forest Research Institute [NAM-MD-45]	This work was supported by a Merit Review Award I01 RX000511 from the United States Department of Veterans Affairs, Rehabilitation Research and Development Service, and research grant NAM-MD-45 from Forest Research Institute. We gratefully acknowledge the contributions of Lan Shao, Michelle Ma, Sherman Culver, and Tricia M. Miller. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Babu CS, 2009, PHARMACOL BIOCHEM BE, V92, P424, DOI 10.1016/j.pbb.2009.01.010; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Beconi Maria G, 2011, PLoS Curr, V3, pRRN1291, DOI 10.1371/currents.RRN1291; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Camarasa J, 2010, PHARMACOL RES, V62, P450, DOI 10.1016/j.phrs.2010.05.004; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cho GS, 2013, NEUROSCI LETT, V538, P9, DOI 10.1016/j.neulet.2013.01.031; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Danysz W, 1997, NEUROSCI BIOBEHAV R, V21, P455, DOI 10.1016/S0149-7634(96)00037-1; Day NL, 2017, NEUROCHEM INT, V111, P57, DOI 10.1016/j.neuint.2017.04.018; Di X, 2003, NEUROL RES, V25, P329, DOI 10.1179/016164103101201643; Di X, 1996, J NEUROSURG, V85, P655, DOI 10.3171/jns.1996.85.4.0655; Di X, 1996, RESTOR NEUROL NEUROS, V9, P231, DOI 10.3233/RNN-1996-9406; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Effgen GB, 2017, J NEUROTRAUM, V34, P934, DOI 10.1089/neu.2016.4528; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gorgulu A, 2000, ACTA NEUROCHIR, V142, P1287, DOI 10.1007/s007010070027; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; Huang CY, 2015, INT J MOL SCI, V16, P14171, DOI 10.3390/ijms160614171; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jung KH, 2009, BIOCHEM BIOPH RES CO, V378, P507, DOI 10.1016/j.bbrc.2008.11.081; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kishi T, 2017, J ALZHEIMERS DIS, V60, P401, DOI 10.3233/JAD-170424; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; KORNHUBER J, 1994, J NEURAL TRANSM-SUPP, P91; Koura SS, 1998, ACT NEUR S, V71, P244; Lamprecht MR, 2015, J NEUROTRAUM, V32, P1361, DOI 10.1089/neu.2015.3912; Landucci E, 2018, NEUROSCI LETT, V668, P103, DOI 10.1016/j.neulet.2018.01.023; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Lorrio S, 2009, BRAIN RES, V1254, P128, DOI 10.1016/j.brainres.2008.11.095; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Minkeviciene R, 2008, NEUROPHARMACOLOGY, V54, P1079, DOI 10.1016/j.neuropharm.2008.02.014; Misztal M, 1996, EUR J PHARMACOL, V296, P1, DOI 10.1016/0014-2999(95)00682-6; Mokhtari M, 2018, J CLIN PHARMACOL, V58, P42, DOI 10.1002/jcph.980; More L, 2008, BEHAV PHARMACOL, V19, P724, DOI 10.1097/FBP.0b013e3283123cad; Moskowitz E, 2018, AM SURGEON, V84, P1314; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PARSONS CG, 1993, NEUROPHARMACOLOGY, V32, P1337, DOI 10.1016/0028-3908(93)90029-3; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; PELLEGRINI JW, 1993, ANN NEUROL, V33, P403, DOI 10.1002/ana.410330414; Periclou A, 2006, CLIN PHARMACOL THER, V79, P134, DOI 10.1016/j.clpt.2005.10.005; Pitsikas N, 2018, BEHAV PHARMACOL, V29, P400, DOI 10.1097/FBP.0000000000000380; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Rao VLR, 2001, BRAIN RES, V911, P96; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rosi S, 2009, BRAIN, V132, P2464, DOI 10.1093/brain/awp148; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Seyedsaadat SM, 2019, REV NEUROSCIENCE, V30, P203, DOI 10.1515/revneuro-2018-0025; Smith-Swintosky V L, 1994, J Neural Transm Suppl, V44, P29; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tuma J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00116; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wang CC, 2018, WORLD NEUROSURG, V112, pE719, DOI 10.1016/j.wneu.2018.01.140; Wang F, 2015, MOL NEUROBIOL, V52, P1458, DOI 10.1007/s12035-014-8949-5; Watanabe T, 2010, J NEUROSCI RES, V88, P1908, DOI 10.1002/jnr.22346; Wenk GL, 1996, NEUROREPORT, V7, P1453, DOI 10.1097/00001756-199606170-00001; WESEMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1243; Wesemann W, 1980, J Neural Transm Suppl, P143; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7	89	3	3	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2019	37	3					245	263		10.3233/RNN-190909			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IE0OM	WOS:000472086700006	31177251				2022-02-06	
J	Albanese, BJ; Macatee, RJ; Stentz, LA; Schmidt, NB; Bryan, CJ				Albanese, Brian J.; Macatee, Richard J.; Stentz, Lauren A.; Schmidt, Norman B.; Bryan, Craig J.			Interactive effects of cumulative lifetime traumatic brain injuries and combat exposure on posttraumatic stress among deployed military personnel	COGNITIVE BEHAVIOUR THERAPY			English	Article						Traumatic brain injury; posttraumatic stress disorder; combat exposure; military	PSYCHOMETRIC PROPERTIES; AFGHANISTAN; IRAQ; TBI; ASSOCIATION; SYMPTOMS; VALIDITY; DUTY; RISK; RELIABILITY	Growing research links Traumatic Brain Injury (TBI) with greater posttraumatic stress disorder (PTSD) symptoms. Much of this research has focused on the influence of the presence or severity of a single TBI while neglecting the potential cumulative effects of multiple TBIs incurred across an individual's lifetime on combat-related PTSD. The present study addressed this gap using a sample of 157 military service members and 4 civilian contractors who underwent structured TBI interviews at a military hospital in Iraq and completed the Combat Experiences Scale (CES) and Posttraumatic Checklist - Military (PCL-M). Results indicated that a greater number of lifetime TBIs were associated with greater PTSD symptoms when accounting for the presence and severity of a recent, deployment-related TBI. Additionally, a significant interaction of number of lifetime TBIs and combat exposure emerged, indicating that exposure to combat yielded greater PTSD symptoms among those with multiple lifetime TBIs compared to those with one or zero lifetime TBIs. These data suggest that incurring multiple TBIs may amplify the link between combat exposure and PTSD and underscore the need to screen for lifetime TBI history.	[Albanese, Brian J.; Macatee, Richard J.; Stentz, Lauren A.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahasssee, FL USA; [Bryan, Craig J.] Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA; [Bryan, Craig J.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA		Bryan, CJ (corresponding author), Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA.; Bryan, CJ (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu	Schmidt, Norman B/C-6426-2015	Schmidt, Norman B/0000-0003-4125-9601	National Institute of Health Integrated Clinical Neuroscience Training for Translational Research [4T32MH093311-05]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH117600, T32MH093311] Funding Source: NIH RePORTER	This work was also in part supported by the National Institute of Health Integrated Clinical Neuroscience Training for Translational Research [grant number 4T32MH093311-05]. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the National Institute of Health.	Albanese BJ, 2019, COGN BEHAV THERAPY, V48, P77, DOI 10.1080/16506073.2018.1478446; Albanese BJ, 2018, PSYCHIATRY, V81, P71, DOI 10.1080/00332747.2017.1309867; Albanese BJ, 2017, COGNITIVE THER RES, V41, P902, DOI 10.1007/s10608-017-9863-8; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bardeen JR, 2016, J PSYCHOPATHOL BEHAV, V38, P320, DOI 10.1007/s10862-015-9522-x; Bardeen JR, 2015, PERS INDIV DIFFER, V81, P124, DOI 10.1016/j.paid.2014.09.010; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Hayes A.F., 2012, PROCESS VERSATILE CO; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shen YC, 2010, MIL MED, V175, P763, DOI 10.7205/MILMED-D-10-00086; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	33	3	3	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1650-6073	1651-2316		COGN BEHAV THERAPY	Cogn. Behav. Ther.		2019	48	1					77	88		10.1080/16506073.2018.1478446			12	Behavioral Sciences; Psychology, Clinical	Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology	HP6BE	WOS:000461766700006	29932812	Green Accepted			2022-02-06	
J	Amaefule, KE; Dahiru, IL; Sule, UM; Ejagwulu, FS; Maitama, MI; Ibrahim, A				Amaefule, K. E.; Dahiru, I. L.; Sule, U. M.; Ejagwulu, F. S.; Maitama, M., I; Ibrahim, A.			Trauma intensive care in a terror-ravaged, resource-constrained setting: Are we prepared for the emerging challenge?	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Trauma admissions; Intensive care; Terrorism; Outcome	INJURIES; UNIT; ADMISSIONS; INFECTION; COUNTRIES; BURDEN; INCOME	Introduction: Trauma in developing countries has been on the increase, a situation perpetuated by rising road traffic collisions, terrorism and firearms proliferation. Some of the victims of trauma are left with life threatening conditions requiring urgent surgical intervention and/or intensive care. The objectives of this study were to determine the pattern of major trauma needing intensive care in the region, and to determine the outcome of major trauma admitted to intensive care unit. Methods: A six-year retrospective cohort study of trauma patients needing intensive care, set in the Intensive Care Unit of Ahmadu Bello University Teaching Hospital, Zaria, North-West Nigeria. Subjects were major trauma patients admitted into the intensive care unit of the institution, identified via an admission register kept in the unit. The main outcomes measured were length of stay and mortality. Results: Trauma admissions represented 25.1% of the all intensive care admissions. Severe traumatic brain injury accounted for 32.1% of the trauma admissions, while burns accounted for 23.2%. Of the injuries, 15.5% were sustained in bomb blasts, and 8.3% were firearm injuries. The majority of the patients stayed for no more than seven days from admission. Burns patients had the worst outcomes, with 82.1% mortality. Conclusion: Major trauma contributes significantly to local intensive care admissions, with terrorism- related trauma now an emerging challenging cause of major trauma in our region. The observed poor outcomes in this study are a reflection of the quality of available intensive care, and lends credence to the concept of appropriately resourced, specialised intensive care units for optimisation of care.	[Amaefule, K. E.; Dahiru, I. L.; Ejagwulu, F. S.; Maitama, M., I] Ahmadu Bello Univ, Teaching Hosp, Dept Orthoped & Trauma Surg, Zaria, Nigeria; [Sule, U. M.] Ahmadu Bello Univ, Teaching Hosp, Dept Anaesthesia, Zaria, Nigeria; [Ibrahim, A.] Ahmadu Bello Univ, Teaching Hosp, Dept Surg, Div Plast & Reconstruct Surg, Zaria, Nigeria		Amaefule, KE (corresponding author), Ahmadu Bello Univ, Teaching Hosp, Dept Orthoped & Trauma Surg, Zaria, Nigeria.	kenamaefule@yahoo.com					Adenekan AT, 2009, AFR J ANAESTH INT CA, V9, P5; Alfa-Wali M, 2015, J EPIDEMIOL GLOB HEA, V5, P201, DOI 10.1016/j.jegh.2014.05.006; [Anonymous], CAUS SPEC MORT REG E; ATKINSON S, 1994, LANCET, V344, P1203, DOI 10.1016/S0140-6736(94)90514-2; Barbieri S, 2003, MINERVA ANESTESIOL, V69, p[625, 34]; Bayat A, 2003, BURNS, V29, P303, DOI 10.1016/S0305-4179(03)00011-1; BYRICK RJ, 1992, CAN J ANAESTH, V39, P260, DOI 10.1007/BF03008787; Chalya PL, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-61; Dongo AE, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-171; Gardiner JP, 2000, NEW ZEAL MED J, V113, P327; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Iribhogbe PE, 2008, PREHOSP DISASTER MED, V23, P16, DOI 10.1017/S1049023X00005495; Kelly FE, 2014, CLIN MED, V14, P376, DOI 10.7861/clinmedicine.14-4-376; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Mitchell VT, 2001, TRAUMA CARE J, V11, P86; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakamura T, 1999, Masui, V48, P1332; Neideen T, 2012, SURG CLIN N AM, V92, P1387, DOI 10.1016/j.suc.2012.08.010; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Olajumoke T O, 2014, Niger J Med, V23, P296; Paniker J, 2015, SICOT-J, V1, DOI 10.1051/sicotj/2015019; Peden M., 2002, INJURY CHART BOOK GR; Sangowawa AO, 2005, ANN IBADAN POSTGRAD, V3, P57; Scalea Thomas, 2002, Int Anesthesiol Clin, V40, P1; Singer Pierre, 2005, Crit Care Med, V33, pS61, DOI 10.1097/01.CCM.0000151068.33935.3E; Tan WT, 2010, ANN ACAD MED SINGAP, V39, P363; Weber J, 2004, BURNS, V30, pA16, DOI 10.1016/j.burns.2004.08.003; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064; Wild Claudia, 2005, Health Policy, V71, P289, DOI 10.1016/j.healthpol.2003.12.020	30	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.		2019	9			S	SI		S32	S37		10.1016/j.afjem.2018.12.007			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HO8FY	WOS:000461186500007	30976498	Green Published, gold			2022-02-06	
J	Bauman, J; Gibbons, LE; Moore, M; Mukherjee, S; McCurry, SM; McCormick, W; Bowen, JD; Trittschuh, E; Glymour, M; Mez, J; Saykin, AJ; Dams-O'Conner, K; Bennett, DA; Larson, EB; Crane, PK				Bauman, Julianna; Gibbons, Laura E.; Moore, Mackenzie; Mukherjee, Shubhabrata; McCurry, Susan M.; McCormick, Wayne; Bowen, James D.; Trittschuh, Emily; Glymour, Maria; Mez, Jesse; Saykin, Andrew J.; Dams-O'Conner, Kristen; Bennett, David A.; Larson, Eric B.; Crane, Paul K.		Executive Prominent AD EPAD Invest	Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Cognition; cognitively-defined Alzheimer's disease subgroups; depression; psychometrics; restless sleep; traumatic brain injury	SYMPTOMS; RISK	Background: There is considerable heterogeneity in clinical presentation among people with late-onset Alzheimer's disease (LOAD). We have categorized people with LOAD into subgroups based on relative impairments across cognitive domains. These 6 groups are people with no relatively impaired domains (AD-No Domains), 4 groups with one relatively impaired domain (AD-Memory, AD-Executive, AD-Language, and AD-Visuospatial), and a group with multiple relatively impaired domains (AD-Multiple Domains). Our previous analysis demonstrated that genetic factors vary across cognitively-defined LOAD groups. Objective: To determine whether risks associated with depression and traumatic brain injury with loss of consciousness (TBI) for cognitively defined LOAD subgroups are similar. Methods: We used cognitive data at LOAD diagnosis from three prospective cohort studies to determine cognitively-defined subgroups. We compared subgroups in endorsement of items from the Centers for Epidemiological Studies Depression (CES-D) scale and history of TBI. Results: Among 1,505 people with LOAD from the three studies, there were substantial differences across subgroups in total CES-D score, with lower scores (less depression) for people with AD with relative impairments in memory (AD-Memory) compared to those in other groups. Differences were noteworthy for the sleep-related item of the CES-D, as people with AD-Memory were less likely to report restless sleep than people in other groups. There were no differences in TBI history across groups. Conclusions: Differences in risk factor associations across subgroups such as differences in endorsement of depression symptoms and restless sleep provide support for the hypothesis that there are biologically coherent subgroups of AD.	[Bauman, Julianna; Moore, Mackenzie] Univ Washington, Coll Arts & Sci, Seattle, WA 98104 USA; [Gibbons, Laura E.; Mukherjee, Shubhabrata; McCormick, Wayne; Crane, Paul K.] Univ Washington, Dept Med, Box 359780,325 Ninth Ave, Seattle, WA 98104 USA; [McCurry, Susan M.] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98104 USA; [Bowen, James D.] Swedish Med Ctr, Dept Neurol, Seattle, WA USA; [Trittschuh, Emily] Geriatr Res Educ & Clin Ctr, VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Trittschuh, Emily] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Glymour, Maria] Univ San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA; [Mez, Jesse] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimers Dis Ctr, Indianapolis, IN 46202 USA; [Dams-O'Conner, Kristen] Mt Sinai Icahn Sch Med, Dept Rehabil Med, New York, NY USA; [Bennett, David A.] Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Larson, Eric B.] Kaiser Permenente Washington Hlth Res Inst, Seattle, WA USA		Crane, PK (corresponding author), Univ Washington, Dept Med, Box 359780,325 Ninth Ave, Seattle, WA 98104 USA.	pcrane@uw.edu	McCurry, Susan M/E-4731-2015	McCurry, Susan M/0000-0001-8624-3772	 [R01 AG042437];  [R01 AG029672];  [K23 AG046377];  [P50 AG005136];  [P30 AG010133];  [R01 AG019771];  [U01 AG006781];  [R01 AG017917];  [P30 AG10161];  [R01 AG15819];  [R01 AG30146]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG046377, R01AG015819] Funding Source: NIH RePORTER	Analyses were funded by R01 AG042437 (P Crane, PI) and R01 AG029672 (P Crane, PI). Dr. Mez's efforts were also supported by K23 AG046377 (J Mez, PI). The efforts of Dr. Gibbons were also supported by P50 AG005136 (T Grabowski, PI). Dr. Saykin's efforts were supported by P30 AG010133 (A Saykin, PI) and R01 AG019771 (A Saykin, PI).; ACT data collection was supported by U01 AG006781 (E Larson and P Crane, MPIs).; MAP data collection was supported by R01 AG017917 (D Bennett, PI). ROS data collection was supported by P30 AG10161 (D Bennett, PI), R01 AG15819 (D Bennett, PI), and R01 AG30146 (D Evans, PI).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Blennow K, 1992, J Geriatr Psychiatry Neurol, V5, P106; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Crane PK, 2017, ALZHEIMERS DEMENT, V13, P1307, DOI 10.1016/j.jalz.2017.04.011; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crane PK, 2016, ALZHEIMERS DEMENT, V12, P419, DOI 10.1016/j.jalz.2015.10.007; Groot C, 2018, ALZHEIMERS DEMENT S, V14, pP76; Hayakawa YK, 2014, NEUROIMAGE-CLIN, V4, P481, DOI 10.1016/j.nicl.2014.03.002; Komarova NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002251; Lam B, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt155; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Mattis S, 1988, DEMENTIA RATING SCAL; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mukherjee S, 2020, MOL PSYCHIATR, V25, P3100, DOI 10.1038/s41380-019-0348-x; Mukherjee S, 2020, MOL PSYCHIATR, V25, P2942, DOI 10.1038/s41380-018-0298-8; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitz C, 2007, J NEUROL SCI, V257, P194, DOI 10.1016/j.jns.2007.01.030; Spreen O, 1991, COMPENDIUM NEUROPSYC; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weschler D, 1987, WMS R WESCHLER MEMOR; Wilson RS, 2002, NEUROLOGY, V59, P364, DOI 10.1212/WNL.59.3.364	28	3	3	2	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	70	2					609	617		10.3233/JAD-181212			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK8SO	WOS:000476865800025	31256124				2022-02-06	
J	Carone, L; Ardley, R; Davies, P				Carone, Laura; Ardley, Rohan; Davies, Patrick			Cycling related traumatic brain injury requiring intensive care: association with non-helmet wearing in young people	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Bike safety; Intensive care; Neurological deficit; Helmets	BICYCLE HELMET; HEAD-INJURIES; TRENDS	Introduction: Traumatic injury is the leading cause of death in children after infancy. Almost 25% of all cyclists killed in the UK are children, and two thirds of these will die because of their head injuries. We compared the population of young people wearing helmets whilst cycling, to those admitted with serious post cycling head injuries to our paediatric critical care unit. Method: All children aged 0-18 years admitted to our intensive care following a bicycle accident between the years January 2011-June 2018 were identified and information on the mechanism of injury, and both immediate and long term clinical data were collected. For comparison data, helmet wearing on a random morning was observed from six schools. All pupils arriving at school by bicycle were observed. Data collected included the school year and sex of the child, and whether each child was wearing a helmet or not. Results: Of 28 cases, 22 were admitted due to head injuries. None wore a helmet. 23/133 school pupils wore a helmet. The intensive care population were significantly less likely to be wearing helmets than the general population (p = 0.044, Fisher's exact test). A Chi-Square test for helmet wearing by school year showed a reduction in helmet wearing with increasing school year with a p value of 0.0026. There was no association between helmet wearing and abdominal injury. Conclusion: Young people admitted to a Critical Care Unit with cycling related head trauma are statistically significantly less likely to wear a helmet than the general, age matched cycling population. Helmet wearing decreases as children get older. Outcomes were mixed, but in the head trauma group only 3/18 recovered with no neurological deficit (C) 2018 Elsevier Ltd. All rights reserved.	[Carone, Laura] LNR Deanery, Leicester, Leics, England; [Ardley, Rohan] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Davies, Patrick] Nottingham Childrens Hosp, Paediat Crit Care Unit, Nottingham, England; [Davies, Patrick] Univ Nottingham, Nottingham, England		Carone, L (corresponding author), LNR Deanery, Leicester, Leics, England.	laurajayne.carone@nhs.net; rardley@doctors.org.uk; Patrick.davies@nuh.nhs.uk					Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Berg P, 2001, Inj Prev, V7, P218, DOI 10.1136/ip.7.3.218; Berg P, 2007, HEALTH PROMOT INT, V22, P191, DOI 10.1093/heapro/dam020; BERGMAN AB, 1990, AM J DIS CHILD, V144, P727, DOI 10.1001/archpedi.1990.02150300127033; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Cryer P C, 1998, Inj Prev, V4, P106; DANNENBERG AL, 1993, AM J PUBLIC HEALTH, V83, P667, DOI 10.2105/AJPH.83.5.667; Dennis J., 2013, BMJ, V346; DIGUISEPPI CG, 1990, AM J DIS CHILD, V144, P83, DOI 10.1001/archpedi.1990.02150250093041; Dowd MD, 2002, CRIT CARE MED, V30, pS385, DOI 10.1097/00003246-200211001-00002; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; Grimard G, 1995, Inj Prev, V1, P21, DOI 10.1136/ip.1.1.21; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Kendrick D, 2003, ARCH DIS CHILD, V88, P876, DOI 10.1136/adc.88.10.876; Knowles J, COLLISIONS INVOLVING; Lajunen T, 2001, J SAFETY RES, V32, P323, DOI 10.1016/S0022-4375(01)00056-1; Lee A J, 2000, Inj Prev, V6, P151, DOI 10.1136/ip.6.2.151; Loubeau PR, 2000, ACCIDENT ANAL PREV, V32, P111, DOI 10.1016/S0001-4575(99)00059-7; The Royal Society for Prevention of Accidents, 2015, ROAD SAF INF CYCL AC; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 1999, COCHRANE DATABASE SY, V4; Towner P, 1992, Fam Med, V24, P156; Wesson D, 2000, J PEDIATR SURG, V35, P688, DOI 10.1053/jpsu.2000.5944; WORRELL J, 1987, INJURY, V18, P5, DOI 10.1016/0020-1383(87)90373-1	24	3	3	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2019	50	1					61	64		10.1016/j.injury.2018.08.015			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HG1LR	WOS:000454717700012	30197205				2022-02-06	
J	Celeghin, A; Galetto, V; Tamietto, M; Zettin, M				Celeghin, Alessia; Galetto, Valentina; Tamietto, Marco; Zettin, Marina			Emotion Recognition in Low-Spatial Frequencies Is Partly Preserved following Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							FACIAL AFFECT RECOGNITION; NEURAL SYSTEMS; HUMAN AMYGDALA; HEAD-INJURY; PERCEPTION; DEFICITS; FACES; DYSFUNCTION; BLINDSIGHT; EXPRESSION	After a Traumatic Brain Injury (TBI), emotion recognition is typically impaired. This is commonly attributed to widespread multifocal damage in cortical areas involved in emotion processing as well as to Diffuse Axonal Injury (DAI). However, current models suggest that emotional recognition is subserved by a distributed network cantered on the amygdala, which involves both cortical and subcortical structures. While the cortical system is preferentially tuned to process high spatial frequencies, the subcortical networks are more sensitive to low-spatial frequencies. The aim of this study was to evaluate whether emotion perception from low-spatial frequencies underpinning the subcortical system is relatively preserved in TBI patients. We tested a group of 14 subjects with severe TBI and 20 matched healthy controls. Each participant was asked to recognize the emotion expressed by each stimulus that consisted of happy and fearful faces, filtered for their low and high spatial frequencies components. Results in TBI patients' performances showed that low-spatial frequency expressions were recognized with higher accuracy and faster reaction times when compared to high spatial frequency stimuli. On the contrary, healthy controls did not show any effect in the two conditions, neither for response accuracy nor for reaction times. The outcomes of this study indicate that emotion perception from low-spatial frequencies is relatively preserved in TBI, thereby suggesting spare of functioning in the subcortical system in mediating emotion recognition.	[Celeghin, Alessia; Tamietto, Marco; Zettin, Marina] Univ Torino, Dept Psychol, I-10123 Turin, Italy; [Galetto, Valentina] CHU Caremeau, Nimes, France; [Galetto, Valentina; Zettin, Marina] Ctr Puzzle, I-10137 Turin, Italy; [Tamietto, Marco] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Tamietto, Marco] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Adv Study Humanities & Social Sc, NL-1001 EW Amsterdam, Netherlands		Celeghin, A (corresponding author), Univ Torino, Dept Psychol, I-10123 Turin, Italy.	alessia.celeghin@unito.it		Zettin, Marina/0000-0002-5298-5329	PRIN 2015 grant [2015NA4S55]; ERC Consolidator grant 2017 [772953]	Alessia Celeghin and Marco Tamietto are supported by a PRIN 2015 grant [2015NA4S55] and by an ERC Consolidator grant 2017 [772953].	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P1281, DOI 10.1016/S0028-3932(03)00064-2; Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; Burra N, 2019, NEUROPSYCHOLOGIA, V128, P44, DOI 10.1016/j.neuropsychologia.2017.10.009; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Celeghin A, 2017, P NATL ACAD SCI USA, V114, pE10475, DOI 10.1073/pnas.1714801114; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Gelder BC, 2003, P NATL ACAD SCI USA, V100, P13105, DOI 10.1073/pnas.1735530100; de Gelder B, 2006, NEUROREPORT, V17, P583, DOI 10.1097/00001756-200604240-00006; Deruelle C, 2005, J EXP CHILD PSYCHOL, V90, P172, DOI 10.1016/j.jecp.2004.09.001; Diano M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45260; Diano M, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02029; Ekman P., 1976, PICTURES OF FACIAL A; Ferrari C, 2016, CEREB CORTEX, V26, P156, DOI 10.1093/cercor/bhu186; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Garvert MM, 2014, NEUROIMAGE, V102, P309, DOI 10.1016/j.neuroimage.2014.07.047; Gonzalez Rafael R. C., 2004, DIGITAL IMAGE PROCES; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grossi D, 2005, INT J GERIATR PSYCH, V20, P668, DOI 10.1002/gps.1339; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jennet B., 1981, MANAGEMENT BRAIN INJ, P258; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; LEDOUX J E, 1992, P339; LeDoux J.E., 1996, EMOTIONAL BRAIN; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; Mendez-Bertolo C, 2016, NAT NEUROSCI, V19, P1041, DOI 10.1038/nn.4324; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Negro E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129970; Perrett D. I., 2002, FACIAL EXPRESSION EM; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rotshtein P, 2007, CEREB CORTEX, V17, P2713, DOI 10.1093/cercor/bhl180; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tamietto M, 2005, NEUROCASE, V11, P399, DOI 10.1080/13554790500259717; Tamietto M, 2008, NEUROPSYCHOLOGIA, V46, P820, DOI 10.1016/j.neuropsychologia.2007.11.002; Tamietto M, 2016, CURR BIOL, V26, pR70, DOI 10.1016/j.cub.2015.11.026; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; Van den Stock J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00030; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038; Yassin W, 2017, BRAIN INJURY, V31, P624, DOI 10.1080/02699052.2017.1285052; Zettin M., 2016, J BEHAV BRAIN SCI, V6, P233, DOI [10.4236/jbbs.2016.66024, DOI 10.4236/JBBS.2016.66024]	61	3	3	3	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2019	2019								9562935	10.1155/2019/9562935			10	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	HL0NL	WOS:000458391100001	30809551	Green Published, Green Submitted, gold			2022-02-06	
J	Chendrasekhar, A				Chendrasekhar, Akella			Persistent symptoms in mild pediatric traumatic brain injury	PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS			English	Article						pediatric; concussion; persistent symptoms	HEAD-INJURY; OUTCOMES	Background: Traumatic brain injury (TBI) is the leading cause of morbidity and mortality for children in the US. The objective was to examine the epidemiology of self-reported neurologic and neuro-psychiatric symptoms in pediatric patients with mild TBI within 14 months post-injury. Methods: A telephone based survey was conducted on all pediatric patients (aged<15 years) with a mild traumatic brain injury diagnosed at our urban level 1 adult/level 2 pediatric trauma center within 1 year. Subjects were identified by our trauma registry, and medical records were reviewed for demographic data and mechanism of injury. Parents or guardians were interviewed using a standardized questionnaire to collect data regarding the presence or absence of headaches, weakness, numbness, coordination impairment, speech impairment, nausea, vomiting, confusion, short-term memory impairment, sleep disturbances, anhedonia, depression, anxiety, fear, and agitation. Results: Thirty-three parents of patients responded. The average age of the patients at time of TBI was 9.3 +/- 1.7 years. The age range was 3-14 years. The mechanisms of injury included pedestrian struck (54.5%), fall (39.4%), motor vehicle collision (3%), and assault (3%). The time from injury was stratified into 1-3 months (n=9), 4-6 months (n=9), 7-9 months (n=6), and 10-12 months (n=8), one patient surveyed was 14 months post-injury. Headaches (39.4%), anxiety (30.3%), fear (18.2%), and anhedonia (18.2%) were the most frequently reported symptoms. Less common were sleep disturbances (12.1%), depression (9.1%), nausea (6.1%), coordination impairment (6.1%), short-term memory impairment (6.1%), weakness (3%), numbness (3%), vomiting (3%), and agitation (3%). There were no instances of speech impairment. Conclusions: Approximately 1/3 of patients complained of anxiety post-injury, and 1/5 reportedly experienced anhedonia and fear. Considering the ongoing neurologic and psychosocial development of the pediatric population, long-term follow-up and periodic screening examinations should be considered in patients diagnosed with TBI.	[Chendrasekhar, Akella] Richmond Univ, Dept Surg, Med Ctr, 355 Bard Ave, Staten Isl, NY 10310 USA; [Chendrasekhar, Akella] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA		Chendrasekhar, A (corresponding author), Richmond Univ, Dept Surg, Med Ctr, 355 Bard Ave, Staten Isl, NY 10310 USA.	chendrasekharakella@gmail.com					Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Lee JB, 2018, DEV NEUROSCI-BASEL, V40, P358, DOI 10.1159/000494134; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440	7	3	3	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1179-9927		PEDIATR HEALTH MED T	Pediatr. Health Med. Ther.		2019	10						57	60		10.2147/PHMT.S206388			4	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	IF2DZ	WOS:000472889100001	31289449	gold, Green Submitted, Green Published			2022-02-06	
J	Deotto, A; Westmacott, R; Fuentes, A; deVeber, G; Desrocher, M				Deotto, Angela; Westmacott, Robyn; Fuentes, Amanda; deVeber, Gabrielle; Desrocher, Mary			Does stroke impair academic achievement in children? The role of metacognition in math and spelling outcomes following pediatric stroke	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Academic achievement; children; executive functioning; math; metacognition; pediatric; stroke	ARTERIAL ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; COGNITIVE OUTCOMES; CHILDHOOD STROKE; WORKING-MEMORY; LESION; MATHEMATICS; AGE; PLASTICITY	Introduction: Current research suggests that pediatric stroke is associated with a reduction in intellectual functioning. However, less is known about academic achievement and the contribution of specific executive functions to math and literacy in this population. The current study investigates behavioral ratings of executive functioning and their relationship to math and spelling performance in children with a history of unilateral arterial ischemic stroke.Method: Thirty-two pediatric patients with stroke (M-age=9.52.7years) and 32 demographically equivalent, healthy controls were tested on standardized measures of arithmetic, spelling, and intelligence. Executive functioning data were collected via standardized parent questionnaire.Results: Relative to controls, stroke participants demonstrated significantly poorer functioning in math, spelling, metacognition, and behavioral-regulation. Pencil and paper arithmetic was particularly challenging for the stroke group, with 40% of patients reaching levels of clinical impairment. Hierarchical regression in stroke participants further revealed that metacognition was a robust predictor of academic deficits. Stroke occurring in later childhood and affecting cortical and subcortical brain regions also presented as potential clinical risk factors.Conclusions: Children with stroke were especially vulnerable to math achievement deficits. Metacognition made a substantial contribution to academic achievement abilities among stroke patients, and results underscore the importance of early metacognitive skills in the completion of schoolwork. Results also emphasize that pediatric stroke patients are a heterogeneous group with regard to functioning and that there is value in examining standard score distributions of clinical participant samples.	[Deotto, Angela; Fuentes, Amanda; Desrocher, Mary] York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Westmacott, Robyn] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada; [deVeber, Gabrielle] Hosp Sick Children, Div Neurol, Dept Pediat, Toronto, ON, Canada		Deotto, A (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	adeotto@yorku.ca			Canadian Institutes of Health Research (CIHR): Institute of Neurosciences, Mental Health and Addiction [201510GSD-368152-221047]; York University, Faculty of Health [400 496085]	This work was supported by the Canadian Institutes of Health Research (CIHR): Institute of Neurosciences, Mental Health and Addiction [funding reference number 201510GSD-368152-221047]; and York University, Faculty of Health [grant number 400 496085].	Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Allman C, 2013, CHILD NEUROPSYCHOL, V19, P97, DOI 10.1080/09297049.2011.639756; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Araujo GC, 2017, J INT NEUROPSYCH SOC, V23, P529, DOI 10.1017/S1355617717000364; Atkinson H., 2018, PEDIAT STROKE REHABI; Avila L, 2010, J CHILD NEUROL, V25, P829, DOI 10.1177/0883073809350724; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; Barnes M. A., 2007, WHY IS MATH SO HARD, P195; Bernier A, 2010, CHILD DEV, V81, P326, DOI 10.1111/j.1467-8624.2009.01397.x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Block GW, 1999, CHILD NEUROPSYCHOL, V5, P81, DOI 10.1076/chin.5.2.81.3169; Brock LL, 2009, EARLY CHILD RES Q, V24, P337, DOI 10.1016/j.ecresq.2009.06.001; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Cardenas JF, 2011, CHILD NERV SYST, V27, P1375, DOI 10.1007/s00381-010-1366-9; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Cohen J., 2013, STAT POWER ANAL BEHA; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Eve M, 2016, APPL NEUROPSYCH-CHIL, V5, P273, DOI 10.1080/21622965.2015.1055563; Feldman HM, 2002, BRAIN LANG, V83, P335, DOI 10.1016/S0093-934X(02)00037-8; FESTA JR, 2008, TXB CLIN NEUROPSYCHO, P363; Friedman Neil, 2009, Adv Pediatr, V56, P271, DOI 10.1016/j.yapd.2009.08.003; Fuentes A, 2017, CHILD NEUROPSYCHOL, V23, P803, DOI 10.1080/09297049.2016.1205008; Fuentes A, 2016, CHILD NEUROPSYCHOL, V22, P1, DOI 10.1080/09297049.2014.969694; Funnell E, 2010, CORTEX, V46, P1248, DOI 10.1016/j.cortex.2010.06.013; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Gennaro M., 2010, CRITICAL REV DOES HA; Gioia GA IP, 2000, BEHAV RATING INVENTO; Hajek CA, 2014, J CHILD NEUROL, V29, P887, DOI 10.1177/0883073813491828; Hartel C, 2004, EUR J NEUROL, V11, P431, DOI 10.1111/j.1468-1331.2004.00861.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jacomb I, 2018, CHILD NEUROPSYCHOL, V24, P287, DOI 10.1080/09297049.2016.1265102; KELLY KR, 1993, GIFTED CHILD QUART, V37, P59, DOI 10.1177/001698629303700202; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Levine SC, 2005, BRAIN COGNITION, V59, P114, DOI 10.1016/j.bandc.2005.05.008; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Long B, 2011, J CHILD NEUROL, V26, P279, DOI 10.1177/0883073810380049; Mackay MT, 2016, J PAEDIATR CHILD H, V52, P158, DOI 10.1111/jpc.13086; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Max JE, 2010, J NEUROPSYCH CLIN N, V22, P30, DOI 10.1176/appi.neuropsych.22.1.30; Mazzocco M. M. M., 2007, WHY IS MATH SO HARD, P29; Meltzer L., 2007, EXECUTIVE FUNCTION E; O'Keeffe F, 2014, CHILD NEUROPSYCHOL, V20, P557, DOI 10.1080/09297049.2013.832740; Rodrigues SD, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/369836; Sanders C, 1997, PERCEPT MOTOR SKILL, V85, P477; Shallice T, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P943; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tall S., 1999, DIRASAT ED SCI, V26, P232; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Till C, 2011, NEUROREPORT, V22, P1005, DOI 10.1097/WNR.0b013e32834dc301; Vargha-Khadem F, 1994, J Child Neurol, V9 Suppl 2, P67; Wechsler D., 2011, WECHSLER ABBREVIATED; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Westmacott R, 2009, STROKE, V40, P2012, DOI 10.1161/STROKEAHA.108.533976; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Woolpert D, 2016, NEUROPSYCHOLOGIA, V89, P105, DOI 10.1016/j.neuropsychologia.2016.06.005; Yvon E, 2018, DEV NEUROREHABIL, V21, P83, DOI 10.1080/17518423.2016.1247923	60	3	3	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2019	41	3					257	269		10.1080/13803395.2018.1533528			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HN0VU	WOS:000459907300004	30350753				2022-02-06	
J	Dubiel, R; Williams, B; Sullivan, E; Callender, L; Bennett, M; Driver, S				Dubiel, Rosemary; Williams, Benecia; Sullivan, Erin; Callender, Librada; Bennett, Monica; Driver, Simon			Prevalence of 25-hydroxyvitamin D deficiency in the acute rehabilitation population following traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injuries; vitamin D; rehabilitation	VITAMIN-D DEFICIENCY; ASSOCIATION	OBJECTIVE: To determine the prevalence of vitamin D deficiency among individuals with traumatic brain injury (TBI) undergoing acute inpatient rehabilitation. SETTING: Inpatient rehabilitation. PARTICIPANTS: Participants were admitted from November 1st, 2010 through June 30th, 2015 with diagnosis of mildsevere TBI and had serum 25 OH vitamin D levels checked upon admission. 369 out of 845 met inclusion. DESIGN: Retrospective cohort. MAIN MEASURES: 25 OH vitamin D, vitamin D treatment. RESULTS: The majority of patients were male (67%), Caucasian (89%) with private insurance (61%) and a mean age of 43.5 +/- 21.0 years. 25 OH vitamin D levels were categorized: deficient (<20 ng/mL), insufficient (20-29.9 ng/mL), and sufficient (>= 30 ng/mL). There were 95 (26%) patients that were deficient, 131 (36%) that were insufficient, and 143 (39%) that were sufficient. Race/ethnicity was found to be significant (p = 0.0145) with the largest percentage of Hispanics found in the insufficient and deficient categories, and the largest percentage of Blacks in the deficient category. Most patients with deficient or insufficient vitamin D levels were prescribed vitamin D replacement during their rehab stay (p < 0.0001). CONCLUSION: The majority of patients undergoing acute inpatient rehabilitation were found to have insufficient or deficient vitamin D levels, therefore it should be routinely screened and treated as indicated.	[Dubiel, Rosemary; Williams, Benecia; Sullivan, Erin; Callender, Librada; Driver, Simon] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Dubiel, Rosemary; Williams, Benecia; Callender, Librada; Bennett, Monica; Driver, Simon] Baylor Univ, Med Ctr Dallas, Dallas, TX USA		Dubiel, R (corresponding author), Baylor Inst Rehabil Dallas, 909 North Washington Ave, Dallas, TX 75246 USA.	rdubiel@bir-rehab.com		driver, simon/0000-0003-2356-432X			Boonen S, 2006, CALCIFIED TISSUE INT, V78, P257, DOI 10.1007/s00223-005-0009-8; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; GLOTH FM, 1995, J AM GERIATR SOC, V43, P822, DOI 10.1111/j.1532-5415.1995.tb07059.x; Grammatiki M, 2017, REV ENDOCR METAB DIS, V18, P227, DOI 10.1007/s11154-016-9403-y; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Houston DK, 2007, J GERONTOL A-BIOL, V62, P440, DOI 10.1093/gerona/62.4.440; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; Kiebzak GM, 2007, AM J PHYS MED REHAB, V86, P435, DOI 10.1097/PHM.0b013e31805b7e20; Kimlin MG, 2008, MOL ASPECTS MED, V29, P453, DOI 10.1016/j.mam.2008.08.005; Muscogiuri G, 2017, INT J CARDIOL, V230, P577, DOI 10.1016/j.ijcard.2016.12.053; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Shan N. L., 2016, J STEROID BIOCHEM; Shinchuk LM, 2006, ARCH PHYS MED REHAB, V87, P904, DOI 10.1016/j.apmr.2006.03.009; van der Schaft J, 2013, AGEING RES REV, V12, P1013, DOI 10.1016/j.arr.2013.05.004	17	3	3	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	45	4					513	517		10.3233/NRE-192888			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC0CJ	WOS:000506854000010	31868688	Bronze			2022-02-06	
J	Gaston, TE; Nair, S; Allendorfer, JB; Martin, RC; Beattie, JF; Szaflarski, JP				Gaston, Tyler E.; Nair, Sangeeta; Allendorfer, Jane B.; Martin, Roy C.; Beattie, Julia Fleming; Szaflarski, Jerzy P.			Memory response and neuroimaging correlates of a novel cognitive rehabilitation program for memory problems in epilepsy: A pilot study	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Memory; epilepsy; memory impairment; rehabilitation; intervention; fMRI; paired associate learning task	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; SELF-GENERATION; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; DEPRESSED MOOD; VERBAL MEMORY; FMRI; ACTIVATION	Background: Memory deficits are very common in epilepsy, but no standard of care exists to effectively manage them. Objective: We assessed effectiveness of cognitive rehabilitation (CR) on memory and neural plasticity in people with epilepsy (PWE) reporting memory impairments. Methods: Nine PWE completed 6 weekly sessions adapted from 2 generic CR programs enriched with information regarding epilepsy. Participants completed neuropsychological, mood, and quality of life (QOLIE-31) measures prior and after completion of CR; 5/9 participants also completed pre- and post-CR fMRI while performing a verbal paired associates learning task. FMRI data were analyzed using group spatial independent components analysis methods; paired t-tests compared spatial activations for pre-/post-CR. Results: Improvements were seen in immediate recall in Rey Auditory Verbal Learning Task, QOLIE-31, and read word recognition in paired associates task (all p's <= 0.05). FMRI changes comparing pre-to-post CR were noted through increased activation in the left inferior frontal gyrus (IFG) and anterior cingulate and decreased activation in the left superior temporal gyrus; also noted were decreased activations in the default mode network (DMN), right cingulate, right middle temporal gyrus, right supramarginal gyrus, and increased DMN activation in the left cuneus. Conclusions: This study demonstrates feasibility of conducting CR program in PWE with fMRI as a mechanistic biomarker. Improvements in cognition and cortical plasticity await confirmation in larger samples.	[Gaston, Tyler E.; Nair, Sangeeta; Allendorfer, Jane B.; Martin, Roy C.; Beattie, Julia Fleming; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35249 USA; [Nair, Sangeeta; Beattie, Julia Fleming] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35249 USA; [Gaston, Tyler E.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept UAB Epilepsy Ctr, Birmingham, AL 35249 USA; [Gaston, Tyler E.] Birmingham Vet Adm Med Ctr, Birmingham, AL USA; [Beattie, Julia Fleming] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA		Gaston, TE (corresponding author), Univ Alabama Birmingham, UAB Epilepsy Ctr, Dept Neurol, 1719 6th Ave South,CIRC 312, Birmingham, AL 35249 USA.	tegaston@uabmc.edu		Martin, Roy/0000-0001-9328-0846; Nair, Sangeeta/0000-0001-9968-151X			Allendorfer JB, 2012, MED SCI MONITOR, V18, pCR135, DOI 10.12659/MSM.882518; ANDREWES DG, 1990, NEUROPSYCHOLOGIA, V28, P957, DOI 10.1016/0028-3932(90)90111-Z; Baker GA, 1997, EPILEPSIA, V38, pS1, DOI 10.1111/j.1528-1157.1997.tb04511.x; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Benarroch E.E., 2012, PRIMER AUTONOMIC NER, V3rd, P9; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Black LC, 2010, EPILEPSY BEHAV, V17, P412, DOI 10.1016/j.yebeh.2010.01.006; Brueggen K, 2017, J ALZHEIMERS DIS, V57, P1315, DOI 10.3233/JAD-160771; Caller TA, 2016, EPILEPSY BEHAV, V57, P111, DOI 10.1016/j.yebeh.2016.01.024; Campbell J, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4292585; Cechetto DF, 2017, CEREBRAL CORTEX IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS: EXPERIMENTAL APPROACHES TO CLINICAL ISSUES, pXV; Cersosimo Maria G, 2013, Handb Clin Neurol, V117, P45, DOI 10.1016/B978-0-444-53491-0.00005-5; Choi J, 2013, NEUROPSYCHOL REV, V23, P48, DOI 10.1007/s11065-013-9227-4; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cramer JA, 1998, EPILEPSIA, V39, P81, DOI 10.1111/j.1528-1157.1998.tb01278.x; Del Felice A, 2017, AM J PHYS MED REHAB, V96, P506, DOI 10.1097/PHM.0000000000000714; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Diez-Cirarda M, 2017, BRAIN IMAGING BEHAV, V11, P1640, DOI 10.1007/s11682-016-9639-x; Dilorio C, 1992, J Neurosci Nurs, V24, P9; Dupont S, 2012, ACTA NEUROL SCAND, V126, P29, DOI 10.1111/ane.12017; Egeland J, 2015, APPL NEUROPSYCH-ADUL, V22, P445, DOI 10.1080/23279095.2014.992069; Eliassen JC, 2008, EPILEPSY BEHAV, V13, P463, DOI 10.1016/j.yebeh.2008.06.011; Farina E, 2015, EPILEPSY RES, V109, P210, DOI 10.1016/j.eplepsyres.2014.10.017; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Fisher RS, 2001, EPILEPSY BEHAV, V2, P330, DOI 10.1006/ebeh.2001.0221; Fritz N, 2005, EPILEPSY BEHAV, V6, P373, DOI 10.1016/j.yebeh.2005.01.002; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Geraldi CD, 2017, ARQ NEURO-PSIQUIAT, V75, P359, DOI [10.1590/0004-282X20170050, 10.1590/0004-282x20170050]; Griffith NM, 2005, EPILEPSY BEHAV, V7, P266, DOI 10.1016/j.yebeh.2005.05.004; Hampstead BM, 2012, HIPPOCAMPUS, V22, P1652, DOI 10.1002/hipo.22006; Helmstaedter C, 2004, EPILEPSY BEHAV, V5, P696, DOI 10.1016/j.yebeh.2004.06.008; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; HELMSTAEDTER C, 1994, EPILEPSIA, V35, P1073, DOI 10.1111/j.1528-1157.1994.tb02557.x; Helmstaedter C, 2001, CURR OPIN NEUROL, V14, P211, DOI 10.1097/00019052-200104000-00013; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kent GP, 2006, EPILEPSY BEHAV, V9, P469, DOI 10.1016/j.yebeh.2006.07.005; Kim KK, 2011, EPILEPSY BEHAV, V20, P613, DOI 10.1016/j.yebeh.2010.11.010; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Leidy NK, 2001, NEUROLOGY, V57, pS69; Leung IHK, 2015, NEUROLOGY, V85, P1843, DOI 10.1212/WNL.0000000000002145; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Mameniskiene R, 2016, EPILEPSY BEHAV, V63, P89, DOI 10.1016/j.yebeh.2016.07.029; Markand ON, 2000, EPILEPSIA, V41, P749, DOI 10.1111/j.1528-1157.2000.tb00238.x; Marmarou A, 2005, EPILEPSY RES, V64, P63, DOI 10.1016/j.eplepsyres.2005.03.001; McNair DM, 1971, PROFILE MOOD STATES; MITCHELL WG, 1992, PEDIATR NEUROL, V8, P19, DOI 10.1016/0887-8994(92)90047-3; Mitolo M, 2015, J NEUROL SCI, V354, P1, DOI 10.1016/j.jns.2015.05.004; Morris DM, 2019, J HEAD TRAUMA REHAB, V34, P268, DOI 10.1097/HTR.0000000000000460; Mosca C, 2014, EPILEPSY BEHAV CASE, V2, P167, DOI 10.1016/j.ebcr.2014.09.002; Mottaghy FM, 1999, EXP BRAIN RES, V128, P332, DOI 10.1007/s002210050853; Nauta IM, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0979-y; Paradiso S, 2001, J NEUROL NEUROSUR PS, V70, P180, DOI 10.1136/jnnp.70.2.180; Parisi L, 2014, BRAIN IMAGING BEHAV, V8, P387, DOI 10.1007/s11682-012-9160-9; Radford K., 2010, MAKING MOST YOUR MEM; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; Schefft BK, 2008, EPILEPSY BEHAV, V13, P162, DOI 10.1016/j.yebeh.2008.01.012; Schmithorst VJ, 2004, MAGN RESON MED, V51, P399, DOI 10.1002/mrm.10706; Siegel M, 2012, BRAIN BEHAV, V2, P789, DOI 10.1002/brb3.98; SMITH D, 1993, EPILEPSIA, V34, P312, DOI 10.1111/j.1528-1157.1993.tb02417.x; Starowicz-Filip A, 2017, PSYCHIATR POL, V51, P661, DOI 10.12740/PP/68547; Szaflarski JP, 2012, EPILEPSY BEHAV, V24, P74, DOI 10.1016/j.yebeh.2012.02.022; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vannest J, 2015, NEUROIMAGE-CLIN, V7, P537, DOI 10.1016/j.nicl.2015.02.006; Vannest J, 2012, BRAIN RES, V1437, P104, DOI 10.1016/j.brainres.2011.12.020; Wiebe S, 2002, J NEUROL NEUROSUR PS, V73, P116, DOI 10.1136/jnnp.73.2.116	68	3	3	2	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2019	37	5					457	468		10.3233/RNN-190919			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JG4IG	WOS:000492037200004	31282442				2022-02-06	
J	Grigg, N; Schoenrock, A; Dick, K; Green, JR; Golshani, A; Wong, A; Dehne, F; Tsai, EC; Biggar, KK				Grigg, Nashira; Schoenrock, Andrew; Dick, Kevin; Green, James R.; Golshani, Ashkan; Wong, Alex; Dehne, Frank; Tsai, Eve C.; Biggar, Kyle K.			Insights into the suitability of utilizing brown rats (Rattus norvegicus) as a model for healing spinal cord injury with epidermal growth factor and fibroblast growth factor-II by predicting protein-protein interactions	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Protein interaction; MP-PIPE; EGF; FGF-2; Spinal cord injury	DENSITY-LIPOPROTEIN RECEPTOR; FAMILY; SPECIFICITY; EXPRESSION; GENE	The stimulation of the proliferation and differentiation of neural stem cells (NSCs) offers the possibility of a renewable source of replacement cells to treat numerous neurological diseases including spinal cord injury, traumatic brain injury and stroke. Epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF-2) have been used to stimulate NSCs to renew, expand, and produce precursors for neural repair within an adult brown rat (Rattus norvegicus). To provide greater insight into the interspecies protein-protein interactions between human FGF-2 and EGF proteins and native R. norvegicus proteins, we have utilized the Massively Parallel Protein-Protein Interaction Prediction Engine (MP-PIPE) in an attempt to computationally shed light on the pathways potentially driving neurosphere proliferation. This study determined similar and differing protein interaction pathways between the two growth factors and the proteins in R. norvegicus compared with the proteins in H. sapiens. The protein-protein interactions predicted that EGF and FGF-2 may behave differently in rats than in humans. The identification and improved understanding of these differences may help to improve the clinical translation of NSC therapies from rats to humans.	[Grigg, Nashira; Golshani, Ashkan; Wong, Alex; Biggar, Kyle K.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Schoenrock, Andrew] Carleton Univ, Sch Comp Sci, Ottawa, ON, Canada; [Dick, Kevin; Green, James R.; Dehne, Frank] Carleton Univ, Dept Syst & Comp Engn, Ottawa, ON, Canada; [Golshani, Ashkan; Biggar, Kyle K.] Carleton Univ, Dept Biochem, Ottawa, ON, Canada; [Tsai, Eve C.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada		Biggar, KK (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	kyle_biggar@carleton.ca	Tsai, Eve/ABE-6056-2021; Tsai, Eve/D-7007-2014	Dick, Kevin/0000-0003-3931-523X; Green, James/0000-0002-6039-2355; Tsai, Eve/0000-0002-8152-349X	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC)	This research was funded by an NSERC discovery grant to KK Biggar.	Bodnar RJ, 2013, ADV WOUND CARE, V2, P24, DOI 10.1089/wound.2011.0326; Canadian Institute for Health Information, 2007, NON TRADITIONAL REF; Chen TC, 2014, J PROTEOME RES, V13, P5339, DOI 10.1021/pr5002737; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Dick K., 2017, COMP INT BIOINF COMP, P1; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fraser SP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0105; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gu HM, 2013, J LIPID RES, V54, P3345, DOI 10.1194/jlr.M041129; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hermann PM, 2000, J NEUROSCI, V20, P6355, DOI 10.1523/JNEUROSCI.20-17-06355.2000; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Hussaini IM, 1999, GLIA, V25, P71, DOI 10.1002/(SICI)1098-1136(19990101)25:1<71::AID-GLIA7>3.0.CO;2-0; Kazmirchuk T, 2017, COMPUT BIOL CHEM, V71, P180, DOI 10.1016/j.compbiolchem.2017.10.011; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Lo YH, 2012, J BIOL CHEM, V287, P27148, DOI 10.1074/jbc.M112.388843; Lou ZC, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007654; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Mestre H, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00108; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; Omidi K, 2018, GENE, V639, P128, DOI 10.1016/j.gene.2017.10.003; Omidi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087248; Park Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-419; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; Piecha D, 2002, BIOCHEM J, V367, P715, DOI 10.1042/BJ20021069; Pitre S, 2008, NUCLEIC ACIDS RES, V36, P4286, DOI 10.1093/nar/gkn390; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Samanfar B, 2017, THEOR APPL GENET, V130, P377, DOI 10.1007/s00122-016-2819-7; Schoenrock A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0383-1; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; SHIMOYAMA Y, 1991, JPN J CANCER RES, V82, P1263, DOI 10.1111/j.1349-7006.1991.tb01791.x; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Su ZJ, 2006, PROTEIN PEPTIDE LETT, V13, P785, DOI 10.2174/092986606777841280; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	37	3	3	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JAN	2019	104						220	226		10.1016/j.compbiomed.2018.11.026			7	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	HI9BU	WOS:000456751100023	30529711				2022-02-06	
J	Hale, AC; Bohnert, KM; Grekin, R; Sripada, RK				Hale, Andrew C.; Bohnert, Kipling M.; Grekin, Rebecca; Sripada, Rebecca K.			Traumatic Brain Injury in the General Population Incidence, Mental Health Comorbidity, and Functional Impact	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Traumatic brain injury; public health; epidemiology; incidence	POSTCONCUSSION SYNDROME; EXECUTIVE FUNCTION; PREVALENCE; RELIABILITY; SYMPTOMS; DISORDER; SEQUELAE; OUTCOMES	Traumatic brain injury (TBI) is a relatively prevalent and burdensome condition with significant public health cost; however, epidemiological studies of TBI in the United States have rarely used nationally representative samples or included measures of functioning. Data were obtained from the third wave of the National Epidemiological Survey on Alcohol and Related Conditions. Of the 36,309 individuals surveyed, 193 (0.53% weighted) reported a past-year TBI. Results from weighted logistic regression modeling indicated that prior active duty military status, mood disorders, posttraumatic stress disorder, and nicotine use disorders were associated with greater odds of TBI. Annual household income greater than $20,000 was associated with lower odds of TBI. Regarding functioning, TBI was associated with greater impairment on SF-12 scales measuring mental and physical health and the organization subscale of the Executive Function Index. Results suggest that many individuals in the US population experience TBI each year and that such injuries are associated with impairment across multiple domains.	[Hale, Andrew C.; Bohnert, Kipling M.; Sripada, Rebecca K.] VA Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Hale, Andrew C.; Bohnert, Kipling M.; Grekin, Rebecca; Sripada, Rebecca K.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Grekin, Rebecca] Severe Mental Illness Treatment Resource & Evalua, Ann Arbor, MI USA		Hale, AC (corresponding author), VA Ctr Clin Management Res, Ann Arbor, MI 48109 USA.	haleac@med.umich.edu			HSRD VA [IK2 HX000970] Funding Source: Medline		Bagalman, 2013, TRAUMATIC BRAIN INJU; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; BIAA (Brain Injury Association of America), 2011, BIAA AD NEW TBI DEF; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, C REP, P19; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Denney JT, 2014, SOC SCI RES, V43, P92, DOI 10.1016/j.ssresearch.2013.09.004; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faul M, 2015, HDB CLIN NEUROLOGY 1; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Grant BF, 2015, DRUG ALCOHOL DEPEN, V148, P27, DOI 10.1016/j.drugalcdep.2014.11.026; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, N ENGL J MED, V11; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Mitchell M, 2008, CLIN NEUROPSYCHOL, V22, P471, DOI 10.1080/13854040701336436; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; Steenland K, 2003, EPIDEMIOLOGY, V14, P74, DOI 10.1097/00001648-200301000-00017; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomsen CJ, 2011, J PSYCHIATR RES, V45, P1321, DOI 10.1016/j.jpsychires.2011.04.003; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	37	3	3	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	JAN	2019	207	1					38	42		10.1097/NMD.0000000000000915			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	HG8MH	WOS:000455255800007	30575707				2022-02-06	
J	Hansen, C; Battikha, M; Teramoto, M				Hansen, Colby; Battikha, Maya; Teramoto, Masaru			Complicated Mild Traumatic Brain Injury at a Level I Pediatric Trauma Center: Burden of Care and Imaging Findings	PEDIATRIC NEUROLOGY			English	Article						Mild traumatic brain injury; Imaging findings; Skull fracture; Complicated mild traumatic brain injury; Level I pediatric trauma center; Glasgow Coma Scale; Concussion	CRANIAL COMPUTED-TOMOGRAPHY; HEAD-INJURY; DECISION RULE; CHILDREN; PREDICTION; CONCUSSION; STATEMENT	OBJECTIVE: The aims of this study were: (1) to characterize mild traumatic brain injury (mTBI), mTBI with skull fracture, and complicated mTBI in school-aged children seen at a Level I pediatric trauma center and (2) to examine the nature of imaging findings seen in children with mTBI with skull fracture and those with complicated mTBI. METHODS: A total of 1777 pediatric patients (male: 1193 or 67.1%; age =11.1 +/- 3.5 years) sustaining mTBI who presented to the Emergency Department or directly to the trauma service in the years 2010 to 2013 were identified and classified into mTBI (n =1,319 or 74.2%), mTBI with skull fracture (n = 127 or 7.2%), and complicated mTBI (n = 331 or 18.6%). Patient characteristics and imaging findings were analyzed using descriptive statistics, Pearson's chi(2) test, Fisher's exact test, and logistic regression analysis. RESULTS: In children with complicated mTBI, subdural hematoma (36.9%) was the most common finding. Of the 331 children with complicated mTBI, 241 (72.8%) had multiple findings compared with one (0.8%) of 127 children having mTBI with skull fracture (Fisher's exact P < 0.001), with logistic regression analysis revealing younger age as a potential risk factor (P < 0.01). Children sustaining a depressed or complex skull fracture were nearly twice as likely as those with simple, linear skull fracture to have intracranial abnormality. CONCLUSIONS: Multiple radiographic findings in children sustaining mTBI with skull fracture or complicated mTBI are prevalent (72.8%), with younger age as a potential risk factor. (C) 2018 Elsevier Inc. All rights reserved.	[Hansen, Colby; Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84108 USA; [Battikha, Maya] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA		Teramoto, M (corresponding author), Univ Utah, Div Phys Med & Rehabil, Sch Med, 590 Wakara Way, Salt Lake City, UT 84108 USA.	Masaru.Teramoto@hsc.utah.edu	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483			American College of Surgeons, 2018, SEARCH VER TRAUM CTR; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Fabbri A, 2011, J TRAUMA, V70, pE79, DOI 10.1097/TA.0b013e3181d4885a; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guzel A, 2009, PEDIATR NEUROSURG, V45, P262, DOI 10.1159/000228984; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lumba-Brown A, 2016, REPORT PEDIAT MILD T; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	35	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	JAN	2019	90						31	36		10.1016/j.pediatrneurol.2018.09.015			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	HJ1AU	WOS:000456895100005	30415875				2022-02-06	
J	Houston, MN; Peck, KY; Malvasi, SR; Roach, SP; Svoboda, SJ; Cameron, KL				Houston, Megan N.; Peck, Karen Y.; Malvasi, Steven R.; Roach, Sean P.; Svoboda, Steven J.; Cameron, Kenneth L.			Reference values for the Balance Error Scoring System as measured by the Tekscan MobileMat in a physically active population	BRAIN INJURY			English	Article						Concussion management; normative values; postural stability	TRAUMATIC BRAIN-INJURY; BASE-LINE; POSTURAL STABILITY; CONCUSSION; SPORT; PERFORMANCE; EXERCISE; CHILDREN; SCAT2	Objectives: The Balance Error Scoring System (BESS) is commonly used to measure postural stability; however, it has demonstrated inconsistent reliability values when administered by humans. The Tekscan MobileMat was developed to automate the assessment of BESS errors and eliminate rater subjectivity. The objective of this study was to report reference values for the BESS, as measured by the MobileMat, and examine the effect of sex, concussion history, and competitive sport level on BESS performance.Methods: Four hundred and forty participants performed the BESS on the MobileMat. Participants were asked to maintain each stance with their eyes closed for 20s. The MobileMat was used to quantify the number of errors.Results: Concussion history (p =0.279-0.979) and competitive sport level (p =0.422-0.979) did not affect BESS performance. Males performed significantly better than females for the single-limb foam stance (p =0.032). No sex differences were detected for the other BESS stances or BESS total score (p =0.067-0.744).Conclusions: Previously reported reference values in collegiate athletes and adolescents were slightly higher thus highlighting the value in establishing population norms and in developing new technologies to objectively quantify BESS performance. Furthermore, sex, concussion history, and competitive sport level do not appear to influence BESS performance as measured by the MobileMat.	[Houston, Megan N.; Peck, Karen Y.; Malvasi, Steven R.; Roach, Sean P.; Cameron, Kenneth L.] Keller Army Community Hosp, Dept Orthopaed Surg, 900 Washington Rd, West Point, NY 10996 USA; [Svoboda, Steven J.] MedStar Georgetown Univ Hosp, Lafayette Ctr Orthopaed & Sports Med, Dept Orthopaed Surg, Washington, DC USA		Houston, MN (corresponding author), Keller Army Community Hosp, Dept Orthopaed Surg, 900 Washington Rd, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil		Cameron, Kenneth/0000-0002-6276-4482	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [HU0001-15-2-0037 (2988)]	This work was supported, in part, by the U.S. Army Medical Research and Materiel Command, under Grant [HU0001-15-2-0037 (2988)].	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alsalaheen B, 2016, BRAIN INJURY, V30, P914, DOI 10.3109/02699052.2016.1146965; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Caccese JB, 2016, J APPL BIOMECH, V32, P329, DOI 10.1123/jab.2015-0273; Caccese JB, 2016, J SPORT REHABIL, V25, P133, DOI 10.1123/jsr.2014-0281; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Susco TM, 2004, J ATHL TRAINING, V39, P241; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	35	3	3	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					299	304		10.1080/02699052.2018.1552021			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400005	30501390				2022-02-06	
J	Hunt, AW; Paniccia, M; Mah, K; Dawson, D; Reed, N				Hunt, Anne W.; Paniccia, Melissa; Mah, Katie; Dawson, Deirdre; Reed, Nick			Feasibility and Effects of the CO-OP Approach (TM) in Postconcussion Rehabilitation	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							CHILDREN; SPORT; CONCUSSION; ADULTS	OBJECTIVE. We determined the feasibility and effects of the Cognitive Orientation to daily Occupational Performance (CO-OP) Approach (TM) on activity performance and satisfaction. symptoms. and mood of adolescents with persistent postconcussion symptoms. METHOD. In a prospective case series. 3 participants with persistent symptoms 3 mo after concussion and difficulties resuming activities were taught to use a metacognitive strategy (Goal-Plan-Do-Check) to work toward occupation-based goals in a 7-wk intervention (10 sessions, 30-60 min each). Participants were assessed pre- and postintervention and at 3-mo follow-up. Feasibility was determined by positive changes on study measures. ease of administration, and acceptability to participants. RESULTS. Clinically significant. positive changes were found in participants. activity performance and satisfaction. All participants had decreases in symptoms and improved mood scores at posttest. CONCLUSION. The CO-OP Approach to rehabilitation for youth postconcussion is feasible and may make a positive contribution to recovery.	[Hunt, Anne W.] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Student Training & Intervent Res, Toronto, ON, Canada; [Hunt, Anne W.; Dawson, Deirdre; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Hunt, Anne W.; Mah, Katie; Dawson, Deirdre; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Paniccia, Melissa; Mah, Katie] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Ottawa, ON, Canada; [Paniccia, Melissa] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Dawson, Deirdre] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Toronto, ON, Canada; [Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Holland Chair Acquired Brain Injury, Bloorview Res Inst, Toronto, ON, Canada		Hunt, AW (corresponding author), Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Student Training & Intervent Res, Toronto, ON, Canada.; Hunt, AW (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.; Hunt, AW (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.	ahunt@hollandbloorview.ca	Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121	Ontario Society of Occupational Therapist's Research Fund Strategic Priorities Grant 2014-15	This research was funded by Ontario Society of Occupational Therapist's Research Fund Strategic Priorities Grant 2014-15 and is registered with ClinicalTrials.gov (NCT03195738). We are especially grateful to our participants for their time and commitment to this project and to Michelle Keightley for her support.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Law M., 2014, CANADIAN OCCUPATIONA, V5th; Mandich, 2004, ENABLING OCCUPATION; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McColl M. A., 2006, RES CANADIAN OCCUPAT; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Missiuna C, 2010, PHYS OCCUP THER PEDI, V30, P205, DOI 10.3109/01942631003761554; Polatajko HJ., 2017, COGNITIVE ORIENTATIO; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Steer, 2005, BECK YOUTH INVENTORI; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	21	3	3	0	2	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2019	73	1							7301205060	10.5014/ajot.2019.027995			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HW1UH	WOS:000466467600007	30839261				2022-02-06	
J	Jolly, AE; Raymont, V; Cole, JH; Whittington, A; Scott, G; De Simoni, S; Searle, G; Gunn, RN; Sharp, DJ				Jolly, Amy E.; Raymont, Vanessa; Cole, James H.; Whittington, Alex; Scott, Gregory; De Simoni, Sara; Searle, Graham; Gunn, Roger N.; Sharp, David J.			Dopamine D2/D3 receptor abnormalities after traumatic brain injury and their relationship to post-traumatic depression	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Dopamine; Depression; PET	D-3 RECEPTORS; PARKINSONS-DISEASE; MAJOR DEPRESSION; WHITE-MATTER; BINDING; D3; TRANSPORTER; COGNITION; STRIATUM; CINGULUM	Objective: To investigate dopamine D2/D3 receptor availability following traumatic brain injury (TBI) and their relationship to the presence of DSM-IV Major Depressive Disorder (MDD) and patterns of axonal injury. Methods: Twelve moderate-severe TBI patients and 26 controls were imaged using [C-11]PHNO positron emission tomography (PET) and structural magnetic resonance imaging (MRI). TBI patients and a second group of 32 controls also underwent diffusion tensor imaging (DTI) and neuropsychological assessment. Patients included six with post-injury MDD (TBI-MDD) and six without (TBI-NON). Non-displaceable binding potential (BPND) [C-11] PHNO values were used to index D2/D3 receptor availability, and were calculated using a reference region procedure. Differences in BP N p were examined using voxelwise and region-of-interest analyses. White matter microstructure integrity, quantified by fractional anisotropy (FA), was assessed and correlated with BPND. Results: Lower [C-11]PHNO BPND was found in the caudate across all TBI patients when compared to controls. Lower [C-11]PHNO BPNP was observed in the caudate of TBI-MDD patients and increased [C-11]PHNO BPND in the Amygdala of TBI-NON patients compared to controls. There were no significant differences in [C-11]PHNO BP. between TBI-MDD and TBI-NON patients. Furthermore, DTI provided evidence of axonal injury following TBI. The uncinate fasciculus and cingulum had abnormally low FA, with the uncinate particularly affected in TBIMDD patients. Caudate [C-11]PHNO BPND correlated with FA within the nigro-caudate tract. Conclusions: [C-11]PHNO BP ND is abnormal following TBI, which indicates post-traumatic changes in D2/D3 receptors. Patterns of [C-11]PHNO BPNP seen in patients with and without MDD suggest that further research would be beneficial to determine whether the use of dopaminergic treatment might be effective in the treatment of post-traumatic depression.	[Jolly, Amy E.; Raymont, Vanessa; Cole, James H.; Scott, Gregory; De Simoni, Sara; Sharp, David J.] Imperial Coll London, Dept Med, Div Brain Sci, London, England; [Raymont, Vanessa] Univ Edinburgh, Ctr Clin Brain Sci, Ctr Dementia Prevent, Edinburgh, Midlothian, Scotland; [Whittington, Alex; Searle, Graham; Gunn, Roger N.] Imperial Coll London, Ctr Imaging Sci, Invicro, London, England; [Raymont, Vanessa] Univ Oxford, Dept Psychiat, Oxford, England		Sharp, DJ (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Cane Rd, London W12 0NN, England.	amy.jolly@imperial.ac.uk; v.raymont@imperial.ac.uk; james.cole@imperial.ac.uk; a.whittington13@imperial.ac.uk; gregory.scott99@imperial.ac.uk; s.desimoni@imperial.ac.uk; graham.searle@invicro.co.uk; roger.gunn@imperial.ac.uk; david.sharp@imperial.ac.uk	Cole, James H/I-5197-2019	Cole, James H/0000-0003-1908-5588; Scott, Gregory/0000-0001-8063-5871; Gunn, Roger/0000-0003-1181-5769; Jolly, Amy/0000-0002-7413-9772; Whittington, Alex/0000-0001-8768-3366	IMPETus award programme; National Institute of Health Research Professorship [NIHR-RP-011-048]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This work was supported by the IMPETus award programme, a National Institute of Health Research Professorship to Prof. Sharp (NIHR-RP-011-048) and the Medical Research Council. The research was also supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre.	Antonini A, 1997, MOVEMENT DISORD, V12, P33, DOI 10.1002/mds.870120107; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; DHAENEN HA, 1994, BIOL PSYCHIAT, V35, P128, DOI 10.1016/0006-3223(94)91202-5; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Erritzoe D, 2014, NEUROPSYCHOPHARMACOL, V39, P1703, DOI 10.1038/npp.2014.18; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gallezot JD, 2012, SYNAPSE, V66, P489, DOI 10.1002/syn.21535; Goldberg JF, 1999, AM J PSYCHIAT, V156, P798; GUNN R, 2016, J NUCL MED S2, V57; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kaasinen V, 2002, NEUROSCI BIOBEHAV R, V26, P785, DOI 10.1016/S0149-7634(02)00065-9; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lammers CH, 2000, MOL PSYCHIATR, V5, P378, DOI 10.1038/sj.mp.4000754; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Larisch R, 1997, NEUROIMAGE, V5, P251, DOI 10.1006/nimg.1997.0267; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meyer JH, 2001, NEUROREPORT, V12, P4121, DOI 10.1097/00001756-200112210-00052; MURRAY AM, 1994, P NATL ACAD SCI USA, V91, P11271, DOI 10.1073/pnas.91.23.11271; Paulsen JS, 2005, J NEUROPSYCH CLIN N, V17, P496, DOI 10.1176/appi.neuropsych.17.4.496; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Roth J, 2005, FUNCT NEUROL, V20, P127; Schotte A, 1996, HISTOCHEM J, V28, P791, DOI 10.1007/BF02272152; Searle G, 2010, BIOL PSYCHIAT, V68, P392, DOI 10.1016/j.biopsych.2010.04.038; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vriend C, 2014, J NEUROL NEUROSUR PS, V85, P159, DOI 10.1136/jnnp-2012-304811; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLNER P, 1983, BRAIN RES REV, V6, P237, DOI 10.1016/0165-0173(83)90007-3; Zhang AF, 2012, NEUROPSYCHOPHARMACOL, V37, P959, DOI 10.1038/npp.2011.279; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784	50	3	3	3	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	24								101950	10.1016/j.nicl.2019.101950			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY8MY	WOS:000504663800054	31352218	gold, Green Published			2022-02-06	
J	Kommaraju, K; Haynes, JH; Ritter, AM				Kommaraju, Kavya; Haynes, Jeffrey H.; Ritter, Ann M.			Evaluating the Role of a Neurosurgery Consultation in Management of Pediatric Isolated Linear Skull Fractures	PEDIATRIC NEUROSURGERY			English	Article						Isolated linear skull fractures; Neurosurgery consultation	TRAUMATIC BRAIN-INJURY; UNITED-STATES; CHILDREN; INTERVENTION; INFANTS	Background: The purpose of this study was to determine if a pediatric neurosurgical consultation for isolated linear skull fractures (ILSF) in pediatric patients with Glasgow Coma Scale (GCS) scores of >= 14 changed their management. Methods: A 10-year retrospective chart review at a Level 1 Pediatric Trauma Center was performed. Exclusion criteria were age >18 years, open, depressed, or skull base fractures, pneumocephalus, poly-trauma, any hemorrhage (intraparenchymal, epidural, subdural, subarachnoid), cervical spine fractures, penetrating head trauma, and initial GCS scores <= 13. Primary outcomes were neurosurgery recommendations to change acuity of care, obtain additional imaging studies, and perform invasive procedures. Secondary outcomes were patient demographics, injury type, transfer status, admitting service, length of hospital stay, consult location, and clinical course. Results: There were 127 cases of ILSF meeting study criteria with an average age of 2.36 years. Unilateral parietal bone fracture was the most common injury (46.5%). Falls were the most common mechanism (81.1%). All patients received pediatric neurosurgical consultations within 24 h of hospital arrival. There were no neurosurgical recommendations to obtain additional imaging studies, change acuity of care, or perform invasive procedures. Conclusions: Routine neurosurgical consultation in children with ILSF and GCS 14-15 does not appear to alter clinical management. (c) 2019 S. Karger AG, Basel	[Kommaraju, Kavya] Virginia Commonwealth Univ, Sch Med, 500 Hull St,Apt 317, Richmond, VA 23224 USA; [Haynes, Jeffrey H.] Virginia Commonwealth Univ Hlth Syst, Childrens Hosp Richmond, Childrens Trauma Ctr, Richmond, VA USA; [Ritter, Ann M.] Virginia Commonwealth Univ Hlth Syst, Dept Neurosurg, Richmond, VA USA		Kommaraju, K (corresponding author), Virginia Commonwealth Univ, Sch Med, 500 Hull St,Apt 317, Richmond, VA 23224 USA.	kommarajuk2@vcu.edu					Addioui A, 2016, J PEDIATR SURG, V51, P1146, DOI 10.1016/j.jpedsurg.2016.01.007; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Kahn EN, 2016, WORLD NEUROSURG, V89, P133, DOI 10.1016/j.wneu.2016.01.075; Kim JW, 2019, PEDIATR EMERG CARE, V35, P856, DOI 10.1097/PEC.0000000000001067; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyons TW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3370; Mackel CE, 2018, J NEUROSURG-PEDIATR, V22, P375, DOI 10.3171/2018.5.PEDS182; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Ray KN, 2017, PEDIATR EMERG CARE, V33, P250, DOI 10.1097/PEC.0000000000000583; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Shane SA, 1997, PEDIATR EMERG CARE, V13, P198, DOI 10.1097/00006565-199706000-00006; Tavor O, 2016, CHILD NERV SYST, V32, P827, DOI 10.1007/s00381-016-3030-5; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vedantam A, 2016, J NEUROSURG-PEDIATR, V18, P638, DOI 10.3171/2016.5.PEDS16155; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352	25	3	3	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2019	54	1					21	27		10.1159/000495792			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HO5TB	WOS:000460989500004	30673671				2022-02-06	
J	Kroshus, E; Hoopes, T; Bernstein, E; Chrisman, SPD; Rivara, FP				Kroshus, Emily; Hoopes, Teah; Bernstein, Ellie; Chrisman, Sara P. D.; Rivara, Frederick P.			Direct Verbal Communication by Parents, Pressure Related to Sport Achievement, and Concussion Safety in Youth Football	JOURNAL OF HEALTH COMMUNICATION			English	Article							REPORTING BEHAVIORS; KNOWLEDGE; INJURY; RATES; DETERMINANTS; ATTITUDES; SMOKING; IMPACT; COACH; SEX	Direct verbal communication from parents about concussion safety and parent pressure related to sport achievement may influence concussion risk-related behavior among youth athletes. This study assessed whether less parental pressure related to sport achievement and more parental communication about concussion safety were associated with lower intentions to continue sport participation while experiencing concussion symptoms. Participants were youth football players (ages 10-14) and their parents (n = 278 dyads, response rate = 45%). Structural equation modeling was used to predict the athlete's intention to continue play with concussive symptoms. One quarter of parents had never talked with their child about any concussion safety topic, and more than half had not talked about concussion safety within the past year. Greater parent communication about concussion and less pressure on sport achievement were both associated with lower child intention to continue playing while symptomatic post-concussion. Parents who placed more pressure on their child related to sport achievement were less likely to talk about concussion safety with their child. Determining how to shape parenting that is supportive of concussion safety is an important avenue for future health education program development work. This may include efforts to parenting behaviors in the sport context that reinforce effort rather than winning.	[Kroshus, Emily; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hoopes, Teah] Seattle & King Cty Publ Hlth, Seattle, WA USA; [Bernstein, Ellie] Harvard Univ, Cambridge, MA USA; [Chrisman, Sara P. D.] Univ Washington, Div Adolescent Med, Seattle, WA 98195 USA		Kroshus, E (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA.	ekroshus@uw.com		Bernstein, Elizabeth/0000-0003-2343-332X; Kroshus, Emily/0000-0002-7484-2601; Chrisman, Sara/0000-0001-5373-7223	Seattle Children's Hospital Academic Enrichment Fund; Seattle Pediatric Concussion Research Collaborative; Sports Institute at UW	Funding for this project was provided by the Seattle Children's Hospital Academic Enrichment Fund, the Seattle Pediatric Concussion Research Collaborative, and The Sports Institute at UW.	Abar CC, 2015, J YOUTH ADOLESCENCE, V44, P1688, DOI 10.1007/s10964-014-0143-6; Amado D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128015; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Australian Football League, AFL KIDS 1; Babkes ML, 1999, PEDIATR EXERC SCI, V11, P44, DOI 10.1123/pes.11.1.44; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Bayes' Theorem, 2016, BAYES THEOREM; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caswell SV, 2015, PEDIATRICS, V135, P26, DOI 10.1542/peds.2014-1451; Centers for Disease Control and Prevention, 2015, CONC SIGNS SYMPT; Centers for Disease Control and Prevention, 2015, CONC INF SHEET; Chassin L, 2002, J PEDIATR PSYCHOL, V27, P485, DOI 10.1093/jpepsy/27.6.485; Dentro KN, 2014, J PHYS ACT HEALTH, V11, pS105, DOI 10.1123/jpah.2014-0184; Dunn CR, 2016, FAM RELAT, V65, P287, DOI 10.1111/fare.12193; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elliott SK, 2017, SPORT EDUC SOC, V22, P391, DOI 10.1080/13573322.2015.1036233; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein JD, 2008, J APPL SOC PSYCHOL, V38, P1442, DOI 10.1111/j.1559-1816.2008.00355.x; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lees NB, 2000, MERRILL PALMER QUART, V46, P632; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNeely C, 2002, J ADOLESCENT HEALTH, V31, P256, DOI 10.1016/S1054-139X(02)00350-6; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rimer BK, 2006, J COMMUN, V56, pS184, DOI 10.1111/j.1460-2466.2006.00289.x; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross AJ, 2015, INT J SPORTS SCI COA, V10, P605, DOI 10.1260/1747-9541.10.4.605; Sanders B, 2013, INT J SPORTS PHYS TH, V8, P180; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Smoll FL, 2007, J YOUTH DEV, V2, P20; Stefansen K, 2018, SPORT EDUC SOC, V23, P162, DOI 10.1080/13573322.2016.1150834; Stephenson MT, 2005, HEALTH COMMUN, V17, P301, DOI 10.1207/s15327027hc1703_6; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wilkinson AV, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-18	46	3	3	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1081-0730	1087-0415		J HEALTH COMMUN	J. Health Commun.		2019	24	10					770	779		10.1080/10810730.2019.1668512			10	Communication; Information Science & Library Science	Social Science Citation Index (SSCI)	Communication; Information Science & Library Science	LY3WB	WOS:000540458200004	31665984				2022-02-06	
J	Kysar-Moon, A; Mustillo, S				Kysar-Moon, Ashleigh; Mustillo, Sarah			Race/Ethnicity and Traumatic Brain Injury: Are There Disparities in Positive Screenings and Diagnoses Among Service Members Returning From Afghanistan and Iraq?	ARMED FORCES & SOCIETY			English	Article						traumatic brain injury; race and ethnicity; health disparities; military	OPERATION ENDURING FREEDOM; MENTAL-HEALTH PROBLEMS; RACIAL/ETHNIC DIFFERENCES; PSYCHIATRIC DIAGNOSES; WAR VETERANS; US VETERANS; CARE; OUTCOMES; RACISM; RACE	The authors examine racial/ethnic differences in screening positive for traumatic brain injury (TBI) and in diagnosis among service members upon returning from war in Afghanistan and Iraq. Using data from the Post-Deployment Health Assessment and Re-Assessment, and military health-care encounters from 2008 to 2009, they estimate logistic regressions in a sample of 46,488 service members. Hispanic and Asian service members do not differ from White service members in screening positive for TBI but have 19% and 33% lower odds of diagnosis, respectively. Compared to White service members, Black service members are less likely to screen positive for TBI immediately after deployment and about as likely 3-6 months later, yet have 27% lower odds of diagnosis. Further, racial/ethnic minority service members have a lower probability of TBI diagnosis than White service members at all self-reported symptom levels, suggesting there is a discrepancy between symptoms and diagnosis related to race/ethnicity.	[Kysar-Moon, Ashleigh] Univ Northern Iowa, Dept Sociol Anthropol & Criminol, Bartlett 1126, Cedar Falls, IA 50614 USA; [Mustillo, Sarah] Univ Notre Dame, Dept Sociol, Notre Dame, IN 46556 USA		Kysar-Moon, A (corresponding author), Univ Northern Iowa, Dept Sociol Anthropol & Criminol, Bartlett 1126, Cedar Falls, IA 50614 USA.	ashleigh.kysar-moon@uni.edu	Kysar-Moon, Ashleigh/AAH-3838-2020	Kysar-Moon, Ashleigh/0000-0002-9083-9154	Office of the Assistant Secretary of Defense for Health Affairs; United States Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-2-0172]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was carried out in cooperation with Force Health Protection and Readiness (FHP& R). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs and the United States Army Medical Research and Materiel Command (USAMRMC) under Award No. W81XWH-09-2-0172.	Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Ashman TA, 2006, MT SINAI J MED, V73, P999; Association of American Medical Colleges, 2010, DIV PHYS WORKF FASTS; Atdjian S, 2005, PSYCHIAT SERV, V56, P1600, DOI 10.1176/appi.ps.56.12.1600; Babcock-Parziale J. L., 2011, EVALUATION VAS TBI C; Bagalman, 2013, TRAUMATIC BRAIN INJU; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bickman L., 2009, PROGRAM EVALUATION P; BRANDT AM, 1978, HASTINGS CENT REP, V8, P21, DOI 10.2307/3561468; Bryan CJ, 2011, PROF PSYCHOL-RES PR, V42, P16, DOI 10.1037/a0022290; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Dennis GC, 1999, J NATL MED ASSOC, V91, P251; Department of Defense, 2010, DEP DEF ICD 9 COD GU; Department of Defense, 2016, DOD NUMB TRAUM BRAIN; Department of Defense, 2006, INSTR DODI 6490 03 D; Department of the Army, 2014, MULT TRAUM BRAIN INJ; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Falca-Dodson M., 2012, BATTL HOM 3 S IND IN; Faul M, 2010, TRAUMATIC BRAIN INJU; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Gifford B, 2005, ARMED FORCES SOC, V31, P201, DOI 10.1177/0095327X0503100203; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hannah Fischer, 2015, GUIDE US MILITARY CA; Harrison R, 2001, J NATL MED ASSOC, V93, p1S; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jaramillo C. A., 2015, COHORT STUDY EXAMINI, P258, DOI [10. 1111/head. 12726, DOI 10.1111/HEAD.12726]; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; Kales HC, 2000, PSYCHIATR SERV, V51, P795, DOI 10.1176/appi.ps.51.6.795; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lau KM, 2016, BRAIN INJURY, V30, P287, DOI 10.3109/02699052.2015.1089601; LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637; Long JS, 2009, GROUP COMP LOGIT PRO; Long S. J., 2006, REGRESSION MODELS CA; Maguen S, 2013, J NEUROTRAUM, V30, P1123, DOI 10.1089/neu.2012.2744; Maguen S, 2012, MIL MED, V177, P797, DOI 10.7205/MILMED-D-11-00412; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; StataCorp, 2011, STAT STAT SOFTW REL; Street RL, 2008, ANN FAM MED, V6, P198, DOI 10.1370/afm.821; Street RL., 2008, HLTH BEHAV HLTH ED T, V4th ed, P237; SZOLOVITS P, 1978, ARTIF INTELL, V11, P115, DOI 10.1016/0004-3702(78)90014-0; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The White House, 2013, FACT SHEET NAT RES A; Thurman DJ., 1995, GUIDELINES SURVEILLA; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilson SR, 2015, HEALTH COMMUN, V30, P772, DOI 10.1080/10410236.2014.899659; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; World Health Organization, 1980, INT CLASS IMP DIS HA	66	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0095-327X	1556-0848		ARMED FORCES SOC	Armed Forces Soc.	JAN	2019	45	1					155	176		10.1177/0095327X18761852			22	Political Science; Sociology	Social Science Citation Index (SSCI)	Government & Law; Sociology	HE2IZ	WOS:000453101400009					2022-02-06	
J	Langdon, C; Alobid, I; Quinto, L; Valero, A; Picado, C; Marin, C; Mullol, J				Langdon, Cristobal; Alobid, Isam; Quinto, Llorenc; Valero, Antonio; Picado, Cesar; Marin, Concepcio; Mullol, Joaquim			Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey	RHINOLOGY			English	Article						smell disorders; anosmia; hyposmia; traumatic brain injury; olfactory dysfunction	ADULT-POPULATION; PREVALENCE; EPIDEMIOLOGY; IDENTIFICATION; IMPAIRMENT; DISABILITY; IMPACT	Background: Traumatic brain injury (TBI) is one of the main causes of smell loss. However, epidemiological studies evaluating the incidence in general population are scarce. The aim of this analysis is to investigate the prevalence of TBI-induced olfactory dysfunction (OD) in a general-based population study. Methodology: A cross-sectional population-based survey was distributed to general population (260,000 households) through the newspaper. The survey included four microencapsulated odorants (smell test) to assess smell loss and two self-administered questionnaires (odour description and epidemiology/health status). Participants were divided into two groups, with or without a history of TBI. Results: From 10,783 returned surveys, 9,348 were analysed. The survey profile was a 43-year old woman with medium-high educational level, living in a city. The overall prevalence of TBI was 5% (N=464, 44.5 +/- 14.1 years old, 57% females). Recorded causes of TBI were traffic, domestic, or work accidents. Subjects with TBI reported a poorer subjective smell self-perception compared to non-TBI participants, and a decreases ability to identify mercaptan (odour added to gas used in cities). Although, using the smell test, both groups showed similar smell capacities. Conclusions: Subjects with TBI history report a higher frequency of self-perceived OD, and a decrease ability to smell the odour added to domestic gas. Having said that, the prevalence of OD, according to the smell test, was similar in both groups.	[Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin, Dept Otorhinolaryngol, Rhinol Unit, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin, Dept Otorhinolaryngol, Smell Clin, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Marin, Concepcio; Mullol, Joaquim] IDIBAPS, IRCE, Sinonasal Inflammatory & Olfactory Res Grp INGENI, Barcelona, Catalonia, Spain; [Langdon, Cristobal; Alobid, Isam; Valero, Antonio; Picado, Cesar; Marin, Concepcio; Mullol, Joaquim] Ctr Biomed Res Resp Dis CIBERES, Madrid, Spain; [Quinto, Llorenc] Inst Salut Global Barcelona ISGlobal, Recerca Salut Int Barcelona CRESIB, Barcelona, Catalonia, Spain; [Valero, Antonio; Picado, Cesar] Univ Barcelona, Hosp Clin, Dept Pneumol & Allergy, Allergy Sect, Barcelona, Spain		Mullol, J (corresponding author), Hosp Clin & Univ, Serv Otorinolaringol, Unitat Rinol & Clin Olfacte, IDIBAPS,Immunoallergia Resp Clin & Expt, Villarroel 170, Barcelona 08036, Catalonia, Spain.	jmullol@clinic.cat	/AAL-7347-2021	Langdon, Cristobal/0000-0003-1540-8095; Quinto, Llorenc/0000-0001-9992-6951			Bainbridge KE, 2018, JAMA OTOLARYNGOL, V144, P807, DOI 10.1001/jamaoto.2018.1446; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Bramerson A, 2007, ACTA OTO-LARYNGOL, V127, P167, DOI 10.1080/00016480600801357; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Dewan M.C., 2018, J NEUROSURG; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Drummond M, 2017, NEUROREHABILITATION, V41, P241, DOI 10.3233/NRE-171477; Fonteyn S, 2014, EUR ANN OTORHINOLARY, V131, P87, DOI 10.1016/j.anorl.2013.03.006; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256; Ottaviano G, 2018, RHINOLOGY, V56, DOI 10.4193/Rhin17.152; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schubert CR, 2012, CHEM SENSES, V37, P325, DOI 10.1093/chemse/bjr102; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	32	3	3	1	1	INT RHINOLOGIC SOC	UTRECHT	UNIV MEDICAL CENTER UTRECHT, RM G05 127, DEPT OTORHINOL, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS	0300-0729			RHINOLOGY	Rhinology		2019	57	6					460	468		10.4193/Rhin18.295			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	KA5DD	WOS:000505816700009	31407726	Bronze			2022-02-06	
J	Lawton, T; Huang, MX				Lawton, Teri; Huang, Ming-Xiong			Dynamic cognitive remediation for a Traumatic Brain Injury (TBI) significantly improves attention, working memory, processing speed, and reading fluency	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injuries; cortical plasticity; perceptual learning; reading; processing speed; attention; working memory; dorsal stream; visual timing; brain exercise; neurorehabilitation; MEG	SIGNAL SPACE SEPARATION; CORTICAL AREAS; ALGORITHMS; MECHANISMS; RESPONSES; CONTRAST; CELLS; MODEL; STATE	Background: In the U.S. 3.8 million people have a Traumatic Brain Injury (TBI) each year. Rapid brain training exercises to improve cognitive function after a mild TBI are needed. Objective: This study determines whether cognitive remediation by discriminating the direction a test pattern moves relative to a stationary background (movement figure-ground discrimination) improves the vision and cognitive deficits that result from a TBI, providing a paradigm shift in treatment methods. Methods: Movement-discrimination neurotraining was used to remediate low-level visual timing deficits in the dorsal stream to determine whether it improved high-level cognitive functions, such as processing speed, reading fluency, and the executive control functions of attention and working memory in four men with a TBI between the ages of 15-68. Standardized tests, as well as Magnetoencephalography (MEG) brain imaging, were administered at the beginning and end of 8-16 weeks of intervention training to evaluate improvements in cognitive skills. Results: Movement-discrimination cognitive neurotraining remediated both low-level visual timing deficits and high-level cognitive functioning, including selective and sustained attention, reading fluency, processing speed, and working memory for all TBI patients we studied. MEG brain imaging, using the Fast-VESTAL procedure, showed that this movement-discrimination training improved time-locked activity in the dorsal stream, attention, and executive control networks. Conclusions: Remediating visual timing deficits in the dorsal stream revealed the causal role of visual movement discrimination training in improving high-level cognitive functions such as focusing and switching attention, working memory, processing speed, and reading. This study found that movement-discrimination training was very rapid and effective in remediating cognitive deficits, providing a new approach that is very beneficial for treating a mild TBI.	[Lawton, Teri] Percept Dynam Inst, Dept Cognit Neurosci, Encinitas, CA 92023 USA; [Huang, Ming-Xiong] VA San Diego Healthcare Syst, Radiol & Res Serv, San Diego, CA USA; [Huang, Ming-Xiong] Univ Calif San Diego, Dept Radiol, Radiol Imaging Lab, San Diego, CA 92103 USA		Lawton, T (corresponding author), Percept Dynam Inst, POB 231305, Encinitas, CA 92023 USA.	tlawton@pathtoreading.com			Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S]; Veterans AffairsUS Department of Veterans Affairs [I01CX000499, I01RX001988] Funding Source: NIH RePORTER	This work was supported in part by Merit Review Grants from the Department of Veterans Affairs to M.X. Huang (I01-CX000499, I01-RX001988, MHBA-010-14F, NURC-022-10F, NEUC-044-06S). We thank our research associates, Ashley Robb Swan and Annemarie Angeles Quinto, at the VA San Diego Healthcare System and the University of California, San Diego. We also thank Dr. John Shelley-Tremblay for doing the behavioral statistical analysis.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischer B., 2012, VISUAL ASPECTS DYSLE, P15; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Higgins K. E., 1984, ARCH OPHTHALMOL-CHIC, V102, P2067; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; JOLLES J, 1986, PROG BRAIN RES, V70, P15; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; Knight RT, 2007, SCIENCE, V316, P1578, DOI 10.1126/science.1144677; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Lawton T., 2015, U. S. Patent No, Patent No. [8,979,263B2, 8979263]; Lawton T, 2009, OPTOM VIS DEV, V40, P82; Lawton T., 2015, 12 ANN WORLD C SOC B; Lawton T., 2011, OPTOM VIS DEV, V42, P142; Lawton T., 2007, OPT VIS DEV, V38, P37; Lawton T., 2017, FRONT HUM NEUROSCI, DOI [10.3389/fnhum.2017.00236/full, DOI 10.3389/FNHUM.2017.00236/FULL]; Lawton T. B., 2000, U.S. Patent No, Patent No. [6,045,515, 6045515]; LAWTON TB, 1984, VISION RES, V24, P139, DOI 10.1016/0042-6989(84)90099-3; LAWTON TB, 1985, J OPT SOC AM A, V2, P1140, DOI 10.1364/JOSAA.2.001140; LAWTON TB, 1989, IEEE T BIO-MED ENG, V36, P130, DOI 10.1109/10.16458; Lawton T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00397; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; POSNER MI, 1984, J NEUROSCI, V4, P1863; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shelley-Tremblay J. F., 2011, J BEHAV OPTOM, V22, P31; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Somers DC, 2014, NEW VISUAL NEUROSCIENCES, P1097; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S., 2004, NEUROL CLIN NEUROPHY, V35, P1; Vidyasagar T. R., 2013, FRONT HUM NEUROSCI, V7, P1; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	65	3	3	7	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2019	37	1					71	86		10.3233/RNN-180856			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HO3IM	WOS:000460814700007	30741708	Green Published, hybrid			2022-02-06	
S	Lee, JY; Lin, R; Nguyen, H; Liska, MG; Lippert, T; Kaneko, Y; Borlongan, CV		Turksen, K		Lee, Jea-Young; Lin, Roger; Nguyen, Hung; Liska, M. Grant; Lippert, Trenton; Kaneko, Yuji; Borlongan, Cesar V.			Histopathological and Behavioral Assessments of Aging Effects on Stem Cell Transplants in an Experimental Traumatic Brain Injury	STEM CELLS AND AGING, 2 EDITION: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Aged; Animal model; Neurodegeneration; Neurogenesis; Regenerative medicine	LONG NONCODING RNAS; NEURAL STEM; PARKINSONS-DISEASE; PROGENITOR CELLS; ADIPOSE; TISSUE; DIFFERENTIATION; THERAPY; NEURONS; ADULT	Traumatic brain injury (TBI) displays cognitive and motor symptoms following the initial injury which can be exacerbated by secondary cell death. Aging contributes significantly to the morbidity of TBI, with higher rates of negative neurological and behaviors outcomes. In the recent study, young and aged animals were injected intravenously with human adipose-derived mesenchymal stem cells (hADSCs) (Tx), conditioned media (CM), or vehicle (unconditioned media) following TBI. The beneficial effects of hADSCs were analyzed using various molecular and behavioral techniques. More specially, DiR-labeled hADSCs were used to observe the biodistribution of the transplanted cells. In addition, a battery of behavior tests was conducted to evaluate the neuromotor function for each treatment group and various regions of the brain were analyzed utilizing Nissl, hematoxylin and eosin (H&E), and human nuclei (HuNu) staining. Finally, flow cytometry was also performed to determine the levels of various proteins in the spleen. Here, we discuss the protocols for characterizing the histopathological and behavioral effects of transplanted stem cells in an animal model of TBI, with an emphasis on the role of aging in the therapeutic outcomes.	[Lee, Jea-Young; Lin, Roger; Nguyen, Hung; Liska, M. Grant; Lippert, Trenton; Kaneko, Yuji] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA		Lee, JY (corresponding author), Univ S Florida, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.						Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bjugstad KB, 2008, EXP NEUROL, V211, P362, DOI 10.1016/j.expneurol.2008.01.025; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Clarkson ED, 2001, DRUG AGING, V18, P773, DOI 10.2165/00002512-200118100-00006; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Isacson O, 2001, PARKINSONISM RELAT D, V7, P205, DOI 10.1016/S1353-8020(00)00059-6; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Muraoka K, 2008, J NEUROSURG, V108, P149, DOI 10.3171/JNS/2008/108/01/0149; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Tajiri N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00227; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yang M, 2003, CELL MOL NEUROBIOL, V23, P851, DOI 10.1023/A:1025017423102; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003	28	3	3	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-9713-8; 978-1-4939-9712-1	METHODS MOL BIOL	Methods Mol. Biol.		2019	2045						299	310		10.1007/7651_2018_121	10.1007/978-1-4939-9713-8		12	Biochemical Research Methods; Cell Biology; Geriatrics & Gerontology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Cell Biology; Geriatrics & Gerontology	BS1ES	WOS:000688195800023	29445958				2022-02-06	
S	Leishman, E; Kunkler, PE; Hurley, JH; Miller, S; Bradshaw, HB		Honn, KV; Zeldin, DC		Leishman, Emma; Kunkler, Phillip E.; Hurley, Joyce H.; Miller, Sally; Bradshaw, Heather B.			Bioactive Lipids in Cancer, Inflammation and Related Diseases	ROLE OF BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RELATED DISEASES	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	15th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases	OCT 22-25, 2017	Puerto Vallarta, MEXICO			mTBI; Endocannabinoids; TRP; Lipidomics; Lipoamine; Acyl amino acid; Acyl amide; Docosahexaenoyl ethanolamine; N-arachidonoyl glycine; BV-2	TRAUMATIC BRAIN-INJURY; DIACYLGLYCEROL LIPASE-ALPHA; ARACHIDONOYL-L-SERINE; TRP CHANNELS; CANNABINOID RECEPTOR; TRIGEMINOVASCULAR SYSTEM; DOCOSAHEXAENOIC ACID; AXONAL INJURY; AMINO-ACIDS; RAT MODEL	Headache is a common complaint after mild traumatic brain injury (mTBI). Changes in the CNS lipidome were previously associated with acrolein-induced headache in rodents. mTBI caused similar headache-like symptoms in rats; therefore, we tested the hypothesis that mTBI might likewise alter the lipidome. Using a stereotaxic impactor, rats were given either a single mTBI or a series of 4 mTBIs 48 h apart. 72 h later for single mTBI and 7 days later for repeated mTBI, the trigeminal ganglia (TG), trigeminal nucleus (TNC), and cerebellum ( CER) were isolated. Using HPLC/MS/MS, similar to 80 lipids were measured in each tissue and compared to sham controls. mTBI drove widespread alterations in lipid levels. Single mTBI increased arachidonic acid and repeated mTBI increased prostaglandins in all 3 tissue types. mTBI affected multiple TRPV agonists, including N-arachidonoyl ethanolamine (AEA), which increased in the TNC and CER after single mTBI. After repeated mTBI, AEA increased in the TG, but decreased in the TNC. Common to all tissue types in single and repeated mTBI was an increase the AEA metabolite, N-arachidonoyl glycine, a potent activator of microglial migration. Changes in the CNS lipidome associated with mTBI likely play a role in headache and in long-term neurodegenerative effects of repeated mTBI.	[Leishman, Emma; Miller, Sally; Bradshaw, Heather B.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Kunkler, Phillip E.; Hurley, Joyce H.] Indiana Univ Sch Med, Stark Neurosci Inst, Indianapolis, IN 46202 USA		Bradshaw, HB (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	hbbradsh@indiana.edu					Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; Baggelaar MP, 2013, ANGEW CHEM INT EDIT, V52, P12081, DOI 10.1002/anie.201306295; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bradshaw HB, 2017, METHOD ENZYMOL, V593, P123, DOI 10.1016/bs.mie.2017.06.024; Bradshaw HB, 2013, LIFE SCI, V92, P404, DOI 10.1016/j.lfs.2012.11.008; Bradshaw HB, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-14; Brone B, 2008, TOXICOL APPL PHARM, V231, P150, DOI 10.1016/j.taap.2008.04.005; Carey LM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916649192; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Donvito G, 2019, NEUROPHARMACOLOGY, V148, P320, DOI 10.1016/j.neuropharm.2018.03.020; Dussor G, 2014, ACS CHEM NEUROSCI, V5, P1085, DOI 10.1021/cn500083e; Eckner JT, 2017, CLIN J SPORT MED, V27, P266, DOI 10.1097/JSM.0000000000000346; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Elliott Melanie B, 2017, Concussion, V2, pCNC49, DOI 10.2217/cnc-2017-0010; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; Han BN, 2013, ANAL BIOCHEM, V432, P74, DOI 10.1016/j.ab.2012.09.031; Harrison JL, 2016, NEURAL REGEN RES, V11, P77, DOI 10.4103/1673-5374.175046; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Hwang SC, 1996, J BIOL CHEM, V271, P18342, DOI 10.1074/jbc.271.31.18342; Jeffries KA, 2016, J LIPID RES, V57, P781, DOI 10.1194/jlr.M062042; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Koivisto A, 2012, ACTA PHYSIOL, V204, P248, DOI 10.1111/j.1748-1716.2011.02318.x; Koivisto A, 2014, BASIC CLIN PHARMACOL, V114, P50, DOI 10.1111/bcpt.12138; Kunkler PE, 2018, PAIN, V159, P540, DOI 10.1097/j.pain.0000000000001124; Kunkler PE, 2015, CEPHALALGIA, V35, P1192, DOI 10.1177/0333102415574845; Kunkler PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103086; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; Leimuranta P, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00420; Leishman E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00436; Leishman E, 2018, BBA-MOL CELL BIOL L, V1863, P479, DOI 10.1016/j.bbalip.2018.02.001; Leishman Emma, 2017, Neurobiol Pain, V1, P28, DOI 10.1016/j.ynpai.2017.03.001; Leishman E, 2016, PHARMACOL RES, V110, P159, DOI 10.1016/j.phrs.2016.04.020; Leishman E, 2016, BBA-MOL CELL BIOL L, V1861, P491, DOI 10.1016/j.bbalip.2016.03.003; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Liu Q, 2018, J PAIN RES, V11, P1129, DOI 10.2147/JPR.S159146; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2018, P NATL ACAD SCI USA, V115, pE6937, DOI 10.1073/pnas.1803389115; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; Mann Aniv, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P209, DOI 10.1515/jbcpp-2015-0092; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Marrone MC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15292; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McHugh Douglas, 2012, J Mol Signal, V7, P10, DOI 10.1186/1750-2187-7-10; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Moran MM, 2018, ANNU REV PHARMACOL, V58, P309, DOI 10.1146/annurev-pharmtox-010617-052832; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Ogasawara D, 2016, P NATL ACAD SCI USA, V113, P26, DOI 10.1073/pnas.1522364112; Oxford GS., 2013, OPEN PAIN J, V6, P37, DOI [10.2174/1876386301306010037, DOI 10.2174/1876386301306010037]; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Park SW, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2499-3; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Raboune S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00195; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Reddy DS, 2017, CLIN PHARMACOL THER, V101, P182, DOI 10.1002/cpt.441; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Russo E.B., 2013, COMPREHENSIVE TREATM, P181, DOI [10.1007/978-1-4614-1560-2_18, DOI 10.1007/978-1-4614-1560-2_18]; Russo EB, 2016, CANNABIS CANNABINOID, V1, P154, DOI 10.1089/can.2016.0009; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Shonesy BC, 2014, CELL REP, V9, P1644, DOI 10.1016/j.celrep.2014.11.001; Smoum R, 2010, P NATL ACAD SCI USA, V107, P17710, DOI 10.1073/pnas.0912479107; Starowicz K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060040; Stuart JM, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/436252; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Sun XF, 2016, J BIOL CHEM, V291, P8231, DOI 10.1074/jbc.M115.707836; Tan B, 2006, AAPS J, V8, pE461, DOI 10.1208/aapsj080354; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Tortoriello G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067865; van der Wel T, 2015, J LIPID RES, V56, P927, DOI 10.1194/jlr.D056390; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Venkatachalam K, 2014, HANDB EXP PHARMACOL, V223, P937, DOI 10.1007/978-3-319-05161-1_9; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang R, 2011, J BIOL CHEM, V286, P31532, DOI 10.1074/jbc.M111.237990; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zygmunt PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081618; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	116	3	3	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-21735-8; 978-3-030-21636-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2019	1161						193	217		10.1007/978-3-030-21735-8_16			25	Biochemistry & Molecular Biology; Oncology; Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Research & Experimental Medicine	BO4FF	WOS:000514083300016	31562631				2022-02-06	
J	Lequerica, AH; Botticello, A; O'Neill, J; Lengenfelder, J; Krch, D; Chiaravalloti, ND; Sander, AM; Bushnik, T; Ketchum, JM; Hammond, FM; Dams-O'Connor, K; Felix, E; Johnson-Greene, D				Lequerica, Anthony H.; Botticello, Amanda; O'Neill, John; Lengenfelder, Jean; Krch, Denise; Chiaravalloti, Nancy D.; Sander, Angelle M.; Bushnik, Tamara; Ketchum, Jessica M.; Hammond, Flora M.; Dams-O'Connor, Kristen; Felix, Elizabeth; Johnson-Greene, Doug			Relationship Between Hispanic Nativity, Residential Environment, and Productive Activity Among Individuals With Traumatic Brain Injury: A TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Ethnicity; productivity; social environment; traumatic brain injury	LONG-TERM DISABILITY; UNITED-STATES; POSTTRAUMATIC AMNESIA; EMPLOYMENT OUTCOMES; ETHNIC-MINORITIES; ACUTE PREDICTORS; HEALTH LITERACY; RETURN; WORK; REHABILITATION	Objective: To examine the influence of nativity and residential characteristics on productive activity among Hispanics at 1 year after traumatic brain injury (TBI). Setting: Acute rehabilitation facilities and community follow-up. Participants: A total of 706 Hispanic individuals in the TBI Model Systems National Database. Design: Secondary data analysis from a multicenter longitudinal cohort study. Main Measures: Nativity (foreign born or US native), productive activity derived from interview questions regarding employment status, and other demographic information. Census data were extracted by zip code to represent residential characteristics of aggregate household income and proportion of foreign language speakers (FLS). Results: Among foreign-born individuals with TBI, those living in an area with a higher proportion of FLS were 2.8 times more likely to be productive than those living in areas with a lower proportion of FLS. Among individuals living in an area with a lower proportion of FLS, US-born Hispanics were 2.7 times more likely to be productive compared with Hispanic immigrants. Conclusion: The relationship between nativity and productive activity at 1 year post-TBI was moderated by the residential proportion of FLS. Findings underscore the importance of considering environmental factors when designing vocational rehabilitation interventions for Hispanics after TBI.	[Lequerica, Anthony H.; Botticello, Amanda; O'Neill, John; Lengenfelder, Jean; Krch, Denise; Chiaravalloti, Nancy D.] Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA; [Lequerica, Anthony H.; Botticello, Amanda; O'Neill, John; Lengenfelder, Jean; Krch, Denise; Chiaravalloti, Nancy D.] Rutgers New Jersey Med Sch, Newark, NJ USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Bushnik, Tamara] NYU Langone Hlth, Rusk Rehabil, New York, NY USA; [Ketchum, Jessica M.] Craig Hosp Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Felix, Elizabeth; Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA		Lequerica, AH (corresponding author), Kessler Fdn, 120 Eagle Rock Ave, E Hanover, NJ 07936 USA.	alequerica@kesslerfoundation.org	Felix, Elizabeth/AAD-6356-2021; Ketchum, Jessica/AAE-8200-2020	Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0032, 90DP0047, 90DP0028, 90DPTB001601, 90DP0038, 90DP0036, 90DP0046, 90DP0034-01-00, 90DP0084-01-00]	This work was funded by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research to the following: Northern New Jersey Traumatic Brain Injury System (grant number 90DP0032); Rusk Rehabilitation Traumatic Brain Injury Model System (grant number 90DP0047); and Texas Traumatic Brain Injury Model System of TIRR (grant numbers 90DP0028 & 90DPTB001601), New York Traumatic Brain Injury Model System at Mount Sinai (grant number 90DP0038), Indiana Traumatic Brain Injury Model System (grant number 90DP0036), South Florida Traumatic Brain Injury Model System (grant number 90DP0046), Rocky Mountain Regional Brain Injury System (grant number 90DP0034-01-00), and Traumatic Brain Injury Model Systems National Data and Statistical Center (grant number 90DP0084-01-00).	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bauer T, 2005, J POPUL ECON, V18, P649, DOI 10.1007/s00148-005-0009-z; Bureau USC, 2016, SEL POP PROF US; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; DeNavas-Walt C., 2014, INCOME POVERTY US 20; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Elliott JR, 2001, SOC PROBL, V48, P341, DOI 10.1525/sp.2001.48.3.341; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flores A., 2017, US HISPANIC POPULATI; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Gelman A, 2008, AM STAT, V62; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Krogstad J.M., 2015, ENGLISH PROFICIENCY; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Liu CY, 2009, J POLICY ANAL MANAG, V28, P600, DOI 10.1002/pam.20457; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Magasi S, 2009, ARCH PHYS MED REHAB, V90, P206, DOI 10.1016/j.apmr.2008.07.023; Miller P. W, 2005, CITY COMMUNITY, V4, P5, DOI [10.1111/ j. 1535- 6841.2005.00101.x, DOI 10.1111/J.1535-6841.2005.00101.X]; Minnesota Population Center, 2016, NAT HIST GEOGR INF S; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Pandit AU, 2009, PATIENT EDUC COUNS, V75, P381, DOI 10.1016/j.pec.2009.04.006; Pappadis MR, 2017, ARCH PHYS MED REHAB, V98, P751, DOI 10.1016/j.apmr.2016.11.016; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Passel JS, 2008, US POPULATION PROJEC; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sevak P, 2015, J DISABIL POLICY STU, V26, P80, DOI 10.1177/1044207315585823; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Stroope S, 2015, J IMMIGR MINOR HEALT, V17, P1055, DOI 10.1007/s10903-014-0033-8; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Warman C, 2007, CAN J ECON, V40, P401, DOI 10.1111/j.1365-2966.2007.00414.x; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	56	3	3	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		E46	E54		10.1097/HTR.0000000000000398			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600013	29863616	Green Submitted			2022-02-06	
J	Llufriu-Daben, G; Meffre, D; Massaad, C; Jafarian-Tehrani, M				Llufriu-Daben, Gemma; Meffre, Delphine; Massaad, Charbel; Jafarian-Tehrani, Mehrnaz			A novel model of trauma-induced cerebellar injury and myelin loss in mouse organotypic cerebellar slice cultures using live imaging	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Focal lesion; Demyelination; Cerebellum; Neuroprotection; Myelin repair	CLOSED-HEAD INJURY; IN-VITRO MODELS; BRAIN-INJURY; MATTER; WHITE; REMYELINATION; EXPRESSION; DAMAGE; ALPHA; DEMYELINATION	Background: Traumatic brain injury (TBI) induces significant cognitive deficits correlated with white matter injury, involving both axonal and myelin damage. Several models of TBI ex vivo are available to mimic focal impact on brain tissue. However, none of them addressed the study of trauma-induced myelin damage. New method: The aim of this study was to set up a novel ex vivo weight-drop model on organotypic cultures obtained from mouse cerebellum, a highly myelinated structure, in order to study the temporal evolution of cerebellar lesion and demyelination. The extent of injury was measured by propidium iodide (PI) fluorescence and demyelination was evaluated by loss of GFP-fluorescence in cerebellar slices from PLP-eGFP mice. Results: Live imaging of slices showed an increase of PI-fluorescence and a significant loss of GFP-fluorescence at 6 h, 24 h and 72 h post-injury. At the impact site, we observed a loss of Purkinje cells and myelin sheaths with a marked loss of myelin protein MBP at 72 h following injury. Etazolate, a known protective compound, was able to reduce both the PI-fluorescence increase and the loss of GFP-fluorescence, emphasizing its protective effect on myelin loss. Comparison with existing methods and conclusions: In line with the existing models of focal injury, we characterized trauma-induced cerebellar lesion with an increase of PI fluorescence by live imaging. Our findings describe a novel tool to study trauma-induced myelin damage in cerebellar slices and to test biomolecules of therapeutic interest for myelin protection.	[Llufriu-Daben, Gemma; Meffre, Delphine; Massaad, Charbel; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, INSERM UMR S 1124, Sorbonne Paris Cite, Fac Sci Fondamentales & Biomed, 45 Rue St Peres, F-75006 Paris, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, INSERM UMR S 1124, Sorbonne Paris Cite, Fac Sci Fondamentales & Biomed, 45 Rue St Peres, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr		Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856; MEFFRE, Delphine/0000-0002-9204-2245	"Fondation des Gueules Cassees"; Paris Descartes University; INSERM (Institut National de la Sante Et de la Recherche Medicate)Institut National de la Sante et de la Recherche Medicale (Inserm)	This work was supported by fundings from the non-profit organization "Fondation des Gueules Cassees" (grants to GLD and MJT), Paris Descartes University and INSERM (Institut National de la Sante Et de la Recherche Medicate). We acknowledge Patrice Jegouzo and Christophe Tourain for the construction of weight-drop injury device, Jean-Maurice Petit for confocal microscopy assistance, Pr Sophie Bernard and Dr Olivier Biondi (INSERM UMR-S 1124, Paris) for their scientific support for the time-lapse microscopy, Dr Anne Simon for her assistance in Figure editing and Dr Abdel M. Ghoumari (INSERM UMR 788, Paris) for providing the PLP-eGFP transgenic mice. The authors acknowledge the assistance of different facilities (animal, molecular biology and imaging facilities) from the Faculty of Basic and Biomedical Sciences (Paris Descartes University).	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; CHASIN M, 1972, BIOCHEM PHARMACOL, V21, P2443, DOI 10.1016/0006-2952(72)90414-5; Chierto E, 2019, MOL NEUROBIOL, V56, P4231, DOI 10.1007/s12035-018-1372-6; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; DALY JW, 1988, BIOCHEM PHARMACOL, V37, P655, DOI 10.1016/0006-2952(88)90139-6; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Doussau F, 2017, EXPERT OPIN DRUG DIS, V12, P1011, DOI 10.1080/17460441.2017.1356285; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gilani AA, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/632376; Guo J, 2014, NEUROSCIENCE, V263, P1, DOI 10.1016/j.neuroscience.2014.01.008; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kondiles BR, 2018, DEV NEUROBIOL, V78, P108, DOI 10.1002/dneu.22540; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Llufriu-Daben G, 2018, NEUROBIOL DIS, V109, P11, DOI 10.1016/j.nbd.2017.09.008; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Marcade M, 2008, J NEUROCHEM, V106, P392, DOI 10.1111/j.1471-4159.2008.05396.x; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; NOTTERPEK LM, 1993, J NEUROSCI RES, V36, P621, DOI 10.1002/jnr.490360603; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reeber SL, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00083; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheller A, 2017, NEUROCHEM RES, V42, P2479, DOI 10.1007/s11064-017-2343-4; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Sun XJ, 2012, EXP NEUROL, V237, P304, DOI 10.1016/j.expneurol.2012.07.011; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Syed YA, 2013, EMBO MOL MED, V5, P1918, DOI 10.1002/emmm.201303123; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Thompson SA, 2002, MOL PHARMACOL, V61, P861, DOI 10.1124/mol.61.4.861; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Weber AM, 2018, NEUROIMAG CLIN N AM, V28, P83, DOI 10.1016/j.nic.2017.09.005	67	3	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 1	2019	311						385	393		10.1016/j.jneumeth.2018.09.023			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HE0CS	WOS:000452935000044	30253198				2022-02-06	
J	Mac Donald, CL; Barber, J; Andre, J; Panks, C; Zalewski, K; Temkin, N				Mac Donald, Christine L.; Barber, Jason; Andre, Jalal; Panks, Chris; Zalewski, Kody; Temkin, Nancy			Longitudinal neuroimaging following combat concussion: sub-acute, 1 year and 5 years post-injury	BRAIN COMMUNICATIONS			English	Article						blast; concussion; imaging; longitudinal outcome	TRAUMATIC BRAIN-INJURY; WHITE-MATTER ABNORMALITIES; DIFFUSION-TENSOR; CORTICAL THICKNESS; DISTORTION CORRECTION; ROBUST ESTIMATION; SERVICE MEMBERS; AXONAL INJURY; BLAST; SYMPTOMS	Questions remain regarding the long-term impact of combat concussive blast exposure. While efforts have begun to highlight the clinical impact, less is known about neuroimaging trajectories that may inform underlying pathophysiological changes post-injury. Through collaborative efforts in combat, following medical evacuation, and at universities in the USA, this study followed service members both with and without blast concussion from the sub-acute to 1-year and 5-year outcomes with quantitative neuroimaging. The following two primary and two exploratory groups were examined: combat-deployed controls without blast exposure history 'non-blast control' and concussive blast patients (primary) and combat concussion arising not from blast 'non-blast concussion' and combat-deployed controls with blast exposure history 'blast control' (exploratory). A total of 575 subjects were prospectively enrolled and imaged; 347 subjects completed further neuroimaging examination at 1 year and 342 subjects completed further neuroimaging examination at 5 years post-injury. At each time point, MRI scans were completed that included high-resolution structural as well as diffusion tensor imaging acquisitions processed for quantitative volumetric and diffusion tensor imaging changes. Longitudinal evaluation of the number of abnormal diffusion tensor imaging and volumetric regions in patients with blast concussion revealed distinct trends by imaging modality. While the presence of abnormal volumetric regions remained quite stable comparing our two primary groups of non-blast control to blast concussion, the diffusion tensor imaging abnormalities were observed to have varying trajectories. Most striking was the fractional anisotropy 'U-shaped' curve observed for a proportion of those that, if we had only followed them to 1 year, would look like trajectories of recovery. However, by continuing the follow-up to 5 years in these very same patients, a secondary increase in the number of reduced fractional anisotropy regions was identified. Comparing non-blast controls to blast concussion at each time point revealed significant differences in the number of regions with reduced fractional anisotropy at both the sub-acute and 5-year time points, which held after adjustment for age, education, gender, scanner and subsequent head injury exposure followed by correction for multiple comparisons. The secondary increase identified in patients with blast concussion may be the earliest indications of microstructural changes underlying the 'accelerated brain aging' theory recently reported from chronic, cross-sectional studies of veterans following brain injury. These varying trajectories also inform potential prognostic neuroimaging biomarkers of progression and recovery.	[Mac Donald, Christine L.; Barber, Jason; Panks, Chris; Zalewski, Kody; Temkin, Nancy] Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 959924, Seattle, WA 98104 USA; [Andre, Jalal] Univ Washington, Dept Radiol, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98104 USA		Mac Donald, CL (corresponding author), Univ Washington, Dept Neurol Surg, 352 9th Ave,Box 959924, Seattle, WA 98104 USA.	cmacd@uw.edu		Andre, Jalal/0000-0002-0896-183X	National Institute of Health RO1 grant from the National Institute of Neurological Disorders and Stroke [1R01NS091618-01]; Department of Defense grant through the Chronic Effects of Neurotrauma ConsortiumUnited States Department of Defense [W81XWH-13-2-0095]	Funding for this longitudinal analysis and 5-year follow-up wave has been provided by a National Institute of Health RO1 grant from the National Institute of Neurological Disorders and Stroke (1R01NS091618-01) and Department of Defense grant through the Chronic Effects of Neurotrauma Consortium (W81XWH-13-2-0095) both awarded to C.M.D.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoy AR, 2014, NEUROIMAGE, V103, P323, DOI 10.1016/j.neuroimage.2014.09.053; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaufman Z., 2016, WM ANAT SNR HELP; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mac Donald CL, 2016, J NEUROTRAUMA; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K., 2011, MRI ATLAS HUMAN WHIT, V2nd Edn.; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Pierpaoli C, 2010, 18 ANN M INT SOC MAG; Rohde GK, 2005, NEUROIMAGE, V26, P673, DOI 10.1016/j.neuroimage.2005.02.023; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Savjani RR, 2017, J NEUROTRAUM, V34, P3107, DOI 10.1089/neu.2017.5022; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; The Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	48	3	3	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							31	10.1093/braincomms/fcz031			13	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100031	31915753	Green Published, gold			2022-02-06	
J	Meysami, S; Raji, CA; Merrill, DA; Porter, VR; Mendez, MF				Meysami, Somayeh; Raji, Cyrus A.; Merrill, David A.; Porter, Verna R.; Mendez, Mario F.			MRI Volumetric Quantification in Persons with a History of Traumatic Brain Injury and Cognitive Impairment	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Magnetic resonance imaging; traumatic brain injury; volumetric quantification	MINI-MENTAL-STATE; RADIOLOGISTS INTERPRETATIONS; MILD; ATROPHY; ENCEPHALOPATHY; PLAYER	Background: While traumatic brain injury (TBI) is recognized as a risk factor for dementia, there is lack of clinical tools to identify brain changes that may confer such vulnerability. Brain MRI volumetric quantification can sensitively identify brain atrophy. Objective: To characterize regional brain volume loss in persons with TBI presenting with cognitive impairment. Methods: IRB approved review of medical records in patients with cognitive decline focused on those who had documented TBI histories and brain MRI scans after TBI (n= 40, 67.7 +/- 14.5 years) with volumetric quantification by applying an FDA cleared software program. TBI documentation included head trauma mechanism. Brain volumes were compared to a normative database to determine the extent of atrophy. Correlations between these regions and global tests of cognition (MMSE in n = 17, MoCA in n= 27, n = 14 in both) were performed. Results: Multiple regions demonstrated volume loss in TBI, particularly ventral diencephalon, putamen, and pallidum with smaller magnitude of atrophy in temporal lobes and brainstem. Lobar structures showed strongest correlations between atrophy and lower scores on MMSE and MoCA. The hippocampus, while correlated to tests of cognitive function, was the least atrophic region as a function of TBI history. Conclusion: Persons with TBI history exhibit show regional brain atrophy. Several of these areas, such as thalamus and temporal lobes, also correlate with cognitive function. Alzheimer's disease atrophy was less likely given relative sparing of the hippocampi. Volumetric quantification of brain MRI in TBI warrants further investigation to further determine its clinical potential in TBI and differentiating causes of cognitive impairment.	[Meysami, Somayeh; Porter, Verna R.; Mendez, Mario F.] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Raji, Cyrus A.] Washington Univ, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 14263 USA; [Merrill, David A.; Mendez, Mario F.] UCLA, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Merrill, David A.; Porter, Verna R.] Providence & St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA; [Merrill, David A.; Porter, Verna R.] Providence & St Johns Hlth Ctr, Pacific Neurosci Inst, Santa Monica, CA USA; [Mendez, Mario F.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA		Raji, CA (corresponding author), Washington Univ, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 14263 USA.	cyrusraji@gmail.com			McLoughlin Cognitive Health Gift Fund; WUSTL NIH KL2 Grant [KL2 TR000450]; Radiological Society of North America Research Scholar Grant; Foundation of the American Society of Neuroradiology Boerger Research Fund for Alzheimer's Disease and Neurocognitive Disorders	Supported by McLoughlin Cognitive Health Gift Fund. Dr. Raji is supported in his research by grants from the WUSTL NIH KL2 Grant (KL2 TR000450 - ICTS Multidisciplinary Clinical Research Career Development Program) and the Radiological Society of North America Research Scholar Grant and the Foundation of the American Society of Neuroradiology Boerger Research Fund for Alzheimer's Disease and Neurocognitive Disorders.	Ahdidan J, 2016, J ALZHEIMERS DIS, V49, P723, DOI 10.3233/JAD-150559; [Anonymous], 2016, MANAGEMENT CONCUSSIO; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Dinomais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Haiyan Li, 2007, International Journal of Vehicle Safety, V2, P345, DOI 10.1504/IJVS.2007.016747; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mettenburg JM, 2019, AM J NEURORADIOL, V40, P440, DOI 10.3174/ajnr.A5966; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Paul R, 2011, ARCH CLIN NEUROPSYCH, V26, P454, DOI 10.1093/arclin/acr017; Raji CA, 2016, AM J GERIAT PSYCHIAT, V24, P784, DOI 10.1016/j.jagp.2016.07.018; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007	33	3	3	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	72	1					293	300		10.3233/JAD-190708			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT1TQ	WOS:000500780700024	31561375	Green Accepted			2022-02-06	
J	Mohammadi, MK; Yeganeh, MR; Ebrahimzadeh, AM; Roshan, ZA; Soodmand, M; Pouralizadeh, M				Mohammadi, Mohammad Kazem; Yeganeh, Mohammad Reza; Ebrahimzadeh, Aida Mohammad; Roshan, Zahra Atrkar; Soodmand, Mostafa; Pouralizadeh, Moluk			The Effects of Familiar Voices on the Level of Consciousness among Comatose Patients: A Single-Blind Randomized Controlled Trial	JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL			English	Article						Coma; auditory stimulation; sensory deprivation; consciousness disorders	TRAUMATIC BRAIN-INJURY; AUDITORY-STIMULATION; MANAGEMENT; MUSIC	Background: Brain injury can reduce consciousness and the ability to respond to environmental stimulation. Objectives: The aim of this study was to investigate the effects of familiar voices on the level of consciousness (LOC) among comatose patients with a brain injury hospitalized in the intensive care unit. Methods: In this randomized controlled trial, sixty comatose patients with head trauma were conveniently selected from an intensive care unit of a hospital in Rasht, Iran, and randomly allocated to either a control or an intervention group. Participants in the intervention group received auditory stimulation for three consecutive days and the level of consciousness was compared in two groups. The Glasgow Coma Scale was used to assess the patients' level of consciousness. The data were analyzed through the Chi-square, the paired-samples t, student's t test, and the repeated-measures analysis of variance. Results: A significant increase was found in the mean LOC in the intervention group after every daily auditory stimulation (P<0.05). However, no significant changes were observed in the control group (P>0.05). The repeated-measures analysis of variance revealed that the time and interaction of time and groups were statistically significant (P<0.001). Conclusion: Auditory stimulation with familiar voice was effective in improving levels of consciousness among comatose patients with a brain injury after three days.	[Mohammadi, Mohammad Kazem; Yeganeh, Mohammad Reza; Pouralizadeh, Moluk] Guilan Univ Med Sci, Sch Nursing & Midwifery, Dept Nursing, Rasht, Iran; [Ebrahimzadeh, Aida Mohammad] Guilan Univ Med Sci, Doctor Heshmat Educ Med Ctr, Dept Nursing Crit Care, Rasht, Iran; [Roshan, Zahra Atrkar] Guilan Univ Med Sci, Sch Med, Dept Biostat, Rasht, Iran; [Soodmand, Mostafa] Guilan Univ Med Sci, Sch Nursing & Midwifery, Student Res Comm, Dept Med Surg Nursing, Rasht, Iran		Pouralizadeh, M (corresponding author), Guilan Univ Med Sci, Sch Nursing & Midwifery, Dept Nursing, Rasht, Iran.	pouralizadehm@gmail.com	Rastekanary, Mohammadreza Yeganeh/J-1151-2017; Soodmand, Mostafa/O-5827-2018; Pouralizadeh, Moluk/U-6500-2017	Rastekanary, Mohammadreza Yeganeh/0000-0001-5579-722X; Soodmand, Mostafa/0000-0002-3405-9858; Pouralizadeh, Moluk/0000-0002-9203-0156	Guilan University of Medical Sciences (GUMS);  [2930162909]	This study is performed in the form of master's dissertation in nursing (No: 2930162909). The authors appreciates financial support of Deputy of Research and Technology of Guilan University of Medical Sciences (GUMS).	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Dijkstra BM, 2010, J CLIN NURS, V19, P1030, DOI 10.1111/j.1365-2702.2009.02968.x; Puggina ACG, 2011, J NEUROSCI NURS, V43, pE8, DOI 10.1097/JNN.0b013e3182029778; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; Grap MJ, 2016, AM J CRIT CARE, V25, pE48, DOI 10.4037/ajcc2016269; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hasanzadeh F., 2012, J N KHORASAN U MED S, V4, P121; Liew B S, 2017, Malays Fam Physician, V12, P22; Mahmoodi G.R., 2013, J RES DEV NURS MIDWI, V10, P1; Moattari M, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.23531; Park S, 2016, INT J NURS PRACT, V22, P391, DOI 10.1111/ijn.12448; Parveen Y, 2015, INDIAN J NEUROTRAUM, V12, P128, DOI 10.1055/s-0035-1569470; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Salmani F, 2017, INT J NURS STUD, V74, P44, DOI 10.1016/j.ijnurstu.2017.05.014; Schnakers C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00297; Shaffer J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01118; Tavangar H, 2015, ADV BIOMED RES, V4; Yeganeh M.R., 2018, HAYAT J SCH NURS MID, V23, P372	22	3	3	0	0	SCIENCEDOMAIN INT	GURGAON	SCIENCEDOMAIN INT, GURGAON, 00000, INDIA	2456-9119			J PHARM RES INT	J. Pharm. Res. Int.		2019	27	2							48788	10.9734/JPRI/2019/v27i230164			8	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	HX5LY	WOS:000467444100004		hybrid			2022-02-06	
J	Nielsen, DA; Spellicy, CJ; Harding, MJ; Graham, DP				Nielsen, David A.; Spellicy, Catherine J.; Harding, Mark J.; Graham, David P.			Apolipoprotein E DNA methylation and posttraumatic stress disorder are associated with plasma ApoE level: A preliminary study	BEHAVIOURAL BRAIN RESEARCH			English	Article						Apolipoprotein; Veterans; Methylation; DNA; Genes; Genotype	TRAUMATIC BRAIN-INJURY; AMYLOID PROTEIN DEPOSITION; MENTAL-HEALTH PROBLEMS; SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; POPULATION-STRUCTURE; E GENE; COMBAT EXPOSURE; GENOTYPE; ONSET	Mild traumatic brain injury (mTBI) occurred in 15-30% of Veterans returning from Iraq and Afghanistan. We examined whether DNA methylation of the apolipoprotein E (APOE) gene promoter region or plasma ApoE protein levels are altered in mTBI. APOE promoter region DNA methylation, APOE genotype, and plasma ApoE concentration were determined in 87 Veterans with or without mTBI who were recruited from 2010-2014. Plasma ApoE concentration was found to be associated with Posttraumatic Stress Disorder (PTSD) symptom severity ratings by hierarchical linear regression (p = .013) and ANCOVA (p = .007). Hierarchical linear regression revealed that plasma ApoE concentration was associated with APOE-epsilon 4 genotype status (p = .022). Higher ApoE plasma levels were found in epsilon 3/ epsilon 3 Veterans than in APOE-epsilon 4 carriers (p = .031). Furthermore, plasma ApoE concentration was associated experiment-wise with DNA methylation at CpG sites -877 (p = .021), and -775 (p = .014). The interaction between APOE-epsilon 4 genotype and having a PTSD diagnosis was associated with DNA methylation at CpG site -675 (p = .009).	[Nielsen, David A.; Harding, Mark J.; Graham, David P.] Michael E DeBakey VA Med Ctr, Neurorehabil Neurons Networks Traumat Brain Injur, Houston, TX USA; [Nielsen, David A.; Spellicy, Catherine J.; Harding, Mark J.; Graham, David P.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Graham, David P.] Michael E DeBakey VA Med Ctr, Houston VA Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA		Nielsen, DA (corresponding author), Michael E DeBakey VAMC, 2002 Holcombe Blvd,Res 151, Houston, TX 77030 USA.	nielsen@bcm.edu	Nielsen, David A/B-4655-2009	Nielsen, David/0000-0002-2583-0233	Veterans Affairs Administration's Rehabilitation Research and Development Service: Neurorehabilitation: Neurons to Networks TBI Center of Excellence [B6812C]; Houston VA HSR&D Center of Excellence [HFP90-020, 2 B7496 W]; Toomim Family Fund	This project was funded, in part, by grants from the Veterans Affairs Administration's Rehabilitation Research and Development Service: Neurorehabilitation: Neurons to Networks TBI Center of Excellence (B6812C), in part by the Houston VA HSR&D Center of Excellence (HFP90-020), a Career Development Award-2 B7496 W (DG); and from the Toomim Family Fund. The authors thank Drs. Harvey Levin, Nicolas Pastorek, and Maya Troyanskaya for the collection and ascertainment of subjects. This material is the result of work supported with resources and the use of facilities at the Michael E. DeBakey VA Medical Center, Houston, TX.	Abdolmaleky HM, 2004, AM J MED GENET B, V127B, P51, DOI 10.1002/ajmg.b.20142; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bekris LM, 2008, J ALZHEIMERS DIS, V13, P255; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Dammann G, 2011, EPIGENETICS-US, V6, P1454, DOI 10.4161/epi.6.12.18363; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Dell'Osso B, 2014, J AFFECT DISORDERS, V166, P330, DOI 10.1016/j.jad.2014.05.020; Ewald ER, 2014, PSYCHONEUROENDOCRINO, V44, P112, DOI 10.1016/j.psyneuen.2014.03.003; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Freeman T, 2005, J NEUROPSYCH CLIN N, V17, P541, DOI 10.1176/appi.neuropsych.17.4.541; Frueh B. C., 2012, ASSESSMENT TREATMENT; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; I. Wani, 2006, INTERNET J RESCUE DI, V7; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson LA, 2015, NEUROPSYCHOPHARMACOL, V40, P2443, DOI 10.1038/npp.2015.95; Johnson LA, 2014, NEUROBIOL DIS, V64, P150, DOI 10.1016/j.nbd.2013.12.016; Kim TY, 2013, DEPRESS ANXIETY, V30, P1194, DOI 10.1002/da.22138; Kimbrel NA, 2015, DEPRESS ANXIETY, V32, P307, DOI 10.1002/da.22348; Kosten TR, 2013, NEUROSCI LETT, V541, P29, DOI 10.1016/j.neulet.2013.02.037; Kosten TR, 2013, BIOL PSYCHIAT, V73, P219, DOI 10.1016/j.biopsych.2012.07.011; Lambert JC, 2001, LANCET, V357, P608, DOI 10.1016/S0140-6736(00)04063-0; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lescai F, 2011, J ALZHEIMERS DIS, V24, P235, DOI 10.3233/JAD-2011-101764; Lounsbury D. E., 2004, EMERGENCY WAR SURG, P1; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nielsen D. A., 2018, BEHAV BRAIN RE UNPUB; Nielsen DA, 2010, HUM GENET, V127, P639, DOI 10.1007/s00439-010-0807-6; Nielsen DA, 2009, NEUROPSYCHOPHARMACOL, V34, P867, DOI 10.1038/npp.2008.108; Nielson DA, 2012, PHARMACOGENOMICS, V13, P1149, DOI [10.2217/PGS.12.94, 10.2217/pgs.12.94]; Peterson CK, 2015, J NEUROPSYCH CLIN N, V27, P157, DOI 10.1176/appi.neuropsych.13090205; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pritchard JK, 2000, GENETICS, V155, P945; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAWLINS FA, 1972, J CELL BIOL, V52, P615, DOI 10.1083/jcb.52.3.615; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Roby Y, 2017, PSYCHIAT GENET, V27, P121, DOI 10.1097/YPG.0000000000000174; Scarabino D, 2016, AM J MED GENET B, V171, P1131, DOI 10.1002/ajmg.b.32495; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SKENE JHP, 1983, P NATL ACAD SCI-BIOL, V80, P4169, DOI 10.1073/pnas.80.13.4169; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Swan GE, 2005, J GERIATR PSYCH NEUR, V18, P196, DOI 10.1177/0891988705281864; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Walton E, 2014, EPIGENETICS-US, V9, P1101, DOI 10.4161/epi.29223; Weathers F.W., 1993, 9 ANN C ISTSS; Yehuda R, 2014, BIOL PSYCHIAT; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	77	3	3	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 1	2019	356						415	422		10.1016/j.bbr.2018.05.013			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HA0JR	WOS:000449894800048	29807071				2022-02-06	
J	Olusa, TAO; Murray, CM; Davies, HMS				Olusa, T. A. O.; Murray, C. M.; Davies, H. M. S.			Radiographic assessment of the equine carpal joint under incremental loads and during flexion	COMPARATIVE EXERCISE PHYSIOLOGY			English	Article						non-physiologic loading; carpal kinematics; hyperextension; radiography; equine; horses	PRESSURE DISTRIBUTION; SLAB FRACTURES; BONE; CONFORMATION; CONTACT; HYPEREXTENSION; RELIABILITY; GONIOMETRY; MOTION	Non-physiologic loading of the carpal bones is believed to result in osteochondral fractures, ligament rupture and axial instability in the equine forelimb; however, the mechanism of carpal damage due to non-physiologic loading of the carpus is largely unknown. To investigate carpal stability (alignment and direction of carpal bones' movement) under load and during flexion, some previously described carpal parameters were measured on radiographs obtained from 24 equine cadaver limbs (aged 10.71 +/- 4.15 years). The limbs were transected at the antebrachial midshaft, axially loaded in a commercial press and serially radiographed under a range of incremental loads (extension) and 2 flexion positions. The extensions were measured by a 10 degrees decrease in the dorsal fetlock angle (DFA) from 160 degrees to 110 degrees (DFA(160) to DFA(110)) using the jacking system of the press; and flexions at palmar carpal angle of 45 degrees and 90 degrees (PCA(45) and PCA(90)). As loading increased from DFA(160 )to DFA(110) there was a progressive significant increase in Third Carpal bone Palmar Facet Angle (C3PalFCA: 86.46 +/- 2.54 degrees to 88.60 +/- 2.51 degrees) but a decrease in Dorsal Carpal Angle (DCA: 173.03 +/- 3.47 degrees to 159.65 +/- 4.09 degrees); Medial Carpal Angle (MCA: 186.31 +/- 1.90 degrees to 184.61 +/- 2.26 degrees); and Groove width of the Cr-Ci intercarpal ligament (GW.Cr-Ci ICL: 9.35 +/- 1.20 degrees to 8.83 +/- 1.13 degrees) while no significant differences were observed for Distal Radial Slope Carpal Angle (DRSCA) and Intermediate carpal bone Proximal Tuberosity-Radial Angle (CiPxTRA). A generalised medio-distal directional displacement in the carpal bones' movement were observed. In conclusion, increased load on the forelimb (carpus) produced carpal hyperextension with measurable radiographic changes in the position and alignment of the carpal bones. The non-stretching (strain) or shortening of the Cr-Ci ICL during loading, indicated by the decrease in GW.Cr-Ci ICL, suggests a relaxed intercarpal ligament within a confined space which appears to absorb compressional load transferred from carpal bones and redistribution of concussion forces within the carpal joint during loading thereby providing a useful mechanism to minimise carpal damage.	[Olusa, T. A. O.; Murray, C. M.; Davies, H. M. S.] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic 3030, Australia		Olusa, TAO (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic 3030, Australia.	tolusa@student.unimelb.edu.au	Davies, Helen/K-6343-2015	Davies, Helen/0000-0002-5110-2002			Abdunnabi A. H., 2011, THESIS; Adair HS, 2016, VET COMP ORTHOPAED, V29, P314, DOI 10.3415/VCOT-15-11-0182; ALRTIB AM, 2015, J VET ADV, V5, P831; AUER JA, 1986, J AM VET MED ASSOC, V188, P595; Brama PAJ, 2001, EQUINE VET J, V33, P26, DOI 10.2746/042516401776767377; Bramlage L. R., 2006, Clinical Techniques in Equine Practice, V5, P259, DOI 10.1053/j.ctep.2006.09.002; Bramlage L R, 1988, Equine Vet J Suppl, P12; BRAMLAGE LR, 1983, VET CLIN N AM-LARGE, V5, P261; Burn JF, 2006, VET J, V171, P169, DOI 10.1016/j.tvjl.2004.10.010; Chateau H, 2005, EQUINE VET J, V37, P12, DOI 10.2746/0425164054406946; Clayton H. M., 2013, EQUINE LOCOMOTION, P99; COLAHAN P, 1987, P AM ASS EQUINE PRAC, V33, P689; DEANE NJ, 1995, NEW ZEAL VET J, V43, P45, DOI 10.1080/00480169.1995.35845; DEANE NJ, 1995, NEW ZEAL VET J, V43, P83, DOI 10.1080/00480169.1995.35855; Dyce K. M., 2002, TXB VET ANATOMY, P586; EKSTRAND J, 1982, ARCH PHYS MED REHAB, V63, P171; ENWEMEKA CS, 1986, SCAND J REHABIL MED, V18, P47; GARCIAELIAS M, 1989, J HAND SURG-AM, V14A, P1017, DOI 10.1016/S0363-5023(89)80053-X; Goodwin J, 1992, Disabil Rehabil, V14, P10; Gupta A, 2002, CLIN BIOMECH, V17, P660, DOI 10.1016/S0268-0033(02)00110-9; HOLMSTROM M, 1990, EQUINE VET J, V22, P186, DOI 10.1111/j.2042-3306.1990.tb04245.x; Jaeger GH, 2007, AM J VET RES, V68, P822, DOI 10.2460/ajvr.68.8.822; Jaegger G, 2002, AM J VET RES, V63, P979, DOI 10.2460/ajvr.2002.63.979; Johnston C, 1997, Equine Vet J Suppl, P84; Kadletz M., 1932, ANATOMISCHER ATLAS E, P21; KAINER RA, 2002, ADAMS LAMENESS HORSE, P1; Lascelles BDX, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-10; Liljebrink Y, 2010, EQUINE VET J, V42, P676, DOI 10.1111/j.2042-3306.2010.00254.x; Linscheid Ronald L., 2002, Keio Journal of Medicine, V51, P140; MacDermid J C, 1999, J Hand Ther, V12, P187; McIlwraith C. W., 2003, Clinical Techniques in Equine Practice, V2, P329, DOI 10.1053/j.ctep.2004.04.006; NAKAMURA R, 1989, J HAND SURG-AM, V14, P412, DOI 10.1016/0363-5023(89)90127-5; Nakamura R., 1985, ORTHOPAEDIC TRAUMA S, V25, P1481; Nishikawa T, 1985, JAPANESE ORTHOPAEDIC, V30, P1119; OHEIDA AH, 2016, J VET ADV, V6, P1258; Olusa T. A. O., 2018, THESIS; PALMER JL, 1994, EQUINE VET J, V26, P197, DOI 10.1111/j.2042-3306.1994.tb04369.x; PALMER SE, 1986, J AM VET MED ASSOC, V188, P1171; PARK RD, 1970, J AM VET MED ASSOC, V157, P1305; Sakane M, 1999, KNEE SURG SPORT TR A, V7, P93, DOI 10.1007/s001670050128; Schneider R K, 1988, Equine Vet J Suppl, P33; SCHUHL JF, 1985, J HAND SURG-AM, V10A, P1006, DOI 10.1016/S0363-5023(85)80026-5; Senna N. A., 2015, Asian Journal of Animal Sciences, V9, P208; SHOEMAKER RS, 1991, VET SURG, V20, P245, DOI 10.1111/j.1532-950X.1991.tb01254.x; STANLEY JK, 1994, J BONE JOINT SURG BR, V76B, P691, DOI 10.1302/0301-620X.76B5.8083254; STEPHENS PR, 1988, J AM VET MED ASSOC, V193, P353; TALEISNIK J, 1988, J BONE JOINT SURG AM, V70A, P1262, DOI 10.2106/00004623-198870080-00025; Taleisnik J., 1985, WRIST, P13; Thomas TM, 2006, AM J VET RES, V67, P1974, DOI 10.2460/ajvr.67.12.1974; THRALL DE, 1971, J AM VET MED ASSOC, V158, P1366; Unt VE, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00192.x; Von Rubeli O., 1925, SCHWEIZ ARCH TIERH, V67, P427; Weller R, 2006, EQUINE VET J, V38, P616, DOI 10.2746/042516406X150394; Whitton RC, 1997, VET SURG, V26, P367, DOI 10.1111/j.1532-950X.1997.tb01695.x; YOUNG DR, 1991, AM J VET RES, V52, P402	55	3	3	0	2	WAGENINGEN ACADEMIC PUBLISHERS	WAGENINGEN	PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS	1755-2540	1755-2559		COMP EXERC PHYSIOL	Comp. Exerc. Physiol.		2019	15	5					359	370		10.3920/CEP180044			12	Veterinary Sciences	Emerging Sources Citation Index (ESCI)	Veterinary Sciences	JV3OX	WOS:000502276700008					2022-02-06	
J	Paniccia, M; Knafo, R; Thomas, S; Taha, T; Ladha, A; Thompson, L; Reed, N				Paniccia, Melissa; Knafo, Ruby; Thomas, Scott; Taha, Tim; Ladha, Alysha; Thompson, Laura; Reed, Nick			Mindfulness-Based Yoga for Youth With Persistent Concussion: A Pilot Study	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							LEISURE ACTIVITIES; CHILDREN; SYMPTOMS; SPORT; QUESTIONNAIRE; PARTICIPATION; RELIABILITY; VALIDATION; RECREATION	OBJECTIVE. We explored the potential impact of mindfulness-based yoga (MBY) for youth with persistent concussion by examining occupation-based and neurophysiological outcomes. METHOD. In this case series design study. 6 youths ages 13-17 yr with concussion symptoms for >4 wk participated in an 8-wk MBY intervention, 1x/wk for 45 min. Participation. self-efficacy, and heart rate variability (24 hr) were collected before. after. and 3 mo after the intervention. Heart rate variability was also measured during each session. RESULTS. Trends of increased self-efficacy in academic. social, and emotional domains were found after MBY and maintained at 3-mo follow-up. Trends of increasing heart rate variability were also found pre- to postintervention and within the eight MBY sessions. CONCLUSION. Preliminary results reveal positive trends after a novel, safe intervention for youth with persistent concussion symptoms and the value of exploring both occupation-based and neurophysiological measures. Future research with a larger sample and control group is warranted.	[Paniccia, Melissa] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Ottawa, ON, Canada; [Paniccia, Melissa] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Knafo, Ruby] Holland View Kids Pyhabilitat Hosp, Concuss Ctr Bloorview Res Inst, Toronto, ON, Canada; [Thomas, Scott; Taha, Tim] Univ Toronto, Rehabil Sci Inst, Fac Phys Educ & Kinesiol, Toronto, ON, Canada; [Thomas, Scott; Taha, Tim] Univ Toronto, Sch Grad Studies Appointment, Toronto, ON, Canada; [Ladha, Alysha; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Toronto, ON, Canada; [Ladha, Alysha] Univ Toronto, Dept Pediat, Div Dev Pediat, Toronto, ON, Canada; [Thompson, Laura] Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Toronto, ON, Canada; [Thompson, Laura; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Sch Grad Studies Appointment, Rehabil Sci Inst, Toronto, ON, Canada		Paniccia, M (corresponding author), Holland Bloorview Kids Rehabil Hosp, Concuss Ctr, Bloorview Res Inst, Ottawa, ON, Canada.; Paniccia, M (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON, Canada.	melissa.paniccia@utoronto.ca	Thomas, Scott G/G-4522-2012	Thomas, Scott G/0000-0002-5564-4271	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [127048]; Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario government; Rehabilitation Sciences Institute at the University of Toronto	This work was funded by the Canadian Institutes of Health Research (127048), the Ontario Neurotrauma Foundation, and the Ontario Brain Institute. The Ontario Brain Institute is an independent nonprofit corporation funded partially by the Ontario government. The opinions, results, and conclusions are those of the authors, and no endorsement by the Ontario Brain Institute is intended or should be inferred. This study was registered at ClinicalTrials.gov (NCT03217695).; This work was originally featured in the first author's doctoral thesis as part of a larger body of work on neurophysiological variation. The authors thank the Rehabilitation Sciences Institute at the University of Toronto for their support throughout the doctoral program. We also acknowledge the efforts of the members of the Canadian Institutes of Health Research NeuroCare Team and the members of the Concussion Centre (Bloorview Research Institute), and specifically Katherine Wilson. Finally, occupational therapy students Alliana Bagtas and Teija Hunt are thanked for their contribution to data collection. We are grateful to the youths and families for their participation in this research.	Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Camm AJ, 1996, CIRCULATION, V93, P1043; Collins C, 1998, J Obstet Gynecol Neonatal Nurs, V27, P563; Deshpande Sudheer, 2009, Int J Yoga, V2, P13, DOI 10.4103/0973-6131.43287; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Fresco DM, 2007, BEHAV THER, V38, P234, DOI 10.1016/j.beth.2006.08.003; GREEN BS, 1997, MILD TRAUMATIC BRAIN; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Henderson A., 2006, HAND FUNCTION CHILD; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Imms Christine, 2008, Phys Occup Ther Pediatr, V28, P389, DOI 10.1080/01942630802307135; Jonsson C, 2013, DEV NEUROREHABIL, V16, P1, DOI 10.3109/17518423.2012.704955; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Muris P, 2001, J PSYCHOPATHOL BEHAV, V23, P145, DOI 10.1023/A:1010961119608; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Paniccia MJ, 2017, CAN J OCCUP THER, V84, P111, DOI 10.1177/0008417416688302; Reed N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008468; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Shephard R., 1997, MED SCI SPORT EXER, V29, pS36, DOI [DOI 10.1097/00005768-199706001-00009, 10.1097/00005768-199706001-00009]; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; WHO, 1992, INT STAT CLASS DIS R; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	32	3	3	1	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2019	73	1							7301205040	10.5014/ajot.2019.027672			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HW1UH	WOS:000466467600005	30839259				2022-02-06	
J	Pisa, FE; Reinold, J; Kollhorst, B; Haug, U; Schink, T				Pisa, Federica Edith; Reinold, Jonas; Kollhorst, Bianca; Haug, Ulrike; Schink, Tania			Antidepressants and the risk of traumatic brain injury in the elderly: differences between individual agents	CLINICAL EPIDEMIOLOGY			English	Article						antidepressants; traumatic brain injury; elderly; health insurance claims databases; pharmacoepidemiology	REUPTAKE INHIBITOR ANTIDEPRESSANTS; RECURRENT FALLS; HIP-FRACTURES; UNITED-STATES; OLDER-ADULTS; DRUG-USE; PEOPLE; PATTERNS; DATABASE; METAANALYSIS	Objective: To determine the association of individual antidepressants (ADs) with the risk of traumatic brain injury (TBI) in the elderly. Patients and methods: We conducted a case-control study nested in a cohort of new users of ADs aged >= 65 years, identified in the German Pharmacoepidemiological Research Database during 2005-2014. Cases were patients first hospitalized for TBI. Up to 100 controls per case were selected using incidence density sampling. AD use was ascertained at the index date based on the supply of last dispensing (adding 150% of the defined daily doses [DDDs]; in sensitivity analysis, no additional DDDs were considered). We estimated adjusted ORs (aORs) and 95% CIs using conditional logistic regression. Results: Among 701,309 cohort members, 16,750 cases were identified and matched to 1,673,320 controls (in both groups: 70.4% women; median age 80 years). Compared with remote users of the same AD, current users had an aOR (95% CI) of 1.87 (1.56-2.24) for duloxetine, 1.74 (1.41-2.15) for escitalopram, 1.70 (1.58-1.83) for citalopram, 1.66 (1.40-1.97) for sertraline, 1.64 (1.24-2.15) for fluoxetine and 1.57 (1.20-2.06) for paroxetine. The aOR was lower for amitriptyline (1.45; 1.32-1.58), trimipramine (1.17; 0.99-1.38) and opipramol (1.11; 0.99-1.25). Mirtazapine had an aOR of 1.03 (0.94-1.12). Sensitivity analysis confirmed the findings. Conclusion: The large variability between individual ADs shows the importance of considering the safety of individual agents rather than focusing on class alone.	[Pisa, Federica Edith; Reinold, Jonas; Haug, Ulrike; Schink, Tania] Leibniz Inst Prevent Res & Epidemiol BIPS, Clin Epidemiol, Bremen, Germany; [Pisa, Federica Edith] Univ Hosp Udine, Inst Hyg & Clin Epidemiol, Udine, Italy; [Kollhorst, Bianca] Leibniz Inst Prevent Res & Epidemiol BIPS, Biometry & Data Management, Bremen, Germany; [Haug, Ulrike] Univ Bremen, Fac Human & Hlth Sci, Bremen, Germany		Pisa, FE (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Clin Epidemiol, Achterstr 30, D-28359 Bremen, Germany.	pisa@leibniz-bips.de	Schink, Tania/A-4585-2017	Schink, Tania/0000-0002-0224-1866; Haug, Ulrike/0000-0002-1886-2923	German Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte); Open Access Fund of the Leibniz Association	The initial phase of this study was financed by the German Federal Institute for Drugs and Medical Devices (Bundesinstitut fur Arzneimittel und Medizinprodukte). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. An abstract of part of this paper was presented at the 14th International Congress of the European Geriatric Medicine Society, October 10-12, 2018, Berlin, Germany, as an abstract presentation with interim and partial findings, and was published in Abstracts of the 14th International Congress of the European Geriatric Medicine Society; Eur Geriatr Med. 2018;9(Suppl 1):1-367 (https://doi.org/10.1007/s41999-018-0097-4). An abstract of part of this paper was also presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 22-26, 2018, Prague, Czech Republic, as an oral presentation with interim and partial findings, and was published in Pharmacoepidemiol Drug Saf; 2018;27(S2):1-2 (https://doi.org/10.1002/pds.4628).	Abbing-Karahagopian V, 2014, EUR J CLIN PHARMACOL, V70, P849, DOI 10.1007/s00228-014-1676-z; Aronson J. K., 2015, MEYLERS SIDE EFFECTS; Bakken MS, 2013, AGE AGEING, V42, P514, DOI 10.1093/ageing/aft009; Carriere I, 2016, OSTEOPOROSIS INT, V27, P3187, DOI 10.1007/s00198-016-3667-7; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Cunningham J, 2014, HEALTH INF MANAG J, V43, P6, DOI 10.1177/183335831404300102; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Eom CS, 2012, J BONE MINER RES, V27, P1186, DOI 10.1002/jbmr.1554; Essebag V, 2005, BMC MED RES METHODOL, V5, P55; Firsching ER, LEITLINIE SCHADEL HI; Gagne JJ, 2012, PHARMACOEPIDEM DR S, V21, P32, DOI 10.1002/pds.2316; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Gribbin J, 2011, DRUG AGING, V28, P895, DOI 10.2165/11592860-000000000-00000; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Jobski K, 2017, EUR J CLIN PHARMACOL, V73, P105, DOI 10.1007/s00228-016-2145-7; Liu B, 1998, LANCET, V351, P1303, DOI 10.1016/S0140-6736(97)09528-7; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marcum ZA, 2016, ANN PHARMACOTHER, V50, P525, DOI 10.1177/1060028016644466; McConeghy KW, 2018, J GERONTOL A-BIOL, V73, P1638, DOI 10.1093/gerona/glx200; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Moore TJ, 2017, JAMA INTERN MED, V177, P274, DOI 10.1001/jamainternmed.2016.7507; Naples JG, 2016, AM J GERIAT PSYCHIAT, V24, P1221, DOI 10.1016/j.jagp.2016.08.008; Noguchi N, 2016, AGING MALE, V19, P168, DOI 10.3109/13685538.2016.1169399; Oderda LH, 2012, ANN PHARMACOTHER, V46, P917, DOI 10.1345/aph.1Q589; Ohlmeier C, 2016, PHARMACOEPIDEM DR S, V25, P778, DOI 10.1002/pds.4005; Park H, 2015, EUR J CLIN PHARMACOL, V71, P1429, DOI 10.1007/s00228-015-1955-3; Pigeot I, 2008, PHARMACOEPIDEM DR S, V17, P215, DOI 10.1002/pds.1545; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rabenda V, 2013, OSTEOPOROSIS INT, V24, P121, DOI 10.1007/s00198-012-2015-9; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RAY WA, 1991, ARCH INTERN MED, V151, P754, DOI 10.1001/archinte.151.4.754; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, V3rd, P111; Schink T, 2010, PHARMACOEPIDEM DR S, V19, pS294; Schmedt N, 2016, INT CLIN PSYCHOPHARM, V31, P159, DOI 10.1097/YIC.0000000000000119; Schmedt N, 2013, J CLIN PSYCHOPHARM, V33, P753, DOI 10.1097/JCP.0b013e3182a412d5; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Souverein PC, 2016, PHARMACOEPIDEM DR S, V25, P88, DOI 10.1002/pds.3862; Taipale H, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0285-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tolppanen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059124; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Wu Q, 2012, OSTEOPOROSIS INT, V23, P365, DOI 10.1007/s00198-011-1778-8; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	3	3	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1349			CLIN EPIDEMIOL	Clin. Epidemiol.		2019	11						185	196		10.2147/CLEP.S173667			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HN9AQ	WOS:000460490600001	30858730	gold, Green Published			2022-02-06	
J	Portnova, GV; Atanov, MS				Portnova, Galina V.; Atanov, Michael. S.			EEG of patients in coma after traumatic brain injury reflects physical parameters of auditory stimulation but not its emotional content	BRAIN INJURY			English	Article						EEG; moderate TBI; coma; emotional perception	COMPONENT; PATTERNS; CRIES	Primary Objective: We aimed to investigate the origin of EEG response of patients in coma and after moderate TBI to emotional stimulation, whether they distinguish emotional content or only react to the physical features of an audio signal.Research Design: We registered EEG during continuous pleasant and unpleasant non-verbal stimulation and in rest. A total of 69 subjects participated in our study: healthy adults, conscious patients after moderate TBI and patients in coma after severe TBI. We analysed the distances between the stimuli according to EEG data and applied correlation analysis to the distances, acoustic parameters of stimuli, subjects' emotional assessment of the stimuli, GCS score and Doppler ultrasound data.Main Outcomes and Results: The EEG response to the stimulation in patients in coma mostly reflects the physical parameters of the stimuli, and correlated with Doppler ultrasound data. The EEG of healthy adults reflects their psychological assessment of the stimuli. Patients after moderate TBI differentiate unpleasant stimuli well and pleasant stimuli poorly, they mainly consider pitch to cope with this task like healthy adults do.Conclusions: The reactivity to the acoustic features of emotional stimulation in patients in coma should be investigated further as a marker of patients' recovery.Abbreviations: TBI: traumatic brain injurym; TBI: moderate TBI; MCA: middle cerebral artery; GCS: Glasgow Coma Scale; M: mean; SD: standard deviation	[Portnova, Galina V.; Atanov, Michael. S.] RAS, Inst Higher Nervous Act & Neurophysiol, Human Higher Nervous Act Lab Moscow, Moscow, Russia; [Portnova, Galina V.] Pushkin Inst Russian Language, Dept Sci Act, Moscow, Russia		Portnova, GV (corresponding author), RAS, Inst Higher Nervous Act & Neurophysiol, 5A Butlerova St, Moscow 117485, Russia.	caviter@list.ru	Atanov, Michael/I-2126-2016; Portnova, Galina/I-1579-2016	Atanov, Michael/0000-0002-0666-6247; Portnova, Galina/0000-0001-7814-0482	Russian Academy of SciencesRussian Academy of Sciences; Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [16-04-00092]	This work was supported by the Russian Academy of Sciences; Russian Foundation for Basic Research [16-04-00092].	Baumeister RF., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, 10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Berlyne DE, 1966, PSYCHON SCI, V4, P101, DOI [10.3758/BF03342198, DOI 10.3758/BF03342198]; BOUKYDIS CFZ, 1982, CHILD DEV, V53, P1291, DOI 10.2307/1129019; Chen CY, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00117; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Crepeau AZ, 2013, J CLIN NEUROPHYSIOL, V30, P247, DOI 10.1097/WNP.0b013e3182933d2f; CUMMINGS KE, 1995, J ACOUST SOC AM, V98, P88, DOI 10.1121/1.413664; Daltrozzo J, 2010, NEUROSCI LETT, V475, P44, DOI 10.1016/j.neulet.2010.03.043; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eghwrudjakpor PO, 2010, LIBYAN J MED, V5, DOI [10.4176/091104, 10.3402/ljm.v5i0.4620]; Ellsworth P. C., 1988, COGNITION EMOTION, V2, P301, DOI DOI 10.1080/02699938808412702; FRICK RW, 1985, PSYCHOL BULL, V97, P412, DOI 10.1037/0033-2909.97.3.412; Galina P., 2014, OPEN J MODERN NEUROS, V4, P81, DOI DOI 10.4236/ojmn.2014.42017; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; Khan M, 2017, J SURG RES, V216, P109, DOI 10.1016/j.jss.2017.04.026; Kotchoubey B, 2018, CLIN NEUROPHYSIOL, V129, P668, DOI 10.1016/j.clinph.2018.01.006; LeDoux, 1996, EMOTIONAL BRAIN, P384; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018626; OGATA S, 1995, PERCEPT MOTOR SKILL, V80, P779, DOI 10.2466/pms.1995.80.3.779; Patel S, 2010, SPEECH PROS 2010 MAY; Pihan H, 2006, PROG BRAIN RES, V156, P269, DOI 10.1016/S0079-6123(06)56014-5; Puggina Ana Cláudia Giesbrecht, 2005, Acta paul. enferm., V18, P313, DOI 10.1590/S0103-21002005000300013; Roik A. O., 2013, NEUROSCI BEHAV PHYSL, V43, P193; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Shin J, 2015, ADV SCI TECHNOL LETT, V107, P46, DOI [10.14257/astl.2015.107.12, DOI 10.14257/ASTL.2015.107.12]; SISSON R, 1990, HEART LUNG, V19, P373; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wyss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068650; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Yu T, 2013, NEUROLOGY, V80, P345, DOI 10.1212/WNL.0b013e31827f0846; Ziegler D, 2010, CRIT CARE, V14, P292, DOI [10.1186/cc8524, DOI 10.1186/CC8524]	38	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					370	376		10.1080/02699052.2018.1553310			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400013	30521421				2022-02-06	
J	Rasmus, A; Goral-Polrola, J; Orlowska, E; Wilkosc-Debczynska, M; Grzywniak, C				Rasmus, Anna; Goral-Polrola, Jolanta; Orlowska, Edyta; Wilkosc-Debczynska, Monika; Grzywniak, Celestyna			Nonverbal communication of trauma patients in a state of minimal consciousness	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						traumatic brain injury; awareness; coma; microgenetic theory; body language	COMA; WAKEFULNESS; DISORDERS	Introduction. In spite of the rapid development in various communication-support technologies for those waking up from a coma, studies describing the sole process of reconstructing communication in this group of patients are scarce. Objective. The aim of this study was to analyze communication reactions in a minimal state of consciousness and describe the nonverbal behaviours characteristic for each stages significant for the therapy of communication. Materials and method. 18 severely brain-injured patients in a minimal state of consciousness participated in the half-year observation study, which included people experiencing at least 4 weeks of consciousness disorder/coma. Age of patients 25 +/- 5 years. Psychological assessment included: observation of various attempts of communications undertaken by patients, caregivers and family interview, the Glasgow Coma Scale (GCS) and Individual Communication Sheet. Results. Data analysis showed a significant increase in preverbal communication, both in primal and sensory areas when compared between Stage II (GCS=6-8 points) and Stage III (GCS=9-12 points). After a time, primary communication reached a high level. Patients produced communication attempts from the behaviour organization level, and an increase in the nonverbal communication level was noted. Based on observations, nonverbal communication profiles for each stage of waking up from a coma were introduced. Conclusions. It was found that in the process of waking up from a coma the patients communicate with the use of the preverbal level of primal communication, the sensory and behaviour organization activities. The characteristics of the communication reactions show that in Stage III there is a significant increase in two preverbal communication areas: primal and sensory acts, when compared with Stage II.	[Rasmus, Anna; Wilkosc-Debczynska, Monika] UKW, Dept Psychol, Bydgoszcz, Poland; [Goral-Polrola, Jolanta] Old Polish Univ, Kielce, Poland; [Orlowska, Edyta] UG, Dept Psychol, Gdansk, Poland; [Grzywniak, Celestyna] Pedag Univ, Krakow, Poland		Goral-Polrola, J (corresponding author), Old Polish Univ, Kielce, Poland.	jgp@stsw.edu.pl	Wilkosc-Debczynska, Monika/B-8318-2015	Wilkosc-Debczynska, Monika/0000-0002-0094-7793; Rasmus, Anna/0000-0001-5125-3081; Orlowska, Edyta/0000-0002-2278-4091			Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown JW, 2015, MICROGENETIC THEORY; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bykova VI, 2014, ACTA NEUROPSYCHOL, V12, P429, DOI 10.5604/17307503.1132370; Chantsoulis M, 2017, ANN AGR ENV MED, V24, P141, DOI [10.5604/12321966.1232770    , 10.5604/12321966.1232770]; Chantsoulis M, 2015, ANN AGR ENV MED, V22, P368, DOI 10.5604/12321966.1152097; de Gelder B., 2006, BIOL THEORY, V1, P130, DOI 10.1162/biot.2006.1.2.130; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; JENNETT B, 2002, VEGETATIVE STATE MED; Kaczmarek BLJ, 2014, ACTA NEUROPSYCHOL, V12, P127, DOI 10.5604/17307503.1111841; Kropotov J. D., 2016, FUNCTIONAL NEUROMARK; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S., 2003, European Journal of Neurology, V10, P224; Nowak A, INDYWIDUALNY ARKUSZ; Pachalska M., 2012, ENCY HIST PSYCHOL TH, V26, P675, DOI DOI 10.1007/978-1-4419-0463-8_150; PACHALSKA M, 2014, NEUROPSYCHOLOGIA KLI; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2017, ACTA NEUROPSYCHOL, V15, P365; Schweiger A, 2000, BRAIN LANG, V71, P213, DOI 10.1006/brln.1999.2252; Schweiger A, 1991, COGNITIVE MICROGENES; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Tomaszewski W, 2013, ANN AGR ENV MED, V20, P361; van Erp WS, 2014, EUR J NEUROL, V21, P1361, DOI 10.1111/ene.12483	24	3	3	0	3	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2019	26	2					304	308		10.26444/aaem/91911			5	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	IE1HM	WOS:000472136600018	31232063	gold			2022-02-06	
J	Sharma, R; Johnson, A; Li, J; DeBoard, Z; Zikakis, I; Grotts, J; Kaminski, S				Sharma, Rohit; Johnson, Arianne; Li, Jing; DeBoard, Zach; Zikakis, Isabella; Grotts, Jonathan; Kaminski, Stephen			Racial disparities and the acute management of severe blunt traumatic brain injury	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						brain injuries; Racial disparities; neurosurgery; outcomes research		BackgroundTraumatic brain injury (TBI) is a significant source of morbidity and mortality. In patients with TBI, racial disparities have been shown to exist in patient outcomes. Identifying where disparities occur along the patient continuum of care will allow for targeted interventions. This study evaluated if racial disparity exists for neuromonitoring and neurointervention rates in patients with severe TBI due to blunt injury.MethodsThe National Trauma Data Bank was used to identify patients aged 18 to 55 years old from 2007 through 2016 with a blunt injury, an initial Glasgow Coma Scale score of 3 to 8, a head Abbreviated Injury Scale score of 3 to 5, and all other anatomic Abbreviated Injury Scale scores less than 3. Coarsened exact matching (CEM) was used to balance covariates between white and non-white patients. Rates of neuromonitoring and neurosurgical interventions were compared between groups. Secondary outcomes were days spent in the intensive care unit (ICU), total hospital length of stay (LOS), and mortality.ResultsA total of 3692 patients with severe isolated TBI due to blunt injury were identified. After applying CEM, 1064 patients were analyzed (644 white, 420 non-white). No differences were observed between white and non-white patient groups for neuromonitoring, neurointervention, mortality, or ICU LOS. White patients had a shorter hospital LOS (8 days vs. 9 days, p<0.05) than non-white patients.DiscussionFor severe isolated blunt TBI, neuromonitoring, neurointervention, and mortality rates were similar for white and non-white patients. Although racial disparities in patient outcomes exist, these differences do not seem to be due to neuromonitoring and neurointervention rates for management of TBI.Level of evidenceLevel III.	[Sharma, Rohit; Johnson, Arianne; DeBoard, Zach; Kaminski, Stephen] Santa Barbara Cottage Hosp, Trauma, Santa Barbara, CA 93015 USA; [Li, Jing; Zikakis, Isabella; Grotts, Jonathan] Santa Barbara Cottage Hosp, Res, Santa Barbara, CA USA		Sharma, R (corresponding author), Santa Barbara Cottage Hosp, Trauma, Santa Barbara, CA 93015 USA.	rsharma@sbch.org					Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bolorunduro OB, 2013, AM J SURG, V205, P365, DOI 10.1016/j.amjsurg.2012.10.026; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Kim J, 2011, ANN SURG, V253, P647, DOI 10.1097/SLA.0b013e3182111102; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Parise CA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-449; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wall SP, 2005, ACAD EMERG MED, V12, P862, DOI 10.1197/j.aem.2005.05.003	16	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000358	10.1136/tsaco-2019-000358			4	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800084	31565678	Green Published, gold			2022-02-06	
J	Shpiner, AC; Bugaev, N; Riesenburger, R; Ng, I; Breeze, JL; Arabian, SS; Rabinovici, R				Shpiner, Aaron C.; Bugaev, Nikolay; Riesenburger, Ron; Ng, Isaac; Breeze, Janis L.; Arabian, Sandra S.; Rabinovici, Reuven			The profile of blunt traumatic supratentorial cranial bleed types	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Intracranial bleed; Supratentorial bleed	PROGRESSIVE HEMORRHAGIC INJURY; BRAIN-INJURY; INTRAVENTRICULAR HEMORRHAGE; SUBARACHNOID HEMORRHAGE; OUTCOME PREDICTION; HEAD-INJURY; DATA-BANK; EPIDEMIOLOGY; HEMATOMA	The characteristics of blunt traumatic supratentorial cranial bleed (STCB) types have not been directly compared. The National Trauma Data Bank (NTDB) 2014 was queried for adults with an isolated single STCB n = 57,278. Patients were grouped by STCB categories: subdural (SDH), subarachnoid (SAH), epidural (EDH), intraparenchymal (IPH), and intraventricular hemorrhage (IVH). Frequency, demographics, clinical characteristics, procedures, and outcomes were compared among groups. SDH was the most common STCB (53%) and occurred mostly in elderly patients after a fall (78%), 30% underwent craniotomy and their mortality was 7%. SAH occurred in 32% of patients and carried the lowest mortality (3%). SAH were least likely to have a severe brain injury (7%), and had the lowest Injury Severity Score (ISS, median 8) and complication rate (1%), as well as the shortest hospital length of stay (HLOS, 4.6 +/- 6.4 days). EDH was uncommon (2%), occurred in younger patients (median 35 years), and had the highest percentage of traffic related injuries (28%). While EDH patients presented with the poorest neurological status (16% Glasgow Coma Scale <= 8, ISS median 18) and were operated on more than any other STCB type (51%), their mortality was lower (4%) and they had the highest discharge to home rate (71%). IVH was the least common (2%), but most lethal (9%) STCB type. These patients had the highest HLOS and intensive care unit LOS, and the lowest craniotomy rate (21%). STCB types have different clinical course, and outcomes. Understanding these differences can be useful in managing patients with STB. (C) 2018 Elsevier Ltd. All rights reserved.	[Shpiner, Aaron C.; Ng, Isaac] Tufts Univ, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; [Bugaev, Nikolay; Arabian, Sandra S.; Rabinovici, Reuven] Tufts Univ, Sch Med, Tufts Med Ctr, Div Trauma & Acute Care Surg, 800 Washington St,4488, Boston, MA 02111 USA; [Riesenburger, Ron] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Neurosurg, 800 Washington St,8484, Boston, MA 02111 USA; [Breeze, Janis L.] Tufts Univ, Tufts Clin & Translat Sci Inst, Kneeland St, Boston, MA 02111 USA; [Breeze, Janis L.] Inst Clin Res & Hlth Policy Studies, Kneeland St, Boston, MA 02111 USA		Bugaev, N (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Div Trauma & Acute Care Surg, 800 Washington St,4488, Boston, MA 02111 USA.	aaron.shpiner@tufts.edu; nbugaev@tuftsmedicalcenter.org; rriesenburger@tuftsmedicalcenter.org; isaac.ng@tufts.edu; jbreeze@tuftsmedicalcenter.org; sarabian@tuftsmedicalcenter.org; reurab@comcast.net	Bugaev, Nikolay/AAC-6963-2022; Bugaev, Nikolay/AAE-2835-2021	Bugaev, Nikolay/0000-0001-6325-6837; Arabian, Sandra Strack/0000-0002-4957-3788; Breeze, Janis/0000-0002-5458-1010	National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001064] Funding Source: NIH RePORTER	This manuscript was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award UL1TR001064.	Amitrano L, 2002, SEMIN LIVER DIS, V22, P83, DOI 10.1055/s-2002-23205; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DARBY DG, 1988, NEUROLOGY, V38, P68, DOI 10.1212/WNL.38.1.68; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hinson HE, 2010, CURR NEUROL NEUROSCI, V10, P73, DOI 10.1007/s11910-010-0086-6; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Kardooni S, 2008, J TRAUMA, V64, P273, DOI 10.1097/TA.0b013e31816335ae; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Yokobori S, 2018, BEHAV BRAIN RES, V340, P23, DOI 10.1016/j.bbr.2016.05.055; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zubkov A, 2007, NEUROL RES, V29, P661, DOI 10.1179/016164107X247227	31	3	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2019	59						79	83		10.1016/j.jocn.2018.10.149			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK1JD	WOS:000457660200015	30420206	Green Accepted			2022-02-06	
J	Teng, TS; Ishak, NL; Subha, ST; Abu Bakar, S				Teng, Tan Sui; Ishak, Noor Liza; Subha, Sethu Thakachy; Abu Bakar, Saraiza			TRAUMATIC TRANSNASAL PENETRATING INJURY WITH CEREBRAL SPINAL FLUID LEAK	EXCLI JOURNAL			English	Article						pencil; penetrating trauma; skull base fracture; CSF leak	ANTERIOR SKULL BASE; ENDOSCOPIC MANAGEMENT	CSF leak in penetrating skull base injury is relatively rare compared to close head injury involving skull base fracture. We report a 5-year-old boy presented with epistaxis and impacted pencil into the left nostril. The child was hemodynamically stable without any neurological deficit. Intraoperatively, there was a nasal septal defect posteriorly with anterior skull base fracture associated with CSF leak. The pencil was removed from the left nostril and the CSF leak was repaired using harvested abdominal fat under the same setting. Computed Tomography (CT) of the brain showed right cribriform plate fracture with small pneumocranium. Postoperatively, a prophylactic antibiotic was given for seven days and he was discharged well. Subsequent clinic visits up to one-year postoperative period showed no recurrence of the CSF leak. History taking, physical examination and CT imaging give valuable diagnostic values in managing the penetrating skull base injury. Early intervention for removal of the foreign body and repair of the CSF leak is advocated to prevent catastrophic complication.	[Teng, Tan Sui; Abu Bakar, Saraiza] Serdang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kajang 43000, Selangor Darul, Malaysia; [Ishak, Noor Liza; Subha, Sethu Thakachy] Univ Putra Malaysia, Ear Nose & Throat Unit, Dept Surg, Fac Med & Hlth Sci, Serdang, Malaysia		Teng, TS (corresponding author), Serdang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kajang 43000, Selangor Darul, Malaysia.	suiteng1987@gmail.com	SUBHA, SETHU THAKACHY/AAM-4656-2020	SUBHA, SETHU THAKACHY/0000-0002-2156-9840			Bernal-Sprekelsen M, 2005, RHINOLOGY, V43, P277; Brinson GM, 2004, OTOLARYNG HEAD NECK, V130, P25, DOI 10.1016/j.otohns.2003.07.010; Cho J, 2016, J RHINOL, V23, P49; Hettige S, 2010, SKULL BASE-INTERD AP, V20, P219, DOI 10.1055/s-0029-1246226; HIRSCH O, 1952, AMA ARCH OTOLARYNGOL, V56, P1; Le C, 2016, J NEUROL SURG PART B, V77, P404, DOI 10.1055/s-0036-1584229; Lund V, 2011, RHINOLOGY, P1; Tsao YH, 2006, OTOLARYNG HEAD NECK, V134, P177, DOI 10.1016/j.otohns.2005.01.002; Wormald PJ, 1997, J LARYNGOL OTOL, V111, P1042, DOI 10.1017/S0022215100139295; Zilinskiene L, 2014, TRAUMA, V16, P243, DOI 10.1177/1460408614539619	10	3	3	0	0	EXCLI JOURNAL MANAGING OFFICE	DORTMUND	LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY	1611-2156			EXCLI J	EXCLI J.		2019	18						223	228		10.17179/excli2018-1971			6	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	HS8IA	WOS:000464112200001	31217785				2022-02-06	
J	Toomey, LM; Bartlett, CA; Majimbi, M; Gopalasingam, G; Rodger, J; Fitzgerald, M				Toomey, Lillian M.; Bartlett, Carole A.; Majimbi, Maimuna; Gopalasingam, Gopana; Rodger, Jennifer; Fitzgerald, Melinda			Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection	EXPERIMENTAL BRAIN RESEARCH			English	Article						Secondary degeneration; Neurotrauma; Ion channel inhibitor; Myelin; Visual function	RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; BRILLIANT BLUE G; MYELIN; CALPAIN; DAMAGE; MODEL; OLIGODENDROCYTES; DEMYELINATION; DISRUPTION	Following neurotrauma, secondary degeneration of neurons and glia adjacent to the injury leads to further functional loss. A combination of ion channel inhibitors (lomerizine+oxATP+YM872) has been shown to be effective at limiting structural and functional loss due to secondary degeneration. Here we assess efficacy of the combination where oxATP is replaced with Brilliant Blue G (BBG), a more clinically applicable P2X(7) receptor inhibitor. Partial optic nerve transection was used to model secondary degeneration in adult female rats. Animals were treated with combinations of lomerizine+YM872+oxATP or lomerizine+YM872+BBG, delivered via osmotic mini-pump directly to the injury site. Outcomes assessed were Iba1+and ED1+microglia and macrophages, oligodendroglial cell numbers, node/paranode structure and visual function using the optokinetic nystagmus test. The lomerizine+BBG+YM872 combination was at least as effective at the tested concentrations as the lomerizine+oxATP+YM872 combination at preserving node/paranode structure and visual function when delivered locally. However, neither ion channel inhibitor combination significantly improved microglial/macrophage nor oligodendroglial numbers compared to vehicle-treated controls. In conclusion, a locally delivered combination of ion channel inhibitors incorporating lomerizine+BBG+YM872 is at least as effective at limiting secondary degeneration following partial injury to the optic nerve as the combination incorporating oxATP.	[Toomey, Lillian M.; Bartlett, Carole A.; Gopalasingam, Gopana; Rodger, Jennifer; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia; [Majimbi, Maimuna; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Rodger, Jennifer; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Rodger, Jennifer/H-5735-2014; Fitzgerald, Melinda/C-4235-2011	Rodger, Jennifer/0000-0003-3413-4229; Fitzgerald, Melinda/0000-0002-4823-8179; Toomey, Lillian/0000-0001-9435-6128	NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]	MF is supported by an NHMRC Career Development Fellowship (APP1087114).	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Anderson Aileen J, 2002, J Spinal Cord Med, V25, P70; Annunziato L, 2003, TOXICOL LETT, V139, P125, DOI 10.1016/S0378-4274(02)00427-7; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; BANIK NL, 1985, J NEUROCHEM, V45, P581, DOI 10.1111/j.1471-4159.1985.tb04026.x; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; Borzelleca JF, 1990, FOOD CHEM TOXICOL, V28; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; Cervetto C, 2013, TOXICOLOGY, V311, P69, DOI 10.1016/j.tox.2013.04.004; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Doan N, 2016, INT J PHYS MED REHAB, V4, P120, DOI [10.4172/2329-9096.1000e120, DOI 10.4172/2329-9096.1000e120]; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Farooqui A.A., 2008, NEUROCHEMICAL ASPECT; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fowler JH, 2003, BRAIN RES, V991, P104, DOI 10.1016/j.brainres.2003.08.004; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Hara H, 1999, CLIN EXP PHARMACOL P, V26, P870, DOI 10.1046/j.1440-1681.1999.03154.x; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Diaz-Hernandez JI, 2012, NEUROBIOL AGING, V33, P1816, DOI 10.1016/j.neurobiolaging.2011.09.040; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Khorchid A, 2002, NAT STRUCT BIOL, V9, P239, DOI 10.1038/nsb0402-239; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1602/neurorx.1.1.46; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Matute C, 2008, MOL NEUROBIOL, V38, P123, DOI 10.1007/s12035-008-8028-x; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Miron VE, 2011, BBA-MOL BASIS DIS, V1812, P184, DOI 10.1016/j.bbadis.2010.09.010; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shields DC, 1997, ANN NY ACAD SCI, V825, P128, DOI 10.1111/j.1749-6632.1997.tb48422.x; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 2002, CNS DRUG REV, V8, P337; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Wong HE, 2011, ACS CHEM NEUROSCI, V2, P645, DOI 10.1021/cn200056g; Wu D, 2005, ACTA MED OKAYAMA, V59, P121; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZS, 2016, J PHYSIOL-LONDON, V594, P39, DOI 10.1113/JP271207	52	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JAN	2019	237	1					161	171		10.1007/s00221-018-5414-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ9MO	WOS:000457523700015	30367192	Green Submitted			2022-02-06	
J	Voris, SE; Steinkopf, J				Voris, Stephanie E.; Steinkopf, Julie			Suffering in the Shadows: Interviews with Wives of Combat Veterans Suffering from Post-Traumatic Stress Disorder and/or Traumatic Brain Injury	MARRIAGE AND FAMILY REVIEW			English	Article						community; military; military spouse; post-traumatic stress disorder; veteran; veteran spouse	INTIMATE PARTNER VIOLENCE; SERVICE MEMBERS; SPOUSES; AFGHANISTAN; SYMPTOMS; DISTRESS; IRAQ	The body of research examining issues confronting combat veterans of the Afghanistan and Iraq wars continues to grow. However, this research focuses primarily upon veterans with very less attention given to the challenges confronting their spouses. Using a semi-structured interview methodology and a feminist perspective, this study examines what it means to be a wife of a combat veteran who suffers from post-traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI). Our findings indicate these women-who experience tremendous emotional, financial, and social challenges that arise from being the caregiver for their husbands-feel isolated from and abandoned by both the military community and the civilian community. Furthermore, the social and emotional disconnection of these women experience amplify the stresses they confront in daily life-stresses that are unique to their relationship to being with a combat veteran spouse who has PTSD and/or TBI. We argue future research should build upon this exploratory study to better understand how both the military community and the civilian community impact the subjectivity of these women and their efforts to reintegrate themselves and their families into civilian life.	[Voris, Stephanie E.] New Mexico State Univ, Dept Social Sci & Educ, Volunteer State Community Coll, Cookeville, TN USA; [Steinkopf, Julie] New Mexico State Univ, Dept Sociol, POB 30001, Las Cruces, NM 88003 USA		Steinkopf, J (corresponding author), New Mexico State Univ, Dept Sociol, POB 30001, Las Cruces, NM 88003 USA.	juliestk@nmsu.edu					Ahmadi K., 2011, J AGGRESSION MALTREA, V20, P636, DOI DOI 10.1080/10926771.2011.595761; Bowen GL, 2003, FAM RELAT, V52, P33, DOI 10.1111/j.1741-3729.2003.00033.x; Brinkmann, 2009, INTERVIEW LEARNING C; Buchanan C, 2011, MIL MED, V176, P743, DOI 10.7205/MILMED-D-10-00378; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; de Burgh HT, 2011, INT REV PSYCHIATR, V23, P192, DOI 10.3109/09540261.2011.560144; Dekel R, 2005, FAM RELAT, V54, P24, DOI 10.1111/j.0197-6664.2005.00003.x; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Finley EP, 2010, J FAM VIOLENCE, V25, P737, DOI 10.1007/s10896-010-9331-7; Foucault Michel, 1994, POWER; Greene T, 2014, J FAM PSYCHOL, V28, P666, DOI 10.1037/a0037848; Hayes J, 2010, J REHABIL RES DEV, V47, P825, DOI 10.1682/JRRD.2009.04.0049; Hosek J, 2013, FUTURE CHILD, V23, P41, DOI 10.1353/foc.2013.0009; Hundt NE, 2012, J TRAUMA STRESS, V25, P191, DOI 10.1002/jts.21688; Kachooei AR, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.16003; Keeling M, 2016, MARRIAGE FAM REV, V52, P511, DOI 10.1080/01494929.2015.1124353; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; Renshaw KD, 2011, J FAM PSYCHOL, V25, P461, DOI 10.1037/a0023994; Sk?ldberg, 2009, REFLEXIVE METHODOLOG; SOLOMON Z, 1992, J MARRIAGE FAM, V54, P316, DOI 10.2307/353063; The Substance Abuse and Health Services Administration (SAMHSA), 2014, VET MIL FAM; Tran K., 2015, J MENTAL HLTH COUNSE, V37, P164, DOI [10.17744/mehc.37.2.07054x614489204m, DOI 10.17744/mehc.37.2.07054x614489204m]; U. S. Army, 2016, FAM READ GROUP DESCR; Warner CH, 2009, PSYCHIAT ANN, V39, P56, DOI 10.3928/00485713-20090201-11; Weedon, 1997, FEMINIST PRACTICE PO	25	3	3	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0149-4929	1540-9635		MARRIAGE FAM REV	Marriage Fam. Rev.		2019	55	6					493	511		10.1080/01494929.2018.1519494			19	Family Studies	Emerging Sources Citation Index (ESCI)	Family Studies	ID6HZ	WOS:000471780100001					2022-02-06	
J	Wang, HW; Liu, H; Wu, J; Li, CQ; Zhou, Y; Liu, J; Ou, L; Xiang, LB				Wang, Hongwei; Liu, Huan; Wu, Jun; Li, Changqing; Zhou, Yue; Liu, Jun; Ou, Lan; Xiang, Liangbi			Age, gender, and etiology differences of sports-related fractures in children and adolescents A retrospective observational study	MEDICINE			English	Article						adolescent; child; fracture; sports; traumatic	HIGH-SCHOOL; EPIDEMIOLOGY; INJURIES; CONCUSSION	To investigate the age, gender, and etiology differences of sports-related fractures in children and adolescents (6-18 years old). We retrospectively reviewed 410 child and adolescent patients (335 males and 75 females aged 13.5 +/- 3.1 years old) with sports-related fractures admitted to our university-affiliated hospitals from 2001 to 2010. The incidence and pattern were summarized with respect to different age groups, genders, etiologies. Playing basketball (97, 23.7%) and running (90, 22.0%) were the most common etiologies. Radius (102, 24.9%) was the most common fracture site. The most common etiologies and fracture sites were biking (19.6%) and humerus fractures (28.0%) in the <= 12 age range group, playing basketball (34.0%) and radius fractures (26.2%) in the 12-15 age range group, playing basketball (31.7%) and radius fractures (23.0%) in the 15-18 age range group. The most common etiologies were playing basketball (27.5%) in the male group and running (24.0%) in the female group. The male presented with significantly higher rate of radius fractures and nerve injury, significantly lower rate of femoral fractures than the female. The most common fracture sites were radius fractures in the basketball group (28.9%) and cricket group (37.5%), humerus fracture in the running group (20.0%), biking group (23.3%), and climbing group (45.0%), tibia fractures in the football group (28.9%) and playing SP bars group (50.0%), and ulna fractures (37.5%) in the ice skating group. Sports-related fractures are common in children and adolescents, particularly in males. Basketball, running, and biking were the most common etiologies; radius, ulna, and humerus were the most common fracture sites.	[Wang, Hongwei; Wu, Jun; Liu, Jun; Xiang, Liangbi] Gen Hosp Shenyang Mil Area Command Chinese PLA, Dept Orthoped, Shenyang, Liaoning, Peoples R China; [Wang, Hongwei] Third Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Wang, Hongwei] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang, Liaoning, Peoples R China; [Wang, Hongwei] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan, Hubei, Peoples R China; [Liu, Huan] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Orthoped, Luzhou, Peoples R China; [Li, Changqing; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China; [Ou, Lan] Third Mil Med Univ, Dept Radiol, Southwest Hosp, Chongqing, Peoples R China		Li, CQ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China.; Wang, HW (corresponding author), Gen Hosp Shenyang Mil Area Command Chinese PLA, Shenyang 110016, Liaoning, Peoples R China.	cplawhw@163.com; younglee_xinqiao@163.com			Foundation of the Liaoning Province Doctor Startup Fund [201601389]; State Key Laboratory of Robotics [2017-O01]; State Key Lab of CADCG [A1718]; State Key Laboratory of Trauma, Burn and Combined Injury [SKLKF201705]; State Key Laboratory of Materials Processing and Die & Mould Technology [P2018-011]	All listed authors have made substantial contributions to the manuscript and do not have any conflicts of interest. This work was supported by the Foundation of the Liaoning Province Doctor Startup Fund (201601389), the State Key Laboratory of Robotics (2017-O01), the Open Project Program of the State Key Lab of CAD&CG (A1718), the Open Project Program of the State Key Laboratory of Trauma, Burn and Combined Injury (SKLKF201705), and the State Key Laboratory of Materials Processing and Die & Mould Technology (P2018-011).	Aitken SA, 2014, J ORTHOP SURG-HONG K, V22, P313, DOI 10.1177/230949901402200309; Court-Brown CM, 2008, INJURY, V39, P1365, DOI 10.1016/j.injury.2008.02.004; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Jones G, 2002, J PAEDIATR CHILD H, V38, P278, DOI 10.1046/j.1440-1754.2002.00811.x; Lyons R A, 1999, Inj Prev, V5, P129; Mattila V, 2004, EUR J EPIDEMIOL, V19, P437, DOI 10.1023/B:EJEP.0000027355.85493.cb; Moon RJ, 2016, BONE, V85, P9, DOI 10.1016/j.bone.2016.01.015; O'Farrell DA, 1997, INJURY, V28, P377, DOI 10.1016/S0020-1383(97)00030-2; Robertson GAJ, 2012, AM J SPORT MED, V40, P1851, DOI 10.1177/0363546512448318; Shah S, 2007, INJURY PREV, V13, P316, DOI 10.1136/ip.2007.016048; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Wang HW, 2018, INT ORTHOP, V42, P625, DOI 10.1007/s00264-018-3777-2; WANG HW, 2017, MEDICINE, V96, DOI DOI 10.1097/MD.0000000000007879; Wood AM, 2010, INJURY, V41, P834, DOI 10.1016/j.injury.2010.04.008	17	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2019	98	4							e13961	10.1097/MD.0000000000013961			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ3FY	WOS:000462296900006	30681556	Green Published, gold			2022-02-06	
J	Wu, SH; Li, RS; Hwu, YM				Wu, Szu-Hsin; Li, Ryh-Sheng; Hwu, Yuh-Ming			Live birth after perimortem cesarean delivery in a 36-year-old out-of-hospital cardiac arrest nulliparous woman	TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY			English	Article						Cardiac arrest; Perimortem cesarean section; Pregnancy; Resuscitation	PREGNANCY	Objective: The aim of this study is to share a valuable experience of perimortem Cesarean delivery (PMCD) when no signs of spontaneous circulation were detected after 4 min of resuscitation. The time interval between maternal cardiac arrest and neonatal delivery was evaluated and reviewed. Case report: We present the case of an out-of-hospital cardiac arrest (OHCA) in a nulliparous woman who survived a car accident with only seatbelt injuries. The term infant was delivered by PMCD at our emergency department at least 43 min after maternal cardiac arrest. The mother only had concussion and was healthy at the time of discharge. The infant survived but had moderate neurological growth impairment (cerebral palsy) at the age of 7 months. Conclusion: Contrary to previous studies and case reports, maternal and neonatal outcomes seem to be better when performing PMCD within 10 min. Multidisciplinary teamwork is the key for optimal outcomes in such situations. (C) 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.	[Wu, Szu-Hsin; Li, Ryh-Sheng; Hwu, Yuh-Ming] MacKay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan North Rd, Taipei 10449, Taiwan; [Hwu, Yuh-Ming] MacKay Med Coll, New Taipei, Taiwan; [Hwu, Yuh-Ming] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan		Hwu, YM (corresponding author), MacKay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan North Rd, Taipei 10449, Taiwan.	tartekikila1203@gmail.com					Beckett VA, 2017, BJOG-INT J OBSTET GY, V124, P1374, DOI 10.1111/1471-0528.14521; Dijkman A, 2010, BJOG-INT J OBSTET GY, V117, P282, DOI 10.1111/j.1471-0528.2009.02461.x; Einav S, 2012, RESUSCITATION, V83, P1191, DOI 10.1016/j.resuscitation.2012.05.005; Jeejeebhoy FM, 2015, CIRCULATION, V132, P1747, DOI 10.1161/CIR.0000000000000300; Katz V, 2005, AM J OBSTET GYNECOL, V192, P1916, DOI 10.1016/j.ajog.2005.02.038; KATZ VL, 1986, OBSTET GYNECOL, V68, P571; Rose CH, 2015, AM J OBSTET GYNECOL, V213, P653, DOI 10.1016/j.ajog.2015.07.019	7	3	3	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1028-4559			TAIWAN J OBSTET GYNE	Taiwan. J. Obstet. Gynecol.	JAN	2019	58	1					43	45		10.1016/j.tjog.2018.11.007			3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	HH0US	WOS:000455435800007	30638478	gold			2022-02-06	
J	Ziaks, L; Giardina, R; Kloos, A				Ziaks, Lauren; Giardina, Rosemary; Kloos, Anne			Integration of Vision and Vestibular Therapy for Vestibulo-Ocular Post-Concussion Disorder - A Case Study	INTERNET JOURNAL OF ALLIED HEALTH SCIENCES AND PRACTICE			English	Article						concussion; protracted recovery; post-concussive; vestibular; oculomotor	VISUAL-ACUITY TEST; CONVERGENCE INSUFFICIENCY; OCULOMOTOR REHABILITATION; BRAIN-INJURY; RELIABILITY; DYSFUNCTION	Purpose: The purpose of this case study was to examine the effectiveness of integrated vision and vestibular therapy for an individual with oculomotor and vestibular system impairments secondary to a concussion further defined as vestibulo-ocular post-concussion disorder. A secondary purpose was to suggest an appropriate timeline to introduce vision therapy and integrate vestibular rehabilitation therapy based on protocol used in an outpatient concussion rehabilitation clinic. Method This was a case study on a 16-year-old female with protracted concussion recovery. Treatment consisted of 9 in-clinic visits for vision therapy with the final 6 visits addressing vision and vestibular deficits. A home exercise program supplemented the weekly clinic sessions. Outcomes measures included the Activity-Specific Balance Confidence Scale (ABC Scale), Brain Injury Vision Symptom Survey (BIVSS), Convergence Insufficiency Symptom Survey (CISS), Dizziness Handicap Inventory (DHI), and Post-Concussion Symptom Scale (PCSS). Improvements in vision and vestibular function were assessed with a comprehensive visuo-vestibular re-evaluation at discharge and 5 month follow up. Results: Improvements in oculomotor control, vergences, vestibular function, and symptomology were reported and measured at discharge and corresponded with clinically meaningful functional outcome improvements. The patient improved from 68% to 96.88% on the ABC (<67% indicates fall risk) 78 to 14 on the DHI (MDC 17.18 points, MDIC 18 points); and 46 points to 10 points on the PCSS (MCID 6.8 points). Improvements were maintained at 5 month follow up, despite occurrence of two subsequent subconcussive head injuries. The patient reported improvements in participation in social activities and academic performances at follow up. Conclusion: Results from this case study suggest integrated vision and vestibular therapy, when done in the appropriate timeline, may be used to efficiently and effectively manage vestibulo-ocular post-concussion disorder.	[Ziaks, Lauren] Intermt Pk City Hosp, Park City, UT 84060 USA; [Giardina, Rosemary] Clement J Zablocki VA Med Ctr, Milwaukee, WI USA; [Kloos, Anne] Ohio State Univ, Dept Phys Therapy, Columbus, OH 43210 USA		Ziaks, L (corresponding author), Intermt Pk City Hosp, Park City, UT 84060 USA.	ziaks.l@gmail.com; giardina.30@osu.edu; Anne.Kloos@osumc.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Amin M.S., 2016, VESTIBULOOCULAR REFL; Amster D., 2011, REV OPTOMETRY; APTA Neurology Section, 2013, TBI EDGE OUTC MEAS O; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2005, BRAIN INJURY, V29, P238; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Herdman SJ, 1998, AM J OTOL, V19, P790; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Riska KM, 2016, OTOL NEUROTOL, V37, P545, DOI 10.1097/MAO.0000000000001014; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M., 2002, UNDERSTANDING MANAGI, V2nd; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Scheiman M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006768.pub2; Skop K., 2015, TRAUMATIC BRAIN INJU; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223	37	3	3	0	6	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE	3200 S UNIVERSITY DR, FORT LAUDERDALE, FL 33328 USA	1540-580X			INTERNET J ALLIED HE	Internet J. Allied Health Sci. Pract.		2019	17	3							11				14	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	IG2RV	WOS:000473646700011					2022-02-06	
J	Zorowitz, RD; Alexander, DN; Formella, AE; Ledon, F; Davis, C; Siffert, J				Zorowitz, Richard D.; Alexander, David N.; Formella, Andrea E.; Ledon, Fred; Davis, Charles; Siffert, Joao			Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial	PM&R			English	Article							POSTSTROKE; IMPACT; SCALE; EMOTIONALISM	Background: Dextromethorphan (DM) / quinidine (Q) was approved for pseudobulbar affect (PBA) treatment based on efficacy and safety trials in patients with PBA caused by amyotrophic lateral sclerosis or multiple sclerosis. The PRISM II trial evaluated DM/Q as PBA treatment in patients with stroke, dementia, or traumatic brain injury. Objective: To report results from the stroke cohort of PRISM II, including the Stroke Impact Scale (SIS). Design: Open-label trial evaluating twice-daily DM/Q over 90 days. Study participants: Adults (n = 113) with a clinical diagnosis of PBA secondary to stroke; stable psychiatric medications were allowed. Methods: PRISM II was an open-label, 12-week trial enrolling adults with PBA caused by dementia, stroke (reported here), or TBI. All study participants received DM/Q 20/10 mg twice daily. Study visits occurred at baseline and at days 30 and 90. Setting: 150 U.S. centers. Main Outcome Measurements: Primary efficacy measure was changed from baseline to day 90 in Center for Neurologic Study-Lability Scale (CNS-LS) scores. Secondary outcomes included PBA episodes (estimated over 7 days), Clinical and Patient/Caregiver Global Impression of Change (CGI-C and PGI-C), Quality of Life-Visual Analog Scale (QOL-VAS), SIS, Patient Health Questionnaire (PHQ-9), and Mini-Mental State Examination (MMSE). Results: Compared with baseline, CNS-LS scores (SD) improved by -6.2 (6.1, P < 0.001) at day 30 and - 7.6 (6.7, P < 0.001) at day 90. PBA episodes were reduced by 65% and 75% at day 30 and 90, respectively. Seventy-five percent of clinicians and 67% of patients/caregivers rated PBA as "much" or "very much improved." All SIS items significantly improved from baseline (P < 0.05, all). Adverse events included diarrhea (4.4%), headache (3.5%), constipation (2.7%), and dizziness (2.7%); 5.3% had adverse events leading to study discontinuation. Conclusions: DM/Q effectively treated PBA and was associated with global and functional improvement; adverse events were consistent with the known safety profile of DM/Q.	[Zorowitz, Richard D.] MedStar Natl Rehabil Network, 102 Irving St NW, Washington, DC 20010 USA; [Alexander, David N.] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Formella, Andrea E.; Ledon, Fred; Siffert, Joao] Avanir Pharmaceut Inc, Aliso Viejo, CA USA; [Davis, Charles] CSD Biostat Inc, Tucson, AZ USA		Zorowitz, RD (corresponding author), MedStar Natl Rehabil Network, 102 Irving St NW, Washington, DC 20010 USA.	richard.zorowitz@medstar.net	Formella, Andrea/AAE-4073-2020; Group, Prescott Medical Communications/AAE-7494-2019	Formella, Andrea/0000-0003-2737-7898; 	Avanir Pharmaceuticals, Inc.	Supported by Avanir Pharmaceuticals, Inc.	Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Brooks BR, 2004, NEUROLOGY, V63, P1364; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Doody R. S., 2015, CNS SPECTRUMS, P1; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Floeter MK, 2014, NEUROLOGY, V83, P620, DOI 10.1212/WNL.0000000000000693; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillespie DC, 2016, J STROKE CEREBROVASC, V25, P688, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.038; Guidetti S, 2014, J REHABIL MED, V46, P963, DOI 10.2340/16501977-1865; Guy W., 1976, CLIN GLOBAL IMPRESSI; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0679-z; Hammond FM, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0609-0; Hammond FM, 2018, PM R; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Lavins BJ, 2009, GASTROENTEROLOGY, V136, pA71; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P486, DOI 10.1177/1545968309356295; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Miller A, 2011, EXPERT REV NEUROTHER, V11, P1077, DOI [10.1586/ERN.11.68, 10.1586/ern.11.68]; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Nuedexta, 2013, NUED SUMM PROD CHAR; Panitch HS, 2006, ANN NEUROL, V59, P780, DOI 10.1002/ana.20828; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Pattee GL, 2014, CURR MED RES OPIN, V30, P2255, DOI 10.1185/03007995.2014.940040; Pioro EP, 2010, ANN NEUROL, V68, P693, DOI 10.1002/ana.22093; Robinson RG, 1997, ANNU REV MED, V48, P217; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; Taylor CP, 2016, PHARM THER; Wang GY, 2016, J STROKE CEREBROVASC, V25, P556, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.003; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001	35	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2019	11	1					17	24		10.1016/j.pmrj.2018.06.003			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HJ5LW	WOS:000457224000003	29964212	hybrid			2022-02-06	
J	Inoue, A; Hifumi, T; Kuroda, Y; Nishimoto, N; Kawakita, K; Yamashita, S; Oda, Y; Dohi, K; Kobata, H; Suehiro, E; Maekawa, T				Inoue, Akihiko; Hifumi, Toru; Kuroda, Yasuhiro; Nishimoto, Naoki; Kawakita, Kenya; Yamashita, Susumu; Oda, Yasutaka; Dohi, Kenji; Kobata, Hitoshi; Suehiro, Eiichi; Maekawa, Tsuyoshi		Brain Hypothermia B-HYPO Stud	Mild decrease in heart rate during early phase of targeted temperature management following tachycardia on admission is associated with unfavorable neurological outcomes after severe traumatic brain injury: a post hoc analysis of a multicenter randomized controlled trial	CRITICAL CARE			English	Article						Traumatic brain injury; Admission heart rate; Heart rate change; Targeted temperature management; Neurological outcomes	GLASGOW COMA SCALE; THERAPEUTIC HYPOTHERMIA; FEVER CONTROL; ARREST; BRADYCARDIA; GUIDELINES; MORTALITY; RESUSCITATION; REACTIVITY; CARE	BackgroundThe association between isolated admission heart rate (HR) and prognosis has been discussed, but not that between gross HR change and neurological outcome in patients with severe traumatic brain injury (TBI). In the acute phase of severe TBI, HR is influenced by several factors (e.g., pain, sympathetic activation, hypovolemia, fever, body temperature). Therefore, admission HR and gross HR change should be examined in patients with TBI treated with a well-designed protocol, such as was done in the Brain Hypothermia (B-HYPO) Study.MethodsThis was a post hoc analysis of the B-HYPO Study, which was conducted as a prospective, multicenter, randomized controlled trial in patients with severe TBI receiving mild therapeutic hypothermia (MTH; 32.0 degrees C-34.0 degrees C) or fever control (35.5 degrees C-37.0 degrees C) in Japan. Patients with MTH were examined, and HR change (%HR) in the early MTH phase was calculated as follows: [admission HR - HR at day 1]/admission HRx100. Patients were divided into six groups, using admission HR (<80, 80-99, 100) and median of %HR; i.e., group (Admission HR <80 and %HR 18.6); group (Admission HR <80 and %HR <18.6); group (Admission HR 80-99 and %HR 18.6); group (Admission HR 80-99 and %HR <18.6); group (Admission HR 100 and %HR 18.6); and group (Admission HR 100 and %HR <18.6). The primary outcome was an adjusted predicted probability of unfavorable neurological outcome at 6 months after TBI according to Glasgow Outcome Scale score, which is a measure of functional recovery and defined as severe disability, persistent vegetative state, and death.ResultsOverall, 79 patients with MTH (52.7% of the original trial) were examined; among these, unfavorable neurological outcomes were observed in 53.2%. Among all the groups, group (Admission HR 100 and %HR <18.6) exhibited the highest proportion of unfavorable outcomes, and 82.3% of patients had an adjusted predicted probability of unfavorable outcomes, whereas those in group (Admission HR <80 and %HR 18.6) developed only 22.8% (p=0.04).ConclusionsMild HR decrease during the early phase of targeted temperature management following tachycardia at admission can be associated with unfavorable neurological outcomes after severe TBI.	[Inoue, Akihiko; Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Inoue, Akihiko] Hyogo Emergency Med Ctr, Dept Emergency & Crit Care Med, Chuo Ku, 1-3-1 Wakinohamakaigandori, Kobe, Hyogo 6510073, Japan; [Hifumi, Toru] St Lukes Int Hosp, Emergency & Crit Care Med, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan; [Nishimoto, Naoki] Hokkaido Univ Hosp, Clin Res & Med Innovat Ctr, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, 1-1 Kouda, Yamaguchi 7458522, Japan; [Oda, Yasutaka; Suehiro, Eiichi] Yamaguchi Univ, Sch Med, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Dohi, Kenji] Showa Univ, Dept Emergency Disaster & Crit Care Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan; [Kobata, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, 11-1 Minamiakutagawacho, Takatsuki, Osaka 5691124, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Univ, 3-2-1 Sakurabatake, Yamaguchi, Yamaguchi 7538502, Japan		Hifumi, T (corresponding author), Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.; Hifumi, T (corresponding author), St Lukes Int Hosp, Emergency & Crit Care Med, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	Aibiki M, 2015, CRIT CARE MED, V43, pE97, DOI 10.1097/CCM.0000000000000785; Bascom K, 2016, CRIT CARE MED, V44, P448, DOI 10.1097/CCM.0000000000001495; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cariou A, 2018, ANAESTH CRIT CARE PA, V37, P481, DOI 10.1016/j.accpm.2017.06.003; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Davies P, 2009, EMERG MED J, V26, P641, DOI 10.1136/emj.2008.061598; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gutierrez G, 2004, CRIT CARE, V8, P373, DOI 10.1186/cc2851; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; HILGARD ER, 1974, PSYCHOPHYSIOLOGY, V11, P692, DOI 10.1111/j.1469-8986.1974.tb01138.x; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inoue A, 2018, CRIT CARE MED, V46, pE881, DOI 10.1097/CCM.0000000000003254; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mourot L, 2008, AVIAT SPACE ENVIR MD, V79, P14, DOI 10.3357/ASEM.2147.2008; Muengtaweepongsa S, 2016, RESUSCITATION, V98, pE15, DOI 10.1016/j.resuscitation.2015.08.026; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Staer-Jensen H, 2014, CRIT CARE MED, V42, P2401, DOI 10.1097/CCM.0000000000000515; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Thomsen JH, 2016, CRIT CARE MED, V44, P308, DOI 10.1097/CCM.0000000000001390; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tokunaga S, 1996, CARDIOVASC RES, V31, P769, DOI 10.1016/S0008-6363(96)00021-1; Umemura T, 2016, SURG TODAY, V46, P774, DOI 10.1007/s00595-015-1263-7	37	3	3	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	DEC 19	2018	22								352	10.1186/s13054-018-2276-6			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HF0XR	WOS:000453888700002	30567590	Green Published, gold			2022-02-06	
J	Jung, A; Johnson, M; Veile, R; Friend, LA; Stevens-Topie, S; Elterman, J; Pritts, T; Makley, A; Goodman, M				Jung, Andrew; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Stevens-Topie, Sabre; Elterman, Joel; Pritts, Timothy; Makley, Amy; Goodman, Michael			Variable saline resuscitation in a murine model of combined traumatic brain injury and haemorrhage	BRAIN INJURY			English	Article						Traumatic brain injury; haemorrhagic shock; polytrauma; saline resuscitation; hypertonic saline	HYPERTONIC SALINE; INTRACRANIAL-PRESSURE; FLUID; HYPERTENSION; MANAGEMENT; 3-PERCENT; NACL	Background: Resuscitation strategies for combined traumatic brain injury (TBI) with haemorrhage in austere environments are not fully established. Our aim was to establish the effects of various saline concentrations in a murine model of combined TBI and haemorrhage, and identify an effective resuscitative strategy for the far-forward environment. Methods: Male C57BL/6 mice underwent closed head injury and subjected to controlled haemorrhage to a systolic blood pressure of 25 mmHg via femoral artery cannulation for 60 min. Mice were resuscitated with a fixed volume bolus or variable volumes of fluid to achieve a systolic blood pressure goal of 80 mmHg with 0.9% saline, 3% saline, 0.1-mL bolus of 23.4% saline, or a 0.1-mL bolus of 23.4% saline followed by 0.9% saline (23.4+). Results: 23.4% saline and 23.4+ resulted in higher mortality at 6 h compared to 0.9% saline. Use of 3% saline required less volume to achieve targeted resuscitation, did not affect survival, and did not exacerbate post-traumatic inflammation. While 23.4+ resuscitation utilized lower volume, it resulted in hypernatremia, azotemia, and elevated systemic pro-inflammatory cytokines. All groups except 3% saline demonstrated progression of neuron damage, with cerebral oedema highest with 0.9% saline. Conclusions: 3% saline demonstrated favourable balance of survival, blood pressure restoration, minimization of inflammation, and prevention of ongoing neurologic injury without contributing to significant physiologic derangements. 23.4% saline administration may not be appropriate in the setting of concomitant hypotension.	[Jung, Andrew; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Stevens-Topie, Sabre; Elterman, Joel; Pritts, Timothy; Makley, Amy; Goodman, Michael] Univ Cincinnati, Dept Surg, Inst Mil Med, Div Res, 231 Bethesda Ave, Cincinnati, OH 45267 USA		Goodman, M (corresponding author), Univ Cincinnati, Dept Surg, 231 Albert Sabin Way,SRU Room 1577, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Pritts, Timothy/0000-0003-2495-3255			Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Dubick MA, 2013, CLINICS, V68, P883, DOI 10.6061/clinics/2013(06)25; Einhaus S L, 1996, J Tenn Med Assoc, V89, P81; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Han J, 2015, SHOCK, V43, P244, DOI 10.1097/SHK.0000000000000303; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jernigan PL, 2016, SHOCK, V46, P148, DOI 10.1097/SHK.0000000000000676; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Makley AT, 2012, MIL MED, V177, P911, DOI 10.7205/MILMED-D-11-00385; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Murao Y, 2003, SHOCK, V20, P29, DOI 10.1097/01.shk.0000071060.78689.f1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Schell TL, 2009, INVISIBLE SOUNDS WAR, P87; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; Schrager JJ, 2012, RESP CARE, V57, P1305, DOI 10.4187/respcare.01881; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	30	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1834	1842		10.1080/02699052.2018.1510542			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600029	30136863				2022-02-06	
J	Lovstad, M; Solbraekke, KN; Kirkevold, M; Geard, A; Hauger, SL; Schanke, AK				Lovstad, Marianne; Solbraekke, Kari Nyheim; Kirkevold, Marit; Geard, Anne; Hauger, Solveig Laegreid; Schanke, Anne-Kristine			"It gets better. It can ' t be worse than what we have been through." Family accounts of the minimally conscious state	BRAIN INJURY			English	Article						Traumatic brain injury; disorders of consciousness; family	VEGETATIVE STATE; CHRONIC DISORDERS; DECISION-MAKING; PROLONGED GRIEF; BRAIN-INJURY; CAREGIVERS; BURDEN; DIAGNOSIS; LIFE	Objectives: The aim of this qualitative study was to explore family life when a family member is in a chronic minimally conscious state (MCS). Experiences with the health care system were also explored. Methods: As part of a larger qualitative study of family life after a family member suffers severe physical injury, we conducted a focus group interview with five family members of three patients in a chronic MCS. The participants included three mothers, one father, and one sibling. The length of time since the brain injuries was four, four, and ten years. A thematic analysis was conducted. Results: Three main themes emerged. Each family reflected on the challenges of maintaining family unity. They also revealed how they had dealt with the ambiguity and severity of the situation, including the communication with the health care system. Finally, they described their journeys back toward a normal, everyday family life. Conclusions: The findings demonstrate challenges faced by family members but also their capacity to withstand and overcome adversity. Clinicians are reminded to maintain a long-term perspective and understand the importance of helping families adjust, maintain hope for a better future, and mitigate their psychological pain.	[Lovstad, Marianne; Geard, Anne; Hauger, Solveig Laegreid; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Lovstad, Marianne; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway; [Solbraekke, Kari Nyheim] Univ Oslo, Inst Hlth & Soc, Dept Hlth Sci, Oslo, Norway; [Kirkevold, Marit] Univ Oslo, Inst Hlth & Soc, Dept Nursing Sci, Oslo, Norway; [Kirkevold, Marit] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv, Oslo, Norway		Lovstad, M (corresponding author), Sunnaaas Rehabil Hosp, Bjornemyrvn 11, N-1453 Bjornemyr, Norway.	Marianne.lovstad@sunnaas.no					Allen D, 2000, SOCIOL HEALTH ILL, V22, P149, DOI 10.1111/1467-9566.00197; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bastianelli A, 2016, J HEALTH PSYCHOL, V21, P844, DOI 10.1177/1359105314539533; Beljaars DEA, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000058; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brinkmann S., 2015, INTERVIEWS LEARNING; Chiambretto P, 2001, ACTA NEUROL SCAND, V104, P364, DOI 10.1034/j.1600-0404.2001.00107.x; Chiambretto P, 2010, BRAIN INJURY, V24, P581, DOI 10.3109/02699051003610490; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cipolletta S, 2016, J HEALTH PSYCHOL, V21, P1197, DOI 10.1177/1359105314550348; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Covelli V, 2016, ACTA NEUROL SCAND, V134, P352, DOI 10.1111/ane.12550; Edgar A, 2015, J EVAL CLIN PRACT, V21, P374, DOI 10.1111/jep.12220; Fins JJ, 2015, RIGHTS COME MIND BRA; Fins Joseph J, 2016, AMA J Ethics, V18, P1182, DOI 10.1001/journalofethics.2016.18.12.ecas2-1612; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Geertz C., 1973, INTERPRETATION CULTU, P3; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2012, BRAIN INJURY, V26, P1493, DOI 10.3109/02699052.2012.695426; Guarnerio C, 2012, PSYCHIAT QUART, V83, P65, DOI 10.1007/s11126-011-9183-1; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Jox RJ, 2015, ARCH PHYS MED REHAB, V96, P323, DOI 10.1016/j.apmr.2014.09.030; Kitzinger C, 2014, SOCIAL CONSTRUCTION, V12, P239; Kuehlmeyer K, 2012, J MED ETHICS, V38, P332, DOI 10.1136/medethics-2011-100373; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Mancini AD, 2012, CURR OPIN PSYCHIATR, V25, P46, DOI 10.1097/YCO.0b013e32834de48a; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; Morgan DL., 2002, HDB INTERVIEW RES CO, P141, DOI DOI 10.2307/1317652; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Riessman K. C., 2008, NARRATIVE METHODS HU; Roscoe LA, 2006, DEATH STUD, V30, P149, DOI 10.1080/07481180500455632; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wilkinson S., 2011, QUALITATIVE RES THEO, P83; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	42	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1659	1669		10.1080/02699052.2018.1539244			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600007	30351974				2022-02-06	
J	O'Connell, B; Wilson, F; Boyle, N; O'Dwyer, T; Denvir, K; Farrell, G; Kelly, AM				O'Connell, Brendan; Wilson, Fiona; Boyle, Noreen; O'Dwyer, Tom; Denvir, Karl; Farrell, Garreth; Kelly, Aine M.			Effects of match play and training on circulating S100B concentration in professional rugby players	BRAIN INJURY			English	Article						Concussion; S100B; brain health; rugby; sports related concussion; blood biomarker	CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORT-RELATED CONCUSSION; MINOR HEAD-INJURY; BRAIN-INJURY; BIOCHEMICAL MARKERS; SERUM-LEVELS; BIOMARKERS; PROTEIN; UTILITY; ADULTS	Objectives: Examine the effects of match play and a season of training on serum S100B concentration in male professional rugby players. To assess the influence of contact play, values were compared with age- and fitness-matched athletes not involved in a contact sport. Methods: Over a 2-year period, blood samples were collected from 38 players in pre-season, end of season, and post-matches (within 2 h). A control group of rowers (n = 15) was assessed pre- and post-training. Results: S100B concentration changed significantly over a season (chi 2(2) = 17.636, p < 0.0005); post-match values were significantly increased from baseline (early season: Z = -3.670, p Z = -3.408, p = 0.001). There were no significant differences in S100B concentrations between pre-seasons (Z = -1.601, p = 0.109), or between end of season and subsequent pre-season (Z = -0.330, p = 0.741). While comparable at baseline, samples taken from rugby players post-match were significantly increased compared with samples taken from rowers post-exercise (U = 47.0, p < 0.0005). Conclusion: Exercise has a significant effect on circulating S100B in elite male athletes, with levels following rugby matches significantly higher than following non-contact sport. This elevation in S100B is temporary, with a return to baseline values after periods without play.	[O'Connell, Brendan; Wilson, Fiona; Boyle, Noreen; O'Dwyer, Tom; Kelly, Aine M.] Univ Dublin, Trinity Coll Dublin, Sch Med, Dublin 2, Ireland; [O'Connell, Brendan; Denvir, Karl; Farrell, Garreth] Leinster Rugby, Dublin, Ireland		Kelly, AM (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Dept Physiol, Dublin 2, Ireland.	aikelly@tcd.ie	O'Dwyer, Tom/Y-3012-2019; Wilson, Fiona/AAZ-1849-2020	O'Dwyer, Tom/0000-0002-8072-4783; Wilson, Fiona/0000-0002-0292-1087; Kelly, Aine/0000-0002-9255-0848			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Arslan F, 2010, TURK J BIOCHEM, V35, P307; Bey T, 2009, WEST J EMERG MED, V10, P6; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; England Professional Rugby Surveillance Project Streering Group, 2015, ENGL PROF RUGB INJ S; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jurimae J, 2003, EUR J APPL PHYSIOL, V90, P533, DOI 10.1007/s00421-003-0879-2; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehta Samit Satish, 2010, Clin Neurosurg, V57, P134; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; World Rugby, 2015, PUTT PLAYERS 1 CONC; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	39	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1811	1816		10.1080/02699052.2018.1532112			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600026	30325242				2022-02-06	
J	Siedlecki, P; Sanzo, P; Zerpa, C; Newhouse, I				Siedlecki, Patrick; Sanzo, Paolo; Zerpa, Carlos; Newhouse, Ian			End-tidal carbon dioxide levels in patients with post-concussion syndrome during neurocognitive and physical tasks compared to a normative control group	BRAIN INJURY			English	Article						Respiration; respiratory rate; walking; neurological function; capnography; mild traumatic brain injury	HEART-RATE-VARIABILITY; CEREBRAL-BLOOD-FLOW; POSTCONCUSSION SYNDROME; NIJMEGEN QUESTIONNAIRE; HIGH-SCHOOL; EXERCISE; HYPERVENTILATION; CO2; VENTILATION; MODULATION	Primary objective: Recent findings suggest breathing may negatively affect performance after concussion. The aim of the study was to examine group differences between individuals with and without post-concussion syndrome (PCS) in end-tidal carbon dioxide (ETCO2) and respiratory rate (RR) during neurocognitive and physical tasks. Hypothesis: Individuals in the PCS group will have elevated ETCO2 and lower RR compared to the control group. Methods: A quasi-experimental study was used in which a capnography unit collected ETCO2 and RR breathing data from 22 participants (control = 17; PCS = 5) during rest, the completion of the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) battery and while slow and fast walking. Four repeated measures mixed factorial ANOVAs, with an alpha level set at p <= 0.05, were used to examine group and task differences. Results: Both groups displayed similar breathing responses to cognitive and physical stress; however, PCS participants had significantly elevated ETCO2 throughout the study (during rest, the ImPACT and while walking) compared to the control. Conversely, no significant group differences were found in RR. Conclusion: Cerebral physiological alterations and deficits in the autonomic nervous system may cause abnormal ETCO2 in individuals after concussion. Future research evaluating breathing patterns in PCS may be warranted.	[Siedlecki, Patrick; Sanzo, Paolo; Zerpa, Carlos; Newhouse, Ian] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON, Canada; [Siedlecki, Patrick] Western Univ, Sch Kinesiol, London, ON, Canada; [Sanzo, Paolo] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON, Canada		Siedlecki, P (corresponding author), Western Univ, Sch Kinesiol, Fac Hlth Sci, London, ON N6A 5B9, Canada.	psiedlec@uwo.ca					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Andreou Georgia, 2014, Sleep Disord, V2014, P768210, DOI 10.1155/2014/768210; Arena Ross, 2012, Congest Heart Fail, V18, P302, DOI 10.1111/j.1751-7133.2012.00296.x; Bartels MN, 2003, CHEST, V124, P863, DOI 10.1378/chest.124.3.863; BARTON CW, 1994, ANN EMERG MED, V23, P560, DOI 10.1016/S0196-0644(94)70078-8; BENNETT FM, 1993, ANN BIOMED ENG, V21, P545, DOI 10.1007/BF02584337; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Bors M, 2015, CHRON RESP DIS, V12, P365, DOI 10.1177/1479972315603552; Bottari C, 2017, NEUROPSYCHOL REHABIL, V27, P871, DOI 10.1080/09602011.2015.1110528; Burton D. A., 2004, CONTINUING EDU ANAES, V4, P185, DOI [10.1093/bjaceaccp/mkh050, DOI 10.1093/BJACEACCP/MKH050]; Bussotti M, 2008, EUR J APPL PHYSIOL, V103, P727, DOI 10.1007/s00421-008-0773-z; Canadian Institute for Health Information, 2017, INJ TRAUM EM DEP HOS; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Coleman KW, 2009, CARDIOPULM PHYS THER, V20, P31; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dogru S, 2016, ACTA MEDICA MEDITERR, V32, P791, DOI 10.19193/0393-6384_2016_3_91; Doorn P, 1983, PSYCHOLOOG, V18, P573; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fluck D, 2014, AM J PHYSIOL-HEART C, V307, pH515, DOI 10.1152/ajpheart.00177.2014; Giza CC, 2001, J ATHL TRAINING, V36, P228; Go SL, 2013, CRIT CARE, V17, DOI 10.1186/cc11389; Grammatopoulou EP, 2014, J ASTHMA, V51, P839, DOI 10.3109/02770903.2014.922190; Grassmann M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8146809; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hildebrandt T, 2010, ANAESTHESIA, V65, P1017, DOI 10.1111/j.1365-2044.2010.06499.x; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Howard RS, 2001, POSTGRAD MED J, V77, P700, DOI 10.1136/pmj.77.913.700; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Hughson RL, 2015, AUTON NEUROSCI-BASIC, V188, P32, DOI 10.1016/j.autneu.2014.10.012; Kenney WL, 2012, PHYSL SPORT EXERCISE, P163; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Kukafka DS, 1998, CHEST, V114, P1613, DOI 10.1378/chest.114.6.1613; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Lee H, 2015, J SCI MED SPORT, V18, P245, DOI 10.1016/j.jsams.2014.04.003; Li M, 2014, NEUROSCI RES, V84, P19, DOI 10.1016/j.neures.2014.02.009; Litchfield PM, 2010, PSYCHOPHYSIOLOGY TOD, V7; Lovell M. R., 2015, IMPACT TEST ADM INTE; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maruff P, 2004, BRIT J SPORT MED, V38, P654; MATEIKA JH, 1995, EUR J APPL PHYSIOL, V71, P1, DOI 10.1007/BF00511228; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLaughlin L, 2014, RECOGNIZING TREATING, P147; McLaughlin L, 2011, MANUAL THER, V16, P51, DOI 10.1016/j.math.2010.08.006; McNicholl DM, 2011, CHEST, V139, P1117, DOI 10.1378/chest.10-2321; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Parker RS, 2001, CONCUSSION BRAIN TRA; Public Health Agency of Canada, 2007, LIF BREATH RESP DIS; Rochester CL, 2002, SEMIN RESP CRIT CARE, V23, P248, DOI 10.1055/s-2002-33033; Rodrigues MK, 2013, CLIN PHYSIOL FUNCT I, V33, P274, DOI 10.1111/cpf.12024; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Sharma G, 2006, CLIN INTERV AGING, V1, P253, DOI 10.2147/ciia.2006.1.3.253; Siedlecki P, 2017, CLIN PRACT, V6, P1, DOI [10.5923/j.cp.20170601.01, DOI 10.5923/J.CP.20170601.01]; Smilek D., 2013, COGNITION; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Tulek B, 2014, RESPIROLOGY, V19, P873, DOI 10.1111/resp.12333; VAI F, 1988, PACE, V11, P1860, DOI 10.1111/j.1540-8159.1988.tb06321.x; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; VANSTEENKISTE J, 1991, EUR RESPIR J, V4, P393; Ward SA, 2007, EXP PHYSIOL, V92, P357, DOI 10.1113/expphysiol.2006.034371; Whipp BJ, 2007, EXP PHYSIOL, V92, P347, DOI 10.1113/expphysiol.2006.034363	67	3	3	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1824	1833		10.1080/02699052.2018.1506945			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600028	30067397				2022-02-06	
J	Veeh, CA; Vaughn, MG; Renn, T				Veeh, Christopher A.; Vaughn, Michael G.; Renn, Tanya			Coping strategies and traumatic brain injury in incarcerated youth: a mediation analysis	BRAIN INJURY			English	Article						Young offenders; traumatic brain injury; coping; substance abuse; depression; anxiety	QUALITY-OF-LIFE; JUVENILE-OFFENDERS; EXECUTIVE FUNCTION; SUBSTANCE USE; PREVALENCE; HEALTH; ADOLESCENTS; 1ST; RELIABILITY; PREDICTORS	Objective: Investigation into whether coping strategies mediated the relationship of traumatic brain injury (TBI) on depression/anxiety and alcohol and drug problems within incarcerated youth. Subjects: A non-probability sample of youth (N = 227) adjudicated for a variety of offences. Methods: Cross-sectional study within two long-term residential facilities for youth offenders in Pennsylvania. TBI assessed with question about lifetime head injury with blackout. Coping measured with Coping Strategies Inventory that included domains of acting-out coping, internalised coping, partying coping, prosocial coping, and expressing coping. Outcomes of depression/anxiety as well as alcohol and drug problems measured with Massachusetts Youth Screening Instrument-Version 2. Results: Mediation was suggested for acting-out coping and internalised coping with 45% and 48% of the total effect mediated between TBI and depression/anxiety, respectively. For alcohol and drug problems, mediation was indicated for acting-out coping and partying coping. Acting-out coping mediated 33% and partying coping mediated 51% of the total effect between TBI and alcohol and drug problems. Conclusion: Study results suggest that addressing the use of avoidant coping, such as acting-out coping, internalised coping, or partying coping, by youth with TBI in the criminal justice system could help ameliorate depression/anxiety and abuse of alcohol and drugs.	[Veeh, Christopher A.] Univ Iowa, Sch Social Work, 351 North Hall, Iowa City, IA 52242 USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Renn, Tanya] Florida State Univ, Coll Social Work, Tallahassee, FL 32306 USA		Veeh, CA (corresponding author), Univ Iowa, Sch Social Work, 351 North Hall, Iowa City, IA 52242 USA.	christopher-veeh@uiowa.edu	Vaughn, Michael/W-2694-2019; Renn, Tanya/ABD-5469-2021				Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Archer RP, 2004, ASSESSMENT, V11, P290, DOI 10.1177/1073191104269863; Calear AL, 2016, EUR CHILD ADOLES PSY, V25, P467, DOI 10.1007/s00787-015-0783-4; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Finset A, 2000, BRAIN INJURY, V14, P887; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gregorio GW, 2015, BRIT J CLIN PSYCHOL, V54, P291, DOI 10.1111/bjc.12074; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Grisso T., 2006, MASSACHUSETTS YOUTH; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Ilie G, 2014, BULLYING OTHER CONDU, V9, P10, DOI DOI 10.1371/J0URNAL.P0NE.0094936; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2013, NEUROREHABILITATION, V32, P721, DOI 10.3233/NRE-130897; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lipsey MW, 2012, ANTISOCIAL BEHAV CRI, P181; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; PATTERSON JM, 1987, J ADOLESCENCE, V10, P163, DOI 10.1016/S0140-1971(87)80086-6; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Rakers SE, 2018, NEUROPSYCHOLOGY, V32, P213, DOI 10.1037/neu0000399; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; StataCorp, 2015, STAT STAT SOFTW REL; The Disabilities Trust Foundation, 2014, BRAIN INJ SCREEN IND; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	48	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1795	1802		10.1080/02699052.2018.1537007			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600024	30359145				2022-02-06	
J	Zarshenas, S; Cullen, N				Zarshenas, Sareh; Cullen, Nora			Association between cognitive ability and functional outcomes following traumatic brain injury- using a computer-based neurocognitive battery	BRAIN INJURY			English	Article						Brain injury; cognition; outcomes; computer-based assessment	INPATIENT REHABILITATION; NEUROPSYCHOLOGICAL TESTS; ATTENTION DEFICITS; PREDICTORS; PERFORMANCE; RECOVERY; MILD; PRODUCTIVITY; SENSITIVITY; IMPAIRMENT	Objective: To investigate the contribution of the Cogstate Brief Battery (CBB (TM)) in the explanation of variation of functional outcomes. Design: Secondary analysis of the practice-based evidence data set. Setting: Inpatient rehabilitation setting. Participants: Patients (>= 18 years of age) with traumatic brain injury who were consecutively admitted to the Toronto Rehabilitation Institute between 2008 and 2011 (n = 65). Interventions: Not applicable Main outcome measure: Cognitive and motor components of the Functional Independence Measure. Results: The addition of the CBB (TM) components resulted in a significantly better model for predicting outcomes than a basic model using demographics and clinical factors. Among all CBB (TM) components, speed and variation in the identification task and accuracy in the one card learning task were significantly associated with cognitive functional outcomes after controlling for demographic and clinical factors. Rehabilitation length of stay was the only significant clinical factor that was correlated with both cognitive and motor outcomes. Conclusions: Findings of this study suggest the importance of considering visual attention and visual memory in predication of cognitive outcome and provide valuable information for researchers to consider the specific cognitive abilities in functional outcome model in future studies in addition to more traditional factors.	[Zarshenas, Sareh; Cullen, Nora] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Zarshenas, Sareh; Cullen, Nora] Univ Hlth Network, Toronto Rehabil Inst, Univ Ctr, Toronto, ON, Canada		Cullen, N (corresponding author), West Pk Healthcare Ctr, 82 Buttonwood Ave, Toronto, ON M6M 2J5, Canada.	nora.cullen@westpark.org		Cullen, Nora/0000-0001-6359-9418	National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; Toronto Rehabilitation Institute scholarship	The National Institutes of Health, National Center for Medical Rehabilitation Research [grant no. 1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [grant no. H133A080023], and Ontario Neurotrauma Foundation [grant no. 2007-ABI-ISIS-525]. Also, SZ was supported by a Toronto Rehabilitation Institute scholarship for graduate students. The opinions contained in this article are those of authors and should not be constructed as an official statement from aforementioned funding sources.	Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maruff Paul, 2013, BMC Psychol, V1, P30, DOI 10.1186/2050-7283-1-30; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Winardi W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129796; Zhang JY, 2016, J NEUROPSYCH CLIN N, V28, P328, DOI 10.1176/appi.neuropsych.16010005	36	3	3	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1678	1683		10.1080/02699052.2018.1517223			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600009	30183385				2022-02-06	
J	Mortimer, D; Bosch, M; Mckenzie, JE; Turner, S; Chau, M; Ponsford, JL; Knott, JC; Gruen, RL; Green, SE				Mortimer, Duncan; Bosch, Marije; Mckenzie, Joanne E.; Turner, Simon; Chau, Marisa; Ponsford, Jennie L.; Knott, Jonathan C.; Gruen, Russell L.; Green, Sally E.			Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments	IMPLEMENTATION SCIENCE			English	Article						Mild head injury; Mild traumatic brain injury; Emergency medicine; Implementation science; Clinical practice guideline; Evidence-based practice; Cost-effectiveness	TRAUMATIC BRAIN-INJURY; COST-EFFECTIVENESS; IMPLEMENTATION STRATEGIES; HEALTH; QUALITY; CONSISTENCY; DEPRESSION; ANXIETY	Background: Evidence-based guidelines for the management of mild traumatic brain injury (mTBI) in the emergency department (ED) are now widely available, and yet, clinical practice remains inconsistent with the guidelines. The Neurotrauma Evidence Translation (NET) intervention was developed to increase the uptake of guideline recommendations and improve the management of minor head injury in Australian emergency departments (EDs). However, the adoption of this type of intervention typically entails an upfront investment that may or may not be fully offset by improvements in clinical practice, health outcomes and/or reductions in health service utilisation. The present study estimates the cost and cost-effectiveness of the NET intervention, as compared to the passive dissemination of the guideline, to evaluate whether any improvements in clinical practice or health outcomes due to the NET intervention can be obtained at an acceptable cost. Methods and findings: Study setting: The NET cluster randomised controlled trial [ACTRN12612001286831]. Study sample: Seventeen EDs were randomised to the control condition and 14 to the intervention. One thousand nine hundred forty-three patients were included in the analysis of clinical practice outcomes (NET sample). A total of 343 patients from 14 control and 10 intervention EDs participated in follow-up interviews and were included in the analysis of patient-reported health outcomes (NET-Plus sample). Outcome measures: Appropriate post-traumatic amnesia (PTA) screening in the ED (primary outcome). Secondary clinical practice outcomes: provision of written information on discharge (INFO) and safe discharge (defined as CT scan appropriately provided plus PTA plus INFO). Secondary patient-reported, post-discharge health outcomes: anxiety (Hospital Anxiety and Depression Scale), post-concussive symptoms (Rivermead), and preference-based health-related quality of life (SF6D). Methods: Trial-based economic evaluations from a health sector perspective, with time horizons set to coincide with the final follow-up for the NET sample (2 months post-intervention) and to 1-month post-discharge for the NET-Plus sample. Results: Intervention and control groups were not significantly different in health service utilisation received in the ED/inpatient ward following the initial mTBI presentation (adjusted mean difference $23.86 per patient; 95%CI -$106, $153; p=0.719) or over the longer follow-up in the NET-plus sample (adjusted mean difference $341.78 per patient; 95%CI -$58, $742; p = 0.094). Savings from lower health service utilisation are therefore unlikely to offset the significantly higher upfront cost of the intervention (mean difference $138.20 per patient; 95%CI $135, $141; p<0.000). Estimates of the net effect of the intervention on total cost (intervention cost net of health service utilisation) suggest that the intervention entails significantly higher costs than the control condition (adjusted mean difference $169.89 per patient; 95%CI $43, $297, p = 0.009). This effect is larger in absolute magnitude over the longer follow-up in the NET-plus sample (adjusted mean difference $505.06; 95%CI $96, $915; p = 0.016), mostly due to additional health service utilisation. For the primary outcome, the NET intervention is more costly and more effective than passive dissemination; entailing an additional cost of $1246 per additional patient appropriately screened for PTA ($169.89/0.1363; Fieller's 95%CI $525, $2055). For NET to be considered cost-effective with 95% confidence, decision-makers would need to be willing to trade one quality-adjusted life year (QALY) for 25 additional patients appropriately screened for PTA. While these results reflect our best estimate of cost-effectiveness given the data, it is possible that a NET intervention that has been scaled and streamlined ready for wider roll-out may be more or less cost-effective than the NET intervention as delivered in the trial. Conclusions: While the NET intervention does improve the management of mTBI in the ED, it also entails a significant increase in cost and-as delivered in the trialis unlikely to be cost-effective at currently accepted funding thresholds. There may be a scope for a scaled-up and streamlined NET intervention to achieve a better balance between costs and outcomes.	[Mortimer, Duncan] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Melbourne, Vic, Australia; [Bosch, Marije; Chau, Marisa] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Bosch, Marije; Chau, Marisa; Gruen, Russell L.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Bosch, Marije; Chau, Marisa; Gruen, Russell L.] Monash Univ, Melbourne, Vic, Australia; [Bosch, Marije] Univ Groningen, Fac Econ & Business, Groningen, Netherlands; [Mckenzie, Joanne E.; Turner, Simon; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Knott, Jonathan C.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan C.] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Gruen, Russell L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Melbourne, Vic, Australia		Mortimer, D (corresponding author), Monash Univ, Monash Business Sch, Ctr Hlth Econ, Melbourne, Vic, Australia.	duncan.mortimer@monash.edu	McKenzie, Joanne/I-2925-2014	McKenzie, Joanne/0000-0003-3534-1641; Mortimer, Duncan Stuart/0000-0002-7211-6454; Turner, Simon/0000-0001-9163-4524	Victorian Transport Accident Commission (TAC), Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian NHMRC Public Health FellowshipNational Health and Medical Research Council of Australia [606726]; Australian Postgraduate AwardAustralian Government; Australian National HealthNational Health and Medical Research Council of Australia; NHMRC Australian Public Health FellowshipNational Health and Medical Research Council of Australia [1072366]; Medical Research Council FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Canada Research Chair in Health Knowledge and Transfer	This trial was part of a 5-year grant (the Neurotrauma Evidence Translation (NET) Program), funded by the Victorian Transport Accident Commission (TAC), Australia (https://www.tac.vic.gov.au/). RLG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council. DAO is supported by an Australian NHMRC Public Health Fellowship (606726). JMG holds a Canada Research Chair in Health Knowledge and Transfer. EJT is supported by an Australian Postgraduate Award, Australian National Health, and Medical Research Council Fellowship. JEM holds an NHMRC Australian Public Health Fellowship (1072366). All funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 64010 ABS; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Baker R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub3; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bosch M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148091; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Brazier JE, 2008, PRONEWSL, V40, P14; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cobiac LJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-398; Edney LC, 2018, PHARMACOECONOMICS, V36, P239, DOI 10.1007/s40273-017-0585-2; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Glick H.A., 2007, EC EVALUATION CLIN T; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hoomans T, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0168-y; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Mortimer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075647; NSW Institute of Trauma and Injury Management, 2011, IN MAN CLOS HEAD INJ; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Scott IA, 2015, MED J AUSTRALIA, V203, P179, DOI 10.5694/mja14.01664; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Vale L, 2007, EUR J HEALTH ECON, V8, P111, DOI 10.1007/s10198-007-0043-8; Vallejo-Torres L, 2016, VALUE HEALTH, V19, P558, DOI 10.1016/j.jval.2016.02.020; Verkerk EW, 2018, INT J QUAL HEALTH C, V30, P736, DOI 10.1093/intqhc/mzy100; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	3	3	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	DEC 5	2018	13								147	10.1186/s13012-018-0834-6			18	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HD2EC	WOS:000452322900001	30518430	Green Published, gold			2022-02-06	
J	Cohen-Zimerman, S; Salvi, C; Krueger, F; Gordon, B; Grafman, J				Cohen-Zimerman, Shira; Salvi, Carola; Krueger, Frank; Gordon, Barry; Grafman, Jordan			Intelligence across the seventh decade in patients with brain injuries acquired in young adulthood	TRENDS IN NEUROSCIENCE AND EDUCATION			English	Article						Intelligence; Penetrating traumatic brain injury; Exacerbated cognitive decline	PENETRATING HEAD-INJURY; MINI-MENTAL-STATE; COGNITIVE DECLINE; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; STABILITY; RECOVERY; RISK; DEMENTIA; SEQUELAE	Objectives: In this longitudinal study we tested for potential predictors and correlates of late midlife intelligence, as well as any recent change in score over the seventh decade, in veterans who suffered a penetrating traumatic brain injury (pTBI) during combat in Vietnam. Methods: Intelligence level was assessed in pTBI patients (n = 120), as well as matched Vietnam combat veterans with no brain damage (n = 33). Intelligence was evaluated using the Armed Forces Qualification Test (AFQT) administered before the injury occurred and then again at three time points over the following 45 years. Results: The pTBI group had lower intelligence scores than the control group when evaluated at fifteen years post-injury but those differences remained stable across subsequent time points. Pre-injury intelligence and the presence of a pTBI were the most consistent predictors of current intelligence scores. Conclusions: While exacerbated intellectual decline occurs following a young-adulthood pTBI and affects everyday life, no evidence for late midlife accelerated cognitive decline or dementia was found.	[Cohen-Zimerman, Shira; Salvi, Carola; Grafman, Jordan] Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, 355 E Erie St, Chicago, IL 60611 USA; [Salvi, Carola] Northwestern Univ, Dept Psychol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] Univ Mannheim, Dept Psychol, Mannheim, Germany; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Cohen-Zimerman, S (corresponding author), Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, 355 E Erie St, Chicago, IL 60611 USA.	scohenzime@sralab.org; jgrafman@northwestern.edu	Salvi, Carola/AAI-1939-2020; Cohen-Zimerman, Shira/X-8330-2019	Cohen-Zimerman, Shira/0000-0001-6098-2550; Salvi, Carola/0000-0001-9312-7649	Smart Family Foundation of New York; Julius N. Frankel Foundation; Therapeutic Cognitive Neuroscience Fund; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 NS047987]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047987] Funding Source: NIH RePORTER	Jordan Grafman received funds from the Smart Family Foundation of New York and the Julius N. Frankel Foundation.; Barry Gordon and Jordan Grafman were supported by the Therapeutic Cognitive Neuroscience Fund.; Carola Salvi was supported by NIH grant no. T32 NS047987.	Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Barnes D., 2011, ALZHEIMERS DEMENTI S, V7, pS347, DOI [10.1016/j.jalz.2011.05.1006, DOI 10.1016/J.JALZ.2011.05.1006]; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Cipolotti L, 2015, NEUROPSYCHOLOGIA, V75, P233, DOI 10.1016/j.neuropsychologia.2015.06.011; CORKIN S, 1989, J NEUROSCI, V9, P3876; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao BL, 2000, J NEUROPSYCH CLIN N, V12, P385, DOI 10.1176/appi.neuropsych.12.3.385; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Hayes JP, 2018, GENES BRAIN BEHAV, V17, P107, DOI 10.1111/gbb.12403; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Larsen L, 2008, INTELLIGENCE, V36, P29, DOI 10.1016/j.intell.2007.01.001; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lyons MJ, 2017, DEV PSYCHOL, V53, P1170, DOI 10.1037/dev0000303; Lyons MJ, 2009, PSYCHOL SCI, V20, P1146, DOI 10.1111/j.1467-9280.2009.02425.x; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Moustafa AA, 2018, REV NEUROSCIENCE, V29, P21, DOI 10.1515/revneuro-2017-0036; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Plassman B. L., 2015, TRAUMATIC BRAIN INJU, DOI [10.1016/B978-0-444-63521-1.00044-3, DOI 10.1016/B978-0-444-63521-1.00044-3]; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; SCHWARTZMAN AE, 1987, CAN J PSYCHOL, V41, P244, DOI 10.1037/h0084155; Soldan A, 2017, NEUROBIOL AGING, V60, P164, DOI 10.1016/j.neurobiolaging.2017.09.002; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wood R. L. I., 2006, J NEUROL NEUROSUR PS, V77, P1180; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	43	3	3	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2452-0837	2211-9493		TRENDS NEUROSCI EDUC	Trends Neurosci. Educ.	DEC	2018	13						1	7		10.1016/j.tine.2018.08.001			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HC7GD	WOS:000451967900001	30613804	Green Accepted, Bronze			2022-02-06	
J	Dagain, A; Aoun, O; Sellier, A; Desse, N; Joubert, C; Beucler, N; Bernard, C; Fouet, M; Delmas, JM; Dulou, R				Dagain, Arnaud; Aoun, Olivier; Sellier, Aurore; Desse, Nicolas; Joubert, Christophe; Beucler, Nathan; Bernard, Cedric; Fouet, Mathilde; Delmas, Jean-Marc; Dulou, Renaud			Acute neurosurgical management of traumatic brain injury and spinal cord injury in French armed forces during deployment	NEUROSURGICAL FOCUS			English	Article						neurosurgical damage control; decompressive craniectomy; war surgery; head injury	MEDICAL-TREATMENT FACILITY; CRANIOCEREBRAL INJURIES; AFGHANISTAN; EXPERIENCE	This article aims to describe the French concept regarding combat casualty neurosurgical care from the theater of operations to a homeland hospital. French military neurosurgeons are not routinely deployed to all combat zones. As a consequence, general surgeons initially treat neurosurgical wounds. The principle of this medical support is based on damage control. It is aimed at controlling intracranial hypertension spikes when neuromonitoring is lacking in resource-limited settings. Neurosurgical damage control permits a medevac that is as safe as can be expected from a conflict zone to a homeland medical treatment facility. French military neurosurgeons can occasionally be deployed within an airborne team to treat a military casualty or to complete a neurosurgical procedure performed by a general surgeon in theaters of operation. All surgeons regardless of their specialty must know neurosurgical damage control. General surgeons must undergo the required training in order for them to perform this neurosurgical technique.	[Dagain, Arnaud; Sellier, Aurore; Desse, Nicolas; Joubert, Christophe; Beucler, Nathan; Bernard, Cedric] Hop Instruct Armees St Anne, Serv Neurochirurg, Toulon, France; [Aoun, Olivier] 5th Armed Forces Med Ctr, Strasbourg, France; [Fouet, Mathilde; Delmas, Jean-Marc; Dulou, Renaud] Hop Instruct Armees Percy, Serv Neurochirurg, Clamart, France		Dagain, A (corresponding author), Hop Instruct Armees St Anne, Toulon, France.	dr.adagain@gmail.com	Joubert, Christophe/AAU-4807-2020	Aoun, Olivier/0000-0001-9554-8439			Agarwalla PK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1038; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Bertani A, 2012, MED SANTE TROP, V22, P405, DOI 10.1684/mst.2012.0112; Bonnet S, 2012, INJURY, V43, P1301, DOI 10.1016/j.injury.2012.03.002; Bordes J, 2017, INJURY, V48, P1047, DOI 10.1016/j.injury.2016.11.023; Breeze J, 2018, J ROY ARMY MED CORPS, V164, P133, DOI 10.1136/jramc-2017-000881; Brevart C, 2011, CASE REP SURG, V2011, DOI 10.1155/2011/476416; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Dagain A, 2017, WORLD NEUROSURG, V102, P6, DOI 10.1016/j.wneu.2017.02.097; Dulou R, 2015, ACTA NEUROCHIR, V157, P1087, DOI 10.1007/s00701-014-2283-6; Dulou R, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1016; Formby PM, 2016, SPINE J, V16, P329, DOI 10.1016/j.spinee.2015.11.027; GEORGE ED, 1995, NEUROSURG CLIN N AM, V6, P753; Giannou C., 2010, WAR SURG WORKING LTD; Joubert C, 2016, ACTA NEUROCHIR, V158, P1453, DOI 10.1007/s00701-016-2843-z; Klimo P Jr, 2010, NEUROSURG FOCUS, V28; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Roux FE, 2013, CLIN NEUROL NEUROSUR, V115, P2438, DOI 10.1016/j.clineuro.2013.09.004; Schoenfeld AJ, 2014, J SPINAL DISORD TECH, V27, P376, DOI 10.1097/BSD.0b013e3182a355c6	22	3	3	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2018	45	6							E9	10.3171/2018.9.FOCUS18368			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD6HR	WOS:000452637400009	30544305	gold			2022-02-06	
J	Digby, R; Wells, A; Menon, D; Helmy, A				Digby, Richard; Wells, Adam; Menon, David; Helmy, Adel			Foix-Chavany-Marie syndrome secondary to bilateral traumatic operculum injury	ACTA NEUROCHIRURGICA			English	Article						Foix-Chavany-Marie; Pseudobulbar palsy; Frontal aslant tract; Supplementary motor area syndrome	SUPPLEMENTARY MOTOR AREA; CONNECTIONS	This report describes a case of a 62-year-old man who developed Foix-Chavany-Marie syndrome subsequent to traumatic brain injury. The initial presentation of the syndrome was profound loss of voluntary control of orofacial muscles, causing a loss of speech and impairment of swallow. Over subsequent months, a remarkable recovery of these functions was observed. The natural history of FCMS in this case was favourable, with good improvement in function over months. Furthermore, the pattern of bilateral opercular injury was more readily recognised on MRI than on CT, supporting the role of MRI in cases of traumatic brain injury.	[Digby, Richard; Wells, Adam; Menon, David; Helmy, Adel] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 0QQ, England		Digby, R (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 0QQ, England.	richard.digby@doctors.org.uk	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Digby, Richard/0000-0001-9733-4741			Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Duffau H, 2003, NEUROSURGERY, V53, P426, DOI 10.1227/01.NEU.0000073990.94180.54; Foix C., 1926, REV NEUROL-FRANCE, V33, P214; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Laurent-Vannier A, 1999, REV NEUROL, V155, P387; Martino J, 2012, J NEUROSURG, V117, P844, DOI 10.3171/2012.7.JNS12404; Nitta N, 2013, CLIN NEUROL NEUROSUR, V115, P1539, DOI 10.1016/j.clineuro.2012.12.036; Nowak DA, 2010, J CLIN NEUROSCI, V17, P1441, DOI 10.1016/j.jocn.2010.02.021; Potgieser ARE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00960; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Vergani F, 2014, J NEUROL NEUROSUR PS, V85, P1377, DOI 10.1136/jnnp-2013-307492; WELLER M, 1993, J NEUROL, V240, P199, DOI 10.1007/BF00818705	12	3	3	1	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2018	160	12					2303	2305		10.1007/s00701-018-3702-x			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HB3XI	WOS:000450984500004	30328523	Green Published, hybrid			2022-02-06	
J	Hurst, HT; Atkins, S; Dickinson, BD				Hurst, Howard T.; Atkins, Stephen; Dickinson, Ben D.			The magnitude of translational and rotational head accelerations experienced by riders during downhill mountain biking	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Injury; Brain; Concussion; Accelerometry; Mountain biking	IMPACT EXPOSURE; BIOMECHANICS; INJURIES; CONTACT	Objectives: To determine the magnitude of translational and rotational head accelerations during downhill mountain biking. Design: Observational study. Methods: Sixteen male downhill cyclists (age 26.4 +/- 8.4 years; stature 179.4 +/- 7.2 cm; mass 75.3 +/- 5.9 kg) were monitored during two rounds of the British Downhill Series. Riders performed two runs on each course wearing a triaxial accelerometer behind the right ear. The means of the two runs for each course were used to determine differences between courses for mean and maximum peak translational (g) and rotational accelerations (rad/s(2)) and impact duration for each course. Results: Significant differences (p<0.05) were revealed for the mean number of impacts (>10g), FW =12.5 +/- 7.6, RYF = 42.8 +/- 27.4 (t((22.96)) = -4.70; p<0.001; 95% CI = 17.00 to 43.64); maximum peak rotational acceleration, FW= 6805.4 +/- 3073.8 rad/s(2),RYF = 9799.9 +/- 3381.7 rad/s(2) (t((32)) = -2.636; p = 0.01; 95% CI = 680.31 to 5308.38); mean acceleration duration FW = 4.7 +/- 1.2 ms, RYF = 6.5 +/- 1.4 ms (t((32)) = -4.05; p<0.001; 95% CI = 0.91 to 2.76) and maximum acceleration duration, FW = 11.6 +/- 4.5 ms, RYF =21.2 +/- 9.1 (t((29)(.)(51)) = -4.06; p = 0.001; 95% CI = 4.21 to 14.94). No other significant differences were found. Conclusions: Findings indicate that downhill riders may be at risk of sustaining traumatic brain injuries and course design influences the number and magnitude of accelerations. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hurst, Howard T.; Dickinson, Ben D.] Univ Cent Lancashire, Sch Sport & Wellbeing, Preston, Lancs, England; [Atkins, Stephen] Univ Salford, Sch Hlth Sci, Salford, Lancs, England		Hurst, HT (corresponding author), Univ Cent Lancashire, Sch Sport & Wellbeing, Preston, Lancs, England.	HTHurst@uclan.ac.uk		Hurst, Howard/0000-0001-7889-8592			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Becker J, 2013, BRIT J SPORT MED, V47, P458, DOI 10.1136/bjsports-2012-091755; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Burr JF, 2012, J SPORT SCI, V30, P1777, DOI 10.1080/02640414.2012.718091; Cohen J., 2013, STAT POWER ANAL BEHA; Davis P, 2013, INT J SPORT PHYSIOL, V10, P53; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hurst H.T., 2013, J SCI CYCL, V2, P25; Hurst HT, 2018, J SCI MED SPORT, V21, P263, DOI 10.1016/j.jsams.2017.05.018; Hurst HT, 2006, J SPORT SCI, V24, P1047, DOI 10.1080/02640410500431997; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kronisch RL, 1996, MED SCI SPORT EXER, V28, P1351, DOI 10.1097/00005768-199611000-00002; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mertz HJ, 1994, 941056 SAE; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Scher I, 2006, J ASTM INT, V3, P1; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Steenstrup SE, 2017, BRIT J SPORT MED, P1; Union Cycliste Internationale, 2012, UN CLOUD SEC REF ARC, P1; VEICSTEINAS A, 1984, J APPL PHYSIOL, V56, P1187, DOI 10.1152/jappl.1984.56.5.1187; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	29	3	3	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2018	21	12					1256	1261		10.1016/j.jsams.2018.03.007			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HF4FM	WOS:000454188600015	29606559	Green Accepted, Green Submitted			2022-02-06	
J	Ichikawa, R; Maeda, Y; Shibuya, A; Umesato, Y; Kondo, Y; Maeda, T; Yoshino, A; Takahashi, S				Ichikawa, Rie; Maeda, Yukihiro; Shibuya, Akiko; Umesato, Yoshimasa; Kondo, Yoshiaki; Maeda, Takeshi; Yoshino, Atsuo; Takahashi, Shori			Prediction of Poor Prognosis After Severe Head Injury in Children Using Logistic Regression	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; outcome prediction; hyperglycemia; Glasgow Coma Scale; subarachnoid hemorrhage	COMA DATA-BANK; BRAIN-INJURY; TRAUMA; HYPERGLYCEMIA; EXPERIENCE; MORTALITY; CLASSIFICATION; EPIDEMIOLOGY; SCALE; JAPAN	Objectives Head trauma is one of the main causes of death in childhood and often leaves severe disability with serious neurological damage. Appropriate treatment must be provided immediately to improve outcomes. This study was performed to identify factors associated with a poor prognosis at an early stage of severe head injury in children. Methods The subjects were registered in the Japan Neurotrauma Data Bank. They were 119 children (mean age, 8 years; male, 67.2%) with severe head injury registered during a period of 4 years (from July 1, 2004 to June 30, 2006 and from July 1, 2009 to June 30, 2011). Univariate and multivariate analyses were performed to examine relationships among factors and outcome 6 months after discharge. Logistic regression analysis was performed to develop models for poor prognosis and death. Results Outcome was evaluated based on the Glasgow Outcome Scale: 73 children (61.3%) had good recovery, 11 (9.2%) had moderate disability, 8 (6.7%) had severe disability, 4 (3.3%) were in a vegetative state, and 23 (19.3%) had died. Four factors were identified as predictors of a poor prognosis: serum glucose level greater than or equal to 200 mg/dL, Glasgow Coma Scale score on admission less than or equal to 5, presence of mydriasis, and presence of traumatic subarachnoid hemorrhage. Three factors were identified as predictors of death: serum glucose level greater than or equal to 200 mg/dL, Glasgow Coma Scale score on admission less than or equal to 5, and presence of mydriasis. Conclusions Using these predictors, subsequent exacerbation may be predicted just after arrival at the hospital and appropriate treatment can be provided immediately.	[Ichikawa, Rie; Maeda, Yukihiro; Shibuya, Akiko; Umesato, Yoshimasa; Kondo, Yoshiaki] Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Tokyo, Japan; [Maeda, Takeshi; Yoshino, Atsuo] Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo, Japan; [Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan		Maeda, Y (corresponding author), Nihon Univ, Sch Med, Dept Hlth Care Serv Management, Itabashi Ku, 30-1 Oyaguchikamicho, Tokyo 1738610, Japan.	yukihiro-m@umin.ac.jp	Takahashi, Shori/AAS-7147-2021; Takahashi, Shori/AAE-6723-2020	Takahashi, Shori/0000-0001-6327-535X			ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Babbitt CJ, 2013, PEDIATR EMERG CARE, V29, P279, DOI 10.1097/PEC.0b013e3182850409; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Mataro M, 2001, J NEUROTRAUM, V18, P869, DOI 10.1089/089771501750451794; MAZUREK AJ, 1994, J ACCID EMERG MED, V11, P9; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Perheentupa U, 2010, INT J PEDIATR OTORHI, V74, P1245, DOI 10.1016/j.ijporl.2010.07.023; Sekii H, 2013, INT J ENV RES PUB HE, V10, P528, DOI 10.3390/ijerph10020528; SNYDER CL, 1990, J TRAUMA, V30, P1239, DOI 10.1097/00005373-199010000-00008; TEASDALE G, 1974, LANCET, V2, P81; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Tursz A, 1990, Paediatr Perinat Epidemiol, V4, P408, DOI 10.1111/j.1365-3016.1990.tb00668.x; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; WALKER ML, 1984, CHILD BRAIN, V11, P387; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	31	3	4	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2018	34	12					825	831		10.1097/PEC.0000000000001321			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HE1YW	WOS:000453071000009	29095390				2022-02-06	
J	Lange, N; Berndt, M; Jorger, AK; Wagner, A; Lummel, N; Ryang, YM; Wantia, N; Meyer, B; Gempt, J				Lange, Nicole; Berndt, Maria; Joerger, Ann-Kathrin; Wagner, Arthur; Lummel, Nina; Ryang, Yu-Mi; Wantia, Nina; Meyer, Bernhard; Gempt, Jens			Clinical Characteristics and Course of Postoperative Brain Abscess	WORLD NEUROSURGERY			English	Article						Brain abscess; Infection; Secondary brain abscess		BACKGROUND: Cerebral abscesses after brain surgery are rare but severe and life-threatening complications. We sought to analyze the clinical aspects of those patients and thereby reveal risk factors and the relevant aspects for their future therapy. METHODS: We identified 44 patients (23 male, 21 female) undergoing surgery or frameless stereotactic drainage at our center from March 2009 to January 2018. We conducted 12,101 cranial surgeries during that time. RESULTS: The mean age was 55 years (range 21-82 years). The median duration between brain surgery and the after brain abscess was 1.5 months (range 1-23 months). Previous brain surgeries were emergency procedures in 27% of the cases. The frequency of surgery type was as follows: tumor resection (61%), craniotomy for traumatic brain injury (16%), aneurysm surgery (7%), biopsies (5%), hemicraniectomy after malignant cerebral infarction (5%), and other. We performed 1.3 surgeries per patient followed by antibiotic treatment for 4 weeks (= median) according to the respective germ spectrum. The germ entity was successfully identified in 39 patients (89%). In 18 cases (41%), we identified Staphylococcus aureus. In total, 20.5% of the patients died during the follow-up period. The mortality rate for patients with isolated bacteria was 18% compared with 40% for patients without isolation of specific microorganisms. CONCLUSIONS: Secondary brain abscess is a rare complication and occurs mainly in patients with tumors and patients receiving emergency surgery. In total, 41% of the patients suffered from a S. aureus infection. Isolation of the responsible microorganisms is often possible and leads to improved outcomes.	[Lange, Nicole; Joerger, Ann-Kathrin; Wagner, Arthur; Ryang, Yu-Mi; Meyer, Bernhard; Gempt, Jens] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany; [Berndt, Maria; Lummel, Nina] Tech Univ Munich, Klinikum Rechts Isar, Dept Neuroradiol, Munich, Germany; [Wantia, Nina] Tech Univ Munich, Klinikum Rechts Isar, Dept Microbiol, Munich, Germany		Lange, N (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany.	Nicole.Lange@tum.de	Meyer, Bernhard/AAH-3329-2019; Ryang, Yu-Mi/Q-8373-2016; Berndt, Maria/O-8882-2019	Meyer, Bernhard/0000-0001-6486-7955; Ryang, Yu-Mi/0000-0002-9045-5038; Berndt, Maria/0000-0001-9124-231X; Gempt, Jens/0000-0003-4123-4690			Alvis Miranda Hernando, 2013, J Neurosci Rural Pract, V4, pS67, DOI 10.4103/0976-3147.116472; Arends JE, 2011, J CLIN MICROBIOL, V49, P4364, DOI 10.1128/JCM.01062-11; Brook I, 2017, J CLIN NEUROSCI, V38, P8, DOI 10.1016/j.jocn.2016.12.035; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deetjen P, 2014, J CLIN MICROBIOL, V52, P695, DOI 10.1128/JCM.02990-13; Lange N, 2018, ACTA NEUROCHIR, V160, P2055, DOI 10.1007/s00701-018-3633-6; Mahabeer Y, 2014, J CLIN MICROBIOL, V52, P1796, DOI 10.1128/JCM.00267-14; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; Moorthy RK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E3; Mylona E, 2012, J CLIN MICROBIOL, V50, P1807, DOI 10.1128/JCM.06658-11; Patel K, 2014, NEUROHOSPITALIST, V4, P196, DOI 10.1177/1941874414540684; RNe al, 2016, DTSCH GESELLSCHAFT N; Tattevin P, 2003, AM J MED, V115, P143, DOI 10.1016/S0002-9343(03)00292-4; Tseng JH, 2006, SURG NEUROL, V65, P557, DOI 10.1016/j.surneu.2005.09.029; Wang JQ, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.05.013; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	19	3	3	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E675	E683		10.1016/j.wneu.2018.08.143			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300083	30165224				2022-02-06	
J	Liu, H; He, JC; Zhang, ZS; Liu, L; Huo, G; Sun, XC; Cheng, CJ				Liu, Han; He, Junchi; Zhang, Zhaosi; Liu, Liu; Huo, Gang; Sun, Xiaochuan; Cheng, Chongjie			Evolution of cerebral perfusion in the peri-contusional cortex in mice revealed by in vivo laser speckle imaging after traumatic brain injury	BRAIN RESEARCH			English	Article						Cerebral perfusion; Laser speckle imaging; Traumatic brain injury	BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; DISRUPTION; MODELS; TENSION	The role of the cerebrovascular network during the acute and chronic phases after traumatic brain injury (TBI) is poorly defined and emerging evidence suggests that cerebral perfusion is altered. The purpose of this study is to explore how the cortical blood flow is pathologically altered following TBI using a newly developed technique, laser speckle imaging. The controlled cortical impact (CCI) model was established in mice. Then, cerebral blood flow was monitored in vivo laser speckle imaging and vessel painting was labeled by Lectin in the peri-contusional cortex. Lastly, mice were assessed for lesion size and neurological functions. Our results indicated that: 1) In the acute phase of TBI, cerebral blood flow and microvessel counts decreased significantly (P < 0.05) 2) In the chronic phase of TBI, cerebral blood flow and microvessel counts recovered gradually (P < 0.05) 3) Cortical lesion volume reduced significantly in the chronic phase of TBI (P < 0.05) 4) Spontaneous neurocognitive recovery occurred following CCI in mice (P < 0.05). In the acute phase of TBI, there is a reduction in cerebral perfusion at the lesion site. However, this reduction recovers in the chronic phase of TBI ultimately, followed by an improvement of ameliorated neurobehavioral functions and a decrease in the lesion size. The novel approach for cerebral blood flow monitoring by laser speckle imaging can be extended from bench to bedside and provide potential therapeutic strategies for TBI patients. (C) 2018 Elsevier B.V. All rights reserved.	[Liu, Han; He, Junchi; Zhang, Zhaosi; Liu, Liu; Huo, Gang; Sun, Xiaochuan; Cheng, Chongjie] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China		Sun, XC; Cheng, CJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	1019266517@qq.com; sunxch1445@qq.com; 358187887@qq.com	He, Junchi/AAD-8482-2019	sun, xiao chuan/0000-0001-6992-332X; Zhang, Zhaosi/0000-0002-4988-501X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]; National Construction Project for Clinical Key Specialty [(2011)170]	This work was supported by the National Natural Science Foundation of China (No. 81571159), National Natural Science Foundation for Youth of China (No. 81601072) and National Construction Project for Clinical Key Specialty (No. (2011)170). In addition, we'd like to thank Rami M. Z. Darwazeh for English proofreading.	Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Davis MA, 2016, BIOMED OPT EXPRESS, V7, P759, DOI 10.1364/BOE.7.000759; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon C. Edward, 2009, P385, DOI 10.1007/978-1-60327-185-1_33; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Le TM, 2007, IEEE T MED IMAGING, V26, P833, DOI 10.1109/TMI.2007.892643; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Parthasarathy AB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526368; Ponticorvo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.090501; Ponticorvo A, 2010, OPT EXPRESS, V18, P8160, DOI 10.1364/OE.18.008160; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Richards LM, 2013, BIOMED OPT EXPRESS, V4, P2269, DOI 10.1364/BOE.4.002269; Romine J., 2014, JOVE-J VIS EXP, V90; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Varsos GV, 2014, NEUROCRIT CARE, V21, P266, DOI 10.1007/s12028-014-9971-1; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51; Zhang YL, 2017, J NEUROSURG, V126, P782, DOI 10.3171/2016.3.JNS152699; Zhong J., 2016, NEUROSCIENCE; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e	42	3	3	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2018	1700						118	125		10.1016/j.brainres.2018.07.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB8PU	WOS:000451353600013	29990491				2022-02-06	
J	Liu, XM; Qiu, YY; Zhang, JB; Zhang, QW; Chen, L; Chen, LZ; Sun, XY				Liu, Xuemeng; Qiu, Yongyi; Zhang, Jibo; Zhang, Qingwen; Chen, Lin; Chen, Lizhu; Sun, Xiangyu			Emergent Single Burr Hole Evacuation for Traumatic Acute Subdural Hematoma with Cerebral Herniation: A Retrospective Cohort Comparison Analysis	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma (ASDH); Cerebral herniation; Decompressive craniectomy and intracranial hematoma removal surgery; Prognosis single burr hole evacuation	DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; BRAIN-INJURY; OUTCOMES; SURGERY; MORTALITY; ADULTS; IMPACT	OBJECTIVE: To investigate the clinical benefits of emergent single burr hole evacuation technology in traumatic acute subdural hematoma (ASDH) with cerebral herniation cases. METHODS: We conducted a review comparing patients with ASDH with cerebral herniation who underwent single burr hole evacuation followed by decompressive craniectomy and intracranial hematoma removal surgery (n = 45, group A) and those who underwent decompressive craniectomy and intracranial hematoma removal surgery after rapid infusion of mannitol 250 mL (n = 53, group B) in our institution. Pre- and postoperative assessments included Glasgow Coma Scale (GCS), Glasgow Outcome Scale (GOS), activities of daily living (ADLs), and common complication incidences. RESULTS: At 1 and 6 months after operation, the median GCS score of group A was significantly higher than group B (P = 0.04 and P = 0.03, respectively). After 6 months, the GOS score and ADLs between the 2 groups had significant differences (P < 0.05). There were no differences between the 2 groups in the common complication incidences. CONCLUSIONS: Emergent single burr hole evacuation in combination with decompressive craniectomy surgery is a useful treatment for ASDH with cerebral herniation, which can achieve reduction of intracranial pressure as soon as possible and improve the prognosis.	[Liu, Xuemeng; Zhang, Qingwen; Chen, Lin; Chen, Lizhu; Sun, Xiangyu] FeiXian People Hosp, Dept Neurosurg, Feixian, Peoples R China; [Qiu, Yongyi; Zhang, Jibo] Wuhan Univ, ZhongNan Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China		Sun, XY (corresponding author), FeiXian People Hosp, Dept Neurosurg, Feixian, Peoples R China.	shuhan5931@163.com					Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cruz J, 2001, NEUROSURGERY, V49, P864; Engel DC, 2010, INJURY, V41, P901, DOI 10.1016/j.injury.2010.01.002; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Moscote-Salazar Luis Rafael, 2013, Bull Emerg Trauma, V1, P175; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; Wan J, 2003, CHINESE J CLIN NEURO, V8, P115; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yanagawa Y, 2012, TURK NEUROSURG, V22, P196, DOI 10.5137/1019-5149.JTN.5206-11.0	23	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E1024	E1030		10.1016/j.wneu.2018.08.219			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300119	30201582				2022-02-06	
J	Mathew, AS; Shi, XY; Yau, ST				Mathew, Anup S.; Shi, Xuyang; Yau, Siu-Tung			Detection of a Traumatic Brain Injury Biomarker at the 10fg/mL Level	MOLECULAR DIAGNOSIS & THERAPY			English	Article							S100B PROTEIN; TRANSISTOR	BackgroundThe detection of minute amounts of protein biomarkers in body fluids is believed to provide early diagnosis and prognosis of mild traumatic brain injury (mTBI). An ultrasensitive detection method was used to detect S100B, the most studied potential marker for the diagnosis of mTBI.MethodsThe detection method was a modified electrochemical immunoassay technique that provides voltage controlled intrinsic current signal amplification. The sandwich immune complex of S100B was formed on the working electrode of the screen-printed electrode. The gating voltage provides amplification of the current signal that flows through the complex.ResultsS100B was spiked in human serum. The limit of detection of S100B in human serum was 10fg/mL. The calibration curves cover four orders of magnitudes from 10fg/mL to 10ng/mL. The specificity of the detection was demonstrated using TAU protein, which is another marker for mTBI.ConclusionThe results reported in this work using the field effect enzymatic detection (FEED)-based immunoassay indicate the feasibility of using this method for the detection of extremely low concentrations of markers of mTBI in human serum. This method can be developed as a platform for a range of markers of mTBI.	[Mathew, Anup S.; Shi, Xuyang; Yau, Siu-Tung] Cleveland State Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44115 USA; [Yau, Siu-Tung] Cleveland State Univ, Appl Bioengn Program, Cleveland, OH 44115 USA		Yau, ST (corresponding author), Cleveland State Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44115 USA.; Yau, ST (corresponding author), Cleveland State Univ, Appl Bioengn Program, Cleveland, OH 44115 USA.	s.yau@csuohio.edu	Shi, Xuyang/H-4115-2018		Multi-College Interdisciplinary Research Program by Cleveland State University	Funding was provided by the Multi-College Interdisciplinary Research Program provided by Cleveland State University.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; CDC, 2003, REP C MILD TRAUM BRA; Choi Y, 2009, ANAL CHEM, V81, P7123, DOI 10.1021/ac901126d; Csoregi E, 2001, FOCUS BIOTECHNOL, V7, P105; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferri T, 1998, BIOELECTROCH BIOENER, V44, P177, DOI 10.1016/S0302-4598(97)00088-3; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Tans SJ, 1998, NATURE, V393, P49; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Wang JP, 2014, CHEMELECTROCHEM, V1, P741, DOI 10.1002/celc.201300180; Wang JP, 2011, BIOSENS BIOELECTRON, V29, P210, DOI 10.1016/j.bios.2011.07.072; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Yau ST, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880445; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	19	3	3	1	5	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1177-1062	1179-2000		MOL DIAGN THER	Mol. Diagn. Ther.	DEC	2018	22	6					729	735		10.1007/s40291-018-0365-5			7	Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Pharmacology & Pharmacy	HB4LR	WOS:000451024900009	30377977	Green Published			2022-02-06	
J	Poulsen, HS; Hansen, AO				Poulsen, Helle S.; Hansen, Alice O.			Occupational performance problems identified by 507 patients: An insight that can guide occupation-based hand therapy	HAND THERAPY			English	Article						Canadian Occupational Performance Measure; hand injuries; hand therapy; occupation; occupational therapy	TRAUMATIC BRAIN-INJURY; DWELLING OLDER-ADULTS; QUALITY-OF-LIFE; FUNCTIONAL IMPACT; TENDON INJURY; EARLY-STAGE; FOLLOW-UP; VALIDITY; REHABILITATION; RESPONSIVENESS	Introduction Several barriers challenge the use of occupation-based interventions in hand therapy. An outpatient clinical setting can be prepared in such a way as to address the most common occupational performance problems which might promote an occupation-based intervention. To this end, more knowledge is needed about which problems patients with hand-related disorders consider most important. Methods Interviews using the Canadian Occupational Performance Measure (COPM)were conducted with 507 patients. Data were entered into Microsoft Excel in the COPM categories: Self-care, productivity and leisure and analysed using descriptive statistics. Data concerning main problem areas were categorized according to the Taxonomic Code of Occupational Performance (TCOP). The analysis included the number of prioritized occupational performance problems (NPOPP) in each COPM category/subcategory; the NPOPP in each category is relative to gender and age and the most frequent problems. Results The total NPOPP was 2384. Problems within productivity and self-care constituted the largest proportion, respectively, 46% and 40%. Gender or age affected the NPOPP in each category to a limited extend. Problems were expressed at all levels in the TCOP, except the lowest level. The most frequently expressed problem was use of utensils when eating. Conclusion The problems mostly concern productivity and self-care, regardless of gender or age. Patients consider problems at the levels of occupation, activities, tasks and actions to be important and meaningful to address in their intervention. This study provides useful knowledge that can be applied when preparing a setting to address the most common problems, which could lead to the promotion of occupation-based interventions.	[Poulsen, Helle S.; Hansen, Alice O.] Odense Univ Hosp, Dept Rehabil, Klovervaenget 8, DK-5000 Odense C, Denmark; [Hansen, Alice O.] Univ Southern Denmark, Dept Clin Res, Res Unit Rehabil, Odense, Denmark		Poulsen, HS (corresponding author), Odense Univ Hosp, Dept Rehabil, Klovervaenget 8, DK-5000 Odense C, Denmark.	helle.s.poulsen@rsyd.dk		Hansen, Alice Orts/0000-0002-8245-6890; Poulsen, Helle/0000-0001-7956-1238	University of Southern Denmark; Region of Southern Denmark; Danish Occupational Therapist Association; Bevica Foundation; Odense University Hospital	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The main trial was supported by the University of Southern Denmark, the Region of Southern Denmark, the Danish Occupational Therapist Association, Bevica Foundation and Odense University Hospital. Funding sources did not have any role in the design of this paper.	Amini D, 2011, AM J OCCUP THER, V65, P29, DOI 10.5014/ajot.2011.09186; Bell J, 2011, INT J THER REHABIL, V18, P370, DOI 10.12968/ijtr.2011.18.7.370; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Caswell A., 2015, CANADIAN OCCUPATIONA, V5th ed; Cederlund RI, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-286; Colaianni D, 2010, OCCUP THER HEALTH CA, V24, P130, DOI 10.3109/07380570903349378; Colaianni DJ, 2015, AUST OCCUP THER J, V62, P177, DOI 10.1111/1440-1630.12192; Daud AZC, 2016, SCAND J OCCUP THER, V23, P57, DOI 10.3109/11038128.2015.1062047; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; de Jong JP, 2014, CLIN ORTHOP SURG, V6, P196, DOI 10.4055/cios.2014.6.2.196; de Putter CE, 2014, INJURY, V45, P1752, DOI 10.1016/j.injury.2014.07.016; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; Dekkers MK, 2011, SCAND J OCCUP THER, V18, P198, DOI 10.3109/11038128.2010.510205; Dekkers MK, 2004, DISABIL REHABIL, V26, P662, DOI 10.1080/09638280410001683173; Dias JJ, 2006, INJURY, V37, P1071, DOI 10.1016/j.injury.2006.07.023; Eriksson M, 2011, J PLAST SURG HAND SU, V45, P28, DOI 10.3109/2000656X.2010.542654; Eyssen ICJM, 2005, CLIN REHABIL, V19, P888, DOI 10.1191/0269215505cr883oa; Eyssen ICJM, 2011, J REHABIL RES DEV, V48, P517, DOI 10.1682/JRRD.2010.06.0110; Fitzpatrick N, 2007, HAND THER, V12, P76; Grice KO, 2015, J HAND THER, V28, P300, DOI 10.1016/j.jht.2015.01.005; Gustafsson M, 2004, J CLIN NURS, V13, P986, DOI 10.1111/j.1365-2702.2004.01019.x; Gustafsson M, 2011, J HAND SURG-EUR VOL, V36E, P590, DOI 10.1177/1753193411408186; Gustafsson M, 2000, J ADV NURS, V32, P1333, DOI 10.1046/j.1365-2648.2000.01630.x; Hansen AO, 2016, HAND THER, V21, P90, DOI 10.1177/1758998316651456; Jackson, 2001, INJ PREV S1, V7, pI21; Khan W, 2010, REGIONAL OUTCOME MEA; Killian A., 2006, ADM MANAGEMENT SPECI, V22, P1; Kingston G, 2010, DISABIL REHABIL, V32, P326, DOI 10.3109/09638280903114410; Kjeken I, 2004, ARTHRIT RHEUM-ARTHR, V51, P709, DOI 10.1002/art.20522; Larsen AE, 2017, SCAND J OCCUP THER, P1; Law M, 1990, Can J Occup Ther, V57, P82; Nielsen TL, 2017, SCAND J OCCUP THER, V24, P235, DOI 10.1080/11038128.2016.1245357; Nielsen TL, 2013, SCAND J OCCUP THER, V20, P143, DOI 10.3109/11038128.2012.748823; Orellano E, 2012, AM J OCCUP THER, V66, P292, DOI 10.5014/ajot.2012.003053; Park HY, 2015, OCCUP THER INT, V22, P104, DOI 10.1002/oti.1389; Polatajko H.A, 2007, ENABLING OCCUPATION; Polatajko Helene J, 2004, Can J Occup Ther, V71, P261; Robinson LS, 2016, AUST OCCUP THER J, V63, P293, DOI 10.1111/1440-1630.12268; Rose BW, 2011, J HAND THER, V24, P84, DOI 10.1016/j.jht.2010.12.003; Schindler VP, 2010, OCCUP THER INT, V17, P105, DOI 10.1002/oti.291; Sewell L., 2001, BRIT J OCCUP THER, V64, P305, DOI [10.1177/030802260106400607, DOI 10.1177/030802260106400607]; Smallfield S, 2017, AM J OCCUP THER, V71, P1; Spadaro A, 2010, CLIN EXP RHEUMATOL, V28, P215; Sumsion Thelma, 2006, Can J Occup Ther, V73, P153; Thornton A, 2016, DISABIL REHABIL, V38, P979, DOI 10.3109/09638288.2015.1070298; Tuntland H, 2016, J MULTIDISCIP HEALTH, V9, P411, DOI 10.2147/JMDH.S113727; van de Ven-Stevens LAW, 2015, PHYS THER, V95, P750, DOI 10.2522/ptj.20130590; World Federation of Occupational Therapy (WFOT), 2012, DEF OCC THER; Yang Shang-Yu, 2017, J Phys Ther Sci, V29, P548, DOI 10.1589/jpts.29.548	49	3	3	2	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1758-9983	1758-9991		HAND THER	Hand Ther.	DEC	2018	23	4					121	129		10.1177/1758998318784316			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HA5HB	WOS:000450299700001					2022-02-06	
J	Qureshi, MSS; Shad, ZS; Shoaib, F; Munawar, K; Saeed, ML; Hussain, SW; Qadeer, A; Khan, MT; Masood, H; Abdullah, A				Qureshi, Muhammad Shoaib Safdar; Shad, Zahid Siddique; Shoaib, Faghia; Munawar, Kamran; Saeed, Muhammad Luqman; Hussain, Syed Waqar; Qadeer, Aayesha; Khan, Muhammad Tariq; Masood, Hassan; Abdullah, Azmat			Early Versus Late Tracheostomy After Decompressive Craniectomy	CUREUS			English	Article						tracheostomy; decompression; craniectomy	TRACHEOTOMY; INTUBATION; ICU	Objective The goal of this study was to determine the efficacy of early tracheostomy (i.e., <= 10 days of intubation) compared with a late tracheostomy (> 10 days of intubation) with regards to timing, frequency of ventilator-associated pneumonia (VAP), mortality rate, and hospital stay in patients who received decompressive craniectomy. Study design We conducted a retrospective study of data from 168 patients who underwent decompression in the department of critical care medicine at Shifa International Hospital, Islamabad, Pakistan, from January 2017 to December 2017. Materials and methods The study included men and women over the age of 18 years who had undergone tracheostomy following decompressive craniectomy in the intensive care unit as a result of stroke, traumatic brain injury, or acute severe injury. Data were analyzed using IBM SPSS Statistics for Windows, Version 23.0 (IBM Corp., Armonk, NY, US). We also applied the Chi-square test, and p <= 0.05 was considered significant. Results Of 168 patient records reviewed, tracheostomy was performed in 48 patients (21 men, 27 women). In the 48 tracheostomy patients, 15 (31%) were early tracheostomies and 33 (69%) were late tracheostomies. The mean age of patients was 44 +/- 11 years. Twenty-eight patients (58.3%) were in the younger age group (age 18 to 45 years) and 20 patients (41.7%) were in the older age group (age > 45 years). Patients who received an early tracheostomy spent significantly less time on a ventilator (<= 12 days) than those patients receiving a late tracheostomy (12 days, p = 0.004). The early tracheostomy group also had a lower incidence rate of VAP than patients with a late tracheostomy (x(2) = 7.855, p = 0.005). Patients who received an early tracheostomy had lower mortality rates than those who received late tracheostomies (x(2)= 6.158, p = 0.013). Finally, the length of hospital stay was <= 15 days for patients who received early tracheostomies; most patients who received a late tracheostomy had a hospital stay of > 15 days (x(2) =11.965, p = 0.001). Conclusions Performing a tracheostomy within 10 days of intubation following decompressive craniectomy significantly reduced ventilator time, mortality, the incidence of VAP, and length of hospital stay. Given the potential benefits of early tracheostomy in critical care patients following decompressive craniectomy, physicians should consider early tracheostomy in appropriate cases.	[Qureshi, Muhammad Shoaib Safdar; Saeed, Muhammad Luqman; Masood, Hassan; Abdullah, Azmat] Shifa Int Hosp, Crit Care Med, Islamabad, Pakistan; [Shad, Zahid Siddique] Shifa Int Hosp, Crit Care Med, Med Intens Care Unit, Islamabad, Pakistan; [Shoaib, Faghia] Bahawal Victoria Hosp, Quaid E Azam Med Coll, Pathol, Bahawalpur, Pakistan; [Munawar, Kamran] Shifa Coll Med, Internal Med, Islamabad, Pakistan; [Hussain, Syed Waqar] Khan Res Labs Hosp, Internal Med Crit Care, Islamabad, Pakistan; [Qadeer, Aayesha] Shifa Int Hosp, Dept Pulmonol & Crit Care Med, Islamabad, Pakistan; [Khan, Muhammad Tariq] Shifa Int Hosp, Pulmonol, Islamabad, Pakistan		Qureshi, MSS (corresponding author), Shifa Int Hosp, Crit Care Med, Islamabad, Pakistan.	drshoaibsafdar@gmail.com					Andriolo BNG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub3; Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Cavaliere S, 2017, MONALDI ARCH CHEST D, V67, P73; Cheung NH, 2014, RESP CARE, V59, P895, DOI 10.4187/respcare.02971; Diehl JL, 1999, AM J RESP CRIT CARE, V159, P383, DOI 10.1164/ajrccm.159.2.9707046; Francois B, 2003, CHEST, V123, P151, DOI 10.1378/chest.123.1.151; Golzari SEJ, 2013, ANESTH ANALG, V116, P1123, DOI 10.1213/ANE.0b013e3182884313; Heffner JE, 2001, CLIN CHEST MED, V22, P55, DOI 10.1016/S0272-5231(05)70025-3; HOLZAPFEL L, 1993, CRIT CARE MED, V21, P1132, DOI 10.1097/00003246-199308000-00010; Huang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092981; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; Ranes JL, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.12.034; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Trouillet JL, 2011, ANN INTERN MED, V154, P373, DOI 10.7326/0003-4819-154-6-201103150-00002; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154; Zheng Y, 2012, CHINESE MED J-PEKING, V125, P1925, DOI 10.3760/cma.j.issn.0366-6999.2012.11.016	18	3	3	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	DEC	2018	10	12							e3699	10.7759/cureus.3699			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HO6VA	WOS:000461069500005	30788188	gold, Green Published, Green Submitted			2022-02-06	
J	Renson, A; Schubert, FD; Bjurlin, MA				Renson, Audrey; Schubert, Finn D.; Bjurlin, Marc A.			Lack of Health Insurance Associated With Lower Probability of Head Computed Tomography Among United States Traumatic Brain Injury Patients	MEDICAL CARE			English	Article						health inequality; traumatic brain injury; insurance status; diagnostic imaging; computed tomography	RISK-FACTORS; INCREASED MORTALITY; ACUTE-CARE; OUTCOMES; RACE; DISPARITIES; IMPACT; REIMBURSEMENT; DISCHARGE; SYSTEM	Background:Uninsured traumatic brain injury (TBI) patients have higher mortality than their insured counterparts. One possible reason is disparities in receipt of appropriate diagnostic imaging.Objective:Examine the association between lack of insurance and use of diagnostic imaging.Research Design:This is a retrospective cohort study.Subjects:All adult patients admitted with severe (AIS>4 and GCS<15) TBI, in the National Trauma Data Bank 2010-2015.Measures:Primary outcome was receipt of head computed tomography (CT) and number of CT scans received. Secondary outcomes included head x-ray, angiography, or magnetic resonance imaging. Patients were classified as uninsured if their payment method was self-pay or not billed.Results:Of 59,540 patients meeting inclusion criteria, 18.9% were uninsured. After adjusting for demographic, clinical, and facility characteristics, compared with patients with any insurance, 4.47 per 100 (95% confidence interval, 1.60-7.34) fewer uninsured patients had a head CT, with uninsured patients receiving 13% (95% confidence interval, 3-21) fewer head CTs. There were no differences in x-ray, angiography, or magnetic resonance imaging receipt.Conclusions:Findings suggest lower receipt of guideline-indicated head CT among uninsured TBI patients. Mechanisms could include unconscious provider bias or institutional financial constraints. Further research is warranted to elucidate mechanisms and assess mediation by diagnostic imaging use of the insurance-mortality association.	[Renson, Audrey; Schubert, Finn D.] NYU, Dept Clin Res, Langone Hosp, Brooklyn, NY USA; [Renson, Audrey] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Bjurlin, Marc A.] NYU, Dept Urol, Langone Hosp, Brooklyn, NY USA		Renson, A (corresponding author), 5800 3rd Ave,Suite B,Room 356, Brooklyn, NY 11220 USA.	audrey.o.renson@gmail.com		Schubert, Finn/0000-0003-4791-8081			Alban RF, 2010, AM SURGEON, V76, P1108; American College of Surgeons Committee on Trauma, 2015, NAT TRAUM DAT BANK A; American Hospital Association, 2017, AHA HOSP STAT FAST F; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bell N, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0146-8; Bolorunduro OB, 2013, AM J SURG, V205, P365, DOI 10.1016/j.amjsurg.2012.10.026; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Condliffe S, 2014, APPL ECON LETT, V21, P613, DOI 10.1080/13504851.2013.879275; Crandall M, 2011, SURGERY, V150, P656, DOI 10.1016/j.surg.2011.07.052; Daly MC, 2016, SPINE, V41, pE37, DOI 10.1097/BRS.0000000000001177; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Downing SR, 2011, J TRAUMA, V70, P130, DOI 10.1097/TA.0b013e3182032b34; Fath JJ, 1999, AM J SURG, V177, P371, DOI 10.1016/S0002-9610(99)00065-3; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fortin EM, 2016, EMERG RADIOL, V23, P597, DOI 10.1007/s10140-016-1424-z; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2014, J TRAUMA ACUTE CARE, V77, P409, DOI 10.1097/TA.0000000000000392; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Haider AH, 2012, ARCH SURG-CHICAGO, V147, P63, DOI 10.1001/archsurg.2011.254; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hemphill J, 2014, MANAGEMENT ACUTE SEV; Henry MC, 2000, ANN EMERG MED, V35, P277, DOI 10.1016/S0196-0644(00)70080-1; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; LEWIS AC, 1993, BRIT MED J, V307, P448, DOI 10.1136/bmj.307.6901.448; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Missios S, 2016, INJURY, V47, P154, DOI 10.1016/j.injury.2015.06.037; Mukaka M., 2016, J MED STAT INFORM, V4, P5, DOI [10.7243/2053-7662-4-5, DOI 10.7243/2053-7662-4-5]; Nace SR, 2014, NEUROIMAG CLIN N AM, V24, P487, DOI 10.1016/j.nic.2014.03.006; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nathens A, 2008, NATL TRAUMA DATA BAN; Parma C, 2014, AM SURGEON, V80, P664; Rodriguez RM, 2014, INJURY, V45, P1345, DOI 10.1016/j.injury.2014.03.011; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Scott JW, 2017, J TRAUMA ACUTE CARE, V82, P887, DOI 10.1097/TA.0000000000001400; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shen YC, 2009, MED CARE, V47, P968, DOI 10.1097/MLR.0b013e31819c9415; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Svenson JE, 2001, AM J EMERG MED, V19, P19, DOI 10.1053/ajem.2001.18041; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White FA, 2007, J EMERG MED, V32, P159, DOI 10.1016/j.jemermed.2006.05.043; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeileis A, 2006, OBJECT ORIENTED COMP; Zibulewsky J, 2001, Proc (Bayl Univ Med Cent), V14, P339	50	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7079	1537-1948		MED CARE	Med. Care	DEC	2018	56	12					1035	1041		10.1097/MLR.0000000000000986			7	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	HA7AV	WOS:000450434100013	30234765				2022-02-06	
J	Scimone, MT; Cramer, HC; Bar-Kochba, E; Amezcua, R; Estrada, JB; Franck, C				Scimone, Mark T.; Cramer, Harry C., III; Bar-Kochba, Eyal; Amezcua, Rodolfo; Estrada, Jonathan B.; Franck, Christian			Modular approach for resolving and mapping complex neural and other cellular structures and their associated deformation fields in three dimensions	NATURE PROTOCOLS			English	Article							TRAUMATIC BRAIN-INJURY; RAT CORTICAL-NEURONS; IN-VITRO MODEL; EXTRACELLULAR-MATRIX; DIFFERENTIAL OUTCOMES; DEPENDENT PROPERTIES; STRAIN-RATE; COLLAGEN; CULTURES; SURVIVAL	Understanding the biological implications of cellular mechanotransduction, especially in the context of pathogenesis, requires the accurate resolution of material deformation and strain fields surrounding the cells. This is particularly challenging for cells displaying branched, 3D architectures. Here, we provide a modular approach for 3D image segmentation and strain mapping of topologically complex structures. We describe how to use our approach, using neural cells and networks as an example. In addition to describing how to implement the computational analysis, we provide details of a cell culture protocol that can be used to generate neural networks for analysis and experimentation. This protocol allows for transformation of matrix-induced strains, and their full resolution across single cells or networks in three dimensions. The protocol also provides analyses to compute both the locally varying cytoskeletal strains and the average strain experienced by cells. An additional module allows spatial correlation of these strain maps with cytoskeletal features, including neurite disruptions such as neuronal blebs. Image processing and strain mapping take >= 3 h, with the exact time required being dependent on use case, software familiarity, and file size.	[Scimone, Mark T.; Cramer, Harry C., III] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Scimone, Mark T.; Cramer, Harry C., III; Bar-Kochba, Eyal; Estrada, Jonathan B.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Amezcua, Rodolfo] Univ Southern Calif, Viterbi Sch Engn, Los Angeles, CA USA; [Franck, Christian] Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; [Estrada, Jonathan B.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA		Franck, C (corresponding author), Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA.	cfranck@wisc.edu	Estrada, Jonathan/ABC-3088-2020	Estrada, Jonathan/0000-0003-1083-4597; Scimone, Mark/0000-0003-0123-3765; Cramer, Harry/0000-0002-3353-7723	RI Science and Technology Council; Haythornthwaite Research Initiation Grant; Office of Naval ResearchOffice of Naval Research; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); Graduate Assistance in Areas of National Need (GAANN) fellowship from the Brown University Institute for Molecular and Nanoscale Innovation	The authors acknowledge M. Patel and A.K. Landauer for helpful discussions, and J. Toyjanova for assistance in early protocol development. The authors gratefully acknowledge financial support from the RI Science and Technology Council, a Haythornthwaite Research Initiation Grant, and the Office of Naval Research (T. Bentley). E.B.-K. acknowledges support from a National Science Foundation Graduate Research Fellowship. J.B.E. acknowledges support from a Graduate Assistance in Areas of National Need (GAANN) fellowship from the Brown University Institute for Molecular and Nanoscale Innovation.	Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bercu MM, 2013, J MOL NEUROSCI, V51, P249, DOI 10.1007/s12031-012-9933-z; Berthiaume F, 2010, ARTECH HSE METH BIOE, P1; Bosi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09562; Boutin ME, 2018, J NEUROSCI METH, V299, P55, DOI 10.1016/j.jneumeth.2017.01.014; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Campbell JJ, 2017, BIOMATERIALS, V114, P34, DOI 10.1016/j.biomaterials.2016.10.048; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/nmat4489, 10.1038/NMAT4489]; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Cuntz H, 2011, NEUROINFORMATICS, V9, P91, DOI 10.1007/s12021-010-9093-7; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; Dingle YTL, 2015, TISSUE ENG PART C-ME, V21, P1274, DOI [10.1089/ten.tec.2015.0135, 10.1089/ten.TEC.2015.0135]; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Donohue DE, 2011, BRAIN RES REV, V67, P94, DOI 10.1016/j.brainresrev.2010.11.003; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Frega M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05489; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Garnotel R, 2000, J IMMUNOL, V164, P5928, DOI 10.4049/jimmunol.164.11.5928; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Madl CM, 2017, NAT MATER, V16, P1233, DOI [10.1038/NMAT5020, 10.1038/nmat5020]; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Mattucci SFE, 2012, J MECH BEHAV BIOMED, V10, P216, DOI 10.1016/j.jmbbm.2012.02.004; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4; O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1; Oh YK, 2012, J ORTHOP RES, V30, P528, DOI 10.1002/jor.21572; Owen LM, 2017, MOL BIOL CELL, V28, P1959, DOI 10.1091/mbc.E17-02-0102; Patel M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23488-y; Peng HC, 2015, NEURON, V87, P252, DOI 10.1016/j.neuron.2015.06.036; Peng HC, 2015, NEUROINFORMATICS, V13, P259, DOI 10.1007/s12021-015-9270-9; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prochnow N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00031; Rizk A, 2014, NAT PROTOC, V9, P586, DOI 10.1038/nprot.2014.037; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Rupert CE, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7648409; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Sonka M., 2015, IMAGE PROCESSING ANA; Stout DA, 2016, P NATL ACAD SCI USA, V113, P2898, DOI 10.1073/pnas.1510935113; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; TAUBIN G, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P852, DOI 10.1109/ICCV.1995.466848; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Toyjanova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090976; Wirth P, 2017, J NEUROSCI METH, V290, P133, DOI 10.1016/j.jneumeth.2017.07.030; Xiao T, 2011, CELL, V146, P164, DOI 10.1016/j.cell.2011.06.016; Zhang SJ, 2017, ANN BIOMED ENG, V45, P2813, DOI 10.1007/s10439-017-1917-2	77	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-2189	1750-2799		NAT PROTOC	Nat. Protoc.	DEC	2018	13	12					3042	3064		10.1038/s41596-018-0077-7			23	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8MG	WOS:000451343400015	30455476				2022-02-06	
J	Taranto, E; Fishman, M; Benjamin, H; Ross, L				Taranto, Eleanor; Fishman, Michael; Benjamin, Holly; Ross, Lainie			Genetic Testing by Sports Medicine Physicians in the United States: Attitudes, Experiences, and Knowledge	SPORTS			English	Article						genetic testing; sports medicine; direct-to-consumer testing; athletic performance; sickle cell trait	SICKLE-CELL TRAIT; METAANALYSIS; PERFORMANCE; CONCUSSION; YOUTH; DEATH	It remains unknown whether and how sports medicine physicians currently utilize genetic testing in their clinical practice. This study sought to assess knowledge of, experience with, and attitudes towards genetic testing by sports medicine physicians in the United States (US). An email with a survey hyperlink was distributed twice to members of the American Medical Society for Sports Medicine (AMSSM) listserv in September 2016, with approximately a 10% response rate. Questions focused on knowledge of, experience with, and attitudes towards testing for different genes related to sports proficiency, injury risk, and disease risk. Few AMSSM physicians believe that genetic testing to adapt training (12%) or to choose a sport (2%) is ready for clinical adoption. Most respondents self-reported minimal knowledge about, and limited experience with, genetic testing. The main exception was screening for sickle cell trait (SCT) for which most (84%) reported moderate/significant/expert knowledge and over two-thirds had ordered testing. Although most respondents thought it appropriate to counsel and test for health conditions associated with cardiac and connective tissue disorders in the setting of a positive family history, only a minority had been asked to do so. Five or fewer respondents (2%) had been asked to test for performance-associated variants (Angiotensin Converting Enzyme (ACE) II and Alpha-Actinin 3 (ACTN3)), and five or fewer (2%) would recommend changes based on the results. Our study provides a baseline of current US sports medicine physicians' minimal experiences with, and knowledge of, genetic testing. The findings of our study indicate that sports medicine physicians require further genetics education as it relates to sports and exercise in order to be prepared to competently engage with their patients and to develop sound professional organizational policies.	[Taranto, Eleanor; Fishman, Michael] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Benjamin, Holly; Ross, Lainie] Univ Chicago Med, Dept Pediat, Chicago, IL 60637 USA; [Benjamin, Holly] Univ Chicago Med, Dept Orthoped Surg & Rehabil Med, Chicago, IL 60637 USA; [Ross, Lainie] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA		Ross, L (corresponding author), Univ Chicago Med, Dept Pediat, Chicago, IL 60637 USA.; Ross, L (corresponding author), Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA.	etaranto@uchicago.edu; mfishman@uchicago.edu; hbenjami@bsd.uchicago.edu; Lross@uchicago.edu		Ross, Lainie/0000-0002-7395-3000			American Medical Society for Sports Medicine (AMSSM), 2017, 2016 2017 ANN REP; Ash GI, 2011, MED SCI SPORT EXER, V43, P590, DOI 10.1249/MSS.0b013e3181f70bd6; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Caulfield T, 2015, J LAW BIOSCI, V2, P627, DOI 10.1093/jlb/lsv038; College of American Pathologists (CAP), 2012, STAT SICKL CELL TRAI; Constant Contact Help Center, 2017, KNOWL BAS PRED SURV; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Cummings D., 2008, RICE U NCAA FACE LAW; Ferrari R, 2015, J GENET COUNS, V24, P873, DOI 10.1007/s10897-015-9849-1; Graham R., 2014, SPORTS RELATED CONCU; Guth LM, 2013, CURR OPIN PEDIATR, V25, P653, DOI 10.1097/MOP.0b013e3283659087; Hess GP, 2015, GENET RES, V97, DOI 10.1017/S0016672315000099; Human Genetics Society of Australasia, 2012, 2012PSO3 POS STAT GE; Jacob Y, 2018, SPORTS, V6, DOI 10.3390/sports6030088; JONES SR, 1970, NEW ENGL J MED, V282, P323, DOI 10.1056/NEJM197002052820607; Kark J.A., 2008, SICKLE CELL TRAIT FA; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kolata Gina., 2015, NEW YORK TIMES; Ma F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054685; Marshall SW, 2010, BRIT J SPORT MED, V44, P8, DOI 10.1136/bjsm.2009.068171; Mattsson CM, 2016, PHYSIOL GENOMICS, V48, P175, DOI 10.1152/physiolgenomics.00109.2015; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; National Athletic Trainers' Association (NATA), 2012, CONS STAT SICKL CELL; Nelson DA, 2016, NEW ENGL J MED, V375, P435, DOI 10.1056/NEJMoa1516257; Neuhauser KM, 1999, MIL MED, V164, P841, DOI 10.1093/milmed/164.12.841; Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), 2010, SCREEN US COLL ATHL; US National Library of Medicine, 2017, WHAT IS PREC MED; Vincent B, 2012, ACTA PHYSIOL, V204, P555, DOI 10.1111/j.1748-1716.2011.02366.x; Vlahovich N, 2017, BRIT J SPORT MED, V51, P5, DOI 10.1136/bjsports-2016-096661; Wackerhage H, 2009, J SPORT SCI, V27, P1109, DOI 10.1080/02640410903114364; Wang G, 2013, ADV GENET, V84, P123, DOI 10.1016/B978-0-12-407703-4.00004-9; Webborn N, 2015, BRIT J SPORT MED, V49, P1398, DOI 10.1136/bjsports-2013-093273; Williams A., 2012, SPORT EXERC SCI, V31, P4	35	3	3	1	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2075-4663			SPORTS	Sports	DEC	2018	6	4							145	10.3390/sports6040145			12	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HH3UC	WOS:000455644100044	30424536	Green Published, Green Submitted, gold			2022-02-06	
J	Uche, EO; Mezue, WC; Onyia, EE; Iloabachie, I; Okorie, C; Ozor, II				Uche, Enoch O.; Mezue, Wilfred C.; Onyia, Ephraim E.; Iloabachie, Izuchukwu; Okorie, Chukwuemeka; Ozor, Ignatius I.			The Ebb and Flow of Neurosurgery in a Re-Emerging Sub-Saharan Center. Lessons from 1025 Consecutive Operated Cases and Progress Models. A Prospective Observational Cohort Study	WORLD NEUROSURGERY			English	Article						Developing country; Neurosurgery; Operations; Training; Trends	NIGERIA; ENUGU; TUMORS	BACKGROUND: The evolution of neurosurgery in our center comprises 2 active phases separated by a decadelong latent phase. This study evaluates our experience in the renaissance phase using 1025 cases. We identify paradigms that predict progress under existing practice conditions. METHODS: A prospective observational study was undertaken of all freshly operated patients from 2009 to 2016. Ethical approval was obtained from the hospital institutional review board. Data of enrolled patients were acquired and analyzed using SPSS software for Windows version 21. Inferences were evaluated using a 95% level of significance. Major and intermediate cases were included, whereas bedside cases as well as patients operated on elsewhere were excluded. RESULTS: Of 5132 patients treated, 3033 had surgical lesions, 1129 (33.2 +/- 2.7% confidence limit [CL]) were operated on, and 1025 satisfied the study criteria. The unmet surgical load (66.1%) was significant (chi(2) = 10.9; degree of freedom = 1; P = 0.001). The most common diseases treated were neurotrauma in 438 patients, congenital malformations in 268, and tumors in 170. The mean annual operative rate was 125 +/- 5.7 patients (95% CL). Cases showed significant variability using 1-way analysis of variance (F = 13.77; P = 0.03). Residency training was a positive influence on surgeons' operative rate (chi(2) = 7.59; P = 0.02). The mean complication rate was 10.3% +/- 2.9%, and the mortality was 5.5% +/- 1.7%. CONCLUSIONS: We found a large unmet neurosurgical load. To resolve this situation, we recommend an increase in the number of training programs for neurosurgery residency. As neurosurgery units evolve, their progress may be evaluated using the NESCAPE (Neurosurgery Care Phase Evolution) paradigm.	[Uche, Enoch O.; Mezue, Wilfred C.; Onyia, Ephraim E.; Iloabachie, Izuchukwu; Okorie, Chukwuemeka; Ozor, Ignatius I.] Univ Nigeria UNN, Dept Surg, Div Neurosurg, Ituku Ozalla Campus, Enugu, Nigeria		Uche, EO (corresponding author), Univ Nigeria UNN, Dept Surg, Div Neurosurg, Ituku Ozalla Campus, Enugu, Nigeria.	enoch.uche@unn.edu.ng	UCHE, Enoch/AAP-6651-2020				Adeloye A., 1976, AFRICAN NEUROSURGEON, P143; Bohl MA, 2018, CUREUS, V10, DOI 10.7759/cureus.2491; Dechambenoit G, 2010, WORLD NEUROSURG, V73, P251, DOI 10.1016/j.wneu.2010.02.046; Dreyfus H. L., 1986, MIND MACHINE; Eke CB, 2016, ANN AFR MED, V15, P126, DOI 10.4103/1596-3519.188892; El Khamlichi A, 1998, SURG NEUROL, V49, P342; El-Fiki M, 2010, WORLD NEUROSURG, V73, P254, DOI 10.1016/j.wneu.2010.02.012; Emejulu JKC, 2008, NIGER J CLIN PRACT, V11, P291; Emejulu JKC, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.09.002; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Krummel TM, 2009, J PEDIATR SURG, V44, P21, DOI 10.1016/j.jpedsurg.2008.10.005; Lee CY, 2017, WORLD NEUROSURG, V104, P499, DOI 10.1016/j.wneu.2017.04.129; Lim S, 2015, J NEUROSURG, V122, P962, DOI 10.3171/2014.11.JNS1494; ODEKU EL, 2007, MEDICINE, V5, P34; OHAEGBULAM SC, 1980, CANCER, V46, P2322, DOI 10.1002/1097-0142(19801115)46:10<2322::AID-CNCR2820461034>3.0.CO;2-F; Rabiu TB, 2016, J NEUROSCI RURAL PRA, V7, P485, DOI 10.4103/0976-3147.188624; Satava RM, 2006, SURG ENDOSC, V20, P1797, DOI 10.1007/s00464-006-0799-4; Sefidbakht S, 2016, IRAN J PEDIATR, V26, DOI 10.5812/ijp.4589; Uche EO, 2016, NIGER J CLIN PRACT, V19, P811, DOI 10.4103/1119-3077.183236; Uche EO, 2013, PEDIATR NEUROSURG, V49, P75, DOI 10.1159/000357384; Uche EO, 2013, CHILD NERV SYST, V29, P1131, DOI 10.1007/s00381-013-2105-9; Uche E O, 2012, Niger J Med, V21, P70; Uche EO, 2018, CHILD NERV SYST, V34, P1683, DOI 10.1007/s00381-018-3848-0	23	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E80	E87		10.1016/j.wneu.2018.07.165			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300012	30071336				2022-02-06	
J	Wall, J; Enblad, P				Wall, Jacob; Enblad, Per			Neurointensive care of patients with cerebral venous sinus thrombosis and intracerebral haemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cerebral sinus thrombosis; Intracerebral haemorrhage; Neurointensive care; Intracranial pressure; Outcome	TRAUMATIC BRAIN-INJURY; GUIDELINES; MANAGEMENT; VEIN	The aim was to review the neurointensive care (NIC) of cerebral venous sinus thrombosis patients with haemorrhage during a 15-year period. This is a severe condition with substantial mortality caused by increased intracranial pressure (ICP) and studies are lacking describing the complex picture of the NIC, which offers a large treatment arsenal for intracranial hypertension. Patients treated 2000-2015 were investigated. Data regarding patient characteristics, symptoms, imaging, ICP-treatment, NIC-treatment intensity, and outcome were collected and analysed. Twenty-four patients (13 women) were studied, mean age 46 (range 16-75). Twenty patients were in Glasgow coma scale motor score 6 (obeys), 2 in score 5 (localizes) and 2 in score 2 (extension) on admission. Mean haemorrhage volume was 17 ml (range 1-70). Twenty patients (83%) received unfractionated heparin and 3 (13%) low molecular weight heparin. Haemorrhagic progression occurred in 10 patients (42%). In 9 patients (38%), 4-6 of the treatment options mechanical ventilation, hyperventilation, ICP-monitoring, cerebrospinal fluid-drainage, osmotherapy, barbiturates or surgery were used. In 3 patients mechanical ventilation only was used (hyperventilation in 1). Twelve patients were not managed with any of those treatment options. At follow up, 15/24 patients (62%) had favourable outcome (4 missing). The study shows that many patients needed multiple actions to treat intracranial preassure but more than 60% achieved favourable clinical outcome. Preferably, patients with cerebral venous sinus thrombosis and haemorrhage who are awake should have fast access to NIC because it appears difficult to predict who will deteriorate and promptly need NIC treatment. (C) 2018 Elsevier Ltd. All rights reserved.	[Wall, Jacob; Enblad, Per] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden		Enblad, P (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden.	Per.enblad@neuro.uu.se			Uppsala university hospital	Supported by Uppsala university hospital.	Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coutinho JM, 2012, STROKE, V43, P3375, DOI 10.1161/STROKEAHA.112.671453; Dentali F, 2006, BLOOD, V108, P1129, DOI 10.1182/blood-2005-12-4795; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ferro JM, 2017, EUR J NEUROL, V24, P1203, DOI 10.1111/ene.13381; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Grande PO, 2012, J NEUROSURG ANESTH, V24, P407, DOI 10.1097/01.ana.0000419730.29492.8b; JENNETT B, 1975, LANCET, V1, P480; Jeong JH, 2017, J INTENSIVE CARE MED; Kowoll CM, 2016, NEUROCRIT CARE, V25, P392, DOI 10.1007/s12028-016-0256-8; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; TEASDALE G, 1974, LANCET, V2, P81; Vivakaran TTR, 2012, J NEUROSURG, V117, P738, DOI 10.3171/2012.6.JNS11102; Zhang S, 2017, J NEUROSURG, V127, P709, DOI 10.3171/2016.8.JNS161112	17	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2018	58						83	88		10.1016/j.jocn.2018.10.003			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HD5OS	WOS:000452580400015	30340972				2022-02-06	
J	Chaudhary, R; Rema, V				Chaudhary, Rahul; Rema, V.			Deficits in Behavioral Functions of Intact Barrel Cortex Following Lesions of Homotopic Contralateral Cortex	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						somatosensory; gap-crossing behavior; plasticity; tactile sensation; brain injury; stroke; vibrissae; diaschisis	EXPERIENCE-DEPENDENT PLASTICITY; PRIMARY SOMATOSENSORY CORTEX; TRAUMATIC BRAIN-INJURY; ADULT-RATS; CORTICAL EXCITABILITY; EMOTION RECOGNITION; SENSORY RESPONSES; WHISKER MOVEMENTS; RECEPTIVE-FIELDS; CEREBRAL-CORTEX	Focal unilateral injuries to the somatosensory whisker barrel cortex have been shown cause long-lasting deficits in the activity and experience-dependent plasticity of neurons in the intact contralateral barrel cortex. However, the long-term effect of these deficits on behavioral functions of the intact contralesional cortex is not clear. In this study, we used the "Gap-crossing task" a barrel cortex-dependent, whisker-sensitive, tactile behavior to test the hypothesis that unilateral lesions of the somatosensory cortex would affect behavioral functions of the intact somatosensory cortex and degrade the execution of a bilaterally learnt behavior. Adult rats were trained to perform the Gap-crossing task using whiskers on both sides of the face. The barrel cortex was then lesioned unilaterally by subpial aspiration. As observed in other studies, when rats used whiskers that directly projected to the lesioned hemisphere the performance of Gap-crossing was drastically compromised, perhaps due to direct effect of lesion. Significant and persistent deficits were present when the lesioned rats performed Gap-crossing task using whiskers that projected to the intact cortex. The deficits were specific to performance of the task at the highest levels of sensitivity. Comparable deficits were seen when normal, bilaterally trained, rats performed the Gap-crossing task with only the whiskers on one side of the face or when they used only two rows of whiskers (D row and E row) intact on both side of the face. These findings indicate that the prolonged impairment in execution of the learnt task by rats with unilateral lesions of somatosensory cortex could be because sensory inputs from one set of whiskers to the intact cortex is insufficient to provide adequate sensory information at higher thresholds of detection. Our data suggest that optimal performance of somatosensory behavior requires dynamic activity-driven interhemispheric interactions from the entire somatosensory inputs between homotopic areas of the cerebral cortex. These results imply that focal unilateral cortical injuries, including those in humans, are likely to have widespread bilateral effects on information processing including in intact areas of the cortex.	[Chaudhary, Rahul; Rema, V.] Natl Brain Res Ctr, Manesar, India		Rema, V (corresponding author), Natl Brain Res Ctr, Manesar, India.	rema@nbrc.ac.in			Wellcome Trust Senior Research FellowshipWellcome Trust [WT066676MA]; Department of Biotechnology, Ministry of Science and Technology, Government of IndiaDepartment of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India [BT/PR6615/MED/14/857/2005]; National Brain Research Centre	This research was supported by The Wellcome Trust Senior Research Fellowship to VR (WT066676MA), a grant from Department of Biotechnology, Ministry of Science and Technology, Government of India to VR (BT/PR6615/MED/14/857/2005) and Core funds from National Brain Research Centre.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Ahissar E, 2016, ELIFE, V5, DOI 10.7554/eLife.12830; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Armstrong-James M. A, 2003, SOC NEUR ABSTR, V59, P12; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Arnett MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109116; Auffret M, 2018, NEUROSCIENCE, V368, P199, DOI 10.1016/j.neuroscience.2017.04.004; Bale MR, 2018, NEUROSCIENCE, V368, P70, DOI 10.1016/j.neuroscience.2017.09.014; BARNEOUD P, 1991, BEHAV BRAIN RES, V44, P87, DOI 10.1016/S0166-4328(05)80242-6; BENUSKOVA L, 1994, P NATL ACAD SCI USA, V91, P4791, DOI 10.1073/pnas.91.11.4791; Benuskova L, 2001, P NATL ACAD SCI USA, V98, P2797, DOI 10.1073/pnas.051346398; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 2005, SOMATOSENS MOT RES, V22, P213, DOI 10.1080/08990220500262505; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Blankenburg F, 2008, J NEUROSCI, V28, P13202, DOI 10.1523/JNEUROSCI.3043-08.2008; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Bush NE, 2016, ELIFE, V5, DOI 10.7554/eLife.13969; Campagner D, 2018, NEUROSCIENCE, V368, P95, DOI 10.1016/j.neuroscience.2017.08.005; Campagner D, 2016, ELIFE, V5, DOI 10.7554/eLife.10696; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chaudhary R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076556; Chu YF, 2013, BEHAV BRAIN RES, V238, P124, DOI 10.1016/j.bbr.2012.10.022; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; EBNER FF, 1962, J NEUROPHYSIOL, V25, P380, DOI 10.1152/jn.1962.25.3.380; Estebanez L, 2018, NEUROSCIENCE, V368, P81, DOI 10.1016/j.neuroscience.2017.08.039; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Forss N, 1999, BRAIN, V122, P1889, DOI 10.1093/brain/122.10.1889; Haidarliu S, 2001, J COMP NEUROL, V429, P372, DOI 10.1002/1096-9861(20010115)429:3<372::AID-CNE2>3.0.CO;2-3; Harris JA, 2000, NEUROREPORT, V11, P263, DOI 10.1097/00001756-200002070-00008; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P223; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hoffman JR, 2003, BRAIN RES, V965, P91, DOI 10.1016/S0006-8993(02)04141-0; Hollins M, 2006, J NEUROSCI, V26, P5582, DOI 10.1523/JNEUROSCI.0028-06.2006; Hong YK, 2018, NATURE, V561, P542, DOI 10.1038/s41586-018-0527-y; HSIAO SS, 1993, ACTA PSYCHOL, V84, P53, DOI 10.1016/0001-6918(93)90072-Y; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jablonka JA, 2010, NEUROSCIENCE, V165, P90, DOI 10.1016/j.neuroscience.2009.09.074; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Juczewski K, 2016, NEUROBIOL DIS, V96, P201, DOI 10.1016/j.nbd.2016.09.007; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P1706, DOI 10.1016/j.apmr.2004.11.043; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lampl I, 2017, NEUROSCIENCE, V343, P66, DOI 10.1016/j.neuroscience.2016.11.043; Leasure JL, 2004, BEHAV BRAIN RES, V150, P83, DOI 10.1016/S0166-4328(03)00254-7; Lee LJ, 2009, EXP NEUROL, V219, P524, DOI 10.1016/j.expneurol.2009.07.012; Li L, 2005, J NEUROPHYSIOL, V94, P3342, DOI 10.1152/jn.00357.2005; Li L, 2006, EXP BRAIN RES, V172, P397, DOI 10.1007/s00221-005-0337-y; Lindner MD, 2003, J NEUROSCI, V23, P10913; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; Mattia D, 2003, INT J NEUROSCI, V113, P465, DOI 10.1080/00207450390162227; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Mcelvain LE, 2018, NEUROSCIENCE, V368, P152, DOI 10.1016/j.neuroscience.2017.08.034; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Morita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020437; Mun-Bryce S, 2004, BRAIN RES, V1026, P218, DOI 10.1016/j.brainres.2004.08.023; NAKASHIMA K, 1985, J NEUROL SCI, V70, P117, DOI 10.1016/0022-510X(85)90081-4; Pammer L, 2013, J NEUROSCI, V33, P6726, DOI 10.1523/JNEUROSCI.4316-12.2013; Papaioannou S, 2013, BRAIN BEHAV, V3, P24, DOI 10.1002/brb3.102; PIDOUX B, 1979, ELECTROEN CLIN NEURO, V46, P715, DOI 10.1016/0013-4694(79)90111-1; Ramirez A, 2014, NAT NEUROSCI, V17, P866, DOI 10.1038/nn.3720; Reig R, 2016, CEREB CORTEX, V26, P4405, DOI 10.1093/cercor/bhw268; Reig R, 2014, NEURON, V83, P1200, DOI 10.1016/j.neuron.2014.07.033; Rema V, 2003, J NEUROSCI, V23, P10378; Rema V, 1998, J NEUROSCI, V18, P10196; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Ring A, 2004, SOMATOSENS MOT RES, V21, P117, DOI 10.1080/08990220410001721275; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Sachdev RNS, 2000, J NEUROPHYSIOL, V84, P1971, DOI 10.1152/jn.2000.84.4.1971; Sathian K, 2016, J NEUROPHYSIOL, V116, P1795, DOI 10.1152/jn.00546.2015; Shuler MG, 2002, CEREB CORTEX, V12, P86, DOI 10.1093/cercor/12.1.86; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Sinclair RJ, 1996, SOMATOSENS MOT RES, V13, P287, DOI 10.3109/08990229609052584; Soumiya H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158583; Stuttgen MC, 2018, NEUROSCIENCE, V368, P3, DOI 10.1016/j.neuroscience.2017.05.009; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Tame L, 2016, COGN NEUROPSYCHOL, V33, P48, DOI 10.1080/02643294.2016.1159547; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; Temereanca S, 2004, NEURON, V41, P639, DOI 10.1016/S0896-6273(04)00046-7; Tommerdahl M, 2006, J NEUROSCI, V26, P5970, DOI 10.1523/JNEUROSCI.5270-05.2006; Towal RB, 2008, J NEUROPHYSIOL, V100, P740, DOI 10.1152/jn.01295.2007; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Tsytsarev V, 2017, J NEUROSCI, V37, P7209, DOI 10.1523/JNEUROSCI.0598-17.2017; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; von Monakow C., 1914, DIASCHISIS LOKALISAT, P26; Wellmann KA, 2015, PHYSIOL BEHAV, V148, P166, DOI 10.1016/j.physbeh.2014.09.002; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Yamashita T, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00033; Yang JW, 2018, CURR OPIN NEUROBIOL, V53, P29, DOI 10.1016/j.conb.2018.04.023	97	3	3	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5137			FRONT SYST NEUROSCI	Front. Syst. Neurosci.	NOV 22	2018	12								57	10.3389/fnsys.2018.00057			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB3FY	WOS:000450937500001	30524251	Green Published, gold			2022-02-06	
J	Caglar, AS; Tanriverdi, F; Karaca, Z; Unluhizarci, K; Kelestimur, F				Caglar, Asli Sezgin; Tanriverdi, Fatih; Karaca, Zuleyha; Unluhizarci, Kursad; Kelestimur, Fahrettin			Sports-Related Repetitive Traumatic Brain Injury: A Novel Cause of Pituitary Dysfunction	JOURNAL OF NEUROTRAUMA			English	Article						combative sports; hypopituitarism; trauma	GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; HEAD TRAUMA; AMATEUR BOXERS; LONG-TERM; ANTIPITUITARY ANTIBODIES; COGNITIVE PERFORMANCE; MULTIPLE CONCUSSIONS; GH DEFICIENCY	Traumatic brain injury (TBI) is one of the major causes of disability and death, particularly in the young population. Recent clinical studies have demonstrated that TBI-induced pituitary dysfunction occurs more frequently than previously estimated, and this may contribute to delayed diagnosis and treatment of hormonal abnormalities. Today, the popularity of combative sports increases, and athletes who deal with these sports have risks of developing hypopituitarism attributed to repetitive TBIs. Pathogenesis and molecular mechanisms are not completely understood yet. Current studies suggest that athletes who had retired, especially from combative sports, should be screened for hypopituitarism. In this review, we aim to increase the awareness of medical communities, athletes, coaches, and athletic trainers about this issue by sharing the current studies regarding the pituitary dysfunction attributed to repetitive TBI associated with sports.	[Caglar, Asli Sezgin; Tanriverdi, Fatih; Karaca, Zuleyha; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol & Metab, 42 Prof Dr Turhan Feyzioglu St, TR-38039 Kayseri, Turkey		Tanriverdi, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol & Metab, 42 Prof Dr Turhan Feyzioglu St, TR-38039 Kayseri, Turkey.	fatihtan@erciyes.edu.tr	Karaca, Zuleyha/ABB-7891-2021; kelestimur, f/ABE-9873-2021				Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Auer M, 2013, DEUT MED WOCHENSCHR, V138, P831, DOI 10.1055/s-0033-1343099; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Cyran E., 1918, DEUT MED WOCHENSCHR, V1918, P1; Diri H, 2015, PITUITARY, V18, P884, DOI 10.1007/s11102-015-0666-1; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Falleti MG, 2006, PSYCHONEUROENDOCRINO, V31, P681, DOI 10.1016/j.psyneuen.2006.01.005; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; Ives JC, 2007, J ATHL TRAINING, V42, P431; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; Karaca Z, 2011, PITUITARY, V14, P134, DOI 10.1007/s11102-010-0270-3; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kovacs G.L., 2016, ENDOCR ONCOL METAB, V2, P234; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Langelier DM, 2017, CLIN J SPORT MED, V27, pE78, DOI 10.1097/JSM.0000000000000408; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Malanowski S, 2015, NEUROETHICS-NETH, V8, P27, DOI 10.1007/s12152-014-9215-2; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Pickel J., 2009, F1000 MED REPORTS, P1; Ritchie EV, 2018, BRAIN INJURY, V32, P523, DOI 10.1080/02699052.2018.1429662; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Tanriverdi F, 2007, J ENDOCRINOL INVEST, V30, P150, DOI 10.1007/BF03347414; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi Fatih, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P131, DOI 10.1586/14737167.6.2.131; Tanriverdi F, 2008, OBES METAB-MILAN, V4, P118; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2013, CLIN ENDOCRINOL, V78, P730, DOI 10.1111/cen.12037; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448	67	3	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1195	1202		10.1089/neu.2018.5751		NOV 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000450733200001	30156462				2022-02-06	
J	Zhao, D; Staton, CA; He, Q; Mmbaga, BT; Vissoci, JRN				Zhao, Duan; Staton, Catherine A.; He, Qing; Mmbaga, Blandina Theophil; Vissoci, Joao Ricardo Nickenig			Cross-Culture Adaptation and Psychometric Properties of the DrInC Questionnaire in Tanzanian Swahili	FRONTIERS IN PUBLIC HEALTH			English	Article						DrInC; Swahili; validation; adaptation; psychometric properties	ALCOHOL-USE DISORDERS; IDENTIFICATION TEST AUDIT; TRAUMATIC BRAIN-INJURY; PRIMARY-CARE; SCREENING TOOL; CONSUMPTION; VALIDATION; BURDEN; MOSHI; RELIABILITY	Aims: To develop Swahili versions of the Drinker Inventory of Consequences (DrInC) and evaluate its psychometric properties among a mixed population in Tanzania. Methods: A Swahili version of the DrInC was developed by a panel of bilingual Swahili and English speakers through translation and back-translation. The translated DrInC was administered to a sample of Tanzanian injury patients and a sample of the general population. The validity and reliability of the scale were tested using standard statistical methods. Results: The translated version of the DrInC questionnaire was found to have outstanding domain coherence and language clarity. The tested scale and subscales have adequate reliability (>0.85). Confirmatory factor analysis (CFA) confirmed the five-factor solution by yielding adequate results. DrInC score is statistically significantly correlated with alcohol consumption quantity and the AUDIT score, suggesting that DrInC is able to predict alcohol use as well. Conclusions: This study presents the first validation of the DrInC questionnaire with injury patients and a general population and the first adaptations of the DrInC questionnaire in the Tanzanian and Swahili setting. DrInC instrument was found to have satisfactory psychometric properties, resulting in a new medical and social research tool in this setting.	[Zhao, Duan] Duke Kunshan Univ, Duke Kunshan Global Hlth Res Ctr, Kunshan, Peoples R China; [Staton, Catherine A.; Mmbaga, Blandina Theophil; Vissoci, Joao Ricardo Nickenig] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [He, Qing] South China Univ Technol, Dept Linguist, Guangzhou, Guangdong, Peoples R China; [Mmbaga, Blandina Theophil] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Clin Res Inst, Res & Innovat, Moshi, Tanzania; [Mmbaga, Blandina Theophil] Kilimanjaro Christian Med Univ Coll, Res & Innovat & Paediat & Child Hlth, Moshi, Tanzania		Staton, CA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	catherine.staton@duke.edu	Mmbaga, Blandina Theophil/AAR-8707-2021; Zhao, Duan/X-8096-2019	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Staton, Catherine/0000-0002-6468-2894	Fogarty International Center of the U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]; Duke Division of Emergency Medicine; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	This project was funded by the Fogarty International Center of the U.S. National Institutes of Health under Award Number K01TW010000 (PI, Staton) and the Duke Division of Emergency Medicine.	Ao TTH, 2011, AIDS BEHAV, V15, P330, DOI 10.1007/s10461-010-9849-y; Babor T. F, 2001, AUDIT ALCOHOL USE DI, P41; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Cherpitel CJ, 1999, J STUD ALCOHOL, V60, P705, DOI 10.15288/jsa.1999.60.705; Cisler RA, 1999, ALCOHOL CLIN EXP RES, V23, P263, DOI 10.1111/j.1530-0277.1999.tb04109.x; CLAUSSEN B, 1993, ADDICTION, V88, P363, DOI 10.1111/j.1360-0443.1993.tb00823.x; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; Erkut S, 2010, CHILD DEV PERSPECT, V4, P19, DOI 10.1111/j.1750-8606.2009.00111.x; Ferreira-Borges C, 2016, TROP MED INT HEALTH, V21, P52, DOI 10.1111/tmi.12618; Forcehimes AA, 2007, ADDICT BEHAV, V32, P1699, DOI 10.1016/j.addbeh.2006.11.009; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ISAACSON JH, 1994, J GEN INTERN MED, V9, P550, DOI 10.1007/BF02599279; Maisto SA, 1999, ADDICT BEHAV, V24, P879, DOI 10.1016/S0306-4603(99)00047-7; Marques P, 2010, ADDICTION, V105, P226, DOI 10.1111/j.1360-0443.2009.02738.x; Miller W.R., 1995, PROJECT MATCH MONOGR, V4; Mitsunaga T, 2008, J BIOSOC SCI, V40, P379, DOI 10.1017/S0021932007002441; Molina PE, 2015, ALCOHOL RES-CURR REV, V37, P263; Padilla MA, 2016, EDUC PSYCHOL MEAS, V76, P436, DOI 10.1177/0013164415593776; Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420; Read JP, 2006, J STUD ALCOHOL, V67, P169, DOI 10.15288/jsa.2006.67.169; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Skipsey K, 1997, DRUG ALCOHOL DEPEN, V45, P157, DOI 10.1016/S0376-8716(97)01353-7; Staton CA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5144-z; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steinbauer JR, 1998, ANN INTERN MED, V129, P353, DOI 10.7326/0003-4819-129-5-199809010-00002; Tanzania N, 2012, POPULATION HOUSING C; Tatham, 1998, MULTIVARIATE DATA AN; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vissoci JRN, 2018, ALCOHOL ALCOHOLISM, V53, P112, DOI 10.1093/alcalc/agx058; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	34	3	3	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2565			FRONT PUBLIC HEALTH	Front. Public Health	NOV 20	2018	6								330	10.3389/fpubh.2018.00330			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HB0MJ	WOS:000450707300001	30515371	Green Published, gold			2022-02-06	
J	Afshari, FT; Yakoub, KM; Zisakis, A; Thomas, A; Ughratdar, I; Sturman, S; Belli, A				Afshari, Fardad T.; Yakoub, Kamal Makram; Zisakis, Athanasios; Thomas, Allan; Ughratdar, Ismail; Sturman, Steven; Belli, Antonio			Traumatic dural venous sinus thrombosis; a challenge in management of head injury patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Venous sinus thrombosis; Traumatic brain injury; Anticoagulation; Head injury	CT VENOGRAPHY; SINOVENOUS THROMBOSIS; MR VENOGRAPHY; DIAGNOSIS; FRACTURE; HEPARIN	Venous sinus thrombosis secondary to traumatic brain injury and head trauma is increasingly detected following contrast enhanced cranial imaging in acute trauma. The presence of sinus thrombosis poses further challenges in the management of traumatic brain injury patients with cerebral contusions, intra-parenchymal haemorrhages or subdural/extradural haemorrhages. The decision to anti-coagulate such trauma induced venous sinus thrombosis is controversial and requires further attention and research to delineate risks versus benefits of treatment. In this article we report 4 cases of venous sinus thrombosis following head trauma and review the literature on management of such patients. (C) 2018 Elsevier Ltd. All rights reserved.	[Afshari, Fardad T.; Yakoub, Kamal Makram; Zisakis, Athanasios; Thomas, Allan; Ughratdar, Ismail; Belli, Antonio] Birmingham Univ Hosp, Dept Neurosurg, Birmingham B15 2GW, W Midlands, England; [Sturman, Steven] Birmingham Univ Hosp, Dept Neurol, Birmingham B15 2GW, W Midlands, England		Afshari, FT (corresponding author), Birmingham Univ Hosp, Dept Neurosurg, Birmingham B15 2GW, W Midlands, England.	afsharifardad@googlemail.com	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Zisakis, Athanasios/0000-0002-9365-3902			Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Battal B, 2013, CHILD NERV SYST, V29, P1971, DOI 10.1007/s00381-013-2237-y; Beer-Furlan A, 2013, CHILD NERV SYST, V29, P1231, DOI 10.1007/s00381-013-2184-7; Benifla M, 2016, J NEUROSURG-PEDIATR, V18, P253, DOI 10.3171/2016.3.PEDS15690; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; Chiewvit P, 2011, NEUROL INT, V3, P50, DOI 10.4081/ni.2011.e13; Coutinho J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002005, 10.1002/14651858.CD002005.pub2]; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Ferro JM, 2017, EUR J NEUROL, V24, P1203, DOI 10.1111/ene.13381; Gaikwad AB, 2008, EMERG RADIOL, V15, P325, DOI 10.1007/s10140-008-0723-4; Ghuman Mandeep Singh, 2016, J Emerg Trauma Shock, V9, P37, DOI 10.4103/0974-2700.173865; Grangeon L, 2017, REV NEUROL-FRANCE, V173, P411, DOI 10.1016/j.neurol.2017.03.025; Hersh DS, 2016, NEUROSURGERY, V63, P169; Ilyas A, 2017, J NEUROINTERV SURG, V9, P1086, DOI 10.1136/neurintsurg-2016-012938; Khandelwal N, 2006, AM J ROENTGENOL, V187, P1637, DOI 10.2214/AJR.05.1249; Linn J, 2007, AM J NEURORADIOL, V28, P946; Ozsvath RR, 1997, AM J ROENTGENOL, V169, P1699, DOI 10.2214/ajr.169.6.9393193; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Salunke P, 2013, ACTA NEUROCHIR, V155, P925, DOI 10.1007/s00701-012-1615-7; Sari S, 2015, CLIN NEUROL NEUROSUR, V134, P44, DOI 10.1016/j.clineuro.2015.04.013; Wilcher J, 2016, PEDIATR EMERG CARE, V32, P872, DOI 10.1097/PEC.0000000000000344	23	3	4	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2018	57						169	173		10.1016/j.jocn.2018.08.047			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3YS	WOS:000448494000033	30170950				2022-02-06	
J	Alsharidah, M; Al-Hussain, F; Iqbal, M; Hamza, A; Yoo, WK; Bashir, S				Alsharidah, M.; Al-Hussain, F.; Iqbal, M.; Hamza, A.; Yoo, W-K; Bashir, S.			The effect of transcranial direct current stimulation combined with functional task training on motor recovery in stroke patients	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Neuromodulation; Neuroengineering; Transcranial direct current stimulation	INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; UPPER-LIMB FUNCTION; HEMIPARETIC STROKE; NEURAL PLASTICITY; REHABILITATION; CORTEX; MODULATION; TDCS; EXCITABILITY	The field of neuromodulation encompasses a wide spectrum of interventional technologies that modify pathological activity within the nervous system to achieve a therapeutic effect. Therapy including transcranial direct current stimulation (tDCS) has all shown promising results across a range of neurological and neuropsychiatric disorders. This article reviews the state-of-the-art of neuromodulation for stroke and discusses the opportunities and challenges available for clinicians and researchers interested in advancing neuromodulation therapy. The annual worldwide incidence of stroke ranges from 27.5 to 63 individuals per 100,000. Stroke, a major cause of adult disability, has devastating effects on patients and their caregivers, which has a tremendous socioeconomic impact on families and healthcare systems around the world. There are only a few treatments available for the improvement of motor function in stroke patients. The majority of these treatments are based on functional motor learning (ML) strategies. Both the mechanisms underlying stroke recovery and the effectiveness of neurorehabilitation interventions still remain poorly understood for widespread implementation, although it strongly depends on the quality of rehabilitation service to reach maximal post-stroke recovery.	[Alsharidah, M.] King Saud Univ, Fac Med, Riyadh, Saudi Arabia; [Al-Hussain, F.] King Saud Univ, Fac Med, Dept Neurol, Riyadh, Saudi Arabia; [Iqbal, M.] King Saud Univ, Fac Med, Dept Physiol, Riyadh, Saudi Arabia; [Hamza, A.] Natl Univ Comp & Emerging Sci, Dept Elect Engn, Lahore, Pakistan; [Yoo, W-K] Univ Sacred Heart Hosp, Div Neurosci Ctr, Dept Phys Med & Rehabil, Anyang, South Korea; [Yoo, W-K] Hallym Univ, Hallym Inst Translat Genom & Bioinformat, Coll Med, Anyang, South Korea; [Bashir, S.] King Fahad Specialist Hosp Dammam, Neurosci Ctr, Dept Neurophysiol, Riyadh, Saudi Arabia		Bashir, S (corresponding author), King Fahad Specialist Hosp Dammam, Neurosci Ctr, Dept Neurophysiol, Riyadh, Saudi Arabia.	sbashir10@gmail.com		Hamza, Ali/0000-0001-9162-7607; nassim ali, eman/0000-0003-2102-6472; Bashir, Shahid/0000-0001-6286-6895	King Saud UniversityKing Saud University [RGP-1438-008]	The authors extend their appreciation to the Deanship of Scientific Research, King Saud University for funding this work through the research group no. (RGP-1438-008).	Alia C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00076; Ang KK, 2015, ARCH PHYS MED REHAB, V96, pS79, DOI 10.1016/j.apmr.2014.08.008; Antal A, 2010, J PAIN SYMPTOM MANAG, V39, P890, DOI 10.1016/j.jpainsymman.2009.09.023; Arya K. N., 2014, Annals of Physical and Rehabilitation Medicine, V57, P696, DOI 10.1016/j.rehab.2014.06.003; Bashir S, 2017, EUR REV MED PHARMACO, V21, P2443; Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Caipa A, 2018, EUR REV MED PHARMACO, V22, P844, DOI 10.26355/eurrev_201802_14321; Caleo M, 2015, NEUROSCIENCE, V311, P180, DOI 10.1016/j.neuroscience.2015.10.029; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Chang FH, 2017, J HEAD TRAUMA REHAB, V32, pE11, DOI 10.1097/HTR.0000000000000258; Clayton E, 2016, BRAIN RES, V1640, P130, DOI 10.1016/j.brainres.2016.01.056; Daly JJ, 2007, THESCIENTIFICWORLDJO, V7, P2031, DOI 10.1100/tsw.2007.299; Di Lazzaro V, 2010, CLIN NEUROPHYSIOL, V121, P464, DOI 10.1016/j.clinph.2009.11.007; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Gor-Garcia-Fogeda MD, 2014, ARCH PHYS MED REHAB, V95, P1174, DOI 10.1016/j.apmr.2014.02.013; Ellis MD, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0203-0; Elsner B, 2015, COCHRANE DB SYST REV, V5; Elsner B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009645.pub3; Floel A, 2008, NEUROREHAB NEURAL RE, V22, P477, DOI 10.1177/1545968308316388; Giszter SF, 2015, CURR OPIN NEUROBIOL, V33, P156, DOI 10.1016/j.conb.2015.04.004; Harvey RL, 2007, TOP STROKE REHABIL, V14, P54, DOI 10.1310/tsr1406-54; Hill AT, 2016, BRAIN STIMUL, V9, P197, DOI 10.1016/j.brs.2015.10.006; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Houweling S, 2010, NEUROIMAGE, V49, P3269, DOI 10.1016/j.neuroimage.2009.11.017; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jorgensen HS, 2000, STROKE, V31, P434, DOI 10.1161/01.STR.31.2.434; Kim JH, 2015, CLIN INTERV AGING, V10, P1839, DOI 10.2147/CIA.S92888; Komitova M, 2006, EXP NEUROL, V199, P42, DOI 10.1016/j.expneurol.2006.03.010; Kourtis D, 2008, BRAIN RES, V1244, P113, DOI 10.1016/j.brainres.2008.09.048; Kratz O, 2011, J ECT, V27, P48, DOI 10.1097/YCT.0b013e3181d2ef85; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Leclercq D, 2011, NEUROSURG CLIN N AM, V22, P253, DOI 10.1016/j.nec.2010.11.004; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Ludemann-Podubecka J, 2014, NEUROSCI BIOBEHAV R, V47, P245, DOI 10.1016/j.neubiorev.2014.07.022; MCCOMAS AJ, 1973, J NEUROL NEUROSUR PS, V36, P183, DOI 10.1136/jnnp.36.2.183; Mebius MJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-4055; Mehrholz J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub4; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006876.pub4; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; Pavlova EL, 2017, RESTOR NEUROL NEUROS, V35, P307, DOI 10.3233/RNN-160706; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Powell ES, 2016, NEUROREHABILITATION, V39, P439, DOI 10.3233/NRE-161375; Rabadi MH, 2017, AM J PHYS MED REHAB, V96, pS178, DOI 10.1097/PHM.0000000000000823; Richards LG, 2008, NEUROPSYCHOLOGIA, V46, P3, DOI 10.1016/j.neuropsychologia.2007.08.013; Rocha S, 2016, DISABIL REHABIL, V38, P653, DOI 10.3109/09638288.2015.1055382; Song L P, 2017, Zhonghua Yi Xue Za Zhi, V97, P1604, DOI 10.3760/cma.j.issn.0376-2491.2017.21.003; Stark A, 2012, BRAIN TOPOGR, V25, P205, DOI 10.1007/s10548-011-0201-2; Straudi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5068127; Sun LM, 2013, NEURORADIOLOGY, V55, P913, DOI 10.1007/s00234-013-1188-z; Tang Q, 2015, NEUROSCI BIOBEHAV R, V57, P392, DOI 10.1016/j.neubiorev.2015.09.003; Todder Doron, 2016, Harefuah, V155, P753; Tyson SF, 2013, ARCH PHYS MED REHAB, V94, P1377, DOI 10.1016/j.apmr.2012.12.025; Zhao HC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00685; Zimerman M, 2012, STROKE, V43, P2185, DOI 10.1161/STROKEAHA.111.645382	64	3	3	0	16	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	NOV	2018	22	21					7385	7392					8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HB4OR	WOS:000451033900035	30468485				2022-02-06	
J	Anton-Martin, P; Braga, B; Megison, S; Journeycake, J; Moreland, J				Anton-Martin, Pilar; Braga, Bruno; Megison, Stephen; Journeycake, Janna; Moreland, Jessica			Craniectomy and Traumatic Brain Injury in Children on Extracorporeal Membrane Oxygenation Support	PEDIATRIC EMERGENCY CARE			English	Article						polytrauma; traumatic brain injury; acute respiratory distress syndrome; extracorporeal membrane oxygenation; heparin	RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; HEMORRHAGIC COMPLICATIONS; INTRACRANIAL HEMORRHAGE; ECMO; FAILURE; PATIENT; LUNG; SHOCK	Severe trauma may cause refractory life-threatening respiratory failure requiring extracorporeal membrane oxygenation (ECMO). Concurrent traumatic brain injury, however, complicates the use of ECMO because of the major risk of intracranial bleeding with systemic anticoagulation. Craniotomy and/or craniectomy for hematoma evacuation during ECMO are extremely high-risk procedures secondary to ongoing anticoagulation, and there are only a few such case reports in the literature. We present the case of a child with multiple thoracic injuries and life-threatening respiratory failure supported on ECMO. She developed an intracranial hemorrhage while systemically heparinized that required emergent decannulation and bedside craniectomy for hematoma extraction. She survived with an excellent neurologic outcome. We also review the relevant literature regarding the use of ECMO in patients with polytrauma and the occurrence of craniectomy on extracorporeal support, with a focus on pediatric publications. Patients with polytrauma with brain injury can be supported on ECMO, but extreme precaution must be taken regarding anticoagulation. The intracranial complications of ECMO in this population are not infrequent, but our case report and review of the literature suggest that neurosurgical intervention should be considered in life-threatening conditions when no other alternatives are available.	[Anton-Martin, Pilar; Moreland, Jessica] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Crit Care Med, 1935 Med Dist Dr, Dallas, TX 75235 USA; [Braga, Bruno] Univ Texas Southwestern Med Ctr, Dept Neurol Surg Pediat, Dallas, TX USA; [Megison, Stephen] Univ Texas Southwestern Med Ctr, Dept Surg Pediat, Dallas, TX USA; [Journeycake, Janna] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Hematol Oncol, Dallas, TX USA		Anton-Martin, P (corresponding author), Univ Texas Southwestern Med Ctr, Dept Pediat, Div Crit Care Med, 1935 Med Dist Dr, Dallas, TX 75235 USA.	Pilar.Anton-Martin@UTSouthwestern.edu		Anton-Martin, Pilar/0000-0003-1215-3285			ANDERSON HL, 1994, J TRAUMA, V37, P266, DOI 10.1097/00005373-199408000-00020; Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Biderman P, 2013, J TRAUMA ACUTE CARE, V75, P907, DOI 10.1097/TA.0b013e3182a8334f; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Downard CD, 2003, J PEDIATR SURG, V38, P1212, DOI 10.1016/S0022-3468(03)00270-7; Factora FNF, 2011, J NEUROSURG ANESTH, V23, P30, DOI 10.1097/ANA.0b013e3181eee55e; Fortenberry JD, 2003, J PEDIATR SURG, V38, P1221, DOI 10.1016/S0022-3468(03)00272-0; Frickey Nathalie, 2008, J Trauma, V64, pE41; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Hervey-Jumper SL, 2011, J NEUROSURG-PEDIATR, V7, P338, DOI 10.3171/2011.1.PEDS10443; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Huang YK, 2009, RESUSCITATION, V80, P535, DOI 10.1016/j.resuscitation.2009.02.016; Hwang GJ, 2013, J KOREAN MED SCI, V28, P962, DOI 10.3346/jkms.2013.28.6.962; Leloup G, 2011, BRIT J ANAESTH, V107, P1014, DOI 10.1093/bja/aer365; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Menut R, 2013, ANN FR ANESTH, V32, P701, DOI 10.1016/j.annfar.2013.04.014; Messing JA, 2014, ASAIO J, V60, P597, DOI 10.1097/MAT.0000000000000103; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Ried M, 2013, CRIT CARE, V17, DOI 10.1186/cc12782; Round JA, 2010, J ROY ARMY MED CORPS, V156, P139; STEINER RB, 1991, J PEDIATR SURG, V26, P1011, DOI 10.1016/0022-3468(91)90664-F; Stoll MC, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.03.039; Vecsei V., 2005, EUR J TRAUMA, V31, P239; WILSON JM, 1993, J PEDIATR SURG, V28, P536, DOI 10.1016/0022-3468(93)90612-O; Zhou R, 2014, PERFUSION, V9	28	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	NOV	2018	34	11					E204	E210		10.1097/PEC.0000000000000907			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	HA2RE	WOS:000450087200002	27749813				2022-02-06	
J	Boyle, TA; Rao, KA; Horkan, DB; Bandeian, ML; Sola, JE; Karcutskie, CA; Allen, C; Perez, EA; Lineen, EB; Hogan, AR; Neville, HL				Boyle, Thomas A.; Rao, Kittu A.; Horkan, Davis B.; Bandeian, Marguerite L.; Sola, Juan E.; Karcutskie, Charles A.; Allen, Casey; Perez, Eduardo A.; Lineen, Edward B.; Hogan, Anthony R.; Neville, Holly L.			Analysis of water sports injuries admitted to a pediatric trauma center: a 13year experience	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pediatrics; Trauma; Water sports; Boat; Personal watercraft; Motor vehicle	CHILDREN; PREVENTION	Background Unintentional injury is the leading cause of death in children and adolescents. Injuries occurring during boating and recreational water sports are poorly described in the literature. Herein, we compare injuries from water sports to those resulting from motor vehicle collisions, which are better described in existing literature. Methods A retrospective review of 1935 consecutive pediatric trauma patients, as defined by age<18 years, admitted to a single level-1 pediatric trauma center between January 2000 and August 2013 was performed. Patients were divided into two cohorts based on the mechanism of injury: water sports injury (WSI) or motor vehicle collision (MVC). Demographics, injury descriptors, and outcomes were reviewed for each patient. Categorical variables were compared by Chi square or Fisher's exact test, and continuous by t test or Mann-Whitney U test. Parametric data are reported as meanstandard deviation and nonparametric as median (interquartile range). Significance was set at alpha level 0.05. Results A total of 18 pediatric patients were admitted for WSI and 615 for MVC during the study period. Among those with WSI, mean age was 12 +/- 4 years, mean Injury Severity Score (ISS) was 11 +/- 10, and mean Revised Trauma Score (RTS) was 7.841(IQR 6.055-7.841). 44% of WSI occurred by personal watercraft (Jet Ski, WaveRunner), 39% by boat, and 17% by other means (e.g., diving, tubing, kite surfing). Overall, the most common WSI included skin/soft-tissue lacerations (59%), head injury/concussion (33%), tendon/ligament lacerations (28%), and extremity fractures (28%). Compared to 615 patients admitted for MVC, age, sex, race, Glasgow Coma Scale, ISS, RTS, spleen and liver laceration rates, neurosurgical consultation, ICU admission, ICU and total length of stay, and mortality were similar. Patients with WSI were more likely to be tourists (44% vs. 5%, p<0.001). Those with WSI showed a significantly higher requirement for any surgical intervention (61% vs. 15%, p=0.001). The rate of open fracture (28% vs. 6%, p=0.006) and, subsequently, orthopedic procedures (39% vs. 17%, p=0.027) were also higher in the WSI group. Conclusion Overall, water sports injuries are similar in in-hospital mortality to motor vehicle collisions. They are more likely to result in penetrating trauma and more likely to require surgical intervention. Primary and secondary prevention strategies should specifically target personal watercraft usage and tourist populations.	[Boyle, Thomas A.; Rao, Kittu A.; Horkan, Davis B.; Bandeian, Marguerite L.; Sola, Juan E.; Karcutskie, Charles A.; Allen, Casey; Perez, Eduardo A.; Lineen, Edward B.; Hogan, Anthony R.; Neville, Holly L.] Univ Miami, Miller Sch Med, Div Pediat Surg, DeWitt Daughtry Family Dept Surg, 1120 NW 14th St 4th Floor, Miami, FL 33136 USA		Boyle, TA (corresponding author), Univ Miami, Miller Sch Med, Div Pediat Surg, DeWitt Daughtry Family Dept Surg, 1120 NW 14th St 4th Floor, Miami, FL 33136 USA.	tab127@miami.edu	Boyle, Thomas/AAW-6319-2021; Boyle, Thomas A./T-2606-2019	Boyle, Thomas A./0000-0003-2628-1325; sola, juan/0000-0003-1352-0307			Baddour LM, 2018, SOFT TISSUE INFECT F; CDC, 2016, ROAD TRAFF SAF; Day C, 2008, PEDIATRICS, V122, pE388, DOI 10.1542/peds.2008-0024; Descottes B, 2003, DIS COLON RECTUM, V46, P971, DOI 10.1007/s10350-004-6695-x; Di Flumeri Giuseppe, 2009, Chir Ital, V61, P131; Herrera C, 2017, MIAMI HERALD; Johnston BD, 2013, ACAD PEDIATR, V13, P499, DOI 10.1016/j.acap.2013.04.016; Keijzer R, 2013, J PEDIATR SURG, V48, P1757, DOI 10.1016/j.jpedsurg.2013.03.055; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Kue RC, 2015, PREHOSP EMERG CARE, V19, P399, DOI 10.3109/10903127.2014.995842; Leonard J, 2016, J TRAUMA ACUTE CARE, V81, P441, DOI 10.1097/TA.0000000000001115; Petronis KA, 2009, CLIN PEDIATR, V48, P534, DOI 10.1177/0009922808330108; Purvis J M, 2001, J Am Acad Orthop Surg, V9, P365; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Theurer WM, 2013, AM FAM PHYSICIAN, V87, P502; USCG, 2016, RECR BOAT STAT; Wadlow K, 2016, MIAMI HERALD	18	3	3	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2018	34	11					1189	1193		10.1007/s00383-018-4336-z			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GW8XC	WOS:000447263600009	30105495				2022-02-06	
J	Conroy, K; Malik, V				Conroy, K.; Malik, V.			bh Hearing loss in the trenches - a hidden morbidity of World War I	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article; Proceedings Paper	Annual Meeting of the British-Society-for-the-History-of-ENT	DEC 03, 2015	London, ENGLAND	British Soc Hist ENT		Warfare; Hearing Loss; Sensorineural; Hearing Loss; Noise-Induced; Otitis Media; Suppurative; Otitis Externa		Background. One hundred years ago, millions of British and Allied troops were fighting in the trenches of the Great War. With a tenth of soldiers losing their lives, hearing loss seemed a low priority; however, vast numbers of troops sustained significant hearing loss. Method. A review was conducted of literature published between 1914 and 1925. Results. Soldiers were exposed to up to 185 dB of sustained noise from new, high-energy weapons, which caused 'labyrinthine concussion'. Traumatic injuries, non-organic hearing loss and malingering were also common. One source estimated that 2.4 per cent of the army was disabled by hearing loss. However, many British doctors viewed this 'soldier's deafness' as a temporary affliction, resulting in soldiers being labelled as malingerers or 'hysterical'. Conclusion. Today, one can recognise that a scant evidence base and misconceptions influenced the mismanagement of hearing loss by otolaryngologists in World War I. However, noise-induced hearing loss is still very much a feature of armed conflict.	[Conroy, K.] Royal Preston Hosp, Dept Otolaryngol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England; [Malik, V.] Blackpool Victoria Hosp, Dept Otolaryngol, Blackpool, England		Conroy, K (corresponding author), Royal Preston Hosp, Dept Otolaryngol, Sharoe Green Lane, Preston PR2 9HT, Lancs, England.	katherine.conroy@cantab.net					Adrian ED, 1917, LANCET, V1, P867; Barrett J., 1918, J LARYNGOLOGY RHINOL, V33, P100, DOI [10.1017/S1755146300018205, DOI 10.1017/S1755146300018205]; British Library, WEAP WORLD WAR ON; Bryant WS., 1918, J LARYNGOLOGY RHINOL, V33, P97, DOI [10.1017/S1755146300018199, DOI 10.1017/S1755146300018199]; Bryant WS., 1917, J LARYNGOLOGY RHINOL, V32, P338, DOI [10.1017/S1755146300017753, DOI 10.1017/S1755146300017753]; Davis E D, 1918, Proc R Soc Med, V11, P8; Dickie J K, 1921, Can Med Assoc J, V11, P893; Faulder T J, 1921, Proc R Soc Med, V14, P41; Fraser J S, 1917, Proc R Soc Med, V10, P56; Fraser JS, 1917, LANCET, V2, P872; Griffith Llewelyn Wyn, 2010, MAMETZ; Groenewold Matthew R., 2011, Morbidity and Mortality Weekly Report, V60, P955; Hearing Health and Technology Matters, HEAR LOSS TRENCH WOR; Hurst AF, 1917, LANCET, V2, P517; Jobson TB, 1917, LANCET, V2, P566; Jones-Phillipson C E, 1917, Proc R Soc Med, V10, P96; Marriage HJ., 1917, P ROY SOC MED, V10, P47; McKenzie D., 1917, LANCET, V190, P729; Milligan W, 1915, Proc R Soc Med, V8, P109; Notes and queries, 1917, J LARYNGOLOGY RHINOL, V32, P272; Spartacus Educational, FRENCH ARM WORLD WAR	21	3	3	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	NOV	2018	132	11					952	955		10.1017/S0022215118001755			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology	HC9SF	WOS:000452146300002	30370887	Bronze			2022-02-06	
J	Dinnes, C; Hux, K; Holmen, M; Martens, A; Smith, M				Dinnes, Carly; Hux, Karen; Holmen, Morgan; Martens, Alaina; Smith, Megan			Writing Changes and Perceptions After Traumatic Brain Injury: "Oh, by the way, I can't write"	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							NARRATIVE DISCOURSE; COLLEGE-STUDENTS; WORKING-MEMORY; WORD RETRIEVAL; LANGUAGE; COMMUNICATION; DEFICITS; METAANALYSIS; MANAGEMENT; STABILITY	Purpose: Language and cognitive disruptions following traumatic brain injury (TBI) can negatively affect written expression and may result in increased difficulty achieving academic, vocational, social, and personal goals; however, scarce literature exists about TBI's effect on writing abilities. The purpose of this qualitative study was to describe the experiences and perceptions of people with TBI regarding their engagement in writing activities. Method: A transcendental phenomenological design structured the research. Data collection from 11 adults with TBI included gathering demographic and background information, completion of a TBI Symptom Checklist, and engagement in semistructured interviews. Results: Four major themes and 21 subthemes about postinjury writing recovery and current writing status emerged from the data analysis. Participants reported the extent to which writing difficulties interfered with daily activities and identified support strategies used to address persistent challenges. Conclusion: Understanding the writing experiences and perceptions of people with TBI can guide professionals in designing assessments and interventions to facilitate educational, vocational, social, and personal success following injury.	[Dinnes, Carly; Hux, Karen; Holmen, Morgan; Martens, Alaina; Smith, Megan] Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE 68588 USA; [Hux, Karen] Qual Living, Omaha, NE USA		Dinnes, C (corresponding author), Univ Nebraska Lincoln, Dept Special Educ & Commun Disorders, Lincoln, NE 68588 USA.	carly.dinnes@huskers.unl.edu	Hux, Karen/AAQ-2078-2020				Berninger V. W., 2012, PRESENT FUTURE CONTR, P177; Bogdan R., 2007, QUALITATIVE RES ED I; Brown J, 2017, NEUROREHABILITATION, V41, P483, DOI 10.3233/NRE-162065; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Creswell J. W., 2016, QUAL INQ; Creswell J.W., 2018, QUALITATIVE INQUIRY; Dietz A, 2011, TOP STROKE REHABIL, V18, P758, DOI 10.1310/tsr1806-758; Dinnes C, 2018, COMMUN DISORD Q, V39, P490, DOI 10.1177/1525740117716416; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Graham S, 2007, WRITING NEXT EFFECTI; Graham S., 2012, PRESENT FUTURE CONTR, P177, DOI [10.4324/9780203805312, DOI 10.4324/9780203805312]; Graham S, 2007, J EDUC PSYCHOL, V99, P445, DOI 10.1037/0022-0663.99.3.445; Hagen C., 2000, TBI REH MAN CAR ENV; Head Injury Hotline, 1998, BRAIN INJURY CHECKLI; Holland A., 1982, CLIN APH P C, P345; Hux K, 2013, ASSISTING SURVIVORS; Hux K., 2017, CURRENT RES CONCUSSI, V4, pE14, DOI [10.1055/s-0037-1606578, DOI 10.1055/S-0037-1606578]; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Ledbetter A, 2017, THESIS; Lichtman M., 2013, QUALITATIVE RES ED U; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Mason L. H., 2008, LEARNING DISABILITIE, V23, P103, DOI DOI 10.1111/J.1540-5826.2008.00268.X; McDonald S., 1999, BRAIN DAM B; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Merriam SB., 2016, QUALITATIVE RES GUID, V4; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; National Commission on Writing, 2004, WRIT TICK WORK TICK; National Commission on Writing, 2005, WRIT POW MESS STAT G; Padilla-Daz M, 2015, INT J ED EXCELLENCE, V1, P101, DOI 10.18562/IJEE.2015.0009; Possl O, 2001, BRAIN INJURY, V15, P15; Prigatano G. P, 1986, NEUROPSYCHOLGICAL RE; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rogers LA, 2008, J EDUC PSYCHOL, V100, P879, DOI 10.1037/0022-0663.100.4.879; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Togher L., 2000, BRAIN DAM B, P1; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Vanderberg R, 2007, READ WRIT, V20, P721, DOI 10.1007/s11145-006-9046-6; Wheeler L, 2014, NEUROREHABILITATION, V34, P29, DOI 10.3233/NRE-131007; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248; Wong MN, 2010, APHASIOLOGY, V24, P1155, DOI 10.1080/02687030903168212; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	54	3	3	1	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2018	27	4					1523	1538		10.1044/2018_AJSLP-18-0025			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HB6TX	WOS:000451206200016	30458465				2022-02-06	
J	Erler, KS; Juengst, SB; Whiteneck, GG; Locascio, JJ; Bogner, JA; Kaminski, J; Giacino, JT				Erler, Kimberly S.; Juengst, Shannon B.; Whiteneck, Gale G.; Locascio, Joseph J.; Bogner, Jennifer A.; Kaminski, Jamie; Giacino, Joseph T.			The Association of Rehospitalization With Participation 5 Years After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health; hospitalization; social participation; traumatic brain injury	HEALTH; REHABILITATION; POPULATION; CONSEQUENCES; SATISFACTION; VALIDITY; LIFE	Objective: To determine whether rehospitalization during the first 2 years after moderate to severe traumatic brain injury (TBI) is associated with poor participation at 5 years post-TBI, after controlling for demographic and severity factors. Setting: TBI Model Systems Program. Participants: Community-dwelling individuals with TBI, 16 years or older (n = 1940). Design: Retrospective data analysis of a multicenter prospective study. Main Measures: Participation Assessment with Recombined Tools-Objective (PART-O). Results: After controlling for demographic and severity factors, a general linear model indicated that rehospitalization status (ie, never rehospitalized during years 1 and 2, rehospitalized either during year 1 or 2, or rehospitalized during both years 1 and 2) predicted less participation at 5 years post-TBI (P = .0353). The PART-O scores were in the hypothesized direction, with the lowest covariate-adjusted mean participation score found for the group with rehospitalizations during both years and the highest covariate-adjusted mean participation score found in the group with no rehospitalizations. Examining total number of rehospitalizations during years 1 and 2, rather than rehospitalization status, yielded analogous results (P = .0148). Conclusions: This study suggests that rehospitalization in the first 2 years after TBI is negatively associated with participation at 5 years after injury. Since participation is considered a key indicator of successful TBI rehabilitation, minimizing the need for rehospitalizations and promoting health in the community setting should be a priority of postacute care for individuals with TBI.	[Erler, Kimberly S.; Kaminski, Jamie; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Locascio, Joseph J.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Erler, KS (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.	kerler@partners.org	Giacino, Joseph/AAF-1952-2021; Juengst, Shannon B/AAC-5891-2019	Giacino, Joseph/0000-0002-7916-9698; Juengst, Shannon B/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0034, 90DP0039, 90DP0040, 90DP0041]; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER	This work was conducted with support from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant numbers 90DP0034, 90DP0039, 90DP0040, 90DP0041). The NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of the NIDILRR, ACL, and HHS, and you should not assume endorsement by the Federal Government. This work was also conducted with support from Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University, and its affiliated academic healthcare centers, or the National Institutes of Health.	Andonian L, 2011, BRIT J OCCUP THER, V74, P2, DOI 10.4276/030802211X12947686093486; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dams-OConnor K, 2016, J HEAD TRAUMA REHAB, V10029, P1; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; HealthCareGov, GLOSSARY; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Medicaid.gov, LONG TERM SERV SUPP; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Noone Peter, 2011, Occup Med (Lond), V61, P71, DOI 10.1093/occmed/kqq173; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schuring M, 2007, J EPIDEMIOL COMMUN H, V61, P597, DOI 10.1136/jech.2006.047456; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 2007, INT CLASS FUNCT DIS	34	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E77	E84		10.1097/HTR.0000000000000386			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600009	29601342				2022-02-06	
J	Gao, W; Ju, YN; Chen, JF; Zhou, Q; Song, CY; Wang, YZ; Cao, HL; Yang, WC				Gao, Wei; Ju, Ying-Nan; Chen, Jian-Feng; Zhou, Qiang; Song, Chun-Yu; Wang, Yue-Zhen; Cao, Hong-Ling; Yang, Wan-Chao			Adrenomedullin Reduces Secondary Injury and Improves Outcome in Rats with Fluid Percussion Brain Injury	WORLD NEUROSURGERY			English	Article						Adrenomedullin; Inflammation; Traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; UNITED-STATES; ENDOTHELIAL-CELLS; EDEMA; AQUAPORIN-4; STROKE; MICE; INFLAMMATION; INHIBITION; APOPTOSIS	OBJECTIVE: Traumatic brain injury (TBI) is a devastating neurologic injury and remains a major cause of death in the world. Secondary injury after TBI is associated with long-term disability in patients with TBI. This study evaluated adrenomedullin (AM) on secondary injury and neurologic functional outcome in rats after TBI. METHODS: Forty-eight Sprague Dawley rats were randomly assigned into 3 groups: sham, TBI, and TBI with AM groups. TBI was induced by fluid percussion injury, and AM was intravenously injected. Neurologic function was examined at 2, 3, and 7 days after TBI. Enzyme-linked immunosorbent assay was used to test tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, and IL-8 levels in the brain. Brain edema and bloodebrain barrier (BBB) permeability in brain tissue were tested. Western blot was used to examine the expression of aquaporin-4, phosphorylated myosin lightchain, and cleaved caspase-3. Terminal deoxynucleotidyl transferase dUTP nick end labeling was used to test the apoptosis. RESULTS: Compared with the sham group, TNF-alpha, IL-1 beta, and IL-6 levels, brain edema, BBB permeability, neurologic examination scores, terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells, and expression of aquaporin-4, phosphorylated myosin light-chain, and cleaved caspase-3 significantly increased in the TBI group. AM treatment significantly inhibited TBI-induced effects. CONCLUSIONS: AM can improve neurologic function and ameliorate brain injury in rats with TBI. AM exerts its neuroprotective effect via its anti-inflammatory and antiapoptotic effect.	[Gao, Wei; Chen, Jian-Feng; Zhou, Qiang; Song, Chun-Yu; Wang, Yue-Zhen; Cao, Hong-Ling; Yang, Wan-Chao] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China; [Gao, Wei; Chen, Jian-Feng; Zhou, Qiang; Song, Chun-Yu; Wang, Yue-Zhen; Cao, Hong-Ling; Yang, Wan-Chao] Harbin Med Univ, Educ Dept, Anesthesiol Key Lab, Harbin, Heilongjiang, Peoples R China; [Ju, Ying-Nan] Harbin Med Univ, Affiliated Hosp 3, Dept Intens Care Unit, Harbin, Heilongjiang, Peoples R China		Yang, WC (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China.; Yang, WC (corresponding author), Harbin Med Univ, Educ Dept, Anesthesiol Key Lab, Harbin, Heilongjiang, Peoples R China.	dachao_1980@163.com			Harbin Science and Technology Commission Foundation [2014RFQGJ113]; Heilongjiang Postdoctoral Fund [LBH-Z15131]	This study was supported by the graduate award from the Harbin Science and Technology Commission Foundation (2014RFQGJ113) and the Heilongjiang Postdoctoral Fund (LBH-Z15131).	Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chaung WW, 2011, MOL MED, V17, P1075, DOI 10.2119/molmed.2010.00104; Chen L, 2005, REGUL PEPTIDES, V130, P27, DOI 10.1016/j.regpep.2005.03.006; Chen TJ, 2014, PEPTIDES, V56, P146, DOI 10.1016/j.peptides.2014.04.005; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Demir H, 2013, PEPTIDES, V43, P27, DOI 10.1016/j.peptides.2013.02.018; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Geven C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00292; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kirisci M, 2013, J SURG RES, V185, P56, DOI 10.1016/j.jss.2013.05.053; Kis B, 2003, HYPERTENS RES, V26, pS61, DOI 10.1291/hypres.26.S61; Kondoh T, 2011, BRAIN RES BULL, V84, P69, DOI 10.1016/j.brainresbull.2010.11.005; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996; Naked GM, 2000, CLIN IMMUNOL, V96, P162, DOI 10.1006/clim.2000.4878; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Talero E., 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/717851; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; Watanabe K, 2001, ACTA NEUROCHIR, V143, P1157, DOI 10.1007/s007010100007; Wu XY, 2009, AM J PHYSIOL-RENAL, V297, pF316, DOI 10.1152/ajprenal.00089.2009; Xia CF, 2006, EXP NEUROL, V197, P521, DOI 10.1016/j.expneurol.2005.10.027; Yang WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167359; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	50	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E765	E773		10.1016/j.wneu.2018.07.265			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300094	30096509	hybrid			2022-02-06	
J	Goedemans, T; van der Veer, O; Verbaan, D; Bot, M; Lequin, MB; Coert, BA; van Furth, WR; Bouma, GJ; Vandertop, WP; Buis, DR; van den Munckhof, P				Goedemans, Taco; van der Veer, Olivier; Verbaan, Dagmar; Bot, Maarten; Lequin, Michiel B.; Coert, Bert A.; van Furth, Wouter R.; Bouma, Gert-Joan; Vandertop, W. Peter; Buis, Dennis R.; van den Munckhof, Pepijn			Skin Augmentation as a Last-Resort Operative Technique During Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Gore-Tex; Intracranial pressure; Skin augmentation; Traumatic brain injury	MIDDLE CEREBRAL-ARTERY; BRAIN; HEMICRANIECTOMY	OBJECTIVE: Since 2009, we have performed skin augmentation using a Gore-Tex patch as a last-resort measure to reduce intracranial pressure (ICP) in uncontrollable brain swelling during decompressive craniectomy (DC). Here, we report our experience and outcome in a consecutive series of patients undergoing DC with skin augmentation (DCDS). METHODS: In 2009-2015, a prospective database was created registering all patients who underwent DCDS when ICP increased >25 mm Hg while approximating the skin edges after DC (or when closing the skin was impossible because of uncontrollable brain swelling in patients without an ICP monitoring catheter). Patients' baseline characteristics and 1-year outcome were compared with patients undergoing DC without the need of skin augmentation in the same time frame. Outcome according to the Glasgow Outcome Scale (GOS) was dichotomized into favorable (GOS score 4-5) and unfavorable (GOS 1-3). RESULTS: Of a total of 180 consecutive patients with DC, 20 (11%) underwent DCDS. Four (20%) survived favorably, 2 (10%) unfavorably, and 14 (70%) died (compared with 36%, 22%, and 42%, respectively, in patients with standard DC). Four of 7 patients in whom DCDS was performed >= 24 hours after injury or at second surgery survived favorably, versus none of the 13 patients in whom DCDS was performed < 24 hours after injury and at first surgery. Two of 10 patients surviving the first week after DCDS had a skinplasty-related infection. CONCLUSIONS: Decompressive craniectomy with skin augmentation may be used as a last-resort measure in cases of severe brain swelling despite DC.	[Goedemans, Taco; van der Veer, Olivier; Verbaan, Dagmar; Bot, Maarten; Lequin, Michiel B.; Coert, Bert A.; van Furth, Wouter R.; Bouma, Gert-Joan; Vandertop, W. Peter; Buis, Dennis R.; van den Munckhof, Pepijn] Acad Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [van der Veer, Olivier] Med Spectrum Twente, Dept Neurosurg, Enschede, Netherlands; [van Furth, Wouter R.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands		van den Munckhof, P (corresponding author), Acad Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands.	p.vandenmunckhoi@amc.nl	van den Munckhof, Pepijn/AAY-9259-2020; Buis, Dennis/L-3247-2019	Buis, Dennis/0000-0002-7411-5383; Bouma, Gerrit/0000-0002-2772-7475; Vandertop, William/0000-0001-5417-0265; van den Munckhof, Pepijn/0000-0001-5044-3705; Verbaan, Dagmar/0000-0002-9212-5470			Akutsu N, 2013, NEUROL MED-CHIR, V53, P56, DOI 10.2176/nmc.53.56; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Kazumata K, 2010, NEUROL MED-CHIR, V50, P884, DOI 10.2176/nmc.50.884; Priban V, 2010, Rozhl Chir, V89, P436; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van den Munckhof P, 2012, J NEUROSURG-PEDIATR, V10, P64, DOI 10.3171/2012.3.PEDS1225; van Middelaar T, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0407-0; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E417	E428		10.1016/j.wneu.2018.07.177			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300051	30071335	hybrid			2022-02-06	
J	Jain, N; Horn, CB; Andrade, EG; Punch, L				Jain, Nirbhay; Horn, Christopher B.; Andrade, Erin G.; Punch, Laurie			Combination of Girdlestone Pseudoarthroplasty and Negative Pressure Wound Therapy with Instillation and Dwell in the Treatment of Invasive Osteomyelitis of the Proximal Femur	CUREUS			English	Article						wound instillation; chronic suppurative osteomyelitis; femur; bone infection; pressure ulcers; osteomyelitis; negative pressure wound therapy; girdlestone; pressure ulcer; paraplegia	ULCERS; MANAGEMENT; INJURY; FLAP	Osteomyelitis is a progressively destructive invasive infection of the bone that can result in both localized and systemic illness. This includes an acute suppurative infection, generalized weakness, a failure to thrive, a pathological fracture, and non-healing ulcers. When chronic osteomyelitis develops, therapeutic options are limited, as antimicrobial agents cannot penetrate the necrotic bone, and repeated surgical debridement may be needed. Reestablishing full thickness coverage of the wounds and ulcers associated with osteomyelitis is challenging due to factors such as ongoing pressure injury, malnutrition, and resistant microorganisms. Classically, Girdlestone pseudoarthroplasty has been used to manage a resistant and invasive infection of the acetabular cavity and proximal femur, but it is now rarely employed because of the morbidity of removing the femoral head and leaving a wound to heal by secondary intention. Negative pressure wound therapy with instillation and dwell (NPWTi-d) offers a powerful adjunct to the management of complex infections and wound healing. In this case series of invasive osteomyelitis of the proximal femur in non-ambulatory patients, we demonstrate that the combination of the Girdlestone and negative pressure wound therapy with instillation and dwell allows for delayed closure within a week of the initial procedure, with favorable outcomes and no recurrence of osteomyelitis. The case log of a single surgeon was analyzed retrospectively over an 18-month period. The case series includes all patients who underwent the Girdlestone procedure for invasive osteomyelitis of the femoral head after failed antibiotic management, were non-ambulatory, and were greater than age 18. A total of 10 patients with 11 Girdlestone operations were found. Patients were predominantly male. The average age was 40 years. All patients were treated with NPWTi-d and then underwent a delayed primary or partial closure on an average of 4.5 days after the initial debridement. All four patients with no pre-existing pressure ulceration of the greater trochanter underwent primary closure without wound complication. Of the remaining patients with pre-operative ulcers of the greater trochanter, three were closed successfully or completely healed secondarily and four had substantial wound healing and reduction in size in the post-operative time period. All but one patient who had pre-operative ulcers of the ipsilateral ischium also had a noted improvement of ulcer dimensions in the postoperative follow-up period. Two patients developed new pressure ulcers on the contralateral side and two patients had a worsening of their pre-existing contralateral pressure ulcers more than 30 days post-operatively. No patient had a recurrence of their osteomyelitis. During the same time period, one patient refused surgical intervention and died secondary to overwhelming sepsis. Girdlestone pseudoarthroplasty is a radical therapy for refractory invasive osteomyelitis. While it has been historically associated with prolonged or failed wound healing, combining this surgery with negative pressure wound therapy with instillation and dwell allows for the successful eradication of infection. In addition, this facilitates wound healing and closure, providing a powerful alternative to the challenge of refractory invasive osteomyelitis of the hip, an ultimately life-threatening infection.	[Jain, Nirbhay; Andrade, Erin G.] Washington Univ, Surg, St Louis, MO USA; [Horn, Christopher B.] St Louis Univ, Surg, St Louis, MO 63103 USA; [Punch, Laurie] Washington Univ, Sch Med, Barnes Jewish Hosp, Surg, St Louis, MO 63110 USA		Punch, L (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, Surg, St Louis, MO 63110 USA.	ljpunch@wustl.edu		Horn, Christopher/0000-0003-0717-3601; Andrade, Erin/0000-0003-0702-4032			[Anonymous], 1943, LANCET, V1, P419; [Anonymous], 2013, THERAPY INDICATIONS; Cordero-Ampuero J, 2012, HIP INT, V22, pS36, DOI 10.5301/HIP.2012.9568; Dudareva Maria, 2017, J Bone Jt Infect, V2, P184, DOI 10.7150/jbji.21692; Eckmann C, 2016, CURR OPIN INFECT DIS, V29, P139, DOI 10.1097/QCO.0000000000000240; FUHRER MJ, 1993, ARCH PHYS MED REHAB, V74, P1172; Gabriel A., 2014, EPLASTY, V14, P328; Gelfand MS, 2006, AM J MED SCI, V332, P357, DOI 10.1097/00000441-200612000-00010; Gupta S, 2016, INT WOUND J, V13, P159, DOI 10.1111/iwj.12452; Jerome D, 2007, J WOUND OSTOMY CONT, V34, P191, DOI 10.1097/01.WON.0000264834.18732.3b; Kim PJ., 2015, WOUNDS, V27, pS2; Larson DL, 2013, ANN PLAS SURG, V71, P398, DOI 10.1097/SAP.0b013e31824e29de; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Malcolm TL, 2015, J ARTHROPLASTY, V30, P1183, DOI 10.1016/j.arth.2015.02.011; Oheim R, 2012, INT ORTHOP, V36, P927, DOI 10.1007/s00264-011-1351-2; Rennert R, 2009, OSTOMY WOUND MANAG, V55, P42; Rubayi S, 2016, ANN PLAS SURG, V77, P645, DOI 10.1097/SAP.0000000000000706; Rycerz AM, 2013, INT WOUND J, V10, P20, DOI 10.1111/iwj.12171; Schein M, 2004, WORLD J SURG, V28, P638, DOI 10.1007/s00268-004-7505-2	20	3	4	0	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV	2018	10	11							e3552	10.7759/cureus.3552			19	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HL4MI	WOS:000458695500019	30648084	Green Submitted, gold, Green Published			2022-02-06	
J	Kelshaw, P; Cortes, N; Caswell, A; Caswell, SV				Kelshaw, Patricia; Cortes, Nelson; Caswell, Amanda; Caswell, Shane, V			Isometric Cervical Muscle Strength Does Not Affect Head Impact Kinematics in High School Boys' Lacrosse	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						acceleration; neck strength; sensors	NECK STRENGTH; CONCUSSION; COLLEGIATE; PLAYERS; SPORTS; RISK; BIOMECHANICS; EXPOSURE	A growing topic in research is that of cervical strength to potentially mitigate head impact kinematics (HIK) and concussion risk. The purpose of this research was two-fold: (a) Assess the effects of isometric cervical muscle strength (ICMS) on HIK in high school boys' lacrosse, and (b) investigate the relationship between cervical anthropometrics and ICMS, to create greater feasibility to approximate ICMS. All participants wore accelerometers during the season, and had their ICMS measured. No significant differences existed among ICMS classifications and HIK measures (p > .05). Cervical circumference showed a positive, moderately strong relationship with ICMS in extension (r = .63, p = .02). Our findings do not support previous research that has identified ICMS as a modifiable risk factor for mitigating HIK.	[Kelshaw, Patricia] George Mason Univ, Manassas, VA USA; [Cortes, Nelson] George Mason Univ, Coll Educ & Human Dev, Manassas, VA 20110 USA; [Caswell, Amanda] George Mason Univ, ATEP, Manassas, VA USA; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Caswell, Shane, V] George Mason Univ, Div Hlth & Human Performance, Manassas, VA USA; [Kelshaw, Patricia; Cortes, Nelson; Caswell, Amanda; Caswell, Shane, V] George Mason Univ, SMART Lab, Manassas, VA 20110 USA		Cortes, N (corresponding author), George Mason Univ, Coll Educ & Human Dev, Manassas, VA 20110 USA.; Cortes, N (corresponding author), George Mason Univ, SMART Lab, Manassas, VA 20110 USA.	ncortes@gmu.edu	Kelshaw, Patricia/AAC-7220-2021	Cortes, Nelson/0000-0001-8762-3144			Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Caswell SV, 2016, MED SCI SPORT EXER, V48, P876, DOI 10.1249/01.mss.0000487626.86468.f8; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, NATL HIGH SCH SPORTS; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Gittleson M., IMPORTANCE TRAINING; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; NFHS, 2016, HIGH SCH ATHL PART S; Omdal R., 2013, RELATIONSHIP OF CERV; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Stone H, 2016, J ATHL TRAINING, V45, P3374; Straus L., MOMSTEAM TRUST SOURC; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	34	3	3	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	NOV	2018	23	6					234	238		10.1123/ijatt.2017-0102			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	GZ2BV	WOS:000449183100005					2022-02-06	
J	Makhov, AS; Medvedev, IN				Makhov, A. S.; Medvedev, I. N.			The Problem Of Traumatic Brain Injury In Humans	RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES			English	Article						brain brain; higher nervous activity; head injury; brain injury; skull damage	BLOOD RHEOLOGICAL FEATURES; PHYSIOLOGICAL FEATURES; NEWBORN PIGLETS; MILK NUTRITION; ARTERIAL-HYPERTENSION; FIBRINOLYTIC-ACTIVITY; PLATELET-AGGREGATION; FUNCTIONAL-ACTIVITY; PROFESSIONAL SKILL; COAGULATION SYSTEM	Traumatic brain injury is one of the most common types of damage and accounts for up to 50% of all types of injuries. Mortality from traumatic brain injury is 1% of total mortality. The frequency of traumatic brain injury and the severity of its consequences give this state great social significance. Traumatic brain injury mainly receives the most active and important socially and labor contingent of the population - people up to 50 years. It also determines large economic losses due to high mortality, frequent. disability of the victims, as well as their temporary disability. There are five categories of traumatic brain injury outcomes: death, permanent vegetative state, severe disability, moderate disability and good recovery. Assessment of the outcome of traumatic brain injury can be carried out no earlier than 6 months after the trauma suffered. Of those admitted to hospitals with severe traumatic brain injury, about 60% survive. Of this group of patients, only 7% have a good recovery after discharge from the hospital. Almost all patients with severe traumatic brain injury have various neurological disorders. However, with the concussion of the brain, the vast majority of patients recover fully. The outcome of a brain contusion and open skull damage depends on the severity of the brain damage. In most cases, survivors have residual cerebral symptoms. Timely removal of a hematoma saves a sick life and in many cases leaves no symptoms. With severe brain damage and delayed medical care, mortality can reach 40-50%.	[Makhov, A. S.; Medvedev, I. N.] Russian State Social Univ, St V Pika,4, Moscow 129226, Russia		Medvedev, IN (corresponding author), Russian State Social Univ, St V Pika,4, Moscow 129226, Russia.		Sergeevich, Makhov Alexander/AAJ-9345-2021; Medvedev, Ilya Nikolaevich/J-3214-2014	Medvedev, Ilya Nikolaevich/0000-0002-9263-2720			Alifirov AI, 2018, RES J PHARM BIOL CHE, V9, P1725; Apanasyuk LA, 2017, SCI NOTES RUSSIAN ST, V16, P143, DOI [10.17922/2071-5323-2017-16-5-143-150, DOI 10.17922/2071-5323-2017-16-5-143-150]; Bespalov DV, 2018, RES J PHARM BIOL CHE, V9, P605; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P407; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P243; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P357; Bikbulatova AA, 2018, BALI MED J, V7, P693, DOI 10.15562/bmj.v7i3.738; Bikbulatova AA, 2018, BALI MED J, V7, P706, DOI 10.15562/bmj.v7i3.947; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P413; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P1648; Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P889; Bikbulatova AA, 2018, Psikhol Nauk Obrazov, V23, P50, DOI 10.17759/pse.2018230206; Glagoleva TI, 2018, RES J PHARM BIOL CHE, V9, P29; Gusarov AV, 2018, RES J PHARM BIOL CHE, V9, P1716; Kotova OV, 2017, BALI MED J, V6, P514, DOI 10.15562/bmj.v6i3.552; Makhova AV, 2018, RES J PHARM BIOL CHE, V9, P478; Maksimov VI, 2018, RES J PHARM BIOL CHE, V9, P454; Maksimov VI, 2018, RES J PHARM BIOL CHE, V9, P2037; Makurina ON, 2018, BALI MED J, V7, P114, DOI 10.15562/bmj.v7i1.626; Maloletko N, 2017, CONT PROBLEMS SOCIAL, V3, P4; Pozdnyakova ML, 2017, CONT PROBLEMS SOCIAL, V3, P39, DOI [10.17922/2412-5466-2017-3-1-39-46, DOI 10.17922/2412-5466-2017-3-1-39-46]; Skorjatina IA, 2018, RES J PHARM BIOL CHE, V9, P977; Skoryatina IA, 2017, BALI MED J, V6, P521, DOI 10.15562/bmj.v6i3.553; Tkacheva ES, 2018, RES J PHARM BIOL CHE, V9, P1912; Tkacheva ES, 2018, RES J PHARM BIOL CHE, V9, P36; Tkacheva ES, 2018, RES J PHARM BIOL CHE, V9, P74; Vatnikov YA, 2018, BALI MED J, V7, P698, DOI 10.15562/bmj.v7i3.739; Vorobyeva NV, 2018, RES J PHARM BIOL CHE, V9, P1186; Zavalishina SY, 2018, BALI MED J, V7, P436, DOI 10.15562/bmj.v7i2.740; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P720; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P680; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P659; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P629; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P753; Zavalishina SY, 2018, RES J PHARM BIOL CHE, V9, P34; Zhalilov AV, 2018, RES J PHARM BIOL CHE, V9, P672	36	3	3	1	5	RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL & CHEMICAL SCIENCES	PRODDATUR	RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL & CHEMICAL SCIENCES, PRODDATUR, 00000, INDIA	0975-8585			RES J PHARM BIOL CHE	Res. J. Pharm. Biol. Chem. Sci.	NOV-DEC	2018	9	6					425	434					10	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	GZ7BW	WOS:000449630700052					2022-02-06	
J	Mooney, SR; Stafford, J; Seats, E				Mooney, Scott R.; Stafford, Jane; Seats, Elizabeth			Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; EVALUATION CONTEXT; MILITARY; MILD; VETERANS; SOLDIERS; SCORES; SCALES	Introduction: Military Service Members (SMs) with post-concussive symptoms are commonly referred for further evaluation and possible treatment to Department of Defense Traumatic Brain Injury Clinics where neuropsychological screening/evaluations are being conducted. Understudied to date, the base rates of noncredible task engagement/performance validity testing (PVT) during cognitive screening/evaluations in military settings appears to be high. The current study objectives are to: (1) examine the base rates of noncredible PVTs of SMs undergoing routine clinical or Medical Evaluation Board (MEB) related workups using multiple objective performance-based indicators; (2) determine whether involvement in MEB is associated with PVT or symptom exaggeration/symptom validity testing (SVT) results; (3) elucidate which psychiatric symptoms are associated with noncredible PVT performances; and (4) determine whether MEB participation moderates the relationship between psychological symptom exaggeration and whether or not SM goes on to demonstrate PVTs failures - or vice versa. Materials and Methods: Retrospective study of 71 consecutive military concussion cases drawn from a DoD TBI Clinic neuropsychology clinic database. As part of neuropsychological evaluations, patients completed several objective performance-based PVTs and SVT. Results: Mean (SD) age of SMs was 36.0 (9.5), ranging from 19-59, and 93% of the sample was male. The self-identified ethnicity resulted in the following percentages: 62% Non-Hispanic White, 22.5% African American, and 15.5% Hispanic or Latino. The majority of the sample (97%) was Active Duty Army and 51% were involved in the MEB at the time of evaluation. About one-third (35.9%) of routine clinical patients demonstrated failure on one or more PVT indicators (12.8% failed 2) while PVT failure rates amongst MEB patients ranged from 15.6% to 37.5% (i.e., failed 2 or 1 PVTs, respectively). Base rates of failures on one or more PVT did not differ between routine clinical versus MEB patients (p = 0.94). MEB involvement was not associated with increased emotional symptom response bias as compared to routine clinical patients. PVT failures were positively correlated with somatization, anxiety, depressive symptoms, suspicious and hostility, atypical perceptions/alienation/subjective cognitive difficulties, borderline personality traits/features, and penchant for aggression in addition to symptom over-endorsement/exaggeration. No differences between routine clinical and MEB patients across other SVT indicators were found. MEB status did not moderate the relationship between any of the SVTs. Conclusion: Study results are broadly consistent with the prior published studies that documented low to moderately high base rates of noncredible task engagement during neuropsychological evaluations in military and veteran settings. Results are in contrast to prior studies that have suggested involvement in MEB is associated with increased likelihood of poor PVT performances. This is the first to show that MEB involvement did not enhance/strengthen the association between PVT performances and evidence of SVTs. Consistent with prior studies, these results do highlight that the same SMs who fail PVTs also tend to be the ones who go on to endorse a myriad of psychiatric symptoms and proclivities. Implications of variable or poor task engagement during routine clinical and MEB neuropsychological evaluation in military settings on treatment and disposition planning cannot be overstated.	[Mooney, Scott R.] TBI Clin Neurosci & Rehabil Ctr, Dwight D Eisenhower Army Med Ctr, 300 E Hosp Rd, Ft Gordon, GA 30905 USA; [Stafford, Jane; Seats, Elizabeth] Univ South Carolina, 471 Univ Pkwy, Aiken, SC 29801 USA		Mooney, SR (corresponding author), TBI Clin Neurosci & Rehabil Ctr, Dwight D Eisenhower Army Med Ctr, 300 E Hosp Rd, Ft Gordon, GA 30905 USA.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; ANDERSON DL, 1984, PERSPECT BIOL MED, V28, P156; [Anonymous], 2009, VA DOD CLIN PRACTICE; Armed Forces Health Surveillance Center, 2013, MSMR, V20, P20; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bass C, 2014, LANCET, V383, P1422, DOI 10.1016/S0140-6736(13)62186-8; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Committee on the Assessment of the Readjustment Needs of Military Personnel V.T. Families Board on the Health of Select Populations Institute of Medicine, 2013, RET HOM IR AFGH ASS; Connor H, 2006, J ROY SOC MED, V99, P444, DOI 10.1258/jrsm.99.9.444; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense Manpower Research, 2013, DEM ACT DUT US MIL; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Guriel Jennifer, 2003, Clin Psychol Rev, V23, P881; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iancu Iulian, 2003, Med Law, V22, P373; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kokcu AT, 2017, J ROY ARMY MED CORPS, V163, P119, DOI 10.1136/jramc-2015-000591; Lande RG, 2013, MIL MED, V178, P50, DOI 10.7205/MILMED-D-12-00138; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Management of Major Depressive Disorder Working Group, 2016, VA DOD CLIN PRACT GU; Marx BP, 2008, AM J PUBLIC HEALTH, V98, P773, DOI 10.2105/AJPH.2007.133223; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McDermott BE, 2012, PSYCHIAT CLIN N AM, V35, P855, DOI 10.1016/j.psc.2012.08.006; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; RESNICK PJ, 1993, ISRAEL J PSYCHIAT, V30, P93; ROGERS R, 1992, J CLIN PSYCHOL, V48, P643; Schnellbacher S, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0740-z; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Slavin-Mulford J, 2012, J PERS ASSESS, V94, P593, DOI 10.1080/00223891.2012.681817; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sumanti M., 2006, CLIN NEUROPSYCHOL, V22, P1080; Tekin L, 2013, J EMERG MED, V45, P714, DOI 10.1016/j.jemermed.2013.01.045; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 1981, WAIS R WECHSLER ADUL; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	57	3	3	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E546	E554		10.1093/milmed/usy038			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4ZP	WOS:000451813600029	29590406	Bronze			2022-02-06	
J	Parrington, L; Fino, NF; Fino, PC; Murchison, CF; Chesnutt, JC; King, LA				Parrington, L.; Fino, N. F.; Fino, P. C.; Murchison, C. F.; Chesnutt, J. C.; King, L. A.			Inflection points in longitudinal models: Tracking recovery and return to play following concussion	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						inertial sensors; linear mixed model; mTBI; return to sport; wearable	DUAL-TASK GAIT; TRAUMATIC BRAIN-INJURY; POSTURAL STABILITY; BALANCE CONTROL; FREQUENCY	The return to play (RTP) process may occur during longitudinal studies tracking recovery after concussion. This factor, which is often omitted within statistical designs, could affect the fit and overall interpretation of the statistical model. This article demonstrates the difference in results and interpretation between 2 linear mixed-model designs: (1) a between-group longitudinal (GROUP) analysis and (2) a between-group longitudinal model that used an inflection point to account for changes around the time of RTP (RTP analysis). These analyses were conducted on instrumented balance data collected on 23 concussed athletes and 25 controls over 8 weeks following concussion. Total sway area and the range of mediolateral acceleration were used as outcome measures. No significant findings were found in the GROUP design for either outcome measure. In contrast, the RTP analysis revealed significant effects of time (P=.007) and RTP change (P=.007), and group*time (P=.028) and group*RTP change (P=.022) interactions for total sway area, and effects of group (P=.011), time (P=.010), and RTP change (P=.014), and group*time (P=.013) and group*RTP change interactions (P=.013) for range of mediolateral acceleration. For both outcomes, the RTP model fit the data significantly better on comparison of likelihood ratios (P <= 027). These results suggest that allowing for an inflection point in the statistical design may assist understanding of what happens around clinically meaningful time points. The choice of statistical model had a considerable effect on the interpretation of findings, and provokes discussion around the best method for analyzing longitudinal datasets when important clinical time points like RTP exist.	[Parrington, L.; Fino, P. C.; Murchison, C. F.; Chesnutt, J. C.; King, L. A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Fino, N. F.] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA; [Parrington, L.; Fino, P. C.; King, L. A.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [Chesnutt, J. C.] Oregon Hlth & Sci Univ, Sch Med, Dept Orthopaed & Rehabil, Portland, OR 97201 USA		Parrington, L (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	parringt@ohsu.edu		Fino, Peter/0000-0002-8621-3706; Parrington, Lucy/0000-0001-8507-9974	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R21HD080398]	This project was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (Award Number R21HD080398). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217	17	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	NOV	2018	28	11					2436	2442		10.1111/sms.13239			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GW5SL	WOS:000446997500020	29885270				2022-02-06	
J	Singichetti, B; Leonard, JC; Janezic, AR; Li, HM; Yi, HG; Yang, JZ				Singichetti, Bhavna; Leonard, Julie C.; Janezic, Alyssa R.; Li, Hongmei; Yi, Honggang; Yang, Jingzhen			Trends in Pediatric Emergency Department Utilization for Mild Traumatic Brain Injury Before and After Legislation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						emergency department; health policy; pediatric trauma; sports injury; traumatic brain injury	SPORTS; CONCUSSION; IMPACT; LAW	Objective: To examine the effect of state youth traumatic brain injury (TBI) legislation on pediatric emergency department (ED) utilization for sports and recreation-related mild TBIs (mTBIs). Participants: ED visits by children ages 5 to 18 years between 2006 and 2014 in the Pediatric Health Information System database (N = 452 900). Design: Retrospective analysis. Main Measures: Rates of ED visits, and injury comparison groups (mTBI, moderate to severe TBI, minor head injury, and long bone fracture). Results: Of the 452 900 ED visits, 123 192 (27.2%) were for mTBI, along with visits for moderate to severe TBIs (n = 5190), minor head injuries (n = 54 566), and long bone fractures (n = 269 952). ED visits for mTBIs were more common among males (67.5%), children ages 10-14 years (42.1%), and the privately insured (50.6%). The proportion of mTBI ED visits increased significantly, particularly from 5 years prelegislation to immediately postlegislation (57.8 to 94.8 mTBI visits per 10 000 ED visits). A similar trend was observed for minor head injuries; however, no significant changes were observed for moderate to severe TBIs and long bone fractures. Conclusion: Pediatric ED utilization trends for the injury comparison groups differed from each other, and from pre- and post-TBI legislation. Further research assessing effects of TBI legislation on healthcare utilization is warranted.	[Singichetti, Bhavna; Leonard, Julie C.; Janezic, Alyssa R.; Li, Hongmei; Yi, Honggang; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RB3, Columbus, OH 43205 USA; [Leonard, Julie C.; Yang, Jingzhen] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Li, Hongmei] Soochow Univ, Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Suzhou, Peoples R China; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr,RB3, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org		Singichetti, Bhavna/0000-0002-2188-3979; Leonard, Julie/0000-0003-3670-1944			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Centers for Disease Control and Prevention, FACTS PHYS MILD TRAU; Checchia PA, 2005, J THORAC CARDIOV SUR, V129, P754, DOI 10.1016/j.jtcvs.2004.07.056; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Conner KA, 2010, J SAFETY RES, V41, P17, DOI 10.1016/j.jsr.2009.10.005; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Ferdinand AO, 2015, AM J PUBLIC HEALTH, V105, P859, DOI 10.2105/AJPH.2014.302537; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodman DM, 2011, PEDIATRICS, V128, P5, DOI 10.1542/peds.2010-2037; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; LawAtlas, POL SURV PORT; Ludwick A, 2009, ACAD EMERG MED, V16, P411, DOI 10.1111/j.1553-2712.2009.00395.x; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; Shah SS, 2008, NEUROSURGERY, V62, P1095, DOI 10.1227/01.neu.0000325871.60129.23; Trojian Thomas, 2015, Inj Epidemiol, V2, P2	20	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E30	E37		10.1097/HTR.0000000000000397			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600004	30395043				2022-02-06	
J	Tang, ZJ; Huang, QL; Zhang, JS; Yang, RJ; Wei, WJ; Liu, HY				Tang, Zhiji; Huang, Qianliang; Zhang, Jinshi; Yang, Ruijin; Wei, Wenjin; Liu, Hongyi			Fourteen-Day Mortality in Pediatric Patients with Traumatic Brain Injury After Early Decompressive Craniectomy: A Single-Center Retrospective Study	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Mortality; Pediatrics; Risk factors; Traumatic brain injury	INTRACRANIAL HYPERTENSION; CENTER EXPERIENCE; SEVERITY SCORE; CHILDREN; PREDICTORS; AGE; RECOVERY; MODERATE; OUTCOMES; TRIAL	OBJECTIVE: The purpose of this study was to analyze the risk factors for 14-day mortality in pediatric patients undergoing early decompressive craniectomy (DC) after traumatic brain injury (TBI). METHODS: This retrospective analysis included all pediatric patients (<= 16 years of age) undergoing DC within 12 hours of TBI between August 2011 and July 2017 at the authors' institute. Demographic information, clinical characteristics, surgical information, and laboratory parameters were retrieved from medical records. Risk factors for 14-day mortality were analyzed using multivariate logistic regression models. First, potentially relevant variables were compared between those who died within 14 days versus those who did not. Variables with P < 0.10 were entered into the final multivariate regression analysis. RESULTS: A total of 36 patients (23 boys and 13 girls; median age, 7 years) were included in the analysis. Fall (n = 19, 52.8%) was the leading cause of injury. The 14-day mortality was 38.9% (14/36). At the time of admission, the median Glasgow Score Scale (GCS) was 6 (IQR 4-8), and the mean Injury Severity Score (ISS) (+/- standard deviation) was 29.03 +/- 8.54. Preoperative hypoxia, defined as oxyhemoglobin arterial saturation <90% or apnea >20 seconds, was observed in 6 patients (16.7%). Coagulopathy was present in 14 patients (38.9%). Multivariate logistic regression analysis suggested an association between 14-day mortality and younger age (odds ratio [OR] = 0.708, 95% confidence interval [CI]: 0.513-0.978; P = 0.036) and higher ISS (OR = 1.399; 95% CI: 1.023-1.914; P = 0.035). CONCLUSIONS: In children undergoing early DC after TBI, risk factors for 14-day mortality include younger age and higher ISS.	[Tang, Zhiji; Liu, Hongyi] Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Tang, Zhiji; Huang, Qianliang; Zhang, Jinshi; Yang, Ruijin; Wei, Wenjin] Ganzhou Peoples Hosp, Dept Neurosurg, Ganzhou, Peoples R China		Liu, HY (corresponding author), Nanjing Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	hyliu518@njmu.edu.cn					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Andruszkow H, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-16; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; da Costa LGV, 2017, CLINICS, V72, P461, DOI 10.6061/clinics/2017(08)02; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Desgranges FP, 2014, CHILD NERV SYST, V30, P1393, DOI 10.1007/s00381-014-2417-4; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Hristova M, 2016, NEURAL PLAST, V2016; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Khan SA, 2014, CHILD NERV SYST, V30, P277, DOI 10.1007/s00381-013-2225-2; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Li YM, 2017, BRAIN INJURY, V31, P1094, DOI 10.1080/02699052.2017.1298004; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; Lin TK, 2016, WORLD NEUROSURG, V93, P133, DOI 10.1016/j.wneu.2016.06.005; Mattei TA, 2012, CHILD NERV SYST, V28, P1129, DOI 10.1007/s00381-012-1824-7; Mhanna MJ, 2015, J NEUROSURG PEDIAT, V16, P1; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	43	3	3	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E389	E394		10.1016/j.wneu.2018.07.173			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300047	30071325				2022-02-06	
J	Wieckowska, A; Gajewska-Wozniak, O; Glowacka, A; Ji, BJ; Grycz, K; Czarkowska-Bauch, J; Skup, M				Wieckowska, Angelika; Gajewska-Wozniak, Olga; Glowacka, Anna; Ji, Benjun; Grycz, Kamil; Czarkowska-Bauch, Julita; Skup, Malgorzata			Spinalization and locomotor training differentially affect muscarinic acetylcholine receptor type 2 abutting on -motoneurons innervating the ankle extensor and flexor muscles	JOURNAL OF NEUROCHEMISTRY			English	Article						C-bouton; complete spinal cord transection; extrasynaptic region; muscarinic receptor M2; postsynaptic membrane; soleus and tibialis anterior -motoneuron	RAT SPINAL-CORD; RECURRENT AXON COLLATERALS; TRAUMATIC BRAIN-INJURY; ALPHA-MOTONEURONS; REGIONAL-DISTRIBUTION; TIBIALIS ANTERIOR; NMDA RECEPTORS; MESSENGER-RNA; IN-VIVO; M2	Complete thoracic spinal cord transection (SCT) impairs excitatory cholinergic inputs to ankle extensor (soleus; Sol) but not to flexor (tibialis anterior; TA) -motoneurons (MNs) modifiable by locomotor training applied post-transection. The purpose of this study was to investigate whether Sol and TA MNs adapt to changes in cholinergic environment by differential regulation of their muscarinic receptors M2 (M2R). We examined Chrm2 (M2R gene) transcript level, high-affinity 3-quinuclidinyl benzilate-H-3 ([H-3]QNB) ligand binding, distribution and density of M2R immunolabeling in lumbar (L) segments in intact and SCT rats, with or without inclusion of 5-week treadmill locomotor training. We show that at the second week after SCT the levels of Chrm2 transcript are reduced in the L3-6 segments, with [H-3]QNB binding decreased selectively in the L5-6 segments, where ankle extensor MNs are predominantly located. At 5weeks after SCT, [H-3]QNB binding differences between the L3-4 and L5-6 segments are maintained, accompanied by higher density of M2R immunolabeling in the plasma membrane and cytoplasm of TA than Sol MNs and by enriched synaptic versus extrasynaptic M2R pools (52% TA vs. 25% Sol MNs). Training normalized M2R in TA MNs, improved locomotion, and reduced frequency of clonic episodes. Our findings indicate higher sensitivity of TA than Sol MNs to cholinergic signaling after SCT, which might shorten flexor twitches duration and contribute to generation of clonic movements. Synaptic enrichment in M2R density may reflect a compensatory mechanism activated in TA and Sol MNs to different extent in response to reduced strength of cholinergic signaling to each MN pool. Open Science: This manuscript was awarded with the Open Materials Badge. For more information see:	[Wieckowska, Angelika; Gajewska-Wozniak, Olga; Glowacka, Anna; Ji, Benjun; Grycz, Kamil; Czarkowska-Bauch, Julita; Skup, Malgorzata] Nencki Inst Expt Biol, Warsaw, Poland		Skup, M (corresponding author), Nencki Inst Expt Biol, Grp Restorat Neurobiol, 3 Pasteur St, PL-02093 Warsaw, Poland.	mskup@nencki.gov.pl	Czarkowska-Bauch, Julita/AAB-6872-2020; Glowacka, Anna/AAC-7236-2020	Glowacka, Anna/0000-0001-9223-5226; Skup, Malgorzata/0000-0002-2605-0124; Wieckowska-Gacek, Angelika/0000-0002-2255-0148; Gajewska-Wozniak, Olga/0000-0003-3529-5788; Grycz, Kamil/0000-0002-1821-2453; Ji, Benjun/0000-0002-9501-5496	Polish National Science Center [NN 401 324739, NCN 2013/09/B/NZ4/03306, 665735-Bio4Med-H2020-MSCA-COFUND-2014]	We express our gratitude to Michal Mlodkowski (Wikom Ltd, Poland) for his invaluable help and advice in the implementation of image analysis, and to Artur Wolny and Natalia Nowak for their assistance in acquisition of confocal images. The authors are grateful to Dr Pawel Boguszewski for expertise and help in statistical analysis and Ms Grazyna Rybka for secretarial assistance. We express our gratitude to Dr Alex Wlodawer (NIH/NCR Institute, USA) for his critical reading of the manuscript and English language corrections. The study was supported by the Polish National Science Center grants NN 401 324739, NCN 2013/09/B/NZ4/03306 (to M.S.), 665735-Bio4Med-H2020-MSCA-COFUND-2014 grant and statutory grant for the Nencki Institute. The authors have no conflict of interest to declare.	Agnati LF, 2010, PROG NEUROBIOL, V90, P157, DOI 10.1016/j.pneurobio.2009.10.004; Alvarez FJ, 1999, J PHYSIOL-LONDON, V515, P787, DOI 10.1111/j.1469-7793.1999.787ab.x; Antri M, 2002, EUR J NEUROSCI, V16, P467, DOI 10.1046/j.1460-9568.2002.02088.x; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; BAKELS R, 1993, J NEUROPHYSIOL, V70, P1300, DOI 10.1152/jn.1993.70.4.1300; BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; Bernard V, 1998, J NEUROSCI, V18, P10207; Bernard V, 2003, MOL CELL NEUROSCI, V23, P121, DOI 10.1016/S1044-7431(03)00034-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casanovas A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40155; Chan JP, 2013, J NEUROSCI, V33, P14146, DOI 10.1523/JNEUROSCI.1359-13.2013; CHARLTON G, 1981, BRAIN RES, V218, P372; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chmykhova NM, 2005, BRAIN RES BULL, V66, P381, DOI 10.1016/j.brainresbull.2004.08.008; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; CONRADI S, 1979, J COMP NEUROL, V184, P741, DOI 10.1002/cne.901840407; CONRADI S, 1969, ACTA PHYSIOL SCAND, P49; Csaba Z, 2013, J COMP NEUROL, V521, P2008, DOI 10.1002/cne.23268; CULLHEIM S, 1978, J PHYSIOL-LONDON, V281, P285, DOI 10.1113/jphysiol.1978.sp012422; CULLHEIM S, 1977, BRAIN RES, V132, P1, DOI 10.1016/0006-8993(77)90702-8; Deardorff AS, 2013, J PHYSIOL-LONDON, V591, P875, DOI 10.1113/jphysiol.2012.240879; Decossas M, 2003, J COMP NEUROL, V462, P302, DOI 10.1002/cne.10734; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Gajewska-Wozniak O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161614; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Grossman EJ, 1998, MUSCLE NERVE, V21, P375, DOI 10.1002/(SICI)1097-4598(199803)21:3<375::AID-MUS12>3.0.CO;2-Z; Heine S, 2011, J NEUROSCI, V31, P11184, DOI 10.1523/JNEUROSCI.6159-10.2011; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Hensbergen E, 1997, EXP BRAIN RES, V115, P325, DOI 10.1007/PL00005701; Hoglund AU, 1997, J PHARMACOL EXP THER, V281, P470; Huang A, 2000, J NEUROPHYSIOL, V83, P3537, DOI 10.1152/jn.2000.83.6.3537; Ichiyama RM, 2006, J COMP NEUROL, V499, P306, DOI 10.1002/cne.21110; Jordan LM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00132; KAYAALP SO, 1980, BRAIN RES, V196, P429; Kimura R, 2014, J NEUROSCI, V34, P10122, DOI 10.1523/JNEUROSCI.0863-14.2014; KOBAYASHI RM, 1978, BRAIN RES, V154, P13, DOI 10.1016/0006-8993(78)91047-8; Lape R, 2000, J NEUROPHYSIOL, V83, P2987, DOI 10.1152/jn.2000.83.5.2987; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; McCall GE, 2009, MUSCLE NERVE, V40, P411, DOI 10.1002/mus.21361; Milan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135525; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Muennich EAL, 2004, J PHYSIOL-LONDON, V554, P673, DOI 10.1113/jphysiol.2003.056192; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; PERRY EK, 1989, J CHEM NEUROANAT, V2, P189; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; VILARO MT, 1992, NEUROSCIENCE, V47, P367, DOI 10.1016/0306-4522(92)90253-X; Vizi ES, 2010, BRIT J PHARMACOL, V160, P785, DOI 10.1111/j.1476-5381.2009.00624.x; Welton J, 1999, BRAIN RES, V817, P215, DOI 10.1016/S0006-8993(98)01208-6; Wetts R, 2001, J COMP NEUROL, V435, P171, DOI 10.1002/cne.1200; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; YAMAMURA HI, 1974, P NATL ACAD SCI USA, V71, P1725, DOI 10.1073/pnas.71.5.1725; Yung KKL, 1997, NEUROSCI LETT, V229, P81, DOI 10.1016/S0304-3940(97)00426-6; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	57	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2018	147	3					361	379		10.1111/jnc.14567			19	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HA2YJ	WOS:000450112100005	30102779	Bronze			2022-02-06	
J	Yamaki, T; Onodera, S; Uchida, T; Ozaki, Y; Yokoyama, K; Henmi, H; Kamezawa, M; Hayakawa, M; Itou, D; Oka, N; Odaki, M; Iwadate, Y; Kobayashi, S				Yamaki, Tomohiro; Onodera, Shinji; Uchida, Tomoki; Ozaki, Yoshihiro; Yokoyama, Kazuaki; Henmi, Haruko; Kamezawa, Mizuho; Hayakawa, Miyoko; Itou, Daisuke; Oka, Nobuo; Odaki, Masaru; Iwadate, Yasuo; Kobayashi, Shigeki			Semi-quantitative Assessment Using [F-18]FDG Tracer in Patients with Severe Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 141; Glucose metabolism; brain injury; FDG-PET; [F-18]FDG; TBI; PET/CT; traumatic brain injury	BEHAVIORAL-DISORDERS; CONSCIOUSNESS; RECOVERY; SCALE; COMA; CARE	Patients with severe traumatic brain injury (sTBI) have difficulty knowing whether they are accurately expressing their thoughts and emotions because of disorders of consciousness, disrupted higher brain function, and verbal disturbances. As a consequence of an insufficient ability to communicate, objective evaluations are needed from family members, medical staff, and caregivers. One such evaluation is the assessment of functioning brain areas. Recently, multimodal brain imaging has been used to explore the function of damaged brain areas. [F-18]-fluorodeoxyglucose positron emission tomography-computed tomography ([F-18]FDG-PET/CT) is a successful tool for examining brain function. However, the assessment of brain glucose metabolism based on [F-18]FDG-PET/CT is not standardized and depends on several varying parameters, as well as the patient's condition. Here, we describe a series of semiquantitative assessment protocols for a region-of-interest (ROI) image analysis using self-produced [F-18]FDG tracers in patients with sTBI. The protocol focuses on screening the participants, preparing the [F-18]FDG tracer in the hot lab, scheduling the acquisition of [F-18]FDG-PET/CT brain images, and measuring glucose metabolism using the ROI analysis from a targeted brain area.	[Yamaki, Tomohiro; Itou, Daisuke; Oka, Nobuo; Odaki, Masaru; Kobayashi, Shigeki] Natl Agcy Automot Safety & Victims Aid, Div Neurosurg, Rehabil Ctr Traumat Apall Chiba, Tokyo, Japan; [Yamaki, Tomohiro; Onodera, Shinji; Uchida, Tomoki; Ozaki, Yoshihiro; Henmi, Haruko; Kamezawa, Mizuho; Hayakawa, Miyoko; Oka, Nobuo] Natl Agcy Automot Safety & Victims Aid, Div PET imaging, Rehabil Ctr Traumat Apall Chiba, Tokyo, Japan; [Yokoyama, Kazuaki] Tokyo Nucl Serv Co Ltd, Tokyo, Japan; [Iwadate, Yasuo] Chiba Univ, Dept Neurol Surg, Grad Sch Med, Chiba, Japan		Yamaki, T (corresponding author), Natl Agcy Automot Safety & Victims Aid, Div Neurosurg, Rehabil Ctr Traumat Apall Chiba, Tokyo, Japan.; Yamaki, T (corresponding author), Natl Agcy Automot Safety & Victims Aid, Div PET imaging, Rehabil Ctr Traumat Apall Chiba, Tokyo, Japan.	t-yamaki@chiba-ryougo.jp		Yamaki, Tomohiro/0000-0002-3528-3229			Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Fischer DB, 2015, NEUROLOGY, V85, P543, DOI 10.1212/WNL.0000000000001748; Fukukita H, 2014, ANN NUCL MED, V28, P693, DOI 10.1007/s12149-014-0849-2; GE Healthcare, 2003, TRACERLABMX OP MAN V; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Klingshirn H, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3153-3; Klingshirn H, 2015, J REHABIL MED, V47, P577, DOI 10.2340/16501977-1983; Koon-Pong Wong, 2016, Brain Informatics, V3, P1, DOI 10.1007/s40708-015-0026-y; Liu S., 2015, BRAIN INFORMAT, V2, P167, DOI 10.1007/s40708-015-0019-x; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Mortensen KN, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6120925; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schwaiger M, 2011, J NUCL MED, V52, p36S, DOI 10.2967/jnumed.110.085738; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; TEASDALE G, 1974, LANCET, V2, P81; Valadka A, 2000, TRAUMA, P377; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; Wagatsuma K, 2017, PHYS MEDICA, V42, P203, DOI 10.1016/j.ejmp.2017.09.124; Yamaki T, 2018, BIOPSYCHOSOC MED, V12, DOI 10.1186/s13030-018-0125-0	25	3	3	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	NOV	2018		141							e58641	10.3791/58641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI5CF	WOS:000456469400091	30474632				2022-02-06	
J	Ubukata, S; Oishi, N; Sugihara, G; Aso, T; Fukuyama, H; Murai, T; Ueda, K				Ubukata, Shiho; Oishi, Naoya; Sugihara, Genichi; Aso, Toshihiko; Fukuyama, Hidenao; Murai, Toshiya; Ueda, Keita			Transcallosal Fiber Disruption and its Relationship with Corresponding Gray Matter Alteration in Patients with Diffuse Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						CC; connectome; GM volume; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; LONGITUDINAL CHANGES; TENSOR; ATROPHY; MICROSTRUCTURE; DISTORTION; INTEGRITY; IMPACT	Diffuse axonal injury (DAI) is characterized by diffuse white matter (WM) disruption caused by shearing forces acting on the brain. Cortical atrophy can be accompanied by WM disruption, which is assumed to reflect the loss of neuron cell bodies in gray matter (GM) regions adjacent to disrupted WM. It remains unclear whether WM disruption leads to regional GM alteration in DAI. The aim of the present study was to assess WM disruption and corresponding GM alterations in patients with DAI using a connectome-based approach. Twenty-four patients and 24 healthy controls underwent magnetic resonance imaging with diffusion tensor imaging (DTI). Deterministic fiber tracking was conducted to investigate structural connectivity between the corpus callosum (CC) and each pre-defined regional cortical area. We calculated 85x85 connectivity matrices for fractional anisotropy (FA). Group comparisons were conducted to identify abnormal connectivity in patients. Further, the regional cortical volume of each connectivity matrix was compared between patients and controls. Finally, correlation analyses between the matrices and regional cortical volumes were performed within the patient group. Connectome analyses revealed that, compared with controls, patients exhibited a FA reduction in connectivity via CC to 32 cortical regions including the frontal, parietal, and occipital cortices. Among these regions, GM volume was reduced in 19 of 32 regions. There were no significant correlations between WM disruption in which abnormal connectivity was identified and the corresponding GM alterations. These results suggest that GM pathology is, at least in part, independent of the corresponding WM damage in DAI.	[Ubukata, Shiho; Sugihara, Genichi; Aso, Toshihiko; Murai, Toshiya; Ueda, Keita] Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Ubukata, Shiho; Oishi, Naoya] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan; [Aso, Toshihiko] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan; [Fukuyama, Hidenao] Kyoto Univ, Res & Educ Unit Leaders Integrated Med Syst, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Fukuyama, Hidenao] Beijing Inst Technol, Beijing, Peoples R China		Ubukata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ubukata@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018; Fukuyama, Hidenao/AAI-7118-2020	Aso, Toshihiko/0000-0003-4814-089X; 	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [150502-02, 15K19722, 17K10327]; General Insurance Association of Japan	The authors thank all participants for their contribution to this project. This work was supported by an Industrial Disease Clinical Research Grant (150502-02), a Health Labour Sciences Research Grant, a Grant-in-Aid for Young Scientists B (15K19722) and C (17K10327) from the Japan Society for the Promotion of Science, and a research grant from the General Insurance Association of Japan.	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kurki T, 2014, NEURORADIOLOGY, V56, P833, DOI 10.1007/s00234-014-1410-7; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Namiki J, 2007, NIPPON RINSYO KYUKYU, V10, P20; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ubukata S, 2016, J NEUROPSYCH CLIN N, V28, P97, DOI 10.1176/appi.neuropsych.15070159; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang R, 2007, P INT SOC MAG RESON, P15; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	48	3	3	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1106	1114		10.1089/neu.2018.5823		OCT 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000447718900001	30234424				2022-02-06	
J	Babbage, DR; Zupan, B; Neumann, D; Willer, B				Babbage, Duncan R.; Zupan, Barbra; Neumann, Dawn; Willer, Barry			Sex differences in response to emotion recognition training after traumatic brain injury	BRAIN INJURY			English	Article						Emotion recognition; sex; affect; traumatic brain injury; RCT; treatment	FACIAL AFFECT RECOGNITION; PERCEPTION DEFICITS; NONVERBAL-COMMUNICATION; VOCAL AFFECT; ABILITY; DIFFICULTIES; METAANALYSIS; INDIVIDUALS; IMPAIRMENTS; GENDER	Objective: To examine sex differences in the effectiveness of a Stories intervention for teaching affect recognition in people with a traumatic brain injury (TBI). Setting: Post-acute rehabilitation facilities. Participants: 203 participants (53 women and 150 men) with moderate to severe TBI were screened. 71 were eligible and randomized to one of three treatment conditions: two affect recognition conditions and an active control (cognition). This paper examines sex differences between the Stories intervention (n = 23, 5 women and 18 men) and the cognitive treatment control (n = 24, 8 women and 16 men). Design: Randomized controlled trial with immediate, 3- and 6-month follow-up post-tests. Interventions were 9 hours of computer-based training with a therapist. Measures: Facial Affect Recognition (DANVA2-AF); Emotional Inference from Stories Test (EIST). Results: A significant treatment effect was observed for the Stories intervention for women, who demonstrated and maintained improved facial affect recognition. In contrast, males in our sample did not benefit from the Stories intervention. Conclusion: This positive finding for the Stories intervention for females contrasts with our conclusions in a previous paper, where an analysis collapsed across sex did not reveal an overall effectiveness of the Stories intervention. This intervention warrants further research and development.	[Babbage, Duncan R.] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Babbage, Duncan R.] Auckland Univ Technol, Ctr eHealth, Auckland, New Zealand; [Zupan, Barbra] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Dept Exercise & Hlth Sci, Rockhampton, Qld, Australia; [Neumann, Dawn] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Neumann, Dawn] Indiana Univ Sch Med, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Babbage, DR (corresponding author), Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand.	duncan.babbage@aut.ac.nz		Babbage, Duncan/0000-0002-9259-9246; Willer, Barry/0000-0002-9586-8448; Barbra, Zupan/0000-0002-4603-333X	National Institute on Disability and Rehabilitation Research [H133G080043]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133G080043).	Babbage DR, 2014, CRIT REV PHYS REHABI, V26, P87, DOI [10. 1615/CritRevPhysRehabilMed. 2014010533, DOI 10.1615/CRITREVPHYSREHABILMED.2014010533]; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Biszak AM, 2014, BRAIN INJURY, V28, P97, DOI 10.3109/02699052.2013.856475; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Filkowski MM, 2017, NEUROIMAGE, V147, P925, DOI 10.1016/j.neuroimage.2016.12.016; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Hazard Munro B, 2004, STAT METHODS HLTH CA; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Lawrence K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00761; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McIntire K. A., 1999, N AM J PSYCHOL, V1, P261; MEHRABIAN A, 1981, SILENT MESSAGES IMPL; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; NOWICKI S, 1993, J SOC PSYCHOL, V133, P749, DOI 10.1080/00224545.1993.9713934; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Pavlova MA, 2017, J NEUROSCI RES, V95, P235, DOI 10.1002/jnr.23871; Planalp S, 1996, COGNITION EMOTION, V10, P137, DOI 10.1080/026999396380303; Planalp Sally, 1998, HDB COMMUNICATION EM, P29; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Sullivan S, 2015, J GERONTOL B-PSYCHOL, V72, P441; Williamson J, 2015, INT J TELEREHABILITA, V7, P13, DOI 10.5195/IJT.2015.6167; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B, 2017, BRAIN IMPAIR, V18, P36, DOI 10.1017/BrImp.2016.22; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	45	3	3	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1492	1499		10.1080/02699052.2018.1497811			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800007	30015503	Green Submitted			2022-02-06	
J	Cripps, A; Livingston, S; Jiang, Y; Mattacola, C; Kitzman, P; McKeon, P; Dressler, E; Quintana, C				Cripps, Andrea; Livingston, Scott; Jiang, Yang; Mattacola, Carl; Kitzman, Patrick; McKeon, Patrick; Dressler, Emily; Quintana, Carolina			Visual perturbation impacts upright postural stability in athletes with an acute concussion	BRAIN INJURY			English	Article						Sports-related concussion; mild traumatic brain injury; vision; balance	TRAUMATIC BRAIN-INJURY; SENSORY ORGANIZATION TEST; SPORT-RELATED CONCUSSION; TASK TESTING PARADIGM; MILD HEAD-INJURY; BALANCE PERFORMANCE; FOOTBALL PLAYERS; SMOOTH-PURSUIT; COGNITIVE TASK; CLINICAL-TEST	Objective: The impact that visual perturbation has on upright postural stability in an athlete with a concussion has not been established. The present study aimed to characterize the influence that visual perturbation stimuli have on upright balance among athletes with acute concussions. Design: A 2X2X2 repeated measure designed was used. Method: The present study examined the influence visual perturbation has on individuals suffering from an acute concussion. Fourteen participants (7 with a concussion and 7 matched controls) underwent various balance assessments with and without visual perturbation. Results: Overall, athletes with acute concussions demonstrated impairments in balance 24-48 hours following a concussion. However, when assessed using a visual perturbation task, athletes with acute concussions demonstrated improved balance, while control subjects did not show any significant changes during the same visual perturbation task. Conclusion: An athlete's ability to disregard visual perturbation stimuli is imperative for successful participation in sports. Due to the observed alterations in balance when given a visual perturbation task, it is suggested that athletes with acute concussions place more attention on the balance task and may disregard other less meaningful tasks.	[Cripps, Andrea] Bowling Green State Univ, Sch Human Movement Sport & Leisure Studies, Bowling Green, OH 43403 USA; [Livingston, Scott] Def Vet Brain Injury, Def Ctr Excellence Psychol Hlth, Silver Spring, MD USA; [Livingston, Scott] Def Vet Brain Injury, Traumat Brain Injury Ctr, Silver Spring, MD USA; [Jiang, Yang] Univ Kentucky, Behav Sci, Lexington, KY USA; [Mattacola, Carl; Kitzman, Patrick; Quintana, Carolina] Univ Kentucky, Dept Rehabil Sci, Lexington, KY USA; [McKeon, Patrick] Ithaca Coll, Sch Hlth Sci & Human Performance, Ithaca, NY 14850 USA; [Dressler, Emily] Wake Forest Univ, Dept Biostat Sci, Winston Salem, NC 27109 USA		Cripps, A (corresponding author), Bowling Green State Univ, Athlet Training Educ, Eppler South 209, Bowling Green, OH 43403 USA.	acripps@bgsu.edu					Almeida J, 2010, PSYCHOL SCI, V21, P772, DOI 10.1177/0956797610371343; [Anonymous], 2009, NEUROCOM INTERNATION; Anzai A, 2010, CURR OPIN NEUROBIOL, V20, P367, DOI 10.1016/j.conb.2010.04.006; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; COHEN H, 1993, PHYS THER, V73, P353, DOI 10.1093/ptj/73.6.353; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Giza CC, 2001, J ATHL TRAINING, V36, P228; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Guerin P, 2008, EXP BRAIN RES, V189, P393, DOI 10.1007/s00221-008-1435-4; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Holladay JT, 1997, J REFRACT SURG, V13, P388; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Kuczynski M, 2011, J SPORT SCI, V29, P539, DOI 10.1080/02640414.2010.544046; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Loughran S, 2005, CLIN OTOLARYNGOL, V30, P255, DOI 10.1111/j.1365-2273.2005.00988.x; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; NASHNER LM, 1982, TRENDS NEUROSCI, V5, P358, DOI 10.1016/0166-2236(82)90204-1; Negahdaripour S, 1998, IEEE T PATTERN ANAL, V20, P961, DOI 10.1109/34.713362; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pagnacco Guido, 2008, Biomed Sci Instrum, V44, P41; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Raiva Viyada, 2004, Journal of the Medical Association of Thailand, V87, pS112; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Weirich G, 2010, J GERIATR PHYS THER, V33, P110, DOI 10.1097/JPT.0b013e3181eda25b; Whitney SL, 2004, ARCH PHYS MED REHAB, V85, P439, DOI 10.1016/j.apmr.2003.05.005	49	3	3	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1566	1575		10.1080/02699052.2018.1497812			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800016	30047794				2022-02-06	
J	Durish, CL; Yeates, KO; Brooks, BL				Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.			Convergent and divergent validity of the Connor-Davidson Resilience Scale in children with concussion and orthopaedic injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; paediatric; psychometrics; validity; hardiness	TRAUMATIC BRAIN-INJURY; CD-RISC; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; EMERGENCY-DEPARTMENT; PROTECTIVE FACTORS; ADOLESCENTS; SYMPTOMS; PERSONALITY; PREDICTORS	Objective. Psychological resilience is an important predictor of outcome in concussion; however, there is no published evidence of psychometric support for use of a measure of psychological resilience in children with concussion. This study examined construct validity of the Connor-Davidson Resilience Scale (CD-RISC) in a paediatric concussion and orthopaedic injury sample. Methods. Seventy-five children with a history of concussion or orthopaedic injury were recruited from a children's hospital. Total sample and within-group correlations between the CD-RISC (25- and 10-item versions) and measures presumed to be related or unrelated to the construct of psychological resilience were analysed. Results. In the total sample, both versions of the CD-RISC were negatively correlated with self-reported depressive symptoms and general behaviour problems. The 10-item version was also negatively correlated with parent-reported general behaviour problems and self-reported anxiety, and was positively correlated with self-reported quality of life. The injury groups did not exhibit significantly different correlations. Conclusions. The construct validity of the CD-RISC is satisfactory when used with children with concussion. The 10-item version may provide a more efficient measure of resiliency with better construct validity in this population.	[Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Durish, Christianne Laliberte; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada		Durish, CL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	christianne.lalibert@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	Shaikh Family Research Award	This work was supported by the Shaikh Family Research Award.	[Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], 2008, ABBREVIATED INJURY S; Babcock L, 2013, JAMA PEDIAT, V156, P161; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bitsika V., 2010, GERMAN J PSYCHIAT, V13, P9; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; do Rosario Pinheiro M, 2013, EUR J SOC BEHAV SCI, V2; Donnon T, 2007, PSYCHOL REP, V100, P963, DOI 10.2466/PR0.100.3.963-978; Faul M, 2010, TRAUMATIC BRAIN INJU; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Fu C, 2014, J AFFECT DISORDERS, V155, P149, DOI 10.1016/j.jad.2013.10.041; Goins RT, 2013, RES AGING, V35, P123, DOI 10.1177/0164027511431989; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hjemdal O, 2006, MEAS EVAL COUNS DEV, V39, P84, DOI 10.1080/07481756.2006.11909791; Huang M. T., 2010, THESIS; IBM Corp, 2016, IBM SPSS STAT WIND V; Ito M.N.S., 2009, 25 ANN M INT SOC TRA; Jorgensen Ivar Elvik, 2008, Int J Adolesc Med Health, V20, P23; Khetani AM, 2018, PEDIATR EMERG CARE, V34, P501, DOI 10.1097/PEC.0000000000000959; Khoshouei MS, 2009, INT J TEST, V9, P60, DOI 10.1080/15305050902733471; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Koupernik, 1974, CHILD HIS FAMILY CHI, P529; Lamond AJ, 2008, J PSYCHIATR RES, V43, P148, DOI 10.1016/j.jpsychires.2008.03.007; Lee I. A., 2013, CALCULATION TEST DIF; Lewis TL, 2008, SIGMIS CPR 2008: PROCEEDINGS OF THE 2008 ACM SIGMIS CPR CONFERENCE, P5; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lyons J.A., 1991, J TRAUMA STRESS, V4, P93, DOI [DOI 10.1007/BF00976011, 10.1002/jts.2490040108, DOI 10.1002/JTS.2490040108]; Masten A.S., 1994, ED RESILIENCE INNER, P3; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Munro Y, 2000, CHILD ADOLESCE UNPUB; Petros N, 2013, PSYCHONEUROENDOCRINO, V38, P2099, DOI 10.1016/j.psyneuen.2013.03.022; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Prince-Embury S., 2007, RESILIENCE CHILDREN, P19, DOI [10.1007/978-1-4614-4939-3_3, DOI 10.1007/978-1-4614-4939-3_3]; Prince-Embury S, 2008, CAN J SCH PSYCHOL, V23, P41, DOI 10.1177/0829573508316592; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Rezaei SA, 2015, BULL ENVIRON PHARMAC, V4, P127; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Sun J, 2007, HEALTH EDUC, V107, P575, DOI 10.1108/09654280710827957; TEASDALE G, 1974, LANCET, V2, P81; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wagnild G M, 1993, J Nurs Meas, V1, P165; WERNER EE, 1984, YOUNG CHILDREN, V40, P68; WERNER EE, 1989, SCI AM, V260, P106, DOI 10.1038/scientificamerican0489-106; Werner EE, 1997, ACTA PAEDIATR, V86, P103; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	64	3	4	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1525	1533		10.1080/02699052.2018.1502471			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800011	30047782				2022-02-06	
J	Gil-Jardine, C; Al Joboory, S; Saint Jammes, JT; Durand, G; Ribereau-Gayon, R; Galinski, M; Salmi, LR; Revel, P; Regis, CA; Valdenaire, G; Poulet, E; Tazarourte, K; Lagarde, E				Gil-Jardine, Cedric; Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Durand, Guillaume; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Regis, Cyril Alexandre; Valdenaire, Guillaume; Poulet, Emmanuel; Tazarourte, Karim; Lagarde, Emmanuel			Prevention of post-concussion-like symptoms in patients presenting at the emergency room, early single eye movement desensitization, and reprocessing intervention versus usual care: study protocol for a two-center randomized controlled trial	TRIALS			English	Article						Stress; Emergency department; Eye movement desensitization and reprocessing; Post-concussion-like symptoms; Post-traumatic stress disorder; Clinical trial	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; LOW-BACK-PAIN; POSTCONCUSSION SYNDROME; HEAD-INJURY; EXTINCTION; EMDR; PREDICTORS; ASSOCIATION	Background: Recent data suggest that 10-20% of injury patients will suffer for several months after the event from diverse symptoms, generally referred to as post-concussion-like symptoms (PCLS), which will lead to a decline in quality of life. A preliminary randomized control trial suggested that this condition may be induced by the stress experienced during the event or emergency room (ER) stay and can be prevented in up to 75% of patients with a single, early, short eye movement desensitization and reprocessing (EMDR) psychotherapeutic session delivered in the ER. The protocol of the SOFTER 3 study was designed to compare the impact on 3-month PCLS of early EMDR intervention and usual care in patients presenting at the ER. Secondary outcomes included 3-month post-traumatic stress disorder, 12-month PCLS, self-reported stress at the ER, self-assessed recovery expectation at discharge and 3 months, and self-reported chronic pain at discharge and 3 months. Methods: This is a two-group, open-label, multicenter, comparative, randomized controlled trial with 3- and 12-month phone follow-up for reports of persisting symptoms (PCLS and post-traumatic stress disorder). Those eligible for inclusion were adults (>= 18 years old) presenting at the ER departments of the University Hospital of Bordeaux and University Hospital of Lyon, assessed as being at high risk of PCLS using a three-item scoring rule. The intervention groups were a (1) EMDR Recent Traumatic Episode Protocol intervention performed by a trained psychologist during ER stay or (2) usual care. The number of patients to be enrolled in each group was 223 to evidence a 15% decrease in PCLS prevalence in the EMDR group. Discussion: In 2012, the year of the last national survey in France, 10.6 million people attended the ER, some of whom did so several times since 18 million visits were recorded in the same year. The SOFTER 3 study therefore addresses a major public health challenge.	[Gil-Jardine, Cedric; Galinski, Michel; Revel, Philippe; Valdenaire, Guillaume] Univ Hosp Bordeaux, Pole Emergency Med, Bordeaux, France; [Gil-Jardine, Cedric; Ribereau-Gayon, Regis; Galinski, Michel; Salmi, Louis-Rachid; Revel, Philippe; Valdenaire, Guillaume; Lagarde, Emmanuel] INSERM, U1219, Bordeaux Populat Hlth Res Ctr, ISPED,Injury Epidemiol Transport Occupat Team, Bordeaux, France; [Al Joboory, Samantha; Saint Jammes, Juliane Tortes; Regis, Cyril Alexandre] Hosp Ctr Cadillac, CASPERTT, Lormont, France; [Durand, Guillaume; Tazarourte, Karim] Hosp Civils Lyon, Univ Hosp Edouard Herriot, Dept Emergency Med, Lyon, France; [Durand, Guillaume; Poulet, Emmanuel] Claude Bernard Univ, Univ Hosp, Lyon, France; [Ribereau-Gayon, Regis] Univ Hosp Bordeaux, Pole Med, Bordeaux, France; [Salmi, Louis-Rachid] Univ Hosp Bordeaux, Pole Publ Hlth, Bordeaux, France; [Poulet, Emmanuel] Hosp Civils Lyon, Univ Hosp Edouard Herriot, Dept Psychiat, Lyon, France; [Tazarourte, Karim] Claude Bernard Univ, Hesper Univ Hosp, EA 7425, Lyon, France; [Gil-Jardine, Cedric] Pellegrin Hosp, Univ Hosp Bordeaux, Emergency Dept, Pl Amelie Raba Leon, F-33000 Bordeaux, France; [Gil-Jardine, Cedric] CHU Bordeaux, Bordeaux Univ Hosp, 12 Rue Dubernat, F-33400 Talence, France		Gil-Jardine, C (corresponding author), Univ Hosp Bordeaux, Pole Emergency Med, Bordeaux, France.; Gil-Jardine, C (corresponding author), INSERM, U1219, Bordeaux Populat Hlth Res Ctr, ISPED,Injury Epidemiol Transport Occupat Team, Bordeaux, France.	cedric.gil-jardine@chu-bordeaux.fr	Lagarde, Emmanuel/F-7132-2013; Salmi, Louis-Rachid/T-1982-2019; Poulet, Emmanuel/P-6646-2019; Regis, RIBEREAU-GAYON/U-5423-2019; VALDENAIRE, GUILLAUME/U-5426-2019; Gil-Jardine, Cedric/T-5552-2019	tazarourte, karim/0000-0002-3376-1258; Poulet, Emmanuel/0000-0001-5709-9038; Gil-Jardine, Cedric/0000-0001-5329-6405	Institut National de la Sante et de la Recherche Medicale (INSERM)Institut National de la Sante et de la Recherche Medicale (Inserm); University Hospital of Bordeaux; Hospital of Cadillac; University Hospital of Lyon	The SOFTER 3 trial is fully funded by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University Hospitals of Bordeaux and Lyon, and the Hospital of Cadillac.	Absolom K, 2007, BREAST, V16, P590, DOI 10.1016/j.breast.2007.05.001; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Baldwin DS, 2014, J PSYCHOPHARMACOL, V28, P403, DOI 10.1177/0269881114525674; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Birur B, 2017, COMMUNITY MENT HLT J, V53, P183, DOI 10.1007/s10597-016-0047-x; Bisson JI, 2004, BRIT J PSYCHIAT, V184, P63, DOI 10.1192/bjp.184.1.63; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cahill S, 2010, EFFECTIVE TREATMENTS, P139; Cain CK, 2005, LEARN MEMORY, V12, P277, DOI 10.1101/lm.88805; Carrasco V, 2003, ETUDES RESULTATS, V8; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gil-Jardine C, 2018, J PSYCHIATR RES, V103, P229, DOI 10.1016/j.jpsychires.2018.05.024; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hallegraeff JM, 2012, J PHYSIOTHER, V58, P165, DOI 10.1016/S1836-9553(12)70107-8; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kutz I, 2008, J EMDR PRACT RES, V2, P190, DOI 10.1891/1933-3196.2.3.190; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Luber M, 2013, IMPLEMENTING EMDR EA; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Myskiw JC, 2014, BRAIN RES BULL, V105, P61, DOI 10.1016/j.brainresbull.2014.04.006; Odeen M, 2013, J OCCUP REHABIL, V23, P209, DOI 10.1007/s10926-013-9451-z; Price M, 2014, J CONSULT CLIN PSYCH, V82, P336, DOI 10.1037/a0035537; Quinn G., 2014, EMDR CLIN PRACT S JO; Quinn G, 2013, CAMB DISABIL LAW POL, P1; Rose SC, 2002, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD000560; Rothbaum BO, 2014, J CLIN PSYCHIAT, V75, P1380, DOI 10.4088/JCP.13m08715; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Seidler GH, 2006, PSYCHOL MED, V36, P1515, DOI 10.1017/S0033291706007963; Shapiro E, 2013, IMPLEMENT EMDR EARLY; Shapiro E, 2012, EUR REV APPL PSYCHOL, V62, P241, DOI 10.1016/j.erap.2012.09.003; Shapiro E, 2008, J EMDR PRACT RES, V2, P79, DOI 10.1891/1933-3196.2.2.79; Shapiro F., 2001, EYE MOVEMENT DESENSI; Sheese ALN, 2014, PROG NEUROL SURG, V28, P149, DOI 10.1159/000358775; Sijbrandij M, 2015, LANCET PSYCHIAT, V2, P413, DOI 10.1016/S2215-0366(14)00121-7; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tarquinio C, 2016, ISSUES MENT HEALTH N, V37, P787, DOI 10.1080/01612840.2016.1224282; Vuagnat A., 2013, URGENCES HOSP QUEN S	55	3	3	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 12	2018	19								555	10.1186/s13063-018-2902-2			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	HM4BH	WOS:000459418100003	30314512	Green Published, gold			2022-02-06	
J	Wang, XH; Liu, Q; Shao, ZT				Wang, Xiao-Hong; Liu, Qiang; Shao, Ze-Tao			Deletion of JDP2 improves neurological outcomes of traumatic brain injury (TBI) in mice: Inactivation of Caspase-3	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Traumatic brain injury (TBI); JDP2; Inflammation; Apoptosis; Caspase-3	JUN DIMERIZATION PROTEIN-2; MICROGLIA; REPRESSOR; PROTECTS; DIFFERENTIATION; OPPORTUNITIES; INFLAMMATION; HYPERTROPHY; ASTROCYTES; ACTIVATION	Traumatic brain injury (TBI) is a major cause of death and disability, also resulting in long-term serious neurological impairment in survivors. However, the pathogenesis of TBI has not been fully understood. Jun dimerization protein 2 (JDP2) is a member of the AP-1 family of transcription factors, containing a basic region-leucine zipper motif. JDP2 plays essential roles in various cellular processes, including differentiation, apoptosis, senescence and aging. In the study, we attempted to explore the effects of JDP2 on TBI progression both in vivo and in vitro. The wild type (WT) and JDP2 knockout (KO) mice were employed in our study and were subjected to TBI. The results showed that JDP2-deficient mice exhibited improved cognitive functions in TBI mice. The inflammatory cytokines, glial amount and apoptosis, as well as the protein of cleaved Caspase-3 were significantly increased after TBI in WT mice, and all these up-regulation were significantly mitigated by JDP2 knockout in mice. We also found that TBI induced JDP2 expression in hippocampus of mice. Lipopolysaccharide (LPS) also stimulated JDP2 expression levels in astrocytes isolated from WT mice, indicating the critical role of JDP2 in TBI. Suppressing Caspase-3 activation could reduce LPS-induced inflammation in astrocytes. Consistent with the results in vivo, LPS-induced inflammatory response and apoptosis were reversed by JDP2 deficiency in cells. Notably, we found that over-expressing JDP2 could further promoted inflammation, apoptosis and Caspase-3 activation induced by LPS. Collectively, JDP2 knockout effectively attenuate TBI in vivo and in vitro through blocking Caspase-3 activation, providing a potential therapeutic target for TBI or even other neurological disorders. (C) 2018 Published by Elsevier Inc.	[Wang, Xiao-Hong] Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan 250022, Shandong, Peoples R China; [Liu, Qiang] Yanan Univ, Affiliated Hosp, Dept Neurol, Yanan 716000, Peoples R China; [Shao, Ze-Tao] Peoples Hosp Changle Cty, Nerve Involvement Dept, Weifang 262400, Peoples R China		Shao, ZT (corresponding author), Peoples Hosp Changle Cty, Nerve Involvement Dept, Weifang 262400, Peoples R China.	shaozetaocl@qq.com					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heger J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26052-w; Hill C, 2013, CARDIOVASC RES, V99, P121, DOI 10.1093/cvr/cvt094; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jonak CR, 2017, J BIOL CHEM, V292, P2646, DOI 10.1074/jbc.M116.771808; Kalfon R, 2017, INT J CARDIOL, V249, P357, DOI 10.1016/j.ijcard.2017.08.074; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pihlaja R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0305-9; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Tan HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04008-w; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; van der Kolk BA, 2005, PSYCHIAT ANN, V35, P401, DOI 10.3928/00485713-20050501-06; Wang CM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020304; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yanagisawa D, 2008, BIOL PHARM BULL, V31, P1121, DOI 10.1248/bpb.31.1121; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	34	3	3	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 12	2018	504	4					805	811		10.1016/j.bbrc.2018.08.055			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	GX4EU	WOS:000447681200029	30217453				2022-02-06	
J	Breitling, B; Brunkhorst, R; Verhoff, M; Foerch, C				Breitling, Benedict; Brunkhorst, Robert; Verhoff, Marcel; Foerch, Christian			Post-mortem serum concentrations of GFAP correlate with agony time but do not indicate a primary cerebral cause of death	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; FORENSIC MEDICINE; TRAUMATIC BRAIN; ACUTE STROKE; EXPRESSION; ISCHEMIA; RELEASE; STRESS	Background and purpose The astroglial protein GFAP is a blood biomarker indicative of intracerebral hemorrhage in patients with acute stroke. Due to its brain specificity and the necessity of brain damage for its detectability in blood, we hypothesized that GFAP could be an interesting marker in cases with primary cerebral cause of death, e.g., traumatic brain injury. Methods All corpses scheduled for an autopsy in the Frankfurt Department of Forensic medicine within a 15-month period were included in the study. Cases with a known history of brain disease in the 3 months before death were excluded. During autopsy, blood was collected and GFAP serum levels were determined using a commercially available ELISA. The autopsy protocols were reviewed for the presence of a primary cerebral or a primary non-cerebral cause of death. Agony time was also determined. Results A total of 129 autopsy cases were included. GFAP concentrations did not differ between cerebral (median 0.96 mu g/l, IQR 5.03) and non-cerebral causes of death (1.21 mu g/l, 3.58). GFAP levels were found to be unaffected by hemolysis or post-mortem interval. GFAP levels were found to be increased in cases with prolonged agony times (median 1.76 mu g/l [IQR 4.70]) compared to short (0.58 mu g/l [0.58]; p<0.001) and ultra-short agony times (0.21 mu g/l [0.12]; p = 0.002). Conclusion Post-mortem GFAP serum concentrations correlate with agony time and might therefore be useful for the evaluation of the severity of brain damage in prolonged death. Elevated GFAP serum levels do not indicate a primary cerebral cause of death.	[Breitling, Benedict; Brunkhorst, Robert; Foerch, Christian] Goethe Univ, Dept Neurol, Frankfurt, Germany; [Verhoff, Marcel] Goethe Univ, Dept Forens Med, Frankfurt, Germany		Foerch, C (corresponding author), Goethe Univ, Dept Neurol, Frankfurt, Germany.	foerch@em.uni-frankfurt.de					Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Chandana R, 2009, INDIAN J MED RES, V129, P189; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Harish G, 2011, BIOPRESERV BIOBANK, V9, P379, DOI 10.1089/bio.2011.0033; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Helwig K, 2017, NEUROCRIT CARE, V27, P68, DOI 10.1007/s12028-016-0371-6; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Katsanos AH, 2017, STROKE, V48, P2586, DOI 10.1161/STROKEAHA.117.018409; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; Magerkurth O, 1996, THESIS; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Missler U, 1999, CLIN CHEM, V45, P138; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Piette MHA, 2011, INT J LEGAL MED, V125, P333, DOI 10.1007/s00414-010-0434-8; Scendoni R, 2016, INT J LEGAL MED, V130, P1639, DOI 10.1007/s00414-016-1402-8; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Strasser S, 2007, FORENSIC SCI INT, V170, P8, DOI 10.1016/j.forsciint.2006.08.023; Wilke N, 2007, INT J LEGAL MED, V121, P385, DOI 10.1007/s00414-006-0132-8; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2018	13	10							e0205323	10.1371/journal.pone.0205323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW4VA	WOS:000446921100079	30304049	Green Submitted, Green Published, gold			2022-02-06	
J	Weng, WJ; Yang, C; Huang, XJ; Zhang, YM; Liu, JF; Yao, JM; Zhang, ZH; Wu, XS; Mei, T; Zhang, CD; Jia, J; Shi, XF; Mao, Q; Feng, JF; Gao, GY; Jiang, JY				Weng, Wei-ji; Yang, Chun; Huang, Xian-jian; Zhang, Yong-ming; Liu, Jin-fang; Yao, Jie-min; Zhang, Zi-heng; Wu, Xue-song; Mei, Tao; Zhang, Chuan-dong; Jia, Jun; Shi, Xiao-feng; Mao, Qing; Feng, Jun-feng; Gao, Guo-yi; Jiang, Ji-yao			Effects of Brain Temperature on the Outcome of Patients with Traumatic Brain Injury: A Prospective Observational Study	JOURNAL OF NEUROTRAUMA			English	Article						body temperature; brain temperature; multi-center study; prospective studies; traumatic brain injury; treatment outcome	INTRACEREBRAL TEMPERATURE; INTRACRANIAL-PRESSURE; RECTAL TEMPERATURES; BODY-TEMPERATURE; HYPOTHERMIA; MANAGEMENT; MORTALITY; FEVER; CARE	A prospective observational study collected temperature data from 51 patients in 11 neurosurgical centers and follow-up outcome information at 6 months in 49 patients. Brain temperature (T-br) was measured directly by an intraventricular temperature sensor. Axillary temperature (T-ax) and rectal temperature (T-re) were measured by electric thermometers. T-br was 0.4 to 1.5 degrees C higher than body temperature. T-re correlated well with the T-br (coefficient: 0.7378; p<0.05). Among all patients, Glasgow Coma Scale (GCS) scores on admission were significantly lower in the patients with post-operatively extreme peak temperature (T-peak, < 37 degrees C or >39 degrees C in first 24h) and major temperature variation (T-vari > 1 degrees C in first 12h; p<0.05, p<0.01, respectively). Among the patients with no temperature intervention, the extreme T-peak group showed a lower Glasgow Outcome Scale-Extended (GOS-E) score at 6 months (p<0.05) with lower GCS scores on admission (p<0.01), compared with the moderate T-peak group. Remarkably, the major T-vari group showed significantly lower GOS-E scores (p<0.05) with the same GCS scores as the minor T-vari group. Thus, T-re is the better candidate to estimate T-br. Spontaneously extreme T-peak in TBI represents both more serious injury on admission and worse prognosis, and T-vari might be used as a novel prognostic parameter in TBI. Brain temperature is therefore one of the critical indicators evaluating injury severity, prognostication, and monitoring in the management of TBI. This prospective observational study has been registered in ClinicalTrials.gov (https://clinicaltrials.gov), and the registration number is NCT03068143.	[Weng, Wei-ji; Yang, Chun; Mao, Qing; Feng, Jun-feng; Gao, Guo-yi; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Dept Neurosurg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China; [Weng, Wei-ji] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai, Peoples R China; [Yang, Chun; Mao, Qing; Feng, Jun-feng; Gao, Guo-yi; Jiang, Ji-yao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Huang, Xian-jian] Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China; [Zhang, Yong-ming] 105 Hosp Peoples Liberat Army, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Liu, Jin-fang] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Yao, Jie-min] Guangxi Med Univ, Dept Neurosurg, Nanning Peoples Hosp 2, Guangxi, Peoples R China; [Zhang, Zi-heng] Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Coll Med, Shantou, Guangdong, Peoples R China; [Wu, Xue-song] Guangxi Med Univ, Dept Neurosurg, Yulin Peoples Hosp 1, Guangxi, Peoples R China; [Mei, Tao] Changde First Peoples Hosp, Dept Neurosurg, Changde, Hunan, Peoples R China; [Zhang, Chuan-dong] Hechi Peoples Hosp, Dept Neurosurg, Guangxi, Peoples R China; [Jia, Jun; Shi, Xiao-feng] Shenzhen Longgang Dist Cent Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China.; Feng, JF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Head Trauma, Dept Neurosurg, Renji Hosp,Sch Med, 160 Pujian Rd,NICU & 9th Floor,7th Bldg, Shanghai 200127, Peoples R China.	fengjfmail@163.com; gao3@sina.com	mei, tao/AAG-9455-2019	Weng, Weiji/0000-0003-3341-7665	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371406, 81771317, 81671198, 81471856, 81772058]; Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support [20152212]; Shanghai Shenkang Clinical Research Plan of SHDC [16CR3011A]; SMC-Star Award Young Scholars (B)	Supported by grants from the National Natural Science Foundation of China (No. 31371406, Jun-feng Feng; No. 81771317, Jun-feng Feng; No. 81671198, Guo-yi Gao; No. 81471856, Ji-yao Jiang; No. 81772058, Ji-yao Jiang), Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support (No. 20152212, Guo-yi Gao), Shanghai Shenkang Clinical Research Plan of SHDC (No. 16CR3011A, Guo-yi Gao) and SMC-Star Award for Young Scholars (B) (Jun-feng Feng).	AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Camboni Daniele, 2008, Interact Cardiovasc Thorac Surg, V7, P922, DOI 10.1510/icvts.2008.181974; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2004, ANAESTHESIA, V59, P192, DOI 10.1111/j.1365-2044.2003.03638.x; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Fischer M, 2011, NEUROSURGERY, V68, P867, DOI 10.1227/NEU.0b013e318208f5fb; Fountas KN, 2003, J NEUROSURG ANESTH, V15, P87, DOI 10.1097/00008506-200304000-00004; Hazard Munro B, 2004, STAT METHODS HLTH CA; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hirashima Y, 1998, J NEUROL NEUROSUR PS, V64, P792, DOI 10.1136/jnnp.64.6.792; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kirk D, 2009, CRIT CARE, V13, DOI 10.1186/cc7898; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; MELLERGARD P, 1992, J NEUROSURG ANESTH, V4, P85, DOI 10.1097/00008506-199204000-00003; Nakagawa K, 2011, NEUROCRIT CARE, V15, P101, DOI 10.1007/s12028-010-9446-y; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sumida K, 2016, NMR BIOMED, V29, P890, DOI 10.1002/nbm.3542; Tokutomi T, 2007, NEUROSURGERY, V61, P256, DOI [10.1227/01.NEU.00000038737.13185.C4, 10.1227/01.neu.0000279221.38257.1a]	33	3	6	3	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1168	1174		10.1089/neu.2018.5881		OCT 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000447010900001	30215286				2022-02-06	
J	Ware, AL; Biekman, B; Hachey, R; MacLeod, M; Bird, W; Pathak, S; Clarke, E; Borrasso, A; Puccio, AM; Glavin, K; Pomiecko, K; Moretti, P; Beers, SR; Levin, HS; Schneider, W; Okonkwo, DO; Wilde, EA				Ware, Ashley L.; Biekman, Brian; Hachey, Rebecca; MacLeod, Marianne; Bird, William; Pathak, Sudhir; Clarke, Emily; Borrasso, Allison; Puccio, Ava M.; Glavin, Kelly; Pomiecko, Kristopher; Moretti, Paolo; Beers, Sue R.; Levin, Harvey S.; Schneider, Walter; Okonkwo, David O.; Wilde, Elisabeth A.			A Preliminary High-Definition Fiber Tracking Study of the Executive Control Network in Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast-induced TBI; executive function; high-definition fiber tracking; mild TBI; veterans	WHITE-MATTER ABNORMALITIES; TENSOR IMAGING DETECTS; PREFRONTAL CORTEX; BASAL-GANGLIA; RESPONSE-INHIBITION; WORKING-MEMORY; POSTTRAUMATIC-STRESS; FUNCTIONAL NETWORKS; MILITARY PERSONNEL; ANTERIOR CINGULATE	Blast-induced traumatic brain injury (bTBI) is common in veterans of the Iraq- and Afghanistan-era conflicts. However, the typical subtlety of neural alterations and absence of definitive biomarkers impede clinical detection on conventional imaging. This preliminary study examined the structure and functional correlates of executive control network (ECN) white matter in veterans to investigate the clinical utility of using high-definition fiber tracking (HDFT) to detect chronic bTBI. Demographically similar male veterans (N=38) with and without bTBI (ages 24 to 50 years) completed standardized neuropsychological testing and magnetic resonance imaging. Quantitative HDFT metrics of subcortical-dorsolateral prefrontal cortex (DLPFC) tracts were derived. Moderate-to-large group effects were observed on HDFT metrics. Relative to comparisons, bTBI demonstrated elevated quantitative anisotropy (QA) and reduced right hemisphere volume of all examined tracts, and reduced fiber count and increased generalized fractional anisotropy in the right DLPFC-putamen tract and DLPFC-thalamus, respectively. The GroupxAge interaction effect on DLPFC-caudate tract volume was large; age negatively related to volume in the bTBI group, but not comparison group. Groups performed similarly on the response inhibition measure. Performance (reaction time and commission errors) robustly correlated with HDFT tract metrics (QA and tract volume) in the comparison group, but not bTBI group. Results support anomalous density and integrity of ECN connectivity, particularly of the right DLPFC-putamen pathway, in bTBI. Results also support exacerbated aging in veterans with bTBI. Similar ECN function despite anomalous microstructure could reflect functional compensation in bTBI, although alternate interpretations are explored.	[Ware, Ashley L.; Biekman, Brian] Univ Houston, Dept Psychol, 4811 Calhoun Rd,3rd Floor, Houston, TX 77204 USA; [Ware, Ashley L.; Biekman, Brian] Univ Houston, Texas Inst Measurement Evaluat & Stat, 4811 Calhoun Rd,3rd Floor, Houston, TX 77204 USA; [Ware, Ashley L.; Biekman, Brian; MacLeod, Marianne; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Moretti, Paolo; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Hachey, Rebecca; Bird, William; Pathak, Sudhir; Clarke, Emily; Glavin, Kelly; Pomiecko, Kristopher; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA USA; [Borrasso, Allison; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Moretti, Paolo; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Neurol Serv, Houston, TX USA; [Moretti, Paolo; Wilde, Elisabeth A.] Univ Utah, Sch Hlth Sci, Dept Neurol, Salt Lake City, UT USA; [Moretti, Paolo] Univ Utah, Sch Hlth Sci, Dept Human & Mol Genet, Salt Lake City, UT USA; [Moretti, Paolo; Wilde, Elisabeth A.] George E Wahlen VA Med Ctr, Neurol Serv, Salt Lake City, UT USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA		Ware, AL (corresponding author), Univ Houston, Dept Psychol, 4811 Calhoun Rd,3rd Floor, Houston, TX 77204 USA.; Ware, AL (corresponding author), Univ Houston, Texas Inst Measurement Evaluat & Stat, 4811 Calhoun Rd,3rd Floor, Houston, TX 77204 USA.	aware2004@gmail.com			Department of Defense (DoD)United States Department of Defense [W81XWH-12-2-0140]	Conflicts of interest: none to report. Funding for this project was granted through the Department of Defense (DoD) congressionally directed medical research programs award W81XWH-12-2-0140. We thank all of the veterans who participated in this study for giving us their time and effort. We additionally thank Dr. Veneetha Cherian, Dr. Mary Newsome, Dr. Wright Williams, and Laura Hollowell for their efforts during participant recruitment; Lacey Berry and Krista Runge at the Core for Advanced MR Imaging (CAMRI) at Baylor College of Medicine for their MRI data collection assistance; Tracy Abildskov at Bringham Young University for his assistance with the figures; and blast consultant, Dr. Keith Clutter for his methodological guidance.	Abhinav K, 2014, BBA-MOL BASIS DIS, V1842, P2286, DOI 10.1016/j.bbadis.2014.08.002; Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chevrier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130992; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., P567; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Connolly TJM, 2010, SAFETY SCI, V48, P1387, DOI 10.1016/j.ssci.2010.05.013; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kansagara D., 2013, COMPLICATIONS MILD T; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Lopez-Larson M., 2013, FRONT PSYCHIATRY, P4; Lopez-Paniagua D, 2011, J COGNITIVE NEUROSCI, V23, P3068, DOI 10.1162/jocn_a_00008; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Maksimovskiy AL, 2013, J ALCOHOL DRUG DEPEN, V2, P144; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mcnab F, 2008, NEUROPSYCHOLOGIA, V46, P2668, DOI 10.1016/j.neuropsychologia.2008.04.023; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Presson N, 2015, BRAIN IMAGING BEHAV, V9, P484, DOI 10.1007/s11682-015-9386-4; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rubia K, 2010, HUM BRAIN MAPP, V31, P287, DOI 10.1002/hbm.20864; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Sebastian A, 2013, NEUROIMAGE, V64, P601, DOI 10.1016/j.neuroimage.2012.09.020; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sivak S, 2016, BRATISL MED J, V117, P22, DOI 10.4149/BLL_2016_005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; Verstynen TD, 2012, J NEUROPHYSIOL, V107, P2984, DOI 10.1152/jn.00995.2011; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yeh FC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005203; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zheng D, 2008, J COGNITIVE NEUROSCI, V20, P1434, DOI 10.1162/jocn.2008.20100; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	110	3	3	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					686	701		10.1089/neu.2018.5725		OCT 2018	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446463900001	30070176				2022-02-06	
J	Folyovich, A; Varga, V; Varallyay, G; Kozak, L; Bakos, M; Scheidl, E; Beres-Molnar, KA; Kajdacsi, Z; Bereczki, D				Folyovich, Andras; Varga, Viktoria; Varallyay, Gyorgy; Kozak, Lajos; Bakos, Maria; Scheidl, Erika; Beres-Molnar, Katalin Anna; Kajdacsi, Zita; Bereczki, Daniel			A case report of isolated distal upper extremity weakness due to cerebral metastasis involving the hand knob area	BMC CANCER			English	Article						Isolated distal upper extremity weakness; Hand knob; Brain metastasis	CORTICAL INFARCTION; LOCALIZATION; PALSY; PARESIS; STROKE	Background: Unilateral weakness of an upper extremity is most frequently caused by traumatic nerve injury or compression neuropathy. In rare cases, lesion of the central nervous system may result in syndromes suggesting peripheral nerve damage by the initial examination. Pseudoperipheral hand palsy is the best known of these, most frequently caused by a small lesion in the contralateral motor cortex of the brain. The 'hand knob' area refers to a circumscribed region in the precentral gyrus of the posterior frontal lobe, the lesion of which leads to isolated weakness of the upper extremity mimicking peripheral nerve damage. The etiology of this rare syndrome is almost exclusively related to an embolic infarction. Case presentation: We present the case of a 70-year-old male patient with isolated left sided upper extremity weakness and clumsiness without sensory disturbance suggesting a lesion of the radial nerve. Nerve conduction studies had normal results excluding peripheral nerve damage. Neuroimaging (cranial CT and MRI) detected 3 space occupying lesions, one of them in the right precentral gyrus. An irregularly shaped tumor was found by CT in the left lung with multiple associated lymph node conglomerates. The metastasis from this mutinous tubular adenocarcinoma with solid anaplastic parts to the 'hand knob' area was responsible for the first clinical sign related to the pulmonary malignancy. Conclusions: Pseudoperipheral palsy of the upper extremity is not necessarily the consequence of an embolic stroke. If nerve conduction studies have normal results, neuroimaging - preferably MRI - should be performed, as lesion in the hand-knob area of the precentral gyrus can also be caused by a malignancy.	[Folyovich, Andras; Varga, Viktoria; Scheidl, Erika; Beres-Molnar, Katalin Anna] Szent Janos Hosp, Dept Neurol, Budapest, Hungary; [Folyovich, Andras; Varga, Viktoria; Scheidl, Erika; Beres-Molnar, Katalin Anna] Szent Janos Hosp, Stroke Ctr, Budapest, Hungary; [Varga, Viktoria] Uzsoki Hosp, Dept Neurol, Budapest, Hungary; [Varallyay, Gyorgy; Kozak, Lajos] Semmelweis Univ, MR Res Ctr, Budapest, Hungary; [Bakos, Maria] Szent Janos Hosp, Dept Diagnost Radiol, Budapest, Hungary; [Kajdacsi, Zita] Koranyi Natl Inst TB & Pulmonol, Budapest, Hungary; [Scheidl, Erika; Bereczki, Daniel] Semmelweis Univ, Dept Neurol, Balassa U 6, H-1083 Budapest, Hungary		Bereczki, D (corresponding author), Semmelweis Univ, Dept Neurol, Balassa U 6, H-1083 Budapest, Hungary.	bereczki.daniel@med.semmelweis.univ.hu	Bereczki, Daniel/AAL-9886-2020	Bereczki, Daniel/0000-0002-8374-0500	Higher Education Institutional Excellence Program of the Ministry of Human Resources of the Government of Hungary	DB was supported by the Higher Education Institutional Excellence Program of the Ministry of Human Resources of the Government of Hungary.	Alstadhaug KB, 2013, CEREBROVASC DIS EXTR, V3, P65, DOI 10.1159/000350708; Back T, 2001, NEUROLOGY, V57, P1143, DOI 10.1212/WNL.57.6.1143; Celebisoy M, 2007, NEUROLOGIST, V13, P376, DOI 10.1097/NRL.0b013e31814db093; Fang S, 2017, AM J NEURORADIOL, V38, P1990, DOI 10.3174/ajnr.A5342; Gass A, 2001, NEUROLOGY, V57, P1589, DOI 10.1212/WNL.57.9.1589; Hall J, 2008, J NEUROL NEUROSUR PS, V79, P406, DOI 10.1136/jnnp.2007.127167; Krieg SM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00261; Krieg SM, 2014, NEURO-ONCOLOGY, V16, P1274, DOI 10.1093/neuonc/nou007; Orosz P, 2018, J STROKE CEREBROVASC, V27, P1949, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.045; Paciaroni M, 2005, J NEUROL NEUROSUR PS, V76, P805, DOI 10.1136/jnnp.2004.047779; Peters N, 2009, J NEUROL, V256, P1146, DOI 10.1007/s00415-009-5104-8; Siniscalchi A, 2018, WEST J EMERG MED, V19, P524, DOI 10.5811/westjem.2018.2.37654; Taniguchi M, 2004, J NEUROL NEUROSUR PS, V75, P466, DOI 10.1136/jnnp.2002.001834; TERAO Y, 1993, STROKE, V24, P2118, DOI 10.1161/01.STR.24.12.2118; Uncini A, 2007, J NEUROL NEUROSUR PS, V78, P100, DOI 10.1136/jnnp.2005.087346; Vastagh I, 2012, CEREBROVASC DIS, V33, P164; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zeller D, 2011, J NEUROL NEUROSUR PS, V82, P578, DOI 10.1136/jnnp.2010.219964	18	3	4	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2407			BMC CANCER	BMC Cancer	OCT 3	2018	18								947	10.1186/s12885-018-4857-9			5	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	GV8QP	WOS:000446410200007	30285670	Green Published, gold			2022-02-06	
J	Adnan, A; Qidwai, S; Bagchi, A				Adnan, Ashfaq; Qidwai, Siddiq; Bagchi, Amit			On the atomistic-based continuum viscoelastic constitutive relations for axonal microtubules	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALPHA-BETA-TUBULIN; MECHANICAL-PROPERTIES; FLEXURAL RIGIDITY; ELASTIC RESPONSE; WAVE PROPAGATION; ACTIN-FILAMENTS; MODEL; PROTEIN; VOLUME	Mechanical response of brain's interior during traumatic brain injury is primarily governed by the cytoskeleton (CSK) and occurs over multiple length scales starting from the axonal substructure level. The axonal cytoskeleton can be viewed as a nanofiber reinforced nanocomposite structure where nano-fibrous microtubules (MTs) are arranged in staggered arrays and cross-linked by Tau proteins. Each MT is made of thirteen laterally connected protofilaments (PFs), each of which is formed via linear polymerization of alpha beta - heterodimer protein called tubulin. Recent studies suggest that the unique viscoelastic nature of axons governs the damage during traumatic brain injury. To understand how the internal substructures of axon influences the viscoelastic mechanical behavior of axon from a theoretical perspective, the viscoelastic properties of MTs need to be properly described. Since viscosity is a bulk property, the measurement methods are fairly consistent. On the other hand, the reported experimentally measured elastic properties of MTs vary by several orders of magnitude due to limitations of experimental tools. Alternatively, many have attempted to determine MT properties using theoretical and computational methods at different length scales ranging between the atomistic and the continuum level. The atomistic approaches capture the dynamics and interactions of a material at the atomic or atomic cluster level but these methods are computationally expensive and can model only a very small physical scale. On the other hand, the continuum theories lack finer scale details. Here, we present an atomistic-based continuum viscoelastic constitutive relation for microtubules (MTs) based on the interatomic potential for proteins and continuum homogenization method. The interaction potential includes both van der Waals and electrostatic interactions between the protein molecules. The calculated Young's modulus of 3.385 GPa agrees reasonably well with the range of experimentally measured value without any parameter fitting. We have then investigated the viscoelastic response of MT based on the estimated viscosity using atomistic simulation and evaluated Young's modulus using our method. The current theory suggests that MT behaves like a viscoelastic material when applied loading rate is extremely high, otherwise it acts like an elastic solid material.	[Adnan, Ashfaq] Univ Texas Arlington, Mech & Aerosp Engn, Arlington, TX 76019 USA; [Qidwai, Siddiq] Natl Sci Fdn, Div Civil Mech & Mfg Innovat, 4201 Wilson Blvd, Arlington, VA 22230 USA; [Bagchi, Amit] US Navy, Res Lab, Multifunct Mat Branch, Washington, DC 20375 USA		Adnan, A (corresponding author), Univ Texas Arlington, Mech & Aerosp Engn, Arlington, TX 76019 USA.	aadnan@uta.edu	Qidwai, Siddiq/K-2866-2019	Qidwai, Siddiq/0000-0002-2389-118X	ONR summer faculty fellowship awards as well ONR award [N00014-16-1-2142]; National Science Foundation under the Internal Research & Development Program; Office of Naval Research (ONR) through the US Naval Research Laboratory's Basic Research Program	AA acknowledges 2014, 2015 and 2017 ONR summer faculty fellowship awards as well ONR award # N00014-16-1-2142 (Dr. Timothy Bentley, Program Manager). SQ acknowledges the support of the National Science Foundation under the Internal Research & Development Program. AB acknowledges funding for this project by the Office of Naval Research (ONR) through the US Naval Research Laboratory's Basic Research Program.	Brinson H. F., 2014, POLYM ENG SCI VISCOE; BROKAW CJ, 1988, MATH BIOSCI, V90, P247, DOI 10.1016/0025-5564(88)90069-7; BROWN PA, 1985, J CELL BIOL, V101, P1492, DOI 10.1083/jcb.101.4.1492; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Chu JW, 2006, BIOPHYS J, V90, P1572, DOI 10.1529/biophysj.105.073924; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DAIVIS PJ, 1994, J CHEM PHYS, V100, P541, DOI 10.1063/1.466970; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Dill E.H., 2006, CONTINUUM MECH ELAST; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; DYE RB, 1993, J BIOL CHEM, V268, P6847; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Fygenson DK, 1997, PHYS REV E, V55, P850, DOI 10.1103/PhysRevE.55.850; FYGENSON DK, 1995, PHYS REV E, V51, P5058, DOI 10.1103/PhysRevE.51.5058; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gu B, 2009, ACTA MECH, V207, P195, DOI 10.1007/s00707-008-0121-8; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; HOWARD WD, 1988, J BIOL CHEM, V263, P1342; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Jiang HQ, 2008, COMPUT MECH, V42, P607, DOI 10.1007/s00466-008-0247-5; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasas S, 2004, CHEMPHYSCHEM, V5, P252, DOI 10.1002/cphc.200300799; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306; Liew KM, 2015, COMPOS STRUCT, V123, P98, DOI 10.1016/j.compstruct.2014.12.020; Liew KM, 2011, COMPOS STRUCT, V93, P1809, DOI 10.1016/j.compstruct.2011.01.017; Lin YC, 2007, MACROMOLECULES, V40, P7714, DOI 10.1021/ma070862l; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; McQuarrie D.A., 1976, STAT MECH; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Nishimura S, 2006, CIRC RES, V98, P81, DOI 10.1161/01.RES.0000197785.51819.e8; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OLMSTED JB, 1973, BIOCHEMISTRY-US, V12, P4282, DOI 10.1021/bi00745a037; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SATO M, 1988, J CELL BIOL, V106, P1205, DOI 10.1083/jcb.106.4.1205; SATO M, 1985, J BIOL CHEM, V260, P8585; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Sept D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018101; Shamloo A, 2015, J BIOMECH, V48, P1241, DOI 10.1016/j.jbiomech.2015.03.007; Shi YJ, 2008, PHYSICA E, V41, P213, DOI 10.1016/j.physe.2008.06.025; Smith DH, 1999, J NEUROSCI, V19, P4263; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Takasone T, 2002, JPN J APPL PHYS 1, V41, P3015, DOI 10.1143/JJAP.41.3015; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Li T, 2008, J BIOMECH, V41, P1722, DOI 10.1016/j.jbiomech.2008.03.003; Todorov IT, 2006, J MATER CHEM, V16, P1911, DOI 10.1039/b517931a; Vanderah TW., 2015, NOLTES HUMAN BRAIN I; Wada H, 2006, EUROPHYS LETT, V75, P645, DOI 10.1209/epl/i2006-10155-0; Wagner O, 1999, BIOPHYS J, V76, P2784, DOI 10.1016/S0006-3495(99)77432-1; Wang CY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.052901; Wang CY, 2006, PHYSICA E, V35, P48, DOI 10.1016/j.physe.2006.05.008; WANG YL, 1984, J CELL BIOL, V99, P1478, DOI 10.1083/jcb.99.4.1478; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177; WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Wu ZH, 2012, BIOPHYS J, V102, P2687, DOI 10.1016/j.bpj.2012.05.003; Xiang P, 2013, COMPUT METHOD APPL M, V254, P14, DOI 10.1016/j.cma.2012.10.013; Yoon J, 2004, COMPOS PART B-ENG, V35, P87, DOI 10.1016/j.compositesb.2003.09.002; Yoon J, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.233402; YU WQ, 1994, J NEUROSCI, V14, P2818	64	3	3	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2018	86						375	389		10.1016/j.jmbbm.2018.06.031			15	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GQ2NE	WOS:000441490900040	30015209	Bronze			2022-02-06	
J	Andrade, P; Ciszek, R; Pitkanen, A; Ndode-Ekane, XE				Andrade, Pedro; Ciszek, Robert; Pitkanen, Asia; Ndode-Ekane, Xavier Ekolle			A web-based application for generating 2D-unfolded cortical maps to analyze the location and extent of cortical lesions following traumatic brain Check for injury in adult rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Automated; Cerebral cortex; Cytoarchitectonic region; Lateral fluid-percussion injury	EPILEPSY; STROKE	Background: Both the type and severity of functional impairments caused by damage to the cerebral cortex depend on the functional cortical areas and networks affected, as well as the lesion extent and type. New method: To accelerate the laborious quantitative analysis of cortical lesion location and size, we created user-friendly software that generates two-dimensional unfolded cortical maps of the lesions in adult rats. The program imports and superimposes simple user-made measurements, e.g., from histologic sections, on a template. The software then quantifies the total lesion area and the area of damage in each cortical cytoarchitechtonic region. To validate the accuracy of the software, we compared computer-generated maps with manually created unfolded maps from 32 rats with lateral fluid-percussion-induced traumatic brain injury. Results: The total area of the cortical lesions varied from 7.37 to 38.45 mm(2) in the automated analysis and from 7.26 to 38.97 mm(2) in the manual analysis (p > 0.05). The Pearson correlation coefficient between the automated and manual analyses was 0.998 (p < 0.001). The mean difference between the automated and manual measurements was 0.50 +/- 0.69 mm(2) (range 0.00-3.30 mm(2)). The slight differences between the analyses related to human error in positioning the measurements to the anteroposterior coordinates on the template map. Comparison with existing methods: Compared with the manual method, the automated method accurately and quickly generates unfolded cortical maps of lesioned cortical areas. Conclusions: Application provides a novel tool for accurately positioning the lesioned area on the cortical mantle and quantifying the lesion area in histologic sections or magnetic resonance images.	[Andrade, Pedro; Ciszek, Robert; Pitkanen, Asia; Ndode-Ekane, Xavier Ekolle] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Pitkanen, Asla/0000-0002-8163-5416	Academy of FinlandAcademy of FinlandEuropean Commission; European UnionEuropean Commission [602102]	This study was supported by the Academy of Finland (A.P.) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 602102 (EPITARGET) (A.P.).	AWAD IA, 1991, EPILEPSIA, V32, P179, DOI 10.1111/j.1528-1157.1991.tb05242.x; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Chen CL, 2000, ARCH PHYS MED REHAB, V81, P447, DOI 10.1053/mr.2000.3837; Di Paola M, 2015, J HEAD TRAUMA REHAB, V30, P402, DOI 10.1097/HTR.0000000000000063; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Macciocchi SN, 1998, ARCH PHYS MED REHAB, V79, P1255, DOI 10.1016/S0003-9993(98)90271-4; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208	10	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 1	2018	308						330	336		10.1016/j.jneumeth.2018.08.028			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5GP	WOS:000449447500031	30194043				2022-02-06	
J	Berlin, L				Berlin, Leonard			Contemporary Risk Management for Radiologists	RADIOGRAPHICS			English	Article							CT SCOUT VIEW; INCIDENTAL FINDINGS; ABDOMINAL CT; REPORTING SPEED; MALPRACTICE; COMMUNICATION; SYSTEM; ERRORS; MAMMOGRAMS; BENEFITS	Although radiologists want to avoid being sued for malpractice, their primary objective is to treat patients in the best way possible. Good risk management safeguards both patients and radiologists. The main objective is not to wait until an untoward event occurs and then manage it retrospectively, but rather to anticipate what may go wrong or cause an injury, so that it can be avoided. Thus, good risk management is characterized by two words: anticipate and avoid. Although avoiding lawsuits is the apparent objective of risk management, the real objective is to optimize the care and treatment of patients. Potential causes of error and injury must be identified to prevent such problems from occurring so that the conduct of radiologists allows patients to benefit from their knowledge and technology. If radiologic diagnoses and treatment are beyond reproach, then malpractice suits are less likely. The most common and potentially injurious risks that should be anticipated and avoided are closely entwined with radiologic diagnosis, incidental findings, communication of findings to referring physicians, "curbstone consultations," disclosure of and apology for errors, breast density laws, American College of Radiology parameters, radiation exposure, the Health Insurance Portability and Accountability Act, electronic health records, and imaging traumatic brain injury with functional MRI. Peer review and the current status of the medical malpractice environment are also relevant. (C) RSNA, 2018	[Berlin, Leonard] Skokie Hosp, Dept Radiol, 9600 Gross Point Rd, Skokie, IL 60076 USA; [Berlin, Leonard] Rush Univ, Dept Radiol, Chicago, IL 60612 USA; [Berlin, Leonard] Univ Illinois, Dept Radiol, Chicago, IL 60607 USA		Berlin, L (corresponding author), Skokie Hosp, Dept Radiol, 9600 Gross Point Rd, Skokie, IL 60076 USA.; Berlin, L (corresponding author), Rush Univ, Dept Radiol, Chicago, IL 60612 USA.; Berlin, L (corresponding author), Univ Illinois, Dept Radiol, Chicago, IL 60607 USA.	lberlin@live.com					American College of Radiology, 2014, ACR PRACT PAR COMM D; American College of Radiology, 2013, ACR SPR PRACT PAR IM; American Medical Association, 2017, COD MED ETH AM MED A, P47; Annas GJ, 2003, NEW ENGL J MED, V348, P1486, DOI 10.1056/NEJMlim035027; [Anonymous], 2011, CHICAGO TRIBUNE, P16; Bahrami S, 2009, RADIOGRAPHICS, V29, P1877, DOI 10.1148/rg.297095123; Basma S, 2011, AM J ROENTGENOL, V197, P923, DOI 10.2214/AJR.11.6691; Bechtold RE, 1997, J COMPUT ASSIST TOMO, V21, P681, DOI 10.1097/00004728-199709000-00001; BERGEN RP, 1975, ARCH OTOLARYNGOL, V101, P182; Berland LL, 2014, J AM COLL RADIOL, V11, P30, DOI 10.1016/j.jacr.2013.06.002; Berlin L, 2017, AM J ROENTGENOL, V208, P241, DOI 10.2214/AJR.16.16804; Berlin L, 2015, RADIOLOGY, V277, P332, DOI 10.1148/radiol.2015150516; Berlin L, 2015, J AM COLL RADIOL, V12, P894, DOI 10.1016/j.jacr.2015.06.010; Berlin L, 2014, AM J ROENTGENOL, V202, P1264, DOI 10.2214/AJR.12.10444; Bosmans JML, 2011, RADIOLOGY, V259, P184, DOI 10.1148/radiol.10101045; Conant EF, 2018, RADIOLOGY, V286, P401, DOI 10.1148/radiol.2017170644; Constance J., 2017, RADIOL BUS J, P24; Consumer Reports, 2015, CONSUMER REPORTS; CURRAN WJ, 1970, NEW ENGL J MED, V282, P325, DOI 10.1056/NEJM197002052820608; Dick JF, 2009, AM J ROENTGENOL, V192, P327, DOI 10.2214/AJR.07.3346; Dickerson EC, 2016, J AM COLL RADIOL, V13, P943, DOI 10.1016/j.jacr.2016.02.005; Donnelly LF, 2018, AM J ROENTGENOL, V210, P578, DOI 10.2214/AJR.17.18660; Edwards AJ, 2003, CLIN RADIOL, V58, P971, DOI 10.1016/S0009-9260(03)00289-7; Eisenberg RL, 2010, RADIOLOGY, V257, P724, DOI 10.1148/radiol.10101015; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Emshwiller SR, 2016, WALL STREET J, pC3; Esmaili A, 2011, J THORAC IMAG, V26, P27, DOI 10.1097/RTI.0b013e3181d73a78; Ginsberg MD, 2002, J MARSHALL LAW REV, V35, P359; Gunderman RB, 2014, RADIOLOGY, V273, P7, DOI 10.1148/radiol.14132795; HARVEY JA, 1993, AM J ROENTGENOL, V161, P1167, DOI 10.2214/ajr.161.6.8249720; James K, 2016, J AM COLL RADIOL, V13, P175, DOI 10.1016/j.jacr.2015.07.028; Johnson PT, 2014, AM J ROENTGENOL, V202, P1256, DOI 10.2214/AJR.13.10545; Johnson PT, 2011, J AM COLL RADIOL, V8, P762, DOI 10.1016/j.jacr.2011.05.012; Langlotz CP, 2015, CREATESPACE, P138; Larson PA, 2014, J AM COLL RADIOL, V11, P552, DOI 10.1016/j.jacr.2013.12.016; Levy S, MEDSCAPE MALPRACTICE; Lim KY, 2014, AM J ROENTGENOL, V202, P738, DOI 10.2214/AJR.13.11436; Lowes R., MALPRACTICE PREMIUMS; Mastroianni AC, 2010, HEALTH AFFAIR, V29, P1611, DOI 10.1377/hlthaff.2009.0134; Meltzer CC, 2014, AM J NEURORADIOL, V35, P632, DOI 10.3174/ajnr.A3711; MUHM JR, 1983, RADIOLOGY, V148, P609, DOI 10.1148/radiology.148.3.6308709; Palazzolo J., 2017, WALL STREET J, VA1, pA10; Pandharipande PV, 2016, J AM COLL RADIOL, V13, P764, DOI 10.1016/j.jacr.2016.03.017; Rao VM, 2011, J AM COLL RADIOL, V8, P642, DOI 10.1016/j.jacr.2011.04.007; Rithidech KN, 2016, HEALTH PHYS, V110, P293, DOI 10.1097/HP.0000000000000430; Schaffer AC, 2017, JAMA INTERN MED, V177, P710, DOI 10.1001/jamainternmed.2017.0311; Shepherd J, 2014, VANDERBILT LAW REV, V67, P151; Singh H, 2007, J AM MED INFORM ASSN, V14, P459, DOI 10.1197/jamia.M2280; Smith-Bindman R, 2018, JAMA INTERN MED, V178, P227, DOI 10.1001/jamainternmed.2017.7557; Thompson WM, 2018, CONT DIAGN RADIOL, V41, P8; Wang MD, 2017, JAMA INTERN MED, V177, P1212, DOI 10.1001/jamainternmed.2017.1548; Welch HG, 2011, OVERDIAGNOSED MAKING, P90; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	53	3	3	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	OCT	2018	38	6					1717	1728		10.1148/rg.2018180012			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GW4FV	WOS:000446868100016	30303788	Bronze			2022-02-06	
J	Bjorkman, A; Weibull, A				Bjorkman, Anders; Weibull, Andreas			Loss of inhibition in ipsilateral somatosensory areas following altered afferent nerve signaling from the hand	NEUROSCIENCE RESEARCH			English	Article						Peripheral nerve injury; Neuropathy; Plasticity; Reorganization; fMRI	BOLD SIGNAL; CORTEX; FMRI; STIMULATION; AMPUTATION; BRAIN	Cutaneous stimulation of the hand results in increased neural activity in the contralateral primary somatosensory cortex (S1) in humans, whereas an inhibition of neurons is seen in the ipsilateral Sl. The aim of this study was to assess changes in neural activity in the S1 bilaterally, with a focus on the ipsilateral hemisphere, following altered afferent nerve signaling from the hand. Three cohorts, all with altered afferent nerve signaling from the hand, participated in the study. There were: 18 patients with traumatic median nerve injury, 10 patients with vibration induced neuropathy and 11 healthy subjects who had their dominant hand and wrist immobilized for 72 h. In addition, 36 healthy subjects were included as controls. Each subject was examined using functional magnetic resonance imaging at 3 T. All three study cohorts showed enlarged activation in the contralateral S1 during tactile stimulation compared to healthy controls. Moreover, inhibition of the ipsilateral S1 was significantly decreased or completely lost. Thus, somatosensory areas of both hemispheres respond to changed afferent nerve signaling from the hand. The loss of inhibition of neurons in the ipsilateral S1 suggests an important role of the ipsilateral hemisphere in the cerebral adaptation following a change in afferent nerve signaling. (C) 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.	[Bjorkman, Anders] Lund Univ, Skane Univ Hosp, Dept Hand Surg, Malmo, Sweden; [Weibull, Andreas] Lund Univ, Skane Univ Hosp, Dept Med Radiat Phys, Malmo, Sweden		Bjorkman, A (corresponding author), Skane Univ Hosp, Dept Translat Med Hand Surg, Jan Waldenstroms G 5, SE-20502 Malmo, Sweden.	anders.bjorkman@med.lu.se; andreas.weibull@med.lu.se	Bjorkman, Anders/AAR-5375-2020				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorkman A, 2010, NEUROREPORT, V21, P722, DOI 10.1097/WNR.0b013e32833b6cce; Bjorkman A, 2009, EUR J NEUROSCI, V29, P837, DOI 10.1111/j.1460-9568.2009.06629.x; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; Chemnitz A, 2015, EUR J NEUROSCI, V42, P2022, DOI 10.1111/ejn.12917; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malinen S, 2014, EUR J NEUROSCI, V39, P738, DOI 10.1111/ejn.12493; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Ragert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016150; Schafer K, 2012, NEUROIMAGE, V59, P3119, DOI 10.1016/j.neuroimage.2011.11.085; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Weibull A, 2011, EUR J NEUROSCI, V33, P699, DOI 10.1111/j.1460-9568.2010.07551.x; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007	19	3	3	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	OCT	2018	135						32	36		10.1016/j.neures.2017.12.004			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS8IU	WOS:000443953800004	29258852				2022-02-06	
J	Bruijel, J; Stapert, SZ; Vermeeren, A; Ponsford, JL; van Heugten, CM				Bruijel, Jessica; Stapert, Sven Z.; Vermeeren, Annemiek; Ponsford, Jennie L.; van Heugten, Caroline M.			Unraveling the Biopsychosocial Factors of Fatigue and Sleep Problems After Traumatic Brain Injury: Protocol for a Multicenter Longitudinal Cohort Study	JMIR RESEARCH PROTOCOLS			English	Article						traumatic brain injury; sleep; fatigue; biopsychosocial model	POSTTRAUMATIC-STRESS-DISORDER; VISUAL ANALOG SCALE; 1ST 2 YEARS; EXECUTIVE DYSFUNCTION; WAKE DISTURBANCES; UTRECHT SCALE; RATING-SCALE; IMPACT; PARTICIPATION; PERFORMANCE	Background: Fatigue and sleep problems are common after a traumatic brain injury (TBI) and are experienced as highly distressing symptoms, playing a significant role in the recovery trajectory, and they can drastically impact the quality of life and societal participation of the patient and their family and friends. However, the etiology and development of these symptoms are still uncertain. Objective: The aim of this study is to examine the development of fatigue and sleep problems following moderate to severe TBI and to explore the changes in underlying biological (pain, brain damage), psychological (emotional state), and social (support family, participation) factors across time. Methods: This study is a longitudinal multicenter observational cohort study with 4 measurement points (3, 6, 12, and 18 months postinjury) including subjective questionnaires and cognitive tasks, preceded by 7 nights of actigraphy combined with a sleep diary. Recruitment of 137 moderate to severe TBI patients presenting at emergency and neurology departments or rehabilitation centers across the Netherlands is anticipated. The evolution of fatigue and sleep problems following TBI and their association with possible underlying biological (pain, brain damage), psychological (emotional state), and social (support family, participation) factors will be examined. Results: Recruitment of participants for this longitudinal cohort study started in October 2017, and the enrollment of participants is ongoing. The first results are expected at the end of 2020. Conclusions: To the authors' knowledge, this is the first study that examines the development of both post-TBI fatigue and sleep longitudinally within a biopsychosocial model in moderate to severe TBI using both subjective and objective measures. Identification of modifiable factors such as mood and psychosocial stressors may give direction to the development of interventions for fatigue and sleep problems post-TBI.	[Bruijel, Jessica; Stapert, Sven Z.; Vermeeren, Annemiek; van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Univ Singel 40, NL-6229 ER Maastricht, Netherlands; [Bruijel, Jessica; Stapert, Sven Z.; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Stapert, Sven Z.] Zuyderland Med Ctr, Dept Clin & Med Psychol, Sittard Geleen, Netherlands; [Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [van Heugten, Caroline M.] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci,Dept Psychiat & Neurop, Maastricht, Netherlands		Stapert, SZ (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.	s.stapert@maastrichtuniversity.nl	; Ponsford, Jennie/H-8341-2014	Bruijel, Jessica/0000-0002-2656-5152; Ponsford, Jennie/0000-0003-0430-125X	Maastricht University	The study is funded by Maastricht University.	Aicher B, 2012, CEPHALALGIA, V32, P185, DOI 10.1177/0333102411430856; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2014, J SLEEP RES, V23, P240, DOI 10.1111/jsr.12158; Basner M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx187; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Benton A., 1976, MULTILINGUAL APHASIA; Blackwell E, 2006, PSYCHOSOM MED, V68, P870, DOI 10.1097/01.psy.0000239144.91689.ca; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brands I, 2014, J REHABIL MED, V46, P869, DOI 10.2340/16501977-1849; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chiou KS, 2016, J HEAD TRAUMA REHAB, V31, pE60, DOI 10.1097/HTR.0000000000000161; Cohen Jacob, 2002, APPL MULTIPLE REGRES, V3th; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; GEORGE B, 1986, NEUROCHIRURGIA, V29, P45; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Highsmith J, 2016, INT J NEUROREHABILIT, V3, DOI [10.4172/2376-0281.1000223, DOI 10.4172/2376-0281.1000223]; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hunsley J., 2008, GUIDE ASSESSMENTS WO; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nazem S, 2016, J HEAD TRAUMA REHAB, V31, P136, DOI 10.1097/HTR.0000000000000225; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ouellet M, 2012, OXFORD HDB SLEEP SLE; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schreurs PJG., 1993, HANDLEIDING UTRECHTS; Schwarzbold ML, 2014, REV BRAS PSIQUIATR, V36, P206, DOI 10.1590/1516-4446-2013-1308; Shaw S, 2015, PSYCHOL ASSESSMENT, V27, P138, DOI 10.1037/a0038195; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Simblett SK, 2017, NEUROPSYCHOL REHABIL, V27, P1124, DOI 10.1080/09602011.2015.1121880; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Singh K, 2016, PEDIATR NEUROL, V60, P30, DOI 10.1016/j.pediatrneurol.2016.02.013; Smith A., 1982, SYMBOL DIGIT MODALIT; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Tellegen B., 1988, UTRECHTSE COPING LIJ; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Zeng EQ, 2016, BALK MED J, V33, P152, DOI 10.5152/balkanmedj.2016.15701; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zuzuarregui J.R.P., 2018, SLEEP SCI PRACT, V2, P2, DOI [10.1186/s41606-018-0020-4, DOI 10.1186/S41606-018-0020-4]	86	3	3	1	3	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	OCT	2018	7	10					137	148	e11295	10.2196/11295			12	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GX6LC	WOS:000447871500014	30348629	Green Published, gold			2022-02-06	
J	Chen, LX; Zhang, WF; Wang, M; Jia, PF				Chen, Li-Xiong; Zhang, Wei-Feng; Wang, Ming; Jia, Pi-Feng			Relationship of calcitonin gene-related peptide with disease progression and prognosis of patients with severe traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; calcitonin gene-related peptide; severe traumatic brain injury; prognosis biomarkers; endothelin-1; mortality; dynamic serum levels; critical care medicine; neural regeneration	NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; SEPTIC SHOCK; ENDOTHELIN-1; EPIDEMIOLOGY; PREDICTORS; BIOMARKERS; DEATH; MODEL	Calcitonin gene-related peptide (CGRP) has been implicated in multiple functions across many bioprocesses; however, whether CGRP is associated with severe traumatic brain injury (TBI) remains poorly understood. In this study, 96 adult patients with TBI (enrolled from September 2015 to December 2016) were divided into a mild/moderate TBI group (36 males and 25 females, aged 38 +/- 13 years) and severe TBI group (22 males and 13 females, aged 38 +/- 11 years) according to Glasgow Coma Scale scores. In addition, 25 healthy individuals were selected as controls (15 males and 10 females, aged 39 +/- 13 years). Radioimmunoassay was used to detect serum levels of CGRP and endothelin-1 at admission and at 12, 24, 48, 72 hours, and 7 days after admission. CGRP levels were remarkably lower, but endothelin-1 levels were obviously higher in the severe TBI group compared with mild/moderate TBI and control groups. Levels of CGRP were remarkably lower, but endothelin-1 levels were obviously higher in deceased patients compared with patients who survived. Survival analysis and logistic regression showed that both CGRP and endothelin-1 levels were associated with patient mortality, with each serving as an independent risk factor for 6-month mortality of severe TBI patients. Moreover, TBI patients with lower serum CGRP levels had a higher risk of death. Thus, our retrospective analysis demonstrates the potential utility of CGRP as a new biomarker, monitoring method, and therapeutic target for TBI.	[Chen, Li-Xiong] Ruijin Hosp, North Hosp, Dept Crit Care Med, Shanghai, Peoples R China; [Zhang, Wei-Feng; Wang, Ming; Jia, Pi-Feng] Ruijin Hosp, North Hosp, Dept Neurosurg, Shanghai, Peoples R China		Jia, PF (corresponding author), Ruijin Hosp, North Hosp, Dept Neurosurg, Shanghai, Peoples R China.	Jiapifeng@sina.com					Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Armstead WM, 2011, NEUROL RES, V33, P133, DOI 10.1179/016164111X12881719352174; Brauner JS, 2000, INTENS CARE MED, V26, P305, DOI 10.1007/s001340051154; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; EDVINSSON L, 1991, NEUROSCI LETT, V121, P151, DOI 10.1016/0304-3940(91)90672-G; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; HOLLAND JP, 1994, STROKE, V25, P2055, DOI 10.1161/01.STR.25.10.2055; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Le Mevel JC, 2012, J EXP BIOL, V215, P1930, DOI 10.1242/jeb.070177; Lin W, 2016, ASIA PAC J CLIN TRIA, V1, P170; Lundberg OHM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1361-y; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Rey C, 2013, CRIT CARE, V17, DOI 10.1186/cc13064; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Wiklund L, 2011, AMINO ACIDS, V41, pS32; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang Z, 2012, PEPTIDES, V34, P343, DOI 10.1016/j.peptides.2012.01.018; Zheng LR, 2012, INT J CARDIOL, V156, P192, DOI 10.1016/j.ijcard.2011.04.009	32	3	3	1	8	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	OCT	2018	13	10					1782	1786		10.4103/1673-5374.238619			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GR6EJ	WOS:000442737900017	30136693	Green Published, gold			2022-02-06	
J	Gillett, G				Gillett, Grant			Concussion in Sport The Unheeded Evidence	CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS			English	Article						concussion; brain function; neuropsychology; the politico-economic environment of health ethics	BRAIN; INJURY	Patients with repeated minor head injury are a challenge to our clinical skills of neurodiagnosis because the relevant evidence objectively demonstrating their impairment was collected in New Zealand (although published in the BMJ and Lancet) and, at the time, was mired in controversy. The effects of repeated closed diffuse head injury are increasingly recognized worldwide, but now suffer from the relentless advance of imaging technology as the dominant form of neurodiagnosis and the considerable financial interests that underpin the refusal to recognize that acute accelerational injury is the most subtle and insidiously damaging (especially when seen in the light of biopsychosocial medicine), and potentially one of the most financially momentous (given the large incomes impacted and needing compensation) phenomena in modern sports medicine. The vested interests in downplaying this phenomenon are considerable and concentrated in North America where diffuse head injury is a widespread feature of the dominant winter sports code: Gridiron or American Rules football. The relationship of this to shattered lives among the brightest and best of young men and the relatively dated objective evidence are a toxic mix in terms of ethical analysis and, therefore, there is a malignant confluence of social forces that tends toward minimizing the injury.	[Gillett, Grant] Univ Otago, Sch Med, Biomed Eth, Dunedin, New Zealand; [Gillett, Grant] Univ Otago, Sch Med, Ctr Bioeth, Dunedin, New Zealand		Gillett, G (corresponding author), Univ Otago, Sch Med, Biomed Eth, Dunedin, New Zealand.; Gillett, G (corresponding author), Univ Otago, Sch Med, Ctr Bioeth, Dunedin, New Zealand.						Anderson L, 2013, INT REV SOCIOL SPORT, V48, P238, DOI 10.1177/1012690211435031; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; EVANS AS, 1976, YALE J BIOL MED, V49, P175; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gillett GR., 2004, BIOETHICS CLIN HIPPO, V1st edn; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNamee MJ, 2016, CLIN SPORT MED, V35, P257, DOI 10.1016/j.csm.2015.10.008; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; STRICH SJ, 1961, LANCET, V2, P443	15	3	3	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0963-1801	1469-2147		CAMB Q HEALTHC ETHIC	Camb. Q. Healthc. Ethics	OCT	2018	27	4			SI		710	716		10.1017/S0963180118000191			7	Health Care Sciences & Services; Health Policy & Services; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Biomedical Social Sciences	HJ8XO	WOS:000457483600017	30198474				2022-02-06	
J	Hall, J; Frenguelli, BG				Hall, Jessicka; Frenguelli, Bruno G.			The combination of ribose and adenine promotes adenosine release and attenuates the intensity and frequency of epileptiform activity in hippocampal slices: Evidence for the rapid depletion of cellular ATP during electrographic seizures	JOURNAL OF NEUROCHEMISTRY			English	Article						Adenosine; ATP; epilepsy; purines; RibAde; seizures	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; CEREBRAL-ISCHEMIA; IN-VITRO; AREA CA1; ANOXIC DEPOLARIZATION; SPREADING DEPRESSION; PURINE RELEASE	In addition to being the universal cellular energy source, ATP is the primary reservoir for the neuromodulator adenosine. Consequently, adenosine is produced during ATP-depleting conditions, such as epileptic seizures, during which adenosine acts as an anticonvulsant to terminate seizure activity and raise the threshold for subsequent seizures. These actions protect neurones from excessive ionic fluxes and hence preserve the remaining cellular content of ATP. We have investigated the consequences of manipulation of intracellular ATP levels on adenosine release and epileptiform activity in hippocampal slices by pre-incubating slices (3 h) with creatine (1 mM) and the combination of ribose (1 mM) and adenine (50 mu M; RibAde). Creatine buffers and protects the concentration of cellular ATP, whereas RibAde restores the reduced cellular ATP in brain slices to near physiological levels. Using electrophysiological recordings and microelectrode biosensors for adenosine, we find that, while having no effect on basal synaptic transmission or paired-pulse facilitation, pre-incubation with creatine reduced adenosine release during Mg(2+-)free/4-aminopyridine-induced electrographic seizure activity, whereas RibAde increased adenosine release. This increased release of adenosine was associated with an attenuation of both the intensity and frequency of seizure activity. Given the depletion of ATP after injury to the brain, the propensity for seizures after trauma and the risk of epileptogenesis, therapeutic strategies elevating the cellular reservoir of adenosine may have value in the traumatized brain. Ribose and adenine are both in use in man and thus their combination merits consideration as a potential therapeutic for the acutely injured central nervous system.	[Hall, Jessicka; Frenguelli, Bruno G.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England		Frenguelli, BG (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	b.g.frenguelli@warwick.ac.uk			BBSRC-funded Doctoral Training Program	JH was supported by a BBSRC-funded Doctoral Training Program. BGF is a Non-Executive Director and shareholder of Sarissa Biomedical Ltd, the company that manufactures the microelectrode biosensors used in this study.	Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Avoli M, 2016, J NEUROSCI METH, V260, P26, DOI 10.1016/j.jneumeth.2015.10.006; Avsar E, 2004, NEUROPHARMACOLOGY, V47, P427, DOI 10.1016/j.neuropharm.2004.04.015; Babits R, 2016, HIPPOCAMPUS, V26, P437, DOI 10.1002/hipo.22533; Balestrino M, 1999, BRAIN RES, V816, P124, DOI 10.1016/S0006-8993(98)01131-7; BALESTRINO M, 1995, J NEUROSCI METH, V59, P99, DOI 10.1016/0165-0270(94)00199-Q; Balestrino M, 2016, AMINO ACIDS, V48, P1955, DOI 10.1007/s00726-016-2173-8; Bayram Melike, 2015, Ther Adv Cardiovasc Dis, V9, P56, DOI 10.1177/1753944715572752; Chung JM, 2014, NEUROL RES, V36, P403, DOI 10.1179/1743132814Y.0000000352; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Etherington LAV, 2004, EUR J NEUROSCI, V19, P2539, DOI 10.1111/j.0953-816X.2004.03355.x; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; Faller Kiterie M E, 2017, Brain Neurosci Adv, V1, p2398212817717112, DOI 10.1177/2398212817717112; Fedele DE, 2006, EXP NEUROL, V200, P184, DOI 10.1016/j.expneurol.2006.02.133; FOWLER JC, 1990, BRAIN RES, V509, P331, DOI 10.1016/0006-8993(90)90560-X; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Frenguelli BG, 2019, NEUROCHEM RES, V44, P661, DOI 10.1007/s11064-017-2386-6; Frenguelli BG, 2016, J NEUROSCI METH, V260, P202, DOI 10.1016/j.jneumeth.2015.09.011; Gervitz LM, 2001, AM J PHYSIOL-REG I, V280, pR639, DOI 10.1152/ajpregu.2001.280.3.R639; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Ipata PL, 2011, CURR TOP MED CHEM, V11, P909; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kohl Z, 2011, J CLIN NEUROSCI, V18, P964, DOI 10.1016/j.jocn.2010.11.017; KRIVANEK J, 1958, NATURE, V182, P1799, DOI 10.1038/1821799a0; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Lopatar J, 2015, NEUROPHARMACOLOGY, V93, P219, DOI 10.1016/j.neuropharm.2015.01.014; Lopatar J, 2011, NEUROPHARMACOLOGY, V61, P25, DOI 10.1016/j.neuropharm.2011.02.011; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; OKADA Y, 1983, NEUROSCI LETT, V41, P119, DOI 10.1016/0304-3940(83)90233-1; Pearson T, 2004, EUR J NEUROSCI, V20, P1555, DOI 10.1111/j.1460-9568.2004.03602.x; Pearson T, 2001, J NEUROSCI, V21, P2298, DOI 10.1523/JNEUROSCI.21-07-02298.2001; Pearson T, 2003, J CELL MOL MED, V7, P362, DOI 10.1111/j.1582-4934.2003.tb00239.x; Pedata F, 2016, NEUROPHARMACOLOGY, V104, P105, DOI 10.1016/j.neuropharm.2015.11.007; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Sebastiao AM, 2015, BRAIN RES, V1621, P102, DOI 10.1016/j.brainres.2014.11.008; Seifert JG, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0205-8; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; THOMAS J, 1956, BIOCHEM J, V64, P335, DOI 10.1042/bj0640335; Tian FM, 2017, PURINERG SIGNAL, V13, P521, DOI 10.1007/s11302-017-9578-z; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Wall MJ, 2015, J NEUROPHYSIOL, V113, P871, DOI 10.1152/jn.00620.2014; Weigand MA, 1999, ANESTHESIOLOGY, V91, P414, DOI 10.1097/00000542-199908000-00015; WHITTINGHAM TS, 1981, J NEUROCHEM, V37, P1618, DOI 10.1111/j.1471-4159.1981.tb06337.x; YONEDA K, 1983, EXP NEUROL, V82, P215, DOI 10.1016/0014-4886(83)90256-X; zur Nedden S, 2014, J NEUROCHEM, V128, P111, DOI 10.1111/jnc.12397; zur Nedden S, 2011, J NEUROSCI, V31, P6221, DOI 10.1523/JNEUROSCI.4039-10.2011	57	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2018	147	2					178	189		10.1111/jnc.14543			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5VX	WOS:000449499000004	29964329	Green Published, hybrid			2022-02-06	
J	Ibrahim, AS; Aly, MG; Abdel-Rahman, KA; Mohamed, MA; Mehany, MM; Aziz, EM				Ibrahim, Abdelrady S.; Aly, Mohamed G.; Abdel-Rahman, Khaled A.; Mohamed, Mona A.; Mehany, Mogedda M.; Aziz, Eman M.			Semi-quantitative Cough Strength Score as a Predictor for Extubation Outcome in Traumatic Brain Injury: A Prospective Observational Study	NEUROCRITICAL CARE			English	Article						Semi-quantitative cough strength score; Mechanical ventilation; Extubation; Traumatic brain injury	CARE-UNIT PATIENTS; MECHANICAL VENTILATION; MYASTHENIC CRISIS; FAILURE; REINTUBATION; MANAGEMENT; CRITERIA; ANEMIA; RISK	Background: Between 25 and 40% of extubated patients with traumatic brain injury (TBI) in the intensive care unit at our hospital (Assiut University Hospital-Assiut-Egypt) require reintubation. This reflects the importance of developing better criteria for predicting successful extubation in TBI. We evaluated the accuracy of semi-quantitative cough strength score (SCSS) and Glasgow coma scale (GCS) in predicting extubation outcomes in TBI. Methods: This prospective observational study included patients (18-65 years), with TBI on mechanical ventilation more than 24 h who were ready to be weaned off. Three tools were used. Tool I: Patient assessment sheet, this tool used to assess socio-demographic and clinical data of patients. Tool II: Semi-quantitative cough strength score (0-5). Tool III: Factors affecting successful extubation, this tool used to confirm the presence or absence of factors that can interfere with the results of extubation outcomes. After extubation, patient was followed up for 72 h to check for extubation success. Multivariate logistic binary regression test was used to calculate odds ratio for different clinical data collected before extubation as independent factors and successful extubation as a dependent factor. Results: Among 80 patients of mean age 40.6 (+/- 16.1), 34% were female, median admission GCS was 8 (4-13), extubation occurred on mean post-injury day 6.5 (+/- 4), and 46.3% required reintubation. Successfully extubated patients had higher semi-quantitative cough scores and GCS. 81.3% patients with SCSS 5 were successfully extubated, while all patients with SCSS 0 were reintubated. All patients with GCS 15 were successfully extubated, and all patients with GCS < 12 required intubation. Conclusion: SCSS has shown promise in predicting successful extubation in TBI.	[Ibrahim, Abdelrady S.; Aly, Mohamed G.; Abdel-Rahman, Khaled A.] Assiut Univ Hosp, Fac Med, Anaesthesia & ICU Dept, Assiut 7111, Egypt; [Mohamed, Mona A.; Mehany, Mogedda M.; Aziz, Eman M.] Assiut Univ, Fac Nursing, Crit Care & Emergency Nursing Dept, Assiut, Egypt		Ibrahim, AS (corresponding author), Assiut Univ Hosp, Fac Med, Anaesthesia & ICU Dept, Assiut 7111, Egypt.	aradys2000@yahoo.com	Ibrahim, Abdelrady/J-7260-2019	Ibrahim, Abdelrady/0000-0002-2676-5605; abdelrahman, khaled/0000-0002-6548-2034			Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Brown CVR, 2011, J TRAUMA, V71, P37, DOI 10.1097/TA.0b013e31821e0c6e; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Duan J, 2015, AM J CRIT CARE, V24, pE86, DOI 10.4037/ajcc2015172; Frutos-Vivar F, 2011, J CRIT CARE, V26, P502, DOI 10.1016/j.jcrc.2010.12.015; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; Ko R, 2009, NEUROCRIT CARE, V10, P269, DOI 10.1007/s12028-008-9181-9; Kulkarni AP, 2008, INDIAN J CRIT CARE M, V12, P1, DOI 10.4103/0972-5229.40942; McEvoy MT, 2013, AM J CRIT CARE, V22, pES1, DOI 10.4037/ajcc2013729; Miu T, 2014, RESP CARE, V59, P178, DOI 10.4187/respcare.02527; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Nevins ML, 2001, CHEST, V119, P1840, DOI 10.1378/chest.119.6.1840; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rabinstein AA, 2005, NEUROCRIT CARE, V3, P213, DOI 10.1385/NCC:3:3:213; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; SAHN SA, 1973, CHEST, V63, P1002, DOI 10.1378/chest.63.6.1002; Saugel B, 2012, J CRIT CARE, V27, P571, DOI 10.1016/j.jcrc.2012.01.010; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P929, DOI 10.1001/archneur.65.7.929; Shadvar K, 2016, ADV BIOSCI CLIN MED, V4, P39; Su WL, 2010, CHEST, V137, P777, DOI 10.1378/chest.07-2808; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Wang SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112198; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	26	3	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2018	29	2					273	279		10.1007/s12028-018-0539-3			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GY3QG	WOS:000448467900016	29644564				2022-02-06	
J	Mackel, CE; Morel, BC; Winer, JL; Park, HG; Sweeney, M; Heller, RS; Rideout, L; Riesenburger, RI; Hwang, SW				Mackel, Charles E.; Morel, Brent C.; Winer, Jesse L.; Park, Hannah G.; Sweeney, Megan; Heller, Robert S.; Rideout, Leslie; Riesenburger, Ron I.; Hwang, Steven W.			Secondary overtriage of pediatric neurosurgical trauma at a Level I pediatric trauma center	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						head injury; pediatric; transfer; triage; trauma	NEUROLOGICALLY INTACT CHILDREN; LINEAR SKULL FRACTURES; BLUNT HEAD TRAUMA; INTERFACILITY TRANSFERS; EMERGENCY-DEPARTMENTS; CENTER DESIGNATION; PATIENT TRANSFERS; INJURED CHILDREN; ADULT TRAUMA; CENTER CARE	OBJECTIVE The authors reviewed the transfer requests for isolated pediatric traumatic brain injuries (TBIs) at a Level I/II facility with the goal of identifying clinical and radiographic traits associated with potentially avoidable transfers that could be safely managed in a non-tertiary care setting. METHODS The authors conducted a retrospective study of patients < 18 years of age classified as having TBI and transferred to their Level I tertiary care center over a 12-year period. The primary outcome of interest was identifying potentially avoidable transfers, defined as transfers of patients not requiring any neurosurgical intervention and discharged 1 hospital day after admission. RESULTS Overall, 70.8% of pediatric patients with isolated TBI did not require neurosurgical intervention or monitoring, indicating an avoidable transfer. Potentially avoidable transfers were associated with outside hospital imaging that was negative (86%) or showed isolated, nondisplaced skull fractures (86%) compared to patients with cranial pathology (53.8%, p < 0.001) as well as age = 6 years (81% [negative imaging/isolated, nondisplaced fractures] vs 54% [positive cranial pathology], p < 0.001). The presence of headaches, nonfocal deficits, and loss of consciousness were associated with necessary transfer (p < 0.05). Patients with potentially avoidable transfers underwent frequent repeat CT studies (19.1%) and admissions to the pediatric intensive care unit (55.9%) but at a lower rate than those whose transfers were necessary (p < 0.001). Neurosurgical interventions occurred in 11% of patients with cranial pathology, which accounted for 17.9% of necessary transfers and 5.2% of all transfers. CONCLUSIONS In the authors' region, potentially up to 70% of interfacility transfers for pediatric brain trauma in the absence of other systemic injuries warranting surgical intervention may not require neurosurgical intervention and could be managed locally. No patients transferred with isolated, nondisplaced skull fractures or negative CT scans required neurosurgical intervention, and 86% were discharged the day after admission. In contrast, 11% of patients with CT scans indicative of cranial pathology required neurosurgical intervention. Age > 6 years, loss of consciousness, and nonfocal deficits were associated with a greater likelihood of needing a transfer. Further studies are required to clarify which patients can be managed at local institutions, but referring centers should practice overcaution given the potential risks.	[Mackel, Charles E.; Morel, Brent C.; Winer, Jesse L.; Park, Hannah G.; Sweeney, Megan; Heller, Robert S.; Rideout, Leslie; Riesenburger, Ron I.] Tufts Med Ctr, Dept Neurosurg, Boston, MA USA; [Mackel, Charles E.; Morel, Brent C.; Winer, Jesse L.; Park, Hannah G.; Sweeney, Megan; Heller, Robert S.; Rideout, Leslie; Riesenburger, Ron I.] Floating Hosp Children, Boston, MA USA; [Hwang, Steven W.] Shriners Hosp Children, Philadelphia, PA 19140 USA		Hwang, SW (corresponding author), Shriners Hosp Children, Philadelphia, PA 19140 USA.	stevenhwang@hotmail.com					American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Amini Rachid, 2011, J Emerg Trauma Shock, V4, P12, DOI 10.4103/0974-2700.76824; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Ashkenazi I, 2015, EMERG MED J, V32, P946, DOI 10.1136/emermed-2014-203930; Bailes J E, 1997, Telemed J, V3, P135, DOI 10.1089/tmj.1.1997.3.135; Boogaarts HD, 2014, J NEUROSURG, V120, P605, DOI 10.3171/2013.9.JNS13640; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Con J, 2015, J SURG RES, V198, P462, DOI 10.1016/j.jss.2015.03.077; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Esposito TJ, 2006, J TRAUMA, V61, P1380, DOI 10.1097/01.ta.0000242862.68899.04; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Fenton SJ, 2016, J PEDIATR SURG, V51, P1688, DOI 10.1016/j.jpedsurg.2016.05.022; Fenton SJ, 2016, J PEDIATR SURG, V51, P645, DOI 10.1016/j.jpedsurg.2015.09.020; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Gattu RK, 2014, PEDIATR EMERG CARE, V30, P26, DOI 10.1097/PEC.0000000000000061; Glance LG, 2012, J AM COLL SURGEONS, V215, P372, DOI 10.1016/j.jamcollsurg.2012.03.018; Goh KYC, 1997, BRIT J NEUROSURG, V11, P52; Goldstein SD, 2015, J PEDIATR SURG, V50, P1028, DOI 10.1016/j.jpedsurg.2015.03.028; KISSOON N, 1990, CAN MED ASSOC J, V142, P27; Krug SE, 2007, PEDIATRICS, V119, P161, DOI 10.1542/peds.2006-2900; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lefort R, 2017, PEDIATR EMERG CARE, V33, P161, DOI 10.1097/PEC.0000000000000863; Leung A, 2016, AM SURGEON, V82, P763; Li J, 2012, PEDIATRICS, V130, P83, DOI 10.1542/peds.2011-1819; Lynch KT, 2016, J SURG RES, V204, P460, DOI 10.1016/j.jss.2016.05.035; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mohr NM, 2016, ACAD EMERG MED, V23, P885, DOI 10.1111/acem.12972; Moya M, 2010, TELEMED J E-HEALTH, V16, P245, DOI 10.1089/tmj.2010.0044; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Osler TM, 2001, J TRAUMA, V50, P96, DOI 10.1097/00005373-200101000-00017; Oyetunji TA, 2011, AM J SURG, V201, P445, DOI 10.1016/j.amjsurg.2010.10.006; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Reuveni-Salzman A, 2016, CHILD NERV SYST, V32, P1669, DOI 10.1007/s00381-016-3175-2; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Tang A, 2014, J TRAUMA ACUTE CARE, V77, P969, DOI 10.1097/TA.0000000000000462; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352	48	3	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2018	22	4					375	383		10.3171/2018.5.PEDS182			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GV6SL	WOS:000446245200009	29957140	Bronze			2022-02-06	
J	Murray, NG; Grotewold, C; Szekely, B; Powell, D; Munkasy, B				Murray, Nicholas G.; Grotewold, Cody; Szekely, Brian; Powell, Doug; Munkasy, Barry			Validity and reliability of the Balance Tracking System during feet together stance	MEASUREMENT			English	Article						Posture; Portable force platform; Center of pressure; Consistency	POSTURAL-CONTROL; CONCUSSION; STABILITY; RECOVERY; PRESSURE; INJURY; SWAY; PLATE	Laboratory and clinical measures of postural control are commonly used in the diagnosis of concussion. A novel instrument, the Balance Tracking System (BTrackS), has similar instrumentation to a force platform (FP), with greater portability and reduced cost. The purpose was to evaluate the concurrent validity of derived center of pressure (CoP) excursion and mean velocity for the raw CoP coordinates produced by the BTrackS and FP during feet together quiet upright stance. Participants stood on the BTrackS and FP at two time points. The BTrackS excursion values were significantly lower than the FP values at both time points but the devices CoP excursion values were strongly related at both time points and in all conditions. For mean velocity data, there were no significant differences between the devices at any time point. The BTrackS had excellent test-retest reliability over time in all conditions for both the excursion and mean velocity data.	[Murray, Nicholas G.; Grotewold, Cody; Szekely, Brian; Munkasy, Barry] Georgia Southern Univ, Waters Coll Hlth Profess, Dept Hlth Sci & Kinesiol, Statesboro, GA 30458 USA; [Powell, Doug] Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA		Murray, NG (corresponding author), Georgia Southern Univ, Waters Coll Hlth Profess, Dept Hlth Sci & Kinesiol, Statesboro, GA 30458 USA.	nmurray@georgiasouthern.edu		Szekely, Brian/0000-0001-9502-0984			[Anonymous], 1995, GAIT POSTURE; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Chang CJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/463792; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hearn MC, 2018, CLIN J SPORT MED, V28, P177, DOI 10.1097/JSM.0000000000000435; HOLM S, 1979, SCAND J STAT, V6, P65; Lemay JF, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-8; Levy SS, 2018, J GERIATR PHYS THER, V41, P102, DOI 10.1519/JPT.0000000000000111; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto T. E., 1996, IEEE T BIOMED ENG, V43; Reed-Jones R, 2017, GAMES HEALTH J, V6, P61, DOI 10.1089/g4h.2016.0054; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson G.E., 2013, RES METHODS BIOMECHA; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	27	3	3	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	OCT	2018	126						96	101		10.1016/j.measurement.2018.05.039			6	Engineering, Multidisciplinary; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Instruments & Instrumentation	GT6MI	WOS:000444627000010					2022-02-06	
J	Parker, SL; Saxena, M; Gowardman, J; Lipman, J; Myburgh, J; Roberts, JA				Parker, Suzanne L.; Saxena, Manoj; Gowardman, John; Lipman, Jeffrey; Myburgh, John; Roberts, Jason A.			Population pharmacokinetics of intravenous paracetamol in critically ill patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Brain injury; Paracetamol; Pharmacokinetic; Trauma	TEMPERATURE; PLASMA; STROKE	Purpose: High-dose paracetamol (6 g/day) is a low-cost intervention that may prevent pyrexia. The purpose of this study was to describe the pharmacokinetics of high-dose intravenous paracetamol, in patients with traumatic brain injury (TBI). Materials and methods: A clinical pharmacokinetic study in adult patients with TBI was performed as a sub-study to a prospective, phase 2B, randomized placebo-controlled study (PARITY). Patients received 1 g of intravenous paracetamol or 0.9% sodium chloride every 4 h for 72 h. Results: All patients were included in the phamiacokinetic sub-study. The mean age, weight and area under the concentration-time curve for the sampled dosing interval were 34.5 yr, 82.3 kg and 39.9 +/- 19.8 mg.h/L, respectively. The concentrations observed in the study patients were well below the threshold of toxicity and there was no evidence of accumulation of paracetamol. Paracetamol clearance was found to be high and variable (25.7 L.h(-1), coefficient of variation (CV) 40.9%), and a wide range of volume of distribution observed (27.6 L, CV 30.6%). A relationship between lower Glasgow coma scores and higher dearance of paracetamol was observed. Conclusion: Due to altered pharmacokinetics, patients experiencing severe TBI may require a higher dose of paracetamol to achieve drug exposure that results in preventing pyrexia. (C) 2018 Elsevier Inc. All rights reserved.	[Parker, Suzanne L.; Lipman, Jeffrey; Roberts, Jason A.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Saxena, Manoj; Myburgh, John] Univ New South Wales, Dept Intens Care Med, St George Hosp Clin Sch, Sydney, NSW, Australia; [Gowardman, John; Lipman, Jeffrey; Roberts, Jason A.] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia; [Lipman, Jeffrey] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia; [Roberts, Jason A.] Univ Queensland, Sch Pharm, Ctr Translat Antiinfect Pharmacodynam, Brisbane, Qld, Australia; [Roberts, Jason A.] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia		Parker, SL (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	suzanne.parker@uq.edu.au	Roberts, Jason A/F-6272-2010; Lipman, Jeffrey/G-2211-2010; Parker, Suzanne/C-5348-2017	Roberts, Jason A/0000-0001-6218-435X; Lipman, Jeffrey/0000-0002-5965-9876; Parker, Suzanne/0000-0002-6124-7475; Saxena, Manoj/0000-0002-0385-6731			Abdul-Aziz MH, 2016, ANTIMICROB AGENTS CH, V60, P206, DOI 10.1128/AAC.01543-15; Allegaert K, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0144-3; Allegaert K, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-77; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; Coimbra C, 1996, ACTA NEUROPATHOL, V92, P447, DOI 10.1007/s004010050545; FDA, 2021, BIOANALYTICAL METHOD GUID IND BIOAN METH; Fuster-Lluch O, 2017, J CLIN PHARMACOL, V57, P1345, DOI 10.1002/jcph.903; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Gibb IA, 2008, ARCH DIS CHILD, V93, P241, DOI 10.1136/adc.2007.126896; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Gregoire N, 2007, CLIN PHARMACOL THER, V81, P401, DOI 10.1038/sj.clpt.6100064; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Langford RA, 2016, ANESTH ANALG, V123, P610, DOI 10.1213/ANE.0000000000001463; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Mathers C. D., 2001, GLOBAL BURDEN DIS RI; Owens KH, 2012, THER DRUG MONIT, V34, P713, DOI 10.1097/FTD.0b013e31826a70ea; Parker SL, 2015, ANTIMICROB AGENTS CH, V59, P6471, DOI 10.1128/AAC.01321-15; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027; Rumack BH, 2002, J TOXICOL-CLIN TOXIC, V40, P3, DOI 10.1081/CLT-120002882; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Taylor C, 2015, PLOS ONE, V10	24	3	3	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	OCT	2018	47						15	20		10.1016/j.jcrc.2018.05.016			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT9WC	WOS:000444896900003	29883885	Green Submitted			2022-02-06	
J	Reuter-Rice, K; Regier, M; Bennett, E; Laskowitz, D				Reuter-Rice, Karin; Regier, Michael; Bennett, Ellen; Laskowitz, Daniel			The Effect of the Relationship of APOE Polymorphisms and Cerebral Vasospasm on Functional Outcomes in Children With Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						apolipoprotein E (APOE); cerebral vasospasm; functional outcome; pediatric; traumatic brain injury	TRANSCRANIAL DOPPLER SONOGRAPHY; APOLIPOPROTEIN-E; FLOW VELOCITIES; HEAD-INJURY; ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS; ALLELE; GENE; AGE	Background: Pediatric traumatic brain injury (TBI) is a leading cause of death and disability. Polymorphisms in the apolipoprotein E (APOE) gene have been linked to cerebral vasospasm (CV) and poor outcomes in adults with TBI, yet these associations remain poorly defined in children. Objective: We examined the effect of the relationship between APOE polymorphisms and CV on functional outcomes in children with a TBI. Method: This prospective, descriptive study examined 60 children (aged 10 days to 15 years) with a TBI. Data included demographic information, genetic sampling for the APOE gene and single-nucleotide polymorphisms (SNPs; rs405509, rs429358, rs7412), and daily transcranial Doppler ultrasounds to evaluate for CV. We examined Glasgow Outcome Scale-Extended Pediatrics (GOS-E Peds) scores at the time of discharge and 4-6 weeks after discharge. Results: More than half (56.7%) of the 60 children (M-age = 5.9 years) were male. Twenty-six participants (43.3%) experienced an occurrence of CV. There were significant differences in injury mechanism (unadjusted p = .048) and age (unadjusted p = .02) between those with and without CV. Also, the noncoding promoter SNP rs405509 T/T, when considered with injury severity, appeared to modify the relationship of APOE genotype to CV. The relationship between APOE and CV had no significant effect on GOS-E Peds scores. Conclusion: Injury severity and the APOE noncoding promoter SNP rs405509 may modify the relationship between APOE and CV in children with TBI. More studies are needed to understand the role of APOE polymorphisms in outcomes in children with TBI.	[Reuter-Rice, Karin] Duke Univ, Dept Pediat, Div Crit Care Med, Sch Nursing,Sch Med, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA; [Regier, Michael] West Virginia Univ, Dept Biostat, Morgantown, WV USA; [Bennett, Ellen; Laskowitz, Daniel] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA		Reuter-Rice, K (corresponding author), Duke Univ, Dept Pediat, Div Crit Care Med, Sch Nursing,Sch Med, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA.	karin.reuter-rice@duke.edu		Reuter-Rice, Karin/0000-0003-1501-8994	NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30 NR014139] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30NR014139] Funding Source: NIH RePORTER		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alexander SA, 2008, BIOL RES NURS, V10, P102, DOI 10.1177/1099800408321722; [Anonymous], 2015, C TRAUM BRAIN INJ US; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; Beers S.R, 2012, J NEUROTRAUM, V29, P1126, DOI [10. 1089/neu. 2011. 2272, DOI 10.1089/NEU.2011.2272]; Bennett E. R., 2016, GENETIC INFLUENCES T, P179; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; BODE H, 1989, J CHILD NEUROL, V4, pS68, DOI 10.1177/0883073889004001S11; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Centers for Disease Control and Prevention, 2016, PERC DISTR TBI REL E; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Khurana V. G., 2006, NEUROSURG FOCUS, V21, P1, DOI DOI 10.3171/FOC.2006.21.3.3; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Ladner TR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/291895; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mesis R.G., 2006, NEUROSURG FOCUS, V21, P1, DOI DOI 10.3171/FOC.2006.21.3.4; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Reuter-Rice Karin, 2017, J Radiol Nurs, V36, P3, DOI 10.1016/j.jradnu.2016.11.003; Reuter-Rice K, 2015, ANNU REV NURS RES-SE, V33, P185, DOI 10.1891/0739-6686.33.185; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Wu HT, 2010, BRAIN RES, V1362, P112, DOI 10.1016/j.brainres.2010.09.013; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	46	3	3	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2018	20	5					566	576		10.1177/1099800418785982			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	GS6PG	WOS:000443819200009	29996665	Green Published			2022-02-06	
J	Song, Y; Xiong, Y; Chen, W; Zuo, F; Tan, LW; Yao, J; Chen, N; Bleys, R; Hu, X; Zhang, SX; Wu, Y				Song, Yan; Xiong, Yan; Chen, Wei; Zuo, Feng; Tan, Liwen; Yao, Jie; Chen, Na; Bleys, Ronald; Hu, Xin; Zhang, Shaoxiang; Wu, Yi			Sectional Anatomy and Three-Dimensional Visualization of the Posterolateral Complex of the Knee Joint Based on Undeformed High-Resolution Sectional Anatomical Images	ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY			English	Article						Chinese visible human; knee joint; posterolateral complex; sectional anatomy; visualization	POSTERIOR CRUCIATE LIGAMENT; VISIBLE HUMAN PROJECT; POPLITEOFIBULAR LIGAMENT; CORNER RECONSTRUCTION; ROTATORY INSTABILITY; POPLITEAL TENDON; HUMAN CVH; STABILITY; CLASSIFICATION; INJURIES	The anatomy of the posterolateral complex (PLC) of the knee is usually studied by dissection and magnetic resonance (MR) imaging, which is still controversial. We aim to study it based on the images and an interactive 3D-PDF from the Chinese Visible Human (CVH) datasets. CVH datasets (six transverse and one coronal) of the PLC and its adjacent structures were segmented and three-dimensionally reconstructed. Histological sections images were used to establish criteria for the segmentation. MR images were studied in comparison with CVH images. The PLC was mainly composed of the fibular collateral ligament (FCL), popliteofibular ligament (PFL), arcuate popliteal ligament (APL), popliteus tendon (PT), fabellofibular ligament (FFL) and biceps femoris tendon (BT). These structures had origins or insertions located close to each other and collectively maintained the stability of the PLC. The origins of the PT and the FCL were located on the lateral condyle of the femur. The APL was "Y" shaped and had a 100% occurrence in our study. Its lateral and medial heads originated, respectively, from the posterolateral part and medial-inferior part of fibrous capsule close to the lateral femoral condyle. The FCL, BT, main trunk of the APL, PFL and FFL had adjacent insertions on the posterolateral fibular head. CVH high-resolution sectional anatomical images and a 3D-pdf provided detailed morphological data for the PLC, and improved the identification and diagnostic accuracy for the PLC in MRI. We speculate that APL has a strong biological and mechanistic significance in the PLC. Anat Rec, 301:1764-1773, 2018. (c) 2018 Wiley Periodicals, Inc.	[Song, Yan; Tan, Liwen; Yao, Jie; Chen, Na; Hu, Xin; Zhang, Shaoxiang; Wu, Yi] Third Mil Med Univ, Inst Digital Med, Biomed Engn Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China; [Song, Yan; Zuo, Feng] Third Mil Med Univ, Informat Management Dept, Chongqing, Peoples R China; [Xiong, Yan] Third Mil Med Univ, Daping Hosp, Dept Orthoped, Chongqing, Peoples R China; [Chen, Wei] Third Mil Med Univ, Xinan Hosp, Dept Radiol, Chongqing, Peoples R China; [Bleys, Ronald] Univ Med Ctr Utrecht, Div Surg Specialties, Dept Anat, Utrecht, Netherlands		Zhang, SX; Wu, Y (corresponding author), Third Mil Med Univ, Inst Digital Med, Biomed Engn Coll, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	zhangsx1021@yahoo.com; wuy1979@tmmu.edu.cn			Military Youth Science Foundation of China [16QNP100]; National Key Research and Development Program of China [2016YFC0106402]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772330, 31771324]; Higher Education Teaching Reform Research Project of China Chongqing [153222]	Grant sponsor: Military Youth Science Foundation of China; Grant number: No. 16QNP100; Grant sponsor: National Key Research and Development Program of China; Grant number: No. 2016YFC0106402; Grant sponsor: National Nature Science Foundation of China; Grant number: No. 81772330 and No. 31771324; Grant sponsor: Higher Education Teaching Reform Research Project of China Chongqing; Grant number: 153222.	Apsingi S, 2008, AM J SPORT MED, V36, P487, DOI 10.1177/0363546508314415; Bonanzinga T, 2015, KNEE SURG SPORT TR A, V23, P2918, DOI 10.1007/s00167-015-3696-3; Collins MS, 2015, KNEE SURG SPORT TR A, V23, P2943, DOI 10.1007/s00167-015-3738-x; Devitt BM, 2015, SPORTS MED ARTHROSC, V23, P10, DOI 10.1097/JSA.0000000000000046; FUSS FK, 1991, ANAT REC, V230, P283, DOI 10.1002/ar.1092300217; Haims AH, 2003, AM J ROENTGENOL, V180, P647, DOI 10.2214/ajr.180.3.1800647; Harish S, 2006, CLIN RADIOL, V61, P457, DOI 10.1016/j.crad.2005.06.014; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P173, DOI 10.2106/00004623-197658020-00002; Kesman TJ, 2011, CLIN ORTHOP RELAT R, V469, P76, DOI 10.1007/s11999-010-1525-z; Kim SJ, 2011, J BONE JOINT SURG AM, V93A, P809, DOI 10.2106/JBJS.I.01266; Krudwig WK, 2002, KNEE SURG SPORT TR A, V10, P91, DOI 10.1007/s00167-001-0269-4; Lee HJ, 2015, KNEE SURG SPORT TR A, V23, P3062, DOI 10.1007/s00167-014-3138-7; Maynard MJ, 1996, AM J SPORT MED, V24, P311, DOI 10.1177/036354659602400311; MCCLUSKEY G, 1980, PHYS THER, V60, P1575, DOI 10.1093/ptj/60.12.1575; Minowa T, 2004, J ORTHOP SCI, V9, P59, DOI 10.1007/s00776-003-0739-2; NIELSEN S, 1986, ARCH ORTHOP TRAUM SU, V104, P357, DOI 10.1007/BF00454430; Noyes FR, 2005, AM J SPORT MED, V33, P646, DOI 10.1177/0363546504271210; ORANSKY M, 1989, ANAT REC, V225, P347, DOI 10.1002/ar.1092250411; Raheem O, 2007, KNEE SURG SPORT TR A, V15, P895, DOI 10.1007/s00167-007-0301-4; Rosas HG, 2016, RADIOGRAPHICS, V36, P1776, DOI 10.1148/rg.2016160027; SEEBACHER JR, 1982, J BONE JOINT SURG AM, V64, P536, DOI 10.2106/00004623-198264040-00008; Thaunat M, 2014, KNEE SURG SPORT TR A, V22, P2121, DOI 10.1007/s00167-013-2643-4; VANLEEUWEN MBM, 1990, STAIN TECHNOL, V65, P37, DOI 10.3109/10520299009105606; Vinson EN, 2008, AM J ROENTGENOL, V190, P449, DOI 10.2214/AJR.07.2051; Wadia FD, 2003, INT ORTHOP, V27, P172, DOI 10.1007/s00264-003-0445-x; Wu Y, 2012, COMPUT MED IMAG GRAP, V36, P336, DOI 10.1016/j.compmedimag.2012.01.003; Yoon KH, 2011, AM J SPORT MED, V39, P2421, DOI 10.1177/0363546511415656; Zhang H, 2016, Beijing Da Xue Xue Bao Yi Xue Ban, V48, P237; Zhang SX, 2005, P ANN INT IEEE EMBS, P4168; Zhang SX, 2004, J ANAT, V204, P165, DOI 10.1111/j.0021-8782.2004.00274.x; Zhang SX, 2006, CLIN ANAT, V19, P204, DOI 10.1002/ca.20273	31	3	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8486	1932-8494		ANAT REC	Anat. Rec.	OCT	2018	301	10					1764	1773		10.1002/ar.23926			10	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	GZ7EJ	WOS:000449639900017	30383338	Bronze			2022-02-06	
J	Bacon, CEW; Kay, MC; Weber, ML; Tierney, DK; McLeod, TCV				Bacon, Cailee E. Welch; Kay, Melissa C.; Weber, Michelle L.; Tierney, Dayna K.; McLeod, Tamara C. Valovich			School Nurses' Perceived Challenges With Concussion Management Procedures in the Secondary School Setting	SAGE OPEN NURSING			English	Article						concussion policy; concussion education; traumatic brain injury; mental health; multidisciplinary team	SPORT-RELATED CONCUSSIONS; ACADEMIC ACCOMMODATIONS; EMERGENCY-DEPARTMENT; KNOWLEDGE; RETURN; STUDENT; PLAY; SUPPORT; LEARN; RECOMMENDATIONS	School nurses have an integral role in managing student health concerns throughout the school day, yet little is known about their specific role in concussion management. Therefore, the purpose of this study was to explore the challenges encountered by school nurses regarding concussion management in the secondary school setting. Twenty-two school nurses employed in the secondary school setting were interviewed via phone. We analyzed the data via the consensual qualitative research paradigm. Overall, we found school nurses face consistent challenges with their role on the concussion management team, specifically related to education of school personnel, parents, and community health-care providers. Challenging topics included the inconsistency of community health-care provider recommendations and others' perceptions of school nurses' preparation and training to be important members of the concussion management team. Efforts to increase concussion education and improve communication across all stakeholders of the concussion management team should be implemented.	[Bacon, Cailee E. Welch; Tierney, Dayna K.; McLeod, Tamara C. Valovich] AT Still Univ, Mesa, AZ USA; [Kay, Melissa C.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Weber, Michelle L.] Univ Georgia, Athens, GA 30602 USA		Bacon, CEW (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.; Bacon, CEW (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, 5850 E Still Circle, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	A.T. Still University Strategic Research Fund	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The A.T. Still University Strategic Research Fund provided financial support for this investigation.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Bacon CEW, 2018, INT J ATHL THER TRAI, V23, P33, DOI 10.1123/ijatt.2017-0043; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Feddermann-Demont N, 2014, J SPORT SCI, V32, P1217, DOI 10.1080/02640414.2014.918273; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Gourley M. M., 2010, ATHLETIC TRAINING SP, V2, P1; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Kasamatsu T. M., 2016, ATHLETIC TRAINING SP, V8, P112, DOI DOI 10.3928/19425864-20160225-01; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lyons VH, 2017, J SCHOOL HEALTH, V87, P416, DOI 10.1111/josh.12510; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Melander J, 2014, ORTHOP NURS, V33, P323, DOI 10.1097/NOR.0000000000000102; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Mummert DK, 2014, J ATHL TRAINING, V49, pS142; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Rains C., 2010, NASN SCH NURSE, V25, P5, DOI DOI 10.1177/1942602X10376672; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sleight A. J., 2015, J ATHL TRAINING, V50, P565; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams R. M., 2015, QUICK QUESTIONS SPOR, P39; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	46	3	4	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2377-9608			SAGE OPEN NURS	SAGE Open Nurs.	SEP 12	2018	4								2377960818798437	10.1177/2377960818798437			12	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	GT5OX	WOS:000444560200001	33415205	gold, Green Published			2022-02-06	
J	Ordek, G; Asan, AS; Cetinkaya, E; Skotak, M; Kakulavarapu, VR; Chandra, N; Sahin, M				Ordek, Gokhan; Asan, Ahmet S.; Cetinkaya, Esma; Skotak, Maciej; Kakulavarapu, Venkata R.; Chandra, Namas; Sahin, Mesut			Electrophysiological Correlates of Blast-Wave Induced Cerebellar Injury	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; MOTOR; FIBER; MILD; SPINOCEREBELLAR; COORDINATION; EXCITATION; CHILDREN; DEFICITS	Understanding the mechanisms underlying traumatic neural injury and the sequelae of events in the acute phase is important for deciding on the best window of therapeutic intervention. We hypothesized that evoked potentials (EP) recorded from the cerebellar cortex can detect mild levels of neural trauma and provide a qualitative assessment tool for progression of cerebellar injury in time. The cerebellar local field potentials evoked by a mechanical tap on the hand and collected with chronically implanted micro-ECoG arrays on the rat cerebellar cortex demonstrated substantial changes both in amplitude and timing as a result of blast-wave induced injury. The results revealed that the largest EP changes occurred within the first day of injury, and partial recoveries were observed from day-1 to day-3, followed by a period of gradual improvements (day-7 to day-14). The mossy fiber (MF) and climbing fiber (CF) mediated components of the EPs were affected differentially. The behavioral tests (ladder rung walking) and immunohistological analysis (calbindin and caspase-3) did not reveal any detectable changes at these blast pressures that are typically considered as mild (100-130 kPa). The results demonstrate the sensitivity of the electrophysiological method and its use as a tool to monitor the progression of cerebellar injuries in longitudinal animal studies.	[Ordek, Gokhan; Asan, Ahmet S.; Cetinkaya, Esma; Skotak, Maciej; Kakulavarapu, Venkata R.; Chandra, Namas; Sahin, Mesut] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Skotak, Maciej; Kakulavarapu, Venkata R.; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07103 USA		Chandra, N; Sahin, M (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.; Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07103 USA.	namas.chandra@njit.edu; sahin@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	New Jersey Commission for Brain Injury Research [CBIR15IRG022]; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [14059001]	This study was supported by: 1) New Jersey Commission for Brain Injury Research (grant # CBIR15IRG022, recipient: Me.S.), and 2) U.S. Army Medical Research and Materiel Command (grant # 14059001, recipient: N.C.). The funding agencies had no role in the design and execution of the study, data collection, analysis and interpretation of the data, preparation, review or approval of the manuscript, and decision for publication. We are grateful for the help obtained during blast exposure experiments and imaging from Eren Alay and Daniel Younger, respectively.	Adamaszek M., 2016, CEREBELLUM; Ai JL, 2004, PHARMACOLOGY, V71, P192, DOI 10.1159/000078085; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; ARMSTRONG DM, 1971, BRAIN RES, V25, P199, DOI 10.1016/0006-8993(71)90582-8; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bengtsson F, 2007, J NEUROPHYSIOL, V98, P1697, DOI 10.1152/jn.00057.2007; Binion D. J., 2014, ANN M BIOMEDICAL ENG; Braga LW, 2007, J CHILD NEUROL, V22, P1084, DOI 10.1177/0883073807306246; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Culic M, 2005, ACTA NEUROBIOL EXP, V65, P11; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dietrichs E, 1981, EXPT BRAIN RES, V44; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; ECCLES J, 1964, NATURE, V203, P245, DOI 10.1038/203245a0; ECCLES JC, 1961, J PHYSIOL-LONDON, V158, P486, DOI 10.1113/jphysiol.1961.sp006782; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; JI Z, 1994, NEUROSCIENCE, V61, P935, DOI 10.1016/0306-4522(94)90414-6; Jorntell H, 2000, J PHYSIOL-LONDON, V522, P297, DOI 10.1111/j.1469-7793.2000.00297.x; Joyal CC, 1996, BRAIN RES, V739, P1, DOI 10.1016/S0006-8993(96)00333-2; Kershman J., 1940, ARCH NEUROLOGY PSYCH, V328, P44; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315, DOI 10.1109/86.788468; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mauk MD, 2000, CURR BIOL, V10, pR522, DOI 10.1016/S0960-9822(00)00584-4; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MEHLER WR, 1974, CONFIN NEUROL, V36, P205; Miller D. R., 2016, BRAIN IMAGING BEHAV; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; Ordek G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00197; Ordek G, 2013, J NEUROPHYSIOL, V109, P1435, DOI 10.1152/jn.00455.2012; Oscarsson O, 1973, HDB SENSORY PHYSIOLO, VII, P339; Palay SL, 1974, CEREBELLAR CORTEX CY, P11; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sankar Viswanath, 2014, Front Neuroeng, V7, P13, DOI 10.3389/fneng.2014.00013; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shambes G. M., 2008, BRAIN BEHAV EVOLUT, V15, P116; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Watson TC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00004; Watson TC, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.018.2009; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Zucca R, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0067-15.2015	67	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 11	2018	8								13633	10.1038/s41598-018-31728-4			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT1ZZ	WOS:000444279000039	30206255	Green Published, gold			2022-02-06	
J	Drange, OK; Vaaler, AE; Morken, G; Andreassen, OA; Malt, UF; Finseth, PI				Drange, Ole Kristian; Vaaler, Arne Einar; Morken, Gunnar; Andreassen, Ole Andreas; Malt, Ulrik Fredrik; Finseth, Per Ivar			Clinical characteristics of patients with bipolar disorder and premorbid traumatic brain injury: a cross-sectional study	INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS			English	Article						Bipolar disorder; Brain injuries; Diagnosis; Principal component analysis; Irritable mood; Migraine disorders	HEAD-INJURY; MANIA; HISTORY; SCHIZOPHRENIA; RELIABILITY; PREVALENCE; SECONDARY; SYMPTOMS; VALIDITY; BEHAVIOR	Background: About one in ten diagnosed with bipolar disorder (BD) has experienced a premorbid traumatic brain injury (TBI), while not fulfilling the criteria of bipolar and related disorder due to another medical condition (BD due to TBI). We investigated whether these patients have similar clinical characteristics as previously described in BD due to TBI (i.e. more aggression and irritability and an increased hypomania/mania: depression ratio) and other distinct clinical characteristics. Methods: Five hundred five patients diagnosed with BD type I, type II, or not otherwise specified, or cyclothymia were interviewed about family, medical, and psychiatric history, and assessed with the Young Mania Rating Scale (YMRS) and the Inventory of Depressive Symptoms Clinician Rated 30 (IDS-C-30). Principal component analyses of YMRS and IDS-C-30 were conducted. Bivariate analyses and logistic regression analyses were used to compare clinical characteristics between patients with (n = 37) and without (n = 468) premorbid TBI. Results: Premorbid TBI was associated with a higher YMRS disruptive component score (OR 1.7, 95% CI 1.1-2.4, p = 0.0077) and more comorbid migraine (OR 4.6, 95% CI 1.9-11, p = 0.00090) independently of several possible confounders. Items on disruptive/aggressive behaviour and irritability had the highest loadings on the YMRS disruptive component. Premorbid TBI was not associated with an increased hypomania/mania: depression ratio. Conclusions: Disruptive symptoms and comorbid migraine characterize BD with premorbid TBI. Further studies should examine whether the partial phenomenological overlap with BD due to TBI could be explained by a continuum of pathophysiological effects of TBI across the diagnostic dichotomy.	[Drange, Ole Kristian; Vaaler, Arne Einar; Morken, Gunnar] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway; [Drange, Ole Kristian; Vaaler, Arne Einar; Morken, Gunnar] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Ostmarka, Div Mental Hlth Care, Trondheim, Norway; [Andreassen, Ole Andreas; Malt, Ulrik Fredrik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Andreassen, Ole Andreas] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT, Oslo, Norway; [Malt, Ulrik Fredrik] Oslo Univ Hosp, Dept Res & Educ, Div Clin Neurosci, Oslo, Norway; [Finseth, Per Ivar] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Broset, Div Mental Hlth Care, Trondheim, Norway		Drange, OK (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Ostmarka, Div Mental Hlth Care, Trondheim, Norway.	ole.kristian.drange@gmail.com	Morken, Gunnar/AAX-3373-2020; Andreassen, Ole A./AAY-7531-2020	Morken, Gunnar/0000-0003-1972-5901	South-East Norway Health Authority; KG Jebsen Foundation; Research Council of NorwayResearch Council of Norway	The study was supported by the South-East Norway Health Authority, the KG Jebsen Foundation, and the Research Council of Norway. The funding bodies have not been involved in the design of the present study, in the collection, analysis, or interpretation of data, or in the writing of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Organization, 1994, DIAGN STAT MAN MENT; Antypa N, 2014, J AFFECT DISORDERS, V156, P178, DOI 10.1016/j.jad.2013.12.013; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baek JH, 2011, J AFFECT DISORDERS, V131, P59, DOI 10.1016/j.jad.2010.11.020; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brage S, 1996, FAM PRACT, V13, P391, DOI 10.1093/fampra/13.4.391; Burton BK, 2017, LANCET PSYCHIAT, V4, P400, DOI 10.1016/S2215-0366(17)30103-7; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Coetzer R, 2008, CNS SPECTRUMS, V13, P1022, DOI 10.1017/S1092852900017065; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Elger CE, 2018, LANCET NEUROL, V17, P279, DOI 10.1016/S1474-4422(18)30038-3; First M., 1997, STRUCTURED CLIN INTE; Fornaro M, 2015, COMPR PSYCHIAT, V59, P141, DOI 10.1016/j.comppsych.2015.02.015; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Hanwella R, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-137; Hibar DP, 2018, MOL PSYCHIATR, V23, P932, DOI 10.1038/mp.2017.73; Ingebrigtsen T, 2000, Tidsskr Nor Laegeforen, V120, P1985; Ismail B, 1998, AM J PSYCHIAT, V155, P84, DOI 10.1176/ajp.155.1.84; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Lamberts H, 1987, INT CLASSIFICATION P; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Leverich GS, 2006, LANCET, V367, P1040, DOI 10.1016/S0140-6736(06)68450-X; Leverich GS, 2001, J AFFECT DISORDERS, V67, P33, DOI 10.1016/S0165-0327(01)00430-X; Lique Ste Fan A, 2015, ANN PHYS REHABIL MED, V59, P5; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Morken G, 2009, BRIT J PSYCHIAT, V194, P559, DOI 10.1192/bjp.bp.108.054452; Muller-Oerlinghausen B, 2010, NEUROPSYCHOBIOLOGY, V62, P43, DOI 10.1159/000314309; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; R Core Team, R LANG ENV STAT COMP; RStudio Team, RSTUDIO INT DEV R; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sagduyu K, 2002, J CLIN PSYCHIAT, V63, P594, DOI 10.4088/JCP.v63n0710a; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Satzer D, 2016, BIPOLAR DISORD, V18, P205, DOI 10.1111/bdi.12387; Serretti A, 2005, J AFFECT DISORDERS, V84, P159, DOI 10.1016/j.jad.2003.09.011; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Skjelstad DV, 2011, J AFFECT DISORDERS, V132, P333, DOI 10.1016/j.jad.2011.03.003; Skjelstad DV, 2010, J AFFECT DISORDERS, V126, P1, DOI 10.1016/j.jad.2009.10.003; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; STOLL AL, 1994, J CLIN PSYCHOPHARM, V14, P311; Strawbridge RJ, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0079-1; Sucksdorff D, 2016, J AFFECT DISORDERS, V206, P109, DOI 10.1016/j.jad.2016.07.034; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vasa RA, 2015, BRAIN INJURY, V29, P921, DOI 10.3109/02699052.2015.1005670; World Health Organization, 1993, ICD 10 CLASS MENT BE; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	58	3	3	0	1	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2194-7511			INT J BIPOLAR DISORD	INT. J. BIBPOLAR DISORD.	SEP 10	2018	6								19	10.1186/s40345-018-0128-6			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GT8LK	WOS:000444788800001	30198055	Green Published, gold			2022-02-06	
J	Wang, LR; Ma, SF; Hu, ZH; McGuire, TF; Xie, XQ				Wang, Lirong; Ma, Shifan; Hu, Ziheng; McGuire, Terence Francis; Xie, Xiang-Qun (Sean)			Chemogenomics Systems Pharmacology Mapping of Potential Drug Targets for Treatment of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chemogenomics systems pharmacology; drug target; secondary injury; transcriptional profile; traumatic brain injury	ALZHEIMERS-DISEASE; ENVIRONMENTAL ENRICHMENT; CONNECTIVITY MAP; AMYLOID-BETA; NEUROPROTECTION; NOREPINEPHRINE; SOD1; KNOWLEDGEBASE; CONSEQUENCES; INHIBITION	Traumatic brain injury (TBI) is associated with high mortality and morbidity. Though the death rate of initial trauma has dramatically decreased, no drug has been developed to effectively limit the progression of the secondary injury caused by TBI. TBI appears to be a predisposing risk factor for Alzheimer's disease (AD), whereas the molecular mechanisms remain unknown. In this study, we have conducted a research investigation of computational chemogenomics systems pharmacology (CSP) to identify potential drug targets for TBI treatment. TBI-induced transcriptional profiles were compared with those induced by genetic or chemical perturbations, including drugs in clinical trials for TBI treatment. The protein-protein interaction network of these predicted targets were then generated for further analyses. Some protein targets when perturbed, exhibit inverse transcriptional profiles in comparison with the profiles induced by TBI, and they were recognized as potential therapeutic targets for TBI. Drugs acting on these targets are predicted to have the potential for TBI treatment if they can reverse the TBI-induced transcriptional profiles that lead to secondary injury. In particular, our results indicated that TRPV4, NEUROD1, and HPRT1 were among the top therapeutic target candidates for TBI, which are congruent with literature reports. Our analyses also suggested the strong associations between TBI and AD, as perturbations on AD-related genes, such as APOE, APP, PSEN1, and MAPT, can induce similar gene expression patterns as those of TBI. To the best of our knowledge, this is the first CSP-based gene expression profile analyses for predicting TBI-related drug targets, and the findings could be used to guide the design of new drugs targeting the secondary injury caused by TBI.	[Wang, Lirong; Ma, Shifan; Hu, Ziheng; McGuire, Terence Francis; Xie, Xiang-Qun (Sean)] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Wang, Lirong; Ma, Shifan; Hu, Ziheng; McGuire, Terence Francis; Xie, Xiang-Qun (Sean)] Univ Pittsburgh, Computat Chem Genom Screening Ctr, Sch Pharm, Pittsburgh, PA USA; [Wang, Lirong; Ma, Shifan; Hu, Ziheng; McGuire, Terence Francis] Univ Pittsburgh, Natl Ctr Excellence Computat Drug Abuse Res, NIH, Pittsburgh, PA USA; [Xie, Xiang-Qun (Sean)] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Xie, Xiang-Qun (Sean)] Univ Pittsburgh, Sch Med, Dept Computat Biol, Pittsburgh, PA USA; [Xie, Xiang-Qun (Sean)] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA USA		Xie, XQ (corresponding author), Univ Pittsburgh, Pharmaceut Sci Drug Discovery Inst, 335 Sutherland Dr,206 Salk Pavil, Pittsburgh, PA 15261 USA.	xix15@pitt.edu		Hu, Ziheng/0000-0002-5482-2734	Department of Defense (DOD)United States Department of Defense [W81XWH-16-1-0490]; National Institutes of Health (NIH) NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P30 DA035778A1]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P30DA035778] Funding Source: NIH RePORTER	The authors would like to acknowledge the funding support to the Xie laboratory from the Department of Defense (DOD) (W81XWH-16-1-0490), and the National Institutes of Health (NIH) NIDA (P30 DA035778A1).	[Anonymous], 2018, TBI GET THE FACTS; Bachstetter A, 2014, ALZHEIMERS DEMENTI S, V10, pP337, DOI [10.1016/j.jalz.2014.05.333, DOI 10.1016/J.JALZ.2014.05.333]; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Berger SI, 2011, WIRES SYST BIOL MED, V3, P129, DOI 10.1002/wsbm.114; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Canterini S, 2012, CEREBELLUM, V11, P28, DOI 10.1007/s12311-010-0211-8; Canterini S, 2009, MOL CELL NEUROSCI, V40, P249, DOI 10.1016/j.mcn.2008.10.013; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; de la Tremblaye PB, 2017, NEUROREHAB NEURAL RE, V31, P977, DOI 10.1177/1545968317739999; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; Dunn-Meynell AA, 1998, BRAIN RES, V800, P245, DOI 10.1016/S0006-8993(98)00524-1; Endo H, 2007, J CEREBR BLOOD F MET, V27, P975, DOI 10.1038/sj.jcbfm.9600399; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Jacoby E, 2011, WIRES COMPUT MOL SCI, V1, P57, DOI 10.1002/wcms.11; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langham J., 2003, COCHRANE DB SYST REV, V12, DOI [10.1002/14651858.CD000033, DOI 10.1002/14651858.CD000033]; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu HB, 2014, J CHEM INF MODEL, V54, P1050, DOI 10.1021/ci500004h; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pasinetti G., 2014, NEUROLOGY S, V82; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Roberts I., 2012, COCHRANE DATABASE SY; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Sheng SJ, 2014, J ETHNOPHARMACOL, V154, P735, DOI 10.1016/j.jep.2014.04.048; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Slemmer JE, 2011, NEUROMETHODS, V48, P643, DOI 10.1007/978-1-60761-898-0_32; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang BL, 2009, CELL ADHES MIGR, V3, P118, DOI 10.4161/cam.3.1.7254; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Ustunel BE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13267; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vogt BA, 2008, BRAIN STRUCT FUNCT, V212, P465, DOI 10.1007/s00429-008-0178-0; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xie XQ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00003; Xu XM, 2016, J MOL GRAPH MODEL, V70, P284, DOI 10.1016/j.jmgm.2016.08.001; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yin Y., 2017, MOL NEUROBIOL, V55, P2454; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zhang H, 2016, SCI REP, V28, P6	73	3	3	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					565	575		10.1089/neu.2018.5757		SEP 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444030200001	30014763	Green Published			2022-02-06	
J	Bestelmeyer, PEG; Davis, NJ; Poliva, O; Rafal, RD				Bestelmeyer, Patricia E. G.; Davis, Nick J.; Poliva, Oren; Rafal, Robert D.			Neuromodulation of Right Auditory Cortex Selectively Increases Activation in Speech-Related Brain Areas in Brainstem Auditory Agnosia	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						auditory agnosia; inferior colliculus; sound recognition; tDCS	DIRECT-CURRENT STIMULATION; MOTOR CORTEX; PATIENT; APHASIA; STROKE; FMRI	Auditory agnosia is an inability to make sense of sound that cannot be explained by deficits in low-level hearing. In view of recent promising results in the area of neurorehabilitation of language disorders after stroke, we examined the effect of transcranial direct current stimulation (tDCS) in a young woman with general auditory agnosia caused by traumatic injury to the left inferior colliculus. Specifically, we studied activations to sound embedded in a block design using functional magnetic resonance imaging before and after application of anodal tDCS to the right auditory cortex. Before tDCS, auditory discrimination deficits were associated with abnormally reduced activations of the auditory cortex and bilateral unresponsiveness of the anterior superior temporal sulci and gyri. This session replicated a previous functional scan with the same paradigm a year before the current experiment. We then applied anodal tDCS over right auditory cortex for 20 min-utes and immediately re-scanned the patient. We found increased activation of bilateral auditory cortices and, for speech sounds, selectively increased activation in Broca's and Wernicke's areas. Future research might consider the long-term behavioral effects after neurostimulation in auditory agnosia and its potential use in the neurorehabilitation of more general auditory disorders.	[Bestelmeyer, Patricia E. G.; Poliva, Oren] Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; [Davis, Nick J.] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England; [Rafal, Robert D.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA		Bestelmeyer, PEG (corresponding author), Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	p.bestelmeyer@bangor.ac.uk	; Bestelmeyer, Patricia E.G./F-2106-2010	Poliva, Oren/0000-0002-3248-9731; Davis, Nick/0000-0001-7630-2097; Bestelmeyer, Patricia E.G./0000-0001-7466-1571			Ashburner J., 2006, STAT PARAMETRIC MAPP, V1st ed.; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bestelmeyer PEG, 2011, CURR BIOL, V21, pR838, DOI 10.1016/j.cub.2011.08.046; Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; Floel A, 2011, STROKE, V42, P2065, DOI 10.1161/STROKEAHA.110.609032; Heimrath K, 2012, Front Psychiatry, V3, P56, DOI 10.3389/fpsyt.2012.00056; Holland R, 2012, APHASIOLOGY, V26, P1169, DOI 10.1080/02687038.2011.616925; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jung YJ, 2013, BIOMED ENG LETT, V3, P39, DOI 10.1007/s13534-013-0087-x; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Ladeira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025399; Menke R, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-118; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; Mori T, 2016, J INT MED RES, V44, P760, DOI 10.1177/0300060516630843; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Otal B, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00236; Pernet CR, 2015, NEUROIMAGE, V119, P164, DOI 10.1016/j.neuroimage.2015.06.050; Poliva O, 2015, COGN BEHAV NEUROL, V28, P160, DOI 10.1097/WNN.0000000000000072; Price AR, 2015, BRAIN STIMUL, V8, P1093, DOI 10.1016/j.brs.2015.06.013; Sale MV, 2015, NEUROSCI BIOBEHAV R, V57, P187, DOI 10.1016/j.neubiorev.2015.09.010; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183	25	3	4	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	SEP	2018	31	3					151	155		10.1097/WNN.0000000000000162			5	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GV0KT	WOS:000445750200004	30239465	Green Submitted, Green Accepted			2022-02-06	
J	Chen, ZY; Xiang, YY; Bao, B; Wu, XB; Xia, ZB; You, JY; Nie, HB				Chen, Zhiying; Xiang, Yuanyuan; Bao, Bing; Wu, Xiangbin; Xia, Zhongbin; You, Jianyou; Nie, Hongbing			Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-kappa B-mediated apoptosis via MyD88/TRIF signaling	MOLECULAR MEDICINE REPORTS			English	Article						simvastatin; cerebrovascular injury; ischemia-reperfusion; nuclear factor-kappa B; myeloid differentiation primary response protein MyD88; toll-interleukin-1 receptor domain-containing adapter molecule 1	TRAUMATIC BRAIN-INJURY; NEURONAL APOPTOSIS; INTRACEREBRAL HEMORRHAGE; OXIDATIVE STRESS; MOUSE MODEL; RATS; PROTECTS; DEFICITS; CELLS; ATORVASTATIN	Cerebrovascular injury is the most prevalent human cerebrovascular disease and frequently results in ischemic stroke. Simvastatin may be a potential therapeutic agent for the treatment of patients with cerebrovascular injury. The present study aimed to investigate the efficacy of and the potential mechanisms regulated by simvastatin in a rat model of ischemia-reperfusion (I/R)-induced cerebrovascular injury. Cerebrovascular injury model rats were established and were subsequently treated with simvastatin or a vehicle control following I/R injury. Cell damage, neurological functions and neuronal apoptosis were examined, as well as the nuclear factor (NF)-kappa B-mediated myeloid differentiation primary response protein 88 (MyD88)/toll-interleukin-1 receptor domain-containing adapter molecule 1 (TRIF) signaling pathway following simvastatin treatment. The results of the present study demonstrated that simvastatin treatment led to a reduction in cell damage, improvement of neurological functions and decreased neuronal apoptosis compared with vehicle-treated I/R model rats, 14 days post-treatment. In addition, simvastatin treatment reduced cerebral water content and blood-brain barrier disruption in cerebrovascular injury induced by I/R. The results also revealed that simvastatin treatment inhibited neuronal apoptosis via the NF-kappa B-mediated MyD88/TRIF signaling pathway. In conclusion, simvastatin treatment may reduce I/R-induced neuronal apoptosis via inhibition of the NF-kappa B-mediated MyD88/TRIF signaling pathway.	[Chen, Zhiying; Xiang, Yuanyuan; Bao, Bing; Wu, Xiangbin; Xia, Zhongbin; You, Jianyou; Nie, Hongbing] Jiujiang Univ, Affiliated Hosp, Dept Neurol, 57 Xunyang East Rd, Jiujiang 332000, Jiangxi, Peoples R China		Nie, HB (corresponding author), Jiujiang Univ, Affiliated Hosp, Dept Neurol, 57 Xunyang East Rd, Jiujiang 332000, Jiangxi, Peoples R China.	niehongbingprof@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660209]	This study was supported by Natural Science Foundation of China 81660209.	Annunziata Ida, 2015, Methods Mol Biol, V1264, P25, DOI 10.1007/978-1-4939-2257-4_3; Atici A, 2008, EARLY HUM DEV, V84, P243, DOI 10.1016/j.earlhumdev.2007.06.005; Balduini W, 2001, STROKE, V32, P2185, DOI 10.1161/hs0901.094287; Cates EA, 2009, COMP IMMUNOL MICROB, V32, P477, DOI 10.1016/j.cimid.2008.06.001; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Gamberini MT, 2015, J ETHNOPHARMACOL, V168, P45, DOI 10.1016/j.jep.2015.03.053; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Hadi Najah R, 2013, ISRN Pharmacol, V2013, P815094, DOI 10.1155/2013/815094; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Hijioka M, 2011, J PHARMACOL EXP THER, V338, P741, DOI 10.1124/jpet.111.182519; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kaltschmidt B, 1999, P NATL ACAD SCI USA, V96, P9409, DOI 10.1073/pnas.96.16.9409; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Leitmeyer K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3580359; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv JL, 2009, BIOCHEM BIOPH RES CO, V380, P81, DOI 10.1016/j.bbrc.2009.01.035; McBride DW, 2018, J CEREBR BLOOD F MET, V38, P433, DOI 10.1177/0271678X17696509; Metais C, 2015, NEUROSCIENCE, V291, P279, DOI 10.1016/j.neuroscience.2015.02.023; Meyrat BJ, 2003, CHILD NERV SYST, V19, P716, DOI 10.1007/s00381-003-0829-7; Montaner J, 2016, STROKE, V47, P2870, DOI 10.1161/STROKEAHA.116.014600; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Park DS, 2009, ACTA OTO-LARYNGOL, V129, P166, DOI 10.1080/00016480802163358; Park JS, 2007, EXP MOL MED, V39, P483, DOI 10.1038/emm.2007.53; Ramadan WH, 2015, VASC HEALTH RISK MAN, V11, P125, DOI 10.2147/VHRM.S79198; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Sompol P, 2006, J MOL NEUROSCI, V29, P279, DOI 10.1385/JMN:29:3:279; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Su DAS, 2012, ANESTH ANALG, V114, P200, DOI 10.1213/ANE.0b013e31823a5d36; Taveira-DaSilva AM, 2015, CHEST, V147, P180, DOI 10.1378/chest.14-0758; Tong LS, 2017, J CEREBR BLOOD F MET, V37, P1971, DOI 10.1177/0271678X16658490; Ueda P, 2014, EUR J EPIDEMIOL, V29, P253, DOI 10.1007/s10654-014-9892-5; Walker T. L., 2014, JOVE-J VIS EXP, V25; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042828; Wen S, 2011, J NEURO-ONCOL, V104, P169, DOI 10.1007/s11060-010-0496-y; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859; Wu XZ, 2018, J BIOL CHEM, V293, P10425, DOI 10.1074/jbc.AC118.001720; Yang DM, 2011, J NEUROSURG, V114, P1135, DOI 10.3171/2010.7.JNS10163; Zhang GY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6929306; Zhao J, 2007, CELL SIGNAL, V19, P831, DOI 10.1016/j.cellsig.2006.10.006; Zhao XH, 2012, MOL MED REP, V5, P483, DOI 10.3892/mmr.2011.641; Zhao YM, 2014, STROKE, V45, P1139, DOI 10.1161/STROKEAHA.113.004296	46	3	3	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	SEP	2018	18	3					3177	3184		10.3892/mmr.2018.9337			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GR7RK	WOS:000442890400075	30066928	hybrid, Green Published, Green Submitted			2022-02-06	
J	Cheng, KY; Tsang, CP; Leung, GKK; Lui, WM				Cheng, Ka Yu; Tsang, Chun Pong; Leung, Gilberto Ka Kit; Lui, Wai Man			The application of point-of-care platelet function assay in guiding platelet transfusion in aspirin-users with intracranial haemorrhages	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Platelet transfusion; Intracranial haemorrhages; Aspirin; Platelet function test; Point-of-care	PRIOR ANTIPLATELET THERAPY; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; OUTCOMES; GROWTH; AGENTS	Background: An increasing number of patients with intracranial haemorrhages are aspirin-users. Neurosurgeons commonly attempt to minimize the risk of re-bleeding by withholding the medication and giving platelet transfusion. However, recent studies raised safety concerns and showed poorer outcome with platelet transfusion when the latter was not guided by changes in platelet function. Aim of study: To study the temporal pattern and degree of changes in platelet activities following a fixed dose of platelet transfusion in aspirin-users with intracranial haemorrhages. Methods: Aspirin-users with intracranial haemorrhages underwent baseline aspirin response units (ARU) using the VerifyNow (R) assay. Those who showed abnormal platelet activity received a single dose of 4 units of platelet concentrate. ARU were then repeated at 4 h, 24 h and 48 h post-transfusion. Patients were classified according to their responses to transfusion. Results: Twenty patients were recruited. At 4 h after transfusion, 11 (55%) patients had normalised platelet activities while the rest may show delayed or absent of normalization. Overall, eight (40%) patients were 'early and persistent transfusion responders', five 'delayed transfusion responders', and five (25%) had persistently abnormal platelet function. Two (10%) patients who initially responded to transfusion failed to maintain normalized platelet activity. Conclusion: Platelet activities in aspirin-users showed considerable heterogeneity up to 48 h following a blanket approach of platelet transfusion. The need for repeated transfusion or alternative therapy strongly argues for a guided practice for transfusion based on point-of-care platelet function assay. Future research should also adopt this approach to re-examine the safety and effectiveness of platelet transfusion in these patients. (C) 2018 Elsevier Ltd. All rights reserved.	[Cheng, Ka Yu; Tsang, Chun Pong; Leung, Gilberto Ka Kit; Lui, Wai Man] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Surg,Div Neurosurg, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China		Leung, GKK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Surg,Div Neurosurg, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	gilberto@hku.hk	; Leung, Gilberto Ka Kit/C-4337-2009	Cheng, Ka Yu/0000-0002-4932-1249; Leung, Gilberto Ka Kit/0000-0003-3147-3057			[Anonymous], 2018, VERIFYNOW ASP ASS PR; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Cheng KY, 2016, 23 ANN SCI M HONG KO; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; Downey DM, 2009, AM SURGEON, V75, P1100; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Engel-Haber E, 2015, CLIN NEUROL NEUROSUR, V137, P12, DOI 10.1016/j.clineuro.2015.06.007; Maree AO, 2007, CIRCULATION, V115, P2196, DOI 10.1161/CIRCULATIONAHA.106.675991; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e	16	3	3	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2018	55						52	56		10.1016/j.jocn.2018.06.037			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX2SH	WOS:000447569900010	30042067				2022-02-06	
J	Connolly, DM; Lee, VM; Hodkinson, PD				Connolly, Desmond M.; Lee, Vivienne M.; Hodkinson, Peter D.			White Matter Status of Participants in Altitude Chamber Research and Training	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						white matter hyperintensity; altitude; decompression; magnetic resonance imaging; head injury; mild traumatic brain injury	U-2 PILOTS; HYPERINTENSITIES; DIVERS; BRAIN; MRI; ABNORMALITIES; PREVALENCE; INTEGRITY; LESIONS; INJURY	INTRODUCTION: Magnetic resonance imaging (MRI) brain scans of U.S. Air Force (USAF) altitude workers show increased white matter hyperintensities (WMH) that appear related to decompression stress. Relevant exposure thresholds are unknown.This MRI survey compares the white matter status of UK participants (UKP) in altitude chamber research and training with USAF cohorts having background and increased WMH. METHODS: UKP (N = 20) comprised 13 research subjects and 7 military altitude chamber instructors ages 33 to 50 yr (16 men, 4 women), encompassing 1417 decompressions over a 15,000-ft (4572 m) pressure altitude (range 11-189; median 50). High resolution MRI reproduced USAF sequences and data were analyzed at the University of Maryland to validate comparison with age-matched USAF control (DOC; N 85) and aerospace operational physiologist (PHY; N = 55) cohorts. RESULTS: UKP data are dichotomous: 17 subjects (85%) had normal scans (total 19 WMH) and three outliers had excess (>15) WMH (total of 83 lesions). WMH were not associated with metrics of decompression history (total exposures, rapid decompression, pressure breathing, hypoxia familiarization, decompression sickness, or exposure intensity). Ranked data indicate that UKP have fewer WMH than PHY but not DOC. UKP outliers' excess WMH are attributable to past mild traumatic brain injury. CONCLUSIONS: WMH in UKP are unrelated to subjects' low intensity (brief, infrequent) experience of altitude chamber decompression, encompassing occasional hypobaric hypoxia and mild decompression sickness, even with cumulative experience over many years. Such low intensity hypobaric exposure appears 'subthreshold' for promotion of WMH.	[Connolly, Desmond M.; Lee, Vivienne M.; Hodkinson, Peter D.] QinetiQ Plc, Human Performance Grp, Farnborough, Hants, England		Connolly, DM (corresponding author), QinetiQ, Cody Technol Pk,Ively Rd, Farnborough GU14 0LX, Hants, England.	dmconnolly@qinetiq.com			UK Ministry of Defence through the Defence Science and Technology Laboratory (DSTL) Aircrew Systems Research Programme	This work was funded by the UK Ministry of Defence through the Defence Science and Technology Laboratory (DSTL) Aircrew Systems Research Programme. The authors would like to thank the volunteer subjects for their enthusiastic and phlegmatic support for the study. We also acknowledge extensive recent guidance and advice received from numerous colleagues, including fellow participants in NATO Research Technology Group 274 and collaborators at the United States Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, Dayton, OH, USA; Centre for Brain Imaging Research, University of Maryland School of Medicine, Baltimore, MD, USA; Sir Peter Mansfield Imaging Centre, Queen's Medical Centre, University of Nottingham, UK; Royal Air Force Centre of Aviation Medicine, RAF Henlow, Bedfordshire, UK; and QinetiQ plc.	Balestra C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00696; Baum KA, 1996, NEURORADIOLOGY, V38, P755, DOI 10.1007/s002340050342; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Gempp E, 2010, AVIAT SPACE ENVIR MD, V81, P1008, DOI 10.3357/ASEM.2786.2010; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Macdiarmid JI, 2004, 230 ELTHI DIV STUD; McGuire S, 2013, NEUROLOGY, V81, P729, DOI 10.1212/WNL.0b013e3182a1ab12; McGuire SA, 2016, AEROSP MED HUM PERF, V87, P983, DOI 10.3357/AMHP.4585.2016; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073	16	3	3	0	2	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	SEP	2018	89	9					777	786		10.3357/AMHP.5090.2018			10	Biophysics; Public, Environmental & Occupational Health; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Research & Experimental Medicine	GR1YC	WOS:000442351100001	30126509				2022-02-06	
J	Daia, CO; Solcan, S; Mihai, AC; Nita, DE; Chiriloi, N; Onose, G				Daia, Cristina Octaviana; Solcan, Sabina; Mihai, Andra Cristina; Nita, Diana Elena; Chiriloi, Nicoleta; Onose, Gelu			Complex Neuro-Muscular favorable rehabilitation program of a patient with politrauma including spinal cord injury and multiple bone fractures	BALNEO RESEARCH JOURNAL			English	Article						rehabilitation; traumatic brain injury; bone fractures; polytrauma	EPIDEMIOLOGY	Introduction: Polytrauma which include spinal cord injuries but are associated with other traumatic events such as limb fractures, generate through their complexity the necessity of a thorough neuro-muscular rehabilitation programme with a long-term aim of reflecting the improvement of the patient's quality of life. Materials and Methods: This paper presents the case of a 43-year- old patient (having the The Teaching Emergency Hospital "Bagdasar-Arseni",TEHBA, Bioethics Committee approval no 9181/11.04.2018), who is hospitalized in our Neuro-muscular Clinic presenting incomplete AIS / Frankel C tetraplegia with C4 neurological level and neurogenic bladder and bowel. Also she associated multiple fractures such as: left scapular fractures, right humerus fracture (surgically stabilized), pelvic fractures, right fibular head fracture without displacement. This polytrauma was caused by a car accident (pedestrian 9.11.2017). At admission the patient had severe motor and functional impairment and was assessed functionally using the following scales: AIS / Frankel, modified Ashworth,Functional Independence Measure (FIM), Life Quality Assessment (QOL), FAC International Scale, Independence Assessment Scale in Daily Activities (ADL / IADL), Walking Scale for Spinal Cord Injury (WISCI). Results: The patient benefited from a complex neuro-muscular rehabilitation programme, having a favourable evolution, therefore the patient reaches incomplete MS / Frankel D tetraplegia with an increase in the evaluated scales scores and thus, with a final performance of walking for short distances with a supporting frame, as well as a sphincter re-education with the neurogenic bladder remission. Conclusions: Based on the collaboration with orthopedic and surgeon fellows the PRM physician developed a complex rehabilitation programme leading to the re-expression of locomotion function, sphincterian control recovery, selfcare ability, all of the mentioned factors improving the patient's quality of life.	[Daia, Cristina Octaviana; Solcan, Sabina; Mihai, Andra Cristina; Nita, Diana Elena; Chiriloi, Nicoleta; Onose, Gelu] Teaching Emergency Hosp Bagdasar Arseni, Bucharest, Romania; [Daia, Cristina Octaviana; Onose, Gelu] Univ Med & Pharm Carol Davila, Bucharest, Romania		Daia, CO (corresponding author), Teaching Emergency Hosp Bagdasar Arseni, Bucharest, Romania.; Daia, CO (corresponding author), Univ Med & Pharm Carol Davila, Bucharest, Romania.	cristdaia@yahoo.com	Onose, Gelu/AAC-6786-2021; Daia, Cristina/R-6294-2018; Daia, Cristina/ABB-8725-2021	Onose, Gelu/0000-0002-6346-8941; Daia, Cristina/0000-0002-9872-6496; Daia, Cristina/0000-0002-9872-6496			Munteanu C, 2017, BALNEO RES J, V8, P136, DOI 10.12680/balneo.2017.149; Onose G, 2008, NON TRADITIONAL REF, V6, P205; Onose G, 2011, CAROL DAVILA; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002	5	3	3	0	3	ROMANIAN ASSOC BALNEOLOGY	BUCHAREST	BUCHAREST, SECTOR 2, ALEEA DOBRINA NO 7, BL D10, SC A, AP 4, BUCHAREST, 00000, ROMANIA	2069-7597	2069-7619		BALNEO RES J	Balneo Res. J.	SEP	2018	9	3					260	263		10.12680/balneo.2018.192			4	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HD6DU	WOS:000452625100010		gold, Green Submitted			2022-02-06	
J	Daia, CO; Mihai, AC; Nita, DE; Solcan, S; Chiriloi, N; Onose, G				Daia, Cristina Octaviana; Mihai, Andra Cristina; Nita, Diana Elena; Solcan, Sabina; Chiriloi, Nicoleta; Onose, Gelu			Complex therapeutical rehabilitation approach in the case of a polytrauma patient with traumatic brain and spinal cord injuries - Case report	BALNEO RESEARCH JOURNAL			English	Article						Traumatic brain injuries; spinal cord injury Polytraumatism		The multidisciplinary approach of polytrauma cases including traumatic brain and spinal cord injuries, the survival represents one of the greatest challenges, but the decrease of dysfunction and minimizing the psycho-cognitive sequels are at least as important, regarding the patient's future quality of life. Material and method Under THEBA Bioethics Commission approval (9181/11.04.2018), this paper presents a case of a 28-year-old patient with AIS/Frankel (A) paraplegia after a spinal cord injury SCI T3 level secondary to T4-T5 fracture surgically treated. SCI was associated with moderate traumatic brain injury TBI (subarachnoid haemorrhage), thoraco-abdominal contusion (pneumothorax stg, hepatic trauma) and multiple fractures (sternum and costal, operated), neurogenic bladder and bowel. This condition was due to a car accident, occurred on November 13, 2017. The patient was admitted with a psycho-cognitive status, complete bilateral motor deficit in the lower limbs - paraplegia, sensitivity disorders anaesthesia type and sphincter disorders. The patient was clinically, paraclinical and functionally assessed according to the standardized protocols implemented in our clinic through the assessment scales: AIS, FIM, QoL-Quality of Life, Ashworth, Penn, FAC, WISCI II. Results: The patient's evolution was slow but favourable. He benefited of neurosurgical care and had thoracic surgery to extract the osteosynthesis material at the sternum. Meanwhile he learned the technique of intermittent catheterisation. As a result of rehabilitation program the patients finally reached the level of wheelchair locomotion and have completely restored the cognitive function. Conclusion: The multidisciplinary team approach consisting of physicians, kinetotherapist, nurses and auxiliary healthcare personnel was the key of the patient's survival, eliminated the cognitive dysfunction and reduced as much as possible the locomotor one.	[Daia, Cristina Octaviana; Mihai, Andra Cristina; Nita, Diana Elena; Solcan, Sabina; Chiriloi, Nicoleta; Onose, Gelu] TEHBA, Bucharest, Romania; [Daia, Cristina Octaviana; Onose, Gelu] UMPCD, Bucharest, Romania		Daia, CO (corresponding author), TEHBA, Bucharest, Romania.; Daia, CO (corresponding author), UMPCD, Bucharest, Romania.	cristinaoctavianadaia@email.com	Daia, Cristina/R-6294-2018; Daia, Cristina/ABB-8725-2021; Onose, Gelu/AAC-6786-2021	Daia, Cristina/0000-0002-9872-6496; Daia, Cristina/0000-0002-9872-6496; Onose, Gelu/0000-0002-6346-8941			Ho CH, 2007, ARCH PHYS MED REHAB, V88, pS49, DOI 10.1016/j.apmr.2006.12.001; Munteanu C, 2017, BALNEO RES J, V8, P136, DOI 10.12680/balneo.2017.149; Onose G, 2008, NON TRADITIONAL REF, V6, P205; Onose G., 2011, GHID DIAGNOSTIC SI T; Rajasekaran S, 2015, INDIAN J ORTHOP, V49, P72, DOI 10.4103/0019-5413.143914	5	3	3	0	4	ROMANIAN ASSOC BALNEOLOGY	BUCHAREST	BUCHAREST, SECTOR 2, ALEEA DOBRINA NO 7, BL D10, SC A, AP 4, BUCHAREST, 00000, ROMANIA	2069-7597	2069-7619		BALNEO RES J	Balneo Res. J.	SEP	2018	9	3					332	334		10.12680/balneo.2018.207			3	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HD6DU	WOS:000452625100025		Green Submitted, gold			2022-02-06	
J	Han, M; Ding, S; Zhang, Y; Lin, ZX; Li, KS				Han, Ming; Ding, Shan; Zhang, Yuan; Lin, Zhexuan; Li, Kangsheng			Serum Copper Homeostasis in Hypertensive Intracerebral Hemorrhage and its Clinical Significance	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Copper homeostasis; Hypertension; Intracerebral hemorrhage; Ceruloplasmin	TRAUMATIC BRAIN-INJURY; CERULOPLASMIN EXPRESSION; IRON-METABOLISM; INFLAMMATION; ABSORPTION; DISORDERS; STROKE	This study was to investigate the alterations of serum copper homeostasis after hypertensive intracerebral hemorrhage (ICH), which is not yet clear. We recruited 85 hypertensive ICH patients and determined their serum levels of total copper (TCu), small molecule copper (SMC), and ceruloplasmin (Cp). Sera from 32 healthy persons and 12 primary hypertension patients were collected and analyzed as well. Serum TCu levels in ICH patients were tested at three time points (on admission, day 3, and day 7) and found to be higher than that in hypertension patients (p < 0.05). The serum SMC levels in hypertension patients and ICH patients at three time points were higher than that in healthy controls (p < 0.05). Higher serum SMC levels on days 3 and 7 were associated with death in the hospital. Additionally, higher serum SMC levels on the seventh day were associated with poor outcome at discharge. High serum Cp levels on admission, as well as low serum Cp levels on the seventh day, were associated with death in the hospital (p = 0.002 and p = 0.034, respectively). Our findings indicated that declines in serum Cp and increases in serum SMC are correlated with lethal or poor outcome in hypertensive ICH patients, possibly as a result of contributions to secondary injury of brain after hemorrhage due to impairment of iron transport and enhanced oxidative stress.	[Han, Ming] Shantou Univ, Emergency Dept, Affiliated Hosp 2, Coll Med, Shantou, Peoples R China; [Han, Ming; Li, Kangsheng] Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou 515041, Peoples R China; [Ding, Shan] Shantou Univ, Craniocerebral Surg Dept, Affiliated Hosp 2, Coll Med, Shantou, Peoples R China; [Zhang, Yuan; Lin, Zhexuan] Shantou Univ, Bioanalyt Lab, Coll Med, Shantou, Peoples R China		Li, KS (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Coll Med, Shantou 515041, Peoples R China.; Lin, ZX (corresponding author), Shantou Univ, Bioanalyt Lab, Coll Med, Shantou, Peoples R China.	g_zxlin@stu.edu.cn; ksli@stu.edu.cn		Li, Kangsheng/0000-0002-6981-9263	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172088]; Joint Scientific Special Foundation of Guangdong Provincial Department of Science and Technology-Academy of Traditional Chinese Medicine [2012A032500009]	This work is supported by the National Natural Science Foundation of China (project number: 81172088), the Joint Scientific Special Foundation of Guangdong Provincial Department of Science and Technology-Academy of Traditional Chinese Medicine (2012A032500009).	Alexandrova ML, 2011, J CLIN NEUROSCI, V18, P247, DOI 10.1016/j.jocn.2010.07.125; Altintas O, 2017, TURK NEUROSURG, V27, P368, DOI 10.5137/1019-5149.JTN.16136-15.1; BARROW L, 1988, EUR J CLIN INVEST, V18, P555, DOI 10.1111/j.1365-2362.1988.tb01267.x; BOGDEN JD, 1977, CLIN CHEM, V23, P485; Chang YZ, 2007, NEUROCHEM INT, V50, P726, DOI 10.1016/j.neuint.2007.01.004; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; CUMMING RLC, 1978, PRACTITIONER, V221, P184, DOI 10.1056/NEJM199912233412607; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Duan XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1203285; Ghayour-Mobarhan M, 2009, J TRACE ELEM MED BIO, V23, P167, DOI 10.1016/j.jtemb.2009.03.006; GITLIN D, 1960, NATURE, V185, P693, DOI 10.1038/185693a0; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; Grammer TB, 2014, FREE RADICAL RES, V48, P706, DOI 10.3109/10715762.2014.901510; Han M, 2013, BIOL TRACE ELEM RES, V154, P268, DOI 10.1007/s12011-013-9725-5; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; Lai MC, 2016, J STROKE CEREBROVASC, V25, P214, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.020; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Lopez-Avila V, 2006, ANAL BIOANAL CHEM, V386, P180, DOI 10.1007/s00216-006-0528-9; de la Ossa NP, 2010, STROKE, V41, P810, DOI 10.1161/STROKEAHA.109.570168; Salman RAS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2586; Taneja SK, 2007, BIOL TRACE ELEM RES, V120, P61, DOI 10.1007/s12011-007-8013-7; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Yang K, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00049; Zhang Y, 2014, CLIN LAB, V60, P543, DOI 10.7754/Clin.Lab.2013.130301; Zhao ZY, 2016, CLIN NEUROL NEUROSUR, V150, P67, DOI 10.1016/j.clineuro.2016.08.023	29	3	5	2	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	SEP	2018	185	1					56	62		10.1007/s12011-017-1227-4			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GP7WA	WOS:000441120100007	29322430				2022-02-06	
J	Holmqvist, A; Berthold Lindstedt, M; Moller, MC				Holmqvist, Anna; Berthold Lindstedt, Marta; Moller, Marika C.			RELATIONSHIP BETWEEN FATIGUE AFTER ACQUIRED BRAIN INJURY AND DEPRESSION, INJURY LOCALIZATION AND AETIOLOGY: AN EXPLORATIVE STUDY IN A REHABILITATION SETTING	JOURNAL OF REHABILITATION MEDICINE			English	Article						fatigue; brain injury; stroke; traumatic brain injury; depression	POSTSTROKE FATIGUE; MENTAL FATIGUE; COGNITIVE FATIGUE; STROKE; DISORDERS; ATTENTION; INFARCTS; MILD	Objective: Fatigue after acquired brain injury may be related to the subcortico-frontal attention network. Depression is also strongly related to fatigue. This study investigates whether injury localization, diagnosis and depression are related to self-rated mental fatigue in patients with an acquired brain injury. Design: Retrospective cross-sectional cohort study. Subjects: Sixty-one patients diagnosed with stroke, subarachnoidal haemorrhage, traumatic brain injury, or brain tumour were included in the study. Methods: Patients who underwent a multidisciplinary team assessment during September 2011 to June 2012, and who were assessed with the Mental Fatigue Scale, were included in the study. Results: A significantly higher number of patients with posterior and non-specific lesions experienced fatigue compared with those with subcortical/frontal injuries. Fewer stroke patients experienced fatigue compared with the other patient groups. How-ever, after logistic regression, only depression remained as an explanatory variable for self-rated fatigue. Nevertheless, although all patients with depression were fatigued, not all fatigued patients were depressed. Conclusion: Although depression explains a high degree of fatigue after an acquired brain injury, mental fatigue after brain injury should be viewed as a condition partly separate from depression. Future extensive comparative studies are required, preferably including neuropsychological measures.	[Holmqvist, Anna; Berthold Lindstedt, Marta; Moller, Marika C.] Danderyd Hosp, Dept Rehabil Med Stockholm, Stockholm, Sweden; [Berthold Lindstedt, Marta; Moller, Marika C.] Karolinska Inst, Danderyd Hosp, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden		Holmqvist, A (corresponding author), Karolinska Univ Hosp Huddinge, Dept Rehabil Med, R61, SE-14120 Huddinge, Sweden.	anna.n.holmqvist@gmail.com	MAller, Marika C/N-8782-2016; Moller, Marika/S-5427-2019	MAller, Marika C/0000-0001-8700-5186; Moller, Marika/0000-0001-8700-5186			Arnold LM, 2008, PSYCHOSOMATICS, V49, P185, DOI 10.1176/appi.psy.49.3.185; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Asher Arash, 2016, CNS Oncol, V5, P91, DOI 10.2217/cns-2015-0008; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; JENNETT B, 1975, LANCET, V1, P480; Johansson B, 2014, INT J PHYS MED REHAB, V2, P2; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Kutlubaev MA, 2012, J PSYCHOSOM RES, V72, P305, DOI 10.1016/j.jpsychores.2011.12.008; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Moller MC, 2014, J CLIN EXP NEUROPSYC, V36, P716, DOI 10.1080/13803395.2014.933779; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tang WK, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0234-8; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Wei CJ, 2016, J NEUROL, V263, P269, DOI 10.1007/s00415-015-7958-2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	36	3	3	1	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2018	50	8					725	731		10.2340/16501977-2365			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GQ0ZR	WOS:000441351600007	30003267	Green Submitted, gold			2022-02-06	
J	Huang, MQ; Cao, XY; Chen, XY; Liu, YF; Zhu, SL; Sun, ZL; Kong, XB; Huo, JR; Zhang, S; Xu, YQ				Huang, Meng-Qiang; Cao, Xiao-Yu; Chen, Xu-Yi; Liu, Ying-Fu; Zhu, Shuang-Long; Sun, Zhong-Lei; Kong, Xian-Bin; Huo, Jing-Rui; Zhang, Sai; Xu, Yun-Qiang			Saikosaponin a increases interleukin-10 expression and inhibits scar formation after sciatic nerve injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; saikosaponin a; anti-inflammatory factor; inflammation; interleukin-10; nerve scar; peripheral nerve injury; sciatic nerve injury; sciatic functional index; nerve conduction velocity; neuroelectrophysiological function; neural regeneration	PERIPHERAL-NERVE; RAT MODEL; SCHWANN-CELLS; REGENERATION; REPAIR; INFLAMMATION; TRANSPLANTATION; MACROPHAGES; APOPTOSIS; CYTOKINES	Nerve scarring after peripheral nerve injury can severely hamper nerve regeneration and functional recovery. Further, the anti-inflammatory cytokine, interleukin-10, can inhibit nerve scar formation. Saikosaponin a (SSa) is a monomer molecule extracted from the Chinese medicine, Bupleurum. SSa can exert anti-inflammatory effects in spinal cord injury and traumatic brain injury. However, it has not been shown whether SSa can play a role in peripheral nerve injury. In this study, rats were randomly assigned to three groups. In the sham group, the left sciatic nerve was directly sutured after exposure. In the sciatic nerve injury (SNI) + SSa and SNI groups, the left sciatic nerve was sutured and continuously injected daily with SSa (10 mg/kg) or an equivalent volume of saline for 7 days. Enzyme linked imnmunosorbent assay results demonstrated that at 7 days after injury, interlcukin-10 level was considerably higher in the SNI + SSa group than in the SNI group. Masson staining and western blot assay demonstrated that at 8 weeks after injury, type I and III collagen content was lower and nerve scar formation was visibly less in the SNI + SSa group compared with the SNI group. Simultaneously, sciatic functional index and nerve conduction velocity were improved in the SNI + SSa group compared with the SNI group. These results confirm that SSa can increase the expression of the anti-inflammatory factor, interleukin-10, and reduce nerve scar formation to promote functional recovery of injured sciatic nerve.	[Huang, Meng-Qiang; Zhu, Shuang-Long; Xu, Yun-Qiang] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Huang, Meng-Qiang; Zhu, Shuang-Long; Xu, Yun-Qiang] Tianjin Med Univ Gen Hosp, Dept Orthoped, Tinajin, Peoples R China; [Cao, Xiao-Yu] Anhui Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Hefei, Anhui, Peoples R China; [Chen, Xu-Yi; Zhang, Sai] Logist Univ Chinese Peoples Armed Police Force, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci, Ctr Neurol & Neurosurg,Affiliated Hosp, Tianjin, Peoples R China; [Liu, Ying-Fu; Huo, Jing-Rui] Cangzhou Med Coll, Sci & Technol Expt Ctr, Cangzhou, Hebei, Peoples R China; [Sun, Zhong-Lei] Jinzhou Med Univ, Grad Sch, Jinzhou, Liaoning, Peoples R China; [Kong, Xian-Bin] Tianjin Univ Tradit Chinese Med, Grad Sch, Tianjin, Peoples R China		Xu, YQ (corresponding author), Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China.; Xu, YQ (corresponding author), Tianjin Med Univ Gen Hosp, Dept Orthoped, Tinajin, Peoples R China.; Zhang, S (corresponding author), Logist Univ Chinese Peoples Armed Police Force, Tianjin Key Lab Neurotrauma Repair, Inst Traumat Brain Injury & Neurosci, Ctr Neurol & Neurosurg,Affiliated Hosp, Tianjin, Peoples R China.	zhangsai718@vip.126.com; docxu@sina.com		Sun, Zhonglei/0000-0002-7048-4851	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11102235, 8167050417]; National Key Research and Development Plan of China [2016YFC1101500]; Key Science and Technology Support Foundation of Tianjin City of China [17YFZCSY00620]; Natural Science Foundation of Tianjin City of ChinaNatural Science Foundation of Tianjin [15JCYBJC28600, 17JCZDJC35400]	This work was financially supported by the National Natural Science Foundation of China, No. 11672332, 11102235, 8167050417; the National Key Research and Development Plan of China, No. 2016YFC1101500; the Key Science and Technology Support Foundation of Tianjin City of China, No. 17YFZCSY00620; the Natural Science Foundation of Tianjin City of China, No. 15JCYBJC28600, 17JCZDJC35400.	Atkins S, 2007, J PERIPHER NERV SYST, V12, P269, DOI 10.1111/j.1529-8027.2007.00148.x; Atkins S, 2006, NEUROREPORT, V17, P1245, DOI 10.1097/01.wnr.0000230519.39456.ea; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barton MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020287; Benga A, 2017, INDIAN J PLAST SURG, V50, P5, DOI 10.4103/ijps.IJPS_14_17; Chen JX, 2015, ONCOTARGET, V6, P42541, DOI 10.18632/oncotarget.6448; Chen PW, 2015, ACTA NEUROPATHOL, V130, P605, DOI 10.1007/s00401-015-1482-4; Chen RJ, 2018, INFLAMMATION, V41, P1297, DOI 10.1007/s10753-018-0778-7; Chen S, 2016, ZHONGGUO ZUZHI GONGC, V20, P6714; Chen YM, 2015, INT J CLIN EXP MED, V8, P13408; da Silva IR, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6573802; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Fregnan F, 2012, NEURAL REGEN RES, V7, P2259, DOI 10.3969/j.issn.1673-5374.2012.29.003; Fu YH, 2015, FREE RADICAL BIO MED, V89, P777, DOI 10.1016/j.freeradbiomed.2015.10.407; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Han AC, 2016, NEURAL REGEN RES, V11, P508, DOI 10.4103/1673-5374.179075; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Hartlehnert M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12744-2; Horasanli B, 2017, J BACK MUSCULOSKELET, V30, P967, DOI 10.3233/BMR-150386; Kang SJ, 2017, ONCOTARGET, V8, P100433, DOI 10.18632/oncotarget.22247; Khan Junad, 2017, Pathophysiology, V24, P155, DOI 10.1016/j.pathophys.2017.04.001; Khan J, 2015, NEUROSCI LETT, V592, P99, DOI 10.1016/j.neulet.2015.03.001; Ko PY, 2018, J MOL NEUROSCI, V64, P601, DOI 10.1007/s12031-018-1056-8; Lang BT, 2014, EXP NEUROL, V258, P17, DOI 10.1016/j.expneurol.2014.04.031; Lemke A, 2018, ACTA BIOMATER, V66, P335, DOI 10.1016/j.actbio.2017.11.042; Leuzzi S, 2014, G CHIR, V35, P101, DOI 10.11138/gchir/2014.35.3.101; Li MY, 2018, EXP CELL RES, V367, P24, DOI 10.1016/j.yexcr.2018.02.006; Li Q, 2016, NEURAL REGEN RES, V11, P835, DOI 10.4103/1673-5374.182713; Li RJ, 2014, CELL BIOCHEM BIOPHYS, V68, P449, DOI 10.1007/s12013-013-9742-1; Li RX, 2018, MOL MED REP, V17, P4360, DOI 10.3892/mmr.2018.8388; Li Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00133; Lin T, 2018, MUSCLE NERVE, V57, P821, DOI 10.1002/mus.26033; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Mao X, 2016, AM J TRANSL RES, V8, P133; Masgutov R, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00086; Mietto BS, 2015, J NEUROSCI, V35, P16431, DOI 10.1523/JNEUROSCI.2119-15.2015; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Ngeow WC, 2011, NEUROSCIENCE, V181, P271, DOI 10.1016/j.neuroscience.2011.02.054; Ngeow WC, 2010, ORAL SURG ORAL MED O, V109, P357, DOI 10.1016/j.tripleo.2009.06.030; Poras JR, 2015, J IMMUNOL METHODS, V420, P38, DOI 10.1016/j.jim.2015.03.013; Rbia N, 2017, J HAND SURG-AM, V42, P367, DOI 10.1016/j.jhsa.2017.02.017; Sakalidou M, 2011, J PERIPHER NERV SYST, V16, P334, DOI 10.1111/j.1529-8027.2011.00368.x; Taskinen HS, 2000, J NEUROIMMUNOL, V102, P17, DOI 10.1016/S0165-5728(99)00154-X; Tricaud N, 2017, CELL MOL LIFE SCI, V74, P4049, DOI 10.1007/s00018-017-2565-2; Wang L, 2015, ASIAN J ANDROL, V17, P776, DOI 10.4103/1008-682X.154306; Xue JW, 2016, ARTIF ORGANS, V40, P514, DOI 10.1111/aor.12584; Yang FD, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7597596; Yao L, 2016, MOL NEUROBIOL, V53, P879, DOI 10.1007/s12035-014-9049-2; Yao P, 2018, NEURAL REGEN RES, V13, P309, DOI 10.4103/1673-5374.226401; Yuan BC, 2017, PHARM BIOL, V55, P620, DOI 10.1080/13880209.2016.1262433; Zhao ZW, 2017, BIOMED PHARMACOTHER, V92, P1103, DOI 10.1016/j.biopha.2017.05.099; Zhou X, 2014, NEUROCHEM RES, V39, P2136, DOI 10.1007/s11064-014-1407-y; Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988	53	3	3	5	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2018	13	9					1650	1656		10.4103/1673-5374.237139			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GR6DG	WOS:000442734700027	30127128	Green Published, gold			2022-02-06	
J	Iacono, D; Lee, P; Hallett, M; Perl, D				Iacono, Diego; Lee, Patricia; Hallett, Mark; Perl, Daniel			Possible Post-Traumatic Focal Dystonia Associated with Tau Pathology Localized to Putamen-Globus Pallidus	MOVEMENT DISORDERS CLINICAL PRACTICE			English	Article						basal ganglia; post-traumatic dystonia; traumatic brain injury; tau pathology; CTE spectrum	MOVEMENT-DISORDERS; STRUCTURAL LESIONS; NEURONAL-ACTIVITY; BASAL-GANGLIA; NEUROPATHOLOGY; PROTEIN; RATS	Background Dystonia is often associated with damage to basal ganglia (BG), but neuropathological assessments of these cases are infrequent. MethodsResultsA brain was assessed with possible post-traumatic focal dystonia that appeared after an accident occurred during childhood. Tau pathology was found within putamen and globus pallidus of the right hemisphere, and chronic traumatic encephalopathy (CTE) was observed in the cortex of the left hemisphere. No diffuse axonal injury (DAI), -amyloid, ubiquitin, p62, or pTDP43 pathology was found. ConclusionsPost-traumatic dystonia could be associated with post-traumatic tau pathology formation. However, more cases are necessary to establish causality. The tau lesions found in the BG of this patient did not fit within CTE criteria. We hypothesize that due to the anatomo-histological characteristics of the BG, tau pathology associated with brain traumas produce histopathological patterns different from sulcal-tau pathology, which is the only tau pathology distribution currently accepted as pathognomonic of CTE.	[Iacono, Diego; Lee, Patricia; Perl, Daniel] USU, Brain Tissue Repository & Neuropathol Core, CNRM, Bethesda, MD USA; [Iacono, Diego] USU, Dept Neurol, F Edward Hebert Sch Med, Bethesda, MD USA; [Iacono, Diego; Perl, Daniel] USU, Dept Pathol, F Edward Hebert Sch Med, Bethesda, MD USA; [Iacono, Diego; Lee, Patricia] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD USA; [Iacono, Diego] NINDS, Complex Neurodegenerat Disorders, Motor Neuron Disorders Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Hallett, Mark] NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Iacono, D (corresponding author), USU, Dept Neurol, Pathol Neuropathol, Neurosci,CNRM,F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	diego.iacono.ctr@usuhs.edu	Iacono, Diego/K-8203-2016	Iacono, Diego/0000-0001-5511-0950; Hallett, Mark/0000-0002-3180-6811	Brain Tissue Repository and Neuropathology Core, CNRM award [308049-4.01-60855]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003031] Funding Source: NIH RePORTER	This study was supported by the Brain Tissue Repository and Neuropathology Core, CNRM award #308049-4.01-60855.	Alam M, 2016, J NEURAL TRANSM, V123, P231, DOI 10.1007/s00702-015-1484-3; Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Asanuma Kotaro, 2005, J Med Invest, V52 Suppl, P272, DOI 10.2152/jmi.52.272; Conte A, 2016, PARKINSONISM RELAT D, V22, pS111, DOI 10.1016/j.parkreldis.2015.09.001; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Defazio G, 2004, LANCET NEUROL, V3, P673, DOI 10.1016/S1474-4422(04)00907-X; Defebvre L, 2016, REV NEUROL-FRANCE, V172, P483, DOI 10.1016/j.neurol.2016.07.006; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; Iacono D, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D8T72G9G; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; Khooshnoodi MA, 2013, J NEUROL SCI, V331, P98, DOI 10.1016/j.jns.2013.05.022; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; Kostic VS, 1996, CAN J NEUROL SCI, V23, P53, DOI 10.1017/S0317167100039184; Krauss Joachim K, 2015, Handb Clin Neurol, V128, P475, DOI 10.1016/B978-0-444-63521-1.00030-3; Kumbhare D, 2017, NEUROSCIENCE, V353, P42, DOI 10.1016/j.neuroscience.2017.03.063; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; Li JF, 2015, INT J CLIN EXP MED, V8, P19682; Liuzzi D, 2016, NEUROL SCI, V37, P1393, DOI 10.1007/s10072-016-2598-6; Lohmann K, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0735-0; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mehanna R, 2013, LANCET NEUROL, V12, P597, DOI 10.1016/S1474-4422(13)70057-7; Monbaliu E, 2016, DEV MED CHILD NEUROL, V58, P138, DOI 10.1111/dmcn.12846; Munchau A, 2000, J NEUROL NEUROSUR PS, V69, P494, DOI 10.1136/jnnp.69.4.494; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Paudel R, 2012, NEUROPATH APPL NEURO, V38, P520, DOI 10.1111/j.1365-2990.2012.01298.x; Prudente CN, 2013, EXP NEUROL, V241, P95, DOI 10.1016/j.expneurol.2012.11.019; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Song B, 2013, NEURAL REGEN RES, V8, P3173, DOI 10.3969/j.issn.1673-5374.2013.34.001; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Steeves TD, 2012, MOVEMENT DISORD, V27, P1789, DOI 10.1002/mds.25244; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045; Zurowski M, 2013, MOVEMENT DISORD, V28, P914, DOI 10.1002/mds.25501	36	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2330-1619			MOV DISORD CLIN PRAC	MOV. DISORD. CLIN. PRACT.	SEP-OCT	2018	5	5					492	498		10.1002/mdc3.12626			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GY5UQ	WOS:000448649000004	30637269	Green Published			2022-02-06	
J	Jin, HH; Mao, TM; Bai, ZQ; Chen, Y; Ji, HL; Jin, Y				Jin, Hang-Huang; Mao, Tian-Ming; Bai, Zhi-Qiang; Chen, Yuan; Ji, Hai-Long; Jin, Yong			The 90-day prognostic value of serum cyclophilin A in traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Cyclophilin A; Mortality; Severity; Prognosis	INTRACRANIAL HYPERTENSION; NUCLEAR TRANSLOCATION; ARTERY-DISEASE; IN-VITRO; EXPRESSION; HYPOXIA; APOPTOSIS; COPEPTIN; PREDICTS; EMMPRIN	Background: Cyclophilin A is involved in many inflammatory diseases and its expression is up-regulated after brain injury. We determined if serum cyclophilin A could be used as a marker for severity and 90-day outcome in patients with traumatic brain injury (TBI). Methods: Serum cyclophilin A concentrations were quantified in 105 severe TBI patients and 105 healthy individuals. Its association with Glasgow Coma Scale (GCS) score, 90-day mortality and 90-day poor outcome (Glasgow Outcome Scale score of 1-3) were investigated. Results: Serum cyclophilin A concentrations were significantly higher in TB! patients than in healthy individuals. Cyclophilin A concentrations had a close relation to GCS scores and showed a high discriminatory ability for 90 day mortality and poor outcome according to area under receiver operating characteristic curve (AUC). Its AUC was in the range of GCS scores. Moreover, its combination with GCS scores significantly improved the predictive performance of GCS scores alone. In addition, serum cyclophilin A emerged as an independent predictor for 90 day mortality, overall survival and poor outcome. Conclusions: Increased serum cyclophilin A concentrations could reflect trauma severity and unfavorable outcome after head trauma, substantializing cyclophilin A as a potential biomarker for prognostic prediction of TBI.	[Jin, Hang-Huang; Mao, Tian-Ming; Bai, Zhi-Qiang; Chen, Yuan; Ji, Hai-Long; Jin, Yong] Zhejiang Taizhou Municipal Hosp, Dept Neurosurg, 381 Zhongshan East Rd, Taizhou 318000, Zhejiang, Peoples R China		Jin, Y (corresponding author), Zhejiang Taizhou Municipal Hosp, Dept Neurosurg, 381 Zhongshan East Rd, Taizhou 318000, Zhejiang, Peoples R China.	taizhoujinyong@163.com					Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Arun P, 2013, NEUROSCI RES, V76, P98, DOI 10.1016/j.neures.2013.02.009; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; De-Lima-Oliveira M, 2018, WORLD NEUROSURG, V113, P110, DOI 10.1016/j.wneu.2018.01.194; Dong XQ, 2017, CLIN CHIM ACTA, V471, P298, DOI 10.1016/j.cca.2017.06.020; Feeney C, 2017, ANN NEUROL, V82, P30, DOI 10.1002/ana.24971; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Goldner FM, 1996, J COMP NEUROL, V372, P283; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Huang CH, 2015, INT J BIOL SCI, V11, P38, DOI 10.7150/ijbs.10271; Jin R, 2017, STROKE, V48, P3356, DOI 10.1161/STROKEAHA.117.018839; Kao HW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001683; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Liu MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09937; Lo WY, 2010, AM J CHINESE MED, V38, P745, DOI 10.1142/S0192415X10008214; Lorente L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0922-2; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakano N, 2017, PATHOL INT, V67, P555, DOI 10.1111/pin.12593; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Ohtsuki T, 2017, ARTERIOSCL THROM VAS, V37, P685, DOI 10.1161/ATVBAHA.116.308986; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Ramachandran S, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-38; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Redell JB, 2007, J NEUROSCI RES, V85, P1980, DOI 10.1002/jnr.21324; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; Seizer P, 2010, ATHEROSCLEROSIS, V209, P51, DOI 10.1016/j.atherosclerosis.2009.08.029; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; Shen LJ, 2014, CLIN CHIM ACTA, V427, P37, DOI 10.1016/j.cca.2013.09.047; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Tsai SF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001802; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2; Zhang M, 2018, INT J CHRONIC OBSTR, V13, P357, DOI 10.2147/COPD.S152898; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; Zuern CS, 2013, EUR J HEART FAIL, V15, P176, DOI 10.1093/eurjhf/hfs185	48	3	3	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP	2018	484						258	264		10.1016/j.cca.2018.06.009			7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	GO6CF	WOS:000440121000041	29885319				2022-02-06	
J	Lamontagne, ME; Bayley, MT; Marshall, S; Kua, A; Marier-Deschenes, P; Allaire, AS; Schmouth, ME; Kagan, C; Truchon, C; Swaine, B				Lamontagne, Marie-Eve; Bayley, Mark Theodore; Marshall, Shawn; Kua, Ailene; Marier-Deschenes, Pascale; Allaire, Anne-Sophie; Schmouth, Marie-Eve; Kagan, Corinne; Truchon, Catherine; Swaine, Bonnie			Assessment of Users' Needs and Expectations Toward Clinical Practice Guidelines to Support the Rehabilitation of Adults With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						guidelines; knowledge translation; rehabilitation; therapeutic approaches for the treatment of CNS injury; traumatic brain injury	IMPLEMENTATION; ATTITUDES; KNOWLEDGE; CARE	Objective: Stakeholder engagement in clinical practice guideline (CPG) creation is thought to increase relevance of CPGs and facilitate their implementation. The objectives were to survey stakeholders involved in the care of adults with traumatic brain injury (TBI) regarding general perceptions of CPGs, key elements to be included, and needs and expectations about format and implementation strategy. Settings: Hospitals and inpatient and outpatient rehabilitation facilities providing services to persons with TBI. Participants: Stakeholders identified as primary end users of the CPG: clinicians, hospital leaders, health system managers, and funders in Quebec and Ontario (Canada). Design: Cross-sectional online survey conducted between May and September 2014. Results: In total, 332 individuals expressed their needs and expectations. Despite positive perceptions of CPGs, only a small proportion of respondents used them. Intensity and frequency of interventions, behaviors disorders and cognitive function impairment, and social participation and community life were important subjects to cover in the CPG. Finally, respondents asked for specific recommendations including a ranking of recommendations based on level of underlying evidence. Conclusion: Respondents have important expectations toward a CPG. We anticipate that early and meaningful engagement of end users could facilitate CPG implementation.	[Lamontagne, Marie-Eve; Marier-Deschenes, Pascale; Allaire, Anne-Sophie; Schmouth, Marie-Eve] Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Bayley, Mark Theodore; Kua, Ailene] Univ Hlth Network, Brain & Spinal Cord Rehabil Program, Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark Theodore] Univ Toronto, Fac Med, Toronto, ON, Canada; [Marshall, Shawn] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Kagan, Corinne] Ontario Neurotrauma Fdn, Toronto, ON, Canada; [Truchon, Catherine] INESSS, Quebec City, PQ, Canada; [Swaine, Bonnie] Montreal Metropolitain CRIR, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Montreal, PQ, Canada		Lamontagne, ME (corresponding author), Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.	Marie-Eve.Lamontagne@fmed.ulaval.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429; Bayley, Mark/0000-0001-7860-9463	Institut national d'excellence en sante et en services sociaux (INESSS); Ontario Neurotrauma Foundation (ONF)	The project described in this article was funded through the Institut national d'excellence en sante et en services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF).; The authors gratefully acknowledge the Institut national d'excellence en sante et en services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF) for their support of this project.	[Anonymous], 2006, TRAUM BRAIN INJ DIAG; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-60; Gagliardi Anna R, 2015, CMAJ Open, V3, pE127, DOI 10.9778/cmajo.20140064; Gagliardi AR, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0098-8; Gagliardi AR, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-404; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Heiwe S, 2011, INT J QUAL HEALTH C, V23, P198, DOI 10.1093/intqhc/mzq083; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Kastner M, 2015, J CLIN EPIDEMIOL, V68, P498, DOI 10.1016/j.jclinepi.2014.12.013; Kastner M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-69; Kerr J, 2005, EMERG MED J, V22, P850, DOI 10.1136/emj.2004.022673; Lamontagne M-E, 2014, INT BRAIN INJ C SAN; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P14, DOI 10.1186/1478-4505-4-14; Scottish Intercollegiate Guidelines Network, 2013, SIGN PUBL, V130; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Upton D, 2014, BRIT J OCCUP THER, V77, P24, DOI 10.4276/030802214X13887685335544; Weng YH, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-112	20	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					288	295		10.1097/HTR.0000000000000429			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500011	30188458				2022-02-06	
J	Najafi, Z; Zakeri, H; Abbaszadeh, A; Ebrahimi, M; Mirhaghi, A				Najafi, Zohre; Zakeri, Hossein; Abbaszadeh, Abbas; Ebrahimi, Mohsen; Mirhaghi, Amir			Does Emergency Severity Index Predict Acuity Among Traumatic Brain Injury Patients?	EURASIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; emergency severity index; triage; prehospital emergency	PREHOSPITAL TIME; MAJOR TRAUMA; TRIAGE; MORTALITY; SURVIVAL; VALIDITY; CARE; RELIABILITY; TRANSFUSION; HEMATOCRIT	Aim: It is unclear whether emergency severity index (ESI) is valid to triage patients with trauma. We aimed to determine the accuracy of ESI in both prehospital and hospital settings. Materials and Methods: This study was an observational prospective cohort where in patients with traumatic brain injury (TBI) were followed from the accident scene to the hospital. Used resources and timing indices were collected both on the scene as well as at the hospital. A logistic regression was performed to ascertain the effects of clinical parameters on the likelihood of survival of patients with TBI regarding 24 hour mortality. Results: A total of 185 patients were included in this study. The mortality rate was 14% (25/185). The logistic regression model was statistically significant at chi 2=57.8, p=0.001. An enter logistic regression analysis showed that used resources either in prehospital or in hospital significantly improved predictions related to mortality. The model explained the 49% variance in survival of patients with TBI. Conclusion: The ESI-used resources can be used to triage patients with TBI for pre-hospital and hospital emergency care. It is recommended that ESI triage tool be used to triage patients with TBI.	[Najafi, Zohre] Shahid Beheshti Univ Med Sci, Sch Nursing & Midwifery, Dept Nursing, Tehran, Iran; [Zakeri, Hossein] Mashhad Univ Med Sci, Sch Med, Hasheminejad Hosp, Dept Emergency Med, Mashhad, Iran; [Abbaszadeh, Abbas] Shahid Beheshti Univ Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Tehran, Iran; [Ebrahimi, Mohsen] Mashhad Univ Med Sci, Sch Med, Imam Reza Hosp, Dept Emergency Med, Mashhad, Iran; [Mirhaghi, Amir] Mashhad Univ Med Sci, Sch Nursing & Midwifery, Evidence Based Care Res Ctr, Mashhad, Iran		Mirhaghi, A (corresponding author), Mashhad Univ Med Sci, Sch Nursing & Midwifery, Evidence Based Care Res Ctr, Mashhad, Iran.	mirhaghi@mail.com	Ebrahimi, Mohsen/AAZ-1132-2021	Ebrahimi, Mohsen/0000-0003-2168-8476	Mashhad University of Medical Sciences	The authors declared that this study has received grant from the Vice Chancellor of Research of Mashhad University of Medical Sciences.	Alarhayem AQ, 2016, AM J SURG, V212, P1101, DOI 10.1016/j.amjsurg.2016.08.018; Allen CJ, 2014, J PEDIATR SURG, V49, P1678, DOI 10.1016/j.jpedsurg.2014.10.044; Baumann MR, 2007, ANN EMERG MED, V49, P234, DOI 10.1016/j.annemergmed.2006.04.011; Desmettre T, 2012, CRIT CARE, V16, DOI 10.1186/cc11647; Dharap SB, 2017, J POSTGRAD MED, V63, P169, DOI 10.4103/0022-3859.201417; Elshove-Bolk J, 2006, J EMERGENCY MED, V30, P237; Esposito T J, 1995, Prehosp Disaster Med, V10, P161; Grossman DC, 1997, J TRAUMA, V42, P723, DOI 10.1097/00005373-199704000-00024; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Karakus A, 2012, ULUS TRAVMA ACIL CER, V18, P289, DOI 10.5505/tjtes.2012.81488; Mackersie RC, 2006, PREHOSP EMERG CARE, V10, P287, DOI 10.1080/10903120600721636; Mirhaghi A, 2016, MED KLIN-INTENSIVMED, V111, P138, DOI 10.1007/s00063-015-0133-9; Mirhaghi Amir, 2017, J Evid Based Med, V10, P129, DOI 10.1111/jebm.12231; Montoya KF, 2015, J ACUTE DIS, V4, P202, DOI 10.1016/j.joad.2015.04.006; Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Rotondo M, 2014, J AM COLL SURG, V6; Salehi O, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.20349; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Tanabe Paula, 2004, J Emerg Nurs, V30, P22, DOI 10.1016/j.jen.2003.11.004; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thorson CM, 2013, J AM COLL SURGEONS, V216, P65, DOI 10.1016/j.jamcollsurg.2012.09.011; Wuerz R, 2001, ACAD EMERG MED, V8, P61; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	25	3	3	1	1	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY	2149-5807	2149-6048		EURASIAN J EMERG MED	Eurasian J. Emerg. Med.	SEP	2018	17	3					103	108		10.5152/eajem.2018.24582			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GW4OS	WOS:000446896600006		Green Submitted, gold			2022-02-06	
J	Radigan, LJ; McGlinchey, RE; Milberg, WP; Fortier, CB				Radigan, Lauren J.; McGlinchey, Regina E.; Milberg, William P.; Fortier, Catherine Brawn			Correspondence of the Boston Assessment of Traumatic Brain Injury-Lifetime and the VA Comprehensive TBI Evaluation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Boston Assessment of Traumatic Brain Injury-Lifetime (BAT-L); Comprehensive TBI Evaluation (CTBIE); diagnosis; OEF; OIF; OND; PTSD; TBI; TBI screen; Translational Research Center for TBI and Stress Disorders (TRACTS); Veteran	CLINICAL INTERVIEW; VETERANS	Objective: To compare the diagnosis of positive versus negative for mild traumatic brain injury (mTBI) using the Boston Assessment of TBI-Lifetime (BAT-L), a validated forensic clinical interview used to identify TBI in research, to the diagnosis of mTBI in the clinical polytrauma service using the Comprehensive TBI Evaluation (CTBIE). Participants: Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans who were enrolled in the Translational Research Center for TBI and Stress Disorders longitudinal cohort study and received a CTBIE at a Veterans Health Administration healthcare facility (n = 104). Main Measures: The BAT-L, CTBIE, and Neurobehavioral Symptom Inventory. Results: There was poor correspondence between the BAT-L and CTBIE mTBI diagnoses ( = 0.283). The CTBIE showed moderate sensitivity but poor specificity relative to the BAT-L. The agreement did not improve after removing individuals who had failed symptom validity measures, as assessed by the Validity-10 scale of the Neurobehavioral Symptom Inventory. Conclusions: This lack of correspondence highlights the difficulties in diagnosing mTBI in Veterans using retrospective self-report. Future work is needed to establish a reliable and valid method for identifying military mTBI both for the care of our Veterans and for appropriate distribution of benefits.	[Radigan, Lauren J.; McGlinchey, Regina E.; Milberg, William P.; Fortier, Catherine Brawn] VA Boston Healthcare Syst, Educ & Clin Ctr, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Radigan, Lauren J.; McGlinchey, Regina E.; Milberg, William P.; Fortier, Catherine Brawn] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Radigan, Lauren J.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [McGlinchey, Regina E.; Milberg, William P.; Fortier, Catherine Brawn] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Radigan, LJ (corresponding author), VA Boston Healthcare Syst, Educ & Clin Ctr, Translat Res Ctr TBI & Stress Disorders & Geriatr, 150 South Huntington Ave, Boston, MA 02130 USA.	catherine_fortier@hms.harvard.edu	Fortier, Catherine/AAS-2163-2021	Fortier, Catherine/0000-0002-8953-9904	Translational Research Center for TBI and Stress Disorders, a VA Rehabilitation Research and Development National Network Research Center for Traumatic Brain Injury [B9254-C]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258]; VA CSR&D Merit Review Award; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001327] Funding Source: NIH RePORTER	This research was supported by the Translational Research Center for TBI and Stress Disorders, a VA Rehabilitation Research and Development National Network Research Center for Traumatic Brain Injury (B9254-C; McGlinchey), NIH NIA K23AG034258 (Fortier); VA CSR&D Merit Review Award (McGlinchey)	Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs and Department of Defense, 2010, VA DOD CLIN PRACT GU; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Grande LJ, 2015, FIN PROGR 43 ANN M; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069	12	3	3	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E51	E55		10.1097/HTR.0000000000000361			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500007	29194179	Green Accepted			2022-02-06	
J	Tirado, MDR; Pampin, JMB; Gomez, RG				Romero Tirado, Maria de los Angeles; Blanco Pampin, Jose Manuel; Gallego Gomez, Rosalia			Dating of Traumatic Brain Injury in Forensic Cases Using Immunohistochemical Markers (I): Neurofilaments and -Amyloid Precursor Protein	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						axonal injury; immunohistochemistry; traumatic brain injury	AXONAL INJURY; HEAD-INJURY; BETA-APP; PATHOLOGY; ENCEPHALOPATHY; NEUROPATHOLOGY; ACCUMULATION; ADULTS; DAMAGE; GFAP	Studies about head trauma are experimental or have a clinical or prognosis purpose. In this study, we used samples from human autopsies to answer common medical-legal questions. We studied 21 problem cases and 4 controls. Samples were obtained directly from the injured area, fixed in 10% formalin during 24 hours and then preserved in 70% ethanol. This procedure optimizes the immunohistochemical technique. The neurofilament antibody shows beaded axons since the first moment; over time, they increase their density and diameter as survival time also increases. These changes begin in the gray matter, 2 hours after trauma can be seen around vessels and in hemorrhagic areas. At 24 hours, beaded axons appear in the white mater, which finally loses its structure and cellular density. On the other hand, the -amyloid precursor protein marker begins to be weakly seen 2 hours after injury. At 24 hours, a diffuse pattern can appear, suggesting primary traumatic injury. The marker reading keeps increasing until day 26, when a Z pattern appears in the white matter, suggesting secondary hypoxic injury. All these chronologic changes could be useful to approach the date of trauma. They let us to distinguish between long surviving cases from those whose death was immediate (within the first 30 minutes).	[Romero Tirado, Maria de los Angeles; Blanco Pampin, Jose Manuel] Inst Legal Med Galicia, Dept Forens Pathol, Santiago De Compostela, Spain; [Gallego Gomez, Rosalia] Univ Santiago de Compostela, Dept Morphol Sci, Med Coll, Santiago De Compostela, Spain		Tirado, MDR (corresponding author), Subdirecc Pontevedra, Inst Med Legal Galicia, C Tomas y Valiente S-N,Edificio Juzgados La Parda, Pontevedra 36001, Spain.	maria.angeles.romero.tirado@xunta.gal					Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hayashi T, 2015, INT J LEGAL MED, V129, P1085, DOI 10.1007/s00414-015-1245-8; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kobek M, 2014, Arch Med Sadowej Kryminol, V64, P268; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; MacKenzie JM, 2015, AM J FOREN MED PATH, V36, P172, DOI 10.1097/PAF.0000000000000166; Maeda H, 2010, FORENSIC SCI INT, V203, P83, DOI 10.1016/j.forsciint.2010.07.024; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison C, 2008, NEUROPATH APPL NEURO, V34, P124, DOI 10.1111/j.1365-2990.2007.00876.x; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pierce JES, 1996, J NEUROSCI, V16, P1083; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ronchao S, 2012, DIAGN PATHOL, V7, P54; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960	28	3	3	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2018	39	3					201	207		10.1097/PAF.0000000000000412			7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	GR4RY	WOS:000442605500003	29901458				2022-02-06	
J	Stretti, F; Klinzing, S; Ehlers, U; Steiger, P; Schuepbach, R; Krones, T; Brandi, G				Stretti, Federica; Klinzing, Stephanie; Ehlers, Ulrike; Steiger, Peter; Schuepbach, Reto; Krones, Tanja; Brandi, Giovanna			Low Level of Vegetative State After Traumatic Brain Injury in a Swiss Academic Hospital	ANESTHESIA AND ANALGESIA			English	Article							OF-LIFE CARE; TREATMENT-LIMITING DECISIONS; ADVANCE DIRECTIVES; SUSTAINING THERAPY; END; WITHDRAWAL; MORTALITY; IMPACT; HEMORRHAGE; PREDICTION	BACKGROUND: No standards exist regarding decision making for comatose patients, especially concerning life-saving treatments. The aim of this retrospective, single-center study was to analyze outcomes and the decision-making process at the end of life (EOL) in patients with traumatic brain injury (TBI) in a Swiss academic tertiary care hospital. METHODS: Consecutive admissions to the surgical intensive care unit (ICU) with stays of at least 48 hours between January 1, 2012 and June 30, 2015 in patients with moderate to severe TBI and with fatality within 6 months after trauma were included. Descriptive statistics were used. RESULTS: Of 994 ICU admissions with TBI in the study period, 182 had an initial Glasgow Coma Scale < 13 and a length of stay in the ICU > 48 hours. For 174 of them, a 6-month outcome assessment based on the Glasgow Outcome Scale (GOS) was available: 43.1% (36.0%-50.5%) had favorable outcomes (GOS 4 or 5), 28.7% (22.5%-35.9%) a severe disability (GOS 3), 0.6% (0%-3.2%) a vegetative state (GOS 2), and 27.6% (21.5%-34.7%) died (GOS 1). Among the GOS 1 individuals, 45 patients had a complete dataset (73% men; median age, 67 years; interquartile range, 43-79 years). Life-prolonging therapies were limited in 95.6% (85.2%-99.2%) of the cases after interdisciplinary prognostication and involvement of the surrogate decision maker (SDM) to respect the patient's documented or presumed will. In 97.7% (87.9%-99.9%) of the cases, a next of kin was the SDM and was involved in the EOL decision and process in 100% (96.3%-100.0%) of the cases. Written advance directives (ADs) were available for 14.0% (6.6%-27.3%) of the patients, and 34.9% (22.4%-49.8%) of the patients had shared their EOL will with relatives before trauma. In the other cases, each patient's presumed will was acknowledged after a meeting with the SDM and was binding for the EOL decision. CONCLUSIONS: At our institution, the majority of deaths after TBI follow a decision to limit life-prolonging therapies. The frequency of patients in vegetative state 6 months after TBI is lower than expected; this could be due to the high prevalence of limitation of life-prolonging therapies. EOL decision making follows a standardized process, based on patients' will documented in the ADs or on preferences assumed by the SDM. The prevalence of ADs was low and should be encouraged.	[Stretti, Federica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Klinzing, Stephanie; Ehlers, Ulrike; Steiger, Peter; Schuepbach, Reto; Brandi, Giovanna] Univ Hosp Zurich, Surg Intens Care Unit, Ramistr 100, CH-8091 Zurich, Switzerland; [Krones, Tanja] Univ Hosp Zurich, Clin Eth, Zurich, Switzerland		Brandi, G (corresponding author), Univ Hosp Zurich, Surg Intens Care Unit, Ramistr 100, CH-8091 Zurich, Switzerland.	giovanna.brandi@usz.ch	Schuepbach, Reto/AAO-6360-2020; Schuepbach, Reto A/J-9737-2012	Schuepbach, Reto/0000-0002-7058-4377; Schuepbach, Reto A/0000-0002-7058-4377			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Ball CG, 2010, J TRAUMA, V69, P1323, DOI 10.1097/TA.0b013e3181f66878; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Buchler A, 2016, MED LAW SWITZERLAND; Buckley TA, 2004, CRIT CARE MED, V32, P415, DOI 10.1097/01.CCM.0000110675.34569.A9; Burns JP, 2007, CHEST, V132, P1987, DOI 10.1378/chest.07-1441; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; De Vleminck A, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0068-1; Detering K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008800; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Erlebach R, AGE RELATED OUT COME; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Frost DW, 2011, CRIT CARE MED, V39, P1174, DOI 10.1097/CCM.0b013e31820eacf2; Gavrin JR, 2007, CRIT CARE MED, V35, pS85, DOI 10.1097/01.CCM.0000252909.52316.27; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Pautex S, 2015, BMJ SUPPORT PALLIAT, P1; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sokol DK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2222; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Swiss Academy of Medical Sciences (SAMS), 2013, DEC CARD RES; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Tolle SW, 2017, NEW ENGL J MED, V376, P1078, DOI 10.1056/NEJMsb1612511; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Delden JJM, 2006, CRIT CARE MED, V34, P1686, DOI 10.1097/01.CCM.0000218417.51292.A7; VINCENT JL, 2001, CRIT CARE MED S, V29; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Weimer JM, 2016, CRIT CARE MED, V44, P1161, DOI 10.1097/CCM.0000000000001570; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Wilkinson DJC, 2011, CURR OPIN ANESTHESIO, V24, P160, DOI 10.1097/ACO.0b013e328343c5af; Wilson WT, 2017, BRIT J NEUROSURG, V31, P254, DOI 10.1080/02688697.2016.1226259	40	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	2018	127	3					698	703		10.1213/ANE.0000000000003375			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HC8UF	WOS:000452079300030	29649031	Green Accepted			2022-02-06	
J	Swaine, B; Bayley, MT; Marshall, S; Kua, A; Marier-Deschenes, P; Allaire, AS; Kagan, C; Truchon, C; Janzen, S; Teasell, R; Lamontagne, ME				Swaine, Bonnie; Bayley, Mark Theodore; Marshall, Shawn; Kua, Ailene; Marier-Deschenes, Pascale; Allaire, Anne-Sophie; Kagan, Corinne; Truchon, Catherine; Janzen, Shannon; Teasell, Robert; Lamontagne, Marie-Eve			Why Do We Need a New Clinical Practice Guideline for Moderate to Severe Traumatic Brain Injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						guidelines; knowledge translation; rehabilitation; therapeutic approaches for the treatment of CNS injury; traumatic brain injury		Objective: Clinical practice guidelines (CPGs) aim to improve quality and consistency of healthcare services. A Canadian group of researchers, clinicians, and policy makers developed/adapted a CPG for rehabilitation post-moderate to severe traumatic brain injury (MSTBI) to respond to end users' needs in acute care and rehabilitation settings. Methods: The rigorous CPG development process began assessing needs and expectations of end users, then appraised existing CPGs, and, during a consensus conference, produced fundamental and priority recommendations. We also surveyed end users' perceptions of implementation gaps to determine future implementation strategies to optimize adherence to the CPG. Results: The unique bilingual (French and English) CPG consists of 266 recommendations (of which 126 are new recommendations), addressing top priorities for MSTBI, rationale, process indicators, and implementations tools (eg, algorithms and benchmarks). Conclusion: The novel approach of consulting and working with end users to develop a CPG for MSTBI should influence knowledge uptake for clinicians wanting to provide evidence-based care.	[Swaine, Bonnie] Ctr Rech Interdisciplinaire Readaptat Montreal Me, 7077 Ave Parc,Local 402-6, Montreal, PQ H3N 1X7, Canada; [Swaine, Bonnie] Univ Montreal, 7077 Ave Parc,Local 402-6, Montreal, PQ, Canada; [Bayley, Mark Theodore; Kua, Ailene] Univ Hlth Network, Toronto Rehabil Inst, Brain & Spinal Cord Rehabil Program, Toronto, ON, Canada; [Bayley, Mark Theodore] Univ Toronto, Fac Med, Toronto, ON, Canada; [Marshall, Shawn] OHRI, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Ottawa, ON, Canada; [Marier-Deschenes, Pascale; Allaire, Anne-Sophie; Lamontagne, Marie-Eve] Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Kagan, Corinne] ONF, Toronto, ON, Canada; [Truchon, Catherine] INESSS, Quebec City, PQ, Canada; [Janzen, Shannon] St Josephs Hlth Care, Lawson Hlth Res Inst, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, St Josephs Hlth Care, London, ON, Canada		Swaine, B (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, 7077 Ave Parc,Local 402-6, Montreal, PQ H3N 1X7, Canada.; Swaine, B (corresponding author), Univ Montreal, 7077 Ave Parc,Local 402-6, Montreal, PQ, Canada.	bonnie.swaine@umontreal.ca		Bayley, Mark/0000-0001-7860-9463; Lamontagne, Marie-Eve/0000-0002-3301-7429	Institut national d'excellence en sante et services sociaux (INESSS); Ontario Neurotrauma Foundation (ONF); Institut national d'excellence en sante et service sociaux (INESSS)	The project described in this article was funded through Institut national d'excellence en sante et services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF). The authors gratefully acknowledge the Institut national d'excellence en sante et service sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF) for their support of this project.	Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Brouwers MC, 2012, J CLIN EPIDEMIOL, V65, P526, DOI 10.1016/j.jclinepi.2011.10.008; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Gagliardi Anna R, 2015, CMAJ Open, V3, pE127, DOI 10.9778/cmajo.20140064; Gagliardi AR, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0098-8; Kastner M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-69; Swaine B, 2018, DISABIL REHABIL, V40, P697, DOI 10.1080/09638288.2016.1262911	8	3	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					285	287		10.1097/HTR.0000000000000427			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500010	30188457	Bronze			2022-02-06	
J	Juelsgaard, J; Rognas, L; Knudsen, L; Hansen, TM; Rasmussen, M				Juelsgaard, Joachim; Rognas, Leif; Knudsen, Lars; Hansen, Troels Martin; Rasmussen, Mads			Prehospital treatment of patients with acute intracranial pathology: adherence to guidelines and blood pressure recommendations by the Danish Air Ambulance	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Helicopter emergency medical service; Guideline adherence; Cerebral pathology; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; HYPOTENSION; MANAGEMENT; HYPOXIA	Background: Hypoxia and hypotension may be associated with secondary brain injury and negative outcomes in patients with traumatic and non-traumatic intracranial pathology. Guidelines exist only for the prehospital management of patients with severe traumatic brain injury (TBI). In patients with non-traumatic intracranial pathology, TBI guideline recommendations may be applied to assess whether hypoxia and hypotension should be avoided during prehospital treatment The main study objective was to assess the extent to which Danish Helicopter Emergency Medical Service (HEMS) critical care teams adhere to the prehospital TBI guideline recommendations for the management of patients with a clinical diagnosis of non-traumatic intracranial pathology or isolated TBI. Furthermore, in the same two groups of patients, we evaluated the adherence of the Danish HEMS critical care teams to recommendations aiming to maintain systolic blood pressure (SBP) > 110 mmHg and > 120 mmHg. Methods: In total, 211 prehospital patient records were studied. All patients were treated for non-traumatic intracranial pathology or isolated TBI by the Danish HEMS critical care teams from October 1,2014, to January 1,2017. Adherence to the prehospital TBI guideline recommendations and the SBP recommendations above was assessed in non-TBI and TBI populations. Results: The adherence rates to TBI guideline recommendations among Danish HEMS critical care teams were 69% (n = 106 [95% CI: 61-77%]) in the non-TBI population and 74% (n = 43 [95% CI: 61-85%]) in the TBI population. SBP > 110 mmHg was observed in 74% (n =113 [95% CI: 66-81%]) and 69% (n =40 [95% CI: 56-81%]) of cases in the non-TBI and TBI population, respectively. SBP > 120 mmHg was observed in 55% (n = 84, [95% CI: 47-63%]) of patients in the non-TBI population and 55% (n = 32 [95% CI: 42-68%]) of the patients in the TBI population. Conclusions: Due to a lack of comparative data, it is difficult to determine the performance quality of the Danish HEMS critical care teams. Our findings may suggest that adherence to TBI guidelines and SBP recommendations needs to be a continuous focal point for the Danish HEMS to avoid secondary brain damage.	[Rognas, Leif; Knudsen, Lars; Hansen, Troels Martin; Rasmussen, Mads] Danish Air Ambulance, Aarhus, Denmark; [Juelsgaard, Joachim; Rognas, Leif] Prehosp Crit Care Serv, Aarhus, Denmark; [Rognas, Leif; Rasmussen, Mads] Aarhus Univ Hosp, Dept Anaesthesia & Intens Care, Sect Neuroanaesthesia, Aarhus, Denmark		Rasmussen, M (corresponding author), Danish Air Ambulance, Aarhus, Denmark.; Rasmussen, M (corresponding author), Aarhus Univ Hosp, Dept Anaesthesia & Intens Care, Sect Neuroanaesthesia, Aarhus, Denmark.	mads.rasmussen@vest.rm.dk	Rognas, Leif/AAI-9373-2020; Rognas, Leif/AAF-6182-2020; Rasmussen, Mads/R-4876-2019	Rognas, Leif/0000-0002-2542-565X; Rasmussen, Mads/0000-0002-0416-6767			Andersen MS, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-53; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Khorgami Z, 2018, AM J SURG, V215, P727, DOI 10.1016/j.amjsurg.2018.01.008; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Pakkanen T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0438-1; Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014	14	3	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 22	2018	26								68	10.1186/s13049-018-0534-x			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GR6YW	WOS:000442829400001	30134933	gold, Green Published			2022-02-06	
J	Krill, ML; Nagelli, C; Borchers, J; Krill, MK; Hewett, TE				Krill, Matthew L.; Nagelli, Christopher; Borchers, James; Krill, Michael K.; Hewett, Timothy E.			Effect of Concussions on Lower Extremity Injury Rates at a Division I Collegiate Football Program	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						football (American); injury; lower extremity; concussion; position group; epidemiology	SPORTS-RELATED CONCUSSION; MUSCULOSKELETAL INJURY; HIGH-SCHOOL; SURVEILLANCE SYSTEM; EPIDEMIOLOGY; POSITION; RISK; INCREASES; FREQUENCY; PATTERNS	Background: Football has one of the highest injury rates (IRs) in sports, ranging from 4.1 to 8.6 per 1000 athlete-exposures (AEs). Previous research has reported that athletes may be at an increased risk of suffering lower extremity (LE) injuries after a concussion. Purpose/Hypothesis: The purpose of this study was to evaluate the rate of LE injuries in collegiate football athletes after a concussion. We predicted that the overall LE IR would increase after a concussion and that each position group would also demonstrate a similar increase in LE injuries after a concussion. Study Design: Cohort study; Level of evidence, 2. Methods: Daily attendance and injury records were prospectively collected by licensed team medical providers for the 2012 through 2016 college football regular seasons. Each injury report included the date of injury, position group, body part injured, and type of injury. IRs per 1000 AEs with 95% CIs were calculated to evaluate LE injuries at different time points after a concussion (remainder of season, next season, any additional seasons) and by months (<6 months, 6-12 months, >12 months). Mid-P exact tests were utilized to establish injury rate ratios (IRRs) to compare the IR between variables. Results: There was no significant difference in LE IRRs between the athletes post- versus preconcussion (P = .20) or between the postconcussion and no concussion (control) athletes (P = .08). There was an increased LE IR beyond 12 months in the postconcussion group (IR, 9.08 [95% CI, 3.68-18.89]) compared with the no concussion group (IR, 2.88 [95% CI, 2.04-3.96]) (IRR, 3.16 [95% CI, 1.21-7.15]; P = .02). Line position players had an increase in LE injuries after a concussion (IRR, 6.22 [95% CI, 1.31-23.68]; P = .03) compared with linemen with no concussion. Conclusion: There was no initial increase in LE IRs immediately after a concussion; however, there was an increased LE IR more than 12 months after a concussion. There was no increase in LE IRs demonstrated by skill and other position groups. Line position players experienced an increased LE IR the next season after a concussion or greater than 12 months after the injury.	[Krill, Matthew L.; Nagelli, Christopher; Borchers, James; Krill, Michael K.; Hewett, Timothy E.] Ohio State Univ, Jameson Crane Sports Med Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Nagelli, Christopher; Hewett, Timothy E.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA; [Krill, Matthew L.; Krill, Michael K.] Ohio State Univ, Wexner Med Ctr, Jameson Crane Sports Med Inst, Motion Anal & Performance Lab, Columbus, OH 43210 USA; [Nagelli, Christopher; Hewett, Timothy E.] Mayo Clin, Orthoped Biomech Lab, Rochester, MN 55905 USA; [Nagelli, Christopher; Hewett, Timothy E.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA; [Nagelli, Christopher] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Borchers, James] Ohio State Univ, Wexner Med Ctr, Dept Family Med, Columbus, OH 43210 USA; [Krill, Michael K.] Washington Univ, Dept Neurol, Div Neurorehabil, Phys Med & Rehabil, St Louis, MO USA; [Hewett, Timothy E.] Mayo Clin, Dept Biomed Engn & Physiol, Rochester, MN 55905 USA; [Hewett, Timothy E.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA		Hewett, TE (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	hewett.timothy@mayo.edu	Krill, Michael/AAF-7180-2020	Krill, Michael/0000-0002-5248-4786	Ohio State University's Department of Athletics; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR55563, R01AR056259]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055563, R01AR056259] Funding Source: NIH RePORTER	This study was partially funded by The Ohio State University's Department of Athletics. The authors acknowledge funding support from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grants R01AR55563 and R01AR056259 to T.E.H.	Agel J, 2013, CLIN J SPORT MED, V23, P33, DOI 10.1097/JSM.0b013e3182717983; Auerbach PS, 2016, JAMA-J AM MED ASSOC, V316, P1260, DOI 10.1001/jama.2016.8184; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Clifton DR, 2017, AM J SPORT MED, V45, P417, DOI 10.1177/0363546516667914; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Fainaru S, YOUTH FOOTBALL PARTI; Heck JF, 2004, J ATHL TRAINING, V39, P101; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Johnson G., MORE STRINGENT TARGE; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Krill MK, 2020, CLIN J SPORT MED, V30, P216, DOI 10.1097/JSM.0000000000000574; Krill MK, 2017, PHYSICIAN SPORTSMED, V45, P259, DOI 10.1080/00913847.2017.1343652; Krill MK, 2017, PHYSICIAN SPORTSMED, V45, P26, DOI 10.1080/00913847.2017.1279520; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Matava MJ, 2016, J KNEE SURG, V29, P370, DOI 10.1055/s-0036-1584313; McCunn R, 2017, INT J SPORT PHYSIOL, V12, P1297, DOI 10.1123/ijspp.2016-0803; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Rothenberg Paul, 2016, Am J Orthop (Belle Mead NJ), V45, P368; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Steiner ME, 2016, SPORTS HEALTH, V8, P217, DOI 10.1177/1941738115626689; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	36	3	3	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG 22	2018	6	8							2325967118790552	10.1177/2325967118790552			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GR3UW	WOS:000442522800001	30151401	Green Published, gold			2022-02-06	
J	Abd-El-Basset, EM; Rao, MS				Abd-El-Basset, Ebtesam M.; Rao, Muddanna S.			Dibutyryl Cyclic Adenosine Monophosphate Rescues the Neurons From Degeneration in Stab Wound and Excitotoxic Injury Models	FRONTIERS IN NEUROSCIENCE			English	Article						stab wound injury; hippocampus; BDNF; dBcAMP; astrogliosis	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ELEMENT-BINDING PROTEIN; NEUROTROPHIC FACTOR; REACTIVE ASTROCYTES; NEURODEGENERATIVE DISEASES; IN-VITRO; MICROGLIAL ACTIVATION; PSYCHIATRIC-DISORDERS; FUNCTIONAL RECOVERY	Dibutyryl cyclic adenosine monophosphate (dBcAMP), a cell-permeable synthetic analog of cAMP, has been shown to induce astrogliosis in culture. However, the exact mechanism underlying how dBcAMP exerts its function in situ is not clear. The objective of this study was to examine the effects of dBcAMP on astrogliosis and survival of neurons in stab wound and kainic acid models of brain injury. Stab wound was done in cerebral cortex of BALB/c male mice. Kainic acid lesion was induced in hippocampus by injecting 1 mu l kainic acid into the lateral ventricle. Animals in both models of injury were divided into L+dBcAMP and L+PBS groups and treated with dBcAMP or PBS for 3, 5, and 7 days respectively. The brain sections were stained for Cresyl violet and Fluro jade-B to assess the degenerating neurons. Immunostaining for GFAP and Iba-1 was done for assessing the astrogliosis and microglial response respectively. Expression of GFAP and BDNF levels in the tissue were estimated by Western blotting and ELISA respectively. The results showed a gradual increase in the number of both astrocytes and microglia in both injuries with a significant increase in dBcAMP-treated groups. The number of degenerating neurons significantly decreased in dBcAMP treated groups. In addition, it was found that dBcAMP stimulated the expression of GFAP and BDNF in both stab wound and kainic acid injuries. Treatment with BDNF receptor inhibitor AZ-23, showed an increase in the degenerating neurons suggesting the role of BDNF in neuroprotection. This study indicates that dBcAMP protects neurons from degeneration by enhancing the production of BDNF and may be considered for use as therapeutic agent for treatment of brain injuries.	[Abd-El-Basset, Ebtesam M.; Rao, Muddanna S.] Kuwait Univ, Fac Med, Dept Anat, Kuwait, Kuwait		Abd-El-Basset, EM (corresponding author), Kuwait Univ, Fac Med, Dept Anat, Kuwait, Kuwait.	ebtesam@hsc.edu.kw			Kuwait University [MA01/14]; OMICS [SRUL02/13]; ARC facility of HSC	This work is supported by Kuwait University, Grant # MA01/14, OMICS # SRUL02/13 and ARC facility of HSC. The authors would like to thank Ms. Amna Najem and Mrs. Josily Joy for technical assistance and Dr. Abd-El-Barr MM for reading the manuscript.	Abd-El-Basset EM, 2000, HISTOCHEM J, V32, P581, DOI 10.1023/A:1026738600838; ABDELBASSET EM, 1989, J NEUROPATH EXP NEUR, V48, P245, DOI 10.1097/00005072-198905000-00002; Adachi Naoki, 2014, World J Biol Chem, V5, P409, DOI 10.4331/wjbc.v5.i4.409; Aguilera-Castrejon A, 2017, NEUROCHEM RES, V42, P415, DOI 10.1007/s11064-016-2086-7; Aras R, 2012, BRAIN RES, V1450, P102, DOI 10.1016/j.brainres.2012.02.056; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Beauquis J, 2014, HIPPOCAMPUS, V24, P257, DOI 10.1002/hipo.22219; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Counts SE, 2010, J NEUROCHEM, V113, P649, DOI 10.1111/j.1471-4159.2010.06622.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FEDOROFF S, 1984, J NEUROSCI RES, V12, P15, DOI 10.1002/jnr.490120103; Franke B, 2000, EXP NEUROL, V165, P125, DOI 10.1006/exnr.2000.7453; Freire MAM, 2016, NEUROPATHOLOGY, V36, P527, DOI 10.1111/neup.12311; Gao Y, 2003, J NEUROSCI, V23, P11770; Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Gransee HM, 2015, J NEUROTRAUM, V32, P185, DOI 10.1089/neu.2014.3464; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kume T, 2008, NEUROSCI LETT, V443, P199, DOI 10.1016/j.neulet.2008.07.079; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopes RS, 2016, J BIOSCIENCES, V41, P381, DOI 10.1007/s12038-016-9621-1; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MENA MA, 1995, J NEUROCHEM, V65, P2612; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nair A, 2006, J BIOSCIENCES, V31, P423, DOI 10.1007/BF02704114; Nakao N, 1998, NEUROSCIENCE, V82, P1009; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Spencer T, 2004, J ANAT, V204, P49, DOI 10.1111/j.1469-7580.2004.00259.x; Thompson MA, 2015, BBA-MOL CELL RES, V1853, P2506, DOI 10.1016/j.bbamcr.2015.06.008; Thress K, 2009, MOL CANCER THER, V8, P1818, DOI 10.1158/1535-7163.MCT-09-0036; Tojima T, 2003, J NEUROSCI RES, V74, P829, DOI 10.1002/jnr.10754; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueda A, 2012, J NEUROGENET, V26, P64, DOI 10.3109/01677063.2011.652752; Vaz SH, 2011, J BIOL CHEM, V286, P40464, DOI 10.1074/jbc.M111.232009; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wirth MJ, 2003, DEVELOPMENT, V130, P5827, DOI 10.1242/dev.00826; Wu H, 2015, MOL MED REP, V12, P6427, DOI 10.3892/mmr.2015.4327; Xiang Y.i, 2014, J CONTROL RELEASE, V190, P637, DOI [10.1016/j.jconrel.2014.06.017, DOI 10.1016/J.JCONREL.2014.06.017]; Xu NY, 2012, HEARING RES, V283, P33, DOI 10.1016/j.heares.2011.11.010; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	70	3	3	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 8	2018	12								546	10.3389/fnins.2018.00546			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP7GY	WOS:000441064900001	30135639	gold, Green Published			2022-02-06	
J	Anwer, M; Bolkvadze, T; Ndode-Ekane, XE; Puhakka, N; Rauramaa, T; Leinonen, V; van Vliet, EA; Swaab, DF; Haapasalo, A; Leskela, S; Bister, N; Malm, T; Carlson, S; Aronica, E; Pitkanen, A				Anwer, Mehwish; Bolkvadze, Tamuna; Ndode-Ekane, Xavier Ekolle; Puhakka, Noora; Rauramaa, Tuomas; Leinonen, Ville; van Vliet, Erwin A.; Swaab, Dick F.; Haapasalo, Annakaisa; Leskela, Stina; Bister, Nea; Malm, Tarja; Carlson, Synnove; Aronica, Eleonora; Pitkanen, Asla			Sushi repeat-containing protein X-linked 2: A novel phylogenetically conserved hypothalamo-pituitary protein	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						hypophysis; hypothalamus; oxytocin; paraventricular nucleus; supraoptic nucleus; Sushi repeat-containing protein X-Linked 2; vasopressin; RRID:AB_2050340; RRID:AB_2157626; RRID:AB_2721268; RRID:AB_90782; RRID:AB_2314534; RRID:AB_321301	TRAUMATIC BRAIN-INJURY; PARAVENTRICULAR NUCLEUS; COLORECTAL-CANCER; GASTRIC-CANCER; SRPX2; SPEECH; DYSFUNCTION; DISORDERS; MIGRATION; OXYTOCIN	Sushi repeat-containing protein X-linked 2 (SRPX2) is a novel protein associated with language development, synaptic plasticity, tissue remodeling, and angiogenesis. We investigated the expression and spatial localization of SRPX2 in normal mouse, rat, monkey, and human brain using in situ hybridization and immunohistochemistry. Antibody specificity was determined using in vitro siRNA based silencing of SRPX2. Cell type-specific expression was verified by double-labeling with oxytocin or vasopressin. Western blot was used to detect SRPX2 protein in rat and human plasma and cerebrospinal fluid. Unexpectedly, SRPX2 mRNA expression levels were strikingly higher in the hypothalamus as compared to the cortex. All SRPX2 immunoreactive (ir) neurons were localized in the hypothalamic paraventricular, periventricular, and supraoptic nuclei in mouse, rat, monkey, and human brain. SRPX2 colocalized with vasopressin or oxytocin in paraventricular and supraoptic neurons. Hypothalamic SRPX2-ir positive neurons gave origin to dense projections traveling ventrally and caudally toward the hypophysis. Intense axonal varicosities and terminal arborizations were identified in the rat and human neurohypophysis. SRPX2-ir cells were also found in the adenohypophysis. Light SRPX2-ir projections were observed in the dorsal and ventral raphe, locus coeruleus, and the nucleus of the solitary tract in mouse, rat and monkey. SRPX2 protein was also detected in plasma and CSF. Our data revealed intense phylogenetically conserved expression of SRPX2 protein in distinct hypothalamic nuclei and the hypophysis, suggesting its active role in the hypothalamo-pituitary axis. The presence of SRPX2 protein in the plasma and CSF suggests that some of its functions depend on secretion into body fluids.	[Anwer, Mehwish; Bolkvadze, Tamuna; Ndode-Ekane, Xavier Ekolle; Puhakka, Noora; Haapasalo, Annakaisa; Leskela, Stina; Bister, Nea; Malm, Tarja; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland; [Rauramaa, Tuomas] Kuopio Univ Hosp, Dept Clin Pathol, Kuopio, Finland; [Leinonen, Ville] Kuopio Univ Hosp, Dept Neurosurg, Kuopio, Finland; [van Vliet, Erwin A.; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Amsterdam, Netherlands; [Swaab, Dick F.] KNAW, Netherlands Inst Neurosci, Dept Neuropsychiat Disorders, Amsterdam, Netherlands; [Carlson, Synnove] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Carlson, Synnove/G-2210-2013; Carlson, Synnove/AAM-2655-2021; van Vliet, Erwin/AAS-4753-2020	Carlson, Synnove/0000-0003-1462-7560; van Vliet, Erwin/0000-0001-5747-3202; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Malm, Tarja/0000-0002-9530-7472; Aronica, Eleonora/0000-0002-3542-3770; Haapasalo, Annakaisa/0000-0003-0959-2957	European Union's Seventh Framework Programme (FP7) [N8602102]; Marie Sklodowska-Curie grant [642881]; Academy of FinlandAcademy of FinlandEuropean Commission	European Union's Seventh Framework Programme (FP7/2007-2013), Grant/Award Number: N8602102; Marie Sklodowska-Curie grant agreement, Grant/Award Number: 642881, Academy of Finland	Armstrong JL, 2007, BRIT J CANCER, V96, P1675, DOI 10.1038/sj.bjc.6603779; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Ferguson AV, 2008, EXPERT OPIN THER TAR, V12, P717, DOI [10.1517/14728222.12.6.717, 10.1517/14728222.12.6.717 ]; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Lin XB, 2017, BIOMED PHARMACOTHER, V93, P398, DOI 10.1016/j.biopha.2017.06.075; Liu KL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0548-4; Liu KL, 2017, DRUG DISCOV THER, V11, P212, DOI 10.5582/ddt.2017.01017; Loewen SP, 2017, EXP PHYSIOL, V102, P1373, DOI 10.1113/EP086436; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Oster B, 2013, INT J CANCER, V132, P2303, DOI 10.1002/ijc.27921; Pfundmair M, 2016, PSYCHONEUROENDOCRINO, V73, P63, DOI 10.1016/j.psyneuen.2016.07.213; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Tanaka K, 2009, INT J CANCER, V124, P1072, DOI 10.1002/ijc.24065; Tang HT, 2016, CELL MOL NEUROBIOL, V36, P1067, DOI 10.1007/s10571-015-0300-9; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Theofanopoulou C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0988; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/NMETH.3995, 10.1038/nmeth.3995]; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Yamada T, 2014, J SURG ONCOL, V109, P836, DOI 10.1002/jso.23602; Ye Z., 2016, J COGNITIVE NEUROSCI, V29, P1; Zhang HF, 2016, NEUROSCI BULL, V32, P423, DOI 10.1007/s12264-016-0046-5	33	3	3	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	AUG 1	2018	526	11					1806	1819		10.1002/cne.24449			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	GI4RU	WOS:000434359700005	29663392				2022-02-06	
J	Bergen, K; Frodin, M; von Gertten, C; Sandberg-Nordqvist, AC; Skold, MK				Bergen, K.; Frodin, M.; von Gertten, C.; Sandberg-Nordqvist, A. -C.; Skold, M. K.			Neurite Growth and Polarization on Vitronectin Substrate after in Vitro Trauma is not Enhanced after IGF Treatment	BRAIN SCIENCES			English	Article						IGF-1; IGFBP-2; vitronectin; in vitro trauma; regeneration; hippocampal neuron	BINDING-PROTEINS; MESSENGER-RNA; BRAIN-INJURY; MOTOR; MIGRATION; EXPRESSION; RESPONSES; NEURONS	Following traumatic brain injuries (TBI), insulin-like growth factor (IGF) is cortically widely upregulated. This upregulation has a potential role in the recovery of neuronal tissue, plasticity, and neurotrophic activity, though the molecular mechanisms involved in IGF regulation and the exact role of IGF after TBI remain unclear. Vitronectin (VN), an extracellular matrix (ECM) molecule, has recently been shown to be of importance for IGF-mediated cellular growth and migration. Since VN is downregulated after TBI, we hypothesized that insufficient VN levels after TBI impairs the potential beneficial activity of IGF. To test if vitronectin and IGF-1/IGFBP-2 could contribute to neurite growth, we cultured hippocampal neurons on +/- vitronectin-coated coverslips and them treated with +/- IGF-1/IGF binding protein 2 (IGFBP-2). Under same conditions, cell cultures were also subjected to in vitro trauma to investigate differences in the posttraumatic regenerative capacity with +/- vitronectin-coated coverslips and with +/- IGF-1/IGFBP-2 treatment. In both the control and trauma situations, hippocampal neurons showed a stronger growth pattern on vitronectin than on the control substrate. Surprisingly, the addition of IGF-1/IGFBP-2 showed a decrease in neurite growth. Since neurite growth was measured as the number of neurites per area, we hypothesized that IGF-1/IGFBP-2 contributes to the polarization of neurons and thus induced a less dense neurite network after IGF-1/IGFBP-2 treatment. This hypothesis could not be confirmed and we therefore conclude that vitronectin has a positive effect on neurite growth in vitro both under normal conditions and after trauma, but that addition of IGF-1/IGFBP-2 does not have a positive additive effect.	[Bergen, K.; Frodin, M.; Skold, M. K.] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [von Gertten, C.; Sandberg-Nordqvist, A. -C.] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Skold, M. K.] Uppsala Univ, Dept Neurosci, Neurosurg Unit, S-75185 Uppsala, Sweden		Skold, MK (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Skold, MK (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg Unit, S-75185 Uppsala, Sweden.	karin.bergen@ki.se; magnus.frodin@ki.se; Christina.Von.Gertten@ki.se; anki.sandberg.nordqvist@ki.se; Mattias.Skold@ki.se	SkAld, Mattias/AAJ-8253-2020		Karolinska InstitutetKarolinska Institutet; Swedish National Defence Research Agency	This research was funded by Karolinska Institutet and Swedish National Defence Research Agency.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Ainscough SL, 2006, EXP EYE RES, V83, P1505, DOI 10.1016/j.exer.2006.08.012; Allard JB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00117; BACH MA, 1991, MOL BRAIN RES, V10, P43; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Breese CR, 1996, J COMP NEUROL, V369, P388; Cao YL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00010; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Clawson TF, 1999, BIOL SIGNAL RECEPT, V8, P281; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Hashimoto K, 2016, MOL CELL NEUROSCI, V70, P76, DOI 10.1016/j.mcn.2015.11.013; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kashyap AS, 2011, ENDOCRINOLOGY, V152, P1388, DOI 10.1210/en.2010-0897; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; Kricker JA, 2010, GROWTH FACTORS, V28, P359, DOI 10.3109/08977194.2010.494603; Lee WH, 1999, ENDOCRINE, V11, P181, DOI 10.1385/ENDO:11:2:181; Loddick SA, 1998, P NATL ACAD SCI USA, V95, P1894, DOI 10.1073/pnas.95.4.1894; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Pomytkin I, 2018, CNS NEUROSCI THER, V24, P763, DOI 10.1111/cns.12866; Pons S, 2000, DEVELOPMENT, V127, P333; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sonden A, 2000, LASER SURG MED, V26, P364, DOI 10.1002/(SICI)1096-9101(2000)26:4<364::AID-LSM4>3.0.CO;2-T; Sonden A, 2002, LASER SURG MED, V31, P233, DOI 10.1002/lsm.10093; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Tafreshi AP, 2017, J COMP NEUROL, V525, P3072, DOI 10.1002/cne.24263; Uriarte M., 2017, NEUROGENESIS AUSTIN, V4, DOI [10.1080/23262133.2016.1259709, DOI 10.1080/23262133.2016.125970928405590]; Van Lonkhuyzen DR, 2007, GROWTH FACTORS, V25, P295, DOI 10.1080/08977190701803752; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006	39	3	3	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2018	8	8							151	10.3390/brainsci8080151			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS0GC	WOS:000443165900014	30103517	gold, Green Published, Green Submitted			2022-02-06	
J	Bushroe, KM; Hade, EM; McCarthy, TA; Bridge, JA; Leonard, JC				Bushroe, Kylie M.; Hade, Erinn M.; McCarthy, Tara A.; Bridge, Jeffrey A.; Leonard, Julie C.			Mental Health after Unintentional Injury in a Pediatric Managed-Medicaid Population	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC STRESS SYMPTOMS; PSYCHIATRIC-DISORDERS; BURN INJURIES; CHILDREN; ADOLESCENTS; SEVERITY; SEQUELAE	Objectives The purpose of this study was to compare the rates of mental health diagnoses and psychotropic prescriptions pre- and posthospitalization for injury in a managed-Medicaid population. We hypothesized that children have increased rates of mental health diagnoses and psychotropic prescriptions after injury. Study design We investigated children (n = 2208) <= 18 years of age treated at a pediatric trauma center from 2005 to 2015 who were enrolled in a managed-Medicaid program at hospital admission and for at least 1 healthcare visit in the preceding year. We used Poisson regression models to estimate rates of mental health diagnoses and psychotropic prescriptions that occurred in the 12 months pre- and postinjury. Results The rate of mental health diagnoses preinjury was 95.9 per 1000 person-years, which increased to 156.7 per 1000 postinjury (rate ratio [RR] 1.63, 95% CI 1.39-1.92). Children ages 0-4 years with burns were more likely to have mental health diagnoses postinjury (race and ethnicity adjusted RR [aRR] 8.56, 95% CI 3.30-22.2). Children with head injuries were also more likely to have mental health diagnoses postinjury: ages 0-4 years (aRR 3.87, 95% CI 1.31-11.5); ages 5-9 (aRR 3.11, 95% CI 1.27-7.59); ages 10-14 (aRR 2.17, 95% CI 1.27-3.73); and ages 15-18 (aRR 5.37, 95% CI 2.12-13.6). The rate of psychotropic prescriptions preinjury was 121.7 per 1000 person-years and increased to 310.9 per 1000 postinjury (RR 2.55, 95% CI 2.26-2.89). Conclusions We identified increased mental health diagnoses and psychotropic prescriptions in children following hospitalization for injury.	[Bushroe, Kylie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Hade, Erinn M.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [McCarthy, Tara A.; Bridge, Jeffrey A.; Leonard, Julie C.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Bridge, Jeffrey A.; Leonard, Julie C.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Bushroe, KM (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.			Leonard, Julie/0000-0003-3670-1944	Ohio State University College of Medicine Roessler Research Grant; National Center For Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001070]	This project was supported by The Ohio State University College of Medicine Roessler Research Grant as well as Award Number Grant UL1TR001070 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. The authors declare no conflicts of interest.	*CDC, INJ PREV CONTR DAT S; Drotar, 2006, TRAUMATOLOGY, V12, P148, DOI [DOI 10.1177/1534765606294562, 10.77/1534765606294562]; Federal Interagency Forum on Child and Family Statistics, CHILD POP CHILDR MIL; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Howie LaJeana D, 2014, NCHS Data Brief, P1; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Kent L, 2000, BURNS, V26, P317, DOI 10.1016/S0305-4179(99)00172-2; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; SAWYER MG, 1983, BURNS, V9, P205, DOI 10.1016/0305-4179(83)90040-2; Schreier H, 2005, J TRAUMA, V58, P353, DOI 10.1097/01.TA.0000152537.15672.B7; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012; WOODWARD J, 1959, BRIT MED J, V1, P1009, DOI 10.1136/bmj.1.5128.1009; WRIGHT L, 1974, PEDIATR RES, V8, P931, DOI 10.1203/00006450-197412000-00003	19	3	3	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	AUG	2018	199						29	+		10.1016/j.jpeds.2018.03.039			22	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GN9CG	WOS:000439478200008	29747938				2022-02-06	
J	Gagnon, I; Friedman, D; Beauchamp, MH; Christie, B; DeMatteo, C; Macartney, G; McFadyen, BJ; Sirois, K; Taneja, C; Zabjek, K; Zemek, R; Mrazik, M				Gagnon, Isabelle; Friedman, Debbie; Beauchamp, Miriam H.; Christie, Brian; DeMatteo, Carol; Macartney, Gail; McFadyen, Bradford J.; Sirois, Katia; Taneja, Chand; Zabjek, Karl; Zemek, Roger; Mrazik, Martin		CanPedCDE Res Group	The Canadian Pediatric Mild Traumatic Brain Injury Common Data Elements Project: Harmonizing Outcomes to Increase Understanding of Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article						common data elements; concussion; mild traumatic brain injury; pediatric; standardization	INTERNATIONAL CLASSIFICATION; CORE SETS; HEALTH; DISABILITY; RECOMMENDATIONS; FRAMEWORK; ICF	A critical component for accelerating the clinical uptake of research data in the area of pediatric concussion or mild traumatic brain injury (MTBI) pertains to the establishment and utilization of common databases. The objective of the first phase of our CanPedCDE initiative was to agree upon pediatric common data elements (CDEs) that could best characterize children with MTBI over their recovery period. The selection of CDEs for our framework aimed to balance factors such as the comprehensiveness of outcomes collected, their applicability to diverse settings, as well as the costs associated with their use. Selection began by identifying relevant domains of functioning (e.g., post-concussion symptoms, attention, and balance). Two sources were used to make this process more efficient: 1) the World Health Organization International Classification of Functioning (ICF) Traumatic Brain Injury Core Set, and the U.S. National Institute of Neurological Disorders and Stroke Traumatic Brain Injury Common Data Elements, both of which had already suggested relevant domains to include in TBI research. The process was completed in two phases: 1) using an online survey of experts and 2) through an in-person consensus meeting. Measurement tools were also proposed that were best felt to capture these domains. Forty experts in MTBI in children from multiple health-related perspectives (e.g., emergency medicine, pediatrics, neurosurgery, nursing, physiotherapy, and neuroscience), as well as knowledge users, participated in the selection process. The final list of CDEs included 77 distinct areas of functioning, covering all categories of the ICF model. Outcome measures were attached to each element, when applicable. The CanPedCDE initiative addresses a significant limitation in MTBI research to date and may help both researchers and clinicians to organize and standardize their assessment of children and youth post-MTBI in order to move the field in promising directions.	[Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Ctr Hlth, Concuss Res Lab, Trauma Ctr,Montreal Childrens Hosp, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Dept Pediat & Pediat Surg, Fac Med, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Trauma Ctr, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Christie, Brian] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada; [Christie, Brian] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Christie, Brian] Univ British Columbia, Isl Med Program, Victoria, BC, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Macartney, Gail] Childrens Hosp Eastern Ontario, Concuss Clin, Ottawa, ON, Canada; [McFadyen, Bradford J.] Univ Laval, Rehabil Dept, Quebec City, PQ, Canada; [McFadyen, Bradford J.; Sirois, Katia] CIRRIS, Quebec City, PQ, Canada; [Sirois, Katia] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Taneja, Chand] Queen Alexandra Ctr Childrens Hlth, Div Med Sci, Victoria, BC, Canada; [Taneja, Chand] Queen Alexandra Ctr Childrens Hlth, Dept Psychol, Victoria, BC, Canada; [Zabjek, Karl] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Mrazik, Martin] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada		Gagnon, I (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, MUHC 5252 Blvd Maisonneuve Ouest,Off 3F-45, Montreal, PQ H4A 3S5, Canada.; Gagnon, I (corresponding author), Montreal Childrens Hosp, Concuss Res Lab, Ctr Trauma, MUHC 5252 Blvd Maisonneuve Ouest,Off 3F-45, Montreal, PQ H4A 3S5, Canada.	Isabelle.gagnon8@mcgill.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Macartney, Gail/0000-0003-3288-4886; Gagnon, Isabelle/0000-0003-2043-1644; McFadyen, Bradford/0000-0003-1992-4927	CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller AC, 2012, J NEUROTRAUM, V29, P634, DOI 10.1089/neu.2011.1932; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	23	3	3	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1849	1857		10.1089/neu.2018.5887			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400002	30074870				2022-02-06	
J	Gallant, C; Barry, N; Good, D				Gallant, Caitlyn; Barry, Nicole; Good, Dawn			Physiological underarousal as a mechanism of aggressive behavior in university athletes with a history of concussion	BRAIN AND BEHAVIOR			English	Article						aggression; arousal; athletes; concussion history	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; GENERALIZED ANXIETY DISORDER; RISK SPORTS PARTICIPANTS; STATES HIGH-SCHOOL; SENSATION SEEKING; COGNITIVE PERFORMANCE; IMPULSIVE AGGRESSION; DIAGNOSIS THREAT; COLLEGE-STUDENTS	Introduction: Research has indicated that athletes who engage in high-risk athletic activities, such as football and hockey, have riskier personalities than their low-risk and nonathlete counterparts (Ahmadi et al., 2011, Procedia Soc Behav Sci, 30 and 247-251; Zuckerman, 1983, Biological bases of sensation seeking, impulsivity, and anxiety, Lawrence Erlbaum Assoc Inc.). For instance, increased sensation-seeking and aggression are common in high-risk athletes, rendering these individuals more likely to sustain a subsequent injury, such as concussion. Elevated levels of certain personality traits, including impulsivity and aggression, have also been observed after concussion (Goswami et al., 2016, Brain Struct Funct, 221 and 1911-1925). The purpose of this study therefore was to determine whether aggressive behavior in university athletes may be accounted for, in part, by a history of concussion, rather than exclusively athletic status. Methods: Using a quasi-experimental design, 66 university students (n = 18 nonathletes, n = 24 low-risk athletes, n = 24 high-risk athletes) with (n = 27) and without a history of concussion (n = 39) completed the Buss & Perry Aggression Questionnaire (BPAQ; Buss & Perry, 1992, J Pers Soc Psychol, 63 and 452) and provided electrodermal activation (EDA) as an index of physiological arousal. Results: It was found that decreased physiological arousal among students with a history of concussion was associated with greater endorsement of physical aggression. Moreover, athletic status did not account for this pattern of aggression, as athletes and nonathletes did not differ in terms of self-reported aggressive tendencies. Conclusions: Physiological compromise after concussive injury may act as an independent mechanism of aggressive behavior in athletes beyond factors, such as athletic status.	[Gallant, Caitlyn; Barry, Nicole; Good, Dawn] Brock Univ, Dept Psychol, Mackenzie Chown B326,1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada; [Good, Dawn] Brock Univ, Ctr Neurosci, St Catharines, ON, Canada		Gallant, C (corresponding author), Brock Univ, Dept Psychol, Mackenzie Chown B326,1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.	cg14xx@brocku.ca		Gallant, Caitlyn/0000-0003-4305-1425			Ahmadi SS, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.049; Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Bara Filho Maurício Gattás, 2005, Rev Bras Med Esporte, V11, P115, DOI 10.1590/S1517-86922005000200004; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; BREDEMEIER BJ, 1986, J SPORT EXERCISE PSY, V8, P304, DOI 10.1123/jsp.8.4.304; Brown KW, 2013, SOC COGN AFFECT NEUR, V8, P93, DOI 10.1093/scan/nss004; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Butt D.S, 1987, PSYCHOL SPORT BEHAV; CHEREK DR, 1981, PSYCHOPHARMACOLOGY, V75, P339, DOI 10.1007/BF00435849; CRAIG KD, 1968, J ABNORM PSYCHOL, V73, P513, DOI 10.1037/h0026531; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A., 1994, DESCARTES ERROR EMOT; DIENSTBIER RA, 1989, PSYCHOL REV, V96, P84, DOI 10.1037/0033-295X.96.1.84; Dietze PM, 2008, MED J AUSTRALIA, V189, P479, DOI 10.5694/j.1326-5377.2008.tb02138.x; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Eysenck H. J., 1985, PERSONALITY INDIVIDU, DOI [10.1007/978-1-4613-2413-3, DOI 10.1007/978-1-4613-2413-3]; EYSENCK HJ, 1982, ADV BEHAV RES THER, V4, P1, DOI 10.1016/0146-6402(82)90004-2; Fisher AJ, 2010, BIOL PSYCHOL, V83, P191, DOI 10.1016/j.biopsycho.2009.12.007; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Gallegos C, 2019, CHRONOBIOL INT, V36, P343, DOI [10.1080/07420528.2018.1543315, 10.1007/s12144-018-9780-3]; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Good D., 2015, EVERYDAY LIVING QUES; Greve KW, 2001, BRAIN INJURY, V15, P255; Hatfield J, 2014, AM J PSYCHOL, V127, P233; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Hingson RW, 2002, J STUD ALCOHOL, V63, P136, DOI 10.15288/jsa.2002.63.136; Houston RJ, 2001, INT J PSYCHOPHYSIOL, V40, P1, DOI 10.1016/S0167-8760(00)00120-3; Huang DB, 1999, PSYCHOL REP, V85, P1251, DOI 10.2466/pr0.1999.85.3f.1251; Iverson G. L., 2009, BLACK BOOK NEUROPSYC; Jack SJ, 1998, PERS INDIV DIFFER, V25, P1063, DOI 10.1016/S0191-8869(98)00081-6; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keeler L.A., 2007, J SPORT BEHAV, V30, P57; KERR JH, 1991, PERS INDIV DIFFER, V12, P613, DOI 10.1016/0191-8869(91)90258-D; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kimble NB, 2010, AGGRESS VIOLENT BEH, V15, P446, DOI 10.1016/j.avb.2010.08.001; KOSS MP, 1993, J INTERPERS VIOLENCE, V8, P94, DOI 10.1177/088626093008001007; Krzeczkowski JE, 2017, MINDFULNESS, V8, P1594, DOI 10.1007/s12671-017-0731-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAZARUS RS, 1963, PSYCHOSOM MED, V25, P19, DOI 10.1097/00006842-196301000-00004; Lemieux P., 2002, ATHLETIC INSIGHT, V4; Lenzi A, 1997, PERCEPT MOTOR SKILL, V84, P139, DOI 10.2466/pms.1997.84.1.139; Limestone Technologies, 2008, POL PROF SUIT; Lumma AL, 2015, INT J PSYCHOPHYSIOL, V97, P38, DOI 10.1016/j.ijpsycho.2015.04.017; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mathias CW, 2003, PERS INDIV DIFFER, V35, P355, DOI 10.1016/S0191-8869(02)00195-2; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morales D., 2007, BRAIN CONTUSION; Nelson TF, 2001, MED SCI SPORT EXER, V33, P43; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; O'Brien KS, 2012, J SCI MED SPORT, V15, P292, DOI 10.1016/j.jsams.2011.10.008; O'Malley PM, 2002, J STUD ALCOHOL, P23, DOI 10.15288/jsas.2002.s14.23; Owings JT, 1998, ARCH SURG-CHICAGO, V133, P941, DOI 10.1001/archsurg.133.9.941; POTGIETER J, 1990, PERCEPT MOTOR SKILL, V71, P1203, DOI 10.2466/PMS.71.7.1203-1206; Rogers G, 2011, BRIT J GEN PRACT, V61, P40, DOI 10.3399/bjgp11X548965; ROWLAND GL, 1986, J SPORT EXERCISE PSY, V8, P212, DOI 10.1123/jsp.8.3.212; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; Schmidt B, 2013, PSYCHOPHYSIOLOGY, V50, P498, DOI 10.1111/psyp.12032; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Short MM, 2016, PERS INDIV DIFFER, V93, P97, DOI 10.1016/j.paid.2015.08.007; Sonderlund AL, 2014, J SCI MED SPORT, V17, P2, DOI 10.1016/j.jsams.2013.03.011; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stanford MS, 2003, ASSESSMENT, V10, P183, DOI 10.1177/1073191103010002009; Starcevic V, 1996, J AFFECT DISORDERS, V37, P75, DOI 10.1016/0165-0327(95)00058-5; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tenenbaum G, 1997, SPORT PSYCHOL, V11, P1, DOI 10.1123/tsp.11.1.1; THOMPSON NJ, 1994, J PEDIATR PSYCHOL, V19, P415, DOI 10.1093/jpepsy/19.4.415; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Verdejo-Garcia A, 2006, CURR NEUROPHARMACOL, V4, P17, DOI 10.2174/157015906775203057; Weiner B., 1974, ACHIEVEMENT MOTIVATI; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Ziaee V, 2012, IRAN J PEDIATR, V22, P9; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8; ZUCKERMAN M, 1983, BIOL BASES SENSATION	88	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	AUG	2018	8	8							e01038	10.1002/brb3.1038			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GZ0QW	WOS:000449070600013	30030911	gold, Green Published			2022-02-06	
J	Gokler, O; Kocak, I; Aydogan, E; Karanfil, I; Bas, C				Gokler, Ozan; Kocak, Ilker; Aydogan, Esra; Karanfil, Isil; Bas, Ceren			Evaluation of Benign Paroxysmal Positional Vertigo in American Football Players	JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY			English	Article						American football; benign paroxysmal positional vertigo; sports; trauma; vertigo	CONCUSSION; DIZZINESS; OUTCOMES	OBJECTIVES: The aim of this investigation was to evaluate the association between posterior channel benign paroxysmal positional vertigo (BPPV) and trauma that is frequently experienced by American football players. MATERIALS and METHODS: Participants wee classified into the following two groups: (1) a study group consisting of 63 male participants aged 18-30 years who had been playing American football for more than 2 years and (2) a control group consisting of 49 male participants aged 18-27 years with no history of otologic/vestibular disease or acute/chronic trauma. Trauma, age, total duration of playing Amer ican football, and weekly training hours of subjects in the study group were analyzed to deter mine any relationship with BPPV occurrence. We performed otologic, audiologic, and vestibular assessments of pure sound audiometry, tympanometry, tandem walking test with eyes open and eyes closed, Romberg, head shaking, roll, and Dix-Hallpike tests to all participants. RESULTS: A positive cor relation between the total year s of Amer ican football played and posterior channel BPPV frequency was observed in the study group. In addition, increasing weekly hours of training was shown to further increase the risk of BPPV. A total of 16 out of 63 athletes experienced BPPV, whereas none of the participants in the control group experienced BPPV. All participants completed the Vertigo Symptom Scale, which revealed that vertigo did not cause any significant negative impact on their training routine and activities of daily living. CONCLUSION: Our results indicate that the weekly training hours and total years of training with American football increase posterior channel BPPV frequency.	[Gokler, Ozan; Kocak, Ilker; Aydogan, Esra; Karanfil, Isil; Bas, Ceren] Koc Univ Hosp, Dept Otolaryngol Head & Neck Surg, Istanbul, Turkey		Karanfil, I (corresponding author), Koc Univ Hosp, Dept Otolaryngol Head & Neck Surg, Istanbul, Turkey.		Gokler, Ozan/AAA-6709-2021; Bas, Ceren/AAJ-4123-2021	Gokler, Ozan/0000-0003-1621-3687; Bas, Ceren/0000-0002-1824-8149			Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Aksoy Songul, 2007, Kulak Burun Bogaz Ihtis Derg, V17, P307; Ardic NF, 2005, IZMIR GUVEN BOOKSTOR, V5-26, P201; Atacan E, 2001, LARYNGOSCOPE, V111, P1257, DOI 10.1097/00005537-200107000-00021; Atlas JT, 2001, CURR OPIN OTOLARYNGO, V9, P284, DOI DOI 10.1097/00020840-200110000-00004; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Chang WC, 2006, OTOLARYNG HEAD NECK, V135, P534, DOI 10.1016/j.otohns.2005.10.001; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; EPLEY JM, 1980, OTOLARYNG HEAD NECK, V88, P599, DOI 10.1177/019459988008800514; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanci D, 2004, ISTANBUL TIP DERGISI, V1, P13; Ikiz A. O., 2013, EAR NOSE THROAT DIS, P325; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; LONGRIDGE NS, 1978, J OTOLARYNGOL, V7, P395; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Penarrocha M, 2001, J ORAL MAXIL SURG, V59, P106, DOI 10.1053/joms.2001.19307; Pisani V, 2015, INT J AUDIOL, V54, P329, DOI 10.3109/14992027.2014.989454; Suarez H, 2011, ACTA OTO-LARYNGOL, V131, P377, DOI 10.3109/00016489.2010.534113; Vibert D, 2007, ANN OTO RHINOL LARYN, V116, P887, DOI 10.1177/000348940711601203	25	3	3	0	1	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY	1308-7649	2148-3817		J INT ADV OTOL	J. Int. Adv. Otol.	AUG	2018	14	2					295	298		10.5152/iao.2018.4384			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	HI0ER	WOS:000456115400025	30256203	Green Published, Green Submitted, gold			2022-02-06	
J	Liska, GM; Lee, JY; Xu, K; Sanberg, PR; Borlongan, CV				Liska, Grant M.; Lee, Jea-Young; Xu, Kaya; Sanberg, Paul R.; Borlongan, Cesario V.			Suppressed acoustic startle response in traumatic brain injury masks post-traumatic stress disorder hyper-responsivity	NEUROREPORT			English	Article						anxiety disorder; brain stem; chronic traumatic encephalopathy; clinical diagnostics; combat veterans; concussion; neurodegeneration	RATS; EPIDEMIOLOGY; HABITUATION; FREQUENCY; VETERANS; SOLDIERS; OUTCOMES; NUCLEUS; ANXIETY; REFLEX	An exaggerated acoustic startle reflex (ASR) is a clinical indicator of anxiety disorders, such as post-traumatic stress disorder (PTSD). Given the prevalence of PTSD following traumatic brain injury (TBI), we studied the effects of TBI on ASR. Adult Sprague Dawley rats exposed to moderate controlled cortical impact injury model of TBI displayed suppression of ASR intensity and sensitivity. As patients with PTSD have been shown to display hyperactive startle responses, the present discrepant observation of TBI-induced suppression of ASR has clinical implications, in that the reduced, instead of elevated, startle response in patients with comorbid TBI/PTSD could be owing to a masking effect of TBI.	[Liska, Grant M.; Lee, Jea-Young; Xu, Kaya; Sanberg, Paul R.; Borlongan, Cesario V.] USF Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, 12901 Bruce B Downs Blvd,MDC 78, Tampa, FL 33612 USA		Borlongan, CV (corresponding author), USF Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, 12901 Bruce B Downs Blvd,MDC 78, Tampa, FL 33612 USA.	cborlong@health.usf.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS071956, R01NS090962, R21NS089851, R21NS094087]; VA Merit ReviewUS Department of Veterans Affairs [I01 BX001407]; State of Florida Governor's Funds for Veteran PTSD; Traumatic Brain Injury Study	CVB is funded by NIH R01NS071956, NIH R01NS090962, NIH R21NS089851, NIH R21NS094087, and VA Merit Review I01 BX001407. This study was funded by State of Florida Governor's Funds for Veteran PTSD and Traumatic Brain Injury Study.	Asmundson Gordon J. G., 2010, Cognitive Behaviour Therapy, V39, P311, DOI 10.1080/16506073.2010.529938; Association AP, 2013, DIAGN STAT MAN MENT, VIV, P943; Bryant RA, 2017, JAMA PSYCHIAT, V74, P135, DOI 10.1001/jamapsychiatry.2016.3470; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Glover EM, 2011, DEPRESS ANXIETY, V28, P1058, DOI 10.1002/da.20880; Gomez-Nieto R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00216; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Inagaki H, 2014, P NATL ACAD SCI USA, V111, P18751, DOI 10.1073/pnas.1414710112; Jordan WP, 1998, PHYSIOL BEHAV, V63, P643, DOI 10.1016/S0031-9384(97)00512-X; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Moaddab M, 2017, NEUROPHARMACOLOGY, V121, P130, DOI 10.1016/j.neuropharm.2017.04.039; Morgan CA, 1996, AM J PSYCHIAT, V153, P64; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Pilz PKD, 1996, NEUROBIOL LEARN MEM, V66, P67, DOI 10.1006/nlme.1996.0044; Pinkney V, 2014, J PSYCHOPHARMACOL, V28, P874, DOI 10.1177/0269881114532858; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5	25	3	3	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 1	2018	29	11					939	944		10.1097/WNR.0000000000001056			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GM0PV	WOS:000437757600010	29771818	Green Published, hybrid			2022-02-06	
J	McGuire, C; Kristman, VL; Martin, L; Bedard, M				McGuire, Connor; Kristman, Vicki L.; Martin, Lynn; Bedard, Michel			The Association Between Depression and Traumatic Brain Injury in Older Adults: A Nested Matched Case Control Study	JOURNAL OF AGING AND HEALTH			English	Article						traumatic brain injury; older adults; depression; and epidemiology	MINIMUM DATA SET; HOME CARE; ELDERLY-PEOPLE; HEAD-INJURY; COMMUNITY; FALLS; RISK; EPIDEMIOLOGY; POPULATION; SYSTEM	Objective: Determine association between depression and traumatic brain injury (TBI) in the older adult home care population of Ontario, Canada (2003-2013). Method: A nested matched case control study was used, and data were retrieved for service users 65 years or older who received home care between 2003 and 2013. Incident TBI cases were matched to four controls by sex, age, and assessment date. Odds ratios and multivariable conditional logistic regression were completed. Results: 554,313 service users were included of which 5,215 (0.9%) had a TBI and 39,048 (7.0%) had depression. Fall history was an effect modifier. The association between depression and TBI was 1.10 (95% confidence interval [CI] = [0.93, 1.31]) for those without a history of falling, while for those with a history of falling it was 1.24 (95% CI = [1.03, 1.48]) after adjusting for education and Alzheimer's disease. Discussion: Depression is associated with sustaining a TBI in those with a history of falling.	[McGuire, Connor; Kristman, Vicki L.; Martin, Lynn; Bedard, Michel] Lakehead Univ, Thunder Bay, ON, Canada; [Kristman, Vicki L.] Inst Work & Hlth, Toronto, ON, Canada; [Kristman, Vicki L.] Univ Toronto, Toronto, ON, Canada; [Kristman, Vicki L.; Bedard, Michel] St Josephs Care Grp, Thunder Bay, ON, Canada		McGuire, C (corresponding author), Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	connor.mcguire@dal.ca			CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline		ANDERSON AJ, 2002, INT J PSYCHOSOC REHA, V6, P69; Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; Biderman A, 2002, J EPIDEMIOL COMMUN H, V56, P631, DOI 10.1136/jech.56.8.631; BLAZER D, 1987, GERONTOLOGIST, V27, P281, DOI 10.1093/geront/27.3.281; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2014, TRI COUNC POL STAT E; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Chi I, 2006, AGING MENT HEALTH, V10, P33, DOI 10.1080/13607860500307712; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Foebel AD, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-457; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldstein L, 2009, BERNOULLI, V15, P569, DOI 10.3150/08-BEJ162; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; InterRAI, 2014, HOM CAR; InterRAI, 2009, HOM CAR HC ASS US MA; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Kleinbaum DG, 2010, LOGISTIC REGRESSION, P203; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; MEATS P, 1991, BRIT J PSYCHIAT, V159, P659, DOI 10.1192/bjp.159.5.659; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Ontario Ministry of Health and Long Term Care, 2006, EL CRIT CCAC SERV; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; RUTHAZER R, 1993, AM J PUBLIC HEALTH, V83, P746, DOI 10.2105/AJPH.83.5.746; SAS Institute, 2015, SAS STAT SOFTW VERS; Sosin DM, 1996, BRAIN INJURY, V10, P47; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Streiner David L, 2003, Clin J Sport Med, V13, P274; Swinkels A, 2009, AGE AGEING, V38, P175, DOI 10.1093/ageing/afn229; Thompson HJ, 2008, J AM GERIATR SOC, V54, P1590; Wiese B., 2011, B C MED J, V53, P341	42	3	3	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0898-2643	1552-6887		J AGING HEALTH	J. Aging Health	AUG	2018	30	7					1156	1168		10.1177/0898264317708072			13	Gerontology; Health Policy & Services	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Health Care Sciences & Services	GO0FT	WOS:000439600600007	28553826				2022-02-06	
J	Nowak, MK				Nowak, Madeleine K.			Visual and vestibular involvement in postural deficits following concussion	JOURNAL OF NEUROPHYSIOLOGY			English	Article						concussion; postural control; vestibular function; visual function	TRAUMATIC BRAIN-INJURY	Postural assessment is often recommended as a component of postconcussion examination: however, a reliable, objective approach to identify and monitor the recovery of postural deficits is still needed. Degani et al. (Degani AM, Santos MM, Leonard CT, Ran TF, Patel SA, Mohapalra S. and Danna-Dos-Santos A. Brain Inj 31: 49-56. 2017) suggest that effects of concussion on postural control can be identified at the group level through spatiotemporal. frequency, and dynamic characteristics of balance. In contrast, Wright et al. (Wright WG, Tierney RT, and McDevitt J. J Vestib Res 27: 27-37, 2017) propose additional vestibular and oculomotor assessments to identify processing deficits that impair balance following concussion in individuals.	[Nowak, Madeleine K.] Indiana Univ, Sch Publ Hlth, 1025 E 7th St, Bloomington, IN 47405 USA		Nowak, MK (corresponding author), Indiana Univ, Sch Publ Hlth, 1025 E 7th St, Bloomington, IN 47405 USA.	mknowak@iu.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Doettl S, 2013, ASHA LEAD, V18, P50; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Yasen AL, 2017, MED SCI SPORT EXER, V49, P1066, DOI 10.1249/MSS.0000000000001217	12	3	3	0	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	AUG	2018	120	2					391	393		10.1152/jn.00895.2017			3	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GP8WE	WOS:000441195200002	29897861	Bronze			2022-02-06	
J	Olympia, RP; Wakefield, H; Wakefield, B; Weber, CJ				Olympia, Robert P.; Wakefield, Hannah; Wakefield, Bryan; Weber, Christopher J.			Injuries Depicted in Sport-Related Films	CLINICAL PEDIATRICS			English	Article						sports; film; injury; rehabilitation	UNITED-STATES; EMERGENCY-DEPARTMENT; SEXUAL-BEHAVIOR; MEDIA; VIOLENCE; EPIDEMIOLOGY; ADOLESCENTS; OUTCOMES; ALCOHOL; TRENDS	The perception that children and adolescents have of injuries may be influenced by their depiction in sport-related films. The objective of this study was to determine the depiction of injuries in a select number of sport-related films. Forty-four films were analyzed. Injury category, on-the-field management, and long-term management were determined for each injury. Major injuries were defined as injuries requiring prompt intervention and immediate discontinuation of sport participation. A total of 49 injuries were depicted, categorized as fracture (n = 11), contusion (n = 10), brain concussion (n = 8), muscle cramps (n = 5), laceration/abrasion (n = 4), ligamentous knee injury (n = 4), shoulder dislocation (n = 2), rotator cuff injury (n = 2), ankle sprain (n = 2), and unspecified injury (n = 1). Of the 38 (78%) injuries considered major, immediate return to the game was the disposition for 13 injuries (34%). Pediatric health care providers, coaching staff, and parents should stress the importance of injury recognition/disclosure and realistic expectations for rehabilitation to pediatric athletes.	[Olympia, Robert P.] Penn State Hershey Med Ctr, Hershey, PA USA; [Wakefield, Hannah] Med Univ South Carolina, Childrens Hosp, Charleston, SC 29425 USA; [Wakefield, Bryan] Coastal Carolina Univ, Myrtle Beach, SC USA; [Weber, Christopher J.] Naval Hosp, Jacksonville, FL USA		Olympia, RP (corresponding author), Penn State Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr, Hershey, PA 17033 USA.	rolympia@pennstatehealth.psu.edu					[Anonymous], 2003, Paediatr Child Health, V8, P301; Bauer M, 2017, CLIN PEDIATR, V56, P1293, DOI 10.1177/0009922816682744; Bergamini E, 2013, JAMA PEDIATR, V167, P634, DOI 10.1001/jamapediatrics.2013.393; Bleakley A, 2014, PEDIATRICS, V133, P71, DOI 10.1542/peds.2013-1922; Bleakley A, 2012, J ADOLESCENT HEALTH, V51, P73, DOI 10.1016/j.jadohealth.2012.02.006; Bushman BJ, 2013, PEDIATRICS, V132, P1014, DOI 10.1542/peds.2013-1600; Charlesworth A, 2005, PEDIATRICS, V116, P1516, DOI 10.1542/peds.2005-0141; Christakou A, 2009, PERSPECT PUBLIC HEAL, V129, P120, DOI 10.1177/1466424008094802; Clement D, 2013, J ATHL TRAINING, V48, P512, DOI 10.4085/1062-6050-48.3.21; Collier KM, 2016, DEV PSYCHOL, V52, P798, DOI 10.1037/dev0000108; Council on Communications and Media, 2016, PEDIATRICS, V138, DOI [10.1542/peds.2016-2592., DOI 10.1542/PEDS.2016-2592.]; Damore DT, 2003, PEDIATR EMERG CARE, V19, P65, DOI 10.1097/00006565-200304000-00001; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fischer P, 2011, RISK ANAL, V31, P699, DOI 10.1111/j.1539-6924.2010.01538.x; Fischer P, 2011, PSYCHOL BULL, V137, P367, DOI 10.1037/a0022267; Gould D, 2000, PSYCHOL SPORTS INJUR; Heil J, 2015, PSYCHOL SPORT INJURI; Kucera KL, 2016, 33 ANN REPORT; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; National Federation of State High School Associations, 2016, 2015 2016 HIGH SCH A; National Institute of Health, 1992, NIH PUBLICATION; O'Hara RE, 2013, SOC SCI MED, V96, P200, DOI 10.1016/j.socscimed.2013.07.032; PAIK H, 1994, COMMUN RES, V21, P516, DOI 10.1177/009365094021004004; Physical Activity Council, 2017, 2017 PART REP; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Rechel JA, 2011, J TRAUMA, V71, P982, DOI 10.1097/TA.0b013e318230e716; Reese LMS, 2012, J SPORT HEALTH SCI, V1, P71, DOI 10.1016/j.jshs.2012.06.003; Shadel WG, 2013, ANN BEHAV MED, V45, P387, DOI 10.1007/s12160-012-9461-7; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; Stiller-Ostrowski JL, 2009, J ATHL TRAINING, V44, P482, DOI 10.4085/1062-6050-44.5.482; Strasburger VC, 2014, PEDIATRICS, V133, P571, DOI 10.1542/peds.2013-2334; Strasburger VC, 2010, PEDIATRICS, V126, P791, DOI 10.1542/peds.2010-1635; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; van Wilgen CP, 2010, DISABIL REHABIL, V32, P1576, DOI 10.3109/09638281003596857; Wakefield HM, 2017, CLIN PEDIATR, V56, P525, DOI 10.1177/0009922816675115; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Webb T, 2007, PEDIATRICS, V119, pE1219, DOI 10.1542/peds.2006-1319; WOOD W, 1991, PSYCHOL BULL, V109, P371, DOI 10.1037/0033-2909.109.3.371; Yokota F, 2000, JAMA-J AM MED ASSOC, V283, P2716, DOI 10.1001/jama.283.20.2716	42	3	3	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	AUG	2018	57	9					1033	1040		10.1177/0009922817743570			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GN3XQ	WOS:000438946200004	29182021				2022-02-06	
J	Peng, P; Coyle, A				Peng, Paul; Coyle, Andrew			Likelihood Ratios for the Emergency Physician	ACADEMIC EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; PULMONARY-EMBOLISM; CLINICAL EXAMINATION; COMPUTED-TOMOGRAPHY; DECISION-MAKING; D-DIMER; RULE; PERFORMANCE	The concept of likelihood ratios was introduced more than 40 years ago, yet this powerful metric has still not seen wider application or discussion in the medical decision-making process. There is concern that clinicians-in-training are still being taught an oversimplified approach to diagnostic test performance and have limited exposure to likelihood ratios. Even for those familiar with likelihood ratios, they might perceive them as mathematically cumbersome in application, if not difficult to determine for a particular disease process. This article takes a conceptual approach to likelihood ratios and applies them to two clinical settings: 1) severe intracranial injury after minor head trauma and 2) suspected pulmonary embolism with shortness of breath. Likelihood ratios are the most appropriate metric for efficient rational clinical examination and can prevent unnecessary and wasteful treatments and procedures.	[Peng, Paul] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA; [Coyle, Andrew] Icahn Sch Med Mt Sinai, Dept Internal Med, New York, NY 10029 USA		Peng, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA.	paulpeng@gmail.com					Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Gallagher EJ, 2003, ANN EMERG MED, V42, P298, DOI 10.1067/mem.2003.273; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; KATZ MA, 1974, NEW ENGL J MED, V291, P1115, DOI 10.1056/NEJM197411212912106; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; McGee S, 2002, J GEN INTERN MED, V17, P646; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Zehtabchi S, 2010, ACAD EMERG MED, V17, P521, DOI 10.1111/j.1553-2712.2010.00739.x	23	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	AUG	2018	25	8					958	965		10.1111/acem.13439			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GQ5PV	WOS:000441740500011	29696770				2022-02-06	
J	Sadrameli, SS; Wong, MS; Kabir, R; Wiese, JR; Podell, K; Volpi, JJ; Gadhia, RR				Sadrameli, Saeed S.; Wong, Marcus S.; Kabir, Rasadul; Wiese, Jonathan R.; Podell, Kenneth; Volpi, John J.; Gadhia, Rajan R.			Changes in Transcranial Sonographic Measurement of the Optic Nerve Sheath Diameter in Non-concussed Collegiate Soccer Players Across a Single Season	CUREUS			English	Article						optic nerve sheath diameter; sports concussion; women's soccer	TRAUMATIC BRAIN-INJURY; ICP	Introduction Bedside ultrasound measurement of the optic nerve sheath diameter (ONSD) is emerging as a non-invasive technique to evaluate and predict raised intracranial pressure (ICP) in both children and adults. The prognostic value of increased ONSD on brain computed tomography (CT) scan has previously been correlated with increased intensive care unit (ICU) mortality in patients with severe traumatic brain injury (TBI). Previous studies have also evaluated the association between high-contact sports, such as soccer, and TBI; however, the related changes in ONSD are still unknown. The aim of this study was to evaluate for the natural evolution of changes in ONSD in athletes who participate in high-contact sports. Methods In this prospective observational study, volunteers from a collegiate women's soccer team underwent the measurement of ONSD with transcranial Doppler (TCD). ONSDs were measured during the initial visit during the pre-season period and again at the three-month follow-up. A single experienced neuro-sonographer performed all measurements to eliminate any operator bias. Results Twenty-four female college soccer players between the ages of 18 and 23 were included in this analysis. Mean ONSD during the initial pre-season clinic visit and the three-month follow-up were 4.14 +/- 0.6 mm and 5.02 +/- 0.72 mm, respectively (P < 0.0001). A two-tailed t-test analysis was performed, which resulted in a t-value of 4.76 and P < 0.00001. The average ONSD measured during the post-season follow-up showed a 21.3% increase compared to the baseline. Conclusion The evaluation of high-contact sports athletes is limited due to the lack of objective radiologic and diagnostic tools. Moreover, in an athlete suffering a concussion, return-to-play decisions are heavily dependent on the symptoms reported by the athletes. In our analysis of collegiate women's soccer players, active participation in soccer competitions and practice may be associated with an increase in ONSD, independent of concussions. Further studies are underway to evaluate the clinical significance of these findings as well as possible correlations between concussions and changes in ONSD.	[Sadrameli, Saeed S.; Wong, Marcus S.] Houston Methodist Neurol Inst, Neurosurg, Houston, TX 77030 USA; [Kabir, Rasadul] Houston Methodist Neurol Inst, Radiol, Houston, TX USA; [Wiese, Jonathan R.; Podell, Kenneth; Volpi, John J.; Gadhia, Rajan R.] Houston Methodist Neurol Inst, Neurol, Houston, TX USA		Sadrameli, SS (corresponding author), Houston Methodist Neurol Inst, Neurosurg, Houston, TX 77030 USA.	ssadrameli@houstonmethodist.org					Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Cartwright MS, 2015, MED HYPOTHESES, V85, P262, DOI 10.1016/j.mehy.2015.05.012; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Padayachy L, 2016, NEUROSURGERY, V63, P151; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Toscano M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1621428; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, P6; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	17	3	3	0	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	AUG	2018	10	8							e3090	10.7759/cureus.3090			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3IL	WOS:000450944400009	30410819	gold, Green Published, Green Submitted			2022-02-06	
J	Vascello, MGF; Marchetti, M; Scaltritti, M; Altoe, G; Spada, MS; Molinero, G; Manfrinati, A				Vascello, Matteo G. F.; Marchetti, Mauro; Scaltritti, Michele; Altoe, Gianmarco; Spada, Maria S.; Molinero, Guido; Manfrinati, Andrea			Are Moral and Socio-conventional Knowledge Impaired in Severe Traumatic Brain Injury?	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; Traumatic brain injury; Social cognition; Morality	FRONTAL-LOBE DAMAGE; PSYCHOSOCIAL ADJUSTMENT; POSTTRAUMATIC AMNESIA; EXECUTIVE CONTROL; COGNITION; BEHAVIOR; DEFICITS; PATIENT; EMPATHY; CORTEX	Objective: The aim of this study was to investigate explicit moral and socio-conventional knowledge in Traumatic Brain Injury (TBI) patients. Method: A group of 28 TBI patients was tested on a new set of moral and socio-conventional items. Responses of TBI patients were compared with those of 28 matched controls. Participants had to report how hard would be to perform specific moral or socio-conventional transgressions, using a 10-point Likert scale. We analyzed our data through mixed-effects models, to jointly assess by-participants and byitems variance. The factors considered were Type of Item (Moral vs. Socio-conventional) and Group (TBI vs. Controls). Results: Results revealed a significant interaction between Type of Item and Group (chi(2)[1] = 25.5, p < .001). Simple-effects analyses showed that TBI, as Controls, were able to differentiate moral and socio-conventional transgressions (chi(2)[1] = 72.3, p < .001), as they deemed the former as more difficult to enact. TBI patients, however, evaluated moral transgressions as easier to fulfill (chi(2)[1] = 12.2, p = .001). Conclusions: TBI patients can clearly differentiate moral and socio-conventional transgressions, suggesting that the explicit knowledge of these two dimensions is spared. TBI patients, however, considered moral transgressions as easier to fulfill with respect to Controls. This finding may suggest a tendency in TBI patients to underestimate the weight of moral transgressions.	[Vascello, Matteo G. F.; Spada, Maria S.] ASST Papa Giovanni XXIII Hosp, Clin Psychol Unit, Bergamo, Italy; [Vascello, Matteo G. F.; Molinero, Guido] ASST Papa Giovanni XXIII Hosp, Phys Med & Rehabil Unit, Bergamo, Italy; [Marchetti, Mauro] Univ Padua, Dept Gen Psychol, Padua, Italy; [Scaltritti, Michele] Aix Marseille Univ, CNRS, LPC, Marseille, France; [Altoe, Gianmarco] Univ Padua, Dept Dev Psychol & Socializat, Padua, Italy; [Manfrinati, Andrea] Univ Milano Bicocca, Dept Psychol, Milan, Italy		Manfrinati, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	andrea.manfrinati@gmail.com		Altoe, Gianmarco/0000-0003-1154-9528	Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission [ANR-16-CONV-0002, ANR-11-LABX-0036, ANR-11-IDEX-0001-02]	M.S. has been supported by Agence Nationale de la Recherche [grant numbers ANR-16-CONV-0002, ANR-11-LABX-0036, ANR-11-IDEX-0001-02].	Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Carlesimo G. A., 1996, EUR NEUROL, V36, P78; Ciaramelli E., 2007, SCAN, V8, P171; Colombo L., 2002, GIORNALE ITALIANO PS, V29, P611; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; Dieci, 2002, NUOVA RIV NEUROLOGIA, V12, P111; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Dwyer S., 1999, PHILOS LINGUISTICS, P169; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Gorno-Tempini ML, 2001, NEUROIMAGE, V14, P465, DOI 10.1006/nimg.2001.0811; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HAUSER M, 2006, MORAL MINDS; Heaton KR, 1993, WISCONSIN CARD SORTI; Huebner B, 2010, J COGN CULT, V10, P1, DOI 10.1163/156853710X497149; Huebner B, 2009, TRENDS COGN SCI, V13, P1, DOI 10.1016/j.tics.2008.09.006; Kelly G., 2008, BRAIN INJURY, V20, P307; Klauer KC, 2010, Q J EXP PSYCHOL, V63, P595, DOI 10.1080/17470210903076826; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Laiacona M., 2001, J NEUROL SCI, V21, P279; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lotto L, 2014, J BEHAV DECIS MAKING, V27, P57, DOI 10.1002/bdm.1782; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manfrinati A, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14000946; Manfrinati A, 2013, COGNITION EMOTION, V27, P1276, DOI 10.1080/02699931.2013.785388; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P619, DOI 10.1080/13803395.2011.553586; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Mikhail J., 2011, ELEMENTS MORAL COGNI; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nelson H.E., 1982, NATL ADULT READING T; Nieuwenhuis R, 2012, R J, V4, P38; Nocentini U, 2006, FUNCT NEUROL, V21, P93; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; NUCCI LP, 1978, CHILD DEV, V49, P400, DOI 10.1111/j.1467-8624.1978.tb02329.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perugini M, 2009, J RES PERS, V43, P747, DOI 10.1016/j.jrp.2009.03.015; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rosati C. S., 2014, STANFORD ENCY PHILOS; Sartori G, 1997, PROFESSIONE PSICOLOG, V4, P1; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith LM, 1995, FAMILY SUPPORT PROGR; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spinnler M., 1987, ITAL J NEUROL SCI, V6, P1; Stein S. C., 1996, NEUROTRAUMA, P31; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turiel Elliot, 1979, NEBRASKA S MOTIVATIO, P77; Turiel Elliot, 1983, DEV SOCIAL KNOWLEDGE; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	86	3	3	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2018	33	5					583	595		10.1093/arclin/acx099			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GS3SF	WOS:000443539600007	29121186	Bronze			2022-02-06	
J	Zhu, L; Tang, T; Fan, R; Luo, JK; Cui, HJ; Zhang, CH; Peng, WJ; Sun, P; Xiong, XG; Wang, Y				Zhu, Lin; Tang, Tao; Fan, Rong; Luo, Jie-Kun; Cui, Han-Jin; Zhang, Chun-Hu; Peng, Wei-Jun; Sun, Peng; Xiong, Xin-Gui; Wang, Yang			Xuefu Zhuyu decoction improves neurological dysfunction by increasing synapsin expression after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; Xuefu Zhuyu decoction; neurological dysfunction; synapsin; synaptophysin; synapsin I; postsynaptic density protein-95; neuroprotection; neural regeneration	HIPPOCAMPAL SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; OXIDATIVE STRESS; SPINAL-CORD; RAT MODEL; MEDICINE; DENDRITES; MORTALITY; PROTEINS; THERAPY	Xuefu Zhuyu decoction has been used for treating traumatic brain injury and improving post-traumatic dysfunction, but its mechanism of action needs further investigation. This study established rat models of traumatic brain injury by controlled cortical impact. Rat models were intragastrically administered 9 and 18 g/kg Xuefu Zhuyu decoction once a day for 14 or 21 days. Changes in neurological function were assessed by modified neurological severity scores and the Morris water maze. Immunohistochemistry, western blot assay, and reverse-transcription polymerase chain reaction were used to analyze synapsin protein and mRNA expression at the injury site of rats. Our results showed that Xuefu Zhuyu decoction visibly improved neurological function of rats with traumatic brain injury. These changes were accompanied by increased expression of synaptophysin, synapsin I, and postsynaptic density protein-95 protein and mRNA in a dose-dependent manner. These findings indicate that Xuefu Zhuyu decoction increases synapsin expression and improves neurological deficits after traumatic brain injury.	[Zhu, Lin; Tang, Tao; Fan, Rong; Luo, Jie-Kun; Cui, Han-Jin; Zhang, Chun-Hu; Xiong, Xin-Gui; Wang, Yang] Cent S Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China; [Peng, Wei-Jun] Cent S Univ, Xiangya Hosp 2, Dept Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China; [Sun, Peng] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan, Shandong, Peoples R China		Wang, Y (corresponding author), Cent S Univ, Inst Integrated Tradit Chinese & Western Med, Xiangya Hosp, Lab Ethnopharmacol, Changsha, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81173175, 81303074]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M600639, 2017T100614]	This work was supported by the National Natural Science Foundation of China, No. 81673719, 81173175 and 81303074; a grant from China Postdoctoral Science Foundation, No. 2016M600639 and 2017T100614.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ferrer I, 1999, DEMENT GERIATR COGN, V10, P55, DOI 10.1159/000051214; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Fu CY, 2016, J SEP SCI, V39, P3457, DOI 10.1002/jssc.201600083; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; Gulino R, 2007, NEUROSCI RES, V57, P148, DOI 10.1016/j.neures.2006.10.001; Gulino R, 2010, EUR J NEUROSCI, V31, P1423, DOI 10.1111/j.1460-9568.2010.07170.x; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; Lin W, 2016, ASIA PAC J CLIN TRIA, V1, P170; Liu X, 2017, ZHONGGUO ZUZHI GONGC, V21, P4709; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou YL, 2016, ZHONGGUO ZUZHI GONGC, V20, P1474; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Pan WS, 2016, EXP THER MED, V12, P1455, DOI 10.3892/etm.2016.3470; Paoletti I, 2013, INFLAMMATION, V36, P1316, DOI 10.1007/s10753-013-9670-7; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Popescu C, 2015, J Med Life, V8, P272; Qihua L.S.W.J., 2015, MOD J INTEGR TRAD CH, V24, P350; Saito S, 2010, PSYCHOGERIATRICS, V10, P45, DOI 10.1111/j.1479-8301.2010.00313.x; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Sun X, 2010, BIOORG MED CHEM LETT, V20, P4120, DOI 10.1016/j.bmcl.2010.05.076; Thickbroom GW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-4; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0095-0; Wang SW, 2011, J NEUROSCI, V31, P7275, DOI 10.1523/JNEUROSCI.6476-10.2011; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zhao JY, 2012, B WORLD HEALTH ORGAN, V90, P461, DOI 10.2471/BLT.11.093849; Zhao WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116976; Zhou ZW, 2017, NEURAL REGEN RES, V12, P1322, DOI 10.4103/1673-5374.213553; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113; 施伟丽, 2013, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V33, P712	54	3	4	3	18	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2018	13	8					1417	1424		10.4103/1673-5374.235297			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GQ8SX	WOS:000442030300024	30106054	Green Published, gold			2022-02-06	
J	Garon, M; Lavallee, MM; Estay, EV; Beauchamp, MH				Garon, Mathieu; Maxime Lavallee, Marie; Vera Estay, Evelyn; Beauchamp, Miriam H.			Visual encoding of social cues predicts sociomoral reasoning	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MORAL DEVELOPMENT; EMPATHY; DESIRABILITY; COGNITION; AGGRESSION; JUDGMENT; VALIDITY; BEHAVIOR; EYE	As the first step of social information processing, visual encoding underlies the interpretation of social cues. Faces, in particular, convey a large amount of affective information, which can be subsequently used in the planning and production of adaptive social behaviors. Sociomoral reasoning is a specific social skill that is associated with engagement in appropriate social behaviors when faced with dilemmas. Previous studies using eye tracking suggest that visual encoding may play an important role in decision-making when individuals are faced with extreme moral dilemmas, but it is not known if this is generalizable to everyday situations. The main objective of this study was to assess the contribution of visual encoding to everyday sociomoral reasoning using eye tracking and ecological visual dilemmas. Participants completed the SocioMoral Reasoning Aptitude Level (SoMoral) task while their eye movements and pupil dilation were recorded. While visual encoding was not a predictor of sociomoral decision-making, sociomoral maturity was predicted by fixation count. Thus, in an ecological context, visual encoding of social cues appears to be associated with sociomoral maturity: the production of a justification is associated with volitional encoding strategies. Implications with regards to the dual-process theory of sociomoral reasoning and social information processing are discussed.	[Garon, Mathieu; Maxime Lavallee, Marie; Vera Estay, Evelyn; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Vera Estay, Evelyn] Pontificia Univ Catolica Chile, Ctr Desarrollo Tecnol Inclus, Escuela Psicol, Macul, Chile; [Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), St Justine Hosp Res Ctr, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca		Garon, Mathieu/0000-0003-1143-8668	National Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [386527]; National Science and Engineering Research Council of Canada graduate scholarship	This study was made possible through a National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) grant (#386527) awarded to M.H.B. and through a National Science and Engineering Research Council of Canada graduate scholarship for doctoral studies awarded to M.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2017, CURR DIR PSYCHOL SCI, V26, P282, DOI 10.1177/0963721417694656; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Arsenio WF, 2010, J ABNORM CHILD PSYCH, V38, P627, DOI 10.1007/s10802-010-9408-z; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barger B, 2013, J MORAL EDUC, V42, P443, DOI 10.1080/03057240.2013.809517; BASINGER KS, 1987, PSYCHOL REP, V61, P139, DOI 10.2466/pr0.1987.61.1.139; Bauman CW, 2014, SOC PERSONAL PSYCHOL, V8, P536, DOI 10.1111/spc3.12131; Bauminger N, 2005, J LEARN DISABIL-US, V38, P45, DOI 10.1177/00222194050380010401; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp M. H., 2012, ADM CODING MANUAL SO; Birmingham E., 2012, COGNITIVE NEUROSCIEN, P251, DOI [10.1093/acprof:oso/9780195315455.003.0010, DOI 10.1093/ACPROF:OSO/9780195315455.003.0010]; Blake BF, 2006, PERS INDIV DIFFER, V40, P1625, DOI 10.1016/j.paid.2005.12.007; BLOOM L, 1959, J Genet Psychol, V95, P3; Bruers S, 2014, PHILOSOPHIA, V42, P251, DOI 10.1007/s11406-013-9507-5; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; CHRISTOPHER FS, 1993, J MARRIAGE FAM, V55, P469, DOI 10.2307/352816; Cottone J, 2007, J SCI STUD RELIG, V46, P37, DOI 10.1111/j.1468-5906.2007.00339.x; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crispo M, 2017, TROLLEYOLOGIE UTILIT; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 1980, MULTIDIMENSIONAL APP; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Edmonds D., 2013, WOULD YOU KILL FAT M; Ehmke C., 2007, IDENTIFYING WEB USAB, P119, DOI [10.5555/1531294.1531311, DOI 10.5555/1531294.1531311]; Einhauser W, 2010, FRONTIERS HUMAN NEUR, V4; ELM DR, 1994, J BUS ETHICS, V13, P341, DOI 10.1007/BF00871762; FeldmanHall O, 2012, COGNITION, V123, P434, DOI 10.1016/j.cognition.2012.02.001; Fiedler S, 2015, CURR OPIN PSYCHOL, V6, P139, DOI 10.1016/j.copsyc.2015.08.008; Fowler, 2008, EUROPEAN J DEV SCI, V2, P303; Francis KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164374; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Gibbs J.C., 2013, MORAL DEV REALITY TH; GIBBS JC, 1982, CHILD DEV, V53, P895, DOI 10.1111/j.1467-8624.1982.tb01351.x; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Greenwood JD, 2011, J THEOR SOC BEHAV, V41, P333, DOI 10.1111/j.1468-5914.2011.00472.x; Gu J, 2013, J EXP PSYCHOL GEN, V142, P307, DOI 10.1037/a0029549; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2008, SOCIAL INTUITIONISTS; Holmqvist K, COMMON PREDICTORS AC; Horsley TA, 2010, J ABNORM CHILD PSYCH, V38, P587, DOI 10.1007/s10802-009-9361-x; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kahneman D, 2005, RES PER NEUROSCI, P91, DOI 10.1007/3-540-29803-7_8; Kastner R. M., 2010, CHRESTOMATHY, V9, P114; KOHLBERG L, 1973, GERONTOLOGIST, V13, P497, DOI 10.1093/geront/13.4.497; Kohlberg L., 1981, PHILOS MORAL DEV MOR; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langdon PE, 2011, AJIDD-AM J INTELLECT, V116, P438, DOI 10.1352/1944-7558-116.6.438; Latif DA, 2000, J BUS ETHICS, V25, P255, DOI 10.1023/A:1006049605298; Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195; LEE M, 1988, J ABNORM CHILD PSYCH, V16, P127, DOI 10.1007/BF00913589; Li JL, 2013, AGGRESS VIOLENT BEH, V18, P357, DOI 10.1016/j.avb.2013.01.001; Loas G, 1995, LENCEPHALE REV PSYCH; Maestripieri D., 2017, BEHAV BRAIN SCI, V40; Malti T, 2013, CHILD DEV, V84, P397, DOI 10.1111/j.1467-8624.2012.01851.x; McCoy M, 2016, ENCY EVOLUTIONARY PS, P1; Narvaez D, 2001, J MORAL EDUC, V30, P43, DOI 10.1080/03057240120033802; Navarrete CD, 2012, EMOTION, V12, P364, DOI 10.1037/a0025561; Norman E., 2009, FDN TRACING INTUITIO, P32; Olsen A, 2012, TOBII VT FIXATION FI; Parnamets P, 2008, THESIS; Parnamets P, 2015, P NATL ACAD SCI USA, V112, P4170, DOI 10.1073/pnas.1415250112; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Patil I, 2014, SOC NEUROSCI-UK, V9, P94, DOI 10.1080/17470919.2013.870091; Piaget J., 1932, JUGEMENT MORAL CHEZ; Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rest J. R., 1986, DIT MANUAL DEFINING; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Saunders L.F., 2009, 2 MINDS DUAL PROCESS, P335, DOI DOI 10.1093/ACPROF:OSO/9780199230167.001.0001; Schonfeld AM, 2005, J STUD ALCOHOL, V66, P545, DOI 10.15288/jsa.2005.66.545; Skulmowski A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00426; Sneddon A, 2007, PHILOS PSYCHOL, V20, P731, DOI 10.1080/09515080701694110; Spraggins EF, 1987, EMPATHY CLIN DIETITI; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Teper R, 2015, PERS SOC PSYCHOL B, V41, P887, DOI 10.1177/0146167215583848; Teper R, 2011, PSYCHOL SCI, V22, P553, DOI 10.1177/0956797611402513; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Turiel Elliot, 1983, DEV SOCIAL KNOWLEDGE; Vera-Estay E, 2015, J MORAL EDUC, V44, P17, DOI 10.1080/03057240.2014.986077; Vera-Estay E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00227; Wechsler D., 1999, MANUAL WECHSLER ABBR; Zarinpoush F, 2000, J MORAL EDUC, V29, P397, DOI 10.1080/713679391	92	3	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2018	13	7							e0201099	10.1371/journal.pone.0201099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GO4AN	WOS:000439942500079	30044875	gold, Green Submitted, Green Published			2022-02-06	
J	Kreutziger, J; Schmid, S; Umlauf, N; Ulmer, H; Nijsten, MW; Werner, D; Schlechtriemen, T; Lederer, W				Kreutziger, Janett; Schmid, Stefan; Umlauf, Nikolaus; Ulmer, Hanno; Nijsten, Maarten W.; Werner, Daniel; Schlechtriemen, Thomas; Lederer, Wolfgang			Association between Blood Glucose and cardiac Rhythms during pre-hospital care of Trauma Patients - a retrospective Analysis	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Cardiac arrest; Tachyarrhythmia; Bradyarrhythmia; Pre-hospital care; Blood glucose	STRESS-INDUCED HYPERGLYCEMIA; INTENSIVE INSULIN THERAPY; MYOCARDIAL-INFARCTION; HEMORRHAGIC-SHOCK; HIGHER MORTALITY; CELL-SURVIVAL; BRAIN-INJURY; ILL PATIENTS; ARREST; ADMISSION	Background: Deranged glucose metabolism is frequently observed in trauma patients after moderate to severe traumatic injury, but little data is available about pre-hospital blood glucose and its association with various cardiac rhythms and cardiac arrest following trauma. Methods: We retrospectively investigated adult trauma patients treated by a nationwide helicopter emergency medical service (34 bases) between 2005 and 2013. All patients with recorded initial cardiac rhythms and blood glucose levels were enrolled. Blood glucose concentrations were categorised; descriptive and regression analyses were performed. Results: In total, 18,879 patients were included, of whom 185 (1.0%) patients died on scene. Patients with tachycardia (>= 100/min, 7.0 +/- 2.4 mmol/L p < 0.0001), pulseless ventricular tachycardia (9.8 +/- 1.8, mmol/L, p = 0.008) and those with ventricular fibrillation (9.0 +/- 3.2 mmol/L, p <0.0001) had significantly higher blood glucose concentrations than did patients with normal sinus rhythm between 61 and 99/min (6.7 +/- 2.1 mmol/L). In patients with low (<= 2.8 mmol/L, 7/79; 8.9%, p < 0.0001) and high (> 10.0 mmol/L, 70/1271; 5.5%, p < 0.0001) blood glucose concentrations cardiac arrest was more common than in normoglycaemic patients (166/9433, 1.8%). ROSC was more frequently achieved in hyperglycaemic (> 10 mmol/L; 47/69; 68.1%) than in hypoglycaemic (<= 4.2 mmol/L; 13/31; 41.9%) trauma patients (p = 0.01). Conclusions: In adult trauma patients, pre-hospital higher blood glucose levels were related to tachycardic and shockable rhythms. Cardiac arrest was more frequently observed in hypoglycaemic and hyperglycaemic pre-hospital trauma patients. The rate of ROSC rose significantly with rising blood glucose concentration. Blood glucose measurements in addition to common vital parameters (GCS, heart rate, blood pressure, breathing frequency) may help identify patients at risk for cardiopulmonary arrest and dysrhythmias.	[Kreutziger, Janett; Lederer, Wolfgang] Med Univ Innsbruck, Dept Anaesthesia & Intens Care Med, Anichstr 35, A-6020 Innsbruck, Austria; [Schmid, Stefan] Med Univ Innsbruck, Dept Gen & Surg Intens Care Med, Anichstr 35, A-6020 Innsbruck, Austria; [Umlauf, Nikolaus] Univ Innsbruck, Fac Econ & Stat, Dept Stat, Univ Str 15, A-6020 Innsbruck, Austria; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Schopfstr 41-1, A-6020 Innsbruck, Austria; [Nijsten, Maarten W.] Univ Groningen, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Werner, Daniel] ADAC Luftrettung gGmbH, German Helicopter Emergency Med Serv, Hansastr 19, D-80686 Munich, Germany; [Schlechtriemen, Thomas] Emergency Med Serv Saarland, Saarpfalz Pk 9, D-66450 Bexbach, Germany; [Schlechtriemen, Thomas] ADAC Luftrettung gGmbH, Qual Management German Helicopter Emergency Med S, Hansastr 19, D-80686 Munich, Germany		Kreutziger, J (corresponding author), Med Univ Innsbruck, Dept Anaesthesia & Intens Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	janett.kreutziger@i.med.ac.at	Ulmer, Hanno/S-6615-2019; Kreutziger, Janett/AAU-4102-2021	Ulmer, Hanno/0000-0001-5911-1002; Kreutziger, Janett/0000-0001-5363-8858; Nikolaus, Umlauf/0000-0003-2160-9803			ADAC Stiftung, 2018, WIE KANN ICH ARZT RE; Alfonsi P, 2003, ANAESTHESIA, V58, P1228, DOI 10.1046/j.1365-2044.2003.03444.x; Aslan B, 2014, AM J CLIN PATHOL, V142, P857, DOI 10.1309/AJCPP5YS2MVSKBYY; BAGSHAW SM, 2009, CRIT CARE, V13; Berrou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062418; Bilhimer MH, 2017, AM J EMERG MED, V35, P87, DOI 10.1016/j.ajem.2016.10.009; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; BLUMBERG D, 1995, J SURG ONCOL, V59, P220, DOI 10.1002/jso.2930590404; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brunauer A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0719-2; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Chen JH, 2015, LEGAL MED-TOKYO, V17, P475, DOI 10.1016/j.legalmed.2015.08.004; Deutsche Diabetes Hilfe, 2017, DTSCH GES DIAB 2017; Dokken BB, 2013, AM J PHYSIOL-HEART C, V304, pH538, DOI 10.1152/ajpheart.00282.2012; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; ENSINGER H, 1992, CRIT CARE MED, V20, P1250, DOI 10.1097/00003246-199209000-00011; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; FRIEDMAN SG, 1982, J TRAUMA, V22, P86, DOI 10.1097/00005373-198202000-00002; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; HART BB, 1989, CRIT CARE MED, V17, P1203, DOI 10.1097/00003246-198911000-00021; Hastie T. J., 1990, GEN ADDITIVE MODELS; Kerby JD, 2012, ANN SURG, V256, P446, DOI 10.1097/SLA.0b013e3182654549; Kim SH, 2014, AM J EMERG MED, V32, P900, DOI 10.1016/j.ajem.2014.05.004; Konesky KL, 2017, EUR J TRAUMA EMERG S; Kreutziger J, 2018, EUR J ANAESTH, V35, P33, DOI 10.1097/EJA.0000000000000733; Kreutziger J, 2015, INJURY, V46, P15, DOI 10.1016/j.injury.2014.09.018; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Kreutziger J, 2009, INTENS CARE MED, V35, P1234, DOI 10.1007/s00134-009-1446-z; LANG CH, 1991, ENDOCRINOLOGY, V128, P645, DOI 10.1210/endo-128-2-645; LANG CH, 1990, METABOLISM, V39, P1096, DOI 10.1016/0026-0495(90)90172-9; Lennmyr F, 2010, CRIT CARE MED, V38, P1726, DOI 10.1097/CCM.0b013e3181e7982e; Losser MR, 2010, CRIT CARE, V14, DOI 10.1186/cc9100; Ma GC, 2006, N-S ARCH PHARMACOL, V373, P415, DOI 10.1007/s00210-006-0102-1; Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053; Marik P. E., 2013, CRIT CARE, V17; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mentzelopoulos SD, 2013, JAMA-J AM MED ASSOC, V310, P270, DOI 10.1001/jama.2013.7832; MESSELKEN M, 2003, NOTFALL RETTUNGSMED, V6, P189; Meyer C, 2003, AM J PHYSIOL-ENDOC M, V285, pE819, DOI 10.1152/ajpendo.00145.2003; Meynaar IA, 2012, J CRIT CARE, V27, P119, DOI 10.1016/j.jcrc.2011.11.004; Molina PE, 1997, NEUROIMMUNOMODULAT, V4, P28, DOI 10.1159/000097312; Nehme Z, 2016, CRIT CARE RESUSC, V18, P69; PEARCE FJ, 1987, J TRAUMA, V27, P1213; Pulzi SA, 2009, SAO PAULO MED J, V127, P259, DOI 10.1590/S1516-31802009000500003; R Development Core Team, 2011, R LANG ENV STAT COMP; Raffay V, 2014, AM J EMERG MED, V32, P139, DOI 10.1016/j.ajem.2013.10.030; Ramachandran B, 2011, PEDIATR CRIT CARE ME, V12, pE297, DOI 10.1097/PCC.0b013e3182192804; Rosso C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120230; Russo JJ, 2016, EUR HEART J ACUTE CA; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Strapazzon G, 2012, ANN EMERG MED, V60, P193, DOI 10.1016/j.annemergmed.2011.11.015; STUMVOLL M, 1995, J CLIN INVEST, V96, P2528, DOI 10.1172/JCI118314; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thorell A, 1999, Curr Opin Clin Nutr Metab Care, V2, P69, DOI 10.1097/00075197-199901000-00012; Tryba M, 1980, NOTFALLSMEDIZIN, V6, P725; Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; van Iersel FM, 2012, INTENS CARE MED, V38, P1999, DOI 10.1007/s00134-012-2681-2; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; Wang JY, 2015, J DIABETES COMPLICAT, V29, P621, DOI 10.1016/j.jdiacomp.2015.04.014; Wouters MPR, 2013, ESICM	64	3	3	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUL 13	2018	26								58	10.1186/s13049-018-0516-z			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GN1PA	WOS:000438763900002	30005711	gold, Green Published			2022-02-06	
J	Cholvin, T; Giorgi, L; Baril, N; Brezun, JM; Poucet, B; Chaillan, FA				Cholvin, Thibault; Giorgi, Lisa; Baril, Nathalie; Brezun, Jean-Michel; Poucet, Bruno; Chaillan, Franck A.			Using MRI to predict the fate of excitotoxic lesions in rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; T2-WEIGHTED MRI; ISOFLURANE; EVOLUTION; SECTIONS; STROKE; MODEL; AREA	Excitotoxic lesions are frequently used to assess the role of cerebral structures in cognitive processes in rodents. However, the precise site and extent of these lesions remain unknown without histological verifications. Using a 7-Teslas MRI system and a T2-weighted turbo-RARE sequence, MR images were acquired at several time points following NMDA lesions (1h, 6h, 24h, 48h, 1 week and 2 weeks). NMDA infusions into the parenchyma induced a clear and delineable hyperintense signal from 1 h up to 1-week post-surgery. Hyperintensity volumes were compared with NeuN and Cresyl violet histological quantifications of the lesion magnitude. NMDA-induced hypersignal is observed as soon as 1 h post-injection and is a reliable estimate of the presence (or absence) of a lesion. Compared to NeuN, Cresyl violet staining underestimates the extent of the lesion in significant proportions. The MRI hyperintensity generated by NMDA instillation into the parenchyma can be used as a powerful tool to confirm the diffusion of the drug into the cerebral tissue, to ascertain the locus of injection and predict with a high success rate the fate of NMDA lesions as soon as 1 h post-surgery. This approach could be very useful in a large variety of lesion studies in rodents.	[Cholvin, Thibault; Giorgi, Lisa; Poucet, Bruno; Chaillan, Franck A.] Aix Marseille Univ, CNRS, LNC, Marseille, France; [Cholvin, Thibault; Baril, Nathalie; Poucet, Bruno; Chaillan, Franck A.] Aix Marseille Univ, CNRS, Federat 3C, Marseille, France; [Brezun, Jean-Michel] Aix Marseille Univ, Inst Sci Mouvement UMR 7287, Equipe Plasticite Syst Nerveux & Musculaire PSNM, Fac Sci Sport, Marseille, France		Chaillan, FA (corresponding author), Aix Marseille Univ, CNRS, LNC, Marseille, France.; Chaillan, FA (corresponding author), Aix Marseille Univ, CNRS, Federat 3C, Marseille, France.	franck.chaillan@univ-amu.fr	Poucet, Bruno/B-4019-2010	Poucet, Bruno/0000-0003-2704-804X; Cholvin, Thibault/0000-0002-9964-7693	Aix Marseille Univ, CNRS, Agence Nationale de la recherche [ANR-14-CE13-0029-02]	This work was supported by Aix Marseille Univ, CNRS, Agence Nationale de la recherche (ANR-14-CE13-0029-02 "THALAME") to BP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Basile BM, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00012; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Brace H, 1997, BRAIN RES BULL, V43, P447, DOI 10.1016/S0361-9230(97)00064-6; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CAMPAGNE MV, 1994, J CEREBR BLOOD F MET, V14, P1011, DOI 10.1038/jcbfm.1994.133; Cholvin T, 2018, J NEUROSCI, V38, P158, DOI 10.1523/JNEUROSCI.2039-17.2017; Cross DJ, 2006, NEUROIMAGE, V32, P1265, DOI 10.1016/j.neuroimage.2006.04.229; Cruz-Orive LM, 1999, J MICROSC-OXFORD, V193, P182, DOI 10.1046/j.1365-2818.1999.00460.x; Dijkhuizen RM, 1996, NMR BIOMED, V9, P84, DOI 10.1002/(SICI)1099-1492(199604)9:2<84::AID-NBM401>3.0.CO;2-B; Fau S, 2013, AM J NEURORADIOL, V34, pE73, DOI 10.3174/ajnr.A3069; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haseneder R, 2009, EUR J PHARMACOL, V623, P47, DOI 10.1016/j.ejphar.2009.09.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; John J, 1996, BRAIN RES BULL, V40, P273, DOI 10.1016/0361-9230(96)00047-0; KING MD, 1991, MAGNET RESON MED, V20, P158, DOI 10.1002/mrm.1910200117; Kumar VM, 1996, NEUROSCI RES, V24, P207, DOI 10.1016/0168-0102(95)00995-7; Laurent D, 1996, NEUROSCI LETT, V213, P209; Lingamaneni R, 2001, ANESTHESIOLOGY, V95, P1460, DOI 10.1097/00000542-200112000-00027; Malkova L, 2001, HIPPOCAMPUS, V11, P361, DOI 10.1002/hipo.1050; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; STEWART GR, 1986, BRAIN RES, V369, P377, DOI 10.1016/0006-8993(86)90555-X; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; VERHEUL HB, 1993, BRAIN RES, V618, P203, DOI 10.1016/0006-8993(93)91267-V	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200659	10.1371/journal.pone.0200659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	WOS:000438457400093	30001411	gold, Green Submitted, Green Published			2022-02-06	
J	Xing, GQ; Ren, M; Verma, A				Xing, Guoqiang; Ren, Ming; Verma, Ajay			Divergent Induction of Branched-Chain Aminotransferases and Phosphorylation of Branched Chain Keto-Acid Dehydrogenase Is a Potential Mechanism Coupling Branched-Chain Keto-Acid-Mediated-Astrocyte Activation to Branched-Chain Amino Acid Depletion-Mediated Cognitive Deficit after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; branched-chain amino acid; branched-chain aminotransferases; branched-chain keto-acid dehydrogenase; catabolism; traumatic brain injury	SYRUP-URINE-DISEASE; CORTICAL IMPACT INJURY; MORPHOLOGICAL ALTERATIONS; GLIAL-CELLS; IN-VIVO; GLUTAMATE; METABOLISM; ENZYMES; RECOVERY; DEATH	Deficient branched-chain amino acids (BCAAs) are implicated in cognitive dysfunction after traumatic brain injury (TBI). The mechanism remains unknown. BCAAs are catabolized by neuron-specific cytosolic and astrocyte-specific mitochondrial branched-chain aminotransferases (BCATc, BCATm) to generate glutamate and branched-chain keto-acids (BCKAs) that are metabolized by the mitochondrial branched-chain keto-acid dehydrogenase (BCKD) whose activity is regulated by its phosphorylation state. BCKD phosphorylation by BCKD kinase (BCKDK) inactivates BCKD and cause neurocognitive dysfunction, whereas dephosphorylation by specific phosphatase restores BCKD activity. Real-time polymerase chain reaction showed rapidly and significantly decreased BCATc messenger RNA (mRNA) levels, but significantly increased BCATm mRNA level post-CCI (controlled cortical impact). BCKD and BCKDK mRNA decreased significantly immediately after CCI-induced TBI (CCI) in the rat. Phosphorylated BCKD proteins (pBCKD) increased significantly in the ipsilateral-CCI hemisphere. Immunohistochemistry revealed significantly increased pBCKD proteins in ipsilateral astrocytes post-CCI. BCKD protein expression is higher in primarily cultured cortical neurons than in astrocytes, whereas pBCKD protein level is higher in astrocytes than in cortical neurons. Transforming growth factor beta treatment (10 mu g/mL for 48 h) significantly increased pBCKD protein expression in astrocytes, whereas glutamate treatment (25 mu M for 24 h) significantly decreased pBCKD protein in neurons. Because increased pBCKD would lead to increased BCKA accumulation, BCKA-mediated astrocyte activation, cell death, and cognitive dysfunction as found in maple syrup urine disease; thus, TBI may potentially induce cognitive deficit through diverting BCAA from glutamate production in neurons to BCKA production in astrocytes through the pBCKD-dependent mechanism.	[Xing, Guoqiang] Nanchong Cent Hosp, North Sichuan Med Coll, Clin Med Coll 2, Dept Radiol & Imaging,Inst Rehabil & Dev Brain Fu, Nanchong 637000, Peoples R China; [Ren, Ming] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Verma, Ajay] United Neurosci, Dublin, Ireland		Xing, GQ (corresponding author), Nanchong Cent Hosp, North Sichuan Med Coll, Clin Med Coll 2, Dept Radiol & Imaging,Inst Rehabil & Dev Brain Fu, Nanchong 637000, Peoples R China.; Ren, M (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	gxing99@yahoo.com; mren201017@hotmail.com	Xing, Guoqiang/ABA-8450-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS37814]; DODUnited States Department of Defense [MDA-905-02-2-0005, MDA905-03-2-0001]; Sciences & Technology Bureau of Sichuan Province [KY-1720]	The authors greatly appreciate the help of Dr. C.J. Lynch who generously provided the gift of pBCKD antibodies and the help of Dr. R. Harris who generously provided the gift of BCKDK antibodies. This work was supported, in part, by the NIH grant NS37814, DOD grants MDA-905-02-2-0005 and MDA905-03-2-0001 (to A. Verma), and a grant from the Sciences & Technology Bureau of Sichuan Province KY-1720 (to G. Xing).	Adeva-Andany MM, 2017, AMINO ACIDS, V49, P1005, DOI 10.1007/s00726-017-2412-7; An YJ, 2012, ACS CHEM BIOL, V7, P2012, DOI 10.1021/cb3004226; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Bixel MG, 2001, J HISTOCHEM CYTOCHEM, V49, P407, DOI 10.1177/002215540104900314; Bixel MG, 1997, J HISTOCHEM CYTOCHEM, V45, P685, DOI 10.1177/002215549704500506; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Bunevicius A, 2016, WORLD NEUROSURG, V95, P197, DOI 10.1016/j.wneu.2016.07.035; CHOI DW, 1987, J NEUROSCI, V7, P369; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; D'Antona G, 2016, ANTIOXID REDOX SIGN, V25, P595, DOI 10.1089/ars.2015.6582; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Funchal C, 2005, METAB BRAIN DIS, V20, P205, DOI 10.1007/s11011-005-7208-x; Funchal C, 2004, GLIA, V48, P230, DOI 10.1002/glia.20072; Funchal C, 2007, J NEUROL SCI, V260, P87, DOI 10.1016/j.jns.2007.04.011; Funchal C, 2006, NEUROCHEM INT, V49, P640, DOI 10.1016/j.neuint.2006.05.007; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Harris R. A, 2005, J NUTR S6, V135, p1527S; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutson S, 2001, PROG NUCLEIC ACID RE, V70, P175, DOI 10.1016/S0079-6603(01)70017-7; Hutson SM, 1998, J NEUROCHEM, V71, P863; Hutson Susan M, 2006, Biochem J, V400, pe1; Hutson SM, 2011, NEUROCHEM INT, V59, P518, DOI 10.1016/j.neuint.2011.05.001; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Jiang M, 2017, MED GAS RES, V7, P48, DOI 10.4103/2045-9912.202910; Jouvet P, 2000, MOL BIOL CELL, V11, P1919, DOI 10.1091/mbc.11.5.1919; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kimball SR, 2004, BIOCHEM BIOPH RES CO, V313, P423, DOI 10.1016/j.bbrc.2003.07.014; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Li JR, 2017, MOL CELL ENDOCRINOL, V452, P120, DOI 10.1016/j.mce.2017.05.023; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Shimomura Y, 2000, J NUTR SCI VITAMINOL, V46, P71, DOI 10.3177/jnsv.46.71; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Soliman A T, 2015, Georgian Med News, P62; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Wang XN, 2004, AM J PHYSIOL-RENAL, V286, pF504, DOI 10.1152/ajprenal.00296.2003; Xing GQ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00173; Xing GQ, 2012, EXP NEUROL, V234, P31, DOI 10.1016/j.expneurol.2011.12.007; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yudkoff M, 2005, J NUTR, V135, P2009; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W; Yudkoff M, 2017, NEUROCHEM RES, V42, P10, DOI 10.1007/s11064-016-2057-z; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	65	3	4	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2482	2494		10.1089/neu.2017.5496		JUL 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000438238400001	29764289	Green Published			2022-02-06	
J	Beliveau, PJH; Boulos, D; Zamorski, MA				Beliveau, P. J. H.; Boulos, D.; Zamorski, M. A.			Contribution of mental and physical disorders to disability in military personnel	OCCUPATIONAL MEDICINE-OXFORD			English	Article						Co-morbidity; disability; mental health; military; physical health; traumatic brain injury	CANADIAN ARMED-FORCES; HEALTH; AFGHANISTAN; RISK; VETERANS	Background Combat operations in Southwest Asia have exposed millions of military personnel to risk of mental disorders and physical injuries, including traumatic brain injury (TBI). The contribution of specific disorders to disability is, however, uncertain. Aims To estimate the contributions of mental and physical health conditions to disability in military personnel. Methods The sample consisted of military personnel who participated in the cross-sectional 2013 Canadian Forces Mental Health Survey. Disability was measured using the World Health Organization Disability Assessment. The International Classification of Functioning, Disability, and Health was used to classify participants with moderate/severe disability. Chronic mental disorders and physical conditions were measured by self-reported health professional diagnoses, and their contribution to disability was assessed using logistic regression and resulting population attributable fractions. Results Data were collected from 6696 military members. The prevalence of moderate/severe disability was 10%. Mental disorders accounted for 27% (95% confidence interval [CI] 23-31%) and physical conditions 62% (95% CI 56-67%) of the burden of disability. Chronic musculoskeletal problems 33% (95% CI 26-39%), back problems 29% (95% CI 23-35%), mood disorders 16% (95% CI 11-19%) and post-traumatic stress disorder (PTSD) 9% (95% CI 5-12%) were the leading contributors to disability. After-effects of TBI accounted for only 3% (95% CI 1-4%) of disability. Mental and physical health interacted broadly, such that those with mental disorders experienced disproportionate disability in the presence of physical conditions. Conclusions Chronic musculoskeletal conditions, back problems, mood disorders and PTSD are primary areas of focus in prevention and control of disability in military personnel.	[Beliveau, P. J. H.; Boulos, D.; Zamorski, M. A.] Canadian Forces Hlth Serv Grp, Res & Anal Sect, Directorate Mental Hlth, Ottawa, ON, Canada; [Zamorski, M. A.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada		Beliveau, PJH (corresponding author), Canadian Forces Hlth Serv Grp, Directorate Mental Hlth, 101 Colonel By Dr Carling Campus,Bldg 9, Ottawa, ON K1A 0K2, Canada.	Peter.Beliveau@forces.gc.ca		Boulos, David/0000-0001-7585-0681; Beliveau, Peter/0000-0002-7081-4769			Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Beckett A, 2012, INJURY, V43, P2072, DOI 10.1016/j.injury.2012.01.005; Belmont PJ, 2016, J AM ACAD ORTHOP SUR, V24, P341, DOI 10.5435/JAAOS-D-15-00123; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Burton A.K., 2006, IS WORK GOOD YOUR HL; Carleton RN, 2018, CAN J PSYCHIAT, V63, P54, DOI 10.1177/0706743717723825; Crisp R, 2007, DISABIL REHABIL, V29, P267, DOI 10.1080/09638280600835267; Fikretoglu D, 2008, MED CARE, V46, P217, DOI 10.1097/MLR.0b013e31815b979a; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; HUBBARD A, 2006, MISS LAW J, V75, P975; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Mota NP, 2016, AM J GERIAT PSYCHIAT, V24, P706, DOI 10.1016/j.jagp.2016.03.004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Rothman KJ., 2002, EPIDEMIOLOGY INTRO; Schoenfeld AJ, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01050; Thompson JM, 2015, DISABIL REHABIL, V37, P884, DOI 10.3109/09638288.2014.947441; Tough H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4308-6; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Ameringen M, 2008, CNS NEUROSCI THER, V14, P171, DOI 10.1111/j.1755-5949.2008.00049.x; Velly AM, PROG NEUROPSYCHOPHAR; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Weeks M, 2016, CAN J PSYCHIAT, V61, p56S, DOI 10.1177/0706743716628853; World Health Organization, 2002, COMM LANG FUNCT DIS, V5, P1; Zamorski MA, 2016, CAN J PSYCHIAT, V61, p10S, DOI 10.1177/0706743716632731	29	3	4	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	JUL	2018	68	5					332	339		10.1093/occmed/kqy066			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GO0TN	WOS:000439653500009	29788489	hybrid, Green Published, Green Submitted			2022-02-06	
J	Brickell, TA; French, LM; Lippa, SM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.			The impact of deployment and traumatic brain injury on the health and behavior of children of US military service members and veterans	CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						Traumatic brain injury; children; military; caregiver; service member; veteran; deployment	PARENTAL DEPLOYMENT; YOUNG-CHILDREN; FAMILIES; CHALLENGES; POLYTRAUMA	This study examined the impact of service member/veteran (SMV) combat deployment and traumatic brain injury (TBI) on the health and behavior of his or her children. Participants were 104 female spouse caregivers of US SMVs who had sustained a mild, severe, or penetrating TBI. Participants completed the Children's Health and Behavior Questionnaire (CHBQ; r=.758 to .881) that evaluates school grades, behavior, medical health, emotional health, and social participation: (a) prior to the first combat deployment, (b) in the month prior to the TBI, (c) within 2 years after the TBI, and (d) 2 or more years after the TBI. A substantial number of children experienced a decline in health and behavior following the TBI (41.7%-79.1%). Of those who declined (a) 68.8%-75.5% declined within the first 2 years post-injury, followed by improvement or stabilization; (b) 6.7%-15.6% declined only after 2 or more years post-injury; (c) 15.6%-25.0% declined within the first 2 years post-injury and then again 2 or more years post-injury; and (d) 16.9%-26.5% experienced a decline as a result of deployment, followed by an additional decline after the SMV's TBI. Services are required for children of SMVs following TBI and deployment, particularly children at risk for poor outcome.	[Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1502B,Bldg 51,8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Dept Rehabil, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Room 1502B,Bldg 51,8901 Wisconsin Ave, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This material is based upon work supported by the Defense and Veterans Brain Injury Center. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy or decision unless so designated by other official documentation.	Aranda MC, 2011, MIL MED, V176, P402, DOI 10.7205/MILMED-D-10-00202; Barnes VA, 2007, MIL MED, V172, P40, DOI 10.7205/MILMED.172.1.40; Chandra A, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P175, DOI 10.1007/978-1-4419-7064-0_9; Chandra A, 2010, J ADOLESCENT HEALTH, V46, P218, DOI 10.1016/j.jadohealth.2009.10.009; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Cozza S. J., 2013, FUTURE CHILD, V23, P1; Cozza SJ, 2005, PSYCHIAT QUART, V76, P371, DOI 10.1007/s11126-005-4973-y; Cozza SJ, 2013, CLIN CHILD FAM PSYCH, V16, P311, DOI 10.1007/s10567-013-0141-3; Cozza SJ, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P259, DOI 10.1007/978-1-4419-7064-0_13; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; DeVellis R.F., 2017, SCALE DEV THEORY APP; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Holmes AK, 2013, FUTURE CHILD, V23, P143, DOI 10.1353/foc.2013.0017; Huebner AJ, 2007, FAM RELAT, V56, P112, DOI 10.1111/j.1741-3729.2007.00445.x; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, J REHABILITATION RES, V46; Nicosia N, 2017, PUBLIC HEALTH REP, V132, P93, DOI 10.1177/0033354916679995; Ramchand R., 2014, HIDDEN HEROES AM MIL; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Tanielian T, 2013, MILITARY CAREGIVERS; Wadsworth SM, 2016, AM J COMMUN PSYCHOL, V57, P190, DOI 10.1002/ajcp.12025	27	3	3	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1359-1045	1461-7021		CLIN CHILD PSYCHOL P	Clin. Child Psychol. Psychiatry	JUL	2018	23	3					425	441		10.1177/1359104517740405			17	Psychology, Clinical; Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	GM9IP	WOS:000438560800006	29139308				2022-02-06	
J	Chaudhry, R; Kukreja, N; Tse, A; Pednekar, G; Mouchli, A; Young, L; Didyuk, O; Wegner, RC; Grewal, N; Williams, GW				Chaudhry, Rabail; Kukreja, Naveen; Tse, Alex; Pednekar, Greesha; Mouchli, Anas; Young, Linda; Didyuk, Oksana; Wegner, Robert C.; Grewal, Navneet; Williams, George W.			Trends and Outcomes of Early Versus Late Percutaneous Endoscopic Gastrostomy Placement in Patients With Traumatic Brain Injury: Nationwide Population-based Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; percutaneous endoscopic gastrostomy; nutrition; national inpatient sample; PEG placement; PEG timing; patient outcomes	IN-HOSPITAL MORTALITY; COMORBIDITY INDEX; ADJUSTMENT; SEVERITY; ICD-9-CM; SURGERY; SCORE	Background:Oral intake for traumatic brain injury (TBI) patients is often not an option because of facial trauma, swallowing dysfunctions, altered consciousness, etc. These patients often require percutaneous endoscopic gastrostomy (PEG) placement for nutrition support. To date, there is lack of studies examining the relationship between the timing of PEG placement and patient outcome in the TBI group.Methods:We conducted a population-based study in a retrospective cohort of TBI patients undergoing PEG, using the national inpatient sample for years 2011 to 2013.Results:A total of 96,625 patients were identified for TBI and 3343 of those patients received PEG. TBI patients who undergo an early or late PEG placement had a higher rate of in-hospital mortality, when compared with patients with a standard timing of PEG placement. Late PEG was preferably placed in patients with higher Charlson index and trauma-related comorbidities, and these patients had a higher incidence of complications, that is, sepsis, urinary tract infection, acute respiratory distress syndrome/pneumonia, and deep vein thrombosis/pulmonary embolism. When stratified by mortality-risk groups, early PEG was associated with higher rates of in-hospital mortality while standard PEG was associated with best mortality outcomes in low-mortality-risk group and moderate-mortality-risk group.Conclusions:The results of this study suggest that if a PEG placement is indicated for a TBI patient, a standard (7 to 14 d) timing may be associated with better patient outcomes. However, secondary to limitations associated with the use of administrative databases, further prospective studies are needed to establish clear guidelines regarding the optimal timing of placing PEG in TBI patients.	[Chaudhry, Rabail; Kukreja, Naveen; Tse, Alex; Pednekar, Greesha; Mouchli, Anas; Young, Linda; Didyuk, Oksana; Wegner, Robert C.; Grewal, Navneet; Williams, George W.] Univ Texas Hlth Sci Ctr Houston UT Hlth, McGovern Med Sch, Dept Anesthesiol, Houston, TX USA		Williams, GW (corresponding author), 6431 Fannin St,MSB 5-020, Houston, TX 77030 USA.	george.w.williams@uth.tmc.edu		Chaudhry, Rabail/0000-0002-8827-0579			Annoni JM, 1998, DISABIL REHABIL, V20, P308, DOI 10.3109/09638289809166086; Arora G, 2013, CLIN GASTROENTEROL H, V11, P1437, DOI 10.1016/j.cgh.2013.04.011; Blomberg J, 2012, SCAND J GASTROENTERO, V47, P737, DOI 10.3109/00365521.2012.654404; Chaudhry R, 2017, NEUROCRIT CARE, V26, P232, DOI 10.1007/s12028-016-0330-2; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Grant MD, 1998, JAMA-J AM MED ASSOC, V279, P1973, DOI 10.1001/jama.279.24.1973; Gullo A, 2012, IMPACT NUTR ROUTE IN, P411; Janes S E J, 2005, J Postgrad Med, V51, P23; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Macario A, 1997, ANESTHESIOLOGY, V86, P92, DOI 10.1097/00000542-199701000-00013; Marimuthu K, 2012, ANN SURG, V255, P1060, DOI 10.1097/SLA.0b013e318252edf8; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rabeneck L, 1996, J GEN INTERN MED, V11, P287, DOI 10.1007/BF02598270; Rutter CE, 2011, HEAD NECK-J SCI SPEC, V33, P1441, DOI 10.1002/hed.21624; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Teno JM, 2012, J AM GERIATR SOC, V60, P1918, DOI 10.1111/j.1532-5415.2012.04148.x; Yoon EWT, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000098	22	3	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2018	30	3					251	257		10.1097/ANA.0000000000000434			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	GJ6CU	WOS:000435472100009	28459729				2022-02-06	
J	Crider, T; Eng, D; Sarkar, PR; Cordero, J; Krusz, JC; Sarkar, SN				Crider, Tiffany; Eng, Derrick; Sarkar, Pooja R.; Cordero, Janet; Krusz, John Claude; Sarkar, Subhendra N.			Microvascular and large vein abnormalities in young patients after mild head trauma and associated fatigue: A brain SPECT evaluation and posture dependence modeling	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild TBI; Fatigue; Mild head trauma; Brain SPECT; Vascular injury; Temporal lobe; Cerebral perfusion; MR venogram in TBI	CEREBRAL VENOUS OUTFLOW; SLEEP DISORDERS; INJURY; NEUROPATHOLOGY; SYMPTOMS; PRESSURE; ECD	Objective: MRI and CT scans are usually normal in mild traumatic brain injury (mTBI) although 15-20% of such patients suffer for months from fatigue, headache, anxiety, sleep and other disorders. mTBI is suspected to be a cerebrovascular injury, similar to moderate and severe TBI. Brain SPECT is more sensitive and shows perfusion abnormalities immediately after mTBI. This work explores the perfusion abnormalities for young patients suffering from fatigue several months after mTBI. Patients and methods: Twelve mTBI patients (age:8-36 yr, 4 male) with no history of fatigue prior to trauma were prospectively studied following onset of fatigue 6-12 months after mTBI utilizing 99 m-Tc ECD brain SPECT with early and delayed radiotracer imaging. Results: The perfusion pattern in the mTBI + fatigue group included left hemispheric deficits in frontal lobes (early phase: 15.2 +/- 4.2%, delayed phase: 9.9 +/- 2.2%) and medial temporal lobes (early phase 11.2 +/- 3.7%, delayed phase: 9.0 +/- 2.3%). Seven patients additionally showed excess tracer accumulation in the parenchyma surrounding internal jugular bulb inferior to temporal lobe. This was modeled as due to increased cellular permeability from TBI induced oxidative stress affecting endothelial tight junctions and consequent tracer leakage across jugular bulbs. Prolonged posture changes from erect to supine position during imaging increase jugular cross-sectional area and venous wall pressure as has been observed in other disease processes and seem to be responsible for tracer leakage from jugular bulbs in our study. Conclusion: This work supports an oxidative stress and BBB disruption model for mTBI. The frontal and temporal lobe perfusion deficits are attributed to anatomical vulnerabilities of these lobes. During a mild TBI both of these lobes are susceptible to grazing impacts with underlying bony ridges. We propose a relation between mTBI and fatigue arising from oxidative stress in mTBI affecting ATP generation and altering endothelial homeostasis for both micro-and-large vasculatures. The tracer leakage observed around jugular veins is due to posture induced changes in venous cross-sections and wall pressure as well as from compromised endothelium post TBI induced oxidative stress.	[Crider, Tiffany] HackensackUMC Palisades, North Bergen, NJ USA; [Eng, Derrick] Orange Reg Med Ctr, Middletown, NY USA; [Sarkar, Pooja R.] Touro Coll Osteopath Med, Middletown, NY USA; [Cordero, Janet; Sarkar, Subhendra N.] CUNY, Dept Radiol Technol & Med Imaging, New York City Coll Technol, 300 Jay St, Brooklyn, NY 11210 USA; [Krusz, John Claude] Anodyne Headache Pain Care & Well Being, Dallas, TX USA		Sarkar, SN (corresponding author), CUNY, Dept Radiol Technol & Med Imaging, New York City Coll Technol, 300 Jay St, Brooklyn, NY 11210 USA.	ssarkar@citytech.cuny.edu	Sarkar, Subhendra/AAF-5273-2020				Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Holmlund P, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0065-2; JacquierSarlin MR, 1996, J NUCL MED, V37, P1694; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003007; JASON LA, 2009, J DISABIL POLICY STU, V20, P93, DOI DOI 10.1177/1044207308325995; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005.04.020; Krusz J. C., 2015, PRACT PAIN MANAGE, V15, P46; Krusz J. C., 2009, PRACT PAIN MANAGE, V9, P70; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Leo P, 2016, TRANSLATIONAL RES TR; Li X., 2012, P 20 ANN M ISMRM MEL, P722; Li XF, 2013, NMR BIOMED, V26, P613, DOI 10.1002/nbm.2898; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Maruya J, 2017, INTERDISCIP NEUROSUR, V7, P64, DOI 10.1016/j.inat.2016.12.002; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rosas-Hernandez H., 2017, MOL NEUROBIOL; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Valdueza JM, 2000, LANCET, V355, P200; Vallabhajosula S, 2015, PATHOPHYSIOLOGIC BAS, P45, DOI 10.1007/978-3-319-06112-2_3; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; WALOVITCH RC, 1989, J NUCL MED, V30, P1892; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535	37	3	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2018	170						159	164		10.1016/j.clineuro.2018.05.019			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GJ8ER	WOS:000435622600029	29800829				2022-02-06	
J	Hu, YW; Li, X; Zhao, RR; Zhang, K				Hu, Yuanwei; Li, Xiang; Zhao, Ruirui; Zhang, Kang			Conservative Treatment for Delayed Infection After Cranioplasty With Titanium Alloy	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cranioplasty; decompressive craniectomy; delayed infection	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; FUNCTIONAL OUTCOMES; COMPLICATIONS; EXPERIENCE; SURGERY	Cranioplasty (CP) is considered a low-risk operation in the field of neurosurgery following decompression craniectomy. Nevertheless, CP is still burdened by surgical complications, among which early or late infections are the most common outcome-threatening ones. Most of infection cases occur within a week after CP. Except that, implant-associated scalp infection is the most common complication, and leads to implant removal in many patients with refractory and recurrent infection. The authors reported a patient presenting with epidural infection about 3 months after titanium implant and cured by anti-infective treatment for 2 weeks.	[Hu, Yuanwei; Li, Xiang; Zhao, Ruirui; Zhang, Kang] Jiangsu Prov Second Chinese Med Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Zhang, K (corresponding author), Nanhu Rd 23, Nanjing 210017, Jiangsu, Peoples R China.	nzykangzhang@yeah.net					Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Golas AR, 2014, J NEURO-ONCOL, V119, P327, DOI 10.1007/s11060-014-1482-6; Honeybul S, 2017, J REHABIL MED, V49, P204, DOI 10.2340/16501977-2209; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Khan AD, 2017, AM SURGEON, V83, P836; Kim E, 2016, J NEUROL SURG PART A, V77, P527, DOI 10.1055/s-0035-1571165; Li A, 2017, WORLD NEUROSURG, V102, P209, DOI 10.1016/j.wneu.2017.03.022; Li YP, 2017, WORLD NEUROSURG, V99, P709, DOI 10.1016/j.wneu.2016.12.069; Liang ES, 2016, BRIT J NEUROSURG, V30, P122, DOI 10.3109/02688697.2015.1080216; Satyarthee GD, 2017, WORLD NEUROSURG, V101, P779, DOI 10.1016/j.wneu.2016.12.101; Sergesketter A, 2017, WORLD NEUROSURG, V100, P244, DOI 10.1016/j.wneu.2017.01.019; Shibahashi K, 2017, WORLD NEUROSURG, V101, P20, DOI 10.1016/j.wneu.2017.01.106; Singla N, 2014, ACTA NEUROCHIR, V156, P1369, DOI 10.1007/s00701-014-2071-3; Szczygielski J, 2017, J NEUROTRAUM, V34, P1623, DOI 10.1089/neu.2016.4615; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	18	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2018	29	5					1258	1260		10.1097/SCS.0000000000004436			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GW0RK	WOS:000446576600063	29521746				2022-02-06	
J	Huet, M; Dany, L; Apostolidis, T				Huet, Magali; Dany, Lionel; Apostolidis, Themistoklis			Explain the "unexplainable': A qualitative enquiry of the representations of the caregivers of brain-injured people	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						caregivers; disability; qualitative research; social representations; traumatic brain injury	HEALTH-CARE; MANAGEMENT; STATE	The aim of our research is to highlight the role of social representations of the traumatic brain-injured person in the adjustments made by caregivers in building and maintaining quality of care. Twenty-three semi-structured interviews were conducted with nursing assistants and medico-psychological assistants, working in a long-term care facility. The interviews were the subject of a thematic content analysis. The analysis shows the role of representations of the traumatic brain-injured person in the way caregivers explain behaviours and situations and in the orientation of their professional practices. In explaining the inexplicable, caregivers establish a more human relationship through individualized care.	[Huet, Magali; Dany, Lionel; Apostolidis, Themistoklis] Aix Marseille Univ, LPS EA 849, F-13621 Aix En Provence, France; [Dany, Lionel] AP HM, Serv Oncol Med, F-13385 Marseille, France		Dany, L (corresponding author), Aix Marseille Univ, Lab Psychol Sociale LPS EA849, Maison Rech Schuman, 29 Ave Robert Schuman, F-13621 Aix En Provence, France.	Lionel.Dany@univ-amu.fr	Apostolidis, Themis/T-9994-2017	Apostolidis, Themis/0000-0002-3549-5547; Dany, Lionel/0000-0003-2350-4300	Fondation de FranceFondation de France [00059759]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research has received funding from the Fondation de France (grant number 00059759).	Adams TL, 2010, SOCIOL COMPASS, V4, P454, DOI 10.1111/j.1751-9020.2010.00294.x; Apostolidis T., 2002, PSYCHOL SOC, V5, P7; Bauer M., 2000, QUALITATIVE RES TEXT, P131, DOI DOI 10.4135; Bessiere S., 2005, REV FR AFF SOC, V1, P17; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; DANY L., 2014, SOIN FIN VIE ETHIQUE, P143; Deary V., 2005, J MENT HEALTH, V14, P213, DOI DOI 10.1080/09638230500136605; Doisc W., 1992, B PSYCHOL, V45, P189; Duxbury J, 2005, J ADV NURS, V50, P469, DOI 10.1111/j.1365-2648.2005.03426.x; Flick U, 2000, J Health Psychol, V5, P315, DOI 10.1177/135910530000500303; Flick U., 2014, INTRO QUALIATIVE RES, P420; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2012, BRAIN INJURY, V26, P1; Goudsmit EM, 1991, PSYCHOLOGIST, V4, P449; Halligan PW, 2006, NEUROPSYCHOL REHABIL, V16, P456, DOI 10.1080/09602010500309762; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Heider F., 1958, PSYCHOL INTERPERSONA; Herzlich C., 1973, HLTH ILLNESS SOCIAL; Hewstone M., 1998, PSYCHOL SOCIAL, P60; JENNETT B, 1972, LANCET, V1, P734; Jodelet D., 1991, MADNESS SOCIAL REPRE; Kelley HH, 1971, ATTRIBUTIONS SOCIAL; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McDonald S, 2014, SOCIAL COMMUNICATION; Moscovici S, 2007, PSYCHOANALYSIS ITS I; Murray M, 2003, J HEALTH PSYCHOL, V8, P485, DOI 10.1177/13591053030085002; Peyla L, 2014, PSYCHO-ONCOLOGIE, V8, P215, DOI 10.1007/s11839-014-0487-x; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Smith J.h., 1995, RETHINKING METHODS P, P9, DOI [DOI 10.4135/9781446221792.N2, 10.4135/9781446221792.n2]; Wagner W., 2005, EVERYDAY DISCOURSE C	32	3	3	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	JUL	2018	23	8					1050	1062		10.1177/1359105316642834			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GK3KY	WOS:000436045100006	27091762				2022-02-06	
J	Hussain, E				Hussain, Elora			Traumatic Brain Injury in the Pediatric Intensive Care Unit	PEDIATRIC ANNALS			English	Article							CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; HEAD TRAUMA; CHILDREN; TRIAL; HYPERTENSION; HEMODYNAMICS; HYPOTHERMIA; SEIZURES	Head trauma is a leading cause of brain injury in children, and it can have profound life-long physical, cognitive, and behavioral consequences. Optimal acute care of children with traumatic brain injury (TBI) requires rapid stabilization and early neurosurgical evaluation by a multidisciplinary team. Meticulous attention is required to limit secondary brain injury after the initial trauma. This review discusses pathophysiology, acute stabilization, and monitoring, as well as supportive and therapeutic measures to help minimize ongoing brain injury and optimize recovery in children with TBI. [Pediatr Ann.2018;47(7):e274-e279.]	[Hussain, Elora] Helen DeVos Childrens Hosp, Neurocrit Care, Div Pediat Crit Care Med, Grand Rapids, MI 49503 USA; [Hussain, Elora] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, E Lansing, MI 48824 USA		Hussain, E (corresponding author), Helen DeVos Childrens Hosp, 100 Michigan St NE,MC 117, Grand Rapids, MI 49503 USA.	elora.hussain@helendevoschildrens.org					Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bilotta F, 2008, NEUROCRIT CARE, V8, P241, DOI 10.1007/s12028-007-9012-4; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Freiss SH, 2013, PEDIAT NEUROCRITICAL, P104; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2011, PEDIAT CRITICAL CARE, P849; Langlois J, 2004, BRAIN INJURY US EMER, P1; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wysowski DK, 2006, ANESTHESIOLOGY, V105, P1047, DOI 10.1097/00000542-200611000-00027	30	3	5	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	JUL	2018	47	7					E274	E279		10.3928/19382359-20180619-01			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GM8NH	WOS:000438485600005	30001441				2022-02-06	
J	Judah, MR; Renfroe, JB; Wangelin, BC; Turner, TH; Tuerk, PW				Judah, Matt R.; Renfroe, Jenna B.; Wangelin, Bethany C.; Turner, Travis H.; Tuerk, Peter W.			Hyperarousal Symptoms Explain the Relationship Between Cognitive Complaints and Working Memory Performance in Veterans Seeking PTSD Treatment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						digit span; hyperarousal; PTSD; TBI	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DIGIT SPAN; MILD; ATTENTION; INDIVIDUALS; VALIDITY; ANXIETY; SUBTEST; DYSFUNCTION	Objective: Comorbidity and symptom overlap between traumatic brain injury and posttraumatic stress disorder (PTSD) in veterans returning from deployment present challenges with respect to differential diagnosis and treatment. Both conditions frequently manifest with attention and working memory deficits, though the underlying neuropsychological basis differs. This study evaluated whether hyperarousal symptoms explain the relationship between subjective and objective measures of cognition in a veteran sample. Participants and Procedures: One-hundred three veterans completed the military version of the PTSD Checklist (PCL), the Neurobehavioral Symptom Inventory, and the Wechsler Memory Scale, 3rd edition digit span task with adequate effort. Results: Hierarchical regression suggested that hyperarousal, but not other PTSD symptoms, explained the relationship between neurobehavioral symptoms and cognitive functioning. This relationship was present regardless of whether veterans met full PTSD diagnostic criteria or screened positive on a traumatic brain injury screener and was robust to other moderators. Conclusion: These findings highlight the importance of considering traumatic brain injury and PTSD symptom overlap, particularly the relationship between hyperarousal symptoms and attention and working memory deficits, in conceptualizing cases and treatment planning.	[Judah, Matt R.] Old Dominion Univ, Dept Psychol, 250 Mills Godwin Bldg, Norfolk, VA 23529 USA; [Judah, Matt R.] Virginia Consortium Program Clin Psychol, Norfolk, VA USA; [Wangelin, Bethany C.; Tuerk, Peter W.] Ralph H Johnson VAMC, Mental Hlth Serv Line, Charleston, SC USA; [Renfroe, Jenna B.] Med Univ South Carolina, Dept Neurol Neurosci, Charleston, SC 29425 USA; [Wangelin, Bethany C.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA		Judah, MR (corresponding author), Old Dominion Univ, Dept Psychol, 250 Mills Godwin Bldg, Norfolk, VA 23529 USA.	mjudah@odu.edu		Judah, Matt/0000-0003-3825-6821			Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fani N, 2012, BIOL PSYCHOL, V90, P134, DOI 10.1016/j.biopsycho.2012.03.001; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Horner MD, 2013, CNS SPECTRUMS, V18, P90, DOI 10.1017/S1092852912000909; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lavric A, 2003, COGNITIVE THER RES, V27, P489, DOI 10.1023/A:1026300619569; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Moores KA, 2008, PSYCHIAT RES-NEUROIM, V163, P156, DOI 10.1016/j.pscychresns.2007.08.011; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Ryan JJ, 2005, INT J NEUROSCI, V115, P129, DOI 10.1080/00207450490512704; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schweizer S, 2016, EMOTION, V16, P16, DOI 10.1037/emo0000072; Sharp PB, 2015, INT J PSYCHOPHYSIOL, V98, P365, DOI 10.1016/j.ijpsycho.2015.07.001; Shaw ME, 2009, PSYCHIAT RES-NEUROIM, V172, P235, DOI 10.1016/j.pscychresns.2008.07.014; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Suvak MK, 2011, J TRAUMA STRESS, V24, P3, DOI 10.1002/jts.20618; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tian FH, 2014, NEUROIMAGE-CLIN, V4, P808, DOI 10.1016/j.nicl.2014.05.005; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V30, P1; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977	49	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					E10	E16		10.1097/HTR.0000000000000356			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900002	29084106				2022-02-06	
J	Lichstein, PM; Kleimeyer, JP; Githens, M; Vorhies, JS; Gardner, MJ; Bellino, M; Bishop, J				Lichstein, Paul M.; Kleimeyer, John P.; Githens, Michael; Vorhies, John S.; Gardner, Michael J.; Bellino, Michael; Bishop, Julius			Does the Watson-Jones or Modified Smith-Petersen Approach Provide Superior Exposure for Femoral Neck Fracture Fixation?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							TOTAL HIP-ARTHROPLASTY; ANTERIOR APPROACH; YOUNG-ADULTS; INTRACAPSULAR FRACTURES; CIRCUMFLEX ARTERY; QUANTIFICATION; HEAD; COMPLICATIONS; DISLOCATIONS; METAANALYSIS	BackgroundA well-reduced femoral neck fracture is more likely to heal than a poorly reduced one, and increasing the quality of the surgical exposure makes it easier to achieve anatomic fracture reduction. Two open approaches are in common use for femoral neck fractures, the modified Smith-Petersen and Watson-Jones; however, to our knowledge, the quality of exposure of the femoral neck exposure provided by each approach has not been investigated.Questions/purposes(1) What is the respective area of exposed femoral neck afforded by the Watson-Jones and modified Smith-Petersen approaches? (2) Is there a difference in the ability to visualize and/or palpate important anatomic landmarks provided by the Watson-Jones and modified Smith-Petersen approaches?MethodsTen fresh-frozen human pelvi underwent both modified Smith-Petersen (utilizing the caudal extent of the standard Smith-Petersen interval distal to the anterosuperior iliac spine and parallel to the palpable interval between the tensor fascia lata and the sartorius) and Watson-Jones approaches. Dissections were performed by three fellowship-trained orthopaedic traumatologists with extensive experience in both approaches. Exposure (in cm(2)) was quantified with calibrated digital photographs and specialized software. Modified Smith-Petersen approaches were analyzed before and after rectus femoris tenotomy. The ability to visualize and palpate seven clinically relevant anatomic structures (the labrum, femoral head, subcapital femoral neck, basicervical femoral neck, greater trochanter, lesser trochanter, and medial femoral neck) was also recorded. The quantified area of the exposed proximal femur was utilized to compare which approach afforded the largest field of view of the femoral neck and articular surface for assessment of femoral neck fracture and associated femoral head injury. The ability to visualize and palpate surrounding structures was assessed so that we could better understand which approach afforded the ability to assess structures that are relevant to femoral neck fracture reduction and fixation.ResultsAfter controlling for age, body mass index, height, and sex, we found the modified Smith-Petersen approach provided a mean of 2.36 cm(2) (95% confidence interval [CI], 0.45-4.28 cm(2); p = 0.015) additional exposure without rectus femoris tenotomy (p = 0.015) and 3.33 cm(2) (95% CI, 1.42-5.24 cm(2); p = 0.001) additional exposure with a tenotomy compared with the Watson-Jones approach. The labrum, femoral head, subcapital femoral neck, basicervical femoral neck, and greater trochanter were reliably visible and palpable in both approaches. The lesser trochanter was palpable in all of the modified Smith-Petersen and none of the Watson-Jones approaches (p < 0.001). All modified Smith-Petersen approaches (10 of 10) provided visualization and palpation of the medial femoral neck, whereas visualization of the medial femoral neck was only possible in one of 10 Watson-Jones approaches (p < 0.001) and palpation was possible in eight of 10 Watson-Jones versus all 10 modified Smith-Petersen approaches (p = 0.470).ConclusionsIn the hands of surgeons experienced with both surgical approaches to the femoral neck, the modified Smith-Petersen approach, with or without rectus femoris tenotomy, provides superior exposure of the femoral neck and articular surface as well as visualization and palpation of clinically relevant proximal femoral anatomic landmarks compared with the Watson-Jones approach. Clinical RelevanceOpen reduction and internal fixation of a femoral neck fracture is typically performed in a young patient (< 60 years old) with the objective of obtaining anatomic reduction that would not be possible by closed manipulation, thus enhancing healing potential. In the hands of surgeons experienced in both approaches, the modified Smith-Petersen approach offers improved direct access for reduction and fixation. Higher quality reductions and fixation are expected to translate to improved healing potential and outcomes. Although our experimental results are promising, further clinical studies are needed to verify if this larger exposure area imparts increased quality of reduction, healing, and improved outcomes compared with other approaches. The learning curve for the exposure is unclear, but the approach has broad applications and is frequently used in other subspecialties such as for direct anterior THA and pediatric septic hip drainage. Surgeons treating femoral neck fractures with open reduction and fixation should familiarize themselves with the modified Smith-Petersen approach.	[Lichstein, Paul M.; Kleimeyer, John P.; Vorhies, John S.; Gardner, Michael J.; Bellino, Michael; Bishop, Julius] Stanford Univ, Med Ctr, Dept Orthopaed Surg, 450 Broadway Pavil C,4th Floor, Redwood City, CA 94063 USA; [Githens, Michael] Harborview Med Ctr, Dept Orthopaed Surg, West Clin, Seattle, WA USA		Lichstein, PM (corresponding author), Stanford Univ, Med Ctr, Dept Orthopaed Surg, 450 Broadway Pavil C,4th Floor, Redwood City, CA 94063 USA.	paulmlichstein@gmail.com	yudong, LI/AAR-5902-2021		Foundation for Orthopaedic Trauma	One of the authors (PML) received funding from the Foundation for Orthopaedic Trauma.	ASKIN SR, 1976, CLIN ORTHOP RELAT R, P259; Baitner AC, 1999, CLIN ORTHOP RELAT R, P300; Bartonicek J, 2001, J ORTHOP TRAUMA, V15, P358, DOI 10.1097/00005131-200106000-00009; Bellamy JL, 2014, J SHOULDER ELB SURG, V23, P895, DOI 10.1016/j.jse.2013.09.013; Berend KR, 2009, J BONE JOINT SURG AM, V91A, P107, DOI 10.2106/JBJS.I.00525; Bhandari M, 2009, ORTHOP CLIN N AM, V40, P329, DOI 10.1016/j.ocl.2009.03.001; Blair JA, 2010, J ORTHOP TRAUMA, V24, P355, DOI 10.1097/BOT.0b013e3181c675d0; Boari N, 2010, J NEUROSURG, V113, P1011, DOI 10.3171/2010.4.JNS091887; Bonnaire FA, 2002, INJURY, V33, pS24; Broos PLO, 1998, J ORTHOP TRAUMA, V12, P235, DOI 10.1097/00005131-199805000-00003; Butt MF, 2008, INJURY, V39, P238, DOI 10.1016/j.injury.2007.09.002; CARLSON DC, 1987, CLIN ORTHOP RELAT R, P161; Chua D, 1998, J ORTHOP TRAUMA, V12, P230, DOI 10.1097/00005131-199805000-00002; CRAWFURD EJP, 1988, J BONE JOINT SURG BR, V70, P195, DOI 10.1302/0301-620X.70B2.3279041; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Duckworth AD, 2011, J BONE JOINT SURG BR, V93B, P811, DOI 10.1302/0301-620X.93B6.26432; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gautam VK, 1998, INJURY, V29, P215, DOI 10.1016/S0020-1383(97)00184-8; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; GERBER C, 1993, CLIN ORTHOP RELAT R, P77; Ghayoumi P, 2015, INJURY, V46, P467, DOI 10.1016/j.injury.2014.10.011; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; Goulding K, 2010, CLIN ORTHOP RELAT R, V468, P2397, DOI 10.1007/s11999-010-1406-5; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; Harmer LS, 2016, J ORTHOP TRAUMA, V30, P235, DOI 10.1097/BOT.0000000000000486; Huh J, 2013, J ORTHOP TRAUMA, V27, P730, DOI 10.1097/BOT.0b013e31828ba91c; KELLER CS, 1980, CLIN ORTHOP RELAT R, P131; Kennon R, 2004, J BONE JOINT SURG AM, V86A, P91, DOI 10.2106/00004623-200412002-00013; Kennon RE, 2003, J BONE JOINT SURG AM, V85A, P39, DOI 10.2106/00004623-200300004-00005; Kim FJ, 2012, SURG ENDOSC, V26, P3408, DOI 10.1007/s00464-012-2351-z; Kurylo JC, 2015, INJURY, V46, P441, DOI 10.1016/j.injury.2014.11.027; Lazaro LE, 2015, BONE JOINT J, V97B, P1204, DOI 10.1302/0301-620X.97B9.34704; Lee GC, 2015, J ARTHROPLASTY, V30, P98, DOI 10.1016/j.arth.2015.03.043; Loizou CL, 2009, INJURY, V40, P1143, DOI 10.1016/j.injury.2008.11.003; Lovell TP, 2008, J ARTHROPLASTY, V23, P64, DOI 10.1016/j.arth.2008.06.027; Marchetti ME, 1996, J ORTHOP TRAUMA, V10, P455, DOI 10.1097/00005131-199610000-00002; Masse A, 2015, CLIN ORTHOP RELAT R, V473, P3744, DOI 10.1007/s11999-015-4352-4; Mehta S, 2008, J ORTHOP TRAUMA, V22, P686, DOI 10.1097/BOT.0b013e31818e2a86; Merck B, 2015, FEMORAL NECK FRACTUR; Molnar RB, 2007, J ORTHOP TRAUMA, V21, P490, DOI 10.1097/BOT.0b013e31804a7f7f; Nakata K, 2009, J ARTHROPLASTY, V24, P698, DOI 10.1016/j.arth.2008.04.012; Papakostidis C, 2015, INJURY, V46, P459, DOI 10.1016/j.injury.2014.12.025; Patzkowski JC, 2012, FOOT ANKLE INT, V33, P900, DOI 10.3113/FAI.2012.0900; Phelps KD, 2016, J ORTHOP TRAUMA, V30, P319, DOI 10.1097/BOT.0000000000000526; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; SIMON WH, 1970, CLIN ORTHOP RELAT R, P152; Slobogean GP, 2015, INJURY, V46, P435, DOI 10.1016/j.injury.2014.11.028; Stankewich CJ, 1996, J ORTHOP TRAUMA, V10, P248, DOI 10.1097/00005131-199605000-00005; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; Watson-Jones R, 1936, BRIT J SURG, V23, P787, DOI 10.1002/bjs.1800239213; Ye Y, 2017, INJURY, V48, P2189, DOI 10.1016/j.injury.2017.08.017; Ye Y, 2015, ORTHOPEDICS, V38, P625, DOI 10.3928/01477447-20151002-05	55	3	6	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2018	476	7					1468	1476		10.1097/01.blo.0000533627.07650.bb			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	GM9AM	WOS:000438532900019	29698292	Bronze, Green Published			2022-02-06	
J	Lowit, A; Ijitona, T; Kuschmann, A; Corson, S; Soraghan, J				Lowit, Anja; Ijitona, Tolulope; Kuschmann, Anja; Corson, Stephen; Soraghan, John			What does it take to stress a word? Digital manipulation of stress markers in ataxic dysarthria	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						stress production; dysarthria; ataxia; digital manipulation	TRAUMATIC BRAIN-INJURY; HYPOKINETIC DYSARTHRIA; FUNDAMENTAL-FREQUENCY; PARKINSONS-DISEASE; CONTRASTIVE STRESS; SENTENCE STRESS; SPEECH; INTELLIGIBILITY; SEGMENTATION; INTONATION	BackgroundStress production is important for effective communication, but this skill is frequently impaired in people with motor speech disorders. The literature reports successful treatment of these deficits in this population, thus highlighting the therapeutic potential of this area. However, no specific guidance is currently available to clinicians about whether any of the stress markers are more effective than others, to what degree they have to be manipulated, and whether strategies need to differ according to the underlying symptoms. AimsIn order to provide detailed information on how stress production problems can be addressed, the study investigated (1) the minimum amount of change in a single stress marker necessary to achieve significant improvement in stress target identification; and (2) whether stress can be signalled more effectively with a combination of stress markers. Methods & ProceduresData were sourced from a sentence stress task performed by 10 speakers with ataxic dysarthria and 10 healthy matched control participants. Fifteen utterances perceived as having incorrect stress patterns (no stress, all words stressed or inappropriate word stressed) were selected and digitally manipulated in a stepwise fashion based on typical speaker performance. Manipulations were performed on F0, intensity and duration, either in isolation or in combination with each other. In addition, pitch contours were modified for some utterances. A total of 50 naive listeners scored which word they perceived as being stressed. Outcomes & ResultsResults showed that increases in duration and intensity at levels smaller than produced by the control participants resulted in significant improvements in listener accuracy. The effectiveness of F0 increases depended on the underlying error pattern. Overall intensity showed the most stable effects. Modifications of the pitch contour also resulted in significant improvements, but not to the same degree as amplification. Integration of two or more stress markers did not result in better results than manipulation of individual stress markers, unless they were combined with pitch contour modifications. Conclusions & ImplicationsThe results highlight the potential for improvement of stress production in speakers with motor speech disorders. The fact that individual parameter manipulation is as effective as combining them will facilitate the therapeutic process considerably, as will the result that amplification at lower levels than seen in typical speakers is sufficient. The difference in results across utterance sets highlights the need to investigate the underlying error pattern in order to select the most effective compensatory strategy for clients.	[Lowit, Anja; Kuschmann, Anja] Strathclyde Univ, Sch Psychol Sci & Hlth, 40 George St, Glasgow G1 1QE, Lanark, Scotland; [Ijitona, Tolulope; Soraghan, John] Strathclyde Univ, Dept Elect & Elect Engn, Glasgow, Lanark, Scotland; [Corson, Stephen] Strathclyde Univ, Dept Math & Stat, Glasgow, Lanark, Scotland		Lowit, A (corresponding author), Strathclyde Univ, Sch Psychol Sci & Hlth, 40 George St, Glasgow G1 1QE, Lanark, Scotland.	a.lowit@strath.ac.uk		Ijitona, Tolulope Bamidele/0000-0003-1801-8201; Lowit, Anja/0000-0003-0842-584X; Kuschmann, Anja/0000-0001-5396-9008	Carnegie Trust for the Universities of Scotland [70484]; Ataxia UK	This work was supported by a grant from the Carnegie Trust for the Universities of Scotland (grant reference number 70484). The authors also thank Ataxia UK for its funding of the original collection of data on which this study is based. A final thanks to the speakers and listeners who gave up their time to participate in our experiments.	Cheang HS, 2007, J NEUROLINGUIST, V20, P221, DOI 10.1016/j.jneuroling.2006.07.001; COOPER WE, 1985, J ACOUST SOC AM, V77, P2142, DOI 10.1121/1.392372; DARKINS AW, 1988, BRAIN LANG, V34, P315, DOI 10.1016/0093-934X(88)90142-3; DEANE KH, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Dilley LC, 2008, J MEM LANG, V59, P294, DOI 10.1016/j.jml.2008.06.006; DOOLING DJ, 1974, J VERB LEARN VERB BE, V13, P255, DOI 10.1016/S0022-5371(74)80062-9; FINE J, 1991, J CHILD PSYCHOL PSYC, V32, P771, DOI 10.1111/j.1469-7610.1991.tb01901.x; FRY DB, 1958, LANG SPEECH, V1, P126, DOI 10.1177/002383095800100207; Hammen VL, 1996, J COMMUN DISORD, V29, P429, DOI 10.1016/0021-9924(95)00037-2; HAMMEN VL, 1994, J SPEECH HEAR RES, V37, P244, DOI 10.1044/jshr.3702.244; HARTELIUS L, 1997, J MED SPEECH-LANG PA, V5, P113; Kochanski G, 2005, J ACOUST SOC AM, V118, P1038, DOI 10.1121/1.1923349; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; Laver J., 1980, PHONETIC DESCRIPTION; Laver John., 1994, PRINCIPLES PHONETICS; LIEBERMAN P, 1960, J ACOUST SOC AM, V32, P451, DOI 10.1121/1.1908095; LISS JM, 1994, CLIN LINGUIST PHONET, V8, P45, DOI 10.1080/02699209408985574; Lowit A, 2014, J COMMUN DISORD, V50, P8, DOI 10.1016/j.jcomdis.2014.03.002; Lowit A, 2012, J SPEECH LANG HEAR R, V55, P1472, DOI 10.1044/1092-4388(2012/11-0263); Lowit A, 2010, J MED SPEECH-LANG PA, V18, P77; Mattys SL, 1997, J MEM LANG, V36, P87, DOI 10.1006/jmla.1996.2472; McHenry M, 1998, BRAIN INJURY, V12, P495, DOI 10.1080/026990598122458; MORTON J, 1965, LANG SPEECH, V8, P159, DOI 10.1177/002383096500800303; Patel R, 2009, J SPEECH LANG HEAR R, V52, P206, DOI 10.1044/1092-4388(2008/07-0078); Ramig Lorraine Olson, 2004, Seminars in Speech and Language, V25, P169; RIETVELD ACM, 1985, J PHONETICS, V13, P299, DOI 10.1016/S0095-4470(19)30761-2; Rothermich K, 2012, NEUROPSYCHOLOGIA, V50, P232, DOI 10.1016/j.neuropsychologia.2011.10.025; SIMMONS N, 1983, CLIN DYSARTHRIA, P283; Terken J., 1987, LANG COGNITIVE PROC, V2, P145, DOI 10.1080/01690968708406928; Tjaden K, 2014, J SPEECH LANG HEAR R, V57, P779, DOI 10.1044/2014_JSLHR-S-12-0372; Tykalova T, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.07.001; Van Nuffelen G, 2010, FOLIA PHONIATR LOGO, V62, P110, DOI 10.1159/000287209; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Watson PJ, 2006, J SPEECH LANG HEAR R, V49, P636, DOI 10.1044/1092-4388(2006/040); YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; YORKSTON KM, 1984, DYSARTHRIA PHYSL ACO, P131; [No title captured]	37	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JUL-AUG	2018	53	4					875	887		10.1111/1460-6984.12396			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GM7EK	WOS:000438342100016	29774624	Green Accepted			2022-02-06	
J	Marsac, ML; Weiss, D; Kohser, KL; Van Allen, J; Seegan, P; Ostrowski-Delahanty, S; McGar, A; Winston, FK; Kassam-Adams, N				Marsac, M. L.; Weiss, D.; Kohser, K. L.; Van Allen, J.; Seegan, P.; Ostrowski-Delahanty, S.; McGar, A.; Winston, F. K.; Kassam-Adams, N.			The Cellie Coping Kit for Children with Injury: Initial feasibility, acceptability, and outcomes	CHILD CARE HEALTH AND DEVELOPMENT			English	Article						child injury; early intervention; parenting; posttraumatic stress; quality of life	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS; UNINTENTIONAL-INJURY; PEDIATRIC INJURY; INTERVENTION; ASSISTANCE; PARENTS; ADOLESCENTS	PurposePhysical and psychological challenges can arise from paediatric injury, which can impact child health outcomes. Evidence-based resources to promote recovery are limited. The low cost, portable Cellie Coping Kit for Children with Injury provides evidence-based strategies to help children manage injury-related challenges. This study aimed to describe intervention feasibility and explore initial outcomes (learning, quality of life [QOL], and trauma symptoms). MethodsThree independent pilot studies were conducted. Child-parent dyads (n=61) participated in the intervention; similar to 36% completed a 4-week follow-up assessment. ResultsResults suggested that the intervention was feasible (e.g., 95% of parents would recommend the intervention; >85% reported that it was easy to use). Over 70% of participants reported learning new skills. No statistically significant differences were detected for children's QOL or trauma symptoms preintervention to postintervention. ConclusionPreliminary research suggests that the Cellie Coping Kit for Children with Injuries is a feasible, low-cost, preventive intervention, which may provide families with strategies to promote recovery from paediatric injury. Future research, including a randomized controlled trial, ought to further examine targeted long-term intervention outcomes.	[Marsac, M. L.; Weiss, D.; Kohser, K. L.; Winston, F. K.; Kassam-Adams, N.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Marsac, M. L.; Winston, F. K.; Kassam-Adams, N.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marsac, M. L.; McGar, A.] Kentucky Childrens Hosp, Dept Pediat, Lexington, KY USA; [Marsac, M. L.] Univ Kentucky, Coll Med, Lexington, KY USA; [Van Allen, J.; Seegan, P.] Texas Tech Univ, Dept Psychol, Lubbock, TX 79409 USA; [Ostrowski-Delahanty, S.] Akron Childrens Hosp, NeuroDev Sci Ctr, Akron, OH USA		Marsac, ML (corresponding author), Univ Kentucky, Coll Med, Kentucky Childrens Hosp, 800 Rose St,MN 472, Lexington, KY 40536 USA.	meghan.marsac@uky.edu		Kassam-Adams, Nancy/0000-0001-7412-1428	Department of Child and Adolescent Psychiatry and Behavioral Sciences at CHOP	Department of Child and Adolescent Psychiatry and Behavioral Sciences at CHOP	Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Alisic E, 2012, CLIN PEDIATR, V51, P274, DOI 10.1177/0009922811423309; Berkowitz SJ, 2011, J CHILD PSYCHOL PSYC, V52, P676, DOI 10.1111/j.1469-7610.2010.02321.x; Blount R., 2003, MANAGEMENT PEDIAT PA; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Centers for Disease Control and Prevention (CDC), 2014, WEB BAS INJ STAT QUE; Cox CM, 2010, J PEDIATR PSYCHOL, V35, P581, DOI 10.1093/jpepsy/jsp095; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eberhardt M., 2001, URBAN RURAL HLTH CHA; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gordon BK, 2016, J CHILD HEALTH CARE, V20, P214, DOI 10.1177/1367493514565409; Kassam-Adams N, 2016, J PEDIATR PSYCHOL, V41, P138, DOI 10.1093/jpepsy/jsv057; Kassam-Adams N, 2015, PEDIATR EMERG CARE, V31, P737, DOI 10.1097/PEC.0000000000000595; Kassam-Adams N, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.22757; Kassam-Adams N, 2013, JAMA PEDIATR, V167, P1158, DOI 10.1001/jamapediatrics.2013.2741; Landolt MA, 2009, J PEDIATR PSYCHOL, V34, P14, DOI 10.1093/jpepsy/jsm088; Marsac M, 2014, CLIN PRACT PEDIAT PS, V4, P10; Marsac ML, 2013, CHILD CARE HLTH DEV, V39, P171, DOI 10.1111/j.1365-2214.2011.01328.x; Marsac ML, 2014, CLIN CHILD PSYCHOL P, V19, P233, DOI 10.1177/1359104513487000; Marsac ML, 2013, J PEDIATR PSYCHOL, V38, P1101, DOI 10.1093/jpepsy/jst053; Marsac ML, 2012, SUPPORT CARE CANCER, V20, P3315, DOI 10.1007/s00520-012-1475-y; Marsac ML, 2011, FAM SYST HEALTH, V29, P279, DOI 10.1037/a0026465; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P272, DOI 10.1176/appi.neuropsych.15030073; Newberry A, 2010, J NEUROSCI NURS, V42, P47, DOI 10.1097/JNN.0b013e3181c1fdd9; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Ramsdell KD, 2016, J TRAUMA NURS, V23, P194, DOI 10.1097/JTN.0000000000000217; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Stoddard FJ, 2001, J AM ACAD CHILD PSY, V40, P1128, DOI 10.1097/00004583-200110000-00007; Stoddard FJ, 2006, AM J PSYCHIAT, V163, P1084, DOI 10.1176/appi.ajp.163.6.1084; Tarnowski K. J., 2009, HDB PEDIAT PSYCHOL, P420; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003	35	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1862	1365-2214		CHILD CARE HLTH DEV	Child Care Health Dev.	JUL	2018	44	4					599	606		10.1111/cch.12565			8	Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics	GJ5SD	WOS:000435441700011	29656405				2022-02-06	
J	Pape, TLB; Smith, B; Babcock-Parziale, J; Evans, CT; Herrold, AA; Maieritsch, KP; High, WM				Pape, Theresa Louise Bender; Smith, Bridget; Babcock-Parziale, Judith; Evans, Charlesnika T.; Herrold, Amy A.; Maieritsch, Kelly Phipps; High, Walter M., Jr.			Diagnostic Accuracy of the Veteran Affairs' Traumatic Brain Injury Screen	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Mass screening; Rehabilitation; Sensitivity and specificity; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TBI IDENTIFICATION METHOD; ADMINISTERED PTSD SCALE; SUBSTANCE USE DISORDERS; MENTAL-HEALTH-SERVICES; PREDICTIVE-VALIDITY; CROSS-VALIDATION; ENDURING FREEDOM; IRAQI FREEDOM; PREVALENCE	Objective: To comprehensively estimate the diagnostic accuracy and reliability of the Department of Veterans Affairs (VA) Traumatic Brain Injury (TBI) Clinical Reminder Screen (TCRS). Design: Cross-sectional, prospective, observational study using the Standards for Reporting of Diagnostic Accuracy criteria. Setting: Three VA Polytrauma Network Sites. Participants: Operation Iraqi Freedom, Operation Enduring Freedom veterans (N=433). Main Outcome Measures: TCRS, Comprehensive TBI Evaluation, Structured TBI Diagnostic Interview, Symptom Attribution and Classification Algorithm, and Clinician-Administered Posttraumatic Stress Disorder (PTSD) Scale. Results: Forty-five percent of veterans screened positive on the TCRS for TBI. For detecting occurrence of historical TBI, the TCRS had a sensitivity of .56 to .74, a specificity of .63 to .93, a positive predictive value (PPV) of 25% to 45%, a negative predictive value (NPV) of 91% to 94%, and a diagnostic odds ratio (DOR) of 4 to 13. For accuracy of attributing active symptoms to the TBI, the TCRS had a sensitivity of .64 to .87, a specificity of .59 to .89, a PPV of 26% to 32%, an NPV of 92% to 95%, and a DOR of 6 to 9. The sensitivity was higher for veterans with PTSD (.80-.86) relative to veterans without PTSD (.57-.82). The specificity, however, was higher among veterans without PTSD (.75-.81) relative to veterans with PTSD (.36-.49). All indices of diagnostic accuracy changed when participants with questionably valid (QV) test profiles were eliminated from analyses. Conclusions: The utility of the TCRS to screen for mild TBI (mTBI) depends on the stringency of the diagnostic reference standard to which it is being compared, the presence/absence of PTSD, and QV test profiles. Further development, validation, and use of reproducible diagnostic algorithms for symptom attribution after possible mTBI would improve diagnostic accuracy. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Pape, Theresa Louise Bender; Herrold, Amy A.] Edward Hines Jr VA Hosp, Res Serv, Dept Vet Affairs VA, Hines, IL USA; [Pape, Theresa Louise Bender; Smith, Bridget; Evans, Charlesnika T.; Herrold, Amy A.] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, VA, Hines, IL USA; [Pape, Theresa Louise Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Smith, Bridget] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Babcock-Parziale, Judith] Southern Arizona VA Hlth Care Syst, Tucson, AZ USA; [Evans, Charlesnika T.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Evans, Charlesnika T.] Northwestern Univ, Ctr Healthcare Studies, Inst Publ Hlth & Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Herrold, Amy A.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Maieritsch, Kelly Phipps] Edward Hines Jr VA Hosp, Mental Hlth Serv, Dept Vet Affairs, Hines, IL USA; [High, Walter M., Jr.] Lexington VA Med Ctr, Somerset, KY USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY USA; [High, Walter M., Jr.] Univ Kentucky, Coll Med, Dept Psychol, Lexington, KY USA		Pape, TLB (corresponding author), 5000 S 5th Ave MC 151H, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	United States Department of Veterans Affairs Health Services Research and Development ServiceUS Department of Veterans Affairs [08-377]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	Supported by a Service-Directed Research Award (no. 08-377) from the United States Department of Veterans Affairs Health Services Research and Development Service. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arbisi P. A., 2006, PSYCHOL SERV, V3, P249, DOI DOI 10.1037/1541-1559.3.4.249; Arbisi PA, 2012, PSYCHOL ASSESSMENT, V24, P1034, DOI 10.1037/a0028014; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blake DD., CLIN ADM PTSD SCALE; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bossuyt PMM, 2008, SEMIN HEMATOL, V45, P189, DOI 10.1053/j.seminhematol.2008.04.001; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gordis L, 2009, EPIDEMIOLOGY; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Institute of Medicine (IOM), 2010, RET HOM IR AFGH PREL; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olson-Madden JH, 2013, COMMUNITY MENT HLT J, V49, P220, DOI 10.1007/s10597-012-9572-4; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; United States Government Accountability Office, 2008, VA HEALTHC MILD TRAU; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Zollman FS, 2014, J HEAD TRAUMA REHAB, V29, P99, DOI 10.1097/HTR.0b013e318294dd37	47	3	3	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2018	99	7					1370	1382		10.1016/j.apmr.2017.11.017			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GL9JZ	WOS:000437552100015	29355506				2022-02-06	
J	Rausch, M; Simon, JE; Starkey, C; Grooms, DR				Rausch, Matthew; Simon, Janet E.; Starkey, Chad; Grooms, Dustin R.			Smartphone virtual reality to increase clinical balance assessment responsiveness	PHYSICAL THERAPY IN SPORT			English	Article						Postural control; Postural stability; Balance error scoring system; Athlete screening	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; POSTURAL STABILITY; CEREBRAL CONCUSSION; RECOVERY; TOOL	Objective: To determine if a low cost smartphone based, clinically applicable virtual reality (VR) modification to the standard Balance Error Scoring System (BESS) can challenge postural stability beyond the traditional BESS. Design: Cross-sectional study. Setting: University research laboratory. Participants: 28 adults (mean age 23.36 +/- 2.38 years, mean height 1.74 m +/- 0.13, mean weight 77.95 kg +/- 16.63). Main outcome measures: BESS postural control errors and center of pressure (CoP) velocity were recorded during the BESS test and a VR modified BESS (VR-BESS). The VR-BESS used a headset and phone to display a rollercoaster ride to induce a visual and vestibular challenge to postural stability. Results: The VR-BESS significantly increased total errors (20.93 vs. 11.42, p<0.05) and CoP velocity summed across all stances and surfaces (52.96 cm/s vs. 37.73 cm/s, p < 0.05) beyond the traditional BESS. Conclusion: The VR-BESS provides a standardized, and effective way to increase postural stability challenge in the clinical setting. The VR-BESS can use any smartphone technology to induce postural stability deficits that may otherwise normalize with traditional testing. Thus, providing a unique relatively inexpensive and simple to operate clinical assessment tool and/or training stimulus. (C) 2018 Elsevier Ltd. All rights reserved.	[Rausch, Matthew; Simon, Janet E.; Starkey, Chad; Grooms, Dustin R.] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Grooms, Dustin R.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA		Grooms, DR (corresponding author), 1 Ohio Univ, Grover Ctr E156, Athens, OH 45701 USA.	groomsd@ohio.edu	Grooms, Dustin/AAO-8917-2021; Starkey, Chad A/I-9466-2012	Grooms, Dustin/0000-0001-6102-8224; 			Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Caccese JB, 2016, J APPL BIOMECH, V32, P329, DOI 10.1123/jab.2015-0273; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kim Kyung-Min, 2017, J Sport Rehabil, V26, DOI 10.1123/jsr.2017-0035; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2008, J SPORT REHABIL, V17, P38, DOI 10.1123/jsr.17.1.38; Nolin P, 2012, BRAIN INJURY, V26, P1564, DOI 10.3109/02699052.2012.698359; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Valovich TC, 2003, J ATHL TRAINING, V38, P51	18	3	3	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JUL	2018	32						207	211		10.1016/j.ptsp.2018.05.017			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GM5MA	WOS:000438180300030	29803943				2022-02-06	
J	Sone, JY; Lamb, SCK; Techar, K; Dammavalam, V; Uppal, M; Williams, C; Bergman, T; Tupper, D; Ort, P; Samadani, U				Sone, Je Yeong; Lamb, S. Courtney-Kay; Techar, Kristina; Dammavalam, Vikalpa; Uppal, Mohit; Williams, Cedric; Bergman, Thomas; Tupper, David; Ort, Paul; Samadani, Uzma			High prevalence of prior contact sports play and concussion among orthopedic and neurosurgical department chairs	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; contact sports; surgeon; resilience; benefits; trauma	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; PARTICIPATION; RISK; ASSOCIATION; YOUTH; LIFE; POPULATION; COLLEGIATE	OBJECTIVE Increased understanding of the consequences of traumatic brain injury has heightened concerns about youth participation in contact sports. This study investigated the prevalence of high school and collegiate contact sports play and concussion history among surgical department chairs. METHODS A cross-sectional survey was administered to 107 orthopedic and 74 neurosurgery chairs. Responses were compared to published historical population norms for contact sports (high school 27.74%, collegiate 1.44%), football (high school 10.91%, collegiate 0.76%), and concussion prevalence (12%). One-proportion Z-tests, chi-square tests, and binary logistic regression were used to analyze differences. RESULTS High school contact sports participation was 2.35-fold higher (65.3%, p < 0.001) for orthopedic chairs and 1.73-fold higher (47.9%, p = 0.0018) for neurosurgery chairs than for their high school peers. Collegiate contact sports play was 31.0-fold higher (44.7%, p < 0.001) for orthopedic chairs and 15.1-fold higher (21.7%, p < 0.001) for neurosurgery chairs than for their college peers. Orthopedic chairs had a 4.30-fold higher rate of high school football participation (46.9%, p < 0.001) while neurosurgery chairs reported a 3.05-fold higher rate (33.3%, p < 0.001) than their high school peers. Orthopedic chairs reported a 28.1-fold higher rate of collegiate football participation (21.3%, p < 0.001) and neurosurgery chairs reported an 8.58-fold higher rate (6.5%, p < 0.001) compared to their college peers. The rate at which orthopedic (42.6%, p < 0.001) and neurosurgical (42.4%, p < 0.001) chairs reported having at least 1 concussion in their lifetime was significantly higher than the reported prevalence in the general population. After correction for worst possible ascertainment bias, all results except high school contact sports participation remained significant. CONCLUSIONS The high prevalence of youth contact sports play and concussion among surgical specialty chairs affirms that individuals in careers requiring high motor and cognitive function frequently played contact sports. The association highlights the need to further examine the relationships between contact sports and potential long-term benefits as well as risks of sport-related injury.	[Sone, Je Yeong] NYU, Dept Chem, Coll Arts & Sci, New York, NY USA; [Ort, Paul] NYU, Sch Med, Dept Orthoped, VA NY Harbor Healthcare, New York, NY USA; [Lamb, S. Courtney-Kay] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Techar, Kristina; Dammavalam, Vikalpa; Uppal, Mohit; Williams, Cedric; Bergman, Thomas; Samadani, Uzma] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Techar, Kristina; Dammavalam, Vikalpa; Uppal, Mohit; Williams, Cedric; Bergman, Thomas; Samadani, Uzma] Hennepin Cty Med Ctr, Dept Surg, Minneapolis, MN 55415 USA; [Tupper, David] Hennepin Cty Med Ctr, Sect Neuropsychol, Minneapolis, MN 55415 USA; [Samadani, Uzma] Minneapolis VA Med Ctr, Surg, Minneapolis, MN USA		Samadani, U (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA.	uzma@samadani.com		Sone, Je Yeong/0000-0002-6451-4401	Integra; AbbottAbbott Laboratories	Uzma Samadani is a consultant to Abbott Laboratories, Medtronic Public Limited Company, Integra, and the National Football League; has grant funding from Integra and Abbott and equity in Oculogica, Inc. She has intellectual properties related to concussion and dementia diagnosis and brain injury treatment held by NYU School of Medicine, VA NY Harbor Healthcare, and Hennepin County Medical Center. She has had honoraria from Wisconsin, Minnesota, and Texas High School Coaches Associations, USA Football, continuing legal education conferences, National Neurotrauma Symposium, and the North America Brain Injury Symposium. David Tupper has received royalties for published books from Oxford University Press and Guilford Publishers, travel expenses and honorarium from the American Academy of Clinical Neuropsychology, honorarium from Psychiatric Annals, and institution grant funding for the Brain in Kidney Disease (BRINK) study.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Blue Cross Blue Shield Association, 2016, STEEP RIS CONC DISGN; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Council on Sports Medicine and Fitness of the American Academy of Pediatrics, 2015, PEDIATRICS, V136, pe1419; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dobosz RP, 1999, ADOLESCENCE, V34, P215; Esteban-Cornejo I, 2014, J PEDIATR-US, V165, P306, DOI 10.1016/j.jpeds.2014.04.044; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Fleiss JH., 1981, STAT METHODS RATES P; Fraser-Thomas J. L., 2005, Physical Education and Sport Pedagogy, V10, P19, DOI 10.1080/1740898042000334890; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Glatter R, 2015, FORBES; Hatfield DP, 2017, HEALTH PROMOT PRACT, V18, P75, DOI 10.1177/1524839916642714; Hebert JJ, 2017, MAYO CLIN PROC, V92, P57, DOI 10.1016/j.mayocp.2016.08.013; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Irick E., 2015, NCAA SPORTS SPONSORS; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kniffin KM, 2015, J LEADERSH ORG STUD, V22, P217, DOI 10.1177/1548051814538099; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; National Federation of State High School Associations, 1969 2014 HIGH SCH A; Omalu B, 2015, NY TIMES, pA23; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Stephens L. J., 2002, NASSP B, V86, P34, DOI [DOI 10.1177/019263650208663005, 10.1177/019263650208663005]; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; U.S. Census Bureau, 1999, STAT ABSTR US 1999; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	39	3	3	2	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2018	22	1					1	8		10.3171/2018.1.PEDS17640			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GL7YL	WOS:000437425100001	29701560	Bronze			2022-02-06	
J	Wasserman, EB; Herzog, MM; Collins, CL; Morris, SN; Marshall, SW				Wasserman, Erin B.; Herzog, Mackenzie M.; Collins, Christy L.; Morris, Sarah N.; Marshall, Stephen W.			Fundamentals of Sports Analytics	CLINICS IN SPORTS MEDICINE			English	Article						Epidemiology; Study design; Analytics; Sports performance; Injury occurrence	INJURY SURVEILLANCE SYSTEMS; WORKLOAD RATIO; PROFESSIONAL SOCCER; POSTURAL STABILITY; RISK; LEAGUE; TOOL; CONCUSSION; PREVENTION; FOOTBALL	Recently, the importance of statistics and analytics in sports has increased. This article describes measures of sports injury and fundamentals of sports injury research with a brief overview of some of the emerging measures of sports performance. The authors describe research study designs that can be used to identify risk factors for injury, injury surveillance programs, and common measures of injury risk and association. Finally, we describe measures of physical performance and training and considerations for using these measures. This article provides sports medicine clinicians with an understanding of current research measures and considerations for designing sports injury research studies.	[Wasserman, Erin B.; Collins, Christy L.; Morris, Sarah N.] Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA; [Herzog, Mackenzie M.] Univ North Carolina Chapel Hill, Dept Epidemiol, Suite 500,Bank Amer Bldg 7505, Chapel Hill, NC 27599 USA; [Herzog, Mackenzie M.] IQVIA, Real World Evidence, 4820 Emperor Blvd, Durham, NC 27703 USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Dept Epidemiol, Suite 500,Bank Amer Bldg 7505, Chapel Hill, NC 27599 USA		Wasserman, EB (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	ewasserman@datalyscenter.org		Wasserman, Erin/0000-0001-5957-5878			[Anonymous], REC GUID APPR MED CO; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P288, DOI 10.1136/bjsm.2004.013391; Bryant DM, 2009, J BONE JOINT SURG AM, V91A, P10, DOI 10.2106/JBJS.H.01597; Colby MJ, 2014, J STRENGTH COND RES, V28, P2244, DOI 10.1519/JSC.0000000000000362; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Ehrmann FE, 2016, J STRENGTH COND RES, V30, P360, DOI 10.1519/JSC.0000000000001093; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Finch CF, 2014, BRIT J SPORT MED, V48, P1276, DOI 10.1136/bjsports-2012-091729; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gray AD, 2017, SPORTS HEALTH, V9, P537, DOI 10.1177/1941738117726323; Hamilton GM, 2011, CLIN J SPORT MED, V21, P508, DOI 10.1097/JSM.0b013e31822e8619; Hulin BT, 2016, BRIT J SPORT MED, V50, P1008, DOI 10.1136/bjsports-2015-095364; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kobusingye, 2001, INJURY SURVEILLANCE; Kooistra B, 2009, J BONE JOINT SURG AM, V91A, P21, DOI 10.2106/JBJS.H.01573; Malone S, 2017, INT J SPORT PHYSIOL, V12, P393, DOI 10.1123/ijspp.2016-0090; Malone S, 2017, J SCI MED SPORT, V20, P561, DOI 10.1016/j.jsams.2016.10.014; Mara JK, 2015, INT J SPORT PHYSIOL, V10, P664, DOI 10.1123/ijspp.2014-0345; McLeod TCV, 2012, J ATHL TRAINING, V47, P557, DOI 10.4085/1062-6050-47.5.05; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Nassis George P, 2017, Br J Sports Med, V51, P486, DOI 10.1136/bjsports-2016-095988; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rothman K.J., 2008, Modern epidemiology, V3rd; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; vanMechelen W, 1997, SPORTS MED, V24, P164, DOI 10.2165/00007256-199724030-00003; Wacholder S, 1996, EPIDEMIOLOGY, V7, P144, DOI 10.1097/00001648-199603000-00007	37	3	3	3	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JUL	2018	37	3					387	+		10.1016/j.csm.2018.03.007			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GN2NR	WOS:000438835300004	29903381				2022-02-06	
J	Yglesias, B; Andrews, K; Hamilton, R; Lea, J; Shah, R; Ebraheim, N				Yglesias, Benjamin; Andrews, Kyle; Hamilton, Ryan; Lea, Justin; Shah, Ronit; Ebraheim, Nabil			Case report: irreducible medial subtalar dislocation with incarcerated anterior talar head fracture in a young patient	JOURNAL OF SURGICAL CASE REPORTS			English	Article								Subtalar dislocations are rare injuries that typically occur from high-energy injuries. All subtalar dislocations should be attempted to be closed reduced, however, similar to 32% are irreducible requiring open reduction. We present an irreducible medial subtalar dislocation following a motor vehicle accident with no associated fractures demonstrated on radiograph. However, open reduction revealed an incarcerated anterior talar head fracture that was reduced and stabilized with retrograde K-wires.	[Yglesias, Benjamin; Andrews, Kyle; Hamilton, Ryan; Lea, Justin; Shah, Ronit; Ebraheim, Nabil] Univ Toledo, Coll Med & Life Sci, Dept Orthopaed Surg, Toledo, OH 43614 USA		Andrews, K (corresponding author), Univ Toledo, Med Ctr, Dept Orthopaed Surg, 3000 Arlington Ave, Toledo, OH 43614 USA.	kyle.andrews3@utoledo.edu		Andrews, Kyle/0000-0001-5358-9515			Bibbo C, 2003, FOOT ANKLE INT, V24, P158, DOI 10.1177/107110070302400210; DELEE JC, 1982, J BONE JOINT SURG AM, V64, P433, DOI 10.2106/00004623-198264030-00014; Fotiadis Elias, 2009, Cases J, V2, P8793, DOI 10.4076/1757-1626-2-8793; Giannoulis D, 2015, WORLD J ORTHOP, V6, P374, DOI 10.5312/wjo.v6.i3.374; Heck BE, 1996, FOOT ANKLE INT, V17, P103, DOI 10.1177/107110079601700208; Hui SH, 2016, BMJ CASE REP, P1; Perugia D, 2002, INT ORTHOP, V26, P56, DOI 10.1007/s002640100296; Stafford H, 2013, BMJ CASE REP, P1; Teo AQA, 2017, J FOOT ANKLE SURG, V56, P1279, DOI 10.1053/j.jfas.2017.04.032; Wagner Richard, 2004, Injury, V35 Suppl 2, pSB36	10	3	3	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2042-8812			J SURG CASE REP	J. Surg. Case Rep.	JUL	2018		7								10.1093/jscr/rjy168			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	GP6DU	WOS:000440968100024	30046437	Green Published, Green Submitted, gold			2022-02-06	
J	Young, S; Gonzalez, RA; Fridman, M; Hodgkins, P; Kim, K; Gudjonsson, GH				Young, Susan; Gonzalez, Rafael A.; Fridman, Moshe; Hodgkins, Paul; Kim, Keira; Gudjonsson, Gisli H.			Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury	BMC PSYCHIATRY			English	Article						Attention deficit/hyperactivity disorder; Head injury; Traumatic brain injury; Prison population; Health-related quality of life; Co-morbidity	TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE-USE; PREVALENCE; INMATES; ADHD; METAANALYSIS; SAMPLE; SYMPTOMS; CHILDREN	Background: Attention-deficit hyperactivity disorder (ADHD) and head injury (including traumatic brain injury (TBI)) manifest in high levels across prison samples and guidance from the National Institute for Health and Care Excellence notes that people with acquired brain injury may have increased prevalence of ADHD. We aimed to examine the association of ADHD with TBI and the impact of the association upon health-related quality of life (HRQoL) and service use among imprisoned adults. Methods: An observational study was performed in 2011-2013, at Porterfield Prison, Inverness, United Kingdom (UK). The all male sample included 390 adult prison inmates with capacity to consent and no history of moderate or severe intellectual disability. Head injury was measured with a series of self-reported questions, addressing history of hits to the head: frequency, severity, loss of consciousness (LOC), and sequelae. Participants were interviewed using the Diagnostic Interview for ADHD in Adults 2.0. The Health Utilities Index Mark 3 was used to measure health status, and to calculate attribute specific HRQoL and Quality-Adjusted Life Year (QALY) scores. Results: 72% of prisoners sampled reported at least one head injury in their lifetime. Among those, 70% of head injuries occurred before age 16 and 70% experienced LOC. Prisoners with ADHD were nearly twice more likely to have TBI. Prisoners with ADHD-only and ADHD with co-morbid TBI had significantly lower scores in several HRQoL attributes, compared with TBI only or the absence of either condition. Adjusted logistic regression models indicated an average reduction of 0.20 QALYs in inmates with ADHD-only and 0.30 QALY loss in those with ADHD with co-morbid TBI compared with inmates with neither condition. Conclusions: There is a robust association between ADHD and TBI, and ADHD with co-morbid TBI confers significantly greater impairment in terms of HRQoL. Managing the short and long-term consequences of TBI is essential to improving care for prisoners and to addressing the criminogenic factors related to them.	[Young, Susan] Psychol Serv Ltd, POB 1735, Croydon CR97AE, England; [Young, Susan; Gudjonsson, Gisli H.] Reykjavik Univ, Reykjavik, Iceland; [Gonzalez, Rafael A.] East London NHS Fdn Trust, East London, England; [Fridman, Moshe] AMF Consulting Inc, Los Angeles, CA USA; [Hodgkins, Paul] Sage Therapeut, Cambridge, MA USA; [Gudjonsson, Gisli H.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England		Young, S (corresponding author), Psychol Serv Ltd, POB 1735, Croydon CR97AE, England.; Young, S (corresponding author), Reykjavik Univ, Reykjavik, Iceland.	suzyyoung@aol.com		Young, Susan/0000-0002-8494-6949	Shire Pharmaceutical Development Limited	This study was funded by Shire Pharmaceutical Development Limited, but the funder had no role in the design of the study, data collection, analysis, interpretation of data, and writing the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Barkley R.A., 2011, BARKLEY ADULT ADHD R; Barkley RA., 2010, J ADHD RELATED DISOR, V1, P5, DOI DOI 10.1176/APPI.AIP.2010.10081172; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Coghill D, 2015, EUR CHILD ADOLESC PS; Comai S, 2016, PROG NEURO-PSYCHOPH, V70, P8, DOI 10.1016/j.pnpbp.2016.04.012; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gonzalez RA, 2016, J ATTEN DISORD, V20, P368, DOI 10.1177/1087054713493322; Gonzalez RA, 2015, J ATTEN DISORD, V19, P301, DOI 10.1177/1087054712461690; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kind P, 1999, POPULATION NORMS EQ; Klassen AF, 2004, PEDIATRICS, V114, pE541, DOI 10.1542/peds.2004-0844; Kooij J. J. S., 2010, ADULT ADHD DIAGNOSTI; Larsson H, 2014, J CHILD PSYCHOL PSYC, V55, P428, DOI 10.1111/jcpp.12140; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; National Institute for Health and Care Excellence, 2018, NICE GUID NG87; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Retz W, 2004, EUR ARCH PSY CLIN N, V254, P201, DOI 10.1007/s00406-004-0470-9; Riley AW, 2006, EUR CHILD ADOLES PSY, V15, P38, DOI 10.1007/s00787-006-1006-9; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Satterfield JH, 2007, J AM ACAD CHILD PSY, V46, P601, DOI 10.1097/chi.0b013e318033ff59; Scott Long J., 1997, REGRESSION MODELS CA, V7; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sobanski E, 2007, EUR ARCH PSY CLIN N, V257, P371, DOI 10.1007/s00406-007-0712-8; StataCorp, 2013, STATA STAT SOFTW REL; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Velez-Pastrana MC, 2016, PSYCHOL ASSESSMENT, V28, P483, DOI 10.1037/pas0000171; Wechsler D., 2011, WECHSLER ABBREVIATED; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Young S, 2016, PSYCHOL MED, V46, P1449, DOI 10.1017/S0033291716000039; Young S, 2015, PSYCHOL MED, V45, P2499, DOI 10.1017/S0033291715000598; Young S, 2015, PSYCHOL MED, V45, P247, DOI 10.1017/S0033291714000762	45	3	3	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	JUN 22	2018	18								209	10.1186/s12888-018-1785-9			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GK2IB	WOS:000435950300003	29929487	Green Published, gold			2022-02-06	
J	Taylor, DN; Wynd, S				Taylor, David N.; Wynd, Shari			Survey of chiropractic clinicians on self-reported knowledge and recognition of concussion injuries	CHIROPRACTIC & MANUAL THERAPIES			English	Article						Chiropractic; Brain concussion; Knowledge; Diagnosis; Surveys and questionnaires; traumatic brain injuries	TRAUMATIC BRAIN-INJURIES; FAMILY PHYSICIANS; MANAGEMENT; MILD; PEDIATRICIANS	Background: There has been little study of the recognition of mild traumatic brain injury (MTBI) by the chiropractic practitioner, or of the inquiry by the clinician to assess those patients who may be suffering from the condition, but fail to report the symptoms. Although severe cases of TBI are more often recognized and treated by attendance to hospital or emergency room, MTBI is less recognizable and would present a long-term risk to the patient. Given the clinical risk associated with failure to recognize such injuries, training of the clinician in the subtle signs of MTBI is imperative. What we currently know about training in the recognition of MTBI is from limited recent knowledge based studies. This study is intended to assess the self-reported mild traumatic brain injury (MTBI) knowledge, recognition and treatment by chiropractic practitioners. Methods: A previously published standardized set of survey items was distributed to a captive audience of chiropractic practitioners at the July 2016 Texas Chiropractic College annual symposium. The sample population was a convenience sample of chiropractic clinicians who were assessed for MTBI knowledge and common practices. Results: There was a response rate of 43% of the 125 attendees. The survey demonstrated confidence in MTBI diagnosis. Average MTBI knowledge and recognition score was only 27% +/- 22%. Frequency of MTBI patients presenting to the chiropractic clinician office was an average of less than one per month. Sixty nine percent (69%) of the clinicians relied upon their history and clinical exam for diagnosis. There was no knowledge of the Balance Error Scoring system and only 20% utilized the Standardized Concussion Assessment Tool (SCAT). The primary action of the chiropractic clinician who suspected MTBI was to refer to a neurological specialist (76%). A small minority of practitioners would provide treatment. Conclusions: There is an overconfidence of the chiropractic practitioner in recognition of MTBI which is incongruent with the low knowledge scores. Further education of the chiropractic clinician is warranted.	[Taylor, David N.] Texas Chiropract Coll, Dept Clin Sci, 5912 Spencer Highway, Pasadena, TX 77505 USA; [Wynd, Shari] Texas Chiropract Coll, Dept Basic Sci, 5912 Spencer Highway, Pasadena, TX 77505 USA		Taylor, DN (corresponding author), Texas Chiropract Coll, Dept Clin Sci, 5912 Spencer Highway, Pasadena, TX 77505 USA.	dtaylor@txchiro.edu	Wynd, Shari E/E-8948-2017	Wynd, Shari E/0000-0002-8523-5137			[Anonymous], 2017, CLEMSON SPORT MANAGE; [Anonymous], CONC HIGH SCH SPORTS; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; DALBY BJ, 1993, J MANIP PHYSIOL THER, V16, P392; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goodman B VB, 2013, NEUROLOGY S, V80; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Kazemi Mohsen, 2016, J Can Chiropr Assoc, V60, P273; Kerr Z, 2015, AM J SPORTS MED, V20, P1; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Moreau WJ, 2015, J CHIROPR MED, V14, P169, DOI 10.1016/j.jcm.2015.08.003; Olson HM, 2016, J CHIROPR MED, V15, P208, DOI 10.1016/j.jcm.2016.04.006; Olson HLS, 2016, ACC RAC C WASH DC; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Taylor DN, 2017, J CHIROPR MED, V16, P19, DOI 10.1016/j.jcm.2016.10.005; Thomas R., 2015, C TRAUM BRAIN INJ US	25	3	3	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2045-709X		CHIROPR MAN THER	Chiropr. Man. Ther.	JUN 14	2018	26								19	10.1186/s12998-018-0186-y			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	GJ4PT	WOS:000435363700001	29946418	Green Published, gold			2022-02-06	
J	Faw, TD; Lerch, JK; Thaxton, TT; Deibert, RJ; Fisher, LC; Basso, DM				Faw, Timothy D.; Lerch, Jessica K.; Thaxton, Tyler T.; Deibert, Rochelle J.; Fisher, Lesley C.; Basso, D. Michele			Unique Sensory and Motor Behavior in Thy1-GFP-M Mice before and after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						locomotor function; rehabilitation; sensory function; spinal cord injury	TRAUMATIC BRAIN-INJURY; STRAIN-RELATED DIFFERENCES; NEUROPATHIC PAIN; DENDRITIC SPINE; MOUSE MODEL; LOCOMOTOR RECOVERY; SENSORIMOTOR INTERACTIONS; INFLAMMATORY RESPONSE; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA	Sensorimotor recovery after spinal cord injury (SCI) is of utmost importance to injured individuals and will rely on improved understanding of SCI pathology and recovery. Novel transgenic mouse lines facilitate discovery, but must be understood to be effective. The purpose of this study was to characterize the sensory and motor behavior of a common transgenic mouse line (Thy1-GFP-M) before and after SCI. Thy1-GFP-M positive (TG+) mice and their transgene negative littermates (TG-) were acquired from two sources (in-house colony, n = 32, Jackson Laboratories, n = 4). C57BL/6J wild-type (WT) mice (Jackson Laboratories, n = 10) were strain controls. Moderate-severe T9 contusion (SCI) or transection (TX) occurred in TG+ (SCI, n = 25, TX, n = 5), TG- (SCI, n = 5), and WT (SCI, n = 10) mice. To determine responsiveness to rehabilitation, a cohort of TG+ mice with SCI (n = 4) had flat treadmill (TM) training 42-49 days post-injury (dpi). To characterize recovery, we performed Basso Mouse Scale, Grid Walk, von Frey Hair, and Plantar Heat Testing before and out to day 42 post-SCI. Open field locomotion was significantly better in the Thy1 SCI groups (TG+ and TG-) compared with WT by 7dpi (p < 0.01) and was maintained through 42dpi (p < 0.01). These unexpected locomotor gains were not apparent during grid walking, indicating severe impairment of precise motor control. Thy1 derived mice were hypersensitive to mechanical stimuli at baseline (p < 0.05). After SCI, mechanical hyposensitivity emerged in Thy1 derived groups (p < 0.001), while thermal hyperalgesia occurred in all groups (p < 0.001). Importantly, consistent findings across TG+ and TG- groups suggest that the effects are mediated by the genetic background rather than transgene manipulation itself. Surprisingly, TM training restored mechanical and thermal sensation to baseline levels in TG+ mice with SCI. This behavioral profile and responsiveness to chronic training will be important to consider when choosing models to study the mechanisms underlying sensorimotor recovery after SCI.	[Faw, Timothy D.] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA; [Faw, Timothy D.; Thaxton, Tyler T.; Deibert, Rochelle J.; Fisher, Lesley C.; Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Faw, Timothy D.; Lerch, Jessica K.; Thaxton, Tyler T.; Deibert, Rochelle J.; Fisher, Lesley C.; Basso, D. Michele] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Lerch, Jessica K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Basso, DM (corresponding author), Ohio State Univ, 453 W 10th Ave, Columbus, OH 43210 USA.	michele.basso@osumc.edu	Faw, Timothy D./AAB-9210-2020	Faw, Timothy D./0000-0001-7794-0074	Florence P. Kendall Post-Professional Doctoral Scholarship; Promotion of Doctoral Studies - Level I Scholarship from the Foundation for Physical Therapy; Promotion of Doctoral Studies - Level II Scholarship from the Foundation for Physical Therapy;  [1F31NS096921-01A1];  [1RO1NS074882-01A1];  [P30-NS04758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS074882, F31NS080512] Funding Source: NIH RePORTER	This work is funded by 1F31NS096921-01A1 (TDF), 1RO1NS074882-01A1 (DMB), P30-NS04758 (CBSCR), a Florence P. Kendall Post-Professional Doctoral Scholarship (TDF) and Promotion of Doctoral Studies - Level I & II Scholarships from the Foundation for Physical Therapy (TDF). The authors would like to thank Drs. Karl Obrietan and Phillip Popovich for generously providing the Thy1-GFP-M mice used in this study.	Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Alstermark B, 2011, J NEUROPHYSIOL, V106, P122, DOI 10.1152/jn.00089.2011; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Avalos AM, 2004, J BIOL CHEM, V279, P39139, DOI 10.1074/jbc.M403439200; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beekhuizen KS, 2008, ARCH PHYS MED REHAB, V89, P602, DOI 10.1016/j.apmr.2007.11.021; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Buehner J.J., 2010, THESIS; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; CHANG HC, 1985, P NATL ACAD SCI USA, V82, P3819, DOI 10.1073/pnas.82.11.3819; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MJ, 2012, GLIA, V60, P1660, DOI 10.1002/glia.22384; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Cooper MA, 2014, J COMP NEUROL, V522, P3351, DOI 10.1002/cne.23615; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; DALES S, 1983, J IMMUNOL, V131, P1332; David BT, 2013, NEUROBIOL DIS, V54, P194, DOI 10.1016/j.nbd.2012.12.012; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Detloff MR, 2016, NEUROREHAB NEURAL RE, V30, P685, DOI 10.1177/1545968315619698; Detloff MR, 2014, EXP NEUROL, V255, P38, DOI 10.1016/j.expneurol.2014.02.013; Detloff MR, 2010, EXP NEUROL, V225, P366, DOI 10.1016/j.expneurol.2010.07.009; DeVivo MJ, 2011, TOP SPINAL CORD REHA, V16, P53, DOI DOI 10.1310/sci1604-53; Dugan EA, 2015, J NEUROTRAUM, V32, P622, DOI 10.1089/neu.2014.3692; Fandel TM, 2016, CELL STEM CELL, V19, P544, DOI 10.1016/j.stem.2016.08.020; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Field-Fote EC, 2002, PHYS THER, V82, P707, DOI 10.1093/ptj/82.7.707; Field-Fote EC, 2009, SPINAL CORD INJURY R, V1st; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Friedenberg DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08120-9; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guo CD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03000-8; Hansen CN, 2016, EXP NEUROL, V282, P86, DOI 10.1016/j.expneurol.2016.05.019; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Hansen CN, 2012, BRAIN BEHAV, V2, P541, DOI 10.1002/brb3.71; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Homanics GE, 1999, PHARMACOL BIOCHEM BE, V63, P21, DOI 10.1016/S0091-3057(98)00232-9; Hornby TG, 2005, PHYS THER, V85, P52, DOI 10.1093/ptj/85.1.52; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Hoschouer EL, 2009, EXP NEUROL, V216, P22, DOI 10.1016/j.expneurol.2008.10.025; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Inman D, 2002, J COMP NEUROL, V451, P225, DOI 10.1002/cne.10340; Irvine KA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00116; Jiang MH, 2013, J NEUROSCI, V33, P19518, DOI 10.1523/JNEUROSCI.1745-13.2013; Kallop DY, 2014, J NEUROSCI, V34, P6425, DOI 10.1523/JNEUROSCI.4963-13.2014; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; King AE, 2012, BRAIN RES, V1465, P90, DOI 10.1016/j.brainres.2012.05.018; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Landi S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00045; Laperchia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056144; Lauterborn JC, 2015, CEREB CORTEX, V25, P516, DOI 10.1093/cercor/bht249; Leblond H, 2003, J NEUROSCI, V23, P11411; Leech KA, 2017, J NEUROTRAUM, V34, P1240, DOI 10.1089/neu.2016.4532; Leech KA, 2016, PHYS THER, V96, P1919, DOI 10.2522/ptj.20150646; Lerch J.K., 2017, ENEURO, V4; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Li MH, 2012, BRAIN RES, V1484, P76, DOI 10.1016/j.brainres.2012.09.028; Li XM, 2017, BEHAV BRAIN RES, V322, P92, DOI 10.1016/j.bbr.2017.01.025; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Ma MH, 2004, J COMP NEUROL, V474, P469, DOI 10.1002/cne.20149; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mills CD, 2001, J NEUROTRAUM, V18, P743, DOI 10.1089/089771501316919111; Mishra A, 2008, MOL CELL BIOL, V28, P2782, DOI 10.1128/MCB.02102-07; Mishra A, 2014, J NEUROSCI, V34, P4187, DOI 10.1523/JNEUROSCI.3671-13.2014; Murakami T, 2013, EXP THER MED, V6, P1194, DOI 10.3892/etm.2013.1296; Murmu RP, 2015, J NEUROSCI, V35, P287, DOI 10.1523/JNEUROSCI.0244-14.2015; Murmu RP, 2013, J NEUROSCI, V33, P12997, DOI 10.1523/JNEUROSCI.5284-12.2013; Musselman KE, 2009, PHYS THER, V89, P601, DOI 10.2522/ptj.20080257; Nees TA, 2016, PAIN, V157, P687, DOI 10.1097/j.pain.0000000000000422; Niisato E, 2012, DEV NEUROBIOL, V72, P1447, DOI 10.1002/dneu.22007; Novrup HG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0159-6; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park Jae-Yeo, 2014, Evid Based Complement Alternat Med, V2014, P895272, DOI 10.1155/2014/895272; Pleiser S, 2014, EUR J CELL BIOL, V93, P225, DOI 10.1016/j.ejcb.2013.11.001; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Qian J, 2017, BRIT J PHARMACOL, V174, P1961, DOI 10.1111/bph.13788; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; RAFF MC, 1979, BRAIN RES, V174, P283, DOI 10.1016/0006-8993(79)90851-5; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; REIF AE, 1966, NATURE, V209, P521, DOI 10.1038/209521b0; REIF AE, 1964, J EXP MED, V120, P413, DOI 10.1084/jem.120.3.413; REIF AE, 1964, NATURE, V203, P886, DOI 10.1038/203886a0; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 2004, CAN J PHYSIOL PHARM, V82, P617, DOI 10.1139/Y04-068; Rossignol S, 2004, PROG BRAIN RES, V143, P163, DOI 10.1016/S0079-6123(03)43016-1; Rossignol S, 2008, BRAIN RES REV, V57, P228, DOI 10.1016/j.brainresrev.2007.06.019; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sajo M, 2016, J NEUROSCI, V36, P9472, DOI 10.1523/JNEUROSCI.0580-16.2016; Sakai Y, 2009, NEUROSCI RES, V65, P319, DOI 10.1016/j.neures.2009.08.008; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Tateda S, 2017, J ORTHOP RES, V35, P93, DOI 10.1002/jor.23328; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; The Jackson Laboratory, 2017, 007788 JACKS LAB; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Wang ITJ, 2013, NEUROBIOL DIS, V58, P3, DOI 10.1016/j.nbd.2013.04.020; Ward PJ, 2014, J NEUROTRAUM, V31, P819, DOI 10.1089/neu.2013.3082; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Winkle CC, 2014, J CELL BIOL, V205, P217, DOI 10.1083/jcb.201311003; Wohleb ES, 2018, BIOL PSYCHIAT, V83, P38, DOI 10.1016/j.biopsych.2017.05.026; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JF, 2016, PAIN, V157, P488, DOI 10.1097/j.pain.0000000000000393; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Zhan Y, 2015, NEUROSCIENCE, V300, P554, DOI 10.1016/j.neuroscience.2015.05.063; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhang H, 2015, J NEUROSCI, V35, P13275, DOI 10.1523/JNEUROSCI.1034-15.2015; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078; Zou CY, 2016, EMBO J, V35, P2213, DOI 10.15252/embj.201694085	150	3	3	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	18					2167	2182		10.1089/neu.2017.5395		JUN 2018	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GT2EF	WOS:000434223400001	29385890	Green Published			2022-02-06	
J	Brau, RH; Acevedo-Salas, Y; Giovannetti, K				Brau, Ricardo H.; Acevedo-Salas, Yaritza; Giovannetti, Katya			Epidemiological Trends of Traumatic Brain and Spinal Cord Injury in Puerto Rico from November 10th, 2006, through May 24th, 2011	PUERTO RICO HEALTH SCIENCES JOURNAL			English	Article						Neurological injuries; Traumatic brain injuries; Spinal cord injuries; Epidemiology; Incidence	US EMERGENCY-DEPARTMENTS; HEAD TRAUMA; OLDER-ADULTS; CLINICAL ARTICLE; FALLS; HOSPITALIZATION; POPULATION; SEVERITY; CHILDREN; AREAS	Objective: According to the Centers for Disease Control and Prevention (CDC), injury to the central nervous system (CNS) continues to be a leading cause of injury-related morbidity and mortality in the US today. Methods: A prospective cohort study was performed to determine the incidence of all traumatic CNS injuries. Descriptive variables were presented as frequencies and percentages. Quantitative variables were expressed as means and averages (plus/minus standard deviation); bivariate cross-tabulation and multiple regression analyses were employed to identify risk factors and compare epidemiological patterns of injury-related variables. Results: Information from 3,202 patients with confirmed CNS injuries was collected and analyzed. Traumatic brain injuries (TBIs) had occurred in 2,524 of the cases (78.8%). Spine injuries had occurred in 831 cases (25.9%), and 197 cases (6.2%) had suffered spinal cord injuries. Overall, most of the cases were male (75.0%) and with a median age of 40 years. Of the total number of cases, newborns and infants (<= 4 years of age) comprised 7.8% and elderly individuals (>65 years of age), 27.4%. Nearly half of the injuries were due to falls (47.5%), followed by motor vehicle and other transport accidents (35.2%). Loss of consciousness occurred in 61.3% of the traumas. The Glasgow Coma Scale (GCS) was used to categorize TBI severity and showed that the majority of TBIs were mild (70.0%). Over 90% of all cases had been injured either at home (42.8%) or on the street (49.1%). Conclusion: These results are evidence that additional collaborative efforts that focus on trauma are needed to increase knowledge, public health awareness, and preventive measures.	[Brau, Ricardo H.; Acevedo-Salas, Yaritza; Giovannetti, Katya] Univ Puerto Rico, Sch Med, Dept Surg, Med Sci Campus, San Juan, PR 00936 USA		Brau, RH (corresponding author), Div Neurol Surg, 400 FD Roosevelt Ave 511, San Juan, PR 00918 USA.	rhbrau@gmail.com			National Center for Research Resources (NCRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U54 RR026139]; National Institute on Minority Health and Health Disparities (NIMHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [8U54MD 007587-03]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007587] Funding Source: NIH RePORTER	This work was supported by award number U54 RR026139 from the National Center for Research Resources (NCRR) and award number 8U54MD 007587-03 from the National Institute on Minority Health and Health Disparities (NIMHD).	ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cadotte DW, 2011, J NEUROSURG, V114, P1502, DOI 10.3171/2010.12.JNS10808; Centers for Disease Control and Prevention, TBI GET FACTS; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, OLD AD FALLS IMP FAC; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Fernandez Mara L, 2010, Bol Asoc Med P R, V102, P26; Ghebrehiwet M, 2009, JEMA, V4, P5; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Muns-Aponte SM, 2017, P R HEALTH SCI J, V36, P159; National Hospital Discharge Survey [NHDS], 2010, NAT HOSP AMB MED CAR; Pascual-Marrero A, 2017, INT J INJ CONTROL SA, V18, P1; Piatt JH, 2015, J NEUROSURG-PEDIATR, V16, P463, DOI 10.3171/2015.2.PEDS1515; Pirouzmand F, 2010, J NEUROSURG-SPINE, V12, P131, DOI 10.3171/2009.9.SPINE0943; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Salgado M, 2015, P R HEALTH SCI J, V34, P109; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Strand IH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-62; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wang HW, 2012, J NEUROSURG-SPINE, V17, P459, DOI 10.3171/2012.8.SPINE111003; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; World Health Organization, SPIN CORD INJ MAN 50; [No title captured]	37	3	3	0	3	UNIV PUERTO RICO MEDICAL SCIENCES CAMPUS	SAN JUAN	OFFICE DEAN ACADEMIC AFFAIRS BOX 365067, SAN JUAN, PR 00936-5067 USA	0738-0658			P R HEALTH SCI J	P. R. Health Sci. J.	JUN	2018	37	2					67	77					11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	GJ0WJ	WOS:000434974900001	29905916				2022-02-06	
J	Curren, R; Blokhuis, JC				Curren, Randall; Blokhuis, J. C.			Friday Night Lights Out: The End of Football in Schools	HARVARD EDUCATIONAL REVIEW			English	Article						football; traumatic brain injury; team sports; values education; informed consent; child welfare	1ST EXPOSURE; CHANNEL ONE; AGE; VIRTUE	In this essay, ethicists grounded in philosophy (Curren) and law (Blokhuis) argue that the US public schools' sponsorship of tackle football is ethically indefensible and inconsistent with their educational aims. Their argument relies on three ethical principles and a growing body of evidence that many students who play football suffer traumatic brain injury and cognitive impairment that undermine their academic success and life prospects, whether or not they suffer concussions. The authors also address educational claims made on behalf of football, the legal principles governing custodial responsibilities of schools and parents, factors that limit the moral and legal significance of children's consent to participate in football programs, and evidence that sponsorship of football programs subjects educational institutions to unsustainable financial risk.	[Curren, Randall] Univ Rochester, Dept Philosophy, Rochester, NY 14627 USA; [Curren, Randall] Univ Rochester, Dept Educ Leadership, Rochester, NY 14627 USA; [Blokhuis, J. C.] Univ Waterloo, Renison Univ Coll, Social Dev Studies, Waterloo, ON, Canada		Curren, R (corresponding author), Univ Rochester, Dept Philosophy, Rochester, NY 14627 USA.; Curren, R (corresponding author), Univ Rochester, Dept Educ Leadership, Rochester, NY 14627 USA.			Curren, Randall/0000-0003-1619-5140			Adams Taylor, 2016, SCHOLAR, V18, P285; Almond S, 2015, FOOTBALL ONE FANS RE; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; [Anonymous], 2016, ESPN NEWS       0831; [Anonymous], 2012, WASHINGTON POST; [Anonymous], 2017, NY TIMES; Aristotle, 1984, COMPLETE WORKS ARIST, DOI [10.1515/9781400835850-011, DOI 10.1515/9781400835850]; Arthur J., 2015, CHARACTER ED UK SCH; Baker David., 2014, SCH SOC ED TRANSFORM; Belson K, 2016, NY TIMES, pB11; Belson K, 2015, NY TIMES, pB11; BELSON K, 2014, NEW YORK TIMES  0511, pA1; Blokhuis JC, 2010, THEORY RES EDUC, V8, P199, DOI 10.1177/1477878510368628; Blokhuis JC, 2015, J PHILOS EDUC, V49, P65, DOI 10.1111/1467-9752.12096; Blokhuis JC, 2008, AM EDUC RES J, V45, P343, DOI 10.3102/0002831208314870; Branch John, 2017, NEW YORK TIMES, pB9; Bredemeier B. J., 1984, SOCIOLOGY SPORT J, V1, P348, DOI DOI 10.1123/SSJ.1.4.348; Brighouse H, 2005, EDUC POLICY, V19, P528, DOI 10.1177/0895904805276145; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Cantu R. C, 2012, NY TIMES, pSP8; Carroll Linda, 2012, CONCUSSION CRISIS AN; Carter Tracey B., 2015, UMKC L REV, V84, P334; Cohen Stanley, 2001, STATES DENIAL KNOWIN; Cudd A, 1997, ETHICS PRACTICE ANTH, P309; Curren R, 2017, WHY CHARACTER ED, DOI DOI 10.1111/IMP.2017.2017; Curren R, 2017, LIVING WELL NOW FUTU, DOI [10.7551/mitpress/9780262036009.001.0001, DOI 10.7551/MITPRESS/9780262036009.001.0001]; Curren R., 2015, ROUTLEDGE COMPANION, P459; Curren R, 2013, THEORY RES EDUC, V11, P231, DOI 10.1177/1477878513498182; Curren R, 2014, THEORY RES EDUC, V12, P266, DOI 10.1177/1477878514545205; Curren R, 2014, SOC PHILOS POLICY, V31, P36, DOI 10.1017/S0265052514000107; Drennan W. A, 2014, SAN FRANCISCO LAW RE, V51, P509; Duncan GJ, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P1; Eilperin J., 2014, WASHINGTON POST; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Farrey T, 2016, ESPN; Feinberg J., 1984, HARM OTHERS; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; Fowers BJ, 2014, THEORY RES EDUC, V12, P309, DOI 10.1177/1477878514546064; French P. A., 2004, ETHICS COLL SPORTS; Gert, 2007, COMMON MORALITY DECI; Gould W. B, 2012, FLORIDA INT U LAW RE, V8, P55; Hannel I, 2014, ENTERTAINMENT ARTS S, V25, P44; Jones Carwyn, 2003, SPORTS ETHICS, P42; Kennell N. M, 1995, GYMNASIUM VIRTUE ED; Kraut, 2007, WHAT IS GOOD WHY ETH, DOI [10.4159/9780674027084, DOI 10.4159/9780674027084]; Macur J, 2016, NY TIMES, pD5; Macur J, 2016, NY TIMES, pD1; Marrou H., 1956, HIST ED ANTIQUITY; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Moe D, 2010, WISCONSIN STATE J; National Collegiate Athletic Association [NCAA], 2015, DEB NCAA CHAMP FEAT; Neisser U., 1998, RISING CURVE LONG TE, DOI [10.1037/10270-000, DOI 10.1037/10270-000]; Pilon M., 2013, NY TIMES, pD2; Raz Joseph, 2003, PRACTICE VALUE; Ripley A., 2013, ATLANTIC; Robeson R, 2014, J LAW MED ETHICS, V42, P334, DOI 10.1111/jlme.12150; Roza M., 2010, ED EC DO SCH FUNDS G; Ruoff J, 2015, STUDENT BRAIN INJURY; Schwarz A., 2016, NEW YORK TIMES, pA1; Schwarz A, 2010, NY TIMES        0217, pA1; Shulman J. L., 2001, GAME LIFE COLL SPORT; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Strauss B, 2015, NY TIMES, pB11; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarver E. C, 2017, NY TIMES; Thoma S, 2013, EUR J DEV PSYCHOL, V10, P239, DOI 10.1080/17405629.2013.766129; Toporek B, 2012, ED WEEK; Wagner W, 2015, ARIZONA STATE U SPOR, V4, P76; [No title captured]	70	3	3	0	4	HARVARD GRADUATE SCHOOL EDUCATION	CAMBRIDGE	8 STORY STREET, 1ST FLOOR, CAMBRIDGE, MA 02138-3752 USA	0017-8055	1943-5045		HARVARD EDUC REV	Harv. Educ. Rev.	SUM	2018	88	2					141	162		10.17763/1943-5045-88.2.141			22	Education & Educational Research	Social Science Citation Index (SSCI)	Education & Educational Research	HM3JH	WOS:000459369100001					2022-02-06	
J	Eckersley, CP; White, TR; Cutcliffe, HC; Shridharani, JK; Wood, GW; Bass, CR				Eckersley, Christopher P.; White, Terrance R.; Cutcliffe, Hattie C.; Shridharani, Jay K.; Wood, Garrett W.; Bass, Cameron R.			Foul tip impact attenuation of baseball catcher masks using head impact metrics	PLOS ONE			English	Article							CONCUSSION; SEVERITY	Currently, no scientific consensus exists on the relative safety of catcher mask styles and materials. Due to differences in mass and material properties, the style and material of a catcher mask influences the impact metrics observed during simulated foul ball impacts. The catcher surrogate was a Hybrid III head and neck equipped with a six degree of freedom sensor package to obtain linear accelerations and angular rates. Four mask styles were impacted using an air cannon for six 30 m/s and six 35 m/s impacts to the nasion. To quantify impact severity, the metrics peak linear acceleration, peak angular acceleration, Head Injury Criterion, Head Impact Power, and Gadd Severity Index were used. An Analysis of Covariance and a Tukey's HSD Test were conducted to compare the least squares mean between masks for each head injury metric. For each injury metric a P-Value less than 0.05 was found indicating a significant difference in mask performance. Tukey's HSD test found for each metric, the traditional style titanium mask fell in the lowest performance category while the hockey style mask was in the highest performance category. Limitations of this study prevented a direct correlation from mask testing performance to mild traumatic brain injury.	[Eckersley, Christopher P.; White, Terrance R.; Cutcliffe, Hattie C.; Shridharani, Jay K.; Wood, Garrett W.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Eckersley, CP (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	christopher.eckersley@duke.edu		Wood, Garrett/0000-0002-5619-5527; Eckersley, Christopher/0000-0001-5467-0358; Cutcliffe, Hattie/0000-0001-8456-1996	Duke Undergraduate Research Support Office with an Undergraduate Research Support Creative Arts Grant	Funding for catcher masks and air cannon materials was provided by the Duke Undergraduate Research Support Office with an Undergraduate Research Support Creative Arts Grant provided to CE. The Duke Undergraduate Research Support Office website can be found at https://undergraduateresearch.duke.edu/opportunities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, BASEBALL T; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Engineers SoA, 2014, SURF VEH REC PRACT 1; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gadd C., 1966, SAE TECHNICAL PAPER; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heald J, 1994, BALL STANDARDS RELEV; Horwitz NH, 1999, NEUROSURGERY, V45, P944, DOI 10.1097/00006123-199910000-00050; Laudner K.G., 2014, J ATHLETIC ENHANCEME, V3, P1; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Newman J, 2000, P INT RES COUNC BIOM; Newman J, 1999, INT IRCOBI C BIOM IM; Newman JA, 1980, SAE TECHNICAL PAPER; NHTSA, 2011, OCC CRASH PROT 571 2; NOCSAE, 2015, 024 NOCSAE; Schwizer P, 2016, PROCEDIA ENGINEER, V147, P228, DOI 10.1016/j.proeng.2016.06.218; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Siu J, 2016, INT J EXERCISE SCI, V9, P3; Theye Fred, 2004, Clin Med Res, V2, P165; Versace J, 1971, SAE TECHNICAL PAPER	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2018	13	6							e0198316	10.1371/journal.pone.0198316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH8ES	WOS:000433900800099	29856814	Green Published, gold, Green Submitted			2022-02-06	
J	Ford, JM; Campbell, KR; Ford, CB; Boyd, KE; Padua, DA; Mihalik, JP				Ford, Julia M.; Campbell, Kody R.; Ford, Cassie B.; Boyd, Kenneth E.; Padua, Darin A.; Mihalik, Jason P.			Can Functional Movement Assessment Predict Football Head Impact Biomechanics?	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; FOOTBALL; MUSCULOSKELETAL INJURY RISK; HELMET; JUMP LANDING; COLLEGIATE ATHLETE	COLLEGIATE-ATHLETIC-ASSOCIATION; MEDIAL KNEE DISPLACEMENT; TRAUMATIC BRAIN-INJURY; LOWER-EXTREMITY INJURY; ERROR SCORING SYSTEM; MUSCULOSKELETAL INJURY; CONCUSSION; PLAYERS; EPIDEMIOLOGY; SPORTS	Purpose: The purposes of this study was to determine functional movement assessments' ability to predict head impact biomechanics in college football players and to determine whether head impact biomechanics could explain preseason to postseason changes in functional movement performance. Methods: Participants (N = 44; mass, 109.0 +/- 20.8 kg; age, 20.0 +/- 1.3 yr) underwent two preseason and postseason functional movement assessment screenings: 1) Fusionetics Movement Efficiency Test and 2) Landing Error Scoring System (LESS). Fusionetics is scored 0 to 100, and participants were categorized into the following movement quality groups as previously published: good (Q75), moderate (50-75), and poor (<50). The LESS is scored 0 to 17, and participants were categorized into the following previously published movement quality groups: good (<= 5 errors), moderate (6-7 errors), and poor (>7 errors). The Head Impact Telemetry (HIT) System measured head impact frequency and magnitude (linear acceleration and rotational acceleration). An encoder with six single-axis accelerometers was inserted between the padding of a commercially available Riddell football helmet. We used random intercepts general linear-mixed models to analyze our data. Results: There were no effects of preseason movement assessment group on the two Head Impact Telemetry System impact outcomes: linear acceleration and rotational acceleration. Head impact frequency did not significantly predict preseason to postseason score changes obtained from the Fusionetics (F-1,F-36 = 0.22, P = 0.643, R-2 = 0.006) or the LESS (F-1,F-36 < 0.01, P = 0.988, R-2 < 0.001) assessments. Conclusions: Previous research has demonstrated an association between concussion and musculoskeletal injury, as well as functional movement assessment performance and musculoskeletal injury. The functional movement assessments chosen may not be sensitive enough to detect neurological and neuromuscular differences within the sample and subtle changes after sustaining head impacts.	[Ford, Julia M.; Campbell, Kody R.; Ford, Cassie B.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Campbell, Kody R.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Boyd, Kenneth E.] Baylor Univ, Baylor Athlet, Waco, TX 76798 USA; [Padua, Darin A.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Sports Med Res Lab, Chapel Hill, NC USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 2201Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Campbell, Kody/0000-0002-4534-5497			Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bell DR, 2013, J ATHL TRAINING, V48, P442, DOI 10.4085/1062-6050-48.3.16; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cameron KL, 2014, ORTHOP J SPORTS MED, V2; Conder Robert L, 2015, N C Med J, V76, P89; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dallinga JM, 2012, SPORTS MED, V42, P791, DOI 10.2165/11632730-000000000-00000; Dorrien J, 2015, ATHLETIC TRAIN SPORT, V7, P197; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Frank BS, 2016, J ATHL TRAINING, V51, pS; Fusionetics, 2015, FUS HUM PERF SYST; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kiesel KB, 2014, J SPORT REHABIL, V23, P88, DOI [10.1123/jsr.2012-0130, 10.1123/JSR.2012-0130]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lisman P, 2013, MED SCI SPORT EXER, V45, P636, DOI 10.1249/MSS.0b013e31827a1c4c; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mauntel TC, 2014, J APPL BIOMECH, V30, P707, DOI 10.1123/jab.2014-0003; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Padua DA, 2012, J ATHL TRAINING, V47, P525, DOI 10.4085/1062-6050-47.5.10; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stanley L, 2016, J ATHL TRAINING, V51, P360; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	43	3	3	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2018	50	6					1233	1240		10.1249/MSS.0000000000001538			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GF8ZE	WOS:000432264300014	29293120				2022-02-06	
J	Giese, H; Meyer, J; Unterberg, A; Beynon, C				Giese, Henrik; Meyer, Jennifer; Unterberg, Andreas; Beynon, Christopher			Preoperative lumbar drainage placement for surgical cranioplasty	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cranioplasty; Decompressive craniectomy; Lumbar drain; Cerebrospinal fluid drainage	EXTERNAL VENTRICULAR DRAIN; DECOMPRESSIVE CRANIECTOMY; HEMORRHAGIC COMPLICATIONS; HEMICRANIECTOMY; ACCURACY; SURGERY; TRIAL	Objective: Intraoperative reduction of cerebrospinal fluid may be required in patients undergoing cranioplasty (CP) surgery, especially in the presence of bulging cranial defects. Direct cannulation of the frontal horn of the lateral ventricle is associated with risks such as intracerebral haemorrhage or postoperative leakage of cerebrospinal fluid. Here we report our initial experiences with preoperative lumbar drain (LD) placement for cranioplasty surgery in patients with bulging cranial defects. Method: The medical records of patients who were treated with LD prior to CP surgery at our institution were retrospectively analysed. Pre-, intra- and postoperative modalities, complications and outcome parameters are described. Results: A total of 14 patients (mean age 46 years) were included in this analysis. The majority of patients had received decompressive craniectomy due to space-occupying cerebral infarction (64.3%) and traumatic brain injury (14.3%). CP was performed unilaterally with autologous bone graft in 93% of cases. No complications occurred during lumbar drainage placement and the grafts were implanted without the need of dural opening and ventricle puncture. LDs were maintained for an average of 17 +/- 15 h (range, 1-48 h). There were no LD related complications in the further course. Conclusion: Our initial experiences demonstrate that preoperative LD placement facilitates CP in patients with bulging cranial defects requiring surgical cranioplasty. lntraoperative puncture of ventricles for reducing cerebrospinal fluid is avoided and therefore, the risk of intracerebral haemorrhage and brain damage is reduced. Further studies are needed to evaluate the advantages of this technique as an alternative to conventional methods of intraoperative CSF reduction. (C) 2018 Elsevier Ltd. All rights reserved.	[Giese, Henrik; Meyer, Jennifer; Unterberg, Andreas; Beynon, Christopher] Heidelberg Univ, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany		Giese, H (corresponding author), Heidelberg Univ, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	Henrik.Giese@med.uni-heidelberg.de		Antritter, Jennifer/0000-0001-8764-114X			Afolabi BB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004350.pub3; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Borg A, 2016, WORLD NEUROSURG, V95, P383, DOI 10.1016/j.wneu.2015.12.105; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Estrera AL, 2009, ANN THORAC SURG, V88, P9, DOI 10.1016/j.athoracsur.2009.03.039; Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI 10.1227/01.NEU.0000335069.30319.1E; Hanna JM, 2013, ANN THORAC SURG, V95, P1968, DOI 10.1016/j.athoracsur.2013.03.016; Hsieh CT, 2011, ACTA NEUROL BELG, V111, P22; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Morton RP, J NEUROSURG, V2017, P1, DOI [10.3171/2016.11JNS161917, DOI 10.3171/2016.11JNS161917]; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Simmerman SR, 1997, J NEUROSURG ANESTH, V9, P159, DOI 10.1097/00008506-199704000-00010; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002	20	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2018	52						88	91		10.1016/j.jocn.2018.03.008			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH7SD	WOS:000433652800014	29622505				2022-02-06	
J	Houa, ZG; Tian, RF; Han, FF; Hao, SY; Wu, WC; Mao, X; Tao, XG; Lu, T; Dong, JQ; Zhen, Y; Liu, BY				Houa, Zonggang; Tian, Runfa; Han, Feifei; Hao, Shuyu; Wu, Weichuan; Mao, Xiang; Tao, Xiaogang; Lu, Te; Dong, Jinqian; Zhen, Yun; Liu, Baiyun			Decompressive craniectomy protects against hippocampal edema and behavioral deficits at an early stage of a moderately controlled cortical impact brain injury model in adult male rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Brain edema; Behavioral deficit; Decompressive craniectomy; Neuroprotection; Traumatic brain injury	TIME-COURSE; SPECTROSCOPY	A decompressive craniectomy (DC) has been shown to be a life-saving therapeutic treatment for traumatic brain injury (TBI) patients, which also might result in post-operative behavioral dysfunction. However, there is still no definite conclusion about whether the behavioral dysfunction already existed at an early stage after the DC operation or is just a long-term post-operation complication. Therefore, the aim of the present study was to analyze whether DC treatment was beneficial to behavioral function at an early stage post TBI. In this study, we established a controlled cortical impact injury rat model to evaluate the therapeutic effect of DC treatment on behavioral deficits at 1 d, 2 d, 3 d and 7 d after TBI, Our results showed that rats suffered significant behavioral and mood deficits after TBI compared to the control group, while decompressive craniectomy treatment could normalize MMP-9 expression levels and reduce hippocampal edema formation, stabilize the expression of Synapsin I, which was a potential indicator of maintaining the hippocampal synaptic function, thus counteracting behavioral but not mood decay in rats subjected to TBI. In conclusion, decompressive craniectomy, excepting for its life-saving effect, could also play a potential beneficial neuroprotective role on behavioral but not mood deficits at an early stage of moderate traumatic brain injury in rats.	[Houa, Zonggang; Tian, Runfa; Hao, Shuyu; Tao, Xiaogang; Lu, Te; Dong, Jinqian; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Tiantan Xili 6, Beijing 100050, Peoples R China; [Houa, Zonggang; Tian, Runfa; Hao, Shuyu; Tao, Xiaogang; Lu, Te; Dong, Jinqian; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China; [Houa, Zonggang; Tian, Runfa; Hao, Shuyu; Tao, Xiaogang; Lu, Te; Dong, Jinqian; Liu, Baiyun] Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China; [Han, Feifei] Xuzhou Med Univ, Dept Diagnost, Clin Coll, Xuzhou 221004, Jiangsu, Peoples R China; [Wu, Weichuan; Zhen, Yun] Baoan Dist Cent Hosp, Dept Neurosurg, Xiyuan St 6, Shenzhen 518102, Peoples R China; [Mao, Xiang] Anhui Med Univ, Dept Neurosurg, Affiliated Hosp 1, Hefei 230000, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing 100050, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing 100050, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Tiantan Xili 6, Beijing 100050, Peoples R China.; Zhen, Y (corresponding author), Baoan Dist Cent Hosp, Dept Neurosurg, Xiyuan St 6, Shenzhen 518102, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Neurotrauma Lab, Beijing Neurosurg Inst, Tiantan Xili 6, Beijing 100050, Peoples R China.	zy1967@163.com; liubaiyun1212@163.com	Dong, Jinqian/AAP-2298-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471238]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]	We would like to acknowledge the assistance of Feifan Xu and Xuetao Chen for their support of this study. This study was supported by the National Natural Science Foundation of China (No. 81471238), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03) and the Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084).	Abraham P, 2017, ACTA NEUROCHIR, V159, P2279, DOI 10.1007/s00701-017-3363-1; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Marchadour C, 2012, J CEREBR BLOOD F MET, V32, P2153, DOI 10.1038/jcbfm.2012.119; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Perez-Hernandez M, 2017, NEUROPHARMACOLOGY, V118, P157, DOI 10.1016/j.neuropharm.2017.03.019; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shah AK, 2017, JAINISM AND ETHICAL FINANCE: A TIMELESS BUSINESS MODEL, P1; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Tian RF, 2015, BRAIN RES, V1622, P339, DOI 10.1016/j.brainres.2015.06.039; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tsaltas E, 2009, PSYCHOPHARMACOLOGY, V202, P457, DOI 10.1007/s00213-008-1311-8; WANG T, 1995, J NEUROSCI, V15, P4796; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	26	3	3	2	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 1	2018	345						1	8		10.1016/j.bbr.2018.02.010			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GD8PM	WOS:000430774600001	29452194				2022-02-06	
J	Katz, MG; Fenton, SJ; Russell, KW; Scaife, ER; Short, SS				Katz, Micah G.; Fenton, Stephen J.; Russell, Kathryn W.; Scaife, Eric R.; Short, Scott S.			Surgical outcomes of pancreaticoduodenal injuries in children	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pancreatic trauma; Duodenal trauma; Pancreaticoduodenal trauma; Trauma Whipple	DUODENAL INJURIES; MANAGEMENT; TRAUMA; ABUSE	Purpose To examine surgical outcomes of children with pancreaticoduodenal injuries at a Quaternary Level I pediatric trauma center. Methods We queried a prospectively maintained trauma database of a level one pediatric trauma center for all cases of pancreatic and/or duodenal injury from 2002 to 2017. Analysis was conducted using JMP 13.1.0. Results 170 children presented with pancreatic and/or duodenal injury. 13 (7.7%) suffered a combined injury and this group forms the basis for this report with mean ISS of 22.8 (+/- 15.1), RTS2 of 6.4(+/- 2.1), and median age of 6.6 (1.3-13.5) years. Child abuse (31%) and bicycle injuries (23%) were the most common mechanisms. 8/13 (61.5%) required operative intervention. Higher AAST pancreatic and duodenal injury grade (2.9 vs. 1.2, p = 0.05 and 3.6 vs. 1.4, p = < 0.01), lower RTS2 (7.84 vs. 5.49, p < 0.01), and lower GCS (9.6 vs. 15, p = 0.03) predicted operative intervention. 6/8 (75%) undergoing surgery survived to discharge with only (2/6) survivors suffering postoperative complications. Both mortalities were secondary to severe traumatic brain injury. Conclusion Surgical management of complex pancreaticoduodenal injury is an uncommon traumatic event that is associated with high injury severity, but survival occurs in most scenarios.	[Katz, Micah G.; Fenton, Stephen J.; Russell, Kathryn W.; Scaife, Eric R.; Short, Scott S.] Univ Utah, Sch Med, Primary Childrens Hosp, Dept Surg,Div Pediat Surg, 100 N Mario Cappechi Dr,Suite 3800, Salt Lake City, UT 84113 USA		Short, SS (corresponding author), Univ Utah, Sch Med, Primary Childrens Hosp, Dept Surg,Div Pediat Surg, 100 N Mario Cappechi Dr,Suite 3800, Salt Lake City, UT 84113 USA.	Micah.Katz@hsc.utah.edu; Stephen.Fenton@imail2.org; Katie.Russell@imail2.org; Eric.Scaife@imail2.org; Scott.Short@imail2.org	Katz, Micah/L-3841-2019	Katz, Micah/0000-0001-8315-0909			Antonacci N, 2011, J HEPATO-BIL-PAN SCI, V18, P195, DOI 10.1007/s00534-010-0329-6; Berkowitz CD, 2017, NEW ENGL J MED, V377, P399, DOI 10.1056/NEJMc1707243; Carter KW, 2016, J PEDIATR SURG, V51, P326, DOI 10.1016/j.jpedsurg.2015.10.056; Clendenon JN, 2004, J PEDIATR SURG, V39, P964, DOI 10.1016/j.jpedsurg.2004.02.032; FELICIANO DV, 1987, ANN SURG, V205, P673, DOI 10.1097/00000658-198706000-00009; Gaines BA, 2004, J PEDIATR SURG, V39, P600, DOI 10.1016/j.jpedsurg.2003.12.010; Krige JE, 2016, EUR J TRAUMA EMERG S, V42, P225, DOI 10.1007/s00068-015-0525-9; Krige JEJ, 2017, EUR J TRAUMA EMERG S, V43, P411, DOI 10.1007/s00068-016-0657-6; Krige JE, 2016, J AM COLL SURGEONS, V222, P737, DOI 10.1016/j.jamcollsurg.2016.02.005; O'Reilly DA, 2015, ANN ROY COLL SURG, V97, P125, DOI 10.1308/003588414X14055925060712; Trauma EAftSo, 2017, EAST PRACT MAN GUID; van der Wilden GM, 2014, WORLD J SURG, V38, P335, DOI 10.1007/s00268-013-2257-5; Wood J, 2005, J TRAUMA, V59, P1203, DOI 10.1097/01.ta.0000196437.07011.b1	13	3	3	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	JUN	2018	34	6					641	645		10.1007/s00383-018-4249-x			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GF9LN	WOS:000432299200007	29623405				2022-02-06	
J	Kondo, T; Takahashi, M; Kuse, A; Morichika, M; Nakagawa, K; Tagawa, Y; Taniguchi, T; Taguchi, Y; Fujiwara, T; Tsuchiya, J; Nakamura, M; Sakurada, M; Asano, M; Ueno, Y				Kondo, Takeshi; Takahashi, Motonori; Kuse, Azumi; Morichika, Mai; Nakagawa, Kanako; Tagawa, Yoshihiro; Taniguchi, Tomoya; Taguchi, Yuji; Fujiwara, Tomohiro; Tsuchiya, Junpei; Nakamura, Masahiko; Sakurada, Makoto; Asano, Migiwa; Ueno, Yasuhiro			Autopsy Case of a Penetrating Wound to the Left Cerebral Hemisphere Caused by an Accidental Shooting With a Crossbow	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						crossbow; accidental shooting; penetrating brain injury; arrow; trajectory; forensic pathology	CARDIAC INJURY; ARROW WOUNDS; BOLT	A crossbow is a bow that shoots an arrow when a gun-like trigger is pulled. Deaths caused by accidental crossbow shootings are extremely rare. Here we describe an autopsy case of a penetrating wound to the left cerebral hemisphere caused by an accidental shooting with a crossbow. A man in his early 60s who lived with his wife and had used crossbows for 20 years as his hobby was found one early morning in the shed of his house, collapsed and bleeding from the head and neck. He was taken to a hospital and died after approximately 3 days of conservative treatment. At autopsy, a penetrating wound between the upper part of the left anterior neck and the left frontoparietal region was evident. Traumatic intracerebral hematoma was observed in the left frontal lobe, and severe traumatic subarachnoid hemorrhage was present throughout the brain. Cerebral contusion and hematoma without any organization were noted around the penetration. The cause of death was determined to be cerebral contusion and intracerebral hematoma due to the penetrating wound by the crossbow arrow. He was probably trying to load an arrow into the crossbow by placing it on the floor, pointing upward, and made a mistake in its operation that resulted in the shooting of the arrow. This case is unique because it was a rare accidental death caused by a crossbow arrow, and a detailed histopathological examination was performed.	[Kondo, Takeshi; Takahashi, Motonori; Kuse, Azumi; Morichika, Mai; Nakagawa, Kanako; Sakurada, Makoto; Ueno, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Community Med & Social Hlth Sci, Div Legal Med, Kobe, Hyogo, Japan; [Tagawa, Yoshihiro; Taniguchi, Tomoya; Taguchi, Yuji; Fujiwara, Tomohiro; Tsuchiya, Junpei; Nakamura, Masahiko] Steel Mem Hirohata Hosp, Himeji Emergency Trauma & Crit Care Ctr, Himeji, Hyogo, Japan; [Asano, Migiwa] Ehime Univ, Grad Sch Med, Dept Legal Med, Matsuyama, Ehime, Japan		Kondo, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Community Med & Social Healthcare Sci, Div Legal Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kondo@med.kobe-u.ac.jp					Besler K, 1998, INT J LEGAL MED, V111, P88, DOI 10.1007/s004140050121; Byard RW, 1999, AM J FOREN MED PATH, V20, P347, DOI 10.1097/00000433-199912000-00007; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DOWNS JCU, 1994, J FORENSIC SCI, V39, P428; Grellner W, 2004, FORENSIC SCI INT, V142, P17, DOI 10.1016/j.forsciint.2003.12.021; HAIN JR, 1989, J FORENSIC SCI, V34, P691; Hessler Christian, 2012, Archiv fuer Kriminologie, V229, P90; Ihama Yoko, 2004, Research and Practice in Forensic Medicine, P13; Joly LM, 2002, ANESTH ANALG, V94, P231, DOI 10.1097/00000539-200201000-00045; Karger B, 2004, INT J LEGAL MED, V118, P332, DOI 10.1007/s00414-004-0474-z; Karger B, 1998, J TRAUMA, V45, P495, DOI 10.1097/00005373-199809000-00011; Kaye K, 2004, J TRAUMA, V57, P653, DOI 10.1097/01.TA.0000044628.62168.B0; Koizumi Takahisa, 2014, Tokai J Exp Clin Med, V39, P64; Preiss M, 2003, SURGERY, V133, P228, DOI 10.1067/msy.2003.35; Rehulka Hynek, 2016, Soud Lek, V61, P2; ROGERS C, 1990, J FORENSIC SCI, V35, P886; SALAM AA, 1990, ARCH EMERG MED, V7, P224; SALVINO CK, 1991, NEUROSURGERY, V28, P904, DOI 10.1227/00006123-199106000-00023; Smyk D, 2009, J FORENSIC LEG MED, V16, P343, DOI 10.1016/j.jflm.2008.12.022; Taupin JM, 1998, J FORENSIC SCI, V43, P205; Xiao JT, 2016, SURGERY, V159, P1234, DOI 10.1016/j.surg.2015.07.017; Zatopkova L, 2011, J FORENSIC SCI, V56, P537, DOI 10.1111/j.1556-4029.2010.01666.x; Zhang HZ, 2014, PEDIATR EMERG CARE, V30, P421, DOI 10.1097/PEC.0000000000000153; Zyck S, 2016, WORLD NEUROSURG, V91, P297, DOI 10.1016/j.wneu.2016.04.012	24	3	3	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2018	39	2					164	168		10.1097/PAF.0000000000000381			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	GG3HQ	WOS:000432583300015	29401110	Green Published			2022-02-06	
J	Lewandowski-Romps, L; Schroeder, HM; Berglund, PA; Colpe, LJ; Cox, K; Hauret, K; Hay, JD; Jones, B; Little, RJA; Mitchell, C; Schoenbaum, M; Schulz, P; Stein, MB; Ursano, RJ; Heeringa, SG				Lewandowski-Romps, Lisa; Schroeder, Heather M.; Berglund, Patricia A.; Colpe, Lisa J.; Cox, Kenneth; Hauret, Keith; Hay, Jeffrey D.; Jones, Bruce; Little, Roderick J. A.; Mitchell, Colter; Schoenbaum, Michael; Schulz, Paul; Stein, Murray B.; Ursano, Robert J.; Heeringa, Steven G.		Army STARRS Collaborators	Medical-encounter mental health diagnoses, non-fatal injury and polypharmacy indicators of risk for accident death in the US Army enlisted soldiers, 2004-2009	PREVENTIVE MEDICINE			English	Article						Military; Mental health; Accident death; Risk factors	COMBAT DEPLOYMENT; ALCOHOL-USE; GENDER-DIFFERENCES; SERVICE MEMBERS; MILITARY; VETERANS; DISORDERS; AFGHANISTAN; RESILIENCE; STARRS	Accidents are a leading cause of deaths in U.S. active duty personnel. Understanding accident deaths during wartime could facilitate future operational planning and inform risk prevention efforts. This study expands prior research, identifying health risk factors associated with U.S. Army accident deaths during the Afghanistan and Iraq war. Military records for 2004-2009 enlisted, active duty, Regular Army soldiers were analyzed using logistic regression modeling to identify mental health, injury, and polypharmacy (multiple narcotic and/or psychotropic medications) predictors of accident deaths for current, previously, and never deployed groups. Deployed soldiers with anxiety diagnoses showed higher risk for accident deaths. Over half had anxiety diagnoses prior to being deployed, suggesting anticipatory anxiety or symptom recurrence may contribute to high risk. For previously deployed soldiers, traumatic brain injury (TBI) indicated higher risk. Two-thirds of these soldiers had first TBI medical-encounter while non-deployed, but mild, combat-related TBIs may have been undetected during deployments. Post-Traumatic Stress Disorder (PTSD) predicted higher risk for never deployed soldiers, as did polypharmacy which may relate to reasons for deployment ineligibility. Health risk predictors for Army accident deaths are identified and potential practice and policy implications discussed. Further research could test for replicability and expand models to include unobserved factors or modifiable mechanisms related to high risk. PTSD predicted high risk among those never deployed, suggesting importance of identification, treatment, and prevention of non-combat traumatic events. Finally, risk predictors overlapped with those identified for suicides, suggesting effective intervention might reduce both types of deaths.	[Lewandowski-Romps, Lisa; Schroeder, Heather M.; Schulz, Paul] Univ Michigan, Inst Social Res, 330 Packard St, Ann Arbor, MI 48104 USA; [Berglund, Patricia A.; Hay, Jeffrey D.; Little, Roderick J. A.; Mitchell, Colter; Heeringa, Steven G.] Univ Michigan, Inst Social Res, 426 Thompson St, Ann Arbor, MI 48104 USA; [Colpe, Lisa J.] NIMH, Div Serv & Intervent Res HN78, 6001 Execut Blvd, Rockville, MD 20852 USA; [Cox, Kenneth; Hauret, Keith; Jones, Bruce] Army Publ Hlth Ctr Provis, 5158 Blackhawk Rd, Aberdeen Proving Ground, MD 21010 USA; [Schoenbaum, Michael] NIMH, Off Sci Policy Planning & Commun HN71B, 6001 Execut Blvd, Rockville, MD 20852 USA; [Stein, Murray B.] Univ Calif San Diego, VA San Diego Healthcare Syst, 9500 Gilman Dr 0855, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr 0855, La Jolla, CA 92093 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Lewandowski-Romps, L (corresponding author), Univ Michigan, Inst Social Res, 330 Packard St, Ann Arbor, MI 48104 USA.	lisalew@umich.edu	Ursano, Robert/ABE-6533-2020	Ursano, Robert/0000-0002-1861-9173	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000371] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01 MH087981] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH087981] Funding Source: NIH RePORTER		Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; American Academy of Sleep Medicine, 2005, INT CLASSLEEP DIS; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; [Anonymous], 2009, Medical Surveillance Montly Report, V16, P2; [Anonymous], EXC ALC US MENS HLTH; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P4; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Brown Cary A, 2013, Sleep Disord, V2013, P160374, DOI 10.1155/2013/160374; Brown JM, 2010, MIL MED, V175, P101, DOI 10.7205/MILMED-D-09-00080; Crump C, 2013, BRIT J PSYCHIAT, V203, P297, DOI 10.1192/bjp.bp.112.123992; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Defense Manpower Data Center (DMDC), 2011, US ACT DUT MIL DEATH; Defense Manpower Data Center (DMDC) Defense Casualty Analysis System (DCAS), 2016, OP END FREED OEF CAS; Gilman SE, 2014, PSYCHOL MED, V44, P2579, DOI 10.1017/S003329171400018X; Goodwin L., 2012, PSYCHOL MED, P1; Heeringa S. G., 2010, APPL SURVEY ANAL; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hooper TI, 2006, ACCIDENT ANAL PREV, V38, P518, DOI 10.1016/j.aap.2005.11.009; Howland J, 2007, ADDICTION, V102, P1411, DOI 10.1111/j.1360-0443.2007.01908.x; Hyman J, 2012, AM J PUBLIC HEALTH, V102, pS138, DOI 10.2105/AJPH.2011.300484; Kelty R, 2010, FUTURE CHILD, V20, P181; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Lande RG, 2007, J AM OSTEOPATH ASSOC, V107, P401; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Lewandowski-Romps L, 2014, AM J PREV MED, V47, P745, DOI 10.1016/j.amepre.2014.07.052; Lillis-Hearne P., 2011, ARMY PAIN MANAGEMENT; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; National Center for Injury Center for Disease Control (CDC), 2015, 10 LEAD CAUS DEATH U; Niebuhr DW, 2013, PSYCHOL SERV, V10, P378, DOI 10.1037/a0032783; Office of the Surgeon General (OTSG)/Medical command (MEDCOM), 2015, GUID MAN POL PREV ME; Payne RA, 2016, CLIN MED, V16, P465, DOI 10.7861/clinmedicine.16-5-465; Possis E, 2014, MIL MED, V179, P633, DOI 10.7205/MILMED-D-13-00327; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P13, DOI 10.1002/da.22316; SAS Institute,, 2003, SAS STAT US GUID VER; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Schumm JA, 2012, ALCOHOL RES-CURR REV, V34, P401; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Southwick SM, PTSD RES Q, V25, P1; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; U. S. Headquarters Department of the Army, 2012, ARM 2020 GEN HLTH DI; Wesensten Nancy J, 2013, US Army Med Dep J, P109; Wilson ALG, 2003, PREV MED, V36, P124, DOI 10.1006/pmed.2002.1054; Wooten NR, 2013, J SUBST ABUSE TREAT, V45, P257, DOI 10.1016/j.jsat.2013.04.001	52	3	3	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0091-7435	1096-0260		PREV MED	Prev. Med.	JUN	2018	111						299	306		10.1016/j.ypmed.2017.11.016			8	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	GG7GV	WOS:000432867400041	29155224	Green Accepted			2022-02-06	
J	Myers, RK; Eagan-Brown, BL; Conway, AT; Nagele, DA; Vaccaro, MJ; Kendi, S; Zonfrillo, MR				Myers, Rachel K.; Eagan-Brown, Brenda L.; Conway, Alexandra T.; Nagele, Drew A.; Vaccaro, Monica J.; Kendi, Sadiqa; Zonfrillo, Mark R.			Examining a Statewide Educational Consulting Program for Pediatric Brain Injury	CLINICAL PEDIATRICS			English	Article						traumatic brain injury; concussion; education; postacute care; pediatric	CHILDREN; SCHOOL; CHILDHOOD; OUTCOMES; SUPPORT; NEEDS; TERM; PERSPECTIVES; ACHIEVEMENT; ADOLESCENTS	This study describes characteristics of students with acquired brain injury enrolled in a statewide educational consultation program and the program's support activities. Utilizing deidentified data from a statewide brain injury school consultation program, descriptive analyses of demographic and injury characteristics, including medical diagnosis (concussion/mild traumatic brain injury [TBI], moderate-severe TBI, and non-TBI), referral characteristics, educational placement, and the types of program activities were undertaken. 70% of students were referred for concussions/mild TBI and students were infrequently referred by medical professionals. Most students with concussion/mild TBI experienced recreational injuries (59%), while students with moderate/severe TBI commonly experienced road traffic injuries (48%). The greatest proportion of program team members' time was spent in consultation with school personnel (24%), communication with families (20%), and communication with school personnel (16%). Results suggest that the program addresses important communication and coordination needs among families, medical professionals, and educators and identifies opportunities to enhance program utilization.	[Myers, Rachel K.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Eagan-Brown, Brenda L.; Nagele, Drew A.; Vaccaro, Monica J.] Brain Injury Assoc Penn, Carlisle, PA USA; [Conway, Alexandra T.] Anal Grp, Boston, MA USA; [Kendi, Sadiqa] Univ Florida, Hlth Shands Childrens Hosp, Gainesville, FL USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA		Myers, RK (corresponding author), Childrens Hosp Philadelphia, Violence Prevent Initiat, 2716 South St,13th Floor, Philadelphia, PA 19146 USA.	myersr@email.chop.edu	Zonfrillo, Mark R./H-9403-2017; Myers, Rachel/AAG-1053-2019	Zonfrillo, Mark R./0000-0002-0610-9563; Kendi, Sadiqa/0000-0002-0247-0933; Myers, Rachel/0000-0003-1998-8162	National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241]; Pennsylvania Department of Health through federal Title V Maternal & Child Family Health Block Grant Funding; Bureau of Special Education via the Pennsylvania Training and Technical Assistance Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD073241] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Zonfrillo received support from the National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant No. K08HD073241. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The BrainSTEPS Program is funded in part by the Pennsylvania Department of Health through federal Title V Maternal & Child Family Health Block Grant Funding, which provides funding to support access to rehabilitative and treatment services for children that are not addressed within the healthcare system. The Pennsylvania Department of Education funding is provided by the core budget of the Bureau of Special Education via the Pennsylvania Training and Technical Assistance Network. No other external sources of support funded this work.	Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Brain Injury Alliance of Colorado, 2016, CASE MANAGEMENT; Brain Injury Association of Pennsylvania Inc, BRAINSTEPS STRAT TEA; Bullock LM, 2005, PREV SCH FAIL, V49, P6, DOI 10.3200/PSFL.49.4.6-10; Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Davies S., 2013, PHYS DISABILITIES ED, V32, P55; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Katz E R, 1992, Child Health Care, V21, P69, DOI 10.1207/s15326888chc2102_1; Koontz K, 2004, J PEDIATR PSYCHOL, V29, P7, DOI 10.1093/jpepsy/jsh002; McCarthy A M, 1998, J Pediatr Oncol Nurs, V15, P143, DOI 10.1177/104345429801500303; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Schilling EJ, 2012, TEACH EXCEPT CHILD, V45, P54, DOI 10.1177/004005991204500108; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; The Center on Brain Injury Research & Training, 2016, CTR BRAIN INJ RES TR; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	30	3	3	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2018	57	6					645	655		10.1177/0009922817732146			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GF6BL	WOS:000432051700003	28933193	Green Accepted			2022-02-06	
J	Ricci, MF; Martin, BJ; Joffe, AR; Dinu, IA; Alton, GY; Guerra, GG; Robertson, CMT				Ricci, M. Florencia; Martin, Billie-Jean; Joffe, Ari R.; Dinu, Irina A.; Alton, Gwen Y.; Guerra, Gonzalo G.; Robertson, Charlene M. T.		Western Canadian Complex Pediat Th	Deterioration of functional abilities in children surviving the Fontan operation	CARDIOLOGY IN THE YOUNG			English	Article						Child; Fontan procedure; activities of daily living; stroke	QUALITY-OF-LIFE; LEFT-HEART SYNDROME; ARTERIAL SWITCH OPERATION; COMPLEX CARDIAC-SURGERY; TRAUMATIC BRAIN-INJURY; ADAPTIVE-BEHAVIOR; RISK-FACTORS; STROKE; OUTCOMES; CHILDHOOD	Functional abilities are needed for activities of daily living. In general, these skills expand with age. We hypothesised that, in contrast to what is normally expected, children surviving the Fontan may have deterioration of functional abilities, and that peri-Fontan stroke is associated with this deterioration. All children registered in the Western Canadian Complex Pediatric Therapies Follow-up Program who survived a Fontan operation in the period 1999-2016 were eligible for inclusion. At the age of 2 years (pre-Fontan) and 4.5 years (post-Fontan), the Adaptive Behavior Assessment System-II general adaptive composite score was determined (population mean: 100, standard deviation: 15). Deterioration of functional abilities was defined as >= 1 standard deviation decrease in pre- to post-Fontan scores. Perioperative strokes were identified through chart review. Multivariable logistic regression analysis determined predictors of deterioration of functional abilities. Of 133 children, with a mean age at Fontan of 3.3 years (standard deviation 0.8) and 65% male, the mean (standard deviation) general adaptive composite score was 90.6 (17.5) at 2 years and 88.3 (19.1) at 4.5 years. After Fontan, deterioration of functional abilities occurred in 34 (26%) children, with a mean decline of 21.8 (7.1) points. Evidence of peri-Fontan stroke was found in 10 (29%) children who had deterioration of functional abilities. Peri-Fontan stroke (odds ratio 5.00 (95% CI 1.74, 14.36)) and older age at Fontan (odds ratio 1.67 (95% CI 1.02, 2.73)) predicted functional deterioration. The trajectory of functional abilities should be assessed in this population, as more than 25% experience deterioration. Efforts to prevent peri-Fontan stroke, and to complete the Fontan operation at an earlier age, may lead to reduction of this deterioration.	[Ricci, M. Florencia] Univ Manitoba, Dept Pediat & Child Hlth, Child Dev Clin, Winnipeg, MB, Canada; [Martin, Billie-Jean] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Joffe, Ari R.; Guerra, Gonzalo G.] Univ Alberta, Div Pediat Crit Care, Dept Pediat, Edmonton, AB, Canada; [Dinu, Irina A.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Alton, Gwen Y.; Robertson, Charlene M. T.] Univ Alberta, Glenrose Rehabil Hosp, Pediat Rehabil, Edmonton, AB, Canada; [Robertson, Charlene M. T.] Univ Alberta, Div Dev Pediat, Dept Pediat, Edmonton, AB, Canada		Ricci, MF (corresponding author), SSCY Ctr, 1155 Notre Dame Ave, Winnipeg, MB R3E 3G1, Canada.	fricci@rccinc.ca		Ricci, M. Florencia/0000-0003-3111-9840	Glenrose Hospital Foundation-clinical Research Grant; Alberta Health and Wellness, Government of Alberta; Stollery Children's Hospital, Edmonton Alberta; Alberta Children's Hospital, Calgary, Alberta; Winnipeg Children's Hospital, Winnipeg, Manitoba; Kinsmen Children's Centre; Regina General Hospital, Regina, Saskatchewan; British Columbia Children's Hospital, Vancouver, British Columbia; Royal University Hospital, Saskatoon, Saskatchewan	Financial support was provided as grants for 1996-1999, 2014-2015, and 2016-2017 from the Glenrose Hospital Foundation-clinical Research Grant, and 2000-2006 by Alberta Health and Wellness, Government of Alberta. Ongoing support is provided by the hospitals of the Western Canadian Complex Pediatric Therapies Follow-up Group: Stollery Children's Hospital, Edmonton Alberta; Alberta Children's Hospital, Calgary, Alberta; Winnipeg Children's Hospital, Winnipeg, Manitoba; Kinsmen Children's Centre and Royal University Hospital, Saskatoon, Saskatchewan; Regina General Hospital, Regina, Saskatchewan; and British Columbia Children's Hospital, Vancouver, British Columbia.	Alsaied T, 2017, HEART, V103, P104, DOI 10.1136/heartjnl-2016-310108; Alton GY, 2015, CARDIOL YOUNG, V25, P655, DOI 10.1017/S1047951114000535; Alton GY, 2010, CARDIOL YOUNG, V20, P668, DOI 10.1017/S1047951110000971; Barker PCA, 2005, AM J CARDIOL, V96, P587, DOI 10.1016/j.amjcard.2005.04.025; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bellinger DC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002302; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Brosig CL, 2017, J PEDIATR-US, V183, P80, DOI 10.1016/j.jpeds.2016.12.044; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapieski L, 2005, EPILEPSY BEHAV, V7, P246, DOI 10.1016/j.yebeh.2005.05.002; Cheng HH, 2016, PEDIATR CRIT CARE ME, V17, P976, DOI 10.1097/PCC.0000000000000902; Chun DS, 2004, AM J CARDIOL, V93, P117, DOI 10.1016/j.amjcard.2003.09.023; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Dixon S., 2006, ENCOUNTERS CHILDREN; Downing TE, 2017, J THORAC CARDIOV SUR, V154, P243, DOI 10.1016/j.jtcvs.2017.01.056; DUPLESSIS AJ, 1995, PEDIATR NEUROL, V12, P230, DOI 10.1016/0887-8994(95)00027-D; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Gaynor JW, 2014, J THORAC CARDIOV SUR, V147, P1276, DOI 10.1016/j.jtcvs.2013.12.019; Gordon AL, 2002, J CHILD NEUROL, V17, P429, DOI 10.1177/088307380201700606; Greenham M, 2016, STROKE, V47, P1159, DOI 10.1161/STROKEAHA.115.011622; Harrison P, 2003, MANUAL ADAPTIVE BEHA; HEBER R, 1958, AM J MENT DEF, V63, P214; Laraja K, 2017, J PEDIATR-US, V184, P130, DOI 10.1016/j.jpeds.2017.01.034; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Martin BJ, 2016, J AM COLL CARDIOL, V67, P946, DOI 10.1016/S0735-1097(16)30947-0; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Oakland T., 2011, ADAPTIVE BEHAV ASSES, V2nd; Oakland T, 2011, J APPL SCH PSYCHOL, V27, P103, DOI 10.1080/15377903.2011.565267; Pike NA, 2012, J CARDIOVASC NURS, V27, P539, DOI 10.1097/JCN.0b013e31822ce5f6; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rempel G, 2014, THERE IS SO MUCH MOR; Rempel GR, 2009, CARDIOL YOUNG, V19, P135, DOI 10.1017/S1047951109003485; Ricci MF, 2015, PEDIATRICS, V136, pE922, DOI 10.1542/peds.2015-1879; Ringle ML, 2016, SEMIN PERINATOL, V40, P556, DOI 10.1053/j.semperi.2016.09.008; Robertson CMT, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/965740; Shiraishi S, 2009, ANN THORAC SURG, V87, P555, DOI 10.1016/j.athoracsur.2008.11.015; Warren SF, 2017, J AUTISM DEV DISORD, V47, P768, DOI 10.1007/s10803-016-2999-7; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226; Willard VW, 2014, J CLIN ONCOL, V32, P2788, DOI 10.1200/JCO.2013.53.1996	40	3	3	0	4	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	JUN	2018	28	6					868	875		10.1017/S1047951118000537			8	Cardiac & Cardiovascular Systems; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cardiovascular System & Cardiology; Pediatrics	GI3CX	WOS:000434250000014	29690942				2022-02-06	
J	Rowe, BH; Eliyahu, L; Lowes, J; Gaudet, LA; Beach, J; Mrazik, M; Cummings, G; Voaklander, D				Rowe, Brian H.; Eliyahu, Leeor; Lowes, Justin; Gaudet, Lindsay A.; Beach, Jeremy; Mrazik, Martin; Cummings, Garnet; Voaklander, Donald			A PROSPECTIVE EVALUATION OF THE INFLUENCE OF AN ELECTRONIC CLINICAL PRACTICE GUIDELINES ON CONCUSSION PATIENTS' FUTURE ACTIVITIES AND OUTCOMES	JOURNAL OF EMERGENCY MEDICINE			English	Article						concussion; emergency department; mild traumatic brain injury; return to activity	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; DISCHARGE INSTRUCTIONS; HEAD-INJURY; SYMPTOMS; POSTCONCUSSION; RETURN; TRIAL; MANAGEMENT; WORK	Background: Patients with mild traumatic brain injury or concussion commonly present to the emergency department for assessment; providing patients with information on usual symptoms and their progression may encourage faster recovery. Objectives: This study aimed to document the role of an electronic clinical practice guideline (eCPG) patient handout on concussion recovery in adult patients discharged from the hospital. Methods: A prospective cohort study was carried out in 3 Canadian urban emergency departments. Adults (>= 17 years of age) with a Glasgow Coma Scale score of 13 to 15 who sustained a concussion were recruited by on-site research assistants. Physician use of a concussion-specific eCPG was documented from physician and patient reports. Patient follow-up calls at 30 and 90 days documented return to work/school activities and patient symptoms. Multivariate analyses were performed using logistic regression methods. Results: Overall, 250 patients were enrolled; the median age was 35 (interquartile range 23-49) and 52% were female. Approximately half (n = 119, 48%) of patients received the eCPG handout, and return to work/school recommendations varied. Symptoms persisted in 60% of patients at 30 days; patients in the eCPG group had fewer symptoms (odds ratio 0.57, 95% confidence interval 0.33-0.99). At 90 days, 40% of patients reported persistent symptoms, with no significant difference between groups. Conclusion: An eCPG handout improved patients' short-term outcomes; however, physician use and adherence to guideline recommendations was low. To further facilitate physician compliance and therefore patient recovery, barriers to use of the eCPG handout need to be identified and addressed. (C) 2018 Elsevier Inc. All rights reserved.	[Rowe, Brian H.; Beach, Jeremy; Voaklander, Donald] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Rowe, Brian H.; Lowes, Justin; Gaudet, Lindsay A.; Cummings, Garnet] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Edmonton, AB, Canada; [Eliyahu, Leeor] Univ Alberta, Dept Family Med, Edmonton, AB, Canada; [Beach, Jeremy] Univ Alberta, Fac Med & Dent, Div Prevent Med, Edmonton, AB, Canada; [Beach, Jeremy] Univ Alberta, Coll Phys & Surg Alberta, Edmonton, AB, Canada; [Mrazik, Martin] Univ Alberta, Fac Educ, Dept Educ Psychol, Edmonton, AB, Canada		Rowe, BH (corresponding author), Univ Alberta, Dept Emergency Med, 1G1-43 Walter C Mackenzie Ctr,8440-112 St NW, Edmonton, AB T6G 2B7, Canada.						Alberti TL, 2013, J AM ACAD NURSE PRAC, V25, P186, DOI 10.1111/j.1745-7599.2012.00767.x; Atzema CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077057; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Carroll LJ, 2014, ARCH PHYS MED REHAB, V95, pS265; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Lane AD, 2017, J EMERG MED, V52, P690, DOI 10.1016/j.jemermed.2016.12.017; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Parizek A, 2016, CURR SPORT MED REP, V15, P23, DOI 10.1249/JSR.0000000000000209; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rowe B, 2003, ACAD EMERG MED, V10, P537; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Studerus-Germann AM, 2017, INT J NEUROSCI, V127, P900, DOI 10.1080/00207454.2017.1278589; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Varner CE, 2017, ACAD EMERG MED, V24, P75, DOI 10.1111/acem.13073; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	31	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUN	2018	54	6					774	783		10.1016/j.jemermed.2018.02.013			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	GI6IJ	WOS:000434472600012	29685463				2022-02-06	
J	Seleznev, A; Shah, NV; Desai, R; Le, C; Cleary, P; Naziri, Q; Basu, NN; Freeman, BJ; Urban, WP; Newman, JM				Seleznev, Aleksey; Shah, Neil, V; Desai, Rohan; Cuong Le; Cleary, Patrick; Naziri, Qais; Basu, Niladri N.; Freeman, Barbara J.; Urban, William P.; Newman, Jared M.			Trends of snowboarding-related fractures that presented to emergency departments in the United States, 2010 to 2016	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Snowboarding; fractures; injuries; trends	SKIING INJURIES; ALPINE; ELITE	Background: Since it was introduced as an Olympic sport in 1998, snowboarding has drawn the participation of individuals of all ages. Despite the growing popularity of this sport, individuals can suffer from a number of musculoskeletal injuries. The specific goals of the study were to: (I) compare the number of injuries and trends of snowboarding injuries; (II) identify the injury occurrences, trends, and incidence of snowboarding-related fractures; and (III) identify the injury occurrences and trends of snowboarding-related fractures by body part. Methods: The National Electronic Injury Surveillance System (NEISS) database was queried for snowboarding injuries and snowboarding-related fractures treated in US emergency departments (EDs) from 2010-2016. The weighted estimate of the number of injuries were obtained by using the NEISS statistical weight calculations that were provided in the data. An estimated total of 248,388 patients (mean age =20 years) experienced a snowboarding-related injury. Linear regression analysis was used to analyze annual trends of snowboarding-related fractures and the snowboarding-related fractures by body part; reported as the correlation coefficient (r) and the coefficient of determination (R-2). Results: The estimated annual number of injuries decreased from 56,223 injuries in 2010 to 17,667 injuries in 2016 (r=-0.967, R-2=0.936, P<0.001). The most common types of injuries were fractures (31.7%), strains/sprains (25.2%), contusions (10.9%), concussions (10.0%), internal injuries (7.2%), and dislocations (4.0%). From 2010 to 2016, the estimated annual number of fractures decreased from 18,757 in 2010 to 4,539 in 2016 (r=-0.978, R-2=0.957, P<0.001), and the annual incidence of snowboarding-related fractures decreased by 23.1%. The most common location of snowboarding-related fractures was the upper extremity, more specifically the wrist (32.3%). There was a decrease in the estimated annual number of fractures of the wrist (r=-0.965, R-2=0.932, P<0.001), forearm (r=-0.821, R-2=0.861, P=0.023), shoulder (r=-0.872, R-2=0.760, P=0.011), elbow (r=-0.901, R-2=0.813, P=0.006), and lower leg (r=-0.929, R-2=0.864, P=0.002). Conclusions: With the growing popularity of snowboarding in the US, it is important to know the common types of injuries that occur. This study found that fractures were the most common injuries, especially of the upper extremity.	[Seleznev, Aleksey; Shah, Neil, V; Desai, Rohan; Naziri, Qais; Basu, Niladri N.; Urban, William P.; Newman, Jared M.] Suny Downstate Med Ctr, Dept Orthopaed Surg, 450 Clarkson Ave Box 30, Brooklyn, NY 11203 USA; [Cuong Le] Suny Downstate Med Ctr, Dept Family Med, Brooklyn, NY 11203 USA; [Cleary, Patrick] Suny Downstate Med Ctr, Dept Sports Med, Brooklyn, NY 11203 USA; [Freeman, Barbara J.] Kings Cty Hosp Ctr, Dept Orthopaed Surg, New York, NY USA		Newman, JM (corresponding author), Suny Downstate Med Ctr, Dept Orthopaed Surg, 450 Clarkson Ave Box 30, Brooklyn, NY 11203 USA.	jared.newman@downstate.edu		Shah, Neil/0000-0002-3439-3071			Basques BA, 2016, KNEE SURG SPORTS TRA; BLADIN C, 1993, AM J SPORT MED, V21, P701, DOI 10.1177/036354659302100511; Bladin C, 2004, SPORTS MED, V34, P133, DOI 10.2165/00007256-200434020-00006; DeFroda SF, 2016, INJURY, V47, P2283, DOI 10.1016/j.injury.2016.07.005; Dohjima T, 2001, ACTA ORTHOP SCAND, V72, P657, DOI 10.1080/000164701317269111; Ehrnthaller C, 2015, OPEN ACCESS J SPORTS, V6, P109, DOI 10.2147/OAJSM.S78861; Idzikowski JR, 2000, AM J SPORT MED, V28, P825, DOI 10.1177/03635465000280061001; Kim S, 2012, AM J SPORT MED, V40, P770, DOI 10.1177/0363546511433279; Kirkpatrick DP, 1998, AM J SPORT MED, V26, P271, DOI 10.1177/03635465980260021901; Machold W, 2000, J TRAUMA, V48, P1109, DOI 10.1097/00005373-200006000-00018; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; McCall D, 2009, BRIT J SPORT MED, V43, P987, DOI 10.1136/bjsm.2009.068767; National electronic injury surveillance system (NEISS), 2016, US CONS PROD SAF COM; NEISS-The National Electronic Injury Surveillance System A Tool for Researchers, 2000, DIV HAZ INJ DAT SYST, P1; Patrick E, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115588280; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Schroeder T., 2001, NEISS SAMPLE DESIGN; SIA Snow Sports Industry Insights Study, 2017, SNOWSPORTS IND AM RE; Steenstrup SE, 2018, BRIT J SPORT MED, V52, P61, DOI 10.1136/bjsports-2017-098240; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Wijdicks CA, 2014, BRIT J SPORT MED, V48, P11, DOI 10.1136/bjsports-2013-093019; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Yamagami T, 2004, J ORTHOP SCI, V9, P225, DOI 10.1007/s00776-004-0776-5	24	3	3	0	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	JUN	2018	6	11							200	10.21037/atm.2018.04.32			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GJ8BV	WOS:000435615200002	30023363	Green Published			2022-02-06	
J	Sours, C; Kinnison, J; Padmala, S; Gullapalli, RP; Pessoa, L				Sours, Chandler; Kinnison, Joshua; Padmala, Srikanth; Gullapalli, Rao P.; Pessoa, Luiz			Altered segregation between task-positive and task-negative regions in mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Task-positive; Default mode network; Segregation; Working memory	WORKING-MEMORY; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; RESTING-STATE; NETWORK ORGANIZATION; HEAD-INJURY; ATTENTION; DEFICITS; INDIVIDUALS; PERFORMANCE	Changes in large-scale brain networks that accompany mild traumatic brain injury (mTBI) were investigated using functional magnetic resonance imaging (fMRI) during the N-back working memory task at two cognitive loads (1-back and 2-back). Thirty mTBI patients were examined during the chronic stage of injury and compared to 28 control participants. Demographics and behavioral performance were matched across groups. Due to the diffuse nature of injury, we hypothesized that there would be an imbalance in the communication between task-positive and Default Mode Network (DMN) regions in the context of effortful task execution. Specifically, a graph-theoretic measure of modularity was used to quantify the extent to which groups of brain regions tended to segregate into task-positive and DMN sub-networks. Relative to controls, mTBI patients showed reduced segregation between the DMN and task-positive networks, but increased functional connectivity within the DMN regions during the more cognitively demanding 2-back task. Together, our findings reveal that patients exhibit alterations in the communication between and within neural networks during a cognitively demanding task. These findings reveal altered processes that persist through the chronic stage of injury, highlighting the need for longitudinal research to map the neural recovery of mTBI patients.	[Sours, Chandler; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA; [Kinnison, Joshua; Padmala, Srikanth; Pessoa, Luiz] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA		Sours, C (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	csour001@umaryland.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; NRSA grant from the National Institute of Neurological Disorders and Stroke [1F31NS081984]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105503] Funding Source: NIH RePORTER	Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725 & W81XWH-12-1-0098 to R.P.G). Chandler Sours was supported by the NRSA grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984).	Balenzuela Pablo, 2010, Front Neuroinform, V4, P116, DOI 10.3389/fninf.2010.00116; Bates D, 2014, LME4 LINEAR MIXED EF; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Creelman, 2005, DETECTION THEORY USE; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; DePalma R. G., 2016, BEHAV BRAIN RES; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Green D.M., 1966, SOCIETY; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Iraji A., 2014, J NEUROTRAUM; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnison J, 2012, J NEUROSCI, V32, P8361, DOI 10.1523/JNEUROSCI.0821-12.2012; Kuznetsova A., 2014, LMERTEST TESTS RANDO; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M., 2000, STANDARDIZED ASSESSM; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McMenamin BW, 2014, J NEUROSCI, V34, P11261, DOI 10.1523/JNEUROSCI.1579-14.2014; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Najafi M, 2016, NEUROIMAGE, V135, P92, DOI 10.1016/j.neuroimage.2016.04.054; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newman M, 2010, NETWORKS INTRO; Newton AT, 2011, HUM BRAIN MAPP, V32, P1649, DOI 10.1002/hbm.21138; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pessoa L, 2004, CEREB CORTEX, V14, P511, DOI 10.1093/cercor/bhh013; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Pessoa L, 2014, PHYS LIFE REV, V11, P400, DOI 10.1016/j.plrev.2014.03.005; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Prado J, 2011, NEUROIMAGE, V56, P2276, DOI 10.1016/j.neuroimage.2011.03.048; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rossi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153148; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Seabold J. S., 2010, P 9 PYTH SCI C; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Talairach J., 1988, COPLANAR STEREOTAXIC; van der Horn H. J., 2015, BRAIN IMAGING BEHAV; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	80	3	4	1	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2018	12	3					697	709		10.1007/s11682-017-9724-9			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI6PB	WOS:000434491400008	28456880	Green Accepted			2022-02-06	
J	Spitoni, GF; Bevacqua, S; Cerini, C; Ciurli, P; Piccardi, L; Guariglia, P; Pezzuti, L; Antonucci, G				Spitoni, Grazia Fernanda; Bevacqua, Sara; Cerini, Claudia; Ciurli, Paola; Piccardi, Laura; Guariglia, Paola; Pezzuti, Lina; Antonucci, Gabriella			Normative Data for the Hayling and Brixton Tests in an Italian Population	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functions; Hayling test; Brixton test; Neuropsychological assessment; Verbal suppression; Normative data	TRAUMATIC BRAIN-INJURY; OBSESSIVE-COMPULSIVE DISORDER; SPATIAL ANTICIPATION TEST; AGE-RELATED DIFFERENCES; EXECUTIVE FUNCTIONS; INHIBITION PROCESSES; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; OLDER-ADULTS	Objective: The Hayling and Brixton tests constitute a short test battery that quickly assesses verbal and spatial inhibition and flexibility. This battery has shown high construct validity and strong reliability in clinical and experimental settings. The aim of this study was to develop an Italian version of the Hayling and Brixton tests and obtain normative values. Method: We collected normative data from 301 healthy Italian participants aged between 16 and 94 years, taking into account all demographics. To maximize the sample size, we used the overlapping interval strategy. Adjusted scores for demographics were obtained by linear regression analysis. Results: The performance on the Hayling and Brixton tests was influenced by age and education. In particular, age affected verbal accuracy and response time on the Hayling Sentence Completion Test, whereas education only affected the former. Differently, the spatial component, as measured by the Brixton Spatial Anticipation Test, was shaped only by age, which decreased the number of correct responses. Conclusions: Our study provides normative data that have been adjusted for relevant demographics and percentile grids in an Italian population. Our data support the use of the Hayling and Brixton tests as a valid instrument for performing neuropsychological evaluations and longitudinal analyses of executive functions in clinical practice and for research purposes.	[Spitoni, Grazia Fernanda; Bevacqua, Sara; Cerini, Claudia; Pezzuti, Lina; Antonucci, Gabriella] Sapienza Univ Rome, Dept Psychol, Via Marsi 78, Rome, Italy; [Spitoni, Grazia Fernanda; Ciurli, Paola; Piccardi, Laura; Antonucci, Gabriella] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy; [Piccardi, Laura] Aquila Univ, Dept Life Hlth & Environm Sci, Laquila, Italy; [Guariglia, Paola] Univ Enna Kore, Dept Human Sci & Soc, Enna, Italy		Spitoni, GF (corresponding author), Sapienza Univ Rome, Dept Psychol, Via Marsi 78, Rome, Italy.	grazia.spitoni@uniroma1.it	Piccardi, laura/AAC-7587-2022; ANTONUCCI, GABRIELLA/F-3827-2011	ANTONUCCI, GABRIELLA/0000-0003-0253-9029			Abbate-Daga G, 2015, INT J EAT DISORDER, V48, P736, DOI 10.1002/eat.22399; Andres P, 2000, J GERONTOL B-PSYCHOL, V55, pP373, DOI 10.1093/geronb/55.6.P373; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Bagshaw R, 2014, PSYCHIAT RES, V220, P483, DOI 10.1016/j.psychres.2014.07.031; Bayard S., 2017, ARCH CLIN NEUROPSYCH, V7, P1; Bayard S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/231469; Bedard MJ, 2009, ARCH CLIN NEUROPSYCH, V24, P585, DOI 10.1093/arclin/acp052; Belleville S, 2006, BRAIN COGNITION, V62, P113, DOI 10.1016/j.bandc.2006.04.006; Bielak AAM, 2006, ARCH CLIN NEUROPSYCH, V21, P141, DOI 10.1016/j.acn.2005.08.006; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Cavallo M, 2016, ARCH CLIN NEUROPSYCH, V31, P868, DOI 10.1093/arclin/acw072; Garcia MC, 2015, ACTA NEUROL SCAND, V131, P313, DOI 10.1111/ane.12345; Chung CSY., 2013, COCHRANE DB SYST REV, V2013, P77; Cipolotti L, 2016, NEUROPSYCHOLOGIA, V93, P1, DOI 10.1016/j.neuropsychologia.2016.09.018; Colangeli S, 2016, AM J ALZHEIMERS DIS, V31, P443, DOI 10.1177/1533317516653826; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; Corben LA, 2017, CEREBELLUM, V16, P757, DOI 10.1007/s12311-017-0848-7; David DP, 2014, J AFFECT DISORDERS, V152, P288, DOI 10.1016/j.jad.2013.09.027; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Gorsuch R. L., 1983, 91 ANN CONV AM PSYCH; Mac Kay APMG, 2016, CODAS, V28, P329, DOI 10.1590/2317-1782/20162016056; Harvey L, 2016, APPL NEUROPSYCH-CHIL, V5, P1, DOI 10.1080/21622965.2013.814087; Heaton RK, 1981, MANUAL WISCONSIN CAR; Jelcic N, 2013, BRAIN INJURY, V27, P1723, DOI 10.3109/02699052.2013.844857; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Macfarlane MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129692; Martin AK, 2015, BRAIN COGNITION, V99, P57, DOI 10.1016/j.bandc.2015.07.009; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Obeso I, 2011, EXP BRAIN RES, V212, P371, DOI 10.1007/s00221-011-2736-6; PAUKER JD, 1988, J CLIN PSYCHOL, V44, P930, DOI 10.1002/1097-4679(198811)44:6<930::AID-JCLP2270440613>3.0.CO;2-H; Perez-Perez A, 2016, ARCH CLIN NEUROPSYCH, V31, P411, DOI 10.1093/arclin/acw027; Potter GG, 2016, INT J GERIATR PSYCH, V31, P466, DOI 10.1002/gps.4351; Raven J. C., 1938, STANDARD PROGR MATRI; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; Robinson GA, 2015, BRAIN, V138, P1084, DOI 10.1093/brain/awv003; Roman CAF, 2016, J CLIN EXP NEUROPSYC, V38, P261, DOI 10.1080/13803395.2015.1105199; Rose AK, 2010, ALCOHOL ALCOHOLISM, V45, P501, DOI 10.1093/alcalc/agq062; Rose Mark, 2011, Clin Child Psychol Psychiatry, V16, P195, DOI 10.1177/1359104511401191; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sharp PB, 2015, INT J PSYCHOPHYSIOL, V98, P365, DOI 10.1016/j.ijpsycho.2015.07.001; Simon Andor E, 2006, Cogn Neuropsychiatry, V11, P437, DOI 10.1080/13546800444000308; Siqueira Larissa de Souza, 2016, Trends Psychiatry Psychother., V38, P164, DOI 10.1590/2237-6089-2016-0019; Spitzer D, 2017, CORTEX, V87, P80, DOI 10.1016/j.cortex.2016.10.004; Stenback V, 2015, SCAND J PSYCHOL, V56, P264, DOI 10.1111/sjop.12206; Tournier I, 2014, ARCH GERONTOL GERIAT, V59, P599, DOI 10.1016/j.archger.2014.07.016; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; van Beilen M, 2005, J PSYCHIATR RES, V39, P585, DOI 10.1016/j.jpsychires.2005.02.001; van den Berg E, 2009, J INT NEUROPSYCH SOC, V15, P695, DOI 10.1017/S1355617709990269; Vandborg SK, 2014, COGN BEHAV NEUROL, V27, P8, DOI 10.1097/WNN.0000000000000021; Volle E, 2012, CEREB CORTEX, V22, P2428, DOI 10.1093/cercor/bhr322; Welsh M. C., 1999, BRAIN COGNITION, V56, P286; Wilson B. A., 1996, BEHAV ASSESSMENT DIS; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P90, DOI 10.1017/S1355617707070129; Zebdi R, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00195; Zimmerman D., 2016, FRONT HUM NEUROSCI, V5, P10	66	3	3	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2018	33	4					466	476		10.1093/arclin/acx072			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GP6ES	WOS:000440971000010	28961765				2022-02-06	
J	Wang, SX; Li, BH; Li, J; Huang, FG; Xiang, Z; Zhong, G; Fang, Y; Yi, M; Zhao, XD; Liu, L				Wang, Shan-Xi; Li, Bo-Hua; Li, Jun; Huang, Fu-Guo; Xiang, Zhou; Zhong, Gang; Fang, Yue; Yi, Min; Zhao, Xiao-Dan; Liu, Lei			Middle-term follow-up results of Pipkin type IV femoral head fracture patients treated by reconstruction plate and bioabsorbable screws	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Femoral head fractures; Acetabular fractures; Pipkin classification; Fracture fixation, internal	KOCHER-LANGENBECK APPROACH; SURGICAL DISLOCATION; AVASCULAR NECROSIS; HIP; ACETABULUM; REDUCTION; OSSIFICATION; FIXATION	Purpose: To investigate the mid-term curative effects of the treatment of Pipkin type IV femoral head fractures using a reconstruction plate and bioabsorbable screws and provide the evidence for clinical practice. Methods: From February 2010 to September 2014, 21 patients with Pipkin type IV femoral head fractures were treated surgically. There were 13 males and 8 females with an average age of 41.1 years (range, 20-65 years). The causes of the fractures included traffic accidents (13 cases), falls from a height (four cases), heavy lifting injuries (three cases), and sport injury (one case). All patients were followed up with radiography and three-dimensional reconstruction computed tomography and other checks and any complications were actively managed. Closed reduction of fracture-dislocation of the hip was attempted under general anesthesia using the Kocher-Langenbeck approach. Femoral head fractures were treated with internal fixation or excision based on the size of the fracture fragments, whereas acetabular fractures were fixed with a reconstruction plate and screws following anatomic reduction. Results: The incisions healed by primary intention in all patients after surgery, without any infection, deep venous thrombosis, or other complications. All 21 patients were followed up for 36-76 months, with an average follow-up duration of 49 months. Postoperative imaging data showed that all dislocations and fractures were anatomically reduced, and bony union of the fractures was achieved. Heterotopic ossification was found in four patients, post-traumatic osteoarthritis in three, and avascular necrosis of the femoral head in two. At the final follow-up, the assessment of hip joint function according to the Thompson-Epstein scoring scale was excellent in 10 cases, good in six cases, fair in three cases, and poor in two cases. The rate of excellent and good functional outcomes was 76.1%. Conclusion: The mid-term curative effects of a reconstruction plate and bioabsorbable screws in the treatment of Pipkin type IV femoral head fractures is significant, and such the treatment can significantly improve the patient's joint function and quality of life. (C) 2018 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V.	[Wang, Shan-Xi; Li, Bo-Hua; Li, Jun; Huang, Fu-Guo; Xiang, Zhou; Zhong, Gang; Fang, Yue; Yi, Min; Zhao, Xiao-Dan; Liu, Lei] Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu 610041, Sichuan, Peoples R China		Liu, L (corresponding author), Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu 610041, Sichuan, Peoples R China.	liuinsistence@163.com	Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-7294-6888			Alexa O, 2013, CHIRURGIA-BUCHAREST, V108, P879; Birkett J, 1869, Med Chir Trans, V52, P133; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Chen Zhi-wen, 2011, Orthopedics, V34, P350, DOI 10.3928/01477447-20110317-09; Chen Zhiwei, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P1184; DAVIS JB, 1950, AM J SURG, V80, P893, DOI 10.1016/0002-9610(50)90473-9; Droll KP, 2007, J AM ACAD ORTHOP SUR, V15, P716, DOI 10.5435/00124635-200712000-00005; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Funsten RV, 1938, J BONE JOINT SURG, V20, P124; Gansslen A, 2009, OPER ORTHOPADE TRAUM, V21, P283, DOI 10.1007/s00064-009-1805-5; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gardner MJ, 2005, J ORTHOP TRAUMA, V19, P334; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; Guo JJ, 2010, INT ORTHOP, V34, P319, DOI 10.1007/s00264-009-0849-3; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; Hermus JPS, 2005, INJURY, V36, P458, DOI 10.1016/j.injury.2004.07.021; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; JUDET R, 1964, Acta Orthop Belg, V30, P285; Kloen P., 2002, EUR J TRAUMA EMERG S, V28, P221, DOI [10.1007/s00068-002-1173-4, DOI 10.1007/S00068-002-1173-4]; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; McMurtry IA, 2001, INJURY, V32, P162, DOI 10.1016/S0020-1383(00)00152-2; Mears DC, 2003, CLIN ORTHOP RELAT R, P173, DOI 10.1097/01.blo.0000043057.62337.3a; Mostafa MF, 2014, ARCH ORTHOP TRAUM SU, V134, P637, DOI 10.1007/s00402-014-1960-5; Negrin LL, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0563-6; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; Scolaro JA, 2017, J ORTHOP TRAUMATOL, V18, P235, DOI 10.1007/s10195-017-0445-z; Siebenrock KA, 2002, J ORTHOP TRAUMA, V16, P543, DOI 10.1097/00005131-200209000-00002; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; STOCKENHUBER N, 1994, CHIRURG, V65, P976; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; Thannheimer A, 2009, CHIRURG, V80, P1140, DOI 10.1007/s00104-009-1738-4; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; TRUETA J, 1953, J BONE JOINT SURG BR, V35, P442, DOI 10.1302/0301-620X.35B3.442; Wang CG, 2016, INT J SURG, V27, P176, DOI 10.1016/j.ijsu.2016.02.003	35	3	7	1	6	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2018	21	3					170	175		10.1016/j.cjtee.2017.12.004			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GK2IQ	WOS:000435952400006	29793730	gold, Green Published			2022-02-06	
J	Olgun Yazar, H; Yazar, T; Yancar Demir, E; Cankaya, S; Enginyurt, O				Olgun Yazar, Hulya; Yazar, Tamer; Yancar Demir, Esra; Cankaya, Soner; Enginyurt, Ozgur			ASSESSMENT OF MENTAL HEALTH OF CARERS ACCORDING TO PATIENT STAGE OF IDIOPATHIC PARKINSON'S DISEASE	IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE			English	Article						idiopathic Parkinson's disease; Short Symptom Inventory; mental health; care load	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CAREGIVER BURDEN; PREDICTORS; DEMENTIA; DEPRESSION; DISORDERS; APPRAISAL; ANXIETY; IMPACT	Purpose - In this study the aim was to collect data to assess the mental health of carers for patients with diagnosis of idiopathic Parkinson's disease (IPD) according to disease stage and to examine precautions to reduce the patient and disease load on carers. Method - The study included 144 patients with staging according to modified Hoehn and Yahr criteria and 144 patient relatives who provided care support for patients every day, for some or all of the day, and who were over the age of 18 years and accepted participation in the research. Our prospective and cross-sectional study performed detailed neurological examination of patients, and after completing the 'Personal Information Form' with the interviewer every patient, with idiopathic Parkinson's disease (IPD) according to 'UK Brain Bank' diagnostic criteria, had the 'Unified Parkinson's Disease Rating Scale (UPDRS)' and 'Modified Hoehn and Yahr scale (HYS)' applied. Carers first completed the 'Personal Information Form' and then had the 'Short Symptom Inventory (SSI)' applied. Results - As the stage of disease increased, the points for all sub-scales of the Short Symptom Inventory increased. Conclusion - With the parallel increase in disease scores and UPDRS stage scores, the points obtained by carers on the SSI sub-scales increased. This data shows that with progressing disease stage, the load on the carer increases and mental health begins to be disrupted.	[Olgun Yazar, Hulya] Ordu Univ, Neurol, Educ & Res Hosp, Cumhuriyet Campus PK 52200 Ctr, Ordu, Turkey; [Yazar, Tamer] Ordu State Hosp, Neurol, Ordu, Turkey; [Yancar Demir, Esra] Ordu Univ, Dept Mental Hlth & Dis, Fac Med, Ordu, Turkey; [Cankaya, Soner] Ordu Univ, Dept Biostat & Med Informat, Fac Med, Ordu, Turkey; [Enginyurt, Ozgur] Ordu Univ, Dept Family Practitioners, Fac Med, Ordu, Turkey		Olgun Yazar, H (corresponding author), Ordu Univ, Neurol, Educ & Res Hosp, Cumhuriyet Campus PK 52200 Ctr, Ordu, Turkey.	hulyazar@yahoo.com	YAZAR, Tamer/U-7069-2019; Olgun, Hulya/U-6806-2019	Olgun, Hulya/0000-0003-2768-6092			Allen SM, 1999, GERONTOLOGIST, V39, P150, DOI 10.1093/geront/39.2.150; Asada T, 2000, PSYCHIAT CLIN NEUROS, V54, P673, DOI 10.1046/j.1440-1819.2000.00768.x; Atagun M., 2011, CURR APPROACHES PSYC, V3, P513, DOI DOI 10.5455/CAP.20110323; Crespo M, 2005, INT J GERIATR PSYCH, V20, P591, DOI 10.1002/gps.1321; Derogatis L. R., 1992, BRIEF SYMPTOM INVENT; Derogatis L.R., 1975, BRIEF SYMPTOM INVENT; DURA JR, 1991, PSYCHOL AGING, V6, P467, DOI 10.1037/0882-7974.6.3.467; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gonzalez-Salvador MT, 1999, INT J GERIATR PSYCH, V14, P701, DOI 10.1002/(SICI)1099-1166(199909)14:9<701::AID-GPS5>3.0.CO;2-#; Harwood DG, 2000, INT J GERIATR PSYCH, V15, P481, DOI 10.1002/1099-1166(200006)15:6<481::AID-GPS984>3.0.CO;2-J; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Koca E, 2017, NOROPSIKIYATRI ARS, V54, P82, DOI 10.5152/npa.2017.11304; Larsen L S, 1998, J Psychosoc Nurs Ment Health Serv, V36, P26; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lokk J, 2008, EUR J PHYS REHAB MED, V44, P39; Morimoto T, 2003, AGE AGEING, V32, P218, DOI 10.1093/ageing/32.2.218; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Roick C, 2006, ACTA PSYCHIAT SCAND, V114, P363, DOI 10.1111/j.1600-0447.2006.00797.x; Rose-Rego SK, 1998, GERONTOLOGIST, V38, P224, DOI 10.1093/geront/38.2.224; Sahin EM, 2003, GERIATRI TURKISH J G, V6, P1013; Sahin NH., 1994, TURKISH J PSYCHOL, V9, P44; Sink KM, 2006, J AM GERIATR SOC, V54, P796, DOI 10.1111/j.1532-5415.2006.00697.x; Sisk RJ, 2000, INT J NURS STUD, V37, P37, DOI 10.1016/S0020-7489(99)00053-X; Torun, 1995, EUR J NEUROL S1, V2, P44; Waite A, 2004, INT J GERIATR PSYCH, V19, P582, DOI 10.1002/gps.1136; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yilmaz A, 2009, AUSTRALAS J AGEING, V28, P16, DOI 10.1111/j.1741-6612.2008.00319.x	28	3	3	0	4	LITERATURA MEDICA	BUDAPEST	MARGIT KRT 31-33, BUDAPEST, 1024, HUNGARY	0019-1442			IDEGGYOGY SZEMLE	Ideggyogy. Szle.	MAY 30	2018	71	5-6					205	212		10.18071/isz.71.0205			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP6AP	WOS:000440959600007	29889463				2022-02-06	
J	Jang, SH; Kim, SH; Kwon, YH				Jang, Sung H.; Kim, Seong H.; Kwon, Young H.			Excessive Daytime Sleepiness and Injury of the Ascending Reticular Activating System Following Whiplash Injury	FRONTIERS IN NEUROSCIENCE			English	Article						excessive daytime sleepiness; ascending reticular activating system; hypersomnia; whiplash injury; diffusion tensor tractography	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; PATIENT; TRACTOGRAPHY; MATTER; TRACT	Objectives: This study investigated injuries of the ascending reticular activating system (ARAS) following whiplash injury, in patients with excessive daytime sleepiness (EDS). Methods: Twenty-three patients with whiplash injury and 26 healthy control subjects were recruited for this study. Epworth Sleepiness Scale (ESS) was used for evaluating sleepiness. According to the ESS score, the patients were classified into two groups: subgroup A ESS score 10, and subgroup B ESS score >= 10. Three components of the ARAS (lower dorsal, lower ventral, and upper) were evaluated for fractional anisotropy (FA) and tract volume (TV). Results: No significant differences were observed in the FA and TV values of the lower dorsal and upper ARAS between the patient and control groups (p > 0.05). Conversely, the values of FA and TV in the lower ventral ARAS of the patient group were significantly lower than those of the control group (p < 0.05). Comparing the values of subgroups A and B. the TV value of subgroup B was significantly lower than subgroup A (p < 0.05). However, no significant differences were observed in the values of the FA and TV in the lower dorsal and upper ARAS, and the FA value in the lower ventral ARAS (p > 0.05). Conclusions: We found significant injury of the lower ventral ARAS in EDS patients with whiplash injury. These results suggest that diffusion tensor tractography (DTT) could provide useful information for detecting injuries of the ARAS following whiplash injury, in patients with EDS.	[Jang, Sung H.; Kwon, Young H.] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daeau, South Korea; [Kim, Seong H.] Yeungnam Univ, Coll Med, Dept Neurosurg, Daeau, South Korea		Kwon, YH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daeau, South Korea.	kyh7648764@daum.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [18-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (18-BD-0401).	Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005958; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005678; Jang SH, 2016, J NEUROL NEUROSUR PS, V87, P1260, DOI 10.1136/jnnp-2016-313093; Jang SH, 2016, BRAIN INJURY, V30, P1271, DOI 10.1080/02699052.2016.1178805; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Jang SH, 2016, SLEEP MED, V17, P124, DOI 10.1016/j.sleep.2015.09.020; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002484; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Jang SH, 2015, INT J STROKE, V10, P162, DOI 10.1111/ijs.12608; Jang SH, 2015, NEUROSCI LETT, V590, P58, DOI 10.1016/j.neulet.2015.01.071; Jang SH, 2014, NEUROSCI LETT, V579, P140, DOI 10.1016/j.neulet.2014.07.024; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Otte A, 1997, J NUCL MED, V38, P1002; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Paus T, 2000, PROG BRAIN RES, V126, P65; Puligheddu M, 2017, SLEEP MED, V34, P96, DOI 10.1016/j.sleep.2017.03.011; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Vallez Garcia D, 2016, EBIOMEDICINE, V10, P249, DOI 10.1016/j.ebiom.2016.07.008; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	34	3	3	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 29	2018	12								348	10.3389/fnins.2018.00348			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH4IV	WOS:000433368000001	29896079	Green Published, gold			2022-02-06	
J	Rios, JMV; Sanchez-Aguilar, M; Kretschmer, T; Heinen, C; Govea, FAM; Juan, SRJ; Schmidt, T				Rios, Juan Manuel Vinas; Sanchez-Aguilar, Martin; Kretschmer, Thomas; Heinen, Christian; Medina Govea, Fatima Azucena; Juan, Sanchez-Rodriguez Jose; Schmidt, Thomas			Predictors of hydrocephalus as a complication of non-traumatic subarachnoid hemorrhage: a retrospective observational cohort study in 107 patients	PATIENT SAFETY IN SURGERY			English	Article						Hydrocephalus; Shunt dependency; Subarachnoid hemorraghe; Vasospasmus; Intraventricular hemorraghe	SHUNT-DEPENDENT HYDROCEPHALUS; NORMAL-PRESSURE HYDROCEPHALUS; INDEPENDENT PREDICTORS; INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; MANAGEMENT; COILING; RUPTURE; SURGERY; TRIAL	Background: The predictors of shunt dependency such as amount of subarachnoid blood, acute hydrocephalus (HC), mode of aneurysm repair, clinical grade at admission and cerebro spinal fluid (CSF) drainage in excess of 1500 ml during the 1st week after the subarachnoid hemorrhage (SAH) have been identified as predictors of shunt dependency. Therefore our main objective is to identify predictors of CSF shunt dependency following non-traumatic subarachnoid hemorrhage. Methods: We performed a retrospective study including patients from January 1st 2012 to September 30th 2014 between 16 and 89 years old and had a non-traumatic subarachnoid hemorrhage in cranial computed tomography (CCT). We excluded patients with the following characteristics: Patients who died 3 days after admittance, lesions in brainstem, previous surgical treatment in another clinic, traumatic brain injury, pregnancy and disability prior to SAH. We performed a descriptive and comparative analysis as well as a logistic regression with the variables that showed a significant difference (p < 0.05). Hence we identified the variables concerning HC after non traumatic SAH and its correlation. Results: One hundred and seven clinical files of patients with non-traumatic SAH were analyzed. Twenty one (48%) later underwent shunt treatment. Shunt patients had significantly clinical and corroborated with doppler ultrasonography vasospasmus (p = 0.015), OR = 5.2. The amount of subarachnoidal blood according to modified Fisher grade was (p = 0.008) OR = 10.9. Endovascularly treated patients were less often shunted as compared with those undergoing surgical aneurysm repair (p = 0.004). Conclusion: Vasospasmus and a large amount of ventricular blood seem to be a predictor concerning hydrocephalus after non-traumatic SAH. Hence according to our results the presence of these two variables could alert the treating physician in the decision whether an early shunt implantation < 7 days after SAH should be necessary.	[Rios, Juan Manuel Vinas] Klinikum Offenbach, Sana Spine Ctr, Bruchfeld Str 74, D-60528 Offenbach, Germany; [Sanchez-Aguilar, Martin; Medina Govea, Fatima Azucena] Univ Autonoma San Luis Potosi, Clin Epidemiol, San Luis Potosi, Mexico; [Kretschmer, Thomas] Klinikum Klagenfurt, Dept Neurosurg, Klagefurt, Austria; [Heinen, Christian; Schmidt, Thomas] Univ Clin Evangel Hosp Oldenburg, Dept Neurosurg, Oldenburg, Germany; [Juan, Sanchez-Rodriguez Jose] Klinikum Braunschweig, Dept Neurosurg, Braunschweig, Germany		Rios, JMV (corresponding author), Klinikum Offenbach, Sana Spine Ctr, Bruchfeld Str 74, D-60528 Offenbach, Germany.	vinasrios@outlook.com	Kretschmer, Thomas/AAW-1331-2020	Kretschmer, Thomas/0000-0002-0419-6720	Colorado Physician Insurance Company	The publication costs for this article were covered in full by a grant from the Colorado Physician Insurance Company (www.copic.com) to Philip F. Stahel, MD. COPIC had no influence on authorship or scientific content of this article.	AUER LM, 1990, NEUROSURGERY, V26, P804, DOI 10.1227/00006123-199005000-00012; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; de Oliveira JG, 2007, NEUROSURGERY, V61, P924, DOI 10.1227/01.neu.0000303188.72425.24; Dehdashti AR, 2004, J NEUROSURG, V101, P402, DOI 10.3171/jns.2004.101.3.0402; Demirgil BT, 2003, MINIM INVAS NEUROSUR, V46, P344, DOI 10.1055/s-2003-812500; Dorai Z, 2003, NEUROSURGERY, V52, P763, DOI 10.1227/01.NEU.0000053222.74852.2D; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Erixon HO, 2014, ACTA NEUROCHIR, V156, P2059, DOI 10.1007/s00701-014-2200-z; Goergen S K, 1993, Australas Radiol, V37, P156, DOI 10.1111/j.1440-1673.1993.tb00040.x; Grand W, 2011, ACTA NEUROCHIR, V153, P2049, DOI 10.1007/s00701-011-1106-2; Hirashima Y, 2003, CEREBROVASC DIS, V16, P205, DOI 10.1159/000071117; Hoh BL, 2011, WORLD NEUROSURG, V76, P548, DOI 10.1016/j.wneu.2011.05.054; Jovanovi Vladimir, 2005, Srp Arh Celok Lek, V133, P401; Kanat A, 2013, WORLD NEUROSURG, V80, P390, DOI 10.1016/j.wneu.2012.12.020; Klopfenstein JD, 2004, J NEUROSURG, V100, P225, DOI 10.3171/jns.2004.100.2.0225; KOLLURI VRS, 1984, SURG NEUROL, V21, P402, DOI 10.1016/0090-3019(84)90121-6; Korinek AM, 2011, NEUROSURGERY, V68, P985, DOI 10.1227/NEU.0b013e318208f360; Kwon JH, 2008, J KOREAN NEUROSURG S, V43, P177, DOI 10.3340/jkns.2008.43.4.177; Lai L, 2013, J CLIN NEUROSCI, V20, P1134, DOI 10.1016/j.jocn.2012.09.033; Misaki K, 2010, NEUROL MED-CHIR, V50, P76, DOI 10.2176/nmc.50.76; Reddy GK, 2011, NEUROSURGERY, V69, P774, DOI 10.1227/NEU.0b013e31821ffa9e; Rincon F, 2010, J NEUROSURG, V113, P774, DOI 10.3171/2010.2.JNS09376; Sorteberg W, 2008, BRIT J NEUROSURG, V22, P53, DOI 10.1080/02688690701593553; Sugawara T, 2016, J NEUROSURG SCI, V60, P154; TAPANINAHO A, 1993, ACTA NEUROCHIR, V123, P118, DOI 10.1007/BF01401866; van Lieshout JH, 2017, WORLD NEUROSURG, V104, P516, DOI 10.1016/j.wneu.2017.05.061; Woernle CM, 2013, J CLIN NEUROSCI, V20, P824, DOI 10.1016/j.jocn.2012.07.015; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12179; Yang TC, 2013, EUR NEUROL, V69, P296, DOI 10.1159/000346119; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8	30	3	3	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.	MAY 22	2018	12								13	10.1186/s13037-018-0160-6			8	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	GG4VO	WOS:000432694600001	29796090	Green Published, gold			2022-02-06	
J	McGinity, MJ; Grandhi, R; Michalek, JE; Rodriguez, JS; Trevino, AM; McGinity, AC; Seifi, A				McGinity, Michael J.; Grandhi, Ramesh; Michalek, Joel E.; Rodriguez, Jesse S.; Trevino, Aron M.; McGinity, Ashley C.; Seifi, Ali			The impact of tackle football injuries on the American healthcare system with a neurological focus	PLOS ONE			English	Article							HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; EPIDEMIOLOGY; PLAYERS	Background Recent interest in the study of concussion and other neurological injuries has heightened awareness of the medical implications of American tackle football injuries amongst the public. Objective Using the National Emergency Department Sample (NEDS) and the National Inpatient Sample (NIS), the largest publicly available all-payer emergency department and inpatient healthcare databases in the United States, we sought to describe the impact of tackle football injuries on the American healthcare system by delineating injuries, specifically neurological in nature, suffered as a consequence of tackle football between 2010 and 2013. Methods The NEDS and NIS databases were queried to collect data on all patients presented to the emergency department (ED) and/or were admitted to hospitals with an ICD code for injuries related to American tackle football between the years 2010 and 2013. Subsequently those with football-related neurological injuries were abstracted using ICD codes for concussion, skull/face injury, intracranial injury, spine injury, and spinal cord injury (SCI). Patient demographics, length of hospital stay (LOS), cost and charge data, neurosurgical interventions, hospital type, and disposition were collected and analyzed. Results A total of 819,000 patients presented to EDs for evaluation of injuries secondary to American tackle football between 2010 and 2013, with 1.13% having injuries requiring inpatient admission (average length of stay 2.4 days). 80.4% of the ED visits were from the pediatric population. Of note, a statistically significant increase in the number of pediatric concussions over time was demonstrated (OR = 1.1, 95% CI 1.1 to 1.2). Patients were more likely to be admitted to trauma centers, teaching hospitals, the south or west regions, or with private insurance. There were 471 spinal cord injuries and 1,908 total spine injuries. Ten patients died during the study time period. The combined ED and inpatient charges were $1.35 billion. Conclusion Injuries related to tackle football are a frequent cause of emergency room visits, specifically in the pediatric population, but severe acute trauma requiring inpatient admission or operative interventions are rare. Continued investigation in the long-term health impact of football related concussion and other repetitive lower impact trauma is warranted.	[McGinity, Michael J.; Grandhi, Ramesh; Rodriguez, Jesse S.; Seifi, Ali] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Michalek, Joel E.; Trevino, Aron M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [McGinity, Ashley C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA		Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	Seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020	Seifi, Ali/0000-0002-5010-5041			[Anonymous], 2014, STUD ATHL PART 1981; [Anonymous], 2012, HEALTHC COST UT PROJ; Bentz JE, 2013, J LANC GEN HOSP, V8; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P221; Domb BG, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114534824; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; HCUP Nationwide Emergency Department Sample (NEDS), 2008, HEALTHC COST UT PROJ; Houck Z, 2016, AM J SPORTS MED; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Kerr Z. Y, 2016, JAMA PEDIAT; King H, 2015, J PHYS ACT HEALTH, V12, P1162, DOI 10.1123/jpah.2014-0356; Lawrence D, 2016, AUST NZ J PSYCHIAT, V50, P876, DOI 10.1177/0004867415617836; Lehman E.J., 2016, AM J SPORTS MED; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Federation of State High School Associations, HIGH SCH ATHL PART S; Nationwide Emergency Department Sample (NEDS), 2007, HEALTHC COST UT PROJ; Nationwide Emergency Department Sample (NEDS), 2009, HEALTHC COST UT PROJ; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Shannon-Missal L., 2016, PROFOOTBALL IS STILL; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; The Physical Activity Council's, 2016, PHYS ACT COUNC ANN S	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195827	10.1371/journal.pone.0195827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	WOS:000431481700005	29734348	Green Published, gold			2022-02-06	
J	Klingshirn, H; Mittrach, R; Braitmayer, K; Strobl, R; Bender, A; Grill, E; Muller, M				Klingshirn, Hanna; Mittrach, Rene; Braitmayer, Kathrin; Strobl, Ralf; Bender, Andreas; Grill, Eva; Mueller, Martin			RECAPDOC - a questionnaire for the documentation of rehabilitation care utilization in individuals with disorders of consciousness in long-term care in Germany: development and pretesting	BMC HEALTH SERVICES RESEARCH			English	Article						Questionnaire development; Cognitive interview; Pretest; Rehabilitation; Long-term care; Disorder of consciousness; Vegetative state; Minimally conscious state	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; PROLONGED DISORDERS; MEDICAL ASPECTS; MODEL SYSTEMS; FOLLOW-UP; EPIDEMIOLOGY; CAREGIVERS; DIAGNOSIS; RECOVERY	Background: A multitude of different rehabilitation interventions and other specific health care services are offered for individuals with disorders of consciousness in long-term care settings. To investigate the association of those services and patient-relevant outcomes, a specific instrument to document the utilization of those services is needed. The purpose of this study was to develop such a questionnaire administered to caregivers in epidemiological studies or patient registries in Germany. Methods: The development process of the RECAPDOC questionnaire was carried out in three steps. Step 1 consisted of a systematic literature review and an online-based expert survey to define the general content Step 2 was an expert interview to evaluate the preliminary content of the questionnaire. Step 3 was a pretest including cognitive interviews with caregivers. After each step, the results were combined into a new version of the questionnaire. Results: The first version of the questionnaire included items on utilization of medical care, medical aids, nursing and therapeutic care. The results of the expert interview led to the integration of five new items and the modification of six other items. The pretest led to some minor modifications of the questionnaire since it was rated as feasible and acceptable. The final questionnaire consisted of 29 items covering the domains "living situation", "social insurance status", "utilisation of home health care", "domestic services", "outpatient health care", "specific diagnostic measures", "adaptive technologies", "medical aids" and "utilization of therapies". Also the experience of family support and multidisciplinary collaboration of health professionals is covered. Conclusions: The developed questionnaire is a first step to make the situation of patients with disorders of consciousness in the long-term care setting accessible for evaluation in epidemiological studies and in the context of patient registries. However, further reliability and validity studies are needed.	[Klingshirn, Hanna; Mittrach, Rene; Braitmayer, Kathrin; Strobl, Ralf; Grill, Eva; Mueller, Martin] Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol, Marchioninistr 17, D-81377 Munich, Germany; [Strobl, Ralf; Grill, Eva] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Marchioninistr 15, D-81377 Munich, Germany; [Bender, Andreas] Ludwig Maximilians Univ Munchen, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany; [Bender, Andreas] Therapiezentrum Burgau, Kapuzinerstr 34, D-89331 Burgau, Germany; [Mueller, Martin] Rosenheim Univ Appl Sci, Fac Appl Hlth & Social Sci, Hsch Str 1, D-83024 Rosenheim, Germany		Muller, M (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Informat Proc Biometry & Epidemiol, Marchioninistr 17, D-81377 Munich, Germany.; Muller, M (corresponding author), Rosenheim Univ Appl Sci, Fac Appl Hlth & Social Sci, Hsch Str 1, D-83024 Rosenheim, Germany.	martin.mueller@fh-rosenheim.de	Grill, Eva/AAF-8104-2020; Mueller, Martin/AAH-1527-2019	Grill, Eva/0000-0002-0273-7984; Mueller, Martin/0000-0002-5575-442X; Bender, Andreas/0000-0002-6328-7104	Deutsche Forschungsgemeinschaft (German Research Foundation)German Research Foundation (DFG) [MU 3603/1-1]	The study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation), project number MU 3603/1-1. The funding body was not involved in any decision regarding design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; *BUND REH, 2003, EMPF STAT LANGZ BEH; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Denzin NK., 1970, RES ACT THEORETICAL; Donis J, 2011, BRAIN INJURY, V25, P1101, DOI 10.3109/02699052.2011.577047; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; Fins JJ, 2007, ARCH NEUROL-CHICAGO, V64, P1400, DOI 10.1001/archneur.64.10.1400; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Grill E, 2013, ARCH PHYS MED REHAB, V94, P1870, DOI 10.1016/j.apmr.2012.10.040; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Klingshirn H, 2015, J REHABIL MED; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; Linstone H.A., 1975, DELPHI METHOD TECHNI; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pagani M, 2014, CLIN PSYCHOL PSYCHOT, V21, P420, DOI 10.1002/cpp.1848; Pagani M, 2014, J CLIN PSYCHOL MED S, V21, P214, DOI 10.1007/s10880-014-9399-y; Patton M.Q., 1990, QUALITATIVE EVALUATI; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Saout V., 2010, Annals of Physical and Rehabilitation Medicine, V53, P96, DOI 10.1016/j.rehab.2010.01.002; Seidl H, 2015, GESUNDHEITSWESEN, V77, P46, DOI 10.1055/s-0034-1372618; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thorn JC, 2013, APPL HEALTH ECON HEA, V11, P155, DOI 10.1007/s40258-013-0022-4; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	34	3	3	1	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	MAY 4	2018	18								329	10.1186/s12913-018-3153-3			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GF4HW	WOS:000431924800002	29728154	Green Published, gold			2022-02-06	
J	Aguerrevere, LE; Calamia, MR; Greve, KW; Bianchini, KJ; Curtis, KL; Ramirez, V				Aguerrevere, Luis E.; Calamia, Matthew R.; Greve, Kevin W.; Bianchini, Kevin J.; Curtis, Kelly L.; Ramirez, Veronica			Clusters of Financially Incentivized Chronic Pain Patients Using the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF)	PSYCHOLOGICAL ASSESSMENT			English	Article						symptom overreporting; MMPI-2-RF; spine pain; psychological overlay; cluster analysis	TRAUMATIC BRAIN-INJURY; CLINICAL RC SCALES; MALINGERED NEUROCOGNITIVE DYSFUNCTION; DIGIT RECOGNITION TEST; CLASSIFICATION ACCURACY; BACK-PAIN; INCREMENTAL VALIDITY; DISABILITY INDEX; MONEY MATTERS; SAMPLE	The Minnesota Multiphasic Personality Inventory (MMPI)-2 Restructured Form (MMPI-2-RF) has been shown to have clinical utility in the assessment of individuals with chronic pain (e.g., predicting surgical outcomes). The purpose of this study was to explore the ability of the MMPI-2-RF Validity Scales in profiling patients with chronic pain who had external financial incentive (e.g., workers' compensation claims) and determine the associations between Validity Scale response patterns and important outcomes. Cluster analysis identified 2 similarly sized clusters of patients with very different MMPI-2-RF profiles. Cluster 1 was characterized by valid responding and showed mean elevations on the somatic and low positive emotion Restructured Clinical scales. Cluster 2 was characterized by patients overreporting on the MMPI-2-RF Validity Scales, who also demonstrated elevations on 7 of the 9 RC scales. Cluster membership was differentially associated with clinical variables: patients in Cluster 2 had greater self-reported pain and disability, were less likely to have spine-related findings on imaging and were more likely to be classified as probable or definite malingerers. These results support the utility of the MMPI-2-RF Validity scales in distinguishing between credible and noncredible responses from patients with chronic pain seen within a medico-legal context.	[Aguerrevere, Luis E.] Stephen F Austin State Univ, Dept Human Serv, Nacogdoches, TX 75962 USA; [Calamia, Matthew R.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Greve, Kevin W.; Bianchini, Kevin J.; Ramirez, Veronica] Jefferson Neurobehav Grp, Metairie, LA USA; [Curtis, Kelly L.] High Point Univ, Dept Psychol, High Point, NC 27268 USA		Curtis, KL (corresponding author), High Point Univ, Dept Psychol, High Point, NC 27268 USA.	kcurtis0@highpoint.edu	Aguerrevere, Luis/P-5684-2019	Aguerrevere, Luis/0000-0001-9160-1044			Arbisi PA, 2008, J PERS ASSESS, V90, P122, DOI 10.1080/00223890701845146; Ben-Porath Y., 2012, JOURNAL OF PERSONALI, V90, P119, DOI [10.1080/00223890701845120, DOI 10.1080/00223890701845120]; Ben-Porath Y.S., 2011, MMPI 2 RF MINNESOTA; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2014, CLIN NEUROPSYCHOL, V28, P1376, DOI 10.1080/13854046.2014.986199; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Block A. R., 2003, THE PSYCHOLOGY OF SP, DOI [10.1037/10613-000, DOI 10.1037/10613-000]; Butcher JN, 2001, MANUAL ADM SCORING M; Chmielewski M, 2017, PSYCHOL ASSESSMENT, V29, P199, DOI 10.1037/pas0000328; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Downing SK, 2008, CLIN NEUROPSYCHOL, V22, P680, DOI 10.1080/13854040701562825; Dzau VJ, 2014, JAMA-J AM MED ASSOC, V312, P1507, DOI 10.1001/jama.2014.12986; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Forbey JD, 2008, J PERS ASSESS, V90, P136, DOI 10.1080/00223890701845161; Gatchel Robert J, 2008, Pain Pract, V8, P91, DOI 10.1111/j.1533-2500.2008.00176.x; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Green P., 2005, GREEN S WORD MEMORY; Green P., 1996, THE WORD MEMORY TEST; Greve K. W., 2012, COPING PSYCHIAT PSYC, P587, DOI DOI 10.1093/MED:PSYCH/9780195174113.003.0026; Greve K. W., 2012, FORENSIC NEUROPSYCHO, P302; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; HAMMONDS W, 1978, SOUTHERN MED J, V71, P664, DOI 10.1097/00007611-197806000-00017; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Harris S, 2003, PAIN, V105, P363, DOI 10.1016/S0304-3959(03)00251-3; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Krause N, 2001, AM J IND MED, V40, P374, DOI 10.1002/ajim.1112; Landau S., 2004, A HANDBOOK OF STATIS, V1; Marek RJ, 2015, PSYCHOL ASSESSMENT, V27, P114, DOI 10.1037/pas0000035; Masters KS, 2003, J CLIN PSYCHOL MED S, V10, P279, DOI 10.1023/A:1026301420769; McCord DM, 2011, J CLIN EXP NEUROPSYC, V33, P140, DOI 10.1080/13803395.2010.495056; Milligan G., 2003, HDB PSYCHOL, V2, P165; Millon T., 1994, MILLON CLINICAL MULT; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Osberg TM, 2008, J PERS ASSESS, V90, P81, DOI 10.1080/00223890701693801; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; Pope K. S., 2006, THE MMPI MMPI 2 MMPI, DOI [10.1037/11437-000, DOI 10.1037/11437-000]; Pulliam CB, 2001, J OCCUP REHABIL, V11, P43, DOI 10.1023/A:1016604208480; RILEY JL, 1995, J SPINAL DISORD, V8, P213, DOI 10.1097/00002517-199506000-00006; RILEY JL, 1993, CLIN J PAIN, V9, P248, DOI 10.1097/00002508-199312000-00005; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sellbom M, 2006, J PERS ASSESS, V86, P196, DOI 10.1207/s15327752jpa8602_09; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Simms LJ, 2005, PSYCHOL ASSESSMENT, V17, P345, DOI 10.1037/1040-3590.17.3.345; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soer R, 2012, SPINE, V37, P711, DOI 10.1097/BRS.0b013e31822c8a7a; Tombaugh T. N., 1996, TEST OF MEMORY MALIN; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042	59	3	3	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	MAY	2018	30	5					634	644		10.1037/pas0000509			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GF5XJ	WOS:000432041000007	28627924				2022-02-06	
J	Chen, JH; Xu, YN; Ji, M; Li, PP; Yang, LK; Wang, YH				Chen, Jun-Hui; Xu, Yi-Nong; Ji, Meng; Li, Pei-Pei; Yang, Li-Kun; Wang, Yu-Hai			Multimodal monitoring combined with hypothermia for the management of severe traumatic brain injury: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						multimodal monitoring; hypothermia; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; NEUROCRITICAL CARE; MILD HYPOTHERMIA; INTENSIVE-CARE; CARDIAC-ARREST; EPIDEMIOLOGY; SEIZURES; OUTCOMES; INDEX	Traumatic brain injury (TBI) is a prominent public health issue that has a significant negative impact on patients and their family members. It is the leading cause of mortality and disability among young (below 50 years old) individuals. Intracranial hypertension (TCH) remains the single most difficult therapeutic challenge for the management of severe TBI. Therapeutic hypothermia may reduce intracranial hypertension and improve patient outcomes; however, the use of hypothermia is controversial. It has been reported that therapeutic hypothermia elicits no therapeutic benefit for patients with TBI. The present study presents two patients with severe(s) TBI who were admitted to 101st Hospital of the People's liberation Army Between June 2017 to October 2017. Multimodal brain monitoring measurements of intracranial pressure, cerebral perfusion pressure (CPP) and bispectral index (BIS) were used during assisted hypothermia for management of patients with sTBI. The duration, degree of hypothermia treatment and speed of re-warming were assessed.	[Chen, Jun-Hui; Li, Pei-Pei; Yang, Li-Kun; Wang, Yu-Hai] 101st Hosp Peoples Liberat Army, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China; [Xu, Yi-Nong; Ji, Meng] Taizhou 4 Hosp, Dept Neurosurg, Taizhou 225300, Jiangsu, Peoples R China		Yang, LK; Wang, YH (corresponding author), 101st Hosp Peoples Liberat Army, Dept Neurosurg, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	beck_yang@163.com; wangyuhai67@126.com	Chen, Junhui/AAS-1669-2021				Abbasi Hamid Reza, 2013, Bull Emerg Trauma, V1, P81; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corry JJ, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0453-9; Cottenceau V, 2008, ANESTH ANALG, V107, P1676, DOI 10.1213/ane.0b013e318184e9ab; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; FAY T, 1940, NY STATE J MED, V40, P1351; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Irimia A, 2013, CLIN NEUROL NEUROSUR, V115, P2159, DOI 10.1016/j.clineuro.2013.08.003; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Mayans DR, 2014, J NEUROIMAGING, V24, P518, DOI 10.1111/jon.12016; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Prins SA, 2007, CRIT CARE, V11, DOI 10.1186/cc6138; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; Tan H, 2001, Chin J Traumatol, V4, P156; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	36	3	3	0	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2018	15	5					4253	4258		10.3892/etm.2018.5994			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GF3JF	WOS:000431850300023	29731820	Green Published, gold, Green Submitted			2022-02-06	
J	Dong, HJ; Zhao, ML; Li, XH; Chen, YS; Wang, J; Chen, MB; Wu, S; Wang, JJ; Liang, HQ; Sun, HT; Tu, Y; Zhang, S; Xiong, J; Chen, C				Dong, Hua-Jiang; Zhao, Ming-liang; Li, Xiao-hong; Chen, Yi-Sheng; Wang, Jing; Chen, Miao-Bin; Wu, Sen; Wang, Jing-Jing; Liang, Hai-Qian; Sun, Hong-Tao; Tu, Yue; Zhang, Sai; Xiong, Jie; Chen, Chong			Hypothermia-Modulating Matrix Elasticity of Injured Brain Promoted Neural Lineage Specification of Mesenchymal Stem Cells	NEUROSCIENCE			English	Article						mild hypothermia; elastic modulus; lineage specification; traumatic brain injury; umbilical cord mesenchymal stem cells	MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; DIFFERENTIATION; FATE; RATS	Both chemical and physical microenvironments appear to be important for lineage specification of umbilical cord mesenchymal stem cells (UCMSCs). However, physical factors such as the elastic modulus in traumatic brain injury (TBI) are seldom studied. Intracranial hypertension and cerebral edema after TBI may change the brain's physical microenvironment, which inhibits neural lineage specification of transplanted UCMSCs. The purpose of this study is to investigate the potential regulatory effect of mild hypothermia on the elastic modulus of the injured brain. First, we found that more UCMSCs grown on gels mimicking the elastic modulus of the brain (0.5 kPa) differentiated into neural cells, which were verified with the formation of branched cells and the expression of neural markers. Then, UCMSCs were transplanted into TBI rats, and we observed that mild hypothermia resulted in the differentiation of more neurons and astrocytes from transplanted UCMSCs. To demonstrate that more neural specification of UCMSCs was due to the regulation of the elastic modulus, we monitored intracranial pressure and cerebral edema. The results showed that mild hypothermia significantly reduced intracranial pressure and brain water content, indicating modulation of the elastic modulus by mild hypothermia. An examination with atomic force microscopy (AFM) in a cell injury model in vitro further verified hypothermia-regulated elastic modulus. In this study, we found a novel role of mild hypothermia in modulating the elastic modulus of the injured brain, resulting in the promotion of neural lineage specification of UCMSCs, which suggested that the combination of mild hypothermia had more advantages in cell-based therapy after TBI. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Dong, Hua-Jiang; Zhao, Ming-liang; Li, Xiao-hong; Chen, Yi-Sheng; Wang, Jing; Chen, Miao-Bin; Wang, Jing-Jing; Liang, Hai-Qian; Sun, Hong-Tao; Tu, Yue; Zhang, Sai; Chen, Chong] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China; [Dong, Hua-Jiang; Wu, Sen] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China; [Xiong, Jie] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Rehabil & Physiotherapy Dept Tradit Chinese Med, Tianjin 300162, Peoples R China		Chen, C (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China.; Xiong, J (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Rehabil & Physiotherapy Dept Tradit Chinese Med, Tianjin 300162, Peoples R China.	drxiongjie@163.com; chongchen12@hotmail.com	Zhao, Mingliang/AAN-1293-2020	, Dong/0000-0002-4141-3077	National Nature Scientific Fund of China [81401067, 81771352, 81471275, 81671222, 81771350]; Nature Scientific Fund of Tianjin [15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600]	This work was supported by the National Nature Scientific Fund of China (81401067, 81771352, 81471275, 81671222, 81771350) and the Nature Scientific Fund of Tianjin (15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600).	Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen C, 2014, NEUROSCIENCE, V257, P1, DOI 10.1016/j.neuroscience.2013.10.056; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haase K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0970; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Lee J, 2016, ACTA BIOMATER, V42, P46, DOI 10.1016/j.actbio.2016.06.037; Li CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11455; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rammensee S, 2017, STEM CELLS, V35, P497, DOI 10.1002/stem.2489; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Simpson RML, 2016, STEM CELLS, V34, P1225, DOI 10.1002/stem.2328; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Torok E, 2009, NEUROSURGERY, V65, P352, DOI 10.1227/01.NEU.0000345632.09882.FF; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374	36	3	3	2	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 1	2018	377						1	11		10.1016/j.neuroscience.2018.02.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB3WA	WOS:000428989300001	29482001				2022-02-06	
J	El-Menyar, A; Consunji, R; Abdelrahman, H; Latifi, R; Wahlen, BM; Al-Thani, H				El-Menyar, Ayman; Consunji, Rafael; Abdelrahman, Husham; Latifi, Rifat; Wahlen, Bianca M.; Al-Thani, Hassan			Predictors and Time-Based Hospital Mortality in Patients with Isolated and Polytrauma Brain Injuries	WORLD JOURNAL OF SURGERY			English	Article							EPIDEMIOLOGY; PATTERNS; PERSPECTIVE; PREVENTION; EUROPE; IMPACT; QATAR	Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. We studied the predictors and time-based mortality in patients with isolated and polytrauma brain injuries in a rapidly developing country. We hypothesized that TBI-related 30-day mortality is decreasing over time. A retrospective analysis was conducted for all patients with moderate-to-severe TBI who were admitted directly to a level 1 trauma center between 2010 and 2014. Patient's data were analyzed and compared according to survival (survived vs. not survived), time (early death [2 days], intermediate [3-7 days] versus late [> 7 days]) post-injury, and type (polytrauma vs. isolated TBI). Cox proportional hazards models were performed for the predictors of mortality. A total of 810 patients were admitted with moderate-to-severe TBI with a median age of 27 years. Traffic-related injury was the main mechanism of TBI (65%). Isolated TBIs represented 22.6% of cases and 56% had head AIS > 3. The overall mortality rate was 27%, and most of deaths occurred in the intermediate (40%) and early period (38%). The incidence of TBI was greater in patients aged 21-30 years but the mortality was proportionately higher among elderly. The average annual incidence was 8.43 per 100,000 population with an overall mortality of 2.28 per 100,000 population. Kaplan-Meier curves showed that polytrauma had greater mortality than isolated TBI. However, Cox survival analysis showed that age [Hazard ratio (HR) 1.02], scene GCS (HR 0.86),subarachnoid hemorrhage (HR 1.7), and blood transfusion amount (HR 1.03) were the predictors of mortality regardless of being polytrauma or isolated TBI after controlling for 14 relevant covariates. The 30-day survival in patients with TBI is improving over the years in Qatar; however, the mortality remains high in the elderly males. The majority of deaths occurred within a week after the injury. Further studies are needed to assess the long-term survival in patients with moderate-to-severe TBI.	[El-Menyar, Ayman] Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar; [Consunji, Rafael; Abdelrahman, Husham; Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg Sect, Dept Surg, Doha, Qatar; [Latifi, Rifat] Westchester Med Ctr, Dept Surg, Valhalla, NY USA; [Wahlen, Bianca M.] Hamad Gen Hosp, Dept Anesthesia, Trauma Surg, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp, Trauma Surg Sect, Clin Res, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar.	aymanco65@yahoo.com; uppgh_sicu@yahoo.com; hushamco@hotmail.com; rifat.latifi@wmchealth.org; bwahlen@googlemail.com; althanih@hotmail.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Latifi, Rifat/0000-0003-1091-3682			Abdelrahman H, 2014, WORLD J SURG, V38, P2804, DOI 10.1007/s00268-014-2705-x; Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Consunji RJ, 2015, INJURY PREV, V21, pE105, DOI 10.1136/injuryprev-2013-040939; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; El-Menyar A, 2017, WORLD NEUROSURG; Faul M, 2010, TRAUMATIC BRAIN INJU; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kuenzler M., 2015, EMERG MED OPEN ACCES, V05, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latifi R, 2015, INT J INJ CONTROL SA, V22, P136, DOI 10.1080/17457300.2013.857693; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sa T., 2019, EMERGEN MED, DOI [10.4172/2165-7548.1000229, DOI 10.4172/2165-7548.1000229]; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tuma Mazin A, 2013, Int J Crit Illn Inj Sci, V3, P3, DOI 10.4103/2229-5151.109408; Vigue B, 2012, ANN UPDATE INTENSIVE, P722; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	29	3	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAY	2018	42	5					1346	1357		10.1007/s00268-017-4310-2			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GC5EL	WOS:000429808200018	29063224				2022-02-06	
J	Hazama, A; Ziechmann, R; Arul, M; Krishnamurthy, S; Galgano, M; Chin, LS				Hazama, Ali; Ziechmann, Robert; Arul, Manu; Krishnamurthy, Satish; Galgano, Michael; Chin, Lawrence S.			The Effect of Keppra Prophylaxis on the Incidence of Early Onset, Post-traumatic Brain Injury Seizures	CUREUS			English	Article						traumatic brain injury (tbi); seizure prophylaxis; keppra; post-traumatic epilepsy	LEVETIRACETAM; PHENYTOIN	Objective: Traumatic brain injury (TBI) is a leading cause of long-term disability. Early onset post-traumatic seizures (PTS) after traumatic injury to the brain is a strong predictor of adverse outcomes in these patients. Our study investigates the role of Keppra in early PTS prophylaxis compared to no treatment, taking into account risk factors including injury severity, seizure history, and anti-epileptic drug (AED) use. Methods: This was a retrospective cohort study based on patient chart data from January 2013 to January 2017 at a level one trauma center in the United States. A t-test was performed with P<0.05 as significant; we utilized a 95% confidence interval (CI) for our findings. Subgroup analysis was performed, with respect to the Glasgow Coma Scale (GCS) score (Group A: Mild GCS=13-15, Keppra N=135, Non-Keppra N=122; Group B: Moderate GCS=9-12, Keppra N=23, Non-Keppra N=19; Group C: Severe GCS= <8, Keppra N=69, Non-Keppra=35). Results: Of 403 patients included in the study, 227 were given Keppra. Demographics between treatment groups were similar. Whole cohort analysis confirmed six patients with PTS, and no significant difference between groups (Keppra N=3, Non-Keppra N=3, OR=0.77, P=0.75, 95% CI= (0.154-3.87)). Subgroup analysis revealed reduction in seizure incidence in Keppra groups A (OR=0.18, P=0.27, 95% CI=(0.008-3.80)) and B (OR=0.82, P=0.92, 95% CI=(0.015-43.7)), but this reduction was not statistically significant. Those with the severe TBI in group C accounted for the majority of seizures (n=4, OR=1.52, P=0.71, 95% CI=(0.15-15.4)). Conclusion: Patients with more severe TBI suffered a higher incidence of early-onset post-traumatic seizures. Data of the cohort as a whole revealed a trend towards a lower seizure incidence in patients who were treated with Keppra prophylaxis. Despite this trend, the decrease in seizure incidence did not reach statistical significance.	[Hazama, Ali; Krishnamurthy, Satish; Galgano, Michael] SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA; [Ziechmann, Robert; Arul, Manu] SUNY Upstate Med Univ, Sch Med, Syracuse, NY 13210 USA; [Chin, Lawrence S.] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA		Hazama, A (corresponding author), SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA.	hazamaa@upstate.edu		Krishnamurthy, Satish/0000-0001-7808-7407			Caballero G Christina, 2013, Hosp Pharm, V48, P757, DOI 10.1310/hpj4809-757; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; Patanwala AE, 2016, BRAIN INJURY, V30, P156, DOI 10.3109/02699052.2015.1089596; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0; Zangbar B, 2016, WORLD J SURG, V40, P2667, DOI 10.1007/s00268-016-3606-y	15	3	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAY	2018	10	5							e2674	10.7759/cureus.2674			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3HD	WOS:000450940700113	30050729	gold, Green Published, Green Submitted			2022-02-06	
J	Kissick, J; Webborn, N				Kissick, James; Webborn, Nick			Concussion in Para Sport	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Para sport; Para athlete; Athletes with a disability; Injury	PROSPECTIVE COHORT; PARALYMPIC GAMES; INJURIES; DISABILITY	Although Para athletes (the International Paralympic Committee term for sportspeople with a disability) are exposed to a risk of concussion just like their able-bodied counterparts, there has been little research into the incidence of concussion in Para sport. Existing assessment and management guidelines and tools have been developed for the general sport population but may not be appropriate for use in some Para athletes. This article examines what is currently known about concussion in Para sport and identifies challenges and opportunities in moving knowledge on this topic forward.	[Kissick, James] Univ Ottawa, Carleton Univ, Sport Med Clin, Dept Family Med, Ottawa, ON, Canada; [Webborn, Nick] Univ Brighton, Ctr Sport & Exercise Sci & Med SESAME, Carlisle Rd, Eastbourne BN20 7SN, England		Kissick, J (corresponding author), Univ Ottawa, Carleton Univ, Sport Med Clin, Dept Family Med, Ottawa, ON, Canada.	jameskissick@me.com		Webborn, Nick/0000-0003-3636-5557			Baker SP, 1973, PREVENTIVE MED PUBLI; Blauwet C, 2016, PM&R, V8, P798, DOI 10.1016/j.pmrj.2016.07.004; Bose Dipan, 2008, Ann Adv Automot Med, V52, P61; Derman W, 2016, BRIT J SPORT MED, V50, P1069, DOI 10.1136/bjsports-2016-096214; Derman W, 2018, BRIT J SPORT MED, V52, P17, DOI 10.1136/bjsports-2017-097962; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Hawkeswood J, 2011, INT J SPORTS PHYS TH, V6, P173; Kajta Z, 2015, INT C MECH MAT MECH; Knapp A., 2012, 5 LEADERSHIP LESSONS; Silva MPME, 2013, INT J SPORTS MED, V34, P239, DOI 10.1055/s-0032-1316358; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Webborn AD, 2007, THE PARALYMPIAN, V2, P11; Webborn N, 2006, MED SCI SPORT EXER, V38, P811, DOI 10.1249/01.mss.0000218120.05244.da; Webborn N, 2017, BR J SPORTS MED; Webborn N, 2016, PM&R, V8, P542; Webborn N, 2012, CLIN J SPORT MED, V22, P3, DOI 10.1097/JSM.0b013e318243309f; Weiler R, 2018, CLIN J SPORT MED, V28, P43, DOI 10.1097/JSM.0000000000000407; Wessels KK, 2012, ARCH PHYS MED REHAB, V93, P275, DOI 10.1016/j.apmr.2011.09.009; Wessels KK, 2013, CONCUSSION ASSESSMEN; West LR, 2017, BRIT J SPORT MED, V51, P1050, DOI 10.1136/bjsports-2016-096767; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374	23	3	3	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2018	29	2					299	+		10.1016/j.pmr.2018.01.002			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	GE5TS	WOS:000431285600008	29627090	Green Submitted			2022-02-06	
J	Li, WB; Wang, X; Wei, XE; Wang, ML				Li, Wenbin; Wang, Xuan; Wei, Xiaoer; Wang, Mingliang			Susceptibility-weighted and diffusion kurtosis imaging to evaluate encephalomalacia with epilepsy after traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							PERIVENTRICULAR LEUKOMALACIA; HEAD TRAUMA; CHILDREN; RISK; BIOMARKERS; IMAGES	Objective: Encephalomalacia after traumatic brain injury (TBI) is one of the factors leading to epilepsy. In this study, magnetic resonance imaging (MRI) was used to explore the brain image features of epilepsy after traumatic encephalomalacia, and to provide objective evidence for predicting the possible occurrence of epilepsy after traumatic encephalomalacia. Methods: Two-hundred-fifty-two patients with traumatic encephalomalacia were prospectively enrolled in the study. All patients underwent MRI after discharge from the hospital. At the 1-year follow-up, participants were divided into epilepsy and nonepilepsy groups. All participants underwent MRI including conventional imaging, susceptibility-weighted imaging (SWI), and diffusion kurtosis imaging (DKI). The lesion volume, iron deposition, mean diffusion (MD), and mean kurtosis (MK) around the lesions were calculated for each group and compared using t-tests. P values < 0.05 were considered statistically significant. Results: Sixty patients with epilepsy and 91 without epilepsy were reported. There were no significant differences in Glasgow Coma Scale (GCS), lesion volume, encephalomalacia, or MD values between the two groups. Iron deposition was significantly higher in the epilepsy group (P < 0.05). The MK values were significantly different (P < 0.05). Interpretation: Advanced MRI is an important means of evaluating risk of developing epilepsy at 1 year due to encephalomalacia in patients with TBI. SWI and DKI could be used to assess the microstructural changes around the encephalomalacia, and therefore be used to evaluate risk of developing epilepsy at 1 year.	[Li, Wenbin; Wang, Xuan; Wei, Xiaoer; Wang, Mingliang] Shanghai Jiao Tong Univ, Dept Radiol, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Li, Wenbin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar 844000, Xinjiang, Peoples R China		Li, WB; Wang, X (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn; 1072884137@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Shanghai Key Discipline of Medical Imaging [2017ZZ02005]	This study was funded by the National Natural Science Foundation of China (grant numbers: 81271540) and Natural Science Foundation of Xinjiang Province (grant number: 2016D01C083). Shanghai Key Discipline of Medical Imaging (grant number: 2017ZZ02005).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BAKER LL, 1988, RADIOLOGY, V168, P809, DOI 10.1148/radiology.168.3.3406411; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Bozzao A, 2003, EUR RADIOL, V13, P1571, DOI 10.1007/s00330-002-1815-2; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dudek FE, 2009, EPILEPSY CURR, V9, P53, DOI 10.1111/j.1535-7511.2008.01290.x; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Engel J, 2006, EPILEPSY RES, V70, pS5, DOI 10.1016/j.eplepsyres.2005.11.014; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; Fleisher W, 2002, AM J PSYCHIAT, V159, P660, DOI 10.1176/appi.ajp.159.4.660; Fukuda Kuniaki, 2010, No To Hattatsu, V42, P291; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Gauffin H, 2014, NEUROPSYCH DIS TREAT, V10, P2183, DOI 10.2147/NDT.S68438; Goncharuk O. A., 1998, Likars'ka Sprava, V0, P99; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Huang LC, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.03.020; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Kazemi H, 2012, INJURY, V43, P2132, DOI 10.1016/j.injury.2012.06.007; Kielbinski M, 2016, NEUROPATH APPL NEURO, V42, P593, DOI 10.1111/nan.12331; Machilsen B, 2007, NEUROIMAGE, V35, P686, DOI 10.1016/j.neuroimage.2006.12.037; Melhem ER, 2000, RADIOLOGY, V214, P199, DOI 10.1148/radiology.214.1.r00dc35199; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Ranson David, 2003, J Law Med, V10, P265; Rauscher A, 2005, AM J NEURORADIOL, V26, P736; Sapina Lidija, 2014, Coll Antropol, V38, P1077; Shorvon S, 2009, LANCET, V373, P1060, DOI 10.1016/S0140-6736(09)60215-4; Willmore LJ, 2010, NEUROLOGY, V75, P202, DOI 10.1212/WNL.0b013e3181e8e94f; WILSON DA, 1986, RADIOLOGY, V160, P507, DOI 10.1148/radiology.160.2.3726133; Winston GP, 2015, QUANT IMAGING MED SU, V5, P279, DOI 10.3978/j.issn.2223-4292.2015.02.03; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhang YZ, 2013, CLIN NEURORADIOL, V23, P293, DOI 10.1007/s00062-013-0212-3; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	35	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAY	2018	5	5					552	558		10.1002/acn3.552			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF4XV	WOS:000431968300004	29761118	gold, Green Published			2022-02-06	
J	Mosleh, Y; Cajka, M; Depreitere, B; Vander Sloten, J; Ivens, J				Mosleh, Yasmine; Cajka, Martin; Depreitere, Bart; Vander Sloten, Jos; Ivens, Jan			Designing safer composite helmets to reduce rotational accelerations during oblique impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Head protection; oblique impact; rotational acceleration; composite foam; helmet	MECHANISMS	Oblique impact is the most common accident situation that occupants in traffic accidents or athletes in professional sports experience. During oblique impact, the human head is subjected to a combination of linear and rotational accelerations. Rotational movement is known to be responsible for traumatic brain injuries. In this article, composite foam with a column/matrix composite configuration is proposed for head protection applications to replace single-layer uniform foam, to better attenuate rotational movement of the head during oblique impacts. The ability of composite foam in the mitigation of rotational head movement is studied by performing finite element (FE) simulations of oblique impact on flat and helmet shape specimens. The performance of composite foam with respect to parameters such as compliance of the matrix foam and the number, size and cross-sectional shape of the foam columns is explored in detail, and subsequently an optimized structure is proposed. The simulation results show that using composite foam instead of single-layer foam, the rotational acceleration and velocity of the headform can be significantly reduced. The parametric study indicates that using a more compliant matrix foam and by increasing the number of columns in the composite foam configuration, the rotation can be further mitigated. This was confirmed by experimental results. The simulation results were also analyzed based on global head injury criteria such as head injury criterion, rotational injury criterion, brain injury criterion and generalized acceleration model for brain injury threshold which further confirmed the superior performance of composite foam versus single-layer homogeneous expanded polystyrene foam. The findings of simulations give invaluable information for design of protective helmets or, for instance, headliners for the automotive industry.	[Mosleh, Yasmine; Ivens, Jan] Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44 Bus 2450, B-3001 Leuven, Belgium; [Cajka, Martin] Tech Univ Kosice, Dept Appl Mech & Mech Engn, Kosice, Slovakia; [Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurosurg, Leuven, Belgium; [Vander Sloten, Jos] Katholieke Univ Leuven, Biomech Sect, Dept Mech Engn, Leuven, Belgium; [Ivens, Jan] Katholieke Univ Leuven, Dept Mat Engn, Campus Nayer, St Katelijne Waver, Belgium		Mosleh, Y (corresponding author), Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44 Bus 2450, B-3001 Leuven, Belgium.	Yasi.mosleh@kuleuven.be	Depreitere, Bart/AAA-9846-2020; Ivens, Jan ID/I-4339-2016	Depreitere, Bart/0000-0002-7458-0648; Ivens, Jan ID/0000-0002-2766-1381	Flemish research funding agency FWO through the project OT-Levenslijn [G.0C67.13]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors wish to thank Flemish research funding agency FWO for the support of this research through the project OT-Levenslijn (G.0C67.13).	Ashby M., 2010, MAT SELECTION MECH D; Ashby M.F., 1997, CELLULAR SOLIDS; Bosche KV, 2017, P I MECH ENG H, V231, P851, DOI 10.1177/0954411917711201; Cui L, 2009, MAT SCI ENG A-STRUCT, V507, P215, DOI 10.1016/j.msea.2008.12.011; Depreitere B, 2008, [Protective helmet, Patent], Patent No. [EP1 776 022 B1, 1776022]; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1971, P 15 STAPP CAR CRASH, P797; Harrison TI, 1996, P INT RES COUNC BIOM; Hilyard J., 1976, HDB HUMAN TOLERANCE, P143; Holbourn AHS, 1943, LANCET, V2, P438; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Mills NJ., 2007, POLYM FOAMS HANDBOOK; Mosleh Y, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700059; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Otte D., 1999, CONTRIBUTION FINAL R; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Rizov VI, 2007, MATER DESIGN, V28, P2632, DOI 10.1016/j.matdes.2006.09.023; Takhounts EG, 2011, P 22 ENH SAF VEH C, P11; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Verschueren P., 2009, BIOMECHANICAL ANAL H; Willinger R, 2000, J SOUND VIB, V235, P611, DOI 10.1006/jsvi.1999.2931	26	3	3	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	MAY	2018	232	5					479	491		10.1177/0954411918762622			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GH0LK	WOS:000433093600005	29543121				2022-02-06	
J	Ngwenya, LB; Suen, CG; Tarapore, PE; Manley, GT; Huang, MC				Ngwenya, Laura B.; Suen, Catherine G.; Tarapore, Phiroz E.; Manley, Geoffrey T.; Huang, Michael C.			Safety and cost efficiency of a restrictive transfusion protocol in patients with traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						packed red blood cells; transfusion; critical care; traumatic brain injury	BLOOD-CELL TRANSFUSION; CRITICALLY-ILL; MORTALITY; THRESHOLD; ANEMIA; ASSOCIATION	OBJECTIVE Blood loss and moderate anemia are common in patients with traumatic brain injury (TBI). However, despite evidence of the ill effects and expense of the transfusion of packed red blood cells, restrictive transfusion practices have not been universally adopted for patients with TBI. At a Level I trauma center, the authors compared patients with TBI who were managed with a restrictive (target hemoglobin level > 7 g/dl) versus a liberal (target hemoglobin level > 10 g/dl) transfusion protocol. This study evaluated the safety and cost-efficiency of a hospital-wide change to a restrictive transfusion protocol. METHODS A retrospective analysis of patients with TBI who were admitted to the intensive care unit (ICU) between January 2011 and September 2015 was performed. Patients < 16 years of age and those who died within 24 hours of admission were excluded. Demographic data and injury characteristics were compared between groups. Multivariable regression analyses were used to assess hospital outcome measures and mortality rates. Estimates from an activity-based cost analysis model were used to detect changes in cost with transfusion protocol. RESULTS A total of 1565 patients with TBI admitted to the ICU were included in the study. Multivariable analysis showed that a restrictive transfusion strategy was associated with fewer days of fever (p = 0.01) and that patients who received a transfusion had a larger fever burden. ICU length of stay, ventilator days, incidence of lung injury, thromboembolic events, and mortality rates were not significantly different between transfusion protocol groups. A restrictive transfusion protocol saved approximately $115,000 annually in hospital direct and indirect costs. CONCLUSIONS To the authors' knowledge, this is the largest study to date to compare transfusion protocols in patients with TBI. The results demonstrate that a hospital-wide change to a restrictive transfusion protocol is safe and cost-effective in patients with TBI.	[Ngwenya, Laura B.; Suen, Catherine G.; Tarapore, Phiroz E.; Manley, Geoffrey T.; Huang, Michael C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Ngwenya, Laura B.; Suen, Catherine G.; Tarapore, Phiroz E.; Manley, Geoffrey T.; Huang, Michael C.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA		Ngwenya, LB (corresponding author), Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way,Med Sci Bldg,ML 0517, Cincinnati, OH 45267 USA.	ngwenyla@ucmail.uc.edu	Huang, Michael/AAO-2940-2020	Huang, Michael/0000-0001-9799-2920; Ngwenya, Laura/0000-0001-7103-971X			Aledort LM, 2005, TRANSFUS MED REV, V19, P66, DOI 10.1016/j.tmrv.2004.09.05; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hebert PC, 2014, NEW ENGL J MED, V371, P1459, DOI 10.1056/NEJMe1408976; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hofmann A, 2013, BEST PRACT RES-CLIN, V27, P59, DOI 10.1016/j.bpa.2013.02.001; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	21	3	3	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2018	128	5					1530	1537		10.3171/2017.1.JNS162234			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2HQ	WOS:000440650000032	28644101				2022-02-06	
J	O'Keefe, KA; Beamon, B; Brewer, KL; Niceler, B				O'Keefe, Kraigher Allan; Beamon, Bradley; Brewer, Kori L.; Niceler, Brock			Sports-Related Concussions in Children Differences in Care and Expectations When Seen in an Emergency Department Versus a Sports Medicine Clinic	PEDIATRIC EMERGENCY CARE			English	Article						athletic trainer; computed tomography; concussion; expectation; radiation; sports	COMPUTED-TOMOGRAPHY; MEDICINE PHYSICIANS; HEAD-INJURY; MANAGEMENT; TRENDS	Objectives: Patient and parent expectations can potentially influence management of care. We compared expectations in the diagnosis of concussion between patients who presented to a pediatric emergency department (ED) and those who presented to a sports medicine clinic, and if there was a difference in computed tomography (CT) scans performed. Methods: Head-injured athletes aged 8 to 18 years presenting to a pediatric ED and a sports medicine clinic were enrolled. Both groups completed questionnaires on their understanding of concussion and expectations of care. Charts were then reviewed. Results: Forty patients were enrolled in the study: 23 from a pediatric ED and 17 from a sports medicine clinic. Forty-one percent of athletes received a head CT in the pediatric ED versus 12% of those in the clinic population with no abnormal findings (P = 0.04). Forty-one percent of athletes and 48% of parents in the pediatric ED setting reported that a CT was "necessary" to diagnose concussion versus 18% in both groups from the clinic (P = 0.12, P = 0.07). Athletes presenting to the clinic were more likely to have been evaluated by an athletic trainer after the injury than those presenting to the pediatric ED (80% vs 23%, P = 0.004). Conclusions: Patients and parents who presented to a pediatric ED for sports-related head injury had a trend toward higher expectations of a CT scan being necessary to diagnose concussion and did have a higher rate of CT scans performed. Education of athletes and parents engaging in organized sports may be worthwhile to assist in setting expectations in diagnosis of concussion.	[O'Keefe, Kraigher Allan] East Carolina Univ, Dept Emergency Med, ECU Emergency Med, Brody Sch Med, 600 Moye Blvd,Mailstop 625, Greenville, NC 27834 USA; [Beamon, Bradley] East Carolina Univ, Brody Sch Med, Greenville, NC USA; [Brewer, Kori L.] East Carolina Univ, Brody Sch Med, Div Res, Greenville, NC USA; [Brewer, Kori L.] East Carolina Univ, Brody Sch Med, Dept Emergency Med, Greenville, NC USA; [Niceler, Brock] East Carolina Univ, Dept Family Med, Greenville, NC USA		O'Keefe, KA (corresponding author), East Carolina Univ, Dept Emergency Med, ECU Emergency Med, Brody Sch Med, 600 Moye Blvd,Mailstop 625, Greenville, NC 27834 USA.	kraigher@gmail.com					Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1570, DOI 10.1212/01.CON.0000458973.71142.7d; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Upshaw JE, 2012, PEDIATR EMERG CARE, V28, P926, DOI 10.1097/PEC.0b013e318267f674	15	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAY	2018	34	5					322	324		10.1097/PEC.0000000000001476			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	GF8AJ	WOS:000432189400012	29715216				2022-02-06	
J	Pacella, M; Prabhu, A; Morley, J; Huang, S; Suffoletto, B				Pacella, Maria; Prabhu, Arjun; Morley, Julia; Huang, Stephanie; Suffoletto, Brian			Postconcussive Symptoms Over the First 14 Days After Mild Traumatic Brain Injury: An Experience Sampling Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; concentration difficulties; experience sampling method; headache; head injury; mild traumatic brain injury; postconcussive symptoms; text messaging; trauma control	POST-CONCUSSION SYMPTOMS; LONG-TERM OUTCOMES; HEAD-INJURY; PREVALENCE; RECOVERY; PREDICTORS; TIME	Objective: This study examined changes in postconcussive symptoms (PCS) over the acute postinjury recovery period, focusing on how daily PCSs differ between mild traumatic brain injury (mTBI) and other injury types. Setting: An urban emergency department (ED) in Western Pennsylvania. Subjects: A total of 108 adult patients with trauma being discharged from the ED were recruited and grouped by injury type: mild TBI (mTBI; n = 39), head injury without mTBI (HI: n = 16), and non-head-injured trauma controls (TCs: n = 53). Main Measures: Subjects completed a baseline assessment and an experience sampling method (ESM) protocol for 14 consecutive days postinjury: outcomes were daily reports of headaches, anxiety, and concentration difficulties. Results: Controlling for confounders, multilevel modeling revealed greater odds of headache and concentration difficulties on day 1 postinjury among the HI and mTBI groups (vs TCs). These odds decreased over time, with greater reductions for the HI and mTBI groups compared with TCs. By day 14, there were no group differences in PCS. In addition, only the HI group reported higher initial levels of anxiety and a steeper slope relative to TCs. Conclusion: Patients with HI, regardless of whether they meet the American Congress of Rehabilitation Medicines definition of mTBI, have higher odds of typical PCS immediately postinjury, but faster rates of recovery than TCs. ESM can improve understanding the dynamic nature of postinjury PCS.	[Pacella, Maria; Prabhu, Arjun; Morley, Julia; Huang, Stephanie; Suffoletto, Brian] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA		Pacella, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 3600 Forbes Ave,Iroquois Bldg,Suite 400A, Pittsburgh, PA 15213 USA.	pacellam@upmc.edu	Suffoletto, Brian/M-4800-2019	Suffoletto, Brian/0000-0002-9628-5260			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Balasundaram AP, 2016, BRAIN INJURY, V30, P1599, DOI 10.1080/02699052.2016.1199902; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; KAHNEMAN D, 1993, MANAGE SCI, V39, P17, DOI 10.1287/mnsc.39.1.17; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; LARSON R., 1983, EXPERIENCE SAMPLING, P41; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Scollon C.N., 2003, J HAPPINESS STUD, V4, P5, DOI [10.1023/A:1023605205115, DOI 10.1023/A:1023605205115, 10.1023/a:1023605205115]; Smith, 2010, MIND CONTEXT; StataCorp, 2011, STAT STAT SOFTW REL; Weathers F. W., 1994, PTSD CHECKLIST CIVIL	35	3	3	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					E31	E39		10.1097/HTR.0000000000000335			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500004	28926480				2022-02-06	
J	Page, JC; Park, J; Chen, Z; Cao, P; Shi, RY				Page, Jessica C.; Park, Jonghyuck; Chen, Zhe; Cao, Peng; Shi, Riyi			Parallel Evaluation of Two Potassium Channel Blockers in Restoring Conduction in Mechanical Spinal Cord Injury in Rat	JOURNAL OF NEUROTRAUMA			English	Article						4-aminopyridine; 4-aminopyridine-3-methanol; demyelination; spinal cord injury	AXONAL CONDUCTION; MULTIPLE-SCLEROSIS; 4-AMINOPYRIDINE DERIVATIVES; IMPULSE CONDUCTION; MYELIN DAMAGE; WHITE-MATTER; DOUBLE-BLIND; CNS TRAUMA; PHASE-I; DEMYELINATION	Myelin damage is a hallmark of spinal cord injury (SCI), and potassium channel blocker (PCB) is proven effective to restore axonal conduction and regain neurological function. Aiming to improve this therapy beyond the U.S. Food and Drug Administration-approved 4-aminopyridine (4-AP), we have developed multiple new PCBs, with 4-aminopyridine-3-methanol (4-AP-3-MeOH) being the most potent and effective. The current study evaluated two PCBs, 4-AP-3-MeOH and 4-AP, in parallel in both ex vivo and in vivo rat mechanical SCI models. Specifically, 4-AP-3-MeOH induced significantly greater augmentation of axonal conduction than 4-AP in both acute and chronic injury. 4-AP-3-MeOH had no negative influence on the electrical responsiveness of rescued axons whereas 4-AP-recruited axons displayed a reduced ability to follow multiple stimuli. In addition, 4-AP-3-MeOH can be applied intraperitoneally at a dose that is at least 5 times higher (5 mg/kg) than that of 4-AP (1 mg/kg) in vivo. Further, 5 mg/kg of 4-AP-3-MeOH significantly improved motor function whereas both 4-AP-3-MeOH (1 and 5 mg/kg) and, to a lesser degree, 4-AP (1 mg/kg) alleviated neuropathic pain-like behavior when applied in rats 2 weeks post-SCI. Based on these and other findings, we conclude that 4-AP-3-MeOH appears to be more advantageous over 4-AP in restoring axonal conduction because of the combination of its higher efficacy in enhancing the amplitude of compound action potential, lesser negative effect on axonal responsiveness to multiple stimuli, and wider therapeutic range in both ex vivo and in vivo application. As a result, 4-AP-3-MeOH has emerged as a strong alternative to 4-AP that can complement the effectiveness, and even partially overcome the short-comings, of 4-AP in the treatment of neurotrauma and degenerative diseases where myelin damage is implicated.	[Page, Jessica C.; Shi, Riyi] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Park, Jonghyuck; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Chen, Zhe; Cao, Peng] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Inst Trauma & Orthoped,Dept Orthoped, Shanghai, Peoples R China		Shi, RY (corresponding author), Purdue Univ, Coll Vet Med, Weldon Sch Biomed Engn, Dept Basic Med Sci, W Lafayette, IN 47907 USA.; Cao, P (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Orthoped, Shanghai 20025, Peoples R China.	dr_caopeng8@163.com; riyi@purdue.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS073636]; state of Indiana [206424]; Science and Technology Commission of Shanghai Municipality, Shanghai, ChinaScience & Technology Commission of Shanghai Municipality (STCSM) [13430722100]; Shanghai Bureau of Health, Shanghai, China [XBR2011024]	Jessica C. Page, Jonghyuck Park, and Zhe Chen conducted experiments; all authors contributed to data analysis and writing. The authors acknowledge financial support from the National Institutes of Health (Grant No. R01NS073636; to R.S.) and the state of Indiana (Grant No. 206424; to R.S.), Science and Technology Commission of Shanghai Municipality, Shanghai, China (No. 13430722100; to P.C.), and grants from the Shanghai Bureau of Health, Shanghai, China (No. XBR2011024; to P.C.).	Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; BEVER CT, 1994, ANN NEUROL, V36, pS118, DOI 10.1002/ana.410360728; Blight A R, 2001, Curr Opin Investig Drugs, V2, P801; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Blight AR, 1991, J NEUROTRAUM, V8, P103, DOI 10.1089/neu.1991.8.103; Blight AR, 2014, ANN NY ACAD SCI, V1329, P33, DOI 10.1111/nyas.12512; Blight Andrew R, 2011, Ther Adv Neurol Disord, V4, P99, DOI 10.1177/1756285611403960; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1987, J NEUROL SCI, V82, P145, DOI 10.1016/0022-510X(87)90014-1; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Halter JA, 2000, SPINAL CORD, V38, P728, DOI 10.1038/sj.sc.3101098; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; Hayes KC, 2004, CNS DRUG REV, V10, P295; Hayes KC, 2003, J CLIN PHARMACOL, V43, P379, DOI 10.1177/0091270003251388; HAYES KC, 1993, PARAPLEGIA, V31, P216, DOI 10.1038/sc.1993.40; HAYES KC, 1994, RESTOR NEUROL NEUROS, V6, P259, DOI 10.3233/RNN-1994-6401; Huff TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017176; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Kaner T, 2010, J NEUROSURG-SPINE, V13, P543, DOI 10.3171/2010.4.SPINE09685; Leung G, 2011, EXP NEUROL, V227, P232, DOI 10.1016/j.expneurol.2010.11.004; Mcbride JM, 2007, NEUROSCIENCE, V148, P44, DOI 10.1016/j.neuroscience.2007.05.039; McBride JM, 2006, EUR J PHARM SCI, V27, P237, DOI 10.1016/j.ejps.2005.10.003; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; Nagoshi N, 2015, EXPERT OPIN INV DRUG, V24, P645, DOI 10.1517/13543784.2015.1009629; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Page JC, 2016, NEURAL REGEN RES, V11, P1226, DOI 10.4103/1673-5374.189172; Park J, 2015, J NEUROCHEM, V135, P987, DOI 10.1111/jnc.13352; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; RUPP SM, 1983, J PHARMACOL EXP THER, V225, P351; Shi R, 2015, FREE RADICAL RES, V49, P888, DOI 10.3109/10715762.2015.1021696; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 2011, NEUROSCI BULL, V27, P36, DOI 10.1007/s12264-011-1048-y; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; Smith DT, 2005, EUR J MED CHEM, V40, P908, DOI 10.1016/j.ejmech.2005.04.017; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Teng YD, 1997, J NEUROSCI, V17, P4359; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Vissers K, 2005, ANESTH ANALG, V101, P457, DOI 10.1213/01.ANE.0000158471.41575.F0; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; Yamamoto K, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0072-8; Yan R, 2016, J NEUROPHYSIOL, V115, P701, DOI 10.1152/jn.00467.2015	61	3	3	2	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	9					1057	1068		10.1089/neu.2017.5297			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC9UG	WOS:000430143700002	29228863	Green Published			2022-02-06	
J	Stephens, J; Nicholson, R; Slomine, B; Suskauer, S				Stephens, Jaclyn; Nicholson, Rachel; Slomine, Beth; Suskauer, Stacy			Development and Pilot Testing of the Dual Task Screen in Healthy Adolescents	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; GAIT BALANCE CONTROL; CONCUSSION; STABILITY; SPORTS	Athletes with mild traumatic brain injury (mTBI) should refrain from high-risk activities until recovered (symptom free and cognitive and physical exam findings normalize). Studies have suggested that this examination may not be sufficiently sensitive because dual-task paradigms, which typically assess motor performance while a person simultaneously completes a distractor task, can detect residual deficits in athletes who otherwise appear recovered from mTBI. Paradigms used to date are time-intensive procedures conducted in laboratory settings. Here, we report findings from a pilot study of the Dual Task Screen (DTS), which is a brief evaluation with two dual-task paradigms. In 32 healthy female adolescents, the DTS was administered in a mean of 5.63 min in the community, and every participant had poorer dual-condition performance on at least one of the motor tasks. The DTS is a clinically feasible measure and merits additional study regarding utility in adolescents with mTBls.	[Stephens, Jaclyn] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Stephens, Jaclyn; Nicholson, Rachel] Kennedy Krieger Inst, Dept Phys Med & Rehabil, Baltimore, MD USA; [Stephens, Jaclyn; Slomine, Beth; Suskauer, Stacy] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Nicholson, Rachel] Immaculata Univ, Malvern, PA USA; [Slomine, Beth] Kennedy Krieger Inst, Ctr Brain Injury Recovery, Baltimore, MD USA; [Slomine, Beth] Kennedy Krieger Inst, Dept Neuropsychol, Training Serv, Baltimore, MD USA; [Slomine, Beth] Kennedy Krieger Inst, Dept Neuropsychol, Neuropsychol Rehabil Serv, Baltimore, MD USA; [Slomine, Beth] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Suskauer, Stacy] Kennedy Krieger Inst, Dept Phys Med & Rehabil, Ctr Brain Injury Recovery, Baltimore, MD USA; [Suskauer, Stacy] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA		Stephens, J (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.; Stephens, J (corresponding author), Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA.	jaclyn.stephens@colostate.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD007414]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER	The authors declare no conflicts of interest. This research was supported by National Institutes of Health Grant 5T32HD007414. The authors thank Ms. Souris and the Bryn Mawr School for their assistance with this study.	Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; KLAVORA P, 1994, PERCEPT MOTOR SKILL, V79, P448, DOI 10.2466/pms.1994.79.1.448; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Reed NP, 2012, CAN J OCCUP THER, V79, P5; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001	12	3	3	0	1	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2018	72	3							7203345020	10.5014/ajot.2018.025361			6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	GL1MX	WOS:000436868300016	29689184	Green Published			2022-02-06	
J	Wang, Q; Wang, GR; Lu, XL; Guo, XL; Du, Q; Lin, F; Fan, QM; Zhang, GY; Wang, DS				Wang, Qiang; Wang, Guangrong; Lu, Xiaolan; Guo, Xiaolan; Du, Qin; Lin, Fang; Fan, Quming; Zhang, Guoyuan; Wang, Dongsheng			A correction formula for neuron-specific enolase measurement in hemolyzed neonatal serum samples	BIOMEDICAL REPORTS			English	Article						neuron-specific enolase; neonatal hemolysis; correction formula	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY	As a specific biomarker in neonatal hypoxic-ischemic encephalopathy (HIE), the measurement of neuron-specific enolase (NSE) has been advocated as a predictor of outcome in neurological injury. However, the measured levels of NSE may be influenced by hemolysis. In the current study, the change in the concentration of NSE in serum was measured by chemiluminescence prior to and following the addition of individual frozen and thawed red blood cells from 86 neonates that were collected within 24 h of birth. The changes in the concentration of NSE were compared with the changes in the concentration of hemoglobin (Hb), measured by the hemoglobin cyanide (HiCN) method, to establish a correction formula. The performance of the correction formula was evaluated by comparing the corrected concentration of NSE using the individual constants and the correction formula. The average individual constant of NSE from the 86 hemolyzed neonatal serum samples was 25.15 +/- 3.94 mg/g Hb. The concentration variation between NSE and Hb in neonatal sera could be described by the equation NSEserum=1.8594+24.0670 xHb(HiCN) (r(2)=0.8045, P<0.001). There was no statistically significant difference in the NSE corrected results between the individual constant group and the correction formula group (Z=-1.645, P=0.100). The linear regression formula of Hb measured with the instrumental method compared with the HiCN method was Hb(instr)=0.9816xHb(HiCN)+0.5596 (r(2)=0.9924, P<0.001). Based on these regression analyses, the correction formula for NSE in hemolyzed neonatal serum was determined as NSEcorr=NSEmeas-24.0670xHb(HiCN)-1.8594 or NSEcorr=NSEmeas-24.5181xHb(instr)+11.8609. In conclusion, hemolysis has a substantial influence on the accurate measurement of NSE in neonatal serum samples. For hemolyzed neonatal serum samples, correcting the NSE results using a correction formula is essential to evaluate the severity of neonatal hypoxic ischemic encephalopathy.	[Wang, Qiang; Guo, Xiaolan; Lin, Fang; Fan, Quming] North Sichuan Med Coll, Fac Lab Med, Nanchong 637000, Sichuan, Peoples R China; [Wang, Qiang; Wang, Guangrong; Lu, Xiaolan; Du, Qin; Zhang, Guoyuan; Wang, Dongsheng] North Sichuan Med Coll, Affiliated Hosp, Dept Lab Med, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China; [Wang, Qiang] North Sichuan Med Coll, Ctr Translat Med, Nanchong 637000, Sichuan, Peoples R China		Wang, DS (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Lab Med, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China.	wangdongshengnc@163.com			Department of Science and Technology of Sichuan Province [2016JY0171]; International Science and Technology Cooperation Program of China [2015DFA30420]	The current study was supported by grants from the Department of Science and Technology of Sichuan Province (grant no. 2016JY0171), and the International Science and Technology Cooperation Program of China (grant no. 2015DFA30420).	Agut T, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-177; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Douglas-Escobar Martha, 2012, Front Neurol, V3, P144, DOI 10.3389/fneur.2012.00144; Filippi L, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-144; Gulczynska E, 2012, GINEKOL POL, V83, P214; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Horn AR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-52; International Committee for Standardization in Haematology, 1967, BRIT J HAEMATOL, V13, P71, DOI DOI 10.1111/J.1365-2141.1967.TB00751.X5608692; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; NAKAJIMA H, 1963, J BIOL CHEM, V238, P3784; National Committee for Clinical Laboratory Standards (NCCLS), EP9A2 NCCLS; Pierrat V, 2005, ARCH DIS CHILD-FETAL, V90, P257, DOI 10.1136/adc.2003.047985; RICHARDS E, 1957, PEDIATRICS, V20, P92; ROBINSON SH, 1971, J CLIN INVEST, V50, P1847, DOI 10.1172/JCI106676; Shang Y, 2014, EXP THER MED, V8, P1259, DOI 10.3892/etm.2014.1869; Tolan NV, 2013, CLIN CHIM ACTA, V424, P216, DOI 10.1016/j.cca.2013.06.009	19	3	3	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	2049-9434	2049-9442		BIOMED REP	Biomed. Rep.	MAY	2018	8	5					491	496		10.3892/br.2018.1081			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GG5FG	WOS:000432720300013	29725527	Green Published, gold			2022-02-06	
J	Zhong, WT; Krueger, F; Wilson, M; Bulbulia, J; Grafman, J				Zhong, Wanting; Krueger, Frank; Wilson, Marc; Bulbulia, Joseph; Grafman, Jordan			Prefrontal Brain Lesions Reveal Magical Ideation Arises From Enhanced Religious Experiences	PEACE AND CONFLICT-JOURNAL OF PEACE PSYCHOLOGY			English	Article						traumatic brain injury; prefrontal cortex; religious beliefs; magical ideation; Supplemental materials	PARANORMAL BELIEFS; SOFTWARE	Magical ideation refers to beliefs about causality that lack empirical bases. Few studies have investigated the neural correlates of magical thinking and religious beliefs. Here, we investigate the association between magical ideation and religious experience in a sample of Vietnam veterans who sustained penetrating traumatic brain injury (pTBI) and matched healthy controls. Scores on the Magical Ideation Scale were positively correlated with scores on the Religious Experience Scale but only in pTBI patients. Lesion mapping analyses in subgroups of pTBI patients indicated that prefrontal cortex (PFC) lesions were associated with increased magical ideation scores, and this relationship was mediated by religious experience. Our findings clarify the mechanism by which the frontal lobe processes modulate magical beliefs. Suppression of the PFC opens people to religious experiences, which in turn increases magical ideation.	[Zhong, Wanting] Shirley Ryan AbilityLab, Cognit Neurosci Lab, 355 East Erie St, Chicago, IL 60611 USA; [Zhong, Wanting] Northwestern Univ, Evanston, IL 60208 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Syst Social Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] Univ Mannheim, Mannheim, Germany; [Wilson, Marc] Victoria Univ Wellington, Psychol, Wellington, New Zealand; [Bulbulia, Joseph] Victoria Univ Wellington, Wellington, New Zealand; [Grafman, Jordan] Shirley Ryan AbilityLab, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Cognit Neurol, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Alzheimers Dis Ctr, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Weinberg Coll Arts & Sci, Dept Psychol, Evanston, IL 60208 USA		Grafman, J (corresponding author), Shirley Ryan AbilityLab, Cognit Neurosci Lab, 355 East Erie St, Chicago, IL 60611 USA.	jgrafman@northwestern.edu		Bulbulia, Joseph/0000-0002-5861-2056; Wilson, Marc/0000-0002-3009-5229; Zhong, Wanting/0000-0002-6025-1739	National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Shirley Ryan AbilityLab; Therapeutic Cognitive Neuroscience Fund	THIS STUDY WAS FUNDED by the National Institute of Neurological Disorders and Stroke Intramural Research Program, the Shirley Ryan AbilityLab (Wanting Zhong), and the Therapeutic Cognitive Neuroscience Fund (Jordan Grafman).	[Anonymous], 1960, DEP DEFENSE FORM 129; Atran S, 2012, SCIENCE, V336, P855, DOI 10.1126/science.1216902; Cristofori I, 2016, NEUROPSYCHOLOGIA, V80, P212, DOI 10.1016/j.neuropsychologia.2015.11.021; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donaldson, 1976, RES MENTAL HLTH RELI, P224; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Kaplan E, 1983, BOSTON NAMING TEST; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Malinowski Bronislaw, 1948, MAGIC SCI RELIG OTHE; McNamara P., 2006, GOD SCI MEET HOW BRA; McNeil M., 1994, REVISED TOKEN TEST; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; R Core Team, 2017, R LANG ENV STAT COMP; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wain O, 2007, INT J NEUROSCI, V117, P135, DOI 10.1080/00207450500534068; Willard AK, 2013, COGNITION, V129, P379, DOI 10.1016/j.cognition.2013.07.016; Wilson MS, 2014, RELIG BRAIN BEHAV, V4, P104, DOI 10.1080/2153599X.2013.779934; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhong WT, 2017, NEUROPSYCHOLOGIA, V100, P18, DOI 10.1016/j.neuropsychologia.2017.04.009	24	3	3	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1078-1919	1532-7949		PEACE CONFL	Peace Confl.	MAY	2018	24	2					245	249		10.1037/pac0000336			5	Psychology, Social	Emerging Sources Citation Index (ESCI)	Psychology	GH1HA	WOS:000433152600015	30364497	Bronze, Green Accepted			2022-02-06	
J	Ruet, A; Joyeux, F; Segobin, S; Jokic, C; Desgranges, B; Eustache, F; Pitel, AL				Ruet, Alexis; Joyeux, Francoise; Segobin, Shailendra; Jokic, Corine; Desgranges, Beatrice; Eustache, Francis; Pitel, Anne-Lise			Severe Traumatic Brain Injury Patients without Focal Lesion but with Behavioral Disorders: Shrinkage of Gray Matter Nuclei and Thalamus Revealed in a Pilot Voxel-Based MRI Study	JOURNAL OF NEUROTRAUMA			English	Article						adult; behavioral disorders; MRI scan; TBI	INFARCTION; MODERATE	After a traumatic brain injury (TBI), behavioral disorders can occur without major focal brain lesion, and in these situations, their pathophysiology remains unclear. The aim of this study is to examine whether TBI patients with behavioral disorders but without any focal damage, as observed from an initial clinical CT scan, present subtle volumetric alterations that could be measured voxel-by-voxel in the whole brain with MRI. Eight male adults with severe TBI who had behavioral sequela but not major focal cerebral lesion and 17 age-matched controls underwent a volumetric T1-weighted 1.5T MRI. A two step analysis was performed. First, gray matter (GM) and white matter (WM) volumes were compared between groups using voxel-based morphometry. Second, we examined brain regions systematically damaged using the sum of the individual binary maps obtained from z-maps thresholded at -1.75 for significant GM and WM atrophy. TBI patients had lower GM volume than controls (p<0.001, uncorrected) in the right parahippocampal gyrus; left and right superior, middle, and inferior temporal gyri; left superior frontal gyrus; right middle frontal gyrus; thalami; mammillary bodies; caudate nuclei; insulae; cerebellar cortex; and vermis. WM volume was lower (p<0.001, uncorrected) in the TBI group than in controls in the periventricular area and around the basal nuclei. We found shrinkage in the dorsomedial thalami in each of the TBI patients, and in the posterior part of the right putamen and caudate nuclei in seven TBI patients. Shrinkage in the dorsomedial thalami and in the posterior part of the right putamen and caudate nuclei may be a common effect of the disseminated microscopic lesions, and be associated with behavioral issues in severe TBI patients without major focal lesions.	[Ruet, Alexis] CHU Caen, Serv Med Phys & Readaptat, F-14000 Caen, France; [Joyeux, Francoise; Segobin, Shailendra; Desgranges, Beatrice; Eustache, Francis; Pitel, Anne-Lise] Normandie Univ, PSL Res Univ, UNICAEN, INSERM,EPHE,Neuropsychol & Imagerie Memoire Humai, Caen, France; [Ruet, Alexis; Joyeux, Francoise; Jokic, Corine] CH Aunay Bayeux, Serv Med Phys & Readaptat, Aunay Odon, France		Ruet, A (corresponding author), CHU Caen, Serv Med Phys & Readaptat, F-14000 Caen, France.	ruet-a@chu-caen.fr	DESGRANGES, BEATRICE/AAK-4756-2021; RUET, Alexis/L-8726-2015; Eustache, Francis/J-9465-2015	DESGRANGES, BEATRICE/0000-0002-3657-9996; RUET, Alexis/0000-0002-5080-5734; Eustache, Francis/0000-0003-4460-8686; PITEL, Anne Lise/0000-0001-8573-9506; Segobin, Shailendra/0000-0003-1977-8210			[Anonymous], 2005, WELLC TRUST CTR NEUR; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BOGOUSSLAVSKY J, 1988, J NEUROL NEUROSUR PS, V51, P116, DOI 10.1136/jnnp.51.1.116; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MRABET A, 1994, REV NEUROL, V150, P67; Narumoto J, 2005, PSYCHIAT CLIN NEUROS, V59, P109, DOI 10.1111/j.1440-1819.2005.01342.x; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Perry DC, 2014, BRAIN, V137, P1621, DOI 10.1093/brain/awu075; Petty Richard G., 1996, British Journal of Psychiatry, V168, P237, DOI 10.1192/bjp.168.2.237; Raven J.C., 1938, GUIDE USING PROGR MA; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149	22	3	3	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1552	1556		10.1089/neu.2017.5242		APR 2018	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000431244500001	29648977				2022-02-06	
J	Pagani, M; Castelnuovo, G; Daverio, A; La Porta, P; Monaco, L; Ferrentino, F; Chiaravalloti, A; Fernandez, I; Di Lorenzo, G				Pagani, Marco; Castelnuovo, Gianluca; Daverio, Andrea; La Porta, Patrizia; Monaco, Leonardo; Ferrentino, Fabiola; Chiaravalloti, Agostino; Fernandez, Isabel; Di Lorenzo, Giorgio			Metabolic and Electrophysiological Changes Associated to Clinical Improvement in Two Severely Traumatized Subjects Treated With EMDR-A Pilot Study	FRONTIERS IN PSYCHOLOGY			English	Article						EMDR; PET imaging; EEG; neuropsychological tests; psychological tests	POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT DESENSITIZATION; CEREBRAL-BLOOD-FLOW; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; REPROCESSING THERAPY; GLUCOSE-METABOLISM; POLICE OFFICERS; PTSD; BRAIN	Neuroimaging represents a powerful tool to investigate the neurobiological correlates of Eye Movements Desensitization and Reprocessing (EMDR). The impact of EMDR on cortical and sub-cortical brain regions has been proven by several investigations demonstrating a clear association between symptoms disappearance and changes in cortical structure and functionality. The aim of this study was to assess by electroencephalography (EEG) and for the first time by positron emission tomography (PET) the changes occurring after EMDR therapy in two cases of psychological trauma following brain concussion and comatose state due to traffic accident. A 28 and a 29 years old men underwent extensive neuropsychological examination, which investigated: (i) categorical and phonological verbal fluency; (ii) episodic verbal memory; (iii) executive functions; (iv) visuospatial abilities; (v) attention and working memory as well as clinical assessment by means of psychopathological tests (CAPS, IFS, BDI, SCL9OR, and DES). They were then treated by eight sessions of EMDR. During the first session EEG monitoring was continuously performed and F-18-FDG PET scans, depicting brain metabolism, were acquired at rest within a week (TO). After the last session, in which the two clients were considered to be symptoms-free, neuropsychological, clinical, and PET assessment were repeated (T1). PET data were semi-quantitatively compared to a group of 18 normal controls, as for EEG the preferential cortical activations were disclosed by thresholding the individual z-score to a p < 0.05. There was a significant improvement in clinical condition for both clients associated with a significant decrease in CAPS scores. IES and BDI were found to be pathological at TO and improved at T1 in only one subject. Visuo-constructive abilities and abstract reasoning improved after EMDR in both subjects. As for EEG, the most striking changes occurred in fronto-temporal-parietal cortex in subject 1 while subject 2 showed only minor changes. PET showed more pronounced metabolism in orbito-frontal and prefrontal cortex at T1 as compared to TO in both subjects. In conclusion both clients had a clear clinical improvement in PTSD symptoms associated with metabolic and electrophysiological changes in limbic and associative cortex, respectively, highlighting the value of EMDR also in such extreme pathological conditions.	[Pagani, Marco] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Castelnuovo, Gianluca] Osped San Giuseppe, Ist Auxol Italian IRCCS, Psychol Res Lab, Verbina, Italy; [Castelnuovo, Gianluca] Univ Cattolica Sacro Cuore, Dept Psychol, Milan, Italy; [Daverio, Andrea; Monaco, Leonardo; Ferrentino, Fabiola; Di Lorenzo, Giorgio] Univ Roma Tor Vergata, Dept Syst Med, Chair Psychiat, Lab Psychophysiol, Rome, Italy; [Daverio, Andrea; Monaco, Leonardo; Ferrentino, Fabiola; Di Lorenzo, Giorgio] Univ Roma Tor Vergata, Dept Syst Med, Chair Psychiat, Rome, Italy; [Daverio, Andrea; Di Lorenzo, Giorgio] Fdn Policlin Tor Vergata, Dept Neurosci, Psychiat & Clin Psychol Unit, Rome, Italy; [La Porta, Patrizia; Fernandez, Isabel] EMDR Italy Assoc, Bovisio Masciago, Italy; [Chiaravalloti, Agostino] Univ Roma Tor Vergata, Dept Nucl Med, Rome, Italy; [Chiaravalloti, Agostino] IRCCS Neuromed, Pozzilli, Italy		Pagani, M (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	marcopagani2@yahoo.it	Chiaravalloti, Agostino/AAA-3342-2021; pagani, marco/AAV-9176-2020; Di Lorenzo, Giorgio/B-1308-2013	Chiaravalloti, Agostino/0000-0002-8017-8858; Di Lorenzo, Giorgio/0000-0002-0576-4064			Acarturk C, 2018, J NERV MENT DIS, V206, P40, DOI 10.1097/NMD.0000000000000693; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Capezzani L, 2013, J EMDR PRACT RES, V7, P134, DOI 10.1891/1933-3196.7.3.134; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chiaravalloti A, 2015, EUR J NUCL MED MOL I, V42, P733, DOI 10.1007/s00259-014-2969-2; Choi SJ, 2007, EUR J OBSTET GYN R B, V132, P182, DOI 10.1016/j.ejogrb.2006.07.024; Cottraux J, 2015, ENCEPHALE, V41, P202, DOI 10.1016/j.encep.2014.03.002; Darves-Bornoz JM, 2008, J TRAUMA STRESS, V21, P455, DOI 10.1002/jts.20357; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dutch National Steering Committee Guidelines Mental Health, 2003, MULT GUID ANX DIS; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Faretta E, 2016, J EMDR PRACT RES, V10, P215, DOI 10.1891/1933-3196.10.3.215; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Gallivanone F, 2017, Q J NUCL MED MOL IM, V61, P115, DOI 10.23736/S1824-4785.16.02749-7; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Hogberg G, 2008, PSYCHIAT RES, V159, P101, DOI 10.1016/j.psychres.2007.10.019; Hogberg G, 2007, NORD J PSYCHIAT, V61, P54, DOI 10.1080/08039480601129408; INSERM, 2004, PSYCH EV 3 APPR; Kennedy SH, 2007, AM J PSYCHIAT, V164, P778, DOI 10.1176/appi.ajp.164.5.778; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kim SY, 2012, PSYCHIAT RES-NEUROIM, V201, P214, DOI 10.1016/j.pscychresns.2011.08.007; Lamprecht F, 2004, NEUROSCI RES, V49, P267, DOI 10.1016/j.neures.2004.02.013; Lange C, 2016, J ALZHEIMERS DIS, V49, P945, DOI 10.3233/JAD-150814; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lansing K, 2005, J NEUROPSYCH CLIN N, V17, P526, DOI 10.1176/appi.neuropsych.17.4.526; Laugharne J, 2016, J NEUROPSYCH CLIN N, V28, P312, DOI 10.1176/appi.neuropsych.16010006; Lee YH, 2014, ANN REHABIL MED-ARM, V38, P310, DOI 10.5535/arm.2014.38.3.310; Lehman AF, 2004, AM J PSYCHIAT, V161, P1; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Lobo I, 2015, J AFFECT DISORDERS, V183, P210, DOI 10.1016/j.jad.2015.05.015; Looi JCL, 2009, PSYCHIAT RES-NEUROIM, V171, P138, DOI 10.1016/j.pscychresns.2008.03.011; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGuire TM, 2014, PSYCHOL RES BEHAV MA, V7, P273, DOI 10.2147/PRBM.S52268; Moreno-Alcazar A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1910-y; Nardo D, 2013, ACTA PSYCHIAT SCAND, V128, P222, DOI 10.1111/acps.12026; Nardo D, 2011, PSYCHOL MED, V41, P2549, DOI 10.1017/S0033291711000912; Nardo D, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00134; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Ni TO, 2009, NEUROSCI RES, V65, P375, DOI 10.1016/j.neures.2009.08.014; O'Doherty DCM, 2017, PSYCHIAT RES-NEUROIM, V266, P1, DOI 10.1016/j.pscychresns.2017.05.008; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; Pagani M, 2005, EUR ARCH PSY CLIN N, V255, P359, DOI 10.1007/s00406-005-0559-9; Pagani M, 2007, NUCL MED COMMUN, V28, P757, DOI 10.1097/MNM.0b013e3282742035; Pagani Marco, 2015, Front Psychol, V6, P1614, DOI 10.3389/fpsyg.2015.01614; Pagani M, 2013, J EMDR PRACT RES, V7, P29, DOI 10.1891/1933-3196.7.1.29; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Pagani M, 2011, J EMDR PRACT RES, V5, P42, DOI 10.1891/1933-3196.5.2.42; Pagani M, 2005, NUCL MED REV, V8, P140; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Porcaro C, 2009, HUM BRAIN MAPP, V30, P660, DOI 10.1002/hbm.20533; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Schafer I, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1255-9; Shapiro E, 2012, EUR REV APPL PSYCHOL, V62, P241, DOI 10.1016/j.erap.2012.09.003; Shapiro F., 2001, EYE MOVEMENT DESENSI; SHAPIRO S, 1989, CANCER, V63, P1873, DOI 10.1002/1097-0142(19890515)63:10<1873::AID-CNCR2820631002>3.0.CO;2-6; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Substance Abuse and Mental Health Administration (SAMHSA), 2011, NAT REG EV BAS PROGR; Tesarz J, 2014, PAIN MED, V15, P247, DOI 10.1111/pme.12303; Thurfjell L, 2000, J NEUROIMAGING, V10, P39, DOI 10.1111/jon200010139; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723; Trentini C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01662; United Kingdom Department of Health, 2001, TREATM CHOIC PSYCH C; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhu YQ, 2016, J NUCL MED, V57, P1474, DOI 10.2967/jnumed.116.173443; Zubieta JK, 1999, J PSYCHIAT RES, V33, P23, DOI 10.1016/S0022-3956(98)00035-1	83	3	3	1	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	APR 16	2018	9								475	10.3389/fpsyg.2018.00475			15	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	GC9NK	WOS:000430124500001	29713297	Green Published, gold			2022-02-06	
J	Wise, A; Barnett-Cowan, M				Wise, Adrienne; Barnett-Cowan, Michael			Perceived Simultaneity and Temporal Order of Audiovisual Events Following Concussion	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; time perception; auditory; visual; simultaneity; temporal order	MULTISENSORY INTEGRATION; COGNITIVE IMPAIRMENT; NEURONS	The central nervous system allows for a limited time span referred to as the temporal binding window (TBW) in order to rapidly determine whether multisensory events correspond with the same event. Failure to correctly identify whether multisensory events occur simultaneously and their sequential order can lead to inaccurate representations of the physical world, poor decision-making and dangerous behavior. Damage to the neural systems that coordinate the relative timing of sensory events may explain some of the long-term consequences associated with concussion. The aim of this study was to investigate whether the perception of simultaneity and the discrimination of temporal order of audiovisual stimuli are impaired in those with a history of concussion. Fifty participants (17 with concussion history) were recruited to complete audiovisual simultaneity judgment (SJ) and temporal order judgment (TOJ) tasks. From these tasks, the TBW and point of subjective simultaneity (PSS) were extracted to assess whether the precision and or the accuracy of temporal perception changes with concussion, respectively. Results demonstrated that those with concussion history have a significantly wider TBW (less precise), with no significant change in the PSS (no change in accuracy), particularly for the TOJ task but no significant differences were found between the SJ and TOJ tasks. Importantly, a negative correlation between the time elapsed since last concussion and TBW width in the TOJ task suggests that precision in temporal perception does improve over time. These findings suggest that those with concussion history display an impairment in the perceived timing of sensory events and that monitoring performance in the SJ and TOJ tasks may be a useful additional assessment tool when making decisions about returning to regular work and play following concussion.	[Wise, Adrienne; Barnett-Cowan, Michael] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada		Barnett-Cowan, M (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	mbc@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-05435-2014]; University of Waterloo Research Incentive Fund Grant	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (#RGPIN-05435-2014) and a University of Waterloo Research Incentive Fund Grant to MB-C.	Bedard G, 2016, EXP BRAIN RES, V234, P331, DOI 10.1007/s00221-015-4466-7; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Capa RL, 2014, SCHIZOPHR RES, V156, P51, DOI 10.1016/j.schres.2014.04.001; Caspary DM, 2005, J NEUROSCI, V25, P10952, DOI 10.1523/JNEUROSCI.2451-05.2005; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Dalecki Marc, 2016, Concussion, V1, pCNC14, DOI 10.2217/cnc-2016-0001; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harris L, 2009, SPACE TIME PERCEPTIO, P232; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; Hillock-Dunn A, 2012, DEVELOPMENTAL SCI, V15, P688, DOI 10.1111/j.1467-7687.2012.01171.x; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; POPPEL E, 1990, NATURWISSENSCHAFTEN, V77, P89, DOI 10.1007/BF01131783; Setti A, 2011, EXP BRAIN RES, V209, P375, DOI 10.1007/s00221-011-2560-z; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Wu JL, 2012, J ALZHEIMERS DIS, V32, P317, DOI 10.3233/JAD-2012-111070	31	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	APR 13	2018	12								139	10.3389/fnhum.2018.00139			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GC7SS	WOS:000429994200001	29706877	Green Published, gold			2022-02-06	
J	Beals, TR; Harris, R; Auston, DA				Beals, Tim R.; Harris, Robert; Auston, Darryl A.			Articular Incongruity in the Lower Extremity How Much Is Too Much?	ORTHOPEDIC CLINICS OF NORTH AMERICA			English	Article						Articular reduction; Periarticular fractures; Lower extremity trauma; Posttraumatic arthritis; PTOA; Articular congruity	INTRAARTICULAR CALCANEAL FRACTURES; TIBIAL PILON FRACTURES; FEMORAL-HEAD FRACTURES; CONTROLLED MULTICENTER TRIAL; PERCUTANEOUS SCREW FIXATION; HUMAN CADAVERIC ANKLES; SOFT-TISSUE INJURY; TERM-FOLLOW-UP; OPERATIVE TREATMENT; INTERNAL-FIXATION	Intraarticular fractures carry a significant risk for posttraumatic osteoarthritis, and this risk varies across different joint surfaces of the lower extremity. These differences are likely due to the anatomic and biomechanical specifics of each joint surface. High-quality human studies are lacking to delineate the threshold articular incongruity that significantly increases risk for posttraumatic osteoarthritis and diminished clinical outcomes for many joint surfaces. Even with anatomic reduction of the articular surface, close attention must be paid to mechanical axis and joint stability to optimize outcomes.	[Beals, Tim R.] Jack Hughston Mem Hosp, Dept Orthoped Surg, 4401 Riverchase Dr, Phenix City, AL 36867 USA; [Harris, Robert] Jack Hughston Mem Hosp, Midtown Med Ctr, Dept Orthoped Surg, Hughston Orthoped Trauma, 4401 Riverchase Dr, Phenix City, AL 36867 USA; [Auston, Darryl A.] Orange Pk Med Ctr, Hughston Trauma, 1895 Kingsley Ave,Suite 300, Orange Pk, FL 32073 USA		Auston, DA (corresponding author), Orange Pk Med Ctr, Hughston Trauma, 1895 Kingsley Ave,Suite 300, Orange Pk, FL 32073 USA.	Darryl.auston@gmail.com					Agren PH, 2013, J BONE JOINT SURG AM, V95A, P1351, DOI 10.2106/JBJS.L.00759; Ali AM, 2003, CLIN ORTHOP RELAT R, P214, DOI 10.1097/01.blo.0000093913.26658.9b; Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; ARNESON TJ, 1988, CLIN ORTHOP RELAT R, P188; Ball ST, 2007, FOOT ANKLE INT, V28, P665, DOI 10.3113/FAI.2007.0665; Barbieri R, 1996, CLIN ORTHOP RELAT R, P16; Beck E, 1993, MAJOR FRACTURES PILO, P49; Blauth M, 2001, J ORTHOP TRAUMA, V15, P153, DOI 10.1097/00005131-200103000-00002; BLOKKER CP, 1984, CLIN ORTHOP RELAT R, P193; BONE L, 1993, CLIN ORTHOP RELAT R, P101; Bonnier P., 1961, FRACTURES PILON; Boraiah S, 2010, J BONE JOINT SURG AM, V92A, P346, DOI 10.2106/JBJS.H.01678; Borrelli J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000132627.13539.02; BOURNE RB, 1989, CLIN ORTHOP RELAT R, P42; BROWN TD, 1988, J ORTHOPAED RES, V6, P851, DOI 10.1002/jor.1100060609; BROWN TD, 1991, J ORTHOPAED RES, V9, P559, DOI 10.1002/jor.1100090412; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001; Calori GM, 2010, INJURY, V41, P1183, DOI 10.1016/j.injury.2010.08.041; Cannada LK, 2010, ORTHOPEDICS, V33, P734, DOI 10.3928/01477447-20100826-16; CARNESALE PG, 1975, J BONE JOINT SURG AM, V57, P1054, DOI 10.2106/00004623-197557080-00003; CATHCART RF, 1971, J BONE JOINT SURG AM, VA 53, P397; Chan DS, 2017, J ORTHOP TRAUMA, V31, P90, DOI 10.1097/BOT.0000000000000728; Csizy M, 2003, J ORTHOP TRAUMA, V17, P106, DOI 10.1097/00005131-200302000-00005; DECOSTER TA, 1988, CLIN ORTHOP RELAT R, P196; DECOULX P, 1961, Rev Chir Orthop Reparatrice Appar Mot, V47, P563; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; Dreinhofer KE, 1996, UNFALLCHIRURG, V99, P400; Egol K A, 2000, Foot Ankle Clin, V5, P873; Elgafy H, 2000, FOOT ANKLE INT, V21, P1023, DOI 10.1177/107110070002101208; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Gary JL, 2012, J ORTHOP TRAUMA, V26, P278, DOI 10.1097/BOT.0b013e31823836d2; Giannoudis PV, 2010, INJURY, V41, P986, DOI 10.1016/j.injury.2010.08.003; Giannoudis PV, 2009, INJURY, V40, P1245, DOI 10.1016/j.injury.2009.10.024; Giannoudis PV, 2005, J BONE JOINT SURG BR, V87B, P2, DOI 10.1302/0301-620X.87B1.15605; Goodwin W, 2010, J ORTHOP RES, V28, P1057, DOI 10.1002/jor.21091; Goreham-Voss CM, 2007, J BIOMECH, V40, P3438, DOI 10.1016/j.jbiomech.2007.05.023; Green DM, 2006, ARTHRITIS RHEUM-US, V54, P1509, DOI 10.1002/art.21812; GREENWALD A S, 1972, Journal of Bone and Joint Surgery British Volume, V54, P157; Guilak F, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000131233.83640.91; HEIM U, 1977, REV CHIR ORTHOP, V63, P5; Homma Y, 2014, ARCH ORTHOP TRAUM SU, V134, P371, DOI 10.1007/s00402-013-1888-1; HONKONEN SE, 1994, CLIN ORTHOP RELAT R, P199; HONKONEN SE, 1995, J ORTHOP TRAUMA, V9, P273, DOI 10.1097/00005131-199509040-00001; Ibrahim T, 2007, INJURY, V38, P848, DOI 10.1016/j.injury.2007.01.003; Inokuchi S, 1996, FOOT ANKLE INT, V17, P748, DOI 10.1177/107110079601701206; Kahler DM, 2000, TECH ORTHOP, V10, P20; KELLAM JF, 1979, J TRAUMA, V19, P593, DOI 10.1097/00005373-197908000-00007; Kenwright J, 1970, J Bone Joint Surg Br, V52, P36; Kim HS, 1997, CLIN ORTHOP RELAT R, P244; KOLMERT L, 1982, ACTA ORTHOP SCAND, V53, P957, DOI 10.3109/17453678208992855; Korkmaz A, 2013, INJURY, V44, P1270, DOI 10.1016/j.injury.2013.06.016; LANSINGER O, 1986, J BONE JOINT SURG AM, V68A, P13, DOI 10.2106/00004623-198668010-00003; LARSON CB, 1973, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197305000-00013; LEFKOE TP, 1993, J ORTHOP TRAUMA, V7, P458, DOI 10.1097/00005131-199310000-00009; LEFKOE TP, 1995, CLIN ORTHOP RELAT R, P253; Letournel E, 1993, FRACTURES ACETABULUM; LINDSAY WRN, 1958, AM J SURG, V95, P555, DOI 10.1016/0002-9610(58)90438-0; Lindvall E, 2004, J BONE JOINT SURG AM, V86A, P2229, DOI 10.2106/00004623-200410000-00014; Liporace FA, 2012, J ORTHOP TRAUMA, V26, P488, DOI 10.1097/BOT.0b013e31822fbdbe; LLINAS A, 1993, J BONE JOINT SURG AM, V75A, P1508, DOI 10.2106/00004623-199310000-00012; Lovasz G, 1998, CLIN ORTHOP RELAT R, P224; Lovasz G, 2001, J BONE JOINT SURG BR, V83B, P428, DOI 10.1302/0301-620X.83B3.9674; Makki D, 2010, J BONE JOINT SURG BR, V92B, P693, DOI 10.1302/0301-620X.92B5.23542; Marsh J L, 1991, J Orthop Trauma, V5, P341, DOI 10.1097/00005131-199109000-00014; Marsh JL, 2003, J BONE JOINT SURG AM, V85A, P287, DOI 10.2106/00004623-200302000-00016; Martin J, 2000, J ORTHOP TRAUMA, V14, P379, DOI 10.1097/00005131-200008000-00001; Martin JA, 2006, BIORHEOLOGY, V43, P517; Matsuda DK, 2009, ARTHROSCOPY, V25, P408, DOI 10.1016/j.arthro.2009.01.011; MATTA JM, 1986, CLIN ORTHOP RELAT R, P241; MATTA JM, 1988, CLIN ORTHOP RELAT R, P83; McCann PA, 2011, INT ORTHOP, V35, P413, DOI 10.1007/s00264-010-1005-9; McFerran M A, 1992, J Orthop Trauma, V6, P195, DOI 10.1097/00005131-199206000-00011; McKinley TO, 2008, OSTEOARTHR CARTILAGE, V16, P1363, DOI 10.1016/j.joca.2008.04.005; McKinley TO, 2006, J ORTHOP TRAUMA, V20, P732, DOI 10.1097/01.bot.0000211150.00919.0e; MINDELL ER, 1963, J BONE JOINT SURG AM, V45, P221, DOI 10.2106/00004623-196345020-00002; Moed BR, 2003, J BONE JOINT SURG AM, V85A, P512, DOI 10.2106/00004623-200303000-00018; Moore T M, 1987, J Orthop Trauma, V1, P97, DOI 10.1097/00005131-198702010-00001; MUHR G, 1993, MAJOR FRACTURES PILO, P65; Okcu G, 2004, J BONE JOINT SURG BR, V86B, P868, DOI 10.1302/0301-620X.86B6.15077; OSTRUM RF, 1995, J ORTHOP TRAUMA, V9, P278, DOI 10.1097/00005131-199509040-00002; OVADIA DN, 1986, J BONE JOINT SURG AM, V68A, P543, DOI 10.2106/00004623-198668040-00010; Park MS, 2014, KNEE SURG SPORT TR A, V22, P898, DOI 10.1007/s00167-013-2821-4; Patterson MJ, 1999, J ORTHOP TRAUMA, V13, P85, DOI 10.1097/00005131-199902000-00003; PENNAL GF, 1980, CLIN ORTHOP RELAT R, P115; Pollack AN, 2003, J BONE JOINT SURG AM, V15, P153; Pugh KJ, 1999, J ORTHOP TRAUMA, V13, P418, DOI 10.1097/00005131-199908000-00005; Pugh KJ, 1999, J TRAUMA, V47, P937, DOI 10.1097/00005373-199911000-00022; Rademakers MV, 2007, J ORTHOP TRAUMA, V21, P5, DOI 10.1097/BOT.0b013e31802c5b51; Rademakers MV, 2004, J ORTHOP TRAUMA, V18, P213, DOI 10.1097/00005131-200404000-00004; Raikin S, 1999, ORTHOPEDICS, V22, P1019; RIES MD, 1990, CLIN ORTHOP RELAT R, P215; ROWE CR, 1961, J BONE JOINT SURG AM, V43, P30, DOI 10.2106/00004623-196143010-00002; RUEDI T P, 1969, Injury, V1, P92, DOI 10.1016/S0020-1383(69)80066-5; RUEDI TP, 1979, CLIN ORTHOP RELAT R, P105; Ryan SP, 2017, J ORTHOP TRAUMA, V31, P644, DOI 10.1097/BOT.0000000000000990; SANDERS R, 1993, CLIN ORTHOP RELAT R, P87; Sanders R, 2014, J ORTHOP TRAUMA, V28, P551, DOI 10.1097/BOT.0000000000000169; Shepherd L, 2002, J ORTHOP TRAUMA, V16, P628, DOI 10.1097/00005131-200210000-00003; SNEPPEN O, 1977, ACTA ORTHOP SCAND, V48, P317, DOI 10.3109/17453677708988775; Stannard James P, 2010, J Knee Surg, V23, P187, DOI 10.1055/s-0030-1268694; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Starr AJ, 2002, J ORTHOP TRAUMA, V16, P116, DOI 10.1097/00005131-200202000-00008; Starr AJ, 1998, J ORTHOP TRAUMA, V12, P51, DOI 10.1097/00005131-199801000-00009; Su EP, 2004, CLIN ORTHOP RELAT R, P240, DOI 10.1097/01.blo.0000119247.60317.bc; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; Swiontkowski MF, 1995, 11 ANN M ORTH TRAUM; Tannast M, 2012, J BONE JOINT SURG AM, V94A, P1559, DOI 10.2106/JBJS.K.00444; TEENY SM, 1993, CLIN ORTHOP RELAT R, P108; Tochigi Y, 2011, J BONE JOINT SURG AM, V93A, P533, DOI 10.2106/JBJS.I.01777; TORNETTA P, 1993, J ORTHOP TRAUMA, V7, P489, DOI 10.1097/00005131-199312000-00001; Vallier HA, 2003, J BONE JOINT SURG AM, V85A, P1716, DOI 10.2106/00004623-200309000-00010; WADDELL JP, 1993, MAJOR FRACTURES PILO, P43; Ward BD, 2008, ARTHRITIS RHEUM-US, V58, P744, DOI 10.1002/art.23288; Watson JT, 2000, CLIN ORTHOP RELAT R, P78; Weigel DP, 2002, J BONE JOINT SURG AM, V84A, P1541, DOI 10.2106/00004623-200209000-00006; Zlowodzki M, 2006, J ORTHOP TRAUMA, V20, P366, DOI 10.1097/00005131-200605000-00013; [No title captured]	119	3	4	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0030-5898	1558-1373		ORTHOP CLIN N AM	Orthop. Clin. North Am.	APR	2018	49	2					167	+		10.1016/j.ocl.2017.11.005			15	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GB3OO	WOS:000428967500006	29499818				2022-02-06	
J	Campolettano, ET; Brolinson, G; Rowson, S				Campolettano, Eamon T.; Brolinson, Gunnar; Rowson, Steven			Postural Control and Head Impact Exposure in Youth Football Players: Comparison of the Balance Error Scoring System and a Force Plate Protocol	JOURNAL OF APPLIED BIOMECHANICS			English	Article						balance; pediatrics; concussion	HIGH-SCHOOL; HEALTHY-YOUNG; CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; SAMPLE ENTROPY; STABILITY; SWAY; RELIABILITY; CHILDREN; ADULTS	Postural control testing is often used by clinicians and athletic trainers to assess the health of athletes during recovery from a concussion. Characterization of postural control as a clinical tool for use with youth athletes is limited though. The objective of this study was to compare performance on the Balance Error Scoring System (BESS) and a force plate protocol at the beginning and end of a season of football within a cohort of 34 healthy youth football players (average age of 9.9 +/- 0.6 y). A secondary aim was to investigate if changes in measures of balance from the postseason to the preseason were correlated with head impact exposure. Players completed testing at the beginning and end of the youth football season. There were no significant differences between BESS scores before the season and after the season (P = .54). Performance on the BESS was not associated with any of the center of pressure metrics considered in this study. No correlation was observed between measures of balance and head impact exposure for the season. Further research is required to determine the viability of postural control testing with this population.	[Campolettano, Eamon T.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Brolinson, Gunnar] Edward Via Coll Osteopath Med, Blacksburg, VA USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	rowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS094410. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. The authors gratefully acknowledge the youth football teams for their participation in this study.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Fino PC, 2016, ANN BIOMED ENG, V44, P1636, DOI 10.1007/s10439-015-1479-0; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Harris, 2009, AM J BIOMED SCI, V1, P364, DOI DOI 10.5099/AJ090400364; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kuznetsov N, 2014, COMPLEX SYSTEMS SPOR, P346; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, SPORTS MED UPDATE, V38, P369, DOI DOI 10.1001/JAMA.290.19.2556.[; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mochizuki L, 2006, J APPL BIOMECH, V22, P51, DOI 10.1123/jab.22.1.51; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; Pellman E.J., 2003, NEUROSURGERY, V53, P812, DOI [DOI 10.1227/01.N1'17.0000083559.68424.31;, DOI 10.1093/NEUROSURGERY/53.3.799]; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Ramdani S, 2011, ANN BIOMED ENG, V39, P161, DOI 10.1007/s10439-010-0137-9; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rhea CK, 2014, MED ENG PHYS, V36, P1473, DOI 10.1016/j.medengphy.2014.07.021; Riach C., 1994, GAIT POSTURE, V2, P167, DOI [10.1016/0966-6362(94)90004-3, DOI 10.1016/0966-6362(94)90004-3]; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shorer Z, 2012, EUR J PEDIATR, V171, P1087, DOI 10.1007/s00431-012-1695-7; Smith AW, 2012, J HUM KINET, V33, P25, DOI 10.2478/v10078-012-0041-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Susco TM, 2004, J ATHL TRAINING, V39, P241; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zech A, 2014, EUR J APPL PHYSIOL, V114, P395, DOI 10.1007/s00421-013-2786-5	54	3	4	0	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	APR	2018	34	2					127	133		10.1123/jab.2017-0066			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GI4EU	WOS:000434324600006	29091524	Green Accepted			2022-02-06	
J	Casamento, A; Bailey, M; Robbins, R; Pilcher, D; Warrillow, S; Ghosh, A; Bellomo, R				Casamento, Andrew; Bailey, Michael; Robbins, Ray; Pilcher, David; Warrillow, Stephen; Ghosh, Angaj; Bellomo, Rinaldo			Patient characteristics, incidence, technique, outcomes and early prediction of tracheostomy in the state of Victoria, Australia	JOURNAL OF CRITICAL CARE			English	Article							MECHANICALLY VENTILATED PATIENTS; TRAUMATIC BRAIN-INJURY; HOSPITAL MORTALITY; LATE TRACHEOTOMY; RISK PREDICTION; INTUBATION; PLACEMENT; SCALE; NEED	Background: Tracheostomy is a relatively common procedure in Intensive Care Unit (ICU) patients. Aims: To study the patient characteristics, incidence, technique, outcomes and prediction of tracheostomy in the State of Victoria, Australia. Methods: We used data from the Australian and New Zealand Intensive Care Society Adult Patient Database (ANZICS APD) and the Victorian Admitted Episode Dataset (VAED) to identify and match patients who had received a tracheostomy from 2004 to 2014. Results: Between 1st January 2004 and 30th June 2014, 9750 patients received a tracheostomy with 7670 available for matching and 6010 (78.4%) successfully matched. Of the matched tracheostomy patients, median age was 61 years, median APACHE IIIJ score was 66 and overall hospital mortality was 21%. The incidence of tracheostomy almost halved over the decade with more than half of tracheostomies (53.5%) being percutaneous. Hospital mortality of patients receiving a tracheostomy decreased from 26.5% in 2004 to 16.5% in 2014 by an average decrease of 6%/year. No robust model could be developed to predict tracheostomy. Conclusion: The incidence of tracheostomy and the adjusted mortality rate of patients who received a tracheostomy have significantly decreased over a decade. Day of admission information could not be used to predict subsequent tracheostomy. (C) 2017 Elsevier Inc. All rights reserved.	[Casamento, Andrew; Warrillow, Stephen; Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Studley Rd, Heidelberg, Vic, Australia; [Casamento, Andrew; Ghosh, Angaj] Northern Hosp, Intens Care Unit, Cooper St, Epping, Vic, Australia; [Bailey, Michael; Pilcher, David] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Bailey, Michael] Monash Hlth, Melbourne, Vic, Australia; [Robbins, Ray] Austin Hosp, Dept Adm Informat, Studley Rd, Heidelberg, Vic, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Commercial Rd, Prahran, Vic, Australia; [Pilcher, David] Ctr Outcome & Resource Evaluat CORE, Australian & New Zealand Intens Care Soc ANZICS, Ievers Terrace, Carlton, Vic, Australia; [Bellomo, Rinaldo] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Royal Melbourne Hosp, Intens Care Unit, Grattan St, Carlton, Vic, Australia		Casamento, A (corresponding author), Austin Hosp, Intens Care Unit, Studley Rd, Heidelberg, Vic, Australia.	Andrew.casamento@austin.org.au		GHOSH, ANGAJ/0000-0002-2067-7276; Warrillow, Stephen/0000-0002-7240-4106			Aggarwal S, 2009, BURNS, V35, P962, DOI 10.1016/j.burns.2009.03.005; Allareddy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132612; Andriolo BNG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub3; Angus DC, 2013, JAMA-J AM MED ASSOC, V309, P2163, DOI 10.1001/jama.2013.6014; Arabi YM, 2009, J CRIT CARE, V24, P435, DOI 10.1016/j.jcrc.2008.07.001; Australian Bureau of Statistics, 2014, 3101 0 AUSTR DEM STA; Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Branco BC, 2011, J TRAUMA, V70, P111, DOI 10.1097/TA.0b013e3181d9a559; Childs BR, 2015, SPINE, V40, P1407, DOI 10.1097/BRS.0000000000001008; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Frutos-Vivar F, 2005, CRIT CARE MED, V33, P290, DOI 10.1097/01.CCM.0000150026.85210.13; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Gurkin MA, 2002, AM SURGEON, V68, P324; Harrop JS, 2004, J NEUROSURG, V100, P20, DOI 10.3171/spi.2004.100.1.0020; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Huttner HB, 2006, CEREBROVASC DIS, V21, P159, DOI 10.1159/000090527; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; LANZA DC, 1990, ANN OTO RHINOL LARYN, V99, P38, DOI 10.1177/000348949009900106; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Mehta AB, 2015, AM J RESP CRIT CARE, V192, P446, DOI 10.1164/rccm.201502-0239OC; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Scales DC, 2008, INTENS CARE MED, V34, P1743, DOI 10.1007/s00134-008-1194-5; Scales DC, 2010, JAMA-J AM MED ASSOC, V303, P1537, DOI 10.1001/jama.2010.462; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Szeder V, 2010, NEUROCRIT CARE, V13, P40, DOI 10.1007/s12028-010-9346-1; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Yaghi S, 2013, CLIN NEUROL NEUROSUR, V115, P695, DOI 10.1016/j.clineuro.2012.08.010; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	34	3	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2018	44						278	284		10.1016/j.jcrc.2017.11.034			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY1IL	WOS:000426565300051	29223064				2022-02-06	
J	Dhillon, NK; Tseng, J; Barmparas, G; Harada, MY; Ko, A; Smith, EJT; Thomsen, GM; Ley, EJ				Dhillon, Navpreet K.; Tseng, Joshua; Barmparas, Galinos; Harada, Megan Y.; Ko, Ara; Smith, Eric J. T.; Thomsen, Gretchen M.; Ley, Eric J.			Impact of early positive cultures in the elderly with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Cultures; Elderly; Infection; Traumatic brain injury; Critical care	HEAD-INJURY; GLUCOCORTICOIDS; CATECHOLAMINES; COMPLICATIONS; PNEUMONIA; LAVAGE	Background: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in the United States, especially in the elderly, who have the highest rates of TBI-related hospitalizations and deaths among all age groups. Sepsis is one of many risk factors that is associated with higher mortality and longer length of hospital stay in this population partially due to the immunosuppressive effects of TBI. The significance of early indicators of infection, such as a positive blood, sputum, or urine culture, is not well described. The purpose of this study was to determine if early positive cultures predict higher mortality in elderly patients with TBI. Methods: All trauma patients aged >= 65 years with TBI, admitted between January 1, 2009 and December 31, 2013 to the surgical intensive care unit, were retrospectively reviewed. Clinical data including results from sputum, blood, and urine cultures were reviewed. Results: Overall, 288 elderly patients with TBI were identified, and 92 (32%) had a positive culture. Patients with positive cultures had longer intensive care unit (median 6.0 versus 2.0 days, P < 0.001) and ventilation days (median 7.0 versus 2.0 days, P < 0.001). Patients who had positive cultures within 2-3 days of admission had a higher adjusted hazard ratio for mortality than those patients who had positive cultures after 6 or more days. Conclusions: In elderly patients with TBI, early positive cultures are associated with a higher risk of mortality. Further research is required to determine the role of obtaining cultures on admission in this subpopulation of trauma patients. (C) 2017 Elsevier Inc. All rights reserved.	[Dhillon, Navpreet K.; Tseng, Joshua; Barmparas, Galinos; Harada, Megan Y.; Ko, Ara; Smith, Eric J. T.; Thomsen, Gretchen M.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	eric.ley@cshs.org	Barmparas, Galinos/L-6530-2019				Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Bhatia GC, 2006, LUNG INDIA, V23, P147; Brattsand R, 1996, ALIMENT PHARM THERAP, V10, P81, DOI 10.1046/j.1365-2036.1996.22164025.x; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Elenkov IJ, 1996, P ASSOC AM PHYSICIAN, V108, P374; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Kim ES, 2012, KOREAN J INTERN MED, V27, P156, DOI 10.3904/kjim.2012.27.2.156; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Schmiemann G, 2010, DTSCH ARZTEBL INT, V107, P361, DOI 10.3238/arztebl.2010.0361; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Smrcka M, 2005, Bratisl Lek Listy, V106, P144; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060	26	3	3	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2018	224						140	145		10.1016/j.jss.2017.11.031			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FZ3FN	WOS:000427472100021	29506830				2022-02-06	
J	Ho, KM; Honeybul, S; Ambati, R				Ho, Kwok M.; Honeybul, Stephen; Ambati, Ravi			Prognostic Significance of Magnetic Resonance Imaging in Patients with Severe Nonpenetrating Traumatic Brain Injury Requiring Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Adult brain injury; Axonal injury; Head trauma; Magnetic resonance imaging; Prognostic model	AXONAL INJURY; MODELS; CRASH; STEM; NEUROTRAUMA; PREDICTION; VALIDATION; FUTILITY	BACKGROUND: Diffuse axonal injury (DAI) detected on magnetic resonance imaging (MRI) may be useful to predict outcome after traumatic brain injury (TBI). METHODS: This study compared the ability of the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) prognostic model with DAI on MRI to predict the 18-month neurologic outcome in 56 patients who had required decompressive craniectomy after TBI. RESULTS: Of the 56 patients included in the study (19 scans occurred within 14 days; median time for all patients 24 days, interquartile range 14-42), 18 (32%) had evidence of DAI on the MRI scans. The presence of DAI on the MRI diffusion-weighted (DW) T2*-weighted gradient echo and susceptibility-weighted (SWI) sequences was associated with an increased risk of unfavorable outcome at 18 months compared with patients without DAI (44% vs. 17%, difference = 27%, 95% confidence interval 2.4-46.7%; P = 0.032), particularly when the brainstem was involved. However, neither the grading (I to IV) nor the number of brain regions with DAI was as good as the IMPACT model in discriminating between patients with unfavorable and favorable outcomes (area under the receiver operating characteristic curve: 0.625 and 0.621 vs. 0.918, respectively; P < 0.001 for both comparisons). After adjustment for the IMPACT prognostic risks, DAI in different brain regions and the grading of DAI were also not independently associated with unfavorable outcome. CONCLUSIONS: The prognostic significance of DAI on MRI may, in part, be captured by the IMPACT prognostic model. More research is needed before MRI should be routinely used to prognosticate the outcomes in patients with TBI requiring decompressive craniectomy.	[Ho, Kwok M.; Ambati, Ravi] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Honeybul, Stephen] Royal Perth Hosp, Dept Neurosurg, Perth, WA, Australia		Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia.; Ho, KM (corresponding author), Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia.; Ho, KM (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004	Raine Medical Research Foundation; WA Health through the Raine Clinical Research Fellowship	K.M. Ho is funded by the Raine Medical Research Foundation and WA Health through the Raine Clinical Research Fellowship.	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Beier AD, 2014, J NEUROSURG-PEDIATR, V14, P421, DOI 10.3171/2014.7.PEDS13376; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Ho KM, 2016, J CRIT CARE, V36, P298, DOI 10.1016/j.jcrc.2016.06.003; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Honeybul S, 2016, ACTA NEUROCHIR, V158, P1251, DOI 10.1007/s00701-016-2818-0; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Honeybul S, 2012, MED J AUSTRALIA, V196, P531, DOI 10.5694/mja11.11485; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Hou K, 2017, WORLD NEUROSURG, V105, DOI 10.1016/j.wneu.2017.06.031; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165	18	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						277	283		10.1016/j.wneu.2018.01.203			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700155	29421447	Green Published			2022-02-06	
J	Hotchen, AJ; Barr, LV; Krkovic, M				Hotchen, Andrew James; Barr, Lynne V.; Krkovic, Matija			Bridging hard callus at 48 days in an open femoral shaft fracture with segmental defect treated with a first-stage Masquelet technique: I wasn't expecting that	STRATEGIES IN TRAUMA AND LIMB RECONSTRUCTION			English	Article						Masquelet procedure; Traumatic brain injury; Segmental defect	TRAUMATIC BRAIN-INJURY; INTERLEUKIN-6; EXPRESSION; MODEL	The Masquelet technique is a strategy for management of segmental bone defects. It is a two-stage procedure that involves inducing a synovial-like membrane that can be used for a bone graft. Segmental bone defects can occur following trauma and can accompany traumatic brain injury. There is a well-documented, albeit debated, association between traumatic brain injury and increased rate of new bone formation. Here, we present a case of unexpected callus formation in a segmental femoral fracture. The patient had a traumatic brain injury and was treated with the first stage of the Masquelet technique. Owing to the amount of large callus, a second stage of the Masquelet was not required. The patient recovered well from the injury and at 16-week follow-up was able to partially weight bear. A case similar to this has not previously been reported within the literature.	[Hotchen, Andrew James; Barr, Lynne V.; Krkovic, Matija] Cambridge Univ Hosp, Addenbrookes Hosp, Dept Trauma & Orthopaed Surg, Cambridge CB2 0QQ, England; [Hotchen, Andrew James] Univ Cambridge, Div Trauma & Orthopaed Surg, Cambridge CB2 0SP, England		Krkovic, M (corresponding author), Cambridge Univ Hosp, Addenbrookes Hosp, Dept Trauma & Orthopaed Surg, Cambridge CB2 0QQ, England.	Matija.krkovic@addenbrookes.nhs.uk		Krkovic, Matija/0000-0003-2172-2849	National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2015-14-016] Funding Source: researchfish		Assal M, 2014, ORTHOPEDICS, V37, pE1045, DOI 10.3928/01477447-20141023-93; Barry F, 2013, NAT REV RHEUMATOL, V9, P584, DOI 10.1038/nrrheum.2013.109; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Bose D, 2015, BONE JOINT J, V97B, P814, DOI 10.1302/0301-620X.97B6.33276; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; HAMMONDS RG, 1991, MOL ENDOCRINOL, V5, P149, DOI 10.1210/mend-5-1-149; Huang W, 2012, J ORAL MAXIL SURG, V70, P2135, DOI 10.1016/j.joms.2012.04.016; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346; Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013	15	3	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1828-8928	1828-8936		STRATEG TRAUMA LIMB	Strateg. Trauma Limb Reconstr.	APR	2018	13	1					57	60		10.1007/s11751-017-0300-z			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GB9IX	WOS:000429388600008	29116576	gold, Green Published			2022-02-06	
J	Lafourcade, P; Bruneau, O; Philippe, A; Bard, A				Lafourcade, P.; Bruneau, O.; Philippe, A.; Bard, A.			Military parachuting	SCIENCE & SPORTS			French	Article						Parachuting; Parachute; Military; Airborne	INJURIES; CONCUSSION; FRACTURE; SPORTS; TRAUMA; JUMPS	Objective. -This paper seeks to expose updated military parachuting technics and induced injuries patterns. Content. -Unlike civilian practice, military parachuting is not a final goal in itself but is meant to deploy combat units in remote places, in hostile environments. The jump is just a step of the mission and its mode depends on the tactical mission's goal. Various jump technics have various physical strains that may cause various traumatic pathologies. First, we will detail different jump modes, then specific injuries. Conclusion. -As a hazardous activity, military parachuting needs trained medical teams that are used to selecting and following up parachutists and used to treating specific injuries. The final goal is to keep combat units operational capacity. (C) 2018 Elsevier Masson SAS. All rights reserved.	[Lafourcade, P.; Bruneau, O.; Philippe, A.; Bard, A.] 181e Antenne Med Pau Zirnheld, Ecole Troupes Aeroportees, BP 1139, F-64011 Pau, France		Lafourcade, P (corresponding author), 181e Antenne Med Pau Zirnheld, Ecole Troupes Aeroportees, BP 1139, F-64011 Pau, France.	pascal.lafourcade@libertysurf.fr					[Anonymous], 2012, 0309EVDGDPMO; [Anonymous], 2013, MAJOR ARMEES PIA 03; [Anonymous], 2005, MAJOR ARMEES PIA 03; [Anonymous], 2015, MAJOR ARMEES INSTRUC; Archibald R, 1999, OCCUP MED-OXFORD, V49, P474, DOI 10.1093/occmed/49.7.474-a; Astolfi A-C, 1988, THESIS, P2; BAGIAN JP, 1992, AVIAT SPACE ENVIR MD, V63, P802; Bakhsheshian J, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.4.FOCUS14159; Bar-Dayan Y, 1998, MIL MED, V163, P1; Bertrand L., 2013, Medecine et Armees, V41, P183; Bouvet R, 1998, RACHIS, V10, P3; Bricknell MCM, 1999, OCCUP MED-OXFORD, V49, P17, DOI 10.1093/occmed/49.1.17; Chang V, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.4.FOCUS1477; CICCONE R, 1948, J BONE JOINT SURG AM, V30-A, P77, DOI 10.2106/00004623-194830010-00010; Comat G, 2014, ORTHOP TRAUMATOL-SUR, V100, P419, DOI 10.1016/j.otsr.2014.02.008; Craig SC, 1997, MIL MED, V162, P162, DOI 10.1093/milmed/162.3.162; Craig SC, 2000, MIL MED, V165, P268, DOI 10.1093/milmed/165.4.268; Defaysse N, 2018, MED ARMEES; Ekeland A, 1997, INJURY, V28, P219, DOI 10.1016/S0020-1383(96)00185-4; Hasler RM, 2012, INJURY, V43, P440, DOI 10.1016/j.injury.2011.06.193; Hay ST, 2006, AUSTR DEFENSE FORCE, V7, P73; HECKMAN JD, 1978, J BONE JOINT SURG AM, V60, P369, DOI 10.2106/00004623-197860030-00019; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Knapik JJ, 2011, AVIAT SPACE ENVIR MD, V82, P797, DOI 10.3357/ASEM.3061.2011; Kragh JF, 1996, MIL MED, V161, P416, DOI 10.1093/milmed/161.7.416; Lacombe J, 1993, J TRAUMATOLOGIE SPOR, V10, P170; Lafourcade P., 2015, Medecine et Armees, V43, P448; Leger A, 1977, MED SPORT, V51, P72; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Mayet A, 2001, MED ARMEES, V3, P3; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Michel B, 2012, FOCUS STRAT, V37; NATO, 1997, 7056 NATO STANAG; Schmitt B, 1984, PATHOLOGIE PARACHUTI, P83; Sergent P, 1974, HIST MONDIALE PARACH; Teyssandier MJ, 1998, MED SPORT, V72, P52; Tobin WJ, 1943, ARCH SURG-CHICAGO, V46, P780, DOI 10.1001/archsurg.1943.01220110196032; TRIPON P, 1990, ANN CHIR, V44, P493; VILLAR RN, 1984, INJURY, V16, P15, DOI 10.1016/0020-1383(84)90105-0	40	3	3	2	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0765-1597			SCI SPORT	Sci. Sports	APR	2018	33	2					127	135		10.1016/j.scispo.2018.02.009			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GH7QE	WOS:000433647700010					2022-02-06	
J	Langness, S; Ward, E; Halbach, J; Lizardo, R; Davenport, K; Bickler, S; Kling, K; Thangarajah, H; Grabowski, J; Fairbanks, T				Langness, Simone; Ward, Erin; Halbach, Jonathan; Lizardo, Radhames; Davenport, Katherine; Bickler, Stephen; Kling, Karen; Thangarajah, Hari; Grabowski, Julia; Fairbanks, Timothy			Plasma D-dimer safely reduces unnecessary CT scans obtained in the evaluation of pediatric head trauma	JOURNAL OF PEDIATRIC SURGERY			English	Article						Traumatic brain injury; Clinically-important traumatic brain injury; Skull fracture; D-dimer; Head CT scan; Negative predictive value; Pediatric head trauma	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; RESOURCE UTILIZATION; SERUM; CHILDREN; S100B; COAGULOPATHY; MORTALITY; MILD	Purpose: SerumD-dimer has been proposed as a biomarker to aid in the diagnosis of pediatric traumatic brain injury (TBI). We investigated the accuracy of D-dimer in predicting the absence of TBI and evaluated the degree by which D-dimer could limit unnecessary computed tomography scans of the head (CTH). Methods: Retrospective review of patients with suspected TBI from2011 to 2013 who underwent evaluation with CTH and quantitative D-dimer. D-dimer levels were compared among patients with clinically-important TBI (ciTBI), TBI, isolated skull fracture and no injury. Results: Of the 663 patients evaluated for suspected TBI, ciTBI was identified in 116 (17.5%), TBI in 77 (11.6%), skull fracture in 61 (9.2%) and no head injury in 409 (61.7%). Patients with no head injury had significantly lower D-dimer values (1531 +/- 1791 pg/mu L) compared to those with skull fracture, TBI and ciTBI (2504 +/- 1769, 2870 +/- 1633 and 4059 +/- 1287 pg/mu L, respectively, p < 0.005). Using a D-dimer value <50 pg/mu L as a negative screen, no ciTBIs would be missed and 209 CTHs avoided (39.7% of total). Conclusion: Low plasma D-dimer predicts the absence of ciTBI for pediatric patient with suspected TBI. Incorporating D-dimer into current diagnostic algorithms may significantly limit the number of unnecessary CTHs performed in this population. Type of study: Study of diagnostic test. (c) 2017 Elsevier Inc. All rights reserved.	[Langness, Simone; Ward, Erin] Univ Calif San Diego, 200 W Arbor Dr,8220, San Diego, CA 92101 USA; [Langness, Simone; Ward, Erin; Halbach, Jonathan; Davenport, Katherine; Bickler, Stephen; Kling, Karen; Thangarajah, Hari; Fairbanks, Timothy] Rady Childrens Hosp, 3030 Childrens Way,Suite 107, San Diego, CA 92123 USA; [Halbach, Jonathan; Lizardo, Radhames] Naval Med Ctr, 34800 Bob Wilson Dr, San Diego, CA 92134 USA; [Grabowski, Julia] Lurie Childrens Hosp, 225 E Chicago Ave, Chicago, IL 60611 USA		Fairbanks, T (corresponding author), 3030 ChildrensWay,Suite 107, San Diego, CA 92123 USA.	slangness@ucsd.edu; epward@ucsd.edu; jonathan.halbach@gmail.com; eliel.lizardo@gmail.com; kate.davenport@gmail.com; sbickler@rchsd.org; kkling@rchsd.org; hthangarajah@rchsd.org; jgrabowski@luriechildrens.org; tfairbanks@rchsd.org					Atabaki SM, 2016, ACAD EMERG MED; Beinfeld MT, 2005, RADIOLOGY, V235, P934, DOI 10.1148/radiol.2353040473; Berger RP, 2015, J PEDIATR-US, V166, P383, DOI 10.1016/j.jpeds.2014.10.036; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Chwals WJ, 2008, J PEDIATR SURG, V43, P2268, DOI 10.1016/j.jpedsurg.2008.08.061; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Goldstein SD, 2015, J PEDIATR SURG, V50, P1028, DOI 10.1016/j.jpedsurg.2015.03.028; Golestanian E, 2007, CRIT CARE MED, V35, P1470, DOI 10.1097/01.CCM.0000265741.16192.D9; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Helmersson-Karlqvist J, 2014, J THROMB THROMBOLYS, V38, P250, DOI 10.1007/s11239-013-1043-4; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; LEGGETT RW, 1983, SCI PROG, V68, P227; Marquardt Udo, 2015, Emerg Nurse, V23, P29, DOI 10.7748/en.23.5.29.e1459; MAYER T, 1981, JAMA-J AM MED ASSOC, V245, P719; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nakae R, 2015, J NEUROTRAUMA; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Prevention. CfDCa, 2000, WEB BAS INJ STAT QUE; Provance AJ, 2016, ORTHOPEDICS, V39, P24, DOI 10.3928/01477447-20151218-13; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sen B, 2014, J CLIN PATHOL, V67, P437, DOI 10.1136/jclinpath-2013-201975; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Swanson CA, 2010, J TRAUMA, V68, P1072, DOI 10.1097/TA.0b013e3181d7a6f2; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	47	3	4	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2018	53	4					752	757		10.1016/j.jpedsurg.2017.08.017			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GB8CF	WOS:000429301400033	29555324				2022-02-06	
J	McNett, MM; Bader, MK; Livesay, S; Yeager, S; Moran, C; Barnes, A; Harrison, KR; Olson, DM				McNett, Molly M.; Bader, Mary Kay; Livesay, Sarah; Yeager, Susan; Moran, Cristina; Barnes, Arianna; Harrison, Kimberly R.; Olson, DaiWai M.			A National Trial on Differences in Cerebral Perfusion Pressure Values by Measurement Location	NEUROCRITICAL CARE			English	Article						Cerebral perfusion pressure; Measurement; Brain injury; Neurocritical care	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MANAGEMENT; HEMORRHAGE; INSULTS	Background Cerebral perfusion pressure (CPP) is a key parameter in management of brain injury with suspected impaired cerebral autoregulation. CPP is calculated by subtracting intracranial pressure (ICP) from mean arterial pressure (MAP). Despite consensus on importance of CPP monitoring, substantial variations exist on anatomical reference points used to measure arterial MAP when calculating CPP. This study aimed to identify differences in CPP values based on measurement location when using phlebostatic axis (PA) or tragus (Tg) as anatomical reference points. The secondary study aim was to determine impact of differences on patient outcomes at discharge. Methods This was a prospective, repeated measures, multi-site national trial. Adult ICU patients with neurological injury necessitating ICP and CPP monitoring were consecutively enrolled from seven sites. Daily MAP/ICP/CPP values were gathered with the arterial transducer at the PA, followed by the Tg as anatomical reference points. Results A total of 136 subjects were enrolled, resulting in 324 paired observations. There were significant differences for CPP when comparing values obtained at PA and Tg reference points (p < 0.000). Differences remained significant in repeated measures model when controlling for clinical factors (mean CPP-PA = 80.77, mean CPP-Tg = 70.61, p < 0.000). When categorizing CPP as binary endpoint, 18.8% of values were identified as adequate with PA values, yet inadequate with CPP values measured at the Tg. Conclusion Findings identify numerical differences for CPP based on anatomical reference location and highlight importance of a standard reference point for both clinical practice and future trials to limit practice variations and heterogeneity of findings.	[McNett, Molly M.; Moran, Cristina] MetroHlth Syst, Dept Nursing Res, Cleveland, OH 44109 USA; [Bader, Mary Kay] Mission Hosp, Neurocrit Care, Mission Viejo, CA USA; [Livesay, Sarah] Rush Univ, Coll Nursing, Chicago, IL 60612 USA; [Yeager, Susan] Ohio State Univ, Neurocrit Care, Wexner Med Ctr, Columbus, OH 43210 USA; [Barnes, Arianna] Mission Hosp, Surg ICU, Mission Viejo, CA USA; [Harrison, Kimberly R.; Olson, DaiWai M.] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX USA		McNett, MM (corresponding author), MetroHlth Syst, Dept Nursing Res, Cleveland, OH 44109 USA.	mmcnett@metrohealth.org	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Glaser, Kimberly/0000-0002-3508-4457; Livesay, Sarah/0000-0001-5427-040X	Agnes Marshall Walker Foundation	This study was funded by a research grant from the Agnes Marshall Walker Foundation.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Foundation The Brain Trauma, 2007, J NEUROTRAUM, V24, pS59; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; JENNETT B, 1975, LANCET, V1, P480; Jones HA, 2009, NURS CRIT CARE, V14, P303, DOI 10.1111/j.1478-5153.2009.00352.x; KIRCHHOFF KT, 1984, NURS RES, V33, P343, DOI 10.1097/00006199-198411000-00008; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kosty JA, 2013, ANESTH ANALG, V117, P694, DOI 10.1213/ANE.0b013e31829cc765; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Le Roux P, 2017, NEUROCRIT CARE S2, V21, P1; Lewis LS, 2016, AANN CORE CURRICULUM, P185; McCann YG, 2001, CHEST, V120, P1322, DOI 10.1378/chest.120.4.1322; Olson DM, 2012, NEUROCRIT CARE, V16, P55, DOI 10.1007/s12028-011-9613-9; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Pohl A, 2005, J CLIN ANESTH, V17, P463, DOI 10.1016/j.jclinane.2004.09.012; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874	23	3	3	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2018	28	2					221	228		10.1007/s12028-017-0467-7			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF5GM	WOS:000431994700012	29067632				2022-02-06	
J	Oberle, C; Becker, C; Scholch, S; Lenz, JU; Studier-Fischer, S; Augat, P; Schwickert, L				Oberle, Corinna; Becker, Clemens; Schoelch, Sabine; Lenz, Joerg-Uwe; Studier-Fischer, Stefan; Augat, Peter; Schwickert, Lars			Inter-rater and intra-rater reliability of an adapted Wolf motor function test for older patients with shoulder injuries	ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE			English	Article							PSYCHOMETRIC PROPERTIES; OUTCOME MEASURE; GRIP STRENGTH; STROKE; REHABILITATION; QUESTIONNAIRE; ARM; HEMIPARESIS; DISABILITY; AGREEMENT	The Wolf motor function test (WMFT) evaluates the upper extremity performance of patients with neurological disorders and traumatic brain injuries by assessing time and functional capacity. It was later modified to also measure the quality of the performed movements. This study aimed to adapt the WMFT for patients with shoulder injuries and to evaluate the inter-rater and intra-rater reliability of this adapted version. A total of 20 individuals with a median age of 80.5 years were assessed using a test-retest design after surgical or conservative treatment of shoulder injuries. Two raters rated performance to determine inter-rater reliability. One rater rated the performance again to determine intra-rater reliability. Both inter-rater and intra-rater agreement were determined by weighted Cohen's kappa statistics with corresponding confidence intervals. Cronbach's alpha was calculated to determine internal consistency. The inter-rater Cohen's kappa values ranged from 0.84-1.00 for functional capacity and from 0.79-1.00 for quality of movement. For intra-rater reliability the Cohen's kappa ranged from 0.71-1.00. Cronbach's alpha was > 0.94 for functional capacity and > 0.96 for quality of movement. The adapted version of the WMFT shows high intra-rater and inter-rater reliability for patients with shoulder injuries.	[Oberle, Corinna; Becker, Clemens; Schoelch, Sabine; Schwickert, Lars] Robert Bosch Krankenhaus, Dept Clin Gerontol, Auerbachstr 110, D-70376 Stuttgart, Germany; [Lenz, Joerg-Uwe] Robert Bosch Krankenhaus, Dept Orthopaed & Trauma Surg, Stuttgart, Germany; [Studier-Fischer, Stefan] BG Trauma Ctr Ludwigshafen, Dept Trauma & Orthoped Surg, Ludwigshafen, Germany; BG Trauma Ctr Murnau, Inst Biomech, Murnau, Germany; [Augat, Peter] Paracelsus Med Univ, Inst Biomech, Salzburg, Austria		Oberle, C (corresponding author), Robert Bosch Krankenhaus, Dept Clin Gerontol, Auerbachstr 110, D-70376 Stuttgart, Germany.	corinna.oberle@rbk.de	Becker, Clemens/ABI-5405-2020; Augat, Peter/A-2051-2011	Augat, Peter/0000-0003-4805-2128; Nerz, Corinna/0000-0001-5160-796X	German Statutory Insurance (Deutsche Gesetzliche Unfallversicherung, DGUV)	The study was funded and supported by the German Statutory Insurance (Deutsche Gesetzliche Unfallversicherung, DGUV). The DGUV had no influence on data assessment or writing of the manuscript.	Bauder H., 2001, BEHANDLUNG MOTORISCH; Boehm D, 2004, UNFALLCHIRURG, V107, P397, DOI 10.1007/s00113-004-0757-3; Bogard K, 2009, NEUROREHAB NEURAL RE, V23, P422, DOI 10.1177/1545968308331141; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Conboy VB, 1996, J BONE JOINT SURG BR, V78B, P229, DOI 10.1302/0301-620X.78B2.0780229; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Dixon D, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-114; Franke S, 2012, OBERE EXTREMITAET-SC, V7, P137, DOI 10.1007/s11678-012-0171-3; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallo JJ, 2006, HDB GERIATRIC ASSESS, P475; George D, 2005, PSS WINDOWS STEP BY, P400; Germann G, 2003, UNFALLCHIRURG, V106, P13, DOI 10.1007/s00113-002-0456-x; Godfrey J, 2007, J SHOULDER ELB SURG, V16, P260, DOI 10.1016/j.jse.2006.07.003; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Handoll HHG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000434.pub2; Kohn D, 1997, ARCH ORTHOP TRAUM SU, V116, P324; Morris DM, 2001, ARCH PHYS MED REHAB, V82, P750, DOI 10.1053/apmr.2001.23183; Nijland R, 2010, J REHABIL MED, V42, P694, DOI 10.2340/16501977-0560; Pereira ND, 2011, REV BRAS FISIOTER, V15, P257, DOI 10.1590/S1413-35552011000300013; Placzek JD, 2004, AM J SPORT MED, V32, P1270, DOI 10.1177/0363546503262193; Raschke MJ, 2009, ALTERSTRAUMATOLOGIE, P586; Resch H, 2003, UNFALLCHIRURG, V106, P602, DOI 10.1007/s00113-003-0661-2; Richards RR, 1987, J SHOULDER ELB SURG, V3, P347; Riem M, 2016, HEIMUNTERBRINGUNG MO; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Schwickert L, 2011, Z GERONTOL GERIATR, V44, P387, DOI 10.1007/s00391-011-0258-2; Taub E., 2011, WOLF MOTOR FUNCTION; Viera AJ, 2005, FAM MED, V37, P360; Whitall J, 2006, ARCH PHYS MED REHAB, V87, P656, DOI 10.1016/j.apmr.2006.02.004; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wu CY, 2011, NEUROREHAB NEURAL RE, V25, P194, DOI 10.1177/1545968310381249; Zech A, 2009, MED SCI SPORT EXER, V41, P1831, DOI 10.1249/MSS.0b013e3181a3cf0d	33	3	3	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-6704	1435-1269		Z GERONTOL GERIATR	Z. Gerontol. Geriatr.	APR	2018	51	3					293	300		10.1007/s00391-017-1226-2			8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	GD3IM	WOS:000430397600005	28364256				2022-02-06	
J	Phillips, JK; Sherman, SA; Oungoulian, SR; Finan, JD				Phillips, Jack K.; Sherman, Sydney A.; Oungoulian, Sevan R.; Finan, John D.			Method for High Speed Stretch Injury of Human Induced Pluripotent Stem Cell-derived Neurons in a 96-well Format	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 134; Stretch; neurotrauma; neuron; human induced pluripotent stem cell; silicone; cell culture; high content imaging	HIPPOCAMPAL SLICE CULTURES; IN-VITRO; CALCIUM INFLUX; TOLERANCE; CHANNELS	Traumatic brain injury (TBI) is a major clinical challenge with high morbidity and mortality. Despite decades of pre-clinical research, no proven therapies for TBI have been developed. This paper presents a novel method for pre-clinical neurotrauma research intended to complement existing pre-clinical models. It introduces human pathophysiology through the use of human induced pluripotent stem cell-derived neurons (hiPSCNs). It achieves loading pulse duration similar to the loading durations of clinical closed head impact injury. It employs a 96-well format that facilitates high throughput experiments and makes efficient use of expensive cells and culture reagents. Silicone membranes are first treated to remove neurotoxic uncured polymer and then bonded to commercial 96-well plate bodies to create stretchable 96-well plates. A custom-built device is used to indent some or all of the well bottoms from beneath, inducing equibiaxial mechanical strain that mechanically injures cells in culture in the wells. The relationship between indentation depth and mechanical strain is determined empirically using high speed videography of well bottoms during indentation. Cells, including hiPSCNs, can be cultured on these silicone membranes using modified versions of conventional cell culture protocols. Fluorescent microscopic images of cell cultures are acquired and analyzed after injury in a semi-automated fashion to quantify the level of injury in each well. The model presented is optimized for hiPSCNs but could in theory be applied to other cell types.	[Phillips, Jack K.; Sherman, Sydney A.; Finan, John D.] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL 60035 USA; [Sherman, Sydney A.] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL USA		Finan, JD (corresponding author), NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL 60035 USA.	JFinan@northshore.org		Finan, John/0000-0003-4626-9702; Phillips, Jack/0000-0002-5362-8833	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS098129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098129] Funding Source: NIH RePORTER	This work is supported in part by a grant from the National Institutes of Health (R21NS098129). We would like to acknowledge excellent technical assistance from SueSan Chen, Jonathan Tan, Courtney Cavanaugh, Shi Kai Ng and Feng Yuan Bu, who designed and built a structure to support lights used during high speed imaging experiments described in this manuscript.	Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Smith DH, 1999, J NEUROSCI, V19, P4263; Sunkara V, 2011, LAB CHIP, V11, P962, DOI [10.1039/c0lc00272k, 10.1039/c01c00272k]; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	19	3	3	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2018		134							e57305	10.3791/57305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS9OW	WOS:000444051300072	29733307	Green Published, Bronze			2022-02-06	
J	Servello, D; Gu, YZ; Gu, C				Servello, Dustin; Gu, Yuanzheng; Gu, Chen			A Microbiomechanical System for Studying Varicosity Formation and Recovery in Central Neuron Axons	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 134; Varicosity; Hippocampal Neuron Culture; Axonal Injury; Traumatic Brain Injury; Calcium Imaging; Micromechanical Stress; Axonal Transport	STRETCH INJURY; AXOTOMY	Axonal varicosities are enlarged structures along the shafts of axons with a high degree of heterogeneity. They are present not only in brains with neurodegenerative diseases or injuries, but also in the normal brain. Here, we describe a newly-established micromechanical system to rapidly, reliably, and reversibly induce axonal varicosities, allowing us to understand the mechanisms governing varicosity formation and heterogeneous protein composition. This system represents a novel means to evaluate the effects of compression and shear stress on different subcellular compartments of neurons, different from other in vitro systems that mainly focus on the effect of stretching. Importantly, owing to the unique features of our system, we recently made a novel discovery showing that the application of pressurized fluid can rapidly and reversibly induce axonal varicosities through the activation of a transient receptor potential channel. Our biomechanical system can be utilized conveniently in combination with drug perfusion, live cell imaging, calcium imaging, and patch clamp recording. Therefore, this method can be adopted for studying mechanosensitive ion channels, axonal transport regulation, axonal cytoskeleton dynamics, calcium signaling, and morphological changes related to traumatic brain injury.	[Servello, Dustin; Gu, Chen] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Gu, Yuanzheng] Biogen, Cambridge, MA USA		Gu, C (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA.; Gu, C (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.	gu.49@osu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS093073, R21AA024873]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS093073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA024873] Funding Source: NIH RePORTER	All animal experiments have been conducted in accordance with the National Institutes of Health Animal Use Guidelines. This work was supported in part by grants from National Institutes of Health (R01NS093073 and R21AA024873) to C. Gu.	Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Wang Q, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/1/015002; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034	14	3	3	0	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2018		134							e57202	10.3791/57202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS9OW	WOS:000444051300054	29757278	Green Published			2022-02-06	
J	Tadesse, K; Amare, H; Hailemariam, T; Gebremariam, T				Tadesse, Kaleab; Amare, Hiwot; Hailemariam, Tesfahun; Gebremariam, Tewodros			Prevalence of Hypertension among Patients with Type 2 Diabetes Mellitus and Its Socio Demographic Factors in Nigist Ellen Mohamed Memorial Hospital Hosanna, Southern Ethiopia	JOURNAL OF DIABETES & METABOLISM			English	Article						Hypertension; Type 2 diabetes mellitus; Prevalence; Multivariable analysis	RISK-FACTORS; BLOOD-PRESSURE; GLOBAL BURDEN	Introduction: World Health Organization revealed 13% of all deaths globally related to hypertension making it an area of prime importance for public health in both developing and developed Country. The problem of hypertension is significant in low and middle income countries like sub-Saharan Africa; however, there are limited studies to report the exact prevalence rate in developing countries, particularly in Ethiopia. Therefore, the aim of this study was to determine prevalence of hypertension among patients with type 2 diabetes mellitus and its socio demographic factors in Nigist Ellen Mohamed Memorial Hospital Hosanna, Southern Ethiopia. Methods: Hospital based cross-sectional study was conducted in 140 randomly selected adult type 2 Diabetes Mellitus patients in Nigist Ellen Mohammed Memorial Hospital, Southern Ethiopia. Data was collected by measuring blood pressure of the study participants by using calibrated devices and interviewer administered questionnaires were used to assess prevalence and socio-demographic factors among the study participants. The collected data were entered, cleared and analyzed by using SPSS 20.0 version. Result: Mean (+/- SD) age of the clients was 46.5(+/- 11.8) years and majority (63.6%) was male. The mean (+/- SD) Systolic blood pressure and Diastolic blood pressure of study subjects among type 2 Diabetes Mellitus clients were 135.98 (+/- 17.11) and 88.89 (+/- 12.77) mmHg respectively. More than half (55%) of the type 2 diabetic clients in this study were hypertensive. Finally, there is a significant association between age, gender, marital status, residence and average working hours. Concussion: Prevalence rate of hypertension among type 2 diabetic patients in Hosanna Nigist Ellen Mohammed Memorial Hospital was high. More than half of the study subjects in Nigist Ellen Mohamed Memorial Hospital hospital were hypertensive.	[Tadesse, Kaleab] Wachemo Univ, Coll Med & Hlth Sci, Sch Med, Dept Human Physiol, Hosaena, Ethiopia; [Amare, Hiwot] Jimma Univ, Coll Med & Hlth Sci, Dept Internal Med, Jimma, Ethiopia; [Hailemariam, Tesfahun] Hawassa Coll Hlth Sci, Dept Hlth Informat, Hawassa, Ethiopia; [Gebremariam, Tewodros] Jimma Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Jimma, Ethiopia		Tadesse, K (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Sch Med, Dept Human Physiol, Hosaena, Ethiopia.; Hailemariam, T (corresponding author), Hawassa Coll Hlth Sci, Dept Hlth Informat, Hawassa, Ethiopia.	kaleabrich@gmail.com; Tesfahunhailemariam@gmail.com		Hailemariam, Hiwot Amare/0000-0003-2365-3963	Jimma University; Dilla University	The expenses for this research work; data collectors, supervisors, data collectors' training, field work and stationary materials were supported by Jimma University and Dilla University.	Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; [Anonymous], 2014, HADIYA ZONE FINANCE; Arshad AR, 2014, PAK HEART J, V47, P78; Berraho M, 2012, PAN AFR MED J, V11; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Diabetes UK, 2014, DIAB FACTS STAT; Giday A, 2010, ETHIOP J HEALTH DEV, V24, P145; Giday TK, 2014, INT J PHARM BIOL SCI, V7, P20; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Ibrahim MM, 1996, J HUM HYPERTENS, V10, pS39; Kabakov Emma, 2006, J Cardiometab Syndr, V1, P95, DOI 10.1111/j.1559-4564.2006.05513.x; Kaplan NM, 2014, KAPLANS CLIN HYPERTE; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Kaur N, 2012, J EXER SCI PHYSIOTHE, V8, P6; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mansour AA, 2012, OPEN CARDIOVASC MED, V6, P68, DOI 10.2174/1874192401206010068; Mengesha Addisu Y, 2007, Afr Health Sci, V7, P244; Obimbo MM, 2008, ANN AFR SURG, V2, P338; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Otieno CF, 2005, E AFR MED J, V83, P405; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Tamiru S, 2010, ETHIOP J HEALTH SCI, V20, P121; Taylor BC, 2011, J GEN INTERN MED, V26, P685, DOI 10.1007/s11606-011-1660-6; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; The Harvard School of Public Health, 2012, MULT INT RES TRAIN H; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054; WHO, 2008, CAUS DEATH GLOB BURD; World Health Organization, 2013, EP HYP S, V61, P12; World Health Organization-WHO, 2013, GLOB BRIEF HYP	32	3	3	1	1	OMICS INT PVT LTD	HEATHROW	HEATHROW STOCKLEY PARK LAKESIDE HOUSE 1 FURZEGROUND WAY, HEATHROW, UB11 1BD, ENGLAND	2155-6156			J DIABETES METAB	J. Diabetes Metab.	APR	2018	9	4							1000792	10.4172/2155-6156.1000792			7	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	GF6SQ	WOS:000432098200002		Bronze			2022-02-06	
J	Turcato, F; Kim, P; Barnett, A; Jin, YM; Scerba, M; Casey, A; Selman, W; Greig, NH; Luo, Y				Turcato, Flavia; Kim, Paul; Barnett, Austin; Jin, Yongming; Scerba, Mike; Casey, Anthony; Selman, Warren; Greig, Nigel H.; Luo, Yu			Sequential combined Treatment of Pifithrin-alpha and Posiphen Enhances Neurogenesis and Functional Recovery After Stroke	CELL TRANSPLANTATION			English	Article						Stroke; neuroregeneration; p53; APP	AMYLOID PRECURSOR PROTEIN; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; GLUCAGON-LIKE PEPTIDE-1; ALZHEIMERS-DISEASE; ADULT NEUROGENESIS; ISCHEMIC-STROKE; TRANSGENIC MICE; BETA-PEPTIDE; COGNITIVE DEFICITS	Objective: Although cerebral ischemia can activate endogenous reparative processes, such as proliferation of endogenous neural stem cells (NSCs) in the subventricular zone (SVZ) and subgranular zone (SGZ), the majority of these new cells die shortly after injury and do not appropriately differentiate into neurons, or migrate and functionally integrate into the brain. The purpose of this study was to examine a novel strategy for treatment of stroke after injury by optimizing the survival of ischemia-induced endogenous NSCs in the SVZ and SGZ. Methods: Adult SVZ and SGZ NSCs were grown as neurospheres in culture and treated with a p53 inactivator, pifithrin-alpha (PFT-alpha), and an amyloid precursor protein (APP)-lowering drug, posiphen, and effects on neurosphere number, size and neuronal differentiation were evaluated. This combined sequential treatment approach was then evaluated in mice challenged with middle cerebral artery occlusion (MCAo). Locomotor behavior and cognition were evaluated at 4 weeks, and the number of new surviving neurons was quantified in nestin creERT2YFP mice. Results: PFT-alpha and posiphen enhanced the self-renewal, proliferation rate and neuronal differentiation of adult SVZ and SGZ NSCs in culture. Their sequential combination in mice challenged with MCAo-induced stroke mitigated locomotor and cognitive impairments and increased the survival of SVZ and SGZ NSCs cells. PFT-alpha and the combined posiphen+PFT-alpha treatment similarly improved locomotion behavior in stroke challenged mice. Notably, however, the combined treatment provided significantly more potent cognitive function enhancement in stroke mice, as compared with PFT-alpha single treatment. Interpretation: Delayed combined sequential treatment with an inhibitor of p53 dependent apoptosis (PFT-alpha) and APP synthesis (posiphen) proved able to enhance stroke-induced endogenous neurogenesis and improve the functional recovery in stroke animals. Whereas the combined sequential treatment provided no further improvement in locomotor function, as compared with PFT-alpha alone treatment, suggesting a potential ceiling in the locomotion behavioral outcome in stroke animals, combined treatment more potently augmented cognitive function recovery after stroke.	[Turcato, Flavia; Kim, Paul; Barnett, Austin; Jin, Yongming; Casey, Anthony; Selman, Warren; Luo, Yu] Case Western Reserve Univ, Dept Neurol Surg, 2109 Adelbert Rd, Cleveland, OH 44106 USA; [Turcato, Flavia] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Physiol, Ribeirao Preto, SP, Brazil; [Scerba, Mike; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program, Baltimore, MD 21224 USA		Luo, Y (corresponding author), Case Western Reserve Univ, Dept Neurol Surg, 2109 Adelbert Rd, Cleveland, OH 44106 USA.; Greig, NH (corresponding author), NIA, Lab Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	greign@grc.nia.nih.gov; yxl710@case.edu		Luo, Yu/0000-0002-7939-5505	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS091213]; Intramural Research Program of the National Institute on Aging, NIH, USA; National Council for Scientific and Technological Development (CNPq), BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the NIH Grant (R01NS091213), and by the Intramural Research Program of the National Institute on Aging, NIH, USA. Flavia Turcato was supported by a scholarship from National Council for Scientific and Technological Development (CNPq), Brazil.	ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; BANATI RB, 1995, J CEREBR BLOOD F MET, V15, P647, DOI 10.1038/jcbfm.1995.80; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Hachinski V, 2011, ARCH NEUROL-CHICAGO, V68, P797, DOI 10.1001/archneurol.2011.118; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; He XS, 2017, J CEREBR BLOOD F MET, V37, P837, DOI 10.1177/0271678X16642242; Hede SM, 2011, J ONCOL, V2011, DOI 10.1155/2011/852970; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124657; Jin YM, 2017, STROKE, V48, P1636, DOI 10.1161/STROKEAHA.117.016650; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lei XH, 2013, CNS NEUROSCI THER, V19, P109, DOI 10.1111/cns.12045; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loris ZB, 2017, EXP NEUROL, V290, P63, DOI 10.1016/j.expneurol.2017.01.006; Luo Y, 2013, J CEREBR BLOOD F MET, V33, P300, DOI 10.1038/jcbfm.2012.172; Luo Y, 2011, J NEURAL TRANSM, V118, P61, DOI 10.1007/s00702-010-0478-4; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Medrano S, 2009, NEUROBIOL AGING, V30, P483, DOI 10.1016/j.neurobiolaging.2007.07.016; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Palma-Tortosa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16109-7; Pu HJ, 2016, TRANSL STROKE RES, V7, P521, DOI 10.1007/s12975-016-0498-y; Quadrato G, 2012, INT REV NEUROBIOL, V105, P71, DOI 10.1016/B978-0-12-398309-1.00005-6; Rogers JT, 2004, CURR DRUG TARGETS, V5, P535, DOI 10.2174/1389450043345272; Sah N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11268-z; Sahathevan R, 2012, INT J STROKE, V7, P61, DOI 10.1111/j.1747-4949.2011.00731.x; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Schmidt A, 2015, STROKE, V46, P1127, DOI 10.1161/STROKEAHA.115.008905; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Silva B, 2015, ARQ NEURO-PSIQUIAT, V73, P655, DOI 10.1590/0004-282X20150083; Song J, 2012, DEV NEUROBIOL, V72, P1032, DOI 10.1002/dneu.22014; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; Sugaya K, 2007, CURR ALZHEIMER RES, V4, P370, DOI 10.2174/156720507781788936; U.S. Department of Health and Human Services F.a.D.A. Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walker T.L., 2014, J VIS EXP; Webster NJ, 2002, J NEUROCHEM, V83, P1262, DOI 10.1046/j.1471-4159.2002.01236.x; Xu F, 2007, STROKE, V38, P2598, DOI 10.1161/STROKEAHA.106.480103; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yokota M, 1996, J CEREBR BLOOD F MET, V16, P1219, DOI 10.1097/00004647-199611000-00016; Yu QS, 1997, J MED CHEM, V40, P2895, DOI 10.1021/jm970210v; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113972; Zhang RL, 2016, J CEREBR BLOOD F MET, V36, P2034, DOI 10.1177/0271678X16674487; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801; Zhu XX, 2002, J MED CHEM, V45, P5090, DOI 10.1021/jm020044d	68	3	3	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	APR	2018	27	4			SI		607	621		10.1177/0963689718766328			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	GM9IE	WOS:000438559500002	29871513	Green Published, gold			2022-02-06	
J	Yu, K; Seal, ML; Reyes, J; Godfrey, C; Anderson, V; Adamson, C; Ryan, NP; Hearps, SJC; Catroppa, C				Yu, Kelleynne; Seal, Marc L.; Reyes, Jonathan; Godfrey, Celia; Anderson, Vicki; Adamson, Chris; Ryan, Nicholas P.; Hearps, Stephen J. C.; Catroppa, Cathy			Brain volumetric correlates of inhibition and cognitive flexibility 16 years following childhood traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; cognitive function; white matter; executive function; inhibition; cognitive flexibility; childhood	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; WHITE-MATTER; EXECUTIVE FUNCTION; LONGITUDINAL CHANGES; PRESCHOOL-CHILDREN; FRONTAL LOBES; ADOLESCENCE; SEVERITY; IMPACT; MILD	Executive functions (EFs), such as inhibition and cognitive flexibility, are essential for everyday functioning, including regulation of socially appropriate emotional responses. These skills develop during childhood and continue maturing into early adulthood. The current study aimed to investigate the very long-term impact of childhood traumatic brain injury (TBI) on inhibition and cognitive flexibility, and to examine whether global white matter is associated with these abilities. Twenty-eight young adult survivors of childhood TBI (mean age at 16-year follow-up=21.67 years, SD = 2.70) and 16 typically developing controls (TDCs), group-matched for age, sex, and socioeconomic status, completed tests of inhibition and cognitive flexibility and underwent structural MRI. Survivors of childhood TBI did not significantly differ from TDCs on EF or white matter volume. However, the relationship between EF and white matter volume differed between survivors of TBI and TDCs. Survivors of TBI did not mimic the brain behavior relationship that characterized EF in TDCs. The inverse brain behavior relationship, exhibited by childhood TBI survivors, suggests disruptions in the whole brain underpinning EF following childhood TBI.	[Yu, Kelleynne; Seal, Marc L.; Reyes, Jonathan; Godfrey, Celia; Anderson, Vicki; Adamson, Chris; Ryan, Nicholas P.; Hearps, Stephen J. C.; Catroppa, Cathy] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Seal, Marc L.; Godfrey, Celia; Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Dept Pediat, Parkville, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Dept Psychol, Parkville, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, MSPS, Parkville, Vic, Australia		Yu, K (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, 50 Flemington Rd, Parkville, Vic 3052, Australia.	kelleynne.yu@mcri.edu.au	Seal, Marc L/J-9290-2019; Hearps, Stephen/L-6853-2016; Ryan, Nicholas/K-5445-2019; Catroppa, Cathy/AAX-9458-2021	Seal, Marc L/0000-0002-8396-140X; Ryan, Nicholas/0000-0002-0878-8889; Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172; Reyes, Jonathan/0000-0002-2155-8797; Reyes, Jonathan/0000-0002-6087-3159	Victorian Neurotrauma Initiative; Victorian Government's Operational Infrastructure Support Program	This work was funded through research grants awarded by the Victorian Neurotrauma Initiative and Victorian Government's Operational Infrastructure Support Program.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Berlin L, 2002, J CLIN CHILD ADOLESC, V31, P242, DOI 10.1207/S15374424JCCP3102_09; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brickman AM, 2006, BIOL PSYCHIAT, V60, P444, DOI 10.1016/j.biopsych.2006.01.011; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Daniel A., 1983, POWER PRIVILEGE PRES; Delis DC., 2001, DELIS KAPLAN EXECUTI; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Faber J., 2016, BRAIN INJURY, V28, P1; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Treble-Barna A., 2016, J NEUROTRAUM, V33, P1; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	62	3	3	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		642	651		10.1002/jnr.24087			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV2DK	WOS:000424374300014	28675465	Green Published			2022-02-06	
J	Hayashi, CY; Neville, IS; Rodrigues, PA; Galhardoni, R; Brunoni, AR; Zaninotto, AL; Guirado, VMD; Cueva, AS; de Andrade, DC; Teixeira, MJ; Paiva, WS				Hayashi, Cintya Yukie; Neville, Iuri Santana; Rodrigues, Priscila Aparecida; Galhardoni, Ricardo; Brunoni, Andre Russowsky; Zaninotto, Ana Luiza; de Paula Guirado, Vinicius Monteiro; Cueva, Ana Sofia; de Andrade, Daniel Ciampi; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Altered Intracortical Inhibition in Chronic Traumatic Diffuse Axonal Injury	FRONTIERS IN NEUROLOGY			English	Article						brain injuries; craniocerebral trauma; diffuse axonal injury; neurophysiology; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-INJURY; CORTICAL EXCITABILITY; NORMATIVE DATA; MOTOR CORTEX; POPULATION; DEPRESSION; INVENTORY	Background: Overactivation of NMDA-mediated excitatory processes and excess of GABA-mediated inhibition are attributed to the acute and subacute phases, respectively, after a traumatic brain injury (TBI). However, there are few studies regarding the circuitry during the chronic phase of brain injury. Objective: To evaluate the cortical excitability (CE) during the chronic phase of TBI in victims diagnosed with diffuse axonal injury (DAI). Methods: The 22 adult subjects were evaluated after a minimum of 1 year from the onset of moderate or severe TBI. Each of the subjects first had a comprehensive neuropsychological assessment to evaluate executive functions-attention, memory, verbal fluency, and information processing speed. Then, CE assessment was performed with a circular coil applying single-pulse and paired-pulse transcranial magnetic stimulation over the cortical representation of the abductor pollicis brevis muscle on M1 of both hemispheres. The CE parameters measured were resting motor threshold (RMT), motor-evoked potentials (MEPs), short-interval intracortical inhibition (SIICI), and intracortical facilitation (ICF). All data were compared with that of a control group that consisted of the healthy age-matched individuals. Results: No significant differences between the left and right hemispheres were detected in the DAI subjects. Therefore, parameters were analyzed as pooled data. Values of RMT, MEPs, and ICF from DAI patients were within normal limits. However, SIICI values were higher in the DAI group-DAI SIICI = 1.28 (1.01; 1.87) versus the control value = 0.56 (0.33; 0.69)-suggesting that they had a disarranged inhibitory system (p < 0.001). By contrast, the neuropsychological findings had weak correlation with the CE data. Conclusion: As inhibition processes involve GABA-mediated circuitry, it is likely that the DAI pathophysiology itself (disruption of axons) may deplete GABA and contribute to ongoing disinhibition of these neural circuits of the cerebrum during the chronic phase of DAI.	[Hayashi, Cintya Yukie; Neville, Iuri Santana; Rodrigues, Priscila Aparecida; Galhardoni, Ricardo; Zaninotto, Ana Luiza; de Paula Guirado, Vinicius Monteiro; Cueva, Ana Sofia; de Andrade, Daniel Ciampi; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Galhardoni, Ricardo] Univ Cidade Sao Paulo UNICID, Sch Med, Sao Paulo, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Inst Psychiat, Hosp Clin HCFMUSP, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil; [Zaninotto, Ana Luiza] Univ Sao Paulo, Hosp Clin HCFMUSP, Div Psychol, Sao Paulo, Brazil		Hayashi, CY (corresponding author), Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil.	cintya.hayashi@yahoo.com.br	Zaninotto, Ana Luiza C./I-4095-2016; Paiva, Wellingson S/G-5517-2013; Rodrigues, Priscila Aparecida/N-9326-2014; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019; Galhardoni, Ricardo/H-2371-2014; Neville, Iuri/AAI-2852-2021; Brunoni, Andre R./H-8394-2012; Neville, Iuri S/P-5360-2014; de Andrade, Daniel Ciampi/O-2205-2013	Zaninotto, Ana Luiza C./0000-0003-0639-0612; Paiva, Wellingson S/0000-0002-5165-7040; Rodrigues, Priscila Aparecida/0000-0001-6105-1061; de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Galhardoni, Ricardo/0000-0002-8947-2770; Neville, Iuri/0000-0002-8561-9069; Brunoni, Andre R./0000-0002-6310-3571; Neville, Iuri S/0000-0002-8561-9069; de Andrade, Daniel Ciampi/0000-0003-3411-632X	CAPES Postgraduate Scholarship ProgramCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Alliance for Research on Schizophrenia and Depression Young Investigator from the Brain & Behavior Research Foundation (NARSAD)NARSAD [13/20493]; Sao Paulo State Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/20911-5]; National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [13/470904, 459077/2014]	Cintya Yukie Hayashi-funded by CAPES Postgraduate Scholarship Program (Coordination for Improvement of Higher Education Staff). Andre Russowsky Brunoni is supported by the following grants: National Alliance for Research on Schizophrenia and Depression 2013 Young Investigator from the Brain & Behavior Research Foundation (NARSAD, Grant Number 13/20493), FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO 2012 Young Researcher from the Sao Paulo State Foundation (FAPESP, Grant Number 12/20911-5) and National Council for Scientific and Technological Development (CNPq, Grant Number 13/470904, 459077/2014).	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Andrade AF, 2015, NEUROTRAUMATOLOGIA; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Campanholo Kenia Repiso, 2014, Dement. neuropsychol., V8, P26, DOI 10.1590/S1980-57642014DN81000005; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Croarkin PE, 2013, JAMA PSYCHIAT, V70, P291, DOI 10.1001/2013.jamapsychiatry.24; Cueva AS, 2016, NEUROPHYSIOL CLIN, V46, P43, DOI 10.1016/j.neucli.2015.12.003; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dwason B, 2004, BASIC CLIN BIOSTATIS; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Glantz SA, 2012, PRIMER BIOSTATISTICS; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lefaucheur Jean-Pascal, 2008, Expert Rev Neurother, V8, P799, DOI 10.1586/14737175.8.5.799; Liuzzi G, 2014, NEUROLOGY, V82, P198, DOI 10.1212/WNL.0000000000000028; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Miotto EC, 2012, ARQ NEURO-PSIQUIAT, V70, P962, DOI 10.1590/S0004-282X2012001200014; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Spielberg CD, 1960, TEST MANUAL STATE TR; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tiffin, 1968, PURDUE PEGBOARD EXAM; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2008, WORLD HLTH STAT 2008; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29	40	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 28	2018	9								189	10.3389/fneur.2018.00189			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GA7WQ	WOS:000428549500001	29643831	gold, Green Published			2022-02-06	
J	Shepherd-Banigan, M; Smith, VA; Stechuchak, KM; Miller, KEM; Hastings, SN; Wieland, GD; Olsen, MK; Kabat, M; Henius, J; Campbell-Kotler, M; Van Houtven, CH				Shepherd-Banigan, Megan; Smith, Valerie A.; Stechuchak, Karen M.; Miller, Katherine E. M.; Hastings, Susan Nicole; Wieland, Gilbert Darryl; Olsen, Maren K.; Kabat, Margaret; Henius, Jennifer; Campbell-Kotler, Margaret; Van Houtven, Courtney Harold			Comprehensive Support for Family Caregivers of Post-9/11 Veterans Increases Veteran Utilization of Long-term Services and Supports: A Propensity Score Analysis	INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING			English	Article						caregiver; long-term services and supports; Veterans; mental health; traumatic brain injury	INFORMAL CARE; RESPITE CARE; RISK ADJUSTMENT; MODEL	Family caregivers are an important component of the long-term services and supports (LTSS) system. However, caregiving may have negative consequences for caregiver physical and emotional health. Connecting caregivers to formal short-term home-and community-based services (HCBS), through information resources and referrals, might alleviate family caregiver burden and delay nursing home entry for the patient. The aim of this study was to evaluate the early impact of the Program of Comprehensive Assistance for Family Caregivers (PCAFC) (established by P.L. 111-163 for family caregivers of seriously injured post-9/11 Veterans) on Veteran use of LTSS. A two-cohort pre-post design with a nonequivalent comparison group (treated n = 15 650; comparison n = 8339) was used to (1) examine the association between caregiver enrollment in PCAFC and any VA-purchased or VA-provided LTSS use among Veterans and (2) describe program-related trends in HCBS and institutional LTSS use. The comparison group was an inverse-propensity-score weighted sample of Veterans whose caregivers applied for, but were not accepted into, the program. From baseline through 24 months post application, use of any LTSS ranged from 13.1% to 17.8% for Veterans whose caregivers were enrolled in PCAFC versus from 3.8% to 5.3% for Veterans in the comparison group. Participation in PCAFC was associated with a statistically significant increased use of any LTSS from 1 to 24 months post application (over time odds ratios ranged from 2.71 [95% confidence interval: 2.31-3.17] to 4.86 [3.93-6.02]). Support for family caregivers may enhance utilization of LTSS for Veterans with physical, emotional, and/or cognitive conditions.	[Shepherd-Banigan, Megan; Smith, Valerie A.; Stechuchak, Karen M.; Miller, Katherine E. M.; Hastings, Susan Nicole; Wieland, Gilbert Darryl; Olsen, Maren K.; Van Houtven, Courtney Harold] Durham VA Med Ctr, Durham, NC USA; [Shepherd-Banigan, Megan; Smith, Valerie A.; Hastings, Susan Nicole; Wieland, Gilbert Darryl; Olsen, Maren K.; Van Houtven, Courtney Harold] Duke Univ, Durham, NC USA; [Kabat, Margaret; Henius, Jennifer; Campbell-Kotler, Margaret] VA Cent Off, Washington, DC USA		Shepherd-Banigan, M (corresponding author), Durham VA Med Ctr, Hlth Serv Res & Dev Serv, 508 Fulton St, Durham, NC 27705 USA.	megan.shepherd-banigan@va.gov	Shepherd-Banigan, Megan/Q-6687-2019	Shepherd-Banigan, Megan/0000-0002-4020-8936; Smith, Valerie/0000-0001-5170-9819; Van Houtven, Courtney/0000-0002-0783-1611	Department of Veterans AffairsUS Department of Veterans Affairs; Caregiver Support Program; Quality Enhancement Research Initiative [PEC 14-272]; Durham VA Center for Health Services Research in Primary Care; Geriatrics Research, Education, and Clinical Center; VA Quality Enhancement Research Initiative (QUERI) [IP1 HX002258-01]; VA OAA HSR&D PhD Fellowship [TPP 21-000]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Department of Veterans Affairs; Caregiver Support Program; Quality Enhancement Research Initiative (PEC 14-272); the Durham VA Center for Health Services Research in Primary Care; Geriatrics Research, Education, and Clinical Center; and the VA Quality Enhancement Research Initiative (QUERI) (grant IP1 HX002258-01). Megan Shepherd-Banigan is funded through the VA OAA HSR&D PhD Fellowship TPP 21-000.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ash AS, 2000, HEALTH CARE FINANC R, V21, P7; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; Costello KJ, 2015, WHO PAYS LONG TERM S; Family Caregiver Alliance, 2017, CAR STAT DEM; Feinberg Lynn Friss, 2006, J Aging Soc Policy, V18, P95, DOI 10.1300/J038v18n03_07; Foster L, 2007, HEALTH SERV RES, V42, P510, DOI 10.1111/j.1475-6773.2006.00672.x; Guo J, 2015, HLTH EC S, V24, P14; Guo J, 2015, MED DECIS MAKING, V35, P106, DOI 10.1177/0272989X14551641; Hendricks A., 2004, EVALUATION VA LONG T; Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; LaPlante Mitchell P, 2007, J Aging Soc Policy, V19, P47, DOI 10.1300/J031v19n03_04; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Mason A, 2007, HEALTH TECHNOL ASSES, V11, P1; National Care Planning Council, 2016, VET LONG TERM CAR BE; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Ramchand R., 2014, HIDDEN HEROES AM MIL; Reaves E. L., 2015, MED LONG TERM SERVIC; Shaw C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13200; Stearns C., 1999, VET MILLENNIUM HLTH, V2116; The American Association for Caregiver Education, DEF FAM CAR; The Family Caregiver Alliance, 2016, NAT POL STAT; The Independent Budget Veterans Service Organizations, 2016, IND BUDG VET AG 114; The Lewin Group, PROC EV OLD AM ACT T; US Department of Veteran Affairs, 2015, GER EXT CAR LONG TER; US Government Accountability Office, 2009, VA HLTH CAR LONG TER; US Government Accountability Office, 2003, VA LONG TERM CAR SER; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; van Houtven CH, 2008, J HEALTH ECON, V27, P134, DOI 10.1016/j.jhealeco.2007.03.002; Van Houtven CH, 2019, MED CARE RES REV, V76, P89, DOI 10.1177/1077558717697015; Vandepitte S, 2016, INT J GERIATR PSYCH, V31, P1277, DOI 10.1002/gps.4504; Wagner TH, 2016, HEALTH SERV RES, V51, P2002, DOI 10.1111/1475-6773.12454	36	3	3	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0046-9580	1945-7243		INQUIRY-J HEALTH CAR	Inquiry-J. Health Care Organ. Provis. Financ.	MAR 28	2018	55								0046958018762914	10.1177/0046958018762914			12	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GC0EE	WOS:000429448900002	29591540	Green Published, gold			2022-02-06	
J	Neumann, M; Liu, W; Sun, CR; Yang, SY; Noble-Haeusslein, LJ; Liu, JL				Neumann, Melanie; Liu, Wei; Sun, Chongran; Yang, Shih Yen; Noble-Haeusslein, Linda J.; Liu, Jialing			Training of the impaired forelimb after traumatic brain injury enhances hippocampal neurogenesis in the Emx1 null mice lacking a corpus callosum	BEHAVIOURAL BRAIN RESEARCH			English	Article						Controlled cortical impact; DCX; Emx1; Neuroplasticity; Skill reaching	INDUCED MOVEMENT THERAPY; CENTRAL-NERVOUS-SYSTEM; FIBROBLAST GROWTH-FACTORS; MOTOR CORTEX; CHRONIC STROKE; INTERHEMISPHERIC INTERACTIONS; KALLMANN-SYNDROME; ADULT RATS; UPPER-LIMB; PLASTICITY	Unilateral brain injury is known to disrupt the balance between the two cortices, as evidenced by an abnormally high interhemispheric inhibitory drive from motor cortex M1(intact) to M1(lesioned) transmitted transcallosally. Our previous work has shown that the deletion of homeobox gene Emx1a not only led to the agenesis of the corpus callosum (cc), but also to reduced hippocampal neurogenesis. The current study sought to determine whether lacking the cc affected the recovery of forelimb function and hippocampal plasticity following training of the affected limb in mice with unilateral traumatic brain injuries (TBI). One week after TBI, produced by a controlled cortical impact to impair the preferred limb, Emx1 wild type (WT) and knock out (I(0) mice were subjected to the single-pellet reaching task with the affected limb for 4 weeks. Both TBI and Emx1 deletion had overall adverse effects on the successful rate of reaching. However, TBI significantly affected reaching performance only in the WT mice and not in the 1(0 mice. Both TBI and Emx1 gene deletion also negatively affected hippocampal neurogenesis, demonstrated by a reduction in doublecortin (DCX)-expressing immature neurons, while limb training enhanced DCX expression. However, limb training increased DCX cells in KO mice only in the TBI-treated group, whereas it induced neurogenesis in both WT mice groups regardless of the treatment. Our finding also suggests that limb training enhances neuroplasticity after brain injury at functionally remote regions including the hippocampus, which may have implications for promoting overall recovery of function after TBI. Published by Elsevier B.V.	[Neumann, Melanie; Liu, Wei; Sun, Chongran; Yang, Shih Yen; Liu, Jialing] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Neumann, Melanie; Liu, Wei; Sun, Chongran; Yang, Shih Yen; Noble-Haeusslein, Linda J.; Liu, Jialing] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94158 USA; [Liu, Wei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol Surg, Beijing 100050, Peoples R China; [Sun, Chongran] Zhejiang Univ, Affiliated Hosp 2, Med Coll, Dept Neurol Surg, Hangzhou, Zhejiang, Peoples R China; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Phys Therapy & Rehabil Sci, San Francisco, CA 94121 USA		Liu, JL (corresponding author), Univ Calif San Francisco, Dept Neurol Surg 112C, 1700 Owens St, San Francisco, CA 94158 USA.; Liu, JL (corresponding author), US Dept Vet Affairs, Med Ctr, 1700 Owens St, San Francisco, CA 94158 USA.	jialing.liu@ucsf.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS071050]; Department of Veteran AffairsUS Department of Veterans Affairs [I01RX000655]; Department of DefenseUnited States Department of Defense [W81XWH-05-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071050] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003335, I01RX000655] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (R01 NS071050 to JL), Department of Veteran Affairs (I01RX000655 to JL) and Department of Defense collaborative in Neuroscience Center of Excellence (W81XWH-05-1 to JL).	Bury SD, 2002, J NEUROSCI, V22, P8597; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Cimolin V, 2012, J HEAD TRAUMA REHAB, V27, P177, DOI 10.1097/HTR.0b013e3182172276; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2004, J MOL MED, V82, P725, DOI 10.1007/s00109-004-0571-y; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Floel A, 2004, ANN NEUROL, V56, P206, DOI 10.1002/ana.20170; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Grotta JC, 2004, STROKE, V35, P2699, DOI 10.1161/01.STR.0000143320.64953.c4; Hoare BJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004149.pub2; Hoare B, 2007, CLIN REHABIL, V21, P675, DOI 10.1177/0269215507080783; Hong SM, 2007, EXP NEUROL, V206, P24, DOI 10.1016/j.expneurol.2007.03.028; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Kobeissy F., FRONT MOL NEUROSCI; Kunkel A, 1999, ARCH PHYS MED REHAB, V80, P624, DOI 10.1016/S0003-9993(99)90163-6; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Liepert J, 2003, SUPPL CLIN NEUROPHYS, V56, P368; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P671, DOI 10.1016/S1388-2457(99)00312-0; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Oomura Y, 1997, Jpn J Physiol, V47 Suppl 1, pS52; Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160; Park SW, 2004, NEUROREHAB NEURAL RE, V18, P95, DOI 10.1177/0888439004265113; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Reuss B, 2003, J NEUROSCI, V23, P6404; SASAKI K, 1994, BRAIN RES BULL, V33, P505, DOI 10.1016/0361-9230(94)90075-2; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Shimizu T, 2000, NEUROREPORT, V11, P3077, DOI 10.1097/00001756-200009280-00009; Taub E, 2001, Curr Atheroscler Rep, V3, P279, DOI 10.1007/s11883-001-0020-0; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Tsuboi F, 2010, EUR J NEUROSCI, V32, P1397, DOI 10.1111/j.1460-9568.2010.07395.x; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; WHISHAW IQ, 1991, BEHAV BRAIN RES, V42, P77, DOI 10.1016/S0166-4328(05)80042-7; Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456; Wurm F, 2007, STROKE, V38, P2833, DOI 10.1161/STROKEAHA.107.485524; Zhao CS, 2009, TOHOKU J EXP MED, V218, P301, DOI 10.1620/tjem.218.301	45	3	3	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		165	171		10.1016/j.bbr.2016.09.013			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400019	27614007	Green Accepted			2022-02-06	
J	Fernando, N; Natoli, R; Racic, T; Wooff, Y; Provis, J; Valter, K				Fernando, Nilisha; Natoli, Riccardo; Racic, Tanja; Wooff, Yvette; Provis, Jan; Valter, Krisztina			The use of the vaccinia virus complement control protein (VCP) in the rat retina	PLOS ONE			English	Article							SENILE MACULAR DEGENERATION; FACTOR-H POLYMORPHISM; PHOTORECEPTOR DEGENERATION; BRUCHS MEMBRANE; 2 PARTS; ACTIVATION; MICROGLIA; DRUSEN; SYSTEM; INFLAMMATION	The complement system is highly implicated in both the prevalence and progression of Age Related Macular Degeneration (AMD). Complement system inhibitors therefore have potential therapeutic value in managing excessive activation of the complement pathways in retinal degenerations. The vaccinia virus complement control protein (VCP) has been shown to be effective as a complement inhibitor in neuroinflammatory models including traumatic brain injury and spinal cord injury. We aimed to investigate the potential of VCP as a therapeutic molecule for retinal degenerations. In this study, we investigated the effect, localisation and delivery of VCP to the rodent retina. Complement inhibition activity of VCP was tested using a hemolytic assay. Photoreceptor cell death, inflammation and retinal stress were assayed to determine if any retinal toxicity was induced by an intravitreal injection of VCP. The effect of VCP was investigated in a model of photo-oxidative retinal degeneration. Localisation of VCP after injection was determined using a fluorescein-tagged form of VCP, as well as immunohistochemistry. Finally, a copolymer resin (Elvax) was trialled for the slow-release delivery of VCP to the retina. We found that a dose equivalent to 20 mu g VCP when intravitreally injected into the rat eye did not cause any photoreceptor cell death or immune cell recruitment, but led to an increase in GFAP. In photo-oxidative damaged retinas, there were no differences in photoreceptor loss, retinal stress (Gfap) and inflammation (Ccl2 and C3) between VCP and saline-injected groups; however, Jun expression was reduced in VCP-treated retinas. After VCP was injected into the eye, it was taken up in all layers of the retina but was cleared within 1-3 hours of delivery. This study indicates that a method to sustain the delivery of VCP to the retina is necessary to further investigate the effect of VCP as a complement inhibitor for retinal degenerations.	[Fernando, Nilisha; Natoli, Riccardo; Racic, Tanja; Wooff, Yvette; Provis, Jan; Valter, Krisztina] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Natoli, Riccardo; Wooff, Yvette; Provis, Jan; Valter, Krisztina] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia		Valter, K (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia.; Valter, K (corresponding author), Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia.	krisztina.valter-kocsi@anu.edu.au	Wooff, Yvette/AAS-4835-2020; Valter, Krisztina/L-3015-2016	Natoli, Riccardo/0000-0002-9350-0439; Valter, Krisztina/0000-0002-2033-0408; Fernando, Nilisha/0000-0002-8488-1348	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1049990]; ARC CoE programAustralian Research Council [CE0561903]; Australian Government Research Training ProgramAustralian Government	This study was supported by the National Health and Medical Research Council (NHMRC, APP1049990), the ARC CoE program (CE0561903) and the Australian Government Research Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Health and Medical Research Council (NHMRC, APP1049990), the ARC CoE program (CE0561903) and the Australian Government Research Training Program. The authors thank Girish Kotwal for his guidance at the early stages of this research, and Kathy Liszewski, Paula Bertram and John Atkinson (Washington University School of Medicine) for kindly providing the VCP antibodies.	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bochot A, 2002, INVEST OPHTH VIS SCI, V43, P253; Costabile M., 2010, JOVE, V37, pE1923; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2013, INT J INFLAMMATION, V2013, P12; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernando N, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0514-x; Fiorani L, 2014, JOVE-J VIS EXP, DOI 10.3791/51563; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Janeway C, 2008, JANEWAYS IMMUNOBIOLO; Jha P, 2003, TRANSPLANT P, V35, P3160, DOI 10.1016/j.transproceed.2003.10.045; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Kim ES, 2009, PHARM RES-DORDR, V26, P1155, DOI 10.1007/s11095-009-9835-0; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kotwal GJ, 2014, MOL IMMUNOL, V61, P204, DOI 10.1016/j.molimm.2014.06.022; Levy O, 2015, EMBO MOL MED; Liszewski MK, 2009, J IMMUNOL, V183, P3150, DOI 10.4049/jimmunol.0901366; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Natoli R, 2016, EXPT EYE RES; Natoli R, 2017, INVEST OPHTH VIS SCI, V58, P2977, DOI 10.1167/iovs.17-21672; Natoli R, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0175-y; Natoli R, 2010, MOL VIS, V16, P1801; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Reynolds DN, 2004, ANN NY ACAD SCI, V1035, P165, DOI 10.1196/annals.1332.011; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Rutar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093343; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Thorbjornsdottir P, 2005, ANN NY ACAD SCI, V1056, P1, DOI 10.1196/annals.1352.001; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xu HP, 2016, EUR J PHARMACOL, V787, P94, DOI 10.1016/j.ejphar.2016.03.001; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhang C, 2005, MOL VIS, V11, P887	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2018	13	3							e0193740	10.1371/journal.pone.0193740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ0JA	WOS:000427253500011	29534078	Green Submitted, gold, Green Published			2022-02-06	
J	Ajdari, A; Boyle, LN; Kannan, N; Wang, J; Rivara, FP; Vavilala, MS				Ajdari, Ali; Boyle, Linda Ng; Kannan, Nithya; Wang, Jin; Rivara, Frederick P.; Vavilala, Monica S.			Simulation of the Emergency Department Care Process for Pediatric Traumatic Brain Injury	JOURNAL FOR HEALTHCARE QUALITY			English	Article						pediatric traumatic brain injury; emergency department; simulation model	HEALTH-CARE; OUTCOMES; SYSTEMS; PAIN	The treatment of patients in the emergency department (ED) with severe pediatric traumatic brain injury (TBI) is challenging, and treatment process strategies that facilitate good outcomes are not well documented. The overall objective of this study was to identify factors that can affect the care process associated with pediatric TBI. This objective was achieved using a discrete-event simulation model of patients with TBI as they progress through the ED treatment process of a Level I trauma center. This model was used to identify areas where the ED length of stay can be reduced. The number of patients arriving at any given time was also varied in the simulation model to observe the impact to bed allocation policies and changes in staff and equipment. The findings showed that implementing changes in the ED (i.e., availability of two computerized tomography scanners, formation of resuscitation teams that included eight staff personnel, and modifying the bed allocation policy) could result in a 17% reduction in the mean ED length of stay. The study outcomes would be of interest to those (e.g., health administrators, health managers, and physicians) who can make decisions related to the treatment process in an ED.	[Ajdari, Ali] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Coll Engn, Seattle, WA 98195 USA; [Kannan, Nithya] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Anesthesiol & Pain Med & Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, HIPRC, Seattle, WA 98195 USA		Boyle, LN (corresponding author), Univ Washington, Coll Engn, Seattle, WA 98195 USA.	linda@uw.edu	Ajdari, Ali/S-7013-2019		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01 NS072308-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	This research was supported by funding by an NIH grant (NINDS R01 NS072308-06).	Ajdari A, 2017, J HEALTHC QUAL, V39, P334, DOI 10.1097/JHQ.0000000000000052; Baesler FF, 2003, PROCEEDINGS OF THE 2003 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1903, DOI 10.1109/WSC.2003.1261651; Banks J., 1998, HDB SIMULATION PRINC; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Brailsford SC, 2009, J SIMUL, V3, P130, DOI 10.1057/jos.2009.10; Burt CW, 2006, ADV DATA, V376, P1; Carayon P, 2014, APPL ERGON, V45, P14, DOI 10.1016/j.apergo.2013.04.023; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forster AJ, 2003, ACAD EMERG MED, V10, P127, DOI 10.1197/aemj.10.2.127; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Kadri F, 2014, SIMUL MODEL PRACT TH, V42, P32, DOI 10.1016/j.simpat.2013.12.004; Kannan N, PEDIAT EMERG CARE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin D, 2014, HEALTH CARE MANAG SC, V17, P88, DOI 10.1007/s10729-013-9241-3; Pegden C. D., 2013, RAPID MODELING SOLUT; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Pines JM, 2007, ACAD EMERG MED, V14, P382, DOI 10.1197/j.aem.2006.11.018; Price RA, 2014, MED CARE RES REV, V71, P522, DOI 10.1177/1077558714541480; Ries BS, 2013, P HUM FACT ERG SOC A, V57, P1536; Robinson S, 2012, EUR J OPER RES, V219, P188, DOI 10.1016/j.ejor.2011.12.029; Sharma S., 2013, THESIS; Shojania KG, 2001, EVID REP TECHNOL ASS, pi; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Wiinamaki A, 2003, PROCEEDINGS OF THE 2003 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1912, DOI 10.1109/WSC.2003.1261653; Wiler JL, 2013, ACAD EMERG MED, V20, P939, DOI 10.1111/acem.12215	28	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1062-2551	1945-1474		J HEALTHC QUAL	J. Healthc. Qual.	MAR-APR	2018	40	2					110	118		10.1097/JHQ.0000000000000119			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GP7LO	WOS:000441081600009	29271801	Green Accepted			2022-02-06	
J	Betthauser, LM; Brenner, LA; Cole, W; Scher, AI; Schwab, K; Ivins, BJ				Betthauser, Lisa M.; Brenner, Lisa A.; Cole, Wesley; Scher, Ann I.; Schwab, Karen; Ivins, Brian J.			A Clinical Evidence-Based Approach to Examine the Effects of mTBI and PTSD Symptoms on ANAM Performance in Recently Deployed Active Duty Soldiers: Results From the Warrior Strong Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ANAM; base rate analysis; cognitive function; low scores; military; mTBI; OEF; OIF; postdeployment; PTSD	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CHRONIC PAIN; COGNITIVE IMPAIRMENT; TEST BATTERIES; MEMORY SCORES; ADULTS; PREVALENCE; VALIDATION	Objective: Service members are frequently diagnosed with comorbid mild traumatic brain injury (mTBI) and posttraumatic stress disorder after returning from Afghanistan and Iraq. Little is known about how mTBI in the postacute and chronic phases combined with current posttraumatic stress disorder symptoms (PTS) affects performance on the Automated Neuropsychological Assessment Metrics, Version 4, Traumatic Brain Injury-Military (ANAM4) battery used by the US military. We examined postdeployment ANAM4 performance using conventional statistical methods, as well as rates of poor performance, below established cutoffs (< 10th and <= 2nd percentile). Methods: A total of 868 soldiers were assessed for history of mTBI during the most recent deployment, as well as, lifetime mTBI, current PTS, and current pain-related symptoms. The ANAM4 was also administered. Results: Soldiers with PTS and/or mTBI performed worse on ANAM4 relative to controls with those with both conditions performing worst. However, a nontrivial minority (similar to 10%-30%) of individuals with mTBI, PTS, or both had scores that were at or below the second percentile. Conclusion: Our results illustrate that a combination of mTBI and PTS is associated with worse ANAM4 performance than either condition alone. Furthermore, only a minority of soldiers with any, or both, of the conditions had ANAM deficits. The long-lasting impacts and unique contribution of each condition have yet to be determined.	[Betthauser, Lisa M.; Brenner, Lisa A.] Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Betthauser, Lisa M.; Brenner, Lisa A.] Univ Colorado, Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Cole, Wesley; Schwab, Karen; Ivins, Brian J.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Cole, Wesley; Ivins, Brian J.] GDIT, Fairfax, VA USA; [Scher, Ann I.; Schwab, Karen] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD USA		Betthauser, LM (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr, Vet Hlth Adm, 1055 Clermont St, Denver, CO 80220 USA.	lisa.betthauser@va.gov	Brenner, Lisa A./AAG-2442-2019	Scher, Ann/0000-0003-4599-9834			Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2009, J HEAD TRAUMA REHAB, V25, P307; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2009, J INT NEUROPSYCH SOC, V15, P613, DOI 10.1017/S1355617709090651; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; CSRC, 2012, ANAM4 MIL ADM MAN; CSRC, 2011, ANAM4 EFF MEAS QUICK; CSRC, MIL NORM REF DAT MIL; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs, US PTSD CHECKL DSM 4; Deployment HealthClinical Center, PTSD; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBM Corp, 2016, IBM SPSS STAT WINDOW; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Kianifard F, 1995, J Biopharm Stat, V5, P115, DOI 10.1080/10543409508835101; Lange RT, 2011, ENCY CLIN NEUROPSYCH, P2368, DOI DOI 10.1007/978-0-387-79948-3_1249; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Patton DE, 2003, CLIN NEUROPSYCHOL, V17, P515, DOI 10.1076/clin.17.4.515.27948; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Von Korff M, 2005, PAIN, V117, P304, DOI 10.1016/j.pain.2005.06.017	42	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					91	100		10.1097/HTR.0000000000000376			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200010	29517590				2022-02-06	
J	Burnette, E; Piker, EG; Frank-Ito, D				Burnette, Elizabeth; Piker, Erin G.; Frank-Ito, Dennis			Reevaluating Order Effects in the Binaural Bithermal Caloric Test	AMERICAN JOURNAL OF AUDIOLOGY			English	Article							RESPONSES; WATER; AIR; VARIABILITY; STIMULATION; IRRIGATION	Purpose: The purpose of this study was to determine whether a significant order effect exists in the binaural bithermal caloric test. Method: Fifteen volunteers (mean age = 24.3 years, range = 18-38 years) with no history of vestibular disorder, hearing loss, concussion, or neurological disease underwent caloric testing on 3 occasions. Irrigations were randomized using 8 possible order combinations. The parameters of interest included unilateral weakness, directional preponderance, total response from the right ear, and total response from the left ear. Results: Order effects were analyzed using 2 methods. The first analysis was done looking at the 8 possible orders. We also had an a priori established hypothesis that the first irrigation tested would influence the calculation of unilateral weakness more than the other 3 irrigations. To test this hypothesis, the 8 orders were condensed into 4 order conditions based on the first irrigation. The effect of order was determined using analysis of variance tests. Although the first irrigation tended to be the largest, no significant effects were observed. Conclusions: This experiment demonstrated that while there is great inter-individual and intra-individual variability in caloric test results, the order of irrigations had no significant effect in the test. Future studies may explore the effects of nonphysiological factors on test results.	[Burnette, Elizabeth; Piker, Erin G.; Frank-Ito, Dennis] Duke Univ, Durham, NC 27708 USA; [Piker, Erin G.] James Madison Univ, Harrisonburg, VA 22807 USA		Burnette, E (corresponding author), Duke Univ, Durham, NC 27708 USA.	e.burnette@duke.edu		Burnette, Elizabeth/0000-0003-4005-5885			ANDERSON S, 1995, BRIT J AUDIOL, V29, P117, DOI 10.3109/03005369509086589; Barin K., 2016, BALANCE FUNCTION ASS, P283; DAVEY PG, 1982, J LARYNGOL OTOL, V96, P599, DOI 10.1017/S0022215100092896; FORD CR, 1978, ARCH OTOLARYNGOL, V104, P380; FURMAN JMR, 1993, ACTA OTO-LARYNGOL, V113, P3, DOI 10.3109/00016489309135759; Jacobson G. P., 1993, HDB BALANCE FUNCTION, P156; Lightfoot GR, 2004, INT J AUDIOL, V43, P276, DOI 10.1080/14992020400050037; Noaksson, 1998, Int Tinnitus J, V4, P71; Oloriz J, 2007, ACTA OTORRINOLAR ESP, V58, P151, DOI 10.1016/S0001-6519(07)74901-4; PROCTOR L, 1985, ACTA OTO-LARYNGOL, V100, P161, DOI 10.3109/00016488509104778; Zapala DA, 2008, EAR HEARING, V29, P585, DOI 10.1097/AUD.0b013e3181734ed0	11	3	4	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1059-0889	1558-9137		AM J AUDIOL	Am. J. Audiol.	MAR	2018	27	1					104	109		10.1044/2017_AJA-17-0028			6	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	FZ5KP	WOS:000427631500010	29383375				2022-02-06	
J	Espino, SLR; Kelly, EH; Rivelli, A; Zebracki, K; Vogel, LC				Espino, Susan L. Ryerson; Kelly, Erin H.; Rivelli, Anne; Zebracki, Kathy; Vogel, Lawrence C.			It is a marathon rather than a sprint: an initial exploration of unmet needs and support preferences of caregivers of children with SCI	SPINAL CORD			English	Article							SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; STRUCTURED PROCESS; RESEARCH STRATEGY; CHRONIC ILLNESS; FAMILY NEEDS; COMMUNITY; DISABILITY; SURVIVORS	Study design Focus group study. Objectives Explore unmet needs and support preferences of caregivers of youth with spinal cord injury (SCI). Setting One pediatric specialty rehabilitation hospital system in the United States. Methods Four focus groups were conducted with a convenience sample of 26 caregivers who were primarily mothers (96%) and married (65%), and had at least some college education (85%). Children living with SCI were on average 12.8 years old (SD = 3.3, 8-18). The average age of injury was 4.7 years (SD = 4.4, 0-16.2); mean injury duration was 8.2 years (SD = 3.9, 2-16); 77% had paraplegia; and 58% were male. Focus groups were digitally recorded, transcribed verbatim, and coded using thematic analysis and NVivo. Results Qualitative data highlighted caregiver perspectives on unmet needs relating to two phases of care: acute and rehabilitation vs. current life with SCI, and two kinds of stressors: those associated with SCI and care vs. those related to other areas of the caregivers' lives, especially their families. Caregivers described stressful interactions with care systems and community services, articulated several concerns regarding well-being of family members, and noted that both they and their children with SCI experienced isolation. Caregivers articulated preferences for additional support from professionals and peers. Conclusions Data suggest the need for ongoing caregiver interventions and strengthened family-centered care systems, including professional assistance navigating health systems and peer support. Intervention development would benefit from further qualitative data collection with additional caregivers of youth with SCI, including multiple family members, and families from more diverse care settings.	[Espino, Susan L. Ryerson; Kelly, Erin H.; Zebracki, Kathy; Vogel, Lawrence C.] Shriners Hosp Children, Chicago, IL 60707 USA; [Espino, Susan L. Ryerson] Marquette Univ, Milwaukee, WI 53233 USA; [Kelly, Erin H.] Amer Acad Pediat, Elk Grove Village, IL USA; [Kelly, Erin H.; Rivelli, Anne] Univ Illinois, Chicago, IL USA; [Zebracki, Kathy] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Vogel, Lawrence C.] Rush Med Coll, Chicago, IL 60612 USA		Espino, SLR (corresponding author), Shriners Hosp Children, Chicago, IL 60707 USA.; Espino, SLR (corresponding author), Marquette Univ, Milwaukee, WI 53233 USA.	srespino@gmail.com	Zebracki, Kathy/ABG-1544-2020	Zebracki, Kathy/0000-0002-5574-4854	Craig H. Neilsen Foundation [288993]	We extend our sincere appreciation to the families who participated in this research or supported loved ones so that they could participate. We are in debt to Titilope Akinlose, Consuella Brown, Mimi Doll, Molly Kane, Denise Roseland, Norma Seledon, and Carly Wesolowski for data collection and early analysis support. We also extend our gratitude to Kerry O'Rourke for her editing assistance. This research was funded by the Craig H. Neilsen Foundation, Grant #288993. The study protocol was approved by the Institutional Review Board of Rush University and ethical procedures were followed in regard to the treatment of human subjects and reporting of all research procedures and findings.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Akhtar M, 2012, J PEDIATR REHAB MED, V5, P301, DOI 10.3233/PRM-2012-00226; Aneshensel C. S., 1995, PROFILES CAREGIVING; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Beauchamp MR, 2016, DISABIL REHABIL, V38, P1884, DOI 10.3109/09638288.2015.1107773; Blanes L, 2007, SPINAL CORD, V45, P399, DOI 10.1038/sj.sc.3102038; Boschen KA, 2005, REHABIL PSYCHOL, V50, P397, DOI 10.1037/0090-5550.50.4.397; Boyer BA, 2000, REHABIL PSYCHOL, V45, P339, DOI 10.1037/0090-5550.45.4.339; Bragge P, 2015, SPINAL CORD, V53, P714, DOI 10.1038/sc.2015.85; Bragge P, 2015, SPINAL CORD, V53, P721, DOI 10.1038/sc.2015.86; Burmeister E, 2012, AUST CRIT CARE, V25, P271, DOI 10.1016/j.aucc.2012.07.002; Campbell R, 1999, J CONSULT CLIN PSYCH, V67, P847, DOI 10.1037/0022-006X.67.6.847; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Dasch KB, 2011, J CLIN PSYCHOL MED S, V18, P361, DOI 10.1007/s10880-011-9258-z; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Elliott T. R., 1998, J VOCATIONAL REHABIL, V10, P123, DOI DOI 10.1016/S1052-2263(98)00007-5; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Folkman S., 1984, STRESS; Fowler S B, 1997, J Trauma Nurs, V4, P68; Fusch PI, 2015, QUAL REP, V20, P1408; Garma SI, 2011, J PEDIATR PSYCHOL, V36, P226, DOI 10.1093/jpepsy/jsq037; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Guggemos A, 2015, SUPPORT CARE CANCER, V23, P1837, DOI 10.1007/s00520-015-2716-7; Haas BM, 2013, SPINAL CORD, V51, P295, DOI 10.1038/sc.2012.143; Hammell KW, 2007, SPINAL CORD, V45, P260, DOI 10.1038/sj.sc.3102034; Harrington B, 2014, SPINAL CORD INJURY C, P3; Hart G, 1981, Rehabil Nurs, V6, P11; Hoy Leontia, 2013, J Perioper Pract, V23, P153; KAZAK AE, 1989, J CONSULT CLIN PSYCH, V57, P25, DOI 10.1037/0022-006X.57.1.25; Kazak AE, 2007, J PEDIATR PSYCHOL, V32, P1099, DOI 10.1093/jpepsy/jsm031; Kelly EH, 2011, SPINAL CORD, V49, P200, DOI 10.1038/sc.2010.78; Kelly Erin H, 2016, Top Spinal Cord Inj Rehabil, V22, P149, DOI 10.1310/sci2016-00012; Kirchberger I, 2010, SPINAL CORD, V48, P603, DOI 10.1038/sc.2009.184; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Krueger R. A., 2000, FOCUS GROUPS PRACTIC, V3rd; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Meade MA, 2004, REHABIL PSYCHOL, V49, P150, DOI 10.1037/0090-5550.49.2.150; Middleton JW, 2015, SPINAL CORD, V53, P729, DOI 10.1038/sc.2015.87; Muscara F, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0519-5; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Raj JT, 2006, SPINAL CORD, V44, P676, DOI 10.1038/sj.sc.3101899; Rivelli A, J SPINAL CORD MED; Sharpe D, 2002, J PEDIATR PSYCHOL, V27, P699, DOI 10.1093/jpepsy/27.8.699; Shewchuk RM, 2004, AM J HEALTH BEHAV, V28, P43, DOI 10.5993/AJHB.28.1.5; Smith EM, 2016, SPINAL CORD, V54, P562, DOI 10.1038/sc.2016.8; Stamataki Z, 2014, SUPPORT CARE CANCER, V22, P435, DOI 10.1007/s00520-013-1994-1; Stewart D. W, 1990, APPL SOCIAL RES METH, V20; Taylor E, 2011, COORDINATED CARE MED; Unalan H, 2001, SPINAL CORD, V39, P318, DOI 10.1038/sj.sc.3101163; Vargo F., 1984, J APPL REHABIL COUNS, V15, P28; Watson SL, 2011, INT REV RES DEV DISA, V41, P31, DOI 10.1016/B978-0-12-386495-6.00002-3; Weitzenkamp DA, 1997, ARCH PHYS MED REHAB, V78, P822, DOI 10.1016/S0003-9993(97)90194-5; Wharewera-Mika J, 2016, CLIN CHILD PSYCHOL P, V21, P268, DOI 10.1177/1359104515589636; Wuest J, 1997, Can J Nurs Res, V29, P99; Wuest J, 1997, J ADV NURS, V26, P49, DOI 10.1046/j.1365-2648.1997.1997026049.x	58	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAR	2018	56	3					284	294		10.1038/s41393-017-0022-6			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY3VL	WOS:000426748900014	29187744	Bronze			2022-02-06	
J	Garling, RJ; Watts, LT; Sprague, S; Digicaylioglu, M				Garling, Richard Justin; Watts, Lora Talley; Sprague, Shane; Digicaylioglu, Murat			Progesterone modulates mTOR in the hippocampus of mice after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; closed skull head injury; neurotrauma; progesterone; pneumatic injury model; neuroprotection; neural regeneration	MAMMALIAN TARGET; CELL-GROWTH; PHOSPHORYLATION; PATHWAY; TSC2; SUPPRESSES; SURVIVAL; GLIOSIS; STRESS; DEATH	The mechanistic target of rapamycin (mTOR) is an intracellular protein kinase that functions as an energy and nutrient sensor in the cellular microenvironment of neurons. Modulation of mTOR is vital when nutrient and energy sources become limited. Hypoxia, traumatic brain injury, cellular energy states, and growth factors all regulate the phosphorylation and total levels of mTOR in cells. Alterations in the microenvironment induce transduction of signals to downstream proteins by mTOR allowing for cells to make the necessary adjustments to counteract stressors and survive. Progesterone, a hydrophobic steroid hormone, has been shown in studies of non-neural tissue to be a suppressor of mTOR and modulator of mTOR phosphorylation. Our study tested the effects of progesterone on mTOR expression following traumatic brain injury. C57BL/6 mice were treated with progesterone (8 mg/kg) at 1 (intraperitoneal), 6 (subcutaneous), 24 (subcutaneous), and 48 (subcutaneous) hours post closed skull traumatic brain injury. The hippocampus was then harvested 72 hours post injury and prepared for western blot analysis. We found that progesterone significantly decreased total mTOR levels in all groups compared to sham treated with vehicle. This was further confirmed by immunostaining showing decreased cytoplasmic mTOR levels compared to sham. Our study shows progesterone is a significant modulator of mTOR levels in the hippocampus of mice following traumatic brain injury.	[Garling, Richard Justin] Wayne State Univ, Dept Neurosurg, Detroit, MI 48202 USA; [Garling, Richard Justin; Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; [Sprague, Shane; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA		Garling, RJ (corresponding author), Wayne State Univ, Dept Neurosurg, Detroit, MI 48202 USA.; Garling, RJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA.	Jgarling@med.wayne.edu					Atif F, 2015, J STEROID BIOCHEM, V146, P62, DOI 10.1016/j.jsbmb.2014.04.007; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Fletcher L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068281; Foster HA, 2014, J STEROID BIOCHEM, V139, P166, DOI 10.1016/j.jsbmb.2013.02.017; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kosmas IP, 2015, GYNECOL ENDOCRINOL, V31, P702, DOI 10.3109/09513590.2015.1065479; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2012, EUR J IMMUNOL, V42, P2683, DOI 10.1002/eji.201142317; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	26	3	3	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2018	13	3					434	439		10.4103/1673-5374.228725			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GB9DL	WOS:000429374200016	29623927	gold, Green Published			2022-02-06	
J	Gunther, M; Al Nimer, F; Piehl, F; Risling, M; Mathiesen, T				Gunther, Mattias; Al Nimer, Faiez; Piehl, Fredrik; Risling, Marten; Mathiesen, Tiit			Susceptibility to Oxidative Stress Is Determined by Genetic Background in Neuronal Cell Cultures	ENEURO			English	Article						oxidative stress; neuronal inflammation; traumatic brain injury; cell culture; Dark Agouti; Piebald Viral Glaxo	TRAUMATIC BRAIN-INJURY; NON-MHC GENES; MITOCHONDRIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; RAT STRAINS; PEROXYNITRITE; ACTIVATION; OXYGEN; NEURODEGENERATION; INFLAMMATION	Traumatic brain injury (TBI) leads to a deleterious and multifactorial secondary inflammatory response in the brain. Oxidative stress from the inflammation likely contributes to the brain damage although it is unclear to which extent. A largely unexplored approach is to consider phenotypic regulation of oxidative stress levels. Genetic polymorphism influences inflammation in the central nervous system and it is possible that the antioxidative response differs between phenotypes and affects the severity of the secondary injury. We therefore compared the antioxidative response in inbred rat strains dark agouti (DA) to piebald viral glaxo (PVG). DA has high susceptibility to inflammatory challenges and PVG is protected. Primary neuronal cell cultures were exposed to peroxynitrite (ONOO-), nitric oxide (NO), superoxide (O-2(-)), and 4-hydroxynonenal (4-HNE). Our findings demonstrated a phenotypic control of the neuronal antioxidative response, specific to manganese O-2(-) dismutase (MnSOD). DA neurons had increased levels of MnSOD, equal levels of peroxiredoxin 5 (PRDX5), decreased oxidative stress markers 3-nitrotyrosine (3-NT) and 4-HNE and decreased neuronal death detected by lactate dehydrogenase (LDH) release after 24 h, and higher oxidative stress levels by CellROX than PVG after 2 h. It is possible that DA neurons had a phenotypic adaptation to a fiercer inflammatory environment. ONOO- was confirmed as the most powerful oxidative damage mediator, while 4-HNE caused few oxidative effects. Inducible NO synthase (iNOS) was not induced, suggesting that inflammatory, while not oxidative stimulation was required. These findings indicate that phenotypic antioxidative regulation affects the secondary inflammation, which should be considered in future individualized treatments and when evaluating antioxidative pharmacological interventions.	[Gunther, Mattias; Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Al Nimer, Faiez; Piehl, Fredrik; Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden		Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Sect Expt Traumatol, Retzius Vag 8,B1 5, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	Nimer, Faiez Al/ABB-9465-2020; , Mattias/A-4442-2013; mathiesen, tiit/ABC-3627-2021	, Mattias/0000-0003-2372-6114; Al Nimer, Faiez/0000-0003-0937-5995; Mathiesen, Tiit/0000-0001-9463-1919	Swedish Defense; ALF Stockholms Lans Landsting	This work was supported by the Swedish Defense and ALF Stockholms Lans Landsting.	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Aderem A, 2004, SEMIN IMMUNOL, V16, P55, DOI 10.1016/j.smim.2003.10.002; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x; Bains M, 2011, BIOCHIM BIOPHYS ACTA, V1822, P675; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Faraci FM, 2006, J APPL PHYSIOL, V100, P739, DOI 10.1152/japplphysiol.01044.2005; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lundberg C, 2001, J COMP NEUROL, V431, P75; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; Malecki A, 2000, J NEUROCHEM, V74, P2278, DOI 10.1046/j.1471-4159.2000.0742278.x; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Misawa H, 2006, NEUROBIOL DIS, V23, P169, DOI 10.1016/j.nbd.2006.02.014; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Pickering AM, 2013, FREE RADICAL BIO MED, V55, P109, DOI 10.1016/j.freeradbiomed.2012.11.001; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Trackey JL, 2001, J NEUROCHEM, V79, P445, DOI 10.1046/j.1471-4159.2001.00584.x; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6	42	3	3	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	MAR-APR	2018	5	2							UNSP e0335-17.2018	10.1523/ENEURO.0335-17.2018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC8BE	WOS:000430017100010	29568799	gold, Green Published			2022-02-06	
J	Huang, MF; Su, CH; Tu, HP; Liu, TL; Lin, CL; Chen, CS; Yeh, YC				Huang, Mei-Feng; Su, Chen-Hsiang; Tu, Hung-Pin; Liu, Tai-Ling; Lin, Chih-Lung; Chen, Cheng-Sheng; Yeh, Yi-Chun			Association between bipolar disorder and subsequent traumatic brain injury in patients who received inpatient treatment	PSYCHIATRY RESEARCH			English	Article						Bipolar disorder; Traumatic brain injury; Risk; Predictor	AGE-OF-ONSET; GENDER-DIFFERENCES; RISK-FACTORS; DISCONTINUATION; PARTICIPANTS; IMPULSIVITY; MORTALITY; LITHIUM	Mental disorders may confer a high risk of traumatic brain injury, but only rare studies have investigated mood disorders. This nationwide cohort study compared the risk of traumatic brain injury in patients with and without bipolar disorder. We compared 1017 patients with bipolar disorder who received inpatient treatment and 9080 compared patients. The annual incidence rate of traumatic brain injury was calculated as the number of new cases divided by the total number of person-years in the available records. The incidence of subsequent traumatic brain injury was significantly higher in the bipolar group than in control group. The adjusted hazard ratio for those with multiple hospitalizations was higher than the counterpart. Except for patients in the 50-59-year age group, those in all other age groups had higher risks of traumatic brain injury. Our findings reveal a higher risk of traumatic brain injury in patients with bipolar disorder. Patients with recurrent hospitalization and multiple psychotropic use had an increased risk of traumatic brain injury. Age may modify the risk of traumatic brain injury, with a higher risk in middle-aged patients.	[Huang, Mei-Feng; Su, Chen-Hsiang; Liu, Tai-Ling; Chen, Cheng-Sheng; Yeh, Yi-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Huang, Mei-Feng; Liu, Tai-Ling; Yeh, Yi-Chun] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Mei-Feng; Liu, Tai-Ling; Chen, Cheng-Sheng; Yeh, Yi-Chun] Kaohsiung Med Univ, Coll Med, Dept Psychiat, Kaohsiung, Taiwan; [Tu, Hung-Pin] Kaohsiung Med Univ, Coll Med, Dept Publ Hlth, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan		Yeh, YC (corresponding author), 100 Tzyou 1st Rd, Kaohsiung 807, Taiwan.	y7552156@gmail.com		Tu, Hung-Pin/0000-0003-1044-2673	Ministry of Science and Technology (MOST), Taiwan [MOST 100-2314-B-037-016-MY3]; Kaohsiung Medical University Hospital (KMUH), Taiwan [KMUH 103-3R58]	This study was supported by grants from the Ministry of Science and Technology (MOST), Taiwan (MOST 100-2314-B-037-016-MY3), and Kaohsiung Medical University Hospital (KMUH), Taiwan (KMUH 103-3R58). The MOST and KMUH had no further role in study design; data collection, analysis, and interpretation; manuscript drafting; and the decision to submit the paper for publication.	Al Jurdi RK, 2008, AM J GERIAT PSYCHIAT, V16, P922, DOI 10.1097/JGP.0b013e318187135f; Arnold LM, 2003, PSYCHIAT CLIN N AM, V26, P595, DOI 10.1016/S0193-953X(03)00036-4; Azorin JM, 2013, J AFFECT DISORDERS, V151, P1033, DOI 10.1016/j.jad.2013.08.031; Azorin JM, 2013, J AFFECT DISORDERS, V150, P993, DOI 10.1016/j.jad.2013.05.026; Bacciardi S, 2017, RIV PSICHIATR, V52, P40, DOI 10.1708/2631.27053; Baldassano CF, 2005, BIPOLAR DISORD, V7, P465, DOI 10.1111/j.1399-5618.2005.00237.x; Biel MG, 2007, BIPOLAR DISORD, V9, P435, DOI 10.1111/j.1399-5618.2007.00389.x; Buchele G, 2016, J AM MED DIR ASSOC, V17, P609, DOI 10.1016/j.jamda.2016.02.032; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carter TDC, 2003, J PSYCHIAT RES, V37, P297, DOI 10.1016/S0022-3956(03)00052-9; Cassidy F, 2001, BIPOLAR DISORD, V3, P181, DOI 10.1034/j.1399-5618.2001.030403.x; Depp CA, 2004, J NERV MENT DIS, V192, P796, DOI 10.1097/01.nmd.0000145055.45944.d6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fellinger M, 2018, J AFFECT DISORDERS, V225, P104, DOI 10.1016/j.jad.2017.08.007; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Joslyn C, 2016, BIPOLAR DISORD, V18, P389, DOI 10.1111/bdi.12419; Kawa I, 2005, BIPOLAR DISORD, V7, P119, DOI 10.1111/j.1399-5618.2004.00180.x; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; Leibenluft E, 1999, CNS Spectr, V4, P25; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; MacQueen GM, 2001, ACTA PSYCHIAT SCAND, V103, P163, DOI 10.1034/j.1600-0447.2001.00059.x; Mitchell MR, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00024; Mitchell PB, 2004, MED J AUSTRALIA, V181, P207, DOI 10.5694/j.1326-5377.2004.tb06238.x; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Ozten M, 2015, COMPR PSYCHIAT, V59, P28, DOI 10.1016/j.comppsych.2015.02.013; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shulman KI, 1999, PSYCHIAT CLIN N AM, V22, P649, DOI 10.1016/S0193-953X(05)70100-3; SUPPES T, 1991, ARCH GEN PSYCHIAT, V48, P1082; Tsai SY, 1999, J AFFECT DISORDERS, V52, P145, DOI 10.1016/S0165-0327(98)00066-4; Turner Cathy, 2003, Inj Control Saf Promot, V10, P123, DOI 10.1076/icsp.10.3.123.14560; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wessa M, 2015, J AFFECT DISORDERS, V178, P18, DOI 10.1016/j.jad.2015.02.018	32	3	3	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	MAR	2018	261						517	521		10.1016/j.psychres.2017.12.061			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FX6UK	WOS:000426222600079	29395874				2022-02-06	
J	Hurst, HT; Rylands, L; Atkins, S; Enright, K; Roberts, SJ				Hurst, Howard T.; Rylands, Lee; Atkins, Stephen; Enright, Kevin; Roberts, Simon J.			Profiling of translational and rotational head accelerations in youth BMX with and without neck brace	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Injury; Accelerometry; Concussion; Cycling	STRENGTH; SOCCER; BIOMECHANICS; FOOTBALL	Objectives: To investigate the influence of BMX helmets and neck braces on translational and rotational accelerations in youth riders. Design: Mixed model, repeated measure and correlation. Methods: Twenty three competitive youth BMX riders classified by age group (6-9 years, 10-13 years and 14-18 years) completed 6 laps of an indoor BMX track at race pace, 3 laps without a neck brace (NB) and 3 without brace (WB). A triaxial accelerometer with gyroscope was placed behind the right ear to determine the mean number of accelerations, translational and rotational, of the head between conditions and by age group. Results: Significant reductions by condition (p = 0.02) and by age (p=0.04) were found for the number of accelerations, though no interactions (condition x age) were revealed. Significant increases by age (p= 0.01) were revealed for translational accelerations, whilst significant increases by condition (p= 0.02) were found for rotational accelerations. In addition, significant correlations were revealed between relative helmet mass and age (r= 0.83; p = 0.001) and relative helmet mass and number of accelerations (r=0.46; p= 0.03). Conclusions: Accelerations at the head decreased with increased age, possibly due to the influence of greater stabilising musculature. Additionally, neck braces also significantly reduced the number of accelerations. However, the magnitude of accelerations may be influenced by riding dynamics. Therefore, the use of neck braces combined with strength work to develop neck strength, could aid in the reduction of head accelerations in youth BMX riders. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hurst, Howard T.] Univ Cent Lancashire, Sch Sport & Wellbeing, Preston, Lancs, England; [Rylands, Lee] Univ Derby, Coll Life & Nat Sci, Derby, England; [Atkins, Stephen] Univ Salford, Sch Hlth Sci, Salford, Lancs, England; [Enright, Kevin; Roberts, Simon J.] Liverpool John Moores, Sch Sport Studies Leisure & Nutr, Liverpool, Merseyside, England		Hurst, HT (corresponding author), Univ Cent Lancashire, Sch Sport & Wellbeing, Preston, Lancs, England.	HTHurst@uclan.ac.uk	Enright, Kevin/S-8641-2019; Enright, Kevin/A-5349-2011	Enright, Kevin/0000-0003-1775-6392; roberts, simon/0000-0001-7370-0161	Liverpool John Moores University, Faculty Research in Excellence and Enterprise (FREE) fund	Funding for this project/study was provided by a Liverpool John Moores University, Faculty Research in Excellence and Enterprise (FREE) fund.	Atkins S, 2016, 5 INT CONS C CONC SP; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cohen J., 2013, STAT POWER ANAL BEHA; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Leatt C, 2012, WHITE PAPER RES DEV; Louis J, 2013, INT J SPORTS MED, V34, P491, DOI 10.1055/s-0032-1327657; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Persaud N., 2012, CAN MED ASSOC J, P1; Rylands L., 2013, J EXERCISE PHYSL ONL, V16, P40; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Thiele G, 2016, J SPORT ENG TECHNOL, V230, P17; Thompson D., 1999, COCHRANE DB SYST REV, P1; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zabala M, 2008, J STRENGTH COND RES, V22, P1645, DOI 10.1519/JSC.0b013e318181febe	20	3	3	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2018	21	3					263	267		10.1016/j.jsams.2017.05.018			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FX1UQ	WOS:000425837700009	28595865	Green Accepted, Green Submitted			2022-02-06	
J	Kim, J; Jung, HJ; Shim, WS				Kim, Jisung; Jung, Hahn Jin; Shim, Woo Sub			Corrective Septorhinoplasty in Acute Nasal Bone Fractures	CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY			English	Article						Nasal Bone; Bone Fractures; Rhinoplasty	CLOSED REDUCTION; MANAGEMENT; INJURIES; NOSE	Objectives. Closed reduction is generally recommended for acute nasal bone fractures, and rhinoplasty is considered in cases with an unsatisfactory outcome. However, concomitant rhinoplasty with fracture reduction might achieve better surgical outcomes. This study investigated the surgical techniques and outcomes in patients who underwent rhinoplasty and fracture reduction concomitantly, during the acute stage of nasal bone fracture. Methods. Forty-five patients who underwent concomitant rhinoplasty and fracture reduction were enrolled. Nasal bone fractures were classified into three major types (type I, simple fracture; type II, fracture line that mimics nasal osteotomy; and type III, comminuted fracture) based on computed tomography images and preoperative facial images. Two independent otolaryngology-head and neck surgeons evaluated the surgical outcomes and telephone based survey were made to evaluate patients satisfaction. Results. Among 45 patients, there were 39 males and 6 females. Type I was the commonest type of fracture with 18 patients (40%), while the most frequently used surgical technique for corrective surgery was dorsal augmentation with 44 patients (97.8%). The mean visual analogue scale satisfaction score of the surgeons and patients were 7.62 and 8, respectively, with no significant differences between fracture types. Conclusion. Concomitant rhinoplasty with fracture reduction can be performed for acute nasal bone fracture patients, and it might lead to better aesthetic outcomes.	[Kim, Jisung; Jung, Hahn Jin; Shim, Woo Sub] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 776 1sunhwan Ro, Cheongju 28644, South Korea		Shim, WS (corresponding author), Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 776 1sunhwan Ro, Cheongju 28644, South Korea.	hwatas@naver.com			Chungbuk National University, Cheongju, Republic of Korea	This work was supported by a research grant from Chungbuk National University, Cheongju, Republic of Korea, in 2014.	Chen CT, 2010, J PLAST RECONSTR AES, V63, P257, DOI 10.1016/j.bjps.2008.10.006; Clark W D, 1986, Ear Nose Throat J, V65, P481; Ferlito A, 2005, AM J OTOLARYNG, V26, P181, DOI 10.1016/j.amjoto.2004.11.006; Fernandes SV, 2004, LARYNGOSCOPE, V114, P587, DOI 10.1097/00005537-200403000-00038; HAUG RH, 1991, J ORAL MAXIL SURG, V49, P1288, DOI 10.1016/0278-2391(91)90304-5; Kim JH, 2013, OTOLARYNG HEAD NECK, V149, P212, DOI 10.1177/0194599813487493; MURRAY JAM, 1984, ARCH OTOLARYNGOL, V110, P797; MURRAY JAM, 1980, J LARYNGOL OTOL, V94, P1405, DOI 10.1017/S0022215100090241; POLLOCK RA, 1992, CLIN PLAST SURG, V19, P133; RENNER GJ, 1991, OTOLARYNG CLIN N AM, V24, P195; Rhee SC, 2004, PLAST RECONSTR SURG, V113, P45, DOI 10.1097/01.PRS.0000096705.64545.69; Rohrich RJ, 2000, PLAST RECONSTR SURG, V106, P266, DOI 10.1097/00006534-200008000-00003; Staffel JG, 2002, LARYNGOSCOPE, V112, P1709, DOI 10.1097/00005537-200210000-00001; WATSON DJ, 1988, CLIN OTOLARYNGOL, V13, P491, DOI 10.1111/j.1365-2273.1988.tb00323.x; Wong CH, 2013, AESTHET SURG J, V33, P505, DOI 10.1177/1090820X13484466	15	3	3	0	0	KOREAN SOC OTORHINOLARYNGOL	SEOUL	DEPT OTORHINOLARYNGOL-HEAD & NECK SURG, SAMSUNG MED CTR, 50 ILWON-DONG, GANGNAM-GU, SEOUL, 135-710, SOUTH KOREA	1976-8710	2005-0720		CLIN EXP OTORHINOLAR	Clin. Exp. Otorhinolaryngol.	MAR	2018	11	1					46	51		10.21053/ceo.2017.00346			6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	FZ2YM	WOS:000427449600008	28602065	Green Submitted, gold, Green Published			2022-02-06	
J	McKechnie, D; Fisher, MJ; Pryor, J; Bonser, M; De Jesus, J				McKechnie, Duncan; Fisher, Murray J.; Pryor, Julie; Bonser, Melissa; De Jesus, Jhoven			Development of the Sydney Falls Risk Screening Tool in brain injury rehabilitation: A multisite prospective cohort study	JOURNAL OF CLINICAL NURSING			English	Article						brain injury; falls; head injury; screening	HOSPITALIZED-PATIENTS; PREDICTIVE MODELS; WILL FALL; VALIDATION; STRATIFY; PREVENTION; INPATIENTS; SETTINGS; FACILITY; INDEX	Aims and objectivesTo develop a falls risk screening tool (FRST) sensitive to the traumatic brain injury rehabilitation population. BackgroundFalls are the most frequently recorded patient safety incident within the hospital context. The inpatient traumatic brain injury rehabilitation population is one particular population that has been identified as at high risk of falls. However, no FRST has been developed for this patient population. Consequently in the traumatic brain injury rehabilitation population, there is the real possibility that nurses are using falls risk screening tools that have a poor clinical utility. DesignMultisite prospective cohort study. MethodsUnivariate and multiple logistic regression modelling techniques (backward elimination, elastic net and hierarchical) were used to examine each variable's association with patients who fell. The resulting FRST's clinical validity was examined. ResultsOf the 140 patients in the study, 41 (29%) fell. Through multiple logistic regression modelling, 11 variables were identified as predictors for falls. Using hierarchical logistic regression, five of these were identified for inclusion in the resulting falls risk screening tool: prescribed mobility aid (such as, wheelchair or frame), a fall since admission to hospital, impulsive behaviour, impaired orientation and bladder and/or bowel incontinence. The resulting FRST has good clinical validity (sensitivity=0.9; specificity=0.62; area under the curve=0.87; Youden index=0.54). The tool was significantly more accurate (p=.037 on DeLong test) in discriminating fallers from nonfallers than the Ontario Modified STRATIFY FRST. ConclusionA FRST has been developed using a comprehensive statistical framework, and evidence has been provided of this tool's clinical validity. Relevance to clinical practiceThe developed tool, the Sydney Falls Risk Screening Tool, should be considered for use in brain injury rehabilitation populations.	[McKechnie, Duncan] Univ Sydney, Sydney Nursing Sch, Brain Injury Unit, Royal Rehab, Sydney, NSW, Australia; [Fisher, Murray J.; Pryor, Julie] Univ Sydney, Sydney Nursing Sch, Nursing Res & Dev, Royal Rehab, Sydney, NSW, Australia; [Bonser, Melissa] Liverpool Hosp, Sydney, NSW, Australia; [De Jesus, Jhoven] Westmead Hosp, Westmead Brain Injury Rehabil Serv, Sydney, NSW, Australia		McKechnie, D (corresponding author), Royal Rehab, Brain Injury Unit, Sydney, NSW, Australia.	duncan.mckechnie@royalrehab.com.au		Pryor, Julie/0000-0003-4907-8530			Altman DG, 1997, BRIT MED J, V315, P1309, DOI 10.1136/bmj.315.7118.1309; Aranda-Gallardo M, 2015, J ADV NURS, V71, P1948, DOI 10.1111/jan.12651; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Barker A, 2009, QUAL SAF HEALTH CARE, V18, P467, DOI 10.1136/qshc.2007.025676; Barker A, 2011, J ADV NURS, V67, P450, DOI 10.1111/j.1365-2648.2010.05503.x; Beyene J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-64; Breisinger TP, 2011, ARCH PHYS MED REHAB, V92, P1696; Carmine H, 2005, BRAIN INJ PROFESS, V2, P26; Chen FY, 2015, STAT MED, V34, P1560, DOI 10.1002/sim.6432; Clinical Excellence Commission, 2013, CLIN FOC REP FALLS; Evans D, 2001, Int J Nurs Pract, V7, P38; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Forrest G, 2012, REHABIL NURS, V37, P56, DOI 10.1002/RNJ.00010; Giles LC, 2006, CIN-COMPUT INFORM NU, V24, P167, DOI 10.1097/00024665-200605000-00014; Grant J S, 1987, Rehabil Nurs, V12, P74; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Halfon P, 2001, J CLIN EPIDEMIOL, V54, P1258, DOI 10.1016/S0895-4356(01)00406-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Healey F., 2007, 3 REPORT PATIENT SAF; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Kim S, 2017, STAT METHODS MED RES, V26, P142, DOI 10.1177/0962280214541852; Latt MD, 2016, AUSTRALAS J AGEING, V35, P167, DOI 10.1111/ajag.12256; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Matarese M, 2015, J ADV NURS, V71, P1198, DOI 10.1111/jan.12542; McFadden D, 1997, QUANTITATIVE METHODS; McKechnie D, 2017, DISABIL REHABIL, V39, P1864, DOI 10.1080/09638288.2016.1212112; McKechnie D, 2016, J ADV NURS, V72, P2238, DOI 10.1111/jan.12977; McKechnie D, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000146; McKechnie D, 2016, J CLIN NURS, V25, P213, DOI 10.1111/jocn.13087; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Morozova O, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0066-2; Myers Helen, 2003, Int J Nurs Pract, V9, P223, DOI 10.1046/j.1440-172X.2003.00430.x; NSW Agency for Clinical Innovation Brain Injury Rehabilitation Directorate, 2015, NSW BRAIN INJ REH PR; Nyberg L, 1997, STROKE, V28, P716, DOI 10.1161/01.STR.28.4.716; Oliver D, 1997, BMJ-BRIT MED J, V315, P1049, DOI 10.1136/bmj.315.7115.1049; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Oliver D, 2008, AGE AGEING, V37, P621, DOI 10.1093/ageing/afn203; Papaioannou A, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-1; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Poe SS, 2007, J NURS CARE QUAL, V22, P293, DOI 10.1097/01.NCQ.0000290408.74027.39; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rosario ER, 2014, REHABIL NURS, V39, P86, DOI 10.1002/rnj.114; Ruroede K, 2016, J NURS CARE QUAL, V31, P146, DOI 10.1097/NCQ.0000000000000158; Sherrington C, 2010, J REHABIL MED, V42, P482, DOI 10.2340/16501977-0550; Stapleton C, 2009, AUSTRALAS J AGEING, V28, P139, DOI 10.1111/j.1741-6612.2009.00375.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tate RL, 2004, BRAIN INJURY OUTCOME; Thomas D, 2016, REHABIL NURS, V41, P253, DOI 10.1002/rnj.211; World Health Organization, 2007, WHO GLOB REP FALLP; Yauk S, 2005, J NURS CARE QUAL, V20, P128, DOI 10.1097/00001786-200504000-00007	53	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	MAR	2018	27	5-6					958	968		10.1111/jocn.14048			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GA6CB	WOS:000428419400057	28833813				2022-02-06	
J	Mistry, DA; Rainer, TH				Mistry, Dylan A.; Rainer, Timothy H.			Concussion assessment in the emergency department: a preliminary study for a quality improvement project	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Background In sport, concussion is assessed using the Sports Concussion Assessment Tool (SCAT) 5 and managed with return to play guidelines. Similar, user-friendly tools are rarely, if ever, used in the emergency department (ED). Objectives To evaluate a modified concussion assessment tool designed for the ED (ED-CAT) in patients presenting with a head injury and to identify variables that predict 30-day reattendance. Methods A preliminary, prospective, evaluation in a quality improvement project was conducted in one hospital in South Wales. Patients were recruited if they were over 13 years, and either did not have an ED-CT head scan or had a scan with no acute changes. The primary outcome was 30-day reattendance. Results 40 patients were recruited, 18 of whom had a CT scan. 37 were discharged on the same day with advice, two discharged the next day and one was admitted. Three (7.5%) patients reattended the department. Predictors of reattendance were headache score (median 3.0 vs 5.0; p<0.05), pressure in head score (2.0 vs 5.0; p<0.05), nausea/vomiting score (1.0 vs 3.0; p<0.05), dizziness score (1.0 vs 4.0; p<0.05), blurred vision score (0 vs 4.0; p<0.01), balance problems score (0 vs 4.0; p<0.05), sensitivity to light and confusion score (0 vs 4.0; p<0.01), orientation score (1. 0 vs 0; p<0.05) and immediate memory score (5.0 vs 4.0; p<0.05). Conclusions Key symptoms and signs predicted 30day reattendance. The ED-CAT requires validation and refinement in a larger population to produce a short, practical, user-friendly, relevant tool for ED head injury assessment.	[Mistry, Dylan A.] Cardiff Univ, Sch Med, Cardiff, Wales; [Rainer, Timothy H.] Cardiff Univ, Univ Hosp Wales, Sch Med, Div Populat Med, Cardiff, Wales		Rainer, TH (corresponding author), Cardiff Univ, Univ Hosp Wales, Sch Med, Div Populat Med, Cardiff, Wales.	thrainer@cuhk.edu.hk	Rainer, Timothy H/I-2591-2013	Rainer, Timothy H/0000-0003-3355-3237			Ahmed OH, 2017, PROG BRAIN RES, V234, P205, DOI 10.1016/bs.pbr.2017.06.014; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bergman K, 2016, J TRAUMA NURS, V23, P327, DOI 10.1097/JTN.0000000000000242; Boyle A, 2016, ROYAL COLL EMERGENCY; Buchanan K, 2011, ANN EMERG MED, V58, pS185, DOI 10.1016/j.annemergmed.2011.06.048; Duignan M, 2016, INT EMERG NURS, V26, P47, DOI 10.1016/j.ienj.2015.11.005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gioia G, 2006, ACUTE CONCUSSION EVA; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanninen T, 2017, J SCI MED SPORT; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Institute for Clinical Excellence, 2016, HEAD INJ BACKGR INF; National Institute of Clinical Excellence, 2014, HEAD INJ ASS EARL MA; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; The Concussion In Sport Group, 2017, SPORT CONC ASS TOOL; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Uy P, 2017, ARCH PHYS MED REHAB, V98, pe177	26	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000445	10.1136/bmjsem-2018-000445			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200131	30687512	Green Accepted, gold, Green Published			2022-02-06	
J	Wright, WG; Handy, JD; Avcu, P; Ortiz, A; Haran, FJ; Doria, M; Servatius, RJ				Wright, W. Geoffrey; Handy, Justin D.; Avcu, Pelin; Ortiz, Alejandro; Haran, F. Jay; Doria, Michael; Servatius, Richard J.			Healthy Active Duty Military with Lifetime Experience of Mild Traumatic Brain Injury Exhibits Subtle Deficits in Sensory Reactivity and Sensory Integration During Static Balance	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				CONDITIONED EYEBLINK RESPONSE; ACOUSTIC STARTLE RESPONSE; POST-CONCUSSIVE SYMPTOMS; ERROR SCORING SYSTEM; FACILITATED ACQUISITION; HIGH-SCHOOL; HABITUATION; DEPLOYMENT; RECOVERY; REFLEX	Postural control and stress reactivity were investigated in active duty coast guard personnel to determine whether they are sensitive to lifetime effects of mild traumatic brain injury (mTBI). A custom-designed and validated virtual reality-based computerized posturography device was used to assess postural stability, whereas emotional reactivity was assessed using the acoustic startle response (ASR), and neurocognitive performance was assessed using the defense-automated neurobehavioral assessment (DANA). It was hypothesized that residual and subtle postural control imbalance and deficits in cognitive and sensory reactivity would be evident in those reporting multiple lifetime mTBI. Active duty military personnel (N = 36; 7 females and 29 males) with no Deployment Limiting Medical Condition were recruited and tested on all assessments. Medical history information provided a history of head injury. Thirty-nine percent of participants reported having a previous mTBI (nine reporting one and five reporting more than one incident). No participant had experienced a head injury within the past year and all were symptom free. A significant effect of number of mTBI was found in the postural assessment (p = 0.002). Lifetime mTBI was associated with suppressed ASR magnitude (p = 0.03) but did not affect neurocognitive performance. The current findings provide new insight into ongoing controversies concerning sensitivity to functional deficits following mTBI and when the window for treatment or restoration ends.	[Wright, W. Geoffrey] Temple Univ, Coll Publ Hlth, Neuromotor Sci Program, 1800 N Broad St, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey; Handy, Justin D.; Ortiz, Alejandro; Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, 800 Irving Ave, Syracuse, NY USA; [Avcu, Pelin; Servatius, Richard J.] Rutgers State Univ, Rutgers Biomed Hlth Sci, Stress & Motivated Behav Inst, 65 Bergen St, Newark, NJ USA; [Haran, F. Jay] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Doria, Michael] US Coast Guard Headquarters, 2701 Martin Luther King Jr Ave SE, Washington, DC USA		Wright, WG (corresponding author), Temple Univ, Coll Publ Hlth, Neuromotor Sci Program, 1800 N Broad St, Philadelphia, PA 19122 USA.; Wright, WG (corresponding author), Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, 800 Irving Ave, Syracuse, NY USA.				Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [RIF127D23 W81XWH-13-C-0189]	This study was supported by a grant from the Congressionally Directed Medical Research Program (CDMRP) (RIF127D23 W81XWH-13-C-0189).	Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Beck KD, 2002, INTEGR PHYS BEH SCI, V37, P128, DOI 10.1007/BF02688825; Beck KD, 2008, PHYSIOL BEHAV, V93, P1019, DOI 10.1016/j.physbeh.2008.01.012; Beck KD, 2008, BEHAV PHARMACOL, V19, P821, DOI 10.1097/FBP.0b013e32831c3b82; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BLUMENTHAL TD, 1991, PSYCHOPHYSIOLOGY, V28, P296, DOI 10.1111/j.1469-8986.1991.tb02198.x; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; DAVIS M, 1970, J COMP PHYSIOL PSYCH, V72, P177, DOI 10.1037/h0029472; DAVIS M, 1974, J COMP PHYSIOL PSYCH, V87, P571, DOI 10.1037/h0036985; DAVIS M, 1969, J COMP PHYSIOL PSYCH, V67, P486, DOI 10.1037/h0027308; DECKER MW, 1995, NEUROBIOL LEARN MEM, V64, P156, DOI 10.1006/nlme.1995.1055; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2012, IEEE ENG MED BIO, P6141, DOI 10.1109/EMBC.2012.6347395; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Holloway JL, 2011, BEHAV BRAIN RES, V216, P301, DOI 10.1016/j.bbr.2010.08.008; Honaker JA, 2015, CLIN J SPORT MED, V25, P361, DOI 10.1097/JSM.0000000000000138; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; King EC, 2011, HUM MOVEMENT SCI, V30, P368, DOI 10.1016/j.humov.2010.07.005; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Larres DT, 2016, MIL MED, V181, P23, DOI 10.7205/MILMED-D-15-00152; LEATON RN, 1991, BEHAV NEUROSCI, V105, P804, DOI 10.1037/0735-7044.105.6.804; Lee YL, 1997, J NEUROSCI, V17, P6424; Lu J, 2004, METHOD ENZYMOL, V386, P200; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Neuner I, 2010, HUM BRAIN MAPP, V31, P1675, DOI 10.1002/hbm.20965; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Scheiman MM, 2016, OPTOMETRY VISION SCI, V94, P74; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Servatius RJ, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00015; SOKOLOV EN, 1990, PAVLOVIAN J BIOL SCI, V25, P142; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Timmann D, 1998, J NEUROL NEUROSUR PS, V65, P771, DOI 10.1136/jnnp.65.5.771; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Williams C, 2012, J CLIN EXP NEUROPSYC, V34, P948, DOI 10.1080/13803395.2012.703641; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196	68	3	3	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			313	320		10.1093/milmed/usx182			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600044	29635588	Bronze			2022-02-06	
J	Yumoto, T; Naito, H; Yorifuji, T; Maeyama, H; Kosakj, Y; Yamamoto, H; Tsukahara, K; Osako, T; Nakao, A				Yumoto, Tetsuya; Naito, Hiromichi; Yorifuji, Takashi; Maeyama, Hiroki; Kosakj, Yoshinori; Yamamoto, Hirotsugu; Tsukahara, Kohei; Osako, Takaaki; Nakao, Atsunori			Cushing's sign and severe traumatic brain injury in children after blunt trauma: a nationwide retrospective cohort study in Japan	BMJ OPEN			English	Article							CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; RESPIRATORY RATE; AGE; PREDICTORS; HYPERTENSION; ASSOCIATION; THRESHOLDS	Objective We tested whether Cushing's sign could predict severe traumatic brain injury (TBI) requiring immediate neurosurgical intervention (BI-NSI) in children after blunt trauma. Design Retrospective cohort study using Japan Trauma Data Bank. Setting Emergency and critical care centres in secondary and tertiary hospitals in Japan. Participants Children between the ages of 2 and 15 years with Glasgow Coma Scale motor scores of 5 or less at presentation after blunt trauma from 2004 to 2015 were included. A total of 1480 paediatric patients were analysed. Primary outcome measures Patients requiring neurosurgical intervention within 24 hours of hospital arrival and patients who died due to isolated severe TBI were defined as BI-NSI. The combination of systolic blood pressure (SBP) and heart rate (HR) on arrival, which were respectively divided into tertiles, and its correlation with BI-NSI were investigated using a multiple logistic regression model. Results In the study cohort, 297 (20.1 %) exhibited BINSI. After adjusting for sex, age category arid with or without haemorrhage shock, groups with higher SBP and lower HR (SBP >= 135 mm Hg; HR <= 92 hpm) were significantly associated with BI-NSI (OR 2.84, 95% Cl 1.68 to 4.80, P<0.001) compared with the patients with normal vital signs. In age-specific analysis, hypertension and bradycardia were significantly associated with BI-NSI in a group of 7-10 and 11-15 years of age; however, no significant association was observed in a group of 2-6 years of age. Conclusions Cushing's sign after blunt trauma was significantly associated with BI-NSI in school-age children and young adolescents.	[Yumoto, Tetsuya; Naito, Hiromichi; Kosakj, Yoshinori; Yamamoto, Hirotsugu; Tsukahara, Kohei; Osako, Takaaki; Nakao, Atsunori] Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama, Japan; [Yumoto, Tetsuya; Maeyama, Hiroki; Nakao, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency & Crit Care Med, Okayama, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama, Japan		Yumoto, T (corresponding author), Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama, Japan.; Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency & Crit Care Med, Okayama, Japan.	tyumoto@cc.okayama-u.ac.jp	Kosaki, Yoshinori/AAJ-2224-2020	Kosaki, Yoshinori/0000-0001-7160-1848; Naito, Hiromichi/0000-0002-7308-1716			Acker SN, 2015, PEDIATR SURG INT, V31, P1041, DOI 10.1007/s00383-015-3789-6; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Barmparas G, 2014, J TRAUMA ACUTE CARE, V77, P592, DOI 10.1097/TA.0000000000000382; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chong SL, 2015, INJURY, V46, P1270, DOI 10.1016/j.injury.2015.04.002; Dark P, 2002, RESUSCITATION, V54, P245, DOI 10.1016/S0300-9572(02)00154-5; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Goksu E, 2012, ULUS TRAVMA ACIL CER, V18, P231, DOI 10.5505/tjtes.2012.79059; Japan Trauma Care and Research, 2016, JAP TRAUM DAT BANK R; Kalmar AF, 2005, BRIT J ANAESTH, V94, P791, DOI 10.1093/bja/aei121; Kannan N, 2016, PEDIAT EMERG CARE, V1; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Loizou E, 2010, RESUSCITATION, V81, P418, DOI 10.1016/j.resuscitation.2009.12.017; Lovett PB, 2005, ANN EMERG MED, V45, P68, DOI 10.1016/j.annemergmed.2004.06.016; Mhanna MJ, 2015, J NEUROSURG-PEDIATR, V16, P508, DOI 10.3171/2014.10.PEDS14117; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Tohira H, 2012, INJURY, V43, P1924, DOI 10.1016/j.injury.2012.08.024; Urbina E. M, 2017, PEDIATRICS, V140; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Yumoto T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0341-1	36	3	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAR	2018	8	3							e020781	10.1136/bmjopen-2017-020781			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH7YZ	WOS:000433881200241	29502094	gold, Green Published			2022-02-06	
J	Zupan, MF; Bullinger, DL; Buffington, B; Koch, C; Parker, S; Fragleasso, S; Fogg, T; Rasmussen-Woerner, S				Zupan, Michael F.; Bullinger, Dyana L.; Buffington, Brenda; Koch, Caroline; Parker, Samantha; Fragleasso, Steve; Fogg, Taylor; Rasmussen-Woerner, Shay			Physiological Effects of Wearing Athletic Mouth Pieces While Performing Various Exercises	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				BITE-ALIGNING MOUTHPIECE; TRAINED MEN; MOUTHGUARDS; STRENGTH; PREVENTION; FOOTBALL; PLAYERS; GUARDS; POWER; CONCUSSIONS	The purpose of this study is to evaluate physiological responses associated with exercise using two different mouthpieces compared with not using a mouthpiece. Improved performance while using the PX3 Bite Regulator (PX3) may significantly reduce the risk of concussions by allowing an athlete to better prepare, react, absorb, and/or avoid impact completely compared with the restricted breathing or mandibular instability that occurs when using mouth-guards. Twenty-three subjects completed a battery of five physiological tests; the 1.5-mile run, sit and reach, anaerobic endurance, leg press, and bench press. Each test battery was completed under three conditions: wearing a PX3, wearing a mouthguard, or no mouthpiece respectfully. The PX3 resulted in significantly faster 1.5-mile run times (667.4 +/- 9.4 vs. 684.9 +/- 9.2 vs. 679 +/- 7.9 s, p <= 0.05) and significantly longer anaerobic endurance runs (311 +/- 23 vs. 283 +/- 18 vs. 286 +/- 18yds, p <= 0.05) compared with the mouthguard and no mouthpiece. The leg press lifts (51.8 +/- 4.1 vs. 46.0 +/- 4.3, p <= 0.05) while wearing the PX3 were significantly greater than when wearing a mouthguard. There were improvements, but no significant differences for sit and reach (16.8 +/- 0.8 vs. 15.9 +/- 0.8 vs. 16.4 +/- 0.8 in., p = 0.73) and bench press (17.7 +/- 1.8 vs. 17.2 +/- 1.6 vs. 17.2 +/- 1.7 lifts, p = 0.94). The increased performance with the PX3 could be a result of better jaw alignment and/or decreased resistance to airflow.	[Zupan, Michael F.; Bullinger, Dyana L.; Koch, Caroline; Parker, Samantha; Fragleasso, Steve; Fogg, Taylor; Rasmussen-Woerner, Shay] US Air Force Acad, Human Performance Lab, 2169 Fieldhouse Dr, Colorado Springs, CO 80840 USA; [Buffington, Brenda] Ohio State Univ, Hlth & Wellness Innovat Healthcare Coll Nursing, 1585 Neil Ave, Columbus, OH 43210 USA		Zupan, MF (corresponding author), US Air Force Acad, Human Performance Lab, 2169 Fieldhouse Dr, Colorado Springs, CO 80840 USA.						Allen CR, 2014, J STRENGTH COND RES, V28, P499, DOI 10.1519/JSC.0b013e3182a95250; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Busca B, 2016, J STRENGTH COND RES, V30, P1102, DOI 10.1519/JSC.0000000000001192; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Duddy FA, 2012, DENT TRAUMATOL, V28, P263, DOI 10.1111/j.1600-9657.2011.01106.x; Dunn-Lewis C, 2012, J STRENGTH COND RES, V26, P1085, DOI 10.1519/JSC.0b013e31824b4d5b; Gebauer DP, 2011, CLIN J SPORT MED, V21, P95, DOI 10.1097/JSM.0b013e31820428b0; Golem DL, 2015, J STRENGTH COND RES, V29, P500, DOI 10.1519/JSC.0000000000000641; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Kececi AD, 2005, DENT TRAUMATOL, V21, P276, DOI 10.1111/j.1600-9657.2005.00354.x; Liew AKC, 2014, DENT TRAUMATOL, V30, P461, DOI 10.1111/edt.12114; Malpezzi P, 2015, J STRENGTH COND RES, V29, P672, DOI 10.1519/JSC.0000000000000695; Morales J, 2015, HUM MOVEMENT SCI, V44, P270, DOI 10.1016/j.humov.2015.09.008; Rapisura KP, 2010, J STRENGTH COND RES, V24, P1263, DOI 10.1519/JSC.0b013e3181d1572d; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Queiroz AFVR, 2013, DENT TRAUMATOL, V29, P450, DOI 10.1111/edt.12026; von Arx T, 2008, INT J SPORTS MED, V29, P435, DOI 10.1055/s-2007-965341; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Zadik Y, 2010, MIL MED, V175, P1000, DOI 10.7205/MILMED-D-10-00150; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	3	3	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			510	515		10.1093/milmed/usx155			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600071	29635564	Bronze			2022-02-06	
J	Pasquesi, SA; Margulies, SS				Pasquesi, Stephanie A.; Margulies, Susan S.			Measurement and Finite element Model Validation of immature Porcine Brain-skull Displacement during rapid sagittal head rotations	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article							DIFFUSE AXONAL INJURY; BRIDGING VEINS; DEFORMATION; DIRECTION; RESPONSES; ACCELERATION; CONCUSSION; SEVERITY; RUPTURE; STRAIN	Computational models are valuable tools for studying tissue-level mechanisms of traumatic brain injury, but to produce more accurate estimates of tissue deformation, these models must be validated against experimental data. In this study, we present in situ measurements of brain-skull displacement in the neonatal piglet head (n = 3) at the sagittal midline during six rapid non-impact rotations (two rotations per specimen) with peak angular velocities averaging 51.7 +/- 1.4 rad/s. Marks on the sagittally cut brain and skull/rigid potting surfaces were tracked, and peak values of relative brain-skull displacement were extracted and found to be significantly less than values extracted from a previous axial plane model. In a finite element model of the sagittally transected neonatal porcine head, the brain-skull boundary condition was matched to the measured physical experiment data. Despite smaller sagittal plane displacements at the brain-skull boundary, the corresponding finite element boundary condition optimized for sagittal plane rotations is far less stiff than its axial counterpart, likely due to the prominent role of the boundary geometry in restricting interface movement. Finally, bridging veins were included in the finite element model. Varying the bridging vein mechanical behavior over a previously reported range had no influence on the brain-skull boundary displacements. This direction-specific sagittal plane boundary condition can be employed in finite element models of rapid sagittal head rotations.	[Pasquesi, Stephanie A.; Margulies, Susan S.] Univ Penn, Dept Bioengn, Injury Biomech Lab, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, Injury Biomech Lab, Philadelphia, PA 19104 USA.	susan.margulies@gatech.edu			American Heart AssociationAmerican Heart Association [12PRE12040315]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 HD078842, R01 NS039679]	The authors would like to thank Connor Bradfield and Jill Ralston for their assistance in experimental preparation and data collection. This study was sponsored by the American Heart Association (12PRE12040315) and the National Institutes of Health (R21 HD078842 and R01 NS039679). The contents of this article first appeared in the doctoral dissertation of Pasquesi (2016). Study sponsors had no role in study design, data collection, interpretation, manuscript writing, or submission.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Benson, 1977, HEAD IMPACT RESPONSE; Bradfield C, 2013, THESIS; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chunsheng Ma, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P1717; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Couper Z, 2010, P I MECH ENG H, V224, P1, DOI 10.1243/09544119JEIM587; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gennarelli T. A., 1987, STAPP CAR CRASH C; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HODGSON VR, 1966, J NEUROSURG, V25, P549, DOI 10.3171/jns.1966.25.5.0549; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Lossec G, 1998, EXP PHYSIOL, V83, P667, DOI 10.1113/expphysiol.1998.sp004148; Maltese M.R., 2012, THESIS; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Pasquesi S. A, 2016, THESIS; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Scott GG, 2015, IEEE T MED IMAGING, V34, P1452, DOI 10.1109/TMI.2015.2396527; Shatsky S. A, 1973, FLASH XRAY CINEMATOG; SHATSKY SA, 1974, J NEUROSURG, V41, P523, DOI 10.3171/jns.1974.41.5.0523; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Stephens JR, 2016, INT J ORAL MAX SURG, V45, P872, DOI 10.1016/j.ijom.2016.01.016; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	55	3	4	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	FEB 21	2018	6								16	10.3389/fbioe.2018.00016			14	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	GO7NE	WOS:000440253700001	29515995	gold, Green Published			2022-02-06	
J	Abrahams, TP; van Dooren, JC				Abrahams, Thomas P.; van Dooren, Joosje C.			Musical Attention Control Training (MACT) in secure residential youth care: A randomised controlled pilot study	ARTS IN PSYCHOTHERAPY			English	Article						Musical Attention Control Training; Music therapy; Attention deficits; Secure residential youth care; Motivation	TRAUMATIC BRAIN-INJURY; OPPOSITIONAL DEFIANT DISORDER; WORKING-MEMORY; THERAPY; ADOLESCENTS; CHILDREN; SKILLS; BEHAVIORS; EDUCATION	With 75% of the population in secure residential youth care diagnosed with attention-related problems, these individuals might benefit from Musical Attention Control Training (MACT). The purpose of this randomised controlled pilot study was to determine the feasibility and preliminary effects of MACT on attention outcomes for youth in secure residential care. Because of the generally low treatment motivation of this population, a non-standardised music therapy intervention (NSMT) with similar goals was included to determine if attendance and effects varied between a standardised and non-standardised intervention. Participants (n = 6) were randomly assigned to MACT, NSMT or a control group (TAU). Both MACT- and NSMT-participants followed a six-week program of once-a-week-music therapy sessions of 45 min. Outcomes in selective, focused, sustained and alternating attention were measured using the Trail Making Test A + B and the WISC-III Digit Span Forward and Backward, which were assessed at baseline and then at six and nine weeks. Results showed that both the interventions and the means of measurement were feasible in this population with an overall attendance rate of 97%. While attention outcomes varied with individual participants, the results demonstrate positive trends wherein more extensive research is necessary to further evaluate the effects. (C) 2017 Elsevier Ltd. All rights reserved.	[Abrahams, Thomas P.; van Dooren, Joosje C.] De Koppeling, Spirit Youth Care, Tafelbergweg 8, NL-1105 BC Amsterdam, Netherlands; [Abrahams, Thomas P.] Pluryn, Ind Weg 50, NL-6541 TW Nijmegen, Netherlands; [Abrahams, Thomas P.] ArtEZ Inst Arts, Van Essengaarde 10, NL-7511 PN Enschede, Netherlands		Abrahams, TP (corresponding author), ArtEZ Inst Arts, Van Essengaarde 10, NL-7511 PN Enschede, Netherlands.	T.Abrahams@ArtEZ.nl					Abrahams T. P., 2014, FACTSHEET VAKTHERAPI; American Psychiatric Association , 2014, HDB CLASS PSYCH STOO; Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1; Bittman Barry, 2009, Adv Mind Body Med, V24, P8; Bruscia K. E., 1987, IMPROVISATIONAL MODE; Bruscia K.E., 2014, DEFINING MUSIC THERA; Burt SA, 2001, J ABNORM PSYCHOL, V110, P516, DOI 10.1037/0021-843X.110.4.516; Centraal Bureau voor de Statistiek, 2017, JONG MET JEUGDZ PERS; Cogo-Moreira H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059984; Colins O, 2010, CAN J PSYCHIAT, V55, P255, DOI 10.1177/070674371005500409; Daykin N, 2013, HEALTH PROMOT INT, V28, P197, DOI 10.1093/heapro/das005; Dumont E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01694; Frick PJ, 2012, ANNU REV CLIN PSYCHO, V8, P77, DOI 10.1146/annurev-clinpsy-032511-143150; Groene R, 2001, J MUSIC THER, V38, P36, DOI 10.1093/jmt/38.1.36; Hakvoort L, 2015, INT J OFFENDER THER, V59, P810, DOI 10.1177/0306624X13516787; Jaschke AC, 2013, REV NEUROSCIENCE, V24, P665, DOI 10.1515/revneuro-2013-0023; Jeugdzorg Nederland, 2013, JEUGDZORGPLUS OMD HE; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kennedy H, 2014, ART PSYCHOTHER, V41, P21, DOI 10.1016/j.aip.2013.10.007; Khalil AK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00564; Kim J, 2008, J AUTISM DEV DISORD, V38, P1758, DOI 10.1007/s10803-008-0566-6; Klein R. M., 2011, COGNITIVE NEUROSCIEN; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kurstjens H., 2012, MUZIEKTHERAPIE JUSTI; Layman D., 2002, MUSIC THERAPY PERSPE, V20, P38, DOI [10.1093/mtp/20.1.38, DOI 10.1093/MTP/20.1.38]; Lee YS, 2007, LEARN INSTR, V17, P336, DOI 10.1016/j.learninstruc.2007.02.010; Maloy M., 2014, PSYCHOMUSICOLOGY, V24, P328, DOI [10.1037/pmu0000083, DOI 10.1037/PMU0000083]; Moreno S, 2015, CHILD DEV, V86, P394, DOI 10.1111/cdev.12297; Mueller C, 2013, THESIS; Nederlandse Instellingen voor Gesloten Jeugdzorg Ministerie van Jeugd & Gezin en Ministerie van Justitie, 2008, STREEFB JEUGDZ MEER; Nijhof K. S., 2011, THESIS; Nutley SB, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00926; Ouellet S., 2012, CANADIAN J MUSIC THE, V18, P79; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pasiali V, 2014, J MUSIC THER, V51, P333, DOI 10.1093/jmt/thu030; Pero S, 2006, BRAIN INJURY, V20, P1207, DOI 10.1080/02699050600983271; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Portowitz A, 2014, INT J MUSIC EDUC, V32, P242, DOI 10.1177/0255761413517056; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robb SL, 2003, J MUSIC THER, V40, P266, DOI 10.1093/jmt/40.4.266; Roden I, 2014, PSYCHOL MUSIC, V42, P284, DOI 10.1177/0305735612471239; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Schellenberg EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141449; Schellenberg EG, 2005, CURR DIR PSYCHOL SCI, V14, P317, DOI 10.1111/j.0963-7214.2005.00389.x; Schoorl J, 2018, CHILD PSYCHIAT HUM D, V49, P298, DOI 10.1007/s10578-017-0749-5; Schuijt M., 2015, FACTSHEET METHOD EVA; Schweinsburg Alecia D, 2008, Curr Drug Abuse Rev, V1, P99; Shuman J, 2016, ART PSYCHOTHER, V49, P50, DOI 10.1016/j.aip.2016.05.014; Smeijsters H., 2009, VAKTHERAPIE JUSTITIE; Strait DL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00113; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; Thaut MH., 2005, RHYTHM MUSIC BRAIN S; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Vermaes I., 2012, MONITOR JEUGDZORGPLU; Wang X, 2015, CONSCIOUS COGN, V36, P169, DOI 10.1016/j.concog.2015.06.014; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wigram T, 2006, CHILD CARE HLTH DEV, V32, P535, DOI 10.1111/j.1365-2214.2006.00615.x; Wilson S., 2013, BENEFITS MUSIC BRAIN; Wolfe, 2013, ABNORMAL CHILD PSYCH; Wolfe D. E., 2007, MUSIC THERAPY PAEDIA; Wolfe DE, 2009, J MUSIC THER, V46, P69, DOI 10.1093/jmt/46.1.69; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05854; Zuk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099868	63	3	3	2	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2018	57						80	87		10.1016/j.aip.2017.10.008			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GE3FN	WOS:000431099300012					2022-02-06	
J	Abu-Arafeh, A; Rodriguez, A; Paterson, RL; Andrews, PJD				Abu-Arafeh, Ahmad; Rodriguez, Aryelly; Paterson, Ross L.; Andrews, Peter J. D.			Temperature Variability in a Modern Targeted Temperature Management Trial	CRITICAL CARE MEDICINE			English	Article						temperature variability; Eurotherm3235 trial; therapeutic hypothermia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; HEAD-INJURY; DISABILITY	Objectives: The Eurotherm3235 trial showed that therapeutic hypothermia was deleterious in patients with raised intracranial pressure following traumatic brain injury. We sought to ascertain if increased temperature variability within the first 48 hours, or for 7 days post randomization, were modifiable risk factors associated with poorer outcome. Design: Eurotherm3235 was a multicenter randomized controlled trial. Patients were randomized to receive either therapeutic hypothermia in addition to standard care or the later only. Mean moving range (mr) was used to stratify subjects into tertiles by the variability present in their core temperature within the first 48 hours post randomization and within 7 days post randomization. The primary outcome measure was a collapsed Glasgow Outcome Scale-Extended at 6 months post randomization. The temperature variability effect was estimated with ordinal logistic regression adjusted for baseline covariates and treatment effect. Setting: Forty-seven critical care units in 18 countries. Patients: Patients enrolled in the Eurotherm3235 trial to either therapeutic hypothermia or control treatments only. Measurements and Main Results: Three hundred eighty-six patients were included in our study. High level of temperature variability during the first 48 hours was associated with poorer collapsed Glasgow Outcome Scale-Extended. This effect remained statistically significant when only the control arm of the study was analyzed. No statistically significant effect was seen within the first 48 hours in the hypothermia group or within 7 days in either group. Conclusions: When targeting normothermia, temperature variability may be a statistically significant variable in an ordinal analysis adjusted for baseline covariates.	[Abu-Arafeh, Ahmad; Paterson, Ross L.] Lothian Univ Hosp Trust, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rodriguez, Aryelly] Univ Edinburgh, Sch Med, Usher Inst Populat Hlth Sci & Informat, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland		Andrews, PJD (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	p.andrews@ed.ac.uk			University of Edinburgh; NHS Lothian; National Institute for Health Research Health Technology Assessment; National Institute for Health ResearchNational Institute for Health Research (NIHR) [11/01/30] Funding Source: researchfish	Supported, in part, by The University of Edinburgh and NHS Lothian.; Dr. Rodriguez's institution received funding from the National Institute for Health Research Health Technology Assessment, and she received funding from the University of Edinburgh. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andrews PJD, 2017, CRIT CARE MED, V45, P883, DOI 10.1097/CCM.0000000000002376; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Glover GW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1552-6; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Holzer M, 2002, NEW ENGL J MED, V346, P549; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kirkman MA, 2016, CURR ANESTHESIOL REP, V6, P214; Kochanek PM, 2017, CRIT CARE MED, V45, P305, DOI 10.1097/CCM.0000000000002182; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Merchant RM, 2006, CRIT CARE MED, V34, pS490, DOI 10.1097/01.CCM.0000246016.28679.36; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Shewhart W., 1931, EC CONTROL QUALITY M; SYDENHAM E, 2009, COCHRANE DATABASE SY; Topjian A, 2001, PEDIATR CRIT CARE ME, V12, P127; von Neumann J, 1941, ANN MATH STAT, V12, P153, DOI 10.1214/aoms/1177731746; Weinert D, 2010, AGEING RES REV, V9, P51, DOI 10.1016/j.arr.2009.07.003; White BC, 1996, ANN EMERG MED, V27, P588, DOI 10.1016/S0196-0644(96)70161-0; Yang D, 2009, FEBS LETT, V583, P2500, DOI 10.1016/j.febslet.2009.07.006	30	3	3	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2018	46	2					223	228		10.1097/CCM.0000000000002832			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX3LT	WOS:000425974200039	29135501				2022-02-06	
J	Cohn, EC; Robertson, TS; Scott, SA; Finley, AM; Huang, R; Miles, DK				Cohn, Ellen C.; Robertson, Tammy S.; Scott, Stacey A.; Finley, Andre M.; Huang, Rong; Miles, Darryl K.			Extubation Failure and Tracheostomy Placement in Children with Acute Neurocritical Illness	NEUROCRITICAL CARE			English	Article						Pediatric intensive care units; Respiration; artificial; Brain injuries; Neurologic disorders; Airway extubation; Child; Tracheostomy; Risk factors	PEDIATRIC INTENSIVE-CARE; VENTILATOR-ASSOCIATED PNEUMONIA; TRAUMATIC BRAIN-INJURY; MECHANICAL VENTILATION; RISK-FACTORS; PREDICTORS; INFANTS; OUTCOMES; UNIT	There is a lack of data describing the risk factors for extubation failure (EF) or tracheostomy placement in pediatric neurocritical care (NCC) patients. A retrospective chart review of children admitted to the pediatric intensive care unit who were intubated for > 24 h with an acute neurocritical illness and had an extubation attempt. Bivariate and multivariate statistical analysis was performed to determine significant associations of demographic, neurologic, pulmonary, and clinical variables with EF and tracheostomy placement. Analysis of predictive factors for EF (within 48 h) and tracheostomy placement during the hospitalization was conducted on a first extubation attempt group (n = 193) and a second attempt group (n = 23) who experienced either EF or a "late re-intubation" (> 48 h-7 days). Traumatic brain injury (37.3%) and seizures/status epilepticus (31.4%) were the most common diagnoses with neuromuscular weakness patients having the highest risk for EF and tracheostomy placement. EF occurred in 20/193 (10.4%) patients after their first attempt and 6/23 (26.1%) after a second attempt. Compared to those with a fair/strong cough, patients with a weak/absent cough had a relative risk (RR) of 9.4 for EF (95% CI, 4.9-17.9, p < 0.001) and 6.7 (95% CI, 2.3-18.9, p = 0.01) for tracheostomy placement on the first and second attempts, respectively. Glasgow Coma Score (GCS), endotracheal tube (ETT) secretion characteristics, and pulmonary variables were not associated with EF or tracheostomy placement. A weak/absent cough reflex is associated with an increased risk of failing extubation and placement of a tracheostomy in intubated pediatric NCC patients.	[Cohn, Ellen C.] Childrens Hlth Childrens Med Ctr Dallas, Dept Clin Res, 1935 Med Dist Dr, Dallas, TX 75235 USA; [Robertson, Tammy S.; Scott, Stacey A.] Childrens Hlth Childrens Med Ctr Dallas, Dept Adv Practice Serv, Crit Care Serv, 1935 Med Dist Dr, Dallas, TX 75235 USA; [Finley, Andre M.] Childrens Hlth Childrens Med Ctr Dallas, Dept Resp Care, 1935 Med Dist Dr, Dallas, TX 75235 USA; [Huang, Rong] Childrens Hlth Childrens Med Ctr Dallas, Dept Clin Res, 1935 Med Dist Dr, Dallas, TX 75235 USA; [Miles, Darryl K.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		Miles, DK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eccohn@wustl.edu; tammy.robertson@childrens.com; stacey.scott@childrens.com; andre.finley@childrens.com; rong.huang@childrens.com; darryl.miles@utsouthwestern.edu					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Anderson CD, 2011, NEUROCRIT CARE, V15, P490, DOI 10.1007/s12028-010-9369-7; Baumeister BL, 1997, PEDIATR PULM, V24, P344, DOI 10.1002/(SICI)1099-0496(199711)24:5<344::AID-PPUL7>3.0.CO;2-I; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Cirulis MM, 2016, PEDIATR CRIT CARE ME, V17, P157, DOI 10.1097/PCC.0000000000000590; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Curley MAQ, 2006, PEDIATR CRIT CARE ME, V7, P107, DOI 10.1097/01.PCC.0000200955.40962.38; Edmunds S, 2001, CHEST, V119, P897, DOI 10.1378/chest.119.3.897; Elward AM, 2002, PEDIATRICS, V109, P758, DOI 10.1542/peds.109.5.758; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Farias JA, 2002, INTENS CARE MED, V28, P752, DOI 10.1007/s00134-002-1306-6; Farias JA, 2001, INTENS CARE MED, V27, P1649, DOI 10.1007/s001340101035; Harel Y, 1997, INT J PEDIATR OTORHI, V39, P147, DOI 10.1016/S0165-5876(97)01488-2; Holscher CM, 2014, J PEDIATR SURG, V49, P590, DOI 10.1016/j.jpedsurg.2013.09.002; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Khamiees M, 2001, CHEST, V120, P1262, DOI 10.1378/chest.120.4.1262; King CS, 2010, RESP CARE, V55, P56; Ko R, 2009, NEUROCRIT CARE, V10, P269, DOI 10.1007/s12028-008-9181-9; Kurachek SC, 2003, CRIT CARE MED, V31, P2657, DOI 10.1097/01.CCM.0000094228.90557.85; Manczur T I, 2000, Pediatr Crit Care Med, V1, P28, DOI 10.1097/00130478-200007000-00005; Monteverde E, 2011, PEDIATR CRIT CARE ME, V12, pE287, DOI 10.1097/PCC.0b013e3182191c0b; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Newth CJL, 2009, PEDIATR CRIT CARE ME, V10, P1, DOI 10.1097/PCC.0b013e318193724d; Ortega HW, 2015, J TRAUMA ACUTE CARE, V78, P1149, DOI 10.1097/TA.0000000000000661; Principi T, 2011, PEDIATR PULM, V46, P452, DOI 10.1002/ppul.21389; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; RIVERA R, 1992, CRIT CARE MED, V20, P193, DOI 10.1097/00003246-199202000-00008; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	30	3	3	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2018	28	1					83	92		10.1007/s12028-017-0429-0			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FW9BQ	WOS:000425631100012	28744846				2022-02-06	
J	Duric, V; Batinic, B; Petrovic, J; Stanic, D; Bulat, Z; Pesic, V				Duric, Vedrana; Batinic, Bojan; Petrovic, Jelena; Stanic, Dusanka; Bulat, Zorica; Pesic, Vesna			A single dose of magnesium, as well as chronic administration, enhances long-term memory in novel object recognition test, in healthy and ACTH-treated rats	MAGNESIUM RESEARCH			English	Article						magnesium; memory; novel object recognition test; ACTH	ALZHEIMERS-DISEASE; BRAIN MAGNESIUM; NMDA RECEPTORS; MODEL; RETRIEVAL; PREVENTS; DEFICITS; STRESS; HUMANS; INJURY	Although a magnesium-mediated attenuation of memory deficits was reported in animal models of ageing and traumatic brain injury, a possible memory enhancement in healthy subjects has not been investigated yet. We used novel object recognition test (NORT) to examine the effects of acute (30 mg/kg) and chronic (50 mg/kg, 28 days) Mg-sulfate treatment on the long-term memory (LTM) in healthy adult male rats, and to test the sustainability of magnesium effects in the models of acute and chronic (21 days) ACTH administration (10 mu g/animal), mimicking the stress- and depression-like conditions. A single dose of Mg-sulfate enhanced the LTM retrieval in the 24 h inter-trial NORT protocol, in healthy, as well as in rats acutely treated with ACTH. Memory enhancement was also detected after 4-week long Mg-sulfate intake, in both healthy and rats chronically treated with ACTH. While the present findings on procognitive effects of chronic Mg-sulfate treatment corroborate with those from studies on the therapeutic potential of Mg-threonate, the current study is the first to report on memory enhancement induced by a single dose of magnesium.	[Duric, Vedrana; Batinic, Bojan; Petrovic, Jelena; Stanic, Dusanka; Pesic, Vesna] Univ Belgrade, Fac Pharm, Dept Physiol, VojvodeStepe 450, Belgrade 11121, Serbia; [Bulat, Zorica] Univ Belgrade, Fac Pharm, Akad Danilo Soldatovic, Dept Toxicol, Belgrade, Serbia		Batinic, B (corresponding author), Univ Belgrade, Fac Pharm, Dept Physiol, VojvodeStepe 450, Belgrade 11121, Serbia.	bojanb@pharmacy.bg.ac.rs		Bulat, Zorica/0000-0001-9830-8772; Batinic, Bojan/0000-0001-9786-2560; Petrovic, Jelena/0000-0002-1821-1362	Ministry of Education, Science and Technological Development, R. Serbia [175036]	support was provided by the Ministry of Education, Science and Technological Development, R. Serbia - Grant No. 175036.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Billard JM, 2006, MAGNESIUM RES, V19, P199; Browne KD, 2004, J NEUROSCI RES, V77, P878, DOI 10.1002/jnr.20215; Chui D, 2011, MAGNESIUM CENTRAL NE, V18, P239; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; GAMALLO A, 1992, PHYSIOL BEHAV, V51, P1201, DOI 10.1016/0031-9384(92)90309-P; GAMALLO A, 1988, HORM METAB RES, V20, P336, DOI 10.1055/s-2007-1010830; HALLAK M, 1994, J SOC GYNECOL INVEST, V1, P25, DOI 10.1177/107155769400100106; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; Held K, 2002, PHARMACOPSYCHIATRY, V35, P135, DOI 10.1055/s-2002-33195; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Kitamura Y, 2002, PHARMACOL BIOCHEM BE, V71, P63, DOI 10.1016/S0091-3057(01)00625-6; Kramer JH, 1997, J MOL CELL CARDIOL, V29, P97, DOI 10.1006/jmcc.1996.0255; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02101-8; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; RUPPERSBERG JP, 1994, SEMIN NEUROSCI, V6, P87; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Siswanto H, 2008, IN VIVO, V22, P435; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Vargas-Caballero M, 2004, J NEUROSCI, V24, P6171, DOI 10.1523/JNEUROSCI.1380-04.2004; Vink R, 2016, MAGNESIUM RES, V29, P95, DOI 10.1684/mrh.2016.0408; Walker AJ, 2015, BEHAV BRAIN RES, V293, P198, DOI 10.1016/j.bbr.2015.07.026; Wang J, 2013, PAIN PHYSICIAN, V16, pE563; Zhang Y, 2016, NEUROL SCI, V37, P1039, DOI 10.1007/s10072-016-2546-5	27	3	3	1	3	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	FEB-MAR	2018	31	1					24	32		10.1684/mrh.2018.0435			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GP8HY	WOS:000441152400003	29991463				2022-02-06	
J	Hewitt, J; Marke, M; Honeyman, C; Huf, S; Lai, AD; Dong, A; Wright, T; Blake, S; Fallaize, R; Hughes, JL; Pearce, L; McCarthy, K				Hewitt, Jonathan; Marke, Margaret; Honeyman, Calum; Huf, Simon; Lai, Aida; Dong, Anni; Wright, Tom; Blake, Sarah; Fallaize, Rebecca; Hughes, Jane L.; Pearce, Lyndsay; McCarthy, Kathryn			Cognitive impairment in older patients undergoing colorectal surgery	SCOTTISH MEDICAL JOURNAL			English	Article						Older people; surgery; cognitive impairment; Montreal Cognitive Assessment	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE DELIRIUM; ASSESSMENT MOCA; VALIDATION; VALIDITY	Background: With increasing numbers of older people being referred for elective colorectal surgery, cognitive impairment is likely to be present and affect many aspects of the surgical pathway. This study is aimed to determine the prevalence of cognitive impairment and assess it against surgical outcomes. Methods: The Montreal Cognitive Assessment (MoCA) was carried out in patients aged more than 65 years. We recorded demographic information. Data were collected on length of hospital stay, complications and 30-day mortality. Results: There were 101 patients assessed, median age was 74 years (interquartile range = 68-80), 54 (53.5%) were women. In total, 58 people (57.4%) 'failed' the Montreal Cognitive Assessment test (score <= 25). There were two deaths (3.4%) within 30 days of surgery in the abnormal Montreal Cognitive Assessment group and none in the normal group. Twenty-nine (28.7%) people experienced a complication. The percentage of patients with complications was higher in the group with normal Montreal Cognitive Assessment (41.9%) than abnormal Montreal Cognitive Assessment (19.9%) (p = 0.01) and the severity of those complications were greater (chi-squared for trend p = 0.01). The length of stay was longer in people with an abnormal Montreal Cognitive Assessment (mean 8.1 days vs. 5.8 days, p = 0.03). Conclusion: Cognitive impairment was common, which has implications for informed consent. Cognitive impairment was associated with less postoperative complications but a longer length of hospital stay.	[Hewitt, Jonathan] Cardiff Univ, Univ Hosp Wales, Div Populat Med, Cardiff, S Glam, Wales; [Marke, Margaret; Honeyman, Calum; Huf, Simon; Lai, Aida; Dong, Anni; Wright, Tom; Blake, Sarah; Fallaize, Rebecca; McCarthy, Kathryn] North Bristol NHS Trust, Bristol, Avon, England; [Hughes, Jane L.; Pearce, Lyndsay] Cent Manchester NHS Trust, Manchester, Lancs, England		Hewitt, J (corresponding author), Cardiff Univ, Univ Hosp Wales, Div Populat Med, Cardiff, S Glam, Wales.	hewittj2@cardiff.ac.uk	HEWITT, JONATHAN/AAC-9713-2019	HEWITT, JONATHAN/0000-0002-7924-1792			Boos Gustavo Luchi, 2005, Rev. Bras. Anestesiol., V55, P517, DOI 10.1590/S0034-70942005000500006; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Evered LA, 2011, ANESTHESIOLOGY, V114, P1297, DOI 10.1097/ALN.0b013e31821b1aab; Fong TG, 2015, LANCET NEUROL, V14, P823, DOI 10.1016/S1474-4422(15)00101-5; George J, 2006, ANN PHARMACOTHER, V40, P645, DOI 10.1345/aph.1G204; Hadjistavropoulos T, 2007, CLIN J PAIN, V23, pS1, DOI 10.1097/AJP.0b013e31802be869; Hars M, 2014, AGE AGEING, V43, P196, DOI 10.1093/ageing/aft163; Hewitt J, 2014, INT J SURG, V12, P1031, DOI 10.1016/j.ijsu.2014.07.020; Kline RP, 2012, ANESTHESIOLOGY, V116, P603, DOI 10.1097/ALN.0b013e318246ec0b; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newman JC, 2011, NEW ENGL J MED, V365, P2447, DOI 10.1056/NEJMp1110652; NICHONCHUBHAIR A, 1995, BRIT J ANAESTH, V75, P481, DOI 10.1093/bja/75.4.481; Partridge JSL, 2012, AGE AGEING, V41, P142, DOI 10.1093/ageing/afr182; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538; Sasajima Y, 2012, EUR J VASC ENDOVASC, V44, P411, DOI 10.1016/j.ejvs.2012.06.028; Sweet L, 2011, INT PSYCHOGERIATR, V23, P1582, DOI 10.1017/S1041610211001451; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Zhao JH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-607	23	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0036-9330	2045-6441		SCOT MED J	Scott. Med. J.	FEB	2018	63	1					11	15		10.1177/0036933017750988			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM9YF	WOS:000438611900003	29471735	Green Accepted			2022-02-06	
J	Hives, F; Karyadi, KA; Nitch, S; Kinney, D				Hives, Frederick, II; Karyadi, Kenny A.; Nitch, Steve; Kinney, Dominique			Locked in and Growing Old: The Psychiatric, Forensic, and Cognitive Correlates of 30 Years of Psychiatric Hospitalization	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Geriatric; schizophrenia; institutionalization; medication; violence; cognition	LATE-LIFE SCHIZOPHRENIA; TERM ANTIPSYCHOTIC TREATMENT; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL STATUS; REPEATABLE BATTERY; 1ST-EPISODE SCHIZOPHRENIA; BIPOLAR DISORDER; RISK-FACTORS; FUNCTIONAL-CAPACITY; ALZHEIMERS-DISEASE	Objective: As the number of older adults in the United States continues to grow, the population of older adults with severe mental illness in institutional settings (OASIS) is expected to place a significant demand on healthcare resources. This study presents an update to research regarding the clinical characteristics of OASIS inpatients with histories of extensive hospitalization through the use of a newly developed psychiatric measure: the Clinician-Rated Dimension of Psychosis Symptom Severity. Methods: We investigated an OASIS sample (N = 55) with an average of nearly 30 continuous years of hospitalization at a forensic state psychiatric hospital. Results: The average OASIS patient exhibited the most prominent psychiatric symptoms via delusions and negative symptoms, received psychotropic medications at substantially higher doses than recommended therapeutic levels, rarely committed acts of institutional violence (IV), and performed more than two standard deviations below the normative mean on cognitive testing. More severe hallucination symptoms were associated with higher psychotropic medication dosage, and more severe depressive symptoms were associated with more IV incidents. OASIS inpatients performed moderately worse than general psychiatric inpatients in the areas of overall cognition, immediate memory, and delayed memory; older age was associated with poorer language and attention. No psychiatric or cognitive factors predicted IV incidents. Conclusion: These results highlight the continued importance of understanding the psychiatric, forensic, and cognitive factors associated with aging in an institutional setting and how these factors among OASIS inpatients may vary from general psychiatric inpatients.	[Hives, Frederick, II] Kaiser Permanente, Adult Psychiat Dept, Fresno, CA USA; [Karyadi, Kenny A.; Nitch, Steve; Kinney, Dominique] Patton State Hosp, Neuropsychol Consultat Serv, Patton, CA USA		Hives, F (corresponding author), Kaiser Permanente, 4785 N First St, Fresno, CA 93720 USA.	frederick.hives-ii@kp.org					Addington J, 2002, J PSYCHIATR NEUROSCI, V27, P188; Almvik R, 2006, INT J GERIATR PSYCH, V21, P368, DOI 10.1002/gps.1474; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; ARNOLD SE, 1995, AM J PSYCHIAT, V152, P731; Arranz B, 2004, J CLIN PSYCHIAT, V65, P1335, DOI 10.4088/JCP.v65n1007; Bader SM, 2015, INT J FORENSIC MENT, V14, P110, DOI 10.1080/14999013.2015.1045633; Bailie JM, 2012, APPL NEUROPSYCH-ADUL, V19, P279, DOI 10.1080/09084282.2012.670146; Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Baune BT, 2010, PSYCHIAT RES, V176, P183, DOI 10.1016/j.psychres.2008.12.001; BIGELOW DA, 1988, HOSP COMMUNITY PSYCH, V39, P181; Bowie Christopher R, 2006, Neuropsychiatr Dis Treat, V2, P531, DOI 10.2147/nedt.2006.2.4.531; Bulgari V, 2017, SCHIZOPHR RES, V181, P124, DOI 10.1016/j.schres.2016.10.016; Cheng JE, 2016, COMMUNITY MENT HLT J, V52, P658, DOI 10.1007/s10597-015-9912-2; Citrome L, 2000, PSYCHIAT ANN, V30, P41, DOI 10.3928/0048-5713-20000101-11; Cohen CI, 2000, AM J GERIAT PSYCHIAT, V8, P19, DOI 10.1097/00019442-200002000-00003; Colby S.L., 2014, PROJECTIONS SIZE COM, pP25; Crocker AG, 2005, CRIM JUSTICE BEHAV, V32, P452, DOI 10.1177/0093854805276407; Danivas V, 2013, INDIAN J PSYCHIAT, V55, P207, DOI 10.4103/0019-5545.111475; Davidson M, 1996, AM J PSYCHIAT, V153, P1274; DAVIDSON M, 1995, AM J PSYCHIAT, V152, P197; Dickerson F, 2004, PSYCHIAT RES, V129, P45, DOI 10.1016/j.psychres.2004.07.002; Fazel S, 2009, J CLIN PSYCHIAT, V70, P362, DOI 10.4088/JCP.08m04274; Flannery RB, 1996, PSYCHIAT QUART, V67, P47, DOI 10.1007/BF02244274; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Fuller R, 2002, AM J PSYCHIAT, V159, P1183, DOI 10.1176/appi.ajp.159.7.1183; Gold JM, 2009, NEUROPSYCHOL REV, V19, P294, DOI 10.1007/s11065-009-9098-x; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2013, COGNITIVE IMPAIRMENT, P85; Harris ST, 2014, AGGRESS VIOLENT BEH, V19, P235, DOI 10.1016/j.avb.2014.04.009; HARVEY PD, 1993, SCHIZOPHRENIA BULL, V19, P723, DOI 10.1093/schbul/19.4.723; Harvey PD, 1997, AM J PSYCHIAT, V154, P205; Harvey PD, 1999, SCHIZOPHR RES, V35, P77, DOI 10.1016/S0920-9964(98)00109-1; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080; Harvey PD, 1999, BIOL PSYCHIAT, V45, P32, DOI 10.1016/S0006-3223(98)00273-X; Harvey PD, 2012, AM J GERIAT PSYCHIAT, V20, P1, DOI 10.1097/JGP.0b013e31823bbf93; Harvey PD, 2010, BIOL PSYCHIAT, V67, P933, DOI 10.1016/j.biopsych.2010.01.008; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; Hodgins S, 2003, BEHAV SCI LAW, V21, P523, DOI 10.1002/bsl.540; Howard RJ, 2010, AM J GERIAT PSYCHIAT, V18, P859, DOI 10.1097/JGP.0b013e3181ef78eb; Hung, 2007, HONG KONG J PSYCHIAT, V17, P87; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P31, DOI 10.1080/09084280802644128; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; KATZ P, 1990, PSYCHIATRY, V53, P262; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Koro CE, 2002, BMJ-BRIT MED J, V325, P243, DOI 10.1136/bmj.325.7358.243; Krakowski MI, 2016, SCHIZOPHRENIA BULL, V42, P963, DOI 10.1093/schbul/sbw005; Leifker FR, 2009, SCHIZOPHR RES, V115, P82, DOI 10.1016/j.schres.2009.09.004; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Mosiolek A, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0749-1; National Research Council, 2014, GROWTH INC US EXPL C; Naudts K, 2006, SCHIZOPHRENIA BULL, V32, P562, DOI 10.1093/schbul/sbj036; Nielssen O, 2010, SCHIZOPHRENIA BULL, V36, P702, DOI 10.1093/schbul/sbn144; O'Callaghan C. E., 2010, ADV PSYCHIAT TREATME, V16, P339, DOI DOI 10.1192/APT.BP.108.006288; Owen PAW, 1999, DRUG AGING, V15, P81; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Preston J, 2017, HDB CLIN PSYCHOPHARM; Preston JD, 2014, CLIN PSYCHOPHARMACOL; Preston JD, 2009, CONSUMERS GUIDE PSYC; PUROHIT DP, 1993, BIOL PSYCHIAT, V33, P255, DOI 10.1016/0006-3223(93)90291-K; Randolph C., 1998, REPEATABLE BATTERY A; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Sergi MJ, 2006, AM J PSYCHIAT, V163, P448, DOI 10.1176/appi.ajp.163.3.448; Soliman AED, 2001, PSYCHIATR SERV, V52, P75, DOI 10.1176/appi.ps.52.1.75; Sommer IEC, 2012, SCHIZOPHRENIA BULL, V38, P704, DOI 10.1093/schbul/sbs034; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Taylor D, 2009, MAUDSLEY PRESCRIBING, V10th; Unutzer J, 2009, J AM GERIATR SOC, V57, P506, DOI 10.1111/j.1532-5415.2008.02134.x; Vahia I., 2007, AGING HLTH, V3, P383, DOI DOI 10.2217/1745509X.3.3.383; Volavka J, 2013, PSYCHIAT DANUB, V25, P24; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776; Witt K, 2014, SCHIZOPHR RES, V154, P61, DOI 10.1016/j.schres.2014.02.001; Witt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055942; Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58; Zhao YJ, 2016, BJPSYCH OPEN, V2, P59, DOI 10.1192/bjpo.bp.115.002576	78	3	3	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	FEB	2018	26	2					188	197		10.1016/j.jagp.2017.10.003			10	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	FW4XW	WOS:000425320200010	29122420				2022-02-06	
J	Jang, SH; Kim, SH; Lee, DH				Jang, Sung Ho; Kim, Seong Ho; Lee, Han Do			Akinetic mutism following prefrontal injury by an electrical grinder a case report A diffusion tensor tractography study	MEDICINE			English	Article						caudate nucleus; diffusion tensor imaging; Glasgow Coma Scale; stroke	FRONTAL-SUBCORTICAL CIRCUITS; TRAUMATIC BRAIN-INJURY; CONNECTIONS; PATIENT; CORTEX	Rationale: A 72-year-old male had suffered from head trauma resulting from injury to his frontal area by an electrical grinder while working at his home. Patient concerns: He lost consciousness for approximately 10 minutes and experienced continuous post-traumatic amnesia. Diagnoses: He was diagnosed as traumatic intracerebral hemorrhage in both frontal lobes, intraventricular hemorrhage, and subarachnoid hemorrhage, and underwent decompressive craniectomy and hematoma removal. Interventions: The patient's Glasgow Coma Scale score was 5. At 2 months after onset, when starting rehabilitation, he showed no spontaneous movement or speech; he remained in a lying position all day with no spontaneous activity. Outcomes: On 2-month diffusion tensor tractography, decreased neural connectivity of the caudate nucleus to the medial prefrontal cortex (PFC, Broadmann area [BA]: 10 and 12) and orbitofrontal cortex (BA 11 and 13) was observed in both hemispheres. Lessons: Akinetic mutism following prefrontal injury.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu, South Korea		Lee, DH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	lhd890221@hanmail.net			Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Fuster JM, 2008, HUMAN NEUROPSYCHOLOG; Jang SH, 2017, BRAIN INJURY, V31, P1548, DOI 10.1080/02699052.2017.1376761; Jang SH, 2017, BRAIN INJURY, V31, P1159, DOI 10.1080/02699052.2017.1288265; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005009; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; Kito S, 2009, EUR PSYCHIAT, V24, P269, DOI 10.1016/j.eurpsy.2008.12.012; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mega MS, 1997, NEUROPSY NEUROPSY BE, V10, P254; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Nagaratnam N, 2004, J CLIN NEUROSCI, V11, P25, DOI 10.1016/j.jocn.2003.04.002; Psarros T, 2003, J NEUROSURG, V99, P397, DOI 10.3171/jns.2003.99.2.0397	15	3	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2018	97	6							e9845	10.1097/MD.0000000000009845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA8GI	WOS:000428576300035	29419694	gold, Green Published			2022-02-06	
J	Kosaki, Y; Yumoto, T; Naito, H; Tsuboi, N; Kameda, M; Hirano, M; Morizane, Y; Senoo, T; Tokuyama, E; Nakao, A				Kosaki, Yoshinori; Yumoto, Tetsuya; Naito, Hiromichi; Tsuboi, Nobushige; Kameda, Masahiro; Hirano, Masayuki; Morizane, Yuki; Senoo, Takaya; Tokuyama, Eijirou; Nakao, Atsunori			Traumatic Globe Luxation with Complete Optic Nerve Transection Caused by Heavy Object Compression	ACTA MEDICA OKAYAMA			English	Article						globe luxation; optic nerve avulsion; traumatic brain injury; facial trauma	EYE	Traumatic eyeball luxation is a rare clinical condition with a dramatic presentation. Here, we describe a unique case of traumatic globe luxation and complete optic nerve transection caused by heavy object compression. A 45-year-old male automobile mechanic was injured when a truck slipped from its supports, crushing his head and face. On arrival, his right eyeball was obviously displaced anteriorly and he had no light perception. Computed tomography revealed complex frontal bone and facial fractures with underlying brain contusion in addition to complete transection of the right optic nerve. The patient was successfully treated using a multidisciplinary approach.	[Kosaki, Yoshinori; Yumoto, Tetsuya; Naito, Hiromichi; Nakao, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama 7008558, Japan; [Tsuboi, Nobushige; Kameda, Masahiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Okayama 7008558, Japan; [Hirano, Masayuki; Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama 7008558, Japan; [Senoo, Takaya; Tokuyama, Eijirou] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Plast & Reconstruct Surg, Okayama 7008558, Japan		Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, Okayama 7008558, Japan.	tyumoto@cc.okayama-u.ac.jp	Kosaki, Yoshinori/AAJ-2224-2020	Kosaki, Yoshinori/0000-0001-7160-1848; Naito, Hiromichi/0000-0002-7308-1716			Amaral MBF, 2015, J MAXILLOFAC ORAL SU, V14, pS323, DOI 10.1007/s12663-013-0539-y; Kiratli H, 1999, ACTA OPHTHALMOL SCAN, V77, P340, DOI 10.1034/j.1600-0420.1999.770319.x; Kumar MA, 2012, INDIAN J OPHTHALMOL, V60, P324, DOI 10.4103/0301-4738.98720; Kumari E, 2015, INDIAN J OPHTHALMOL, V63, P682, DOI 10.4103/0301-4738.169795; Lelli GJ, 2007, OPHTHAL PLAST RECONS, V23, P158, DOI 10.1097/IOP.0b013e31803045b4; Morris WR, 2002, OPHTHAL PLAST RECONS, V18, P261, DOI 10.1097/00002341-200207000-00006; Osman EA, 2014, INDIAN J OPHTHALMOL, V62, P812, DOI 10.4103/0301-4738.138626; Tok L, 2014, CASE REP OPHTHALM, V5, P429, DOI 10.1159/000370043	8	3	3	0	1	OKAYAMA UNIV MED SCHOOL	OKAYAMA	EDITORIAL OFFICE, ACTA MEDICA OKAYAMA OKAYAMA UNIVERSITY MEDICAL SCHOOL 2-5-1 SHIKATA-CHO, KITA-KU, OKAYAMA, 700-8558, JAPAN	0386-300X			ACTA MED OKAYAMA	Acta Med. Okayama	FEB	2018	72	1					85	88					4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FY1AA	WOS:000426542800014	29463945				2022-02-06	
J	Lovett, ME; Moore-Clingenpeel, M; Ayad, O; O'Brien, N				Lovett, Marlina E.; Moore-Clingenpeel, Melissa; Ayad, Onsy; O'Brien, Nicole			Reduction of hyperthermia in pediatric patients with severe traumatic brain injury: a quality improvement initiative	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						quality improvement; brain injury; pediatric intensive care; hyperthermia reduction; trauma	LENGTH-OF-STAY; TEMPERATURE; INFECTION; RISK	OBJECTIVE Severe traumatic brain injury remains a leading cause of morbidity and mortality in the pediatric population. Providers focus on reducing secondary brain injury by avoiding hypoxemia, avoiding hypotension, providing normoventilation, treating intracranial hypertension, and reducing cerebral metabolic demand. Hyperthermia is frequently present in patients with severe traumatic brain injury, contributes to cerebral metabolic demand, and is associated with prolonged hospital admission as well as impaired neurological outcome. The objective of this quality improvement initiative was to reduce the duration of hyperthermia for pediatric patients with severe traumatic brain injury during the initial 72 hours of admission to the pediatric intensive care unit. METHODS A retrospective chart review was performed to evaluate the incidence and duration of hyperthermia within a preintervention cohort. The retrospective phase was followed by three 6-month intervention periods (intervention Phase 1, the maintenance phase, and intervention Phase 2). Intervention Phase 1 entailed placement of a cooling blanket on the bed prior to patient arrival and turning it on once the patient's temperature rose above normothermia. The maintenance phase focused on sustaining the results of Phase 1. Intervention Phase 2 focused on total prevention of hyperthermia by initiating cooling blanket use immediately upon patient arrival to the intensive care unit. RESULTS The median hyperthermia duration in the preintervention cohort (n = 47) was 135 minutes. This was reduced in the Phase 1 cohort (n = 9) to 45 minutes, increased in the maintenance phase cohort (n = 6) to 88.5 minutes, and decreased again in the Phase 2 cohort (n = 9) to a median value of 0 minutes. Eight percent of patients in the intervention cohorts required additional sedation to tolerate the cooling blanket. Eight percent of patients in the intervention cohorts became briefly hypothermic while on the cooling blanket. No patient required neuromuscular blockade to tolerate the cooling blanket, experienced an arrhythmia, had new coagulopathy, or developed a pressure ulcer. CONCLUSIONS The placement of a cooling blanket on the bed prior to patient arrival and actively targeting normothermia successfully reduced the incidence and duration of hyperthermia with minimal adverse events.	[Lovett, Marlina E.; Ayad, Onsy; O'Brien, Nicole] Nationwide Childrens Hosp, Res Inst, Div Crit Care, Columbus, OH 43205 USA; [Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Res Inst, Biostat Core, Columbus, OH 43205 USA; [Lovett, Marlina E.; Ayad, Onsy; O'Brien, Nicole] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Lovett, ME (corresponding author), Nationwide Childrens Hosp, Div Pediat Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA.	marlina.lovett@nationwidechildrens.org	Ayad, Onsy S./C-6422-2013; Moore-Clingenpeel, Melissa/K-7232-2019				Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Hata JS, 2008, NEUROCRIT CARE, V9, P37, DOI 10.1007/s12028-007-9015-1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Suz P, 2006, J NEUROSURG ANESTH, V18, P5, DOI 10.1097/01.ana.0000189079.26212.37; TEASDALE G, 1974, LANCET, V2, P81; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	17	3	3	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2018	21	2					164	170		10.3171/2017.8.PEDS17104			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FU5CF	WOS:000423869600010	29192867	Bronze			2022-02-06	
J	Marshman, LAG; Hennessy, M; Delle Baite, L; Britton, G				Marshman, Laurence A. G.; Hennessy, Maria; Delle Baite, Lorryn; Britton, Grace			Utility of Retrograde Amnesia Assessment Alone, Compared with Anterograde Amnesia Assessment in Determining Recovery After Traumatic Brain Injury: Prospective Cohort Study	WORLD NEUROSURGERY			English	Article						Amnesia; Anterograde; Posttraumatic; Retrograde	POSTTRAUMATIC AMNESIA; HEAD-INJURY; PRACTICAL SCALE	BACKGROUND: Posttraumatic amnesia (PTA) after traumatic brain injury (TBI) comprises anterograde amnesia (AA), disorientation, and retrograde amnesia (RA). However, RA is often neither assessed nor emphasized. A recent study demonstrated that although AA and disorientation were both present in non-TBI inpatients uniformly taking opioids, RA was absent. This suggests potentially significant utility with RA assessment alone since opioids are commonly prescribed post TBI. METHODS: We compared RA recovery with AA recovery in a prospective cohort post TBI. The Galveston Orientation and Amnesia Test (GOAT) represented a crude test for PTA (GOAT <75). AA was primarily assessed using the Westmead PTA Scale, and RA was assessed using the GOAT. All patients were prescribed oxycodone. RESULTS: Results were obtained (n = 31). While RA recovery coincided with a GOAT recovery in 19/31 (61%), AA recovery coincided with GOAT recovery in only 6/31 (19%), (chi(2) = 11.5, P < 0.001). RA recovery preceded AA recovery in 15/31 (48%), while AA recovery preceded RA recovery in 7/31 (23%) (chi(2) = 8.6, P = 0.003). Where RA recovery less frequently followed AA recovery, temporal lobe contusions were more frequent. RA recovery preceded/coincided with AA recovery in 100% of those who recovered when AA was defined as x3 consecutive 12/12 scores (as is current widespread practice). AA recovery typically followed RA recovery with minimal delay. CONCLUSIONS: In the presence of potential in-hospital confounders including opioids, RA recovered significantly sooner after TBI than AA and was predictive of imminent AA recovery. RA assessment alone therefore had significant and novel utility in post-TBI assessment. RA assessment should be routinely recorded in all PTA assessment. Given its simplicity and resilience to common confounders, RA assessment should also be incorporated into the Glasgow Coma Scale.	[Marshman, Laurence A. G.] Townsville Hosp, Dept Neurosurg, Douglas, Qld, Australia; [Marshman, Laurence A. G.] James Cook Univ, Sch Med & Dent, Douglas, Qld, Australia; [Hennessy, Maria; Delle Baite, Lorryn; Britton, Grace] James Cook Univ, Dept Psychol, Douglas, Qld, Australia		Marshman, LAG (corresponding author), Townsville Hosp, Dept Neurosurg, Douglas, Qld, Australia.; Marshman, LAG (corresponding author), James Cook Univ, Sch Med & Dent, Douglas, Qld, Australia.	l.a.g.marshman@btinternet.com	Hennessy, Dr Maria/K-6241-2016	Hennessy, Dr Maria/0000-0002-3500-7128			[Anonymous], 1942, Proc R Soc Med, V35, P601; Becker DP, 1990, NEUROLOGICAL SURG, V3, P2017; Cartlidge NEF, 1981, HEAD INJURY, P52; Greenberg MS, 2016, HDB NEUROSURGERY, P140; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McLellan J, 2017, J CLIN NEUROSCI, V44, P184, DOI 10.1016/j.jocn.2017.06.027; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1935, LANCET, V1, P486; Symonds CP, 1937, P ROY SOC MED, V30, P34; Symonds CP, 1935, LANCET, V226, P1217, DOI [10.1016/S0140-6736(00)47408-8, DOI 10.1016/S0140-6736(00)47408-8]; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; TEASDALE G, 1974, LANCET, V2, P81; WASTERLAIN CG, 1971, EUR NEUROL, V5, P225, DOI 10.1159/000114074	19	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E830	E834		10.1016/j.wneu.2017.11.131			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900107	29191531				2022-02-06	
J	Shibahashi, K; Sugiyama, K; Okura, Y; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi			Serious Concomitant Injuries in Pediatric Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Concomitant injury; Mortality; Pediatrics; Trauma; Traumatic brain injury	EXTRACRANIAL INJURY; HEAD-INJURY; CHILDREN; MORTALITY; DISABILITY; PREDICTORS; OUTCOMES; SCORE; RISK	BACKGROUND: Severe traumatic brain injury (TBI) is a leading cause of death among children. Although several studies have reported the negative effects of concomitant injuries on mortality in adults with TBI, their effect on pediatric patients remains unclear. Our objective was to describe the effect of serious concomitant injuries on outcomes in pediatric patients with severe TBI. METHODS: We identified pediatric patients (<18 years) with severe TBI between 2004 and 2015, through the Japan Trauma Data Bank. We excluded patients who had cardiopulmonary arrest on arrival and those whose main outcome (mortality) was missed from the analyses. Two groups with severe TBI were compared on the basis of the presence of serious concomitant injuries (maximum Abbreviated Injury Scale score >= 3 in regions other than the head) and adjusted for potential confounders using multiple logistic regression analysis. RESULTS: One-thousand-and-thirty-four participants were eligible for analysis, of which 472 had serious concomitant injuries. Pediatric patients with a serious concomitant injury had higher mortality. The probability difference was 11.5 (95% confidence interval [CI]: 6.1%-16.9%), which was greater than the mortality of 1.5 (95% CI: 1.2%-1.8%) observed in patients with a serious injury but not TBI. The presence of a serious concomitant injury was significantly associated with increased mortality, even after adjusting for possible confounders (adjusted odds ratio, 2.01; 95% CI, 1.40-2.89; P < 0.001). CONCLUSION: Serious concomitant injuries are associated with higher mortality in pediatric patients with severe TBI, as a direct consequence, as well as due to concomitant injuries potentiating TBI pathobiology.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064; Hoda, Hidenori/0000-0002-4283-4412			Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Prasad Ganesh, 2003, Acta Orthop Belg, V69, P546; Shaikh Nissar, 2009, J Emerg Trauma Shock, V2, P29, DOI 10.4103/0974-2700.44680; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	26	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E1078	E1084		10.1016/j.wneu.2017.12.002			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900137	29241696				2022-02-06	
J	Smith, PJ; Hollins, AM; Sawyer, JR; Spence, DD; Outlaw, S; Kelly, DM				Smith, Patrick J.; Hollins, Anthony M.; Sawyer, Jeffrey R.; Spence, David D.; Outlaw, Shane; Kelly, Derek M.			Characterization of American Football Injuries in Children and Adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						football-related injuries; children; adolescents; injury patterns; concussion	EMERGENCY-DEPARTMENT VISITS; HEAD IMPACT EXPOSURE; YOUTH FOOTBALL; UNITED-STATES; SPORTS; PLAYERS; CONCUSSION; FREQUENCY; YOUNG	Background:As a collision sport, football carries a significant risk of injury, as indicated by the large number of pediatric football-related injuries seen in emergency departments. There is little information in the medical literature focusing on the age-related injury patterns of this sport. Our purpose was to evaluate the types of football-related injuries that occur in children and adolescents and assess which patient characteristics, if any, affect injury pattern.Methods:Retrospective chart review was performed of football-related injuries treated at a level 1 pediatric referral hospital emergency department and surrounding urgent care clinics between January 2010 and January 2014. Patients with e-codes for tackle football selected from the electronic medical record were divided into 4 age groups: younger than 8 years old, 8 to 11, 12 to 14, and 15 to 18 years. Data collected included diagnosis codes, procedure codes, and hospital admission status.Results:Review identified 1494 patients with 1664 football-related injuries, including 596 appendicular skeleton fractures, 310 sprains, 335 contusions, 170 closed head injuries, 62 dislocations, 9 spinal cord injuries, and 14 solid organ injuries. There were 646 (43.2%) athletes with upper extremity injuries and 487 (32.6%) with injuries to the lower extremity. Hospital admissions were required in 109 (7.3%) patients. Fracture was the most common injury in all four patient age groups, but occurred at a lower rate in the 15 to 18 years old age group. The rate of soft tissue injury was higher in the 15 to 18 years old age group. The rate of closed head injury, which included concussions, was highest in the younger than 8 years old age group.Conclusions:Age does influence the rates of certain football-related injuries in children and adolescents. Fractures decrease with increasing age, while the rate of soft tissue trauma increases with increasing age. Younger patients (younger than 8y old) trended toward higher rates of closed head injury compared with other age groups. Awareness of these variations in injury patterns based on age could result in age-specific changes in equipment, training, and safety rules.Level of Evidence:Level IVcase series.	[Smith, Patrick J.] Univ S Alabama, Coll Med, Dept Orthopaed Surg, Mobile, AL USA; [Outlaw, Shane] Univ S Alabama, Coll Med, Mobile, AL USA; [Hollins, Anthony M.] Memphis Shoulder & Orthopaed Surg, Memphis, TN USA; [Sawyer, Jeffrey R.; Spence, David D.; Kelly, Derek M.] Univ Tennessee, Campbell Clin, Dept Orthopaed Surg & Biomed Engn, Le Bonheur Childrens Hosp, Memphis, TN USA		Kelly, DM (corresponding author), 1211 Union Ave,Suite 510, Memphis, TN 38104 USA.	dkelly@campbellclinic.com					Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; [Anonymous], 2014, YOUTH SPORTS SAFETY; [Anonymous], 2012, P WARNER RULE CHANGE; Barenius B, 2014, AM J SPORT MED, V42, P1049, DOI 10.1177/0363546514526139; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Cantu R., 2012, CONCUSSIONS OUR KIDS; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Harris D, 2013, HIGH SCH FOOTBALL BA; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lykissas MG, 2013, J PEDIATR ORTHOPED, V33, P803, DOI 10.1097/BPO.0000000000000099; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Monroe KW, 2011, CLIN PEDIATR, V50, P17, DOI 10.1177/0009922810378735; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Nordenvall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104681; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Robbins L, 2012, REAL CLEAR SPORTS; Simon TD, 2006, PEDIATR EMERG CARE, V22, P309, DOI 10.1097/01.pec.0000215139.29039.5c; Stracciolini A, 2013, AM J SPORT MED, V41, P1922, DOI 10.1177/0363546513490644; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	30	3	3	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	FEB	2018	38	2					E57	E60		10.1097/BPO.0000000000001101			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	FZ5MX	WOS:000427639100005	29189531				2022-02-06	
J	Tonui, PM; Spilman, SK; Pelaez, CA; Mankins, MR; Sidwell, RA				Tonui, Peter M.; Spilman, Sarah K.; Pelaez, Carlos A.; Mankins, Mark R.; Sidwell, Richard A.			Head CT before Transfer Does Not Decrease Time to Craniotomy for TBI Patients	AMERICAN SURGEON			English	Article							I TRAUMA CENTER; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; RETROSPECTIVE-ANALYSIS; MAJOR TRAUMA; SCANS; ARRIVAL; IMPACT; RECOMMENDATIONS; EXPERIENCE	Rural trauma education emphasizes that radiologic imaging should be discouraged if it delays transfer to definitive care. With increased capacity for image sharing, however, radiography obtained at referring hospitals (RH) could help providers at trauma centers (TC) prepare for patients with traumatic brain injury. We evaluated whether a head CT prior to transfer accelerated time to neurosurgical intervention at the TC. The study was conducted at a combined adult Level I and pediatric Level II TC with a catchment area that includes rural hospitals within a 150 mile radius. The trauma registry was used to identify patients with traumatic brain injury who went to surgery for a neurosurgical procedure immediately after arrival at the TC. All patients were transferred in from a RH. Differences between groups were assessed using analysis of variance and chi-square. Fifty-six patients met study criteria during the study period (2010-2015). The majority (86%) of patients received head CT imaging at the RH, including a significant percentage of patients (18%) who presented with GCS <= 8. There was no statistically significant decrease in time to surgery when patients received imaging at the RH. CT imaging was associated with a delay in transfer that exceeded 90 minutes. Findings demonstrate that imaging at the RH delayed transfer to definitive care and did not improve time to neurosurgical intervention at the TC. Transfer to the TC should not be obstructed by imaging, especially for patients with severe TBI.	[Tonui, Peter M.; Pelaez, Carlos A.; Sidwell, Richard A.] Iowa Clin, Des Moines, IA USA; [Tonui, Peter M.; Spilman, Sarah K.; Pelaez, Carlos A.; Sidwell, Richard A.] UnityPoint Hlth, Dept Trauma Serv, Des Moines, IA USA; [Mankins, Mark R.; Sidwell, Richard A.] UnityPoint Hlth, Gen Surg Residency Program, Des Moines, IA USA		Spilman, SK (corresponding author), UnityPoint Hlth, Iowa Methodist Med Ctr, Trauma Serv, 1200 Pleasant St, Des Moines, IA 50309 USA.	sarah.spilman@unitypoint.org		Spilman, Sarah/0000-0001-6890-2332			American College of Surgeons, 2014, RES OPT CAR INJ PAT; American College of Surgeons, 2012, ADV TRAUMLIF SUPP AT; [Anonymous], 2015, RUR TRAUM TEAM DEV C; Benedict LA, 2014, J PEDIATR SURG, V49, P184, DOI 10.1016/j.jpedsurg.2013.09.056; Berkseth TJ, 2014, INJURY, V45, P835, DOI 10.1016/j.injury.2014.01.002; Carmont MR, 2005, POSTGRAD MED J, V81, P87, DOI 10.1136/pgmj.2004.021543; Chwals WJ, 2008, J PEDIATR SURG, V43, P2268, DOI 10.1016/j.jpedsurg.2008.08.061; Dennis BM, 2016, J TRAUMA ACUTE CARE, V81, P632, DOI 10.1097/TA.0000000000001188; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Emick DM, 2012, J TRAUMA ACUTE CARE, V72, P1255, DOI 10.1097/TA.0b013e3182452b6f; Flanagan PT, 2012, J AM COLL RADIOL, V9, P648, DOI 10.1016/j.jacr.2012.04.014; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Gupta R, 2010, J TRAUMA, V69, P253, DOI 10.1097/TA.0b013e3181e4d579; Haley Theodore, 2009, Am J Surg, V198, P858, DOI 10.1016/j.amjsurg.2009.05.030; Havrda Jonathan B, 2014, Radiol Technol, V86, P187; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Jarman MP, 2016, SURGERY, V160, P1551, DOI 10.1016/j.surg.2016.06.020; Jones AC, 2012, J TRAUMA ACUTE CARE, V73, P1564, DOI 10.1097/TA.0b013e31826fc85f; Kappel DA, 2011, J TRAUMA, V70, P315, DOI 10.1097/TA.0b013e318209589e; Liepert AE, 2011, J SURG RES, V170, P309, DOI 10.1016/j.jss.2011.06.018; McNeeley MF, 2013, J AM COLL RADIOL, V10, P361, DOI 10.1016/j.jacr.2012.09.031; McSwain N, 2012, BRIT J SURG, V99, P309, DOI 10.1002/bjs.7734; Mohan D, 2010, ANN SURG, V251, P946, DOI 10.1097/SLA.0b013e3181d76cb5; Moore HB, 2013, J TRAUMA ACUTE CARE, V74, P813, DOI 10.1097/TA.0b013e3182789399; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Psoter KJ, 2014, J AM COLL RADIOL, V11, P616, DOI 10.1016/j.jacr.2013.02.014; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Watson JJJ, 2016, AM J SURG, V211, P908, DOI 10.1016/j.amjsurg.2016.01.010; Whiteman Charles, 2014, W V Med J, V110, P14; Young AJ, 2012, AM SURGEON, V78, P675	32	3	3	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2018	84	2					201	207					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FY1SM	WOS:000426593400025	29580346				2022-02-06	
J	Yan, KX; Pang, LJ; Gao, H; Zhang, HZ; Zhen, Y; Ruan, SY; Wu, W; Xu, WD; Gong, K; Zhou, XM; Na, HR				Yan, Kaixuan; Pang, Lujun; Gao, Heng; Zhang, Hengzhu; Zhen, Yong; Ruan, Shiyan; Wu, Wei; Xu, Weidong; Gong, Kai; Zhou, Xinmin; Na, Hanrong			The Influence of Sedation Level Guided by Bispectral Index on Therapeutic Effects for Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Bispectral Index; Intracranial pressure; Richmond Agitation Sedation Scale; Sedation; Traumatic brain injury	PROGNOSTIC VALUE; MANAGEMENT; PRESSURE; PROPOFOL; IMPACT; CARE; EPIDEMIOLOGY; ASSOCIATION; PREVENTION; GUIDELINES	BACKGROUND: Sedation therapy is vital for treating severe traumatic brain injury (TBI). Yet, types of sedation assessment tools and sedation levels that are suitable for sedation treatment have not been investigated. OBJECTIVE: To investigate the influence of different sedation levels guided by the Bispectral Index (BIS) on the therapeutic effects for severe TBI. METHODS: According to inclusion, exclusion, and rejection criteria, 35 patients were prospectively included and divided into Richmond Agitation Sedation Scale (RASS), BIS(I), and BIS(II) groups. The RASS group was controlled the level of sedation to within -2 or -3, and the BIS(I) and (II) groups within the range of 40-50 and 50-60, respectively. In addition to clinical data, RASS, BIS, and intracranial pressure (ICP) values were collected. RASS and ICP variability were introduced to investigate the different of sedative control effect with or without BIS monitor, and the control effect of ICP between different sedation levels. Statistical analysis was performed to estimate the effectiveness of different sedation levels guided by BIS in sedation treatment within 72 hours. RESULTS: There were no significant differences in de-mographics among the 3 groups. RASS variability of the BIS(I) and (II) groups was significantly lower than that of the RASS group (P < 0.05), and in the BIS(I) group it was insignificantly lower than in the BIS(II) group. The ICP of the BIS(I) and (II) groups declined to < 13.5 mm Hg significantly earlier than that of the RASS group (P < 0.05), and the difference between BIS(I) and (II) was insignificant. ICP variability of RASS group was higher than those of the BIS(I) and (II) groups (P < 0.05), and ICP variability of the BIS(I) group was significantly lower than that of the BIS(II) group (P < 0.05). Differences in days in the neurosurgery intensive care unit and outcomes among the 3 groups were insignificant. CONCLUSIONS: BIS is more reliable than RASS for maintaining a stable sedation status and ICP. Deeper sedation levels (BIS 40-50) cause ICP to decrease more quickly, with lower ICP variability.	[Yan, Kaixuan; Gao, Heng; Wu, Wei; Xu, Weidong; Gong, Kai; Zhou, Xinmin; Na, Hanrong] Southeast Univ, Affiliated Jiangyin Hosp, Sch Med, Dept Neurosurg, Jiangyin City, Jiangsu, Peoples R China; [Pang, Lujun; Zhang, Hengzhu; Zhen, Yong; Ruan, Shiyan] Yangzhou Univ, Su Bei Peoples Hosp Jiangsu Prov, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China		Gao, H (corresponding author), Southeast Univ, Affiliated Jiangyin Hosp, Sch Med, Dept Neurosurg, Jiangyin City, Jiangsu, Peoples R China.	ikhutgj@qq.com					Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, 2017, WORLD J SURG, V41, P1; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Brosh A, 2007, J ANIM SCI, V85, P1213, DOI 10.2527/jas.2006-298; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Consales G, 2006, MINERVA ANESTESIOL, V72, P329; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Egerod I, 2006, INTENS CARE MED, V32, P60, DOI 10.1007/s00134-005-2856-1; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Huang Qi-bing, 2013, Zhonghua Yi Xue Za Zhi, V93, P1788; Johansen JW, 2000, ANESTHESIOLOGY, V93, P1336, DOI 10.1097/00000542-200011000-00029; Kelley S., 2007, MONITORING CONSCIOUS, P1; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Ogilvie MP, 2011, J TRAUMA, V71, P1415, DOI 10.1097/TA.0b013e3182178b8b; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Powers KS, 2005, PEDIATRICS, V115, P1666, DOI 10.1542/peds.2004-1979; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Roberts R, 2012, CRIT CARE MED, V40, P406, DOI 10.1097/CCM.0b013e31822f0af5; Rosow C, 2001, Anesthesiol Clin North Am, V19, P947; SIGL JC, 1994, J CLIN MONITOR, V10, P392, DOI 10.1007/BF01618421; Soar J, 2016, RESUSCITATION, V95, P748; Stammet P, 2009, RESUSCITATION, V80, P437, DOI 10.1016/j.resuscitation.2009.01.008; Yaman F, 2012, EUR REV MED PHARMACO, V16, P660; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zeng T, 2010, CHIN J TRAUMATOL, V13, P146, DOI 10.3760/cma.j.issn.1008-1275.2010.03.003; Zhang L P, 2016, Zhonghua Yi Xue Za Zhi, V96, P1656, DOI 10.3760/cma.j.issn.0376-2491.2016.21.008	38	3	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E671	E683		10.1016/j.wneu.2017.11.079			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900090	29196250				2022-02-06	
J	Aarela, T; Maatta, K; Uusiautti, S				Aaerela, Tanja; Maatta, Kaarina; Uusiautti, Satu			The challenges of parent-teacher collaboration in the light of hospital school pedagogy	EARLY CHILD DEVELOPMENT AND CARE			English	Article						Hospital school; parent-teacher collaboration; special education teacher; hospital school pedagogy; teacher as researcher	TRAUMATIC BRAIN-INJURY; CHRONIC HEALTH CONDITIONS; MAINSTREAM SCHOOL; YOUNG-PEOPLE; CHILDREN; PERSPECTIVES; NEEDS; ADOLESCENTS; CARE; INVOLVEMENT	This article provides viewpoints to the development of hospital school pedagogy by analysing challenges of collaboration and encounters between a hospital school teacher and students' parents. The teacher's pedagogical work necessitates the ability to work with quite a heterogeneous student group and their parents, and with teachers from students' own schools. The article is based on experience as a special education teacher at a hospital school and a researcher's diary of the everyday encounters in the teacher's work. The observation period formed the data of this study. Findings are presented as the process of collaboration negotiation between the hospital school teacher and the students' parents. Based on the data and findings, collaboration with students' own teachers had a significant role. The findings lean on case examples from a hospital school teacher's everyday work. The research helps to understand the nature of a hospital school teacher's work and develop hospital school pedagogy.	[Aaerela, Tanja; Maatta, Kaarina; Uusiautti, Satu] Univ Lapland, Fac Educ, Rovaniemi, Finland		Aarela, T (corresponding author), Univ Lapland, Fac Educ, Rovaniemi, Finland.	Tanja.Aarela@ulapland.fi		Uusiautti, Satu/0000-0002-2409-6460			Aarela T., 2014, J STUDIES ED, V4, P45, DOI [10.5296/jse.v4i4.6452, DOI 10.5296/JSE.V4I4.6452]; Aarela T., 2016, GLOBAL J HUMAN SOCIA, V16, P9; Adams CM, 2009, EDUC ADMIN QUART, V45, P4, DOI 10.1177/0013161X08327550; ALILA S, 2016, INT ELECT J ELEMENTA, V0008, P00351; Altrichter H., 2005, TEACHER INVESTIGATE; [Anonymous], 2016, VAAT ER TUEN K UNPUB; Backhouse M, 1999, AUST OCCUP THER J, V46, P99, DOI DOI 10.1046/J.1440-1630.1999.00183.X; Berger Eugenia Hepworth, 2003, PARENTS PARTNERS ED; Bogan AM, 1997, BRAIN INJURY, V11, P431; Bradford R., 1990, EARLY CHILD DEV CARE, V59, P43, DOI [10.1080/0300443900590105, DOI 10.1080/0300443900590105]; Breitweiser S S, 1991, Health Care Manage Rev, V16, P27; Bruce BS, 2008, J PEDIATR ONCOL NURS, V25, P331, DOI 10.1177/1043454208323619; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Champion TB, 1999, TOP LANG DISORD, V19, P52, DOI 10.1097/00011363-199905000-00006; CHAVKIN NF, 1988, EDUC HORIZONS, V66, P87; Chesire DJ, 2011, J APPL SCH PSYCHOL, V27, P60, DOI 10.1080/15377903.2011.540513; Clemens EV, 2011, PREV SCH FAIL, V55, P202, DOI 10.1080/1045988X.2010.532521; COMER JP, 1991, ELEM SCHOOL J, V91, P271, DOI 10.1086/461654; Coyne I, 2006, J CLIN NURS, V15, P61, DOI 10.1111/j.1365-2702.2005.01247.x; Creswell J., 2009, RES DESIGN, V3rd; Crossland A., 2002, ALTA J EDUC RES, V48, P5; Davison CM, 2009, N DIRECT EVAL, V2009, P75, DOI DOI 10.1002/EV.315; DELBANCO TL, 1978, MT SINAI J MED, V45, P628; DiVasta AD, 2008, J ADOLESCENT HEALTH, V42, pS25; Dixon M, 2014, INT J INCLUSIVE EDUC, V18, P270, DOI 10.1080/13603116.2012.676084; Domina T, 2005, SOCIOL EDUC, V78, P233, DOI 10.1177/003804070507800303; Epstein J. L., 1992, ENCY ED RES, P1139; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Georgiadi M, 2010, PROCD SOC BEHV, V5, P1278, DOI 10.1016/j.sbspro.2010.07.275; Glang A, 2008, NEUROREHABILITATION, V23, P477; Hartman LR, 2015, BRAIN INJURY, V29, P1387, DOI 10.3109/02699052.2015.1071431; Hollins E., 1995, ACTION TEACHER ED, V17, P70; Hoover-Dempsey KV, 2005, ELEM SCHOOL J, V106, P105, DOI 10.1086/499194; Hurt JA, 2000, YOUNG CHILDREN, V55, P88; Laftman SB, 2008, BRIT J SOCIOL, V59, P757, DOI 10.1111/j.1468-4446.2008.00218.x; Lasky S., 2000, ANN M AM ED RES ASS; Lian M. J., 2003, PHYS DISABILITIES ED, V22, P37; Lindsay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124679; Lindsey C. N., 1981, ED UNLIMITED, V3, P30; Maatta K, 2015, PROBL EDUC 21ST CENT, V66, P29; Mac an Ghaill M., 2002, DOING ED RES, P101; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McLoone JK, 2011, J ADOLESC YOUNG ADUL, V1, P87, DOI 10.1089/jayao.2011.0006; Mescon J. A. W., 1995, EARLY CHILD DEV CARE, V111, P107, DOI DOI 10.1080/0300443951110108; Mestry R, 2007, ED RES REV, V2, P176; Mills G., 2007, ACTION RES GUIDE TEA; Moore S., 2000, BUILDING BRIDGES HOM, P13; Mukherjee S, 2002, CHILD CARE HLTH DEV, V28, P21, DOI 10.1046/j.1365-2214.2002.00242.x; Mukherjee S, 2000, EDUC RES, V42, P59, DOI 10.1080/001318800363917; Nabors LA, 2008, PSYCHOL SCHOOLS, V45, P217, DOI 10.1002/pits.20292; Plotts C, 2012, J HEAD TRAUMA REHAB, V27, pE25; Prevatt FF, 2000, J SCHOOL PSYCHOL, V38, P447, DOI 10.1016/S0022-4405(00)00046-7; Price-Mitchell M., 2009, SCH COMMUNITY J, V19, P9; Reiss JG, 2005, PEDIATRICS, V115, P112, DOI 10.1542/peds.2004-1321; Robinson C A, 1987, Matern Child Nurs J, V16, P181; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; Romaniuk D, 2014, COMPR CHILD ADOLES N, V37, P103, DOI 10.3109/01460862.2014.880532; Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Simon JB, 2010, RESID TREAT CHILD YO, V27, P41, DOI 10.1080/08865710903508084; St Leger P, 2014, INT J INCLUSIVE EDUC, V18, P253, DOI 10.1080/13603116.2012.679320; Stuart J. L., 1996, TEACHING EXCEPTIONAL, V28, P58, DOI DOI 10.1177/004005999602800212; Sylva K, 2008, BRIT J EDUC PSYCHOL, V78, P435, DOI 10.1348/000709907X255718; Thies KM, 2001, J SCHOOL HEALTH, V71, P167, DOI 10.1111/j.1746-1561.2001.tb07309.x; Tilus P., 2011, SAIRAALAOPETUKSEN LA; Ubha N, 2014, EDUC PSYCHOL PRACT, V30, P272, DOI 10.1080/02667363.2014.920304; Uusiautti S, 2016, INT FORUM TEACHING S, V12, P10; Uusiautti S., 2016, BASICS CARING RES; Uusiautti S, 2012, J COMP FAM STUD, V43, P151; Van Leeuwen J., 1977, PSYCHOL PROBLEMS CHI, P334; WalKer-Dalhouse D, 2009, TEACH TEACH EDUC, V25, P328, DOI 10.1016/j.tate.2008.07.014; Wanat C. L., 1994, J SCH LEADERSHIP, V4, P631; Wherry JH, 2009, PRINCIPAL, V88, P7; Wray N, 2007, QUAL HEALTH RES, V17, P1392, DOI 10.1177/1049732307308308; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Young Choi， Mi, 2014, Child Health Nursing Research, V20, P105, DOI 10.4094/chnr.2014.20.2.105	76	3	4	3	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0300-4430	1476-8275		EARLY CHILD DEV CARE	Early Child Dev. Care		2018	188	6					709	722		10.1080/03004430.2016.1230108			14	Education & Educational Research; Psychology, Developmental	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology	GD9PL	WOS:000430844900006					2022-02-06	
S	Asken, BM; Hack, DC; McCrea, MA		Hainline, B; Stern, RA		Asken, Breton M.; Hack, Dallas C.; McCrea, Michael A.			The modern landscape of sport-related concussion research: key achievements and future directions	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; BRAIN-INJURY; HIGH-SCHOOL; EXERCISE; SYMPTOMS; RECOVERY; SUICIDE; DIAGNOSIS; IMPACT	The study of contact and collision sport athletes at risk for concussion began approximately three decades ago. Since then, sport-related concussion (SRC) research across several medical specialties has helped to develop consensus guidelines for clinical management through interdisciplinary efforts. The modern landscape of SRC research includes large-scale investigations to define the natural history of concussion and identify factors that should guide prevention, diagnosis, and treatment specific to the individual patient. We now know that the clinical and physiologic effects of concussion are related but independent constructs deserving further scientific exploration. This has sparked research that incorporates advanced neuroimaging, fluid biomarkers, biomechanics, and genomics, in addition to standard clinical outcomes. Additionally, translational research has informed our understanding of optimal rehabilitation strategies and led to a shift from the "complete rest" approach to earlier, active management interventions after concussion. Collectively, these advancements are likely to substantially improve patient outcomes after SRC and, ultimately, may prove beneficial for identifying and appropriately managing those at risk for longer-term difficulties associated with repetitive head impact exposure. The broader public health implications of improving sports safety and encouraging developmentally appropriate participation among youth and adolescents are a particularly important byproduct of continued research into SRC.	[Asken, Breton M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Hack, Dallas C.] Natl Collegiate Athlet Assoc, Indianapolis, IN USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu		Asken, Breton/0000-0001-8419-142X			Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Critchley M, 1949, PUNCH DRUNK SYNDROME; Echemendia RJ., 2017, BR J SPORTS MED; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	60	3	3	0	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						269	278		10.1016/B978-0-444-63954-7.00026-4			10	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100028	30482355				2022-02-06	
J	Bacon, CEW; Cohen, GW; Kay, MC; Tierney, DK; McLeod, TCV				Bacon, Cailee E. Welch; Cohen, Gary W.; Kay, Melissa C.; Tierney, Dayna K.; McLeod, Tamara C. Valovich			Athletic Trainers' Perceived Challenges Toward Comprehensive Concussion Management in the Secondary School Setting	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						concussion education; traumatic brain injury; return-to-play; multidisciplinary collaboration	SPORT-RELATED CONCUSSION; ACADEMIC ACCOMMODATIONS; KNOWLEDGE TRANSFER; RUGBY PLAYERS; HEAD-INJURY; STUDENT; PERCEPTIONS; GUIDELINES; CHILDREN; RETURN	Available financial and personnel resources often dictate the specifics of concussion policies and procedures in the secondary school setting. The purpose of this qualitative study was to explore athletic trainers' perceived challenges toward comprehensive concussion management in the secondary school setting. The findings indicate several challenges exist toward concussion management in the secondary school, including facility, personnel, and community resources, education levels of various stakeholders, and general perceptions of concussion and athletic trainers. It is important to identify challenges athletic trainers may face in order to develop strategies to align current concussion management procedures with current best practices.	[Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA; [Bacon, Cailee E. Welch; Cohen, Gary W.; Tierney, Dayna K.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [Kay, Melissa C.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA		Bacon, CEW (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA.; Bacon, CEW (corresponding author), AT Still Univ, Athlet Training Programs, Mesa, AZ USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Donaworth MA, 2016, PHYSICIAN SPORTSMED, V44, P1, DOI 10.1080/00913847.2016.1135039; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Lueke L, 2011, J LEGAL MED, V32, P483, DOI 10.1080/01947648.2011.632710; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McAvoy K., 2010, REAP BENEFITS GOOD C; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Minthorn L. M., 2014, J ATHL TRAINING, V49, pS140; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Phan K, 2012, ATHL TRAIN ED J, V7, P103; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thrasher AB, 2015, J ATHL TRAINING, V50, P321, DOI 10.4085/1062-6050-49.3.67; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Welch CE, 2014, J ATHL TRAINING, V49, P220, DOI 10.4085/1062-6050-49.2.14; Welch CE, 2014, J ATHL TRAINING, V49, P234, DOI 10.4085/1062-6050-49.2.15; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Williams RM, 2015, QUICK QUESTIONS SPOR, P199; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	50	3	3	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JAN	2018	23	1					33	41		10.1123/ijatt.2017-0043			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	GC2IZ	WOS:000429606900007					2022-02-06	
J	Bagnato, S; Andriolo, M; Boccagni, C; Sant'Angelo, A; D'Ippolito, ME; Galardi, G				Bagnato, Sergio; Andriolo, Maria; Boccagni, Cristina; Sant'Angelo, Antonino; D'Ippolito, Maria Enza; Galardi, Giuseppe			Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness	BRAIN INJURY			English	Article						Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY	Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.	[Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Andriolo, Maria; D'Ippolito, Maria Enza] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy		Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Boccagni, Cristina/0000-0002-6317-015X			Bagnato S, 2017, J NEUROTRAUM, V34, P2475, DOI 10.1089/neu.2016.4837; Bagnato S, 2017, NEUROREPORT, V28, P250, DOI 10.1097/WNR.0000000000000748; Bertens D, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0233-7; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Carrillo-Mora P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/795375; Dai CL, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0227-5; Fan Z, 2017, BRAIN, V140, P792, DOI 10.1093/brain/aww349; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Janelidze S, 2017, JAMA NEUROL, V74, P1492, DOI 10.1001/jamaneurol.2017.2814; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Novak P, 2017, LANCET NEUROL, V16, P123, DOI [10.1016/S1474-4422(16)30331-3, 10.1016/s1474-4422(16)30331-3]; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Royal College of Physicians, 2016, PROL DIS CONSC NAT C; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Seifan A, 2015, J ALZHEIMERS DIS, V43, P315, DOI 10.3233/JAD-140279; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sjogren M, 2001, CLIN CHEM, V47, P1776; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Vanderstichele H, 2006, CLIN CHEM LAB MED, V44, P1472, DOI 10.1515/CCLM.2006.258; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Zetterberg H, 2015, CURR OPIN PSYCHIATR, V28, P402, DOI 10.1097/YCO.0000000000000179; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zilka N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-47; Zwan M, 2014, J ALZHEIMERS DIS, V41, P801, DOI 10.3233/JAD-132561	38	3	4	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1056	1060		10.1080/02699052.2018.1479042			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400013	29792528				2022-02-06	
J	Bearer, EL; Mulligan, BS				Bearer, Elaine L.; Mulligan, Brianna S.			Epigenetic Changes Associated with Early Life Experiences: Saliva, A Biospecimen for DNA Methylation Signatures	CURRENT GENOMICS			English	Article						Adverse Childhood Experience (ACE); Illumina methylation BeadChip array; Methyl-binding pull-down; Bisulfite sequencing; Saliva cell composition; DNA methylation; Pediatric trauma	POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; SEROTONIN TRANSPORTER; CHILD MALTREATMENT; GENE-EXPRESSION; MEMORY IMPAIRMENTS; PRENATAL EXPOSURE; CELL COMPOSITION; BIOLOGICAL RISK; TET1	Background: Adverse Childhood Experiences (ACEs), which include traumatic injury, are associated with poor health outcomes in later life, yet the biological mechanisms mediating this association are unknown. Neurocircuitry, immune system and hormone regulation differ from normal in adults reporting ACEs. These systems could be affected by epigenetic changes, including methylation of cytosine (5mC) in genomic DNA, activated by ACEs. Since 5mC levels influence gene expression and can be long-lasting, altered 5mC status at specific sites or throughout the genome is hypothesized to influence mental and physical outcomes after ACE(s). Human and animal studies support this, with animal models allowing experiments for attributing causality. Here we provide a lengthy introduction and background on 5mC and the impact of early life adversity. Objective: Next we address the issue of a mixture of cell types in saliva, the most accessible biospecimen for 5mC analysis. Typical human bio-specimens for 5mC analysis include saliva or buccal swabs, whole blood or types of blood cells, tumors and post-mortem brain. In children saliva is the most accessible biospecimen, but contains a mixture of keratinocytes and white blood cells, as do buccal swabs. Even in saliva from the same individual at different time points, cell composition may differ widely. Similar issues affect analysis in blood, where nucleated cells represent a wide array of white blood cell types. Unless variations in ratios of these cells between each sample are included in the analysis, results can be unreliable. Methods: Several different biochemical assays are available to test for site-specific methylation levels genome-wide, each producing different information, with high-density arrays being the easiest to use, and bisulfite whole genome sequencing the most comprehensive. We compare results from different assays and use high-throughput computational processing to deconvolve cell composition in saliva samples. Results: Here we present examples demonstrating the critical importance of determining the relative contribution of blood cells versus keratinocytes to the 5mC profile found in saliva. We further describe a strategy to perform a reference-based computational correction for cell composition, and therefore to identify differential methylation patterns due to experience, or for the diagnosis of phenotypes that correlate between traits, such as hormone levels, trauma status and various mental health outcomes. Conclusion: Specific sites that respond to adversity with altered methylation levels in either blood cells, keratinocytes or both can be identified by this rigorous approach, which will then be useful as diagnostic biomarkers and therapeutic targets.	[Bearer, Elaine L.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, MSC 08-4640, Albuquerque, NM 87131 USA; [Mulligan, Brianna S.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA		Bearer, EL (corresponding author), Univ New Mexico, Dept Pathol, Hlth Sci Ctr, MSC 08-4640, Albuquerque, NM 87131 USA.	ebearer@salud.unm.edu			UNM CTSA [RO1 MH096093, TR000041]; USC CTSA [TR000131]; Harvey Family Endowment;  [P50 GM085273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM085273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH096093] Funding Source: NIH RePORTER	We are grateful to Julia Stephen at University of New Mexico and the Mind Research Network, for children's saliva samples, for laboratory assistance by Kathleen Kilpatrick, Nicole Patterson, Mabel Padilla, and Juanita Martinez, for the initial computational analysis by Amber J. Zimmerman, and administrative assistance from Kevin P. Reagan. We are also grateful to Children's Institute Inc. for their support of saliva collections and Bill Monro at the USC Suzanne Dworkin-Peck School of Social Work, for some project management. We are especially grateful to Darrell Dinwiddie, and to Scott Ness and his UNM ATG-lab team for help with the MeDIP sequencing, and to Dan Weisenberger at USC Keck Epigenomics Center for the Illumina Chip assays. We are indebted to Arthur Riggs at City of Hope for helpful discussions. All saliva was collected with parental consent under an IRB approval from the UNM Human Research Protections Office. This work was supported by RO1 MH096093, TR000041 (UNM CTSA), TR000131 (USC CTSA), and P50 GM085273 and the Harvey Family Endowment.	Almli LM, 2015, AM J MED GENET B, V168, P327, DOI 10.1002/ajmg.b.32315; Arloth J, 2015, NEURON, V86, P1189, DOI 10.1016/j.neuron.2015.05.034; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Baram TZ, 2012, AM J PSYCHIAT, V169, P907, DOI 10.1176/appi.ajp.2012.11091347; Bearer E. L., 2015, AUSTIN J CLIN PATHOL, V2, P1028; Bearer E. L, 2010, HDB DEV SCI BEHAV GE; Bearer EL, 2004, NATURE AND NURTURE, P171; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bluestone C. D., 2003, PEDIAT ENDOCRINOLOGY, V2; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; Bohacek J, 2015, PSYCHONEUROENDOCRINO, V52, P1, DOI 10.1016/j.psyneuen.2014.10.026; Brown SE, 2008, NEUROSCI LETT, V440, P49, DOI 10.1016/j.neulet.2008.05.028; Caldji C, 2000, BIOL PSYCHIAT, V48, P1164, DOI 10.1016/S0006-3223(00)01084-2; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chen WSV, 2017, SCIENCE, V356, P406, DOI 10.1126/science.aal3231; Chen YC, 2016, J NEUROSCI, V36, P11295, DOI 10.1523/JNEUROSCI.2542-16.2016; Chen YC, 2016, NEUROPSYCHOPHARMACOL, V41, P197, DOI 10.1038/npp.2015.181; Chen Z, 2016, P NATL ACAD SCI USA, V113, pE3002, DOI 10.1073/pnas.1603712113; Cicchetti D, 2016, DEV PSYCHOPATHOL, V28, P1305, DOI 10.1017/S0954579416000869; Cicchetti D, 2015, DEV PSYCHOPATHOL, V27, P553, DOI 10.1017/S0954579415000152; Cipriany BR, 2010, ANAL CHEM, V82, P2480, DOI 10.1021/ac9028642; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; Cole SW, 2015, PSYCHONEUROENDOCRINO, V62, P11, DOI 10.1016/j.psyneuen.2015.07.001; Coll C. G, 2004, NATURE NATURE COMPLE, P278; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Edwards V., 2005, VICTIMIZATION CHILDR; Ehlert U, 2013, PSYCHONEUROENDOCRINO, V38, P1850, DOI 10.1016/j.psyneuen.2013.06.007; Ehrlich KB, 2016, DEV PSYCHOPATHOL, V28, P1273, DOI 10.1017/S0954579416000845; Esposito EA, 2016, DEV PSYCHOPATHOL, V28, P1385, DOI 10.1017/S0954579416000055; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Felitti VJ, 2009, ACAD PEDIATR, V9, P131, DOI 10.1016/j.acap.2009.03.001; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Felling RJ, 2012, EPIGENOMICS-UK, V4, P125, DOI [10.2217/EPI.12.2, 10.2217/epi.12.2]; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gallagher JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057597; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gold Jeffrey I, 2008, J Pediatr Nurs, V23, P81, DOI 10.1016/j.pedn.2007.08.005; Graff J, 2014, CELL, V156, P261, DOI 10.1016/j.cell.2013.12.020; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; HARLOW HF, 1971, P NATL ACAD SCI USA, V68, P1534, DOI 10.1073/pnas.68.7.1534; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herd P, 2012, J GERONTOL B-PSYCHOL, V67, P503, DOI 10.1093/geronb/gbs048; Holm K, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0685-5; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0; Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Houtepen LC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10967; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jedema HP, 2010, MOL PSYCHIATR, V15, P512, DOI 10.1038/mp.2009.90; JONES PA, 1986, CANCER RES, V46, P461; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kaushal A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1611-2; Klughammer J, 2015, CELL REP, V13, P2621, DOI 10.1016/j.celrep.2015.11.024; Kumar Dinesh, 2015, Neuroepigenetics, V4, P12; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lam LL, 2013, P NATL ACAD SCI USA, V110, pE1247, DOI 10.1073/pnas.1222104110; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Larkin H, 2014, SOC WORK PUBLIC HLTH, V29, P1, DOI 10.1080/19371918.2011.619433; Levendosky Alytia A, 2013, Psychodyn Psychiatry, V41, P351, DOI 10.1521/pdps.2013.41.2.351; Lezak KR, 2014, J MOL NEUROSCI, V54, P477, DOI 10.1007/s12031-014-0269-8; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu JY, 2014, SCHIZOPHRENIA BULL, V40, P769, DOI 10.1093/schbul/sbt080; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lomanowska AM, 2017, NEUROSCIENCE, V342, P120, DOI 10.1016/j.neuroscience.2015.09.029; Lutz PE, 2014, NEUROSCIENCE, V264, P142, DOI 10.1016/j.neuroscience.2013.07.069; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Makley AT, 2010, SEMIN PEDIATR SURG, V19, P292, DOI 10.1053/j.sempedsurg.2010.06.006; Marie R, 2012, J BIOPHOTONICS, V5, P673, DOI 10.1002/jbio.201200050; Marx V, 2016, NAT METHODS, V13, P911, DOI 10.1038/nmeth.4036; McClelland S, 2011, NEUROBIOL LEARN MEM, V96, P79, DOI 10.1016/j.nlm.2011.02.008; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McGowan PO, 2015, DEV PSYCHOPATHOL, V27, P637, DOI 10.1017/S0954579415000206; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mennen FE, 2010, CHILD ABUSE NEGLECT, V34, P647, DOI 10.1016/j.chiabu.2010.02.007; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Molet J, 2016, HIPPOCAMPUS, V26, P1618, DOI 10.1002/hipo.22661; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Negriff S, 2015, J DEV BEHAV PEDIATR, V36, P708, DOI 10.1097/DBP.0000000000000204; Neumann A, 2015, OPT EXPRESS, V23, P23208, DOI 10.1364/OE.23.023208; Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028; Non AL, 2016, AM J PHYS ANTHROPOL, V161, P84, DOI 10.1002/ajpa.23010; O'Connor TG, 2013, DEV PSYCHOBIOL, V55, P145, DOI 10.1002/dev.21007; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Odenbach J, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-19; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Pena CJ, 2017, SCIENCE, V356, P1185, DOI 10.1126/science.aan4491; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Pratchett LC, 2011, DEV PSYCHOPATHOL, V23, P477, DOI 10.1017/S0954579411000186; Prins NW, 2017, J NEUROSCI METH, V284, P35, DOI 10.1016/j.jneumeth.2017.04.004; Raddatz G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003146; Ramiro AR, 2015, TRENDS BIOCHEM SCI, V40, P172, DOI 10.1016/j.tibs.2015.01.006; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Rincon-Cortes M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.205; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roszkowski M, 2016, NEUROPHARMACOLOGY, V107, P329, DOI 10.1016/j.neuropharm.2016.03.046; Roth TL, 2013, GENES BRAIN BEHAV, V12, P673, DOI 10.1111/gbb.12067; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Roth TL, 2005, BIOL PSYCHIAT, V57, P823, DOI 10.1016/j.biopsych.2005.01.032; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Santarelli S, 2017, PSYCHONEUROENDOCRINO, V78, P213, DOI 10.1016/j.psyneuen.2017.01.021; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; Schraut KG, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.107; Slopen N, 2014, PSYCHOSOM MED, V76, P481, DOI 10.1097/PSY.0000000000000081; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stelzer Y, 2016, CELL REP, V16, P3167, DOI 10.1016/j.celrep.2016.08.066; Su D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166486; Suderman M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-13; Suderman M, 2013, P NATL ACAD SCI USA, V110, pE1246, DOI 10.1073/pnas.1221019110; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Suomi SJ, 2004, NATURE AND NURTURE, P35; Suomi SJ, 2008, INTEGR PSYCHOL BEHAV, V42, P354, DOI 10.1007/s12124-008-9072-9; Surtees P, 2003, INT J BEHAV MED, V10, P251, DOI 10.1207/S15327558IJBM1003_05; Szyf M, 2013, CHILD DEV, V84, P49, DOI 10.1111/j.1467-8624.2012.01793.x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teh AL, 2016, EPIGENETICS-US, V11, P36, DOI 10.1080/15592294.2015.1132136; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Toyoda S, 2014, NEURON, V82, P94, DOI 10.1016/j.neuron.2014.02.005; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Trickett PK, 2014, CHILD MALTREATMENT, V19, P27, DOI 10.1177/1077559513520466; van der Knaap LJ, 2015, PSYCHONEUROENDOCRINO, V58, P46, DOI 10.1016/j.psyneuen.2015.04.012; Vijayendran Meeshanthini, 2012, Front Psychiatry, V3, P55, DOI 10.3389/fpsyt.2012.00055; Warren WC, 2015, GENOME RES, V25, P1921, DOI 10.1101/gr.192922.115; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Wilting SM, 2016, ONCOTARGET, V7, P43805, DOI 10.18632/oncotarget.9698; Wren ME, 2015, CLIN THER, V37, P529, DOI 10.1016/j.clinthera.2015.02.022; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Xia DY, 2008, NANO LETT, V8, P1610, DOI 10.1021/nl080190s; Yang BZ, 2013, AM J PREV MED, V44, P101, DOI 10.1016/j.amepre.2012.10.012; Zannas AS, 2015, BIOL PSYCHIAT, V78, P327, DOI 10.1016/j.biopsych.2015.04.003; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang XW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011506; Zhao ZG, 2015, CELL REP, V13, P1692, DOI 10.1016/j.celrep.2015.10.037; Ziller MJ, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0105-1	162	3	3	1	7	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-2029	1875-5488		CURR GENOMICS	Curr. Genomics		2018	19	8					676	698		10.2174/1389202919666180307150508			23	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Genetics & Heredity	HK6PY	WOS:000458105800005	30532647	Green Published, Green Submitted			2022-02-06	
J	Bell, C; Hackett, J; Hall, B; Pulhorn, H; McMahon, C; Bavikatte, G				Bell, Chris; Hackett, James; Hall, Benjamin; Pulhorn, Heinke; McMahon, Catherine; Bavikatte, Ganesh			Symptomatology following traumatic brain injury in a multidisciplinary clinic: experiences from a tertiary centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Brain injuries; traumatic; neurological rehabilitation; neurosurgery; neurocognitive disorders; post-concussion syndrome	HEAD-INJURY; EPIDEMIOLOGY; COMPLAINTS; SYMPTOMS; DISORDER	Background: Physical, cognitive and emotional sequelae in patients with traumatic brain injury (TBI) have been identified; some as late as two years post-injury. To aid in the specialist management of such patients, a multidisciplinary neurotrauma clink was initiated at a tertiary centre. Aim: This study sought to describe the clinical features of patients who attended the clinic. Methods: Patient data was collected under several categories: basic demographics, mechanism and severity of injury, initial CT findings and management, hospital stay and discharge details, symptoms in clinic and actions performed by clinic staff (medication changes, referrals to other services, etc.). Results: Three hundred and five patients met the inclusion criteria. Mean age was 47.5 and most patients were male (72.1%). Commonest mechanism of injury was falls (53.1%). 17.4% of injuries were classed as mild, 68.2% moderate and 14.1% severe. Commonest injury locations were frontal (21.6%) and temporal (16.1%) with contusions (374%) and subdural hematomas (27.9%) the commonest type of injury on initial CT scan. The most frequent physical complaints were headache (47.9%) and memory problems (42.0%). 7.9% complained of new seizures since TBI. 41.6% were referred to further services: most frequently psychology (19.3%) and neuropsychiatry (18.4%). Of 184 known to be employed before their injury, 48.4% of these returned to work before their last appointment. 28.5% were unable to continue driving. Conclusion: Our study provides an insight into the reality of long term sequelae of TBI, especially those at the more severe end of the spectrum, who are likely to present to tertiary or specialist services. Information gathered in this study about characteristics of the TBI population and their outcomes allows for better targeting of suitable patients for referral to a multidisciplinary clinic and improved resource planning.	[Bell, Chris; Hackett, James; Hall, Benjamin] Univ Liverpool, Sch Med, Cedar House,Ashton St, Liverpool L69 3GE, Merseyside, England; [Pulhorn, Heinke; McMahon, Catherine] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Bavikatte, Ganesh] Walton Ctr NHS Fdn Trust, Neurorehabil Unit, Liverpool, Merseyside, England		Bell, C (corresponding author), Univ Liverpool, Sch Med, Cedar House,Ashton St, Liverpool L69 3GE, Merseyside, England.	c.bell3@liv.ac.uk	Bavikatte, Ganesh/AAM-9872-2020	Bell, Chris/0000-0002-3587-5339			[Anonymous], 2016, NEUROTRAUMA; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Cullen N, 2014, BRAIN INJURY, V28, P189, DOI 10.3109/02699052.2013.862738; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Headway the brain injury association, 2015, ACQ BRAIN INJ NUMB H; Hoofien D, 2001, BRAIN INJURY, V15, P189; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jorge Ricardo E, 2015, Handb Clin Neurol, V128, P613, DOI 10.1016/B978-0-444-63521-1.00038-8; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Little Deborah M, 2015, Handb Clin Neurol, V131, P465, DOI 10.1016/B978-0-444-62627-1.00027-5; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Yablon S. A., 2001, PHYS MED REHABIL STA, V15, P301; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	38	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2018	32	5					495	500		10.1080/02688697.2018.1490945			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	HD8VZ	WOS:000452839400009	29989436				2022-02-06	
J	Bernety, HM; Venkatesh, S; Schurig, D				Bernety, Hossein Mehrpour; Venkatesh, Suresh; Schurig, David			Performance Analysis of a Helmet-Based Radar System for Impact Prediction	IEEE ACCESS			English	Article						Antennas; collision; concussion; FMCW radar; impact prediction; short range; traumatic brain injury (TBI)	FMCW; EPIDEMIOLOGY	We analyze the performance of a helmet-based frequency modulated continuous wave (FMCW) radar system for use in impact prediction in contact sports, or other risky environments. It has been shown that the head trauma and concussions can have significant detrimental effects on the health and quality life of contact sport athletes, from the high school to professional level. Impact prediction capability could be an important part of a comprehensive, helmet-based system for mitigating the neurological damage caused by impacts. Mitigation strategies include using imminent impact information in an audible warning system, or dynamic preloading and control of an active helmet suspension. Our analysis centers on the prediction of an impact offset parameter (and its uncertainty) in a representative player interaction scenario. We consider realistic radar measurement specifications consistent with our player interaction scenario, and COTS radar hardware, including oscillator phase noise, operation frequency, sweep frequency, bandwidth, range, target scattering cross-section, and antenna gain.	[Bernety, Hossein Mehrpour; Venkatesh, Suresh; Schurig, David] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA		Schurig, D (corresponding author), Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.	david.schurig@utah.edu	Venkatesh, Suresh/J-3659-2019	Venkatesh, Suresh/0000-0002-9867-3021	National Science FoundationNational Science Foundation (NSF) [1622741]	This work was supported by the National Science Foundation under Grant 1622741.	[Anonymous], 2015, MATLAB STAT TOOLB RE; Balanis C. A., 2016, ANTENNA THEORY ANAL; Bernety HM, 2017, IEEE ANTENNAS PROP, P1379, DOI 10.1109/APUSNCURSINRSM.2017.8072732; Breitbarth J., 2006, THESIS; Brooker G.M., 2005, P 1 INT C SENS TECHN, P152; Choi JH, 2015, IEEE T INSTRUM MEAS, V64, P3517, DOI 10.1109/TIM.2015.2450294; Curry G. R., 2004, RADAR SYSTEM PERFORM; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Gavin H.P., 2015, LEVENBERG MARQUARDT, DOI [10.1080/10426914.2014.941480, DOI 10.1080/10426914.2014.941480, 10.1080/10426914.2014.941480.]; Giannini V, 2014, IEEE J SOLID-ST CIRC, V49, P2925, DOI 10.1109/JSSC.2014.2355819; Hasch J, 2012, IEEE T MICROW THEORY, V60, P845, DOI 10.1109/TMTT.2011.2178427; Im YT, 2013, MICROW OPT TECHN LET, V55, P474, DOI 10.1002/mop.27343; Ince T, 2010, RADIOENGINEERING, V19, P129; Issakov V, 2010, MICROWAVE CIRCUITS FOR 24 GHZ AUTOMOTIVE RADAR IN SILICON-BASED TECHNOLOGIES, P1, DOI 10.1007/978-3-642-13598-9; Jia HK, 2016, IEEE J SOLID-ST CIRC, V51, P2299, DOI 10.1109/JSSC.2016.2580599; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Nicolson ST, 2008, IEEE T MICROW THEORY, V56, P1092, DOI 10.1109/TMTT.2008.921268; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Richards M.A., 2010, PRINCIPLES MODERN RA; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Skolnik M.I., 2001, INTRO RADAR SYSTEMS, V3rd; STOVE AG, 1992, IEE PROC-F, V139, P343, DOI 10.1049/ip-f-2.1992.0048; Wang GC, 2014, IEEE T MICROW THEORY, V62, P2812, DOI 10.1109/TMTT.2014.2358572	26	3	3	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2018	6						75124	75131		10.1109/ACCESS.2018.2882768			8	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	HF7EE	WOS:000454401200001		gold			2022-02-06	
J	Bitan, T; Simic, T; Saverino, C; Jones, C; Glazer, J; Collela, B; Wiseman-Hakes, C; Green, R; Rochon, E				Bitan, Tali; Simic, Tijana; Saverino, Cristina; Jones, Cheryl; Glazer, Joanna; Collela, Brenda; Wiseman-Hakes, Catherine; Green, Robin; Rochon, Elizabeth			Changes in Resting-State Connectivity following Melody-Based Therapy in a Patient with Aphasia	NEURAL PLASTICITY			English	Article							RIGHT FRONTAL-CORTEX; INTONATION THERAPY; FUNCTIONAL CONNECTIVITY; LANGUAGE FUNCTION; NONFLUENT APHASIA; RECOVERY; SPEECH; BRAIN; PET; MUSIC	Melody-based treatments for patients with aphasia rely on the notion of preserved musical abilities in the RH, following left hemisphere damage. However, despite evidence for their effectiveness, the role of the RH is still an open question. We measured changes in resting-state functional connectivity following melody-based intervention, to identify lateralization of treatment-related changes. A patient with aphasia due to left frontal and temporal hemorrhages following traumatic brain injuries (TBI) more than three years earlier received 48 sessions of melody-based intervention. Behavioral measures improved and were maintained at the 8-week posttreatment follow-up. Resting-state fMRI data collected before and after treatment showed an increase in connectivity between motor speech control areas (bilateral supplementary motor areas and insulae) and RH language areas (inferior frontal gyrus pars triangularis and pars opercularis). This change, which was specific for the RH, was greater than changes in a baseline interval measured before treatment. No changes in RH connectivity were found in a matched control TBI patient scanned at the same intervals. These results are compatible with a compensatory role for RH language areas following melody-based intervention. They further suggest that this therapy intervenes at the level of the interface between language areas and speech motor control areas necessary for language production.	[Bitan, Tali] Univ Haifa, Haifa, Israel; [Bitan, Tali; Simic, Tijana; Jones, Cheryl; Wiseman-Hakes, Catherine; Green, Robin; Rochon, Elizabeth] Univ Toronto, Toronto, ON, Canada; [Simic, Tijana; Saverino, Cristina; Glazer, Joanna; Collela, Brenda; Wiseman-Hakes, Catherine; Green, Robin; Rochon, Elizabeth] Toronto Rehabil Inst, Toronto, ON, Canada; [Simic, Tijana; Rochon, Elizabeth] Canadian Partnership Stroke Recovery Heart & Stro, Ottawa, ON, Canada		Bitan, T (corresponding author), Univ Haifa, Haifa, Israel.; Bitan, T (corresponding author), Univ Toronto, Toronto, ON, Canada.	tbitan@research.haifa.ac.il	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Rochon, Elizabeth/0000-0001-5521-0513; Simic, Tijana/0000-0001-6638-6514; Green, Robin/0000-0001-9451-3963; Bitan, Tali/0000-0001-6160-587X			Abel S, 2015, BRAIN, V138, P1097, DOI 10.1093/brain/awv022; Abo M, 2004, NEUROREPORT, V15, P1891, DOI 10.1097/00001756-200408260-00011; Ackermann H, 2010, BRAIN STRUCT FUNCT, V214, P419, DOI 10.1007/s00429-010-0257-x; Al-Janabi S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00037; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; ALBERT ML, 1973, ARCH NEUROL-CHICAGO, V29, P130, DOI 10.1001/archneur.1973.00490260074018; Baker F.A., 2000, MUSIC THER PERSPECT, V18, P110, DOI [10.1093/mtp/18.2.110, DOI 10.1093/MTP/18.2.110]; Baldo JV, 2011, CORTEX, V47, P800, DOI 10.1016/j.cortex.2010.07.001; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; Benjamin ML, 2014, NEUROREHAB NEURAL RE, V28, P545, DOI 10.1177/1545968313517754; Blasi V, 2002, NEURON, V36, P159, DOI 10.1016/S0896-6273(02)00936-4; Bonakdarpour B, 2003, APHASIOLOGY, V17, P75, DOI 10.1080/729254891; Breier JI, 2010, J CLIN EXP NEUROPSYC, V32, P309, DOI 10.1080/13803390903029293; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Cappa SF, 1997, BRAIN LANG, V56, P55, DOI 10.1006/brln.1997.1737; Coltheart M., 1992, PALPA PSYCHOLINGUIST; Crosson B, 2009, BRAIN LANG, V111, P73, DOI 10.1016/j.bandl.2009.08.001; Fan YT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085880, 10.1371/journal.pone.0102471, 10.1371/journal.pone.0097178]; Fridriksson J, 2010, J NEUROSCI, V30, P11558, DOI 10.1523/JNEUROSCI.2227-10.2010; Heiss WD, 2003, NEUROIMAGE, V20, pS42, DOI 10.1016/j.neuroimage.2003.09.005; Helm-Estabrooks N., 1981, HELM ELICITED LANGUA; Hough MS, 2010, APHASIOLOGY, V24, P775, DOI 10.1080/02687030903501941; Howard D, 1992, PYRAMIDS PALM TREES; Hurkmans J, 2012, APHASIOLOGY, V26, P1, DOI 10.1080/02687038.2011.602514; James GA, 2009, TOP STROKE REHABIL, V16, P270, DOI 10.1310/tsr1604-270; Jeffries KJ, 2003, NEUROREPORT, V14, P749, DOI 10.1097/00001756-200304150-00018; Jungblut M, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/841982; Kaplan E., 2001, ASSESSMENT APHASIA R; Kim M, 2008, TOP STROKE REHABIL, V15, P555, DOI 10.1310/tsr1506-555; Leonard C, 2015, APHASIOLOGY, V29, P506, DOI 10.1080/02687038.2014.971099; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; Muller AM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00228; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Naeser MA, 2004, NEUROIMAGE, V22, P29, DOI 10.1016/j.neuroimage.2003.11.016; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; Orellana CPM, 2014, BRAIN BEHAV, V4, P615, DOI 10.1002/brb3.245; Petrides M., 2014, NEUROANATOMY LANGUAG; Postman-Caucheteux WA, 2010, J COGNITIVE NEUROSCI, V22, P1299, DOI 10.1162/jocn.2009.21261; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2005, CURR OPIN NEUROL, V18, P429, DOI 10.1097/01.wco.0000168081.76859.c1; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Rochon E, 2010, BRAIN LANG, V114, P164, DOI 10.1016/j.bandl.2010.05.005; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rosenbek, 1984, APRAXIA SPEECH ADULT; SAMSON S, 1994, NEUROPSYCHOLOGIA, V32, P231, DOI 10.1016/0028-3932(94)90008-6; SAMSON S, 1988, BRAIN COGNITION, V7, P348, DOI 10.1016/0278-2626(88)90008-5; Sandberg CW, 2015, BRAIN LANG, V150, P103, DOI 10.1016/j.bandl.2015.09.002; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schlaug G, 2008, MUSIC PERCEPT, V25, P315, DOI 10.1525/MP.2008.25.4.315; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schuppert M, 2000, BRAIN, V123, P546, DOI 10.1093/brain/123.3.546; Shuster LI, 2009, BRAIN LANG, V111, P66, DOI 10.1016/j.bandl.2009.06.003; SPARKS R, 1974, Cortex, V10, P303; Tabei K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00148; Thaut MH, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01185; Tie YM, 2014, HUM BRAIN MAPP, V35, P1018, DOI 10.1002/hbm.22231; Tourville JA, 2011, LANG COGNITIVE PROC, V26, P952, DOI 10.1080/01690960903498424; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van de Sandt-Koenderman M, 2010, PROCD SOC BEHV, V6, P241, DOI 10.1016/j.sbspro.2010.08.121; van de Wal M, 2016, ACTA ONCOL, V55, P821, DOI 10.3109/0284186X.2016.1150607; Van der Meulen I, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00533; van der Meulen I, 2014, NEUROREHAB NEURAL RE, V28, P536, DOI 10.1177/1545968313517753; van der Meulen I, 2012, ARCH PHYS MED REHAB, V93, pS46, DOI 10.1016/j.apmr.2011.05.029; van Hees S, 2014, HUM BRAIN MAPP, V35, P3919, DOI 10.1002/hbm.22448; Vines BW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00230; Wan CY, 2014, BRAIN LANG, V136, P1, DOI 10.1016/j.bandl.2014.03.011; Wilson SJ, 2006, MUSIC PERCEPT, V24, P23, DOI 10.1525/mp.2006.24.1.23; Winhuisen L, 2005, STROKE, V36, P1759, DOI 10.1161/01.STR.0000174487.81126.ef; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zipse L, 2012, ANN NY ACAD SCI, V1252, P237, DOI 10.1111/j.1749-6632.2012.06454.x	77	3	3	1	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2018	2018								6214095	10.1155/2018/6214095			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GC3JZ	WOS:000429681500001	29796017	Green Submitted, Green Published, gold			2022-02-06	
S	Bragin, DE; Lara, DA; Bragina, OA; Kameneva, MV; Nemoto, EM		Thews, O; LaManna, JC; Harrison, DK		Bragin, D. E.; Lara, D. A.; Bragina, O. A.; Kameneva, M. V.; Nemoto, E. M.			Resuscitation Fluid with Drag Reducing Polymer Enhances Cerebral Microcirculation and Tissue Oxygenation After Traumatic Brain Injury Complicated by Hemorrhagic Shock	OXYGEN TRANSPORT TO TISSUE XL	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	45th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT)	AUG 19-23, 2017	Martin Luther Univ, Med Fac, Halle, GERMANY	Int Soc Oxygen Transport Tissue, Oxford Optronix, Hamamatsu Photon, Univ Hosp Halle	Martin Luther Univ, Med Fac		PRESSURE; HYPOXIA; FLOW	Traumatic brain injury (TBI) is frequently accompanied by hemorrhagic shock (HS) which significantly worsens morbidity and mortality. Existing resuscitation fluids (RF) for volume expansion inadequately mitigate impaired microvascular cerebral blood flow (mvCBF) and hypoxia after TBI/HS. We hypothesized that nanomolar quantities of drag reducing polymers in resuscitation fluid (DRP-RF), would improve mvCBF by rheological modulation of hemodynamics. Methods: TBI was induced in rats by fluid percussion (1.5 atm, 50 ms) followed by controlled hemorrhage to a mean arterial pressure (MAP) = 40 mmHg. DRP-RF or lactated Ringer (LR-RF) was infused to MAP of 60 mmHg for 1 h (pre-hospital), followed by blood re-infusion to a MAP = 70 mmHg (hospital). Temperature, MAP, blood gases and electrolytes were monitored. In vivo 2-photon laser scanning microscopy was used to monitor microvascular blood flow, hypoxia (NADH) and necrosis (i.v. propidium iodide) for 5 h after TBI/HS followed by MRI for CBF and lesion volume. Results: TBI/HS compromised brain microvascular flow leading to capillary microthrombosis, tissue hypoxia and neuronal necrosis. DRP-RF compared to LR-RF reduced microthrombosis, restored collapsed capillary flow and improved mvCBF (82 +/- 9.7% vs. 62 +/- 9.7%, respectively, p < 0.05, n = 10). DRP-RF vs LR-RF decreased tissue hypoxia (77 +/- 8.2% vs. 60 +/- 10.5%, p < 0.05), and neuronal necrosis (21 +/- 7.2% vs. 36 +/- 7.3%, respectively, p < 0.05). MRI showed reduced lesion volumes with DRP-RF. Conclusions: DRP-RF effectively restores mvCBF, reduces hypoxia and protects neurons compared to conventional volume expansion with LR-RF after TBI/HS.	[Bragin, D. E.; Lara, D. A.; Bragina, O. A.; Nemoto, E. M.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; [Kameneva, M. V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA		Bragin, DE (corresponding author), Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Bragin, Denis/E-5494-2016; Bragina, Olga A/H-6696-2016	Bragin, Denis/0000-0003-4894-0061; Bragina, Olga A/0000-0003-2810-9764	DODUnited States Department of Defense [DM160142, R21NS091600]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091600] Funding Source: NIH RePORTER	Supported by DOD DM160142, R21NS091600 and RMSE No 17.1223.2017/AP.	Bragin DE, 2017, J CEREBR BLOOD F MET, V37, P762, DOI 10.1177/0271678X16684153; Bragin DE, 2014, CRIT CARE MED, V42, P2582, DOI 10.1097/CCM.0000000000000655; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Fumagalli S, 2011, STROKE, V42, P1429, DOI 10.1161/STROKEAHA.110.603704; Kameneva MV, 2012, INT J ENG SCI, V59, P168, DOI 10.1016/j.ijengsci.2012.03.014; Kameneva MV, 2004, BIORHEOLOGY, V41, P53; Lee EJ, 1999, J NEUROL SCI, V164, P117, DOI 10.1016/S0022-510X(99)00068-4; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979	10	3	3	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-91287-5; 978-3-319-91285-1	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1072						39	43		10.1007/978-3-319-91287-5_7			5	Medicine, Research & Experimental; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Physiology	BL6LR	WOS:000454396400008	30178321	Green Accepted			2022-02-06	
J	Byard, RW; Donkin, J; Vink, R				Byard, Roger W.; Donkin, James; Vink, Robert			The Forensic Implications of Amphetamine Intoxication in Cases of Inflicted Blunt Craniocerebral Trauma	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; amphetamine toxicity; traumatic brain injury; blunt head trauma; neuroprotection; dopamine; flight or fight	LOW-DOSE METHAMPHETAMINE; BRAIN-INJURY; RATS; DYSFUNCTION; ECSTASY; IMPACT	The effects of D-amphetamine on outcome after blunt craniocerebral trauma are characterized and the potential legal implications discussed. Traumatic brain injury (TBI) was induced under general anesthesia in adult, male Sprague Dawley rats using the impact acceleration model. At 10min prior to injury, D-amphetamine (5mg/kg) or saline vehicle was administered subcutaneously; animals were subsequently assessed over a 7-day period post-trauma for motor outcome using a rotarod device. D-amphetamine treated animals performed significantly better (p<0.001; ANOVA) than vehicle treated controls on their motor assessment, suggesting that D-amphetamine exposure prior to injury either is neuroprotective or enhances motor performance. It is possible, therefore, that an individual who has taken amphetamines may function at a better motor level after head trauma than one who has not been exposed to the drug. Future interpretations of the potential effects of amphetamines on TBI should include this possibility.	[Byard, Roger W.] Univ Adelaide, Sch Med, Frome Rd,Level 3 Med Sch North Bldg, Adelaide, SA 5005, Australia; [Donkin, James] Univ Sunshine Coast, Maroochydore, Qld 4558, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia		Byard, RW (corresponding author), Univ Adelaide, Sch Med, Frome Rd,Level 3 Med Sch North Bldg, Adelaide, SA 5005, Australia.	roger.byard@sa.gov.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Byard RW, 1998, AM J FOREN MED PATH, V19, P261, DOI 10.1097/00000433-199809000-00013; Caldicott DGE, 2003, J TOXICOL-CLIN TOXIC, V41, P143, DOI 10.1081/CLT-120019130; CHANDLER JV, 1980, MED SCI SPORT EXER, V12, P65; Chapotot F, 2003, PSYCHOPHARMACOLOGY, V166, P127, DOI 10.1007/s00213-002-1315-8; desWit H, 1997, PHARM BIOCH BEHAV, V57, P333; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Edut S, 2014, J MOL NEUROSCI, V54, P684, DOI 10.1007/s12031-014-0399-z; Fernando T, 2012, J FORENSIC SCI, V57, P1137, DOI 10.1111/j.1556-4029.2012.02107.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Karch S.B., 2016, KARCHS PATHOLOGY DRU, Vfifth, P273; Marshall JF, 2012, TRENDS NEUROSCI, V35, P536, DOI 10.1016/j.tins.2012.05.006; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Phelan K, 2013, NEUROCRIT CARE, V19, P183, DOI 10.1007/s12028-013-9871-9; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Rau T, 2016, PROG NEURO-PSYCHOPH, V64, P231, DOI 10.1016/j.pnpbp.2015.02.013; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Shoblock JR, 2003, PSYCHOPHARMACOLOGY, V165, P359, DOI 10.1007/s00213-002-1288-7; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Vearrier D, 2012, DM-DIS MON, V58, P38, DOI 10.1016/j.disamonth.2011.09.004; Vink R, 2012, J FORENSIC SCI, V57, P979, DOI 10.1111/j.1556-4029.2012.02108.x	24	3	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	JAN	2018	63	1					151	153		10.1111/1556-4029.13509			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FR9HW	WOS:000419385600016	28383154				2022-02-06	
J	Byrne, N				Byrne, Nicole			Internet images of the speech pathology profession	AUSTRALIAN HEALTH REVIEW			English	Article						allied health; career choice; content analysis; workforce	TRAUMATIC BRAIN-INJURY; HEALTH INFORMATION; MEDIA; NURSE	Objective The Internet provides the general public with information about speech pathology services, including client groups and service delivery models, as well as the professionals providing the services. Although this information assists the general public and other professionals to both access and understand speech pathology services, it also potentially provides information about speech pathology as a prospective career, including the types of people who are speech pathologists (i.e. demographics). The aim of the present study was to collect baseline data on how the speech pathology profession was presented via images on the Internet. Methods A pilot prospective observational study using content analysis methodology was conducted to analyse publicly available Internet images related to the speech pathology profession. The terms Speech Pathology' and speech pathologist' to represent both the profession and the professional were used, resulting in the identification of 200 images. These images were considered across a range of areas, including who was in the image (e.g. professional, client, significant other), the technology used and the types of intervention. Results The majority of images showed both a client and a professional (i.e. speech pathologist). While the professional was predominantly presented as female, the gender of the client was more evenly distributed. The clients were more likely to be preschool or school aged, however male speech pathologists were presented as providing therapy to selected age groups (i.e. school aged and younger adults). Images were predominantly of individual therapy and the few group images that were presented were all paediatric. Conclusion Current images of speech pathology continue to portray narrow professional demographics and client groups (e.g. paediatrics). Promoting images of wider scope to fully represent the depth and breadth of speech pathology professional practice may assist in attracting a more diverse group of people into the profession in the future. What is known about the topic? To date, research has not considered the promotional profile of allied health professionals on the Internet. There has been a lack of consideration of whether the way in which the professions are promoted may affect clients accessing allied health services or people entering careers. What does this paper add? This paper raises awareness of the lack of promotion of a diverse workforce in speech pathology and considers how this may affect changing the professional demographics in the future. It also provides a starting point for documentation in the form of a baseline for tracking future changes. It allows consideration of the fact that when designing health promotional and educational materials, it is crucial that diversity is displayed in the professional role, the client role and the setting in order to provide information and education to the general public about the health services provided. What are the implications for practitioners? The presentation of narrow demographics of both the professional and client may potentially affect people considering speech pathology as a future career. The appearance of narrow client demographics and diagnosis groups may also deter people from accessing services. For example, if the demonstrated images do not show older people accessing speech pathology services, then this may suggest that services are only for children. The results from the present case example are transferrable to other health professions with similar professional demographic profiles (e.g. occupational therapy). Consideration of the need to display a diverse client profile is relevant to all health and medical services, and demonstrates steps towards inclusiveness and increasing engagement of clients who may be currently less likely to access health services (including people who are Aboriginal or from a culturally and linguistically diverse background).	[Byrne, Nicole] Univ Newcastle, Fac Educ & Arts, Sch Humanities & Social Sci, GP2-28,Gen Purpose Bldg,Univ Dr, Callaghan, NSW 2308, Australia		Byrne, N (corresponding author), Univ Newcastle, Fac Educ & Arts, Sch Humanities & Social Sci, GP2-28,Gen Purpose Bldg,Univ Dr, Callaghan, NSW 2308, Australia.	Nicole.Byrne@newcastle.edu.au					Australian Council Education Research, 2015, TEACH WORKF AUSTR SU; Australian Institute of Health and Welfare (AIHW), 2013, AUSTR I HLTH WELF NA, V5; Beauregard MA, 2003, J NURS ADMIN, V33, P510, DOI 10.1097/00005110-200310000-00005; Bernstam EV, 2005, INT J MED INFORM, V74, P13, DOI 10.1016/j.ijmedinf.2004.10.001; Bimrose J, 2017, CAREER COUNSELLING C; Boyd S, 2001, INT J LANG COMM DIS, V36, P167, DOI 10.3109/13682820109177878; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Byrne N, 2010, INT J SPEECH LANGUAG, V12, P1; Byrne N., 2007, THESIS; Byrne N., 2008, J ALLIED HLTH, V37, P24; Byrne N., 2015, J CLIN PRACTICE SPEE, V17, P32; Coulson NS, 2007, PATIENT EDUC COUNS, V68, P173, DOI 10.1016/j.pec.2007.06.002; Ellis G, 1962, J AUST COLL SPEECH T, V12, P24; Fox S, 2006, ONLINE HLTH SEARCH 2; Glazer H, 1994, J Healthc Educ Train, V8, P13; Hallam J, 2000, NURSING IMAGE MEDIA; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; Health Workforce Australia, 2014, DETAILED REPORT; IER, 1995, GEN PUBL PERC SPEECH; Inhwa Kim, 2010, Journal of Computing and Information Technology - CIT, V18, P369, DOI 10.2498/cit.1001924; Kalisch BJ, 2007, NURS OUTLOOK, V55, P182, DOI 10.1016/j.outlook.2006.09.002; Krippendorff K., 2018, CONTENT ANAL INTRO I; Krippendorff K., 2009, CONTENT ANAL READER; Liamputtong P., 2005, QUALITATIVE RES METH; Litosseliti L, 2013, INT J LANG COMM DIS, V48, P90, DOI 10.1111/j.1460-6984.2012.00188.x; Macnamara J., 2005, ASIA PACIFIC PUBLIC, V6, P1, DOI [10.1093/irap/lci133, DOI 10.1093/irap/lci133]; McAllister L, 2005, P SPEECH PATH AUSTR, P1; Mendick H, 2013, GENDER EDUC, V25, P325, DOI 10.1080/09540253.2012.740447; Murton D, 2015, AUSTR INTERNET SOCIA; NEUENDORF K.A., 2017, CONTENT ANAL GUIDEBO; Nickless T, 2004, ACQUIRING KNOWLEDGE, V6, P167; Powers G, 2000, COMMUNICATION SCI DI, P3; PRYOR RGL, 1986, AUST PSYCHOL, V21, P363, DOI 10.1080/00050068608256914; Rainie L., 2000, ONLINE HLTH CARE REV; Ramanadhan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1129; Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032; Ricker JH, 2003, NEUROREHABILITATION, V18, P179; Rudy RM, 2010, SEX ROLES, V62, P705, DOI 10.1007/s11199-010-9807-1; Sheridan J, 1999, RCSLT B, V562, P3; Speech Pathology Australia, 2014, REAL MEN DO SPEECH P; Speech Pathology Australia, 2016, SPEECH PATH 2030 MAK; Speech Pathology Australia, 2014, INQ PREV DIFF UNPUB; Speech Pathology Australia, 2011, COMP BAS OCC STAND S; Speech Pathology Australia, 1999, ACQ, V1, P3; Stapleford J, 1998, Int J Lang Commun Disord, V33 Suppl, P261; Thayer A, 2007, J TECH WRIT COMMUN, V37, P267	46	3	3	0	8	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2018	42	4					420	428		10.1071/AH17033			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GP2NH	WOS:000440670300009	28578754				2022-02-06	
J	Campbell, KA; Kennedy, RE; Brunner, RC; Hollis, SD; Lumsden, RA; Novack, TA				Campbell, Kelsey A.; Kennedy, Richard E.; Brunner, Robert C.; Hollis, Sean D.; Lumsden, Ross A.; Novack, Thomas A.			The effect of donepezil on the cognitive ability early in the course of recovery from traumatic brain injury	BRAIN INJURY			English	Article						Cognition; rehabilitation; TBI	LONG-TERM DISABILITY; UNITED-STATES; HEAD-INJURY; MEMORY; NEUROTRANSMISSION; PHARMACOTHERAPY; REHABILITATION; ACETYLCHOLINE; METABOLISM; MECHANISMS	Objective: To investigate the effect of donepezil on cognitive ability in patients who have sustained a traumatic brain injury (TBI). We hypothesized that donepezil, an acetylcholinesterase inhibitor, would enhance cognitive recovery beyond that of usual care in an acute rehabilitation facility.Methods: This retrospective, longitudinal analysis included 55 patients who were non-randomly prescribed donepezil during acute care and compared them to 74 patients who received usual rehabilitation treatment. All 129 patients completed neuropsychological assessment at two time points. Donepezil was increased from 5 to 10mg 7-10days after initiation and maintained until follow-up cognitive assessment.Main outcomes: Primary cognitive abilities of interest included processing speed, attention and memory. Cognitive and functional abilities were assessed by a standard neuropsychological battery for TBI.Results: Propensity scores were used to adjust for differences between groups. Mixed effect model analysis showed no significant differences between treatment and control groups on all neuropsychological subtests over time.Conclusions: Acute administration of donepezil did not significantly improve measures of cognitive or functional ability beyond that of treatment as usual in patients with moderate-to-severe TBI.	[Campbell, Kelsey A.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Kennedy, Richard E.] Univ Alabama Birmingham, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA; [Brunner, Robert C.; Hollis, Sean D.; Lumsden, Ross A.; Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Novack, TA (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, Spain Rehabil Ctr 530, 619 19th St South, Birmingham, AL 35249 USA.	tnovack@uabmc.edu	Kennedy, Richard/K-1525-2018	Kennedy, Richard/0000-0003-4638-126X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0044]	This work was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research [90DP0044].	Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; [Anonymous], 2015, C TRAUM BRAIN INJ US; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; Brown H., 2015, APPL MIXED MODELS ME; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; EGHWRUDJAKPOR PO, 1991, SURG NEUROL, V35, P273, DOI 10.1016/0090-3019(91)90004-S; Foster M, 2008, J NEUROPSYCH CLIN N, V20, P106, DOI 10.1176/jnp.2008.20.1.106; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Kaye NS, 2003, J NEUROPSYCHIATRY CL, V15, P383; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Liepert J, 2016, CURR OPIN NEUROL, V29, P700, DOI 10.1097/WCO.0000000000000381; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reitan R, 1985, HALSTEAD REITAN NEUR; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; Samuel G S, 2013, Med J Malaysia, V68, P376; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Sugden SG, 2006, NEUROREHABILITATION, V21, P3; Taverni JP, 1998, BRAIN INJURY, V12, P77; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; VANWOERKOM TCAM, 1977, LANCET, V1, P812; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 2008, WECHSLER MEMORY SCAL; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Williams MW, 2017, REHABIL PSYCHOL, V62, P407, DOI 10.1037/rep0000168; Wirkowski E, 1991, J Neuropsychiatry Clin Neurosci, V3, P73; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yoo JH, 2007, J AUTISM DEV DISORD, V37, P1883, DOI 10.1007/s10803-006-0322-8; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	55	3	4	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		972	979		10.1080/02699052.2018.1468574			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400003	29737870				2022-02-06	
J	Catapano, JS; Chapman, AJ; Farber, SH; Horner, LP; Morgan, C; Brigeman, S; Hendricks, BK; Lu, MG; Fraser, DR				Catapano, Joshua S.; Chapman, Alistair J.; Farber, S. Harrison; Horner, Lance P.; Morgan, Clinton; Brigeman, Scott; Hendricks, Benjamin K.; Lu, Minggen; Fraser, Douglas R.			Treadmill associated head injuries on the rise: an 18 year review of US emergency room visits	BRAIN INJURY			English	Article						Traumatic Brain Injury; Treadmill Injuries; Head Trauma	HOME EXERCISE EQUIPMENT; FRICTION INJURIES	Objective: The treadmill is the most commonly used aerobic exercise equipment with studies showing many gym-related injuries are attributed to treadmills. The purpose of this study is to examine the incidence of treadmill-associated head injuries within the US.Methods: Retrospective data from 1997 to 2014 was collected via the National Electronic Injury Surveillance System, which provides annual es7timates of injuries associated with consumer products. Patients over 18years who sustained treadmill-associated head injuries were included, and the estimated annual incidence was determined.Results: An estimated 4929 patients presented to US emergency departments with a head injury while exercising on a treadmill between 1997 and 2014. A >1000% increase in the number of head injuries was observed over the study period (p-value <0.001). Patients over 50 had a 14 times greater risk of admission than younger patients (p-value <0.001). Injuries were greater in women than men.Conclusion: Our study demonstrates a significant increase treadmill-associated head injuries from 1997 to 2014. This phenomenon is most pronounced in older and female populations. The exact etiology of this large increase remains unclear. Education on the proper use of treadmills as well as further investigation into the cause of the increase are warranted.	[Catapano, Joshua S.; Farber, S. Harrison; Morgan, Clinton; Brigeman, Scott; Hendricks, Benjamin K.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Fraser, Douglas R.] Univ Nevada Las Vegas, Dept Surg, Sch Med, Las Vegas, NV USA; [Horner, Lance P.] Univ Nevada, Sch Med, Dept Surg, Reno, NV 89557 USA; [Lu, Minggen] Univ Nevada, Dept Community Hlth Sci, Reno, NV 89557 USA; [Chapman, Alistair J.] Michigan State Univ, Dept Surg, Spectrum Hlth, Coll Human Med, Grand Rapids, MI USA		Catapano, JS (corresponding author), Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	Joshua.Catapano@barrowbrainandspine.com	Hendricks, Benjamin/AAI-6544-2020	Hendricks, Benjamin/0000-0002-7123-4387; Catapano, Joshua/0000-0001-6599-0269; Morgan, Clinton/0000-0002-7511-0488			Abbas Mazen I., 2004, Journal of the American Osteopathic Association, V104, P372; [Anonymous], 2013, SPORTS FITNESS LEISU; Collier ML, 2004, J BURN CARE REHABIL, V25, P441, DOI 10.1097/01.BCR.0000138296.96905.EF; Division of Aging and Seniors and PHAo Canada, 2002, J CLIN EPIDEMIOL, V55, P1088; Graves JM, 2014, INJURY PREV, V20, P281, DOI 10.1136/injuryprev-2013-040833; Han T, 2005, BURNS, V31, P906, DOI 10.1016/j.burns.2005.04.023; Jeremijenko L, 2009, J PAEDIATR CHILD H, V45, P310, DOI 10.1111/j.1440-1754.2008.01329.x; Juang D, 2011, J SURG RES, V170, P139, DOI 10.1016/j.jss.2011.02.015; Kessler E., 1999, NEISS SAMPLE DESIGN; Lehrer MS, 1997, J TRAUMA, V43, P100, DOI 10.1097/00005373-199707000-00023; Lohana P, 2012, ANN ROY COLL SURG, V94, P121, DOI 10.1308/003588412X13171221501942; Maguina P, 2004, J BURN CARE REHABIL, V25, P201, DOI 10.1097/01.BCR.0000111760.85642.AB; Martinez A, 2011, CLIN PEDIATR, V50, P553, DOI 10.1177/0009922810396547; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	14	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					800	803		10.1080/02699052.2018.1458149			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200015	29601218				2022-02-06	
J	Chen, K; Xiong, B; Ren, YP; Dvorkin, AY; Gaebler-Spira, D; Sisung, CE; Zhang, LQ				Chen, Kai; Xiong, Bo; Ren, Yupeng; Dvorkin, Assaf Y.; Gaebler-Spira, Deborah; Sisung, Charles E.; Zhang, Li-Qun			ANKLE PASSIVE AND ACTIVE MOVEMENT TRAINING IN CHILDREN WITH ACUTE BRAIN INJURY USING A WEARABLE ROBOT	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation; robotics; acute-phase	PEDIATRIC REHABILITATION; STROKE; NEUROREHABILITATION; VALIDATION; ABILITIES; RECOVERY; IMPROVE; BALANCE; TBI	Objective: To evaluate the feasibility and effectiveness of a wearable robotic device in guiding isometric torque generation and passive-active movement training for ankle motor recovery in children with acute brain injury. Participants/setting: Ten inpatient children with acute brain injury being treated in a rehabilitation hospital. Design: Daily robot-guided ankle passive-active movement therapy for 15 sessions, including isometric torque generation under real-time feedback, stretching, and active movement training with motivating games using a wearable ankle rehabilitation robot. Main measures: Ankle biomechanical improvements induced by each training session including ankle range of motion (ROM), muscle strength, and clinical (Fugl-Meyer Lower-Extremity (FMLE), Pediatric Balance Scale (PBS)) and biomechanical (ankle ROM and muscle strength) outcomes over 15 training sessions. Results: As training progressed, improvements in biomechanical performance measures followed logarithmic curves. Each training session increased median dorsiflexion active range of motion (AROM) 2.73 degrees (standard deviation (SD) 1.14), dorsiflexion strength 0.87 Nm (SD 0.90), and plantarflexion strength 0.60 Nm (SD 1.19). After 15 training sessions the median FMLE score had increased from 14.0 (SD 10.11) to 23.0 (SD 11.4), PBS had increased from 33.0 (SD 19.99) to 50.0 (SD 23.13) (p < 0.05), median dorsiflexion and plantarflexion strength had improved from 0.21 Nm (SD 4.45) to 4.0 Nm (SD 7.63) and 8.33 Nm (SD 10.18) to 18.45 Nm (SD 14.41), respectively, median dorsiflexion AROM had improved from -10.45 degrees (SD 12.01) to 11.87 degrees (SD 20.69), and median dorsiflexion PROM increased from 20.0 degrees (SD 9.04) to 25.0 degrees (SD 8.03). Conclusion: Isometric torque generation with real-time feedback, stretching and active movement training helped promote neuroplasticity and improve motor performance in children with acute brain injury.	[Chen, Kai; Ren, Yupeng; Dvorkin, Assaf Y.; Gaebler-Spira, Deborah; Sisung, Charles E.; Zhang, Li-Qun] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Xiong, Bo; Dvorkin, Assaf Y.; Gaebler-Spira, Deborah; Sisung, Charles E.; Zhang, Li-Qun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Zhang, Li-Qun] Northwestern Univ, Dept Orthopaed Surg, Chicago, IL 60611 USA; [Zhang, Li-Qun] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Zhang, Li-Qun] Univ Maryland, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Zhang, Li-Qun] Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA; [Zhang, Li-Qun] Univ Maryland, Dept Bioengn, College Pk, MD 20742 USA		Zhang, LQ (corresponding author), Univ Maryland, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA.	zhangl@umd.edu		Xiong, Bo/0000-0002-6566-8322; Gaebler-Spira, Deborah/0000-0001-6827-4241	National Institute on Disability and Rehabilitation Research [NIDRR H133E100007]; National Science FoundationNational Science Foundation (NSF) [IIP-0750515]	This study was supported in part by the National Institute on Disability and Rehabilitation Research (NIDRR H133E100007) and National Science Foundation (IIP-0750515).	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Becher JG, 1998, J REHABIL RES DEV, V35, P314; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bharadwaj K, 2005, J BIOMECH ENG-T ASME, V127, P1009, DOI 10.1115/1.2049333; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Chen JJJ, 2005, ARCH PHYS MED REHAB, V86, P1655, DOI 10.1016/j.apmr.2005.03.019; Chin LF, 2010, SINGAP MED J, V51, P709; Christensen H. I., 2009, ROADMAP US ROBOTICS; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; Faul M, 2010, TRAUMATIC BRAIN INJU; Fowler EG, 2009, DEV MED CHILD NEUROL, V51, P607, DOI 10.1111/j.1469-8749.2008.03186.x; Freivogel S, 2008, BRAIN INJURY, V22, P625, DOI 10.1080/02699050801941771; Gazzellini S, 2012, EUR J PHYS REHAB MED, V48, P423; Hesse S, 2003, CURR OPIN NEUROL, V16, P705, DOI 10.1097/00019052-200312000-00010; Hoofien D, 2001, BRAIN INJURY, V15, P189; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; Lynch D, 2005, CLIN REHABIL, V19, P594, DOI 10.1191/0269215505cr901oa; Mohammed S, 2012, ADV ROBOTICS, V26, P1, DOI 10.1163/016918611X607356; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Reinkensmeyer D J, 1999, IEEE Trans Rehabil Eng, V7, P1, DOI 10.1109/86.750543; Ren Y, 2016, IEEE T NEURAL SYST R; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; Sandin Karl J, 2012, Minn Med, V95, P46; Tefertiller C, 2011, J REHABIL RES DEV, V48, P387, DOI 10.1682/JRRD.2010.04.0055; The Management Of Stroke Rehabilitation Working Group, 2010, VA DOD CLIN PRACT GU; Volpe Bruce T, 2005, Curr Neurol Neurosci Rep, V5, P465, DOI 10.1007/s11910-005-0035-y; Waldman G, 2013, NEUROREHABILITATION, V32, P625, DOI 10.3233/NRE-130885; Zhang LQ, 2002, IEEE T NEUR SYS REH, V10, P149, DOI 10.1109/TNSRE.2002.802857; Zhang MM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-30; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	34	3	4	3	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2018	50	1					30	36		10.2340/16501977-2285			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GJ6ZD	WOS:000435532700006	29104998	gold, Green Submitted			2022-02-06	
J	Cronin, H; O'Loughlin, E				Cronin, Heather; O'Loughlin, Emer			Sleep and fatigue after TBI	NEUROREHABILITATION			English	Article						Sleep disturbance; fatigue; brain injury; neuropsychological rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; 1ST 2 YEARS; MULTIPLE-SCLEROSIS; DAYTIME SLEEPINESS; MENTAL FATIGUE; OBJECTIVE MEASURES; QUALITY INDEX; HEAD-INJURY; POOR SLEEP	BACKGROUND: Whilst post traumatic brain injury fatigue (PTBIF) and sleep disturbance are common sequelae following brain injury, underlying mechanisms, and the potential for targeted interventions remain unclear. OBJECTIVE: To present a review of recent studies exploring the epidemiology of PTBIF and sleep disturbance, the relationship and neuropsychological correlates of these issues, potential approaches to intervention, and implications for neurorehabilitation. METHODS: A review of relevant literature was undertaken, with a focus on PTBIF relating to sleep disturbance, the neuropsychological correlates of these issues and implications for neurorehabilitation. This paper does not set out to provide a systematic review. RESULTS: Multidimensional approaches to assessment and treatment of sleep disturbance and PTBIF are required. CONCLUSIONS: There is a need for more robust findings in determining the complex nature of relationships between PTBIF, sleep disturbance, and correlates. Longitudinal prospective data is required to increase our understanding of the nature and course of PTBIF and sleep disturbance post TBI. Large scale clinical trials are required in evaluating the potential benefits of interventions.	[Cronin, Heather] Natl Rehabil Hosp, Rochestown Ave, Dun Laoghaire A96 P235, Dublin, Ireland; [O'Loughlin, Emer] Hlth Serv Execut Ireland, Dublin, Ireland		Cronin, H (corresponding author), Natl Rehabil Hosp, Rochestown Ave, Dun Laoghaire A96 P235, Dublin, Ireland.	Heather.cronin@nrh.ie					Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arand D, 2005, SLEEP, V28, P123, DOI 10.1093/sleep/28.1.123; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beaulieu-Bonneau S, 2017, NEUROPSYCHOL REHABIL, V27, P983, DOI 10.1080/09602011.2016.1162176; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Bogdanov S, 2017, SLEEP OUTCOMES FOLLO, V30, P422; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Carney C, 2008, OVERCOMING INSOMNIA; Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Duntley SP, 2005, ISS CLIN COGN NEUROP, P209; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fernie BA, 2015, J PSYCHOSOM RES, V78, P411, DOI 10.1016/j.jpsychores.2015.02.012; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Folkman S., 1984, STRESS; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kolakowsky-Hayner SA, 2017, NEUROPSYCHOL REHABIL, V27, P1002, DOI 10.1080/09602011.2016.1229680; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lequerica A, 2014, NEUROREHABILITATION, V35, P485, DOI 10.3233/NRE-141141; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Levine J, 2009, PHYS MED REH CLIN N, V20, P347, DOI 10.1016/j.pmr.2008.12.006; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Malley D, 2014, ADV CLIN NEUROSCIENC, V14, P17; Masel BE, 2017, NEUROPSYCHOL REHABIL, V27, P1071, DOI 10.1080/09602011.2015.1125374; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Neu D, 2010, ACTA NEUROL BELG, V110, P15; Nguyen S., 2017, DISABIL REHABIL, P1; Nguyen S, 2018, DISABIL REHABIL, V40, P1906, DOI 10.1080/09638288.2017.1315461; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford J., 2017, NEUROBEHAVIOURAL DIS, P178; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Ritterband LM, 2017, JAMA PSYCHIAT, V74, P68, DOI 10.1001/jamapsychiatry.2016.3249; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Theadom A, 2018, CLIN REHABIL, V32, P619, DOI 10.1177/0269215517736671; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; van den Akker LE, 2016, J PSYCHOSOM RES, V90, P33, DOI 10.1016/j.jpsychores.2016.09.002; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vincent N, 2009, SLEEP, V32, P807, DOI 10.1093/sleep/32.6.807; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Wu S, 2015, INTERVENTIONS POSTST; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	111	3	3	2	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					307	317		10.3233/NRE-182484			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200007	30347625				2022-02-06	
S	Danilov, Y; Paltin, D		Srivastava, AK; Cox, CS		Danilov, Yuri; Paltin, Dafna			Translingual Neurostimulation (TLNS): Perspective on a Novel Approach to Neurorehabilitation after Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Neurorehabilitation; Neuromodulation; Translingual neurostimulation; PoNS device; Targeted therapy; Cranial nerve; Neuroplasticity	LONG-TERM POTENTIATION; ELECTRICAL TONGUE STIMULATION; SYNAPTIC PLASTICITY; PERFORATED SYNAPSES; NERVE-STIMULATION; HUMAN HAND; ELECTROTACTILE; BALANCE; NEUROMODULATION; NETWORK	CN-NINM technology represents a synthesis of a new noninvasive brain stimulation technique with applications in physical medicine, cognitive, and affective neurosciences. Our new stimulation method appears promising for the treatment of a full spectrum of movement disorders and for both attention and memory dysfunction associated with traumatic brain injury. The integrated CN-NINM therapy proposed here aims to restore function beyond traditionally expected limits by employing both newly developed therapeutic mechanisms for progressive physical and cognitive training while simultaneously applying brain stimulation through a portable neurostimulation device called the PoNS (TM). Based on our previous research and recent pilot data, we believe a rigorous in-clinic CN-NINM training program, followed by regular at-home exercises that will also be performed with CN-NINM, will simultaneously enhance, accelerate, and extend recovery from multiple impairments (e.g. movement, vision, speech, memory, attention, and mood), based on divergent but deeply interconnected neurophysiological mechanisms of neuroplasticity.	[Danilov, Yuri; Paltin, Dafna] Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA		Danilov, Y (corresponding author), Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.		Danilov, Yuri/P-7917-2018	Danilov, Yuri/0000-0002-3123-4016			Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Chiluwal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07219-3; Chisholm AE, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-96; Danilov Y, 2015, BRAIN NEUROTRAUMA MO, P605, DOI DOI 10.1201/B18126-51; Danilov YP, 2015, BIODEVICES: Proceedings of the 2015 International Conference on Biomedical Electronics and Devices, P88, DOI 10.5220/0005200000880094; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Ghulyan-Bedikian V, 2013, GAIT POSTURE, V38, P777, DOI 10.1016/j.gaitpost.2013.03.018; Harry JD, 2017, Patent No. [US9616234 B2, 9616234]; Ignatova T, 2018, P 11 INT JOINT C BIO, V4, P332, DOI [10.5220/0006732403320337, DOI 10.5220/0006732403320337.IN]; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JONES DG, 1991, MOL NEUROBIOL, V5, P217, DOI 10.1007/BF02935547; Kaczmarek KA, 2011, SCI IRAN, V18, P1476, DOI 10.1016/j.scient.2011.08.020; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Kaczmarek KA, 2000, IEEE T REHABIL ENG, V8, P268, DOI 10.1109/86.847828; Kacznaarek KA, 1995, VIRTUAL ENV ADV INTE, V55, P349; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kublanov V. S., 2008, BIOMEDICAL ENG, V42, P206; LARKMAN AU, 1995, CURR OPIN NEUROBIOL, V5, P324, DOI 10.1016/0959-4388(95)80045-X; Leonard Gabriel, 2017, Mult Scler J Exp Transl Clin, V3, p2055217317690561, DOI 10.1177/2055217317690561; Levenes C, 1998, PROG NEUROBIOL, V55, P79, DOI 10.1016/S0301-0082(97)00096-8; Miller Sarah, 1800, Pract Neurol, V16, P362, DOI 10.1136/practneurol-2015-001298; Neren D, 2016, NEUROCRIT CARE, V24, P308, DOI 10.1007/s12028-015-0203-0; Petrenko TS, 2015, EUR PSYCHIAT, V30, DOI 10.1016/S0924-9338(15)30657-X; Pol HH, 2013, EUR NEUROPSYCHOPHARM, V23, P1, DOI 10.1016/j.euroneuro.2012.12.004; Retyunskii KY, 2016, NEUROSCI BEHAV PHYSL, V46, P748; Robinson BS, 2009, J NEUROL PHYS THER, V33, P150, DOI 10.1097/NPT.0b013e3181a79373; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Slavin KV, 2011, PROG NEUROL SURG, V24, P1; Soss J, 2015, EPILEPSY BEHAV, V42, P44, DOI 10.1016/j.yebeh.2014.10.029; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Straube Andreas, 2016, MMW Fortschr Med, V158, P74, DOI 10.1007/s15006-016-8010-x; Straube A, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0543-3; SZETO AYJ, 1982, IEEE T BIO-MED ENG, V29, P300, DOI 10.1109/TBME.1982.324948; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tully K, 2007, NEURON, V56, P757, DOI 10.1016/j.neuron.2007.11.011; Tyler Mitchell, 2003, J Integr Neurosci, V2, P159, DOI 10.1142/S0219635203000263; Tyler ME, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-79; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Wildenberg JC, 2013, BRAIN CONNECT, V3, P87, DOI 10.1089/brain.2012.0123; Wildenberg JC, 2011, BRAIN CONNECT, V1, P255, DOI 10.1089/brain.2011.0029; Wildenberg JC, 2011, NEUROIMAGE, V56, P2129, DOI 10.1016/j.neuroimage.2011.03.074; Wildenberg JC, 2010, BRAIN IMAGING BEHAV, V4, P199, DOI 10.1007/s11682-010-9099-7; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2; [No title captured]	54	3	3	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						307	327		10.1007/978-1-4939-8564-7_19	10.1007/978-1-4939-8564-7		21	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100021					2022-02-06	
J	Davenport, ND; Gullickson, JT; Grey, SF; Hirsch, S; Sponheim, SR				Davenport, Nicholas D.; Gullickson, James T.; Grey, Scott F.; Hirsch, Shawn; Sponheim, Scott R.		Chronic Effects Neurotrauma	Longitudinal evaluation of ventricular volume changes associated with mild traumatic brain injury in military service members	BRAIN INJURY			English	Article						Concussion; mild brain injury; military; neurodegeneration; MRI	POSTTRAUMATIC-STRESS-DISORDER; MATTER ABNORMALITIES; CONCUSSIVE SYMPTOMS; ATROPHY; OUTCOMES; HEALTH; BLAST; MR; SEGMENTATION; CONSEQUENCES	Primary objective: To investigate differences in longitudinal trajectories of ventricle-brain ratio (VBR), a general measure of brain atrophy, between Veterans with and without history of mild traumatic brain injury (mTBI).Research design: Structural magnetic resonance imaging (MRI) was used to calculate VBR in 70 Veterans with a history of mTBI and 34 Veterans without such history at two time points approximately 3 and 8years after a combat deployment.Main outcomes and results: Both groups demonstrated a quadratic relationship between VBR and age that is consistent with normal developmental trajectories. Veterans with history of mTBI had larger total brain volume, but no interaction between mTBI and age was observed for brain volume, ventricular volume, or VBR.Conclusions: In our longitudinal sample of deployed Veterans, mTBI was not associated with gross brain atrophy as reflected by abnormally high VBR or abnormal increases in VBR over time.	[Davenport, Nicholas D.; Gullickson, James T.; Sponheim, Scott R.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Davenport, Nicholas D.; Gullickson, James T.; Sponheim, Scott R.; Chronic Effects Neurotrauma] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Grey, Scott F.; Hirsch, Shawn] RTI Int, Res Triangle Pk, NC USA		Davenport, ND (corresponding author), VA Med Ctr B68 2, 1 Vet Dr, Minneapolis, MN 55417 USA.	nicholas.davenport@va.gov	Davenport, Nicholas/AAY-8057-2020; Grey, Scott/AAK-9922-2021; Sponheim, Scott/J-3857-2017	Davenport, Nicholas/0000-0002-3441-7256; Sponheim, Scott/0000-0002-2782-0856; Hirsch, Shawn/0000-0001-6280-9559			Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; Ar M, 2010, PROSPECTIVE DIFFUSIO, V74, P643; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bourisly AK, 2015, NEURORADIOL J, V28, P450, DOI 10.1177/1971400915598078; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Davenport ND, 2016, BRAIN INJURY, V30, P1491, DOI 10.1080/02699052.2016.1219057; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Diggle P J, 2002, ANAL LONGITUDINAL DA; DVBIC, 2017, DOD WORLDW NUMB TBI; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Farmer CM, 2016, UNDERSTANDING TREATM, P16; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Military WD., 2006, J HEAD TRAUMA REHAB, V21, P398, DOI [10.1097/00001199-200609000-00004, DOI 10.1097/00001199-200609000-00004]; Molenberghs G., 2000, LINEAR MIXED MODELS; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	58	3	3	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1245	1255		10.1080/02699052.2018.1494854			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200011	29985658				2022-02-06	
J	Dougherty, AL; MacGregor, AJ; Viirre, E; Clouser, MC; Han, PP; Quinn, KH; Galarneau, MR				Dougherty, Amber L.; MacGregor, Andrew J.; Viirre, Erik; Clouser, Mary C.; Han, Peggy P.; Quinn, Kimberly H.; Galarneau, Michael R.			Preliminary study of hearing protection and non-impact, blast-induced concussion in US military personnel	BRAIN INJURY			English	Article						Blast; combat; concussion; hearing protection; injury; military	TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM; IMPULSE NOISE; OVERPRESSURE; PATHOLOGY; PRESSURE; REGISTRY	Primary objective: To examine the relationship between hearing protection and non-impact, blast-induced concussion in US military personnel. Research design: Retrospective cohort study. Methods and procedures: A total of 501 US service members from the Expeditionary Medical Encounter Database with hearing protection status reported either 'worn' or 'not worn' were eligible for analysis. Clinical records were reviewed for concussion diagnoses. Univariate and multiple logistic regressions were performed. Main outcomes and results: Overall, 270 (53.9%) service members sustained non-impact, blast-induced concussion and 231 (46.1%) sustained other blast injuries. Only 39.6% (107 of 270) of service members with concussion wore hearing protection at the point of injury compared with 61.0% (141 of 231) of those with other injuries (p < 0.001). After adjusting for covariates, service members wearing hearing protection had significantly lower odds of concussion compared with those not wearing hearing protection (odds ratio = 0.42, 95% confidence interval = 0.29-0.62). Conclusions: To our knowledge, this preliminary study is the first to demonstrate that hearing protection is associated with lower odds of non-impact, blast-induced concussion. The benefits of using hearing protection in terms of force readiness could be significant since many service members wounded in recent conflicts were diagnosed with concussion.	[Dougherty, Amber L.; MacGregor, Andrew J.; Clouser, Mary C.; Han, Peggy P.; Quinn, Kimberly H.; Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Viirre, Erik] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA		Dougherty, AL (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	amber.l.dougherty.ctr@mail.mil		MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60808]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured/Psychological Health/Traumatic Brain Injury Program, Work Unit No. 60808.	AC Hart, 2008, ICD 9 CM PROFESSIONA; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Buck K, 2009, INT J OCCUP SAF ERGO, V15, P227, DOI 10.1080/10803548.2009.11076804; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Champion HR, 2010, J TRAUMA, V68, P1139, DOI 10.1097/TA.0b013e3181d86a0d; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Darley DS, 2010, DISASTER MED PUBLIC, V4, P145, DOI 10.1001/dmphp.D-08-00057R2; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Gruss E, 2006, J TRAUMA, V60, P1284, DOI 10.1097/01.ta.0000220015.21948.ec; Hart AC, 2008, ICD 9 CM PROFESSIONA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2009, GULF WAR HLTH, V7; Kerr A G, 1987, Rev Environ Health, V7, P65; KERR AG, 1975, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5957.559; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lovejoy J, 2007, INLEXT0712320; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Nakashima A, 2006, 2006231 DRDC TM; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141	33	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1423	1428		10.1080/02699052.2018.1496476			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000015	30001164				2022-02-06	
J	Flinn, LC; Hassett, CL; Braham, L				Flinn, Lucinda Charlotte; Hassett, Charlotte Louise; Braham, Louise			Development of forensic normative data for the WAIS-IV	JOURNAL OF FORENSIC PRACTICE			English	Article						Forensic; Cognitive assessment; High secure; Normative data; WAIS-IV; Wechsler	TRAUMATIC BRAIN-INJURY; COGNITIVE REMEDIATION; SUBSTANCE-ABUSE; SCHIZOPHRENIA; INFORMATION; SPEED; EXPERIENCES; IMPAIRMENT; OFFENDERS; SERVICES	Purpose - The Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) (Wechsler, 2008) is a cognitive assessment that is often used in secure forensic settings, however it has not been normed on this population. The purpose of this paper is to develop forensic normative data. Design/methodology/approach - Patient files in a high secure forensic hospital were reviewed in order to obtain completed WAIS-IV (Wechsler, 2008) assessments and scores from the five indexes (verbal comprehension, perceptual reasoning, working memory, processing speed and full scale intelligence quotient (FSIQ)). This included reviewing patient files from all directorates, including male mental health, male learning disability, male personality disorder and the women's service, yielding a sample size of n = 86. Findings - The qualitative descriptors obtained across the hospital ranged between extremely low and superior. The learning disability service scored significantly lower than the mental health and personality disorder services in verbal comprehension index, perceptual reasoning index, working memory index and FSIQ, and significantly lower than the mental health, personality disorder and women's services in processing speed index. Mean scores from this study were significantly lower in comparison to those from the UK validation study (Wechsler, 2008). Practical implications - The significant difference between scores from the current study and those from the UK validation study (Wechsler, 2008) highlights the need to have appropriate normative data for forensic populations. Clinicians should consider interventions that may serve to increase cognitive function, such as cognitive remediation therapy. Originality/value - Whilst several special group studies have previously been conducted, this study is the first to develop forensic normative data for the WAIS-IV (Wechsler, 2008). Whilst the sample size was relatively small with limited female participants, the data collated will enable clinicians working in forensic establishments to interpret their assessments in light of this information.	[Flinn, Lucinda Charlotte; Hassett, Charlotte Louise] Rampton Hosp, Retford, England; [Braham, Louise] St Andrews Healthcare, Northampton, England		Flinn, LC (corresponding author), Rampton Hosp, Retford, England.	lucinda.flinn2@nottshc.nhs.uk					Ahmed AO, 2015, J PSYCHIATR RES, V68, P8, DOI 10.1016/j.jpsychires.2015.05.013; Bowie CR, 2012, AM J PSYCHIAT, V169, P710, DOI 10.1176/appi.ajp.2012.11091337; Brekke JS, 2007, SCHIZOPHRENIA BULL, V33, P1247, DOI 10.1093/schbul/sbl072; British Psychological Society, 2009, ASS EFF CLIN TEST CO; Dillon J, 2012, J CRITICAL PSYCHOL C, V12, P145; El-Hage Wissam, 2006, Cogn Neuropsychiatry, V11, P33; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Heaton RK, 2001, ARCH GEN PSYCHIAT, V58, P24, DOI 10.1001/archpsyc.58.1.24; Hill M., 1997, ISSUES CRIMINOLOGICA, V27, P34; Hill M., 1998, CRIM BEHAV MENT HEAL, V8, DOI [https://doi.org/10.1002/cbm.268, DOI 10.1002/CBM.268]; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Karbasforoushan H, 2015, PSYCHOL MED, V45, P109, DOI 10.1017/S0033291714001111; Kaufman SB, 2012, INTELLIGENCE, V40, P123, DOI 10.1016/j.intell.2012.01.009; Latvala A, 2009, ADDICTION, V104, P1558, DOI 10.1111/j.1360-0443.2009.02656.x; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenberger ElizabethO., 2013, ESSENTIALS WAIS 4 AS, V2nd ed.; Lindsay W.R., 2004, OFFENDERS DEV DISABI, P163; Lindsay WR, 2007, J INTELLECT DEV DIS, V32, P55, DOI 10.1080/13668250701378520; Lindsay WR, 2010, CRIM JUSTICE BEHAV, V37, P678, DOI 10.1177/0093854810363725; Lowings G. R, 2010, UNPUB; Lowings G, 2013, ADV MENT HEALTH INTE, V7, P356, DOI 10.1108/AMHID-10-2012-0002; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602; Serafim AD, 2015, ARCH CLIN PSYCHIAT, V42, P63, DOI 10.1590/0101-60830000000049; Vik PW, 2004, PSYCHIAT CLIN N AM, V27, P97, DOI 10.1016/S0193-953X(03)00110-2; Watkins MW, 2007, APPL NEUROPSYCHOL, V14, P13, DOI 10.1080/09084280701280353; WECHSLER D, 1992, WECHSLER INDIVIDUAL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D., 2008, WECHSLER ADULT INTEL; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	36	3	3	1	14	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	2050-8794	2050-8808		J FORENSIC PRACT	J. Forensic Pract.		2018	20	1					58	67		10.1108/JFP-08-2017-0029			10	Criminology & Penology	Emerging Sources Citation Index (ESCI)	Criminology & Penology	FT5IE	WOS:000423186400007					2022-02-06	
J	Fujita, H; Shiotani, Y; Takada, Y; Nishimura, S				Fujita, Hiroshi; Shiotani, Yoko; Takada, Yuko; Nishimura, Shigeko			Effects of potassium adsorption filters on the removal of ammonia from blood products	BLOOD TRANSFUSION			English	Article						neonatal transfusion; potassium adsorption filter; traumatic brain injury; ammonia	WHOLE-BLOOD; TRANSFUSION; CELLS; HYPERAMMONEMIA	Background. Although ammonia in plasma does not usually pass through the blood-brain barrier (BBB), in cases of traumatic brain injury it may do so, acting as a neurotoxin on the brain. Excess intake of ammonia should be restricted in conditions involving BBB breakdown, such as traumatic brain injury. Washing is a method to remove ammonia from blood products, but fresh-frozen plasma and albumin products cannot be washed. A potassium adsorption filter (PAF) can remove not only potassium, but also ammonia from red blood cell solutions. We, therefore, examined the effects of a PAF on the removal of ammonia from a range of blood products. Materials and methods. Ammonia concentrations were measured in expired red blood cell solutions, fresh-frozen plasma, and platelet concentrates and purchased albumin products before and after filtration through a PAF. The PAF was primed with saline, which was removed before the filter was used. Results. The percentages of ammonia removal from the red blood cell solutions, fresh-frozen plasma, plasma concentrates, 20% albumin and 5% albumin were approximately 76-87%, 21-31%, 53%, 77-92% and 49-63%, respectively. Discussion. A PAF appears capable of removing ammonia from a range of blood products, although the reason for the lesser effect on the ammonia concentration in fresh-frozen plasma compared to other blood products remains unknown. We hypothesise that, by lowering ammonia levels in blood products, the PAF could improve the clinical prognosis of neonates with an underdeveloped BBB or patients with BBB breakdown following traumatic brain injury.	[Fujita, Hiroshi; Nishimura, Shigeko] Tokyo Metropolitan Bokutoh Hosp, Dept Transfus Med, Tokyo, Japan; [Shiotani, Yoko; Takada, Yuko] Tokyo Metropolitan Bokutoh Hosp, Clin Lab, Tokyo, Japan		Fujita, H (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Transfus Med, 4-23-15 Koutoubashi Sumida Ku, Tokyo 1308575, Japan.	hiroshi_fujita@tmhp.jp			Tokyo Metropolitan GovernmentTokyo Metropolitan Government	This study was supported by a grant from Tokyo Metropolitan Government.	Apushkin M, 2013, TRANSFUS APHER SCI, V49, P459, DOI 10.1016/j.transci.2013.05.002; BARTA E, 1982, RESUSCITATION, V10, P135, DOI 10.1016/0300-9572(82)90021-1; BESSMAN AN, 1958, J CLIN INVEST, V37, P990, DOI 10.1172/JCI103695; Cid J, 2008, TRANSFUSION, V48, P1966, DOI 10.1111/j.1537-2995.2008.01776.x; Eid T, 2013, NAT MED, V19, P1572, DOI 10.1038/nm.3420; Haberle J, 2011, EUR J PEDIATR, V170, P21, DOI 10.1007/s00431-010-1369-2; Hagiwara A, 2009, J TRAUMA, V67, P115, DOI 10.1097/TA.0b013e3181a5e63e; Huber D, 2013, PEDIATR ANESTH, V23, P1021, DOI 10.1111/pan.12232; Inaba S, 2000, TRANSFUSION, V40, P1469, DOI 10.1046/j.1537-2995.2000.40121469.x; Jorgensen TC, 2003, WATER RES, V37, P1723, DOI 10.1016/S0043-1354(02)00571-7; Kanamoto M, 2012, J SURG RES, V173, P180, DOI 10.1016/j.jss.2010.09.011; Matsuura H, 2015, VOX SANG, V108, P428, DOI 10.1111/vox.12242; Morrison A, 2015, TRANSFUSION MED, V25, P320, DOI 10.1111/tme.12227; Ruder J, 2014, PEDIATR NEUROL, V51, P553, DOI 10.1016/j.pediatrneurol.2014.07.010; Scott JG, 1960, MED J AUSTRALIA, V20, P290; U-King-Im JM, 2011, AM J NEURORADIOL, V32, P413, DOI 10.3174/ajnr.A2290; UKRAINSKI CT, 1981, TRANSFUSION, V21, P113, DOI 10.1046/j.1537-2995.1981.21181127472.x; Waddell L. S., 2001, Journal of Veterinary Emergency and Critical Care, V11, P23; Yamada C, 2010, TRANSFUSION, V50, P1926, DOI 10.1111/j.1537-2995.2010.02742.x	19	3	3	1	5	SIMTI SERVIZI SRL	MILAN	VIA DESIDERIO 21, MILAN, 20131, ITALY	1723-2007			BLOOD TRANSFUS-ITALY	Blood Transf.		2018	16	2					173	177		10.2450/2017.0231-16			5	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	FY1HG	WOS:000426562000008	28287384				2022-02-06	
J	Green, SL; Keightley, ML; Lobaugh, NJ; Dawson, DR; Mihailidis, A				Green, Stephanie L.; Keightley, Michelle L.; Lobaugh, Nancy J.; Dawson, Deirdre R.; Mihailidis, Alex			Changes in working memory performance in youth following concussion	BRAIN INJURY			English	Article						Adolescent; athlete; children; cognition; concussion; traumatic brain injury	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; HIGH-SCHOOL; CHILDREN; SYMPTOMS; ADOLESCENTS; RECOVERY	Objective: The purpose of this study was to compare the working memory (WM) performance pre- and post-concussion, and investigate the relationships between performance changes and characteristics such as self-reported symptom scores, number of days post-injury and age at injury in 10-14-year-old youth. Methods: Twenty-one youth (17 males) aged 10-14 years recruited from the community completed verbal and non-verbal WM tasks pre- and post-concussion. Performance was measured using accuracy and performance errors (false alarms and misses). Pre- and post-tests were compared using a Wilcoxon signed rank test, and effect size was determined using matched-pairs rank biserial correlation. Results: Comparisons showed lower verbal WM accuracy at post-test, greater verbal and non-verbal WM false alarm errors at post-test, and greater verbal WM miss errors at post-test (all r >= 0.30). Correlations between performance and characteristics revealed associations between younger youth and lower nonverbal WM accuracy and more false alarms at post-test, as well as an association among non-verbal WM miss errors, higher PCS scores and fewer days since injury at post-test. Conclusions: The current study found lower WM performance in youth following concussion. Furthermore, the findings suggest that false alarm errors may be a useful screening measure acutely post-concussion when assessing WM performance in youth.	[Green, Stephanie L.; Keightley, Michelle L.; Dawson, Deirdre R.] Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle L.] Univ Toronto, Holland Bloorview Kids Rehab, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle L.; Dawson, Deirdre R.; Mihailidis, Alex] Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Fac Med, Res Imaging Ctr, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Fac Med, Div Neurol, Toronto, ON, Canada; [Dawson, Deirdre R.] Univ Toronto, Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Mihailidis, Alex] Univ Hlth Network, Toronto Rehab Inst, Toronto, ON, Canada; [Mihailidis, Alex] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada		Green, SL (corresponding author), Univ Toronto, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	stephanie.green@utoronto.ca	Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121	CIHRCanadian Institutes of Health Research (CIHR) [484706] Funding Source: Medline		Alloway T., 2007, AUTOMATED WORKING ME; [Anonymous], 2011, INJURIES CANADA INSI; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen J., 1988, STAT POWER ANAL BEHA, P509; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Forns J, 2014, NEUROPSYCHOLOGY, V28, P519, DOI 10.1037/neu0000085; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kerby D.S, 2014, COMPR PSYCHOL, V3, P11; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Reed N, 2011, PHYS OCCUP THER PEDI, V31, P222, DOI 10.3109/01942638.2011.589719; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Simmering VR, 2012, J EXP CHILD PSYCHOL, V111, P695, DOI 10.1016/j.jecp.2011.10.007; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	41	3	4	6	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					182	190		10.1080/02699052.2017.1358396			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600004	29190189				2022-02-06	
J	Groswasser, Z; Peled, I; Ross, S; Truelle, JL; Von Steinbuchel, N				Groswasser, Zeev; Peled, Israela; Ross, Sharon; Truelle, Jean-Luc; Von Steinbuechel, Nicole			Validation of the QOLIBRI - Quality of Life after Brain Injury questionnaire in patients after TBI in Israel	BRAIN INJURY			English	Article						TBI; Hebrew version of the QOLIBRI; quality of life	GLASGOW OUTCOME SCALE; HEALTH SURVEY SF-36; HOSPITAL ANXIETY; DEPRESSION SCALE; HEAD-INJURY; VALIDITY; EPIDEMIOLOGY; RELIABILITY; DISABILITY; MODERATE	Background: The QOLIBRI - Quality of Life after Brain Injury questionnaire was developed by the QOLIBRI Task Force (QTF). Our goal was to investigate the applicability, validity and reliability of the QOLIBRI in Israel.Methods: Validation of the Hebrew questionnaire was performed after it had been administered to 128 adults with traumatic brain injury (TBI), who were between 3months' and 15years' post-discharge from rehabilitation.Results: The internal consistency of the QOLIBRI subscales with the QOLIBRI Total scale was high (Cronbach's =0.92); the same was true regarding the correlations between each QOLIBRI subscale and its own items (=0.92-0.95). Significant and high Pearson's and Spearman's correlations of the QOLIBRI subscales with demographic and clinical characteristics of the GOSE, ADL, HADS, SF-36, and various aspects of self-reported health status were found. Factor analyses (FA) were applied to confirm the validity of the Hebrew version, using the maximum likelihood method. The six subscales explained 100% of the variance.Conclusion: The Hebrew version of the QOLIBRI was found to be useful, meaningful and meeting psychometric criteria in persons after TBI in Israel. The findings support the cross-cultural applicability of the QOLIBRI, regardless of cultural and social differences.	[Groswasser, Zeev; Peled, Israela; Ross, Sharon] Loewenstein Hosp & Rehabil Ctr, TBI Res Unit, Raanana, Israel; [Groswasser, Zeev; Peled, Israela; Ross, Sharon] Tel Aviv Univ, Clalit Hlth Serv, Tel Aviv, Israel; [Groswasser, Zeev; Peled, Israela; Ross, Sharon] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Truelle, Jean-Luc] CHU Raymond Poincare, Serv Med Phys & Readapt, Garches, France; [Von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany		Groswasser, Z (corresponding author), Loewenstein Hosp & Rehabil Ctr, 278 Achuza St,POB 3, IL-4310001 Raanana, Israel.	zeevg@clalit.org.il			Research Fund on Insurance Matters of the Association of Insurance Companies in Israel	The research was partially funded by the Research Fund on Insurance Matters of the Association of Insurance Companies in Israel.	Bentur N., 2001, GERONTOLOGY, V28, P187; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johnson RJ, 2010, FRONT HEAT MASS TRAN, V1, DOI 10.5098/hmt.v1.1.3007; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lewin-Epstein N, 1998, MED CARE, V36, P1361, DOI 10.1097/00005650-199809000-00008; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Melamed S, 1982, PSYCHOSOCIAL RES REH, P59; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Petersen C, 2005, PROG BRAIN RES, V150, P545, DOI 10.1016/S0079-6123(05)50038-4; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; READ JL, 1987, J CHRON DIS, V40, pS7, DOI 10.1016/S0021-9681(87)80027-9; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Ware JE, 2002, SF COMMUNITY; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	3	3	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					879	888		10.1080/02699052.2018.1466196			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900008	29688070				2022-02-06	
J	Guo, Y; Yu, L; He, BM; Li, SP; Zhu, Q; Sun, HB				Guo, Yi; Yu, Liang; He, Baoming; Li, Suping; Zhu, Qiong; Sun, Hongbin			Aetiological Features of Elderly Patients with Newly Diagnosed Symptomatic Epilepsy in Western China	BIOMED RESEARCH INTERNATIONAL			English	Article							STATUS EPILEPTICUS; CLINICAL-FEATURES; SEIZURES; POPULATION; NEUROCYSTICERCOSIS; EPIDEMIOLOGY; PREVALENCE; DEMENTIA; COHORT; ILAE	Aims. Recent epidemiological studies have indicated that the incidence of epilepsy peaks after 60 years old, and epilepsy has become increasingly prevalent in elderly populations. The aim of this study is to identify the aetiologic characteristics of epilepsy in the elderly. Methods. We retrospectively recruited elderly patients with newly diagnosed epilepsy identified in three epilepsy centres in western China; elderly patients were defined as individuals aged 60 years or older. Demographic characteristics, clinical epilepsy data, and the diagnosis and aetiology of epilepsy were recorded. Results. A total of 760 patients with newly diagnosed epilepsy were enrolled in our study. Of these patients, 25% had experienced one or more episodes of status epilepticus, and 62.4% were confirmed as symptomatic. Among the symptomatic cohort, stroke and traumatic brain injury (TBI) were the two most common causes of epilepsy, followed by cerebral tumour, dementia, hippocampal sclerosis (HS), and central nervous system (CNS) infection. When analysed by residence and age, ischaemic stroke was the most common cause of epilepsy in urban patients, whereas traumatic brain injury was the leading cause of epilepsy in rural patients. Conclusion. More than three-fifths of newly diagnosed epilepsy cases in elderly patients were confirmed as symptomatic, and stroke and traumatic brain injury were the primary aetiologies in elderly epileptic patients.	[Guo, Yi; Yu, Liang; He, Baoming; Li, Suping; Zhu, Qiong; Sun, Hongbin] Univ Elect Sci & Technol China, Affiliated Hosp, Dept Neurol, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Guo, Yi] Sixth Peoples Hosp Chengdu, Dept Neurol, Chengdu, Sichuan, Peoples R China		Zhu, Q; Sun, HB (corresponding author), Univ Elect Sci & Technol China, Affiliated Hosp, Dept Neurol, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.	zhuqiong427@126.com; shb1369@aliyun.com		Yu, liang/0000-0002-2020-1446	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401081]; Scientific Research Foundation of Sichuan Academy of Medical Sciences; Sichuan Provincial People's Hospital [30305030589]	This work was supported by the National Natural Science Foundation of China (Project no. 81401081), the Scientific Research Foundation of Sichuan Academy of Medical Sciences, and the Sichuan Provincial People's Hospital for Doctors or Youths (no. 30305030589). The authors are sincerely grateful for the support of the First Affiliated Hospital of Chongqing Medical University and West China Hospital for collecting data. The authors also thank all the patients for their participation in this study.	Ahmad MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/638036; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Armstrong TS, 2016, NEURO-ONCOLOGY, V18, P779, DOI 10.1093/neuonc/nov269; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; de Assis TR, 2015, ARQ NEURO-PSIQUIAT, V73, P83, DOI 10.1590/0004-282X20140217; Fergus P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/986736; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Ge Y, 2015, EPILEPSY RES, V116, P99, DOI 10.1016/j.eplepsyres.2015.07.006; Govoni V, 2008, EUR NEUROL, V59, P120, DOI 10.1159/000111873; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hiyoshi T, 2000, EPILEPSIA, V41, P31, DOI 10.1111/j.1528-1157.2000.tb02217.x; Huang C, 2016, SEIZURE-EUR J EPILEP, V38, P26, DOI 10.1016/j.seizure.2016.03.011; Hussain SA, 2006, EPILEPSY RES, V71, P195, DOI 10.1016/j.eplepsyres.2006.06.018; Imfeld P, 2013, EPILEPSIA, V54, P700, DOI 10.1111/epi.12045; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Khow KSF, 2017, CLIN GERIATR MED, V33, P357, DOI 10.1016/j.cger.2017.03.002; LI SC, 1985, EPILEPSIA, V26, P391, DOI 10.1111/j.1528-1157.1985.tb05669.x; Reddy DS, 2017, SEIZURE-EUR J EPILEP, V52, P176, DOI 10.1016/j.seizure.2017.10.004; Serafini A, 2015, NEUROEPIDEMIOLOGY, V45, P50, DOI 10.1159/000382078; Si Y, 2012, SEIZURE-EUR J EPILEP, V21, P40, DOI 10.1016/j.seizure.2011.09.008; Sinha S, 2013, J CLIN NEUROSCI, V20, P423, DOI 10.1016/j.jocn.2012.02.050; Stefan H, 2014, ACTA NEUROL SCAND, V129, P283, DOI 10.1111/ane.12218; Stefan H, 2011, ACTA NEUROL SCAND, V124, P223, DOI 10.1111/j.1600-0404.2010.01464.x; Subota A, 2017, EPILEPSIA, V58, P962, DOI 10.1111/epi.13744; Tabatabaei SS, 2013, NEUROL SCI, V34, P1441, DOI 10.1007/s10072-012-1261-0; Tanaka T, 2017, NEUROCHEM INT, V107, P219, DOI 10.1016/j.neuint.2017.02.002; Tang DH, 2015, J CLIN NEUROL, V11, P252, DOI 10.3988/jcn.2015.11.3.252; Tanti MJ, 2017, ACTA NEUROL SCAND, V136, P246, DOI 10.1111/ane.12711; Tellez-Zenteno JF, 2017, EPILEPSY BEHAV, V76, P146, DOI 10.1016/j.yebeh.2017.01.030; Tian HJ, 2015, INT J CLIN EXP MED, V8, P2399; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Verma A, 2017, ACTA NEUROL BELG, V117, P139, DOI 10.1007/s13760-016-0719-x; Wang WZ, 2006, LANCET NEUROL, V5, P46, DOI 10.1016/S1474-4422(05)70254-4; Zhang NJ, 2012, GERONTOLOGIST, V52, P589, DOI 10.1093/geront/gns105; Zhao Y., 2017, CURRENT NEUROPHARMAC, V16; Zhao YD, 2001, WORLD J SURG, V25, P1202	39	3	3	1	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								4104691	10.1155/2018/4104691			6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	GE0OJ	WOS:000430914000001	29854751	Green Published, gold			2022-02-06	
J	Haciyakupoglu, E; Yilmaz, DM; Kinali, B; Arpaci, T; Akbas, T; Haciyakupoglu, S				Haciyakupoglu, Ersin; Yilmaz, Dervis Mansuri; Kinali, Burak; Arpaci, Taner; Akbas, Tugana; Haciyakupoglu, Sebahattin			Recurrent chronic subdural hematoma: Report of 13 cases	OPEN MEDICINE			English	Article						Recurrent; Chronic subdural hematoma; Craniotomy; Duraectomy; Membranectomy; Surgical treatment	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT; MEMBRANECTOMY; HYPERTENSION; PREDICTORS	Chronic subdural hematoma is a frequent type of hemorrhage, which terminates with mortality if not diagnosed and treated early. The aim of this clinical study is to evaluate the patients with unilateral and bilateral recurrent chronic subdural hematoma. The study group consisted of 13 cases with unilateral and bilateral recurrent chronic subdural hematomas who underwent aggressive wide craniotomy, duraectomy, inner and outer membranectomy, dural border coagulation, incision through cortical vein trace and hang up of dural edge, between 2009 - 2016. All of our patients were diagnosed by preoperative Magnetic Resonance Imaging. We evaluated the age, gender, complaints and neurologic signs, localization and thickness of the hematoma. We can estimate that wide craniotomy, duraectomy and membranectomy is a good option in preventing recurrent chronic subdural hematoma and complications.	[Yilmaz, Dervis Mansuri] Cukurova Univ, Fac Med, Dept Neurosurg, Balcali Hosp, TR-01330 Adana, Turkey; [Haciyakupoglu, Ersin] Klin Wirbelsaulen Chirurg & Neurotraumatol, D-8060 Zwickau, Germany; [Kinali, Burak] Tepecik Educ & Res Hosp, Dept Neurosurg, Izmir, Turkey; [Arpaci, Taner; Akbas, Tugana] Acibadem Univ, Sch Med, Dept Radiol, Acibadem Adana Hosp, Adana, Turkey; [Haciyakupoglu, Sebahattin] Acibadem Univ, Sch Med, Dept Neurosurg, Acibadem Adana Hosp, Adana, Turkey		Yilmaz, DM (corresponding author), Cukurova Univ, Fac Med, Dept Neurosurg, Balcali Hosp, TR-01330 Adana, Turkey.	mansuriyilmaz@gmail.com	Akbas, Tugana/W-9899-2019; Yilmaz, Dervis Mansuri/V-5890-2018	Akbas, Tugana/0000-0002-6869-2467; KINALI, BURAK/0000-0002-1124-6888			Apuzzo JLM, 1993, BRAIN SURG, P1931; Bohem SK, 1998, NEWSPHYSIOL SCI C, V13, P331; Brokinkel B., 2013, TURKISH NEUROSURGERY, P458; Chon KH, 2012, ACTA NEUROCHIR, V154, P1541, DOI 10.1007/s00701-012-1399-9; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Fang H, 2014, J IMMUNOL, V192, P5984, DOI 10.4049/jimmunol.1400054; Fay P. W., 2013, THROMBOTIC HEMORRHAG, P1; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; GOTTLIEB AI, 1991, LAB INVEST, V65, P123; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Liu LB, 1997, J BIOL CHEM, V272, P1997, DOI 10.1074/jbc.272.3.1997; Maggio W. W., 1993, BRAIN SURG COMPLICAT, P1299; Mohamed EEHH, 2003, BRIT J NEUROSURG, V17, P244, DOI 10.1080/0268869031000153134; Mostofi K, 2011, TURK NEUROSURG, V21, P522, DOI [10.5137/1019-5149.JTN .4390-11.0, 10.5137/1019-5149.JTN.4390-11.0]; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murakami H, 2002, J NEUROSURG, V96, P877, DOI 10.3171/jns.2002.96.5.0877; Nayil K, 2014, TURK NEUROSURG, V24, P246, DOI 10.5137/1019-5149.JTN.8465-13.0; Prabhu S. S., 2004, NEUROLOGICAL SURG, P5145; Roth J., 2012, MANAGEMENT BRAIN TUM, P339; Schin VB, 1994, ENDOTHELIUM DERIVED, P349; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vaquero J, 2002, ACTA NEUROCHIR, V144, P343, DOI 10.1007/s007010200047; Winn EH, 2004, CLIN PATHOPHYSIOLOGY, P5044	28	3	3	0	0	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2391-5463			OPEN MED-WARSAW	Open Med.		2018	13	1					520	527		10.1515/med-2018-0076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY7DA	WOS:000448763100007	30426091	Green Published, gold			2022-02-06	
J	Hanson, SS				Hanson, Stephen S.			'He didn't want to let his team down': the challenge of dual loyalty for team physicians	JOURNAL OF THE PHILOSOPHY OF SPORT			English	Article						Dual loyalty; sports medicine; informed consent; return-to-play decisions; concussion	ETHICS	Team physicians have a complicated job that involves potentially conflicting obligations to multiple entities. Though responsible for the medical care of the athletes as individuals, they also have obligations to the team that employs them which can include returning athletes to play who are at heightened risk of re-injury. The fact that the athletes and owners have some overlapping interests (e.g. players playing well and winning games) only complicates this issue. Further, there are strong financial incentives to do what is necessary to obtain and keep a position as a team physician. This article examines dual loyalty and conflict of interest in sports medicine, and argues that there is not now a widely accepted or adequate solution to either. Moving toward a solution will require fairly serious changes in the role of the team physician.	[Hanson, Stephen S.] Univ Louisville, Dept Philosophy, Louisville, KY 40292 USA		Hanson, SS (corresponding author), Univ Louisville, Dept Philosophy, Louisville, KY 40292 USA.	stephen.hanson@louisville.edu					Anderson L, 2009, BRIT J SPORT MED, V43, P1079, DOI 10.1136/bjsm.2008.051086; [Anonymous], COD OF ETH; Beauchamp Tom L, 1986, HIST THEORY INFORM C; Belson K., 2013, WARNING LABELS HELME; Brown C., 2013, REDSKINS VS SEAHAWKS; Chiapelli K., 2017, NFL PUNISHMENT TEXAN; Cosentino D., 2016, NFL DIDNT FOLLOW ITS; Devitt BM, 2010, BRIT J SPORT MED, V44, P175, DOI 10.1136/bjsm.2009.068056; Eifling S., 2013, WALK IT CHAMP WHY NF; ESPNcom News Services, 2013, RG III SET MRI KNEE; FIMS (Federation Internationale de Medecine Sportive), FIMS COD ETH SPORTS; Gaines C., 2015, ENGLISH PREMIER LEAG; Holm S, 2011, BRIT J SPORT MED, V45, P1170, DOI 10.1136/bjsm.2011.086124; Johnson R, 2004, CLIN SPORT MED, V23, P175, DOI 10.1016/j.csm.2004.01.003; McNamee M, 2007, ETHICS SPORT, P1; Murphy A., 2016, FOOTBALLS ENDGAME WH; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Polsky S, 1998, J Contemp Health Law Policy, V14, P503; Rodwin Marc C., 1993, MED MONEY MORALS PHY, P268; Sporting News Staff, 2013, SPORTING NEWS STAFF; Tucker AM, 2004, CLIN SPORT MED, V23, P227, DOI 10.1016/j.csm.2004.01.001; van Bibber R., 2013, RGIII INJURY REDSKIN	22	3	3	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0094-8705	1543-2939		J PHILOS SPORT	J. Philos. Sport		2018	45	3					215	227		10.1080/00948705.2018.1486199			13	Ethics; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	GV5BG	WOS:000446115200001					2022-02-06	
J	Hayward, RD; Fessler, MM; Buck, J; Fessler, RD				Hayward, R. David; Fessler, Mary M.; Buck, Joseph; Fessler, Richard D.			Risk factors for recurrent neurotrauma: a population-based study in Southeastern Michigan	BRAIN INJURY			English	Article						Traumatic brain injury; demographics; comorbidities; psychiatric; substance abuse	TRAUMATIC BRAIN-INJURY; ALCOHOL	Introduction: Studies have shown an increased risk of traumatic brain injury (TBI) for individuals who suffer an initial TBI. The current study hypothesized that individuals with recurrent neurotrauma would originate from populations considered 'vulnerable', i.e. low income and/or with psychiatric comorbidities. Methods: Data from the Michigan State Inpatient Database from 2006 to 2014 for the Detroit metropolitan area enlisted a study population of 50 744 patients with neurotrauma. Binary logistic regression was used to assess risk factors associated with admission for subsequent neurotrauma compared with single neurotrauma admission. Results: Patients with repeated neurotrauma admissions were similar to those with one-time trauma in terms of age at first admission and neighbourhood income levels. However, patients with repeated neurotrauma admissions were more likely to be male (p < .001) and African-American (p < .001). Comorbid alcohol use and drug use were 39% and 15% less likely to be readmitted with neurotrauma, respectively. Comorbid conditions associated with greater risk of repeat neurotrauma included depression, psychosis, and neurological disorders, increasing risk by 38%, 22%, and 58%, respectively. Conclusion: This study validated the hypothesis that comorbid psychiatric conditions are a significant risk factor for recurrent neurotrauma and validate prior studies showing gender and race as significant risk factors.	[Hayward, R. David; Fessler, Mary M.; Buck, Joseph; Fessler, Richard D.] St John Hosp & Med Ctr, Dept Surg, Div Neurosurg, Detroit, MI USA		Hayward, RD (corresponding author), St John Hosp & Med Ctr, Dept Surg, 22151 Moross Rd,PB 1,Suite 212, Detroit, MI 48236 USA.	Richard.Hayward@ascension.org	Hayward, R. David/A-8654-2009	Hayward, R. David/0000-0002-9845-6131			Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Graham R., 2014, SPORTSRELATED CONCUS; (IRS) TIRS, 2017, SOI TAX STATS IND IN; Lucke-Wold B, 2015, ALZHEIMERS DEMENTI S, V11, pP186, DOI [10.1016/j.jalz.2015.07.160, DOI 10.1016/J.JALZ.2015.07.160]; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	17	3	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1373	1376		10.1080/02699052.2018.1487584			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000009	29913083				2022-02-06	
J	Helmich, I				Helmich, Ingo			Game-specific characteristics of sport-related concussions	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Athletic injuries; Traumatic brain injury; Soccer; Basketball; Volleyball	STATES HIGH-SCHOOL; ICE HOCKEY; INJURIES; EPIDEMIOLOGY; FOOTBALL; PLAYERS	BACKGROUND: Concussions are common incidences in sports. However, game-specific characteristics such as tactics, field positions, etc. might positively/negatively contribute to the occurrence of mild traumatic brain injuries (mTBI) in various sports such as soccer, volleyball, handball, or basketball. Thus, the intention of this study was to analyze game-specific characteristics of concussive incidents in active players from the perspective of different sportive disciplines. METHODS: Four sport-specific questionnaires for soccer, handball, volleyball and basketball were established using an online survey tool. RESULTS: A total of 3001 participants completed the questionnaires. 18% of the participants answered that they had experienced a concussion which significantly differed depending on the sport practiced (chi(2)(3)=56.868, P<0.001; soccer 25%, handball 24%, volleyball 13%, basketball 15%). Whereas handball and soccer players experienced most concussions on the amateur level, volleyball players experienced most on the professional level and basketball players during leisure play (chi(2)(9)= 112.667, P<0.001). Soccer players experienced most concussions by a collision with another player, volleyball players instead experienced most concussions by hits from the ball (chi(2)(6)= 211.260, P<0.001). In soccer, goalkeepers and defensive midfield players showed most concussive incidences (chi(2)(7)= 19.638, P<0.01); in volleyball, the libero position and outside positions showed to be significantly affected from sport-related concussions (chi(2)(6)= 13.617, P<0.05). CONCLUSIONS: The present results showed that factors critically contributing to the occurrence of concussions are sport-specific and particularly concern amateurs. This indicates that most concussions in ball games appear in situations, where medical care units are not necessarily present. Preventive measures should therefore especially address amateurs in ball sports.	[Helmich, Ingo] German Sport Univ Cologne, Dept Neurol Psychosomat Med & Psychiat, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany		Helmich, I (corresponding author), German Sport Univ Cologne GSU, Dept Neurol Psychosomat Med & Psychiat, Inst Hlth Promot & Clin Movement Sci, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	i.helmich@dshs-koeln.de					Agel J, 2007, J ATHL TRAINING, V42, P295; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Batt ME, 2004, CLIN J SPORT MED, V14, P178, DOI 10.1097/00042752-200405000-00011; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Deutscher-Fussball-Bund, 2015, MITGL; Drawer S, 2002, BRIT J SPORT MED, V36, P33, DOI 10.1136/bjsm.36.1.33; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langevoort G, 2007, SCAND J MED SCI SPOR, V17, P400, DOI 10.1111/j.1600-0838.2006.00587.x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Ozbay G, 2013, EUR ARCH PAEDIATR DE, V14, P41, DOI 10.1007/s40368-012-0005-4; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Schmehl I, 2015, LEICHTES SCHADEL HIR; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Yde J, 1990, Br J Sports Med, V24, P51	26	3	3	2	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JAN-FEB	2018	58	1-2					172	179		10.23736/S0022-4707.16.06677-9			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GL5ER	WOS:000437187000022	27636403				2022-02-06	
J	Heruti, I; Levy, S; Avitsur, R; Deutscher, D; Gutvirtz, M; Berkovitz, T; Shiloh, S				Heruti, Irit; Levy, Sigal; Avitsur, Ronit; Deutscher, Daniel; Gutvirtz, Moshe; Berkovitz, Tamar; Shiloh, Shoshana			Development of the Injury Perceptions Questionnaire (InjPQ)	PSYCHOLOGY & HEALTH			English	Article						Injury; perceptions; questionnaire; InjPQ	COMMON-SENSE MODEL; MOTOR-VEHICLE ACCIDENT; TRAUMATIC BRAIN-INJURY; ILLNESS PERCEPTIONS; SENSITIVITY INDEX; SELF-REGULATION; UNITED-STATES; HEALTH; OUTCOMES; REPRESENTATIONS	Objectives: Injuries are major causes of morbidity and mortality in the population. Given the central role of perceptions in self-regulation of health conditions, it is important to investigate how they are perceived. This article describes the development of the Injury Perceptions Questionnaire (InjPQ).Methods: A concurrent study in a diverse sample of injured individuals (n=333). The internal structure and the reliability (Cronbach's ) of InjPQ sub-scales were explored by factor analyses. Relationships between injury perception dimensions and equivalent illness perception scales and outcome measures (self-assessed health; physical, emotional and social functioning; depression, anxiety and somatisation; satisfaction with life) were investigated.Results:The InjPQ was found to represent the following perception scales: injury identity composed of social and body part components, PTSD symptoms, Injury event, Injury specific emotions, Injured self-image, Positive consequences, Responsibility/guilt, Coping, Time distance, Dependency, Healthy self, External attributions and Injury risk factors. The reliability and construct validity of the scales were found adequate.Conclusions: Injury perceptions can be reliably measured. While partly overlapping with equivalent illness perception scales, the InjPQ depicts cognitive dimensions unique to injury that add significantly to explaining variance in outcomes. The InjPQ is recommended for research and clinical use as a measure of injury perceptions.	[Heruti, Irit; Levy, Sigal; Avitsur, Ronit] Tel Aviv Acad Coll, Sch Behav Sci, Tel Aviv, Israel; [Deutscher, Daniel; Gutvirtz, Moshe; Berkovitz, Tamar] Maccabi Healthcare Org, Tel Aviv, Israel; [Shiloh, Shoshana] Tel Aviv Univ, Sch Psychol Sci, Gordon Fac Social Sci, Tel Aviv, Israel; [Heruti, Irit] Rabin Med Ctr, Dept Psychol, Petah Tiqwa, Israel		Shiloh, S (corresponding author), Tel Aviv Univ, Sch Psychol Sci, Gordon Fac Social Sci, Tel Aviv, Israel.	shoshi@freud.tau.ac.il					Aujla N, 2016, PSYCHOL HEALTH, V31, P931, DOI 10.1080/08870446.2016.1153640; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Bryant RA, 2011, DEPRESS ANXIETY, V28, P99, DOI 10.1002/da.20786; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; Carleton RN, 2006, DEPRESS ANXIETY, V23, P340, DOI 10.1002/da.20138; Carleton RN, 2005, J PSYCHOPATHOL BEHAV, V27, P235, DOI 10.1007/s10862-005-2403-y; Chaboyer W, 2012, J CLIN NURS, V21, P3466, DOI 10.1111/j.1365-2702.2011.03964.x; Chowdhury PP, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6504a1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Hagger MS, 2005, J APPL SOC PSYCHOL, V35, P2345, DOI 10.1111/j.1559-1816.2005.tb02106.x; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hall PA, 2011, REHABIL PSYCHOL, V56, P43, DOI 10.1037/a0022443; Harris IA, 2008, ANZ J SURG, V78, P583, DOI 10.1111/j.1445-2197.2008.04578.x; Kupchik M, 2007, DEPRESS ANXIETY, V24, P244, DOI 10.1002/da.20189; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H., 2003, SELF REGULATION HLTH, V1, P42, DOI DOI 10.1093/RHEUMATOLOGY/KEM060; LINKOWSKI DC, 1971, REHABIL COUNS BULL, V14, P236; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; O'Donnell ML, 2010, MED J AUSTRALIA, V192, P328, DOI 10.5694/j.1326-5377.2010.tb03532.x; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Phelps C, 2010, PSYCHO-ONCOLOGY, V19, P847, DOI 10.1002/pon.1629; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Price M, 2015, J AFFECT DISORDERS, V186, P149, DOI 10.1016/j.jad.2015.06.012; ROSENBERG M, 1962, J PSYCHIAT RES, V1, P135, DOI 10.1016/0022-3956(62)90004-3; Shiloh S, 2016, J HEALTH PSYCHOL, V21, P1516, DOI 10.1177/1359105314557876; Shiloh S, 2011, INT J REHABIL RES, V34, P321, DOI 10.1097/MRR.0b013e32834d2048; Sleet DA, 2012, J SAFETY RES, V43, P233, DOI 10.1016/j.jsr.2012.09.002; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Thompson J, 2014, REHABIL PSYCHOL, V59, P247, DOI 10.1037/a0036543; van Wilgen CP, 2010, DISABIL REHABIL, V32, P1576, DOI 10.3109/09638281003596857; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wong EC, 2011, PSYCHOL TRAUMA-US, V3, P67, DOI 10.1037/a0020587	40	3	3	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0887-0446	1476-8321		PSYCHOL HEALTH	Psychol. Health		2018	33	5					614	633		10.1080/08870446.2017.1381957			20	Public, Environmental & Occupational Health; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Psychology	GD3TS	WOS:000430427300003	29022358				2022-02-06	
J	Herzer, G; Mirth, C; Illievich, UM; Voelckel, WG; Trimmel, H				Herzer, Guenther; Mirth, Claudia; Illievich, Udo M.; Voelckel, Wolfgang G.; Trimmel, Helmut			Analgosedation of adult patients with elevated intracranial pressure	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						Sedation; Delirium management; Scores; Clinical practice; Neurointensive medicine	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; SPREADING DEPOLARIZATIONS; SUBARACHNOID HEMORRHAGE; GREEN URINE; SEDATION; PAIN; SCALE; PROPOFOL	Background Analgesia and sedation are key items in intensive care. Recently published S3 guidelines specifically address treatment of patients with elevated intracranial pressure. Methods The Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine carried out an online survey of neurointensive care units in Austria in order to evaluate the current state of practice in the areas of analgosedation and delirium management in this high-risk patient group. Results The response rate was 88%. Induction of anesthesia in patients with elevated intracranial pressure is carried out with propofol/fentanyl/rocuronium in > 80% of the intensive care units (ICU), 60% use midazolam, 33.3% use esketamine, 13.3% use barbiturates and 6.7% use etomidate. For maintenance of analgosedation up to 72 h, propofol is used by 80% of the ICUs, followed by remifentanil (46.7%), sufentanil (40%) and fentanyl (6.7%). For long-term sedation, 86.7% of ICUs use midazolam, 73.3% sufentanil and 73.3% esketamine. For sedation periods longer than 7 days, 21.4% of ICUs use propofol. Reasons for discontinuing propofol are signs of rhabdomyolysis (92.9%), green urine, elevated liver enzymes (71.4% each) and elevated triglycerides (57.1%). Muscle relaxants are only used during invasive procedures. Inducing a barbiturate coma is rated as a last resort by 53.3% of respondents. The monitoring methods used are bispectral index (BIS (TM), 61.5% of ICUs), somatosensory-evoked potentials (SSEP, 53.8%), processed electroencephalography (EEG, 38.5%), intraparenchymal partial pressure of oxygen (pO(2), 38.5%) and microdialysis (23.1%). Sedation and analgesia are scored using the Richmond agitation and sedation score (RASS, 86.7%), sedation agitation scale (SAS, 6.7%) or numeric rating scale (NRS, 50%) and behavioral pain scale (BPS, 42.9%), visual analogue scale (VAS), critical care pain observation tool (CCPOT, each 14.3%) and verbal rating scale (VRS, 7.1%). Delirium monitoring is done using the confusion assessment method for intensive care units (CAM-ICU, 46.2%) and intensive care delirium screening checklist (ICDSC, 7.7%). Of the ICUs 46.2% do not carry out delirium monitoring. Conclusion We found good general compliance with the recommendations of the current S3 guidelines. Room for improvement exists in monitoring and the use of scores to detect delirium.	[Herzer, Guenther; Trimmel, Helmut] Gen HospitalWiener Neustadt, Dept Anesthesia Emergency Med & Intens Care, Corvinusring 3-5, A-2700 Wiener Neustadt, Austria; [Herzer, Guenther; Trimmel, Helmut] Gen HospitalWiener Neustadt, Karl Landsteiner Inst Emergency Med Med Simulat &, Corvinusring 3-5, A-2700 Wiener Neustadt, Austria; [Mirth, Claudia] Univ Hosp, Clin Dept Anesthesia & Intens Care, St Polten, Austria; [Illievich, Udo M.] Kepler Univ Hosp, Dept Neuroanesthesia & Intens Care, Linz, Austria; [Voelckel, Wolfgang G.] AUVA Trauma Hosp, Dept Anesthesia & Intens Care, Salzburg, Austria		Trimmel, H (corresponding author), Gen HospitalWiener Neustadt, Dept Anesthesia Emergency Med & Intens Care, Corvinusring 3-5, A-2700 Wiener Neustadt, Austria.; Trimmel, H (corresponding author), Gen HospitalWiener Neustadt, Karl Landsteiner Inst Emergency Med Med Simulat &, Corvinusring 3-5, A-2700 Wiener Neustadt, Austria.	helmut.trimmel@wienerneustadt.lknoe.at					Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; European Medicines Agency, 2016, DEXD ANN 1 SUMM PROD; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; Foundation BT., 2016, GUIDELINES MANAGEMEN; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Herzer G, 2010, ANAESTHESIST, V59, P371, DOI 10.1007/s00101-010-1708-8; Herzer G, 2016, WIEN KLIN WOCHENSCHR, V128, P649, DOI 10.1007/s00508-016-1027-4; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Kowoll CM, 2014, NEUROCRIT CARE, V20, P176, DOI 10.1007/s12028-013-9893-3; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Martin J, 2007, CRIT CARE, V11, DOI 10.1186/cc6189; Martin J, 2006, INTENS CARE MED, V32, P1137, DOI 10.1007/s00134-006-0214-6; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Rawal G, 2015, J CLIN DIAGN RES, V9, pOD03, DOI 10.7860/JCDR/2015/15681.6706; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; Sharshar T, 2014, INTENS CARE MED, V40, P484, DOI 10.1007/s00134-014-3214-y; Shioya Nobuki, 2011, Case Rep Emerg Med, V2011, P242514, DOI 10.1155/2011/242514; Tan CK, 2008, KIDNEY INT, V74, P978, DOI 10.1038/ki.2008.139; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y	34	3	4	0	17	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	JAN	2018	130	1-2					45	53		10.1007/s00508-017-1228-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT0GD	WOS:000422799700007	28733841				2022-02-06	
J	Jiang, Y; Wang, YK; Shi, XL; Wang, SH; Li, YM; Wang, JY; Zhang, DF; Ma, C; Yu, MK; Hou, LJ				Jiang, Ying; Wang, Yun-Kun; Shi, Xiao-Lei; Wang, Shen-Hao; Li, Yi-Ming; Wang, Jun-Yu; Zhang, Dan-Feng; Ma, Chao; Yu, Ming-Kun; Hou, Li-Jun			Improvement of cerebral blood perfusion in certain cerebral regions after cranioplasty could be monitored via tympanic membrane temperature changes	BRAIN INJURY			English	Article						Cranioplasty; cerebral perfusion; tympanic membrane temperature; noninvasive method; cerebral perfusion monitoring; Glasgow comascale	TRAUMATIC BRAIN-INJURY; TRANSIT-TIME HETEROGENEITY; DECOMPRESSIVE CRANIECTOMY; FLOW REGULATION; CT; METABOLISM; TOMOGRAPHY; TISSUE	Objective: Delayed neurological deficit was often observed in patients underwent craniectomy, which could be improved by cranioplasty. Little is known about hemodynamic improvement before and after cranioplasty. Methods: Cerebral blood perfusion, tympanic membrane temperature (TMT), neuropsychological and cognitive function were assessed in eleven craniectomy patients before and after cranioplasty. Results: Before cranioplasty, the cerebral blood volume (CBV) on the decompressed side was significantly lower than that of the contralateral side. The cranioplasty led to instant improvement (7 days after cranioplasty) of cerebral perfusion at the cranioplasty side in the frontal lobe, parietal lobe, temporal lobe, mesencephalon, basal ganglia and thalamus, but not the occipital lobe and epencephalon. Interestingly, CBV of the thalamus and basal ganglia gradually decreased to pre-surgical status 6 months later while the frontal lobe, parietal lobe, temporal lobe, mesencephalon remained well perfused. Meanwhile, the TMT changes acquired positive correlation with the perfusion of temporal lobe and mesencephalon as well as the GCS and MMSE score. Conclusion: The cranioplasty remarkably improves neurological and cognitive function by ameliorating cerebral perfusion in certain regions. The TMT could be used as a non-invasive method to monitor the cerebral perfusion improvement after the cranioplasty.	[Jiang, Ying; Wang, Yun-Kun; Wang, Shen-Hao; Li, Yi-Ming; Wang, Jun-Yu; Zhang, Dan-Feng; Yu, Ming-Kun; Hou, Li-Jun] China Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Neurosurg, 415 Feng Yang Rd, Shanghai 200003, Peoples R China; [Shi, Xiao-Lei; Ma, Chao] China Second Mil Med Univ, Shanghai Chang Zheng Hosp, Radiol, Shanghai, Peoples R China		Jiang, Y (corresponding author), China Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Neurosurg, 415 Feng Yang Rd, Shanghai 200003, Peoples R China.	yjiang1@vt.edu		Jiang, Ying/0000-0001-9800-6432			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Amorim RL, 2014, STROKE, V45, P1375, DOI 10.1161/STROKEAHA.113.003670; Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; BENZINGER T. H., 1959, PROC NATL ACAD SCI, V45, P645, DOI 10.1073/pnas.45.4.645; BENZINGER TH, 1969, J AMER MED ASSOC, V209, P1200, DOI 10.1001/jama.209.8.1200; Dorn F, 2011, EUR RADIOL, V21, P1803, DOI 10.1007/s00330-011-2128-0; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Eskildsen SF, 2017, NEUROBIOL AGING, V50, P107, DOI 10.1016/j.neurobiolaging.2016.11.004; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; GUIDO LJ, 1976, J NEUROSURG, V45, P348, DOI 10.3171/jns.1976.45.3.0348; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Jelcic N, 2013, BRAIN INJURY, V27, P1723, DOI 10.3109/02699052.2013.844857; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Lichtenberger EO., 2006, ASSESSING ADOLESCENT; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; Mah Jon Kooi, 2016, Asian J Neurosurg, V11, P15, DOI 10.4103/1793-5482.172593; MARIAK Z, 1994, EUR J APPL PHYSIOL O, V69, P545, DOI 10.1007/BF00239873; Mariak Z, 2003, PFLUG ARCH EUR J PHY, V446, P279, DOI 10.1007/s00424-003-1021-3; Pennes HH, 1998, J APPL PHYSIOL, V85, P5, DOI 10.1152/jappl.1998.85.1.5; Salota Vishal, 2016, Br J Nurs, V25, P490, DOI 10.12968/bjon.2016.25.9.490; Sarubbo S, 2014, NEURORADIOLOGY, V56, P237, DOI 10.1007/s00234-014-1318-2; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Shahid A, 2017, J NEUROSURG, V20416; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TEASDALE G, 1974, LANCET, V2, P81; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	37	3	3	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1405	1412		10.1080/02699052.2018.1493615			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000013	29985665				2022-02-06	
J	Jonasdottir, AD; Sigurjonsson, P; Olafsson, IH; Karason, S; Sigthorsson, G; Sigurjonsdottir, HA				Jonasdottir, Asta Dogg; Sigurjonsson, Petur; Olafsson, Ingvar Hakon; Karason, Sigurbergur; Sigthorsson, Gudmundur; Sigurjonsdottir, Helga Agusta			Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage	BRAIN INJURY			English	Article						Hypopituitarism; Traumatic brain injury (TBI); Subarachnoid haemorrhage (SAH); insulin tolerance test; GHRH-arginine test	ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; ADULT GH DEFICIENCY; CARDIOVASCULAR-DISEASE; CONSENSUS GUIDELINES; ENDOCRINE-SOCIETY; ARGININE TEST; RISK-FACTORS; ACUTE-PHASE; DIAGNOSIS	Objective. High prevalence of hypopituitarism (HP) has been reported after traumatic brain injury (TBI) and subarachnoid haemorrhage (SAH). The aim of the study was to prospectively evaluate the prevalence and progression of HP in patients after TBI and SAH in Icelandic population.Design: A 12month prospective single-centre study.Methods and procedures: A total of 27 patients were included, 15 patients with TBI and 12 patients with SAH. Pituitary function was evaluated with baseline hormone measurements and diagnostic tests. An insulin tolerance test was used unless contraindicated, then the GHRH-arginine test and Synachten test were used.Results. At three months, 16.7% (2/12) of the patients had HP after TBI and 33.3% (4/12) after SAH. At 12months, 21.4% (3/14) of patients had HP after TBI and 9.1% (1/11) after SAH. Gonadotropin deficiency was the most common deficiency at 3months and GH and gonadotropin deficiency at 12months.Conclusions. There is a considerable risk of HP after TBI and reason to study pituitary function further in patients with SAH. We believe that neuroendocrine evaluation is important in these patients. Since recovery commonly occurs 12months after the event, evaluation should be performed after that time if not clinically indicated earlier.	[Jonasdottir, Asta Dogg; Sigurjonsdottir, Helga Agusta] Landspitali Univ Hosp, Dept Endocrinol, Reykjavik, Iceland; [Sigurjonsson, Petur; Karason, Sigurbergur] Landspitali Univ Hosp, Dept Intens Care, Reykjavik, Iceland; [Olafsson, Ingvar Hakon] Landspitali Univ Hosp, Dept Neurosurg, Reykjavik, Iceland; [Karason, Sigurbergur; Sigurjonsdottir, Helga Agusta] Univ Iceland, Reykjavik, Iceland; [Sigthorsson, Gudmundur] Landspitali Univ Hosp, Dept Clin Chem, Reykjavik, Iceland		Jonasdottir, AD (corresponding author), Karolinska Univ Hosp, Dept Renal Med, S-14186 Stockholm, Sweden.	asta.jonasdottir@sll.se					Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Colao A, 2002, J CLIN ENDOCR METAB, V87, P1088, DOI 10.1210/jc.87.3.1088; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gisladottir EH, 2014, LAEKNABLADID, V100, P331, DOI 10.17992/lbl.2014.06.547; Gola M, 2005, J CLIN ENDOCR METAB, V90, P1864, DOI 10.1210/jc.2004-0545; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Prabhakar VKB, 2006, POSTGRAD MED J, V82, P259, DOI 10.1136/pgmj.2005.039768; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P553, DOI 10.1530/eje.1.02258; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306	40	3	4	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					310	317		10.1080/02699052.2017.1418906			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700004	29283287				2022-02-06	
J	Keim, LW; Koneru, S; Ramos, VFM; Murr, N; Hoffnung, DS; Murman, DL; Cooper, JS; Torres-Russotto, D				Keim, Lon W.; Koneru, Sreekanth; Ramos, Vesper Fe Marie; Murr, Najib; Hoffnung, Deborah S.; Murman, Daniel L.; Cooper, Jeffrey S.; Torres-Russotto, Diego			Hyperbaric oxygen for late sequelae of carbon monoxide poisoning enhances neurological recovery: case report	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						carbon monoxide poisoning; hyperbaric oxygen; delay to treatment	TRAUMATIC BRAIN-INJURY; CELL-PROLIFERATION; STEM-CELLS; THERAPY	Neuropsychiatric sequelae have been reported in 15%-45% of survivors of carbon monoxide (CO) poisoning. Hyperbaric oxygen (HBO2) therapy reduces the incidence of cognitive and neurological a dysfunction. The efficacy of providing HBO2 beyond the first one to two days after initial insult is unknown. However, some evidence exists for the benefit of this treatment. We report on treating a patient 14 months after CO injury, who responded with markedly improved neurologic status. A 27-year-old scholar was found comatose due to CO poisoning (carboxyhemoglobin = 31.7%). He received five acute HBO2 treatments. After discharge, he developed chorea, Parkinsonism, dystonia, memory loss, slowed processing speed and verbal fluency, leaving him disabled. After the patient reached a clinical plateau, HBO2 was tried again at 90 minutes at 2.4 ATA plus air breaks. Neuropsychological testing was performed at baseline and after each 20 HBO2 cycles, five of which were performed during the period from 14-22 months after CO exposure. After the first 20 treatments, Parkinsonism and dystonia improved. After 40 sessions, further improvements were seen on mental speed, verbal fluency, and fine motor movements. The outcome following 100 treatments was that the patient regained independence, including the ability to drive and to become gainfully employed. Our case calls into question the concept that HBO2 therapy has no role during the chronic phase of CO brain injury. Randomized clinical trials should be considered to evaluate the therapeutic efficacy of HBO2 in patients with neurological sequelae following CO injury.	[Keim, Lon W.; Cooper, Jeffrey S.] Nebraska Med, Hyperbar Med Ctr, Omaha, NE 68105 USA; [Koneru, Sreekanth; Ramos, Vesper Fe Marie; Murr, Najib; Murman, Daniel L.; Torres-Russotto, Diego] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE USA; [Hoffnung, Deborah S.] CHI Hlth, Dept Neuropsychol, Omaha, NE USA		Cooper, JS (corresponding author), Nebraska Med, Hyperbar Med Ctr, Omaha, NE 68105 USA.	jeffrey.cooper@unmc.edu	COOPER, JEFFREY/AAF-9733-2021	Torres-Russotto, Diego/0000-0002-0567-6435; cooper, jeffrey/0000-0001-7686-361X			CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; Comella CL, 2003, MOVEMENT DISORD, V18, P303, DOI 10.1002/mds.10377; Crawford C, 2017, J HEAD TRAUMA REHAB, V32, pE27, DOI 10.1097/HTR.0000000000000256; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Feng ZC, 2013, NEURAL REGEN RES, V8, P1220, DOI 10.3969/j.issn.1673-5374.2013.13.007; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; LEE MS, 1994, MOVEMENT DISORD, V9, P550, DOI 10.1002/mds.870090508; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Myers RAM, 1998, J CLIN PSYCHOL, V54, P555, DOI 10.1002/(SICI)1097-4679(199808)54:5<555::AID-JCLP1>3.0.CO;2-K; Senol MG, 2009, MED PRIN PRACT, V18, P67, DOI 10.1159/000163050; Shandley S, 2017, UNDERSEA HYPERBAR M, V44, P257; Spagnolo F, 2011, J NEUROL, V258, P1553, DOI 10.1007/s00415-011-5958-4; Steindler DA, 2002, LANCET, V359, P1047, DOI 10.1016/S0140-6736(02)08096-0; Stoller KP, 2007, NEUROL RES, V29, P146, DOI 10.1179/016164107X181770; Subbotina N, 2008, HYPERBARIC OXYGEN NE, P377; Sykes OT, 2016, CORTEX, V74, P440, DOI 10.1016/j.cortex.2015.07.033; Weaver LK, 2014, UNDERSEA HYPERBAR M, V41, P339; Weaver LK, 1996, ANN EMERG MED, V27, P736, DOI 10.1016/S0196-0644(96)70192-0; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; ZISER A, 1984, BRIT MED J, V289, P960, DOI 10.1136/bmj.289.6450.960	23	3	3	0	4	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	JAN-FEB	2018	45	1					83	87					5	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	GF0XG	WOS:000431654400011	29571236				2022-02-06	
J	Kleffelgaard, I; Langhammer, B; Sandhaug, M; Pripp, AH; Soberg, HL				Kleffelgaard, Ingerid; Langhammer, Birgitta; Sandhaug, Maria; Pripp, Are Hugo; Soberg, Helene Lundgaard			Measurement properties of the modified and total Balance ERror SCoring System - the BESS, in a healthy adult sample	EUROPEAN JOURNAL OF PHYSIOTHERAPY			English	Article						Balance; postural stability; concussion; measurement properties; rehabilitation; sport injuries	RELIABILITY; CONCUSSION; SPORT	Background: Measurement properties of the modified balance error scoring system (BESS) have not been widely reported, and are variable for the BESS. Thus, the purpose of this study was to assess the inter-rater reliability and minimal detectable change (MDC), the criterion validity and floor and ceiling effects for the modified BESS and the BESS in a healthy adult sample. Methods: Two experienced raters scored the modified and total BESS on 42 healthy young adults 21 female, mean age 23.3, SD 3.8). A force plate obtained measures of body sway (sway velocity mm/s), and represented the gold standard for the criterion validity. Results: The inter-rater reliability ICC was 0.80 (95% CI 0.67-0.89) and 0.66 (95% CI 0.48-0.81) for the modified BESS and the BESS, respectively. The inter-rater MDC was 3.2 and 10.2. The calculations of the criterion validity, (Spearman's Rho) were large and medium for the modified BESS and BESS, respectively. A small ceiling effect was found for the modified BESS, but not for BESS. Conclusions: The results imply that the measurement properties for the modified BESS is acceptable, however the weaker results for the BESS may limit the utility as an outcome measure for balance for both clinicians and researchers.	[Kleffelgaard, Ingerid; Soberg, Helene Lundgaard] Oslo Univ Hosp HF, Dept Phys Med & Rehabil, Oslo, Norway; [Kleffelgaard, Ingerid; Langhammer, Birgitta; Pripp, Are Hugo; Soberg, Helene Lundgaard] Oslo Univ Coll Appl Sci, Inst Physiotherapy, Oslo, Norway; [Kleffelgaard, Ingerid] Univ Oslo, Fac Med, Oslo, Norway; [Sandhaug, Maria] Statped Head Off Oslo, Oslo, Norway		Kleffelgaard, I (corresponding author), Oslo & Akershus Univ Coll Appl Sci, Postboks 4,St Olavs Pl, N-0130 Oslo, Norway.	inff@live.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; [Anonymous], 2010, REH MEAS DAT BAL ERR; Balance Error Scoring System (BESS), 2014, 275998700 BESS NC U; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROSNER B, 2005, FUNDAMENTALS BIOSTAT; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Shumway-Cook A, 2017, MOTOR CONTROL TRANSL, V5th; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395	24	3	3	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2167-9169	2167-9177		EUR J PHYSIOTHER	Eur. J. Physiother.		2018	20	1					25	31		10.1080/21679169.2017.1352020			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	GF7GN	WOS:000432136500005					2022-02-06	
J	Koh, CH; Pronin, S; Hughes, M				Koh, Chan Hee; Pronin, Savva; Hughes, Mark			Chondroitinase ABC for neurological recovery after acute brain injury: systematic review and meta-analyses of preclinical studies	BRAIN INJURY			English	Article						Neurosurgery; rehabilitation; animal models; medical management; traumatic brain injury; stroke	SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; SULFATE PROTEOGLYCANS; AXONAL REGENERATION; SURGICAL RESECTION; RAT-BRAIN; PLASTICITY; PROMOTES; STROKE; DEGRADATION	Objectives: Damage to critical brain regions causes deficits in important neurological functions. Chondroitinase ABC (ChABC) has been shown to promote neuroplasticity and may ameliorate neurological deficits caused by disease or trauma. This systematic review identifies and evaluates preclinical studies of ChABC as a treatment for acute brain injury.Methods: Four databases were searched for studies relating to ChABC and brain or brain injuries. Controlled studies in mammals with acute brain injuries treated with ChABC were included in meta-analyses of neurobehavioural outcomes. Means and standard deviations from the fifth day of treatment were extracted, and normalised mean differences were calculated.Results: Of 775 identified records, 16 studies administered ChABC after acute brain injury, of which 9 reported neurobehavioural outcomes. The estimated treatment effect on neurological recovery over the duration of included studies was 49.4% (CI: 30.3-68.4% with Hartung-Knapp-Sidik-Jonkman adjustment, p=0.0002). The mechanisms of action may involve decreasing astroglial scar formation, promoting neuronal sprouting, and selective synaptic strengthening of sprouting neurites and activated neural pathways.Conclusions: The summary of published evidence suggests that ChABC treatment is effective in improving neurological outcomes in preclinical models of acute brain injury. However, more studies are needed for better assessment of the specific translational potential of ChABC.Abbreviations: AVM - Arteriovenous Malformation; ChABC - Chondroitinase ABC; CI - Confidence Interval; CSPG - Chondroitin Sulphate Proteoglycans; HKSJ - Hartung-Knapp-Sidik-Jonkman; MCA - Middle Cerebral Artery; NMD - Normalised Mean Difference; NSPC - Neural Stem/Progenitor Cells; PI - Prediction Interval; SD - Standard Deviation; SMD - Standardised Mean Difference; TBI - Traumatic Brain Injury.	[Koh, Chan Hee; Pronin, Savva] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Hughes, Mark] Univ Edinburgh, Translat Neurosurg Unit, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland		Koh, CH (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Edinburgh Med Sch, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	Chanhee.Koh@gmail.com					Babu R, 2016, J NEUROSURG, V124, P998, DOI 10.3171/2015.4.JNS142200; Borenstein M., 2009, INTRO META ANAL, P225, DOI DOI 10.1002/9780470743386.CH24; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chen L, 2013, BBA-REV CANCER, V1836, P158, DOI 10.1016/j.bbcan.2013.04.003; Chen XR, 2014, BRAIN RES, V1543, P324, DOI 10.1016/j.brainres.2013.12.002; Deng YP, 2015, EXP NEUROL, V269, P213, DOI 10.1016/j.expneurol.2015.03.026; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Dwyer CA, 2014, J NEURO-ONCOL, V120, P63, DOI 10.1007/s11060-014-1541-z; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Finan John D, 2016, BMC Res Notes, V9, P160, DOI 10.1186/s13104-016-1968-8; Garcia-Alias G, 2015, EXP NEUROL, V266, P112, DOI 10.1016/j.expneurol.2015.01.009; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gherardini L, 2015, CEREB CORTEX, V25, P202, DOI 10.1093/cercor/bht217; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Hoyt ADR& WT, 2014, MAD MET AN MEAN DIFF; Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Karmarkar SW, 2010, COMPARATIVE MED, V60, P256; Krieg SM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-51; Lee SU, 2009, CAN J NEUROL SCI, V36, P443, DOI 10.1017/S0317167100007769; Li HP, 2007, J NEUROSCI RES, V85, P536, DOI 10.1002/jnr.21141; Li HP, 2013, J NEUROTRAUM, V30, P413, DOI 10.1089/neu.2012.2513; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lu RQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-607; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rankin-Gee EK, 2015, EPILEPSIA, V56, P1124, DOI 10.1111/epi.13026; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Ringel F, 2016, NEURO-ONCOLOGY, V18, P96, DOI 10.1093/neuonc/nov145; Sato Y, 2008, REPROD SCI, V15, P613, DOI 10.1177/1933719108317299; Schucht P, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.10.FOCUS14524; Shah A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.145; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Sim H, 2009, J BIOL CHEM, V284, P26547, DOI 10.1074/jbc.M109.013185; Soleman S, 2012, BRAIN, V135, P1210, DOI 10.1093/brain/aws027; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Viechtbauer W., 2020, METAFOR METAANALYSIS; Vinukonda G, 2013, EXP NEUROL, V247, P630, DOI 10.1016/j.expneurol.2013.02.018; Xu M, 2015, ANIMAL MODELS STUDYI, V2015; Zhang Y, 2013, J CRANIOFAC SURG, V24, P2153, DOI 10.1097/01.SCS.0000436700.65891.3b; Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2	46	3	4	2	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					715	729		10.1080/02699052.2018.1438665			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200004	29436856				2022-02-06	
J	Koumlis, S; Cheng, H; Morgan, TE; Finch, CE; Eliasson, V				Koumlis, S.; Cheng, H.; Morgan, T. E.; Finch, C. E.; Eliasson, V.			Glial Model for Traumatic Brain Injury: Network Strain Field and Inflammation Induced by Repeated Mechanical Impacts In Vitro	EXPERIMENTAL MECHANICS			English	Article						Traumatic brain injury model; In vitro glial network; Blunt impact induced TBI; Substrate strain; Digital image correlation	TUMOR-NECROSIS-FACTOR; FIBRILLARY ACIDIC PROTEIN; CELLS; PATHOPHYSIOLOGY; CULTURES; NEURONS; STRETCH; DAMAGE; VIVO	Traumatic brain injury (TBI) is a form of acquired brain trauma in which sudden external mechanical insults damage brain structures and cells. With a wide range of severities, TBI induces inflammatory responses with neurodegeneration and dysfunction. To develop new treatments, reproducible models of implementation are needed. Moreover, these models need to exhibit high biological and mechanical fidelity to the injurious event that they are trying to mimic. Here, the Highly Automated Mechanical Impactor (HAMr) is used to deliver 64 controlled pressure-pulses of known magnitude and duration to mixed glia cultures as a model for repetitive TBI. The mechanical response of those glial networks was quantified in terms of induced strain histories using Digital Image Correlation (DIC) under high-speed microscopic imaging. Four hours post-impact, glial network shearing and gene expression increases of TNF alpha and IL-1 alpha were observed. However, select microglia and astrocyte markers were unchanged. These findings validate HAMr as a tool that enables quantification of the cell-substrate strain history during impact loading while reproducibly inducing inflammation and damaging glial network integrity, which are both common consequences of TBI.	[Koumlis, S.; Eliasson, V.] Univ Southern Calif, Aerosp & Mech Engn, Los Angeles, CA 90007 USA; [Cheng, H.; Morgan, T. E.; Finch, C. E.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Eliasson, V.] Univ Calif San Diego, Dept Struct Engn, San Diego, CA 92103 USA		Eliasson, V (corresponding author), Univ Southern Calif, Aerosp & Mech Engn, Los Angeles, CA 90007 USA.; Eliasson, V (corresponding author), Univ Calif San Diego, Dept Struct Engn, San Diego, CA 92103 USA.	eliasson@ucsd.edu	Finch, Caleb/AAA-7250-2022; Koumlis, Stylianos/AAS-8848-2021	Cheng, Hank/0000-0003-3793-0394			Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Bilston LE, 2011, BIOL MED PHYS BIOMED, P69, DOI 10.1007/978-1-4419-9997-9_4; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Jones EMC, 2014, EXP MECH, V54, P971, DOI 10.1007/s11340-014-9873-3; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Koumlis S, 2015, EXP MECH, V55, P1441, DOI 10.1007/s11340-015-0052-y; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Morgan TE, 2011, ENVIRON HEALTH PERSP, V119, P1003, DOI 10.1289/ehp.1002973; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Roebuck-Spencer T, 2014, HDB NEUROPSYCHOLOGY; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Schatter Beate, 2005, BMC Pharmacology, V5, P3, DOI 10.1186/1471-2210-5-3; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	44	3	3	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4851	1741-2765		EXP MECH	Exp. Mech.	JAN	2018	58	1					125	135		10.1007/s11340-017-0338-3			11	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	FR1BE	WOS:000418799700010					2022-02-06	
J	Kozina, ZL; Kalinicenko, VE; Cretu, M; Osiptsov, AV; Kudryavtsev, MD; Polishchuk, SB; Ilnickaya, AS; Minenok, AO				Kozina, Zh. L.; Kalinicenko, V. E.; Cretu, M.; Osiptsov, A., V; Kudryavtsev, M. D.; Polishchuk, S. B.; Ilnickaya, A. S.; Minenok, A. O.			Influence of music on the level of physical fitness of the students practicing rugby (rugby players students)	PHYSICAL EDUCATION OF STUDENTS			English	Article						rugby; music; endurance; strength; fitness	KING-DEVICK TEST; UNION; JUDO; CONCUSSION; INJURIES; SPORTS; LEAGUE	Purpose: to develop a training technology with the application of music at rugby training of 16-17-year-olds players. Material: Rugby players (n=20) from sports club "KhTZ" (16-17-year-olds) participated in a research. Athletes were divided into two groups: the control group (n=10), the experimental group (n=10). The experimental group trained with music. The groups were tested on the level of physical fitness at the beginning and at the end of the experiment. The following tests were applied: 30 m run, 400 m run, barbell press in a prone position (maximum value), 3 km run. Results: It is defined the influence of music on physical fitness indicators of athletes. It is revealed a confident increase in indicators of the general endurance (3 km run) and special endurance (400 m run) in students of the experimental group. The students of the control group had a confident increase in result in 400 m but in smaller significance value. Conclusions: The received data confirm the expediency of music application in young athletes' training for the development of the general and special endurance.	[Kozina, Zh. L.; Kalinicenko, V. E.; Polishchuk, S. B.; Ilnickaya, A. S.] HS Skovoroda Kharkiv Natl Pedag Univ, Dept Olymp & Profess Sports & Sports Games, Alchevskyh Str 29, UA-61002 Kharkov, Ukraine; [Cretu, M.] Univ Pitesti, Fac Sci Phys Educ & Informat, Str Targul Din Vale 1, Pitesti 110040, Arges, Romania; [Osiptsov, A., V] Mariupol State Univ, Dept Phys Educ & Hlth, Budivelnykiv Ave 129a, UA-87500 Mariupol, Ukraine; [Kudryavtsev, M. D.] Krasnoyarsk State Pedag Univ VP Astafyev, Dept Phys Training, Ada Lebedeva St 89, Krasnoyarsk 660049, Russia; [Kudryavtsev, M. D.] Siberian Fed Univ, 79 Svobodny Pr, Krasnoyarsk 660041, Russia; [Kudryavtsev, M. D.] Reshetnev Siberian State Univ Sci & Technol, Off A 406, 31 Krasnoyarsky Rabochy Ave, Krasnoyarsk 660014, Russia; [Kudryavtsev, M. D.] Siberian Law Inst, Minist Internal Affair Russia, Rokossovskia Str 20, Krasnoyarsk 660131, Russia; [Minenok, A. O.] Natl Univ, Chernigiv Coll TG Shevchenko, Fac Phys Educ, Hetman Polubotko Str 53, UA-14013 Chernigiv, Ukraine		Kozina, ZL (corresponding author), HS Skovoroda Kharkiv Natl Pedag Univ, Dept Olymp & Profess Sports & Sports Games, Alchevskyh Str 29, UA-61002 Kharkov, Ukraine.	Zhanneta.kozina@gmail.com	Osiptsov, Andrey/F-2414-2018; Kozina, Zhanneta/J-9579-2015; Kudryavtsev, Mikhail/AAE-2076-2020; Kozina, Zhanna/D-4453-2018; Polishchuk, Stanislav/X-6645-2018; Ilnitskaya, Anna/L-3477-2018; Cretu, Marian/C-2044-2015; Kudravcev, M. D./Q-2614-2016	Kozina, Zhanneta/0000-0001-5588-4825; Kozina, Zhanna/0000-0002-0131-3194; Ilnitskaya, Anna/0000-0002-2520-5294; Cretu, Marian/0000-0003-1934-0534; Kudravcev, M. D./0000-0002-2432-1699	Ministry of Education and Science of Ukraine [0113U002003, 0115U004036, 0117U000650]	The research is conducted according to:; the research work of Ministry of Education and Science of Ukraine for 2013-2014. "Theoretical and methodical bases of application the information, pedagogical and medical-biological technologies for formation of healthy lifestyle" (No of the state registration 0113U002003);; the research work of Ministry of Education and Science of Ukraine for 2015-2016. "Theoretical and methodical bases of means application the information, pedagogical, medical-biological orientation for motor and spiritual development and formation of healthy lifestyle" (No of the state registration 0115U004036).; the research work of Ministry of Education and Science of Ukraine for 2017-2018. "Theoretical and methodical bases of application of information, medical-biological and pedagogical technologies for realization of individual physical, intellectual and spiritual potential and formation of healthy lifestyle" (No of the state registration 0117U000650).	Brown JC, 2015, J SCI MED SPORT, V18, P394, DOI 10.1016/j.jsams.2014.06.015; Cabane C, 2016, LABOUR ECON, V41, P90, DOI 10.1016/j.labeco.2016.05.012; Cheng E, 2016, LEISURE STUD, V35, P549, DOI 10.1080/02614367.2015.1031270; Cizek E, 2016, MED PROBL PERFORM AR, V31, P63, DOI 10.21091/mppa.2016.2013; Clark IN, 2016, NORD J MUSIC THER, V25, P76, DOI 10.1080/08098131.2015.1008558; Collins T., 2006, RUGBYS GREAT SPLIT C; Cummins A, 2016, LECT NOTES COMPUT SC, V9768, P16, DOI 10.1007/978-3-319-40621-3_2; Dalgalarrondo S, 2015, SOCIOL TRAV, V57, P516, DOI 10.1016/j.soctra.2015.09.004; Doroshenko EY, 2017, ARCH BUDO SCI MARTIA, V13, P165; Ferriss T, 2016, TOOLS TITANS TACTICS; Jagiello M, 2017, ARCH BUDO SCI MARTIA, V13, P63; Jagiello W, 2017, BIOL SPORT, V34, P401, DOI 10.5114/biolsport.2017.70526; Karageorghis CI, 1999, J SPORT SCI, V17, P713, DOI 10.1080/026404199365579; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Korobeynikov G., 2016, J PHYS ED SPORT, V16, P976, DOI [10.7752/jpes.2016.03154, DOI 10.7752/JPES.2016.03154]; Korobeynikov G, 2010, ARCH BUDO, V6, P129; Kovac Z, 2011, RELATION MUSIC PHYS; Kozina Z., 2016, Journal of Physical Education and Sport, V16, P1348; Kozina Z, 2017, J PHYS ED SPORT, V17, P648, DOI DOI 10.7752/JPES.2017.02097; Kozina Z, 2017, J PHYS ED SPORT, V17, P378; Kozina Z, 2018, J HUM SPORT EXERC, V13, P99, DOI 10.14198/jhse.2018.131.10; Kozina ZL, 2016, RES J PHARM BIOL CHE, V7, P1068; Kozina ZL, 2016, ZDOROVA SPORT REABIL, V2, P52; Kriventsova I, 2017, J HUM SPORT EXERC, V12, P1289, DOI 10.14198/jhse.2017.124.15; Madrigal L, 2016, J CLIN SPORT PSYCHOL, V10, P137, DOI 10.1123/JCSP.2015-0021; Madrigal L, 2015, SPORT PSYCHOL, V29, P310, DOI 10.1123/tsp.2014-0139; Olsen P, 2015, EUR J PREV CARDIOL, V22, P1254, DOI 10.1177/2047487314539433; Orr R, 2016, J SCI MED SPORT, V19, P212, DOI 10.1016/j.jsams.2015.03.007; Osipov AY, 2017, ARCH BUDO, V13, P179; Osipov AY, 2017, ARCH BUDO, V13, P1; Osipov AYu, 2018, ARCH BUDO, P14; Pecen E, 2016, SPORT EXERC PERFORM, V5, P377, DOI 10.1037/spy0000067; Pretorius J, 2015, BIOMED RES-INDIA, V26, P249; Quarrie KL, 2017, BRIT J SPORT MED, V51, P421, DOI 10.1136/bjsports-2016-096191; Sheppard JR, 2015, J ROY MUSIC ASSN, V140, P343, DOI 10.1080/02690403.2015.1075810; Tan ZJ, 2011, STUDY ROLE MUSIC AER; Vogelsang L, 2016, DREAMING, V26, P132, DOI 10.1037/drm0000018	38	3	3	2	14	IERMAKOV S S	KHARKOV-68	BOX 11135, KHARKOV-68, 61068, UKRAINE	2075-5279	2308-7250		PHYS EDUC STUD	Phys. Educ. Stud.		2018	22	3					120	126		10.15561/20755279.2018.0302			7	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	GJ7ZP	WOS:000435609400002		Green Submitted, gold			2022-02-06	
S	Leisman, G; Machado, C; Machado, Y; Chinchilla-Acosta, M		Pokorski, M		Leisman, Gerry; Machado, Calixto; Machado, Yanin; Chinchilla-Acosta, Mauricio			Effects of Low-Level Laser Therapy in Autism Spectrum Disorder	CLINICAL MEDICINE RESEARCH	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Autism spectrum disorder; Brain; Clinical trial; Low-level laser therapy; Neuronal networks; Photobiomodulation	TRAUMATIC BRAIN-INJURY; DEFAULT MODE; FUNCTIONAL CONNECTIVITY; RATING-SCALE; NETWORK; BEHAVIOR; PHOTOBIOMODULATION; SCHIZOPHRENIA; ASSOCIATION; COGNITION	The study examined the efficacy of low-level laser therapy, a form of photobiomodulation, for the treatment of irritability associated with autistic spectrum disorder in children and adolescents aged 5-17 years. Twenty-one of the 40 participants received eight 5-min procedures administered to the base of the skull and temporal areas across a 4-week period (test, i.e., active treatment participants). All the participants were evaluated with the Aberrant Behavior Checklist (ABC), with the global scale and five subscales (irritability/agitation, lethargy/social withdrawal, stereotypic behavior, hyperactivity/noncompliance, and inappropriate speech), and the Clinical Global Impressions (CGI) Scale including a severity-of-illness scale (CGI-S) and a global improvement/change scale (CGI-C). The evaluation took place at baseline, week 2 (interim), week 4 (endpoint), and week 8 (postprocedure) of the study. The adjusted mean difference in the baseline to study endpoint change in the ABC irritability subscale score between test and placebo participants was -15.17 in favor of the test procedure group. ANCOVA analysis found this difference to be statistically significant (F = 99.34, p < 0.0001) compared to the baseline ABC irritability subscale score. The study found that low-level laser therapy could be an effective tool for reducing irritability and other symptoms and behaviors associated with the autistic spectrum disorder in children and adolescents, with positive changes maintained and augmented over time.	[Leisman, Gerry] Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel; [Leisman, Gerry] Natl Inst Brain & Rehabil Sci, Nazareth, Israel; [Leisman, Gerry] Univ Med Sci, Fac Manuel Fajrdo, Havana, Cuba; [Machado, Calixto; Machado, Yanin; Chinchilla-Acosta, Mauricio] Inst Neurol & Neurosurg, Havana, Cuba		Leisman, G (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel.; Leisman, G (corresponding author), Natl Inst Brain & Rehabil Sci, Nazareth, Israel.; Leisman, G (corresponding author), Univ Med Sci, Fac Manuel Fajrdo, Havana, Cuba.	g.leisman@edu.haifa.ac.il	Leisman, Gerry/U-3267-2019	Leisman, Gerry/0000-0002-9975-7331			AMAN MG, 1985, AM J MENT DEF, V89, P492; AMAN MG, 1985, AM J MENT DEF, V89, P485; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Behrmann M, 2013, TRENDS COGN SCI, V17, P210, DOI 10.1016/j.tics.2013.03.007; Berk M, 2008, J EVAL CLIN PRACT, V14, P979, DOI 10.1111/j.1365-2753.2007.00921.x; Black B, 2013, OPT LETT, V38, P2174, DOI 10.1364/OL.38.002174; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Carroll J, 2015, J ORTHOP RHEUMATOL, V2, DOI [10.15406/mojor.2015.02.00068, DOI 10.15406/MOJOR.2015.02.00068]; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Dawood MS, 2013, LASER MED SCI, V28, P941, DOI 10.1007/s10103-012-1182-4; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Ding SF, 2017, COGN COMPUT, V9, P194, DOI 10.1007/s12559-016-9446-0; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Farivar S, 2014, J LASERS MED SCI, V5, P58; Farmer C, 2012, ENCY AUTISM SPECTRUM; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Gadow KD, 2012, RES DEV DISABIL, V33, P1157, DOI 10.1016/j.ridd.2012.01.004; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Griffiths TD, 2017, NEURON, V94, P5, DOI 10.1016/j.neuron.2017.03.031; Grover F, 2017, PHOTOMED LASER SURG, V35, P136, DOI 10.1089/pho.2015.4036; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hiwaki O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192095; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Leisman G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00036; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P406, DOI 10.1038/sj.npp.1300873; Machado C, 2015, J AUTISM DEV DISORD, V45, P406, DOI 10.1007/s10803-013-1909-5; McPartland J, 2012, HAND CLINIC, V106, P407, DOI 10.1016/B978-0-444-52002-9.00023-1; Melillo R, 2010, NEUROBEHAVIORAL DISO; Melillo R, 2009, REV NEUROSCIENCE, V20, P111; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Pessoa L, 2012, BEHAV BRAIN SCI, V35, P158, DOI 10.1017/S0140525X11001567; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Purushothurnan S, 2015, NEUROSCI LETT, V591, P155, DOI 10.1016/j.neulet.2015.02.037; Quirk BJ, 2011, PHOTOMED LASER SURG, V29, P143, DOI 10.1089/pho.2011.3014; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salo E, 2017, BRAIN RES, V1664, P25, DOI 10.1016/j.brainres.2017.03.021; Scherman M, 2012, OPT EXPRESS, V20, P4346, DOI 10.1364/OE.20.004346; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shanks S, 2018, ADV EXP MED BIOL, V1096, P41, DOI 10.1007/5584_2018_188; South M, 2012, AUTISM RES, V5, P398, DOI 10.1002/aur.1255; Testa-Silva G, 2012, CEREB CORTEX, V22, P1333, DOI 10.1093/cercor/bhr224; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Wang LN, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/630361; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wu XJ, 2012, LASER SURG MED, V44, P227, DOI 10.1002/lsm.22004; Zappella M, 2012, AM J MED GENET C, V160C, P111, DOI 10.1002/ajmg.c.31328; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	62	3	4	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-0300-4837-2	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1116						111	130		10.1007/5584_2018_234	10.1007/978-3-030-04837-2		20	Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	BL9PW	WOS:000458012300011	29956199				2022-02-06	
J	Li, ZQ; Wu, X; Wu, XH; Yu, J; Yuan, Q; Du, ZY; Hu, J				Li, Zhiqi; Wu, Xing; Wu, Xuehai; Yu, Jian; Yuan, Qiang; Du, Zhuoying; Hu, Jin			Admission circulating monocytes level is an independent predictor of outcome in traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; blood test; monocyte; outcome assessment	SEVERE HEAD-INJURY; CLINICAL-TRIALS; STROKE; MACROPHAGES; ACTIVATION; IMMUNE; PROGESTERONE; GUIDELINES; PROGNOSIS; SYSTEM	Objective: The aim of this study was to assess the prognostic value of admission immune cell levels in the peripheral blood in determining outcomes in patients with TBI.Method: We studied 141 adult patients with mild-to-severe TBI (Glasgow Coma Scale (GCS) 3-15). Patient outcome was assessed using the Extended Glasgow Outcome Scale (GOSE) at 6months post-injury. The area under the curve (AUC) was used to evaluate the predictive ability of immune cell levels. Uni- and multivariate analyses were performed to assess the independent predictors of 6-month outcome.Results: We found that admission monocyte count was not only a better predictor (AUC=0.778; 95% confidence interval (CI), 0.679-0.858) of favourable outcomes (GOSE 5-8) at 6months post-injury than were admission haemoglobin (AUC=0.629; 95% CI, 0.522-0.728) and blood glucose (AUC=0.616; 95% CI, 0.508-0.716) levels for patients with moderate-to-severe TBI (GCS12), but also an independent predictor of 6-month outcome (adjusted odds ratio, 1.35; 95% CI, 1.10-1.65; p=0.004).Conclusions: The present study suggests that an increase in admission monocyte count is correlated with a favourable 6-month outcome in patients with moderate-to-severe TBI.	[Li, Zhiqi; Wu, Xing; Wu, Xuehai; Yu, Jian; Yuan, Qiang; Du, Zhuoying; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai, Peoples R China.	hujin_dana@126.com		li, zhiqi/0000-0003-0988-8125	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271375]	This study was supported by National Natural Science Foundation of China (NSFC) [grant number 81271375].	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnelly J, 2015, NEUROCRIT CARE, V22, P20, DOI 10.1007/s12028-014-0042-4; GARCIA JH, 1994, AM J PATHOL, V144, P188; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Majetschak M, 1999, CRIT CARE MED, V27, P313, DOI 10.1097/00003246-199902000-00037; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Pankhurst MW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-172; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Urra X, 2009, J CEREBR BLOOD F MET, V29, P994, DOI 10.1038/jcbfm.2009.25; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035; Yuan Q, 2015, J CRIT CARE, V30, P116, DOI 10.1016/j.jcrc.2014.07.009; Ziegler-Heitbrock HWL, 2000, J LEUKOCYTE BIOL, V67, P603, DOI 10.1002/jlb.67.5.603	38	3	3	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					515	522		10.1080/02699052.2018.1429023			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400016	29355430				2022-02-06	
J	Litofsky, NS; Miller, DC; Chen, ZZ; Simonyi, A; Klakotskaia, D; Giritharan, A; Feng, Q; McConnell, D; Cui, JK; Gu, ZZ				Litofsky, N. Scott; Miller, Douglas C.; Chen, Zhenzhou; Simonyi, Agnes; Klakotskaia, Diana; Giritharan, Andrew; Feng, Qi; McConnell, Diane; Cui, Jiankun; Gu, Zezong			Anaemia worsens early functional outcome after traumatic brain injury: a preliminary study	BRAIN INJURY			English	Article						Anaemia; haemoglobin; traumatic brain injury; outcome; mouse; electromagnetic impactor	BLOOD-CELL TRANSFUSION; MOUSE MODEL; ASSOCIATION	Objective: To determine early effects on outcome from traumatic brain injury (TBI) induced by controlled cortical impact (CCI) associated with anaemia in mice.Hypothesis: Outcome from TBI with concomitant anaemia would be worse than TBI without anaemia.Methods: CCI was induced with electromagnetic impaction in four groups of C57BL/6J mice: sham, sham+anaemia; TBI; and TBI+anaemia. Anaemia was created by withdrawal of 30% of calculated intravascular blood volume and saline replacement of equal volume. Functional outcome was assessed by beam-walking test and open field test (after pre-injury training) on post-injury days 3 and 7. After functional assessment, brains removed from sacrificed animals were pathological reviewed with haematoxylin and eosin, cresyl violet, Luxol Fast Blue, and IBA-1 immunostains.Results: Beam-walking was similar between animals with TBI and TBI+anaemia (p=0.9). In open field test, animals with TBI+anaemia walked less distance than TBI alone or sham animals on days 3 (p<0.001) and 7 (p<0.05), indicating less exploratory and locomotion behaviours. No specific pathologic differences could be identified.Conclusions: Anaemia associated with TBI from CCI is associated with worse outcome as measured by less distance travelled in the open field test at three days than if anaemia is not present.	[Litofsky, N. Scott; Feng, Qi; McConnell, Diane] Univ Missouri, Sch Med, Div Neurol Surg, One Hosp Dr,MC 321, Columbia, MO 65212 USA; [Miller, Douglas C.; Chen, Zhenzhou; Giritharan, Andrew; McConnell, Diane; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Simonyi, Agnes] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Klakotskaia, Diana] Univ Missouri, Dept Psychol Sci, Columbia, MO USA		Litofsky, NS (corresponding author), Univ Missouri, Sch Med, Div Neurol Surg, One Hosp Dr,MC 321, Columbia, MO 65212 USA.	litofskyn@health.missouri.edu		Klakotskaia, Diana/0000-0002-9851-5330	Department of Surgery, University of Missouri School of Medicine; Division of Neurological Surgery, University of Missouri School of Medicine; NFL Charity Foundation; MIZZOU Advantage; Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine	This work was supported by an internal grant from the Department of Surgery, University of Missouri School of Medicine in 2013-2014 and research funds from the Division of Neurological Surgery, University of Missouri School of Medicine. Additional support was provided in part from the NFL Charity Foundation and MIZZOU Advantage (ZG) and research funds from the Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine (JC and ZG).	Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; DONOVAN J, 2006, CURRENT PROTOCOLS IM; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Kumar MA, 2012, NEUROTHERAPEUTICS, V9, P56, DOI 10.1007/s13311-011-0094-5; Litofsky SN, 2016, WORLD NEURO IN PRESS, DOI [10.1016/j.wneu.2016.02.076, DOI 10.1016/J.WNEU.2016.02.076]; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Office of Animal Care and Use National Institutes of Health., NIH GUID SURV BLEED; Raabe BM, 2011, J AM ASSOC LAB ANIM, V50, P680; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Travers S, 2016, J TRAUMA TREAT, V5, P347; Travers S, 2016, BRAIN INJURY, V30, P1525, DOI 10.1080/02699052.2016.1199907; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Yang CJ, 2011, J TRAUMA, V71, pE132, DOI 10.1097/TA.0b013e31820ea36b; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942	23	3	3	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					342	349		10.1080/02699052.2018.1425913			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700009	29333886				2022-02-06	
J	Liu, B; Zhang, YH; Jia, N; Lan, M; Du, L; Zhao, DC; He, Q				Liu, Bing; Zhang, Yunhe; Jia, Na; Lan, Ming; Du, Ling; Zhao, Dachun; He, Qing			Study of the Safety of Extracorporeal Cardiac Shock Wave Therapy: Observation of the Ultrastructures in Myocardial Cells by Transmission Electron Microscopy	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article						extracorporeal cardiac shock wave; safety; rat; myocardial ultrastructure; transmission electron microscopy	CORONARY-ARTERY-DISEASE; TRAUMATIC BRAIN-INJURY; STRIATED MUSCLE; ISCHEMIA; HEART; RAT; STRESS; ULTRASOUND; SARCOLEMMA; EXPOSURE	Extracorporeal cardiac shock wave therapy (CSWT) has been used to treat patients with severe coronary heart disease and cardiac failure with good results; however, the safety of this treatment is still controversial. Its safety in clinical setting and on microstructures has been confirmed, but the influence of shock wave on the ultrastructures of myocardial cells is not clear. In this study, 12 Sprague-Dawley rats were randomly divided into control (NC) and CSWT therapy (NC+SW) groups. The heart rate, blood pressure, serum troponin I (TNI), and cardiac ultrasound were evaluated, and the myocardial inflammatory responses and fibrosis changes were compared. The samples were observed by transmission electron microscopy to evaluate the changes in myocardial tissue ultrastructure. The CSWT had no significant influence on rat hemodynamics indices and serum TNI, did not affect left ventricular function, and did not cause myocardial inflammatory response and fibrosis changes. The scores of myocardial ultrastructure damage in the NC and NC+SW groups were 1.39 +/- 0.982 and 2.42 +/- 1.009, respectively (P = .103). The CSWT did not cause significant additional damage to myocardial ultrastructures. The safety of CWST has been preliminarily proved at the clinical, microstructure, and ultrastructure levels, but its long-term safety needs further exploration.	[Liu, Bing; Du, Ling; He, Qing] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China; [Liu, Bing; Jia, Na; Lan, Ming; Du, Ling; He, Qing] Beijing Hosp, Dept Cardiol, Natl Ctr Gerontol, Beijing, Peoples R China; [Zhang, Yunhe] Sichuan Acad Med Sci, Dept Geriatr Med, Chengdu, Sichuan, Peoples R China; [Zhang, Yunhe] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Zhao, Dachun] Beijing Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China		He, Q (corresponding author), Beijing Hosp, 1 Dahua Rd, Beijing 100730, Peoples R China.	heqingli2001@126.com		HE, QING/0000-0003-2899-0950	Capital Health Project [Z131100004013032]; Beijing Hospital Clinical Research 121 Project [121-2016004]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470427]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by grants from projects of the Capital Health Project (Z131100004013032), Beijing Hospital Clinical Research 121 Project (121-2016004), and the National Natural Science Foundation of China (81470427).	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; Auge Brian K, 2002, Curr Opin Urol, V12, P287, DOI 10.1097/00042307-200207000-00005; BENNETT H. STANLEY, 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P171, DOI 10.1083/jcb.2.4.171; BENNETT HS, 1953, AM J ANAT, V93, P61, DOI 10.1002/aja.1000930104; BRYANT RE, 1958, CIRC RES, V6, P699, DOI 10.1161/01.RES.6.6.699; CAULFIELD J, 1959, AM J PATHOL, V35, P489; Chen H, 2011, ULTRASOUND MED BIOL, V37, P2139, DOI 10.1016/j.ultrasmedbio.2011.09.013; Ciampa AR, 2005, FEBS LETT, V579, P6839, DOI 10.1016/j.febslet.2005.11.023; Daud FV, 2009, REV BRAS CIR CARDIOV, V24, P173, DOI 10.1590/S0102-76382009000200013; DE SOUZA SANTOS P, 1956, J Biophys Biochem Cytol, V2, P143; DEMPSEY E. W., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P305, DOI 10.1083/jcb.2.4.305; Di Meglio F, 2012, J CELL MOL MED, V16, P936, DOI 10.1111/j.1582-4934.2011.01393.x; Ferreira C, 1992, Arq Bras Cardiol, V58, P457; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Golomb E, 2012, TOXICOL PATHOL, V40, P779, DOI 10.1177/0192623312441409; Gutersohn A., 2000, EUR J HEART FAIL, V2, P42, DOI DOI 10.1016/S1388-9842(00)80143-9; HAUPT G, 1992, UROLOGY, V39, P529, DOI 10.1016/0090-4295(92)90009-L; Henney JE, 2000, JAMA-J AM MED ASSOC, V284, P2711, DOI 10.1001/jama.284.21.2711-a; HODGE A. J., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P131, DOI 10.1083/jcb.2.4.131; HUXLEY HE, 1957, J BIOPHYS BIOCHEM CY, V3, P631, DOI 10.1083/jcb.3.5.631; Jargin SV, 2010, INT J CARDIOL, V144, P116, DOI 10.1016/j.ijcard.2008.12.198; Julian MW, 2011, INT J EXP PATHOL, V92, P366, DOI 10.1111/j.1365-2613.2011.00783.x; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; KRAUSS M, 1956, EXP CELL RES, V11, P637, DOI 10.1016/0014-4827(56)90172-0; Lenzi P, 2003, ENVIRON HEALTH PERSP, V111, P467, DOI 10.1289/ehp.5847; Melo RCN, 2009, J CELL MOL MED, V13, P279, DOI 10.1111/j.1582-4934.2008.00388.x; MOORE DH, 1957, J BIOPHYS BIOCHEM CY, V3, P261, DOI 10.1083/jcb.3.2.261; MUIR AR, 1957, J BIOPHYS BIOCHEM CY, V3, P193, DOI 10.1083/jcb.3.2.193; MUIR AR, 1957, J ANAT, V91, P251; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ogden JA, 2001, CLIN ORTHOP RELAT R, P47, DOI 10.1097/00003086-200106000-00007; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; PALADE GEORGE E., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P85, DOI 10.1083/jcb.2.4.85; Piper RD, 1997, AM J RESP CRIT CARE, V156, P1473, DOI 10.1164/ajrccm.156.5.96-10085; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; PRICE KC, 1955, J EXP MED, V101, P687, DOI 10.1084/jem.101.6.687; SCHLEBERGER R, 1992, ARCH ORTHOP TRAUM SU, V111, P224, DOI 10.1007/BF00571482; Schmid JP, 2013, CARDIOVASC THER, V31, pe1, DOI 10.1111/j.1755-5922.2012.00313.x; SPIRO DAVID, 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P157, DOI 10.1083/jcb.2.4.157; VALCHANOU VD, 1991, INT ORTHOP, V15, P181; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; WANG H, 1956, EXP CELL RES, V11, P452, DOI 10.1016/0014-4827(56)90121-5; Wang Y, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-35; WATSON ML, 1956, J BIOPHYS BIOCHEM CY, V2, P639, DOI 10.1083/jcb.2.6.639; Wess O, 1997, HIGH ENERGY SHOCK WA, P63; Wu JR, 2007, PROG BIOPHYS MOL BIO, V93, P363, DOI 10.1016/j.pbiomolbio.2006.07.016; Yang P, 2013, HEART VESSELS, V28, P284, DOI 10.1007/s00380-012-0244-7; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; Zhang Y, 2016, CHIN J CARDIOVASC ME, V2, P6	51	3	4	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-2484	1940-4034		J CARDIOVASC PHARM T	J. Cardiovasc. Pharmacol. Ther.	JAN	2018	23	1					79	88		10.1177/1074248417725877			10	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	FQ0LP	WOS:000418048000008	28862043				2022-02-06	
J	Torices, MIM; Hidalgo-Ruzzante, N; Daugherty, JC; Jimenez-Gonzalez, P; Perez Garcia, M				Marin Torices, Ma Isabel; Hidalgo-Ruzzante, Natalia; Daugherty, Julia C.; Jimenez-Gonzalez, Pilar; Perez Garcia, Miguel			Validation of neuropsychological consequences in victims of intimate partner violence in a Spanish population using specific effort tests	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Intimate partner violence; effort tests; performance validity; symptom validity	TRAUMATIC BRAIN-INJURY; MEMORY MALINGERING TOMM; UNDERGRADUATE RESEARCH PARTICIPANTS; POSTTRAUMATIC-STRESS-DISORDER; BATTERED WOMEN; PERFORMANCE VALIDITY; SYMPTOM VALIDITY; IMPAIRMENT; PREVALENCE; SCALES	Neuropsychological consequences in female survivors of intimate partner violence are being used in courts as evidence of acquired injury and for criminal exculpation. To support the validity of neuropsychological test performance and the veracity of victim testimony, effort tests can be used by expert witnesses. Nevertheless, no study has evaluated whether the two principle types of effort tests, Symptom validity tests or Performance validity tests, are most adequate for this population. The study's objective was to compare the false positive rates of a Performance validity test (Test of Memory Malingering: TOMM) and a Symptom validity test (Structured Inventory of Malingered Symptomatology: SIMS). The sample included 68 female intimate partner violence victims and 40 control females. SIMS showed a significantly higher rate of false positives in victims on four of five subtests, reaching a 59.3% in the total score. There were 0% false positives in both groups on the TOMM. Findings indicate that the SIMS may incorrectly score female IPV victims, undermining the victim's testimony in judicial cases.	[Marin Torices, Ma Isabel] Alameda Salud, Granada, Spain; [Hidalgo-Ruzzante, Natalia; Daugherty, Julia C.; Perez Garcia, Miguel] Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Hidalgo-Ruzzante, Natalia] Univ Granada, Sch Educ, Granada, Spain; [Daugherty, Julia C.; Perez Garcia, Miguel] Univ Granada, Sch Psychol, Granada, Spain; [Jimenez-Gonzalez, Pilar] Activa, Granada, Spain		Hidalgo-Ruzzante, N (corresponding author), Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Hidalgo-Ruzzante, N (corresponding author), Univ Granada, Sch Educ, Granada, Spain.	nhidalgo@ugr.es	Daugherty, Julia C./Q-8716-2017; Hidalgo-Ruzzante, Natalia/F-1108-2016; Garcia, Miguel Perez/F-9630-2010	Daugherty, Julia C./0000-0002-1221-4394; Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478; Garcia, Miguel Perez/0000-0003-4775-7556			American Psychiatric Association, 2013, SPAN ED DESK REF DIA, DOI [10.1176/appi.books.9780890425657, DOI 10.1176/APPI.BOOKS.9780890425657]; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Center for Disease Control, 2016, INT PARTN VIOL DEF; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Copeland CT, 2016, ARCH CLIN NEUROPSYCH, V31, P18, DOI 10.1093/arclin/acv065; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Echeburua E., 1994, ENTREVISTA SEMIESTRU; Gonzalez Ordi H., 2010, EDUPSYKHE, V9, P3; Gonzalez Ordi H., 2009, ADAPTACION ESPANOLA; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hunt S, 2014, ARCH CLIN NEUROPSYCH, V29, P164, DOI 10.1093/arclin/act069; IVANY A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI DOI 10.1097/FCH.0000000000000094; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Alvarez-Bello FJ, 2013, ANU PSICOL JURID, V23, P53, DOI 10.5093/aj2013a9; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Marin M. I., 2016, PSICOLOGIA CONDUCTUA, V24, P361; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Ministry of Health Social Services and Equality, 2015, MACR VIOL WOM 2015; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rogers R, 2014, BEHAV SCI LAW, V32, P455, DOI 10.1002/bsl.2131; Ruiz-Perez I, 2017, ATEN PRIM, V49, P93, DOI 10.1016/j.aprim.2016.03.006; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; State Attorney General, 2016, REP 2016 STAT ATT GE; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Vilar R., 2013, MANUAL NEUROPSICOLOG, P261; Vilar-Lopez R., 2012, TOMM TEST SIMULACION; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012; Widows MR, 2004, SIMS STRUCTURED INVE; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	48	3	3	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.		2018	29	1					86	98		10.1080/14789949.2017.1339106			13	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	FR9NX	WOS:000419401500006					2022-02-06	
J	Matsui, Y; Oikawa, S; Hosokawa, N				Matsui, Yasuhiro; Oikawa, Shoko; Hosokawa, Naruyuki			Effectiveness of wearing a bicycle helmet for impacts against the front of a vehicle and the road surface	TRAFFIC INJURY PREVENTION			English	Article						Cyclist; helmet; head injury; vehicle impact experiment; road surface impact experiment; headform		Objective: To assess the effect of wearing a bicycle helmet using an adult headform in terms of the head injury criterion (HIC) when the frontal and lateral parts of the helmet impact a vehicle body and also when the frontal part of the helmet impacts the road surface.Methods: The adult headform was made to impact the hood, windscreen, roof top, and roof side rail of a vehicle body at an impact velocity of 35km/h, which is a common head-to-vehicle impact velocity in real-world cyclist-vehicle collisions, in which the vehicle impacts the cyclist at 40km/h. For the road surface impact experiments, we set a drop height of 1.5 m (impact velocity of 20km/h).Results: Helmet usage helped to reduce the HIC when the frontal and lateral parts of the helmet impacted vehicle parts other than the hood. The HIC reduction for the frontal impact was greater than that for the lateral impact. Moreover, the higher the stiffness index of the vehicle structure, the greater was the HIC reduction. However, helmet usage was ineffective for reducing skull fracture risk (HIC 2558) when the lateral part of the helmet impacted stiffer parts of the vehicle, such as the roof side rail close to the B-pillar. Helmet usage helped to reduce the HIC by 91% when the frontal part of the helmet impacted the road surface.Conclusions: Wearing a helmet reduces skull fracture risk when the frontal and lateral parts of the helmet impact vehicle parts (excluding the hood) at 35km/h and the road surface at 20km/h. However, when the lateral part of the helmet impacts the B-pillar, the helmet cannot effectively reduce the skull fracture risk at these real-world velocities.	[Matsui, Yasuhiro; Hosokawa, Naruyuki] Natl Traff Safety & Environm Lab, Automot Res Dept, 7-42-27 Jindaiji Higashi Machi, Chofu, Tokyo 1820012, Japan; [Oikawa, Shoko] Natl Inst Technol, Tokyo Coll, Dept Mech Engn, Hachioji, Tokyo, Japan		Matsui, Y (corresponding author), Natl Traff Safety & Environm Lab, Automot Res Dept, 7-42-27 Jindaiji Higashi Machi, Chofu, Tokyo 1820012, Japan.	ymatsui@ntsel.go.jp			project "Clarification of Behavior and Biomechanics of Cyclist in Traffic Accidents"	This study was funded by a Grant-in-Aid for Scientific Research, Japan, from 2013 to 2016, under the project "Clarification of Behavior and Biomechanics of Cyclist in Traffic Accidents."	Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Economic and Social Council, 2007, ECETRANSWP29 EC SOC; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Eppinger R, 1999, DTNH2293Y17028; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Institute for Traffic Accident Research and Data Analysis of Japan, 2017, ANN TRAFF ACC REP 20; Matsui Y, 2004, INT J CRASHWORTHINES, V9, P129, DOI 10.1533/ijcr.2004.0280; Matsui Yasuhiro, 2015, Stapp Car Crash J, V59, P385; Matsui Y, 2013, SAE INT J TRANSP SAF, V1, P297, DOI 10.4271/2013-01-0777; Matsui Y, 2014, INT J CRASHWORTHINES, V19, P115, DOI 10.1080/13588265.2013.875272; OGK Kabuto, 2012, FIGO INSTR MAN; Oikawa S, 2016, J BIOMECH SCI ENG, V11, P1; Omoda Y, 2015, T SOC AUTOMOTIVE ENG, V46, P485; Peng Y, 2012, SAFETY SCI, V50, P1749, DOI 10.1016/j.ssci.2012.03.005; Yamada H., 2014, J SOC AUTOMOTIVE ENG, V46, P639	15	3	3	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19	7					773	777		10.1080/15389588.2018.1498089			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	HE3JG	WOS:000453249800017	30001152				2022-02-06	
J	Mc Fie, S; Abrahams, S; Patricios, J; Suter, J; Posthumus, M; September, AV				Mc Fie, Sarah; Abrahams, Shameemah; Patricios, Jon; Suter, Jason; Posthumus, Michael; September, Alison V.			The association between harm avoidance personality traits and self-reported concussion history in South African rugby union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Rugby; Personality; Temperament; Athletic injuries	TRAUMATIC BRAIN-INJURY; RISK-TAKING; SPORT; PREDICTORS; PERCEPTION	Objectives: Personality traits have been proposed to affect the risk of sports concussion, but evidence is limited. Cloninger's Tridimensional Personality Questionnaire (TPQ) measures novelty seeking, harm avoidance (HA), and reward dependence traits. The aim of this study was to investigate the relationship between TPQ scores and concussion history in rugby union players. Design: Cross-sectional study. Methods: Rugby players from high schools, senior amateur clubs, and professional teams provided a self-reported concussion history and completed the TPQ. Participants reporting no previous concussions formed the control group, while participants reporting concussion formed the case group. A one-way analysis of covariance, with age as a covariate, was used to examine the differences in TPQ scores between groups. Results: Of the 309 participants, 54% reported a minimum of one concussion (junior: 47%; amateur: 52%; professional: 72%). HA scores were significantly higher in junior players without a history of concussion compared to cases (p = 0.006). Specifically, the junior control group had higher "anticipatory worry" (p = 0.009) and "fear of uncertainty" (p = 0.008). In contrast, the professional control group had lower HA scores than cases (p = 0.009), while the amateur cohort displayed no differences between control and case groups. Conclusions: This study identified a novel association between HA and concussion in rugby players, adding evidence to the role of personality in a multifactorial risk-model of concussion. The findings suggest that lower HA may lead to increased dangerous play in youth rugby, influencing concussion susceptibility. Contrasting associations in the professional cohort suggest further research is required to understand the role of personality in concussion. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Mc Fie, Sarah; Abrahams, Shameemah; Posthumus, Michael; September, Alison V.] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa; [Patricios, Jon] Morningside Sports Med Clin, Johannesburg, South Africa; [Patricios, Jon] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci Sports & Exercise Med Clin, Cape Town, South Africa		September, AV (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa.	alison.september@uct.ac.za		Abrahams, Shameemah/0000-0002-1120-678X; Patricios, Jon/0000-0002-6829-4098; September, Alison V/0000-0003-0950-286X	South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town; Thembakazi Trust	SM and SA were funded by the South African National Research Foundation and the University of Cape Town. MP was funded by the Thembakazi Trust. This study was in part funded by the South African National Research Foundation and the University of Cape Town.	Alizadeh MH, 2012, WORLD J SPORT SCI, V6, P401; Bandura A., 1994, SELF EFFICACY, P71; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Deroche T, 2007, PERS INDIV DIFFER, V43, P2218, DOI 10.1016/j.paid.2007.06.031; Fresan A, 2011, COMPR PSYCHIAT, V52, P774, DOI 10.1016/j.comppsych.2010.11.003; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Freixanet MGI, 2012, AN PSICOL-SPAIN, V28, P223; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Jack SJ, 1998, PERS INDIV DIFFER, V25, P1063, DOI 10.1016/S0191-8869(98)00081-6; Jelalian E, 1997, J PEDIATR PSYCHOL, V22, P513, DOI 10.1093/jpepsy/22.4.513; Johnson U, 2011, SCAND J MED SCI SPOR, V21, P129, DOI 10.1111/j.1600-0838.2009.01057.x; Junge A, 2000, AM J SPORT MED, V28, pS10; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Kurowski B, 2012, J TRAUMA ACUTE CARE, V29, P997; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morrongiello BA, 1998, J PEDIATR PSYCHOL, V23, P33, DOI 10.1093/jpepsy/23.1.33; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Pud D, 2004, EUR J PAIN, V8, P31, DOI 10.1016/S1090-3801(03)00065-X; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Viljoen W., 2008, S AFR J SPORTS MED, V20, P64, DOI [10.17159/2078-516X/2008/v20i3a633, DOI 10.17159/2078-516X/2008/V20I3A633]; Webbe FM, 2007, J CLIN SPORT PSYCHOL, V1, P379, DOI 10.1123/jcsp.1.4.379; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6	32	3	3	1	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JAN	2018	21	1					16	21		10.1016/j.jsams.2017.07.014			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FT1KE	WOS:000422893800005	28778825	Green Submitted			2022-02-06	
S	McAllister, TW; Wall, R		Hainline, B; Stern, RA		McAllister, Thomas W.; Wall, Rachel			Neuropsychiatry of sport-related concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; HEAD-INJURY; SYMPTOMS QUESTIONNAIRE; DEPRESSIVE SYMPTOMS; HIGH-SCHOOL; PREDICTORS; RECOVERY; SEQUELAE; PSYCHOPATHOLOGY	Changes in mood, emotions, and behavior are common components of the acute clinical picture of sport-related concussion (SRC). Common concussion symptom inventories such as the Sport Concussion Assessment Tool-5 (SCAT5) contain a large number of questions that assess these neuropsychiatric domains. In fact, of 22 items assessed by the SCAT5, arguably only five of the items do not overlap with symptoms assessed by standard measures of anxiety and depression, suggesting that concussion is best viewed as a neuropsychiatric syndrome. Furthermore, it is important to understand the complex relationship between preinjury psychologic health, acute injury symptom profile, and the role that changes in mood, emotions, and behavior play in the recovery trajectory after concussion. Some research suggests that there may also be long-term neuropsychiatric effects of concussion, repetitive concussion, and repetitive head impacts. This chapter provides a review of the neuropsychiatric sequelae of acute SRC, the current evidence for long-term neuropsychiatric effects of repetitive concussion, and the impact of neuropsychiatric symptoms on recovery trajectory. Clinical principles relevant to management are described.	[McAllister, Thomas W.; Wall, Rachel] Indiana Univ Sch Med, Dept Psychiat, 355 W 16th St,Suite 4800, Indianapolis, IN 46202 USA		McAllister, TW (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 355 W 16th St,Suite 4800, Indianapolis, IN 46202 USA.	twmcalli@iupui.edu			U.S. Department of DefenseUnited States Department of Defense [W81XWH-14-2-0151]; National Collegiate Athletic Association [IP00361935]	This work was supported in part by grants from the U.S. Department of Defense (W81XWH-14-2-0151) and the National Collegiate Athletic Association (IP00361935).	Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; American Psychiatric Association, 2017, DIAGN STAT MAN MENT, VDSM-5; [Anonymous], 2017, IMPACT IMMEDIATE POS; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; ARCINIEGAS DB, 2008, PSYCHOPHARM REV, V43, P91; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister T.W., 2011, CLIN NEUROSCI, V13, P287; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2005, J NEUROPSYCHIATRY CL, V17, P287; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; National Heart Lung and Blood Institute. National Institutes of Health. & US Department of Health and Human Services, 2018, STUD QUAL ASS TOOLS; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Thompson E, 2015, OCCUP MED-OXFORD, V65, P601, DOI 10.1093/occmed/kqv054; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; World Health Organization, 1992, ICD 10 CLASSIFICATIO	67	3	3	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						153	162		10.1016/B978-0-444-63954-7.00016-1			10	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100018	30482343				2022-02-06	
J	Meichtry, C; Glauser, U; Glardon, M; Ross, SG; Lechner, I; Kneubuehl, BP; Gascho, D; Spadavecchia, C; von Rotz, A; Stojiljkovic, A; Stoffel, MH				Meichtry, Carmen; Glauser, Urs; Glardon, Matthieu; Ross, Steffen G.; Lechner, Isabel; Kneubuehl, Beat P.; Gascho, Dominic; Spadavecchia, Claudia; von Rotz, Alois; Stojiljkovic, Ana; Stoffel, Michael H.			Assessment of a specifically developed bullet casing gun for the stunning of water buffaloes	MEAT SCIENCE			English	Article						Bubalus bubalis; Skull anatomy; Concussion; Animal welfare; Slaughtering	PARANASAL SINUSES; CATTLE; TOMOGRAPHY	Water buffaloes and cattle differ considerably with respect to the anatomy of the head. As a result, captive bolt stunners often fail to reliably produce adequate loss of consciousness in water buffaloes and, thus, do not fulfill animal welfare requirements. The goal of the present study was to assess and validate a new stunning device for water buffaloes meeting animal welfare and occupational safety requirements. The newly designed bullet casing gun uses .357 Mag/10.2 g hollow point bullets and has additional safety features. Its effectiveness and usability were assessed under practical conditions in an abattoir as based on widely accepted criteria. Stunning resulted in deep unconsciousness in 19 out of 20 water buffaloes. One 9-year old male did not immediately collapse. Except for very old bulls, the device presented herewith provides a means to stun water buffaloes of both sexes effectively and reliably while keeping occupational hazards to a minimum.	[Meichtry, Carmen; von Rotz, Alois; Stojiljkovic, Ana; Stoffel, Michael H.] Univ Bern, Div Vet Anat, Langgassstr 120,POB 3350, CH-3001 Bern, Switzerland; [Glauser, Urs] Waffen Glauser AG, Aarberg, Switzerland; [Glardon, Matthieu; Kneubuehl, Beat P.] Univ Bern, Inst Forens Med Forens Phys & Ballist, Bern, Switzerland; [Ross, Steffen G.; Gascho, Dominic] Univ Zurich, Inst Forens Med Forens Med & Radiol, Zurich, Switzerland; [Lechner, Isabel] Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland; [Spadavecchia, Claudia] Univ Bern, Div Vet Anesthesiol, Bern, Switzerland		Stoffel, MH (corresponding author), Univ Bern, Div Vet Anat, Langgassstr 120,POB 3350, CH-3001 Bern, Switzerland.	info@waffenglauser.ch; matthieu.glardon@inn.unibe.ch; s.ross@spitalmaennedorf.ch; isabel.lechner@vetsuisse.unibe.ch; bpkneubuehl@bpk-thun.ch; dominic.gascho@irm.uzh.ch; claudia.spadavecchia@vetsuisse.unibe.ch; alois.vonrotz@vetsuisse.unibe.ch; ana.stojiljkovic@vetsuisse.unibe.ch; michael.stoffel@vetsuisse.unibe.ch	Stoffel, Michael Hubert/I-6939-2015; Gascho, Dominic/Y-4933-2019; Stojiljkovic, Ana/AAR-9472-2020	Stoffel, Michael Hubert/0000-0002-4699-5125; Gascho, Dominic/0000-0001-9004-4362; Stojiljkovic, Ana/0000-0001-6194-0811; Glardon, Matthieu/0000-0003-1179-294X; Lechner, Isabel/0000-0001-5155-9734	Federal Food Safety and Veterinary Office of Switzerland [2.13.k]	This study was funded by the Federal Food Safety and Veterinary Office of Switzerland, grant 2.13.k. The outstanding support of Mr. Andre Windisch is gratefully acknowledged.	Alsafy MAM, 2013, ANAT HISTOL EMBRYOL, V42, P220, DOI 10.1111/ahe.12005; AVMA, 2013, GUID EUTH AN 2013 ED; bsi-Schwarzenbek, 2013, GUT FACHL PRAX TIER; European Food Safety Authority, 2013, EFSA J, V11, DOI [10.2903/j.efsa.2013.3067, 10.2903/j.efsa.2013.3143, 10.2903/j.efsa.2013.3179]; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Glardon M., 2017, ENERGY LOSS IMPACT V; Grandin T, 2002, J AM VET MED ASSOC, V221, P1258, DOI 10.2460/javma.2002.221.1258; Grandin T., 2012, PLANTS; Gregory NG, 2009, MEAT SCI, V81, P178, DOI 10.1016/j.meatsci.2008.07.016; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; Kamel S H, 1966, Zentralbl Veterinarmed A, V13, P746; Moustafa M S, 1971, Zentralbl Veterinarmed A, V18, P530; SAIGAL RP, 1977, ANAT ANZEIGER, V141, P6; Schwenk BK, 2016, MEAT SCI, V113, P35, DOI 10.1016/j.meatsci.2015.11.010; Tierschutzgesetz S. R., 2014, 455 SWISS FEDERAL CO; Verhoeven MTW, 2015, ANIMAL, V9, P320, DOI 10.1017/S1751731114002596; Verordnung d. B. L V., 2014, TIERSCHUTZ SCHLACHTE; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	18	3	3	1	21	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	JAN	2018	135						74	78		10.1016/j.meatsci.2017.09.004			5	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	FN1WO	WOS:000415782100012	28938106				2022-02-06	
J	O'Brien, KH; Schellinger, SK; Kennedy, MRT				O'Brien, Katy H.; Schellinger, Sarah K.; Kennedy, Mary R. T.			Self-regulation strategies used by students with brain injury while transitioning to college	NEUROREHABILITATION			English	Article						Traumatic brain injury; concussion; college; postsecondary education; strategies; self-regulation; coaching; academics	LEARNING-STRATEGIES; UNIVERSITY-STUDENTS; MODEL	PURPOSE: Students with TBI enter college with strategies that they have used prior to being injured yet often without knowing which ones will be effective in helping them to be successful. The purpose here is to describe how semi-structured interviews were used to identify self-regulated learning strategies, to demonstrate the utility and reliability of coding self-regulated learning strategies, and to provide examples of student-centered goals derived from survey and interview responses. METHODS: College students completed the College Survey for Students with Brain Injury (CSS-BI) and were interviewed before and after coaching support that focused on teaching self-regulated learning. Responses to interview questions about strategies were coded using a modified version of Zimmerman and Martinez-Pons's (1986) schema. Coders also rated strategies for specificity. RESULTS: Strategies were reliably coded into 16 categories of self-regulation. Inter and intra-reliability were strong. Four of the five students reported using a larger variety of self-regulation strategies and strategies that were more specific after coaching support. DISCUSSION AND CONCLUSIONS: It is possible to reliably code self-regulation learning strategies reported by college students with TBI. These measures have potential as functional 'outcomes' for students who are transitioning to college. Interview responses can be used to collaboratively create student-centered goals.	[O'Brien, Katy H.] Univ Georgia, Commun Sci & Special Educ, Athens, GA 30602 USA; [Schellinger, Sarah K.] St Xavier Univ, Commun Sci & Disorders, Chicago, IL USA; [Kennedy, Mary R. T.] Chapman Univ, Commun Sci & Disorders, Orange, CA USA		Kennedy, MRT (corresponding author), Chapman Univ, Commun Sci & Disorders, Crean Coll Hlth & Behav Sci, 9401 Jeronimo Rd, Irvine, CA 92816 USA.	markenne@chapman.edu			University of Minnesota - Twin Cities, Department of Speech-Language-Hearing Sciences; Minnesota Department of Employment and Economic Development (DEED)	This work was supported in part by the University of Minnesota - Twin Cities, Department of Speech-Language-Hearing Sciences and a grant with the Minnesota Department of Employment and Economic Development (DEED). Aspecial acknowledgment is extended to Lauren O'Connor and Alissa Allison who served as research assistant coders.	Kennedy M. R. T., 2009, COLL SURVEY STUDENTS; Kennedy M. R. T., 2017, COACHING COLL STUDEN; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2014, BRAIN INJURY, V28, P1748, DOI 10.3109/02699052.2014.955883; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Ley K, 1998, CONTEMP EDUC PSYCHOL, V23, P42, DOI 10.1006/ceps.1997.0956; Nandagopal K, 2012, LEARN INDIVID DIFFER, V22, P597, DOI 10.1016/j.lindif.2011.11.018; Purdie N, 1996, J EDUC PSYCHOL, V88, P87, DOI 10.1037/0022-0663.88.1.87; Raue K., 2011, REMEDIAL ED DEGREE G; Ruban L, 2006, ROEPER REV, V28, P148, DOI 10.1080/02783190609554354; Ruban LM, 2003, J LEARN DISABIL-US, V36, P270, DOI 10.1177/002221940303600306; Tang E. L., 2015, J ED SCI PSYCHOL, V3, P40; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tuckman BW, 2011, J EXP EDUC, V79, P478, DOI 10.1080/00220973.2010.512318; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; ZIMMERMAN BJ, 1986, AM EDUC RES J, V23, P614, DOI 10.2307/1163093; ZIMMERMAN BJ, 1988, J EDUC PSYCHOL, V80, P284, DOI 10.1037/0022-0663.80.3.284	18	3	3	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					365	375		10.3233/NRE-172413			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300011	29660969				2022-02-06	
J	Ozevren, H; Deveci, E; Tuncer, MC				Ozevren, H.; Deveci, E.; Tuncer, M. C.			Histopathological changes in the choroid plexus after traumatic brain injury in the rats: a histologic and immunohistochemical study	FOLIA MORPHOLOGICA			English	Article						traumatic brain injury; choroid plexus; vascular endothelial growth factor (VEGF); E-cadherin; proliferating cell nuclear antigen (PCNA)	CEREBROSPINAL-FLUID BARRIER; ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ADHESION MOLECULES; E-CADHERIN; EXPRESSION; DAMAGE; PROLIFERATION; LOCALIZATION; INFLAMMATION	Background: Traumatic brain injury (TBI) is in part associated with the disruption of the blood-brain barrier. In this study, we analysed the histopathological changes in E-cadherin and vascular endothelial growth factor (VEGF) expression after TBI in rats. Materials and methods: The rats were divided into two groups as the control and the trauma groups. Sprague-Dawley rats were subjected to TBI with a weight-drop device using 300 g/1 m weight-height impact. After 5 days of TBI, blood samples were taken under ketamine hydroxide anaesthesia and biochemical analyses were performed. The control and trauma groups were compared in terms of biochemical values. Results: There was no change in glutathione (GSH) levels and blood-brain barrier permeability. However, malondialdehyde (MDA) and myeloperoxidase (MPO) activity levels increased in the trauma group. In the histopathological examination, choroid plexus in the lateral ventricle, near the pia mater membrane, was removed. In the traumatic group, some of epithelial cells were hyperplasic. Some of them were peeled off the apical surface and had local degeneration. Conclusions: In addition, we observed congestion in capillary vessels and mononuclear cell infiltration around the vessels. After TBI, the increase in VEGF levels, vascular permeability, and interaction with VEGF receptors in endothelial cells lead to oedema of the vessel wall. On the other hand, E-cadherin expression decreased in the tight-junction structures between epithelial cells and basal membrane, resulting in an increase in cerebrospinal fluid in the intervillous area.	[Ozevren, H.] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Deveci, E.] Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey; [Tuncer, M. C.] Dicle Univ, Fac Med, Dept Anat, Diyarbakir, Turkey		Tuncer, MC (corresponding author), Dicle Univ, Fac Med, Dept Anat, Diyarbakir, Turkey.	drcudi@hotmail.com	Tuncer, Mehmet Cudi/A-6572-2016; Ozevren, Huseyin/AAC-1236-2021	Tuncer, Mehmet Cudi/0000-0001-7317-5467; Ozevren, Huseyin/0000-0002-5437-4003			Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Brunetti B, 2003, J VET MED A, V50, P496, DOI 10.1111/j.1439-0442.2003.00577.x; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; FIGARELLABRANGER D, 1995, ACTA NEUROPATHOL, V89, P248; Garabedian BVD, 2000, MOL BRAIN RES, V75, P259, DOI 10.1016/S0169-328X(99)00320-4; Georgescu CV, 2007, J GASTROINTEST LIVER, V16, P133; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; IKEDA J, 1992, NEUROSCI LETT, V142, P257, DOI 10.1016/0304-3940(92)90386-L; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Johanson C. E., 2010, 7 C GLOB COLL NEUR N, P47; Kaur C, 2010, J PINEAL RES, V48, P185, DOI 10.1111/j.1600-079X.2009.00740.x; Kleine TO, 2006, CYTOM PART A, V69A, P147, DOI 10.1002/cyto.a.20225; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; NAGAHIRO S, 1994, BRAIN RES, V633, P305, DOI 10.1016/0006-8993(94)91553-9; NATHANSON JA, 1989, P NATL ACAD SCI USA, V86, P1684, DOI 10.1073/pnas.86.5.1684; Ozevren H, 2017, ANAL QUANT CYTOPATHO, V39, P35; Preston GW, 2016, ANAL BIOANAL CHEM, V408, P2187, DOI 10.1007/s00216-016-9334-1; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rothstein RP, 2002, DEV NEUROSCI-BASEL, V24, P426, DOI 10.1159/000069052; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Sivakumar V, 2008, BRAIN PATHOL, V18, P71, DOI 10.1111/j.1750-3639.2007.00104.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sohrab G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28551; Steffen BJ, 1996, AM J PATHOL, V148, P1819; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vercellino M, 2008, J NEUROIMMUNOL, V199, P133, DOI 10.1016/j.jneuroim.2008.04.035; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wolburg K, 1999, CELL TISSUE RES, V296, P259, DOI 10.1007/s004410051287; Yang J, 2010, J NEUROL SCI, V296, P39, DOI 10.1016/j.jns.2010.06.012	42	3	3	1	1	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.		2018	77	4					642	648		10.5603/FM.a2018.0029			7	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	HD3LA	WOS:000452416600004	29569703	gold			2022-02-06	
J	Pedrini, D; Panzarini, SR; Tiveron, ARF; de Abreu, VM; Sonoda, CK; Poi, WR; Brandini, DA				Pedrini, Denise; Panzarini, Sonia Regina; Ferreira Tiveron, Adelisa Rodolfo; de Abreu, Valeria Marisel; Sonoda, Celso Koogi; Poi, Wilson Roberto; Brandini, Daniela Atili			Evaluation of cases of concussion and subluxation in the permanent dentition: a retrospective study	JOURNAL OF APPLIED ORAL SCIENCE			English	Article						Tooth injuries; Periodontal ligament; Wound healing	TRAUMATIC DENTAL INJURIES; CHILDREN; TEETH; MANAGEMENT; FRACTURES; PULP	Objectives: This study evaluated the evolution of cases of concussion and subluxation through a retrospective study of 20 years. Material and Methods: Were examined clinical and radiographic records of 1,309 patients who underwent treatment of dentoalveolar trauma in the discipline of Integrated Clinic of the School of Dentistry of Aracatuba, UNESP, of which we selected 137 whose patients had concussion and subluxation injuries, with average age of 23.3 (SD - 10.96). The variables collected were: gender, age, history of previous and actual trauma, treatments performed, the presence of necrotic pulp, and time elapsed until the same trauma. The concussion and subluxation groups were subjected to statistical analyses using the SPSS 16.0 version software (alpha=0.05), Chi-square, and t-tests. Results: Of the 301 teeth involved, 49 (16.3%) suffered concussion and 252 (83.7%), subluxation, being the upper anterior teeth the most affected (75.1%) for both conditions. Subluxation and concussion traumas were more prevalent in men aged 10 to 20 years, most caused by cycling accidents (36.2%). There was a concomitant presence of crown fracture in 21% of cases of concussion and 34.7% of subluxation. Pulp necrosis was detected in 16.3% (concussion) and 27.1% (subluxation) (p=0.12), and most occurred within 6 months after the trauma (p=0.29). The pulp necrosis shows a positive correlation with motorcycle accidents (p=0.01), direct impact (p <= 0.0001), crown fracture with pulp exposure (p <= 0.0001), darkening of the crown (p=0.004) and spontaneous pain (p <= 0.0001); and negative correlation with indirect impact (p <= 0.0001). Conclusions: Although concussion and subluxation traumas are considered of minor degrees, they must be monitored, since the possibility of pulp necrosis exists, and its early treatment favors a good prognosis.	[Pedrini, Denise; Panzarini, Sonia Regina; Sonoda, Celso Koogi; Poi, Wilson Roberto; Brandini, Daniela Atili] Univ Estadual Paulista, UNESP, Fac Odontol Aracatuba, Dept Cirurgia & Clin Integrada, Aracatuba, SP, Brazil; [Ferreira Tiveron, Adelisa Rodolfo; de Abreu, Valeria Marisel] Univ Estadual Paulista, UNESP, Fac Odontol Aracatuba, Programa Posgrad Ciencia Odontol, Aracatuba, SP, Brazil		Pedrini, D (corresponding author), Univ Estadual Paulista, UNESP, Fac Odontol Aracatuba, Disciplina Clin Integrada, Rua Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, Brazil.	pedrini@foa.unesp.br	Brandini, Daniela/U-2186-2019; Sonoda, Celso K./C-3776-2012; Sonoda, Celso/AAT-3205-2020	Brandini, Daniela/0000-0003-3444-8519; Pedrini, Denise/0000-0001-9177-5597; Poi, Wilson Roberto/0000-0002-1025-0164			Andersson L, 2013, PEDIATR DENT, V35, P102; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; Andreasen JO, 2004, DENT TRAUMATOL, V20, P192, DOI 10.1111/j.1600-9657.2004.00279.x; Bruno KF, 2009, J APPL ORAL SCI, V17, P508, DOI 10.1590/S1678-77572009000500028; de Cleen M, 2002, QUINTESSENCE INT, V33, P661; DiAngelis AJ, 2012, DENT TRAUMATOL, V28, P2, DOI 10.1111/j.1600-9657.2011.01103.x; Emshoff R, 2010, J ORAL REHABIL, V37, P107, DOI 10.1111/j.1365-2842.2009.02025.x; EPSTEIN JB, 2010, J CAN DENT ASS, V76; Fariniuk LF, 2010, J APPL ORAL SCI, V18, P343, DOI 10.1590/S1678-77572010000400004; Jokic NI, 2009, DENT TRAUMATOL, V25, P84, DOI 10.1111/j.1600-9657.2008.00711.x; Koyuturk AE, 2008, DENT TRAUMATOL, V24, P16, DOI 10.1111/j.1600-9657.2008.00579.x; Malhotra Neeraj, 2013, Dent Update, V40, P48; Moule AJ, 2007, AUST DENT J, V52, pS122, DOI 10.1111/j.1834-7819.2007.tb00520.x; Moule Alex J, 2009, Dent Clin North Am, V53, P639, DOI 10.1016/j.cden.2009.06.004; Oginni Adeleke O, 2007, BMC Oral Health, V7, P11, DOI 10.1186/1472-6831-7-11; ONETTO JE, 1994, ENDOD DENT TRAUMATOL, V10, P223; Panzarini Sônia Regina, 2008, Braz. oral res., V22, P229; Toprak ME, 2014, DENT TRAUMATOL, V30, P280, DOI 10.1111/edt.12092; Zaleckiene Vaida, 2014, Stomatologija, V16, P7; ZERMAN N, 1993, ENDOD DENT TRAUMATOL, V9, P61	20	3	3	0	5	UNIV SAO PAULO FAC ODONTOLOGIA BAURU	BAURU-SP	AL DR OCTAVIO PINHEIRO BRISOLLA, 9-75, BAURU-SP, 17012-901, BRAZIL	1678-7757	1678-7765		J APPL ORAL SCI	J. Appl. Oral Sci.		2018	26									10.1590/1678-7757-2017-0287			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	GF2QY	WOS:000431786000001	29742251	Green Submitted, Green Published, gold			2022-02-06	
J	Post, A; Kendall, M; Cournoyer, J; Taylor, K; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, MD; Marshall, S				Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Taylor, Karen; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael D.; Marshall, Shawn			Falls resulting in mild traumatic brain injury and focal traumatic brain injury: a biomechanical analysis	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Mild traumatic brain injury; traumatic brain injury; biomechanics; falls; prediction	SUBDURAL-HEMATOMA; HEAD IMPACTS; RECONSTRUCTION; FOOTBALL; ELEMENT; ACCELERATION; CONCUSSION	This research focuses on describing the differences between mild traumatic brain injury (mTBI) and focal traumatic brain injury (fTBI). The purpose of this research was to compare clinical mTBI and fTBI groups who incurred brain injury from falls to hard surfaces to identify clinical and biomechanical factors that may delineate between these two outcomes. Reconstructions of mTBI (n = 11) and fTBI (n = 20) cases that resulted from falls presented themselves at the hospital were conducted using computational and physical models. The cases were compared using peak and component dynamic response, brain injury criterion (BrIC), Gadd severity index and head injury criterion. Peak resultant rotational acceleration had the best percentage correct classification with 50% risk of severe TBI was found to be 21 krad/s(2). The BrIC and component acceleration and rotational velocity of impact were also found to have significant predictions of risk between the two groups. This data provides information to improve risk thresholds for fTBI with application to helmet standards/development.	[Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Taylor, Karen; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Post, Andrew; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Marshall, Shawn] Ottawa Gen Hosp, Ottawa, ON, Canada		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Post, Andrew/0000-0002-5960-5552	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research [grant number TIR-103946]; Ontario Neurotrauma Foundation.	[Anonymous], 2015, 00213M15 NOCSAE; AUER C, 2001, P INT SOC BIOM 18 C; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Brolinson P.G., 2006, P IRCOBI C IRCOBI ZU, P353; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Gennarelli T.A., 1987, 872197 SAE, P49; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI [10.4172/2155-9562.1000181, DOI 10.4172/2155-9562.1000181]; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Kendall M., 2012, P IRCOBI C IRCOBI DU; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A., 2013, THESIS; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; THOMAS LM, 1966, J NEUROL NEUROSUR PS, V29, P404, DOI 10.1136/jnnp.29.5.404; Van Lierde C, 2005, THESIS; Versaci J., 1971, P 15 STAPP CAR CRASH; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P 39 STAPP CAR CRASH	49	3	3	5	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2018	23	3					278	289		10.1080/13588265.2017.1316048			12	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GF8SS	WOS:000432243900003					2022-02-06	
J	Reza, A; Riahi, E; Daneshi, A; Golchini, E				Reza, Ahadi; Riahi, Esmail; Daneshi, Abdolhadi; Golchini, Ehsan			The incidence of traumatic brain injury in Tehran, Iran	BRAIN INJURY			English	Article						Traumatic brain injuries; epidemiology; mortality; head injuries; accident	EMERGENCY-DEPARTMENT; UNITED-STATES	Primary objective: To assess the demographics, causes, treatment and outcome of traumatic brain injury (TBI) in Tehran, Iran.Research design and methods: This retrospective study was conducted in a major trauma centre in south of Tehran using clinical data registry of 3818 traumatic patients who admitted to the hospital from 2009 to 2013. The main factors measured were the external cause of trauma, the type of TBI, and treatment outcome.Main outcomes and results: The highest rate of TBIs occurred in age categories 2130 (31.5%), 3140 (19.2%) and 4150 (12.3%) years. Transport accidents were the most common cause of TBIs (2915 cases, 76.4%). The most frequent types of head injuries were subarachnoid (1676, 43.9%) subdural (1140, 29.8%), and epidural haemorrhage (974, 25.5%). A binomial logistic regression showed that mortality (612 patients, 16%) was significantly associated with the external cause of TBI, the type of main and additional head injuries, cervical spine injury, intra-abdominal organ injury, having a brain or abdominal surgery, and length of hospital stay.Conclusion: The mechanism of TBI, the type of head injuries, and accompanying spine and abdominal injuries were significant prognostic factors in traumatic patients.	[Reza, Ahadi] Iran Univ Med Sci, Dept Anat Sci, Tehran, Iran; [Riahi, Esmail] Univ Tehran Med Sci, Sch Medicene, Dept Physiol, Tehran, Iran; [Daneshi, Abdolhadi] Iran Univ Med Sci, Haft E Tir Hosp, Dept Neurosurg, Tehran, Iran; [Golchini, Ehsan] Iran Univ Med Sci, Sch Med, Dept Anat, Tehran, Iran		Daneshi, A (corresponding author), Iran Univ Med Sci, Haft E Tir Hosp, Dept Neurosurg, Tehran, Iran.	rcrdc.rasoul5@gmail.com	Riahi, Esmail/Q-6063-2018; Golchini, Ehsan/AAK-8241-2021	Riahi, Esmail/0000-0002-0994-1195; Daneshi, Abdolhadi/0000-0001-7255-4692			Aghakhani K, 2014, J FORENSIC LEG MED, V28, P36, DOI 10.1016/j.jflm.2014.09.009; Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj; Cer DA, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gonczak M, 2008, NEUROL NEUROCHIR POL, V42, P231; Groswasser Z, 1998, BRAIN INJ, V12, P805, DOI 10.1080/026990598122197; Harrison JE, 2008, INJURY RES STAT SERI; Kasmaei VM, 2015, EMERGENCY, V3, P141; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Langlois JA, 2006, J HEAD TRAUMA REHABI, V21, P375, DOI 10.1097/00001199-200609000-00001; Lh SUSAN, 1997, BRAIN INJ, V11, P649, DOI 10.1080/026990597123205; Moppett I, 2007, BR J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Rasouli MR, 2008, CHIN J TRAUMATOL ENG, V11, P131, DOI 10.1016/S1008-1275(08)60028-0; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHABI, V21, P544, DOI 10.1097/00001199-200611000-00009; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Tagliaferri F, 2006, ACTA NEUROCHIR WIEN, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHABI, V14, P602, DOI 10.1097/00001199-199912000-00009; Vafaee R, 2013, WULFENIA, V20, P257; Werner C, 2007, BR J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson ML, 2017, EUR J PAEDIATR NEURO, V21, P374, DOI 10.1016/j.ejpn.2016.10.008	24	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					487	492		10.1080/02699052.2018.1429658			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400012	29405787				2022-02-06	
J	Rike, PO; Johansen, HJ; Ulleberg, P; Lundqvist, A; Schanke, AK				Rike, Per-Ola; Johansen, Hans J.; Ulleberg, Pal; Lundqvist, Anna; Schanke, Anne-Kristine			Exploring associations between self-regulatory mechanisms and neuropsychological functioning and driver behaviour after brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; traumatic brain injury; automobile driving; self-regulation; executive function	IMPULSIVE PERSONALITY-TRAITS; REPORTED EXECUTIVE FUNCTIONS; ROAD DRIVING PERFORMANCE; INDIVIDUAL-DIFFERENCES; CEREBRAL-DAMAGE; OLDER DRIVERS; CRASH RISK; FOLLOW-UP; PREDICTORS; STROKE	The objective of this prospective one-year follow-up study was to explore the associations between self-regulatory mechanisms and neuropsychological tests as well as baseline and follow-up ratings of driver behaviour. The participants were a cohort of subjects with stroke and traumatic brain injury (TBI) who were found fit to drive after a multi-disciplinary driver assessment (baseline). Baseline measures included neuropsychological tests and ratings of self-regulatory mechanisms, i.e., executive functions (Behavior Rating Inventory of Executive Function-Adult Version; BRIEF-A) and impulsive personality traits (UPPS Impulsive Behavior Scale). The participants rated pre-injury driving behaviour on the Driver Behaviour Qestionnaire (DBQ) retrospectively at baseline and after one year of post-injury driving (follow-up). Better performance on neuropsychological tests was significantly associated with more post-injury DBQ Violations. The BRIEF-A main indexes were significantly associated with baseline and follow-up ratings of DBQ Mistakes and follow-up DBQ Inattention. UPPS (lack of) Perseverance was significantly associated with baseline DBQ Inattention, whereas UPPS Urgency was significantly associated with baseline DBQ Inexperience and post-injury DBQ Mistakes. There were no significant changes in DBQ ratings from baseline (pre-injury) to follow-up (post-injury). It was concluded that neuropsychological functioning and self-regulatory mechanisms are related to driver behaviour. Some aspects of driver behaviour do not necessarily change after brain injury, reflecting the influence of premorbid driving behaviour or impaired awareness of deficits on post-injury driving behaviour. Further evidence is required to predict the role of self-regulatory mechanisms on driver behaviour and crashes or near misses.	[Rike, Per-Ola; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Nesodden, Norway; [Johansen, Hans J.] Stavern Rehabil Hosp, Stavern, Norway; [Ulleberg, Pal; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway; [Lundqvist, Anna] Univ Hosp, Dept Rehabil Med, Linkoping, Sweden		Rike, PO (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	perola.rike@sunnaas.no			Extrastiftelsen [2008/2/0113]	The study was supported by grants from Extrastiftelsen [grant number 2008/2/0113].	Aberg L, 1998, ERGONOMICS, V41, P39, DOI 10.1080/001401398187314; Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anstey KJ, 2009, TRAFFIC INJ PREV, V10, P84, DOI 10.1080/15389580802486399; Aufman EL, 2013, AM J PHYS MED REHAB, V92, P627, DOI 10.1097/PHM.0b013e318282bc0d; Banfield J. F., 2004, HDB SELF REGULATION, P62; Baumeister Roy, 2011, HDB SELF REGULATION; Bjornskau T., 2003, ROAD TRAFFIC RISK NO; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Cellar DF, 2000, PSYCHOL REP, V86, P454, DOI 10.2466/PR0.86.2.454-456; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Constantinou E, 2011, ACCIDENT ANAL PREV, V43, P1323, DOI 10.1016/j.aap.2011.02.002; Costa P. T., 1992, REVISED NEO PERSONAL; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; Delis D. C., 2001, EXAMINERS MANUAL DEL; Dolan SL, 2008, BEHAV SCI LAW, V26, P799, DOI 10.1002/bsl.845; ELANDER J, 1993, PSYCHOL BULL, V113, P279, DOI 10.1037/0033-2909.113.2.279; Ellekjaer Hanne, 2007, Tidsskr Nor Laegeforen, V127, P740; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Evans L., 2004, TRAFFIC SAFETY; Fong G, 2001, SOC PSYCH PSYCH EPID, V36, P277, DOI 10.1007/s001270170045; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Gianutsos R., 1981, COGREHAB I COMPUTER; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; GRIFFITHS KM, 1988, J CLIN EXP NEUROPSYC, V10, P800, DOI 10.1080/01688638808402815; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Hatakka M., 2002, TRANSPORT RES F TRAF, V5, P201, DOI 10.1016/s1369-8478(02)00018-9; Heaton RK, 1991, COMPREHENSIVE NORMS; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Lajunen T, 2003, TRANSPORT RES F TRAF, V6, P97, DOI [DOI 10.1016/S1369-8478(03)00008-1, 10.1016/S1369-8478(03)00008-1, 10.1016/ S1369-8478(03)00008-1]; Ledesma RD, 2010, TRAFFIC INJ PREV, V11, P142, DOI 10.1080/15389580903497139; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Morris LJ, 2008, RELATIONSHIPS AGE EX; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Ozkan T, 2006, ACCIDENT ANAL PREV, V38, P386, DOI 10.1016/j.aap.2005.10.012; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Poole J, 2010, ARCH CLIN NEUROPSYCH, V25, P528; Prigatano G. P., 1991, AWARENESS OF DEFICIT; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rike PO, 2015, TRANSPORT RES F-TRAF, V29, P34, DOI 10.1016/j.trf.2015.01.004; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Roca J, 2013, TRANSPORT RES F-TRAF, V17, P98, DOI 10.1016/j.trf.2012.10.005; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Sagberg F., 2003, UERFAREN BAK RATTET; Sakai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045920; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Scialfa C, 2010, J GERONTOL B-PSYCHOL, V65, P434, DOI 10.1093/geronb/gbq032; Selander H, 2010, SCAND J OCCUP THER, V17, P10, DOI [10.1080/11038120802714898, 10.3109/11038120802714898]; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Smith A., 1982, SYMBOL DIGITS MODALI; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sumer N, 2003, ACCIDENT ANAL PREV, V35, P949, DOI 10.1016/S0001-4575(02)00103-3; Sumer N., 2005, P 3 INT DRIV S HUM F; SUNDET K, 1995, SCAND J PSYCHOL, V36, P47, DOI 10.1111/j.1467-9450.1995.tb00967.x; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wickens CM, 2008, ACCIDENT ANAL PREV, V40, P1223, DOI 10.1016/j.aap.2008.01.006; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	78	3	3	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	3					466	490		10.1080/09602011.2016.1170702			25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4BY	WOS:000428275800009	28278592				2022-02-06	
J	Ryan, JJ; Kreiner, DS; Umfleet, LG; Gontkovsky, ST; Myers-Fabian, A				Ryan, Joseph J.; Kreiner, David S.; Umfleet, Laura Glass; Gontkovsky, Samuel T.; Myers-Fabian, Allison			WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cognitive Proficiency Index (CPI); Full Scale IQ (FSIQ); General Ability Index (GAI); multiple sclerosis; traumatic brain injury; Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV)	INTELLIGENCE SCALE-4TH EDITION; GENERAL ABILITIES INDEX; COGNITION; PERFORMANCE; DEFICIT; UTILITY; SPEED	We examined relationships between the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) General Ability Index (GAI) and Cognitive Proficiency Index (CPI) in two clinical samples. The mean pattern produced by 42 individuals with multiple sclerosis (MS) and 47 with traumatic brain injury (TBI) was the same, GAI > CPI. This pattern occurred in 61.9% and 78.7% of the protocols of patients with MS or TBI, respectively. The MS sample earned a significantly larger CPI mean than did patients with TBI. The group means did not differ on the GAI. Patients with TBI had significantly larger GAI-CPI discrepancy score means than those with MS. Receiver operating characteristics (ROC) analysis assessed the ability of GAI-CPI discrepancies to differentiate the samples. The area under curve (AUC) was 0.67, 95% [0.55, 0.78], which indicated low accuracy in terms of group classification.	[Ryan, Joseph J.; Kreiner, David S.] Univ Cent Missouri, Psychol Sci, Lovinger 1111, Warrensburg, MO 64093 USA; [Umfleet, Laura Glass] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Gontkovsky, Samuel T.] Mercy Hlth, Youngstown, OH USA; [Myers-Fabian, Allison] Austin Neuropsychol PLLC, Austin, TX USA		Kreiner, DS (corresponding author), Univ Cent Missouri, Psychol Sci, Lovinger 1111, Warrensburg, MO 64093 USA.	kreiner@ucmo.edu					Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Devena SE, 2012, J APPL SCH PSYCHOL, V28, P133, DOI 10.1080/15377903.2012.669743; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drozdick LW, 2013, PRACT RESOUR MENT, P407, DOI 10.1016/B978-0-12-386934-0.00009-2; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Forn C, 2008, J CLIN EXP NEUROPSYC, V30, P789, DOI 10.1080/13803390701779560; Harrison AG, 2008, J PSYCHOEDUC ASSESS, V26, P247, DOI 10.1177/0734282907304032; Holdnack JA, 2013, PRACT RESOUR MENT, P171, DOI 10.1016/B978-0-12-386934-0.00004-3; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lichtenberger ElizabethO., 2013, ESSENTIALS WAIS 4 AS, V2nd ed.; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Michel NM, 2013, ASSESSMENT, V20, P462, DOI 10.1177/1073191113478153; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI [10.1016/B978-012564930-8/50002-4, DOI 10.1016/B978-012564930-8/50002-4]; Ryan JJ, 2012, J CLIN EXP NEUROPSYC, V34, P571, DOI 10.1080/13803395.2012.666229; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Weiss LG, 2010, PRACT RESOUR MENT, P61, DOI 10.1016/B978-0-12-375035-8.10003-5; Weiss LG, 2010, PRACT RESOUR MENT, P97, DOI 10.1016/B978-0-12-375035-8.10004-7	25	3	3	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	1					51	56		10.1080/23279095.2016.1241786			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FY7NF	WOS:000427048500007	27779426				2022-02-06	
J	Sandel, NK; Worts, PR; Burkhart, S; Henry, L				Sandel, Natalie K.; Worts, Phillip R.; Burkhart, Scott; Henry, Luke			Comparison of baseline ImPACT performance in amateur motocross riders to football and basketball athletes	BRAIN INJURY			English	Article						Concussion; motocross; neurocognitive testing; baseline testing; ImPACT	TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; CONCUSSION ASSESSMENT; ONLINE VERSION; SPORTS; HEAD; SYMPTOMS; INJURY; SPECIFICITY	Primary Objective: The American Motorcyclist Association requires professional riders to undergo baseline computerized neurocognitive testing (CNT) using the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test for concussion management. It is recommended this practice be expanded to the amateur level, but limited research has explored whether baseline testing is necessary for youth when normative data is available. This study evaluates the utility of baseline testing for amateur riders by comparing their performance to those of traditional youth sports comprising normative datasets.Design/Methods: An cross-sectional study comparing amateur motocross (N=100) riders matched by age and sex to football (N=100) and basketball (N=100) athletes performance on baseline ImPACT testing.Results: ANCOVAs revealed a significant medium effect of group on measures of visual motor speed (F=11.25, p<0.001) and reaction time (F=13.61, p<0.001). Post hoc analyses revealed that motocross riders were significantly slower compared to football and basketball athletes. There were no significant differences (p>.05) between sport on measures of memory or symptoms.Conclusions: Youth motocross riders performed significantly slower on speed measures compared to football and basketball athletes, providing preliminary support for the expansion of baseline ImPACT testing to the amateur level.	[Sandel, Natalie K.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15213 USA; [Worts, Phillip R.; Burkhart, Scott] Florida State Univ, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA; [Worts, Phillip R.] Tallahassee Orthoped Clin, Tallahassee, FL USA; [Burkhart, Scott] Tallahassee Orthoped Clin, Concuss Ctr, Tallahassee, FL USA; [Henry, Luke] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Sandel, NK (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, 3200 S Water St, Pittsburgh, PA 15213 USA.	sandelnk@upmc.edu	Worts, Phillip Robert/J-9063-2019	Worts, Phillip Robert/0000-0002-5571-5404			American Motorcyclist Association, 2016, MOT AR; American Motorcyclist Association, 2016, AMA AM COMP 2016 RUL; Barth JT, 1989, MILD HEAD INJURY, P257; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Bruce JM, 2004, NEUROLOGY, V63, P1516; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conn J. M., 2006, Morbidity and Mortality Weekly Report, V55, P621; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 2006, IMPACT NEUROPSYCHOLO; Luo TD, 2015, J NEUROSURG-PEDIATR, V15, P255, DOI 10.3171/2014.11.PEDS14127; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Tsushima WT, 2016, APPL NEUROPSYCHOL, V7, P14; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	40	3	3	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					493	497		10.1080/02699052.2018.1429020			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400013	29381402				2022-02-06	
J	Shankar, S				Shankar, Sneha			An Autoethnography About Recovering Awareness Following Brain Injury: Is My Truth Valid?	QUALITATIVE INQUIRY			English	Article						autoethnography; ethnographies; methodologies; recovery; rehabilitation; brain injury; critical theory	SELF-AWARENESS; POSITIVE PSYCHOLOGY; HEAD-INJURY; REHABILITATION; EXPERIENCE; DEFICITS; MISCONCEPTIONS; DISTURBANCES; IDENTITY; LIFE	This autoethnography confronts the assumptions and treatment of patients who have had a traumatic brain injury (TBI). TBI may be followed by deficits that can impact a person's self-awareness, and I describe my experience with this symptom. In this personal poetic narrative, I provide a glimpse into how I experienced typical symptoms of brain injury and illustrate the complexity of recovery. I suggest patient voices are too often discredited, which goes against the medical framework of patient-centeredness. I provide a voice to the lived experience of brain injury and illuminate the dehumanizing nature of being a patient of this injury.	[Shankar, Sneha] Univ British Columbia, Measurement Evaluat & Res Methodol Program, Dept Educ & Counselling Psychol & Special Educ, Fac Educ, Vancouver, BC, Canada		Shankar, S (corresponding author), Univ British Columbia, 2125 Main Mall, Vancouver, BC V6T 1Z4, Canada.	sneha.shankar@ubc.ca					Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Ashman TA, 2006, MT SINAI J MED, V73, P999; Atkinson E. P., 2014, HDB ETHNOGRAPHY; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Berg L, 2007, SCAND J CARING SCI, V21, P500, DOI 10.1111/j.1471-6712.2007.00497.x; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Centers for Disease Control and Prevention, 2011, NAT CTR INJ PREV CON; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Charmaz K., 2016, QUALITATIVE INQUIRY, V8, P302; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Crowe TP, 2006, PSYCHIAT SERV, V57, P1497, DOI 10.1176/appi.ps.57.10.1497; Darragh A. R., 1998, AM J OCCUPATIONAL TH, V55, P191; Davidson L, 2006, PSYCHIATRY, V69, P151, DOI 10.1521/psyc.2006.69.2.151; Deegan P., 2002, OCCUP THER MENT HEAL, V17, P5, DOI [10.1300/J004v17n03_02, DOI 10.1300/J004V17N03_02]; Deegan P.E., 1992, PSYCHOSOC REHABIL J, V15, pe3, DOI [10.1037/h0095769, DOI 10.1037/H0095769]; Dockree PM, 2015, J INT NEUROPSYCH SOC, V21, P473, DOI 10.1017/S1355617715000594; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Ellis C., 2004, ETHNOGRAPHIC; Ellis C., 1996, COMPOSING ETHNOGRAPH; Farkas M, 2007, WORLD PSYCHIATRY, V6, P4; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1996, BRAIN INJURY, V10, P1; Frank A, 1997, HEALTH, V1, P131, DOI DOI 10.1177/136345939700100201; Frank A., 1998, HEALTH, V2, P329, DOI DOI 10.1177/136345939800200304; Frantz G, 2016, PSYCHOL PERSPECT, V59, P242, DOI 10.1080/00332925.2016.1170567; Freire P., 2000, PEDAGOGY OPPRESSED; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Graybeal C, 2001, FAM SOC-J CONTEMP H, V82, P233, DOI 10.1606/1044-3894.236; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Jones Stacy Holman, 2005, SAGE HDB QUALITATIVE, P763; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Lane Mary Rockwood, 2005, Holist Nurs Pract, V19, P122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawson S, 2008, THER RECREAT J, V42, P236; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lewington PJ, 1993, CANADIAN J COUNSELIN, V1993, P274; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moran GS, 2013, PSYCHIATR REHABIL J, V36, P202, DOI 10.1037/prj0000012; Naidu T., 2014, FORUM QUALITATIVE SO, V15, P1; O'Byme P, 2007, QUAL HEALTH RES, V17, P1381, DOI 10.1177/1049732307308304; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Oades Lindsay, 2005, Australas Psychiatry, V13, P279, DOI 10.1111/j.1440-1665.2005.02202.x; OJEMANN G, 1986, CAN PSYCHOL, V27, P158; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Register ME, 2006, ADV NURS SCI, V29, P340, DOI 10.1097/00012272-200610000-00007; Richards R, 2008, QUAL HEALTH RES, V18, P1717, DOI 10.1177/1049732308325866; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segal D, 2010, INT J CHILD YOUTH FA, V1, P293, DOI 10.18357/ijcyfs13/420102093; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Shattell M, 2004, J CLIN NURS, V13, P714, DOI 10.1111/j.1365-2702.2004.00965.x; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Smith C., 2008, FORUM QUALITATIVE SO, V9, P2; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trueba ET, 2002, ETHNOGRAPHY SCH QUAL, P87; Uotinen J, 2011, QUAL HEALTH RES, V21, P1307, DOI 10.1177/1049732311413908; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wall S., 2008, INT J QUAL METH, V7, P38; Watkins J. M., 1994, KNOWLEDGE POLICY, V7, P55; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	72	3	3	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1077-8004	1552-7565		QUAL INQ	Qual. Inq.	JAN	2018	24	1			SI		56	69		10.1177/1077800417728960			14	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	FP8EO	WOS:000417873500006		Bronze			2022-02-06	
J	Smaakjaer, P; Todten, ST; Rasmussen, RS				Smaakjaer, Peter; Todten, Signe Tornoe; Rasmussen, Rune Skovgaard			Therapist-assisted vision therapy improves outcome for stroke patients with homonymous hemianopia alone or combined with oculomotor dysfunction	NEUROLOGICAL RESEARCH			English	Article						Stroke; vision therapy; oculomotor dysfunction; hemianopia	TRAUMATIC BRAIN-INJURY; POSTSTROKE FATIGUE; DISORDERS	Objective: To improve visual performance and perception in stroke patients suffering from visual impairments by the use of therapist-assisted vision therapy. Methods: This study was an interventional efficacy open-label investigation. The vision therapy was designed to enhance binocular vision, and saccadic ability, and vergence ranges maximally, and for patients with hemianopia also to improve peripheral awareness. The vision training consisted of one lesson a week for 12 weeks carried out by an optometrist and a vision therapist. Between lessons, patients were to train at home for a minimum of 15-20 min daily. Results: Twenty-four patients completed the course. Significant improvements in visual performance were measured for all test parameters from the baseline to the evaluation after the last lesson of vision training. The COPM results improved both in terms of satisfaction with the completion of a task and with the way the task was carried out (p = 0.001). Groffman tracing test results improved from median 7.5 to 16 (p = 0.002), reading speed in words increased (p = 0.0004), and peripheral awareness of visual markers improved (p = 0.002). Conclusion: Therapist-assisted vision therapy increased peripheral visual awareness. Furthermore patients felt safer in the traffic and in outdoor activities. Reading speed significantly increased, and the ability to keep a moving object in focus improved.	[Smaakjaer, Peter; Todten, Signe Tornoe; Rasmussen, Rune Skovgaard] CSU, Dept Vis, Rosenkildevej 88 B, DK-4200 Slagelse, Denmark		Smaakjaer, P (corresponding author), CSU, Dept Vis, Rosenkildevej 88 B, DK-4200 Slagelse, Denmark.	pesma@slagelse.dk		Rasmussen, Rune/0000-0002-5630-122X; Smaakjaer, Peter/0000-0002-0861-4010	Synoptik Foundation; Centre for Special Education (CSU), Slagelse, Denmark	This study has been supported by the Synoptik Foundation and Centre for Special Education (CSU), Slagelse, Denmark.	Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Groffman S., 1966, J AM OPTOM ASSOC, V37, P139; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Law M, 1990, Can J Occup Ther, V57, P82; LEPORE FE, 1995, ARCH NEUROL-CHICAGO, V52, P924, DOI 10.1001/archneur.1995.00540330106022; Mast BT, 2010, HANDBOOK OF ASSESSMENT IN CLINICAL GERONTOLOGY, 2ND EDITION, P503, DOI 10.1016/B978-0-12-374961-1.10019-3; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nauta WJH, 1986, FUNDAMENTAL NEUROANA; Nelles G, 2001, NEUROSCI LETT, V306, P189, DOI 10.1016/S0304-3940(01)01907-3; Paulus JK, 2014, RES SYNTH METHODS, V5, P152, DOI 10.1002/jrsm.1101; Poulsen MB, 2015, STROKE, V46, P3470, DOI 10.1161/STROKEAHA.115.010860; Rasmussen RS, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.8334; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Suchoff I B, 1986, J Am Optom Assoc, V57, P119; van Essen D.C., 1985, P259; Weiss T, 2004, EUR J NEUROSCI, V20, P3413, DOI 10.1111/j.1460-9568.2004.03790.x; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Yeterian EH, 1997, J COMP NEUROL, V378, P562	23	3	3	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2018	40	9					752	757		10.1080/01616412.2018.1475321			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV0ZG	WOS:000445794000006	29792389				2022-02-06	
J	Ssemugabo, C; Mukama, T; Halage, AA; Paichadze, N; Gibson, DG; Kobusingye, O				Ssemugabo, Charles; Mukama, Trasias; Halage, Abdullah Ali; Paichadze, Nino; Gibson, Dustin G.; Kobusingye, Olive			Incidence and characteristics of unintentional injuries among children in a resource limited setting in Kampala, Uganda	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						Incidence; slum; unintentional; injury; children; Uganda	SEX-DIFFERENCES; GLOBAL BURDEN; COUNTRIES; HEALTH; RATES; EPIDEMIOLOGY; DISABILITY; RECALL	Given that little is known about the epidemiology of unintentional injuries in children in low-income countries, this study sought to determine the incidence and characteristics of unintentional injuries among children aged 18years in a slum community in Uganda. From a household survey, the incidence and odds ratios for factors associated with unintentional injury characteristics were calculated. Of 1583 children, 706 had suffered 787 unintentional injuries yielding an annual incidence rate of 497 injuries per 1000 children. Commonest injuries were cuts, bites or open wounds (30.6%) and bruises or superficial injuries (28.6%) with majority (75.5%) occurring at home. Boys were more likely to be injured at school (AOR 4.34; 95% CI 1.22-15.54) and to be injured from falls (AOR 1.41; 95% CI 1.01-1.96). Older children (12-18 years) were more likely to suffer from fractures (AOR 2.37; 95% CI 1.26-4.43), concussions and organ system injuries (AOR 3.58; 95% CI 1.03-12.39) and cuts, bites or open wounds (AOR 2.05; 95% CI 1.21-3.48). Older children were less likely to suffer burns or scalds as compared to the young children (AOR: 0.23; 95% CI 0.11-0.50). Unintentional injury incidence rate was high among children with most occurring in the homes.	[Ssemugabo, Charles; Mukama, Trasias; Halage, Abdullah Ali; Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Paichadze, Nino; Gibson, Dustin G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA		Ssemugabo, C (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Dept Dis Control & Environm Hlth, Kampala, Uganda.	cssemugabo@gmail.com	Mukama, Trasias/U-7179-2019	Mukama, Trasias/0000-0002-6520-5272; Kobusingye, Olive/0000-0003-2413-599X	Fogarty International Center of the U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW009284]	This study was supported from the Fogarty International Center of the U.S. National Institutes of Health (Chronic Consequences of Trauma, Injuries, Disability Across the Lifespan: Uganda) [grant number D43TW009284].	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; BLOCK JH, 1983, CHILD DEV, V54, P1335, DOI 10.2307/1129799; Browman B., 2006, DIS MORTALITY SUBSAH, P365; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Chowdhury Salim Mahmud, 2013, BMC Public Health, V13, P1022, DOI 10.1186/1471-2458-13-1022; Daniel, 1999, BIOSTATISTICS FDN AN; EATON WO, 1989, CHILD DEV, V60, P1005, DOI 10.2307/1131040; FAGOT BI, 1978, CHILD DEV, V49, P459, DOI 10.1111/j.1467-8624.1978.tb02336.x; Fatmi Z, 2009, PAEDIATR PERINAT EP, V23, P229, DOI 10.1111/j.1365-3016.2009.01024.x; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; Gyedu A, 2015, INJURY PREV, V21, pE71, DOI 10.1136/injuryprev-2013-040950; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haggerty R J, 1996, Inj Prev, V2, P290, DOI 10.1136/ip.2.4.290; Hang HM, 2009, PUBLIC HEALTH, V123, P58, DOI 10.1016/j.puhe.2008.07.018; Hang HM, 2003, SCAND J PUBLIC HEALT, V31, P38, DOI 10.1080/14034950310015095; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Hsia RY, 2011, J PUBLIC HEALTH AFR, V2, P63, DOI 10.4081/jphia.2011.e15; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Hyder Adnan A, 2006, Traffic Inj Prev, V7, P381, DOI 10.1080/15389580600942965; Jagnoor J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-487; de Domingo AJ, 2017, AN PEDIATR, V86, P337, DOI 10.1016/j.anpedi.2015.12.004; Kjellstrom T, 2007, J URBAN HEALTH, V84, pI86, DOI 10.1007/s11524-007-9171-9; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Lafta R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131834; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Macfarlane SBJ, 1997, TROP DOCT, V27, P14, DOI 10.1177/004947559702700108; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mirkazemi R, 2014, INT J INJ CONTROL SA, V21, P9, DOI 10.1080/17457300.2012.745577; Mock C, 1999, INT J EPIDEMIOL, V28, P750, DOI 10.1093/ije/28.4.750; Mock C, 2008, B WORLD HEALTH ORGAN, V86, P420, DOI 10.2471/BLT.08.054767; Morrow V, 2014, HEALTH POLICY PLANN, V29, P67, DOI 10.1093/heapol/czs134; Moshiro C, 2005, INJURY PREV, V11, P48, DOI 10.1136/ip.2004.005645; Mutto M, 2012, INT J INJ CONTROL SA, V19, P357, DOI 10.1080/17457300.2011.648675; Mutto Milton, 2011, J Inj Violence Res, V3, P13, DOI 10.5249/jivr.v3i1.56; Norton R., 2006, UNINTENTIONAL INJURI; Peden M, 2008, WORLD REPORT CHILD I; ROSEN BN, 1990, CLIN PSYCHOL REV, V10, P187, DOI 10.1016/0272-7358(90)90057-H; Simon Raymond, 2013, J Trauma Manag Outcomes, V7, P10, DOI 10.1186/1752-2897-7-10; Soori Hamid, 2016, Int J Crit Illn Inj Sci, V6, P33, DOI 10.4103/2229-5151.177366; Sozen I, 2016, TURK J SURG, V32, P168, DOI 10.5152/UCD.2016.3285; UBOS, 2001, COMP STAT CONC DEF U; UBOS, 2014, NAT POP HOUS CENS 20; Unger A, 2013, ARCH DIS CHILD, V98, P799, DOI 10.1136/archdischild-2011-301621; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wiegand H, 1968, BIOMETR Z, V10, P88, DOI [10.1002/bimj.19680100122, DOI 10.1002/BIMJ.19680100122]; Zia Nukhba, 2012, BMC Res Notes, V5, P37, DOI 10.1186/1756-0500-5-37	49	3	3	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.		2018	25	4					449	457		10.1080/17457300.2018.1473445			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HD8YF	WOS:000452846100017	29846121				2022-02-06	
J	Steijn, R; Stewart, R; Czosnyka, M; Donnelly, J; Ercole, A; Absalom, A; Elting, JW; Haubrich, C; Smielewski, P; Aries, M				Steijn, Romy; Stewart, Roy; Czosnyka, Marek; Donnelly, Joseph; Ercole, Ari; Absalom, Antony; Elting, Jan W.; Haubrich, Christina; Smielewski, Peter; Aries, Marcel			Survey in expert clinicians on the validity of automated calculation of optimal cerebral perfusion pressure	MINERVA ANESTESIOLOGICA			English	Article						Intracranial pressure; Cerebrovascular circulation; Neurophysiological monitoring	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBROVASCULAR REACTIVITY; NEUROCRITICAL CARE; BLOOD-PRESSURE; MANAGEMENT; VOLUME; FLOW	BACKGROUND: Optimal cerebral perfusion pressure (CPPopt) targeting in traumatic brain injury (TBI) patients constitutes an active and controversial area of research. It has been suggested that an autoregulation guided CPP therapy may improve TBI outcome. Prerequisites of a CPPopt intervention study would be objective criteria for the CPPopt detection. This study compared the agreement between automated and visual CPPopt detection. METHODS: Twenty-five clinicians from 18 centers worldwide, familiar with brain monitoring and using dedicated software, reviewed ten 4-hour CPPopt screenshots at 48 hours after ictus in selected TBI patients. Each screenshot displayed the trends of cerebral perfusion pressure (CPP), intracranial pressure (ICP), cerebrovascular pressure reactivity (PRx) as well as the "CPP-optimal" curve and its associated value (automated CPPopt). The main objective was to evaluate the agreement between expert clinicians as well as the agreement between the clinicians and automated CPPopt. RESULTS : Twenty-two clinicians responded to our call (88%). Three screenshots were judged as "CPPopt not determinable" by > 45% of the clinicians. For the whole group, the consensus between automated CPPopt and clinicians' visual CPPopt was high. Three clinicians were identified as outliers. All clinicians recommended to modify CPP when patients differed >+/- 5 mmHg from their CPPopt. The inter-observer consensus was highest in cases with current CPP below the optimal value. CONCLUSIONS: The overall agreement between automated CPPopt and visual CPPopt identified by autoregulation experts was high, except for those cases when the curve was deemed by the clinicians not reliable enough to yield a trustworthy CPPopt.	[Steijn, Romy] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, Groningen, Netherlands; [Stewart, Roy] Univ Groningen, Univ Med Ctr Groningen, Dept Med Stat, Groningen, Netherlands; [Czosnyka, Marek; Donnelly, Joseph; Haubrich, Christina; Smielewski, Peter; Aries, Marcel] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Absalom, Antony] Univ Groningen, Univ Med Ctr Groningen, Div Anesthesia, Groningen, Netherlands; [Elting, Jan W.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Aries, Marcel] Maastricht Univ, Med Ctr, Dept Intens Care, Maastricht, Netherlands		Aries, M (corresponding author), Maastricht Univ, Med Ctr, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	marcel.aries@mumc.nl	Ercole, Ari/B-6288-2009; Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Ercole, Ari/0000-0001-8350-8093; Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Absalom, Anthony/0000-0001-7563-9157; Stewart, Roy/0000-0001-9227-433X	Dutch Society of Intensive Care; Woolf Fisher Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI	Marcel Aries has received an unrestricted grant from the Dutch Society of Intensive Care. Joseph Donnelly is supported by a Woolf Fisher Trust scholarship. The software for brain monitoring ICM+(R) (https://icmplus.neurosurg.camac.uk) is licensed by the University of Cambridge (Cambridge Enterprise). Peter Smielewski and Marek Czosnyka have a financial interest in a part of the licensing fee. The remaining authors have no conflict of interest.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; da Costa CS, 2015, J PEDIATR-US, V167, P86, DOI 10.1016/j.jpeds.2015.03.041; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Robertson CS, 2015, NEW ENGL J MED, V373, P2469, DOI 10.1056/NEJMe1511174; Schmidt JM, 2016, CRIT CARE MED, V44, P1958, DOI 10.1097/CCM.0000000000001918; Sekhon MS, 2016, RESUSCITATION, V106, P120, DOI 10.1016/j.resuscitation.2016.05.019; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	22	3	3	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JAN	2018	84	1					40	+		10.23736/S0375-9393.17.11982-6			11	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	GB4CH	WOS:000429007500010	28643998	Green Submitted, Green Published			2022-02-06	
J	Suchy, Y; Franchow, EI; Niermeyer, MA; Ziemnik, RE; Williams, PG; Pennington, NN				Suchy, Yana; Franchow, Emilie I.; Niermeyer, Madison A.; Ziemnik, Rosemary E.; Williams, Paula G.; Pennington, Nicholas N.			Exaggerated reaction to novelty as a predictor of incipient cognitive decline among community-dwelling older adults	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Action planning; aging; cognitive decline; novelty; openness; preclinical	TRAUMATIC BRAIN-INJURY; PRECLINICAL ALZHEIMERS-DISEASE; SCALE-ELECTRONIC VERSION; DEMENTIA RATING-SCALE; INSTRUMENTAL ACTIVITIES; EXECUTIVE FUNCTION; FUNCTIONAL MRI; IMPAIRMENT; MOTOR; MEMORY	Objective: The ability to detect covert markers of incipient cognitive decline among older adults before cognitive decline becomes overtly evident on traditional cognitive tests represents an important topic of research. Exaggerated reactions to novelty, reflected in novelty-induced increases in action planning latencies (novelty effect; NE) and low openness to experience (openness), have been previously associated with incipient cognitive decline among older adults who appeared cognitively normal at baseline. The purposes of the present study were to extend prior research on the utility of these markers by examining whether (a) NE and openness each predict cognitive change uniquely, and (b) whether these indices predict cognitive change above and beyond measures of memory, executive functions, processing speed/efficiency, premorbid IQ, and depressive symptoms.Method: Sixty-one cognitively normal community-dwelling older adults were administered a battery of tests assessing the relevant constructs at baseline and one-year follow up. Changes in cognitive status were assessed using the Demetia Rating Scale, 2nd Edition, NE was assessed using the Push-Turn-Taptap task (an electronic motor sequence learning task), and openness using the NEO Personality Inventory-Revised. The Test of Premorbid Functioning, and subtests from Repeatable Battery for the Assessment of Neuropsychological Status, Delis-Kaplan Executive Function System, and Wechsler Adult Intelligence Scale, 4th Edition, were used for additional assessment of baseline cognition. Depressive symptoms were assessed using the Geriatric Depression Scale.Results: Results confirmed our hypothesis that both NE and openness contribute to prediction of cognitive change beyond baseline cognition and depressive symptoms, but none of the covariates (i.e., depression, executive functions, processing efficiency, or memory) themselves contributed to the model. NE and openness each contributed unique variance and were independent of each other.Conclusions: Openness and NE have the potential to provide evidence-based methods for estimating risk of future cognitive change in persons with currently normal standardized test scores.	[Suchy, Yana; Franchow, Emilie I.; Niermeyer, Madison A.; Ziemnik, Rosemary E.; Williams, Paula G.; Pennington, Nicholas N.] Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA; [Franchow, Emilie I.] New Mexico Vet Affairs Hlth Care Syst, Behav Healthcare Line, Albuquerque, NM USA		Suchy, Y (corresponding author), Univ Utah, Dept Psychol, 380 S 1530 E,Rm 502, Salt Lake City, UT 84112 USA.	yana.suchy@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Amieva H, 2014, BRAIN, V137, P1167, DOI 10.1093/brain/awu035; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Baldauf D, 2011, NEUROPSYCHOLOGIA, V49, P1383, DOI 10.1016/j.neuropsychologia.2011.01.041; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bonnet MC, 2006, J NEUROL SCI, V251, P23, DOI 10.1016/j.jns.2006.08.002; Bortoletto M, 2010, NEUROIMAGE, V49, P3338, DOI 10.1016/j.neuroimage.2009.11.048; Bosch B, 2010, CORTEX, V46, P451, DOI 10.1016/j.cortex.2009.05.006; Brovelli A, 2008, CEREB CORTEX, V18, P1485, DOI 10.1093/cercor/bhm198; Brown GG, 1999, J GERIATR PSYCH NEUR, V12, P180, DOI 10.1177/089198879901200403; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; Clark LR, 2012, J INT NEUROPSYCH SOC, V18, P118, DOI 10.1017/S1355617711001524; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Cooper DB, 2004, ALZ DIS ASSOC DIS, V18, P120, DOI 10.1097/01.wad.0000127442.15689.92; Costa P. T., 1992, MANUAL REVISED NEO P; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; DeGrauw X, 2016, J SAFETY RES, V56, P105, DOI 10.1016/j.jsr.2015.11.002; Delis DC., 2001, DELIS KAPLAN EXECUTI; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00762; DeYoung CG, 2014, J PERS ASSESS, V96, P46, DOI 10.1080/00223891.2013.806327; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Duchek JM, 2007, J GERONTOL B-PSYCHOL, V62, pP353, DOI 10.1093/geronb/62.6.P353; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P81, DOI 10.1093/arclin/acp105; Edmonds GW, 2009, J RES PERS, V43, P806, DOI 10.1016/j.jrp.2009.06.006; Euler MJ, 2016, NEUROPSYCHOLOGY, V30, P109, DOI 10.1037/neu0000219; Evans DA, 2011, ALZHEIMERS DEMENT, V7, P110, DOI 10.1016/j.jalz.2010.11.008; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Franchow E.I., 2013, J AGING SCI, V1, P1, DOI [10.4172/2329-8847.1000109, DOI 10.4172/2329-8847.1000109]; Garcia-Ptacek S, 2016, NEUROLOGIA, V31, P562, DOI 10.1016/j.nrl.2013.02.007; Gerloff C., 2003, BEREITSCHAFTSPOTENTI, P175; Gildengers AG, 2009, BIPOLAR DISORD, V11, P744, DOI 10.1111/j.1399-5618.2009.00739.x; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Gujral S, 2016, INT J GERIATR PSYCH, V31, P592, DOI 10.1002/gps.4365; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Josefsson M, 2012, J AM GERIATR SOC, V60, P2308, DOI 10.1111/jgs.12000; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; Kenworthy L., 2008, NEUROPSYCHOLOGY REV; Koepsell TD, 2012, NEUROLOGY, V79, P1591, DOI 10.1212/WNL.0b013e31826e26b7; Korotkevich Y, 2015, EXP BRAIN RES, V233, P937, DOI 10.1007/s00221-014-4169-5; Kraybill ML, 2008, J CLIN EXP NEUROPSYC, V30, P903, DOI 10.1080/13803390701874361; Larsen R.J., 2015, APA HDB PERSONALITY, V4, P369, DOI [DOI 10.1037/14343-017, 10.1037/14343-017]; Larson JCG, 2015, PSYCHOL RES-PSYCH FO, V79, P590, DOI 10.1007/s00426-014-0586-0; Lenzi D, 2011, NEUROBIOL AGING, V32, P1542, DOI 10.1016/j.neurobiolaging.2009.09.006; Lopez OL, 2012, NEUROLOGY, V79, P1599, DOI 10.1212/WNL.0b013e31826e25f0; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Machulda MM, 2017, CLIN NEUROPSYCHOL, V31, P99, DOI 10.1080/13854046.2016.1241303; Marchand WR, 2011, NEUROIMAGE, V55, P194, DOI 10.1016/j.neuroimage.2010.12.030; Mattis S., 2001, DEMENTIA RATING SCAL; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McDaniel WF, 2000, CLIN NEUROPSYCHOL, V14, P72, DOI 10.1076/1385-4046(200002)14:1;1-8;FT072; Mortimer JA, 2005, J GERIATR PSYCH NEUR, V18, P218, DOI 10.1177/0891988705281869; Niermeyer MA, 2017, CLIN NEUROPSYCHOL, V31, P598, DOI 10.1080/13854046.2016.1257071; Niermeyer MA, 2016, J INT NEUROPSYCH SOC, V22, P671, DOI 10.1017/S1355617716000473; Nilsson LG, 2006, NEUROPSYCHOLOGY, V20, P645, DOI 10.1037/0894-4105.20.6.645; Nordlund A, 2010, DEMENT GERIATR COGN, V30, P403, DOI 10.1159/000321352; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pearson, 2009, ADV CLIN SOL WAIS 4; Plehn K, 2004, CLIN NEUROPSYCHOL, V18, P101, DOI 10.1080/13854040490507190; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Potter LM, 2006, EXP BRAIN RES, V171, P56, DOI 10.1007/s00221-005-0244-2; Rajan KB, 2013, J GERONTOL A-BIOL, V68, P624, DOI 10.1093/gerona/gls208; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Riddle M, 2015, INT PSYCHOGERIATR, V27, P707, DOI 10.1017/S1041610214002543; Ritchie K, 2000, COMPR PSYCHIAT, V41, P61, DOI 10.1016/S0010-440X(00)80010-3; Roberts R, 2013, CLIN GERIATR MED, V29, P753, DOI 10.1016/j.cger.2013.07.003; Schretlen DJ, 2010, J CLIN EXP NEUROPSYC, V32, P1068, DOI 10.1080/13803391003689770; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Soubelet A, 2011, DEV PSYCHOL, V47, P303, DOI 10.1037/a0021816; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; St John P, 2002, INT J GERIATR PSYCH, V17, P814, DOI 10.1002/gps.559; Staff RT, 2004, BRAIN, V127, P1191, DOI 10.1093/brain/awh144; Stephan Y, 2014, J RES PERS, V49, P1, DOI 10.1016/j.jrp.2013.12.003; Stern Y, 2007, COGNITIVE RESERVE TH; Suchy Y, 2005, CLIN NEUROPSYCHOL, V19, P4, DOI 10.1080/13854040490888585; Suchy Y., 2011, J INT NEUROPSYCH SOC, V17, P1; Suchy Y, 2007, J CLIN EXP NEUROPSYC, V29, P648, DOI 10.1080/13803390600910506; Suchy Y, 2016, HEALTH PSYCHOL, V35, P661, DOI 10.1037/hea0000326; Suchy Y, 2014, BRAIN INJURY, V28, P972, DOI 10.3109/02699052.2014.888766; Suchy Y, 2010, J GERONTOL B-PSYCHOL, V65, P542, DOI 10.1093/geronb/gbq037; Suchy Y, 2010, J INT NEUROPSYCH SOC, V16, P26, DOI 10.1017/S1355617709990804; Tabachnick B.G., 2013, USING MULTIVARIATE S; Thorgusen SR, 2016, J INT NEUROPSYCH SOC, V22, P453, DOI 10.1017/S1355617715001332; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Trewartha KM, 2009, PSYCHOL AGING, V24, P450, DOI 10.1037/a0015498; US Consumer Product Safety Commission, 2003, SPEC REP EM ROOM INJ; van Oijen M, 2007, ALZHEIMERS DEMENT, V3, P92, DOI 10.1016/j.jalz.2007.01.011; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Welmer AK, 2014, J GERONTOL A-BIOL, V69, P1503, DOI 10.1093/gerona/glu047; Williams PG, 2013, J RES PERS, V47, P945, DOI 10.1016/j.jrp.2013.09.006; Williams PG, 2010, J RES PERS, V44, P485, DOI 10.1016/j.jrp.2010.06.002; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	100	3	3	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	10					987	999		10.1080/13803395.2018.1457627			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GT7JS	WOS:000444703700003	30112978				2022-02-06	
S	Suri, AK; Lipton, ML		Hainline, B; Stern, RA		Suri, Asif K.; Lipton, Michael L.			Neuroimaging of brain trauma in sports	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							NEURITE ORIENTATION DISPERSION; DEFAULT-MODE NETWORK; CEREBRAL-BLOOD-FLOW; WHITE-MATTER; TECHNETIUM-99M-HMPAO SPECT; INJURY; CONCUSSION; PERFUSION; MAGNETOENCEPHALOGRAPHY; MRI	Computed tomography (CT) and magnetic resonance imaging (MRI) have revolutionized the assessment of traumatic brain injury (TBI) by permitting rapid detection and localization of acute intracranial injuries. In concussion, the most common presentation of sports-related head trauma, CT and MRI are unrevealing. This normal appearance of the brain on standard neuroimaging, however, belies the structural and functional pathology that underpins concussion-related symptoms and dysfunction. Advances in neuroimaging have expanded our ability to gain insight into this microstructural and functional brain pathology. This chapter will present both conventional and more advanced imaging approaches (e.g., diffusion tensor imaging, magnetization transfer imaging, magnetic resonance spectroscopy, functional MRI, arterial spin labeling, magnetoencephalography) to the assessment of TBI in sports and discuss some of the current and potential future roles of brain imaging in the assessment of injured athletes.	[Suri, Asif K.; Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA; [Suri, Asif K.; Lipton, Michael L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Michael.Lipton@einstein.yu.edu					Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Audenaert K, 2003, MED SCI MONITOR, V9; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chai C, 2017, NEUROIMAGE-CLIN, V15, P625, DOI 10.1016/j.nicl.2017.06.008; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gonyea JV, 2015, J MAGN RESON IMAGING, V42, P1623, DOI 10.1002/jmri.24954; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Heath F, 2018, DEV NEUROBIOL, V78, P136, DOI 10.1002/dneu.22552; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; ICHISE M, 1994, J NUCL MED, V35, P217; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacobs A, 1996, J NUCL MED, V37, P1605; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kimura-Ohba S, 2016, J CEREBR BLOOD F MET, V36, P1731, DOI 10.1177/0271678X16630556; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Minoshima S, 2016, J NUCL MED, V57; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Osborn AG, 2013, OSBORNS BRAIN IMAGIN; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Shemesh N, 2010, NMR BIOMED, V23, P757, DOI 10.1002/nbm.1550; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sikoglu EM, 2015, COGN BEHAV NEUROL, V28, P181, DOI 10.1097/WNN.0000000000000076; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	70	3	3	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						205	216		10.1016/B978-0-444-63954-7.00021-5			12	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100023	30482348				2022-02-06	
J	Temiz, NC; Kose, G; Tehli, O; Acikel, C; Hatipoglu, S				Temiz, Nail Caglar; Kose, Gulsah; Tehli, Ozkan; Acikel, Cengizhan; Hatipoglu, Sevgi			A Comparison Between the Effectiveness of Full Outline of Unresponsiveness and Glasgow Coma Score at Neurosurgical Intensive Care Unit Patients	TURKISH NEUROSURGERY			English	Article						Glasgow coma score; Full outline of unresponsiveness score; Neurosurgery; Intensive care unit	TRAUMATIC BRAIN-INJURY; SCALE; VALIDATION; CONSCIOUSNESS	AIM: To evaluate the effectiveness and the use of Glasgow Coma Score (GCS) and Full Outline of Unresponsiveness (FOUR) score by nurses in the follow-up and evaluation of patients admitted to the neurosurgical intensive care unit for cranial surgery or head trauma. MATERIAL and METHODS: The study was performed at a neurosurgical intensive care unit. Sample size was determined as 47 patients (alpha=0.05, power=0.95). The correlation coefficient less than 0.5 was accepted as weak. In the first 24 hours, Karnofsky Performance Scale was applied and the Acute Physiology and Chronic Health Evaluation II (APACHE II) Score calculated for patients who were admitted to the intensive care unit for cranial surgery or head trauma. Also FOUR and GCS were applied by two different nurses twice a day. Intraclass Correlation Coefficient, Pearson Correlation and Cronbach's Alpha Security Index analyses were used to evaluate the data. RESULTS: Concordance was above 0.810 and correlation was above 0.837 between GCS and FOUR score evaluation results of nurses. Correlation of two different evaluation at every shift for GCS was 0.887, and for FOUR was 0.827 and above. Karnofsky Performance Scale correlation with FOUR and GCS scores of patients at admission and discharge from the intensive care unit was 0.709 and above. The correlation between APACHE II and FOUR was 0.851; between APACHE II and GCS 0.853. There was no difference between the evaluations of two scores and two nurses statistically. CONCLUSION: Concordance between nurses was found high both for GCS and FOUR. The FOUR score is as effective as GCS on the follow-up of patients who are managed in the neurosurgical intensive care units.	[Temiz, Nail Caglar; Kose, Gulsah; Tehli, Ozkan] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Acikel, Cengizhan] Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Biostat, Ankara, Turkey; [Hatipoglu, Sevgi] Near Est Univ, Fac Hlth Sci, Sch Nursing, Lefkosa, North Cyprus, Turkey		Temiz, NC (corresponding author), Univ Hlth Sci, Gulhane Training & Res Hosp, Dept Neurosurg, Ankara, Turkey.	ctemiz1972@gmail.com					Baratloo A, 2016, ARCH IRAN MED, V19, P215, DOI 0161903/AIM.0011; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Gujjar AR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.009; Hickisch A, 2016, J NEUROSCI NURS, V48, P195, DOI 10.1097/JNN.0000000000000205; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; Johnson VD, 2013, DIMENS CRIT CARE NUR, V32, P180, DOI 10.1097/DCC.0b013e3182998082; Khanal K, 2016, INDIAN J CRIT CARE M, V20, P473, DOI 10.4103/0972-5229.188199; Kramer AA, 2012, CRIT CARE MED, V40, P2671, DOI 10.1097/CCM.0b013e318258fd88; Le Gall JR, 2005, INTENS CARE MED, V31, P1618, DOI 10.1007/s00134-005-2825-8; McNett MM, 2016, J NEUROSCI NURS, V48, P207, DOI 10.1097/JNN.0000000000000225; Peng J, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0508-9; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Sepahvand E, 2016, TURK NEUROSURG, V26, P720, DOI 10.5137/1019-5149.JTN.13536-14.0; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	16	3	3	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2018	28	2					248	250		10.5137/1019-5149.JTN.19504-16.0			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GA0ZP	WOS:000428044700012	28094429	Bronze			2022-02-06	
J	Thakkar, HH; Agrawal, A; Trivedi, S; Singh, K				Thakkar, Hansa H.; Agrawal, Apeksha; Trivedi, Stuti; Singh, Kartikey			Bilateral medial rectus palsy due to midbrain infarction following concussion head injury	INDIAN JOURNAL OF OPHTHALMOLOGY			English	Article						Diffusion-weighted imaging in medial rectus palsy; infarct; medial rectus palsy		Here, we report a rare case of bilateral medial rectus palsy following closed head injury. An adult male had an accidental fall which rendered him unconscious. This was followed by diplopia and restricted ocular motility. He received supportive medical therapy. He was examined for systemic medical and ophthalmic findings. Routine laboratory tests and imaging techniques were employed as per the symptoms. Diffusion-weighted imaging on magnetic resonance imaging proved it to be a rare presentation of small bilateral midbrain infarct. He recovered fully after 8 months.	[Thakkar, Hansa H.; Agrawal, Apeksha; Trivedi, Stuti; Singh, Kartikey] M&J Inst Ophthalmol, Dept Strabismus & Paediat Ophthalmol, Ahmadabad, Gujarat, India		Singh, K (corresponding author), B-508,New PG Hostel Phase 2,Civil Hosp Campus, Ahmadabad 380016, Gujarat, India.	kartikey.singh25@gmail.com					Al-Sofiani M, 2015, AM J CASE REP, V16, P715, DOI 10.12659/AJCR.893875; Bal Simerpreet, 2009, Neurol India, V57, P499, DOI 10.4103/0028-3886.55579; Kwon JH, 2003, ARCH NEUROL-CHICAGO, V60, P1633, DOI 10.1001/archneur.60.11.1633; Lee HS, 2008, NEUROLOGY, V71, pE64, DOI 10.1212/01.wnl.0000335267.63332.2c; LYLE T K, 1959, Trans Ophthalmol Soc U K, V79, P519; Rabadi MH, 2005, AM J MED, V118, P836, DOI 10.1016/j.amjmed.2005.01.050; Tehra K G, 1976, Indian J Ophthalmol, V24, P25	7	3	3	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0301-4738	1998-3689		INDIAN J OPHTHALMOL	Indian J. Ophthalmol.	JAN	2018	66	1					166	167		10.4103/ijo.IJO_570_17			2	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	FX8JP	WOS:000426338600041	29283153	Green Published, gold			2022-02-06	
J	Vining, RD; Salsbury, SA; Cooley, WC; Gosselin, D; Corber, L; Goertz, CM				Vining, Robert D.; Salsbury, Stacie A.; Cooley, W. Carl; Gosselin, Donna; Corber, Lance; Goertz, Christine M.			Patients receiving chiropractic care in a neurorehabilitation hospital: a descriptive study	JOURNAL OF MULTIDISCIPLINARY HEALTHCARE			English	Article						chiropractic; spinal cord injury; stroke; rehabilitation; integrative medicine	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; UNITED-STATES; STROKE; PAIN; REHABILITATION; PROFESSIONALS; PERSPECTIVES; INTEGRATION	Objectives: Individuals rehabilitating from complex neurological injury require a multidis-ciplinary approach, which typically does not include chiropractic care. This study describes inpatients receiving multidisciplinary rehabilitation including chiropractic care for brain injury, spinal cord injury (SCI), stroke, and other complex neurological conditions. Design: Chiropractic services were integrated into Crotched Mountain Specialty Hospital (CMSH) through this project. Patient characteristics and chiropractic care data were collected to describe those receiving care and the interventions during the first 15 months when chiropractic services were available. Setting: CMSH, a 62-bed subacute multidisciplinary rehabilitation, skilled nursing facility located in Greenfield, New Hampshire, USA. Results: Patient mean (SD) age (n=27) was 42.8 (13) years, ranging from 20 to 64 years. Males (n=18, 67%) and those of white race/ethnicity (n=23, 85%) comprised the majority. Brain injury (n=20) was the most common admitting condition caused by trauma (n=9), hemorrhage (n=7), infarction (n=2), and general anoxia (n=2). Three patients were admitted for cervical SCI, 1 for ankylosing spondylitis, 1 for traumatic polyarthropathy, and 2 for respiratory failure with encephalopathy. Other common comorbid diagnoses potentially complicating the treatment and recovery process included myospasm (n=13), depression (n=11), anxiety (n=10), dysphagia (n=8), substance abuse (n=8), and candidiasis (n=7). Chiropractic procedures employed, by visit (n=641), included manual myofascial therapies (93%), mechanical percussion (83%), manual muscle stretching (75%), and thrust manipulation (65%) to address patients with spinal-related pain (n=15, 54%), joint or regional stiffness (n=14, 50%), and extremity pain (n=13, 46%). Care often required adapting to participant limitations or conditions. Such adaptations not commonly encountered in outpatient settings where chiropractic care is usually delivered included the need for lift assistance, wheelchair dependence, contractures, impaired speech, quadriplegia/paraplegia, and the presence of feeding tubes and urinary catheters. Conclusion: Patients suffered significant functional limitations and comorbidity resulting in modifications to the typical delivery of chiropractic care. Chiropractic services focused on relieving musculoskeletal pain and stiffness.	[Vining, Robert D.; Salsbury, Stacie A.; Corber, Lance; Goertz, Christine M.] Palmer Coll Chiropract, Palmer Ctr Chiropract Res, 741 Brady St, Davenport, IA 52803 USA; [Cooley, W. Carl] Geisel Sch Med Dartmouth, Dept Pediat, Hanover, NH USA		Vining, RD (corresponding author), Palmer Coll Chiropract, Palmer Ctr Chiropract Res, 741 Brady St, Davenport, IA 52803 USA.	robert.vining@palmer.edu	Salsbury, Stacie/K-6575-2019	Vining, Robert/0000-0003-4672-4613; Salsbury (Lyons), Stacie/0000-0002-9668-2426	Kiernan Chiropractic Care in Rehabilitation at Crotched Mountain program	This study was funded through the Kiernan Chiropractic Care in Rehabilitation at Crotched Mountain program, a philanthropic gift from Dr William J Kiernan and Mary A Kiernan through the Kiernan Family Trust. The authors also wish to acknowledge Jeb Thurmond, DC, who provided chiropractic care and collected treatment data; Kimberlee Case, BSN, who organized and collected MDS and FIM data; and David Kontak, Master of Arts, Master of Science, Occupational Therapist, Registered, Licensed, who managed recruitment and the informed consent process.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 1985, 36 ANN NEUR C 11 JUL; Arienti C, 2011, SPINAL CORD, V49, P515, DOI 10.1038/sc.2010.170; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bialosky JE, 2009, MANUAL THER, V14, P531, DOI 10.1016/j.math.2008.09.001; Bowden BS, 2016, J CHIPROPR EDUC, V30, P114, DOI 10.7899/JCE-15-7; Cardenas DD, 2009, PM&R, V1, P1077, DOI 10.1016/j.pmrj.2009.07.002; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Commission on the Accreditation of Rehabilitation Facilities (CARF), 2018, 2018 MED REH PROGR D, P2; Coronado RA, 2012, J ELECTROMYOGR KINES, V22, P752, DOI 10.1016/j.jelekin.2011.12.013; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dagenais S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1140-5; Dellefield ME, 2006, GERONTOLOGIST, V46, P128, DOI 10.1093/geront/46.1.128; Dunn AS, 2009, J MANIP PHYSIOL THER, V32, P749, DOI 10.1016/j.jmpt.2009.10.009; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Finnerup NB, 2008, SPINAL CORD, V46, P198, DOI 10.1038/sj.sc.3102097; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hsieh YW, 2009, STROKE, V40, P1386, DOI 10.1161/STROKEAHA.108.530584; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kalichman L, 2011, AM J PHYS MED REHAB, V90, P768, DOI 10.1097/PHM.0b013e318214e976; Karlen EK, 2015, SPINELIN         FEB; Lew HL, 2009, PM&R, V1, pS19, DOI 10.1016/j.pmrj.2009.01.017; Lisi AJ, 2016, J MANIP PHYSIOL THER, V39, P381, DOI 10.1016/j.jmpt.2016.04.005; Lombard LA, 2009, PM&R, V1, pS13, DOI 10.1016/j.pmrj.2009.01.016; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Meeker WC, 2000, J MANIP PHYSIOL THER, V23, P123, DOI 10.1016/S0161-4754(00)90081-2; Menke JM, 2003, J MANIP PHYSIOL THER, V26, P254, DOI 10.1016/S0161-4754(02)54113-0; Mor V, 2004, MED CARE, V42, P50, DOI 10.1097/01.mlr.0000120104.01232.5e; Nabhan DC, 2015, J CHIROPR MED, V14, P68, DOI 10.1016/j.jcm.2015.04.001; Nas K, 2015, WORLD J ORTHOP, V6, P8, DOI 10.5312/wjo.v6.i1.8; Nelson CD, 2000, J MANIP PHYSIOL THER, V23, P202, DOI 10.1016/S0161-4754(00)90250-1; Vining R, 2017, COMPREHENSIVE PAIN M, P575; Vining RD, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007837; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Wong JJ, 2014, J CHIPROPR EDUC, V28, P112, DOI 10.7899/JCE-14-16; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008	39	3	3	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2390			J MULTIDISCIP HEALTH	J. Multidiscip. Healthc.		2018	11						223	231		10.2147/JMDH.S159618			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	GE7ZB	WOS:000431450500001	29760552	Green Published, gold, Green Submitted			2022-02-06	
J	Waganekar, A; Sadasivan, J; Prabhu, AS; Harichandrakumar, KT				Waganekar, Archana; Sadasivan, Jagadish; Prabhu, A. Sathia; Harichandrakumar, K. T.			Computed Tomography Profile and its Utilization in Head Injury Patients in Emergency Department: A Prospective Observational Study	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Computed tomography; emergency department; Glasgow Coma scale; head injury	TRAUMATIC BRAIN-INJURIES; INTRACRANIAL INJURY; METAANALYSIS; PREVENTION; DIAGNOSIS	Context: Based on Glasgow Coma Scale (GCS), head injury can be classified as minor (GCS 13-15), moderate (GCS 9-12), and severe (GCS 3-8). There is a lot of controversy in the use of computed tomography (CT) in head injury patients. Aims: This study was intended to estimate the rate of CT positivity in head injury patients and to define the criteria for doing CT in head injury patients. Settings and Design: This was a prospective observational study in the emergency department (ED) over a 12-month period. Subjects and Methods: Study involved all head injury patients attending ED. Risk factors studied were a loss of consciousness (LOC), vomiting, seizures, ear bleed, nosebleed, external injuries, and alcohol intoxication. Statistical Analysis Used: Comparison of CT positivity with the patient's demographics and clinical characteristics was carried out using Chi-square. Results: A total of 1782 patients were included in this study. Overall CT positivity was 50.9%. In minor head injury (MHI), CT positivity rate was 38%. The study showed significant association of CT positivity with five variables: LOC > 5 min, vomiting, seizures, ear bleed, and nosebleed. Conclusions: From the study, we recommend following: CT is indicated in all patients with moderate and severe head injury (GCS <= 12). Low threshold for taking CT is advisable in elderly and alcohol-intoxicated patients. In MHI, CT is indicated if any one of the following risk factors are present: LOC > 5 min, history of vomiting, history of seizures, history of ear bleed, and history of nosebleed.	[Waganekar, Archana; Sadasivan, Jagadish] Jawaharlal Inst Postgrad Med Educ & Res, Dept Emergency Med & Trauma, E-37, Pondicherry 605006, India; [Prabhu, A. Sathia] Jawaharlal Inst Postgrad Med Educ & Res, Dept Neurosurg, Pondicherry, India; [Harichandrakumar, K. T.] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biometr & Informat Biostat, Pondicherry, India		Waganekar, A (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Emergency Med & Trauma, E-37, Pondicherry 605006, India.	drarchanasunil@gmail.com					[Anonymous], NEUROSURGERY; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CW, 2012, SCI WORLD J, DOI 10.1100/2012/340317; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inamasu J, 2000, AM J EMERG MED, V18, P810, DOI 10.1053/ajem.2000.18111; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; Munivenkatappa A, 2013, J PEDIATR NEUROSCI, V8, P183, DOI 10.4103/1817-1745.123659; Nayebaghayee Hossein, 2016, Asian J Neurosurg, V11, P46, DOI 10.4103/1793-5482.165780; Saadat S, 2009, J NEUROSURG, V111, P688, DOI 10.3171/2009.2.JNS08909; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Tomar SS, 2013, OPEN J CLIN DIAGN, V3, P109; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Walleck C A, 1992, AACN Clin Issues Crit Care Nurs, V3, P19; Wright DW, 2016, TINTINALLIS EMERGENC, P1692	26	3	5	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JAN-MAR	2018	11	1					25	30		10.4103/JETS.JETS_112_17			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GS6WZ	WOS:000443842000006	29628665	gold, Green Published			2022-02-06	
B	Walker, S; Wicks, B	Walker, S; Wicks, B			Walker, Sue; Wicks, Beth	Walker, S; Wicks, B		Most common areas of difficulty provoked by ABI	EDUCATING CHILDREN AND YOUNG PEOPLE WITH ACQUIRED BRAIN INJURY, 2ND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY										Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Catroppa C., 2004, J DEV NEUROPSYCHOLOG, V23, P359; Dick F., 2008, CHILD NEUROPSYCHOL, P139; Duffy J. R., 2012, MOTOR SPEECH DISORDE; Gupta Y K, 2006, Indian J Physiol Pharmacol, V50, P7; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Powell T., 1994, HEAD INJURY PRACTICA; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Ylvisaker M., 1994, ED DIMENSIONS ACQUIR, P69; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	12	3	3	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-21102-5; 978-1-315-45369-9; 978-1-138-21101-8				2018							29	54					26	Education, Special	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Education & Educational Research	BM7IB	WOS:000467938100006					2022-02-06	
J	Walter, KH; Glassman, LH; Hunt, WM; Otis, NP; Thomsen, CJ				Walter, Kristen H.; Glassman, Lisa H.; Hunt, W. Michael; Otis, Nicholas P.; Thomsen, Cynthia J.			Evaluation of an integrated treatment for active duty service members with comorbid posttraumatic stress disorder and major depressive disorder: Study protocol for a randomized controlled trial	CONTEMPORARY CLINICAL TRIALS			English	Article						Posttraumatic stress disorder; Major depressive disorder; Cognitive processing therapy; Behavioral activation; Comorbidity; Military	COGNITIVE-PROCESSING THERAPY; BEHAVIORAL ACTIVATION TREATMENT; TRAUMATIC BRAIN-INJURY; PROLONGED EXPOSURE; FEMALE VICTIMS; VETERANS; PTSD; METAANALYSIS; MEDICATION; SYMPTOMS	Posttraumatic stress disorder (PTSD) commonly co-occurs with major depressive disorder (MDD) in both civilian and military/veteran populations. Existing, evidence-based PTSD treatments, such as cognitive processing therapy (CPT), often reduce symptoms of both PTSD and depression; however, findings related to the influence of comorbid MDD on PTSD treatment outcomes are mixed, and few studies use samples of individuals with both conditions. Behavioral activation (BA), an approach that relies on behavioral principles, is an effective treatment for depression. We have integrated BA into CPT (BA + CPT), a more cognitive approach, to address depressive symptoms among active duty service members with both PTSD and comorbid MDD. We describe an ongoing randomized controlled trial investigating the efficacy of our innovative, integrated BA + CPT intervention, compared with standard CPT, for active duty service members with PTSD and comorbid MDD. We detail the development of this integrated treatment, as well as the design and implementation of the randomized controlled trial, to evaluate its effect on symptoms.	[Walter, Kristen H.; Glassman, Lisa H.; Otis, Nicholas P.] Leidos, 140 Sylvester Rd, San Diego, CA 92106 USA; [Walter, Kristen H.; Hunt, W. Michael] Naval Med Ctr San Diego, Directorate Mental Hlth, San Diego, CA USA; [Thomsen, Cynthia J.] Naval Hlth Res Ctr, Hlth & Behav Sci, 140 Sylvester Rd, San Diego, CA 92106 USA		Walter, KH (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	kristen.h.walter.ctr@mail.mil; lisa.h.glassman.ctr@mail.mil; william.m.hunt.civ@mail.mil; nicholas.p.otis.ctr@mail.mil; cynthia.j.thomsen.civ@mail.mil	Walter, Kristen H/S-1827-2019	Otis, Nicholas/0000-0003-1078-2862	Navy Bureau of Medicine and Surgery [N1422]	This work was supported by the Navy Bureau of Medicine and Surgery [work unit no. N1422].	Acierno R, 2012, AM J HOSP PALLIAT ME, V29, P13, DOI 10.1177/1049909111411471; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boscarino JA, 2004, PSYCHIAT SERV, V55, P274, DOI 10.1176/appi.ps.55.3.274; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Coffman SJ, 2007, J CONSULT CLIN PSYCH, V75, P531, DOI 10.1037/0022-006X.75.4.531; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; First M., 2015, STRUCTURED CLIN INTE; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa E.B., 2008, EFFECTIVE TREATMENTS; Green BL, 2006, J CLIN PSYCHOL, V62, P815, DOI 10.1002/jclp.20279; Gros D.F., 2011, PRIM CARE COMPANION, P13; Gros DF, 2012, BEHAV MODIF, V36, P580, DOI 10.1177/0145445512448097; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Jaycox, 2008, INVISIBLE WOUNDS WAR; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Lejuez CW, 2001, BEHAV MODIF, V25, P255, DOI 10.1177/0145445501252005; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Martell C.R., 2001, DEPRESSION CONTEXT S; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nixon RDV, 2004, J AFFECT DISORDERS, V82, P315, DOI 10.1016/j.jad.2004.01.008; Nixon RDV, 2011, J TRAUMA STRESS, V24, P451, DOI 10.1002/jts.20654; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Resick P. A., 1993, COGNITIVE PROCESSING; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; RESICK PA, 1992, J CONSULT CLIN PSYCH, V60, P748, DOI 10.1037/0022-006X.60.5.748; Resick PA, 2014, COGNITIVE PROCESSING; Resick PA, 2015, COGNITIVE PROCESSING; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Ronconi JM, 2015, J NERV MENT DIS, V203, P522, DOI 10.1097/NMD.0000000000000322; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab K, 2013, NEUROLOGY, V80; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stapleton JA, 2006, MIL MED, V171, P562, DOI 10.7205/MILMED.171.6.562; Strachan M, 2012, BEHAV THER, V43, P560, DOI 10.1016/j.beth.2011.03.003; Taft CT, 2009, J FAM VIOLENCE, V24, P407, DOI 10.1007/s10896-009-9243-6; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Weathers F., 2013, CLINICIAN ADMINISTER; Weathers FW, PTSD CHECKLIST DSM 5	50	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2018	64						152	160		10.1016/j.cct.2017.10.010			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	FU1ZE	WOS:000423647200019	29107036				2022-02-06	
J	Winter, L; Moriarty, HJ; Short, TH				Winter, Laraine; Moriarty, Helene J.; Short, Thomas H.			Beyond anger: emotion regulation and social connectedness in veterans with traumatic brain injury	BRAIN INJURY			English	Article						Veterans; emotional self-regulation; depression; social roles; functional competence	POSTTRAUMATIC-STRESS-DISORDER; SELF-AWARENESS; SHORT-FORM; MANAGEMENT; QUALITY; DISTURBANCES; ASSOCIATION; PERSONALITY; AGGRESSION; EXPRESSION	Primary objective: Patients with traumatic brain injury (TBI) often present with emotion dysregulation. Most TBI rehabilitation has addressed this impairment primarily in relation to anger, irritability and aggressiveness. Yet, emotion regulation (ER) may have broader ramifications for psychological well-being. The present study examined ER's association to several aspects of social connectedness.Research design: Cross-sectional studyMethods and procedures: 83 veterans with TBI who were outpatients at a VA medical rehabilitation service were interviewed in their homes. A 5-item ER subscale, drawn from the Patient Competency Rating Scale, was subjected to psychometric analysis and examined as a predictor of five social connectedness measures: community reintegration (CR), interpersonal functioning, quality of relationship with key family members and social role limitations due to physical problems and due to emotional problems. Sociodemographic, military and medical information was also collected.Main outcomes and results: The ER subscale showed good psychometric properties. ER contributed significantly to CR, interpersonal functioning and limitations in social roles. This underscores ER's role in social connectedness among veterans with TBI.Conclusions: Impairments in ER should be regarded as a risk factor for poor interpersonal outcomes, a target for mental health treatment and a focus for interventions aimed at improving psychological well-being in TBI.	[Winter, Laraine] Philadelphia Res & Educ Fdn, Corporal Michael C Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19054 USA; [Winter, Laraine; Moriarty, Helene J.] Corporal Michael C Crescenz Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA USA; [Moriarty, Helene J.] Villanova Univ, Coll Nursing, Villanova, PA 19085 USA; [Short, Thomas H.] West Chester Univ Penn, Dept Math, W Chester, PA USA		Winter, L (corresponding author), Philadelphia Res & Educ Fdn, Corporal Michael C Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19054 USA.	Laraine.winter@gmail.com			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD068857] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR018655] Funding Source: Medline		Aboulafia-Brakha T, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000171; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Baumeister RF, 2006, J PERS, V74, P1773, DOI 10.1111/j.1467-6494.2006.00428.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Gross JJ, 2015, PSYCHOL INQ, V26, P1, DOI 10.1080/1047840X.2014.940781; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Kazis LE, 2004, HEALTH CARE FINANC R, V25, P43; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kim E, 2002, NEUROREHABILITATION, V17, P297; Koole SL, 2010, PERS SOC PSYCHOL REV, V14, P95, DOI 10.1177/1088868309351109; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Koole SL, 2011, HDB SELF REGULATION; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Marroquin B, 2015, J PERS SOC PSYCHOL, V109, P836, DOI 10.1037/pspi0000034; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P286, DOI 10.1097/HTR.0000000000000277; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P283, DOI 10.1097/HTR.0000000000000337; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; O'Rourke HM, 2017, J GERONTOL NURS, V11, P1; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sun F, 2009, PSYCHOL AGING, V24, P177, DOI 10.1037/a0014760; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Toepoel V, 2013, SOC INDIC RES, V113, P355, DOI 10.1007/s11205-012-0097-6; Tornas S, 2016, ARCH PHYS MED REHAB, V97, P1841, DOI 10.1016/j.apmr.2016.06.014; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; US Department of Health and Human Service, 2016, TRAUM BRAIN INJ US R; US Department of Veterans Affairs and Department of Defense, 2009, CLIN PRACT GUID MAN; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; WILLIAMSON GM, 1990, PSYCHOL AGING, V5, P502, DOI 10.1037/0882-7974.5.4.502; Winter L, 2016, BRAIN INJURY, V16, P1; Winter L, 2017, BRAIN INJURY, V31, P493, DOI 10.1080/02699052.2017.1283534; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093	55	3	3	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					593	599		10.1080/02699052.2018.1432895			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200010	29393692				2022-02-06	
S	Zafonte, RD; Shih, SL; Iaccarino, MA; Tan, CO		Hainline, B; Stern, RA		Zafonte, Ross D.; Shih, Shirley L.; Iaccarino, Mary Alexis; Tan, Can Ozan			Neurologic benefits of sports and exercise	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; NEUROTROPHIC FACTOR LEVELS; N-ACETYL-ASPARTATE; AEROBIC EXERCISE; PHYSICAL-ACTIVITY; TREADMILL EXERCISE; DYNAMIC EXERCISE; CONTROLLED-TRIAL; CO2 REACTIVITY	Traumatic brain injury (TBI) is associated with several pathophysiologic changes, including: neurostructural alterations; molecular changes with shifts in circulating neurotrophins; impaired neural metabolism; changes in cerebrovascular autoregulation, vasoreactivity, and neurovascular coupling; and alterations in functional brain connectivity. In animal models of TBI, aerobic exercise reduces neuronal injury, promotes neuronal survival, and enhances the production of neuroprotective trophic factors. However, the timing of exercise initiation is an important consideration as early exercise in the acute postinjury period may impede recovery mechanisms, although evidence for this in humans is lacking. Though human clinical studies are limited, aerobic exercise post-TBI engages cerebrovascular mechanisms and may impart neurophysiologic benefits to mitigate post-TBI pathophysiologic changes. Additionally, subsymptom threshold exercise in humans has been demonstrated to be safe, feasible, and effective in decreasing symptom burden in individuals with mild TBI, and to counteract the detrimental effects of prolonged inactivity, subsequent physical deconditioning, and its negative emotional sequelae. This chapter will explore the potential role of aerobic exercise in neurorecovery after TBI.	Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA		Zafonte, RD (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA.	rzafonte@mgh.harvard.edu	Tan, Can Ozan/E-2598-2016	Tan, Can Ozan/0000-0001-9673-9907			Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; ARVIGO F, 1985, SURG NEUROL, V24, P211, DOI 10.1016/0090-3019(85)90187-9; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bellon K, 2015, BRAIN INJURY, V29, P313, DOI 10.3109/02699052.2014.974670; Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brian JE, 1996, CLIN EXP PHARMACOL P, V23, P449, DOI 10.1111/j.1440-1681.1996.tb02760.x; Brys M, 2003, AM J PHYSIOL-HEART C, V285, pH1048, DOI 10.1152/ajpheart.00062.2003; Buckley J, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/Mhum.2014.00747, 10.3389/fnhum.2014.00747, 10.3389/fnhum.2014.00584]; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Coelho FGD, 2014, J ALZHEIMERS DIS, V39, P401, DOI 10.3233/JAD-131073; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; El-Tamawy MS, 2014, NEUROREHABILITATION, V34, P209, DOI 10.3233/NRE-131020; Elsworth C, 2009, INT J THER REHABIL, V16, P17, DOI 10.12968/ijtr.2009.16.1.37936; Erickson KI, 2012, BRAIN BEHAV, V2, P32, DOI 10.1002/brb3.30; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Fogelman D, 2012, PM&R, V4, P908, DOI 10.1016/j.pmrj.2012.09.028; Frazzitta G, 2014, NEUROREHAB NEURAL RE, V28, P163, DOI 10.1177/1545968313508474; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Gonzales MM, 2013, BRAIN TOPOGR, V26, P126, DOI 10.1007/s10548-012-0248-8; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herting MM, 2014, DEV COGN NEUROS-NETH, V7, P65, DOI 10.1016/j.dcn.2013.11.003; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; JONES TA, 1994, J NEUROSCI, V14, P2140; JORGENSEN LG, 1992, J APPL PHYSIOL, V72, P1123, DOI 10.1152/jappl.1992.72.3.1123; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Koo HM, 2013, J PHYS THER SCI, V25, P1103, DOI 10.1589/jpts.25.1103; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LINKIS P, 1995, J APPL PHYSIOL, V78, P12, DOI 10.1152/jappl.1995.78.1.12; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; MORAINE JJ, 1993, EUR J APPL PHYSIOL O, V67, P35, DOI 10.1007/BF00377701; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; PETTEGREW JW, 1990, J NEUROPATH EXP NEUR, V49, P237, DOI 10.1097/00005072-199005000-00005; Raichlen DA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00610; Rasmussen P, 2006, EUR J APPL PHYSIOL, V96, P299, DOI 10.1007/s00421-005-0079-3; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Rowell LB, 1993, HUMAN CARDIOVASCULAR; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vaughan S, 2014, AGE AGEING, V43, P623, DOI 10.1093/ageing/afu010; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Weinstein AA, 2017, J HEAD TRAUMA REHAB, V32, pE49, DOI 10.1097/HTR.0000000000000253; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533	112	3	3	0	3	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						463	471		10.1016/B978-0-444-63954-7.00042-2			9	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100044	30482373				2022-02-06	
S	Zhu, L		Fu, BM; Wright, NT		Zhu, Liang			Hypothermia Used in Medical Applications for Brain and Spinal Cord Injury Patients	MOLECULAR, CELLULAR, AND TISSUE ENGINEERING OF THE VASCULAR SYSTEM	Advances in Experimental Medicine and Biology		English	Article; Book Chapter							CEREBRAL-BLOOD-FLOW; MILD THERAPEUTIC HYPOTHERMIA; HOSPITAL CARDIAC-ARREST; ACUTE ISCHEMIC-STROKE; COLD SALINE INFUSION; INTERSTITIAL COOLING DEVICE; UPPER RESPIRATORY-TRACT; THEORETICAL HUMAN-MODEL; MODERATE HYPOTHERMIA; SYSTEMIC HYPOTHERMIA	Despite more than 80 years of animal experiments and clinical practice, efficacy of hypothermia in improving treatment outcomes in patients suffering from cell and tissue damage caused by ischemia is still ongoing. This review will first describe the history of utilizing cooling in medical treatment, followed by chemical and biochemical mechanisms of cooling that can lead to neuroprotection often observed in animal studies and some clinical studies. The next sections will be focused on current cooling approaches/devices, as well as cooling parameters recommended by researchers and clinicians. Animal and clinical studies of implementing hypothermia to spinal cord and brain tissue injury patients are presented next. This section will review the latest outcomes of hypothermia in treating patients suffering from traumatic brain injury (TBI), spinal cord injury (SCI), stroke, cardiopulmonary surgery, and cardiac arrest, followed by a summary of available evidence regarding both demonstrated neuroprotection and potential risks of hypothermia. Contributions from bioengineers to the field of hypothermia in medical treatment will be discussed in the last section of this review. Overall, an accumulating body of clinical evidence along with several decades of animal research and mathematical simulations has documented that the efficacy of hypothermia is dependent on achieving a reduced temperature in the target tissue before or soon after the injury-precipitating event. Mild hypothermia with temperature reduction of several degrees Celsius is as effective as modest or deep hypothermia in providing therapeutic benefit without introducing collateral/ systemic complications. It is widely demonstrated that the rewarming rate must be controlled to be lower than 0.5 degrees C/h to avoid mismatch between local blood perfusion and metabolism. In the past several decades, many different cooling methods and devices have been designed, tested, and used in medical treatments with mixed results. Accurately designing treatment protocols to achieve specific cooling outcomes requires collaboration among engineers, researchers, and clinicians. Although this problem is quite challenging, it presents a major opportunity for bioengineers to create methods and devices that quicklyand safely produce hypothermia in targeted tissue regions without interfering with routine medical treatment.	[Zhu, Liang] Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21228 USA		Zhu, L (corresponding author), Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21228 USA.	zliang@umbc.edu					Abou-Chebl A, 2011, STROKE, V42, P2164, DOI 10.1161/STROKEAHA.110.613000; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2005, BRIT J ANAESTH, V94, P330, DOI 10.1093/bja/aei025; Bachet J, 2002, J CARDIAC SURG, V17, P115, DOI 10.1111/j.1540-8191.2002.tb01185.x; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Belliard G, 2007, RESUSCITATION, V75, P252, DOI 10.1016/j.resuscitation.2007.04.014; BERING EA, 1961, AM J PHYSIOL, V200, P417; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2008, RESUSCITATION, V76, P311, DOI 10.1016/j.resuscitation.2007.07.017; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; BIGELOW WG, 1950, ANN SURG, V132, P531, DOI 10.1097/00000658-195009000-00018; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Bommadevara M, 2002, BIOMECH MODEL MECHAN, V1, P137, DOI 10.1007/s10237-002-0011-2; Bricolo A, 1976, Surg Neurol, V6, P101; BUSIJA DW, 1987, AM J PHYSIOL, V253, pH869, DOI 10.1152/ajpheart.1987.253.4.H869; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambers S, 1999, Nurs Crit Care, V4, P112; Cheriyan T, 2014, SPINE J, V14, pS86; Choi JH, 2010, AM J NEURORADIOL, V31, P928, DOI 10.3174/ajnr.A1961; Choi JH, 2006, STROKE, V37, P419, DOI 10.1161/01.STR.0000198808.90579.65; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Covaciu L, 2011, INTENS CARE MED, V37, P1277, DOI 10.1007/s00134-011-2264-7; Dae MW, 2003, STROKE, V34, P734, DOI 10.1161/01.STR.0000057461.56040.FE; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Denn BH, 2003, J BIOMECH ENG-T ASME, V125, P832, DOI [10.1115/1.16324991, 10.1115/1.1634991]; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diao CG, 2006, MED PHYS, V33, P2565, DOI 10.1118/1.2208918; Dididze M, 2013, SPINAL CORD, V51, P395, DOI 10.1038/sc.2012.161; DIETRICH WD, 1993, J NEUROPATH EXP NEUR, V52, P351, DOI 10.1097/00005072-199307000-00002; Ding YC, 2004, NEUROSURGERY, V54, P956, DOI 10.1227/01.NEU.0000114513.96704.29; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doufas AG, 2002, ANESTH ANALG, V95, P1752, DOI 10.1097/00000539-200212000-00052; DRAKE CG, 1962, CAN MED ASSOC J, V87, P887; Eginton ML, 2007, THESIS U MARYLAND BA; Els T, 2006, CEREBROVASC DIS, V21, P79, DOI 10.1159/000090007; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Esposito E, 2014, J CEREBR BLOOD F MET, V34, P743, DOI 10.1038/jcbfm.2014.29; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Ferreira IA, 2009, NETH HEART J, V17, P378, DOI 10.1007/BF03086288; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; Fukuda T, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0139-2; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; GILLINOV AM, 1993, ANN THORAC SURG, V56, P847, DOI 10.1016/0003-4975(93)90342-F; Gong M, 2016, J THORAC DIS, V8, P925, DOI 10.21037/jtd.2016.02.75; Grahn D, 1998, J APPL PHYSIOL, V85, P1643, DOI 10.1152/jappl.1998.85.5.1643; Grahn DA, 2005, J APPL PHYSIOL, V99, P972, DOI 10.1152/japplphysiol.00093.2005; Grahn DA, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-14; Grulova I, 2013, SPINE J, V13, P1881, DOI 10.1016/j.spinee.2013.06.073; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Guo JG, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-94; Gutsche JT, 2014, HEART LUNG VESSEL, V6, P43; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hansebout RR, 2014, J NEUROSURG-SPINE, V20, P550, DOI 10.3171/2014.2.SPINE13318; Harris BA, 2007, BRIT J ANAESTH, V98, P93, DOI 10.1093/bja/ael308; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; HOFFMAN WE, 1982, CRYOBIOLOGY, V19, P392, DOI 10.1016/0011-2240(82)90168-7; Holzer M, 2005, CRIT CARE MED, V33, P1346, DOI 10.1097/01.CCM.0000166356.45902.A2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hong JM, 2014, STROKE, V45, P134, DOI 10.1161/STROKEAHA.113.003143; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ibayashi S, 2000, NEUROCHEM RES, V25, P369, DOI 10.1023/A:1007593004806; Inderbitzen B, 2002, NEUROSURGERY, V50, P364, DOI 10.1097/00006123-200202000-00023; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Janssen FEM, 2005, PHYS MED BIOL, V50, P4065, DOI 10.1088/0031-9155/50/17/010; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kabat H, 1940, AM J PHYSIOL, V130, P0588, DOI 10.1152/ajplegacy.1940.130.3.588; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Kollmar R, 2009, STROKE, V40, P1907, DOI 10.1161/STROKEAHA.108.530410; Konstas AA, 2007, J APPL PHYSIOL, V102, P1329, DOI 10.1152/japplphysiol.00805.2006; KOUCHOUKOS NT, 1994, ANN SURG, V219, P699, DOI 10.1097/00000658-199406000-00014; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Kurasako T, 2003, J CEREB BLOOD FLOW M, V27, P1919; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; Ley O, 2003, INT J HEAT MASS TRAN, V46, P3233, DOI 10.1016/S0017-9310(03)00100-5; Ley O, 2004, P IMECE NOV 13 19 AN; Li PC, 2014, BRAIN INJURY, V28, P1036, DOI 10.3109/02699052.2014.910609; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Mack WJ, 2003, STROKE, V34, P1994, DOI 10.1161/01.STR.0000079813.31539.6D; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1996, CRIT CARE MED, V24, pS81; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MEACHAM WF, 1973, SOUTH MED J, V66, P95, DOI 10.1097/00007611-197301000-00016; MELLERGARD P, 1990, NEUROSURGERY, V27, P654, DOI 10.1227/00006123-199010000-00029; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Michenfelder J, 1988, ANESTHESIA BRAIN CLI, P181; MILLER JA, 1949, SCIENCE, V110, P113, DOI 10.1126/science.110.2848.113; MILLER JH, 1993, J VASC SURG, V17, P546; Moomiaie RM, 2012, J NEUROINTERV SURG, V4, P130, DOI 10.1136/jnis.2010.004432; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; Morino T, 2008, SPINAL CORD, V46, P425, DOI 10.1038/sj.sc.3102163; Mouritzen CV, 1966, J THORAC CARDIOVASC, V51, P579; MOYER DJ, 1992, STROKE, V23, P1812, DOI 10.1161/01.STR.23.12.1812; Negrin J Jr, 1973, Paraplegia, V10, P336; Neimark MA, 2007, P ANN INT IEEE EMBS, P6349; Neimark MA, 2008, J THEOR BIOL, V253, P333, DOI 10.1016/j.jtbi.2008.03.025; Neimark MA, 2007, J APPL PHYSIOL, V103, P1837, DOI 10.1152/japplphysiol.00542.2007; Neimark MAH, 2013, J NEUROINTERV SURG, V5, P165, DOI 10.1136/neurintsurg-2011-010150; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nussmeier Nancy A, 2002, J Extra Corpor Technol, V34, P4; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Okubo K, 2001, PEDIATR INT, V43, P496, DOI 10.1046/j.1442-200X.2001.01444.x; Olsen TS, 2003, LANCET NEUROL, V2, P410, DOI 10.1016/S1474-4422(03)00436-8; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Petrovic M, 2011, VOJNOSANIT PREGL, V68, P495, DOI 10.2298/VSP1106495P; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Poli S, 2013, STROKE, V44, P708, DOI 10.1161/STROKEAHA.112.672923; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Purdy PD, 2013, AM J NEURORADIOL, V34, P252, DOI 10.3174/ajnr.A3175; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Rosengart AJ, 2009, J CLIN NEUROSCI, V16, P51, DOI 10.1016/j.jocn.2008.04.003; Safar P, 2001, NEW ENGL J MED, V345, P66; Saxena M, 2015, INTENS CARE MED, V41, P823, DOI 10.1007/s00134-015-3676-6; Schenone AL, 2016, RESUSCITATION, V108, P102, DOI 10.1016/j.resuscitation.2016.07.238; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Schwab S, 1998, ACT NEUR S, V71, P131; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SELKER R G, 1971, Surgical Forum (Chicago), V22, P411; Shaefi S, 2016, SURG NEUROL INT, V103, P7; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Slotboom J, 2007, J APPL PHYSIOL, V102, P1303, DOI 10.1152/japplphysiol.00105.2007; Slotboom J, 2004, NEURORADIOLOGY, V46, P923, DOI 10.1007/s00234-004-1286-z; Smith KD, 2010, MED BIOL ENG COMPUT, V48, P783, DOI 10.1007/s11517-010-0635-9; Smith KD, 2010, MED BIOL ENG COMPUT, V48, P167, DOI 10.1007/s11517-009-0543-z; Springborg JB, 2013, NEUROCRIT CARE, V18, P400, DOI 10.1007/s12028-012-9806-x; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; STONE JG, 1995, ANESTHESIOLOGY, V82, P344, DOI 10.1097/00000542-199502000-00004; Strauch JT, 2004, EUR J CARDIO-THORAC, V25, P708, DOI 10.1016/j.ejcts.2004.01.007; TATOR CH, 1972, CAN MED ASSOC J, V107, P143; Thoresen M, 1997, ACTA PAEDIATR, V86, P1029, DOI 10.1111/j.1651-2227.1997.tb14799.x; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; Tripathy S, 2011, NEUROCRIT CARE, V15, P525, DOI 10.1007/s12028-011-9529-4; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Van Leeuwen GMJ, 2000, PEDIATR RES, V48, P351, DOI 10.1203/00006450-200009000-00015; VANDAM LD, 1959, NEW ENGL J MED, V261, P595, DOI 10.1056/NEJM195909172611206; VANDAM LD, 1959, NEW ENGL J MED, V261, P546, DOI 10.1056/NEJM195909102611106; Vanden Hoek Terry L, 2004, Crit Care Med, V32, pS425, DOI 10.1097/01.CCM.0000134259.59793.B8; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; Virkkunen I, 2004, RESUSCITATION, V62, P299, DOI 10.1016/j.resuscitation.2004.04.003; Wagner KR, 2005, NEUROL RES, V27, P238, DOI 10.1179/016164105X25261; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang JQ, 2015, INT J MOL SCI, V16, P16848, DOI 10.3390/ijms160816848; Wang YJ, 2008, INT J HEAT MASS TRAN, V51, P5662, DOI 10.1016/j.ijheatmasstransfer.2008.04.042; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; Wass CT, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603440-00008; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Wei G, 2008, J NEUROTRAUM, V25, P549, DOI 10.1089/neu.2007.0498; WELSH FA, 1990, J CEREBR BLOOD F MET, V10, P557, DOI 10.1038/jcbfm.1990.98; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yenari MA, 2000, BRAIN RES, V885, P208, DOI 10.1016/S0006-8993(00)02942-5; Yoshitake A, 2004, J THORAC CARDIOVASC, V134, P1220; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Zeiner A, 1996, CIRCULATION, V94, P54; Zeiner A, 1996, CRIT CARE MED, V24, pA115; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhu L, 2000, ANN BIOMED ENG, V28, P269, DOI 10.1114/1.266; Zhu L, 2009, ADV NUMER HEAT TRANS, V3, P197; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; Zhu L, 2008, HEAT TRANSFER ENG, V29, P284, DOI 10.1080/01457630701758062	187	3	6	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-3199-6445-4	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1097						295	319		10.1007/978-3-319-96445-4_16	10.1007/978-3-319-96445-4		25	Cell & Tissue Engineering; Cardiac & Cardiovascular Systems; Cell Biology; Engineering, Biomedical	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Cardiovascular System & Cardiology; Engineering	BL9PY	WOS:000458013600017	30315552				2022-02-06	
J	Zimmer, A; Heyanka, D; Proctor-Weber, Z				Zimmer, Adam; Heyanka, Daniel; Proctor-Weber, Zoe			Concordance validity of PVTs in a sample of veterans referred for mild TBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concordance validity; mild TBI; performance validity; veterans	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL STATUS RBANS; REY 15-ITEM MEMORIZATION; FALSE-POSITIVE RATES; RESPONSE BIAS SCALE; RELIABLE DIGIT SPAN; SYMPTOM VALIDITY; REPEATABLE BATTERY; EFFORT INDEX	Concordance validity of commonly used performance validity tests (PVTs) was assessed in a sample of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) veterans referred to an mTBI screening clinic in a south-eastern Veterans Affairs hospital. Veteran service members (total n=184) completed the Rey-15, Repeatable Battery of the Assessment for Neuropsychological Status Effort Index (RBANS EI), and Reliable Digit Span (RDS) from the Wechsler Intelligence Scales. Kappa coefficients and percentage of agreement were established to determine the level of concordance between the three measures. PVT failure rate ranged from 7.4% of the sample (Rey-15) to 26.1% (RBANS EI Liberal). The highest concordance was found between the Rey 15 and RBANS EI highly suspicious cut-off, with the lowest agreement noted between all PVTs and the RBANS EI liberal cut-score. All concordance coefficients fell within the fair to moderate levels. Overall, the observed agreement between the explored measures was generally consistent with or greater than other studies of PVT concordance. Given the rates of concordance, the current results continue to suggest that PVTs are likely to measure a construct separate from the typical cognitive domains.	[Zimmer, Adam] Univ S Florida, Neuropsychol Div, Pediat, 4202 E Fowler Ave, Tampa, FL 33620 USA; [Heyanka, Daniel] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Oklahoma City, OK 73190 USA; [Proctor-Weber, Zoe] Bay Pines VA Healthcare Syst, Mental Hlth, Bay Pines, FL USA		Zimmer, A (corresponding author), Univ S Florida, Neuropsychol Div, Pediat, 4202 E Fowler Ave, Tampa, FL 33620 USA.	adam.zimmer.psyd@gmail.com			Bay Pines VA Healthcare System in Bay Pines, Florida	This material is the result of work supported with resources and the use of facilities at the Bay Pines VA Healthcare System in Bay Pines, Florida.	Altman D.G., 1999, PRACTICAL STAT MED R; Armistead-Jehle P, 2016, ARCH CLIN NEUROPSYCH, V31, P465, DOI 10.1093/arclin/acw033; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Crighton AH, 2015, ARCH CLIN NEUROPSYCH, V30, P181, DOI 10.1093/arclin/acv002; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lee A, 2000, CLIN NEUROPSYCHOL, V14, P303, DOI 10.1076/1385-4046(200008)14:3;1-P;FT303; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Vanderploeg RD, 2001, NEUROREHABILITATION, V16, P245; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Whitney KA, 2008, APPL NEUROPSYCHOL, V15, P287, DOI 10.1080/09084280802325215; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	51	3	3	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	5					385	394		10.1080/23279095.2017.1319835			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GK9MN	WOS:000436574500001	28489416				2022-02-06	
J	Wu, RH; Shi, J; Cao, JC; Mao, YM; Dong, B				Wu, Ruhong; Shi, Jia; Cao, Jiachao; Mao, Yumin; Dong, Bo			Two occurrences of delayed epidural hematoma in different areas following decompressive craniectomy for acute subdural hematoma in a single patient: a case report	BMC SURGERY			English	Article						Acute subdural hematoma; Acute epidural hematoma; Delayed epidural hematoma; Decompressive craniectomy; Computed tomography	CONTRALATERAL EXTRADURAL HEMATOMA; TRAUMATIC BRAIN-INJURY; EVACUATION; SURGERY; RISK	Background: Delayed epidural hematoma (DEH) following evacuation of traumatic acute subdural hematoma (ASDH) or acute epidural hematoma (EDH) is a rare but devastating complication, especially when it occurs sequentially in a single patient. Case presentation: A 19-year-old man who developed contralateral DEH following craniotomy for evacuation of a traumatic right-side ASDH and then developed a left-side DEH of the posterior cranial fossa after craniotomy for evacuation of the contralateral DEH. He was immediately returned to the operating room for additional surgeries and his neurological outcome was satisfactory. Conclusions: Although DEH occurring after evacuation of ASDH or acute EDH is a rare event, timely recognition is critical to prognosis.	[Wu, Ruhong; Shi, Jia; Cao, Jiachao; Mao, Yumin; Dong, Bo] Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, Changzhou 213003, Peoples R China		Dong, B (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 3, Changzhou 213003, Peoples R China.	30468476@qq.com					BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Boviatsis EJ, 2004, IRISH J MED SCI, V173, P217, DOI 10.1007/BF02914555; Carney N, 2016, NEUROSURGERY; Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; FUKAMACHI A, 1986, NEUROSURGERY, V19, P589, DOI 10.1227/00006123-198610000-00013; Kim SH, 2015, BRIT J NEUROSURG, V29, P243, DOI 10.3109/02688697.2014.967749; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Meguins Lucas Crociati, 2014, J Med Case Rep, V8, P153, DOI 10.1186/1752-1947-8-153; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Nadig AS, 2012, BRIT J NEUROSURG, V26, P877, DOI 10.3109/02688697.2012.697217; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; Saberi Hooshang, 2009, Cases J, V2, P6282, DOI 10.4076/1757-1626-2-6282; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Solomiichuk Volodymyr O, 2013, Surg Neurol Int, V4, P134, DOI 10.4103/2152-7806.119234; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Takeuchi S, 2013, TURK NEUROSURG, V23, P294, DOI 10.5137/1019-5149.JTN.5009-11.1; Talbott JF, 2014, AM J NEURORADIOL, V35, P1930, DOI 10.3174/ajnr.A4001; Tomycz Nestor D, 2010, J Trauma, V68, pE11, DOI 10.1097/TA.0b013e31811eaaf5; Vilcinis R, 2017, WORLD NEUROSURG; Xu GZ, 2014, J CRANIOFAC SURG, V25, pE17, DOI 10.1097/SCS.0b013e3182a2ed26	24	3	5	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2482			BMC SURG	BMC Surg.	DEC 4	2017	17								123	10.1186/s12893-017-0303-1			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO6PV	WOS:000416988900001	29202748	Green Published, gold			2022-02-06	
J	Bialunska, A; Salvatore, AP				Bialunska, Anita; Salvatore, Anthony P.			The auditory comprehension changes over time after sport-related concussion can indicate multisensory processing dysfunctions	BRAIN AND BEHAVIOR			English	Article						auditory comprehension; auditory processing; concussion; sensorimotor integration; timing	TRAUMATIC BRAIN-INJURY; SENSORIMOTOR INTEGRATION; SYMPTOMS; SYNCHRONIZATION; ABNORMALITIES; RELIABILITY; DISORDERS; RECOVERY	BackgroundAlthough science findings and treatment approaches of a concussion have changed in recent years, there continue to be challenges in understanding the nature of the post-concussion behavior. There is growing a body of evidence that some deficits can be related to an impaired auditory processing. PurposeTo assess auditory comprehension changes over time following sport-related concussion (SRC) in young athletes. MethodsA prospective, repeated measures mixed-design was used. A sample of concussed athletes (n=137) and the control group consisted of age-matched, non-concussed athletes (n=143) were administered Subtest VIII of the Computerized-Revised Token Test (C-RTT). The 88 concussed athletes selected for final analysis (neither previous history of brain injury, neurological, psychiatric problems, nor auditory deficits) were evaluated after injury during three sessions (PC1, PC2, and PC3); controls were tested once. Between- and within-group comparisons using RMANOVA were performed on the C-RTT Efficiency Score (ES). ResultsES of the SRC athletes group improved over consecutive testing sessions (F=14.7, p<.001), while post-hoc analysis showed that PC1 results differed from PC2 and PC3 (ts4.0, ps<.001), but PC2 and PC3 C-RTT ES did not change statistically (t=0.6, p=.557). The SRC athletes demonstrated lower ES for all test session when compared to the control group (ts>2.0, Ps<.01). ConclusionDysfunctional auditory comprehension performance following a concussion improved over time, but after the second testing session improved performance slowed, especially in terms of its timing. Yet, not only auditory processing but also sensorimotor integration and/or motor execution can be compromised after a concussion.	[Bialunska, Anita; Salvatore, Anthony P.] Univ Texas El Paso, Coll Hlth Sci, Dept Rehabil Sci, El Paso, TX 79968 USA; [Bialunska, Anita] Univ Finance & Management Warsaw, Dept Cognit Psychol, Warsaw, Poland; [Salvatore, Anthony P.] Univ Louisiana Lafayette, Dept Communicat Disorders, Lafayette, LA 70504 USA		Bialunska, A (corresponding author), Univ Texas El Paso, Coll Hlth Sci, Dept Rehabil Sci, El Paso, TX 79968 USA.	abialunska@utep.edu			Department of Health and Human Services (HHS), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Advanced Rehabilitation Research and Training (ARRT) [90AR5016-03-00, 93.433]	The study was supported by the grant funded by Department of Health and Human Services (HHS), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Advanced Rehabilitation Research and Training (ARRT) Program no. 90AR5016-03-00, CFDA No. 93.433	Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Bialunska A, 2011, PSYCHOL RES-PSYCH FO, V75, P43, DOI 10.1007/s00426-010-0282-7; Bolouri H., 2015, BRAIN NEUROTRAUMA MO; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Dalla Bella S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42005; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Eberwein CA, 2007, J SPEECH LANG HEAR R, V50, P865, DOI 10.1044/1092-4388(2007/061); Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kraus N, 2017, FREQUENCY FOLLOWING; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Machado S, 2010, REV NEUROLOGIA, V51, P427; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McNeil MR, 2015, J SPEECH LANG HEAR R, V58, P311, DOI 10.1044/2015_JSLHR-L-13-0030; McNeil MR, 1978, REVISED TOKEN TEST; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, MUSIC PERCEPT, V27, P389, DOI 10.1525/mp.2010.27.5.389; Salvatore Anthony P, 2017, Concussion, V2, pCNC37, DOI 10.2217/cnc-2016-0024; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Stanley ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123950; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Velasques B, 2011, WORLD J BIOL PSYCHIA, V12, P560, DOI 10.3109/15622975.2010.551405	39	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2017	7	12							e00874	10.1002/brb3.874			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FR1UP	WOS:000418853300016	29299391	gold, Green Published			2022-02-06	
J	Carlin, MN; Daneshpajouh, A; Catino, J; Bukur, M				Carlin, Margo Nicole; Daneshpajouh, Alireza; Catino, Joseph; Bukur, Marko			Money well spent? A cost and utilization analysis of prophylactic inferior vena cava filter placement in high-risk trauma patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Prophylactic vena cava filter; Trauma; Venous thromboembolism; Pulmonary embolism; Cost analysis	MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; BRAIN-INJURY; ENOXAPARIN; PREVENTION; MANAGEMENT; THROMBOSIS	Background: Inferior vena cava filters (IVCF) for venous thromboembolic prophylaxis in high-risk trauma patients is a controversial practice. Utilization of IVCF prophylaxis was evaluated at a level 1 trauma center. Daily cost of IVCF prophylaxis, time to IVCF, duration between IVCF and chemoprophylaxis, and number of patients needed to treat (NNT) to prevent pulmonary embolism (PE) was calculated. Methods: A retrospective review of prophylactic IVCF over a 5-year period (2010-2014). Demographic, physiologic, injury, procedural, and outcome data were abstracted from the administrative trauma database. Medicare fees and days without chemoprophylaxis were used to determine daily IVCF cost. NNT was calculated using PE events in a cohort without IVCF. Results: Over the 5-year period, 146 patients with mean age 56.3 y (SD +/- 24.2), 67.8% male, underwent prophylactic IVCF. Predominant mechanisms of injuries were falls (45.9%) and motor vehicle accidents (20.5%) with median Injury Severity Score of 25 (intraquartile range [IQR] 16-29) and head Abbreviated Injury Score of 3 (IQR 3-5). Most common operative interventions required in 24.7% were orthopedic (25.3%) and neurosurgical (21.9%). Median time to IVCF was 78 h (IQR 48-144). Most common IVCF indications were closed head injury (48.6%) and spinal injuries (30.8%). Median time to administration of chemoprophylaxis was 96 h after IVCF (IQR 24-192) in 57.5%. Median IVCF cost was $759/d (IQR $361-$1897) compared with $4.32 for chemoprophylaxis. PE occurred in 0.26% without IVCF. PE did not occur with prophylactic IVCF. Estimated NNT was 379 (95% CI 265, 661). Conclusions: Prophylactic IVCF placement is a costly practice with relatively low benefit. Anticipated time without chemoprophylaxis and patient criteria should be considered before routine IVCF placement. (C) 2017 Elsevier Inc. All rights reserved.	[Carlin, Margo Nicole; Daneshpajouh, Alireza; Catino, Joseph] Nova Southeastern Univ, Delray Med Ctr, Dept Trauma & Crit Care, 5352 Linton Blvd, Delray Beach, FL 33484 USA; [Carlin, Margo Nicole; Daneshpajouh, Alireza] Nova Southeastern Univ, Larkin Community Hosp, Dept Gen Surg, South Miami, FL USA; [Bukur, Marko] NYU, Dept Acute Care Surg, Bellevue Hosp Ctr, Sch Med, New York, NY USA		Carlin, MN (corresponding author), Nova Southeastern Univ, Delray Med Ctr, Dept Trauma & Crit Care, 5352 Linton Blvd, Delray Beach, FL 33484 USA.	margoca@pcom.edu		Bukur, Marko/0000-0002-1850-7147			Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Albrecht RM, 2012, AM J SURG, V203, P297, DOI 10.1016/j.amjsurg.2011.09.006; Brakenridge SC, 2011, AM J SURG, V201, P209, DOI 10.1016/j.amjsurg.2009.12.005; Coleman JJ, 2015, J AM COLL SURGEONS, V220, P731, DOI 10.1016/j.jamcollsurg.2014.12.032; College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel, 2012, CHEST S, V141, p7Se47S; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Fanikos J, 2013, AM J MED, V126, P127, DOI 10.1016/j.amjmed.2012.07.025; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Grewal S, 2016, CARDIOVASC DIAGN THE, V6, P632, DOI 10.21037/cdt.2016.09.08; Hemmila MR, 2015, ANN SURG, V262, P577, DOI 10.1097/SLA.0000000000001434; Ho KM, 2015, BRIT J ANAESTH, V114, P63, DOI 10.1093/bja/aeu195; Ido Weinberg, 2016, APPROPRIATE USE INFE; Leeper WR, 2016, EUR J TRAUMA EMERG S, V42, P459, DOI 10.1007/s00068-015-0553-5; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; Meizoso JP, 2017, J SURG RES, V207, P138, DOI 10.1016/j.jss.2016.08.072; Pannucci CJ, 2017, ANN SURG, V265, P1094, DOI 10.1097/SLA.0000000000002126; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Sarosiek S, 2017, JAMA SURG, V152, P75, DOI 10.1001/jamasurg.2016.3091; Selby LV, 2016, J AM COLL SURGEONS, V222, P129, DOI 10.1016/j.jamcollsurg.2015.11.011; Taccone FS, 2015, J TRAUMA ACUTE CARE, V79, P456, DOI 10.1097/TA.0000000000000756; Testroote M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006681.pub2; Van Ha Thuong G, 2006, Semin Intervent Radiol, V23, P150, DOI 10.1055/s-2006-941445; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020	25	3	3	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2017	220						105	111		10.1016/j.jss.2017.07.004			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FP5YO	WOS:000417699100014	29180170				2022-02-06	
J	Arango-Lasprilla, J; Olabarrieta-Landa, L; Ertl, MM; Stevens, LF; Morlett-Paredes, A; Andelic, N; Zasler, N				Carlos Arango-Lasprilla, Juan; Olabarrieta-Landa, Laiene; Ertl, Melissa M.; Flores Stevens, Lillian; Morlett-Paredes, Alejandra; Andelic, Nada; Zasler, Nathan			Survey on International Health Professional Training and Attitudes on Sexuality After Traumatic Brain Injury	SEXUALITY AND DISABILITY			English	Article						Traumatic brain injury; Attitudes; Training; Sexuality; Spain	KNOWLEDGE	Traumatic brain injury (TBI) is associated with a range of deficits that may negatively impact sexuality. Few studies have explored how professionals respond to sexuality issues among individuals with TBI. The present study aimed to examine the attitudes and level of training of international health professionals working with individuals with TBI and whether guidelines exist in their work settings related to sexual issues. A survey composed of 53 questions was developed to evaluate attitudes, professional training, and assessment related to sexuality among health professionals working with individuals with TBI. The sample consisted of 324 self-identified health care professionals. During their training, 83% of professionals reported not taking any specific courses, and 61% reported not taking any type of clinical practice related to sexuality issues after TBI. Approximately 70% reported knowing little information about sexuality issues related to TBI and believed it affected the way in which they address the topic with their patients. Professionals believed sexual expression among both cognitively intact (100%) and cognitively impaired (90%) patients was healthy. Sixty-nine percent reported their work setting had no guidelines to determine if an individual with TBI can consent to sexual activity or not. Sixty-six percent of professionals believed that a patient with severe TBI could consent to sexual activities; however 58% believed it is not their responsibility to determine that. Results demonstrated a need for enhanced educational curriculums with specific courses related to sexuality after TBI. Furthermore, institutions should develop guidelines for the assessment of capacity to consent to sexual activity.	[Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain; [Olabarrieta-Landa, Laiene] Univ Deusto, Psychol & Educ Fac, Bilbao, Bizkaia, Spain; [Ertl, Melissa M.] SUNY Albany, Div Counseling Psychol, Albany, NY 12222 USA; [Flores Stevens, Lillian] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Flores Stevens, Lillian; Morlett-Paredes, Alejandra] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Flores Stevens, Lillian; Morlett-Paredes, Alejandra; Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Oslo, Norway; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan] IBIA, London, England		Arango-Lasprilla, J (corresponding author), Cruces Univ Hosp, BioCruces Hlth Res Inst, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.; Arango-Lasprilla, J (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Bizkaia, Spain.	jcalasprilla@gmail.com	Landa, Laiene Olabarrieta/V-6207-2017; Blanco, Leire/O-5114-2017	Landa, Laiene Olabarrieta/0000-0002-8305-8720; Andelic, Nada/0000-0002-3719-4406; Ertl, Melissa/0000-0002-1022-1777			[Anonymous], 2015, C TRAUM BRAIN INJ US; Centers for Disease Control and Prevention, 2017, TBI GET FACTS; Clayton A.H, 2006, INT C INT SOC STUD W; Corp I.B.M, 2015, IBM SPSS STAT VERS 2; Dogan S, 2008, INT PSYCHOGERIATR, V20, P1019, DOI 10.1017/S1041610208007229; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gianotten WL, 2006, SEX RELATSH THER, V21, P303, DOI DOI 10.1080/14681990600754559; Gill K. M., 1988, STAFF NEEDS AS UNPUB; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Gill KM, 2007, SEX DISABIL, V25, P73, DOI 10.1007/s11195-007-9033-0; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juergens MH, 2009, REHABIL COUNS BULL, V53, P34, DOI 10.1177/0034355209340587; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kazukauskas KA, 2010, REHABIL COUNS BULL, V54, P15, DOI 10.1177/0034355209348239; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Pebdani RN, 2015, REHABIL COUNS BULL, V58, P173, DOI 10.1177/0034355214553308; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Shears S., 2010, SOC CARE NEURODISABI, V1, P4, DOI [10.5042/scn.2010.0597, DOI 10.5042/SCN.2010.0597]; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; SIMPSON GK, 1999, YOU ME ED PROGRAM SE	28	3	3	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0146-1044	1573-6717		SEX DISABIL	Sex. Disabil.	DEC	2017	35	4					473	484		10.1007/s11195-017-9503-y			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	FL4WP	WOS:000414232500008					2022-02-06	
J	Follent, AM; Rumbach, AF; Ward, EC; Marshall, J; Dodrill, P; Lewindon, P				Follent, Anna M.; Rumbach, Anna F.; Ward, Elizabeth C.; Marshall, Jeanne; Dodrill, Pamela; Lewindon, Peter			Dysphagia and feeding difficulties post-pediatric ingestion injury: Perspectives of the primary caregiver	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Caregiver; Trauma; Dysphagia; Button battery; Ingestion	TRAUMATIC BRAIN-INJURY; CAUSTIC INGESTION; YOUNG-CHILDREN; FAMILY NEEDS; PARENTS; IMPACT; ESOPHAGEAL; MANAGEMENT; SYMPTOMS; STRESS	Purpose: To explore the experiences of children with dysphagia and/or feeding difficulties post-chemical or button battery ingestion injury from the perspective of the primary caregiver. Method: Five primary caregivers of children with a history of dysphagia and/or feeding difficulties post ingestion injury (4 chemical, 1 button battery) completed the Children's Picky Eating Questionnaire (CPEQ), and participated in a semi-structured interview. Interviews explored experiences of caring for a child with dysphagia and/or feeding difficulties, impressions of services and supports, and additional impacts to the child and family. Content analysis was used to identify key themes. Result: Primary caregiver report and CPEQ results confirmed all children had some degree of persisting dysphagia and/or feeding difficulties at time of interview (mean 4.13 years' post-injury). Interviews identified five key themes: 1) The initial trauma of the injury, 2) The experience of associated and ongoing medical issues, 3) Managing altered oral intake, 4) Experiences of services and support, and 5) Impacts on the child, primary caregiver, and wider family unit. All caregivers reported significant challenges and concerns, and potential areas of service improvement were highlighted. Conclusion: The current data highlights specific issues experienced by primary caregivers, and poses areas for improving primary caregiver and family supports. Family-centered models of care are needed to support the whole family unit in caring for a child with dysphagia and/or feeding difficulties post ingestion injury. (C) 2017 Published by Elsevier Ireland Ltd.	[Follent, Anna M.; Rumbach, Anna F.; Ward, Elizabeth C.] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; [Ward, Elizabeth C.] Ctr Functioning & Hlth Res, POB 6053, Buranda, Qld 4102, Australia; [Marshall, Jeanne; Lewindon, Peter] Lady Cilento Childrens Hosp, 501 Stanley St, South Brisbane, Qld 4101, Australia; [Dodrill, Pamela] Boston Childrens Hosp, Feeding & Swallowing Program, Dept Otolaryngol, Boston, MA USA		Follent, AM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	anna.follent@uqconnect.edu.au	Marshall, Jeanne H/K-7162-2016; Ward, Elizabeth/F-9652-2010	Marshall, Jeanne H/0000-0003-0652-9258; Ward, Elizabeth/0000-0002-2680-8978	Speech Pathology Department at the Lady Cilento Children's Hospital, Brisbane	The authors express their sincere thanks to the caregivers for sharing their experiences, and to the Speech Pathology Department at the Lady Cilento Children's Hospital, Brisbane, for supporting this research.	Abaskharoun RD, 2007, CAN J GASTROENTEROL, V21, P757, DOI 10.1155/2007/218103; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Aldridge VK, 2010, J CHILD HEALTH CARE, V14, P261, DOI 10.1177/1367493510370456; Arevalo-Silva C, 2006, LARYNGOSCOPE, V116, P1422, DOI 10.1097/01.mlg.0000225376.83670.4d; Arvedson JC, 2008, DEV DISABIL RES REV, V14, P118, DOI 10.1002/ddrr.17; Arvedson Joan C, 2000, Lang Speech Hear Serv Sch, V31, P28, DOI 10.1044/0161-1461.3101.28; Bakker A, 2014, EUR CHILD ADOLES PSY, V23, P813, DOI 10.1007/s00787-014-0518-y; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Buttazzoni E, 2015, INT J PEDIATR OTORHI, V79, P2200, DOI 10.1016/j.ijporl.2015.10.003; Carnevale F A, 1999, Off J Can Assoc Crit Care Nurs, V10, P16; Carruth BR, 2002, J AM COLL NUTR, V21, P88, DOI 10.1080/07315724.2002.10719199; Carruth BR, 2000, J AM COLL NUTR, V19, P771, DOI 10.1080/07315724.2000.10718077; Cassidy JD, 2007, SPINE, V32, P126, DOI 10.1097/01.brs.0000249526.76788.e8; CHRISTESEN HBT, 1994, J TOXICOL-CLIN TOXIC, V32, P557, DOI 10.3109/15563659409011060; Contini S, 2013, WORLD J GASTROENTERO, V19, P3918, DOI 10.3748/wjg.v19.i25.3918; Cowpe E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005934; De Blecourt ACE, 2008, DISABIL REHABIL, V30, P13, DOI 10.1080/09638280601178816; Dobbelsteyn C, 2005, DYSPHAGIA, V20, P89, DOI 10.1007/s00455-004-0026-1; Dodrill P, 2004, EARLY HUM DEV, V76, P23, DOI 10.1016/j.earlhumdev.2003.10.001; Dodrill P., 2014, J GASTROENTEROL HEPA, V3; Follent A. M., 2016, J PEDIAT GASTROENTER; Follent A. M., 2016, DISABIL REHABIL, P1; Follent A. M., 2015, SPEECH LANGUAGE HEAR, V18, P116; Fuentes Sara, 2014, J Emerg Trauma Shock, V7, P316, DOI 10.4103/0974-2700.142773; GAUDREAULT P, 1983, PEDIATRICS, V71, P767; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hewetson R, 2009, DYSPHAGIA, V24, P322, DOI 10.1007/s00455-009-9210-7; Johnson CM, 2012, ARCH OTOLARYNGOL, V138, P1111, DOI 10.1001/jamaoto.2013.672; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Kay M, 2009, CURR OPIN PEDIATR, V21, P651, DOI 10.1097/MOP.0b013e32832e2764; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Lupa M, 2009, OCHSNER J, V9, P54; Mahant S, 2011, PEDIATRICS, V128, pE395, DOI 10.1542/peds.2010-1253; Mason KE, 2011, PEDIATR CRIT CARE ME, V12, pS157, DOI 10.1097/PCC.0b013e318234a812; McGarry S, 2015, DISABIL REHABIL, V37, P41, DOI 10.3109/09638288.2014.892640; Millar AJW, 2015, PEDIATR SURG INT, V31, P111, DOI 10.1007/s00383-014-3642-3; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Pedersen SD, 2004, CHILD CARE HLTH DEV, V30, P507, DOI 10.1111/j.1365-2214.2004.00437.x; Powers SW, 2002, DIABETES CARE, V25, P313, DOI 10.2337/diacare.25.2.313; Ramsay M, 2013, DIS ESOPHAGUS, V26, P410, DOI 10.1111/dote.12062; Riffat F, 2009, DIS ESOPHAGUS, V22, P89, DOI 10.1111/j.1442-2050.2008.00867.x; Rimmer R. B., 2013, J BURN CARE RES, P1; Rogers B, 2005, MENT RETARD DEV D R, V11, P74, DOI 10.1002/mrdd.20055; Rumbach AF, 2016, AM J SPEECH-LANG PAT, V25, P470, DOI 10.1044/2016_AJSLP-15-0043; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Snyder C, 2003, J BURN CARE REHABIL, V24, P217, DOI 10.1097/01.BCR.0000075969.19229.EE; Sullivan PB, 2004, DEV MED CHILD NEUROL, V46, P796, DOI 10.1017/S0012162204001392; Weigert A, 2005, BJA EDUC, V5, P5, DOI 10.1093/bjaceaccp/mki007; Wieczorek B., 2015, J PEDIAT INTENSIVE C, P129; Wiley S, 2011, INT J PEDIATR OTORHI, V75, P1040, DOI 10.1016/j.ijporl.2011.05.019; Wilken M, 2013, ARCH DIS CHILD, V98, P856, DOI 10.1136/archdischild-2012-303558; Wilken M, 2012, J PEDIATR NURS, V27, P248, DOI 10.1016/j.pedn.2011.01.032; Willebrand M, 2016, BURNS, V42, P414, DOI 10.1016/j.burns.2015.08.004	54	3	4	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	DEC	2017	103						20	28		10.1016/j.ijporl.2017.09.013			9	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology; Pediatrics	FU1WM	WOS:000423640200006	29224759	Green Accepted			2022-02-06	
J	Hollott, J				Hollott, John			Ventilatory choices for intubated patients during helicopter stretcher winching	EMERGENCY MEDICINE AUSTRALASIA			English	Article						helicopters; intratracheal intubation; prehospital emergency care; pulmonary ventilation; rescue stretchers	TRAUMATIC BRAIN-INJURY; EMERGENCY-MEDICINE; PREHOSPITAL AIRWAY; RESCUE MISSIONS; HYPOXIA; MANAGEMENT; CARE	Introduction: The winching of intubated patients on a stretcher into a helicopter is a rare event. Intermittent positive pressure ventilation is mandatory, which can either be performed manually with a self-inflating bag, or automatically using a portable ventilator. Theoretically automatic ventilation would provide improved oxygenation, more stable arterial carbon dioxide levels and a reduced risk of airway disconnection. Furthermore, the stretcher attendant may better perform winching procedures with higher situational awareness, contributing to crew and patient safety. However ventilator failure, and the diagnosis and management of such, is of concern. Objective: The aim of this study is to compare automatic against manual ventilation during intubated helicopter stretcher winching. Method: The trial had two phases. Initially a static winch on a hoist simulator was performed, followed by live winching into a helicopter. All stretcher attendants performed two winches with an intubated manikin. During one winch, the manikin was manually ventilated, and an automatic ventilator was used for the other. Airway pressures were measured. Results: Automatic ventilation did not fail. Compared with automatic ventilation, manual ventilation displayed significant pauses, inconsistent rates and both high and low airway pressures. Automatic ventilation permitted better situational awareness and performance in winching manoeuvres. One airway disconnection occurred during manual ventilation. Conclusions: During helicopter winching, automatic ventilation is superior in providing controlled, consistent and reliable ventilation for intubated patients. The stretcher attendant is also able to provide more attention to the winching manoeuvres with subsequent safety gains. The risk of automatic ventilator failure is low.	[Hollott, John] Hunter New England Local Hlth Dist, Hunter Retrieval Serv, Lookout Rd, Newcastle, NSW 2305, Australia		Hollott, J (corresponding author), Hunter New England Local Hlth Dist, Hunter Retrieval Serv, Lookout Rd, Newcastle, NSW 2305, Australia.	drkranky@gmail.com		Hollott, John/0000-0002-3462-7341	NSW Ambulance and Westpac Rescue Helicopter Service	This research was generously supported by NSW Ambulance and Westpac Rescue Helicopter Service. Gratitude is given to Drs Mary Morgan, Gary Hoffman and Peter Harrigan for support and review.	Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Burns Brian J, 2012, Air Med J, V31, P84, DOI 10.1016/j.amj.2011.07.003; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Lavon O, 2010, AM J EMERG MED, V28, P523, DOI 10.1016/j.ajem.2010.02.001; Pasquier M, 2012, INJURY, V43, P1377, DOI 10.1016/j.injury.2011.06.196; Sherren PB, 2014, EMERG MED J, V31, P229, DOI 10.1136/emermed-2012-201879; Skaugset LM, 2016, ANN EMERG MED, V68, P189, DOI 10.1016/j.annemergmed.2015.10.003; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Wilson MH, 2015, LANCET, V386, P2526, DOI 10.1016/S0140-6736(15)00985-X; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	14	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	DEC	2017	29	6					692	696		10.1111/1742-6723.12845			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FT6SG	WOS:000423283500013	28845544				2022-02-06	
J	Hwang, HF; Chen, CY; Lin, MR				Hwang, Hei-Fen; Chen, Chih-Yi; Lin, Mau-Roung			Patient-Proxy Agreement on the Health-Related Quality of Life One Year After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							OLDER-ADULTS; WHOQOL-BREF; RELIABILITY; UTILITY; RELATIVES; SYMPTOMS; SCALE	Objective: To examine the level of agreement between patients and their proxies on a measure of health-related quality of life (HRQL) 1 year after traumatic brain injury (TBI). Design: A cross-sectional study. Setting: Four hospitals in Taipei. Participants: Participants (N=176) were patients with TBI (n=88) identified from discharge records of 4 hospitals in Taiwan and family members or friends (n=88) who could answer questions regarding the patient's health and HRQL 1 year after the injury. Interventions: Not applicable. Main Outcome Measures: A health profile of the brief Taiwanese version of the World Health Organization Quality of Life (WHOQOL-BREF) and 2 health utility measures of the time tradeoff (TTO) and standard gamble (SG). Results: Compared with proxy responses, patients provided higher ratings on the domains of the WHOQOL-BREF and lower ratings on the TTO and SG. Intraclass correlation coefficients between patient and proxy ratings varied among the 4 domains of the WHOQOL-BREF, in which levels of agreement were moderate or good for physical capacity (.69) and low for psychological well-being (.45), social relationships (.24), and the environment (.32). Levels of agreement were extremely low for the TTO (0.0) and SG (.10). A profile analysis showed that patients' ratings on the WHOQOL-BREF, on average, were significantly greater than those of their proxies (mean difference, 3.07), with a similar distribution of scatter responses (mean difference,.002) and shape agreement (mean difference,.57). Greater variations in the patient-proxy level of agreement appeared in patients who were younger and had more severe injuries, and also with parent and child proxies. Conclusions: To assess the HRQL of patients with a TBI, the level of patient-proxy agreement was adequate for the physical domain but was lower for the social and environmental domains, and the agreement was very low for the TTO and SG. Furthermore, a patient's age and injury severity, and the patient-proxy' relationship may affect the agreement. (C) 2017 by the American Congress of Rehabilitation Medicine	[Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hwang, Hei-Fen; Chen, Chih-Yi; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan; [Lin, Mau-Roung] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan.	mrlin@tmu.edu.tw			Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST103-2314-B-038-012, MOST105-2627-M-038-001]; National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX106-10317PI]	Supported by the Ministry of Science and Technology (grant nos. MOST103-2314-B-038-012, MOST105-2627-M-038-001) and the National Health Research Institutes (grant no. NHRI-EX106-10317PI), Taiwan.	Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Dijkers MP, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50241; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Drummond M., 2005, METHODS EC EVALUATIO; Faul M, 2010, TRAUMATIC BRAIN INJU; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; GAFNI A, 1984, MANAGE SCI, V30, P440, DOI 10.1287/mnsc.30.4.440; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MAHONEY F I, 1965, Md State Med J, V14, P61; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Novella JL, 2006, QUAL LIFE RES, V15, P811, DOI 10.1007/s11136-005-5434-7; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Pickard AS, 2004, STROKE, V35, P607, DOI 10.1161/01.STR.0000110984.91157.BD; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REVICKI DA, 1992, MED CARE, V30, pMS274, DOI 10.1097/00005650-199205001-00027; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sneeuw KCA, 2002, J CLIN EPIDEMIOL, V55, P1130, DOI 10.1016/S0895-4356(02)00479-1; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; TEASDALE G, 1974, LANCET, V2, P81; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weinfurt KP, 2002, J CLIN EPIDEMIOL, V55, P608, DOI 10.1016/S0895-4356(02)00392-X; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	44	3	3	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2017	98	12					2540	2547		10.1016/j.apmr.2017.05.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FO5FK	WOS:000416878700026	28629989				2022-02-06	
J	Jang, SH; Kwon, HG				Jang, Sung Ho; Kwon, Hyeok Gyu			Severe disinhibition due to injuries of neural tracts related to emotion circuit in a patient with traumatic brain injury: A case report	MEDICINE			English	Article						amygdala; anterior cingulate cortex; diffusion tensor tractography; disinhibition; orbitofrontal cortex; traumatic brain injury; violence	PREFRONTAL CORTEX; ANGER; RESPONSES; BEHAVIOR; VIOLENCE; PET	Rationale:Approximately 30% of patients with traumatic brain injury (TBI) develop disinhibition, a condition that involves several brain structures, including the amygdala, orbitofrontal cortex (OFC), and anterior cingulate cortex (ACC). Using diffusion tensor tractography (DTT), we report on a patient with severe disinhibition and injuries of the amygdala, OFC, and ACC following TBI.Patient concerns:A 27-year-old male patient suffered an in-car accident.Diagnoses:Since the onset of the TBI, the patient showed severe disinhibition including violence, as follows: 1) he sometimes attacked therapists and nurses with no provocation, 2) while he was laying on a bed, he shouted and kicked the bed when asked questions, and 3) during therapy with a difficult task, he behaved violently to a therapist. The subscale of disinhibition in Neuropsychiatric Inventory scored three points for severity and for distress.Interventions:N/A.Outcomes: On 10-month DTT, the connectivity of amygdala to the prefrontal cortex including the medial prefrontal cortex and OFC had decreased in both hemispheres. In the prefronto-thalamic tracts, the orbitofronto-thalamic tractshad narrowed (the right hemisphere), and were non-reconstructed (the left hemisphere). Discontinuations of both anterior cingulums were observed in both hemispheres.Lessons:Using DTT, concurrent injuries of the amygdala, OFC, and ACC were demonstrated in a patient with severe disinhibition following TBI. Our result suggests the need to assess these neural structures in patients with disinhibition after brain injury.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Gyongsan, South Korea; [Kwon, Hyeok Gyu] Catholic Univ Pusan, Coll Hlth Sci, Dept Phys Therapy, 57 Oryundae Ro, Busan 46252, South Korea		Kwon, HG (corresponding author), Catholic Univ Pusan, Coll Hlth Sci, Dept Phys Therapy, 57 Oryundae Ro, Busan 46252, South Korea.	khg0715@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A4A01020385]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A4A01020385).	Abercrombie HC, 1996, PSYCHOPHYSIOLOGY, V33, pS17; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005009; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; Lai CKY, 2014, CLIN INTERV AGING, V9, P1051, DOI 10.2147/CIA.S63504; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Osborne-Crowley K, 2016, J NEUROPSYCHOL; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218	25	3	3	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2017	96	52							e9493	10.1097/MD.0000000000009493			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW5VC	WOS:000425386300054	29384946	Green Published, gold			2022-02-06	
J	Kavurma, C; Tas, FV; Demirgoren, BS; Demirci, F; Akan, P; Eyuboglu, D; Guvenir, T				Kavurma, Canem; Tas, Fatma Varol; Demirgoren, Burcu Serim; Demirci, Ferhat; Akan, Pinar; Eyuboglu, Damla; Guvenir, Taner			Do serum BDNF levels vary in self-harm behavior among adolescents and are they correlated with traumatic experiences?	PSYCHIATRY RESEARCH			English	Article						BDNF; Self-harm; Neuroplasticity; Childhood trauma	NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; DEPRESSED-PATIENTS; CHILDHOOD TRAUMA; SUICIDE ATTEMPTS; GENE-EXPRESSION; RAT-BRAIN; INJURY; RELIABILITY; ENVIRONMENT	The aim of this study was to compare serum brain-derived neurotrophic factor (BDNF) levels between adolescents that harm themselves, those that receive psychiatric treatment but do not harm themselves, healthy adolescents, and childhood traumas and to investigate the relationship between traumatic experiences and serum BDNF levels. The cases were divided into two groups of 40 adolescents exhibiting self-harm behavior (self-harm/diagnosed group) and 30 adolescents receiving psychiatric treatment but not exhibiting self-harm behaviors (non self-harm/diagnosed group). The control group (healthy control group) consisted of 35 healthy adolescents with no psychiatric disorders or self-harm behaviors. The adolescents were asked to fill in the Inventory of Statements About Self Injury (ISAS) and Childhood Trauma Questionnaire (CTQ). For BDNF measurement, blood samples were taken from the cases and controls. The serum BDNF level of self-harming adolescents who used the self-cutting method was significantly lower than that of other groups, and serum BDNF levels decreased with the increase in the emotional neglect and abuse severity of self-harming adolescents during childhood. In our study, serum BDNF levels decreased with the increase in emotional abuse in self-harming adolescents. This finding may indicate that neuroplasticity can be affected by a negative emotional environment during the early period.	[Kavurma, Canem; Tas, Fatma Varol; Demirgoren, Burcu Serim; Eyuboglu, Damla; Guvenir, Taner] Dokuz Eylul Univ, Fac Med, Dept Child & Adolescent Psychiat, Izmir, Turkey; [Demirci, Ferhat; Akan, Pinar] Dokuz Eylul Univ, Fac Med, Dept Biochem, Izmir, Turkey; [Kavurma, Canem] Manisa Mental Hlth Hosp, Dept Child & Adolescent Psychiat, Manisa, Turkey; [Demirci, Ferhat] Dr Suat Seren Chest Dis & Thorac Surg Teaching &, Dept Biochem, Izmir, Turkey; [Eyuboglu, Damla] Mardin State Hosp, Dept Child & Adolescent Psychiat, Mardin, Turkey		Demirgoren, BS (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Child & Adolescent Psychiat, Izmir, Turkey.	burcuserim@hotmail.com	AKAN, Pinar/A-1135-2018; Demirgoren, Burcu Serim/A-4256-2019	eyuboglu, damla/0000-0001-6042-7768	Department of Scientific Research Projects of Dokuz Eylul University [2013.KB.SAG.005]	This study was supported by the Department of Scientific Research Projects of Dokuz Eylul University (2013.KB.SAG.005).	Althoff RR, 2005, BIPOLAR DISORD, V7, P598, DOI 10.1111/j.1399-5618.2005.00268.x; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Asian S. H., 1999, TURK PSIKIYATR DERG, V10, P275; Benedetti F, 2017, NEUROSCI LETT, V656, P177, DOI 10.1016/j.neulet.2017.07.043; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bildik T, 2013, TURK PSIKIYATR DERG, V24, P49, DOI 10.5080/u6901; Bresin K, 2013, J AFFECT DISORDERS, V150, P594, DOI 10.1016/j.jad.2013.01.050; Briere J, 1998, AM J ORTHOPSYCHIAT, V68, P609, DOI 10.1037/h0080369; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Deveci A, 2007, NEUROPSYCHOBIOLOGY, V56, P93, DOI 10.1159/000111539; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Givre S., 2002, J NEURO-OPHTHALMOL, V22, P135; Gokler B., 2004, COCUK GENCLIK RUH SA; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Klonsky ED, 2009, J PSYCHOPATHOL BEHAV, V31, P215, DOI 10.1007/s10862-008-9107-z; Laye-Gindhu A, 2005, J YOUTH ADOLESCENCE, V34, P447, DOI 10.1007/s10964-005-7262-z; Lee BH, 2010, J AFFECT DISORDERS, V125, P369, DOI 10.1016/j.jad.2010.01.074; Lundh LG, 2011, SCAND J PSYCHOL, V52, P476, DOI 10.1111/j.1467-9450.2011.00894.x; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mandelli L, 2011, J PSYCHIATR RES, V45, P742, DOI 10.1016/j.jpsychires.2010.11.005; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Muehlenkamp JJ, 2010, J NERV MENT DIS, V198, P258, DOI 10.1097/NMD.0b013e3181d612ab; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Perroud N, 2008, GENES BRAIN BEHAV, V7, P314, DOI 10.1111/j.1601-183X.2007.00354.x; Pregelj P, 2011, J AFFECT DISORDERS, V128, P287, DOI 10.1016/j.jad.2010.07.001; Ray E. H., 2007, MULTIDIMENSIONAL ANA; Schenkel LC, 2010, PROG NEURO-PSYCHOPH, V34, P940, DOI 10.1016/j.pnpbp.2010.04.023; VANDERKOLK BA, 1991, AM J PSYCHIAT, V148, P1665; Zarrilli F, 2009, AM J MED GENET B, V150B, P599, DOI 10.1002/ajmg.b.30849; Zetterstrom TSC, 1999, NEUROPHARMACOLOGY, V38, P1063, DOI 10.1016/S0028-3908(99)00022-2	34	3	3	1	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC	2017	258						130	135		10.1016/j.psychres.2017.09.069			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FN7FQ	WOS:000416184500020	29017139				2022-02-06	
J	Kumar, MA; Levine, J; Faerber, J; Elliott, JP; Winn, HR; Doerfler, S; Le Roux, P				Kumar, Monisha A.; Levine, Joshua; Faerber, Jennifer; Elliott, J. Paul; Winn, H. Richard; Doerfler, Sean; Le Roux, Peter			The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Aneurysm; Delayed cerebral ischemia; Neurocritical care; Subarachnoid hemorrhage; Transfusion; Vasospasm	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; CEREBRAL OXYGEN DELIVERY; PROPENSITY SCORE; HEMOGLOBIN CONCENTRATION; RESTRICTIVE TRANSFUSION; INTRACRANIAL ANEURYSMS; CLINICAL-PRACTICE; CRITICAL-CARE; ANEMIA	BACKGROUND: The optimal red blood cell transfusion (RBCT) trigger for patients with aneurysmal subarachnoid hemorrhage (SAH) is unknown. In patients with cerebral vasospasm, anemia may increase susceptibility to ischemic injury; conversely, RBCT may worsen outcome given known deleterious effects. OBJECTIVE: To examine the association between RBCT, delayed cerebral ischemia (DCI), vasospasm, and outcome after SAH. METHODS: A total of 421 consecutive patients with SAH, admitted to a neurocritical care unit at a universityaffiliated hospital and who underwent surgical occlusion of their ruptured aneurysm were retrospectively identified from a prospective observational database. Propensity score methods were used to reduce the bias associated with treatment selection. RESULTS: Two hundred and sixty-one patients (62.0%) received an RBCT. Angiographic vasospasm (odds ratio [OR] 1.6; 95% confidence interval [CI], 1.1-2.3; P = 0.025) but not severe angiographic spasm, DCI, or delayed infarction was associated with RBCT. A total of 283 patients (67.2%) experienced a favorable outcome, defined as good or moderately disabled on the Glasgow Outcome Scale; 47 (11.2%) were severely disabled or vegetative and 91 patients (21.6%) were dead at 6-month follow-up. Among patients who survived >= 2 days, RBCT was associated with unfavorable outcome (OR, 2.6; 95% CI, 1.6-4.1). Transfusion of >= 3 units of blood was associated with an increased incidence of unfavorable outcome. Propensity analysis to control for the probability of exposure to RBCT conditional on observed covariates measured before RBCT indicates that RBCT is associated with unfavorable outcome in the absence of DCI (OR, 2.17; 95% CI, 1.56-3.01; P < 0.0001) but not when DCI is present (OR, 0.82; 95% CI, 0.35-1.92; P = 0.65). CONCLUSIONS: Blood transfusions are associated with unfavorable outcome after SAH particularly when DCI is absent. Propensity analysis suggests that RBCT may be associated with poor outcome rather than being a marker of disease severity. However, when DCI is present, RBCT may help improve outcome.	[Kumar, Monisha A.; Levine, Joshua; Doerfler, Sean] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.; Levine, Joshua] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Kumar, Monisha A.; Levine, Joshua] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Faerber, Jennifer] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Elliott, J. Paul] Colorado Neurol Inst, Englewood, CO USA; [Winn, H. Richard] Mt Sinai Hosp, Dept Neurosurg, New York, NY 10029 USA; [Le Roux, Peter] Lankenau Med Ctr, Brain & Spine Ctr, Wynnewood, PA 19096 USA; [Le Roux, Peter] Lankenau Med Ctr, Lankenau Inst Med Res, Wynnewood, PA 19096 USA		Le Roux, P (corresponding author), Lankenau Med Ctr, Brain & Spine Ctr, Wynnewood, PA 19096 USA.; Le Roux, P (corresponding author), Lankenau Med Ctr, Lankenau Inst Med Res, Wynnewood, PA 19096 USA.	lerouxp@mlhs.org			Integra Foundation	Part of this research was supported by a grant from the Integra Foundation (P.D.L.R.).	Ba VN, 2003, CRIT CARE MED, V31, P406, DOI 10.1097/01.CCM.0000048623.00778.3F; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Festic E, 2013, NEUROCRIT CARE, V18, P209, DOI 10.1007/s12028-012-9777-y; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2001, CHEST, V119, P1850, DOI 10.1378/chest.119.6.1850; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jennett B, 1975, Ciba Found Symp, P3; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kramer AH, 2009, NEUROCRIT CARE, V10, P157, DOI 10.1007/s12028-008-9171-y; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Kurtz P, 2010, NEUROCRIT CARE, V13, P10, DOI 10.1007/s12028-010-9357-y; Le Roux PD, 2001, NEUROSURGERY, V49, P1068, DOI 10.1097/00006123-200111000-00009; Le Roux PD, 2011, NEUROCRIT CARE, V15, P342, DOI 10.1007/s12028-011-9582-z; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Nassiri F, 2016, NEUROCRIT CARE, V25, P351, DOI 10.1007/s12028-016-0266-6; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Palmieri TL, 2006, CRIT CARE MED, V34, P1602, DOI 10.1097/01.CCM.0000217472.97524.0E; Patel A, 2013, NEW ENGL J MED, V368, P1362, DOI 10.1056/NEJMc1301256; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Sampson TR, 2010, NEUROCRIT CARE, V12, P4, DOI 10.1007/s12028-009-9273-1; Samra SK, 2007, STROKE, V38, P1864, DOI 10.1161/STROKEAHA.106.477448; Sayari AJ, 2016, J PEDIATR SURG, V51, P927, DOI 10.1016/j.jpedsurg.2016.02.052; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sihler KC, 2010, CHEST, V137, P209, DOI 10.1378/chest.09-0252; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Stein SC, 2006, NEUROSURG FOCUS, V21, P2; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; Tu YK, 1997, J NEUROL SCI, V150, P115, DOI 10.1016/S0022-510X(97)00111-1; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Zou BM, 2016, STAT MED, V35, P3537, DOI 10.1002/sim.6943	63	3	3	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						807	816		10.1016/j.wneu.2017.09.038			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900106	29038077				2022-02-06	
J	Sanchez, JL; Martin, J; Lopez, C				Luis Sanchez, Juan; Martin, Javier; Lopez, Carolina			Diagnostic Utility of the Shortened Version of the Wisconsin Card Sorting Test in Patients With Sporadic Late Onset Alzheimer Disease	AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS			English	Article						Wisconsin Card Sorting Test; sporadic late onset Alzheimer disease; executive function; neuropsychological examination; convergent validity; shortened version	TRAUMATIC BRAIN-INJURY; VALIDITY; WCST-64; DEMENTIA; FORM	Background: The classic version of the Wisconsin Card Sorting Test (WCST) consists of correctly sorting 128 cards according to changing sorting criteria. Its application is costly in terms of the time employed, with all the negative consequences this entails (decrease in motivation, frustration, and fatigue). Method: The main objective of this study was to test the usefulness of the shortened version of the WCST as compared to the full test by analyzing the equivalence between the two decks comprising the full 128-card version on a sample of patients diagnosed with sporadic late onset Alzheimer disease (SLOAD) and to check its clinical usefulness. Results: The variables showed equivalence between the two decks and their ability to differentiate between the control group (CG) and the Alzheimer disease (AD) group. Conclusion: The scores obtained suggest equivalence between decks and that the application of only the first deck is sufficient.	[Luis Sanchez, Juan; Lopez, Carolina] Univ Salamanca, Fac Psychol, Dept Basic Psychol Psychobiol & Methodol, E-37008 Salamanca, Spain; [Martin, Javier] Univ Salamanca, Dept Stat, Fac Med, Salamanca, Spain		Sanchez, JL (corresponding author), Univ Salamanca, Fac Psychol, Dept Basic Psychol Psychobiol & Methodol, E-37008 Salamanca, Spain.	jlsanch@usal.es	Vallejo, Francisco Javier F J Martin/B-4029-2012	Vallejo, Francisco Javier F J Martin/0000-0003-3962-7356; Lopez De Luis, Carolina/0000-0002-5875-2200			American Psychiatric Association, 2014, GUIA CONS CRIT DIAGN, P438; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Basso MR, 2001, CLIN NEUROPSYCHOL, V15, P471, DOI 10.1076/clin.15.4.471.1883; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bowden SC, 1998, NEUROPSYCHOL REHABIL, V8, P243, DOI 10.1080/713755573; Chao JianKang, 2013, Open Journal of Preventive Medicine, V3, P172, DOI 10.4236/ojpm.2013.32023; Valle GD, 2008, REV NEUROLOGIA, V46, P142, DOI 10.33588/rn.4603.2007236; Donders J, 2004, CLIN NEUROPSYCHOL, V18, P521, DOI 10.1080/11385404049052411; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Heaton PDRK., 1993, WISCONSIN CARD SORTI; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Martinez Lage J. M., 2000, ALZHEIMER TEORIA PRA; Martinez Lage JM, 1996, MANUAL DE DEMENCIAS; Merrick EE, 2003, CLIN NEUROPSYCHOL, V17, P153, DOI 10.1076/clin.17.2.153.16512; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Paolo AM, 1996, J CLIN EXP NEUROPSYC, V18, P892, DOI 10.1080/01688639608408310; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Rainville C, 2002, ARCH CLIN NEUROPSYCH, V17, P513, DOI 10.1016/S0887-6177(01)00132-9; ROSSELLI M, 1997, NEUROPSICOLOGIA INFA; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Silva-Filho José Humberto, 2007, Dement. neuropsychol., V1, P181, DOI 10.1590/s1980-57642008dn10200011; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Su CY, 2008, CLIN NEUROPSYCHOL, V22, P273, DOI 10.1080/13854040701220036; Vayalakkara J, 2000, INT J NEUROSCI, V103, P131, DOI 10.3109/00207450009003259; Weschler D., 1997, WESCHLER ADULT INTEL	31	3	3	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1533-3175	1938-2731		AM J ALZHEIMERS DIS	Am. J. Alzheimers Dis. Other Dement.	DEC	2017	32	8					472	478		10.1177/1533317517728334			7	Geriatrics & Gerontology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	FL8LN	WOS:000414501400003	28859490				2022-02-06	
J	Makela, P				Makela, Petra			"They brought you back to the fact you're not the same": Sense of self after traumatic brain injury	SUBJECTIVITY			English	Article						Sense of self; Traumatic brain injury; Neurorehabilitation; Counter-narratives	INTERSUBJECTIVITY; SUBJECTIVITY; NARRATIVES; CHILDREN; IDENTITY; MODEL; CARE	This paper considers contexts following traumatic brain injury, exploring what may be at stake when dominant expectations predict a 'lost' or 'broken' self. I explore stories co-constructed with one young man and his mother to illustrate their personal and intersubjective understandings of identity, at times conflicting, within family interactions and when encountering normative practices of neurorehabilitation clinicians. The power relations portrayed confront this man's narrative attempts to align his present and pre-injury self, including standard assessments delineating change, administered by healthcare professionals. I consider a need for greater attention to interaction-generated disruption to sense of self, within contemporary conceptualisations of 'person-centred care'.	[Makela, Petra] Univ Westminster, 101 New Cavendish St, London W1W 6XH, England		Makela, P (corresponding author), Univ Westminster, 101 New Cavendish St, London W1W 6XH, England.	p.makela@nhs.net		Makela, Petra/0000-0002-0938-1175			Abi- Rached Joelle M., 2013, NEURO NEW BRAIN SCI; Atkin K, 2010, SOC SCI MED, V71, P386, DOI 10.1016/j.socscimed.2010.04.011; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blackman L, 2007, BODY SOC, V13, P1, DOI 10.1177/1357034X07077770; Boger E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130990; Bonham J, 2017, J SOCIOL, V53, P687, DOI 10.1177/1440783317715805; Bradby H, 2017, SOC THEOR HEALTH, V15, P206, DOI 10.1057/s41285-017-0028-3; Britten N, 2017, HEALTH EXPECT, V20, P407, DOI 10.1111/hex.12468; Burton CD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015689; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Callard F., 2016, RETHINKING INTERDISC; Carel H, 2014, MED HEALTH CARE PHIL, V17, P529, DOI 10.1007/s11019-014-9560-2; Charmaz, 2002, QUALITATIVE INQUIRY, V8, P302, DOI [DOI 10.1177/107780040200800307, 10.1177/107780040200800307]; Charmaz K., 2002, OCCUP THER J RES, V22, P31; Clandinin J, 2014, ENGAGING NARRATIVE I; Csordas TJ, 2008, SUBJECTIVITY, V22, P110, DOI 10.1057/sub.2008.5; Cummins C, 2016, NEUROREHABILITATION; Fisher P, 2007, SOCIOL HEALTH ILL, V29, P66, DOI 10.1111/j.1467-9566.2007.00518.x; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fricker M., 2007, EPISTEMIC INJUSTICE; Gardner J, 2017, BIOSOCIETIES, V12, P239, DOI 10.1057/biosoc.2016.6; Gardner J, 2016, SOCIOL HEALTH ILL, V38, P1043, DOI 10.1111/1467-9566.12431; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Greenhalgh T., 2015, BMC MED, V13, P1, DOI DOI 10.1186/S12916-015-0279-6]; Harding E., 2015, STATE PLAY PERSON CT; Health Foundation, 2014, PERS CTR CAR MAD SIM; Hunt KJ, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2366-1; Hyett N, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.23606; Jackson M., 1998, MINIMA ETHNOGRAPHICA; Jones RA, 2011, CULT PSYCHOL, V17, P339, DOI 10.1177/1354067X11408135; Kaiser K, 2009, QUAL HEALTH RES, V19, P1632, DOI 10.1177/1049732309350879; Kapur S., 2017, MEMORY ATTENTION AGI; Kean S., 2014, NEW YORK TIMES SUNDA, pSR8; Kemp R, 2007, FOR SOCIAL EC, V36, P43; Kirschner SR, 2013, CULT PSYCHOL, V19, P225, DOI 10.1177/1354067X13478985; Kovarsky Dana, 2007, Commun Med, V4, P53, DOI 10.1515/CAM.2007.029; Kuehner A, 2016, QUAL INQ, V22, P725, DOI 10.1177/1077800416658068; Lachman P, 2013, BMJ QUAL SAF, V22, P888, DOI 10.1136/bmjqs-2013-002322; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Makela P, 2016, BRIT SOC ASS MED SOC; Markova I, 2003, CULT PSYCHOL, V9, P249, DOI 10.1177/1354067X030093006; Martin E, 2010, SUBJECTIVITY, V3, P366, DOI 10.1057/sub.2010.23; Mattingly Cheryl, 2010, READER MED ANTHR THE, P121; May C, 2006, SOC SCI MED, V62, P1022, DOI 10.1016/j.socscimed.2005.07.003; May V, 2011, SOCIOLOGY, V45, P363, DOI 10.1177/0038038511399624; Medved Maria I, 2007, Psychol Health Med, V12, P603, DOI 10.1080/13548500601164404; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Medved MI, 2011, J HEALTH PSYCHOL, V16, P322, DOI 10.1177/1359105310377246; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menzies Lyth I., 1988, CONTAINING ANXIETY I, V1; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Ownsworth T., 2014, SELF IDENTITY BRAIN; Pickersgill M, 2011, SUBJECTIVITY, V4, P346, DOI 10.1057/sub.2011.10; Polkinghorne, 1988, NARRATIVE KNOWING HU; Riley GA, 2016, COGENT PSYCHOL, V3, DOI 10.1080/23311908.2016.1154308; ROGER K, 2014, QUAL STUD HLTH WELL, V9, P1; Selland MK, 2017, TEACH TEACH, V23, P244, DOI 10.1080/13540602.2016.1205016; Sivertsen M, 2015, PHYSIOTHER THEOR PR, V31, P153, DOI 10.3109/09593985.2014.986350; Weeks J., 1990, IDENTITY COMMUNITY C; Wilde A, 2014, DISABIL SOC, V29, P198, DOI 10.1080/09687599.2013.796880; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111; Woods A, 2011, NARRAT INQ, V21, P399, DOI 10.1075/ni.21.2.20woo; Wright K, 2011, LONG TERM CONDITIONS; Wright M. M., 2016, Journal of Communication in Healthcare, V9, P190; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	68	3	3	0	3	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1755-6341	1755-635X		SUBJECTIVITY	Subjectivity	DEC	2017	10	4			SI		358	373		10.1057/s41286-017-0036-8			16	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	FV2WG	WOS:000424428100003		Green Accepted, Green Submitted			2022-02-06	
J	Maruta, J; Spielman, LA; Tseretopoulos, ID; Hezghia, A; Ghajar, J				Maruta, Jun; Spielman, Lisa A.; Tseretopoulos, Irene D.; Hezghia, Adrienne; Ghajar, Jamshid			Possible Medication-Resistant Deficits in Adult ADHD	JOURNAL OF ATTENTION DISORDERS			English	Article						assessment; case-control; eye movement; fatigue; ocular pursuit	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; VISUAL TRACKING SYNCHRONIZATION; SACCADIC EYE-MOVEMENTS; TRAUMATIC BRAIN-INJURY; HYPERACTIVITY DISORDER; SLEEP-DEPRIVATION; SMOOTH-PURSUIT; WORKING-MEMORY; SYMPTOMS; METHYLPHENIDATE	Objective: The nature of ADHD, especially in adulthood, is not well-understood. Therefore, we explored subcomponents of attention in adult ADHD. Method: Twenty-three adults with ADHD were tested on neurocognitive and visual tracking performance both while on their regular prescription stimulant medication and while abstaining from the medication for 1 day. Pairwise comparisons to 46 two-for-one matched normal controls were made to detect medication-resistant effects of ADHD, and within-participant comparisons were made to detect medication-sensitive effects in patients. Results: Even when on medication, patients performed more poorly than controls on a spatial working memory task, and on visual tracking and simple reaction time tasks immediately following other attention-demanding tasks. Patients' visual tracking performance degraded while off-medication in a manner consistent with reduced vigilance. Conclusion: There may be persistent cognitive impairments in adult ADHD despite medication. In addition, the benefit of stimulants seems reduced under cognitive fatigue.	[Maruta, Jun; Spielman, Lisa A.; Tseretopoulos, Irene D.; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Hezghia, Adrienne] Brain Trauma Fdn, Res Team, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Neurosurg, Stanford, CA 94305 USA		Maruta, J (corresponding author), Brain Trauma Fdn, World Trade Ctr 7, 34th Floor,250 Greenwich St, New York, NY 10007 USA.	jmaruta@braintrauma.org	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605; Hezghia, Adrienne/0000-0002-7307-7741	Congressionally Directed Medical Research Programs through an Advanced Technology Award [W81XWH-08-1-0646]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Congressionally Directed Medical Research Programs through an Advanced Technology Award (W81XWH-08-1-0646) to Jamshid Ghajar.	Adolfsdottir S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-9; Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BALA SP, 1981, DEV MED CHILD NEUROL, V23, P323; Barkley RA, 2008, CNS SPECTRUMS, V13, P977, DOI 10.1017/S1092852900014036; Berman SM, 2009, MOL PSYCHIATR, V14, P123, DOI 10.1038/mp.2008.90; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1217, DOI 10.4088/JCP.v69n0803; Biederman J, 2012, J CLIN PSYCHIAT, V73, P941, DOI 10.4088/JCP.11m07529; Blockmans D, 2006, AM J MED, V119; Bramham J, 2012, PSYCHOL MED, V42, P2225, DOI 10.1017/S0033291712000219; Breitbart W, 2001, ARCH INTERN MED, V161, P411, DOI 10.1001/archinte.161.3.411; Carpenter R. H. S., 1981, EYE MOVEMENTS COGNIT, P237; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cornoldi C, 2008, Q J EXP PSYCHOL, V61, P674, DOI 10.1080/17470210701774200; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fassbender C, 2006, CLIN PSYCHOL REV, V26, P445, DOI 10.1016/j.cpr.2006.01.003; Fransson PA, 2008, J VESTIBUL RES-EQUIL, V18, P209; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HODGKINS Paul, 2012, FRONT PSYCHIATRY, V2, P1; Ishigami Y, 2010, J NEUROSCI METH, V190, P117, DOI 10.1016/j.jneumeth.2010.04.019; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kuo FE, 2004, AM J PUBLIC HEALTH, V94, P1580, DOI 10.2105/AJPH.94.9.1580; Lundervold AJ, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-27; Mahone EM, 2009, J AM ACAD CHILD PSY, V48, P749, DOI 10.1097/CHI.0b013e3181a565f1; Mannuzza S, 1997, J AM ACAD CHILD PSY, V36, P1222, DOI 10.1097/00004583-199709000-00014; Maruta J., 2012, P SOC PHOTO-OPT INS, V8371; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McGough JJ, 2004, AM J PSYCHIAT, V161, P1948, DOI 10.1176/appi.ajp.161.11.1948; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Mick E, 2004, PSYCHIAT CLIN N AM, V27, P215, DOI 10.1016/j.psc.2004.01.003; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Porcu S, 1998, PHYSIOL BEHAV, V65, P437, DOI 10.1016/S0031-9384(98)00181-4; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapport MD, 2001, J CLIN CHILD PSYCHOL, V30, P48, DOI 10.1207/S15374424JCCP3001_6; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Ross RG, 2000, BIOL PSYCHIAT, V48, P197, DOI 10.1016/S0006-3223(00)00825-8; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Shiels K, 2008, J ABNORM CHILD PSYCH, V36, P903, DOI 10.1007/s10802-008-9221-0; Silverstein SM, 2010, J CLIN EXP NEUROPSYC, V32, P937, DOI 10.1080/13803391003596496; Tong JL, 2014, EXP BRAIN RES, V232, P121, DOI 10.1007/s00221-013-3725-8; Weiss MD, 2006, J CLIN PSYCHIAT, V67, P38; Young JL, 2013, POSTGRAD MED, V125, P162, DOI 10.3810/pgm.2013.01.2631	54	3	3	1	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	DEC	2017	21	14			SI		1169	1179		10.1177/1087054714538659			11	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	FL5TU	WOS:000414309400004	24970719				2022-02-06	
J	Moore, L; Evans, D; Yanchar, NL; Thakore, J; Stelfox, HT; Hameed, M; Simons, R; Kortbeek, J; Clement, J; Lauzier, F; Turgeon, AF				Moore, Lynne; Evans, David; Yanchar, Natalie L.; Thakore, Jaimini; Stelfox, Henry Thomas; Hameed, Morad; Simons, Richard; Kortbeek, John; Clement, Julien; Lauzier, Francois; Turgeon, Alexis F.			Canadian benchmarks for acute injury care	CANADIAN JOURNAL OF SURGERY			English	Article							LENGTH-OF-STAY; TRAUMA-CARE; AMERICAN-COLLEGE; MORTALITY; MODEL; OUTCOMES; SYSTEM	Background Acute care injury outcomes vary substantially across Canadian provinces and trauma centres. Our aim was to develop Canadian benchmarks to monitor mortality and hospital length of stay (LOS) for injury admissions. Methods Benchmarks were derived using data from the Canadian National Trauma Registry on patients with major trauma admitted to any level I or II trauma centre in Canada and from the following patient subgroups: isolated traumatic brain injury (TBI), isolated thoracoabdominal injury, multisystem blunt injury, age 65 years or older. We assessed predictive validity using measures of discrimination and calibration, and performed sensitivity analyses to assess the impact of replacing analytically complex methods (multiple imputation, shrinkage estimates and flexible modelling) with simple models that can be implemented locally. Results The mortality risk adjustment model had excellent discrimination and calibration (area under the receiver operating characteristic curve 0.886, Hosmer-Lemeshow 36). The LOS risk-adjustment model predicted 29% of the variation in LOS. Overall, observed:expected ratios of mortality and mean LOS generated by an analytically simple model correlated strongly with those generated by analytically complex models (r > 0.95, on outliers > 0.90). Conclusion We propose Canadian benchmarks that can be used to monitor quality of care in Canadian trauma centres using Excel (see the appendices, available at canjsurg.ca). The program can be implemented using local trauma registries, providing that at least 100 patients are available for analysis. Contexte L'issue des traitements dispenses dans les services de traumatologie d'urgence varie substantiellement d'une province canadienne et d'un centre de traumatologie a l'autre. Notre but etait d'etablir des valeurs de reference pour suivre la mortalite et la duree des sejours hospitaliers en traumatologie au Canada. Methodes Les parametres ont ete selectionnes a partir des donnees du Registre national des traumatismes concernant les grands polytraumatises admis dans tout centre de traumatologie de niveau I ou II au Canada et selon les categories de patients suivantes : traumatisme cranien isole (TCI), traumatisme thoraco-abdominal isole, traumatisme plurisystemique ferme, age de 65 ans ou plus. Nous avons evalue la validite predictive a l'aide de criteres discriminants et de parametres d'etalonnage et nous avons procede a des analyses de sensibilite pour evaluer l'impact du remplacement de methodes analytiques complexes (imputation multiple, estimations par contraction des coefficients et modelisation flexible) par des modeles simples applicables a l'echelle locale. Resultats Le modele d'ajustement du risque de mortalite s'est revele dote d'un pouvoir discriminant et d'un etalonnage excellents (aire sous la courbe de la fonction d'efficacite du recepteur [ROC] 0,886, test de Hosmer-Lemeshow 36). Le modele d'ajustement du risque pour la duree du sejour hospitalier a permis de predire 29 % de sa variation. De plus, les rapports observes:attendus pour la mortalite et la duree moyenne des sejours hospitaliers generes par un modele analytique simple ont ete en etroite correlation avec les rapports generes par les modeles analytiques complexes (r > 0,95, pour valeurs aberrantes > 0,90). Conclusion Nous proposons des valeurs de reference canadiennes qui peuvent etre utilisees pour faire le suivi de la qualite des soins dans les centres de traumatologie canadiens a l'aide d'un simple programme Excel (voir les annexes, accessible a l'adresse canjsurg.ca). Le programme peut etre applique a l'aide des donnees des registres de traumatologie locaux a la condition qu'au moins 100 patients y soient accessibles pour analyse.	[Moore, Lynne] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Moore, Lynne; Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Hop Enfants Jesus, Traumatol Urgence Soins Intensifs,Ctr Rech, Axe Sante Populat & Prat Optimales Sante,CHU Queb, Quebec City, PQ, Canada; [Yanchar, Natalie L.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Evans, David; Thakore, Jaimini; Hameed, Morad] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Stelfox, Henry Thomas] Univ Calgary, Dept Crit Care Med Med & Community Hlth Sci, Calgary, AB, Canada; [Stelfox, Henry Thomas] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Kortbeek, John] Univ Calgary, Dept Surg, Div Gen Surg, Calgary, AB, Canada; [Kortbeek, John] Univ Calgary, Div Crit Care, Calgary, AB, Canada; [Clement, Julien] Inst Natl Excellence Sante & Serv Sociaux, Quebec City, PQ, Canada; [Clement, Julien] Univ Laval, Dept Surg, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada		Moore, L (corresponding author), Univ Laval, CHU Quebec, Res Ctr, 1401,18e Rue,Local H-012A, Quebec City, PQ G1J 1Z4, Canada.	lynne.moore@fmed.ulaval.ca	Kortbeek, John B/AAO-5298-2020; Lauzier, Francois/B-9237-2015	Stelfox, Henry/0000-0003-1231-1490; Lauzier, Francois/0000-0002-6530-5513	Canadian Institutes of Health Research New Investigator AwardCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante award; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [110996]	L. Moore, H. Stelfox and A. Turgeon are supported by a Canadian Institutes of Health Research New Investigator Award; F. Lauzier is supported by a Fonds de Recherche du Quebec - Sante award; and L. Moore is supported by a Canadian Institutes of Health Research operating grant (#110996).	Agency for Healthcare Research and Quality, 2013, MEAS BENCHM CLIN PER; Altman D.G., 1990, PRACTICAL STAT MED R; *AM ASS ADV AUT ME, 1990, ABBR INJ SCAL; American Association for the Advancement of Automotive Medicine, CONV DIFF AIS VERS; [Anonymous], TRAUM SYST ACCR GUID; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Daly L., 2008, INTERPRETATION USES; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Lemeshow S, 2000, APPL LOGISTIC REGRES; Little R. J., 2019, STAT ANAL MISSING DA, V793; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2017, ANN SURG, V265, P212, DOI 10.1097/SLA.0000000000001614; Moore L, 2015, WORLD J SURG, V39, P1397, DOI 10.1007/s00268-015-2977-9; Moore L, 2014, ANN SURG, V260, P1121, DOI 10.1097/SLA.0000000000000648; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore Lynne, 2013, J Emerg Trauma Shock, V6, P95, DOI 10.4103/0974-2700.110754; Moore Lynne, 2012, J Emerg Trauma Shock, V5, P333, DOI 10.4103/0974-2700.102404; Moore L, 2010, ANN SURG, V251, P952, DOI 10.1097/SLA.0b013e3181d97589; Moore L, 2009, ANN SURG, V249, P1040, DOI 10.1097/SLA.0b013e3181a6cd97; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nathens AB, 2012, SURG CLIN N AM, V92, P441, DOI 10.1016/j.suc.2012.01.003; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964	30	3	3	0	1	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	DEC	2017	60	6					380	387		10.1503/cjs.002817			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FP7OY	WOS:000417826300010	28930046	Green Published			2022-02-06	
J	Narin, F; Hanalioglu, S; Ustun, H; Kilinc, K; Bilginer, B				Narin, Firat; Hanalioglu, Sahin; Ustun, Huseyin; Kilinc, Kamer; Bilginer, Burcak			Topiramate as a neuroprotective agent in a rat model of spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; topiramate; neuroprotection; oxidative damage; nitric oxide; motor function; neural regeneration	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; CELL-DEATH; MOTOR FUNCTION; MECHANISMS; ANTIOXIDANT; APOPTOSIS; PHARMACOKINETICS; ANTAGONIST	Topiramate (TPM) is a widely used antiepileptic and antimigraine agent which has been shown to exert neuroprotective effects in various experimental traumatic brain injury and stroke models. However, its utility in spinal cord injury has not been studied extensively. Thus, we evaluated effects of TPM on secondary cellular injury mechanisms in an experimental rat model of traumatic spinal cord injury (SCI). After rat models of thoracic contusive SCI were established by free weight-drop method, TPM (40 mg/kg) was given at 12-hour intervals for four times orally. Post TPM treatment, malondialdehyde and protein carbonyl levels were significantly reduced and reduced glutathione levels were increased, while immunoreactivity for endothelial nitric oxide synthase, inducible nitric oxide synthase, and apoptotic peptidase activating factor 1 was diminished in SCI rats. In addition, TPM treatment improved the functional recovery of SCI rats. This study suggests that administration of TPM exerts neuroprotective effects on SCI.	[Narin, Firat; Hanalioglu, Sahin; Bilginer, Burcak] Hacettepe Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Ustun, Huseyin] Ankara Numune Training & Res Hosp, Dept Pathol, Ankara, Turkey; [Kilinc, Kamer] TOBB Univ Econ & Technol, Fac Med, Dept Biochem, Ankara, Turkey		Hanalioglu, S (corresponding author), Hacettepe Univ, Fac Med, Dept Neurosurg, Ankara, Turkey.	sahinhanalioglu@gmail.com			Turkish Neurosurgical Society	Preparation for publication of this article has been partly supported by Turkish Neurosurgical Society.	Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bilginer B, 2009, CHILD NERV SYST, V25, P1555, DOI 10.1007/s00381-009-0985-5; Cardenas-Rodriguez N, 2013, NEUROL SCI, V34, P741, DOI 10.1007/s10072-012-1127-5; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; DAWSON VL, 1993, J NEUROSCI, V13, P2651; Dinoff BL, 2003, J SPINAL CORD MED, V26, P401, DOI 10.1080/10790268.2003.11753712; Dodgson SJ, 2000, EPILEPSIA, V41, pS35, DOI 10.1111/j.1528-1157.2000.tb06047.x; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Estevez AG, 1998, J NEUROSCI, V18, P3708; Farooque M, 1999, ACTA NEUROPATHOL, V98, P22, DOI 10.1007/s004010051047; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gensel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033519; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; KOOZEKANANI SH, 1976, J NEUROSURG, V44, P429, DOI 10.3171/jns.1976.44.4.0429; Kouzounias K, 2011, NEUROSCIENCE, V183, P171, DOI 10.1016/j.neuroscience.2011.03.069; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Naziroglu M, 2013, CELL MOL NEUROBIOL, V33, P589, DOI 10.1007/s10571-013-9936-5; Osuka K, 2007, NEUROSCIENCE, V145, P241, DOI 10.1016/j.neuroscience.2006.10.034; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; SCHWARTZ LM, 1993, IMMUNOL TODAY, V14, P582, DOI 10.1016/0167-5699(93)90197-S; Shakeri R, 2017, BIOCHIMIE, V135, P111, DOI 10.1016/j.biochi.2017.02.001; Shank RP, 2008, CNS NEUROSCI THER, V14, P120, DOI 10.1111/j.1527-3458.2008.00041.x; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Walters MR, 2005, CEREBROVASC DIS, V20, P304, DOI 10.1159/000087929; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Wu XH, 2007, J NEUROTRAUM, V24, P1502, DOI 10.1089/neu.2006.0228; Yang JY, 2007, SPINAL CORD, V45, P731, DOI 10.1038/sj.sc.3102036	35	3	3	1	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2017	12	12					2071	2076		10.4103/1673-5374.221164			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FS7UZ	WOS:000422615700024	29323048	Green Published, gold			2022-02-06	
J	Son, SM; Shin, SM				Son, Su Min; Shin, So Min			Disruption of the Corticoreticular Tract in Pediatric Patients With Trunk Instability: A Diffusion Tensor Tractography Study	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Diffusion tensor imaging; Corticoreticular tract; Gait dysfunction; Trunk instability; Pediatric patients	TRAUMATIC BRAIN-INJURY; PROXIMAL WEAKNESS; PATHWAY	The authors report the diffusion tensor tractography (DTT) findings of three pediatric patients with gait dysfunction and corticoreticular tract (CRT) disruption. All three patients showed unilateral trunk instability, but they did not show any spasticity or weakness of the distal extremities. Clinical evaluation of trunk instability using a Trunk Control Measurement Scale (TCMS) revealed that the more affected side had a lower score than the contralateral side. DTT showed disrupted CRTs in hemispheres contralateral to the hemiparetic sides, which were associated with unilateral proximal instability, although conventional MRI showed no abnormal lesion explaining the hemiplegic symptom. Compared to the results in age-matched controls, these three patients had decreased values of fractional anisotropy (FA) and tract volumes (TV) of the affected CRTs, and these values were also decreased compared to those in the contralateral side. On the other hand, values of FA and TV of the corticospinal tracts on the ipsilateral and contralateral sides were only marginally different. In conclusion, diffusion tensor imaging can be helpful for investigating the state of the CRT in pediatric patients with trunk instability and gait dysfunction.	[Son, Su Min; Shin, So Min] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 170 Hyeonchungno, Daegu 42415, South Korea		Son, SM (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 170 Hyeonchungno, Daegu 42415, South Korea.	nocturne27@naver.com			Chunma medical research foundation, Korea	This work was supported by a grant from Chunma medical research foundation, Korea, 2016.	Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; FREUND HJ, 1984, EXP BRAIN RES, V53, P479; Heyrman L, 2011, RES DEV DISABIL, V32, P2624, DOI 10.1016/j.ridd.2011.06.012; LASSEK AM, 1947, RES PUBL ASSOC RES N, V27, P106; Lee HD, 2015, BRAIN INJURY, V29, P1219, DOI 10.3109/02699052.2015.1045028; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Yeo SS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00573; Yeo SS, 2013, NEUROREHABILITATION, V32, P665, DOI 10.3233/NRE-130889; Yeo SS, 2013, NEUROREHABILITATION, V32, P305, DOI 10.3233/NRE-130848; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	10	3	4	0	2	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	DEC	2017	41	6					1093	1099		10.5535/arm.2017.41.6.1093			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FR2FD	WOS:000418881700023	29354588	gold, Green Published, Green Submitted			2022-02-06	
J	Wadas, MJ; Tweardy, M; Bajaj, N; Murray, AK; Chiu, GTC; Nauman, EA; Rhoads, JF				Wadas, Michael J.; Tweardy, Mackenzie; Bajaj, Nikhil; Murray, Allison K.; Chiu, George T-C; Nauman, Eric A.; Rhoads, Jeffrey F.			Detection of Traumatic Brain Injury Protein Biomarkers With Resonant Microsystems	IEEE SENSORS LETTERS			English	Article						Mass sensors; microsensors; s100 beta; traumatic brain injury		Microelectromechanical resonators enable the sensitive and inexpensive detection of biological molecules associated with specific diseases, infections, or other medical conditions that are commonly referred to as biomarkers. The focus of this effort is the detection of s100 beta, which is a protein biomarker that is secreted in relatively high concentrations in the cerebrospinal fluid of victims of traumatic brain injury (TBI). Sensor functionalization via polymer/antibody coatings is explored as a method to allow for the adsorption of s100 beta onto the surface of the resonator. A high-precision, piezoelectrically actuated pipette system is utilized to improve sensor functionalization and biomarker exposure techniques. High-frequency resonators are utilized for their high mass sensitivity. Frequency-domain characterization of multiple sensors reveals shifts in their resonant peaks caused by the adsorption of s100 beta. Successful detection of s100 beta was achieved (p = 0.000012) at sensitivities that are theoretically sufficient to enable the diagnosis of TBI.	[Wadas, Michael J.; Tweardy, Mackenzie; Bajaj, Nikhil; Murray, Allison K.; Chiu, George T-C; Nauman, Eric A.; Rhoads, Jeffrey F.] Purdue Univ, Coll Engn, W Lafayette, IN 47907 USA		Rhoads, JF (corresponding author), Purdue Univ, Coll Engn, W Lafayette, IN 47907 USA.	jfrhoads@purdue.edu	Chiu, George T.-C./E-8374-2010	Chiu, George T.-C./0000-0002-4445-2821; Rhoads, Jeffrey/0000-0002-3930-1308; Murray, Allison/0000-0001-5775-8005			Abcam Shanghai China, 2017, ANT S100 BET ANT EP1; Chen PY, 2015, ADV DRUG DELIVER REV, V95, P90, DOI 10.1016/j.addr.2015.09.005; Fischer LM, 2008, SENSOR ACTUAT B-CHEM, V134, P613, DOI 10.1016/j.snb.2008.06.003; Frank RL, 2008, J EMERG MED, V35, P149, DOI 10.1016/j.jemermed.2007.03.024; Hanay MS, 2012, NAT NANOTECHNOL, V7, P602, DOI [10.1038/NNANO.2012.119, 10.1038/nnano.2012.119]; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; MARTIN SJ, 1991, ULTRASON, P393, DOI 10.1109/ULTSYM.1991.234193; Rickert J, 1997, BIOSENS BIOELECTRON, V12, P567, DOI 10.1016/S0956-5663(96)00077-2; Speight RE, 2012, J MOL RECOGNIT, V25, P451, DOI 10.1002/jmr.2209; Varshney M, 2008, ANAL CHEM, V80, P2141, DOI 10.1021/ac702153p; Ziegler C, 2004, ANAL BIOANAL CHEM, V379, P946, DOI 10.1007/s00216-004-2694-y	12	3	3	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2475-1472			IEEE SENSOR LETT	IEEE Sens. Lett.	DEC	2017	1	6							2501304	10.1109/LSENS.2017.2768514			4	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Emerging Sources Citation Index (ESCI)	Engineering; Instruments & Instrumentation; Physics	VK5JC	WOS:000722159900007					2022-02-06	
J	Zaremski, JL; Diamond, MC; Aagesen, A; Casey, E; Davis, B; Ellen, M; Mautner, K; McInnis, K; Nichols, J; Rao, A; Krabak, B				Zaremski, Jason L.; Diamond, Matthew C.; Aagesen, Andrea; Casey, Ellen; Davis, Brian; Ellen, Mark; Mautner, Kenneth; McInnis, Kelly; Nichols, Jerome; Rao, Ashwin; Krabak, Brian			Musculoskeletal and Sports Medicine Physical Medicine and Rehabilitation Curriculum Guidelines	PM&R			English	Article							REGENERATIVE MEDICINE; CONSENSUS STATEMENT; FUTURE; EXERCISE; DEPRESSION; CONCUSSION; ULTRASOUND; RETURN; PLAY		[Zaremski, Jason L.] Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div PM&R,OSMI, POB 112727, Gainesville, FL 32611 USA; [Zaremski, Jason L.] Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div Sports Med,OSMI, POB 112727, Gainesville, FL 32611 USA; [Zaremski, Jason L.] Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div Res,OSMI, POB 112727, Gainesville, FL 32611 USA; [Diamond, Matthew C.] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY USA; [Aagesen, Andrea] Univ Michigan Hosp & Hlth Syst, Dept Phys Med & Rehabil, Michigan NeuroSport Program, Sports Med & Rehabil, Ann Arbor, MI USA; [Casey, Ellen] Univ Penn, Penn Ctr Female Athlete, Penn Musculoskeletal Ctr, Philadelphia, PA 19104 USA; [Davis, Brian] Univ Calif Davis, Dept PM&R, Davis Med Ctr, Sacramento, CA 95817 USA; [Ellen, Mark] Univ Alabama Birmingham, Med Sch Birmingham, Birmingham VA Med Ctr, Birmingham, AL USA; [Mautner, Kenneth] Emory Sports Med Ctr, Dept PM&R, Atlanta, GA USA; [Mautner, Kenneth] Emory Sports Med Ctr, Dept Orthoped, Atlanta, GA USA; [McInnis, Kelly] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Sports Med, Boston, MA USA; [Nichols, Jerome] Virginia Tech, Carilion Sch Med, Dept Med Phys Med & Rehabil, Roanoke, VA USA; [Rao, Ashwin] Univ Washington, Dept Family Med, Sports Med Sect, Seattle, WA 98195 USA; [Krabak, Brian] Univ Washington, Dept Rehabil, Seattle, WA 98195 USA; [Krabak, Brian] Seattle Childrens Hosp, Dept Orthopaed & Sports Med & Pediat, Seattle, WA USA		Zaremski, JL (corresponding author), Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div PM&R,OSMI, POB 112727, Gainesville, FL 32611 USA.; Zaremski, JL (corresponding author), Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div Sports Med,OSMI, POB 112727, Gainesville, FL 32611 USA.; Zaremski, JL (corresponding author), Univ Florida, Adolescent & High Sch Sports Med Outreach Program, Dept Orthoped & Rehabil, Div Res,OSMI, POB 112727, Gainesville, FL 32611 USA.	zaremjl@ortho.ufl.edu					ACSM, ACSM EIM EX MED ACSM; AIUM. The American Institute of Ultrasound in Medicine (AIUM), AIUM MUSC ULTR EX; Ajibade DA, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113519935; Asif IM, 2017, CLIN J SPORT MED, V27, P231, DOI 10.1097/JSM.0000000000000428; Best TM, 2017, CURR SPORT MED REP, V16, P202, DOI 10.1249/JSR.0000000000000357; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Concannon LG, 2012, PM&R, V4, P833, DOI 10.1016/j.pmrj.2012.08.007; De Souza MJ, 2014, CLIN J SPORT MED, V24, P96, DOI 10.1097/JSM.0000000000000085; Drezner JA, BR J SPORTS IN PRESS; Drezner JA, 2017, BRIT J SPORT MED, V51, P704, DOI 10.1136/bjsports-2016-097331; Finnoff JT, 2016, PM&R, V8, pS133, DOI 10.1016/j.pmrj.2015.09.022; Finnoff JT, 2015, CLIN J SPORT MED, V25, P6, DOI 10.1097/JSM.0000000000000175; Guttmann I, 2013, CLIN SPORT MED, V32, P239, DOI 10.1016/j.csm.2012.12.006; Hogan MV, 2015, ARTHROSCOPY, V31, P1017, DOI 10.1016/j.arthro.2014.11.033; Juyia RF, 2014, SPORTS HEALTH, V6, P239, DOI 10.1177/1941738114528468; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Malanga G, 2014, PHYS MED REH CLIN N, V25, P881, DOI 10.1016/j.pmr.2014.06.007; McCrory P, BR J SPORTS IN PRESS; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Rao AL, 2016, BRIT J SPORT MED, V50, P136, DOI 10.1136/bjsports-2015-095658; Rifat Sami F, 2003, Curr Sports Med Rep, V2, P93; Sepulveda F, 2015, PM&R, V7, pS76, DOI 10.1016/j.pmrj.2015.01.004; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092	25	3	3	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2017	9	12					1244	1267		10.1016/j.pmrj.2017.07.006			24	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FQ7CT	WOS:000418521100008	29274677	Green Published			2022-02-06	
J	Hines, M; Brunner, M; Poon, S; Lam, M; Tran, V; Yu, D; Togher, L; Shaw, T; Power, E				Hines, M.; Brunner, M.; Poon, S.; Lam, M.; Tran, V.; Yu, D.; Togher, L.; Shaw, T.; Power, E.			Tribes and tribulations: interdisciplinary eHealth in providing services for people with a traumatic brain injury (TBI)	BMC HEALTH SERVICES RESEARCH			English	Article						Multidisciplinary; Electronic health record; Technology; Allied health; Team; Telehealth	QUALITATIVE RESEARCH; REHABILITATION; INFORMATION; TECHNOLOGY; COGNITION; CARE	Background: eHealth has potential for supporting interdisciplinary care in contemporary traumatic brain injury (TBI) rehabilitation practice, yet little is known about whether this potential is being realised, or what needs to be done to further support its implementation. The purpose of this study was to explore health professionals' experiences of, and attitudes towards eHealth technologies to support interdisciplinary practice within rehabilitation for people after TBI. Methods: A qualitative study using narrative analysis was conducted. One individual interview and three focus groups were conducted with health professionals (n = 17) working in TBI rehabilitation in public and private healthcare settings across regional and metropolitan New South Wales, Australia. Results: Narrative analysis revealed that participants held largely favourable views about eHealth and its potential to support interdisciplinary practice in TBI rehabilitation. However, participants encountered various issues related to (a) the design of, and access to electronic medical records, (b) technology, (c) eHealth implementation, and (d) information and communication technology processes that disconnected them from the work they needed to accomplish. In response, health professionals attempted to make the most of unsatisfactory eHealth systems and processes, but were still mostly unsuccessful in optimising the quality, efficiency, and client-centredness of their work. Conclusions: Attention to sources of disconnection experienced by health professionals, specifically design of, and access to electronic health records, eHealth resourcing, and policies and procedures related to eHealth and interdisciplinary practice are required if the potential of eHealth for supporting interdisciplinary practice is to be realised.	[Hines, M.; Brunner, M.; Tran, V.; Togher, L.; Shaw, T.; Power, E.] Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia; [Brunner, M.] Univ Newcastle, Fac Educ & Arts, Univ Dr, Callaghan, NSW 2308, Australia; [Poon, S.; Yu, D.] Univ Sydney, Fac Engn & Informat Technol, Camperdown, NSW 2006, Australia; [Lam, M.] Univ Technol Sydney, Fac Hlth, Ultimo, NSW 2007, Australia; [Togher, L.] Univ New South Wales, Sch Psychol, NHMRC Ctr Res Excellence Brain Recovery, Moving Ahead, Camperdown, NSW 2052, Australia		Hines, M (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	monique.hines@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Brunner, Melissa/AAS-5965-2020; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Hines, Monique/0000-0002-3919-1401; Togher, Leanne/0000-0002-4518-6748	University of Sydney Faculty of Health Sciences Collaborative Research Scheme grant	The Interdisciplinary eHealth Advancement and Research Team (IeHART) membership is supported by a University of Sydney Faculty of Health Sciences Collaborative Research Scheme grant which is designed to support collaborative research across the university. The authors alone are responsible for the content and writing of this paper. The funding body had no input into study design, data collection, or interpretation of findings.	Al-Ubaydli M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5575; Australian Digital Health Agency, MY HLTH REC; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Clark P, 2016, HEALTHCARE TEAMWORK; Coiera E, 2004, BRIT MED J, V328, P1197, DOI 10.1136/bmj.328.7449.1197; Coleman JJ, 2015, AM J SPEECH-LANG PAT, V24, P295, DOI 10.1044/2015_AJSLP-14-0028; Cresswell K, 2013, INT J MED INFORM, V82, pE73, DOI 10.1016/j.ijmedinf.2012.10.007; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Department of Health and Aging (DoHA), 2011, EHEALTH READ AUSTR A; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kruger R, 2009, FOCUS GROUPS PRACTIC, DOI [10.1111/1467-9566ep11347023, DOI 10.1111/1467-9566EP11347023]; Labov W., 1982, ANAL DISCOURSE TEXT, P219; Lewis FD, 2015, NEUROREHABILITATION, V36, P243, DOI 10.3233/NRE-151213; Neale J, 2014, ADDICTION, V109, P175, DOI 10.1111/add.12408; Patton M., 2015, QUALITATIVE RES EVAL, V4; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Ratwani RM, 2015, J AM MED INFORM ASSN, V22, P1179, DOI 10.1093/jamia/ocv050; Riessman C, 2004, SAGE ENCY SOCIAL SCI, V2; Riessman CK., 2005, QUALITATIVE SOCIAL W, V4, P391, DOI DOI 10.1177/1473325005058643; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tran V, 2017, BRAIN INJURY, V31, P1701, DOI 10.1080/02699052.2017.1387932; World Health Organization [WHO], 2012, INT TEL UN ITU NAT E	29	3	3	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	NOV 21	2017	17								757	10.1186/s12913-017-2721-2			13	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	FN5JS	WOS:000416044100012	29162086	Green Published, gold			2022-02-06	
J	Tiba, MH; McCracken, BM; Ansari, S; Belle, A; Cummings, BC; Rajajee, V; Patil, PG; Alam, HB; Ward, KR				Tiba, Mohamad H.; McCracken, Brendan M.; Ansari, Sardar; Belle, Ashwin; Cummings, Brandon C.; Rajajee, Venkatakrishna; Patil, Parag G.; Alam, Hasan B.; Ward, Kevin R.			Novel Noninvasive Method of Cerebrovascular Blood Volume Assessment Using Brain Bioimpedance	JOURNAL OF NEUROTRAUMA			English	Article						bioimpedance; blood flow; CBF autoregulation; cerebral blood volume; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; AUTOREGULATION; REACTIVITY; STIMULATION; INJURY; FLOW	Cerebrovascular autoregulation (CAR) is the ability of vessels to modulate their tone in response to changes in pressure. As an auto-protective mechanism, CAR is critical in preventing secondary brain injury post-trauma. Monitoring of changes in cerebral blood volume might be valuable in evaluating CAR and response to various therapies. In this study, we utilized an ocular-brain bioimpedance interface to assess real time changes in cerebral blood volume in response to a number of physiological challenges. We hypothesize that changes in brain bioimpedance (dz) would track changes in cerebral blood volume. Anesthetized animals were instrumented for monitoring of intracranial pressure (ICP), mean arterial blood pressure, cerebral perfusion pressure (CPP) and cerebral blood flow (CBF). Bioimpedance was monitored continuously through electrocardiographic electrodes placed over the eyelids. Interventions such as hyperventilation, vasopressor administration, creation of an epidural hematoma, and systemic hemorrhage were used to manipulate levels of ICP, CPP, and CBF. The dz correlated with changes in ICP, CPP, and CBF (r=-0.72 to -0.88, p < 0.0001). The receiver operating characteristic for dz at different thresholds of CPP and CBF showed high impedance performance with area under the curve between 0.80-1.00 (p < 0.003) and sensitivity and specificity varying between 83%-100% and 70%-100%, respectively. Our preliminary tests show that brain bioimpedance as measured through the ocular-brain interface tracks changes in CPP and CBF with high precision and may prove to be valuable in the future in assessing changes in cerebral blood volume and CAR.	[Tiba, Mohamad H.; McCracken, Brendan M.; Ansari, Sardar; Belle, Ashwin; Cummings, Brandon C.; Ward, Kevin R.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna; Patil, Parag G.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Patil, Parag G.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Patil, Parag G.; Ward, Kevin R.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Tiba, Mohamad H.; McCracken, Brendan M.; Ansari, Sardar; Belle, Ashwin; Cummings, Brandon C.; Rajajee, Venkatakrishna; Patil, Parag G.; Alam, Hasan B.; Ward, Kevin R.] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA		Ward, KR (corresponding author), Univ Michigan, 2800 Plymouth Rd,10-A103, Ann Arbor, MI 48109 USA.	keward@med.umich.edu		Tiba, Mohamad/0000-0002-6789-7532	Michigan Center for Integrative Research in Critical Care (MCIRCC); Massey Foundation	The authors would like to acknowledge and thank the Michigan Center for Integrative Research in Critical Care (MCIRCC) and the Massey Foundation funding program for their support.	Ang BT, 2007, J NEUROL NEUROSUR PS, V78, P298, DOI 10.1136/jnnp.2005.082735; Antal A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3616807; Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Babu J P, 1990, J Postgrad Med, V36, P57; Bation R, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.001; Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025; Bhuta A C, 1990, J Postgrad Med, V36, P64; Buchman TG, 2016, CRIT CARE MED, V44, P1635, DOI 10.1097/CCM.0000000000002028; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Buitrago MM, 2004, EXP BRAIN RES, V158, P336, DOI 10.1007/s00221-004-1906-1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1998, ACT NEUR S, V71, P74; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Ferreira J, 2013, IEEE ENG MED BIO, P559, DOI 10.1109/EMBC.2013.6609561; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Metzger A, 2015, SHOCK, V44, P96, DOI 10.1097/SHK.0000000000000314; NYBOER J, 1950, CIRCULATION, V2, P811, DOI 10.1161/01.CIR.2.6.811; Shaw Martin, 2012, Acta Neurochir Suppl, V114, P61, DOI 10.1007/978-3-7091-0956-4_11; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5; Underwood E, 2016, SCIENCE, V352, P397, DOI 10.1126/science.352.6284.397; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	27	3	4	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3089	3096		10.1089/neu.2017.5090			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000004	28657491				2022-02-06	
J	Weber, M; Maia, PD; Kutz, JN				Weber, Melanie; Maia, Pedro D.; Kutz, J. Nathan			Estimating Memory Deterioration Rates Following Neurodegeneration and Traumatic Brain Injuries in a Hopfield Network Model	FRONTIERS IN NEUROSCIENCE			English	Article						neurodegenerative diseases; traumatic brain injuries; Hopfield neuronal network; associative memory encoding; memory impairments; axonal swellings	AXON DEGENERATION; FRONTAL-LOBE; IMPAIRMENTS; MECHANISMS; DEFICITS; DISEASES; NEURONS; DEATH	Neurodegenerative diseases and traumatic brain injuries (TBI) are among the main causes of cognitive dysfunction in humans. At a neuronal network level, they both extensively exhibit focal axonal swellings (FAS), which in turn, compromise the information encoded in spike trains and lead to potentially severe functional deficits. There are currently no satisfactory quantitative predictors of decline in memory-encoding neuronal networks based on the impact and statistics of FAS. Some of the challenges of this translational approach include our inability to access small scale injuries with non-invasive methods, the overall complexity of neuronal pathologies, and our limited knowledge of how networks process biological signals. The purpose of this computational study is three-fold: (i) to extend Hopfield's model for associative memory to account for the effects of FAS, (ii) to calibrate FAS parameters from biophysical observations of their statistical distribution and size, and (iii) to systematically evaluate deterioration rates for different memory-recall tasks as a function of FAS injury. We calculate deterioration rates for a face-recognition task to account for highly correlated memories and also for a discrimination task of random, uncorrelated memories with a size at the capacity limit of the Hopfield network. While it is expected that the performance of any injured network should decrease with injury, our results link, for the first time, the memory recall ability to observed FAS statistics. This allows for plausible estimates of cognitive decline for different stages of brain disorders within neuronal networks, bridging experimental observations following neurodegeneration and TBI with compromised memory recall. The work lends new insights to help close the gap between theory and experiment on how biological signals are processed in damaged, high-dimensional functional networks, and towards positing new diagnostic tools to measure cognitive deficits.	[Weber, Melanie; Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA		Weber, M (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	melwe@uw.edu; pmaia@uw.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257	scholarship of the Konrad Adenauer foundation	MW was supported by a scholarship of the Konrad Adenauer foundation.	Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Faul M, 2010, TRAUMATIC BRAIN INJU; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; HOPFIELD JJ, 1985, BIOL CYBERN, V52, P141; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Knutson AR, 2012, P NATL ACAD SCI USA, V109, P13106, DOI 10.1073/pnas.1208876109; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maia PD, 2017, J COMPUT NEUROSCI, V42, P323, DOI 10.1007/s10827-017-0643-y; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; RUPPIN E, 1995, NEURAL COMPUT, V7, P1105, DOI 10.1162/neco.1995.7.5.1105; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weyrauch B., 2004, 1 IEEE WORKSH FAC PR; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	29	3	3	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	NOV 9	2017	11								623	10.3389/fnins.2017.00623			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM1RF	WOS:000414757000001	29170624	Green Published, gold			2022-02-06	
J	Chen, XM; Xue, BH; Li, YP; Song, CH; Jia, PJ; Ren, XH; Zang, WD; Wang, J				Chen, Xuemei; Xue, Bohan; Li, Yuping; Song, Chunhua; Jia, Peijun; Ren, Xiuhua; Zang, Weidong; Wang, Jian			META-ANALYSIS OF STEM CELL TRANSPLANTATION FOR REFLEX HYPERSENSITIVITY AFTER SPINAL CORD INJURY	NEUROSCIENCE			English	Article						spinal cord injury; stem cells; neuropathic pain; meta-analysis	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROPATHIC PAIN; FUNCTIONAL RECOVERY; SCHWANN-CELLS; RATS; PRECURSORS; CONTUSION; THERAPY; REPAIR	Stem cells have been used in novel therapeutic strategies for spinal cord injury (SCI), but the effect of stem cell transplantation on neuropathic pain after SCI is unclear. The current meta-analysis evaluates the effects of stem cell transplantation on neuropathic pain after SCI. We first conducted online searches of PubMed, Web of Science, China Academic Journals Full-text Database, and Wanfang Data for randomized controlled trials that compared stem cell transplantation and vehicle treatments in rodent models of neuropathic pain after SCI. Quality assessment was performed using Cochrane Reviewer's Handbook 5.1.0, and meta-analysis was conducted with RevMan 5.3. Then, we developed a rat model of SCI and transplanted bone marrow mesenchymal stem cells to verify meta-analysis results. Twelve randomized, controlled trials (n = 354 total animals) were included in our meta-analysis and divided by subgroups, including species, timing of behavioral measurements, and transplantation time after SCI. Subgroup analysis of these 12 studies indicated that stem cell-treated animals had a higher mechanical reflex threshold than vehicle groups, with a significant difference in both rats and mice. The thermal withdrawal latency showed the same results in mouse subgroups, but not in rat subgroups. In addition, mesenchymal stem cell transplantation was an effective treatment for mechanical, but not thermal reflex hypersensitivity relief in rats. Transplantation showed a positive effect when carried out at 3 or 7 days post-SCI. Stem cell transplantation alleviates mechanical reflex hypersensitivity in rats and mice and thermal reflex hypersensitivity in mice after SCI. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chen, Xuemei; Xue, Bohan; Li, Yuping; Jia, Peijun; Ren, Xiuhua; Zang, Weidong; Wang, Jian] Zhengzhou Univ, Dept Human Anat, Basic Med Coll, Zhengzhou 450001, Henan, Peoples R China; [Song, Chunhua] Zhengzhou Univ, Dept Epidemiol & Stat, Coll Publ Hlth, Zhengzhou 450001, Henan, Peoples R China; [Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Chen, XM; Zang, WD (corresponding author), Zhengzhou Univ, Dept Human Anat, Basic Med Coll, Zhengzhou 450001, Henan, Peoples R China.	chenxm@zzu.edu.cn; zwd@zzu.edu.cn	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471144]; Postdoctoral Science Foundation of ChinaChina Postdoctoral Science Foundation [2016M592314]; Fundamental and Frontier Science of Henan Province Natural Science Fund of China [142300410038]; Youth Development Foundation of Basic Medical College of Zhengzhou University (China) [JCYXY2016-YQ-10]; Department of Education in Henan Province Foundation of China [17A310006]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078026, R01AT007317, R56NS096549, R21NS101614]; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins UniversityJohns Hopkins University; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078026, R56NS096549] Funding Source: NIH RePORTER	This research was supported by Grants from the National Natural Science Foundation of China (No. 81471144), the Postdoctoral Science Foundation of China (2016M592314), the Fundamental and Frontier Science of Henan Province Natural Science Fund of China (No. 142300410038), the Youth Development Foundation of Basic Medical College of Zhengzhou University (China, No. JCYXY2016-YQ-10), the Department of Education in Henan Province Foundation of China (No. 17A310006), the National Institutes of Health (R01NS078026, R01AT007317, R56NS096549 and R21NS101614), and a "Stimulating and Advancing ACCM Research (StAAR)" Grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University. We thank Claire Levine, MS, ELS, for assistance with manuscript preparation.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Amemori T, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0255-2; Amemori T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt219; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; Baastrup C, 2010, PAIN, V151, P670, DOI 10.1016/j.pain.2010.08.024; Ban DX, 2011, REGEN MED, V6, P707, DOI [10.2217/RME.11.32, 10.2217/rme.11.32]; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Budh CN, 2003, CLIN REHABIL, V17, P685, DOI 10.1191/0269215503cr664oa; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Choi JI, 2013, BIOMATERIALS, V34, P4956, DOI 10.1016/j.biomaterials.2013.02.037; Dagci T, 2011, LIFE SCI, V88, P746, DOI 10.1016/j.lfs.2011.02.013; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Donnelly C, 2005, SPINAL CORD, V43, P278, DOI 10.1038/sj.sc.3101702; Ferrero G, 2015, Musculoskelet Surg, V99 Suppl 1, pS53, DOI 10.1007/s12306-015-0363-2; Furuya T, 2009, BRAIN RES, V1295, P192, DOI 10.1016/j.brainres.2009.07.087; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hassanijirdehi M, 2015, KOREAN J PAIN, V28, P129, DOI 10.3344/kjp.2015.28.2.129; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kumagai G, 2013, EXP NEUROL, V248, P369, DOI 10.1016/j.expneurol.2013.06.028; Lee KH, 2007, ACTA NEUROBIOL EXP, V67, P13; Macias MY, 2006, EXP NEUROL, V201, P335, DOI 10.1016/j.expneurol.2006.04.035; Moshourab RA, 2015, BRAIN NEUROTRAUMA MO; Nutt SE, 2013, EXP NEUROL, V248, P491, DOI 10.1016/j.expneurol.2013.07.010; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Salewski RP, 2015, STEM CELLS DEV, V24, P36, DOI 10.1089/scd.2014.0096; Saulino M, 2014, PHYS MED REH CLIN N, V25, P397, DOI 10.1016/j.pmr.2014.01.002; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; STENSMAN R, 1994, PARAPLEGIA, V32, P416, DOI 10.1038/sc.1994.68; Tao F, 2013, STEM CELLS, V31, P83, DOI 10.1002/stem.1258; Urdzikova LM, 2014, INT J MOL SCI, V15, P11275, DOI 10.3390/ijms150711275; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Watanabe S, 2015, STEM CELLS, V33, P1902, DOI 10.1002/stem.2006; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Westgren N, 1998, ARCH PHYS MED REHAB, V79, P1433, DOI 10.1016/S0003-9993(98)90240-4; Yao ZG, 2015, INT J CLIN EXP MED, V8, P404; Yousefifard M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0295-2	40	3	4	2	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 5	2017	363						66	75		10.1016/j.neuroscience.2017.06.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK9IN	WOS:000413824900008	28663095	Green Accepted			2022-02-06	
J	Aase, DM; DiGangi, JA; Babione, JM; Schroth, C; Levy, DM; Kennedy, AE; Proescher, E; Greenstein, JE; Walters, R; Passi, H; Langenecker, SA; Phan, KL				Aase, Darrin M.; DiGangi, Julia A.; Babione, Joseph M.; Schroth, Christopher; Levy, David M.; Kennedy, Amy E.; Proescher, Eric; Greenstein, Justin E.; Walters, Robert; Passi, Holly; Langenecker, Scott A.; Phan, K. Luan			PTSD symptoms are associated with visual retrieval performance in OEF/OIF/OND veterans	PSYCHIATRY RESEARCH			English	Article						Trauma; Neuropsychology; Cognition; Memory; Attention	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; BLAST EXPOSURE; MENTAL-HEALTH; SELF-REPORT; SUBTHRESHOLD; AFGHANISTAN; DEPLOYMENT; VALIDITY; MEMORY	Posttraumatic stress disorder (PTSD) is associated with poorer performance on neuropsychological tests in veterans. However, prior studies have generally compared individuals with PTSD to control groups, often excluding individuals with moderate symptoms. The present study evaluated neuropsychological performance among OEF/OIF/OND veterans as a function of overall PTSD severity, while also exploring potential associations between cognitive performance and PTSD symptom clusters. Using a brief neuropsychological battery, clinical interviews, and self-report instruments, we evaluated neuropsychological and psychiatric functioning in 90 OEF/OIF/OND veterans. When controlling for the effects of premorbid intellectual functioning and combat exposure, higher PTSD severity predicted worse visual retrieval performance, but not attention, verbal retrieval, visual learning, or executive functioning performance. A trend was observed where higher PTSD symptoms predicted worse verbal learning performance. All PTSD symptom clusters were associated with visual retrieval performance within the full sample. Avoidance and numbing symptoms were associated with verbal learning in the full sample. Findings suggest that among OEF/OIF/OND veterans with a range of PTSD symptoms, the assessment of visual memory may have implications for clinical practice.	[Aase, Darrin M.; DiGangi, Julia A.; Babione, Joseph M.; Schroth, Christopher; Levy, David M.; Kennedy, Amy E.; Proescher, Eric; Greenstein, Justin E.; Walters, Robert; Passi, Holly; Phan, K. Luan] Jesse Brown VA Med Ctr, Mental Hlth Serv Line, 820 S Damen Ave, Chicago, IL 60612 USA; [Aase, Darrin M.; DiGangi, Julia A.; Schroth, Christopher; Kennedy, Amy E.; Proescher, Eric; Greenstein, Justin E.; Langenecker, Scott A.; Phan, K. Luan] Univ Illinois, Dept Psychiat, 1747 Roosevelt Rd, Chicago, IL 60608 USA; [Aase, Darrin M.] Governors State Univ, Coll Hlth & Human Serv, 1 Univ Pkwy, University Pk, IL 60484 USA; [Phan, K. Luan] Univ Illinois, Dept Psychol, 808 S Wood St, Chicago, IL 60612 USA; [Phan, K. Luan] Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St, Chicago, IL 60612 USA		Aase, DM (corresponding author), Governors State Univ, Coll Hlth & Human Serv, 1 Univ Pkwy, University Pk, IL 60484 USA.	daase@govst.edu	Langenecker, Scott/F-3548-2012	Langenecker, Scott/0000-0002-7932-5494	U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01BX007080]	This work was supported by the U.S. Department of Veterans Affairs [I01BX007080 to KLP].	Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Benedict R., 1997, BRIEF VISUOSPATIAL M; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Conners C. K., 2000, CONNERS CONTINUOUS P; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Eekhout I, 2016, LANCET PSYCHIAT, V3, P58, DOI 10.1016/S2215-0366(15)00368-5; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Golden CJ., 2002, STROOP COLOR WORD TE; Grubaugh AL, 2005, J NERV MENT DIS, V193, P658, DOI 10.1097/01.nmd.0000180740.02644.ab; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jakupcak M, 2011, J NERV MENT DIS, V199, P272, DOI 10.1097/NMD.0b013e3182124604; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Litz B. T., 2009, PTSD RES Q, V20, P1; Lobo I, 2015, J AFFECT DISORDERS, V183, P210, DOI 10.1016/j.jad.2015.05.015; McLaughlin KA, 2015, BIOL PSYCHIAT, V77, P375, DOI 10.1016/j.biopsych.2014.03.028; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P739, DOI 10.1002/da.20574; Schwab KA, 2006, NEUROLOGY, V66, pA235; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Wrocklage KM, 2016, J INT NEUROPSYCH SOC, V22, P399, DOI 10.1017/S1355617716000059	39	3	3	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	NOV	2017	257						156	162		10.1016/j.psychres.2017.07.041			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FK3KZ	WOS:000413385300026	28756343				2022-02-06	
J	Cherry, JC; Gordon, KE				Cherry, Jonathan C.; Gordon, Kevin Eric			Stuttering as a Symptom of Concussion: Confirmation of Association Using Nontraditional Information Sources	PEDIATRIC EMERGENCY CARE			English	Article						brain concussion; brain injury; stuttering; association; concept co-occurrence	HEAD-INJURY	Objective A 12-year-old girl presented to our pediatric emergency department after a head injury with symptoms of concussion and acute stuttering. A PubMed search identified only 1 similar pediatric case. We investigated whether new-onset stuttering may be seen in the presence of acute concussive symptoms using an infodemiologic approach. Methods We conducted a search with a metabrowser search engine (www.dogpile.com) using the free-text words concussion and stuttering. The first 100 hits were scanned specifically for forum posts, extracting reports of concussions that were followed by new-onset stuttering. Duplicates were minimized by cross-referencing user name, location, date, and reported age and sex. Results Of the first 100 hits, we identified 17 unique posts that described an injury leading to a concussion followed within a short interval by new-onset stuttering. Posts were primarily by the affected individual (76%) and 64% involved female individuals. Sports and falls/injury accounted for most injuries (71%). Forty-one percent of posts explicitly stated that the concussion had been formally diagnosed. For those that reported the timing of stuttering onset (47%), the stuttering was documented within 1 hour of the injury (4/8) or between 1 and 24 hours (4/8). Conclusions The ease with which we found so many reports of stuttering after head injury with concussive symptoms confirms that new-onset stuttering may be a symptom of concussion. Our experience highlights both a failure of using conventional medical literature and a success of using nontraditional information sources in identifying uncommonly associated symptoms of frequently encountered conditions.	[Cherry, Jonathan C.] Dalhousie Univ, Div Pediat, Dept Pediat, Halifax, NS, Canada; [Gordon, Kevin Eric] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS, Canada		Gordon, KE (corresponding author), IWK Hlth Ctr, Div Pediat Neurol, Dept Pediat, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca					BOHME G, 1968, FOLIA PHONIATR, V20, P239; Craig A, 1996, J SPEECH HEAR RES, V39, P808, DOI 10.1044/jshr.3904.808; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Helm-Estabrooks Nancy, 1998, Seminars in Speech and Language, V19, P23, DOI 10.1055/s-2008-1064032; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; Manaut-Gil E, 2005, REV NEUROLOGIA, V40, P587, DOI 10.33588/rn.4010.2004487; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Yeoh HK, 2006, CHILD NERV SYST, V22, P310, DOI 10.1007/s00381-005-1154-0	10	3	3	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	NOV	2017	33	11					e137	e139		10.1097/PEC.0000000000001326			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	FM6AX	WOS:000415128500011	29095783				2022-02-06	
J	Choi, WJ; Robinovitch, SN; Ross, SA; Phan, J; Cipriani, D				Choi, W. J.; Robinovitch, S. N.; Ross, S. A.; Phan, J.; Cipriani, D.			Effect of neck flexor muscle activation on impact velocity of the head during backward falls in young adults	CLINICAL BIOMECHANICS			English	Article						Falls; Traumatic brain injury; Impact velocity; Head injury; Muscle activation; Neck muscles	LONG-TERM-CARE; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; RISK-FACTORS; BIOMECHANICS; KINEMATICS; DYNAMICS; STRENGTH; PLAYERS; HUMANS	Falls are a common cause of traumatic brain injuries (TBI) across the lifespan. A proposed but untested hypothesis is that neck muscle activation influences impact severity and risk for TBI during a fall. We conducted backward falling experiments to test whether activation of the neck flexor muscles facilitates the avoidance of head impact, and reduces impact velocity if the head contacts the ground. Young adults (n = 8) fell from standing onto a 30 cm thick gymnastics mat while wearing a helmet. Participants were instructed to fall backward and (a) prevent their head from impacting the mat ("no head impact" trials); (b) allow their head to impact the mat, but with minimal impact severity ("soft impact" trials); and (c) allow their head to impact the mat, while inhibiting efforts to reduce impact severity ("hard impact" trials). Trial type associated with peak magnitude of electromyographic activity of the stemocleidomastoid (SCM) muscles (p < 0.017), and with the vertical and horizontal velocity of the head at impact (p < 0.001). Peak SCM activations, expressed as percent maximal voluntary isometric contraction (%MVIC), averaged 75.3, 67.5, and 44.5%MVIC in "no head impact", "soft impact", and "hard impact" trials, respectively. When compared to "soft impact" trials, vertical impact velocities in "hard impact" trials averaged 87% greater (3.23 versus 1.73 m/s) and horizontal velocities averaged 83% greater (2.74 versus 1.50 m/s). For every 10% increase in SCM % MVIC, vertical impact velocity decreased 0.24 m/s and horizontal velocity decreased 0.22 m/s. We conclude that SCM activation contributes to the prevention and modulation of head impact severity during backward falls.	[Choi, W. J.] Yonsei Univ, Dept Phys Therapy, Injury Prevent & Biomech Lab, Wonju, Kangwon Do, South Korea; [Robinovitch, S. N.; Ross, S. A.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Phan, J.] Chapman Univ, Dept Phys Therapy, Irvine, CA USA; [Cipriani, D.] West Coast Univ, Dept Phys Therapy, Ctr Grad Studies, Los Angeles, CA USA		Choi, WJ (corresponding author), Yonsei Univ, Dept Phys Therapy, Yonseidae Gil 1, Wonju 26493, Kangwon Do, South Korea.	wcjchoi@yonsei.ac.kr	Cipriani, Daniel/K-1591-2019; Ross, Stephanie A./Q-3910-2019	Ross, Stephanie A./0000-0003-3512-9579; Robinovitch, Stephen/0000-0003-3881-6227			Aziz O, 2014, GAIT POSTURE, V39, P506, DOI 10.1016/j.gaitpost.2013.08.034; Baures R, 2011, PERCEPTION, V40, P674, DOI 10.1068/p6945; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Blouin JS, 2003, NEUROSCI LETT, V347, P1, DOI 10.1016/S0304-3940(03)00632-3; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Caccese V., 2014, EXP TECH, V40, P413; Choi WJ, 2015, J BIOMECH, V48, P911, DOI 10.1016/j.jbiomech.2015.02.025; DIETZ V, 1981, J PHYSIOL-LONDON, V311, P113, DOI 10.1113/jphysiol.1981.sp013576; Ding L, 2016, J BIOMECH, V49, P238, DOI 10.1016/j.jbiomech.2015.12.009; Feldman F, 2007, J BIOMECH, V40, P2612, DOI 10.1016/j.jbiomech.2007.01.019; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hodgson V. R., 1971, DOTHS800583 NHTSA; Hsiao ET, 1998, J BIOMECH, V31, P1; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; LEGGETT SH, 1991, AM J SPORT MED, V19, P653, DOI 10.1177/036354659101900618; Liu J, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028033; Liu X, 2017, GEROSCIENCE, V39, P93, DOI 10.1007/s11357-017-9963-0; Lockhart TE, 2003, ERGONOMICS, V46, P1136, DOI 10.1080/0014013031000139491; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Robinovitch SN, 2004, J BIOMECH, V37, P1329, DOI 10.1016/j.jbiomech.2003.12.015; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rosenblatt NJ, 2012, ARCH PHYS MED REHAB, V93, P718, DOI 10.1016/j.apmr.2011.08.038; Saari P, 2007, ARCH GERONTOL GERIAT, V45, P207, DOI 10.1016/j.archger.2006.10.012; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Troy KL, 2007, CLIN BIOMECH, V22, P1088, DOI 10.1016/j.clinbiomech.2007.07.014; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003	31	3	3	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	NOV	2017	49						28	33		10.1016/j.clinbiomech.2017.08.007			6	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Orthopedics; Sport Sciences	FO5GO	WOS:000416881700005	28843128				2022-02-06	
J	Cicuendez, M; Castano-Leon, A; Ramos, A; Hilario, A; Gomez, PA; Lagares, A				Cicuendez, Marta; Castano-Leon, Ana; Ramos, Ana; Hilario, Amaya; Gomez, Pedro A.; Lagares, Alfonso			Magnetic resonance in traumatic brain injury: A comparative study of the different conventional magnetic resonance imaging sequences and their diagnostic value in diffuse axonal injury	NEUROCIRUGIA			Spanish	Article						Magnetic resonance imaging; Diffuse axonal injury; Traumatic brain injury; Severe head trauma	SEVERE HEAD-INJURY; PROGNOSTIC VALUE; LONGITUDINAL MRI; CORPUS-CALLOSUM; MODERATE; CLASSIFICATION; IMPACT; LESION; STEM	Objective: To compare the identification capability of traumatic axonal injury (TAI) by different sequences on conventional magnetic resonance (MR) studies in traumatic brain injury (TBI) patients. Material and methods: We retropectevely analyzed 264 TBI patients to whom a MR had been performed in the first 60 days after trauma. All clinical variables related to prognosis were registered, as well as the data from the initial computed tomography. The MR imaging protocol consisted of a 3-plane localizer sequence T1-weighted and T2-weighted fast spin-echo, FLAIR and gradient-echo images (GRET2*). TAI lesions were classified according to Gentry and Firsching classifications. We calculated weighted kappa coefficients and the area under the ROC curve for each MR sequence. A multivariable analyses was performed to correlate MR findings in each sequence with the final outcome of the patients. Results: TAI lesions were adequately visualized on T2, FLAIR and GRET2* sequences in more than 80% of the studies. Subcortical TAI lesions were well on FLAIR and GRET2* sequences visualized hemorrhagic TAI lesions. We saw that these MR sequences had a high inter-rater agreement for TAI diagnosis (0.8). T2 sequence presented the highest value on ROC curve in Gentry (0.68, 95%CI: 0.61-0.76, p <0.001, Nagerlkerke-R-2 0.26) and Firsching classifications (0.64, 95%CI 0.57-0.72, p < 0.001, Nagerlkerke-R-2 0.19), followed by FLAIR and GRET2* sequences. Both classifications determined by each of these sequences were associated with poor outcome after performing a multivariable analyses adjusted for prognostic factors (p <0.02). Conclusions: We recommend to perform conventional MR study in subacute phase including T2, FLAIR and GRET2* sequences for visualize TAI lesions. These MR findings added prognostic information in TBI patients. (C) 2017 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Cicuendez, Marta] Hosp Univ Vall dHebron, Dept Neurocirugia, Barcelona, Spain; [Castano-Leon, Ana; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense Madrid, Hosp Univ Octubre 12, Inst Invest I 12, Dept Neurocirugia, Madrid, Spain; [Ramos, Ana; Hilario, Amaya] Univ Complutense Madrid, Hosp Univ Octubre 12, Dept Neurorradiol, Madrid, Spain		Cicuendez, M (corresponding author), Hosp Univ Vall dHebron, Dept Neurocirugia, Barcelona, Spain.	marta.cicuendez@gmail.com	Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020; Lagares, Alfonso/B-2969-2011	Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049; Lagares, Alfonso/0000-0003-3996-0554			Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Carney N, 2016, NEUROSURGERY; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; Edlow BL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0375-y; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	33	3	4	0	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	NOV-DEC	2017	28	6					266	275		10.1016/j.neucie.2017.06.007			10	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN8TF	WOS:000416297700003	28728755				2022-02-06	
J	Frendl, I; Katko, M; Galgoczi, E; Boda, J; Zsiros, N; Nemeti, Z; Bereczky, Z; Hudak, R; Kappelmayer, J; Erdei, A; Turchanyi, B; Nagy, EV				Frendl, Istvan; Katko, Monika; Galgoczi, Erika; Boda, Judit; Zsiros, Noemi; Nemeti, Zoltan; Bereczky, Zsuzsanna; Hudak, Renata; Kappelmayer, Janos; Erdei, Annamaria; Turchanyi, Bela; Nagy, Endre V.			Plasminogen Activator Inhibitor Type 1: A Possible Novel Biomarker of Late Pituitary Dysfunction after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hemostasis; mild traumatic brain injury; PAI-1; pituitary dysfunction	HYPOPITUITARISM; COAGULATION; TISSUE; PAI-1; HEMORRHAGE; SECONDARY	More than 80% of traumatic brain injury (TBI) patients suffer from mild TBI (mTBI). However, even mTBI carries the risk of late pituitary dysfunction. A predictive biomarker at the time of injury that could identify patients who subsequently may develop permanent pituitary dysfunction would help to direct patients toward endocrine care. We enrolled 508 TBI patients (406 with mTBI) into our study. Blood samples were collected for identification of predictive biomarkers of late pituitary dysfunction at the time of admission. Follow-up blood samples were collected between 6 and 12 months after the TBI and were evaluated for pituitary function. Of the 406 mTBI patients, 76 were available for follow-up. Preexisting mild pituitary dysfunction was found for 15 patients based on hormone levels at the time of injury. Of the remaining 61 patients, 10 have shown deficiency in at least one pituitary hormone: 4 had growth hormone deficiency, 3 gonadotropin, 2 thyrotropin, and 1 patient combined gonadotropin and thyrotropin deficiency. Hence, newly developed pituitary hormone deficiency was found in 16% of mTBI patients. Neither the cause of mTBI nor its complications were predictive of late pituitary dysfunction. Of the hemostasis parameters studied, lower plasminogen activator inhibitor type 1 (PAI-1) level at the time of injury was found to be predictive for the development of late pituitary dysfunction; sensitivity, specificity, and positive and negative predictive values were 80%, 67%, 32%, and 94%, respectively. Even mTBI carries a substantial risk of endocrine consequences. Serum PAI-1 level at the time of TBI may serve as a predictive biomarker of late pituitary dysfunction in mTBI patients.	[Frendl, Istvan; Nemeti, Zoltan; Turchanyi, Bela] Univ Debrecen, Fac Med, Dept Trauma & Hand Surg, Debrecen, Hungary; [Katko, Monika; Galgoczi, Erika; Boda, Judit; Zsiros, Noemi; Erdei, Annamaria; Nagy, Endre V.] Univ Debrecen, Fac Med, Dept Med, Div Endocrinol, Nagyerdei Krt 98, H-4032 Debrecen, Hungary; [Bereczky, Zsuzsanna; Hudak, Renata; Kappelmayer, Janos] Univ Debrecen, Fac Med, Dept Lab Med, Debrecen, Hungary		Nagy, EV (corresponding author), Univ Debrecen, Fac Med, Dept Med, Div Endocrinol, Nagyerdei Krt 98, H-4032 Debrecen, Hungary.	nagy@internal.med.unideb.hu	Erdei, Annamaria/AAL-5765-2020				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Alessi MC, 2007, CURR OPIN LIPIDOL, V18, P240, DOI 10.1097/MOL.0b013e32814e6d29; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Fernandez-Rodriguez Eva, 2011, Front Endocrinol (Lausanne), V2, P25, DOI 10.3389/fendo.2011.00025; Frieden R. T., 2015, REP C TRAUM BRAIN IN; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; HALASZ B, 1962, J ENDOCRINOL, V25, P147, DOI 10.1677/joe.0.0250147; Halasz B., 1985, PITUITARY GLAND, P1; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lee TW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00396; Medcalf RL, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00222; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Oishi K, 2009, CLIN EXP HYPERTENS, V31, P208, DOI 10.1080/10641960902822468; Owens G, 2004, AM J MANAG CARE, V10, pS424; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tjarnlund-Wolf A, 2012, STROKE, V43, P2833, DOI 10.1161/STROKEAHA.111.622217; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zheng P, 2014, J ENDOCRINOL INVEST, V37, P309, DOI 10.1007/s40618-014-0059-8	46	3	3	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3238	3244		10.1089/neu.2017.5198		NOV 2017	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414525800001	28931364	Green Submitted			2022-02-06	
J	Kabore, AF; Ouedraogo, A; Ki, KB; Traore, SSI; Traore, IA; Bougouma, CTH; Arnaudovski, D; Diallo, O; Zabsonre, S; Ouedraogo, N; Augustin, P				Kabore, Armel Flavien; Ouedraogo, Aziz; Ki, Kelan Bertille; Traore, Salah Seif Idriss; Traore, Ibrahim Alain; Bougouma, Cheik Tidiane Hafiz; Arnaudovski, Darko; Diallo, Ousseini; Zabsonre, Sylvain; Ouedraogo, Nazinigouba; Augustin, Pascal			Head Computed Tomography Scan in Isolated Traumatic Brain Injury in a Low-Income Country	WORLD NEUROSURGERY			English	Article						Computed tomography scan; Evaluation; Traumatic brain injury	NEUROCRITICAL CARE; PREDICTORS	BACKGROUND: Head computed tomography scan (HCTS) is the cornerstone of the management of traumatic brain injury (TBI). The impact of performing a HCTS in TBI has been scarcely investigated in low-income countries (LICs). Furthermore, the cost of a HCTS is a burden for family finances. METHODS: A prospective observational study was conducted in Burkina Faso. All consecutive patients with isolated TBI needing a HCTS were included. Result and impact of HCTS were evaluated. RESULTS: There were 183 patients prescribed a HCTS for an isolated TBI. Mild, moderate, and severe TBIs represented 55%, 31%, and 14% of the cases, respectively. In 72 patients, HCTS was not performed because of economic barrier. Among the 110 HCTSs performed, there were intracranial lesions in 81 (74%) patients. Among the 110 performed HCTS, 34 (31% [22.3%-39.5%]) HCTSs altered the management of TBI, with 16 (15%) cases of surgical indications, and 20 (18%) cases of modification of the medical treatment. In patients without neurologic signs, the rate of alteration of management was 28%. The realization of the HCTSs was associated with the presence of neurologic signs and income level. Inhospital mortality was 11% (n = 21). Among the 162 patients discharged alive from the hospital, 27 (20%) were discharged with a severe disability state (Glasgow Outcome Scale score <= 3). The rate of return to work was 77%. CONCLUSIONS: No modification of guidelines can be advocated from this study. However, given the financial burden on family of performing HCTS, research may identify criteria allowing for avoiding HCTS. Guidelines specific to LICs are needed to get closer to the best interest of patients.	[Kabore, Armel Flavien; Ouedraogo, Aziz; Traore, Salah Seif Idriss; Ouedraogo, Nazinigouba] Ctr Hosp Univ, Serv Anesthesie Reanimat, Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Diallo, Ousseini] Ctr Hosp Univ, Serv Imagerie Med, Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Zabsonre, Sylvain] Ctr Hosp Univ, Serv Neurochirurg, Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Kabore, Armel Flavien; Ki, Kelan Bertille; Bougouma, Cheik Tidiane Hafiz; Diallo, Ousseini; Zabsonre, Sylvain; Ouedraogo, Nazinigouba] Univ Ouaga 1 Pr Joseph KI Zerbo, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso; [Ki, Kelan Bertille] Ctr Hosp Univ Pediat Charles de Gaulle, Serv Anesthesie Reanimat, Ouagadougou, Burkina Faso; [Traore, Ibrahim Alain] Ctr Hosp Univ Souro Sanou, Serv Anesthesie Reanimat, Bobo Dioulasso, Burkina Faso; [Traore, Ibrahim Alain] Univ Polytech Bobo Dioulasso, Bobo Dioulasso, Burkina Faso; [Bougouma, Cheik Tidiane Hafiz] Ctr Hosp Univ Tengandogo, Serv Anesthesie Reanimat, Ouagadougou, Burkina Faso; [Arnaudovski, Darko; Augustin, Pascal] Ctr Hosp Univ Bichat Claude Bernard, Dept Anesthesie Reanimat, Paris, France		Augustin, P (corresponding author), Ctr Hosp Univ Bichat Claude Bernard, Dept Anesthesie Reanimat, Paris, France.	pascalaugustin@hotmail.com					Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; Prieto-Palomino MA, 2016, BRAIN INJURY, V30, P441, DOI 10.3109/02699052.2016.1141434; [Anonymous], 2016, LANCET GLOB HEALTH, V4, pE579, DOI 10.1016/S2214-109X(16)30190-5; Bezuidenhout A Fourie, 2013, S Afr Med J, V103, P646, DOI 10.7196/samj.6876; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; De Allegri M, 2012, J PUBLIC HEALTH POL, V33, P439, DOI 10.1057/jphp.2012.27; Glasziou P, 2017, LANCET, V390, P169, DOI 10.1016/S0140-6736(16)30946-1; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENNETT B, 1975, LANCET, V1, P480; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Marion DW, 2006, NEUROSURGERY, V58, P655; Mateen FJ, 2011, NEUROCRIT CARE, V15, P593, DOI 10.1007/s12028-011-9623-7; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Ohaegbulam Samuel C, 2011, Surg Neurol Int, V2, P182, DOI 10.4103/2152-7806.91137; Owolabi M, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000105; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saini V, 2017, LANCET, V390, P105, DOI 10.1016/S0140-6736(16)32573-9; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Su TT, 2013, EUR J HEALTH ECON, V14, P75, DOI 10.1007/s10198-011-0354-7; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	31	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						382	388		10.1016/j.wneu.2017.07.160			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500052	28826717				2022-02-06	
J	Lyu, Y; Zhang, YW; Tan, L; Ji, WL; Yu, P; Mao, LQ; Zhou, F				Lyu Yang; Zhang Ya-Wen; Tan Lei; Ji Wen-Liang; Yu Ping; Mao Lan-Qun; Zhou Fang			Continuously Monitoring of Concentration of Extracellular Ascorbic Acid in Spinal Cord Injury Model	CHINESE JOURNAL OF ANALYTICAL CHEMISTRY			Chinese	Article						Ascorbic acid; Spinal cord injury; In vivo microdialysis; On-line electrochemical detection	PERFORMANCE LIQUID-CHROMATOGRAPHY; GLUTAMATE; ISCHEMIA; RATS; MICRODIALYSIS; DOPAMINE; SYSTEM; TISSUE; BRAIN	Acute traumatic spinal cord injury (SCI) represents one of the most devastating injuries that afflict the human body. Ascorbic acid (AA) plays an important role in mammalian central nervous system, especially in SCI. In this study, the change of AA concentration after SCI was investigated by using an on. line electrochemical method integrated with in vivo microdialysis. A microdialysis probe (2 mm in length) was implanted into the spinal cord of an anesthetized rat (Thoracic-10). Microdialysis perfusate (2 mu L/min) was collected in the sample loop of an on-line injector for direct injection onto a glassy carbon electrode which was modified with the heat. treated single-walled carbon nanotubes (SWNTs). Normal ascorbic acid concentration in the extracellular fluids of spinal cords was (26.17 +/- 1.25) mu mol/L (n = 8). The experimental spinal cord injury, induced by a lesion at T=10, significantly increased the extracellular ascorbic acid levels to (53.24 +/- 1.95) mu mol/L (n = 8). This study provides the experimental evidence on the essential roles of ascorbic acid in spinal cord injuries.	[Lyu Yang; Zhang Ya-Wen; Tan Lei; Zhou Fang] Peking Univ, Hosp 3, Beijing 100191, Peoples R China; [Ji Wen-Liang; Yu Ping; Mao Lan-Qun] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China		Zhou, F (corresponding author), Peking Univ, Hosp 3, Beijing 100191, Peoples R China.; Mao, LQ (corresponding author), Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China.	lqmao@iccas.ac.cn; zhou.md@126.com	Yu, Ping/C-7879-2019	Yu, Ping/0000-0002-6096-1933	Beijing Science and Technology Project (New), China [2144000021]	This work was supported by the Beijing Science and Technology Project (New), China (No. 2144000021)	BARABAS J, 1995, ARCH GERONTOL GERIAT, V21, P43, DOI 10.1016/0167-4943(95)00654-4; Chehensse C, 2013, HUM REPROD UPDATE, V19, P507, DOI 10.1093/humupd/dmt029; Jin PF, 2012, J PHARMACEUT BIOMED, V70, P151, DOI 10.1016/j.jpba.2012.06.020; Li LJ, 2016, ANALYST, V141, P2199, DOI 10.1039/c6an00064a; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu K, 2013, ANAL CHEM, V85, P9947, DOI 10.1021/ac402620c; McAdoo DJ, 2008, PHARMACOL BIOCHEM BE, V90, P282, DOI 10.1016/j.pbb.2008.03.001; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; Serarslan Y, 2010, J CLIN NEUROSCI, V17, P349, DOI 10.1016/j.jocn.2009.03.036; Szultka M, 2014, ELECTROPHORESIS, V35, P585, DOI 10.1002/elps.201300439; Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9612(03)00497-6; Tao L, 2013, ANAL CHIM ACTA, V761, P194, DOI 10.1016/j.aca.2012.11.046; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tsai PJ, 2005, CLIN CHIM ACTA, V362, P94, DOI 10.1016/j.cccn.2005.05.033; Xu GY, 2004, EXP NEUROL, V187, P329, DOI 10.1016/j.expneurol.2004.01.029; Yusa T, 2001, BRAIN RES, V897, P104, DOI 10.1016/S0006-8993(01)02099-6; Zhang CZ, 2016, CHINESE J ANAL CHEM, V44, P1263, DOI 10.11895/j.issn.0253.3820.160095; Zhang RY, 2012, CHINESE J ANAL CHEM, V40, P909, DOI 10.3724/SP.J.1096.2012.11171; Zhu MF, 2011, ELECTROANAL, V23, P907, DOI 10.1002/elan.201000712	19	3	3	6	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0253-3820	1872-2040		CHINESE J ANAL CHEM	Chin. J. Anal. Chem.	NOV	2017	45	11					1595	1599		10.11895/j.issn.0253.3820.171091			5	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	FR6LP	WOS:000419177900002					2022-02-06	
J	McIntyre, L; Campo, M				McIntyre, Lauren; Campo, Marc			Descriptive Values for Dancers on Baseline Concussion Tools	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion baseline examinations; concussion-management modifiers; traumatic brain injuries	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; FOOTBALL PLAYERS; NORMATIVE DATA; STATEMENT; CHILDREN; SLEEP; SCAT2	Context: Capturing baseline data before a concussion can be a valuable tool in individualized care. However, not all athletes, including dancers, have access to baseline testing. When baseline examinations were not performed, clinicians consult normative values. Dancers are unique athletes; therefore, describing values specific to dancers may assist those working with these athletes in making more informed decisions. Objective: To describe values for key concussion measures of dancers. Our secondary aim was to examine whether differences existed between sexes and professional status. Finally, we explored factors that may affect dancers' scores. Design: Cross-sectional study. Setting: Professional dance companies and a collegiate dance conservatory. Patients or Other Participants: A total of 238 dancers (university = 153, professional = 85; women = 171; men = 67; age = 21.1 +/- 4.8 years). Main Outcome Measure (s): We calculated the total symptom severity from the Sport Concussion Assessment Tool-3rd edition; the Standardized Assessment of Concussion score; the modified Balance Error Scoring System score; and the King-Devick score for each participant. Group differences were analyzed with Mann-Whitney or t tests, depending on the data distribution. We used bivariate correlations to explore the effects of other potential influencing factors. Results: Participants demonstrated the following baseline outcomes: symptom severity = 16.6 +/- 12.8; Standardized Assessment of Concussion = 27.5 +/- 1.8; modified Balance Error Scoring System = 3.2 +/- 3.1 errors; and King-Devick = 41.5 +/- 8.2 seconds. A Mann-Whitney test revealed differences in King-Devick scores between female (40.8 +/- 8.0 seconds) and male (43.4 +/- 8.4 seconds) dancers (P = .04). An independent-samples t test also demonstrated a difference in modified Balance Error Scoring System scores between female (2.95 +/- 3.1 errors) and male (3.8 +/- 3.1 errors) dancers (P = .02). Age, hours of sleep, height, and history of concussion, depression, or injury did not display moderate or strong associations with any of the outcome measures. Conclusions: Dancers' symptom severity scores appeared to be higher than the values reported for other athletes. Additional studies are needed to establish normative values and develop a model for predicting baseline scores.	[McIntyre, Lauren] Harkness Ctr Dance Injuries, 614 2nd Ave,Floor 2,Suite G, New York, NY 10016 USA; [Campo, Marc] Mercy Coll, Dobbs Ferry, NY 10522 USA		McIntyre, L (corresponding author), Harkness Ctr Dance Injuries, 614 2nd Ave,Floor 2,Suite G, New York, NY 10016 USA.	lauren.mcintyre@nyumc.org		Campo, Marc/0000-0003-0478-4255			Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; [Anonymous], ED STAT; [Anonymous], OCC OUTL HDB DANC CH; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown CN, 2007, J ATHL TRAINING, V42, P515; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Diamond T., 2007, 17 ANN M INT ASS DAN; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eusanio Jacqueline, 2014, J Dance Med Sci, V18, P106, DOI 10.12678/1089-313X.18.3.106; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; HAMILTON LH, 1989, AM J SPORT MED, V17, P263, DOI 10.1177/036354658901700219; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Hanrahan SJ, 2007, 17 ANN M INT ASS DAN; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Institute of Medicine and National Research Council, 2014, SPORTS REL CONC YOUT; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Krasnow D., 1999, J DANCE MED SCI, V3, P51; Liederbach M., DANCE MED STRATEGIES; Liederbach M., 2007, J DANCE MED SCI, V11, P45; Liederbach M., 1995, P ANN C INT ASS DANC; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McIntyre Lauren, 2016, J Dance Med Sci, V20, P79, DOI 10.12678/1089-313X.20.2.79; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; O'Neill JR, 2011, RES Q EXERCISE SPORT, V82, P373, DOI 10.1080/02701367.2011.10599769; Padham Melissa, 2014, J Dance Med Sci, V18, P37, DOI 10.12678/1089-313X.18.1.37; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; SCHON LC, 1994, CLIN SPORT MED, V13, P865; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	42	3	3	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2017	52	11					1035	1040		10.4085/1062-6050-52.10.14			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FR0MQ	WOS:000418756400006	29120225	Green Published, Bronze			2022-02-06	
J	Sahyouni, R; Mahmoodi, A; Tran, DK; Tran, P; Chen, JW				Sahyouni, Ronald; Mahmoodi, Amin; Tran, Diem K.; Tran, Peter; Chen, Jefferson W.			Linguistic Validation of Interactive Educational Interventions in Neurologic Trauma	WORLD NEUROSURGERY			English	Article						Brain injury; Concussion; Culture; Education; iBook; Language; Neurologic surgery	BRAIN-INJURY; PATIENT EDUCATION; IBOOKS AUTHOR; INFORMATION; CONCUSSION; SETTINGS; LANGUAGE; PLAYERS; IMPACT; RISK	BACKGROUND: Neurological surgeons oftentimes educate patients and their families on complex medical conditions and treatment options. Time constraints and varied linguistic and cultural backgrounds limit the amount of information that can be disbursed. In this study, we assessed the linguistic validity of interactive educational interventions in non-English-speaking patients with traumatic brain injury (TBI) and concussion and their families. METHODS: A total of 273 English-, Spanish-, Korean-, and Vietnamese-speaking neurotrauma patients (n = 124) and family members (n = 149) completed a presurvey to evaluate their incipient understanding, interacted with an iPad-based iBook (Apple) on concussion or TBI in their native language, completed a postsurvey to gauge changes in understanding, and then consulted with their neurosurgeon. RESULTS: All participants (124 patients and 149 family members) had significantly increased (95% confidence interval [CI], P < 0.01) postsurvey scores (average pre-iBook score, 2.810; average post-iBook score, 4.109), regardless of native language or cultural background. Caucasian participants scored significantly higher than the combination of all ethnicities on both the baseline survey (95% CI, P < 0.01) and the post-iBook survey (95% CI, P < 0.01), and Asian participants scored significantly lower (95% CI, P < 0.05) than the combination regardless of similar baseline scores. CONCLUSIONS: Interactive iBook-based interventions on concussion and TBI can increase participants' comprehension, improve their comfort with their medical condition and the follow-up care, and enhance communication with their physicians. These findings are linguistically valid irrespective of the participants' native language or cultural background.	[Sahyouni, Ronald] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Sahyouni, Ronald] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Mahmoodi, Amin; Tran, Diem K.; Tran, Peter; Chen, Jefferson W.] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA		Chen, JW (corresponding author), Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.	jeffewc1@uci.edu	chen, jeff/AAR-7375-2020	chen, jeff/0000-0003-0624-6864; Mahmoodi, Amin/0000-0003-0012-9245; Sahyouni, Ronald/0000-0002-2124-0535	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-GM08620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008620] Funding Source: NIH RePORTER	R.S. is funded in part by a Medical Scientist Training Program Grant from the National Institutes of Health (T32-GM08620). The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	[Anonymous], 2006, NEUROSURG FOCUS; Briggs M, 2014, J VIS COMMUN MED, V37, P59, DOI 10.3109/17453054.2014.974516; Brito J, 2012, AM SOC MECH ENG 2012; Chen, 2017, TRAUMA ACUTE CARE, V2, P32; Chen JW, 2015, CONCUSSION; Chen JW, 2015, TRAUMATIC BRAIN INJU; Chen JW, 2015, BENH CHAN DONG NAO; COLEMAN M, 1975, J APPL PSYCHOL, V60, P283, DOI 10.1037/h0076540; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Cusea J., 1992, COOPERATIVE LEARNING, V2, P2; Ferguson WJ, 2002, FAM MED, V34, P353; Forsyth BH, 2007, FIELD METHOD, V19, P264, DOI 10.1177/1525822X07302105; Fox MP, 2009, PATIENT EDUC COUNS, V77, P6, DOI 10.1016/j.pec.2009.02.011; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gliem J. A., 2003, MIDW RES TO PRACT C; Goldberg PK, 1996, 5862 NBER; Graham Suzanne, 2008, Perm J, V12, P67; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harkness J, 2004, METHODS TESTING EVAL, DOI [DOI 10.1002/0471654728.CH22, DOI 10.1002/0471654728]; HARKNESS JA, 1998, ZUMA NACHRICHTEN SPE, V0003; Hendrickson S G, 1998, Inj Prev, V4, P126; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; JENNETT B, 1975, LANCET, V1, P480; Jossey-Bass Bonwell C. C., 1991, 1 ASHEERIC G WASH U; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Millis B. J., 1997, AM COUNCIL ED SERIES; Moshtaghi O, 2017, AM J OTOLARYNG, V38, P174, DOI 10.1016/j.amjoto.2016.12.004; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Pan Y., 2007, ROLE SOCIOLINGUISTIC; PARKIN PC, 1993, PEDIATRICS, V91, P772; Payne KFB, 2012, J VIS COMMUN MED, V35, P162, DOI 10.3109/17453054.2012.747173; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Ritzhaupt AD, 2013, J RES TECHNOL EDUC, V45, P291, DOI 10.1080/15391523.2013.10782607; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sahyouni R, NEUROSURGERY; Sahyouni R, 2017, CLIN NEUROL NEUROSUR, V156, P41, DOI 10.1016/j.clineuro.2017.03.003; Sarmiento K, 2008, J HEAD TRAUMA REHAB, V23, P164, DOI 10.1097/01.HTR.0000319933.22709.61; Stewart S, 2015, ANAT SCI EDUC, V8, P429, DOI 10.1002/ase.1501; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Thomas N, 2012, WORLDC 12 2012 WORLD; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weidmer B, 1994, 49 ANN C AM ASS PUBL	47	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107						87	93		10.1016/J.WNEU.2017.07.118			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500014	28778780	Green Accepted			2022-02-06	
J	Santana, MVD; Eber, S; Barth, S; Cypel, Y; Dursa, E; Schneiderman, A				Santana, Mary Vanellys Diaz; Eber, Stephanie; Barth, Shannon; Cypel, Yasmin; Dursa, Erin; Schneiderman, Aaron			Health-Related Quality of Life Among US Veterans of Operation Enduring Freedom and Operation Iraqi Freedom-Results From a Population-Based Study	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; PERSIAN-GULF-WAR; POSTTRAUMATIC-STRESS-DISORDER; UNITED-STATES VETERANS; FOLLOW-UP; ENVIRONMENTAL EXPOSURES; AFGHANISTAN VETERANS; NATIONAL-HEALTH; NEW-GENERATION; RISK-FACTORS	Introduction: Recent studies have demonstrated health problems among veterans of the wars in Afghanistan and Iraq (Operation Enduring Freedom and Operation Iraqi Freedom). Veterans from these conflicts have a higher prevalence of mental disorders and physical diseases, though most studies were conducted using administrative data. Materials and Methods: This study analyzes data from the National Health Study for a New Generation of U.S. Veterans, a population-based survey that collected data on Operation Enduring Freedom/Operation Iraqi Freedom veterans between 2009 and 2011. Weighted prevalence estimates of deployed and nondeployed veterans were calculated for SF-12 general health perception and clinic and hospital visits. Weighted mean physical (PCS) and mental component summary (MCS) scores were calculated by demographic and military characteristics. Weighted, adjusted odds ratios (aORs), 95% confidence intervals (95% CI), and prevalence estimates were calculated for physiciandiagnosed medical conditions comparing deployed to nondeployed veterans. Results: Of 60,000 veterans sampled, 20,563 responded to the survey (response rate = 34%). Deployed veterans had increased odds for significant hearing loss (aOR = 1.48; 95% CI = 1.35, 1.63), and lower odds for arthritis (aOR = 0.90; 95% CI = 0.83, 0.98), diabetes (aOR = 0.70; 95% CI = 0.58, 0.84), and migraines (aOR = 0.88; 95% CI = 0.80, 0.97) compared to nondeployed veterans. The prevalence of clinic visits was nearly equal between deployed and nondeployed veterans, though nondeployed veterans reported a higher percentage of hospitalizations that were overnight or longer. The SF-12 MCS was higher among the nondeployed group compared to the deployed group (p < 0.0001), though the deployed group reported a higher PCS compared to the nondeployed (p < 0.0001). The SF-12 MCS and PCS were lower than the U.S. population mean of 50. Conclusions: Deployed veterans are at increased risk for some health conditions; however, nondeployed veterans also report a variety of health conditions. Addressing the unique health concerns of both deployed and nondeployed veterans is important and continued observation of all veterans is recommended.	[Santana, Mary Vanellys Diaz] Univ Massachusetts, Dept Publ Hlth, 412 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA; [Santana, Mary Vanellys Diaz] Univ Massachusetts Amherst, Dept Biostat & Epidemiol, 412 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA; [Santana, Mary Vanellys Diaz; Eber, Stephanie; Barth, Shannon; Cypel, Yasmin; Dursa, Erin; Schneiderman, Aaron] US Dept Vet Affairs, Postdeployment Hlth Epidemiol Program, Off Patient Care Serv, 810 Vermont Ave NW 10P4Q, Washington, DC 20420 USA		Santana, MVD (corresponding author), Univ Massachusetts, Dept Publ Hlth, 412 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA.; Santana, MVD (corresponding author), Univ Massachusetts Amherst, Dept Biostat & Epidemiol, 412 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA.; Santana, MVD (corresponding author), US Dept Vet Affairs, Postdeployment Hlth Epidemiol Program, Off Patient Care Serv, 810 Vermont Ave NW 10P4Q, Washington, DC 20420 USA.				Department of Veterans AffairsUS Department of Veterans Affairs	This study was funded by the Department of Veterans Affairs.	Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Armed Forces Health Surveillance Center, 2007, MED SURVEILLANCE MON, V14, P2; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; Barbour KE, 2017, MMWR-MORBID MORTAL W, V66, P246, DOI 10.15585/mmwr.mm6609e1; Barth SK, 2014, MIL MED, V179, P241, DOI 10.7205/MILMED-D-13-00338; Barth SK, 2009, AM J IND MED, V52, P663, DOI 10.1002/ajim.20718; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; CDC, NAT HLTH INT SURV QU; CDC, HIGH BLOOD PRESS FAC; Centers for Disease Control and Prevention, VET HLTH ACT VIET EX; Centers for Disease Control and Prevention (CDC), 2014, NAT DIAB STAT REP; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Dillman DA., 2007, MAIL INTERNET SURVEY; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Epidemiology Program Post-Deployment Health Group, 2001, OFF PUBL HLTH VET HL; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Helmer DA, 2007, J OCCUP ENVIRON MED, V49, P475, DOI 10.1097/JOM.0b013e318042d682; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kang HK, 2006, AM J IND MED, V49, P875, DOI 10.1002/ajim.20385; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; McAndrew LM, 2016, J REHABIL RES DEV, V53, P59, DOI 10.1682/JRRD.2014.10.0255; NIOSH, OCC HEAR LOSS SURV; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Richards EE, 2011, MIL MED, V176, P22, DOI 10.7205/MILMED-D-11-00083; SAS Institute Inc., 2002, SAS STAT SOFTW VERS; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Smith BN, 2013, J OCCUP ENVIRON MED, V55, P116, DOI 10.1097/JOM.0b013e318270d709; Smith TC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-340; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Yoon FB, 1996, JSM P MENTAL HLTH ST	48	3	3	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2017	182	11-12					E1885	E1891		10.7205/MILMED-D-17-00020			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT7FF	WOS:000423317600014	29087858	Bronze			2022-02-06	
J	Suri, P; Stolzmann, K; Iverson, KM; Williams, R; Meterko, M; Yan, K; Gormley, K; Pogoda, TK				Suri, Pradeep; Stolzmann, Kelly; Iverson, Katherine M.; Williams, Rhonda; Meterko, Mark; Yan, Kun; Gormley, Katelyn; Pogoda, Terri K.			Associations Between Traumatic Brain Injury History and Future Headache Severity in Veterans: A Longitudinal Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Headache; Migraine disorders; Post-concussion syndrome; Tension-type headache; Brain injuries, traumatic	POST-CONCUSSION SYNDROME; COHORT; DEPRESSION; COMPLAINTS; INCREASES; SOLDIERS; RISK; IRAQ; PAIN	Objective: To determine whether traumatic brain injury (TBI) history is associated with worse headache severity outcomes.& para;& para;Design: Prospective cohort study.& para;& para;Setting: Department of Veterans Affairs (VA) outpatient clinics.& para;& para;Participants: Veterans (N =2566) who completed a mail follow-up survey an average of 3 years after a comprehensive TBI evaluation (CTBIE).& para;& para;Interventions: Not applicable.& para;& para;Main Outcome Measures: The presence or absence of TBI, and TBI severity were evaluated by a trained clinician and classified according to VA/Department of Defense clinical practice guidelines. Headache severity was evaluated at both the baseline CTBIE assessment and 3-year follow-up using a 5-level headache score ranging from 0 ("none") to 4 ("very severe") based on headache-associated activity interference in the past 30 days. We examined associations of mild and moderate/severe TBI history, as compared to no TBI history, with headache severity in cross-sectional and longitudinal analyses, with and without adjustment for potential confounders.& para;& para;Results: Mean headache severity scores were 2.4 at baseline and 2.3 at 3-year follow-up. Mild TBI was associated with greater headache severity in multivariate-adjusted cross-sectional analyses (beta [SE] = .61 [.07], P<.001), as compared with no TBI, but not in longitudinal analyses (beta [SE] = .09 [.07], P = .20). Moderate/severe TBI was significantly associated with greater headache severity in both cross-sectional (beta [SE] = .66 [.09], P < .001) and longitudinal analyses (beta [SE] = .18 [.09], P = .04 ).& para;& para;Conclusions: Headache outcomes are poor in veterans who receive VATBI evaluations, irrespective of past TBI exposure, but significantly worse in those with a history of moderate/severe TBI. No association was found between mild TBI and future headache severity in veterans. Veterans with headache presenting for TBI evaluations, and particularly those with moderate/severe TBI, may benefit from further evaluation and treatment of headache. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Suri, Pradeep; Williams, Rhonda] VA Puget Sound Hlth Care Syst, Div Rehabil Care Serv, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Suri, Pradeep; Williams, Rhonda] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Stolzmann, Kelly; Gormley, Katelyn; Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Meterko, Mark] Edith Nourse Rogers Mem Vet Hosp, Off Performance Measurement, Vet Hlth Adm, Bedford, MA USA; [Meterko, Mark; Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Yan, Kun] Northern Calif VA Healthcare Syst, Dept Phys Med & Rehabil, Sacramento, CA USA		Suri, P (corresponding author), VA Puget Sound Healthcare Syst, Div Rehabil Care Serv, Seattle Epidemiol Res & Informat Ctr ERIC, 1660 S Columbian Way, Seattle, WA 98108 USA.	pradeep.suri@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780	HSR&D Career Development Award [CDA 10-029]; VA Rehabilitation Research and Development Career Development Award; VA Puget Sound Health Care SystemUS Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services Investigator Initiated Research [11-078, 11- 358]; Presidential Early Career Award for Scientists and EngineersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [US 14-275]	Supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (HSR&D) Services Investigator Initiated Research (grant nos. 11-078,11- 358); the VA Puget Sound Health Care System and a VA Rehabilitation Research and Development Career Development Award; an HSR&D Career Development Award (CDA 10-029) and a Presidential Early Career Award for Scientists and Engineers (US 14-275). This material is also the result of work supported with resources and the use of facilities at the VA Boston Healthcare System. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the United States Government.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Bilmes L, 2007, SOLDIERS RETURNING I; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Forde G, 2016, MED CLIN N AM, V100, P121, DOI 10.1016/j.mcna.2015.09.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; International Classification of Headache Disorders, 2016, 5 HEAD ATTR TRAUM IN; Jacobson IG., 2013, DEF HLTH BOARD M NOV; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Law S, 2016, COCHRANE DB SYST REV, V4; Law S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009455.pub2; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Mulleners WM, 2015, CEPHALALGIA, V35, P51, DOI 10.1177/0333102414534325; Neogi T, 2013, RHEUM DIS CLIN N AM, V39, P1, DOI 10.1016/j.rdc.2012.10.004; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Stovner LJ, 2008, NEUROLOGY, V71, P383, DOI 10.1212/01.wnl.0000324088.61277.3f; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; U. S. Department of Veterans Affairs, 2016, SRV CONN DIS; United States Government Accountability Office, 2008, VA HLTH CAR MILD TRA; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	33	3	3	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2017	98	11					2118	2125		10.1016/j.apmr.2017.04.008			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL5KK	WOS:000414275500002	28483652				2022-02-06	
J	Weng, JY; Wang, CC; Chen, PJ; Lim, SW; Kuo, JR				Weng, Jui-Yu; Wang, Che-Chuna; Chen, Pei-Jar; Lim, Sher-Wei; Kuo, Jinn-Rung			The Application of a Three-Dimensional Printed Product to Fill the Space After Organ Removal	WORLD NEUROSURGERY			English	Article						Organ donation; Three-dimensional printer; Transplantation	DONATION; ATTITUDES	BACKGROUND: Maintaining body integrity, especially in Asian societies, is an independent predictor of organ donation. CASE DESCRIPTION: Herein, we report the case of an 18-year-old man who suffered a traumatic brain injury with ensuing brain death caused by a car accident. According to the family's wishes, we used a 3-dimensional printer to create simulated heart, kidneys, and liver to fill the spaces after the patient's organs were removed. This is the first case report to introduce this new clinical application of 3-dimensional printed products during transplantation surgery. CONCLUSIONS: This new clinical application may have supportive psychological effects on the family and caregivers; however, given the varied responses to our procedure, this ethical issue is worth discussing.	[Weng, Jui-Yu; Chen, Pei-Jar] Southern Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan, Taiwan; [Wang, Che-Chuna] Southern Taiwan Univ Sci & Technol, Dept Gen Educ, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuna; Lim, Sher-Wei; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan		Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	kuojinnrung@gmail.com					Auras R.A., 2010, POLYLACTIC ACID SYNT; Cheung AHS, 1998, TRANSPLANT P, V30, P3609, DOI 10.1016/S0041-1345(98)01156-7; Li C, 2017, SURG INNOV, V24, P82, DOI 10.1177/1553350616681889; Liu YL, 1997, CHINESE MED J-PEKING, V110, P210; Lo CM, 2012, LIVER TRANSPLANT, V18, pS5, DOI 10.1002/lt.23545; Radecki CMM, 1997, HEALTH PSYCHOL, V16, P183, DOI 10.1037/0278-6133.16.2.183; Robson NZMH, 2010, ASIA-PAC J PUBLIC HE, V22, P271, DOI 10.1177/1010539509357446; Soyama A, 2016, SURG TODAY, V46, P387, DOI 10.1007/s00595-015-1211-6; Wong LP, 2010, TRANSPL P, V42, P1439, DOI 10.1016/j.transproceed.2009.11.053; Zhang L, 2007, TRANSPL P, V39, P1303, DOI 10.1016/j.transproceed.2007.02.096	10	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2017	107								PMID 1045.e17	10.1016/j.wneu.2017.07.149			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2XV	WOS:000415860500157					2022-02-06	
J	Woodruff, SI; Galarneau, MR; McCabe, CT; Luu, BN; Sack, DI; Han, PP				Woodruff, Susan I.; Galarneau, Michael R.; McCabe, Cameron T.; Luu, Bethi N.; Sack, Daniel I.; Han, Peggy P.			Body-Region-Specific Injuries as Predictors of Psychosocial Outcomes Among Those Injured in Combat: Results From the Wounded Warrior Recovery Project	MILITARY PSYCHOLOGY			English	Article						combat injury; quality of life; PTSD; depression	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PTSD CHECKLIST PCL; PSYCHOMETRIC PROPERTIES; HEALTH CONDITIONS; SERVICE MEMBERS; OLDER-ADULTS; RISK-FACTORS	Associations between body region injured and psychosocial outcomes may have implications for injury prevention and mitigation strategies. The present study investigated the association of body-region-specific injuries and their association with 3 psychosocial outcomes (i.e., quality of life, QOL; posttraumatic stress disorder, PTSD; and depression) among a large sample of U.S. military service members injured in combat. A total of 1,011 individuals wounded in combat enrolled in the Wounded Warrior Recovery Project and provided QOL, depression, and PTSD measures on a Web-based survey. These psychosocial variables were linked with the presence/absence of combat injuries in 9 different body regions (head, face, neck, thorax, spine, abdomen, upper extremity, lower extremity, and external skin/other), as well as overall injury severity and demographic factors. Two-step hierarchical linear regressions revealed that after adjusting for overall injury severity and time since injury, those with combat-related head and spine injuries were particularly at risk for relatively worse psychosocial outcomes. Head and spinal injuries were associated with lower QOL and higher PTSD and depression. Overall, even those with relatively minor injuries may be at risk of lower QOL and adverse psychosocial outcomes. These findings may highlight the need for early interventions to minimize the psychological effects of combat injuries to the head and spine.	[Woodruff, Susan I.; McCabe, Cameron T.; Luu, Bethi N.; Han, Peggy P.] Leidos Inc, San Diego, CA USA; [Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Sack, Daniel I.] Axiom, San Diego, CA USA		McCabe, CT (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	cameron.t.mccabe.ctr@mail.mil		McCabe, Cameron/0000-0001-8395-9142	Bureau of Medicine and Surgery, under the Wounded, Ill, and Injured Psychological Health and Traumatic Brain Injury Program [Work Unit 60808]	Susan I. Woodruff was a principal investigator and Michael R. Galarneau is a principal investigator of the Wounded Warrior Recovery Project. Cameron T. McCabe is a research psychologist, Bethi N. Luu was the enrollment coordinator, Daniel I. Sack is the project manager, and Peggy P. Han was the database manager on the project. Based on report 15-06, supported by the Bureau of Medicine and Surgery, under the Wounded, Ill, and Injured Psychological Health and Traumatic Brain Injury Program (Work Unit 60808). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. government. Approved for public release; distribution is unlimited; U.S. Government Work (17 U.S. C. 105). Not copyrighted in the United States. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (Protocol NHRC.2009.0014).	Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; Auerbach SM, 2008, J ORAL MAXIL SURG, V66, P755, DOI 10.1016/j.joms.2007.12.006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergman HE, 2017, MIL PSYCHOL, V29, P117, DOI 10.1037/mil0000154; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Chiu S, 2011, PUBLIC HEALTH REP, V126, P201, DOI 10.1177/003335491112600211; David KM, 2008, QUALITY WELL BEING S; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gennarelli TA, 2005, ABBREVIATED INJURY S; Glynn SM, 2007, J TRAUMA, V62, P410, DOI 10.1097/01.ta.0000231556.05899.b0; Glynn SM, 2003, J ORAL MAXIL SURG, V61, P785, DOI 10.1016/S0278-2391(03)00239-8; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Halligan S., 2000, PTSD RES Q, V11, P1; Hart A. C., 2008, ICD 9 CM PROFESSION, V2; Hart AC, 2008, ICD 9 CM PROFESSIONA; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; Kennedy P, 2001, SPINAL CORD, V39, P1, DOI 10.1038/sj.sc.3101100; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kozlowski Moreau O, 2015, ANN PHYS REHABIL MED, V58, pe148; Kypri K, 2011, PREV MED, V53, P274, DOI 10.1016/j.ypmed.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawnick MM, 2013, J TRAUMA ACUTE CARE, V75, P573, DOI 10.1097/TA.0b013e3182a53bc6; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Melcer T, 2013, J ORTHOP TRAUMA, V27, pE31, DOI 10.1097/BOT.0b013e3182517e1c; Middleton J, 2007, ARCH PHYS MED REHAB, V88, P1643, DOI 10.1016/j.apmr.2007.09.001; O'Donnell ML, 2008, CLIN PSYCHOL REV, V28, P387, DOI 10.1016/j.cpr.2007.07.008; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pereira CCA, 2011, QUAL LIFE RES, V20, P969, DOI 10.1007/s11136-010-9813-3; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Putzke JD, 2002, PAIN, V100, P231, DOI 10.1016/S0304-3959(02)00069-6; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Radnitz CL, 1998, J TRAUMA STRESS, V11, P505, DOI 10.1023/A:1024404729251; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Richmond TS, 2000, J TRAUMA STRESS, V13, P681, DOI 10.1023/A:1007866318207; Smith BM, 2008, SPINAL CORD, V46, P507, DOI 10.1038/sc.2008.2; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; van Delft-Schreurs CCHM, 2014, QUAL LIFE RES, V23, P1353, DOI 10.1007/s11136-013-0546-y; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Wallace AE, 2006, PSYCHIAT SERV, V57, P851, DOI 10.1176/appi.ps.57.6.851; Weathers F.W., 1993, 9 ANN C ISTSS; Westgren N, 1998, ARCH PHYS MED REHAB, V79, P1433, DOI 10.1016/S0003-9993(98)90240-4; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woodruff SI, 2014, MIL MED, V179, P265, DOI 10.7205/MILMED-D-13-00444	56	3	3	0	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.	NOV	2017	29	6					590	600		10.1037/mil0000181			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FM8DU	WOS:000415316600009					2022-02-06	
J	Kontos, P; Grigorovich, A; Nowrouzi, B; Sharma, B; Lewko, J; Mollayeva, T; Colantonio, A				Kontos, P.; Grigorovich, A.; Nowrouzi, B.; Sharma, B.; Lewko, J.; Mollayeva, T.; Colantonio, A.			A qualitative exploration of work-related head injury: vulnerability at the intersection of workers' decision making and organizational values	BMC PUBLIC HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; OCCUPATIONAL-HEALTH; CARE WORK; HIDDEN CURRICULUM; SAFETY HAZARDS; BEHAVIOR; RISK; VIOLENCE; GENDER; SECTOR	Background: Work-related head injury is a critical public health issue due to its rising prevalence; the association with profound disruption of workers' lives; and significant economic burdens in terms of medical costs and lost wages. Efforts to understand and prevent these types of injuries have largely been dominated by epidemiological research and safety science, which has focused on identifying risk at the level of the individual worker, population group, or organizational sector. Limited research has focused on the perspectives of the workers, a key stakeholder group for informing understanding of vulnerability to work-related head injury. This study explored workers' perspectives to better understand their decision-making and how and why their injuries occurred. Methods: We conducted a qualitative study using in-depth semi-structured interviews with thirty-two adult workers who had sustained a work-related head injury. Workers were recruited from an urban clinic in central Ontario, Canada. Labour Process Theory informed the thematic analysis. Results: Three hazardous work conditions were identified: insufficient training; inadequate staffing; and inattention to the physical environment. In addition, professional and organizational norms were implicated in vulnerability to head injury including putting the client before the worker and the pressure to work unsafely. The findings also highlight a complex interrelationship between workers' decision-making and professional and organizational norms that produces vulnerability to head injury, a vulnerability which oftentimes is reproduced by workers' decisions to work despite hazardous conditions. Conclusions: Our findings suggest that, beyond the need to redress the inattention to hazards in the physical environment, there is a need to address norms that influence worker decision-making to improve the safety of workers. Using Labour Process Theory highlights an important social dynamic within workplace sectors that could inform future development and implementation of multi-level and integrated public health strategies to reduce work-related head injury.	[Kontos, P.; Grigorovich, A.; Nowrouzi, B.; Sharma, B.; Mollayeva, T.; Colantonio, A.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Kontos, P.; Grigorovich, A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lewko, J.] Laurentian Univ, Ctr Res Human Dev, Sudbury, ON, Canada; [Colantonio, A.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Nowrouzi, B.] Laurentian Univ, Sudbury, ON, Canada; [Sharma, B.; Mollayeva, T.] Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Colantonio, A.] Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Kontos, P (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.; Kontos, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	pia.kontos@uhn.ca	, Mollayeva/A-4522-2018; Nowrouzi-Kia, Behdin/Y-4486-2018	Colantonio, Angela/0000-0003-2094-4765; Nowrouzi-Kia, Behdin/0000-0002-5586-4282; Kontos, Pia/0000-0002-8893-2544	Ontario Ministry of Labour [13-R-056 ROP]; CIHR Research Chair in Gender, Work and Health [CGW-126580]; Ontario Ministry of Health and Long-Term Care, Ontario, Canada	Funding for this project was provided by the Ontario Ministry of Labour (#13-R-056 ROP). Support for Dr. Colantonio was provided by the CIHR Research Chair in Gender, Work and Health (#CGW-126580). Alisa Grigorovich holds a Postdoctoral Ontario Women's Health Scholars Award, funded by the Ontario Ministry of Health and Long-Term Care, Ontario, Canada.	Armstrong P., 2008, CRITICAL CARE INVISI; Ashcraft KarenL., 2005, MANAGEMENT COMMUNICA, V19, P67; Baines D, 2006, GENDER WORK ORGAN, V13, P129, DOI 10.1111/j.1468-0432.2006.00300.x; Baines D., 2005, SOCIAL JUSTICE, V32, P132; Baines D, 2011, WORK EMPLOY SOC, V25, P760, DOI 10.1177/0950017011419710; Bal E, 2015, SAFETY SCI, V72, P46, DOI 10.1016/j.ssci.2014.08.003; Barnetson B, 2010, LABOUR ACROSS BORDER, P1; Bowen G., 2008, INT J QUAL METH, V5, P12; Burawoy Michael, 1979, MANUFACTURING CONSEN; Carcary Marian, 2009, Electronic Journal of Business Research Methods, V7, P11; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colley SK, 2013, SAFETY SCI, V51, P69, DOI 10.1016/j.ssci.2012.06.001; Deetz S., 1995, TRANSFORMING COMMUNI; DeJoy DM, 2005, SAFETY SCI, V43, P105, DOI 10.1016/j.ssci.2005.02.001; Denzin NK., 1998, COLLECTING INTERPRET; EDWARDS P, 1986, CONFLICT WORK; GARAVAN TN, 2001, IR J MANAG, V22, P141; Gaufberg EH, 2010, ACAD MED, V85, P1709, DOI 10.1097/ACM.0b013e3181f57899; Gray GC, 2009, BRIT J CRIMINOL, V49, P326, DOI 10.1093/bjc/azp004; Hopkins A, 2006, SAFETY SCI, V44, P583, DOI 10.1016/j.ssci.2006.01.001; Howe J, 2000, SAFETY CULTURE EFFEC, P225; HOYOS CG, 1995, APPL PSYCHOL-INT REV, V44, P233, DOI 10.1111/j.1464-0597.1995.tb01078.x; Hsiao HW, 2014, IND HEALTH, V52, P381, DOI 10.2486/indhealth.2014-0110; Hughes P., 2013, INT HLTH SAFETY WORK; Karreman D, 2009, HUM RELAT, V62, P1115, DOI 10.1177/0018726709334880; Karnieli-Miller O, 2011, ACAD MED, V86, P369, DOI 10.1097/ACM.0b013e3182087d15; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kosla MT, 2015, HEALTH RISK SOC, V17, P388, DOI 10.1080/13698575.2015.1116499; Kosny AA, 2008, HEALTH RISK SOC, V10, P149, DOI 10.1080/13698570802159899; Lay AM, 2016, AM J IND MED, V59, P119, DOI 10.1002/ajim.22535; Luo XC, 2016, SAFETY SCI, V84, P216, DOI 10.1016/j.ssci.2015.12.026; Markkanen P, 2014, AM J IND MED, V57, P445, DOI 10.1002/ajim.22287; Miyata H., 2009, INT J QUAL METH, V8, P64, DOI DOI 10.1177/160940690900800106; Mullen J, 2004, J SAFETY RES, V35, P275, DOI 10.1016/j.jsr.2004.03.011; Mumby D.K., 2005, MANAGEMENT COMMUNICA, V19, P19, DOI [10.1177/0893318905276558, DOI 10.1177/0893318905276558]; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Polivka BJ, 2015, WORKPLACE HEALTH SAF, V63, P512, DOI 10.1177/2165079915595925; Premji S, 2014, PISTES, V16, P1; Premji S, 2010, AM J IND MED, V53, P875, DOI 10.1002/ajim.20845; Quinlan M, 2001, INT J HEALTH SERV, V31, P335, DOI 10.2190/607H-TTV0-QCN6-YLT4; Ritzer G, 1993, MCDONALDIZATION SOC; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Smith G.S., 2001, INJ PREV S1, V7, pi3, DOI [10.1136/ip.7.suppl_1.i3, DOI 10.1136/IP.7.SUPPL_1.I3]; Somerville M., 2005, PEDAGOGY CULTURE SOC, V13, P5, DOI DOI 10.1080/14681360500200212; Strauss A., 1994, HDB QUALITATIVE RES, V17, P273, DOI DOI 10.1007/BF00988593; Thompson P, 2010, WORKING LIFE RENEWIN; Tierney KJ, 1999, SOCIOL FORUM, V14, P215, DOI 10.1023/A:1021414628203; Treiber, 2009, J APPL SOC SCI, V3, P36, DOI DOI 10.1177/193672440900300105; Vallmuur K, 2016, INJURY PREV, V22, P34, DOI 10.1136/injuryprev-2015-041813; Vosko L.F., 2005, PRECARIOUS EMPLOYMEN; Webster F, 2015, ACAD MED, V90, P56, DOI 10.1097/ACM.0000000000000499; Weil D, 2009, J IND RELAT, V51, P411, DOI 10.1177/0022185609104842; WSIB, 2014, STAT REP WORKPL SAF, P2015; Zoller HM, 2009, NEW SOLUT, V19, P289, DOI 10.2190/NS.19.3.b; Zoller HM, 2003, J APPL COMMUN RES, V31, P118, DOI 10.1080/0090988032000064588	55	3	3	0	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	OCT 18	2017	17								824	10.1186/s12889-017-4823-5			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FK4OI	WOS:000413474600005	29047336	gold, Green Published			2022-02-06	
J	Brewer-Smyth, K; Pohlig, RT				Brewer-Smyth, Kathleen; Pohlig, Ryan T.			Risk Factors for Women Being Under the Influence of Alcohol Compared With Other Illicit Substances at the Time of Committing Violent Crimes	JOURNAL OF FORENSIC NURSING			English	Article						Adverse childhood experiences (ACEs); Alcohol; child abuse; childhood sexual abuse; cortisol; crime; family; female; injury; inmate; prisoner; sexual abuse; TBI; traumatic brain injury; violence; violent; violent crimes; women	TRAUMATIC BRAIN-INJURY; INTIMATE PARTNER VIOLENCE; ADVERSE CHILDHOOD EXPERIENCES; FEMALE PRISON-INMATES; GENDER-DIFFERENCES; MENTAL-HEALTH; UNITED-STATES; SEXUAL-ABUSE; DEVELOPMENTAL TRAUMATOLOGY; SALIVARY CORTISOL	Purpose: We investigated women under the influence of alcohol compared with other illicit substances at the time of committing a crime to identify predictors of being under the influence of alcohol and female-enacted crime. Methods: Analyses of data, obtained from private interviews and examinations of female prison inmates, included regression analyses exploring predictors of being under the influence of alcohol at the time of the crime and predictors of violent crime. In addition, a reanalysis of a previously reported model, predicting conviction of a violent crime, was conducted including a new variable, being under the influence of alcohol at the time of the crime. Results: Those under the influence of alcohol at the time of their crime had experienced greater nonfamilial childhood sexual abuse and traumatic brain injuries with loss of consciousness predating their crime. They were more likely to have committed a violent, rather than nonviolent, crime compared with those under the influence of other substances, with the latter being not significantly different for those not under the influence of any substance. Being under the influence of alcohol increased the risk of committing a violent crime, adjusting for other predictors of female violence. Conclusion: Women under the influence of alcohol are at a greater risk for committing violent crimes than those under the influence of other substances. Female nonfamilial childhood sexual abuse and traumatic brain injury victims were at a higher risk for being under the influence of alcohol, in comparison with other substances, at the time of committing a violent crime.	[Brewer-Smyth, Kathleen; Pohlig, Ryan T.] Univ Delaware, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA		Brewer-Smyth, K (corresponding author), Univ Delaware, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health [U54-GM104941]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [20RR016472-04]; Sigma Theta Tau International Honor Society/Rehabilitation Nursing Foundation of the Association of Rehabilitation Nurses Research Grant Award; Baxter Foundation; University of Delaware General University Research Fund; University of Delaware Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	Data collection for this study was funded in part by the National Institutes of Health 20RR016472-04, Sigma Theta Tau International Honor Society/Rehabilitation Nursing Foundation of the Association of Rehabilitation Nurses Research Grant Award; The Baxter Foundation; University of Delaware General University Research Fund; and the University of Delaware Research Foundation.; Analysis work supported by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under Grant number U54-GM104941 (PI: Binder-Macleod).	Alwin DF, 2012, J GERONTOL B-PSYCHOL, V67, P206, DOI 10.1093/geronb/gbr146; Bai JR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-50; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bratberg GH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3384-3; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, ADV NURS SCI, V31, P119, DOI 10.1097/01.ANS.0000319562.84007.22; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Brewer-Smyth K, 2015, J FORENSIC NURS, V11, P4, DOI 10.1097/JFN.0000000000000062; Brewer-Smyth K, 2014, REHABIL NURS, V39, P183, DOI 10.1002/rnj.150; Castano-Monsalve B, 2013, REV NEUROLOGIA, V56, P363, DOI 10.33588/rn.5607.2012412; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ PRIS; Cook PJ, 2005, JAMA-J AM MED ASSOC, V294, P598, DOI 10.1001/jama.294.5.598; Court Services and Offender Supervision Agency, 2016, STAT WOM OFF 2016; Crum RM, 2013, JAMA PSYCHIAT, V70, P718, DOI 10.1001/jamapsychiatry.2013.1098; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Bellis MD, 2012, INTERGENERATIONAL TR; De Bellis MD, 2014, CHILD ADOL PSYCH CL, V23, P185, DOI 10.1016/j.chc.2014.01.002; De Bellis MD, 2011, J CHILD SEX ABUS, V20, P548, DOI 10.1080/10538712.2011.607753; Federal Bureau of Investigation, 2015, VIOL CRIM CRIM US; Fenton MC, 2013, PSYCHOL MED, V43, P1045, DOI 10.1017/S0033291712001729; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Giele J.Z., 1998, METHODS LIFE COURSE; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Harford TC, 2014, CHILD ABUSE NEGLECT, V38, P1389, DOI 10.1016/j.chiabu.2014.02.011; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V93, P21, DOI 10.1016/j.drugalcdep.2007.08.017; Keyes KM, 2012, DRUG ALCOHOL DEPEN, V122, P77, DOI 10.1016/j.drugalcdep.2011.09.013; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Keyes KM, 2010, AM J PSYCHIAT, V167, P969, DOI 10.1176/appi.ajp.2009.09081161; Kim HK, 2015, PSYCHONEUROENDOCRINO, V51, P35, DOI 10.1016/j.psyneuen.2014.09.013; Kirschbaum KM, 2013, FORENSIC SCI INT, V226, P230, DOI 10.1016/j.forsciint.2013.01.031; Kiser LJ, 2014, CHILD ABUSE NEGLECT, V38, P1083, DOI 10.1016/j.chiabu.2014.02.017; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Lee M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-415; Mair C, 2012, ANN EPIDEMIOL, V22, P832, DOI 10.1016/j.annepidem.2012.09.008; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; MUENZENMAIER K, 1993, HOSP COMMUNITY PSYCH, V44, P666; Nayak MB, 2012, DRUG ALCOHOL DEPEN, V123, P213, DOI 10.1016/j.drugalcdep.2011.11.016; da Silva SSP, 2013, J INTERPERS VIOLENCE, V28, P1989, DOI 10.1177/0886260512471077; Pernanen Kai, 1976, BIOL ALCOHOL, V4; Robinson SM, 2014, ADDICT BEHAV, V39, P39, DOI 10.1016/j.addbeh.2013.09.029; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shin SH, 2009, ADDICT BEHAV, V34, P277, DOI 10.1016/j.addbeh.2008.10.023; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Stuart GL, 2013, J CONSULT CLIN PSYCH, V81, P681, DOI 10.1037/a0032876; Substance Abuse and Mental Health Services Administration, 2014, NSDUH SER H, VH-48; Substance Abuse and Mental Health Services Administration, 2012, NAT SURV DRUG US HLT; Taylor S, 1983, AGGRESSION THEORETIC, V2, P77; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; White House Council on Women and Girls, 2011, WOM AM IND SOC EC WE; Wolff N, 2012, INT J ENV RES PUB HE, V9, P1908, DOI 10.3390/ijerph9051908	59	3	3	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-3693	1939-3938		J FORENSIC NURS	J. Forensic Nurs.	OCT-DEC	2017	13	4					186	195		10.1097/JFN.0000000000000177			10	Criminology & Penology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Criminology & Penology; Nursing	FS1SL	WOS:000419557900007	29176519	Green Accepted			2022-02-06	
J	Herklots, MW; Moudrous, W; Oldenbeuving, A; Roks, G; Mourtzoukos, S; Schoonman, GG; Ganslandt, O				Herklots, Martin W.; Moudrous, Walid; Oldenbeuving, Annemarie; Roks, Gerwin; Mourtzoukos, Stylianos; Schoonman, Guus G.; Ganslandt, Oliver			Prospective Evaluation of Noninvasive HeadSense Intracranial Pressure Monitor in Traumatic Brain Injury Patients Undergoing Invasive Intracranial Pressure Monitoring	WORLD NEUROSURGERY			English	Article						HeadSense; Intracranial pressure; Noninvasive ICP; Traumatic brain injury		BACKGROUND: Currently, intracranial pressure (ICP) is measured by invasive methods with a significant risk of infectious and hemorrhagic complications. Because of these high risks, there is a need for a noninvasive ICP (nICP) monitor with an accuracy similar to that of an invasive ICP (iICP) monitor. OBJECTIVE: We sought to assess prospectively the accuracy and precision of an nICP monitor compared with iICP measurement in severe traumatic brain injury (TBI) patients. METHODS: Participants were ICP-monitored patients who had sustained TBI. In parallel with the standard invasive ICP measurements, nICP was measured by the HeadSense HS-1000, which is based on sound propagation. The device generated an acoustic signal using a small transmitter, placed in the patient's ear, and picked up by an acoustic sensor placed in the other ear. The signal is then analyzed using proprietary algorithms, and the ICP value is calculated in millimeter of mercury (mm Hg). RESULTS: Analysis of 2911 paired iICP and nICP measurements from 14 severe TBI patients showed a good accuracy of the nICP monitor indicated by a mean difference of 0.5 mm Hg. The precision was also good with a standard deviation of 3.9 mm Hg. The Pearson r correlation was 0.604 (P < 0.001). CONCLUSIONS: The HeadSense HS-1000 nICP monitor seems sufficiently accurate to measure the ICP in severe TBI patients, is patient friendly, and has minimal risk of complications.	[Herklots, Martin W.; Moudrous, Walid; Roks, Gerwin; Schoonman, Guus G.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Oldenbeuving, Annemarie] Elisabeth Tweesteden Hosp, Dept Intens Care Med, Tilburg, Netherlands; [Mourtzoukos, Stylianos; Ganslandt, Oliver] Stuttgart Hosp, Dept Neurosurg, Stuttgart, Germany		Herklots, MW (corresponding author), Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands.	m.herklots@etz.nl					Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Levinsky A, 2016, MED ENG PHYS, V38, P477, DOI 10.1016/j.medengphy.2016.02.009; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Speck V, 2011, NEUROCRIT CARE, V14, P208, DOI 10.1007/s12028-010-9459-6; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110	12	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2017	106						557	562		10.1016/j.wneu.2017.07.022			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2UP	WOS:000415850400070	28712896				2022-02-06	
J	Lilley, R; Lower, T; Davie, G				Lilley, Rebbecca; Lower, Tony; Davie, Gabrielle			Towards a harmonised approach to reducing quad-related fatal injuries in Australia and New Zealand: a cross-sectional comparative analysis	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH			English	Article						fatal injury; injury prevention; work; farm; quad bike; all-terrain vehicle (ATV); Australia; New Zealand		Objective: This study compares the patterns of quad-related fatal injuries between Australia and New Zealand (NZ). Method: Fatal injuries from July 2007 to June 2012 involving a quad (quad bike or all-terrain vehicle) were identified from coronial files. Data described the socio-demographic, injury, vehicle and environment factors associated with incidents. Injury patterns were compared between countries. Results: A total of 101 quad-related fatalities were identified: 69 in Australia and 32 in NZ (7.3 and 8.0 annual fatalities per 100,000 vehicles). Of these, 95 closed cases were examined in detail and factors in common included fatalities occurring mainly in males, on farms, involving a rollover and resulting in crush injuries to the head and thorax. Helmet use and alcohol/drug involvement were infrequent. Differences were observed with regard to age, season of fatal incident and the presence of a slope. Conclusions: Fatality patterns are broadly similar. The few differences could be attributed to differing agricultural commodity mix, demographics and topography. Implications: This study's findings support harmonised cross-country injury prevention efforts primarily focused on safe design and engineering principles to reduce this injury burden.	[Lilley, Rebbecca; Davie, Gabrielle] Univ Otago, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 52, Dunedin 9054, New Zealand; [Lower, Tony] Univ Sydney, Sch Publ Hlth, Australian Ctr Agr Hlth & Safety, Sydney, NSW, Australia		Lilley, R (corresponding author), Univ Otago, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 52, Dunedin 9054, New Zealand.	rebbecca.lilley@otago.ac.nz		Davie, Gabrielle/0000-0001-5466-5364			Australian Bureau of Statistics, 2012, 41020 ABS; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Fawcett VJ, 2016, SAFETY, V2, DOI 10.3390/safety2020015; Fragar L, 2011, HLTH SAFETY AUSTR FA; Freund S., 2015, INQUEST DEATHS D EVE; Garland S., 2014, NATL ESTIMATES VICTI; Grzebieta R., 2015, SUPPLEMENTAL REPORT; Grzebieta R., 2015, FINAL PROJECT SUMMAR; Helmkamp JC, 2011, J AGRIC SAF HEALTH, V17, P147, DOI 10.13031/2013.36498; Helmkamp JC, 2012, PUBLIC HEALTH REP, V127, P364, DOI 10.1177/003335491212700404; Herde E, 2013, FARM INJURY OPTIMAL; Jennissen C, 2014, PREVALENCE CARRYING; Kahane, 2013, 811766 DOT HS NAT HI; Lilley R., 2009, EFFECTIVE OCCUPATION; Lilley R, 2009, EFFECTIVE OCCUPATION; Lock J., 2015, INQUEST 9 9 DEATHS C; Lower T, 2003, AUST NZ J PUBL HEAL, V27, P333, DOI 10.1111/j.1467-842X.2003.tb00403.x; Lower T, 2016, ESTIMATED NUMBER QUA; Lower T., 2015, FARM RELATED INJURIE; Lower T., 2012, J HLTH SAF ENV, V28, P7; Lower T, 2013, AUST NZ J PUBL HEAL, V37, P173, DOI 10.1111/1753-6405.12036; Lower T, 2013, AUST NZ J PUBL HEAL, V37, P105, DOI 10.1111/1753-6405.12025; Magistrates Court of Tasmania, 2016, COR INQ PEND; Mitchell WK, 2012, FRONT PHYSIOL, V3, P39; Moore D., 2007, THESIS; National Coronial Information System, 2016, NAT COR INF SYST; Ollie J., 2009, INVESTIGATION DEATHS; Queensland's Safety and Workers Compensation Services, 2016, STAT PLAN IMPR QUAD; Rautiainen RH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006398.pub2; Safe Work Australia, 2016, QUAD BIK RUR WORKPL; SafeWork NSW, 2015, HEADS WORKPL SAF AUT; Shortland B., 2013, CERTIFICATE FINDINGS; Shulruf B, 2010, ACCIDENT ANAL PREV, V42, P612, DOI 10.1016/j.aap.2009.10.007; Specialty Vehicle Institute of America, 2010, AM NAT STAND 4 WHEEL; STATA, 2013, STATA STAT STAT SOFT; Statistics New Zealand, 2013, 2013 CENS POP DWELL; Watts S, 2014, DELOITTE AGRIBUSINES; Work Safe Victoria, 2016, NEW APPR DES MAK QUA; WorkSafe New Zealand, 2016, STAT WORKPL FAT FOC; WorkSafe New Zealand, 2014, QUAD BIK HARM RED PR	40	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1326-0200	1753-6405		AUST NZ J PUBL HEAL	Aust. N. Z. Publ. Health	OCT	2017	41	5					524	529		10.1111/1753-6405.12675			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FI8ZN	WOS:000412292500014	28712158	gold			2022-02-06	
J	Mihalik, JP; Sumrall, AZ; Yeargin, SW; Guskiewicz, KM; King, KB; Trulock, SC; Shields, EW				Mihalik, Jason P.; Sumrall, Adam Z.; Yeargin, Susan W.; Guskiewicz, Kevin M.; King, Kevin B.; Trulock, Scott C.; Shields, Edgar W.			Environmental and Physiological Factors Affect Football Head Impact Biomechanics	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CORE BODY TEMPERATURE; DEHYDRATION; ENVIRONMENTAL CONDITIONS; HEAD IMPACT; PHYSIOLOGICAL RESPONSE; TRAUMATIC BRAIN INJURY	ASSOCIATION POSITION STATEMENT; ASSESS BODY-TEMPERATURE; AMERICAN FOOTBALL; HYDRATION STATUS; UNITED-STATES; BRAIN-INJURY; HIGH-SCHOOL; EXERCISE; DEHYDRATION; PLAYERS	Purpose: Recent anecdotal trends suggest a disproportionate number of head injuries in collegiate football players occur during preseason football camp. In warmer climates, this season also represents the highest risk for heat-related illness among collegiate football players. Because concussion and heat illnesses share many common symptoms, we need 1) to understand if environmental conditions, body temperature, and hydration status affect head impact biomechanics; and 2) to determine if an in-helmet thermistor could provide a valid measure of gastrointestinal temperature. Methods: A prospective cohort of 18 Division I college football players (age, 21.1 +/- 1.4 yr; height, 187.7 +/- 6.6 cm; mass, 114.5 +/- 23.4 kg). Data were collected during one control and three experimental sessions. During each session, the Head Impact Telemetry System recorded head impact biomechanics (linear acceleration, rotational acceleration, and severity profile) and in-helmet temperature. A wet bulb globe device recorded environmental conditions, and CorTemp (TM) Ingestible Core Body Temperature Sensors recorded gastrointestinal temperature. Results: Our findings suggest that linear acceleration (P = 0.57), rotational acceleration (P = 0.16), and Head Impact Technology severity profile (P = 0.33) are not influenced by environmental or physiological conditions. Conclusions: We did not find any single or combination of predictors for impact severity. Rotational acceleration was approaching significance between our early experimental sessions when compared with our control session. More research should be conducted to better understand if rotational accelerations are a component of impact magnitudes that are affected due to changes in environmental conditions, body temperature, and hydration status.	[Mihalik, Jason P.; Sumrall, Adam Z.; Guskiewicz, Kevin M.; Shields, Edgar W.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Yeargin, Susan W.] Univ South Carolina, Exercise Sci Dept, Columbia, SC USA; [King, Kevin B.] Carolina Panthers, Charlotte, NC USA; [Trulock, Scott C.] Jacksonville Jaguars, Jacksonville, FL USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 2201 Stallings Evans Sports Med Complex, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu			Canadian Athletic Therapists Association (CATA; Calgary, Alberta, Canada); National Operating Committee on Standards for Athletic Equipment (NOCSAE)	The corresponding author was awarded a research grant from the Canadian Athletic Therapists Association (CATA; Calgary, Alberta, Canada) to support the completion of this project. Some of the data collection was funded in part by a grant from the National Operating Committee on Standards for Athletic Equipment (NOCSAE). The opinions expressed herein are those of the authors and do not necessarily reflect the opinions of the CATA or the NOCSAE. The authors would like to thank Douglas J. Casa, PhD, ATC, FACSM, FNATA (University of Connecticut, Storrs, CT), for his assistance with interpretation of the data, and HQ Inc. (Palmetto, FL) for providing materials upon request necessary to support the study. The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The results of the present study do not constitute endorsement by ACSM.	Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Armstrong LE, 2010, J ATHL TRAINING, V45, P117, DOI 10.4085/1062-6050-45.2.117; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; Armstrong LE, 2002, REV NEUROSCIENCE, V13, P271; Binkley HM, 2002, J ATHL TRAINING, V37, P329; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Boulant J. A., 2010, COMPREHENSIVE PHYSL; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Carter R, 2006, J APPL PHYSIOL, V101, P1744, DOI 10.1152/japplphysiol.00200.2006; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Casa DJ, 2007, J ATHL TRAINING, V42, P333; Casa DJ, 2010, J ATHL TRAINING, V45, P147, DOI 10.4085/1062-6050-45.2.147; Cooper ER, 2006, J ATHL TRAINING, V41, P332; CRAIG FN, 1966, J APPL PHYSIOL, V21, P670, DOI 10.1152/jappl.1966.21.2.670; Decher NR, 2008, INT J SPORT PHYSIOL, V3, P262, DOI 10.1123/ijspp.3.3.262; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Ely BR, 2013, EUR J APPL PHYSIOL, V113, P1027, DOI 10.1007/s00421-012-2506-6; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Ganio MS, 2009, J ATHL TRAINING, V44, P124, DOI 10.4085/1062-6050-44.2.124; Giza CC, 2001, J ATHL TRAINING, V36, P228; Godek SF, 2006, J ATHL TRAINING, V41, P8; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hainsworth R, 2004, CLIN AUTON RES, V14, P18, DOI 10.1007/s10286-004-1004-2; Howe AS, 2007, AM J SPORT MED, V35, P1384, DOI 10.1177/0363546507305013; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nielsen B, 2003, SPORTS MED, V33, P1, DOI 10.2165/00007256-200333010-00001; Patel AV, 2007, J ATHL TRAINING, V42, P66; Sosin DM, 1996, BRAIN INJURY, V10, P47; Volpe SL, 2009, J ATHL TRAINING, V44, P624, DOI 10.4085/1062-6050-44.6.624; Watson P, 2010, MED SCI SPORT EXER, V42, P2197, DOI 10.1249/MSS.0b013e3181e39788; Wilson TE, 2006, AM J PHYSIOL-REG I, V291, pR1443, DOI 10.1152/ajpregu.00712.2005; Yeargin SW, 2006, J STRENGTH COND RES, V20, P463; Yeargin SW, 2010, J ATHL TRAINING, V45, P136, DOI 10.4085/1062-6050-45.2.136	38	3	3	0	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	OCT	2017	49	10					2093	2101		10.1249/MSS.0000000000001325			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FH4UC	WOS:000411156600017	28509764				2022-02-06	
J	Pennington, R; Cooper, A; Edmond, E; Faulkner, A; Reidy, MJ; Davies, PSE				Pennington, Rachel; Cooper, Ashley; Edmond, Evan; Faulkner, Alastair; Reidy, Michael J.; Davies, Peter S. E.			INJURIES IN QUIDDITCH: A DESCRIPTIVE EPIDEMIOLOGICAL STUDY	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; descriptive epidemiological study; fracture; Harry Potter; injury; quidditch	SURVEILLANCE SYSTEM; PROSPECTIVE COHORT; FOOTBALL; SOCCER	Background: Quidditch is a fast growing, physically intense, mixed-gender full-contact sport. Originally adapted from Harry Potter novels, quidditch was first played in 2005 in the USA but is now played worldwide. It is essential to elucidate patterns of injury for the safety and growth of the sport of quidditch. It also provides a unique opportunity to study injury patterns in mixed-gender full-contact sport, an area of increasing importance with the developing culture of transition from single-gender to mixed-gender sports. Purpose: The purpose of this investigation was to examine the types of injuries sustained while playing quidditch in terms of their incidence, anatomical distribution and severity, and gender distribution. Methods: An anonymous self-reporting questionnaire was distributed to all active quidditch players in the UK. Data collection included player demographics, type of injury, mechanism of injury, player position, experience and treatment required, relating to the previous 12 months. Results: A total of 348 participants of 684 eligible athletes responded to the questionnaire representing a 50.87% response rate. There were 315 injuries reported by 180 athletes in total, with an overall incidence of 4.06 injuries per 1,000 hours. A statistically significantly different rate of concussion was observed with female athletes sustaining more concussion than males (p = 0.006). The overall rate of concussion was 0.651/1000hrs in males and 1.163/1000hrs in females (0.877/1000 hours overall). Conclusions: This study provides the first quantitative description of injury rates in quidditch. The overall injury rates are no higher than those reported in other recreational contact sports. Female athletes were found to have a higher rate of concussion, which needs further investigation. These findings are relevant to players concerned about safety in quidditch and to governing bodies regarding governance of the sport.	[Pennington, Rachel] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Cooper, Ashley] Cent Manchester Fdn Trust, Manchester Royal Infirm, Manchester, Lancs, England; [Edmond, Evan] John Radcliffe Hosp, Oxford, England; [Faulkner, Alastair; Reidy, Michael J.; Davies, Peter S. E.] Ninewells Hosp, Dept Trauma & Orthopaed, Dundee DD2 1UB, Scotland		Davies, PSE (corresponding author), Ninewells Hosp, Dept Trauma & Orthopaed, Dundee DD2 1UB, Scotland.	petersedavies@doctors.org.uk		Edmond, Evan/0000-0003-4641-3583; Davies, Peter/0000-0002-4367-7439			Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P221; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Kaux JF, 2015, SPORTS, V3, P21, DOI 10.3390/sports3010021; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mufty S, 2015, ACTA ORTHOP BELG, V81, P289; Myklebust G, 1998, SCAND J MED SCI SPOR, V8, P149, DOI 10.1111/j.1600-0838.1998.tb00185.x; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Swain MS, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0098-7	13	3	3	0	2	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2017	12	5					833	839		10.26603/ijspt20170833			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FV1EK	WOS:000424303600013	29181260	Green Published			2022-02-06	
J	Razak, NA; Nordin, R; Abd Rahman, N; Ramli, R				Razak, Nurliza Abdul; Nordin, Rifqah; Abd Rahman, Normastura; Ramli, Roszalina			A retrospective analysis of the relationship between facial injury and mild traumatic brain injury	DENTAL TRAUMATOLOGY			English	Article						facial injury; mild traumatic brain injury; retrospective study	CLOSED-HEAD INJURIES; MAXILLOFACIAL FRACTURES; CONCUSSION; MOTORCYCLISTS; TRENDS; IMPACT	Background/AimsThe association between facial injury characteristics and mild traumatic brain injury (mTBI) is unclear. The aim of this study was to determine the association between facial injury characteristics and mTBI. MethodsA retrospective review utilizing patients' medical records at the Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Kuala Lumpur, Malaysia, was performed. Records of subjects with a history of facial trauma from 1 April 2012 to 31 December 2012 were selected. Various levels and surgical speciality records were reviewed to ascertain the diagnoses of facial injuries and mTBI. ResultsA total of 348 medical records with the diagnosis of facial injuries were included. The prevalence of mTBI among these patients was 41.4% (95% CI 36.2-46.6). The majority of the patients with mTBI were in the age group of 18-25 years old. Patients with or without facial lacerations that were located on the lower face had a significant association with mTBI, P=.001, compared to other types of soft tissue injury. In addition, a statistically significant association was observed between facial fractures occurring to the middle face and mTBI, P=.018. Pearson chi-square test also showed statistically significant association between the severity of facial injuries and mTBI, P=.018. ConclusionsMild traumatic brain injury should be suspected in patients with facial injuries and particularly those with lower face lacerations, midface fractures, moderate to severe facial injury and presence of multiple injuries.	[Razak, Nurliza Abdul] Hosp Teluk Intan, Oral & Maxillofacial Surg, Teluk Intan, Perak, Malaysia; [Nordin, Rifqah; Ramli, Roszalina] Univ Kebangsaan Malaysia, Med Ctr, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Abd Rahman, Normastura] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian, Malaysia		Ramli, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	roszalina@ppukm.ukm.edu.my	Nordin, Rifqah/AAA-6274-2019; Rahman, Normastura Abd/G-5750-2016; Abd Rahman, Normastura Abd/AAX-7584-2021	Abd Rahman, Normastura Abd/0000-0002-1008-9913			Al-Khateeb T, 2007, J ORAL MAXIL SURG, V65, P1094, DOI 10.1016/j.joms.2006.09.013; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U, P51; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Colorado Medical Society, 1990, REP SPORTS MED COMM; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Department of Statistics Malaysia, 2010, POP HOUS CENS; Fasola AO, 2003, J ORAL MAXIL SURG, V61, P1140, DOI 10.1016/S0278-2391(03)00671-2; Forman JL, 2012, ACCIDENT ANAL PREV, V49, P229, DOI 10.1016/j.aap.2011.02.020; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Hohlrieder M, 2004, INT J ORAL MAX SURG, V33, P389, DOI 10.1016/j.ijom.2003.10.011; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Ong TK, 1999, INJURY, V30, P357, DOI 10.1016/S0020-1383(99)00101-1; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Ramli R, 2014, J FORENSIC LEG MED, V26, P39, DOI 10.1016/j.jflm.2014.06.007; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Serafin B, 2010, ORAL MAXILLOFACIAL S, P911; SHEPHERD JP, 1987, BRIT J PLAST SURG, V40, P614, DOI 10.1016/0007-1226(87)90157-3; Sobin L, 2016, JAMA FACIAL PLAST SU, V18, P15, DOI 10.1001/jamafacial.2015.1339; TEASDALE G, 1974, LANCET, V2, P81; TELFER MR, 1991, BRIT J ORAL MAX SURG, V29, P250, DOI 10.1016/0266-4356(91)90192-8; WHO, 2011, INT STAT CLASS DIS R; Whyte T, 2016, J NEUROTRAUM, V33, P1802, DOI 10.1089/neu.2015.4208; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	33	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2017	33	5					400	405		10.1111/edt.12355			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FH3FX	WOS:000411031700011	28649703				2022-02-06	
J	Schmidt, R; Piliavska, K; Maier-Ring, D; van Husen, DK; Dettmers, C				Schmidt, Roger; Piliavska, Kateryna; Maier-Ring, Dominik; van Husen, Dominik Klaasen; Dettmers, Christian			Psychotherapy in Neurorehabilitation	AKTUELLE NEUROLOGIE			German	Article						comorbidity; psychotherapeutic approaches; multimodal psychotherapy; bio-psychosocial approach; interdisciplinary	TRAUMATIC BRAIN-INJURY; FUNCTIONAL NEUROLOGICAL SYMPTOMS; MILD COGNITIVE IMPAIRMENT; QUALITY-OF-LIFE; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; SOMATOFORM DISORDERS; PSYCHIATRIC COMORBIDITIES; NEUROPSYCHIATRIC SYMPTOMS; DEPRESSIVE SYMPTOMS	The range of treatments available for neurorehabilitation must include appropriate psychotherapeutic approaches, if only because of the frequent occurrence of psychological co-morbidities, not always diagnosed and appropriately treated. The current situation is characterized by a large variety of available treatments, dearth of treatment studies and proven evidence. This state of affairs emphasizes the diversity and complexity of neurological disease. The presence of collateral psychological problems in particular requires individually tailored treatments. Damage to the CNS requires that particular attention be paid to the closely interwoven functions of the body and mind. What follows is the need for multimodal psychotherapy, grounded in neurology. Taking into account the various treatment approaches and regimens, therapy needs to be directly integrated in a meaningful, coherent way into other measures of neurological rehabilitation. Against this background, the paper gives an overview on clinical needs and therapeutic procedures as well as on the requirements and perspectives in the further development of psychotherapy in neurorehabilitation.	[Schmidt, Roger; van Husen, Dominik Klaasen] Kliniken Schmieder Konstanz, Psychotherapeut Neurol, D-78464 Constance, Germany; [Schmidt, Roger; Piliavska, Kateryna; Maier-Ring, Dominik; Dettmers, Christian] Univ Konstanz, Lurija Inst Rehabil Wissensch & Gesundheitsforsch, Kliniken Schmieder Allensbach, Constance, Germany; [Dettmers, Christian] Kliniken Schmieder Konstanz, Neurol, Constance, Germany		Schmidt, R (corresponding author), Kliniken Schmieder Konstanz, Psychotherapeut Neurol, D-78464 Constance, Germany.	roger.schmidt@uni-konstanz.de					Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Allet JL, 2006, CURR OPIN PSYCHIATR, V19, P413, DOI 10.1097/01.yco.0000228764.25732.21; Anderson SI, 1999, BRIT J NEUROSURG, V13, P480, DOI 10.1080/02688699908540622; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P457, DOI 10.1007/s11940-002-0013-5; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Baumeister H, 2011, BUNDESGESUNDHEITSBLA, V54, P52, DOI 10.1007/s00103-010-1185-x; Baumeister H, 2014, PSYCHISCHE KOMORBIDI; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Bener A, 2013, J PAIN RES, V6, P95, DOI 10.2147/JPR.S40740; Bengel J, 2003, PSYCHOTHER PSYCH MED, V53, P83, DOI 10.1055/s-2003-36964; Bombardier CH, 2004, MULT SCLER, V10, P35, DOI 10.1191/1352458504ms989oa; Brenner P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104165; Broen MPG, 2016, MOVEMENT DISORD, V31, P1125, DOI 10.1002/mds.26643; Broomfield NM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0198-8; Buoli M, 2016, J GERIATR PSYCH NEUR, V29, P72, DOI 10.1177/0891988715606233; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Buse DC, 2013, J NEUROL, V260, P1960, DOI 10.1007/s00415-012-6725-x; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Ceravolo R, 2009, PARKINSONISM RELAT D, V15, pS111, DOI 10.1016/S1353-8020(09)70847-8; Cheston R, 1996, AGEING SOC, V16, P579, DOI 10.1017/S0144686X00020249; Chwastiak LA, 2007, PSYCHIAT CLIN N AM, V30, P803, DOI 10.1016/j.psc.2007.07.003; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Cumming TB, 2016, INT J STROKE, V11, P968, DOI 10.1177/1747493016669861; de Mello RF, 2016, J STROKE CEREBROVASC, V25, P618, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.021; Dickstein LP, 2015, PSYCHOSOMATICS, V56, P44, DOI 10.1016/j.psym.2014.05.008; Edmondson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066435; Ettinger AB, 2005, NEUROLOGY, V65, P535, DOI 10.1212/01.wnl.0000172917.70752.05; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Fiess J, 2015, J PSYCHOSOM RES, V79, P477, DOI 10.1016/j.jpsychores.2015.10.009; Fink P, 2005, PSYCHOSOMATICS, V46, P540, DOI 10.1176/appi.psy.46.6.540; Finkenzeller W, 2009, NERVENARZT, V80, P805, DOI 10.1007/s00115-008-2649-1; Fisk JD, 1998, CAN J NEUROL SCI, V25, P230, DOI 10.1017/S0317167100034065; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Gallagher M, 2016, NEUROPSYCHOL REHABIL, V22, P1; Gauggel S., 2007, NEUROL REHABIL, V13, P90; GLATZEL PM, 1995, FORTSCHR NEUROL PSYC, V63, P49, DOI 10.1055/s-2007-996602; Goebel S, 2011, SUPPORT CARE CANCER, V19, P1797, DOI 10.1007/s00520-010-1021-8; Gore M, 2012, SPINE, V37, pE668, DOI 10.1097/BRS.0b013e318241e5de; Graziano F, 2014, CLIN REHABIL, V28, P264, DOI 10.1177/0269215513501525; Gross DW, 2004, NEUROLOGY, V62, P2095, DOI 10.1212/01.WNL.0000127623.03766.75; Grossman P, 2010, NEUROLOGY, V75, P1141, DOI 10.1212/WNL.0b013e3181f4d80d; Hallett M, 2016, FUNCTIONAL NEUROLOGI; Harter M, 2007, H BENGEL J PSYCHISCH, V55, P69; Harter MC, 2000, PSYCHOTHER PSYCH MED, V50, P274, DOI 10.1055/s-2000-8822; Helmchen H, 2001, NERVENARZT, V72, P181, DOI 10.1007/s001150050737; Jensen MP, 2009, INT J CLIN EXP HYP, V57, P198, DOI 10.1080/00207140802665476; Johnson J, 2003, MULT SCLER J, V9, P82, DOI 10.1191/1352458503ms856oa; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Jones SM, 2014, REHABIL PSYCHOL, V59, P354, DOI 10.1037/a0037074; Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; LaFrance WC, 2008, INT REV NEUROBIOL, V83, P347, DOI 10.1016/S0074-7742(08)00020-2; Larouche E, 2015, BEHAV BRAIN RES, V276, P199, DOI 10.1016/j.bbr.2014.05.058; Leo RJ, 2016, SCAND J PAIN, V11, P136, DOI 10.1016/j.sjpain.2015.12.002; Liedl A, 2008, SCHMERZ, V22, P644, DOI 10.1007/s00482-008-0714-0; Lucius-Hoene G, 2008, REHABILITATION, V47, P90, DOI 10.1055/s-2008-1042447; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos Constantin G, 2007, Dialogues Clin Neurosci, V9, P111; Maaijwee NAMM, 2016, EUR J NEUROL, V23, P1262, DOI 10.1111/ene.13009; Madhusoodanan Subramoniam, 2007, Expert Rev Neurother, V7, P343, DOI 10.1586/14737175.7.4.343; Madhusoodanan S, 2015, WORLD J PSYCHIATR, V5, P273, DOI 10.5498/wjp.v5.i3.273; Marlock G., 2006, HDB KORPERPSYCHOTHER; Marrie RA, 2015, NEUROLOGY, V85, P1972, DOI 10.1212/WNL.0000000000002174; Marrie RA, 2015, MULT SCLER J, V21, P305, DOI 10.1177/1352458514564487; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Morgan JC, 2005, NEUROLOGY, V65, pE12, DOI 10.1212/01.wnl.0000170367.33505.e9; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nash SS, 2009, HARVARD REV PSYCHIAT, V17, P389, DOI 10.3109/10673220903465726; Ness Debra, 2007, J Neurol Phys Ther, V31, P30; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Oberg GK, 2015, PHYSIOTHER THEOR PR, V31, P244, DOI 10.3109/09593985.2014.1002873; Onofrj M, 2010, NEUROLOGY, V74, P1598, DOI 10.1212/WNL.0b013e3181df09dd; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ostermann T, 2006, MUSIC THERAPY TREATM, V6, P469; Petersen C, 2014, KUNSTTHERAPIE NEUROL, P84; Pickut BA, 2013, CLIN NEUROL NEUROSUR, V115, P2419, DOI 10.1016/j.clineuro.2013.10.002; Prigatano G P, 2004, NEUROPSYCHOLOGISCHE, V139, P156; Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; Schmidt R, DEPRESSIVE STORUNGEN; Schmidt R, 2007, NEUROL REHABIL, V13, P51; Schmidt R, 1995, PRAGMATISCHE INTEGRA, V8, P193; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Schussler G, 1998, PSYCHOTHERAPEUT, V43, P382, DOI 10.1007/s002780050140; Seetlani N K, 2015, FREQUENCY DEPRESSION, V21, P22; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Simon F B, 1988, UNTERSCHIEDE MACHEN; Simpson GK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00078; Simpson R, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-15; Song TJ, 2017, CEPHALALGIA, V37, P845, DOI 10.1177/0333102416653235; Stalder-Luthy F, 2013, ARCH PHYS MED REHAB, V94, P1386, DOI 10.1016/j.apmr.2013.02.013; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Steffen A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0514-x; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Tang WK, 2011, ARCH PHYS MED REHAB, V92, P1336, DOI 10.1016/j.apmr.2011.02.018; Thomson P, 2006, CAMBRIDGE INTRO LIT, P1, DOI [10.2277/ 0521542510, 10.1002/14651858.CD004431.pub2]; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Vink AC, 2011, COCHRANE DB SYST REV, P1, DOI DOI 10.1002/14651858.CD003477.PUB2; Wahbeh H, 2008, NEUROLOGY, V70, P2321, DOI 10.1212/01.wnl.0000314667.16386.5e; Weintraub D, 2005, AM J GERIAT PSYCHIAT, V13, P844, DOI 10.1176/appi.ajgp.13.10.844; Wong GKC, 2014, J CLIN NEUROSCI, V21, P1695, DOI 10.1016/j.jocn.2014.02.018; Xie CL, 2015, NEUROL SCI, V36, P833, DOI 10.1007/s10072-015-2118-0; Zarei MR, 2016, ACTA ODONTOL SCAND, V74, P633, DOI 10.1080/00016357.2016.1232435	105	3	3	0	11	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350	1438-9428		AKTUEL NEUROL	Aktuelle Neurol.	OCT	2017	44	8					578	585		10.1055/s-0043-104525			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FJ2LX	WOS:000412560300006					2022-02-06	
J	Silva, LOJE; Bellolio, MF; Smith, EM; Daniels, DJ; Lohse, CM; Campbell, RL				Silva, Lucas Oliveira J. e; Bellolio, M. Fernanda; Smith, Elisa M.; Daniels, David J.; Lohse, Christine M.; Campbell, Ronna L.			Motocross-associated head and spine injuries in adult patients evaluated in an emergency department	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Motocross; Motorcycle; Sports injury; Trauma; Traumatic brain injury; Traumatic spinal cord injury	UNITED-STATES; CONCUSSION; SPORTS; EPIDEMIOLOGY; ACCIDENTS; MEDICINE; CHILDREN	Background: Motor vehicle-related injuries (including off-road) are the leading cause of traumatic brain injury (TBI) and acute traumatic spinal cord injury in the United States. Objectives: To describe motocross-related head and spine injuries of adult patients presenting to an academic emergency department (ED). Methods: We performed an observational cohort study of adult ED patients evaluated for motocross-related injuries from 2010 through 2015. Electronic health records were reviewed and data extracted using a standardized review process. Results: A total of 145 motocross-related ED visits (143 unique patients) were included. Overall, 95.2% of patients were men with a median age of 25 years. Sixty-seven visits (46.2%) were associated with head or spine injuries. Forty-three visits (29.7%) were associated with head injuries, and 46 (31.7%) were associated with spine injuries. Among the 43 head injuries, 36 (83.7%) were concussions. Seven visits (16.3%) were associated with at least 1 head abnormality identified by computed tomography, including skull fracture (n = 2), subdural hematoma (n = 1), subarachnoid hemorrhage (n = 4), intraparenchymal hemorrhage (n = 3), and diffuse axonal injury (n= 3). Among the 46 spine injuries, 32 (69.6%) were acute spinal fractures. Seven patients (4.9%) had clinically significant and persistent neurologic injuries. One patient (0.7%) died, and 3 patients had severe TBIs. Conclusion: Adult patients evaluated in the ED after motocross trauma had high rates of head and spine injuries with considerable morbidity and mortality. Almost half had head or spine injuries (or both), with permanent impairment for nearly 5% and death for 0.7%. (C) 2017 Published by Elsevier Inc.	[Silva, Lucas Oliveira J. e; Bellolio, M. Fernanda; Smith, Elisa M.; Campbell, Ronna L.] Mayo Clin, Dept Emergency Med, 200 First St SW, Rochester, MN 55905 USA; [Daniels, David J.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Lohse, Christine M.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Silva, Lucas Oliveira J. e] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil		Campbell, RL (corresponding author), Mayo Clin, Dept Emergency Med, 200 First St SW, Rochester, MN 55905 USA.	campbell.ronna@mayo.edu		Campbell, Ronna/0000-0001-6305-6990; Bellolio, Fernanda/0000-0002-1632-4750			American Motorcyclist Association, 2016, STAT LAWS DAT; Centers for Disease Control and Prevention, 2006, TRAUM BRAIN INJ US E; Conn J. M., 2006, Morbidity and Mortality Weekly Report, V55, P621; Cordell H. K., 2008, OFF HIGHWAY VEHICLE; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Gorski TF, 2003, AM SURGEON, V69, P895; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Liu BC, 2008, COCHRANE DB SYST REV, V23, P1; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Luo TD, 2015, J NEUROSURG-PEDIATR, V15, P255, DOI 10.3171/2014.11.PEDS14127; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Trauma Databank, 2016, NAT TRAUM DAT STAND; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358; Singh R, 2015, BMJ OPEN SPORT EXERC, V1; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	24	3	3	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	OCT	2017	35	10					1485	1489		10.1016/j.ajem.2017.04.058			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM6RG	WOS:000415183400019	28499787				2022-02-06	
J	Wani, AA; Sarmast, AH; Ahangar, M; Malik, NK; Chhibber, SS; Arif, SH; Ramzan, AU; Dar, BA; Ali, Z				Wani, Abrar Ahad; Sarmast, Arif Hussain; Ahangar, Muzaffar; Malik, Nayil Khursheed; Chhibber, Sarabjit Singh; Arif, Sajad Hussain; Ramzan, Altaf Umar; Dar, Bashir Ahmed; Ali, Zulfiqar			Pediatric Head Injury: A Study of 403 Cases in a Tertiary Care Hospital in a Developing Country	JOURNAL OF PEDIATRIC NEUROSCIENCES			English	Article						Glasgow Coma Scale; outcome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTERIZED-TOMOGRAPHY; EXTRADURAL HEMATOMAS; PROGNOSTIC VALUE; CHILDREN; COMA; SCALE; PREDICTION; FRACTURE; INFANTS	Introduction: Traumatic brain injury (TBI) in children is a significant cause of morbidity and mortality worldwide. Falls are the most common type of injury, followed by motor vehicle-related accidents and child abuse. Aims and Objectives: The aim and objective of this study was to elucidate the various modes of injury, prognostic factors, complications, incidence of various modes of injury, and outcome in TBI in pediatric population. Materials and Methods: Patients with TBI, 18 years or less in age, managed in our Department of Neurosurgery, over a period of 2 years, were studied prospectively. Detailed history, general physical examination, systemic examination, and central nervous system examination including assessment of Glasgow Coma Scale score (GCS) and pupillary size and reaction were noted in every patient. Based on GCS, patients were divided into mild head injury (GCS 13-15), moderate head injury (GCS 9-12), and severe head injury (GCS <= 8) categories. All the patients were subjected to plain computed tomography (CT) scan head, and CT findings were noted. Patients were managed conservatively or surgically as per the standard indications. The outcome of all these patients was assessed by Glasgow outcome scale and divided into good (normal, moderate disability) and poor (severe, vegetative, dead) outcome. Outcome was assessed in relation to age, sex, GCS, pupil size and reaction, CT scan features, intervention, and associated injuries. Results: A total of 403 patients aged between 1 day and 18 years were included in the study comprising 252 males (63%) and 151 females (37.75%). The common modes of injury were fall 228 (56.6%) followed by road traffic accidents 138 (34.2%), assault 10 (2.5%), and others 27 (6.7%) which include sports injury, hit by some object on head, and firearm injury. Majority of our patients had a GCS of 13-15 (mild head injury), 229 (57.3%), followed by 9-12 (moderate head injury) 119 (29.8%), followed by 8 or less (severe head injury) 52 (13%). In group of patients in the category of GCS <= 8, poor outcome was seen in 65.3%, followed by patients in group GCS 9-12 at 2.45% succeeded by group of patients with GCS 13-15 at 2.6%, which was statistically significant (P < 0.0001). A total of 354 (87.8%) patients had normal pupils, 37 (9.2%) had anisocoria, and 12 (3%) patients had fixed dilated pupils. Fixed dilated pupil had poor outcome (100%) followed by anisocoria (40.5%) and normal pupils (16%), which was statistically significant (P < 0.0001). Conclusion: Majority of children who suffer from TBI do well although it still continues to be a significant cause of morbidity and mortality in them. The outcome is directly related to the neurological status in which they present to the hospital.	[Wani, Abrar Ahad; Ahangar, Muzaffar; Malik, Nayil Khursheed; Chhibber, Sarabjit Singh; Arif, Sajad Hussain; Ramzan, Altaf Umar] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India; [Dar, Bashir Ahmed; Ali, Zulfiqar] Sherikashmir Inst Med Sci, Dept Anesthesiol, Srinagar, Jammu & Kashmir, India; [Sarmast, Arif Hussain] AMU, Jawaharlal Nehru Med Coll, Dept Neurosurg, Aligarh 202002, Uttar Pradesh, India		Sarmast, AH (corresponding author), AMU, Jawaharlal Nehru Med Coll, Dept Neurosurg, Aligarh 202002, Uttar Pradesh, India.	arifhsarmast@gmail.com					Adirim TA, 1999, AM J EMERG MED, V17, P499, DOI 10.1016/S0735-6757(99)90184-5; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Astrand R, 2010, PEDIATR NEUROSURG, V46, P101, DOI 10.1159/000319006; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CHOUX M, 1975, CHILD BRAIN, V1, P337; Comninos S C, 1979, Acta Neurochir Suppl (Wien), V28, P144; Dunning J, 2004, EMERG MED J, V21, P404, DOI 10.1136/emj.2004.014944; Francel PC, 1996, NEUROLOGICAL SURG, P1730; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Jane JA, 2008, J NEUROSURG-PEDIATR, V2, P238, DOI 10.3171/PED.2008.2.10.237; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Paret G, 1999, HAREFUAH, V136, P755; Paret Gideon, 1999, Harefuah, V136, P677; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; Ringl H, 2009, EUR RADIOL, V19, P2416, DOI 10.1007/s00330-009-1435-1; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Su F, 2004, EMEDICINE J, V5, P1; Suresh HS, 2003, NEUROL INDIA, V51, P16; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Tomberg T, 1996, ACTA NEUROCHIR, V138, P543, DOI 10.1007/BF01411174; Trenchs V, 2009, EUR J EMERG MED, V16, P150, DOI 10.1097/MEJ.0b013e328321b7b5; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Wani AA, 2008, PEDIATR NEUROSURG, V44, P204, DOI 10.1159/000120151; Wani AA, 2011, J NEUROSURG-PEDIATR, V7, P276, DOI 10.3171/2010.12.PEDS10241; Wani AA, 2010, PEDIATR NEUROSURG, V46, P25, DOI 10.1159/000314054; Wani AA, 2007, INDIAN J NEUROTRAUM, V4, P79, DOI 10.1016/S0973-0508(07)80021-9; Yi W, 2010, PEDIATR NEUROSURG, V46, P259, DOI 10.1159/000321800	38	3	3	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1817-1745	1998-3948		J PEDIATR NEUROSCI	J. Pediatr. Neurosci.	OCT-DEC	2017	12	4					332	337		10.4103/jpn.JPN_80_17			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GF8WM	WOS:000432256700005	29675071	Green Published			2022-02-06	
J	Yoneshige, A; Hagiyama, M; Inoue, T; Tanaka, T; Ri, A; Ito, A				Yoneshige, Azusa; Hagiyama, Man; Inoue, Takao; Tanaka, Tomonori; Ri, Aritoshi; Ito, Akihiko			Modest Static Pressure Can Cause Enteric Nerve Degeneration Through Ectodomain Shedding of Cell Adhesion Molecule 1	MOLECULAR NEUROBIOLOGY			English	Article						Cell adhesion molecule 1; Ectodomain shedding; Intraluminal pressure; Mechanical ileus; Neurodegenerative disease; Water pressure-loadable two-chamber culture; Azusa Yoneshige and Man Hagiyama contributed equally to this study	SLOW-TRANSIT CONSTIPATION; ASPARTIC-ACID RESIDUES; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; SYNAPTIC ADHESION; HUMAN LENS; APOPTOSIS; DISEASE; COLON; CADM1	Internal pressure is often involved in neurode-generation; intraocular and intraventricular pressure elevations over 20-30 cmH(2)O cause glaucoma and hydrocephalus, respectively. Here, we investigated enteric nerve degeneration in colon segments having tumor-induced stenosis and dilation and examined the mechanism of intraluminal pressure involvement. Histological examination revealed that the enteric ganglion neurons and neurites decreased in density in the dilated colons proportionate to the degree of dilation. Western blot analysis for cell adhesion molecule 1 (CADM1), an immunoglobulin superfamily member expressed in enteric neurons, revealed that ectodomain shedding of CADM1 increased proportionate to colon dilation, with increased production of its C-terminal fragment alpha CTF, a proapoptotic intracellular molecule. To link these neuro-degenerative events to increased intraluminal pressure, we devised a two-chamber culture system wherein cells cultured on a semipermeable membrane were subjected to increased medium height (water pressure up to 50 cmH(2)O). Mouse dorsal root ganglion (DRG) neurons were examined for expansion of their neurite networks in this system. As the pressure increased to 15, 30, and 45 cmH(2)O, the neurites decreased in density and became thinner. In addition, CADM1 shedding increased with more aCTF production. CADM1 immunofluorescence and Mitotracker mitochondrial labeling revealed that as the pressure increased, neuritic CADM1 distribution changed from uniform to punctate staining patterns, and neuritic mitochondria decreased in number and appeared as course particles. These pressure-induced phenotypes were reproduced by exogenous expression of alpha CTF in standard DRG neuron cultures. Therefore, increases in colonic intraluminal pressure might cause enteric nerve degeneration by inducing CADM1 shedding and alpha CTF production.	[Yoneshige, Azusa; Hagiyama, Man; Inoue, Takao; Tanaka, Tomonori; Ri, Aritoshi; Ito, Akihiko] Kindai Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan		Ito, A (corresponding author), Kindai Univ, Fac Med, Dept Pathol, Osaka 5898511, Japan.	aito@med.kindai.ac.jp	Tanaka, Tomonori/AAH-6168-2020		Japan Society for the Promotion of Science KakenhiMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K08723, 25860302, 15K01734, 24590492]; Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); twenty-first century joint research enhancement grant of Kindai University	The authors thank Yoshitaka Horiuchi and Yasumitsu Akahoshi (Kindai University Life Science Research Institute, Osaka, Japan) and Yoichiroh Hosokawa and Takanori Iino (Nara Institute of Science and Technology, Nara, Japan) for their technical assistance. This study was supported by the Japan Society for the Promotion of Science Kakenhi (16K08723 to AY, 25860302 to MH, 15K01734 to TI and 24590492 to AI), Ministry of Education, Culture, Sports, Science and Technology-Supported Program for the Strategic Research Foundation at Private Universities 2015-17 (to AI), and twenty-first century joint research enhancement grant of Kindai University (to AI).	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bampton PA, 2000, AM J GASTROENTEROL, V95, P1027, DOI 10.1111/j.1572-0241.2000.01839.x; Bassotti G, 2006, GUT, V55, P41, DOI 10.1136/gut.2005.073197; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRATT CG, 1987, J UROLOGY, V137, P845, DOI 10.1016/S0022-5347(17)44270-4; Cabrera-Benitez NE, 2012, CRIT CARE MED, V40, P510, DOI 10.1097/CCM.0b013e31822f09d7; Fogel AI, 2010, J BIOL CHEM, V285, P34864, DOI 10.1074/jbc.M110.120865; FRYKBERG T, 1985, ACTA NEUROPATHOL, V66, P184, DOI 10.1007/BF00688582; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Furuno T, 2012, J NEUROIMMUNOL, V250, P50, DOI 10.1016/j.jneuroim.2012.05.016; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; Hagiyama M, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0173-8; Hagiyama M, 2011, J IMMUNOL, V186, P5983, DOI 10.4049/jimmunol.1002244; Hagiyama M, 2009, AM J PATHOL, V174, P2278, DOI 10.2353/ajpath.2009.080743; Haun Florian, 2013, J Cell Death, V6, P27; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito A, 2012, ISLETS, V4; Ito A, 2007, HEPATOLOGY, V45, P684, DOI 10.1002/hep.21501; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koma YI, 2008, GASTROENTEROLOGY, V134, P1544, DOI 10.1053/j.gastro.2008.01.081; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Maeda H, 2015, ANAL CHEM, V87, P561, DOI 10.1021/ac504413e; Mimae T, 2014, THORAX, V69, P223, DOI 10.1136/thoraxjnl-2013-203867; Mimae T, 2012, CLIN CANCER RES, V18, P945, DOI 10.1158/1078-0432.CCR-11-1946; Nagara Y, 2012, BIOCHEM BIOPH RES CO, V417, P462, DOI 10.1016/j.bbrc.2011.11.140; Nagata M, 2012, INT J CANCER, V130, P1329, DOI 10.1002/ijc.26160; Rao SSC, 2016, NAT REV GASTRO HEPAT, V13, P295, DOI 10.1038/nrgastro.2016.53; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SCHMIDT E, 1978, CHIRURG, V49, P104; Sugihara K, 1987, Ann Acad Med Singap, V16, P504; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; WEINREICH J, 1976, SCAND J GASTROENTERO, V11, P577; Yoneshige A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0255-x; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107	40	3	3	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	OCT	2017	54	8					6378	6390		10.1007/s12035-016-0166-y			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF5NP	WOS:000409039000051	27722927				2022-02-06	
J	Finkel, AG; Klaric, JS; Yerry, JA; Choi, YS				Finkel, Alan G.; Klaric, John S.; Yerry, Juanita A.; Choi, Young S.			Staying in service with posttraumatic headache A retrospective cohort study of patient outcome	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DEPLOYMENT; SUGGESTIBILITY; EPIDEMIOLOGY; PREVALENCE; RESILIENCE; PREDICTORS; DISORDERS; DIAGNOSIS; SEVERITY	Objective: To predict the probability of a military outcome (medical discharge/retirement) in patients with mild traumatic brain injury from a clinical analysis of predetermined patient and headache characteristics. Methods: This retrospective cohort study sampled all new patients referred for headache evaluation at the Brain Injury Clinic of the Womack Army Medical Center, Ft. Bragg, NC (August 2008-January 2010). Headache characteristics were extracted and analyzed. Multivariable binary logistic regressions were conducted to predict probability of medical discharge/retirement. Results: Ninety-five soldiers (age 31.3 +/- 7.4 years, male 93.7%) reported 166 headaches. The most common injury cited was a blast (53.7%). Patients with a continuous headache have almost 4 times the odds of a medically related discharge/retirement compared to patients without such a headache (continuous headache regression coefficient estimate: p<0.042, odds ratio 3.98, 95% Wald confidence interval 1.05-15.07). Results suggest that, compared to service members who did not have a continuous headache, patients with headache histories with severe holocephalic pain who medicate to keep functioning had the highest probability of medical discharge/retirement. Conclusions: Certain headache characteristics may be predictive of military outcomes after mild traumatic brain injury, and we propose a profile that may be useful in that prediction. These data could be useful in future attempts to assess and treat patients with posttraumatic headache and to advise longer-term planning for return to duty or discharge.	[Finkel, Alan G.; Klaric, John S.; Choi, Young S.] Womack Army Med Ctr, Ft Bragg, NC 28310 USA; [Finkel, Alan G.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Finkel, Alan G.] Carolina Headache Inst, Chapel Hill, NC USA; [Yerry, Juanita A.] Vet Adm Hosp, Fayetteville, NC USA		Finkel, AG (corresponding author), Womack Army Med Ctr, Ft Bragg, NC 28310 USA.; Finkel, AG (corresponding author), Def & Vet Brain Injury Ctr, Silver Spring, MD USA.; Finkel, AG (corresponding author), Carolina Headache Inst, Chapel Hill, NC USA.	finkela@chi09.com					Amara J, 2014, MIL MED, V179, P964, DOI 10.7205/MILMED-D-13-00559; Awerbuch M, 2004, INTERN MED J, V34, P416, DOI 10.1111/j.1444-0903.2004.00640.x; CLASSEN W, 1983, NEUROPSYCHOBIOLOGY, V10, P44, DOI 10.1159/000117982; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Finkel AG, 2017, CEPHALALGIA, V37, P548, DOI 10.1177/0333102416651285; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Ford S, 2008, HEADACHE, V48, P523, DOI 10.1111/j.1526-4610.2008.00859.x; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lamberty GJ, 2013, BEHAV SCI LAW, V31, P814, DOI 10.1002/bsl.2091; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Melhorn JM, 1999, J OCCUP ENVIRON MED, V41, P84, DOI 10.1097/00043764-199902000-00002; Oktay C, 2015, CEPHALALGIA, V35, P579, DOI 10.1177/0333102414553821; PASSCHIER J, 1993, HEADACHE, V33, P73, DOI 10.1111/j.1526-4610.1993.hed3302073.x; Peck KR, 2015, HEADACHE, V55, P1102, DOI 10.1111/head.12633; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Raggi A, 2014, NEUROL SCI, V35, pS23, DOI 10.1007/s10072-014-1736-2; Scher AI, 63 ANN M AM AC NEUR; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Schwab K, DEPLOYMENT RELATED M; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024	38	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 12	2017	89	11					1186	1194		10.1212/WNL.0000000000004358			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FG3JY	WOS:000410051500016	28814458				2022-02-06	
J	Botolin, S; VanderHeiden, TF; Moore, EE; Fried, H; Stahel, PF				Botolin, Sergiu; VanderHeiden, Todd F.; Moore, Ernest E.; Fried, Herbert; Stahel, Philip F.			The role of pre-reduction MRI in the management of complex cervical spine fracture-dislocations: an ongoing controversy?	PATIENT SAFETY IN SURGERY			English	Article						Cervical spine trauma; Fracture-dislocation; Perched facet; Intervertebral disc herniation; Timing of surgery; Spinal cord injury; Patient safety	POSTERIOR-ANTERIOR APPROACH; FACET DISLOCATION; SURGICAL-TREATMENT; CORD-INJURY; TRAUMA; HERNIATION; DISC	Background: Cervical spine fracture-dislocations in neurologically intact patients represent a surgical challenge due to the risk of inflicting iatrogenic spinal cord compression by closed reduction maneuvers. The use of MRI for early advanced imaging in these injuries remains controversially debated. Case presentation: A 54-year old man sustained a fall over the handlebars of his racing bicycle. The helmeted patient sustained a fall on his head which resulted in a hyperflexion injury of the neck. He was neurologically intact on presentation. Initial CT imaging revealed a complex multisegmental cervical spine injury with a leftsided C6/C7 perched facet, a right sided C7/T1 fracture-dislocation, and a right-sided C6 and C7 traumatic laminotomy. The initial management consisted of temporary external Halo fixator application without closed reduction maneuver, to mitigate the risk of a delayed spinal cord injury. Subsequent advanced imaging by MRI revealed an acute traumatic C7/T1 disc herniation, with the intervertebral disc completely extruded into the spinal canal. Definitive surgical management was then accomplished by employing a three-stage anterior-posterior-anterior spinal decompression, realignment, fixation and fusion C4-T2 in one operative session. The patient recovered well and retained full neurological function. He resumed bicycle street racing within 10 months of the injury following successful spinal reconstruction. Conclusions: The diagnostic evaluation of cervical fracture-dislocations should include advanced imaging by MRI in order to fully understand the injury pattern prior to proceeding with spinal reduction maneuvers which may impose the imminent threat of a devastating iatrogenic injury to the spinal cord. The presented staged management by initial Halo fixation without attempts for spinal reduction, followed by a surgical decompression and multilevel fusion, appears to represent a feasible and safe strategy for patients at risk of a delayed neurological injury.	[Botolin, Sergiu; VanderHeiden, Todd F.; Stahel, Philip F.] Univ Colorado, Dept Orthopaed, Sch Med, 777 Bannock St, Denver, CO 80204 USA; [Botolin, Sergiu; VanderHeiden, Todd F.; Moore, Ernest E.; Fried, Herbert; Stahel, Philip F.] Denver Hlth Med Ctr, 777 Bannock St, Denver, CO 80204 USA; [Moore, Ernest E.] Univ Colorado, Dept Surg, Sch Med, Denver, CO 80204 USA; [Fried, Herbert; Stahel, Philip F.] Univ Colorado, Dept Neurosurg, Sch Med, 777 Bannock St, Denver, CO 80204 USA		Stahel, PF (corresponding author), Univ Colorado, Dept Orthopaed, Sch Med, 777 Bannock St, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Denver Hlth Med Ctr, 777 Bannock St, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Univ Colorado, Dept Neurosurg, Sch Med, 777 Bannock St, Denver, CO 80204 USA.	philip.stahel@gmail.com					Bartels RHMA, 2002, J NEUROSURG, V97, P362, DOI 10.3171/spi.2002.97.3.0362; Darsaut TE, 2006, SPINE, V31, P2085, DOI 10.1097/01.brs.0000232166.63025.68; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; DORAN SE, 1993, J NEUROSURG, V79, P341, DOI 10.3171/jns.1993.79.3.0341; EISMONT FJ, 1991, J BONE JOINT SURG AM, V73A, P1555, DOI 10.2106/00004623-199173100-00014; Feuchtbaum E, 2016, CURR REV MUSCULOSKE, V9, P496, DOI 10.1007/s12178-016-9377-0; Grauer JN, 2009, J SPINAL DISORD TECH, V22, P96, DOI 10.1097/BSD.0b013e31816a9ebd; Hart RA, 2002, SPINE, V27, P116, DOI 10.1097/00007632-200201010-00030; Hussain M, 2012, ASIAN SPINE J, V6, P29, DOI 10.4184/asj.2012.6.1.29; Joaquim AF, 2014, J SPINAL CORD MED, V37, P420, DOI 10.1179/2045772313Y.0000000143; Joaquim AF, 2014, GLOB SPINE J, V4, P63, DOI 10.1055/s-0033-1356764; Kandziora Frank, 2005, Injury, V36 Suppl 2, pB36; Khezri N, 2017, NEUROSURG CLIN N AM, V28, P125, DOI 10.1016/j.nec.2016.07.005; Kossmann T, 2000, SCHWEIZ MED WSCHR, V130, P816; Kumar Y, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1169-6; Lins CC, 2016, ARQ NEURO-PSIQUIAT, V74, P745, DOI 10.1590/0004-282X20160078; Lu GH, 2009, CHIN J TRAUMATOL, V12, P148, DOI 10.3760/cma.j.issn.1008-1275.2009.03.005; Lu K, 1998, ACTA NEUROCHIR, V140; MAHALE YJ, 1993, J BONE JOINT SURG BR, V75, P403, DOI 10.1302/0301-620X.75B3.8496208; MERIANOS P, 1994, INJURY, V25, P645, DOI 10.1016/0020-1383(94)90004-3; Nassr A, 2008, SPINE, V33, pE188, DOI 10.1097/BRS.0b013e3181696118; Payer M, 2007, J CLIN NEUROSCI, V14, P782, DOI 10.1016/j.jocn.2006.04.021; Payer M, 2006, J CLIN NEUROSCI, V13, P73, DOI 10.1016/j.jocn.2005.02.010; RIZZOLO SJ, 1991, SPINE, V16, pS187, DOI 10.1097/00007632-199106001-00002; Schwarz N, 1993, Eur Spine J, V2, P65, DOI 10.1007/BF00302705; Shimada Takashi, 2013, J Med Case Rep, V7, P9, DOI 10.1186/1752-1947-7-9; Stahel PF, 2012, CURR OPIN CRIT CARE, V18, P651, DOI 10.1097/MCC.0b013e32835a0e54; Talekar K, 2016, SEMIN ULTRASOUND CT, V37, P431, DOI 10.1053/j.sult.2016.05.007; Tumialan LM, 2009, SPINE, V34, pE703, DOI 10.1097/BRS.0b013e3181b1fc3a; Vaccaro AR, 1999, SPINE, V24, P1210, DOI 10.1097/00007632-199906150-00007; 2002, NEUROSURGERY S3, V50, P44	31	3	3	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-9493			PATIENT SAF SURG	Patient Saf. Surg.	SEP 8	2017	11								23	10.1186/s13037-017-0139-8			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	FG8PM	WOS:000410696800001	28904564	gold, Green Published			2022-02-06	
J	Shen, B; Li, L; Li, T				Shen, Bo; Li, Lin; Li, Ting			Concurrence of Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt Wasting Syndromes after Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						the syndrome of inappropriate antidiuretic hormone; cerebral salt wasting syndrome; traumatic brain injury; hyponatremia; central venous pressure	NATRIURETIC PEPTIDE; HYPONATREMIA; SODIUM; MANAGEMENT; DIAGNOSIS; RECOMMENDATIONS; VASOPRESSIN	Syndrome of inappropriate antidiuretic hormone (SIADH) and cerebral salt wasting syndrome (CSWS) as the two most common neuroendocrine diseases, have been recognized and understood by many neurologists. Although SIADH and CSWS are the common causes of central hyponatremia after traumatic brain injury (TBI), a few cases are mixed, with the coexistence of the two pathological pathomechanism. However, the mixed type of both SIADH and CSWS has not been clearly reported in any literature. Here, we present the first description of the concurrent syndrome of SIADH and CSWS after TBI in four patients who underwent standard diagnostic procedures, treatment and follow up. Our findings further support that this rare neuroendocrine disease may exist in clinical practice, in which the traditional-conventional treatment shows poor efficacy.	[Shen, Bo] Peoples Hosp Shanxi Prov, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China; [Shen, Bo; Li, Ting] Peoples Hosp Shanxi Prov, Div Neurocrit Care, Taiyuan, Shanxi, Peoples R China; [Shen, Bo] Shanxi Med Univ, Acad Dept Neurosurg, Taiyuan, Shanxi, Peoples R China; [Li, Lin] Peoples Hosp Shanxi Prov, Dept Clin Nursing, Taiyuan, Shanxi, Peoples R China		Shen, B (corresponding author), Peoples Hosp Shanxi Prov, Dept Neurosurg, Taiyuan, Shanxi, Peoples R China.; Shen, B (corresponding author), Peoples Hosp Shanxi Prov, Div Neurocrit Care, Taiyuan, Shanxi, Peoples R China.; Shen, B (corresponding author), Shanxi Med Univ, Acad Dept Neurosurg, Taiyuan, Shanxi, Peoples R China.	wsnbb-qbb@qq.com	Shen, Bo/R-6571-2019				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Bankir L, 2001, CARDIOVASC RES, V51, P372, DOI 10.1016/S0008-6363(01)00328-5; Berl T, 2013, CLIN J AM SOC NEPHRO, V8, P469, DOI 10.2215/CJN.03100312; Bhuvaneswar CG, 2009, CNS DRUGS, V23, P1003, DOI 10.2165/11530020-000000000-00000; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; Chang CH, 2008, AM J MED SCI, V335, P390, DOI 10.1097/MAJ.0b013e318149e6f1; Cuesta M, 2016, J ENDOCRINOL INVEST, V39, P991, DOI 10.1007/s40618-016-0463-3; de Denus S, 2004, CHEST, V125, P652, DOI 10.1378/chest.125.2.652; Dick M, 2015, ENDOCRINOL DIAB META, DOI 10.1530/EDM-15-0070; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Filippatos TD, 2016, EUR J INTERN MED, V29, P22, DOI 10.1016/j.ejim.2015.11.022; Furst H, 2000, AM J MED SCI, V319, P240, DOI 10.1097/00000441-200004000-00007; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Kazama I, 2007, NEPHROL DIAL TRANSPL, V22, P68, DOI 10.1093/ndt/gfl110; Kerns E, 2014, CLIN NEPHROL, V82, P397, DOI 10.5414/CN108014; Kim Dong Ki, 2009, Electrolyte Blood Press, V7, P51, DOI 10.5049/EBP.2009.7.2.51; Lange-Asschenfeldt C, 2013, J CLIN PSYCHOPHARM, V33, P799, DOI 10.1097/JCP.0b013e3182a4736f; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Musch W, 1998, QJM-MON J ASSOC PHYS, V91, P749, DOI 10.1093/qjmed/91.11.749; Papadimitriou DT, 2007, J PEDIATR ENDOCR MET, V20, P1145; Rhee CM, 2016, NEPHROL DIAL TRANSPL, V31, P992, DOI 10.1093/ndt/gfv341; Sachdeo RC, 2002, ANN NEUROL, V51, P613, DOI 10.1002/ana.10190; Soudan K, 2012, AM J MED SCI, V343, P507, DOI 10.1097/MAJ.0b013e318245faaf; Taylor P, 2017, ENDOCRINOL DIAB META, DOI 10.1530/EDM-16-0142; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Wu XH, 2016, WORLD NEUROSURG, V88, P483, DOI 10.1016/j.wneu.2015.10.011; Zaino Christian J, 2013, Am J Orthop (Belle Mead NJ), V42, P522	30	3	3	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 6	2017	11								499	10.3389/fnins.2017.00499			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG1KV	WOS:000409555900001	28932182	Green Published, gold			2022-02-06	
J	Esianor, BI; Haider, AS; Engelhardt, MI; Osumah, T; Vayalumkal, S; Thakur, R; Leonard, D; Haithcock, J; Layton, KF				Esianor, Brandon, I; Haider, Ali S.; Engelhardt, Margaret, I; Osumah, Tijani; Vayalumkal, Steven; Thakur, Richa; Leonard, Dean; Haithcock, Jeffrey; Layton, Kennith F.			Intracranial Ischemic Infarct Due to Blunt Force Trauma in a High School Football Player	CUREUS			English	Article						internal carotid artery dissection; head trauma; traumatic brain injury (tbi); stroke; athlete; sports trauma	CAROTID-ARTERY DISSECTION	Ischemic stroke is an uncommon cause of death among teenagers and young adults; however, the etiologies differ when compared to ischemic strokes in older individuals. Large-vessel atherosclerosis and small-vessel disease causing ischemic stroke are rare for the teenage population, while cervicocerebral arterial dissections account for up to 20% of ischemic strokes. Here, we present the case of a 16-year-old male who developed internal carotid artery dissection (ICAD) after a head injury and subsequently developed ischemic stroke and seizures.	[Esianor, Brandon, I; Engelhardt, Margaret, I] Mcgovern Med Sch, Otolaryngol, Houston, TX USA; [Haider, Ali S.] Texas A&M Coll Med, Neurosurg, Bryan, TX USA; [Osumah, Tijani] Ross Univ, Sch Med, Miramar, FL USA; [Vayalumkal, Steven] St Georges Univ, Sch Med, True Blue Point, Grenada; [Thakur, Richa; Leonard, Dean] Texas A&M Coll Med, Bryan, TX USA; [Haithcock, Jeffrey; Layton, Kennith F.] Baylor Univ, Med Ctr, Dept Radiol, Waco, TX 76798 USA		Vayalumkal, S (corresponding author), St Georges Univ, Sch Med, True Blue Point, Grenada.	svayalurnka1999@grnail.com	Thakur, Richa/G-8975-2016; Thakur, Richa/AAT-2076-2021	Thakur, Richa/0000-0002-1086-3390; Thakur, Richa/0000-0002-1086-3390; Haider, Ali/0000-0002-4368-871X			Benninger DH, 2004, STROKE, V35, P482, DOI 10.1161/01.STR.0000109766.27393.52; KITANI R, 1987, J NEUROSURG, V67, P296, DOI 10.3171/jns.1987.67.2.0296; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; OSULLIVAN RM, 1990, AM J NEURORADIOL, V11, P1150; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Tsurukiri J, 2013, SIGNA VITAE, V8, P67, DOI 10.22514/SV82.102013.13; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Yang ST, 2006, J CLIN NEUROSCI, V13, P123, DOI 10.1016/j.jocn.2005.02.016	9	3	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP	2017	9	9							e1659	10.7759/cureus.1659			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HE7NR	WOS:000453625000025	29147634	Green Published, gold, Green Submitted			2022-02-06	
J	Gravel, J; Carriere, B; D'Angelo, A; Crevier, L; Beauchamp, MH; M asse, B				Gravel, Jocelyn; Carriere, Benoit; D'Angelo, Antonio; Crevier, Louis; Beauchamp, Miriam H.; Masse, Benoit			Ondansetron for pediatric concussion; a pilot study for a randomized controlled trial	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						children; mTBI; concussion; ondansetron	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; HEAD-INJURY; INTERNATIONAL-CONFERENCE; ACUTE GASTROENTERITIS; COMPUTED-TOMOGRAPHY; CONSENSUS STATEMENT; EARLY INTERVENTION; ORAL ONDANSETRON	Objectives: Assess the feasibility of a study evaluating one dose of oral ondansetron to decrease post-concussion symptoms at one week and one month following concussion in children aged 8 to 17 years old. Method: This was a pilot study for a randomized, triple-blind controlled trial of one dose of either ondansetron or placebo performed in a tertiary care pediatric emergency department. Participants were children aged 8 to 17 years who sustained a concussion in the previous 24 hours and visited a single emergency department. The outcome of interest was an increase from pre-concussion baseline of at least 3 symptoms from the Post-Concussion Symptom Inventory, measured at one week and at one month following concussion. The primary outcome was to determine the proportion of children who completed the assessment at one week following the intervention. Secondary outcome was the proportion of children who completed the assessment at one month following the intervention. All children, care givers, and those assessing the outcomes were blinded to the group assignment. Results: Of the 218 children presenting with a concussion during the study period, we screened 108 and found 36/108 (33%) eligible to participate and 16/108 (14.8%) agreed to participate. All enrolled patients were compliant with the intervention and follow-up. Conclusion: In our study population, approximately one-third of the screened concussion patients were eligible to participate and approximately one half of those eligible agreed to participate. Our study found that most enrolled patients preferred electronic follow-up; the noncompliance rate was minimal.	[Gravel, Jocelyn; Carriere, Benoit; D'Angelo, Antonio] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Chirurg, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Masse, Benoit] Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ, Canada		Gravel, J (corresponding author), Univ Montreal, Hop St Justine, Dept Pediat, Div Emergency Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	Graveljocelyn@hotmail.com		Beauchamp, Miriam/0000-0002-8637-6361; Gravel, Jocelyn/0000-0001-5901-4990			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P68; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; BOHNEN NI, 1993, NEUROLOGY, V43, P103, DOI 10.1212/WNL.43.1_Part_1.103; Bolton CM, 2006, BRIT J ANAESTH, V97, P593, DOI 10.1093/bja/ael256; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Boutis K, 2013, PEDIATRICS, V132, P305, DOI 10.1542/peds.2013-0378; Brackins Todd, 2011, J Pharm Pract, V24, P541, DOI 10.1177/0897190011426557; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASEY R, 1987, PEDIATRICS, V80, P159; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; FILIPOVA M, 1989, Human Psychopharmacology, V4, P47, DOI 10.1002/hup.470040108; Fontenelle LF, 2011, DRUGS, V71, P827, DOI 10.2165/11591790-000000000-00000; Freedman SB, 2006, NEW ENGL J MED, V354, P1698, DOI 10.1056/NEJMoa055119; Freedman Stephen B, 2013, Evid Based Child Health, V8, P1123, DOI 10.1002/ebch.1932; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Fujii Y, 2008, CURR DRUG SAF, V3, P27, DOI 10.2174/157488608783333934; Fujii Y, 2009, CURR DRUG SAF, V4, P62, DOI 10.2174/157488609787354413; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heskestad B, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-10; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Kharbanda AB, 2013, J PEDIATR-US, V163, P230, DOI 10.1016/j.jpeds.2012.12.013; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KLEINERMAN KB, 1993, ANN PHARMACOTHER, V27, P566, DOI 10.1177/106002809302700505; KRAUS JF, 1987, PEDIATRICS, V79, P501; Langston WT, 2008, ANN EMERG MED, V52, P30, DOI 10.1016/j.annemergmed.2008.01.326; Lindley C, 2005, AM J CLIN ONCOL-CANC, V28, P270, DOI 10.1097/01.coc.0000145983.35929.2a; LOWDON IMR, 1989, INJURY, V20, P193, DOI 10.1016/0020-1383(89)90109-5; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Pasek TA, 2015, CLIN NURSE SPEC, V29, P80, DOI 10.1097/NUR.0000000000000108; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Reeves JJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e62; Reichmann James P, 2012, Manag Care, V21, P44; Society CP, 2015, SPORT REL CONC INF P; Somaini Lorenzo, 2011, Recent Pat CNS Drug Discov, V6, P146; Spitzer TR, 2000, BONE MARROW TRANSPL, V26, P203, DOI 10.1038/sj.bmt.1702479; Sturm JJ, 2013, AM J EMERG MED, V31, P166, DOI 10.1016/j.ajem.2012.07.002; Sturm JJ, 2012, PEDIATR EMERG CARE, V28, P247, DOI 10.1097/PEC.0b013e3182494d87; Sturm JJ, 2012, AM J EMERG MED; Swift R, 2010, CURR PHARM DESIGN, V16, P2136, DOI 10.2174/138161210791516323; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220	60	3	3	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	SEP	2017	19	5					338	346		10.1017/cem.2016.369			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FK6NS	WOS:000413622800002	27609399	Bronze			2022-02-06	
J	Hardy, JJ; Mooney, SR; Pearson, AN; McGuire, D; Correa, DJ; Simon, RP; Meller, R				Hardy, Jimmaline J.; Mooney, Scott. R.; Pearson, Andrea. N.; McGuire, Dawn; Correa, Daniel. J.; Simon, Roger P.; Meller, Robert			Assessing the accuracy of blood RNA profiles to identify patients with post-concussion syndrome: A pilot study in a military patient population	PLOS ONE			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; ISCHEMIC-STROKE; RECOVERY; LACUNAR	Mild traumatic brain injury (mTBI) is a complex, neurophysiological condition that can have detrimental outcomes. Yet, to date, no objective method of diagnosis exists. Physical damage to the blood-brain-barrier and normal waste clearance via the lymphatic system may enable the detection of biomarkers of mTBI in peripheral circulation. Here we evaluate the accuracy of whole transcriptome analysis of blood to predict the clinical diagnosis of post-concussion syndrome (PCS) in a military cohort. Sixty patients with clinically diagnosed chronic concussion and controls (no history of concussion) were recruited (retrospective study design). Male patients (46) were split into a training set comprised of 20 long-term concussed (> 6 months and symptomatic) and 12 controls (no documented history of concussion). Models were validated in a testing set (control = 9, concussed = 5). RNA_Seq libraries were prepared from whole blood samples for sequencing using a SOLiD5500XL sequencer and aligned to hg19 reference genome. Patterns of differential exon expression were used for diagnostic modeling using support vector machine classification, and then validated in a second patient cohort. The accuracy of RNA profiles to predict the clinical diagnosis of post-concussion syndrome patients from controls was 86% (sensitivity 80%; specificity 89%). In addition, RNA profiles reveal duration of concussion. This pilot study shows the potential utility of whole transcriptome analysis to establish the clinical diagnosis of chronic concussion syndrome.	[Hardy, Jimmaline J.; Pearson, Andrea. N.; Simon, Roger P.; Meller, Robert] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Mooney, Scott. R.; Correa, Daniel. J.] Dwight D Eisenhower Army Med Ctr, Neurosci & Rehabil Ctr, Ft Gordon, GA USA; [McGuire, Dawn; Simon, Roger P.] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA		Meller, R (corresponding author), Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA.	rmeller@msm.edu	Correa, Daniel/AAU-9441-2020; Correa, Daniel Jose/U-8633-2019	Correa, Daniel Jose/0000-0002-6490-9331; Hardy, Jimmaline/0000-0002-9292-3894	clinical career development grant [5U54M D007588-05];  [U54NS08393];  [S21MD000101];  [R01NS59588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS083932, R01NS059588] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007588, S21MD000101] Funding Source: NIH RePORTER	The study was primarily funded by a clinical career development grant to R Meller (5U54M D007588-05). JH was supported by U54NS08393. Additional support was provided by S21MD000101 and R01NS59588 (RM).	Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dykstra-Aiello C, 2015, TRANSL STROKE RES, V6, P284, DOI 10.1007/s12975-015-0407-9; Gill J, 2015, J HEAD TRAUMA REHABI; Giza CC, 2013, SUMMARY EVIDENCE BAS; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Jickling GC, 2013, ANN NEUROL, V74, P232, DOI 10.1002/ana.23883; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Jickling GC, 2011, ANN NEUROL, V70, P477, DOI 10.1002/ana.22497; Jickling GC, 2010, ANN NEUROL, V68, P681, DOI 10.1002/ana.22187; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meller R, 2016, ANN CLIN TRANSL NEUR, V3, P70, DOI 10.1002/acn3.272; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Sharp FR, 2007, STROKE, V38, P691, DOI 10.1161/01.STR.0000247940.27518.38; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sirbu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050986; Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0183113	10.1371/journal.pone.0183113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	WOS:000408816900004	28863142	Green Submitted, gold, Green Published			2022-02-06	
J	Hou, K; Zhao, JC; Gao, XF; Zhu, XB; Li, GC				Hou, Kun; Zhao, Jinchuan; Gao, Xianfeng; Zhu, Xiaobo; Li, Guichen			Delayed Brainstem Hemorrhage Secondary to Mild Traumatic Head Injury: Report of Case with Good Recovery	WORLD NEUROSURGERY			English	Article						Duret hemorrhage; Mild traumatic head injury; Secondary traumatic brainstem hemorrhage	DURET HEMORRHAGE; HERNIATION	BACKGROUND: In clinical practice, secondary traumatic brainstem hemorrhage often develops during descending transtentorial herniation due to raised intracranial pressure, which is known as Duret hemorrhage. Although usually considered a fatal and irreversible event, in rare circumstances, victims of Duret hemorrhage could gain favorable outcomes. To our knowledge, secondary brainstem hemorrhage due to mild traumatic head injury without descending transtentorial herniation has never been reported. In this report, we present a case of delayed brainstem hemorrhage secondary to a relatively mild traumatic brain injury that experienced a rapid and favorable recovery. CASE DESCRIPTION: A 48-year-old man was admitted for a motorcycle accident. Head computed tomography 2 hours after the accident revealed mild subarachnoid hemorrhage at the interpeduncular cistern. In the following in-hospital days, he experienced 2 episodes of mental state deterioration and increase of the SAH and hematoma extension to the brainstem. A digital subtraction angiography was performed with no positive finding of vascular anomaly and evident cerebral vasospasm. He experienced a rapid and favorable recovery. His Glasgow Outcome Scale score was 5 at 3 months' follow-up. CONCLUSIONS: We present a rare case of secondary traumatic brainstem hemorrhage that experienced a rapid and good recovery process. The mechanism is still obscure to us and needs to be further studied. Although traumatic brainstem hemorrhage usually means a fatal event to most of the patients, some patients may experience a favorable recovery. This rare circumstance should be stressed in prognosis consultation and clinical management of these kinds of patients.	[Hou, Kun; Zhao, Jinchuan; Gao, Xianfeng; Zhu, Xiaobo] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China; [Li, Guichen] Jilin Univ, Hosp 1, Dept Neurol, Changchun, Jilin, Peoples R China		Li, GC (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun, Jilin, Peoples R China.	gretchen666@yeah.net		Hou, Kun/0000-0001-7112-7883; Li, Guichen/0000-0003-2128-9969			ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; Andeweg J, 1999, NEURORADIOLOGY, V41, P233, DOI 10.1007/s002340050739; Nguyen HS, 2016, INT MED CASE REP J, V9, P15, DOI 10.2147/IMCRJ.S95809; Ishizaka S, 2014, BRAIN INJURY, V28, P374, DOI 10.3109/02699052.2013.864422; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314	7	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105								PMID 1035.e11	10.1016/j.wneu.2017.06.031			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600168					2022-02-06	
J	Howell, DR; Meehan, WP; Loosemore, MP; Cummiskey, J; von Rosenberg, JPG; McDonagh, D				Howell, David R.; Meehan, William P., III; Loosemore, Michael P.; Cummiskey, Joseph; von Rosenberg, Jean-Paul Grabner; McDonagh, David			Neurological tests improve after Olympic-style boxing bouts: a pretournament and post-tournament study in the 2016 Women's World Boxing Championships	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ERROR SCORING SYSTEM; KING-DEVICK TEST; SPORT-RELATED CONCUSSION; BALANCE MEASURES; REFERENCE VALUES; AMATEUR BOXERS; PERFORMANCE; ADOLESCENTS; RELIABILITY; TASK	Aim To prospectively examine the neurocognitive, postural, dual-task and visual abilities of female Olympic-style boxers before and after participation in a tournament. Methods Sixty-one females completed the modified Balance Error Scoring System (mBESS), King-Devick test and 3 m timed-up-and-go test in single-task and dual-task conditions. A subset (n=31) completed the CogState computerised neurocognitive test. Initial testing was completed prior to the 2016 Women's World Boxing Championships; each participant repeated the testing protocol within a day of elimination. No participant sustained a concussion. Pretournament and posttournament performance variables were compared using paired t-tests or Wilcoxon signed-rank tests. Results Participants completed a mean of 7.5 +/- 4.5 rounds of Olympic-style boxing over 2-8 days. Posttournament scores were significantly lower than pretournament scores for total mBESS (2.2 +/- 1.9 errors vs 5.5 +/- 2.9 errors, p< 0.001, d=1.23) and King-Devick time (14.2 +/- 3.9 s vs 18.0 +/- 8.3 s, p=0.002, d=0.53). Processing speed was significantly faster after the boxing tournament (maze chase task: 1.39 +/- 0.34 correct moves/ second vs 1.17 +/- 0.44 correct moves/ second, p=0.001, d=0.58). No significant changes across time were detected for the other obtained outcome variables. Conclusions Female boxers demonstrated either improvement or no significant changes in test performance after competing in an Olympic-style boxing tournament, relative to pretournament performance. As many of the test tasks were novel for the boxers, practice effects may have contributed to improved performance. When there is a short time frame between assessments, clinicians should be aware of potential practice effects when using ringside neurological tests.	[Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Howell, David R.; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Loosemore, Michael P.; Cummiskey, Joseph; McDonagh, David] AIBA Sci Commiss, AIBA Med Commiss, Maison Sport, Lausanne, Switzerland; [Loosemore, Michael P.] Univ Coll London Hosp, Inst Sport Exercise & Hlth, London, England; [von Rosenberg, Jean-Paul Grabner; McDonagh, David] St Olavs Hosp, Dept Orthoped, Trondheim, Norway; [McDonagh, David] St Olavs Hosp, Municipal Emergency Dept, Trondheim, Norway		Howell, DR (corresponding author), Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Micheli Ctr Sports Injury Prevent, 9 Hope Ave, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu			International Boxing Association	This work was supported by the International Boxing Association. This organisation played no role in the design of the study, or in the collection, analysis and interpretation of the data or in writing of the manuscript.	Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-20; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Davis P, 2016, INT J SPORT PHYSIOL, V11, P55, DOI 10.1123/ijspp.2014-0133; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Fischer TD, 2016, J NEUROTRAUM, V33, P1237, DOI 10.1089/neu.2015.3990; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, PHYSICIAN SPORTSMED, V44, P304, DOI 10.1080/00913847.2016.1197763; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Howell DR, 2016, J SPORT MED, V1; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Loosemore Mike, 2008, Br J Sports Med, V42, P564; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Massimiliano B, 2011, BRIT J SPORT MED, V45, P563, DOI 10.1136/bjsm.2009.061135; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; STEWART WF, 1994, AM J EPIDEMIOL, V139, P573, DOI 10.1093/oxfordjournals.aje.a117047; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307	39	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2017	51	17					1279	1284		10.1136/bjsports-2016-097160			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FE1ZB	WOS:000408015000007	28501805				2022-02-06	
J	Jang, SH; Ahn, SH; Cho, YW; Lim, JW; Cho, IT				Jang, Sung Ho; Ahn, Sang Ho; Cho, Yun Woo; Lim, Ji Woon; Cho, Ik Tae			Diffusion Tensor Tractography for Detection of Concomitant Traumatic Brain Injury in Patients With Traumatic Spinal Cord Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cingulum; corticoreticulospinal tract; corticospinal tract; diffusion tensor tractography; fornix; traumatic brain injury; traumatic spinal cord injury	CLOSED HEAD-INJURY; CORTICOSPINAL TRACT; HEMISPHERE; STEM	Objectives: We investigated concomitant traumatic brain injury in patients with traumatic spinal cord injury (TSCI) who had head trauma history, using diffusion tensor tractography (DTT). Design: Retrospective survey. Participants: We recruited 14 consecutive patients with TSCI and coexisting head trauma history at the time of TSCI and 30 control subjects. Methods: The corticospinal tract (CST), corticoreticulospinal tract (CRT), cingulum, and fornix were reconstructed using DTT, and DTT parameters (fractional anisotropy and fiber volume) and configuration were estimated. Results: The values of fractional anisotropy and fiber volume in the CST, CRT, cingulum, and fornix of the patient group were significantly lower than those of the control group (P < .05). On configurational analysis of DTT for each tract, the neural tracts for motor function (the CST and CRT) had more injury than the neural tracts for cognitive function (the cingulum and fornix). No association between the severity of TSCI and traumatic brain injury was observed in terms of DTT parameters. Conclusions: Using DTT, we found injury of the neural tracts in patients with head trauma history at the time of TSCI. Our results suggest that brain evaluation using DTT can be recommended for the patients with head trauma history at the time of TSCI irrespective of the results of conventional brain MRI.	[Jang, Sung Ho; Ahn, Sang Ho; Cho, Yun Woo; Lim, Ji Woon; Cho, Ik Tae] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Taegu 705717, South Korea		Cho, IT (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Taegu 705717, South Korea.	chov019@naver.com			National Research Foundation of Korea - Korean Government (MSIP) [2015R1A2A2A01004073]	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Concha L, 2005, AM J NEURORADIOL, V26, P2267; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003007; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002620; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030; Yoo JS, 2014, BRAIN INJURY, V28, P1257, DOI 10.3109/02699052.2014.901557	28	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E44	E49		10.1097/HTR.0000000000000300			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800005	28422895				2022-02-06	
J	Jang, S; Kim, J; Seo, Y; Kwak, S				Jang, Sungho; Kim, Jonghoon; Seo, Yousung; Kwak, Soyoung			Recovery of an injured corticobulbar tract in a patient with stroke A case report	MEDICINE			English	Article						corticobulbar tract; diffusion tensor tractography; dysphagia; intracerebral hemorrhage; stroke	DIFFUSION TENSOR TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; SUBFALCINE HERNIATION; INTERNAL CAPSULE; DYSARTHRIA; CRANIOPLASTY	Rationale: The corticobulbar tract (CBT) is known to be involved in the motor function of the non-oculomotor cranial nuclei and controls the muscles of the face, head, and neck. Several studies have reported injury of the CBT in patients with brain injury, however, little is known about recovery of the injured CBT. Patient concerns: A 59-year-old right-handed male underwent decompressive craniectomy for management of brain swelling and intracerebral hemorrhage following an infarction in the left middle cerebral artery territory. Initially, the patient had showed severe dysphagia and had to be fed using a Levin tube. Five weeks after the onset of stroke, the patient was transferred to the rehabilitation department and underwent comprehensive rehabilitative therapy. Cranioplasty was performed eight weeks after the onset. The patient was completely recovered from dysphagia and the Levine tube was removed nine weeks after the onset. Interventions: Diffusion tensor imaging was performed twice; at five weeks and nine weeks from the onset. Outcome: On five-week diffusion tensor tractography (DTT), the right CBT was discontinued at the subcortical white matter and showed severe narrowing and the left CBT was not reconstructed. By contrast, on nine-week DTT, the right CBT was extended to the cerebral cortex and thickened while the left CBT remained not reconstructed in DTT. Lessons: This case demonstrates the association of the recovery of injured CBT with the recovery of dysphagia using DTT.	[Jang, Sungho; Seo, Yousung; Kwak, Soyoung] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea; [Kim, Jonghoon] Yeungnam Univ, Dept Neurosurg, Coll Med, Daegu, South Korea		Kwak, S (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 170 Hyeonchung Ro, Daegu 42415, South Korea.	soyoung.kwak@daum.net			National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Afifi AK, 2005, FUNCTIONAL NEUROANAT; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE187, DOI 10.1097/PHM.0000000000000519; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE167, DOI 10.1097/PHM.0000000000000499; Jang SH, 2016, CLIN NEUROPHYSIOL, V127, P2708, DOI 10.1016/j.clinph.2016.04.022; Jang SH, 2016, J KOREAN NEUROSURG S, V59, P306, DOI 10.3340/jkns.2016.59.3.306; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE60, DOI 10.1097/PHM.0000000000000439; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE58, DOI 10.1097/PHM.0000000000000424; Jang SH, 2015, NEUROSCI LETT, V590, P80, DOI 10.1016/j.neulet.2015.01.072; Kwon HG, 2016, INT J NEUROSCI, V126, P361, DOI 10.3109/00207454.2015.1020536; Liegeois F, 2013, NEUROLOGY, V80, P926, DOI 10.1212/WNL.0b013e3182840c6d; Pan C, 2012, AM J NEURORADIOL, V33, P1274, DOI 10.3174/ajnr.A2952; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Yim SH, 2013, J NEUROL SCI, V334, P63, DOI 10.1016/j.jns.2013.07.015	19	3	3	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP	2017	96	38							e7636	10.1097/MD.0000000000007636			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH8PR	WOS:000411460900004	28930819	gold, Green Published			2022-02-06	
J	Johnson, RS; Provenzano, MK; Shumaker, LM; McLeod, TCV; Bacon, CEW				Johnson, Rachel S.; Provenzano, Mia K.; Shumaker, Larynn M.; McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch			The Effect of Cognitive Rest as Part of Postconcussion Management for Adolescent Athletes: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						return-to-learn; return-to-play; post-concussion symptom scale; mild traumatic brain injury	SPORT-RELATED CONCUSSION; ACADEMIC ACCOMMODATIONS; FAMILIARITY; PERCEPTIONS; STATEMENT; SYMPTOMS	Clinical Scenario: It is hypothesized that cognitive activity following a concussion may potentially hinder patient recovery. While the recommendation of cognitive rest is often maintained and rationalized, a causal relationship between cognitive activity and symptom duration has yet to be established. Clinical Question: Does the implementation of cognitive rest as part of the postconcussion management plan reduce the number of days until the concussed adolescent patient is symptom free compared to a postconcussion management plan that does not incorporate cognitive rest? Summary of Key Findings: A thorough literature search returned 7 possible studies; 5 studies met the inclusion criteria and were included. Three studies indicated that increased cognitive activity is associated with longer recovery from a concussion, and, therefore, supported the use of cognitive rest. One study indicated that the recommendation for cognitive rest was not significantly associated with time to concussion symptom resolution. One study indicated that strict rest, defined as 5 days of no school, work, or physical activity; might prolong symptom duration. Clinical Bottom Line: There is moderate evidence to support the prescription of moderate cognitive rest for concussed patients. Clinicians who intend on implementing cognitive rest in their concussion protocols should be aware of inconsistencies and be open-minded to alternative treatment progressions while taking into consideration each individual patient and maintaining adequate patient-centered care principles. Strength of Recommendation: Grade B evidence exists that prescription of moderate cognitive rest for concussed patients may be beneficial as a supplement to physical rest as treatment for symptom reduction in adolescents.	[Johnson, Rachel S.; Provenzano, Mia K.; Shumaker, Larynn M.; McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich; Bacon, Cailee E. Welch] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA		Bacon, CEW (corresponding author), AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2007, J ATHL TRAINING, V36, P228; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81	13	3	3	2	11	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2017	26	5					437	446		10.1123/jsr.2015-0167			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FK7ZR	WOS:000413727200012	27632824				2022-02-06	
J	Krutsch, V; Krutsch, W; Jansen, P; Hoffmann, H; Angele, P; Lehmann, J; Loose, O; Gansslen, A; Nerlich, M; Weber, J				Krutsch, Volker; Krutsch, Werner; Jansen, Petra; Hoffmann, Helmut; Angele, Peter; Lehmann, Jennifer; Loose, Oliver; Gaensslen, Axel; Nerlich, Michael; Weber, Johannes			Prevention of Head and Brain Injuries in Football: Is there a Need to Ban Headings?	SPORTVERLETZUNG-SPORTSCHADEN			German	Article						football; junior; heading; head injury; prevention	PROFESSIONAL SOCCER PLAYERS; SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ELITE MALE; RISK; ASSOCIATION; MECHANISMS; HISTORY; ZURICH	Football, the most popular sports worldwide, is associated with a high number of injuries. Head and brain injuries in football are less frequent, but may result in severe long-term damage. The mechanisms of these injuries in football are multifactorial, and the ball is rarely the main cause of a head injury. Short-term, medium-term and long-term consequences of headings in football are insufficiently examined, and there are hardly any case reports about severe episodes. Heading has been banned in US junior football since November 2015, which is understandable considering the higher risk for head injuries in popular American sports such as ice hockey or American football and people's fear associated with this risk. However, the decision to ban heading in football is not based on scientific results, and different experiences have been made in European football. Therefore, this decision should not simply be transferred to Europe. In fact, other injury prevention strategies for head injuries in junior football are necessary, such as the adaptation of ball sizes, which has already been implemented. It is not necessary to change match rules in the form of a general ban on heading in football. Further scientific studies are needed for standardisation in football worldwide.	[Krutsch, Volker; Krutsch, Werner; Jansen, Petra; Hoffmann, Helmut; Angele, Peter; Lehmann, Jennifer; Loose, Oliver; Gaensslen, Axel; Nerlich, Michael; Weber, Johannes] Inst Klinikum Nurnberg Nord, Hals Nasen Ohrenheilkunde, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany		Krutsch, V (corresponding author), Inst Klinikum Nurnberg Nord, Hals Nasen Ohrenheilkunde, Prof Ernst Nathan Str 1, D-90419 Nurnberg, Germany.	Volker.Krutsch@klinikum-nuernberg.de		Loose, Oliver/0000-0001-8498-5772			Akoglu Ebru, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.01.2011.3787; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andren-Sandberg A, 2003, FOOTBALL MED, P475; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Beghi E, 2013, AMYOTROPH LAT SCL FR, V14, P501, DOI 10.3109/21678421.2013.809764; Biener K, 1983, FUSSBALL SPORTMEDIZI, P47; Boyd KT, 2001, BRIT J SPORT MED, V35, P409, DOI 10.1136/bjsm.35.6.409; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Dvorak J., 2009, FOOTBALL MED MANUAL; Dvorak J, 2000, AM J SPORTS MED, V28, P12; Ekblom B, 1994, HDB SPORTS MED SCI F, V198, P208; Ekblom B, 1994, HDB SPORTS MED SCI F, V1, P19; Ekblom B, 1994, HDB SPORTS MED SCI F, V59, P77; Faude O, 2009, DEUT Z SPORTMED, V60, P139; Federation Internationale de Football Association, 2014, FUTS SPIELR 2014 201, V6, P14; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gansslen A, 2016, DTSCH ARZTEBL, V113, P37; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hamidou B, 2014, EUR J EPIDEMIOL, V29, P459, DOI 10.1007/s10654-014-9923-2; Hoffmann H, 1983, DFB UBUNGSLEITER, V18, P20; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Junge A, 2010, BRIT J SPORT MED, V44, P1089, DOI 10.1136/bjsm.2010.076752; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; Koch M, 2016, ARCH ORTHOP TRAUM SU, V136, P353, DOI 10.1007/s00402-015-2350-3; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kontos A P, 2016, BR J SPORTS MED; Krutsch V, 2018, KNEE SURG SPORT TR A, V26, P1295, DOI 10.1007/s00167-017-4431-z; Krutsch W, 2014, ARCH ORTHOP TRAUM SU, V134, P1301, DOI 10.1007/s00402-014-2041-5; Kuhn AW, 2016, BR J SPORTS MED; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2016, BR J SPORTS MED; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Murphy, 1988, SCI FOOTBALL, P394; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pforringer W, 1989, FUSSBALL RISIKEN ERK, V21, P84; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Reehal P, 2010, CURR SPORT MED REP, V9, P27, DOI 10.1249/JSR.0b013e3181cd2c04; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Rutherford A, 2011, FOCUS COGNITIVE DISO, V181, P226; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Tarnutzer A A, 2016, BR J SPORTS MED; Tegner Y, 2003, FOOTBALL MED, V229, P240; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174	58	3	3	0	25	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	SEP	2017	31	3					143	153		10.1055/s-0043-113208			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FF7JJ	WOS:000409192000019	28869996				2022-02-06	
J	McLaughlin, C; Kearns, NT; Bennett, M; Roden-Foreman, JW; Roden-Foreman, K; Rainey, EE; Funk, G; Powers, MB; Warren, AM				McLaughlin, Cory; Kearns, Nathan T.; Bennett, Monica; Roden-Foreman, Jacob W.; Roden-Foreman, Kenleigh; Rainey, Evan Elizabeth; Funk, Geoffrey; Powers, Mark B.; Warren, Ann Marie			Alcohol and drug toxicology screens at time of hospitalization do not predict PTSD or depression after traumatic injury	AMERICAN JOURNAL OF SURGERY			English	Article						Trauma; PTSD; Depression; Toxicology; Alcohol; Drugs	POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD-INJURY; SUBSTANCE USE; BRAIN-INJURY; RISK; ABUSE; CONSUMPTION; METAANALYSIS; MORTALITY; SYMPTOMS	Background: Identifying risk factors for the development of PTSD and depression is critical for intervention and recovery after injury. Given research linking toxicology screens and substance use and the evidenced relationship between substance misuse and distress, the current study aimed to gauge the predictive value of toxicology testing on PTSD and depression. Methods: Patients admitted to a Level I Trauma Center (N = 379) completed the PC-PTSD, PCL-C, and PHQ-8 at baseline, 3, 6, and 12 months. Results: Results showed 52% of tested patients had a positive toxicology test, 51% screened for PTSD, and 54% screened for depression. Positive drug or alcohol toxicology tests were not significantly associated with PTSD or depression. Conclusions: Toxicology testing may not meaningful predict depression or PTSD in traumatic injury patients. Future research using validated measures of problematic substance use is needed to better understand how misuse may influence the development of psychological distress. (C) 2017 Elsevier Inc. All rights reserved.	[McLaughlin, Cory; Bennett, Monica; Roden-Foreman, Jacob W.; Rainey, Evan Elizabeth; Funk, Geoffrey; Powers, Mark B.; Warren, Ann Marie] Baylor Univ, Med Ctr, Dallas, TX USA; [Kearns, Nathan T.] Univ North Texas, Denton, TX 76203 USA; [Roden-Foreman, Kenleigh] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Kearns, NT (corresponding author), Univ North Texas, Dept Psychol, 1155 Union Circle,311280, Denton, TX 76203 USA.	NathanKearns@my.unt.edu	Powers, Mark/ABB-3291-2021	McMinn, PhD, Kenleigh/0000-0002-4623-8634; McShan, Evan Elizabeth/0000-0002-9250-3240; Warren, Ann Marie/0000-0002-3753-5573; Roden-Foreman, Jacob/0000-0002-8338-397X	Stanley Seeger Fund of the Baylor Health Care System	Funding for this study was provided by the Stanley Seeger Fund of the Baylor Health Care System. The study sponsors did not have any role or oversight in study design, data collection or analysis, manuscript writing, or decision to submit this work for publication.	American College of Surgeons Committee on Trauma (ACS COT), 2014, RESOURCES OPTIMAL CA; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Cherpitel CJ, 2004, ALCOHOL ALCOHOLISM, V39, P256, DOI 10.1093/alcalc/agh053; CHERPITEL CJ, 1993, ALCOHOL CLIN EXP RES, V17, P762, DOI 10.1111/j.1530-0277.1993.tb00837.x; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; HEINEMANN AW, 1990, REHABIL PSYCHOL, V35, P217, DOI 10.1037/h0079065; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hruska B, 2011, PSYCHOL ADDICT BEHAV, V25, P405, DOI 10.1037/a0022439; Kasper D, 2015, HARRISONS PRINCIPLES, V19th; Kaysen D, 2006, J TRAUMA STRESS, V19, P399, DOI 10.1002/jts.20122; Keane T M, 1988, Recent Dev Alcohol, V6, P27; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Kuendig H, 2008, J TRAUMA, V65, P203, DOI 10.1097/TA.0b013e318068fc64; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Maes M, 2001, J AFFECT DISORDERS, V63, P113, DOI 10.1016/S0165-0327(00)00173-7; McFarlane AC, 2009, J AFFECT DISORDERS, V118, P166, DOI 10.1016/j.jad.2009.01.017; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Prins A, PRIM CARE PSYCHIAT, V9, P9; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Read JP, 2014, PSYCHOL ADDICT BEHAV, V28, P1052, DOI 10.1037/a0038348; Rehm J, 2008, INT J METH PSYCH RES, V17, P141, DOI 10.1002/mpr.259; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Rivara FP, 1993, ARCH SURG-CHICAGO, V128, P912; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Spurling MC, 2005, ANN FAM MED, V3, P47, DOI 10.1370/afm.243; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Taylor B, 2008, AM J EPIDEMIOL, V168, P1119, DOI 10.1093/aje/kwn215; TEASDALE G, 1974, LANCET, V2, P81; Warren AM, 2014, J TRAUMA NURS, V21, P139, DOI 10.1097/TA.0b013e3182858ab9; Weathers F, 1996, MEASUREMENT STRESS T; WEISS RD, 1992, AM J DRUG ALCOHOL AB, V18, P121, DOI 10.3109/00952999208992825; Xiao HY, 2012, WORLD J EMERG MED, V3, P270, DOI [10.5847/wjem.j.issn.1920-8642.2012.04.006, 10.5847/wjem.j.1920-8642.2012.04.006]; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	43	3	3	0	4	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	SEP	2017	214	3					390	396		10.1016/j.amjsurg.2017.06.026			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FM7AI	WOS:000415218400002	28683894				2022-02-06	
J	Pasquini, JM; Barrantes, FJ; Quinta, HR				Pasquini, Juana M.; Barrantes, Francisco J.; Quinta, Hector R.			Normal development of spinal axons in early embryo stages and posterior locomotor function is independent of GAL-1	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						Axonal development; 3-DISCO; Galectin-1; 3-D axonal reconstruction; PlexinA4; RRID: AB_2532998; RRID: AB_10014322; RRID: AB_944890; RRID: AB_2284441; RRID: AB_1841228; RRID:AB_640838	SEMAPHORIN-III; CORD-INJURY; NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; GALECTIN-1; GUIDANCE; MICE; BINDING; REGENERATION; PROTEIN	It was recently described that Galectin-1 (Gal-1) promotes axonal growth after spinal cord injury. This effect depends on protein dimerization, since monomeric Gal-1 fails to stimulate axonal re-growth. Gal-1 is expressed in vivo at concentrations that favor the monomeric species. The aim of the present study is to investigate whether endogenous Gal-1 is required for spinal axon development and normal locomotor behavior in mice. In order to characterize axonal development, we used a novel combination of 3-DISCO technique with 1-photon microscopy and epifluorescence microscopy under high power LED illumination, followed by serial image section deconvolution and 3-D reconstruction. Cleared whole lgals-1(-/-) embryos were used to analyze the 3-D cytoarchitecture of motor, commissural, and sensory axons. This approach allowed us to evaluate axonal development, including the number of fibers, fluorescence density of the fiber tracts, fiber length as well as the morphology of axonal sprouting, deep within the tissue. Gal-1 deficient embryos did not show morphological/anatomical alterations in any of the axonal populations and parameters analyzed. In addition, specific guidance receptor PlexinA4 did not change its axonal localization in the absence of Gal-1. Finally, Gal-1 deficiency did not change normal locomotor activity in post-natal animals. Taken together, our results show that development of spinal axons as well as the locomotor abilities observed in adult mice are independent of Gal-1. Supporting our previous observations, the present study further validates the use of lgals-1(-/-) mice to develop spinal cord- or traumatic brain injury models for the evaluation of the regenerative action of Gal-1.	[Pasquini, Juana M.; Quinta, Hector R.] Univ Buenos Aires, Inst Quim & Fis Quim Biol, Dept Quim Biol, Buenos Aires C1113AAD, Buenos Aires, DF, Argentina; [Barrantes, Francisco J.] BIOMED UCA CONICET, Lab Mol Neurobiol, Buenos Aires, DF, Argentina		Quinta, HR (corresponding author), Univ Buenos Aires, Inst Quim & Fis Quim Biol, Dept Quim Biol, Buenos Aires C1113AAD, Buenos Aires, DF, Argentina.	quintaramiro@hotmail.com			Council of Scientific and Technical Research (CONICET) [PIPCONICET 11220130100356CO, PIPCONICET 11220110101023]; Foundation Florencio Fiorini	Council of Scientific and Technical Research (CONICET), Grant/Award number: PIPCONICET 11220130100356CO and PIPCONICET 11220110101023; Foundation Florencio Fiorini.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Belle M, 2014, CELL REP, V9, P1191, DOI 10.1016/j.celrep.2014.10.037; Bergeron Y, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00026; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; Engelhard C, 2013, ELIFE, V2, DOI 10.7554/eLife.01160; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Gutekunst CA, 2012, J CHEM NEUROANAT, V44, P1, DOI 10.1016/j.jchemneu.2012.03.002; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Kobayakawa Y, 2015, NEUROPATH APPL NEURO, V41, P227, DOI 10.1111/nan.12123; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LEE VMY, 1987, J NEUROSCI, V7, P3474; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Pasterkamp RJ, 2013, CELL, V153, P494, DOI 10.1016/j.cell.2013.03.031; Pasterkamp RJ, 1999, CELL MOL BIOL, V45, P763; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Petracca YL, 2016, DEVELOPMENT, V143, P880, DOI 10.1242/dev.129254; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; Quinta HR, 2014, CELL DEATH DIFFER, V21, P941, DOI 10.1038/cdd.2014.14; Quinta HR, 2012, BRIT J PHARMACOL, V166, P637, DOI 10.1111/j.1476-5381.2011.01783.x; Quinta HR, 2016, EXP NEUROL, V283, P165, DOI 10.1016/j.expneurol.2016.06.009; Quinta HR, 2015, J NEUROCHEM, V133, P113, DOI 10.1111/jnc.13017; Quinta HR, 2014, MEDICINA-BUENOS AIRE, V74, P321; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; REGAN LJ, 1986, P NATL ACAD SCI USA, V83, P2248, DOI 10.1073/pnas.83.7.2248; Romaniuk MA, 2012, FASEB J, V26, P2788, DOI 10.1096/fj.11-197541; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Trivedi N, 2007, J NEUROSCI, V27, P507, DOI 10.1523/JNEUROSCI.4227-06.2007; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Yoshida Y, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00071, 10.3389/fnmo1.2012.00071]; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhao XY, 2011, J BIOL CHEM, V286, P36808, DOI 10.1074/jbc.M111.247262	42	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	SEP 1	2017	525	13					2861	2875		10.1002/cne.24243			15	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	EZ5NT	WOS:000404764900005	28512739	Green Published			2022-02-06	
J	Pircher, R; Perdekamp, MG; Thierauf-Emberger, A; Kramer, L; Pollak, S; Geisenberger, D				Pircher, Rebecca; Perdekamp, Markus Grosse; Thierauf-Emberger, Annette; Kramer, Lena; Pollak, Stefan; Geisenberger, Dorothee			Wound morphology in contact shots from blank cartridge handguns: a study on composite models	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Alarm gun; Starter's pistol; Blank cartridge; Gas jet; Contact shot; Skin hole; Composite model; Penetration depth	HEAD-INJURY; GAS; PISTOL; GUNSHOTS; POWDER	It is a well-known fact that blank cartridge guns can cause penetrating and even fatal injuries when discharged in contact or at very close ranges. In these cases, the gas jet perforates the skin leaving an entrance wound similar to that from a conventional gun. In order to investigate the wound morphology in contact shots from blank firearms, test shots were fired at composite models of pig skin and gelatin blocks using three different calibre 9-mm blank cartridge handguns (two pistols and one revolver) and two types of ammunition. It turned out that the penetrating gas jet produced roundish skin defects resembling bullet entrance holes. Small skin particles from the perforation site were dispersed in the underlying simulant where radiating cracks containing greyish gunshot residues indicated the original expansion of the inrushing combustion gases. Apart from the size of the permanent entrance hole in the skin and the final position of the displaced tissue particles, the penetration depth of the gas jet was determined. Under the specified conditions of the test shots, the zone of mechanical destruction within the simulant was 2.2 to 6.1 cm in length, which illustrates the injuring potential of contact shots inflicted with blank cartridge handguns.	[Pircher, Rebecca; Perdekamp, Markus Grosse; Thierauf-Emberger, Annette; Kramer, Lena; Pollak, Stefan; Geisenberger, Dorothee] Univ Freiburg, Fac Med, Med Ctr, Inst Legal Med, Albertstr 9, D-79104 Freiburg, Germany		Pircher, R (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Inst Legal Med, Albertstr 9, D-79104 Freiburg, Germany.	rebecca.pircher@uniklinik-freiburg.de					Anderson PJ, 1996, HUM EXP TOXICOL, V15, P461, DOI 10.1177/096032719601500601; Bungardt Nikola, 2005, Archiv fuer Kriminologie, V216, P1; Buyuk Y, 2009, J FORENSIC LEG MED, V16, P354, DOI 10.1016/j.jflm.2009.01.011; Clarot F, 2003, FORENSIC SCI INT, V137, P45, DOI 10.1016/S0379-0738(03)00282-2; Demirci S, 2011, J FORENSIC LEG MED, V18, P237, DOI 10.1016/j.jflm.2011.05.005; DiMaio VJM, 1999, GUNSHOT WOUNDS, P305; Frank M, 2009, FORENSIC SCI INT, V192, P83, DOI 10.1016/j.forsciint.2009.08.002; Frank M, 2017, INT J LEGAL IN PRESS; Geisenberger D, 2015, FORENSIC SCI INT, V257, P341, DOI 10.1016/j.forsciint.2015.09.018; Giese A, 2002, SURG NEUROL, V57, P268, DOI 10.1016/S0090-3019(02)00643-2; Grosse Perdekamp M, 2001, Arch Kriminol, V208, P88; Grosse Perdekamp M, 2011, FOL SOC MED LEG SLOV, V1, P58; Herrmann A, 2004, UNFALLCHIRURG, V107, P22, DOI 10.1007/s00113-003-0712-8; JACOB B, 1990, AM J FOREN MED PATH, V11, P285, DOI 10.1097/00000433-199012000-00003; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P1, DOI 10.1007/978-3-642-20356-5; Kneubuehl BP, 1998, PHYSIKALISCH BALLIST, V1436; LIESKE K, 1991, INT J LEGAL MED, V104, P235, DOI 10.1007/BF01369813; MAXEINER H, 1989, Archiv fuer Kriminologie, V184, P84; Nadjem Hadi, 1996, Archiv fuer Kriminologie, V197, P175; Ogunc GI, 2009, FORENSIC SCI INT, V193, P112, DOI 10.1016/j.forsciint.2009.09.021; Perdekamp MG, 2006, INT J LEGAL MED, V120, P257, DOI 10.1007/s00414-005-0073-7; Perdekamp MG, 2015, INT J LEGAL MED, V129, P125, DOI 10.1007/s00414-014-1064-3; Perdekamp MG, 2011, INT J LEGAL MED, V125, P67, DOI 10.1007/s00414-010-0529-2; Perdekamp MG, 2005, INT J LEGAL MED, V119, P217, DOI 10.1007/s00414-005-0542-z; Perdekamp MG, 2005, FORENSIC SCI INT, V149, P75, DOI 10.1016/j.forsciint.2004.06.035; Pircher R, 2017, INT J LEGAL MED, V131, P1557, DOI 10.1007/s00414-017-1539-0; Pircher R, 2017, INT J LEGAL MED, V131, P441, DOI 10.1007/s00414-016-1501-6; POLLAK S, 1989, Archiv fuer Kriminologie, V184, P30; Pollak S, 2013, ENCY FORENSIC SCI, P130; Puschel Klaus, 2001, Archiv fuer Kriminologie, V207, P26; Rothschild M A, 1994, Med Law, V13, P511; Rothschild MA, 1998, HNO, V46, P986, DOI 10.1007/s001060050346; Rothschild MA, 1998, INT J LEGAL MED, V111, P78, DOI 10.1007/s004140050118; Rothschild MA, 1999, FORENSIC SCI INT, V101, P151, DOI 10.1016/S0379-0738(99)00020-1; Rothschild MA, 1996, FORENSIC SCI INT, V83, P1, DOI 10.1016/0379-0738(96)02019-1; ROTHSCHILD MA, 1994, INT J LEGAL MED, V106, P274, DOI 10.1007/BF01225420; ROTHSCHILD MA, 1996, ARCH KRIMINOL, V198, P151; ROTHSCHILD MA, 1998, RECHTSMEDIZIN, V8, P77; Rothschild MA, 1998, RECHTSMEDIZIN, V9, P9; Rothschild MA, 1999, FREIVERKAUFLICHE SCH, p[59, 103, 119, 153]; Rothschild Markus A., 1998, Archiv fuer Kriminologie, V201, P172; Rothschild Markus A., 1996, Archiv fuer Kriminologie, V197, P65; Schulz G, 1981, Arch Kriminol, V168, P165; Schyma, 1999, RECHTSMEDIZIN, V9, P210, DOI 10.1007/s001940050112; Schyma C, 2015, INT J LEGAL MED, V129, P1027, DOI 10.1007/s00414-015-1151-0; Schyma C, 2012, INT J LEGAL MED, V126, P371, DOI 10.1007/s00414-011-0641-y; Schyma P, 2000, Versicherungsmedizin, V52, P141; TAUSCH D, 1978, KRIMINALISTIK, V32, P451; TAUSCH D, 1974, Z RECHTSMED, V75, P71, DOI 10.1007/BF02114965; Vendura K, 1997, Arch Kriminol, V200, P39; Voisard MX, 2010, AM J FOREN MED PATH, V31, P95, DOI 10.1097/PAF.0b013e3181c65e49; Weimann W, 1927, ARCH KRIMINOL, V80, P40; ZINK P, 1976, Z RECHTSMED, V78, P91	53	3	3	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2017	131	5					1333	1339		10.1007/s00414-017-1650-2			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FD7VW	WOS:000407735100021	28717964				2022-02-06	
J	Plohmann, AM; Hurter, M				Plohmann, Andrea M.; Hurter, Max			Prevalence of poor effort and malingered neurocognitive dysfunction in litigating patients in Switzerland	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			English	Article						Malingered cognitive disorders; mental disorders; sociodemographic parameters; independent medical examinations; insurance medicine	SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; RELIABLE DIGIT SPAN; NEUROPSYCHOLOGICAL ASSESSMENT; PSYCHOLOGICAL-ASSESSMENT; PERFORMANCE VALIDITY; RESPONSE BIAS; 15-ITEM TEST; MEMORY TEST; EXAGGERATION	To determine the prevalence of inauthentic cognitive test results, the data of 455 examinees who had finished at least two performance validity tests (PVTs) were analyzed retrospectively. The PVTs administered were the WMT, MSVT, NV-MSVT, ASTM, BSV, RMT, and RDS. Classification as "definite" or "probable" malingering was done according to the Slick criteria. Sociodemographic variables and diagnoses were described using binary logistic regression. Poor effort in at least two PVTs correlated significantly with education levels, immigration, and origin. Irrespective of education level, the highest risk of definite malingering was found in first-generation migrants. Cervical spine dysfunction, normal cerebral imaging, PTSD, somatoform, and/or depressive disorders also correlated with negative response bias. The probability that psychiatric patients fulfill criteria of probable malingering was higher than in patients with isolated organic mental disorders.	[Plohmann, Andrea M.] Practice Neuropsychol & Psychotherapy, Basel, Switzerland; [Hurter, Max] Spital Linth, Memory Clin, Uznach, Switzerland		Plohmann, AM (corresponding author), Praxis Neuropsychol & Psychotherapie, Freie Str 59, CH-4001 Basel, Switzerland.	andrea.plohmann@neuropsych.ch			SUVA	This study was supported by a grant from the SUVA research fund. We thank Thomas Zumbrunn (Clinical Trial Unit, University Hospital of Basel) for his help with statistical analysis. There are no conflicts of interest.	[Anonymous], 2015, 8C8172014 BGE; [Anonymous], 2017, 9C7152016 BGE; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arbeitsgemeinschaft fur Methodik und Dokumentation in der Psychiatrie (AMDP), 2007, DAS AMDP SYST; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Bachmann R., 2006, BEKAMPFUNG VERSICHER; Bartlett MS, 2014, CURR BIOL, V24, P738, DOI 10.1016/j.cub.2014.02.009; Baum S, 2014, APPL PSYCHOLINGUIST, V35, P857, DOI 10.1017/S0142716414000174; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Blaker H, 2000, CAN J STAT, V28, P783, DOI 10.2307/3315916; Blaskewitz N., 2006, Z NEUROPSYCHOL, V17, P35, DOI DOI 10.1024/1016-264X.17.1.35; Bodenburg S, 2014, Z NEUROPSYCHOL, V25, P89, DOI 10.1024/1016-264X/a000123; Bolliger C., 2009, MIGRANTINNEN MIGRANT; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Brockhaus R., 2003, J INT NEUROPSYCH SOC, V9, P503; Burton V, 2012, ARCH CLIN NEUROPSYCH, V27, P262, DOI 10.1093/arclin/acs026; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J. N., 1996, INT ADAPTATIONS MMPI, Vxxxi; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Custer, 2006, FORENSIC EXAMINER, V15, P6, DOI DOI 10.1177/0146167207311282; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dandachi-FitzGerald B, 2011, CLIN NEUROPSYCHOL, V25, P812, DOI 10.1080/13854046.2011.583280; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Frei A, 2016, Z NEUROPSYCHOL, V27, P107, DOI 10.1024/1016-264X/a000177; Gasquoine PG, 2017, CLIN NEUROPSYCHOL, V31, P587, DOI 10.1080/13854046.2016.1277786; Gasquoine PG, 2012, ARCH CLIN NEUROPSYCH, V27, P268, DOI 10.1093/arclin/acs004; Giger Peter, 2013, Clínica y Salud, V24, P153, DOI 10.5093/cl2013a16; Green P., 2003, GREENS WORD MEMORY T; Green P., 2008, GREENS NONVERBAL MED; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2009, ADV INTERPRETATION P; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P2182; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, NEUROTOXICOLOGY, V27, P940, DOI 10.1016/j.neuro.2006.06.009; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Hampson NE, 2014, APPL NEUROPSYCH-ADUL, V21, P183, DOI 10.1080/09084282.2013.787425; HARTING C, 2000, WMS R WECHSLER GEDCH; HATHAWAY SR, 2000, MINNESOTA MULTIPHASI, V2; Hausotter W, 2007, BEGUTACHTUNG BEI MEN; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; Hegedish O, 2013, EUR J PSYCHOL ASSESS, V29, P253, DOI 10.1027/1015-5759/a000154; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heubrock D., 2000, TESTBATTERIE FORENSI; Hoffmann-Richter E., 2012, HANDWERKARZTLICHER B; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Johnson-Greene D, 2013, CLIN NEUROPSYCHOL, V27, P148, DOI 10.1080/13854046.2012.733732; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kieser U., 2012, JB SOZIALVERSICHERUN, P1671; Kieser U., 2015, GUTACHTEN FRAGEN VOR; Kool J., 2008, EINSATZ BESCHWERDENV; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T., 2010, GERMAN J PSYCHIAT, V13, P140; MERTEN T, 2004, Z NEUROPSYCHOL, V15, P81; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Miller HA, 2005, CRIM JUSTICE BEHAV, V32, P591, DOI 10.1177/0093854805278805; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Neumann-Zielke L, 2009, Z NEUROPSYCHOL, V20, P69, DOI 10.1024/1016-264X.20.1.69; Neumann-Zielke L, 2015, Z NEUROPSYCHOL, V26, P289, DOI 10.1024/1016-264X/a00065; Nijdam-Jones A, 2017, PSYCHOL ASSESSMENT, V29, P1321, DOI 10.1037/pas0000438; Ott W., 2007, NICHT ZIELKONFORME L; Petermann F, 2012, WECHSLER MEMORY SCAL; Petermann F., 2012, WECHSLER ADULT INTEL; Plohmann A.M., 2008, EPILEPTOLOGIE, V25, P182; R Core Team, 2017, R LANG ENV STAT COMP; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds CR, 1998, CRIT ISS NE, P261; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R., 2008, CLIN ASSESSMENT MALI; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; SCHIEMANN S, 2003, PSYCHOL SCI, V45, P80; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHMAND B, 2005, AMSTERDAM SHORT TERM; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schweizerische Vereinigung der Neuropsychologen, 2014, LEITL KLASS INT NEUR; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Strutt AM, 2011, CLIN NEUROPSYCHOL, V25, P1253, DOI 10.1080/13854046.2011.609839; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Thommen A., 2006, NICHTOBJEKTIVIERBARE; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trueblood W, 1997, ARCH CLIN NEUROPSYCH, V12, P13, DOI 10.1016/S0887-6177(96)00027-3; TYDECKS S, 2006, INT J FORENSIC PSYCH, V0001, P00029; van Hout MSE, 2006, J NEUROL NEUROSUR PS, V77, P296, DOI 10.1136/jnnp.2004.047167; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; von Aster M., 2006, WECHSLER INTELLIGENZ; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wechsler D., 2009, ADV CLIN SOLUTIONS W; *WHO, 1994, POCK GUID ICD 10 CLA; Wittchen HU, 1990, CIDI COMPOSITE INT D; Wittchen HU, STRUKTURIERTES KLIN; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Zenisek R, 2016, ARCH CLIN NEUROPSYCH, V31, P426, DOI 10.1093/arclin/acw025	112	3	3	1	4	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	SEP	2017	28	2					97	116		10.1024/1016-264X/a000200			20	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	FK7CI	WOS:000413661500003					2022-02-06	
J	Rastogi, N; Mathur, P				Rastogi, Neha; Mathur, Purva			Ochrobactrum anthropi: An emerging pathogen causing meningitis with sepsis in a neurotrauma patient	JOURNAL OF INFECTION IN DEVELOPING COUNTRIES			English	Article						Ochrobactrum anthropi; emerging; pathogen; nosocomial	BACTEREMIA; HOST	Ochrobactrum anthropi is an unusual emerging pathogen especially in the hospital environment. Most of the reported cases are nosocomially acquired infections in patients with various indwelling and invasive medical devices, such as central venous catheters and drainage tubes. We report a case of nosocomially transmitted invasive catheter related septicaemia with meningitis due to O. anthropi, in an elderly immunocompetent male with a head trauma admitted to a level -1 trauma centre. This report describes clinical and microbiological characteristics of rare pathogen and also highlights the importance of rapid identification, susceptibility testing of such opportunistic pathogens in trauma settings and its unique antibiotic susceptibility profiles. This requires prompt treatment with timely intervention, and appropriate antimicrobial therapy, alongside adherence to strict infection control practices.	All India Inst Med Sci, JPNA Trauma Ctr, Dept Lab Med, New Delhi, India; All India Inst Med Sci, JPNA Trauma Ctr, Hosp Infect Control, New Delhi, India		Mathur, P (corresponding author), All India Inst Med Sci, JPNA Trauma Ctr, Hosp Infect Control, Dept Lab Med, New Delhi 110029, India.	purvamathur@yahoo.co.in					Arora U, 2008, INDIAN J MED MICROBI, V26, P81, DOI 10.4103/0255-0857.38868; Chang HJ, 1996, J INFECT DIS, V173, P656, DOI 10.1093/infdis/173.3.656; Hagiya H, 2013, J CLIN MICROBIOL, V51, P1330, DOI 10.1128/JCM.03238-12; Hardesty JS, 2010, INFECT DIS CLIN PRAC, V18, P299; Kettaneh A, 2003, J CLIN MICROBIOL, V41, P1339, DOI 10.1128/JCM.41.3.1339-1341.2003; Mastroianni Antonio, 1999, Clin Microbiol Infect, V5, P570, DOI 10.1111/j.1469-0691.1999.tb00437.x; Mudshingkar SS, 2013, INDIAN J MED MICROBI, V31, P306, DOI 10.4103/0255-0857.115664; Vaidya SA, 2006, J CLIN MICROBIOL, V44, P1184, DOI 10.1128/JCM.44.3.1184-1186.2006; Vila A, 2016, J INFECT DEV COUNTR, V10, P432, DOI 10.3855/jidc.7532	9	3	3	0	1	J INFECTION DEVELOPING COUNTRIES	TRAMANIGLIO	JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY	1972-2680			J INFECT DEV COUNTR	J. Infect. Dev. Ctries.	SEP	2017	11	9					733	735		10.3855/jidc.9146			3	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	FN5SQ	WOS:000416068600009	31600165	gold			2022-02-06	
J	Winter, L; Moriarty, HJ; Short, TH				Winter, Laraine; Moriarty, Helene J.; Short, Thomas H.			Self-Reported Driving Difficulty in Veterans With Traumatic Brain Injury: Its Central Role in Psychological Well-Being	PM&R			English	Article							COMMUNITY INTEGRATION; DEPRESSIVE SYMPTOMS; REHABILITATION; CESSATION; RETURN; TBI; PREDICTION; VALIDITY; HEALTH	Background: The ability to drive is a core function supporting independent living. Traumatic brain injury (TBI) may impair driving capacity in numerous ways. Previous research has documented that individuals with TBI have more driving-related problems than other people and has identified predictors of driving status or capacity, mostly among civilians; however, no research has examined the implications of driving limitations for the well-being of individuals with TBI. Objective: To examine the association between self-reported difficulty in driving with important domains of psychological well-being in veterans with TBI, with adjustment for posttraumatic stress disorder( PTSD) and years since most recent TBI. Design: Cross-sectional. Setting: Veterans' homes. Participants: A total of 61 veterans of the Global Wars on Terrorism diagnosed with TBI, all outpatients at a Veterans Affairs medical center rehabilitation service. Methods: Home interviews as a baseline assessment for a larger randomized controlled trial. Main Outcome Measures: Community reintegration( extent of social participation), depressive symptomatology, and role limitations due to physical health problems and those due to emotional problems. Self-rated competence in driving was the predictor, and sociodemographic characteristics, diagnosis of PTSD, severity of TBI, and time since most recent TBI were covariates. Results: Self-rated driving difficulty was associated with decreased community reintegration (beta =.280, P = .028), greater depressive symptomatology (beta = -.402, P < .001), and greater role limitations due to physical problems (beta = -.312, P = .011) and to emotional problems (beta = .324, P < .006), after we adjusted for PTSD and other variables. Discussion: The self-reported ability to drive seems to be central to psychological well-being in veterans with TBI, showing clear associations with depression, community reintegration, and health-related role limitations. These associations cannot be attributed to comorbid PTSD. Conclusion: Rehabilitation specialists should view driving difficulty as a risk factor for poor psychosocial outcomes in veterans with TBI and seek ways to compensate for the veteran's loss of driving if it is no longer advisable.	[Winter, Laraine] Philadelphia Res & Educ Fdn, Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Winter, Laraine] Villanova Univ, Coll Nursing, Villanova, PA 19085 USA; [Moriarty, Helene J.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA USA; [Short, Thomas H.] West Chester Univ, Dept Math, W Chester, PA 19380 USA		Winter, L (corresponding author), Philadelphia Res & Educ Fdn, Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.; Winter, L (corresponding author), Villanova Univ, Coll Nursing, Villanova, PA 19085 USA.	laraine.winter@gmail.com			Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD068857-01]	The project described was supported by award number R21 HD068857-01 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health. This material is also the result of work supported with resources and the use of facilities at the Corporal Michael C. Crescenz Veterans Affairs Medical Center (CMC-VAMC). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, the Eunice Kennedy Shriver National Institute of Child Health & Human Development, or the National Institutes of Health.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cullen N, 2014, BRAIN INJURY, V28, P189, DOI 10.3109/02699052.2013.862738; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Liddle J, 2012, AUST OCCUP THER J, V59, P79, DOI 10.1111/j.1440-1630.2011.00978.x; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schultheis Maria T, 2014, Curr Phys Med Rehabil Rep, V2, P176; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Skodol A, 2000, HDB PSYCHIAT MEASURE, P45; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Windsor TD, 2007, GERONTOLOGIST, V47, P215, DOI 10.1093/geront/47.2.215; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; YOUNGBLUT JM, 1993, RES NURS HEALTH, V16, P459, DOI 10.1002/nur.4770160610; Zimmerman M, 2006, J CLIN PSYCHIAT, V67, P1536, DOI 10.4088/JCP.v67n1007	51	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					901	909		10.1016/j.pmrj.2017.01.007			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500008	28167305				2022-02-06	
J	Yang, XF; Meng, YY; Wen, L; Wang, H				Yang, Xiao-Feng; Meng, Yuan-Yuan; Wen, Liang; Wang, Hao			Criteria for Performing Cranial Computed Tomography for Chinese Patients With Mild Traumatic Brain Injury: Canadian Computed Tomography Head Rule or New Orleans Criteria?	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Computed tomography; mild traumatic brain injury	CT; ADULTS; RISKS	Computed tomography (CT) provides the primary diagnostic evidence for traumatic brain injury (TBI), but few positive traumatic findings are discovered in patients with mild TBI. In China, there are no existing criteria for selecting patients with mild TBI to undergo CT, and almost all of these patients undergo cranial CT in the emergency department. This retrospective study was performed to evaluate the necessity of cranial CT among patients with mild TBI, as well as the feasibility of 2 popular criteria (Canadian CT head rule [CCHR] and New Orleans Criteria [NOC]) in China. Patients with mild TBI who underwent cranial CT within 24 hours of the trauma were included in our institute. Two neurosurgeons reviewed the CT images independently to identify positive CT findings. The sensitivity and specificity of CCHR and NOC for positive CT findings related to TBI were analyzed. Finally, this study included 625 patients. Positive CT findings related to TBI were discovered in 13.12% (82/625) of these patients on cranial CT, and 6.88% (43/625) of them were admitted to the hospital for further management. Ultimately, 11 patients (1.76%, 11/625) underwent neurosurgery. In this study, the sensitivities of both the CCHR and NOC were 100%, but the specificity of CCHR was 43.36% and that of NOC was 33.12%. Based on our study, both CCHR and NOC have high sensitivity for the detection of positive CT findings related to head trauma in patients with mild TBI.	[Yang, Xiao-Feng; Meng, Yuan-Yuan; Wen, Liang; Wang, Hao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China		Wen, L (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	wenliang@zju.edu.cn					Arab AF, 2015, NEURORADIOL J, V28, P591, DOI 10.1177/1971400915610699; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2005, JAMA-J AM MED ASSOC, V294, P1551, DOI 10.1001/jama.294.12.1551; Huang X, 2013, PAK J MED SCI, V29, P951, DOI 10.12669/pjms.294.3469; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119; Zhou JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040403	18	3	4	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2017	28	6					1594	1597		10.1097/SCS.0000000000003759			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO7IW	WOS:000417048300080	28692515				2022-02-06	
J	Yoon, SY; Choi, YJ; Park, SH; Hwang, JH; Hwang, SK				Yoon, Sang-Youl; Choi, Yeon-Ju; Park, Seong-Hyun; Hwang, Jeong-Hyun; Hwang, Sung Kyoo			Traumatic Brain Injury in Children under Age 24 Months : Analysis of Demographic Data, Risk Factors, and Outcomes of Post-traumatic Seizure	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Craniocerebral trauma; Infants; Demography; Risk factors; Seizures; Glasgow outcome scale	ISOLATED SKULL FRACTURE; BLUNT HEAD TRAUMA; EMERGENCY-DEPARTMENTS; YOUNG-CHILDREN; EPILEPSY; PROPHYLAXIS; PREDICTORS; CHILDHOOD; INFANTS	Objective : Traumatic brain injury (TBI) in children under age 24 months has characteristic features because the brain at this age is rapidly growing and sutures are opened. Moreover, children this age are completely dependent on their parents. We analyzed the demographic data and risk factors for outcomes in TBI patients in this age group to elucidate their clinical characteristics. Methods : We retrospectively reviewed the medical records and radiological films of children under 24 months who were admitted to Kyungpook National University Hospital from January 2004 to December 2013 for TBI. Specifically, we analyzed age, cause of injury, initial Glasgow coma scale (GCS) score, radiological diagnosis, seizure, hydrocephalus, subdural hygroma, and Glasgow outcome scale (GOS) score, and we divided outcomes into good (GOS 4-5) or poor (GOS 1-3). We identified the risk factors for post-traumatic seizure (PTS) and outcomes using univariate and multivariate analyses. Results : The total number of patients was 60, 39 males and 21 females. Most common age group was between 0 to 5 months, and the median age was 6 months. Falls were the most common cause of injury (n= 29, 48.3%); among them, 15 were falls from household furniture such as beds and chairs. Ten patients (16.7%) developed PTS, nine in one week; thirty-seven patients (61.7%) had skull fractures. Forty-eight patients had initial GCS scores of 13-15, 8 had scores of 12-8, and 4 had scored 3-7. The diagnoses were as follows : 26 acute subdural hematomas, 8 acute epidural hematomas, 7 focal contusional hemorrhages, 13 subdural hygromas, and 4 traumatic intracerebral hematomas larger than 2 cm in diameter. Among them, two patients underwent craniotomy for hematoma removal. Four patients were victims of child abuse, and all of them had PTS. Fifty-five patients improved to good-to-moderate disability. Child abuse, acute subdural hematoma, and subdural hygroma were risk factors for PTS in univariate analyses. Multivariate analysis found that the salient risk factor for a poor outcome was initial GCS on admission. Conclusion : The most common cause of traumatic head injury in individuals aged less than 24 months was falls, especially from household furniture. Child abuse, moderate to severe TBI, acute subdural hematoma, and subdural hygroma were risk factors for PTS. Most of the patients recovered with good outcomes, and the risk factor for a poor outcome was initial mental status.	[Yoon, Sang-Youl; Choi, Yeon-Ju; Park, Seong-Hyun; Hwang, Jeong-Hyun; Hwang, Sung Kyoo] Kyungpook Natl Univ Hosp, Dept Neurosurg, 130 Dongdeok Ro, Daegu 41944, South Korea		Hwang, SK (corresponding author), Kyungpook Natl Univ Hosp, Dept Neurosurg, 130 Dongdeok Ro, Daegu 41944, South Korea.	shwang@knu.ac.kr		Hwang, Jeong-Hyun/0000-0002-5306-6922			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Fakharian E, 2014, CHIN J TRAUMATOL, V17, P153, DOI 10.3760/cma.j.issn.1008-1275.2014.03.006; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kieslich M, 2001, DISABIL REHABIL, V23, P665; KIESLICH M, 1995, LANCET, V345, P187, DOI 10.1016/S0140-6736(95)90188-4; Kim JK, 1998, J KOREAN NEUROSURG S, V27, P625; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Ostahowski PJ, 2016, J NEUROSURG-PEDIATR, V18, P499, DOI 10.3171/2016.4.PEDS1698; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019	29	3	6	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2017	60	5					584	590		10.3340/jkns.2016.0707.008			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN5VM	WOS:000416076800013	28881122	Green Published, gold			2022-02-06	
J	Karanja, SW; Harrichandparsad, R; Royston, D; Motebejane, SM; Mitha, A				Karanja, Susan W.; Harrichandparsad, Rohen; Royston, Duncan; Motebejane, Samson M.; Mitha, Ayesha			Comparing computed tomography (CT) angiography versus digital subtraction angiography for the screening of traumatic pseudoaneurysms in transcranial stab injuries	SA JOURNAL OF RADIOLOGY			English	Article							PENETRATING BRAIN-INJURY; WOUNDS	Introduction: Transcranial stab injuries among the civilian population in South Africa are more common than in the West. In a study conducted in Durban, South Africa, in 1992, transcranial stab injuries accounted for 6% of all head injuries admitted to the neurosurgical unit. Digital subtraction angiography (DSA) has been the gold standard for diagnosing traumatic pseudoaneurysms. Its use as a screening tool is, however, limited and carries risks of neurological deficits. We postulate that the newer generation computed tomography (CT) scanner would serve as a better screening tool for traumatic pseudoaneurysms following transcranial stab injuries with the blade removed, provided the image quality is good. Methods: All patients admitted with a stab to the head with total calvarial penetration from September 2014 to January 2016 were included in the study. Those with a retained metallic fragment, incomplete imaging protocols, no penetration of the blade into the brain parenchyma or other causes of penetrating head injury were not included in the study. A retrospective chart review was then done on a prospectively recruited patient cohort. All CT angiograms were performed using a dual source CT scanner. Results: A total of 26 patients met the inclusion criteria. There were seven vascular injuries identified on DSA: three traumatic pseudoaneurysms and four vessel cut-offs. One traumatic pseudoaneurysm was missed on computed tomography angiography (CTA) because of a poor quality scan. The average sensitivity and specificity of CTA compared with DSA was 67% and 95.5%, respectively. Negative predictive value for CTA was 99.5%. Conclusion: A good quality CTA carried out on the newer generation CT scanners allows for use of CTA as a screening tool for patients with a transcranial stab injury and no retained blade or metallic foreign bodies.	[Karanja, Susan W.; Harrichandparsad, Rohen; Motebejane, Samson M.] Univ KwaZulu Natal, Dept Neurosurg, Durban, South Africa; [Royston, Duncan] Entabeni Hosp, Dept Radiol, Durban, South Africa; [Mitha, Ayesha] Inkosi Albert Luthuli Hosp, Dept Radiol, Durban, South Africa		Karanja, SW (corresponding author), Univ KwaZulu Natal, Dept Neurosurg, Durban, South Africa.	wanjirukiiru@yahoo.com					[Anonymous], 2001, J TRAUMA, V51, pS7; Bieler D, 2014, UNFALLCHIRURG, V117, P995, DOI 10.1007/s00113-014-2647-7; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Bodanapally UK, 2014, NEURORADIOL J, V27, P138, DOI 10.15274/NRJ-2014-10024; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Larson PS, 2000, NEUROSURG FOCUS, V8; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Stallmeyer MJB, 2006, RADIOL CLIN N AM, V44, P13, DOI 10.1016/j.rcl.2005.08.003; Syed FK, 2011, J EMERG TRAUMA SHOCK, P395; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; Temple N, 2015, J MED RADIAT SCI, V62, P122, DOI 10.1002/jmrs.101	12	3	3	0	0	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	1027-202X	2078-6778		SA J RADIOL	SA J. Radiol.	AUG 31	2017	21	1							a1197	10.4102/sajr.v21i1.1197			5	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	FF5YH	WOS:000409077100001		gold			2022-02-06	
J	Alsulaim, HA; Smart, BJ; Asemota, AO; Haring, RS; Canner, JK; Efron, DT; Haut, ER; Schneider, EB				Alsulaim, Hatim A.; Smart, Blair J.; Asemota, Anthony O.; Haring, R. Sterling; Canner, Joseph K.; Efron, David T.; Haut, Elliott R.; Schneider, Eric B.			Conscious status predicts mortality among patients with isolated traumatic brain injury in administrative data	AMERICAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; TBI; Surgical outcomes; Administrative databases; Trauma	UNITED-STATES; HOSPITALIZATION; SURVEILLANCE	BACKGROUND: Outcome studies in trauma using administrative data traditionally employ anatomy-based definitions of injury severity; however, physiologic factors, including consciousness, may correlate with outcomes. We examined whether accounting for conscious status in administrative data improved mortality prediction among patients with moderate to severe TBI. METHODS: Patients meeting Centers for Disease Control and Prevention (CDC) guidelines for TBI in the 2006 to 2011 Nationwide Emergency Department Sample were identified. Patients were dichotomized as having no/brief loss of consciousness (LOC) vs extended LOC greater than 1 hour using International Classification of Diseases, Ninth Revision (ICD-9) fifth digit modifiers. Receiver operating curves compared the ability of logistic regression to predict mortality in models that included LOC vs models that did not. RESULTS: Overall, 98,397 individuals met criteria, of whom 25.8% had extended LOC. In univariate analysis, AIS alone predicted mortality in 69.6% of patients (area under receiver operating characteristic curve .696, 95% CI .689 to .702), extended LOC alone predicted mortality in 76.8% (AUROC .768, 95% CI .764 to .773), and a combination of AIS and extended LOC predicted mortality in 82.6% of cases (AUROC .826, 95% CI .821 to .830). Similar differences were observed in best-fit models. CONCLUSIONS: Accounting for LOC along with anatomical measures of injury severity improves mortality prediction among patients with moderate/severe TBI in administrative datasets. Further work is warranted to determine whether other physiological measures may also improve prediction across a variety of injury types. (C) 2016 Elsevier Inc. All rights reserved.	[Alsulaim, Hatim A.; Smart, Blair J.; Asemota, Anthony O.; Haring, R. Sterling; Canner, Joseph K.; Efron, David T.; Haut, Elliott R.; Schneider, Eric B.] Johns Hopkins Sch Med, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD 21205 USA; [Efron, David T.; Haut, Elliott R.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Smart, Blair J.] USC, Keck Sch Med, Dept Surg, Los Angeles, CA USA; [Haring, R. Sterling; Schneider, Eric B.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA		Schneider, EB (corresponding author), Johns Hopkins Sch Med, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD 21205 USA.; Schneider, EB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA.	eschneider3@partners.org	Haut, Elliott R./J-3948-2019	Haring, R. Sterling/0000-0002-5417-3914; Haut, Elliott/0000-0001-7075-771X			Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Clark DE., ICDPIC STATA MODULE; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferreros I, 2012, REV NEUROLOGIA, V54, P719, DOI 10.33588/rn.5412.2011701; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Raum MR, 2009, CRIT CARE MED, V37, P1972, DOI 10.1097/CCM.0b013e31819fe96a; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39	9	3	3	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	AUG	2017	214	2					207	210		10.1016/j.amjsurg.2016.07.012			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FG7TN	WOS:000410627700007	27663651				2022-02-06	
J	Amari, A; Suskauer, SJ; Paasch, V; Grodin, LK; Slomine, BS				Amari, Adrianna; Suskauer, Stacy J.; Paasch, Valerie; Grodin, Lauren K.; Slomine, Beth S.			Conducting Preference Assessments for Youth With Disorders of Consciousness During Rehabilitation	REHABILITATION PSYCHOLOGY			English	Article						preference assessment; rehabilitation; children; disorders of consciousness; minimally conscious state	TRAUMATIC BRAIN-INJURY; IDENTIFYING REINFORCERS; VEGETATIVE STATE; DEVELOPMENTAL-DISABILITIES; MULTIPLE DISABILITIES; BEHAVIORAL-ASSESSMENT; YOUNG-ADULTS; CHILDREN; INDIVIDUALS; CHOICE	Purpose: Care and rehabilitation for individuals with disorders of consciousness (DOC) can be challenging; the use of observational data collection, individualized treatment programs, and incorporation of preferred, personally meaningful and salient items may be helpful in addressing such challenges during assessment and intervention. In this article, we extend the predominantly adult literature on use of salient items to promote differential responding by describing our methodology to identify preferred items across sensory domains for application during inpatient rehabilitation with children with DOC. Method: Details on the indirect and direct preference assessment procedures rooted in applied behavior analysis that we have tailored for this population are provided. We describe steps of the procedures, including structured caregiver interview, staff survey, item inclusion, in vivo single-item stimulus preference assessment, and treatment. Clinical case examples further illustrate implementation of our methodology, observed response topographies, individually identified preferred items, and their application for 3 children in a minimally conscious state. In addition, we introduce a new structured caregiver interview, the Preference Assessment for Youth with Disorders of Consciousness (PAYDOC), modeled on the Reinforcer Assessment for Individuals with Severe Disabilities (RAISD; Fisher, Piazza, Bowman, & Amari, 1996) and modified to be appropriate for future use as a clinical tool to enhance assessment of preferences with this pediatric brain injury population. Implications: This methodology can be used to identify highly idiosyncratic stimuli that can be incorporated in multiple ways throughout rehabilitation to optimize care for youth with DOC.	[Amari, Adrianna; Paasch, Valerie; Grodin, Lauren K.] Kennedy Krieger Inst, Dept Behav Psychol, 707 North Broadway, Baltimore, MD 21205 USA; [Amari, Adrianna; Paasch, Valerie; Grodin, Lauren K.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Suskauer, Stacy J.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Slomine, Beth S.] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD 21205 USA; [Grodin, Lauren K.] Joe DiMaggio Childrens Hosp, Dept Pediat Behav Hlth, Hollywood, FL USA		Amari, A (corresponding author), Kennedy Krieger Inst, Dept Behav Psychol, 707 North Broadway, Baltimore, MD 21205 USA.	amari@kennedykrieger.org					Amari A, 2012, BRAIN INJURY, V26, P524; Ashwal S, 2004, NEUROREHABILITATION, V19, P349; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; Bardin J. C., 2011, SOC NEUR WASH DC; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cannella HI, 2005, RES DEV DISABIL, V26, P1, DOI 10.1016/j.ridd.2004.01.006; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Cote CA, 2007, J APPL BEHAV ANAL, V40, P157, DOI 10.1901/jaba.2007.177-05; Eilander HJ, 2013, J PEDIATR REHAB MED, V6, P73, DOI 10.3233/PRM-130241; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; FISHER W, 1992, J APPL BEHAV ANAL, V25, P491, DOI 10.1901/jaba.1992.25-491; Fisher WW, 1996, AM J MENT RETARD, V101, P15; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GREEN CW, 1988, J APPL BEHAV ANAL, V21, P31, DOI 10.1901/jaba.1988.21-31; Hagopian LP, 2004, BEHAV MODIF, V28, P668, DOI 10.1177/0145445503259836; Heinicke MR, 2013, BRAIN INJURY, V27, P48, DOI 10.3109/02699052.2012.722250; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P379, DOI 10.1007/s10882-008-9104-x; Lancioni GE, 2012, COGN PROCESS, V13, pS219, DOI 10.1007/s10339-012-0485-5; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Logan K. R., 2001, EXCEPTIONALITY, V9, P123, DOI [DOI 10.1207/S15327035EX0903_3, 10.1207/S15327035EX0903_3]; Logan KR, 2001, J DEV PHYS DISABIL, V13, P97, DOI 10.1023/A:1016624923479; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Magee WL, 2007, BRAIN INJURY, V21, P593, DOI 10.1080/02699050701426907; O'Kelly J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00884; PACE GM, 1985, J APPL BEHAV ANAL, V18, P249, DOI 10.1901/jaba.1985.18-249; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01102; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Pool J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00202; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Sharon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074711; Steinhoff N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00291; Thengone D. J., 2012, SOC NEUR NEW ORL LA; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5	42	3	3	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2017	62	3					227	237		10.1037/rep0000152			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT3KV	WOS:000423046900002	28594194				2022-02-06	
J	Banga, MS; Sandeep, BV; Roy, K; Saha, SK; Dixit, S; Ghosh, P				Banga, Manpreet Singh; Sandeep, B., V; Roy, Kaushik; Saha, Suniti Kumar; Dixit, Sourabh; Ghosh, Partha			Contrecoup Head Injury	INDIAN JOURNAL OF NEUROSURGERY			English	Article						contrecoup; coup; Glasgow coma scale	LESION; COUP	Contrecoup injuries comprise a group of focal brain injuries that occur at areas distant from the point of impact. It has been hypothesized that patients with contrecoup injuries would have a worse outcome because of the diffuse nature of injury. At Nilratan Sircar Medical College, Kolkata, 74 patients presenting with contrecoup injuries over a period of 1 year were prospectively analyzed. Site of primary impact was determined by clinical and CT scan criteria. The age, modes of injury, Glasgow coma scale (GCS), site of injury, pattern of injury, and mortality were analyzed. Delayed presentation of contrecoup injury in patients who deteriorated over time was also noted in imaging. The presence of contrecoup injury implies that the traumatic forces have dissipated into the brain, and from the biomechanisms explained, the brain is likely to have suffered greater damage than the case in coup injury alone. The present study shows that the presence of contrecoup contusions is associated with a poor prognosis across all GCS and age categories.	[Banga, Manpreet Singh; Sandeep, B., V; Roy, Kaushik; Saha, Suniti Kumar; Dixit, Sourabh; Ghosh, Partha] Nilratan Sircar Med Coll, Dept Neurosurg, 138 AJC Bose Rd, Kolkata 700014, W Bengal, India		Banga, MS (corresponding author), Nilratan Sircar Med Coll, Dept Neurosurg, 138 AJC Bose Rd, Kolkata 700014, W Bengal, India.	dr.msbanga@gmail.com					Adams JH, 1982, RECENT ADV NEUROPATH, P165; Asha'ari ZA, 2011, J LARYNGOL OTOL, V125, P781, DOI 10.1017/S0022215111000545; Bhateja A, 2009, INDIAN J NEUROTRAUM, V6, P115, DOI 10.1016/S0973-0508(09)80004-X; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Graham DI, 1997, BRAIN PATHOL, V7, P1285; JAYAKUMAR PN, 1991, ACTA NEUROCHIR, V108, P30, DOI 10.1007/BF01407663; Kraus J F, 1990, NINS HEAD INJURY CLI, P113; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Mahapatra AK, 2003, NEUROSCI TODAY, V7, P29; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14	12	3	3	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	AUG	2017	6	2					103	106		10.1055/s-0037-1601361			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	FS4LS	WOS:000419764300007		gold, Green Submitted			2022-02-06	
J	Carter, C; Human, T				Carter, Chris; Human, Theresa			Efficacy, Safety, and Timing of 5% Sodium Chloride Compared With 23.4% Sodium Chloride for Osmotic Therapy	ANNALS OF PHARMACOTHERAPY			English	Article						clinical pharmacy; drug administration; supportive care; adult medicine; central nervous system	TRAUMATIC BRAIN-INJURY; HYPERTONIC SALINE; INTRACRANIAL HYPERTENSION; PRESSURE; MANAGEMENT; MANNITOL; METAANALYSIS	Background: Bolus doses of 23.4% sodium chloride (NaCl) are commonly used for the treatment of intracranial hypertension; however, delays in administration may occur in patients without central intravenous access. At our institution, equiosmolar bolus doses of 5% NaCl have emerged as potential alternatives to 23.4% NaCl because they may be safely administered through peripheral lines. Objectives: We sought to assess the efficacy in reducing intracranial pressure (ICP), time to administration, and safety of 5% NaCl as compared with 23.4% NaCl for the treatment of intracranial hypertension. Methods: Patients admitted from July 2012 to June 2014 who received boluses of 5% NaCl or 23.4% NaCl for a sustained ICP > 20 mm Hg were included. Data collected included measurements of ICP, time to administration, and adverse events. Results: A total of 44 patients were identified; 11 received 5% NaCl, and 33 received 23.4% NaCl. The median percentage reductions in ICP at 30, 60, and 120 minutes in patients who received 5% versus 23.4% NaCl were 34% versus 26% (P = 0.850), 48% versus 40% (P = 0.700), and 46% versus 30% (P = 0.064), respectively. The median time to administration was shorter in the 5% NaCl group (7 vs 11 minutes, P = 0.364). Both groups had a 27% rate of adverse events and no infusion site reactions. Conclusions: These data suggest that 5% NaCl may be as effective as 23.4% NaCl at lowering ICP if given at equiosmolar doses, has a shorter time to administration, and has no difference in the prevalence of adverse events.	[Carter, Chris] SSM Hlth St Clare Hosp, Fenton, MO USA; [Carter, Chris; Human, Theresa] Barnes Jewish Hosp, St Louis, MO 63110 USA; [Human, Theresa] Washington Univ, Sch Med, St Louis, MO USA		Carter, C (corresponding author), SSM Hlth St Clare Hosp, Dept Pharm, 1015 Bowles Ave, Fenton, MO 63026 USA.	christopher_carter@ssmhc.com	Carter, Chris/I-6900-2019	Carter, Chris/0000-0003-4723-1853			DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Grape S, 2012, J NEUROSURG ANESTH, V24, P402, DOI 10.1097/01.ana.0000419729.52363.64; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Hinson HE, 2013, J INTENSIVE CARE MED, V28, P3, DOI 10.1177/0885066611400688; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	18	3	3	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1060-0280	1542-6270		ANN PHARMACOTHER	Ann. Pharmacother.	AUG	2017	51	8					625	629		10.1177/1060028017701220			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FA6SA	WOS:000405573100001	28707549				2022-02-06	
J	Chieregato, A; Venditto, A; Russo, E; Martino, C; Bini, G				Chieregato, Arturo; Venditto, Alessandra; Russo, Emanuele; Martino, Costanza; Bini, Giovanni			Aggressive medical management of acute traumatic subdural hematomas before emergency craniotomy in patients presenting with bilateral unreactive pupils. A cohort study	ACTA NEUROCHIRURGICA			English	Article						Brain injuries; Mannitol; Mydriasis; Outcome; Subdural hematoma; Transtentorial herniation	SEVERE HEAD-INJURY; DILATED PUPILS; INTRACRANIAL-PRESSURE; BRAIN; MANNITOL; HERNIATION; SURGERY; COMA	Background The outcome of patients with severe traumatic brain injury (TBI) and acute traumatic subdural hematoma (aSDH) admitted to the emergency room with bilaterally dilated, unreactive pupils (bilateral mydriasis) is notoriously poor. Methods Of 2074 TBI patients consecutively admitted to our facility between 1997 and 2012, 115 had a first CT scan with aSDH, unreactive bilateral mydriasis, and a Glasgow Coma Score of 3 or 4. Sixty-two patients were unoperated and died within hours or a few days. The remaining 53 patients (2.5% of the 2074 consecutive patients) were scheduled for emergent evacuation of the aSDH. We compared three different dosages of mannitol to landmark different comprehensive levels of treatment: (1) a "basic" level of treatment characterized by a single conventional dose (18 to 36 g), (2) "reinforced" treatment landmarked by a single high dose (54 to 72 g), and (3) "aggressive" treatment landmarked by a single high dose (90 to 106 g). Doses above 36 g were administered intravenously over a period of 5 min. Results Of the 53 selected patients, 7 were aggressively managed (13.2%) and 24 (45.3%) received reinforced treatment. Rates of hyperventilation and barbiturate bolus administration were appropriately associated with increasing doses of mannitol. After adjustment for age, aggressive management was significantly associated with a lower risk of death and persistent vegetative state [adjusted OR 0.016 (95% 0.001-0.405)]. Patients surviving after aggressive management suffered more severe disability at 1 year. Conclusion The study shows an association between reduced mortality and persistent vegetative state, albeit at the cost of increased long-term severe disability in survivors, and aggressive medical preoperative management of mydriatic patients with aSDH following TBI.	[Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, Piazza Osped Maggiore 3, I-20162 Milan, Italy; [Venditto, Alessandra; Russo, Emanuele; Martino, Costanza; Bini, Giovanni] Osped Gen Provinciale M Bufalini, Anestesia & Rianimaz, Area Vasta Romagna, Cesena, Italy		Chieregato, A (corresponding author), ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, Piazza Osped Maggiore 3, I-20162 Milan, Italy.	arturo.chieregato@gmail.com; avenditto80@gmail.com; lelegaiola@gmail.com; costanza.martino@auslromagna.it; gionbini@libero.it	Russo, Emanuele/AAP-5645-2020	Russo, Emanuele/0000-0002-6531-5527			Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Chieregato A, 2014, ANAESTHESIA, V69, P1117, DOI 10.1111/anae.12806; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Poole D, 2017, INTENS CARE MED, V43, P575, DOI 10.1007/s00134-017-4696-1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Schrot RJ, 2002, LANCET, V359, P1633, DOI 10.1016/S0140-6736(02)08545-8; Scotter J, 2015, EMERG MED J, V32, P654, DOI 10.1136/emermed-2014-204260; Servadei F, 2002, J Neurosurg Sci, V46, P111; SHAPIRO HM, 1973, BRIT J ANAESTH, V45, P1057, DOI 10.1093/bja/45.10.1057; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Sousa J, 2002, NEUROL INDIA, V50, P430; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wise BL, 2004, J NEUROSURG, V101, P566	28	3	3	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2017	159	8					1553	1559		10.1007/s00701-017-3190-4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA6CM	WOS:000405530900028	28435989				2022-02-06	
J	Ichimiya, Y; Kaku, N; Sakai, Y; Yamashita, F; Matsuoka, W; Muraoka, M; Akamine, S; Mizuguchi, S; Torio, M; Motomura, Y; Hirata, Y; Ishizaki, Y; Sanefuji, M; Torisu, H; Takada, H; Maehara, Y; Ohga, S				Ichimiya, Yuko; Kaku, Noriyuki; Sakai, Yasunari; Yamashita, Fumiya; Matsuoka, Wakato; Muraoka, Mamoru; Akamine, Satoshi; Mizuguchi, Soiai; Torio, Michiko; Motomura, Yoshitomo; Hirata, Yuichiro; Ishizaki, Yoshito; Sanefuji, Masafumi; Torisu, Hiroyuki; Takada, Hidetoshi; Maehara, Yoshihiko; Ohga, Shouichi			Transient dysautonomia in an acute phase of encephalopathy with biphasic seizures and late reduced diffusion	BRAIN & DEVELOPMENT			English	Article						Dysautonomia; Paroxysmal sympathetic hyperactivity (PSH); Therapeutic hypothermia; Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD)	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; ACQUIRED BRAIN-INJURY; FEBRILE SEIZURES; CHILDREN	Paroxysmal sympathetic hyperactivity (PSH) is a dysautonomic condition that is associated with various types of acquired brain injuries. Traumatic brain lesions have been documented as the leading cause of PSH. However, detailed clinical features of pediatric PSH caused by intrinsic brain lesions remain to be elusive. We present a 3-year-old boy, who had been diagnosed as having cerebral palsy, developmental delay and epilepsy after perinatal hypoxia-induced brain injury. He developed status epilepticus with fever on the third day of respiratory infection. Whereas the seizure was terminated by systemic infusion of midazolam, consciousness remained disturbed for the next 48 h. Serial magnetic resonance imaging studies revealed that acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) evolved on 3 days after the seizure. Therapeutic hypothermia was immediately introduced, however, the brain lesion extended to the whole subcortical white matters on day 8. The intermittent bilateral dilation of pupils with increased blood pressure and tachycardia were observed until day 12. Real-time monitoring of electroencephalograms ruled out the recurrent attacks of seizures. The abnormal signs of autonomic nervous system gradually ceased and never relapsed after recovery from the hypothermia. PSH or a transient condition of dysautonomia may emerge and persist during the acute phase of AESD. (C) 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ichimiya, Yuko; Kaku, Noriyuki; Sakai, Yasunari; Yamashita, Fumiya; Matsuoka, Wakato; Muraoka, Mamoru; Akamine, Satoshi; Mizuguchi, Soiai; Torio, Michiko; Motomura, Yoshitomo; Hirata, Yuichiro; Ishizaki, Yoshito; Sanefuji, Masafumi; Torisu, Hiroyuki; Takada, Hidetoshi; Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Ichimiya, Yuko; Kaku, Noriyuki; Matsuoka, Wakato; Muraoka, Mamoru; Mizuguchi, Soiai; Motomura, Yoshitomo; Hirata, Yuichiro; Maehara, Yoshihiko] Kyushu Univ, Emergency & Crit Care Ctr, Fukuoka, Japan; [Torisu, Hiroyuki] Fukuoka Dent Coll Med & Dent Hosp, Dept Pediat, Fukuoka, Japan		Sakai, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan.	ysakai22q13@gmail.com	Yue, Yuhang/AAW-9279-2021; Sakai, Yasunari/S-7965-2018	Sakai, Yasunari/0000-0002-5747-8692	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K09624, 16K09991, 26860848, 26461547]; Ministry of Health, Labour and Welfare of JapanMinistry of Health, Labour and Welfare, Japan; Japan Epilepsy Research Foundation	We thank Drs. Ryutaro Kira and Sooyoung Lee at Fukuoka Children's Hospital for helpful discussion. This work was supported by JSPS KAKENHI No. 15K09624 (Y.S.), 16K09991 (M.S.), 26860848 (M.T.), 26461547 (Y.I.), Evidence-based early diagnosis and treatment strategies for neuroimmunological diseases from the Ministry of Health, Labour and Welfare of Japan (Y.S.), and The Japan Epilepsy Research Foundation (Y.S.).	Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Delogu AB, 2011, EPILEPSIA, V52, P55, DOI 10.1111/j.1528-1167.2011.03003.x; Farias-Moeller R, 2015, NEUROCRIT CARE, V23, P380, DOI 10.1007/s12028-015-0124-y; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Lee S, 2016, J NEUROL SCI, V370, P39, DOI 10.1016/j.jns.2016.09.018; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Saitoh M, 2015, EPILEPSY RES, V117, P1, DOI 10.1016/j.eplepsyres.2015.08.001; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5	10	3	3	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	AUG	2017	39	7					621	624		10.1016/j.braindev.2017.03.023			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	FD9WV	WOS:000407873700011	28413125				2022-02-06	
J	Lahey, S; Beaulieu, C; Sandbach, K; Colaiezzi, A; Balkan, S				Lahey, Sarah; Beaulieu, Cynthia; Sandbach, Karen; Colaiezzi, Angela; Balkan, Staci			The Role of the Psychologist With Disorders of Consciousness in Inpatient Pediatric Neurorehabilitation: A Case Series	REHABILITATION PSYCHOLOGY			English	Article						pediatric brain injury; disorders of consciousness; rehabilitation	TRAUMATIC BRAIN-INJURY; COMA RECOVERY SCALE; EARLY INTENSIVE NEUROREHABILITATION; PROLONGED UNCONSCIOUS STATE; SENSORY STIMULATION PROFILE; PERSISTENT VEGETATIVE STATE; SLOW-TO-RECOVER; IMPAIRED CONSCIOUSNESS; CONTROLLED-TRIAL; YOUNG-ADULTS	Purpose/Objective: The psychologist in an inpatient pediatric neurorehabilitation setting provides a vital role in the assessment, treatment, and management of pediatric patients with disorders of consciousness (DoC). Competencies are drawn from several specialty areas of professional psychology, including rehabilitation psychology, pediatric neuropsychology, and pediatric psychology. This specialized knowledge forms the basis for tailoring assessment and treatment plans specific to the individual brain injury profile, with the goals of enhancing diagnosis, prognosis, and care transition decision. Aim: To describe the role of the psychologist in the differential diagnosis and treatment of pediatric patients with severe brain injury and DoC during inpatient rehabilitation. Research Method/Design: Three pediatric cases admitted to inpatient rehabilitation with suspected DoC illustrate the psychologist's role in diagnostics, case conceptualization, assessment design, and data collection based on patient-specific brain injury profiles. Customized data collection informs diagnostic decisions and treatment planning, with the goal of improved of care and resource utilization. The psychologist also provides ongoing psychoeducation, psychotherapy, and supportive interventions to the patient's family and caregivers to facilitate family adjustment to disability and promote long-term adaptation and adjustment. Conclusions/Implications: This case series illustrates the role of the psychologist in the use of individual brain injury profiles to coordinate assessment, diagnosis, and care for children with severe brain injury. Implications include the need for focused research to demonstrate the value-added role of the psychologist on the interdisciplinary team working in the neurorehabilitation of this complex patient population.	[Lahey, Sarah; Beaulieu, Cynthia; Sandbach, Karen; Colaiezzi, Angela; Balkan, Staci] Brooks Rehabil Hosp, 3599 Univ Blvd South, Jacksonville, FL 32216 USA		Lahey, S (corresponding author), Brooks Rehabil Hosp, 3599 Univ Blvd South, Jacksonville, FL 32216 USA.	sarah.lahey@brooksrehab.org					Ahmed A, 2013, THER CLIN RISK MANAG, V9, P483, DOI 10.2147/TCRM.S53906; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; Beaulieu C., 2000, 24 ANN WILL TRAUM BR; Beaulieu C., 2014, INT BRAIN INJ ASS 10; Beaulieu C. L., 1999, 76 ANN M AM C REH ME; Chwalisz K., 2010, HDB REHABILITATION P, P301; Cusick A, 2014, AUST OCCUP THER J, V61, P276, DOI 10.1111/1440-1630.12128; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2013, J PEDIATR REHAB MED, V6, P73, DOI 10.3233/PRM-130241; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Evanson Nathan K, 2016, Curr Phys Med Rehabil Rep, V4, P56; Farmer J. E., 2010, HDB REHABILITATION P, DOI [https://doi.org/10.1037/15972-019, DOI 10.1037/15972-019]; Farmer J. E., 2006, TREATING NEURODEVELO, P269; Feng Y, 2015, PEDIATR NEUROSURG, V50, P301, DOI 10.1159/000439282; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Godbolt AK, 2012, BRAIN INJURY, V26, P188, DOI 10.3109/02699052.2011.648708; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hibbard M. R., 2010, HDB REHABILITATION P, P467; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Jacinto SJ, 2001, PEDIATR CLIN N AM, V48, P647, DOI 10.1016/S0031-3955(05)70332-1; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Palermo TM, 2014, J PEDIATR PSYCHOL, V39, P965, DOI 10.1093/jpepsy/jsu015; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Patrick PD, 2009, BRAIN INJURY, V23, P528, DOI 10.1080/02699050902926325; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Rey-Casserly C, 2012, PROF PSYCHOL-RES PR, V43, P422, DOI 10.1037/a0028721; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rolland JS, 1994, FAMILIES ILLNESS DIS; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thibaut A, 2015, BRAIN INJURY, V29, P830, DOI 10.3109/02699052.2015.1005132; Vargus-Adams JN, 2010, PM&R, V2, P37, DOI 10.1016/j.pmrj.2009.10.010; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Ward LM, 2011, CONSCIOUS COGN, V20, P464, DOI 10.1016/j.concog.2011.01.007; Whiteneck G, 2012, J SPINAL CORD MED, V35, P484, DOI 10.1179/2045772312Y.0000000057; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	59	3	3	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2017	62	3					238	248		10.1037/rep0000156			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT3KV	WOS:000423046900003	28682095				2022-02-06	
J	Lin, WS; Lin, TC; Hung, Y; Lin, WY; Lin, CS; Lin, CL; Cheng, SM; Kao, CH				Lin, Wei-Shiang; Lin, Tzu-Chiao; Hung, Yuan; Lin, Wen-Yu; Lin, Chin-Sheng; Lin, Cheng-Li; Cheng, Shu-Meng; Kao, Chia-Hung			Traumatic intracranial haemorrhage is in association with an increased risk of subsequent atrial fibrillation	HEART			English	Article							BRAIN; STROKE; ANTICOAGULATION; MORTALITY; INJURY; DYSFUNCTION; EXPRESSION	Objective Traumatic intracranial haemorrhage (ICH) leads to systemic inflammatory response and arrhythmia. Atrial fibrillation (AF), the most common arrhythmia, is associated with systemic inflammation. However, limited evidence is available regarding the association between traumatic ICH and AF. Methods This study used the National Health Insurance Research Database, a nationwide population-based cohort, in Taiwan and total 130 171 individuals with traumatic ICH from 2000 to 2011 were identified. Furthermore, individuals without traumatic ICH were selected as a comparison cohort by the propensity score method. Individuals with prior history of AF were excluded from this study. The endpoint of interest was the occurrence of AF and the follow-up was terminated by the occurrence of AF, loss of follow-up or the passing of 31 December 2011. Results During the follow-up period, the incidence of AF was higher in patients with traumatic ICH than in those without traumatic ICH (4.24 vs 4.12 per 1000 person-years). After adjustment for age, sex and all AF-associated comorbidities, the individuals with traumatic ICH had a 1.25-fold increased risk of AF (HR=1.25, 95% CI=1.18 to 1.32; p<0.001). Stratified by sex and age, the incidence of AF was consistently higher in the traumatic ICH group. Relative to the individuals without traumatic ICH and without comorbidities, the risk of AF was the highest in the individuals with both traumatic ICH and comorbidities; this risk was higher than that of the individuals with only traumatic ICH; it was also higher than the risk for those only with comorbidities. Conclusion In this large-scale cohort study, the future risks of AF are higher in patients with traumatic ICH compared with the comparison cohort. Carefully monitoring the occurrence of AF and proper anticoagulation therapy might be important in patients with traumatic ICH.	[Lin, Wei-Shiang; Lin, Tzu-Chiao; Hung, Yuan; Lin, Wen-Yu; Lin, Chin-Sheng; Cheng, Shu-Meng] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan		Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung 404, Taiwan.	d10040@mail.cmuh.org.tw	Lin, Wei-Shiang/ABA-7928-2020	Hung, Yuan/0000-0002-2199-8338	Taiwan's Ministry of National Defense [MAB-105-014]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by grants from Taiwan's Ministry of National Defense (MAB-105-014); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan. No additional external funding received for this study.	An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ceconi C, 1998, EUR HEART J, V19, pF2; Chang SL, 2011, CLIN EXP PHARMACOL P, V38, P666, DOI 10.1111/j.1440-1681.2011.05553.x; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; El-Chami MF, 2010, J AM COLL CARDIOL, V55, P1370, DOI 10.1016/j.jacc.2009.10.058; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldstein JN, 2010, CLEV CLIN J MED, V77, P791, DOI 10.3949/ccjm.77a.10018; Goldstein JN, 2009, NEUROCRIT CARE, V10, P28, DOI 10.1007/s12028-008-9134-3; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Lin YK, 2010, CIRC J, V74, P1547, DOI 10.1253/circj.CJ-09-0999; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; Montaigne D, 2015, INT J CARDIOL, V184, P597, DOI 10.1016/j.ijcard.2015.03.012; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Nielsen PB, 2015, CHEST, V147, P1651, DOI 10.1378/chest.14-2099; Parekh N, 2000, J AM COLL CARDIOL, V36, P1328, DOI 10.1016/S0735-1097(00)00857-3; Parsons LS, 2004, P 29 ANN SAS US GROU, P11; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Schillinger KJ, 2012, J GERIATR CARDIOL, V9, P379, DOI 10.3724/SP.J.1263.2012.08141; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Zazulia A, 2015, NEUROL CLIN, V33, P329, DOI 10.1016/j.ncl.2014.12.005	30	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1355-6037	1468-201X		HEART	Heart	AUG	2017	103	16					1286	1291		10.1136/heartjnl-2016-310451			6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	FB7GO	WOS:000406309300013	28389522				2022-02-06	
J	Lu, K; Liang, CL; Li, PC; Liliang, PC; Huang, CY; Lee, YC; Wang, KW; Yang, SN; Sun, YT; Wang, HK				Lu, Kang; Liang, Cheng-Loong; Li, Ping-Chia; Liliang, Po-Chou; Huang, Chih-Yuan; Lee, Yi-Che; Wang, Kuo-Wei; Yang, San-Nan; Sun, Yuan-Ting; Wang, Hao-kuang			Risk factors for myocardial dysfunction after traumatic brain injury: A one-year follow-up study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						TBI; Myocardial dysfunction; Retrospective; Cohort	SYSTEMIC COMPLICATIONS; HEAD-INJURY; INFARCTION	Introduction: Traumatic brain injury has been associated with an increased risk of myocardial dysfunction. Common abnormalities accompanying this pathology include electrocardiographic abnormalities, elevated creatine kinase levels, arrhythmias, and pathologic changes of the myocardium. The aim of this study was to determine if TBI patients have a higher risk of myocardial dysfunction than the general population and to identify the risk factors of myocardial dysfunction in TBI patients. Patients and methods: The study sample was drawn from Taiwan's National Health Insurance Research Database of reimbursement claims, and comprised 26,860 patients who visited ambulatory care centers or were hospitalized with a diagnosis of TBI. The comparison group consisted of 134,300 randomly selected individuals. The stratified Fine and Gray regression was performed to evaluate independent risk factors for myocardial dysfunction in all patients and to identify risk factors in TBI patients. Results: During a 1-year follow-up period, 664 patients with TBI and 1494 controls developed myocardial dysfunction. TBI was independently associated with increased risk of myocardial dysfunction. Diabetes, hypertension, peptic ulcer disease, chronic liver disease and chronic renal disease were risk factors of myocardial dysfunction in TBI patients. Conclusions: Individuals with TBI are at greater risk of developing myocardial dysfunction after adjustments for possible confounding factors. Early monitor should be initiated to decrease disability and dependence in patients with TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Lu, Kang; Liang, Cheng-Loong; Liliang, Po-Chou; Wang, Kuo-Wei; Wang, Hao-kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Lu, Kang; Liang, Cheng-Loong; Li, Ping-Chia; Liliang, Po-Chou; Wang, Kuo-Wei; Yang, San-Nan; Wang, Hao-kuang] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Huang, Chih-Yuan] Natl Cheng Kung Univ Hosp, Dept Surg, Neurosurg Serv, Tainan, Taiwan; [Lee, Yi-Che] I Shou Univ, E Da Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Sun, Yuan-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Neurol, Coll Med, Tainan, Taiwan		Wang, HK (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan.	ed101393@gmail.com		Wang, Hao-Kuang/0000-0002-1928-7502	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [103-2314-B-214 -007 -MY2]; E-da hospital, Kaohsiung, Taiwan [EDPJ103075, EDPJ104072, EDAHP 10662]	This study was supported in part by grants from the Ministry of Science and Technology, Taiwan (103-2314-B-214 -007 -MY2), E-da hospital, Kaohsiung, Taiwan (EDPJ103075, EDPJ104072, EDAHP 10662).	Berman M, 2010, J HEART LUNG TRANSPL, V29, P957, DOI 10.1016/j.healun.2010.04.008; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boateng S, 2013, DM-DIS MON, V59, P83, DOI 10.1016/j.disamonth.2012.12.004; Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; Fouad YM, 2014, WORLD J HEPATOL, V6, P41, DOI 10.4254/wjh.v6.i1.41; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Kanjwal K, 2010, CARDIOL J, V17, P482; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Mierzewska-Schmidt M, 2015, ANAESTH INTENSIVE TH, V47, P175, DOI 10.5603/AIT.2015.0017; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; WHITE M, 1995, CIRCULATION, V92, P2183, DOI 10.1161/01.CIR.92.8.2183; Wijayatilake DS, 2015, CURR OPIN ANESTHESIO, V28, P525, DOI 10.1097/ACO.0000000000000236	30	3	3	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2017	48	8					1794	1800		10.1016/j.injury.2017.07.004			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2KW	WOS:000408046200013	28701282				2022-02-06	
J	Nikolian, VC; Pan, BH; Mesar, T; Dennahy, IS; Georgoff, PE; Duan, XZ; Liu, BL; Wu, XZ; Duggan, MJ; Alam, HB; Li, YQ				Nikolian, Vahagn C.; Pan, Baihong; Mesar, Tomaz; Dennahy, Isabel S.; Georgoff, Patrick E.; Duan, Xiuzhen; Liu, Baoling; Wu, Xizi; Duggan, Michael J.; Alam, Hasan B.; Li, Yongqing			Lung Protective Effects of Low-Volume Resuscitation and Pharmacologic Treatment of Swine Subjected to Polytrauma and Hemorrhagic Shock	INFLAMMATION			English	Article						hemorrhagic shock; valproic acid; hypertonic saline; resuscitation; acute lung injury; inflammation	TRAUMATIC BRAIN-INJURY; FLUID RESUSCITATION; VALPROIC ACID; MODEL; COAGULOPATHY; TRANSFUSION; ACETYLATION; MECHANISMS; CAVEOLIN-1; HUMANS	Hemorrhage is a common cause of death in the battlefield. Valproic acid (VPA) has been associated with improved outcomes in multiple models of trauma, when combined with isotonic fluid resuscitation. However, isotonic fluid administered in this setting is logistically impractical and may be associated with complications. In this study, we sought to evaluate the feasibility and immunologic impact of combining VPA treatment with low-volume hypertonic saline (HTS). In vivo: female Yorkshire swine were subjected to hemorrhage (40% total blood volume) and polytrauma (rib fracture and delayed liver injury). Animals were kept in shock for 30 minutes and resuscitated with (1) normal saline (NS, 3x hemorrhaged volume), (2) HTS (7.5% saline, 4 mL/kg), or (3) HTS + VPA (4 mg/kg; 150 mg/kg; n = 3/cohort). After 18 hours of observation, animals were euthanized and the lungs evaluated for acute injury and expression of myeloperoxidase (MPO) and caveolin-1 (Cav-1). In vitro: human umbilical vein endothelial cells (HUVECs) were exposed to anoxic conditions (5% CO2, 95% N-2) for 16 hours in (1) normosmotic, (2) hyperosmotic (400 mOsm), or (3) hyperosmotic + VPA (4 mM) media. Immunohistochemistry and Western blots were performed to determine Cav-1 expression. Lungs from VPA-treated animals demonstrated decreased acute injury, MPO expression, and endothelial expression of Cav-1 when compared to lungs from animals resuscitated with NS or HTS alone. Similarly, HUVECs cultured in hyperosmotic media containing VPA demonstrated decreased expression of Cav-1. This study demonstrates that combined treatment with VPA and HTS is a viable strategy in hemorrhagic shock and polytrauma. Attenuation of lung injury following VPA treatment may be related to modulation of the inflammatory response.	[Nikolian, Vahagn C.; Pan, Baihong; Dennahy, Isabel S.; Georgoff, Patrick E.; Liu, Baoling; Alam, Hasan B.; Li, Yongqing] Univ Michigan Hlth Syst, Dept Surg, NCRC Bldg 26 Room 363N,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Pan, Baihong] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Mesar, Tomaz; Duggan, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA USA; [Duan, Xiuzhen] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [Wu, Xizi] China Med Univ, Hosp 1, Emergency Dept, Shenyang, Peoples R China		Li, YQ (corresponding author), Univ Michigan Hlth Syst, Dept Surg, NCRC Bldg 26 Room 363N,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	yqli@med.umich.edu		Dennahy, Isabel/0000-0002-4778-8910	Department of DefenseUnited States Department of Defense [W81XWH-09-2-0001]	This work was funded by a grant from Department of Defense W81XWH-09-2-0001to YL. Designed study: HBA, YL; performed research: BP, XD, BL; collected data: BP, TM, MJD; analyzed data: BP, PEG, XD; wrote paper: VCN, BP, ISD; revised manuscript: VCN, BP, XW, YL.	Alam HB, 2011, J TRAUMA, V70, P636, DOI 10.1097/TA.0b013e31820d0dcc; Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Balogh ZJ, 2014, LANCET, V384, P1466, DOI 10.1016/S0140-6736(14)61689-5; Bambakidis T., 2016, J NEUROTRAUMA; Bento-Abreu A, 2009, J NEUROCHEM, V111, P49, DOI 10.1111/j.1471-4159.2009.06304.x; Bogert JN, 2016, J INTENSIVE CARE MED, V31, P177, DOI 10.1177/0885066614558018; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger Eileen M, 2012, Adv Surg, V46, P73; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Champion HR, 2003, J TRAUMA, V54, pS7, DOI 10.1097/01.TA.0000056154.34788.C6; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; Findlay LJ, 2015, THER CLIN RISK MANAG, V11, P75, DOI 10.2147/TCRM.S57695; Georgoff P., 2016, J TRAUMA ACUTE CARE; Gerhordt R. T., 2012, CAPT U FUNDAMENTALS, V9, P85; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Lennartsson A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0043-3; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Liu ZC, 2013, J TRAUMA ACUTE CARE, V74, P991, DOI 10.1097/TA.0b013e31828583e3; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Neal MD, 2014, ANN SURG, V260, P378, DOI 10.1097/SLA.0000000000000526; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Park PK, 2013, J TRAUMA ACUTE CARE, V75, pS238, DOI 10.1097/TA.0b013e31829a8c71; Rasmussen Todd E, 2015, J Trauma Acute Care Surg, V79, pS61, DOI 10.1097/TA.0000000000000795; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Sailhamer EA, 2008, SURGERY, V144, P204, DOI 10.1016/j.surg.2008.03.034; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yang YY, 2015, SUSTAINABILITY-BASEL, V7, P1, DOI 10.3390/su7010001	40	3	5	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	AUG	2017	40	4					1264	1274		10.1007/s10753-017-0569-6			11	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	EZ4DL	WOS:000404661800015	28493077				2022-02-06	
J	Rabiu, TB; Adetunmbi, B				Rabiu, Taopheeq Bamidele; Adetunmbi, Babatunde			Posttraumatic Seizures in a Rural Nigerian Neurosurgical Service	WORLD NEUROSURGERY			English	Article						Posttraumatic epilepsy; Posttraumatic seizures; Rural neurosurgery; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; RISK-FACTORS; EPILEPSY; CHILDREN; MULTICENTER; MANAGEMENT; ADULTS	BACKGROUND: Traumatic brain injury (TBI) is a recognized risk factor for seizures. In Nigeria, there is paucity of literature on posttraumatic seizure (PTS). This study provides the profile and pattern of PTS in patients with TBI in a rural Nigerian neurosurgical service. METHODS: A prospective observational study of patients with TBI was performed. Clinical and radiological data including outcomes of care were analyzed with SPSS version 15. A P value of < 0.05 was considered statistically significant. RESULTS: A total of 199 patients were managed for TBI. There were 20 (10.1%) cases of PTS. Mean age was 28.4 years (range: 5-80 years) and most were male (n = 16; 80%). The average admission Glasgow Coma Scale score was 10 (range: 3-15). Of the 20 patients with PTS, 10 (50%) had mild head injury whereas 3 (15%) and 7 (35%) had moderate and severe head injuries, respectively. PTS peaked in young patients aged 17e45 years (n = 14, 70%). Fourteen (n = 14, 70%) had immediate PTS, whereas 6 (30%) had early PTS. Increasing severity of head injury resulted in a greater incidence of PTS (7.8%, 10.3%, and 17.1% for mild, moderate, and severe head injuries, respectively). Findings of acute subdural hematoma and contusions on computed tomography scan are significant risk factors for PTS (c 2: 22.8; P value: 0.0004). Five (25%) patients required anticonvulsant therapy because of seizure recurrence, but only one progressed to late PTS. Four (20.0%) died, whereas the rest had good outcome. CONCLUSIONS: Severe TBI and computed tomography findings of acute subdural hematoma and cerebral contusions are predictors of PTS in our environment. Progression of immediate/early to late PTS is rare.	[Rabiu, Taopheeq Bamidele; Adetunmbi, Babatunde] Fed Teaching Hosp, Dept Surg, Div Neurol Surg, Ido Ekiti, Nigeria; [Rabiu, Taopheeq Bamidele] Lautech Teaching Hosp, Dept Surg, Div Neurol Surg, Osogbo, Nigeria		Rabiu, TB (corresponding author), Fed Teaching Hosp, Dept Surg, Div Neurol Surg, Ido Ekiti, Nigeria.; Rabiu, TB (corresponding author), Lautech Teaching Hosp, Dept Surg, Div Neurol Surg, Osogbo, Nigeria.	eshohealth@gmail.com					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bhattacharyya Kalishankar, 2014, J Indian Med Assoc, V112, P93; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Csepregi Gyula, 2007, Orvosi Hetilap, V148, P771, DOI 10.1556/OH.2007.27879; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; De Santis A, 1979, J Neurosurg Sci, V23, P207; Emejulu J. K. C., 2008, East and Central African Journal of Surgery, V13, P86; Emejulu JK, 2009, J CLIN MED RES, V1, P13; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hillbom E., 1959, ACTA PSYCHIAT NEUROL, V34, P7; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Hup CK, 2010, MALAYS J MED SCI, V17, P36; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mandal K, 2001, CHILD NERV SYST, V17, P670, DOI 10.1007/s00381-001-0520-9; Odebode OT, 2008, NIGER J CLIN PRACT, V11, P193; Oluwole OSA, 2011, BRAIN INJURY, V25, P980, DOI 10.3109/02699052.2011.589798; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077	32	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						367	371		10.1016/j.wneu.2017.04.133			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100050	28461273				2022-02-06	
J	Reed, N; Taha, T; Greenwald, R; Keightley, M				Reed, Nick; Taha, Tim; Greenwald, Richard; Keightley, Michelle			Player and Game Characteristics and Head Impacts in Female Youth Ice Hockey Players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; mild traumatic brain injuries; adolescents; helmets; sports injuries	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; RISK; MECHANISMS; EXPOSURE; SYSTEM	Context: Despite the growing popularity of ice hockey among female youth and interest in the biomechanics of head impacts in sport, the head impacts sustained by this population have yet to be characterized. Objectives: To describe the number of, biomechanical characteristics of, and exposure to head impacts of female youth ice hockey players during competition and to investigate the influences of player and game characteristics on head impacts. Design: Cohort study. Methods: Twenty-seven female youth ice hockey players (mean age = 12.5 +/- 0.52 years) wore instrumented ice hockey helmets during 66 ice hockey games over a 3-year period. Data specific to player, game, and biomechanical head impact characteristics were recorded. A multiple regression analysis identified factors most associated with head impacts of greater frequency and severity. Results: A total of 436 total head impacts were sustained during 6924 minutes of active ice hockey participation (0.9 +/- 0.6 impacts per player per game; range, 0-2.1). A higher body mass index (BMI) significantly predicted a higher number of head impacts sustained per game (P = .008). Linear acceleration of head impacts was greater in older players and those who played the forward position, had a greater BMI, and spent more time on the ice (P = .008), whereas greater rotational acceleration was present in older players who had a greater BMI and played the forward position (P = .008). During tournament games, increased ice time predicted increased severity of head impacts (P = .03). Conclusions: This study reveals for the first time that head impacts are occurring in female youth ice hockey players, albeit at a lower rate and severity than in male youth ice hockey players, despite the lack of intentional body checking.	[Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Reed, Nick; Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada; [Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Greenwald, Richard] Simbex, Lebanon, NH USA; [Greenwald, Richard] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	nreed@hollandbloorview.ca			Ontario Neurotrauma Foundation	The study was financially supported by the Ontario Neurotrauma Foundation (Dr Keightley). We thank Stephanie Green, Jennifer McBrearty, Danielle Plante, Eva Wu, Cindy Lee, Alexandra Bhatnagar, Jessica Galbraith, and Joni Miller for their assistance with data collection and analysis and Katherine Wilson at the Bloorview Research Institute for all of the efforts put forth.	Agel J, 2007, J ATHL TRAINING, V42, P249; [Anonymous], 2010, R LANG ENV STAT COMP; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cubos J, 2009, J ASTM INT, V6, P1; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Montelpare W, 2007, MULTIDISCIPLINARY AP; Montelpare W. J., 2007, INT J SPORTS SCI ENG, V1, P183; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wattie N, 2010, CLIN J SPORT MED, V20, P113, DOI 10.1097/JSM.0b013e3181d2de78; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	27	3	3	1	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2017	52	8					771	775		10.4085/1062-6050-52.5.04			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FF5ZN	WOS:000409081500007	28715282	Green Published, Bronze			2022-02-06	
J	Singh, BK; Dutta, A; Ahmed, S; Hussain, Z; Hazarika, R; Singh, B				Singh, Binoy Kumar; Dutta, Abinash; Ahmed, Shameem; Hussain, Zakir; Hazarika, Rajib; Singh, Bineta			Traumatic cerrebral fungus: Experience from an institution in North East India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						External ventricular drain; Glasgow coma score; Glasgow outcome score; meningitis; traumatic brain fungus		Background: Traumatic brain fungus is manifestation of neglected head injury. Although rare it is not uncommon. The patients are usually intact with good Glasgow coma (GCS) score inspite of complex injuries and exposed brain parenchyma but morbidity and mortality is very high with time if no proper and timely management is offered. There is very less study on traumatic brain fungus with no defined management protocols. So an attempt was made to explain in details the surgical strategies and other management techniques in patients with traumatic brain fungus. Aims: To study and evaluate the pattern of causation, clinical presentations, modalities of management of traumatic brain fungus and outcome after treatment. Methods: All patients with fungus cerebri, admitted to our centre from January 2012 to December 2015 were studied prospectively. All the patients were examined clinically and triaged urgently for surgery. CT head was done in all patients to look for any brain parenchymal injury. All patients were managed surgically. Outcome was assessed as per the Glassgow Outcome Score. Results: Total 10 patients were included in the study. 8 were men and 2 women. The patients' ages ranged from 3-48 years (mean 31.6 years). The interval between initial injury and protrusion ranged from 3 days to 6 days (mean 4.1 days). Mean GCS at the time of presentation was 13.2.60% of the patients (n = 6) sustained moderate head injury. (GCS-9-13). Size of the fungus ranged from 5cmx3cm to 8cmx10cm. Conclusion: Early and proper local wound treatment prevents fungus formation. Pre-emptive antibiotics, AEDs and cerebral decongestants are recommended. Loose water-tight duroplasty prevents CSF leak. But mortality and morbidity can be reduced significantly if brain fungus is managed properly by applying basic surgical principles and antibiotic protocols combined with newer surgical modalities.	[Singh, Binoy Kumar] Paras Hosp, Dept Neurosurg, Gurgaon, Haryana, India; [Dutta, Abinash; Hussain, Zakir; Hazarika, Rajib] Gauhati Med Coll & Hosp, Dept Neurosurg, Gauhati, Assam, India; [Ahmed, Shameem; Singh, Bineta] Apollo Int Hosp, Gauhati, Assam, India		Singh, BK (corresponding author), Paras Hosp, Gurgaon, Haryana, India.	drbinoysingh@yahoo.com					[Anonymous], 2001, J TRAUMA, V51, pS29; [Anonymous], 2001, J TRAUMA, V51, pS34; [Anonymous], 2001, J TRAUMA, V51, pS3; [Anonymous], 2001, J TRAUMA, V51, pS16; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; O Connell JEA, 1943, BRIT J SURG, V30, P201, DOI 10.1002/bjs.18003011905	6	3	3	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	AUG	2017	8			1			37	43		10.4103/jnrp.jnrp_10_17			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FE9OJ	WOS:000408532700010	28936070	gold, Green Published			2022-02-06	
J	Zavialova, MG; Shevchenko, VE; Nikolaev, EN; Zgoda, VG				Zavialova, M. G.; Shevchenko, V. E.; Nikolaev, E. N.; Zgoda, V. G.			Is myelin basic protein a potential biomarker of brain cancer?	EUROPEAN JOURNAL OF MASS SPECTROMETRY			English	Article; Proceedings Paper	2nd International Conference on Innovations in Mass Spectrometry - Instrumentation and Methods (INNMS)	NOV 07-11, 2016	Moscow, RUSSIA	Skolkovo Inst Sci & Technol, State Univ, Moscow Inst Phys & Technol, Natl Res Nucl Univ MEPHI, Russian Acad Sci, V I Talroze Inst Energy Problems Chem Phys, Russian Acad Sci, V N Orekhovich Inst Biomed Chem		Proteomics; pseudo-selected reaction monitoring; brain cancer; cerebral spinal fluid; myelin basic protein	CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; QUANTITATIVE PROTEOMICS; IDENTIFICATION; SAMPLES; DAMAGE	Myelin basic protein is a potential biomarker for the central nervous system diseases in which the myelin sheath is destroyed. Using pseudo-selected reaction monitoring and the method of standard additions, we have measured the myelin basic protein level in the cerebrospinal fluid of patients with neurotrauma (n = 6), chronic neurodegenerative diseases (n = 2) and brain cancer (n = 5). Myelin basic protein was detected only in four out of five cerebrospinal fluid samples of patients with brain cancer. The cerebrospinal fluid myelin basic protein level ranged from 3.7 to 8.8 ng ml(-1). We suggest that monitoring of myelin basic protein in cerebrospinal fluid can serve as a diagnostic test for the brain cancer.	[Zavialova, M. G.; Nikolaev, E. N.; Zgoda, V. G.] Inst Biomed Chem IBMC, Moscow, Russia; [Shevchenko, V. E.] Blokhin Russian Canc Res Ctr, Moscow, Russia; [Nikolaev, E. N.] Skolkovo Inst Sci & Technol Skoltech, Skolkovo, Russia		Zavialova, MG (corresponding author), Nauchno Issledovatelskiy Inst Biomed Khimii VN Or, Pogodinskaya Ulitsa 10, Moscow 119121, Russia.	mariag.zavyalova@gmail.com	Shevchenko, Valery/AAC-2033-2020; Zgoda, Victor G/F-1791-2017; Zavialova, Maria G./F-1635-2017	Zgoda, Victor G/0000-0002-4532-4274; Zavialova, Maria G./0000-0003-0761-2299	Russian Scientific FoundationRussian Science Foundation (RSF) [16-44-03007]; Russian Science FoundationRussian Science Foundation (RSF) [16-44-03007] Funding Source: Russian Science Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work is supported by the Russian Scientific Foundation grant no. 16-44-03007.	Begcevic I, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9111-3; Bjerke M, 2014, DEMENT GER COGN D EX, V4, P385, DOI 10.1159/000366119; Burman J, 2014, ACTA NEUROL SCAND, V130, P81, DOI 10.1111/ane.12239; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Chen S, 2012, NEUROCHEM RES, V37, P2805, DOI 10.1007/s11064-012-0874-2; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Fitzner B, 2015, AUTOIMMUN REV, V14, P903, DOI 10.1016/j.autrev.2015.06.001; Gallien S, 2015, EXPERT REV PROTEOMIC, V12, P489, DOI 10.1586/14789450.2015.1069188; Golfinos JG, 1997, CLIN CANCER RES, V3, P799; Greene DN, 2012, AM J CLIN PATHOL, V138, P262, DOI 10.1309/AJCPCYCH96QYPHJM; Guldbrandsen A, 2014, MOL CELL PROTEOMICS, V13, P3152, DOI 10.1074/mcp.M114.038554; Hjalmarsson C, 2014, J CENT NERV SYST DIS, V6, P51, DOI 10.4137/JCNSD.S13821; Kopylov A. T., 2007, Biomeditsinskaya Khimiya, V53, P613; Kopylov AT, 2016, J PROTEOME RES, V15, P4039, DOI 10.1021/acs.jproteome.6b00384; Law KP, 2013, EXPERT REV PROTEOMIC, V10, P551, DOI 10.1586/14789450.2013.858022; Ly L, 2011, J PROTEOME RES, V10, P4855, DOI 10.1021/pr200672n; Martinez-Morillo E, 2014, J PROTEOME RES, V13, P969, DOI 10.1021/pr401111h; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P1176, DOI 10.1016/j.jpsychires.2010.04.014; NAKAGAWA H, 1994, NEUROSURGERY, V34, P825, DOI 10.1227/00006123-199405000-00006; Ostrom QT, 2016, NEURO-ONCOLOGY, V18, P1, DOI 10.1093/neuonc/nov297; Percy AJ, 2014, J PROTEOME RES, V13, P3733, DOI 10.1021/pr500317d; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Sherrod SD, 2012, J PROTEOME RES, V11, P3467, DOI 10.1021/pr201240a; Xu BH, 2016, EXP GERONTOL, V73, P31, DOI 10.1016/j.exger.2015.11.016; Zavialova M. G., 2014, Biomeditsinskaya Khimiya, V60, P668	26	3	3	0	78	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1469-0667	1751-6838		EUR J MASS SPECTROM	Eur. J. Mass Spectrom.	AUG	2017	23	4					192	196		10.1177/1469066717719810			5	Physics, Atomic, Molecular & Chemical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Physics; Spectroscopy	FD7QO	WOS:000407720800013	29028399				2022-02-06	
J	Zhang, SG; Qian, CF; Sun, G; Li, XL				Zhang, Shuguang; Qian, Chunfa; Sun, Guan; Li, Xiaoliang			Clinical application of the supraorbital key-hole approach to the treatment of unilateral-dominant bilateral frontal contusions	ONCOTARGET			English	Article						key-hole approach; bilateral frontal contusion; craniotomy	BIFRONTAL DECOMPRESSIVE CRANIOTOMY; TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; SURGICAL-TREATMENT; MANAGEMENT	We compared the surgical efficacy of the supraorbital key-hole approach (SKA) to conventional unilateral frontotemporal craniotomy (UFTC) for the treatment of patients with unilateral-dominant bilateral frontal contusions (BFCs). A retrospective analysis of 62 patients with unilateral-dominant BFCs who underwent surgery at our institute between 2014 and 2017 was performed. There were 26 patients who underwent SKA (group A) and 36 who underwent UFTC (group B). Postoperative computed tomography scans showed satisfactory evacuation of the frontal cerebral contusions in both groups (p > 0.05). There was less intraoperative blood loss in group A than group B (17.1 +/- 4.55 vs. 67.6 +/- 10.28 mL, p < 0.05). The operative time was also shorter in group A (82.7 +/- 13.73 vs. 132.4 +/- 9.17 min, p < 0.05). Postoperative bleeding occurred in three cases in group A and in only one case in group B (p > 0.05). The average length of hospitalization was shorter in group A than group B (7.3 +/- 1.09 vs. 12.9 +/- 1.71 days, p < 0.05). No differences in the Glasgow Outcome Scale were observed between the two groups after 6 months of follow-up (p > 0.05). Thus, compared to UFTC, SKA is associated with shorter operation times and less trauma to the surrounding brain tissue.	[Zhang, Shuguang; Li, Xiaoliang] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Qian, Chunfa] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Sun, Guan] Nantong Univ, Affiliated Yancheng Hosp 4, Dept Neurosurg, Yancheng, Peoples R China		Qian, CF (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	qianchunfa@126.com	qian, chunfa/AAX-6075-2021		China Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81370062, 81000963, 81201976]; Jiangsu Province's 333 Talent Program [BRA2011046]; Six Talents Peak Project in Jiangsu Province [WSN146]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK2012670]; Medical Research Foundation by Jiangsu Province Health Department [YG201301, Z201215, Z201318]; Clinical Technology Development of Jiangsu University [JLY20120053]; Brain Clinic and Basic Research Team Program of the First People's Hospital of Kunshan [KYC004]	This work was supported by the China Natural Science Foundation (81370062, 81000963, and 81201976), Jiangsu Province's 333 Talent Program (BRA2011046), the Six Talents Peak Project in Jiangsu Province (WSN146), Jiangsu Province's Natural Science Foundation (BK2012670), the Medical Research Foundation by Jiangsu Province Health Department (YG201301, Z201215, and Z201318), the Clinical Technology Development of Jiangsu University (JLY20120053), and the Brain Clinic and Basic Research Team Program of the First People's Hospital of Kunshan (KYC004).	Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Dong JR, 2012, J CRANIOFAC SURG, V23, P1819, DOI 10.1097/SCS.0b013e318271042e; Dong JR, 2010, CHIN J TRAUMATOL, V13, P51, DOI 10.3760/cma.j.issn.1008-1275.2010.01.010; Elwatidy S, 2006, SAUDI MED J, V27, P1547; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Gupta DK, 2016, NEUROL INDIA, V64, P259, DOI 10.4103/0028-3886.177617; Iacoangeli M, 2016, NEUROL MED-CHIR, V56, P180, DOI 10.2176/nmc.oa.2015-0242; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Magnone S, 2016, ULUS TRAVMA ACIL CER, V22, P242, DOI 10.5505/tjtes.2015.19540; PEREIRA WC, 1977, ARQ NEURO-PSIQUIAT, V35, P99, DOI 10.1590/S0004-282X1977000200002; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Reisch R, 2009, MINIM INVAS NEUROSUR, V52, P163, DOI 10.1055/s-0029-1238285; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Wu H, 2014, J CRANIOFAC SURG, V25, P2105, DOI 10.1097/SCS.0000000000001050	15	3	3	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	JUL 18	2017	8	29					48343	48349		10.18632/oncotarget.15983			7	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FA8KD	WOS:000405694000136	28415664	Green Submitted, Green Published, gold			2022-02-06	
J	Badenhorst, M; Verhagen, EALM; van Mechelen, W; Lambert, MI; Viljoen, W; Readhead, C; Baerecke, G; Brown, JC				Badenhorst, Marelise; Verhagen, Evert A. L. M.; van Mechelen, Willem; Lambert, Michael I.; Viljoen, Wayne; Readhead, Clint; Baerecke, Gail; Brown, James C.			A comparison of catastrophic injury incidence rates by Provincial Rugby Union in South Africa	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Football; Spinal cord injuries; Brain injuries; Prospective studies	SPINAL-CORD INJURIES; CERVICAL-SPINE; SPORT; PREVENTION; BOKSMART; PROGRAM; SAFETY; RISK	Objectives: To compare catastrophic injury rates between the 14 South African Provincial Rugby Unions. Design: A prospective, population-based study conducted among all South African Unions between 2008-2014. Methods: Player numbers in each Union were obtained from South African Rugby's 2013 Census. Catastrophic injuries were analysed from BokSmart's serious injury database. Incidence rates with 95% Confidence Intervals were calculated. Catastrophic injuries (Acute Spinal Cord Injuries and catastrophic Traumatic Brain Injuries) within Unions were compared statistically, using a Poisson regression with Incidence Rate Ratios (IRR) and a 95% confidence level (p < 0.05). Results: Catastrophic injury incidence rates per Union ranged from 1.8 per 100 000 players (95% CI: 0.0-6.5) to 7.9 (95% CI: 0.0-28.5) per 100000 players per year. The highest incidence rate of permanent outcome Acute Spinal Cord Injuries was reported at 7.1 per 100000 players (95% CI: 0.0-17.6). Compared to this Union, five (n = 5/14,36%) of the Unions had significantly lower incidence rates of Acute Spinal Cord Injuries. Proportionately, three Unions had more Acute Spinal Cord Injuries and three other Unions had more catastrophic Traumatic Brain Injuries. Conclusions: There were significant differences in the catastrophic injury incidence rates amongst the Provincial Unions in South Africa. Future studies should investigate the underlying reasons contributing to these provincial differences. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Badenhorst, Marelise; Verhagen, Evert A. L. M.; van Mechelen, Willem; Lambert, Michael I.; Viljoen, Wayne; Readhead, Clint; Brown, James C.] UCT, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Badenhorst, Marelise; Verhagen, Evert A. L. M.; van Mechelen, Willem; Lambert, Michael I.; Brown, James C.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam Collaborat Hlth & Safety Sports, Amsterdam, Netherlands; [Badenhorst, Marelise; Verhagen, Evert A. L. M.; van Mechelen, Willem; Lambert, Michael I.; Brown, James C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Viljoen, Wayne; Readhead, Clint] South African Rugby Union SA Rugby, Cape Town, South Africa; [Baerecke, Gail] Chris Burger Petro Jackson Players Fund, Cape Town, South Africa		Badenhorst, M (corresponding author), UCT, Fac Hlth Sci, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa.; Badenhorst, M (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam Collaborat Hlth & Safety Sports, Amsterdam, Netherlands.; Badenhorst, M (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands.	marelise@physiomb.co.za	Brown, James Craig/H-7637-2019; Verhagen, Evert/A-1502-2013	Brown, James Craig/0000-0002-7778-7783; Verhagen, Evert/0000-0001-9227-8234; Viljoen, Wayne/0000-0002-9432-6153; Badenhorst, Marelise/0000-0001-8443-9173; van Mechelen, Willem/0000-0001-7136-6382	Vrije Universiteit Amsterdam/NRF South Africa Desmond Tutu Doctoral Scholarship; Oppenheimer Memorial Trust	The authors would like to thank the Chris Burger/Petro Jackson Players Fund (CBPJPF) and BokSmart for granting access to the data presented in this study. Special thanks to Ms Gail Baerecke, the Serious Injury Case Manager of the Chris Burger/Petro Jackson Players Fund, for the collection of the information that has been presented in this study. MB's PhD is funded by the Vrije Universiteit Amsterdam/NRF South Africa Desmond Tutu Doctoral Scholarship, administered through SAVUSA, and the Oppenheimer Memorial Trust.	Banerjee R, 2004, AM J SPORT MED, V32, P1760, DOI 10.1177/0363546504268931; Brown J., 2011, S AFR J SPORTS MED, V23, P149; Brown JC, 2016, SCAND J MED SCI SPOR, V2015, P1; Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384; Carmody DJ, 2005, MED J AUSTRALIA, V182, P561, DOI 10.5694/j.1326-5377.2005.tb06814.x; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Fuller CW, 2008, SPORT MED, V38, P975; Green M., 2013, SARU DEV SURVEY; Hermanus FJ, 2010, SAMJ S AFR MED J, V100, P230, DOI 10.7196/SAMJ.4061; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Noakes TD, 2007, BMJ-BRIT MED J, V334, P1122, DOI 10.1136/bmj.39156.483634.80; Patricios J, 2014, CURR SPORT MED REP, V13, P142, DOI 10.1249/JSR.0000000000000049; Patricios JS, 2014, CURR SPORT MED REP, V13, P326, DOI 10.1249/JSR.0000000000000086; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Secin FP, 1999, BRIT J SPORT MED, V33, P33, DOI 10.1136/bjsm.33.1.33; Shelly MJ, 2006, J BONE JOINT SURG BR, V88B, P771, DOI 10.1302/0301-620X.88B6; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Verhagen EALM, 2010, BRIT J SPORT MED, V44, P158, DOI 10.1136/bjsm.2009.066316; Verhagen E, 2011, BRIT J SPORT MED, V45, P1015, DOI 10.1136/bjsports-2011-090485; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	22	3	3	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUL	2017	20	7					643	647		10.1016/j.jsams.2017.01.232			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FA2FI	WOS:000405255800007	28173970				2022-02-06	
J	Chang, FH; Chen, CY; Liang, WM; Lin, MR				Chang, Feng-Hang; Chen, Chih-Yi; Liang, Wen-Miin; Lin, Mau-Roung			Validating the Quality of Life After Brain Injury Through Rasch Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; outcome measurement; psychometrics; quality of life; Rasch analysis	HEALTH; QUESTIONNAIRE; INDIVIDUALS; QOLIBRI; TAIWAN; SCALE	Objective: The Quality of Life after Brain Injury (QOLIBRI), a cross-cultural instrument, has been validated in several languages; however, traditional psychometric approaches have critical limitations. Therefore, we applied the Rasch model for validating the 37-item QOLIBRI scale among a Chinese population with traumatic brain injury. Participants and Setting: In total, 587 participants (mean age: 44.2 +/- 15.4 years; women, 46.3%) were surveyed in neurosurgery departments at 6 hospitals in Taipei, Taiwan. Main Outcome Measure: The QOLIBRI. Results: Of the 6 subscales of the QOLIBRI, 4 (cognition, self, daily life and autonomy, and social relationships) were unidimensional, valid, and reliable, whereas the remaining 2 (emotions and physical problems) exhibited poor unidimensionality, item and person reliability, and person-item targeting. Five items (energy, concentrating, getting out and about, sex life, and achievements) showed considerable differential item functioning among age groups, disability levels, and time since traumatic brain injury. Conclusion: According to item response theory, we identified psychometric issues in the emotions and physical problems subscales of the QOLIBRI as well as several differential item functioning items. Future research is required to determine whether similar results are observed in other language versions of the QOLIBRI or in other countries.	[Chang, Feng-Hang; Chen, Chih-Yi; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan; [Lin, Mau-Roung] Taipei Med Univ, Master Program Long Term Care, Taipei, Taiwan; [Liang, Wen-Miin] China Med Univ, Grad Inst Biostat, Taichung, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw			National Health Research InstitutesNational Health Research Institutes, JapanNational Health Research Institutes - Taiwan [NHRI-EX104-10317PI]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST103-2314-B-038-012-MY3, MOST104-2627-M-038-001]	This study has not previously been presented in any form. This study was funded by the National Health Research Institutes (NHRI-EX104-10317PI) and the Ministry of Science and Technology (MOST103-2314-B-038-012-MY3 and MOST104-2627-M-038-001), Taiwan.	Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Boone W, 2014, RASCH ANAL HUMAN SCI; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullinger M, 2005, ACTA NEUROCHIR S, V93, P69; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Faul M, 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fisher Jr WP, 2007, RASCH MEAS TRANS, V21, P1095, DOI DOI 10.1111/J.1600-0528.2012.00694.X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Linacre JM., 2015, WINSTEPS RASCH MEASU; Linacre John M, 2002, J Appl Meas, V3, P85; MAHONEY F I, 1965, Md State Med J, V14, P61; Mallinson T, 2004, MED CARE, V42, P17, DOI 10.1097/01.mlr.0000103522.78233.c3; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Taylor A, 2011, AGE AGEING, V40, P538, DOI 10.1093/ageing/afr049; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; [No title captured]	35	3	3	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					E11	E18		10.1097/HTR.0000000000000258			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200002	28489697				2022-02-06	
J	Cho, JH; Kim, JW; Park, HW; Suh, JD; Kim, JK; Yoon, JH				Cho, Jae Hoon; Kim, Jin Won; Park, Hyoung Woo; Suh, Jeffrey D.; Kim, Jin Kook; Yoon, Joo-Heon			Arterial supply of the human soft palate	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Soft palate; Uvula; Arterial supply; Ascending palatine artery	OBSTRUCTIVE SLEEP-APNEA; ANATOMY	Palatal surgery for snoring or obstructive sleep apnea is commonly performed; however, the vascular anatomy of the soft palate is not well described. The purpose of this study was to evaluate the vascular anatomy of the soft palate. This study was performed on 22 adult cadaveric heads. All specimens were prepared with vascular injections using red liquid silicone through the common carotid artery. The palate was then harvested and decolorized, and the vascular anatomy was studied. Of 22 specimens, 20 had sufficient uptake of the silicone dye. The anterior and posterior branches of the ascending palatine artery were the main feeding vessels of the soft palate; however, they were not always present simultaneously. The anterior branch alone was identified 25% of the time (5/20), while the posterior branch alone was found in 35% (7/20) of specimens. Both anterior and posterior branches were simultaneously present in 40% (8/20) of cases. Mean diameter of the anterior branch (0.73 +/- 0.09 mm) was significantly greater than that of the posterior branch (0.48 +/- 0.08 mm, p < 0.001). Mean vertical distance from the palatal arch to the posterior branch was 9.3 +/- 2.4 mm. The soft palate is supplied by the anterior and posterior branches of the ascending palatine artery; however, the arteries were not always present simultaneously. In cases where the anterior branch is absent and the posterior branches terminate close to the uvula, injury to the primary blood supply to the palate might occur more frequently during surgery.	[Cho, Jae Hoon; Kim, Jin Kook] Konkuk Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Kim, Jin Won; Yoon, Joo-Heon] Yonsei Univ, Dept Otorhinolaryngol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea; [Park, Hyoung Woo] Yonsei Univ, Dept Anat, Coll Med, Seoul, South Korea; [Suh, Jeffrey D.] UCLA Sch Med, Dept Head & Neck Surg, Los Angeles, CA USA; [Yoon, Joo-Heon] Yonsei Univ, Airway Mucus Inst, Coll Med, Seoul, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Project Med Sci BK21, Coll Med, Seoul, South Korea		Yoon, JH (corresponding author), Yonsei Univ, Dept Otorhinolaryngol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.; Yoon, JH (corresponding author), Yonsei Univ, Airway Mucus Inst, Coll Med, Seoul, South Korea.; Yoon, JH (corresponding author), Yonsei Univ, Project Med Sci BK21, Coll Med, Seoul, South Korea.	jhyoon@yuhs.ac		Park, Hyoung Woo Park/0000-0002-5341-9249			Azagra-Calero E, 2012, MED ORAL PATOL ORAL, V17, pE925, DOI 10.4317/medoral.17706; Caples SM, 2010, SLEEP, V33, P1396, DOI 10.1093/sleep/33.10.1396; Cho JH, 2013, LARYNGOSCOPE, V123, P2900, DOI 10.1002/lary.24067; Han DM, 2002, LARYNGOSCOPE, V112, P2081, DOI 10.1097/00005537-200211000-00032; Huang MHS, 1998, PLAST RECONSTR SURG, V102, P655, DOI 10.1097/00006534-199809030-00007; Lee CH, 2012, LARYNGOSCOPE, V122, P237, DOI 10.1002/lary.22344; Maistry T, 2012, INT J MORPHOL, V30, P847, DOI 10.4067/S0717-95022012000300014; MERCER NSG, 1995, PLAST RECONSTR SURG, V96, P1038, DOI 10.1097/00006534-199510000-00005; Owens RL, 2008, CURR OPIN PULM MED, V14, P519, DOI 10.1097/MCP.0b013e3283130f66; Powers DB, 2010, MIL MED, V175, P676, DOI 10.7205/MILMED-D-10-00132; Rama AN, 2002, CHEST, V122, P1139, DOI 10.1378/chest.122.4.1139; Shiozaki K, 2013, BIOTECH HISTOCHEM, V88, P290, DOI 10.3109/10520295.2013.773379; Valbuza JS, 2010, SLEEP BREATH, V14, P299, DOI 10.1007/s11325-010-0377-9; Zunon-Kipre Y, 2012, SURG RADIOL ANAT, V34, P15, DOI 10.1007/s00276-011-0888-5	14	3	3	0	1	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	JUL	2017	39	7					731	734		10.1007/s00276-016-1798-3			4	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	EY8AN	WOS:000404215500005	28138793				2022-02-06	
J	Cline, MM; Ostlie, MA; Cross, CG; Garwin, GG; Minoshima, S; Cross, DJ				Cline, Marcella M.; Ostlie, Megan A.; Cross, Chloe G.; Garwin, Gregory G.; Minoshima, Satoshi; Cross, Donna J.			Assessing Spatial Memory Impairment in a Mouse Model of Traumatic Brain Injury Using a Radial Water Tread Maze	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 125; Traumatic brain injury; cognitive testing; behavioral testing; water maze; controlled-cortical impact; Neuroscience; mouse model; mice	MICE; DEFICITS	Despite the recent increase in use of mouse models in scientific research, researchers continue to use cognitive tasks that were originally designed and validated for rat use. The Radial Water Tread (RWT) maze test of spatial memory (designed specifically for mice and requiring no swimming) has been shown previously to successfully distinguish between controlled cortical impact-induced TBI mice and sham controls. Here, a detailed protocol for this task is presented. The RWT maze capitalizes on the natural tendency of mice to avoid open areas in favor of hugging the sides of an apparatus (thigmotaxis). The walls of the maze are lined with nine escape holes placed above the floor of the apparatus, and mice are trained to use visual cues to locate the escape hole that leads out of the maze. The maze is filled with an inch of cold water, sufficient to motivate escape but not deep enough to require that the mouse swim. The acquisition period takes only four training days, with a test of memory retention on day five and a long-term memory test on day 12. The results reported here suggest that the RWT maze is a feasible alternative to rat-validated, swimming-based cognitive tests in the assessment of spatial memory deficits in mouse models of TBI.	[Cline, Marcella M.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Ostlie, Megan A.; Garwin, Gregory G.; Minoshima, Satoshi; Cross, Donna J.] Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA; [Cross, Chloe G.] VA Puget Sound, Geriatr Res Educ & Clin Ctr GRECC, Seattle, WA USA		Cross, DJ (corresponding author), Univ Utah, Dept Radiol, Salt Lake City, UT 84132 USA.	Donna.Cross@hsc.utah.edu		Cross, Donna/0000-0003-1918-2214; Minoshima, Satoshi/0000-0002-0043-3047; Cline, Marcella/0000-0002-9590-3725	Institute for Translational Health Sciences pilot project grant opportunity [UL1TR000423]; University of Washington Center on Human Development and DisabilityUniversity of Washington; University of Washington Animal Behavior Core and Brain Imaging Core; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002319, UL1TR000423] Funding Source: NIH RePORTER	This research was supported by the Institute for Translational Health Sciences pilot project grant opportunity (UL1TR000423), the University of Washington Center on Human Development and Disability, and the University of Washington Animal Behavior Core and Brain Imaging Core. We would like to acknowledge Dr. Warren Ladiges for his role in the development and dissemination of the original Radial Water Tread maze design and protocol presented here. We also thank Toby Cole for his assistance with this project.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Cline MM, 2017, BRAIN RES, V1657, P140, DOI 10.1016/j.brainres.2016.11.027; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P472, DOI 10.1037//0735-7044.116.3.472; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; FRANCIS DD, 1995, PHYSIOL BEHAV, V58, P57, DOI 10.1016/0031-9384(95)00009-8; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Iivonen H, 2003, BEHAV BRAIN RES, V141, P207, DOI 10.1016/S0166-4328(02)00369-8; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Pettan-Brewer C, 2013, PATHOBIOL AGING AGE, V3, DOI 10.3402/pba.v3i0.20679; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118	21	3	3	0	7	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2017		125							e55986	10.3791/55986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3TS	WOS:000407455900062	28745642	Green Published			2022-02-06	
J	Dahdah, MN; Hofmann, M; Pretz, C; An, V; Barnes, SA; Bennett, M; Dreer, LE; Bergquist, T; Shafi, S				Dahdah, Marie N.; Hofmann, Melissa; Pretz, Christopher; An, Viktoriya; Barnes, Sunni A.; Bennett, Monica; Dreer, Laura E.; Bergquist, Thomas; Shafi, Shahid			Factors Associated With Rehabilitation Outcomes After Traumatic Brain Injury: Comparing Functional Outcomes Between TBIMS Centers Using Hierarchical Linear Modeling	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; inpatients; rehabilitation; treatment outcome	LENGTH-OF-STAY; OLDER-ADULTS; SYSTEMS; DISABILITY; PATIENT; PREDICTORS; COMMUNITY; VARIABLES; SEVERITY	Objective: To examine differences in patient outcomes across Traumatic Brain Injury Model Systems (TBIMS) rehabilitation centers and factors that influence these differences using hierarchical linear modeling (HLM). Setting: Sixteen TBIMS centers. Participants: A total of 2056 individuals 16 years or older with moderate to severe traumatic brain injury (TBI) who received inpatient rehabilitation. Design: Multicenter observational cohort study using HLM to analyze prospectively collected data. Main Outcome Measures: Functional Independence Measure and Disability Rating Scale total scores at discharge and 1 year post-TBI. Results: Duration of posttraumatic amnesia (PTA) demonstrated a significant inverse relationship with functional outcomes. However, the magnitude of this relationship (change in functional status for each additional day in PTA) varied among centers. Functional status at discharge from rehabilitation and at 1 year post-TBI could be predicted using the slope and intercept of each TBIMS center for the duration of PTA, by comparing it against the average slope and intercept. Conclusions: HLM demonstrated center effect due to variability in the relationship between PTA and functional outcomes of patients. This variability is not accounted for in traditional linear regression modeling. Future studies examining variations in patient outcomes between centers should utilize HLM to measure the impact of additional factors that influence patient rehabilitation functional outcomes.	[Dahdah, Marie N.] Baylor Inst Rehabil, 909 N Washington Ave,Ste 232, Dallas, TX 75246 USA; [Dahdah, Marie N.] Baylor Reg Med Ctr Plano, Plano, TX USA; [Dahdah, Marie N.; Shafi, Shahid] Baylor Inst Rehabil, North Texas TBIMS, Dallas, TX USA; [Hofmann, Melissa; Pretz, Christopher; An, Viktoriya] Craig Hosp, Natl Data & Stat Ctr, Englewood, CO USA; [Barnes, Sunni A.; Bennett, Monica; Shafi, Shahid] Baylor Scott & White Hlth, Off Chief Qual Officer, Dallas, TX USA; [Dreer, Laura E.] Univ Alabama Birmingham, Traumat Brain Injury Model Syst, Birmingham, AL USA; [Bergquist, Thomas] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Bergquist, Thomas] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA		Dahdah, MN (corresponding author), Baylor Inst Rehabil, 909 N Washington Ave,Ste 232, Dallas, TX 75246 USA.	Marie.Dahdah@BSWHealth.org			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0045-01-0]; Ginger Murchison Foundation	The contents of this article were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant no. 90DP0045-01-0). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The project was also supported by the Ginger Murchison Foundation.	[Anonymous], 2006, CHARLSON COMORBIDITY; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Farin E, 2005, Rehabilitation (Stuttg), V44, P157; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Mieczkowski, 1997, UNIVARIATE MULTIVARI; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Osborne J., 2000, PRACTICAL ASSESSMENT, V7, P1; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Wright J., INTRO FIM TM	29	3	3	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					E1	E10		10.1097/HTR.0000000000000270			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200001	28489704				2022-02-06	
J	Deane, AM; Hodgson, CL; Young, P; Little, L; Singh, V; Poole, A; Young, M; Mackle, D; Lange, K; Williams, P; Peake, SL; Chapman, MJ; Iwashyna, TJ				Deane, A. M.; Hodgson, C. L.; Young, P.; Little, L.; Singh, V.; Poole, A.; Young, M.; Mackle, D.; Lange, K.; Williams, P.; Peake, S. L.; Chapman, M. J.; Iwashyna, T. J.			The rapid and accurate categorisation of critically ill patients (RACE) to identify outcomes of interest for longitudinal studies: a feasibility study	ANAESTHESIA AND INTENSIVE CARE			English	Article						research design; critical care; clinical trial design; critical care outcomes; functional outcomes	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; CRITICAL ILLNESS; INTENSIVE-CARE; CLINICAL-TRIAL; FOLLOW-UP; PHYSICAL REHABILITATION; SLIDING DICHOTOMY	The capacity to measure the impact of an intervention on long-term functional outcomes might be improved if research methodology reflected our clinical approach, which is to individualise goals of care to what is achievable for each patient. The objective of this multicentre inception cohort study was to evaluate the feasibility of rapidly and accurately categorising patients, who were eligible for simulated enrolment into a clinical trial, into unique categories based on premorbid function. Once a patient met eligibility criteria a rapid 'baseline assessment' was conducted to categorise patients into one of eight specified groups. A subsequent 'gold standard' assessment was made by an independent blinded assessor once patients had recovered sufficiently to allow such an assessment to occur. Accuracy was predefined as agreement in >80% of assessments. One hundred and twenty-two patients received a baseline assessment and 104 (85%) were categorised to a unique category. One hundred and six patients survived to have a gold standard assessment performed, with 100 (94%) assigned to a unique category. Ninety-two patients had both a baseline and gold standard assessment, and these agreed in 65 (71%) patients. It was not feasible to rapidly and accurately categorise patients according to premorbid function.	[Deane, A. M.] Univ Melbourne, Intens Care Unit, Royal Melbourne Hosp, Melbourne, Vic, Australia; [Hodgson, C. L.; Little, L.; Singh, V.; Young, M.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Young, P.; Mackle, D.] Med Res Inst New Zealand, Wellington, New Zealand; [Poole, A.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Lange, K.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Williams, P.; Peake, S. L.; Chapman, M. J.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Iwashyna, T. J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA		Deane, AM (corresponding author), Univ Melbourne, Intens Care Unit, Royal Melbourne Hosp, Melbourne, Vic, Australia.	adam.deane@mh.org.au	Deane, Adam/AAF-7370-2020; Williams, Patricia/AAH-6571-2019	Deane, Adam/0000-0002-7620-5577; Poole, Alexis/0000-0002-3345-1356; Young, Paul/0000-0002-3428-3083			Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Dinglas VD, 2016, THORAX, V71, P401, DOI 10.1136/thoraxjnl-2015-208017; Dinglas VD, 2013, CRIT CARE MED, V41, P9, DOI 10.1097/CCM.0b013e318265f340; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Elliott D, 2011, CRIT CARE, V15, DOI 10.1186/cc10265; Elliott D, 2011, AUST CRIT CARE, V24, P155, DOI 10.1016/j.aucc.2011.05.002; Feemster LC, 2015, ANN AM THORAC SOC, V12, P35, DOI 10.1513/AnnalsATS.201404-172OC; Freedman VA, 2011, J GERONTOL A-BIOL, V66, P1013, DOI 10.1093/gerona/glr087; Gallagher M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001601; Gifford JM, 2010, CRIT CARE MED, V38, P855, DOI 10.1097/CCM.0b013e3181cd10c7; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1416, DOI 10.1164/rccm.201410-1832CP; GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Heyland DK, 2000, CRIT CARE MED, V28, P3599, DOI 10.1097/00003246-200011000-00006; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ilodigwe D, 2013, J NEUROSURG, V118, P3, DOI 10.3171/2012.9.JNS111383; Iwashyna TJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1388-0; Iwashyna TJ, 2015, AM J RESP CRIT CARE, V192, P1045, DOI 10.1164/rccm.201411-2125CP; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Needham Dale M, 2013, BMJ, V346, pf1532, DOI 10.1136/bmj.f1532; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Parry SM, 2015, INTENS CARE MED, V41, P744, DOI 10.1007/s00134-015-3672-x; Parry SM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0829-5; Peake SL, 2014, AM J CLIN NUTR, V100, P616, DOI 10.3945/ajcn.114.086322; Prescott HC, 2016, AM J RESP CRIT CARE, V194, P147, DOI 10.1164/rccm.201512-2544CP; Reid DB, 2016, ANAESTH INTENS CARE, V44, P406, DOI 10.1177/0310057X1604400309; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Rygard SL, 2016, INTENS CARE MED, V42, P1685, DOI 10.1007/s00134-016-4437-x; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; Walsh TS, 2015, JAMA INTERN MED, V175, P901, DOI 10.1001/jamainternmed.2015.0822; Wei XJ, 2015, CRIT CARE MED, V43, P1569, DOI 10.1097/CCM.0000000000001000	39	3	3	0	0	AUSTRALIAN SOC ANAESTHETISTS	EDGECLIFF	P O BOX 600, EDGECLIFF, NSW 2027, AUSTRALIA	0310-057X	1448-0271		ANAESTH INTENS CARE	Anaesth. Intensive Care	JUL	2017	45	4					476	482		10.1177/0310057X1704500411			7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	FB3YQ	WOS:000406079100011	28673218	Bronze			2022-02-06	
J	Fawcett, N; Gibson, H; Abraham, S				Fawcett, Nicole; Gibson, Hannah; Abraham, Sam			Perceptions of College Student-Athletes Regarding the Long-Term Effects of Concussions	HEALTH CARE MANAGER			English	Article						concussion education for student-athletes; concussions in student-athletes; concussions and long-term effects; undiagnosed concussions in student-athletes	SPORT-RELATED CONCUSSION; CONSEQUENCES; SYMPTOMS	A comprehensive review of the literature was completed to investigate college student-athletes' perceptions regarding the long-term effects of concussions. Based on the findings, it was determined that there is a need for more education among student-athletes regarding this topic. This was a quantitative, cross-sectional, nonexperimental study with a descriptive design. A survey with 7 demographic and 17 Likert-type statements was collected from 100 student-athletes in a Midwestern college at their specified team practice sites for data collection.	[Fawcett, Nicole] Parkview Reg Med Ctr, Med 7, Ft Wayne, IN USA; [Gibson, Hannah] Franciscan Alliance, Cardiothorac Vasc Transplant Unit, Indianapolis, IN USA; [Abraham, Sam] Bethel Coll, Sch Nursing, 1001 Bethel Cir, Mishawaka, IA 46545 USA		Abraham, S (corresponding author), Bethel Coll, Sch Nursing, 1001 Bethel Cir, Mishawaka, IA 46545 USA.	abrahams383@att.net	Abraham, Sam/L-1182-2016	Abraham, Sam/0000-0002-5635-0769			Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259	12	3	3	5	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1525-5794	1550-512X		HEALTH CARE MANAG	Health Care Manag.	JUL-SEP	2017	36	3					210	218		10.1097/HCM.0000000000000169			9	Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	FC1NP	WOS:000406604600002	28650871				2022-02-06	
J	Joanes, V				Joanes, Vicente			Organisation of care and initial management of severe head injury in Spain: Results of a national survey	NEUROCIRUGIA			Spanish	Article						Intracranial head injury; Management; Monitoring; Survey; Guidelines; Intracranial pressure monitoring	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; EUROPEAN-BRAIN; INTENSIVE-CARE; EPIDEMIOLOGY; TELERADIOLOGY; GUIDELINES; VOLUME; TRENDS	Objective: The main objective of the study is to obtain knowledge about the organisation of care for severe head trauma as well as the initial management of these patients in Neurosurgical Departments in Spain. Material and method: A 22-item questionnaire was designed and sent to 59 Neurosurgical Departments. The aim of the questionnaire was to collect data regarding the general profile of the patients with a severe head injury, the general characteristics of the hospitals, the initial care of these patients, the monitoring techniques used, and the measures used to control Intracranial pressure (ICP). Results: Of the 59 Neurosurgical Departments identified, 29 (49.2%) completed the questionnaire. There was a wide variability in the number of patients treated per year between the different departments. The leadership of care often fell (58.6%) on the intensive care specialist. Many (69%) of the departments did not have a neurosurgeon specially dedicated to the management and monitoring of these patients. The initial care in the Emergency department usually fell (51.7%) on the general medicine practitioner. The availability of computed tomography (CT) was universal. The use of telemedicine was highly variable. ICP monitoring was performed on more than 75% of patients in most (89.7%) of departments, but there was limited use of other monitoring techniques. Most Departments followed the recommendations of the Brain Trauma Foundation (BTF) guidelines for the control of ICP. Conclusions: The organisation of care and the initial management of severe head trauma in Spain is very similar to its neighbouring countries. However, there are shortcomings, such as low participation by a neurosurgeon in the initial management of these patients, insufficient use of telemedicine, and the low implementation of certain brain monitoring techniques (SjO(2), PtiO(2), and Doppler). (C) 2017 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Joanes, Vicente] Hosp Gen Univ Valencia, Serv Neurocirugia, Valencia, Spain		Joanes, V (corresponding author), Hosp Gen Univ Valencia, Serv Neurocirugia, Valencia, Spain.	v_joanes@hotmail.com					ACS-COT. American College of Surgeons Committee on Trauma, 1998, RES OPT CAR INJ PAT; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Blackwell T, 2003, INJURY, V34, P735, DOI 10.1016/S0020-1383(03)00152-9; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM, P67; Brell M, 2001, NEUROCIRUGIA, V12, P105; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1995, GUIDELINES MANAGEMEN; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; GENTLEMAN D, 1992, INT SURG, V77, P297; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Goh KYC, 1997, CAN J NEUROL SCI, V24, P235, DOI 10.1017/S0317167100021867; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Gonzalez Darder JM, 1990, NEUROCIRUGIA DECISIO; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KAGAN RJ, 1994, AM SURGEON, V60, P394; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 1997, AM ASS NEUROLOGI SUM, P2; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; PITTS LH, 1987, J NEUROSURG, V67, P783; Poca MA, 2004, NEUROCIRUGIA, V15, P17; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	39	3	3	0	4	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JUL-AUG	2017	28	4					167	175		10.1016/j.neucir.2017.01.001			9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EZ6JQ	WOS:000404824600002	28242158				2022-02-06	
J	Martin, RK; Hrubeniuk, TJ; Witiw, CD; MacDonald, P; Leiter, J				Martin, R. Kyle; Hrubeniuk, Travis J.; Witiw, Christopher D.; MacDonald, Peter; Leiter, Jeff			Concussions in Community-Level Rugby: Risk, Knowledge, and Attitudes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						rugby; sports-related concussion; mild traumatic brain injury; attitudes; knowledge	UNION PLAYERS; UNITED-STATES; HIGH-SCHOOL; INJURIES; EPIDEMIOLOGY; MANAGEMENT; SERIES; SPORT; MENS; SEX	Background: Rugby is a popular collision sport where participants are at risk of sustaining concussions. Most research focuses on elite-level or youth divisions. Comparatively, little is known about adult community rugby. The aim of this research was to estimate the risk of sustaining a concussion during participation in community-level rugby and summarize the collective knowledge and attitudes toward concussions. Hypothesis: Concussion symptoms will be reported frequently among community-level rugby players and a substantial proportion will report a willingness to continue participation despite the risk. Study Design: Cross-sectional analysis. Level of Evidence: Level 3. Methods: An anonymous, voluntary survey was administered to all 464 senior rugby players registered in the province of Manitoba in 2015. Two primary domains were assessed: (1) concussion history from the preceding season including occurrence, symptomatology, and impact on daily activities and (2) knowledge and attitudes toward concussion risks and management. Results: In total, 284 (61.2%) rugby players responded. Concussive symptoms were reported by 106 (37.3%). Of those, 87% were formally diagnosed with a concussion and 27% missed school and/or work as a result. The danger of playing while symptomatic was recognized by 93.7% of participants, yet 29% indicated they would continue while symptomatic. Furthermore, 39% felt they were letting others down if they stopped playing due to a concussion. Conclusion: Concussive symptoms were common among the study cohort and had a notable impact on daily activities. A high proportion of players were willing to continue while experiencing symptoms despite recognizing the danger. The observed discord between knowledge and attitudes implicates a culture of "playing injured."	[Martin, R. Kyle; Hrubeniuk, Travis J.; MacDonald, Peter; Leiter, Jeff] Pan Clin, Winnipeg, MB, Canada; [Martin, R. Kyle; MacDonald, Peter; Leiter, Jeff] Univ Manitoba, Dept Surg, Sect Orthopaed, Winnipeg, MB, Canada; [Hrubeniuk, Travis J.; Leiter, Jeff] Univ Manitoba, Fac Kinesiol & Recreat Management, Winnipeg, MB, Canada; [Witiw, Christopher D.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada		Leiter, J (corresponding author), Pan Clin Fdn, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	jleiter@panamclinic.com		Martin, R. Kyle/0000-0001-9918-0264	Pan Am Clinic Foundation	The authors would like to thank the Pan Am Clinic Foundation for their support of this research, as well as Rugby Canada, Rugby Manitoba, and Winnipeg Wasps Rugby for their cooperation.	Agel J, 2010, CAN J SURG, V53, P319; [Anonymous], PUTT PLAYERS 1 IRB C; Carson JD, 1999, CLIN J SPORT MED, V9, P75, DOI 10.1097/00042752-199904000-00006; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Leiter J, 2013, CAN AC SPORT EX MED; Lopez V, 2012, AM J SPORT MED, V40, P179, DOI 10.1177/0363546511427124; MacDougall N., RUGBY CANADA DETAILE; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	22	3	3	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2017	9	4					312	317		10.1177/1941738117695777			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FH9XL	WOS:000411570600003	28661825	Green Published			2022-02-06	
J	Puanglumyai, S; Lekawanvijit, S				Puanglumyai, Supot; Lekawanvijit, Suree			The importance of optic nerve sheath hemorrhage as a postmortem finding in cases of fatal abusive head trauma: A 13-year study in a tertiary hospital	FORENSIC SCIENCE INTERNATIONAL			English	Article						Optic nerve sheath hemorrhage; Abusive head trauma; Child abuse; Autopsy; Postmortem investigation	SHAKEN-BABY-SYNDROME; RETINAL HEMORRHAGES; YOUNG-CHILDREN; INFANTS; INJURIES; TELEVISION; AUTOPSY; DEATHS; FALLS	Fatal abusive head trauma is a major cause of death in children and toddlers who suffer from cruel physical abuse. Postmortem differentiation of fatal abusive head trauma from accidental head trauma can be a complicated process. This consecutive case series study aimed to determine the role of subdural optic nerve sheath hemorrhage (ONSH) in 70 autopsy cases of children <= 3 years old in making this differentiation. The study took place over a 13 year period (between August 1st 2003 and July 31st 2016) at a tertiary hospital in Thailand. Eleven cases were diagnosed with fatal abusive head trauma and 10 were identified as being accidental closed head trauma cases. Bilateral retinal hemorrhage was noted in antemortem medical records in every hospitalized abusive head trauma case (n = 10). Upon autopsy, ONSH was observed in all 11 fatal cases of abusive head trauma (bilateral = 10 and unilateral = 1) but not in any cases of accidental head trauma ( 0/5). Subdural hemorrhage was found in 10 out of 11 abusive head trauma victims but not in any of the 10 with accidental head trauma. Other postmortem findings in abusive head trauma included subarachnoid hemorrhage (5/11), marked brain swelling (3/11), skull fracture (4/11) and brain contusion (1/11). This study suggests that ONSH, together with subdural hemorrhage, plays an essential role in an accurate postmortem diagnosis of fatal abusive head trauma. Therefore, an ocular investigation should be performed in all autopsy cases where child abuse is suspected and where there is no reliable history/witnesses, confession or antemortem ophthalmologic examination. (C) 2017 Elsevier B.V. All rights reserved.	[Puanglumyai, Supot] Chonburi Hosp, Dept Forens Med, Chon Buri, Thailand; [Lekawanvijit, Suree] Chiang Mai Univ, Dept Pathol, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand		Lekawanvijit, S (corresponding author), Chiang Mai Univ, Dept Pathol, Fac Med, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	slekawan@hotmail.com			Chonburi Research Center (Chonburi Hospital); Faculty Research Fund (Faculty of Medicine, Chiang Mai University); Ananda Mahidol Foundation	This work was supported by The Chonburi Research Center (Chonburi Hospital); Faculty Research Fund (Faculty of Medicine, Chiang Mai University) and The Ananda Mahidol Foundation.	Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Breazzano MP, 2014, AM J OPHTHALMOL, V158, P1146, DOI 10.1016/j.ajo.2014.08.011; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P271, DOI 10.1097/PAF.0b013e3182a0a454; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P130, DOI 10.1097/PAF.0b013e31828629ca; Deisch J, 2011, J FORENSIC SCI, V56, P1049, DOI 10.1111/j.1556-4029.2011.01765.x; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Emerson MV, 2007, OPHTHALMOLOGY, V114, P1384, DOI 10.1016/j.ophtha.2007.04.015; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kobayashi Y, 2009, JPN J OPHTHALMOL, V53, P384, DOI 10.1007/s10384-009-0681-8; Kodikara S, 2012, LEGAL MED-TOKYO, V14, P197, DOI 10.1016/j.legalmed.2012.02.005; LAMBERT SR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1509; Lynoe N., 2017, ACTA PAEDIAT; Mills M, 1998, J AAPOS, V2, P67, DOI 10.1016/S1091-8531(98)90066-0; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Narang SK, 2016, J PEDIATR-US, V177, P273, DOI 10.1016/j.jpeds.2016.06.036; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Platt MS, 2011, J FORENSIC SCI, V56, P1364, DOI 10.1111/j.1556-4029.2011.01770.x; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; RIFFENBURGH R, 2005, CLIN SURG OPHTHALMOL, V23, P178; Serinelli S, 2017, J FORENSIC SCI, V62, P107, DOI 10.1111/1556-4029.13219; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038	33	3	3	1	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUL	2017	276						5	11		10.1016/j.forsciint.2017.04.008			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	EY5JB	WOS:000404012000009	28458085				2022-02-06	
J	Tao, ZY; Gao, P; Yan, YH; Li, HY; Song, J; Yang, JX				Tao, Zhen-yu; Gao, Peng; Yan, Yu-hui; Li, Hong-yan; Song, Jie; Yang, Jing-xian			Osthole Enhances the Therapeutic Efficiency of Stem Cell Transplantation in Neuroendoscopy Caused Traumatic Brain Injury	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						osthole; neural stem cell; transplantation; apoptosis; blood brain barrier; traumatic brain injury	ENDOSCOPIC 3RD VENTRICULOSTOMY; ALZHEIMERS-DISEASE; NEURONAL DIFFERENTIATION; CEREBRAL-ISCHEMIA; FLUORO-JADE; SPINAL-CORD; MOUSE MODEL; MACAB-TOLC; ADULT; INFLAMMATION	Neuroendoscopy processes can cause severe traumatic brain injury. Existing therapeutic methods, such as neural stem cell transplantation and osthole have not been proven effective. Therefore, there is an emerging need on the development of new techniques for the treatment of brain injuries. In this study we propose to combine the above stem cell based methods and then evaluate the efficiency and accuracy of the new method. Mice were randomly divided into four groups: group 1 (brain injury alone); group 2 (osthole); group 3 (stem cell transplantation); and group 4 (osthole combined with stem cell transplantation). We carried out water maze task to exam spatial memory. Immunocytochemistry was used to test the inflammatory condition of each group, and the differentiation of stem cells. To evaluate the condition of the damaged blood brain barrier restore, we detect the Evans blue (EB) extravasation across the blood brain barrier. The result shows that osthole and stem cell transplantation combined therapeutic method has a potent effect on improving the spatial memory. This combined method was more effective on inhibiting inflammation and preventing neuronal degeneration than the single treated ones. In addition, there was a distinct decline of EB extravasation in the combined treatment groups, which was not observed in single treatment groups. Most importantly, the combined usage of osthole and stem cell transplantation provide a better treatment for the traumatic brain injury caused by neuroendoscopy. The collective evidence indicates osthole combined with neural stem cell transplantation is superior than either method alone for the treatment of traumatic brain injury caused by neuroendoscopy.	[Tao, Zhen-yu; Yan, Yu-hui; Li, Hong-yan; Song, Jie; Yang, Jing-xian] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China; [Gao, Peng] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Peoples R China		Yang, JX (corresponding author), Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China.	jingxianyang0520@163.com					Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Ahn JY, 2015, NEURAL REGEN RES, V10, P1251, DOI 10.4103/1673-5374.162757; Altarche-Xifro W, 2016, EBIOMEDICINE, V8, P83, DOI 10.1016/j.ebiom.2016.04.016; Arvidsson L, 2015, J NEUROIMMUNOL, V288, P47, DOI 10.1016/j.jneuroim.2015.09.001; Bacigaluppi M, 2016, J NEUROSCI, V36, P10529, DOI 10.1523/JNEUROSCI.1643-16.2016; Batty R, 2015, J CLIN EXP NEUROPSYC, V37, P917, DOI 10.1080/13803395.2015.1068279; Casanova F, 2014, J NEUROSCI METH, V237, P79, DOI 10.1016/j.jneumeth.2014.08.012; Cascella M, 2016, KOREAN J ANESTHESIOL, V69, P113, DOI 10.4097/kjae.2016.69.2.113; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Deng P, 2016, NEURAL REGEN RES, V11, P702, DOI 10.4103/1673-5374.182682; Diaz D, 2015, NEUROSCIENTIST, V21, P637, DOI 10.1177/1073858414547538; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Duan J, 2016, INT J MOL MED, V37, P207, DOI 10.3892/ijmm.2015.2402; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gao XQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3081939; Gao Z, 2014, J PHARMACOL SCI, V124, P54, DOI 10.1254/jphs.13144FP; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Grand W, 2016, NEUROSURGERY, V78, P109, DOI 10.1227/NEU.0000000000000994; Grand W, 2011, ACTA NEUROCHIR, V153, P2049, DOI 10.1007/s00701-011-1106-2; Grand W, 2011, J NEUROSURG, V114, P446, DOI 10.3171/2010.10.JNS101000; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Herz J, 2015, STROKE, V46, P2916, DOI 10.1161/STROKEAHA.115.010620; Hou XQ, 2015, REJUV RES, V18, P111, DOI 10.1089/rej.2014.1603; Hu Y, 2013, BIOL PHARM BULL, V36, P1950, DOI 10.1248/bpb.b13-00561; Huang P, 2014, CYTOTHERAPY, V16, P1336, DOI 10.1016/j.jcyt.2014.05.007; Hwang DH, 2014, J NEUROSCI, V34, P12788, DOI 10.1523/JNEUROSCI.5359-13.2014; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Isaacs AM, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16193; Kang JM, 2016, J ALZHEIMERS DIS, V54, P879, DOI 10.3233/JAD-160406; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kong L, 2015, BIOL PHARM BULL, V38, P1290, DOI 10.1248/bpb.b15-00142; Koutsoudaki PN, 2016, GLIA, V64, P763, DOI 10.1002/glia.22959; Kuai XL, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0024-2; Kuitunen H, 2017, J NEURO-ONCOL, V131, P293, DOI 10.1007/s11060-016-2293-8; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Liu H, 2015, BIOL PHARM BULL, V38, P1439, DOI 10.1248/bpb.b15-00013; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lu S, 2013, J BACTERIOL, V195, P4865, DOI 10.1128/JB.00756-13; Lu S, 2012, MOL MICROBIOL, V86, P1132, DOI 10.1111/mmi.12046; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Madhavan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137136; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Monfared A, 2007, CURR OPIN NEUROL, V20, P726, DOI 10.1097/WCO.0b013e3282f1a043; Owens T, 2001, NAT MED, V7, P161, DOI 10.1038/84603; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pollak D, 2003, J NEURAL TRANSM-SUPP, P149; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shen WB, 2016, CELL TRANSPLANT, V25, P1085, DOI 10.3727/096368915X689550; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song J, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00182; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Neves KRT, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/108179; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tsuda K, 2011, NEUROL MED-CHIR, V51, P694, DOI 10.2176/nmc.51.694; Vulcu S, 2015, J NEUROSURG, V123, P1456, DOI 10.3171/2014.11.JNS14414; Wang GH, 2016, CYTOTHERAPY, V18, P53, DOI 10.1016/j.jcyt.2015.10.006; Xia Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0373-x; Yadav YR, 2016, TURK NEUROS IN PRESS; Zhao L, 2016, NEUROBIOLOG IN PRESS; Zhou HX, 2016, NEURAL REGEN RES, V11, P107, DOI 10.4103/1673-5374.175054; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	78	3	3	0	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JUL	2017	40	7					1043	1054		10.1248/bpb.b17-00072			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EZ4GB	WOS:000404670100013	28674247	gold			2022-02-06	
J	Wu, PH; Dixit, A; Tan, DMK; Shen, L; Chee, YH				Wu, Pang Hung; Dixit, Anushri; Tan, David Meng Kiat; Shen, Liang; Chee, Yu Han			Prospective study of surgical fixation of radial head fractures using cannulated headless compression screws for simple and complex radial head fractures	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						fixation of radius; headless compression screws; radial head	OPEN REDUCTION; BONE SCREW; MANAGEMENT; NECK	Introduction: Fixing the two-part Mason II radial head fracture using screws is becoming a popular practice. However, the screw fixation efficacy for three-partMason III and IV fractures is controversial. The purpose of this study is to determine the effectiveness of using a uniform technique of headless compression screw fixation in simple, isolated Mason II and complex three-part Mason III and IV radial head fractures in terms of functional outcome, treatment efficiency and assessment of complications with the procedure. Methods: A prospective evaluation were performed on 31 adult patients with closed, non-pathological Mason II, III and IV radial head fractures sustained due to trauma and who underwent fixation using either two or three cannulated headless compression screws of 2.0 to 2.5 mm, and all patients were followed up for 2 years after the injury. They were divided into simple Mason II fracture group and complex three-part Mason III-IV fracture group. Operation time, time to discharge and radiological union were used as parameters for assessment of clinical outcome, while Mayo Elbow Performance Score, range of motion and complications were used to assess the functional outcomes. Results: Twelve cases of two-part simple fracture group and 18 cases of complex fracture group were identified. The mean age of 39 years is comparable between the two groups. Both groups had comparable days to union, mean hospital stay and operation time. In the simple fracture group, the mean Mayo Elbow Score was 97 (80-100), which is better than the complex fracture group score of 89 (75-100), p = 0.035. Both groups had no statistical difference in complication rates. All fractures united in our series. The mean range of motion for the simple fracture group was significant, with 133 degrees +/- 17.0 degrees for flexion-extension arc, 85 degrees +/- 5 degrees in pronation and supination as compared to the complex fracture group with 120 degrees +/- 20 degrees flexion-extension arc, 69 degrees +/- 10 degrees in pronation and 70 degrees +/- 8 degrees in supination, p = 0.068. Conclusion: Overall clinical and functional outcomes of this technique are satisfactory in both simple and complex fracture groups, with simple Mason II fracture group doing better than the complex three-part Mason III and IV fractures in terms of Mayo Elbow Score and range of motion. Screw fixation has the advantage of less periosteal stripping and less impingement compared to other fixation methods and also allows for flexible fixation in constrained areas. Headless compression screw fixation can be considered as a method of fracture fixation for both simple and complex three-part radial head fractures.	[Wu, Pang Hung] Ng Teng Feng Gen Hosp, Dept Orthopaed Surg, Jurong Hlth Campus, Singapore, Singapore; [Dixit, Anushri] Queen Mary Univ London, Fac Med & Dent, London, England; [Tan, David Meng Kiat] Natl Univ Hlth Syst, Div Hand & Reconstruct Microsurg, Dept Univ Orthopaed, Hand & Reconstruct Microsurgery Cluster, Singapore, Singapore; [Shen, Liang] Natl Univ Singapore, Yong Loo Lin Sch Med, Med Deans Off, Singapore, Singapore; [Chee, Yu Han] Natl Univ Hlth Syst, Div Musculoskeletal Trauma Surg, Dept Univ Orthopaed, Hand & Reconstruct Microsurgery Cluster, Singapore, Singapore		Wu, PH (corresponding author), Natl Univ Hosp Syst, Ng Teng Feng Gen Hosp, Dept Orthopaed Surg, Jurong Hlth Campus,1 Jurong East St 21, Singapore 609606, Singapore.	pang_hung_wu@juronghealth.com.sg					BUNKER TD, 1985, INJURY, V16, P621, DOI 10.1016/0020-1383(85)90011-7; Burkhart KJ, 2010, INJURY, V41, P1015, DOI 10.1016/j.injury.2010.03.001; Calfee RP, 2011, J BONE JOINT SURG AM, V93A, P81, DOI 10.2106/JBJS.I.01242; Demiroglu M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2189-2; Duckworth DG, 2012, ANZ J SURG, V82, P434, DOI 10.1111/j.1445-2197.2012.06094.x; Erturer E, 2010, ACTA ORTHOP TRAUMATO, V44, P20, DOI 10.3944/AOTT.2010.2234; FAITHFULL DK, 1984, J HAND SURG-BRIT EUR, V9B, P167, DOI 10.1016/S0266-7681(84)80021-2; Gardner AW, 2012, J HAND SURG-AM, V37A, P1845, DOI 10.1016/j.jhsa.2012.05.044; HERBERT TJ, 1984, J BONE JOINT SURG BR, V66, P114, DOI 10.1302/0301-620X.66B1.6693468; HERBERT TJ, 1992, J HAND SURG-BRIT EUR, V17B, P415, DOI 10.1016/S0266-7681(05)80265-7; Kodde IF, 2015, WORLD J ORTHOP, V6, P954, DOI 10.5312/wjo.v6.i11.954; Kovacevic D, 2015, HAND CLIN, V31, P547, DOI 10.1016/j.hcl.2015.06.004; MCARTHUR RA, 1987, CLIN ORTHOP RELAT R, P79; Neumann M, 2011, J BONE JOINT SURG BR, V93B, P223, DOI 10.1302/0301-620X.93B2.24760; Pearce MS, 1996, J ROY SOC MED, V89, pP340, DOI 10.1177/014107689608900616; Pogliacomi Francesco, 2015, Acta Biomed, V86, P242; Ring D, 2011, J SHOULDER ELB SURG, V20, pS107, DOI 10.1016/j.jse.2010.11.011; Sun Hao, 2016, Eur J Orthop Surg Traumatol, V26, P283, DOI 10.1007/s00590-016-1739-1; Wheeler DL, 1998, CLIN ORTHOP RELAT R, P237; Wu PH, 2016, J ORTHOP SURG-HONG K, V24, P57, DOI 10.1177/230949901602400114; Zwingmann J, 2013, INJURY, V44, P1540, DOI 10.1016/j.injury.2013.04.003	21	3	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1022-5536	2309-4990		J ORTHOP SURG-HONG K	J. Orthop. Surg.	JUN 28	2017	25	2					1	8	2309499017716278	10.1177/2309499017716278			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	EZ3TF	WOS:000404632600001	28656872	gold			2022-02-06	
J	Cizman, US; Vidmar, G; Drnovsek, P				Cizman, Ursa S.; Vidmar, Gaj; Drnovsek, Petra			Influence of the rehabilitation outcome on returning to drive after neurological impairment	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						driving ability; Functional Independence Measure; Glasgow Coma Scale; stroke; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACCIDENT RATE; PREDICTION; ABILITY; TBI	In traumatic brain injury (TBI) and stroke rehabilitation, the question of reintegration of the driver into traffic is faced very often. Driving is an important domain and for some patients, return to driving represents a crucial event for community inclusion. The aim of our study was to examine the utility of Glasgow Coma Scale within the first 24 h of injury and the Functional Independence Measure (FIM) at rehabilitation admission for predicting the return to driving. We included 72 patients after TBI or stroke. Driving outcome was assessed in terms of being allowed to drive without restrictions as opposed to failing the test or being allowed to drive with restrictions. We examined two samples: the TBI patients only and the entire sample including patients after stroke. The results indicate that for TBI patients, Glasgow Coma Scale and motor FIM could be predictors of driving outcome; in the entire sample, the unrestricted driving outcome was also associated with a high score on the FIM motor scale. Early prediction of return to driving after TBI and stroke is important for the patients, their families and the rehabilitation teams to set realistic goals that enable the best possible reintegration after rehabilitation. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Cizman, Ursa S.; Vidmar, Gaj; Drnovsek, Petra] Univ Rehabil Inst, Linhartova Cesta 51, Ljubljana 1000, Slovenia; [Vidmar, Gaj] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Vidmar, Gaj] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia		Cizman, US (corresponding author), Univ Rehabil Inst, Linhartova Cesta 51, Ljubljana 1000, Slovenia.	ursa.cizman@ir-rs.si					Alexandersen A, 2009, BRAIN INJURY, V23, P313, DOI 10.1080/02699050902788428; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Bliokas VV, 2011, BRAIN INJURY, V25, P471, DOI 10.3109/02699052.2011.559609; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cullen N, 2014, BRAIN INJURY, V28, P189, DOI 10.3109/02699052.2013.862738; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Dimarco F, 2001, EURA MEDICOPHYS, V37, P215; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; FORMISANO R, 2001, EUROPA MEDICOPHYSICA, V37, P257; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Kaivanto K, 2008, J CLIN EPIDEMIOL, V61, P517, DOI 10.1016/j.jclinepi.2007.10.011; Katz M, 2011, MULTIVARIABLE ANAL P; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Masson M, 2013, BRAIN INJURY, V27, P538, DOI 10.3109/02699052.2013.766926; Newson R., 2014, INTERPRETATION SOMER; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Raad J, 2014, REHAB MEASURES GLASG; Raad J, 2015, REHAB MEASURES FIM I; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Yale SH, 2006, CLIN MED RES, V1, P177; Zupan A, 2013, REHABILITATION LJ S1, V12, P36	31	3	3	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2017	40	2					107	111		10.1097/MRR.0000000000000213			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	ET7JH	WOS:000400471100002	28454124				2022-02-06	
J	Engelson, MA; Bruns, R; Nightingale, CJ; Bardwell, KM; Mason, CA; Tu, SF; Nelson, L; Butterfield, SA				Engelson, Melissa A.; Bruns, Richard; Nightingale, Christopher J.; Bardwell, Kevin M.; Mason, Craig A.; Tu, Shihfen; Nelson, Laney; Butterfield, Stephen A.			Validation of the OptoGait System for Monitoring Treatment and Recovery of Post-Concussion Athletes	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Validation Studies; Head Injuries; Closed; Brain Concussion; Post-Concussion Syndrome	BALANCE; MANAGEMENT; VALIDITY; IMPACT	Objective: This study sought to investigate correlations between OptoGait motion analysis technology and 2 commonly used concussion assessment instruments, the Balance Evaluation Scoring System(BESS) and the Immediate Post-Concussion Assessment andCognitiveTesting (ImPACT) computerized neurocognitive assessment software, to see ifOptoGaitmight be a valid concussion assessment tool. Methods: Twenty Division-1 college women varsity soccer players completed trials of 8 different conditions of the OptoGait test battery. Then participants completed the BESS and ImPACT tests. One hundred twenty-eight total spatiotemporal variableswere recorded for each trial ofOptoGait. Pearson's r correlations among these variables and BESS and ImPACT results were calculated, and pattern analysis was completed to evaluate for emergent patterns in the data. Results: Correlations for the 8 OptoGait mean-score subtests were related to the balance double-leg foam test (BESS). Correlations for the 8 OptoGait mean-score subtests were related to the balance double-leg foam test (BESS), and correlations between OptoGait standard deviation measures and the balance tandem hard surface test (BESS) both indicated potentially significant patterns. No consistent patterns of correlation existed between the OptoGait variables and the ImPACT results. Conclusion: OptoGait conditions correlate at higher than predicted rates with subtests of the BESS instruments but not the ImPACT measures.	[Engelson, Melissa A.] Logan Univ, Human Performance Ctr, Chesterfield, MO USA; [Bruns, Richard] Bruns Chiropract, Bangor, ME USA; [Nightingale, Christopher J.; Butterfield, Stephen A.] Univ Maine, Dept Kinesiol Phys Educ & Athlet Training, Orono, ME USA; [Bardwell, Kevin M.] Bardwell Chiropract, Yarmouth, ME USA; [Mason, Craig A.; Tu, Shihfen] Univ Maine, Dept Learning & Teaching, Orono, ME USA; [Nelson, Laney] Camp 4 Human Performance, Taylorsville, UT USA		Nightingale, CJ (corresponding author), Univ Maine, 5740 Lengyel Hall Room 115, Orono, ME 04469 USA.	Christopher.nightingale@maine.edu		Mason, Craig/0000-0002-9690-1692			Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lienhard K, 2013, MED ENG PHYS, V35, P500, DOI 10.1016/j.medengphy.2012.06.015; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Suelto MD, 1999, ANESTHESIOLOGY; Vartiainen MV, 2016, J CLIN EXP NEUROPSYC, V38, P293, DOI 10.1080/13803395.2015.1107031; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005	13	3	3	0	5	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	JUN	2017	16	2					163	169		10.1016/j.jcm.2016.12.001			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EX3DE	WOS:000403111400010	28559757	Green Published			2022-02-06	
J	Goreth, MB				Goreth, Michelle Borzik			Pediatric Mild Traumatic Brain Injury and Population Health An Introduction for Nursing Care Providers	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Pediatric mild traumatic brain injury; Concussion; Population health; Health-related quality of life; Health disparities; Pediatric trauma	QUALITY-OF-LIFE; CHILDREN; DISPARITIES	Despite increasing injury prevalence of traumatic brain injury (TBI) in children, most injuries in children are mild in severity. Even mild injuries can result in long-term or chronic effects not apparent until the child ages, resulting in increased economic burden and overall lifetime costs related to injury. Early recognition of TBI is essential for ongoing evaluation and management of acute symptoms and reduction of chronic health effects. Providing early interventions to manage acute and post-concussive symptoms and reducing health disparities in children with mild TBI can minimize adverse events that impact health-related quality of life for the injured child and their family and increase overall population health.	[Goreth, Michelle Borzik] Univ Mississippi, Med Ctr, Div Pediat Surg, Dept Surg, 2500 North State St, Jackson, MS 39216 USA		Goreth, MB (corresponding author), Univ Mississippi, Med Ctr, Div Pediat Surg, Dept Surg, 2500 North State St, Jackson, MS 39216 USA.	dmgoreth@umc.edu					Agency for Healthcare Research and Quality, 2015, AHRQ PUB; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Albert M., 2014, INJURY RELATED EMERG; American Association of Neuroscience Nurses and Association of Rehabilitation Nurses, 2011, CAR PAT MILD TRAUM B; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Carr BG, 2010, CURR OPIN PEDIATR, V22, P326, DOI 10.1097/MOP.0b013e3283392a48; CDC, 2016, RAT TBI REL DEATHS A; CDC, 2016, RAT TBI REL HOSP AG; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Fineblit S, 2016, J NEUROTRAUM, V33, P1; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Mason Christine Narad, 2013, Pediatr Nurs, V39, P267; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Struder M, 2014, J INT NEUROPSYCH SOC, V20, P982; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	24	3	3	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	JUN	2017	29	2					157	+		10.1016/j.cnc.2017.01.003			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	ET7HO	WOS:000400466000004	28460697				2022-02-06	
J	Huang, KT; Chavakula, V; Gormley, WB				Huang, Kevin T.; Chavakula, Vamsidhar; Gormley, William B.			Keen's Point for External Ventricular Drainage in Traumatic Brain Injury Patients: An Uncommon Indication for An Old Technique	WORLD NEUROSURGERY			English	Article						Cerebrospinal fluid diversion; External ventricular drainage; Intracranial hypertension; Keen's point; Traumatic brain injury	CEREBROSPINAL-FLUID DRAINAGE; INCREASED INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT	BACKGROUND: In cases of severe traumatic brain injury, cerebrospinal fluid (CSF) diversion though an external ventricular drain (EVD) is a proven method to assist in the control of elevated intracranial pressure. Under normal circumstances, the EVD is placed in a frontal location. However, in cases of multifocal intracranial injury and swelling, collapse of the frontal horns of the lateral ventricles leads to frequent failure of frontal CSF drainage. In this series we describe the utility of the Keen's point EVD as a safe alternative to maintain continuous CSF diversion for patients in whom frontal drainage is not feasible. CASE DESCRIPTIONS: Three patients (ages 30-46 years) with diffuse intracranial injury following severe trauma were admitted to our neurointensive care unit. One of these patients had decompressive craniectomy before transfer, while the other 2 patients did not undergo any surgical procedures. Each of these patients had severe refractory elevation of intracranial pressure and significant frontal swelling, ultimately necessitating bedside placement of a Keen's point EVD. CONCLUSIONS: In all cases, we were able to reliably maintain continuous CSF diversion for an extended period of time. There was 1 mortality due to the severity of initial injuries. In the remaining 2 patients, intracranial pressure was able to be normalized following placement of the Keen point EVD. The Keen point EVD is a viable option to maintain continuous CSF drainage in patients with diffuse intracranial injury and should be considered in patients whom a frontal EVD cannot reliably maintain continuous drainage of CSF.	[Huang, Kevin T.; Chavakula, Vamsidhar; Gormley, William B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA		Gormley, WB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA.	khuang3@partners.org		Chavakula, Vamsidhar/0000-0002-7700-7353; Huang, Kevin/0000-0002-1302-0559			Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Joseph M, 2003, NEUROL INDIA, V51, P333; Keen, 1890, LANCET, V136, P553, DOI DOI 10.1016/S0140-6736(00)48676-9; Keen WW, 1888, MED NEWS, V53, P603; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Lescot T, 2012, NEUROCHIRURGIE, V58, P235, DOI 10.1016/j.neuchi.2012.03.010; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUNDERS RL, 1979, CRIT CARE MED, V7, P556, DOI 10.1097/00003246-197912000-00010; Suarez JI, 2004, CRITICAL CARE NEUROL; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003	24	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2017	102								6940	10.1016/j.wneu.2017.03.145			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5HA	WOS:000405472500099	28400228				2022-02-06	
J	Kearns, NT; Blumenthal, H; Rainey, EE; Bennett, MM; Powers, MB; Foreman, ML; Warren, AM				Kearns, Nathan T.; Blumenthal, Heidemarie; Rainey, Evan E.; Bennett, Monica M.; Powers, Mark B.; Foreman, Michael L.; Warren, Ann Marie			Discrepancy in Caregiving Expectations Predicts Problematic Alcohol Use Among Caregivers of Trauma Injury Patients Six Months After ICU Admission	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article						alcohol; caregiver burden; traumatic injury; intensive care unit; family members	INTENSIVE-CARE-UNIT; IDENTIFICATION TEST AUDIT; USE DISORDERS; FAMILY-MEMBERS; BRAIN-INJURY; SUBSTANCE USE; SUPPORT PROJECT; SELF-MEDICATION; SCREENING-TEST; HEAD-INJURY	This prospective study examined the influence of caregiving variables on the development of problematic alcohol use among family members of patients admitted to an urban Level I trauma center. Data were collected from 124 caregivers 48 hrs after initial hospitalization of their family member. The final sample included 81 participants (24.6% male; M-age = 47.8) who completed their follow-up assessment at 6 months. Hierarchical linear and logistic regression analyses assessed increases in consumption and odds of a positive screen for problematic alcohol use in association with caregiver burden, actual time spent in the caregiving role, and caregiving differential (i.e., anticipated time spent caregiving at baseline in relation to actual time caregiving at 6 months). At 6 months, 24.7% of caregivers screened positive for problematic alcohol use. Results uniquely highlighted caregiving differential as a significant predictor of both increases in general alcohol consumption (Delta R-2 = .06, p < .01) and odds of screening positive for problematic alcohol use at 6 months (Odds Ratio = 1.05, 95% CI [1.02-1.09]). More specifically, our adjusted model found that providing 10% more time caregiving, relative to expectations at baseline, was associated with an increase in the probability of problematic alcohol use by 22% (95% CI: 8-37%) at 6 months. These results suggest that a discrepancy in expectations regarding anticipated time caregiving and actual time caregiving, rather than solely the amount of caregiving or perceived caregiver burden, may be an important predictor of caregiver alcohol use 6 months after a family member's ICU hospitalization.	[Kearns, Nathan T.; Blumenthal, Heidemarie] Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA; [Rainey, Evan E.; Powers, Mark B.; Foreman, Michael L.; Warren, Ann Marie] Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, Dallas, TX USA; [Bennett, Monica M.] Baylor Univ, Med Ctr, Dallas, TX USA		Kearns, NT (corresponding author), Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	nathankearns@my.unt.edu	Powers, Mark/ABB-3291-2021	McShan, Evan Elizabeth/0000-0002-9250-3240; Blumenthal, Heidemarie/0000-0003-4865-6239; Warren, Ann Marie/0000-0002-3753-5573	Ginger Murchison Traumatic Brain Injury Fund of the Baylor Health Care System Foundation	This research was supported in part by the Ginger Murchison Traumatic Brain Injury Fund of the Baylor Health Care System Foundation.	AFFLECK G, 1987, J PERS SOC PSYCHOL, V53, P273, DOI 10.1037/0022-3514.53.2.273; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Babor TF, 2001, AUDIT ALCOHOL USE DI; BARUSCH AS, 1991, J GERONTOL SOC WORK, V17, P7; Biddle B. J., 2013, ROLE THEORY EXPECTAT; Blom H, 2013, INTENS CRIT CARE NUR, V29, P1, DOI 10.1016/j.iccn.2012.04.002; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Bugge C, 1999, STROKE, V30, P1517, DOI 10.1161/01.STR.30.8.1517; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chien LY, 2011, INT J GERIATR PSYCH, V26, P1089, DOI 10.1002/gps.2660; Conner KR, 2009, J SUBST ABUSE TREAT, V37, P127, DOI 10.1016/j.jsat.2008.11.007; Cooper M.L., 1994, PSYCHOL ASSESS, V6, P117, DOI [DOI 10.1037/1040-3590.6.2.117, 10.1037/1040-3590.6.2.117]; Cornwell EE, 1998, AM SURGEON, V64, P461; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Empeno J, 2011, J PALLIAT MED, V14, P593, DOI 10.1089/jpm.2010.0520; Feldner MT, 2007, BEHAV MODIF, V31, P80, DOI 10.1177/0145445506295057; First M. B., 2014, STRUCTURED CLIN INTE; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Gallant MP, 1997, J AGING HEALTH, V9, P373, DOI 10.1177/089826439700900306; Hajema KJ, 1998, ADDICTION, V93, P1717, DOI 10.1046/j.1360-0443.1998.931117179.x; Halm M A, 1993, Clin Nurs Res, V2, P414; Ham RJ, 1999, ALZ DIS ASSOC DIS, V13, pS27, DOI 10.1097/00002093-199911002-00005; Hauser JM, 2004, CLIN GERIATR MED, V20, P671, DOI 10.1016/j.cger.2004.07.003; Houser A. N., 2008, VALUING INVALUABLE E; Institute for Patient-and Family-Centered Care, 2015, FREQ ASK QUEST WHAT; Johnson P, 2001, Intensive Crit Care Nurs, V17, P219, DOI 10.1054/iccn.2001.1577; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Khantzian EJ, 2003, PRIMARY PSYCHIAT, V10, P47; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6; Lindvall K, 2014, PEDIATR BLOOD CANCER, V61, P706, DOI 10.1002/pbc.24856; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Miller MW, 2006, J ABNORM PSYCHOL, V115, P369, DOI 10.1037/0021-843X.115.2.369; Mitchell GJ, 2000, NURS SCI QUART, V13, P216, DOI 10.1177/08943180022107591; Northouse Laurel L, 2012, Semin Oncol Nurs, V28, P236, DOI 10.1016/j.soncn.2012.09.006; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Powers MB, 2014, J ANXIETY DISORD, V28, P301, DOI 10.1016/j.janxdis.2014.01.003; Read JP, 2004, ADDICT BEHAV, V29, P1665, DOI 10.1016/j.addbeh.2004.02.061; ROBINSON NC, 1991, J NURS ADMIN, V21, P29; Robinson-Whelen S, 2001, J ABNORM PSYCHOL, V110, P573, DOI 10.1037//0021-843X.110.4.573; Rospenda KM, 2010, J ADDICT DIS, V29, P314, DOI 10.1080/10550887.2010.489450; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; SAS Institute, 2014, BAS SAS 9 4 PROC GUI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; THOMPSON SC, 1981, PSYCHOL BULL, V90, P89, DOI 10.1037/0033-2909.90.1.89; Verhaeghe S, 2005, J CLIN NURS, V14, P501, DOI 10.1111/j.1365-2702.2004.01081.x; Volk RJ, 1997, ADDICTION, V92, P197, DOI 10.1111/j.1360-0443.1997.tb03652.x; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; Wellard S J, 1999, Int J Nurs Pract, V5, P132, DOI 10.1046/j.1440-172x.1999.00163.x; Whittier Stephanie, 2005, J Aging Soc Policy, V17, P45; Wilsnack S C, 1991, J Subst Abuse, V3, P133; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001	63	3	3	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	JUN	2017	31	4					497	505		10.1037/adb0000282			9	Substance Abuse; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Substance Abuse; Psychology	EX8HN	WOS:000403489600012	28493754				2022-02-06	
J	Metin, O; Tufan, AE; Binici, N; Saracli, O; Atalay, A; Tahiroglu, A				Metin, Ozge; Tufan, Ali Evren; Cevher Binici, Nagihan; Saracli, Ozge; Atalay, Adnan; Yolga Tahiroglu, Aysegul			Executive Functions in Frontal Lob Syndrome: A Case Report	TURK PSIKIYATRI DERGISI			Turkish	Article						Frontal lobe; executive function; neuropsychological tests	TRAUMATIC BRAIN-INJURY; RISPERIDONE; DISORDER; CHILDREN	Prefrontal cortex in frontal lobe (FL) is the center of executive functions (EF). FL damage can lead to executive dysfunction by influencing frontal-subcortical circuits (dorsolateral, orbitofrontal, ventromedial). Damage to the dorsolateral prefrontal cortex (DLPFC) can lead to deterioration in EF, whereas damage to the orbitofrontal cortex (OFC) can lead to personality changes with the characteristic of disinhibition and irritability. In addition, damage to the anterior cingulate cortex/medial prefrontal cortex (ACC/MPFC) can result in decreased spontaneity. Neuropsychological tests are important components in the assessment of EF including goal-directed behavior, decision-making, risk assessment, making plans for the future, setting of priorities and order of our actions. Clinical conditions affecting frontal-subcortical connections outside of the FL can also lead to executive dysfunctions and frontal lobe syndrome (FLS). This case report is about an adolescent patient diagnosed as FLS. The clinical symptoms, assessment and treatment processes of this case are discussed in this report. The case is a 15-year-old boy that was admitted to our clinic with behavioral problems, which began after a car accident three years ago. Magnetic resonance imaging (MRI) of the brain indicated hyperintense signal increase in periventricular deep white matter that is associated with traumatic brain damage. Neuropsychological tests results (Stroop, Wisconsin Card Sorting Test, Serial Digit Learning Test, Line Orientation Test, Verbal Memory Processes Scale) have demonstrated impairment in cognitive flexibility, verbal fluency, setting priority, inappropriate response inhibition, sustained attention, planning, problem solving, organization skills and subcortical memory functions. We thought that cognitive and behavioral symptoms of this case were associated with the dysfunctions of frontal-subcortical circuits, independent of an obvious frontal lesion. FLS for the patients with sudden-onset behavioral and cognitive problems after head traumas should be kept in mind in differential diagnosis, even in the absence of an obvious frontal lesion.	[Metin, Ozge] Cukurova Univ, Adana, Turkey; [Yolga Tahiroglu, Aysegul] Cukurova Univ, Tip Fak, Cocuk & Ergen Ruh Sagligi & Hastaliklari AD, Adana, Turkey; [Tufan, Ali Evren] Abant Izzet Baysal Univ, Tip Fak, Cocuk & Ergen Ruh Sagligi & Hastaliklari AD, Bolu, Turkey; [Cevher Binici, Nagihan] Behcet Uz Cocuk Hastaliklari & Cerrahisi Egitim &, Cocuk & Ergen Psikiyatri Bl, Izmir, Turkey; [Saracli, Ozge] Zonguldak Bulent Ecevit Univ, Tip Fak, Ruh Sagligi & Hastaliklari AD, Zonguldak, Turkey; [Atalay, Adnan] Hitit Univ, Corum Egitim & Arastirma Hastanesi, Psikiyatri Bl, Corum, Turkey		Metin, O (corresponding author), Cukurova Univ, Adana, Turkey.	drozgem@gmail.com	Cevher, Nagihan/Q-2206-2018; Tufan, Evren/C-5074-2015	Cevher, Nagihan/0000-0002-4715-1768; Tufan, Evren/0000-0001-5207-6240			Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Aydin N, 2009, TURKIYE KLIN, V2, P47; Basselin M, 2008, NEUROCHEM RES, V33, P2229, DOI 10.1007/s11064-008-9700-2; Burnett DM, 1999, NEUROREHABILITATION, V13, P165; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; HARIRI AG, 2004, ANADOLU PSIKIYATR DE, V5, P179; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Karakal S, 2011, BILNOT COCUK, V1; Karakas Hakki Muammer, 2006, Diagn Interv Radiol, V12, P9; Karakas HM, 2001, KLIN PSIKIYATRI DERG, V4, P79; Koroglu E, 1994, MENTAL BOZUKLULDARIN; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Lyketsos CG, 2004, PSYCHOSOMATICS, V45, P247, DOI 10.1176/appi.psy.45.3.247; Mizoguchi Y, 2002, J NEUROPSYCH CLIN N, V14, P87, DOI 10.1176/appi.neuropsych.14.1.87-a; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Mori E, 2002, ANN NY ACAD SCI, V977, P141, DOI 10.1111/j.1749-6632.2002.tb04809.x; Nishio Y, 2003, EUR J NEUROL, V10, P457, DOI 10.1046/j.1468-1331.2003.00628.x; Oktem Tanor, 2011, OKTEM SOZEL BELLEK S; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; Silver BV, 2003, BRAIN INJURY, V17, P237, DOI 10.1080/0269905021000013192; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Zimnitzky BM, 1996, J CHILD ADOL PSYCHOP, V6, P75, DOI 10.1089/cap.1996.6.75	31	3	3	1	24	TURKIYE SINIR VE RUH SAGLIGI DERNEGI	YENISEHIR	PK 401, YENISEHIR, 06442, TURKEY	1300-2163			TURK PSIKIYATR DERG	Turk. Psikiyatr. Derg.	SUM	2017	28	2					135	138		10.5080/u14849			4	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	FC3JC	WOS:000406733900010	29192947	gold			2022-02-06	
J	Milbourn, HR; Toomey, LM; Gavriel, N; Gray, CGG; Gough, AH; Giacci, MK; Fitzgerald, M				Milbourn, Hannah R.; Toomey, Lillian M.; Gavriel, Nikolas; Gray, Chloe G. G.; Gough, Alexander H.; Giacci, Marcus K.; Fitzgerald, Melinda			Limiting Oxidative Stress Following Neurotrauma with a Combination of Ion Channel Inhibitors	DISCOVERY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; OLIGODENDROCYTE PRECURSOR CELLS; AMPA RECEPTOR ANTAGONIST; SPINAL-CORD-INJURY; BRILLIANT BLUE G; CHRONIC SECONDARY DEGENERATION; REGIONAL CEREBRAL EDEMA; OPTIC-NERVE INJURY; FREE-RADICALS; POLY(ADP-RIBOSE) SYNTHETASE	Following injury to the central nervous system, secondary degeneration is mediated by Ca2+ imbalances and overproduction of reactive oxygen species from mitochondria, and is associated with myelin deficits and loss of function. Preventing intracellular Ca2+ influx at the acute phase of injury is a potential strategy for limiting these deficits and preserving function. The use of single ion channel inhibitors has had little success in attenuating morphological and functional deficits, potentially due to the many pathways by which calcium can traverse the cell membrane. Focus has shifted to the simultaneous administration of a combination of ion channel inhibitors: lomerizine, oxATP, and YM872. The combination has resulted in reductions in oxidative damage, as well as preservation of function and myelin ultrastructure, potentially due to the protection of oligodendrocytes and their progenitors. The use of multiple ion channel inhibitors is promising and suggests a reduction in total intracellular Ca2+ influx is necessary and sufficient for the protection of neurons and glia following neurotrauma. Optimization of treatment timing, inhibitor choice, and method of delivery will be required for translation of this strategy to the clinic.	[Milbourn, Hannah R.; Toomey, Lillian M.; Gavriel, Nikolas; Gray, Chloe G. G.; Gough, Alexander H.; Giacci, Marcus K.] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6102, Australia.; Fitzgerald, M (corresponding author), Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Fehily, Brooke/0000-0002-8432-4621; Milbourn, Hannah/0000-0003-4479-8635; Toomey, Lillian/0000-0001-9435-6128			Atsumi T, 2003, ACT NEUR S, V86, P305; Bai HY, 2013, NEUROSCI BULL, V29, P390, DOI 10.1007/s12264-013-1338-7; Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bernardo A, 2009, J NEUROPATH EXP NEUR, V68, P797, DOI 10.1097/NEN.0b013e3181aba2c1; BORGES K, 1994, NEUROSCIENCE, V63, P135, DOI 10.1016/0306-4522(94)90012-4; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Chu KT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-69; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; DYKENS JA, 1994, J NEUROCHEM, V63, P584; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; FULTON BP, 1992, J NEUROSCI, V12, P4816; Furukawa T, 2003, J NEUROTRAUM, V20, P269, DOI 10.1089/089771503321532851; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hara H, 1999, CLIN EXP PHARMACOL P, V26, P870, DOI 10.1046/j.1440-1681.1999.03154.x; Hartline DK, 2008, NEURON GLIA BIOL, V4, P153, DOI 10.1017/S1740925X09990263; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HUSAIN J, 1995, BRAIN RES, V698, P86, DOI 10.1016/0006-8993(95)00832-B; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Karim MD, 2006, CURR EYE RES, V31, P273, DOI 10.1080/02713680500536647; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kruman I, 1997, J NEUROSCI, V17, P5089; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; L Shahsuvaryan Marianne, 2013, Med Hypothesis Discov Innov Ophthalmol, V2, P41; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; Mylonas C, 1999, IN VIVO, V13, P295; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nishiyama Tomoki, 2004, J Anesth, V18, P113, DOI 10.1007/s00540-004-0230-z; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Ren YL, 2014, J CHROMATOGR B, V947, P96, DOI 10.1016/j.jchromb.2013.12.026; Ridderstrom M, 2014, NEUROREPORT, V25, P1405, DOI 10.1097/WNR.0000000000000286; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Seo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103174; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shimizu-Sasamata M, 1998, STROKE, V29, P2141, DOI 10.1161/01.STR.29.10.2141; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Szabo C, 1997, BIOCHEM SOC T, V25, P919, DOI 10.1042/bst0250919; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Takahashi M, 2002, CNS DRUG REV, V8, P337; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Vatassery GT, 2004, NEUROCHEM INT, V45, P963, DOI 10.1016/j.neuint.2004.06.009; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yamaya Y, 2002, J NEUROSCI RES, V70, P588, DOI 10.1002/jnr.10425; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608; Zang DW, 2003, J NEUROTRAUM, V20, P1215, DOI 10.1089/089771503770802880; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	108	3	4	1	4	DISCOVERY MEDICINE	TIMONIUM	10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA	1539-6509	1944-7930		DISCOV MED	Discov. Med.	JUN	2017	23	129					361	369					9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FH9UO	WOS:000411558700003	28877447				2022-02-06	
J	Mustafa, G; Hou, LM; Nelson, R; Tsuda, S; Jahan, M; Mohammad, NS; Watts, JV; Thompson, FJ; Bose, P				Mustafa, Golam; Hou, Liamei; Nelson, Rachel; Tsuda, Shigeharu; Jahan, Mansura; Mohammad, Naweed S.; Watts, Joseph V.; Thompson, Floyd J.; Bose, Prodip			Mild closed head traumatic brain injury-induced changes in monoamine neurotransmitters in the trigeminal subnuclei of a rat model: mechanisms underlying orofacial allodynias and headache	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; mild to moderate traumatic brain injury; trigeminal sensory system; neuro-modulators; facial and somatic allodynia; thermal hyperalgesia; headache; migraine; neural regeneration	CEREBRAL VASOCONSTRICTION SYNDROME; CHRONIC PAIN; STIMULATION; MIGRAINE; NEURONS; NUCLEUS; PATHOPHYSIOLOGY; CLASSIFICATION; SENSITIZATION; SPASTICITY	Our recent findings have demonstrated that rodent models of closed head traumatic brain injury exhibit comprehensive evidence of progressive and enduring orofacial allodynias, a hypersensitive pain response induced by non-painful stimulation. These allodynias, tested using thermal hyperalgesia, correlated with changes in several known pain signaling receptors and molecules along the trigeminal pain pathway, especially in the trigeminal nucleus caudalis. This study focused to extend our previous work to investigate the changes in monoamine neurotransmitter immunoreactivity changes in spinal trigeminal nucleus oralis, pars interpolaris and nucleus tractus solitaries following mild to moderate closed head traumatic brain injury, which are related to tactile allodynia, touch-pressure sensitivity, and visceral pain. Our results exhibited significant alterations in the excitatory monoamine, serotonin, in spinal trigeminal nucleus oralis and pars interpolaris which usually modulate tactile and mechanical sensitivity in addition to the thermal sensitivity. Moreover, we also detected a robust alteration in the expression of serotonin, and inhibitory molecule norepinephrine in the nucleus tractus solitaries, which might indicate the possibility of an alteration in visceral pain, and existence of other morbidities related to solitary nucleus dysfunction in this rodent model of mild to moderate closed head traumatic brain injury. Collectively, widespread changes in monoamine neurotransmitter may be related to orofacial allodynhias and headache after traumatic brain injury.	[Mustafa, Golam; Hou, Liamei; Nelson, Rachel; Jahan, Mansura; Mohammad, Naweed S.; Watts, Joseph V.; Thompson, Floyd J.; Bose, Prodip] North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr Excellence, Gainesville, FL 32608 USA; [Mustafa, Golam; Hou, Liamei; Tsuda, Shigeharu; Thompson, Floyd J.; Bose, Prodip] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Thompson, Floyd J.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Bose, Prodip] Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA		Bose, P (corresponding author), North Florida South Georgia Vet Hlth Syst, Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr Excellence, Gainesville, FL 32608 USA.; Bose, P (corresponding author), Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.; Bose, P (corresponding author), Univ Florida, Coll Med, Dept Neurol, McKnight Brain Inst, Gainesville, FL 32611 USA.	pkbose@ufl.edu			United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service [B6570R, B78071, B1005-R]; Veterans AffairsUS Department of Veterans Affairs [I01RX001005] Funding Source: NIH RePORTER	This work was supported by Merit Review Awards (No. B6570R, B78071, and B1005-R) from the United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service.	Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Bernstein AI, 2013, TOXICOL LETT, V219, P93, DOI 10.1016/j.toxlet.2013.03.003; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Bose P, 2005, EXP NEUROL, V191, P13, DOI 10.1016/j.expneurol.2004.08.028; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Chen SL, 2008, AM J PHYSIOL-GASTR L, V294, pG1441, DOI 10.1152/ajpgi.00588.2007; Cortelli P, 2003, NEUROL SCI, V24, pS68; Couturier EGM, 1997, CEPHALALGIA, V17, P188, DOI 10.1046/j.1468-2982.1997.1703188.x; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Deyama S, 2009, BEHAV BRAIN RES, V197, P279, DOI 10.1016/j.bbr.2008.08.024; Ducros A, 2016, HEADACHE, V56, P657, DOI 10.1111/head.12797; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Eriksen MK, 2004, EUR J NEUROL, V11, P583, DOI 10.1111/j.1468-1331.2004.00890.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goldsmith T, 2000, INT ANESTHESIOL CLIN, V38, P219, DOI 10.1097/00004311-200007000-00013; Hines ME, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P375; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KESSLER JP, 1985, EUR J PHARMACOL, V118, P77, DOI 10.1016/0014-2999(85)90665-X; Kitchen AM, 2006, AM J PHYSIOL-HEART C, V290, pH807, DOI 10.1152/ajpheart.00889.2005; Limmroth V, 1996, J NEUROL SCI, V138, P60, DOI 10.1016/0022-510X(95)00344-2; Limmroth V, 2007, HEADACHE, V47, P13, DOI 10.1111/j.1526-4610.2007.00648.x; Lipton RB, 2004, NEUROLOGY, V63, P427, DOI 10.1212/01.WNL.0000133301.66364.9B; Machado BH, 2000, AM J PHYSIOL-HEART C, V279, pH67, DOI 10.1152/ajpheart.2000.279.1.H67; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller TR, 2015, AM J NEURORADIOL, V36, P1580, DOI 10.3174/ajnr.A4215; Miller TR, 2015, AM J NEURORADIOL, V36, P1392, DOI 10.3174/ajnr.A4214; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Noseda R, 2013, PAIN S, V154, P1, DOI DOI 10.1016/J.PAIN.2013.07.021; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Saito Y, 2006, NEUROPEDIATRICS, V37, P115, DOI 10.1055/s-2006-924428; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; SESSLE BJ, 1986, PAIN, V27, P219, DOI 10.1016/0304-3959(86)90213-7; Sokolov AY, 2012, J HEADACHE PAIN, V13, P75, DOI 10.1007/s10194-011-0404-7; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tsuda S, 2016, 322 TRAUMATIC BRAIN; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102	47	3	4	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2017	12	6					981	986		10.4103/1673-5374.208594			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EZ9YU	WOS:000405087300023	28761433	Green Published, gold			2022-02-06	
J	Stucky, EC; Erndt-Marino, J; Schloss, RS; Yarmush, ML; Shreiber, DI				Stucky, Elizabeth C.; Erndt-Marino, Joshua; Schloss, Rene S.; Yarmush, Martin L.; Shreiber, David I.			Prostaglandin E-2 Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory Response	NANO LIFE			English	Article						Astroglia; inflammatory mediators; mesenchymal stromal cells; prostaglandin E-2; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; PGE(2) EP2 RECEPTOR; STEM-CELLS; NEUROTROPHIC FACTORS; EXCITOTOXIC INJURY; NEURONAL SURVIVAL; INNATE IMMUNITY; RAT	Astroglia are well known for their role in propagating secondary injury following brain trauma. Modulation of this injury cascade, including inflammation, is essential to repair and recovery. Mesenchymal stromal cells (MSCs) have been demonstrated as trophic mediators in several models of secondary CNS injury, however, there has been varied success with the use of direct implantation due to a failure to persist at the injury site. To achieve sustained therapeutic benefit, we have encapsulated MSCs in alginate microspheres and evaluated the ability of these encapsulated MSCs to attenuate neuro-inflammation. In this study, astroglial cultures were administered lipopolysaccharide (LPS) to induce inflammation and immediately co-cultured with encapsulated or monolayer human MSCs. Cultures were assayed for the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-alpha) produced by astroglia, MSC-produced prostaglandin E-2, and expression of neurotrophin-associated genes. We found that encapsulated MSCs significantly reduced TNF-alpha produced by LPS-stimulated astrocytes more effectively than monolayer MSCs, and this enhanced benefit commences earlier than that of monolayer MSCs. Furthermore, in support of previous findings, encapsulated MSCs constitutively produced high levels of PGE(2), while monolayer MSCs required the presence of inflammatory stimuli to induce PGE(2) production. The early, constitutive presence of PGE(2) significantly reduced astrocyte-produced TNF-alpha, while delayed administration had no effect. Finally, MSC-produced PGE(2) was not only capable of modulating inflammation, but appeared to have an additional role in stimulating astrocyte neurotrophin production. Overall, these results support the enhanced benefit of encapsulated MSC treatment, both in modulating the inflammatory response and providing neuroprotection.	[Stucky, Elizabeth C.] Rutgers State Univ, Dept Chem & Biochem Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA; [Erndt-Marino, Joshua] Coll New Jersey, Dept Biomed Engn, 2000 Pennington Rd, Ewing, NJ 08628 USA; [Schloss, Rene S.; Yarmush, Martin L.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA		Stucky, EC (corresponding author), Rutgers State Univ, Dept Chem & Biochem Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.	ecstucky@rutgers.edu; erndtj2@rpi.edu; schloss@soemail.rutgers.edu; yarmush@rci.rutgers.edu; shreiber@rci.rutgers.edu	Shreiber, David/ABE-8254-2021	Stucky Hunter, Elizabeth/0000-0003-0797-9453; Shreiber, David/0000-0001-8248-419X	New Jersey Commission on Brain Injury Research [SNJDHSSCBIR-CBIE12IPG019, 10-3215-BIR-E-0]; National Institute of Health GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB002503]; Rutgers-UMDNJ Biotechnology Training Fellowship [T32GM00008339e21]; NSF Stem Cell IGERT Fellowship [0801620]; NSF REUNational Science Foundation (NSF)NSF - Office of the Director (OD) [NSF-EEC-1262924]; Div Of Engineering Education and CentersNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1262924] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This research was supported by the New Jersey Commission on Brain Injury Research (SNJDHSSCBIR-CBIE12IPG019 and 10-3215-BIR-E-0), National Institute of Health Grant P41EB002503, Rutgers-UMDNJ Biotechnology Training Fellowship T32GM00008339e21, NSF Stem Cell IGERT Fellowship 0801620, and NSF-EEC-1262924 NSF REU Site: Cellular Bioengineering - From Biomaterials to Stem Cells.	Ae T, 2010, AM J PHYSIOL-GASTR L, V299, pG1139, DOI 10.1152/ajpgi.00013.2010; Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad M, 2007, J NEUROIMMUNOL, V184, P172, DOI 10.1016/j.jneuroim.2006.12.012; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barminko J, 2011, BIOTECHNOL BIOENG, V108, P2747, DOI 10.1002/bit.23233; Barminko JA, 2014, BIOTECHNOL BIOENG, V111, P2239, DOI 10.1002/bit.25282; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Bernardino L, 2008, J NEUROCHEM, V106, P271, DOI 10.1111/j.1471-4159.2008.05387.x; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; da Costa BLDA, 2009, NEUROCHEM INT, V55, P199, DOI 10.1016/j.neuint.2009.02.015; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Goulet JL, 2004, J IMMUNOL, V173, P1321, DOI 10.4049/jimmunol.173.2.1321; Hamdi Y, 2011, J NEUROCHEM, V118, P416, DOI 10.1111/j.1471-4159.2011.07315.x; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Hutchinson AJ, 2009, NEUROCHEM INT, V54, P439, DOI 10.1016/j.neuint.2009.01.018; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI200214459; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawamori T, 2003, CARCINOGENESIS, V24, P985, DOI 10.1093/carcin/bgg033; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Layla TG, 2011, NEUROL RES INT, V2011, P1; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; Li XW, 2012, FASEB J, V26, P3075, DOI 10.1096/fj.11-200279; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Liu D, 2005, ANN NEUROL, V57, P758, DOI 10.1002/ana.20461; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748; Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Meja KK, 1997, BRIT J PHARMACOL, V122, P149, DOI 10.1038/sj.bjp.0701360; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakano H, 2001, BRIT J PHARMACOL, V133, P438, DOI 10.1038/sj.bjp.0704092; Nakayama Y, 2002, ANESTHESIOLOGY, V97, P1254, DOI 10.1097/00000542-200211000-00032; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; PETROSKI RE, 1991, DEV BIOL, V147, P1, DOI 10.1016/S0012-1606(05)80002-8; Rahmat Z, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt160; Reinold H, 2005, J CLIN INVEST, V115, P673; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Schafer S, 2012, J NEUROIMMUNOL, V249, P40, DOI 10.1016/j.jneuroim.2012.04.018; Schreiner A.E., 2013, ISRN NEUROL, V2013; Shastri A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/342931; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stucky EC, 2015, CYTOTHERAPY, V17, P1353, DOI 10.1016/j.jcyt.2015.05.002; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Szczepanik AM, 1996, NEUROSCIENCE, V70, P57, DOI 10.1016/0306-4522(95)00296-U; Thanos CG, 2007, J BIOMED MATER RES A, V81A, P1, DOI 10.1002/jbm.a.31033; Toyomoto M, 2004, FEBS LETT, V562, P211, DOI 10.1016/S0014-5793(04)00246-7; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Woodling NS, 2014, J NEUROSCI, V34, P5882, DOI 10.1523/JNEUROSCI.0410-14.2014; Wu LJ, 2007, NEUROSCI LETT, V421, P253, DOI 10.1016/j.neulet.2007.05.055; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Zhang LL, 2000, J NEUROSCI RES, V62, P389, DOI 10.1002/1097-4547(20001101)62:3<389::AID-JNR9>3.0.CO;2-M; Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004	81	3	3	0	6	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-9844	1793-9852		NANO LIFE	Nano Life	JUN	2017	7	2							UNSP 1750005	10.1142/S1793984417500052			13	Materials Science, Biomaterials	Emerging Sources Citation Index (ESCI)	Materials Science	EZ1KQ	WOS:000404470300005	29682085	Green Accepted			2022-02-06	
J	Yuan, L; Wei, FL; Zhang, X; Guo, XH; Lu, XF; Su, B; Zhang, T; Wu, H; Chen, DX				Yuan, Lin; Wei, Feili; Zhang, Xin; Guo, Xianghua; Lu, Xiaofan; Su, Bin; Zhang, Tong; Wu, Hao; Chen, Dexi			Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder	AGING AND DISEASE			English	Article						HIV; ICAM5; cognitive impairment; biomarker	TRAUMATIC BRAIN-INJURY; HAART ERA; ICAM-5; BIOMARKERS; TELENCEPHALIN; IMPAIRMENT; SERUM; DYSFUNCTION; PREVALENCE; ACTIVATION	Despite the use of antiretroviral drugs HIV associated neurocognitive disorders (HAND) are still common in HIV-seropositive patients. Identification of HIV patients with cognitive impairment in early-stage might benefit a great deal from disease progression monitoring and treatment adjustment. Intercellular adhesion molecule-5 (ICAM5), characteristically expressed on neuron, may suppress immune functions by inhibition of T cell activation in central nervous system. Previous studies have shown that ICAM5 could be detected in patients with brain injury. To investigate the relationship between cognitive impairment and ICAM5 in HIV patients, we compared soluble ICAM5 levels in paired CSF and plasma specimens from HIV-infected individuals with or without neurocognitive impairment. sICAM5 concentrations were measured by ICAM5 ELISA kit. A total of 41 Patients were classified into HIV infected with normal cognition (HIV-NC) and impaired cognition groups (HIV-CI) based on Memorial Sloan-Kettering Scale. CSF and plasma levels of sICAM5 in HIVCI patients were significantly higher than HIV-NC group (p<0.0001, p=0.0054 respectively). sICAM5 concentrations in plasma strongly correlated with sICAM5 in CSF (r = 0.7250, p<0.0001) and S100B in CSF (r=0.3812, p<0.0139). Among 6 follow-up patients we found that sICAM5 levels in CSF and plasma might change consistently with HAND progression. In summary, we have shown that the expressions of sICAM5 in CSF and plasma may correlate with neurocognitive impairment in HIV infected patients. The elevation of sICAM5 in plasma were correspond with that in CSF as a consequence of blood-brain barrier permeability changes. ICAM5 can serve as a potential and readily accessible biomarker to predict HIV associated neurocognitive disorder.	[Yuan, Lin; Zhang, Xin; Lu, Xiaofan; Su, Bin; Zhang, Tong; Wu, Hao] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing 100069, Peoples R China; [Wei, Feili; Guo, Xianghua; Chen, Dexi] Capital Med Univ, Beijing Inst Hepatol, Beijing Youan Hosp, Beijing 100069, Peoples R China; [Chen, Dexi] Qingdao Univ, Affiliated Hosp, Organ Transplantat Ctr, Qingdao 266003, Shandong, Peoples R China		Wu, H; Chen, DX (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China.	whdoc900@hotmail.com; dexichen@ccmu.edu.cn			Beijing Municipal Science and Technology Program [Z141100002114037]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272266, 81361120401]; Capital Health Research and Development Special grants [2014-1-1151]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20150502]; AIDS Research Beijing Key Laboratory [BZ0089]	This work was supported by grants from Beijing Municipal Science and Technology Program (Z141100002114037), the National Natural Science Foundation of China (81272266 and 81361120401), the Capital Health Research and Development Special grants (2014-1-1151), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20150502) and AIDS Research Beijing Key Laboratory (BZ0089).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Bandaru VVR, 2007, NEUROLOGY, V68, P1481, DOI 10.1212/01.wnl.0000260610.79853.47; Bebell LM, 2008, J INFECT DIS, V198, P710, DOI 10.1086/590503; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Chavarria A, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00064; Clifford DB, 2009, NEUROLOGY, V73, P1982, DOI 10.1212/WNL.0b013e3181c5b445; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Conant K, 2011, J NEUROCHEM, V118, P521, DOI 10.1111/j.1471-4159.2010.07153.x; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Gahmberg CG, 2008, IMMUNOL LETT, V117, P131, DOI 10.1016/j.imlet.2008.02.004; Guo H, 2000, ANN NEUROL, V48, P590, DOI 10.1002/1531-8249(200010)48:4<590::AID-ANA5>3.3.CO;2-Z; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hino H, 1997, BRAIN RES, V753, P353, DOI 10.1016/S0006-8993(97)00158-3; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Lindsberg PJ, 2002, NEUROLOGY, V58, P446, DOI 10.1212/WNL.58.3.446; McGuire D, 2009, NEUROLOGY, V73, P1942, DOI 10.1212/WNL.0b013e3181c51a92; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Ning L, 2013, J CELL SCI, V126, P77, DOI 10.1242/jcs.106674; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Price RW, 2007, NEUROLOGY, V69, P1781, DOI 10.1212/01.wnl.0000278457.55877.eb; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Rieckmann P, 1998, LANCET, V352, P370, DOI 10.1016/S0140-6736(05)60469-2; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357; Tian L, 2008, BLOOD, V111, P3615, DOI 10.1182/blood-2007-09-111179; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Tse MCL, 2009, J NEUROIMMUNOL, V213, P12, DOI 10.1016/j.jneuroim.2009.06.007; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Wright EJ, 2008, J NEUROVIROL, V14, P465, DOI 10.1080/13550280802235932; Wu H, 2016, BRAIN RES, V1637, P154, DOI 10.1016/j.brainres.2016.02.026; Yuan L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/506872; Yuan L, 2013, J NEUROVIROL, V19, P144, DOI 10.1007/s13365-013-0150-5	35	3	4	0	5	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	JUN	2017	8	3					250	256		10.14336/AD.2016.0918			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	EZ2HK	WOS:000404530200001	28580181	Green Published, Green Submitted, gold			2022-02-06	
J	Xiao, Y; Fu, YG; Zhou, Y; Xia, JG; Wang, LN; Hu, CH				Xiao, Yong; Fu, Yigang; Zhou, Yi; Xia, Jianguo; Wang, Lina; Hu, Chunhong			Proton Magnetic Resonance Spectroscopy (H-1-MRS) Study of Early Traumatic Brain Injury in Rabbits	MEDICAL SCIENCE MONITOR			English	Article						Brain Injuries; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy		Background: The aim of this study was to investigate the relationship between dynamic changes of cerebral metabolism and degree of trauma in rabbit models of traumatic brain injury (TBI) by using proton magnetic resonance spectroscopy (1H-MRS). Material/Methods: Thirty-five Chinese rabbits were randomly divided into control, mild, moderate, and severe TBI groups. 1H-MRS was performed 1, 6, and 24 h after trauma. The concentrations of NAA, Cr, Cho, and Lac, and NAA/Cr and Cho/Cr ratios in each group, were estimated. Results: Compared with the control group, NAA, Cr, and Cho peaks were decreased. NAA/Cr ratio in the ipsilateral cortex was reduced in the mild, moderate, and severe TBI groups by 12.79%, 28.90%, and 45.02% at 1 h, and decreased by 25.11%, 39.81%, and 51.18% at 24 h after trauma, respectively. There were significant negative correlations between NAA/Cr ratio and severity of attack. Cho/Cr ratio in the ipsilateral cortex in the mild, moderate, and severe TBI groups was decreased by 10.86%, 15.94%, and 34.78% at 1 h, and reduced by 24.63%, 29.71%, and 42.02% at 6 h, respectively, and increased slightly at 24 h after trauma. The Lac/Cr ratio in the injured side was increased, most obviously in the severe TBI group. NAA/Cr ratio and Cho/Cr ratio showed significant changes between each group at the same time point. Conclusions: 1H-MRS can noninvasively and dynamically detect metabolic changes in early TBI. The NAA/Cr ratio is most sensitive, and has positive significance for early diagnosis and prognosis assessment of TBI.	[Xiao, Yong; Hu, Chunhong] Soochow Univ, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Xiao, Yong; Fu, Yigang; Zhou, Yi] Yancheng First Peoples Hosp, Yancheng, Jiangsu, Peoples R China; [Xia, Jianguo] Taizhou Peoples Hosp, Taizhou, Zhejiang, Peoples R China; [Wang, Lina] Jiangsu Vocat Coll Med, Yancheng, Jiangsu, Peoples R China		Hu, CH (corresponding author), Soochow Univ, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China.	sdhuchunhong@sina.com					Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; [王秀彬 Wang Xiubin], 2013, [实用放射学杂志, Journal of Practical Radiology], V29, P1334; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; [杨昂 Yang Ang], 2015, [临床放射学杂志, Journal of Clinical Radiology], V34, P186; [叶伟 Ye Wei], 2010, [中华神经外科杂志, Chinese Journal of Neurosurgery], V26, P510; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zhang GB, 2006, ESTABLISHMENT SEVERE	15	3	3	0	6	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAY 19	2017	23						2365	2372		10.12659/MSM.904788			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EV5UM	WOS:000401833100002	28524120	Green Published, Green Submitted			2022-02-06	
J	Andersson, E; Rackauskaite, D; Svanborg, E; Csajbok, L; Ost, M; Nellgard, B				Andersson, E.; Rackauskaite, D.; Svanborg, E.; Csajbok, L.; Ost, M.; Nellgard, B.			A prospective outcome study observing patients with severe traumatic brain injury over 10-15 years	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							SEVERE HEAD-INJURY; LUND CONCEPT; FOLLOW-UP; SCALE; DISABILITY; FATIGUE; REHABILITATION; PRINCIPLES; MANAGEMENT; MORTALITY	Background: Severe traumatic brain injury (sTBI) can be divided into primary and secondary injuries. Intensive care protocols focus on preventing secondary injuries. This prospective cohort study was initiated to investigate outcome, including mortality, in patients treated according to the Lund Concept after a sTBI covering 10-15 years post-trauma. Methods: Patients were included during 2000-2004 when admitted to the neurointensive care unit, Sahlgrenska University Hospital. Inclusion criteria were: Glasgow coma scale score of 8, need for artificial ventilation and intracranial monitoring. Glasgow Outcome Scale (GOS) was used to evaluate outcome both at 1-year and 10-15 years post-trauma. Results: Ninety-five patients, (27 female and 68 male), were initially included. Both improvement and deterioration were noted between 1- and 10-15 years post-injury. Mortality rate (34/95) was higher in the studied population vs. a matched Swedish population, (Standard mortality rate (SMR) 9.5; P < 0.0001). When dividing the cohort into Good (GOS 4-5) and Poor (GOS 2-3) outcome at 1-year, only patients with Poor outcome had a higher mortality rate than the matched population (SMR 7.3; P < 0.0001). Further, good outcome (high GOS) at 1-year was associated with high GOS 10-15 years post-trauma (P < 0.0001). Finally, a majority of patients demonstrated symptoms of mental fatigue. Conclusion: This indicates that patients with severe traumatic brain injury with Good outcome at 1-year have similar survival probability as a matched Swedish population and that high Glasgow outcome scale at 1-year is related to good long-term outcome. Our results further emphasise the advantage of the Lund concept.	Sahlgrens Univ Hosp, Dept Anaesthesiol & Intens Care Med, Gothenburg, Sweden; Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden		Andersson, E (corresponding author), Sahlgrenska Univ Hosp Molndal, Dept Anaesthesia & Intens Care, Goteborgsvagen 31, S-43180 Molndal, Sweden.	emma.a.andersson@vgregion.se	Ost, Martin/AAY-5827-2020		Stroke Foundation, Sweden; Medical Faculty, University of Gothenburg, Sweden	This study was supported by the Stroke Foundation, Sweden, and the Medical Faculty, University of Gothenburg, Sweden.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2000, SCHWEIZ MED WSCHR, V130, P1538; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MAHONEY F I, 1965, Md State Med J, V14, P61; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Ronnback L, 2016, HJARNTROTTHET; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Svensson E, 2002, J REHABIL MED, V34, P251, DOI 10.1080/165019702760390338; Taw BBT, 2012, ASIAN J SURG, V35, P117, DOI 10.1016/j.asjsur.2012.04.027; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Ulfarsson T, 2014, BRAIN INJURY, V28, P1675, DOI 10.3109/02699052.2014.947625; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	42	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAY	2017	61	5					502	512		10.1111/aas.12880			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	ER1OM	WOS:000398561700006	28374472				2022-02-06	
J	Darvishi, H; Rezaei, M; Khodayar, MJ; Zargar, HR; Dehghani, MA; Vardanjani, HR; Ghanbari, S				Darvishi, Hadi; Rezaei, Mohsen; Khodayar, Mohammad Javad; Zargar, Hamid Reza; Dehghani, Mohammad Amin; Vardanjani, Hossein Rajabi; Ghanbari, Sahebeh			Differential Effects of Meloxicam on Pentylenetetrazole- and Maximal Electroshock-Induced Convulsions in Mice	JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS			English	Article						Meloxicam; Pentylenetetrazole; Maximal Electroshock; Convulsions; Mice	TRAUMATIC BRAIN INJURY; COX-2 INHIBITOR; ANTICONVULSANT ACTIVITY; CYCLOOXYGENASE INHIBITORS; SEIZURES; EPILEPSY; INFLAMMATION; MECHANISM; DISEASE; DRUGS	Background: Epilepsy is a group of disorders associated with the abnormal electrical activity of different regions of the brain. The use of anticonvulsant drugs is limited because of their low efficacy, side effects, and toxicity. Therefore, research on new drugs for epilepsy is required. Meloxicam is a non-steroidal anti-inflammatory drug with several biological effects, such as antioxidant, neuroprotective, and anti-inflammatory. Objectives: Earlier studies gave conflicting reports on the effect of cyclooxygenase inhibitors on seizures. Accordingly, this study was designed to evaluate the effects of meloxicam on pentylenetetrazole (PTZ) and maximal electroshock (MES) models of convulsions Methods: For each model of convulsion, 48 mice were randomly divided into 6 groups of 8 animals. Group I in two models of convulsions were considered as the control group and the intraperitoneally (i.p.) received vehicle (10 mL/kg). Group II in the PTZ model received the reference anticonvulsant drug, diazepam (1 mg/kg, i.p.), and group II in the MES model was treated with phenytoin (25 mg/kg, i.p.). Groups III-VI in two models of convulsions received four different doses of meloxicam (2.5, 5, 10, and 20 mg/kg, i.p.), respectively. Thirty minutes later, convulsion was induced by PTZ (85 mg/kg, i.p.) in PTZ model and by using ear-clip electrodes in the MES model of convulsion. Results: In the PTZ model, meloxicam showed a significant delayed onset of seizures, Straub's tail, and myoclonic seizure. Different doses of meloxicam reduced the mortality of animals in the PTZ model. In the MES model, meloxicam did not change the duration of hindlimb tonic extension and caused the death of animals unlike the PTZ model. Conclusions: According to the results, meloxicam has differential effects on two PTZ and MES models of seizure. The anticonvulsant and neuroprotective effects of meloxicam on the PTZ model may be mediated by anti-inflammatory and antioxidant properties. In the MES model, meloxicam did not show any beneficial effect and aggravated convulsive behavior. In the PTZ model, prostaglandins could be involved in the induction of convulsion. Conversely, in the MES model, prostaglandins may attenuate the severity of seizure at the basal level and prevent the development of convulsions. Nevertheless, more studies must be conducted to clarify the mechanisms of action of prostaglandins and meloxicam in the two PTZ and MES models of seizure.	[Darvishi, Hadi; Khodayar, Mohammad Javad; Zargar, Hamid Reza; Dehghani, Mohammad Amin; Vardanjani, Hossein Rajabi; Ghanbari, Sahebeh] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Toxicol, Ahvaz, Iran; [Rezaei, Mohsen] Tarbiat Modares Univ, Dept Toxicol, Fac Med Sci, Tehran, Iran; [Khodayar, Mohammad Javad; Dehghani, Mohammad Amin] Ahvaz Jundishapur Univ Med Sci, Toxicol Res Ctr, Ahvaz, Iran		Khodayar, MJ (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Toxicol, Ahvaz, Iran.	jkhodayar@yahoo.com	Rezaei, Mohsen/V-5497-2019; Khodayar, Mohammad Javad/D-2779-2018	Rezaei, Mohsen/0000-0001-6823-2463; Khodayar, Mohammad Javad/0000-0001-9518-1286; Rajabi Vardanjani, Hossein/0000-0002-6793-5105	grant from the toxicology research center of Jundishapur University of Medical Sciences under Ahvaz Jundishapur University of Medical Sciences	This study was supported by a grant from the toxicology research center of Jundishapur University of Medical Sciences under the deputy of research affairs of Ahvaz Jundishapur University of Medical Sciences.	Abbasnejad M., 2012, J BABOL U MED SCI, V14, P20; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Dhir A., 2006, Inflammopharmacology, V14, P222, DOI 10.1007/s10787-006-1535-3; Dhir A, 2005, CLIN EXP PHARMACOL P, V32, P579, DOI 10.1111/j.1440-1681.2005.04233.x; Dhir A, 2007, SEIZURE-EUR J EPILEP, V16, P691, DOI 10.1016/j.seizure.2007.05.016; Dhir Ashish, 2006, Indian Journal of Experimental Biology, V44, P286; Edfawy M, 2012, INT J TOXICOL, V31, P276, DOI 10.1177/1091581812442939; Engelhardt G, 1996, BIOCHEM PHARMACOL, V51, P29, DOI 10.1016/0006-2952(95)02110-8; Gates BJ, 2005, MELOXICAM REAPPRAISA; Gurocak S, 2010, UROL, V76, P1; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Kalonia H, 2011, LIFE SCI, V88, P784, DOI 10.1016/j.lfs.2011.02.020; Katyal J, 2015, EPILEPSY BEHAV, V44, P98, DOI 10.1016/j.yebeh.2014.12.032; Kim HJ, 2008, BRAIN RES, V1193, P153, DOI 10.1016/j.brainres.2007.12.017; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Luszczki JJ, 2007, NEUROSCI RES, V59, P18, DOI 10.1016/j.neures.2007.05.004; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Mirhadi K., 2012, MIDDLE-EAST J SCI RE, V11, P272; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Namvaran A, 2012, EFFECT SALVIA OFFICI; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; PETERSON SL, 1991, BRAIN RES BULL, V26, P43, DOI 10.1016/0361-9230(91)90190-U; Rijkers K, 2009, EXP NEUROL, V216, P258, DOI 10.1016/j.expneurol.2008.12.014; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Sayyah M, 2002, J ETHNOPHARMACOL, V82, P105, DOI 10.1016/S0378-8741(02)00166-6; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Takemiya T, 2007, NEUROCHEM INT, V51, P112, DOI 10.1016/j.neuint.2007.05.009; Tegeder I, 2000, J PHARMACOL EXP THER, V292, P1161; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x; WALLENSTEIN MC, 1984, PHARMACOLOGY, V29, P85, DOI 10.1159/000137996; Zhang HJ, 2009, MED CHEM RES, V18, P71, DOI 10.1007/s00044-008-9109-0	34	3	3	0	4	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	1735-7780	2228-7876		JUNDISHAPUR J NAT PH	Jundishapur J. Nat. Pharm. Prod.	MAY	2017	12	2							e36412	10.5812/jjnpp.36412			6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	FR8FO	WOS:000419310200011		hybrid			2022-02-06	
J	Erdevig, HE; Russek, SE; Carnicka, S; Stupic, KF; Keenan, KE				Erdevig, Hannah E.; Russek, Stephen E.; Carnicka, Slavka; Stupic, Karl F.; Keenan, Kathryn E.			Accuracy of magnetic resonance based susceptibility measurements	AIP ADVANCES			English	Article; Proceedings Paper	61st Annual Conference on Magnetism and Magnetic Materials (MMM)	OCT 31-NOV 04, 2016	New Orleans, LA	AIP Publishing, IEEE Magnet soc			IRON; INVERSION; COSMOS	Magnetic Resonance Imaging (MRI) is increasingly used to map the magnetic susceptibility of tissue to identify cerebral microbleeds associated with traumatic brain injury and pathological iron deposits associated with neurodegenerative diseases such as Parkinson's and Alzheimer's disease. Accurate measurements of susceptibility are important for determining oxygen and iron content in blood vessels and brain tissue for use in noninvasive clinical diagnosis and treatment assessments. Induced magnetic fields with amplitude on the order of 100 nT, can be detected using MRI phase images. The induced field distributions can then be inverted to obtain quantitative susceptibility maps. The focus of this research was to determine the accuracy of MRI-based susceptibility measurements using simple phantom geometries and to compare the susceptibility measurements with magnetometry measurements where SI-traceable standards are available. The susceptibilities of paramagnetic salt solutions in cylindrical containers were measured as a function of orientation relative to the static MRI field. The observed induced fields as a function of orientation of the cylinder were in good agreement with simple models. The MRI susceptibility measurements were compared with SQUID magnetometry using NIST-traceable standards. MRI can accurately measure relative magnetic susceptibilities while SQUID magnetometry measures absolute magnetic susceptibility. Given the accuracy of moment measurements of tissue mimicking samples, and the need to look at small differences in tissue properties, the use of existing NIST standard reference materials to calibrate MRI reference structures is problematic and better reference materials are required. (C) 2017 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).	[Erdevig, Hannah E.; Russek, Stephen E.; Carnicka, Slavka; Stupic, Karl F.; Keenan, Kathryn E.] NIST, Phys Measurement Lab, Boulder, CO 80305 USA; [Erdevig, Hannah E.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA		Erdevig, HE (corresponding author), NIST, Phys Measurement Lab, Boulder, CO 80305 USA.; Erdevig, HE (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.			Keenan, Kathryn/0000-0001-9070-5255			Cheng YCN, 2009, PHYS MED BIOL, V54, P1169, DOI 10.1088/0031-9155/54/5/005; CUMMING RLC, 1978, PRACTITIONER, V221, P184, DOI 10.1056/NEJM199912233412607; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke E. M., 2011, SUSCEPTIBILITY WEIGH, P517; Jain V, 2012, MAGN RESON MED, V68, P863, DOI 10.1002/mrm.23282; Jensen JH, 2009, MAGN RESON MED, V61, P481, DOI 10.1002/mrm.21823; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Neelavalli J., 2011, SUSCEPTIBILITY WEIGH, P17; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sharma SD, 2015, MAGN RESON MED, V74, P673, DOI 10.1002/mrm.25448; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Tan H, 2014, INVEST RADIOL, V49, P498, DOI 10.1097/RLI.0000000000000043; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358	19	3	3	0	5	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2158-3226			AIP ADV	AIP Adv.	MAY	2017	7	5							056718	10.1063/1.4975700			6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Science & Technology - Other Topics; Materials Science; Physics	EW8VV	WOS:000402797100421		gold, Green Submitted			2022-02-06	
J	Gan, Q; Zhao, HX; Zhang, HM; You, C				Gan, Qi; Zhao, Hexiang; Zhang, Hanmei; You, Chao			Rapid Spontaneously Resolving Acute Subdural Hematoma	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Acute subdural hematoma; rapid spontaneous resolution; traumatic brain injury	SPONTANEOUS RESOLUTION; REDISTRIBUTION; HEMORRHAGE	Introduction: This study reports a rare patient of a rapid spontaneously resolving acute subdural hematoma. In addition, an analysis of potential clues for the phenomenon is presented with a review of the literature. Patient Presentation: A 1-year-and-2-month-old boy fell from a height of approximately 2 m. The patient was in a superficial coma with a Glasgow Coma Scale of 8 when he was transferred to the authors' hospital. Computed tomography revealed the presence of an acute subdural hematoma with a midline shift beyond 1 cm. His guardians refused invasive interventions and chose conservative treatment. Repeat imaging after 15 hours showed the evident resolution of the hematoma and midline reversion. Progressive magnetic resonance imaging demonstrated the complete resolution of the hematoma, without redistribution to a remote site. Conclusions: Even though this phenomenon has a low incidence, the probability of a rapid spontaneously resolving acute subdural hematoma should be considered when patients present with the following characteristics: children or elderly individuals suffering from mild to moderate head trauma; stable or rapidly recovered consciousness; and simple acute subdural hematoma with a moderate thickness and a particularly low-density band in computed tomography scans.	[Gan, Qi; You, Chao] Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Zhao, Hexiang] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming, Peoples R China; [Zhang, Hanmei] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China		You, C (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.						Batik V, 2013, CLIN NEUROL NEUROSUR, V115, P849, DOI 10.1016/j.clineuro.2012.09.007; Berker M, 2003, ACTA NEUROCHIR, V145, P715, DOI 10.1007/s00701-003-0090-6; Cosar M, 2007, TURK NEUROSURG, V17, P224; Erol FS, 2004, PEDIATR NEUROSURG, V40, P238, DOI 10.1159/000082299; Huang Shu-Hung, 2005, Kaohsiung Journal of Medical Sciences, V21, P291; Kapsalaki EZ, 2007, CLIN NEUROL NEUROSUR, V109, P287, DOI 10.1016/j.clineuro.2006.11.005; Kato N, 2001, NEUROL MED-CHIR, V41, P140, DOI 10.2176/nmc.41.140; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; Lee CH, 2009, J KOREAN MED SCI, V24, P1224, DOI 10.3346/jkms.2009.24.6.1224; Liu B, 2013, CLIN NEUROL NEUROSUR, V115, P2310, DOI 10.1016/j.clineuro.2013.06.022; Liu B, 2013, MED HYPOTHESES, V81, P159, DOI 10.1016/j.mehy.2013.05.019; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; Park Jae-Young, 2013, J Med Case Rep, V7, P67, DOI 10.1186/1752-1947-7-67; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; Shin DW, 2013, J KOREAN NEUROSURG S, V54, P431, DOI 10.3340/jkns.2013.54.5.431; Wen L, 2009, IRISH J MED SCI, V178, P367, DOI 10.1007/s11845-008-0168-5; Wong ST, 2009, SURG NEUROL, V71, P99, DOI 10.1016/j.surneu.2007.06.079; Yadav YR, 2011, INDIAN J NEUROTRAUM, V8, P45, DOI 10.1016/S0973-0508(11)80025-0	21	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2017	28	3					E287	EE289		10.1097/SCS.0000000000003533			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ET9TA	WOS:000400649800119	28468224	Green Published			2022-02-06	
J	Kalemci, O; Aydin, HE; Kizmazoglu, C; Kaya, I; Yilmaz, H; Arda, NM				Kalemci, Orhan; Aydin, Hasan Emre; Kizmazoglu, Ceren; Kaya, Ismail; Yilmaz, Hulya; Arda, Nuri M.			Effects of Quercetin and Mannitol on Erythropoietin Levels in Rats Following Acute Severe Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries; Traumatic; Quercetin; Mannitol; Erythropoietin; Hematocrit	OXIDATIVE STRESS; INTRACRANIAL-PRESSURE; HEART-DISEASE; IN-VITRO; FLAVONOIDS; MODEL; NEUROPROTECTION; GLUTATHIONE; PROTECTION; INCREASE	Objective : The aim of this study to investigate the normal values of erythropoietin (EPO) and neuroprotective effects of quercetin and mannitol on EPO and hematocrit levels after acute severe traumatic brain injury (TBI) in rat model. Methods : A weight-drop impact acceleration model of TBI was used on 40 male Wistar rats. The animals were divided into sham (group I), TBI (group II), TBI+quercetin (50 mg/kg intravenously) (group III), and TBI+mannitol (1 mg/kg intravenously) (group IV) groups. The malondialdehyde, glutathione peroxidase, catalase, EPO, and hematocrit levels were measured 1 and 4 hour after injury. Two-way repeated measures analysis of variance and Tukey's test were used for statistical analysis. Results : The malondialdehyde levels decreased significantly after administration of quercetin and mannitol compared with those in group II. Catalase and glutathione peroxidase levels increased significantly in groups III and IV. Serum EPO levels decreased significantly after mannitol but not after quercetin administration. Serum hematocrit levels did not change significantly after quercetin and mannitol administration 1 hour after trauma. However, mannitol administration decreased serum hematocrit levels significantly after 4 hour. Conclusion : This study suggests that quercetin may be a good alternative treatment for TBI, as it did not decrease the EPO levels.	[Kalemci, Orhan; Kizmazoglu, Ceren; Arda, Nuri M.] Dokuz Eylul Univ, Sch Med & Hosp, Dept Neurosurg, Izmir, Turkey; [Aydin, Hasan Emre] Eskisehir Osmangazi Univ, Dept Pharmacol, Eskisehir, Turkey; [Aydin, Hasan Emre] Dumlupinar Univ, Sch Med & Hosp, Dept Neurosurg, Kutahya, Turkey; [Kaya, Ismail] Kilis State Hosp, Dept Neurosurg, Kilis, South Korea; [Yilmaz, Hulya] Eskisehir Osmangazi Univ, Dept Biostat & Med Informat, Eskisehir, Turkey		Kalemci, O (corresponding author), Dokuz Eylul Univ, Sch Med & Hosp, Dept Neurosurg, TR-35340 Inciralti Izmir, Turkey.	okalemci@gmail.com	Kalemci, Orhan/P-6893-2019; Aydin, Hasan Emre/AAA-4657-2021; Kalemci, Orhan/Q-2503-2019; Ozen, Hulya/AAG-1731-2020; kaya, ismail/AAP-3568-2021	Kalemci, Orhan/0000-0002-8607-6860; Aydin, Hasan Emre/0000-0002-8932-1542; Ozen, Hulya/0000-0003-4144-3732; 			Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002; Balak N, 2009, J KOREAN NEUROSURG S, V45, P151, DOI 10.3340/jkns.2009.45.3.151; Basarslan SK, 2015, ULUS TRAVMA ACIL CER, V21, P235, DOI 10.5505/tjtes.2015.66502; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Blaha M, 2010, J KOREAN NEUROSURG S, V47, P7, DOI 10.3340/jkns.2010.47.1.7; Bleilevens C, 2013, EXP BRAIN RES, V224, P155, DOI 10.1007/s00221-012-3296-0; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeWitt D S, 1995, New Horiz, V3, P376; Dong YS, 2014, INT J MED SCI, V11, P282, DOI 10.7150/ijms.7634; Dugas AJ, 2000, J NAT PROD, V63, P327, DOI 10.1021/np990352n; Faria A, 2010, CELL MOL BIOL LETT, V15, P234, DOI 10.2478/s11658-010-0006-4; Fernandez SP, 2006, EUR J PHARMACOL, V539, P168, DOI 10.1016/j.ejphar.2006.04.004; Ferrali M, 2000, BIOCHEM PHARMACOL, V59, P1365, DOI 10.1016/S0006-2952(00)00273-2; Fisher JW, 2003, EXP BIOL MED, V228, P1; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2015, WORLD NEUROSURG, V84, P1491, DOI 10.1016/j.wneu.2015.05.056; Haleagrahara N, 2009, EUR J PHARMACOL, V621, P46, DOI 10.1016/j.ejphar.2009.08.030; Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Jager AK, 2011, MOLECULES, V16, P1471, DOI 10.3390/molecules16021471; Juul SE, 2009, PEDIATR RES, V65, P485, DOI 10.1203/PDR.0b013e31819d90c8; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kook D, 2008, INVEST OPHTH VIS SCI, V49, P1712, DOI 10.1167/iovs.07-0477; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Middleton E, 2000, PHARMACOL REV, V52, P673; Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ossola B, 2009, EXPERT OPIN DRUG SAF, V8, P397, DOI 10.1517/14740330903026944; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Park JE, 2009, J KOREAN NEUROSURG S, V45, P90, DOI 10.3340/jkns.2009.45.2.90; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Rangel-Ordonez L, 2010, PLANTA MED, V76, P1683, DOI 10.1055/s-0030-1249962; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rossi R, 2006, CLIN CHEM, V52, P1406, DOI 10.1373/clinchem.2006.067793; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	51	3	3	0	4	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAY	2017	60	3					355	361		10.3340/jkns.2016.0505.015			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EX3UI	WOS:000403158600013	28490163	Green Submitted, gold, Green Published			2022-02-06	
J	Langelier, DM; Schneider, KJ; Hurlbert, J; Debert, CT				Langelier, David M.; Schneider, Kathryn J.; Hurlbert, John; Debert, Chantel T.			The importance of a neck exam in sport-related concussion: Cervical schwannoma in post concussion syndrome	PHYSICAL THERAPY IN SPORT			English	Article						Neck pain; Schwannoma; Post concussion syndrome; Sport-related concussion; Mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; PAIN	Objective: Few cases of cervical schwannoma have been reported following head trauma. The present case, involves a schwannoma of the C2 spinal nerve mimicking post-concussion symptoms following a sport-related concussion (SRC). Design: Case study. Setting: University of Calgary, Sport Medicine Clinic, Calgary, Alberta, Canada. Results: We report a 28 year old, athlete who developed headache, dizziness, photophobia, and neck pain following a cycling accident. She presented nine months later to our sports clinic with persistent symptoms. She had a normal neurological examination but complained of painful neck range of.motion, and exacerbation of symptoms with neck extension. On palpation, a lump was found in the right sub occipital muscles and MRI showed a 12 hyperintense mass at the C1-2 level. The patient underwent resection and histology revealed a schwannoma of the C2 nerve root. Following resection her symptoms improved, with no recurrence at 2 months follow up. Conclusion: Our patient's slow recovery following SRC is consistent with a schwannoma formation, which may have been precipitated by the injury itself or merely unmasked from trauma. This case illustrates the importance of a thorough physical examination and broad differential in patients presenting with worsening of symptoms after initial improvement in SRC. (C) 2017 Elsevier Ltd. All rights reserved.	[Langelier, David M.; Hurlbert, John; Debert, Chantel T.] Univ Calgary, Div Phys Med & Rehabil, Foothills Med Ctr, Dept Clin Neurosci, 1403 29th ST NW, Calgary, AB T2H 2T9, Canada; [Schneider, Kathryn J.; Hurlbert, John; Debert, Chantel T.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn J.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada		Debert, CT (corresponding author), Dept Clin Neurosci, Div Phys Med & Rehabil, 1403-29 St NW, Calgary, AB T2N 2T9, Canada.	dmlangel@ucalgary.ca; kjschnei@ucalgary.ca; jhurlber@ucalgary.ca; chantel.debert@gmail.com		Schneider, Kathryn/0000-0002-5951-5899; Debert, Chantel/0000-0002-2704-0438; Langelier, David/0000-0002-9863-5084			Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Campbell DG, 1944, J NERV MENT DIS, V99, P544, DOI 10.1097/00005053-194405000-00009; Chowdhury Forhad Hossain, 2013, Acta Neurol Taiwan, V22, P59; Fedakar R, 2008, ACTA ORTHOP TRAUMATO, V42, P208, DOI 10.3944/AOTT.2008.208; FEINSTEIN B, 1954, THE JOURNAL OF BONE, V5, P981; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Givan G, 2011, CURR SPORT MED REP, V10, P37, DOI 10.1249/JSR.0b013e318205e0d7; Hingley S, 2016, ARCH DIS CHILDHOOD-E, V101, P58, DOI 10.1136/archdischild-2014-307252; Jotwani V., 2013, CURRENT SPORTS MED R, V9, P21; Kennedy W. P., 2015, LARYNGOSCOPE, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Matuszak J. M., 2016, SPORTS HLTH; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nasreddine Z., 2011, MONTREAL COGNITIVE A; Newton H B, 1995, Cancer Pract, V3, P207; Obermann M, 2015, THER ADV NEUROL DISO, V8, P311, DOI 10.1177/1756285615605699; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; RUBINSTEIN AB, 1989, NEUROSURGERY, V24, P929, DOI 10.1227/00006123-198906000-00026; Safavi-Abbasi S, 2008, J NEUROSURG-SPINE, V9, P40, DOI 10.3171/SPI/2008/9/7/040; Salcman M., 2004, KEMPES OPERATIVE NEU, P149; Steilen Danielle, 2014, Open Orthop J, V8, P326, DOI 10.2174/1874325001408010326; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; WILKINSON JM, 1995, J NEUROL NEUROSUR PS, V59, P358, DOI 10.1136/jnnp.59.4.358; World Health Organization, 2004, INT STAT CLASS DIS R, V1	25	3	3	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2017	25						84	88		10.1016/j.ptsp.2017.01.003			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EX0YF	WOS:000402946000013	28262355				2022-02-06	
J	Murray, NG; D'Amico, NR; Powell, D; Mormile, ME; Grimes, KE; Munkasy, BA; Gore, RK; Reed-Jones, RJ				Murray, Nicholas G.; D'Amico, Nathan R.; Powell, Douglas; Mormile, Megan E.; Grimes, Katelyn E.; Munkasy, Barry A.; Gore, Russell K.; Reed-Jones, Rebecca J.			ASB clinical biomechanics award winner 2016: Assessment of gaze stability within 24-48 hours post-concussion	CLINICAL BIOMECHANICS			English	Article						Concussion; Mild traumatic brain injury; Oculomotor; Vestibular ocular reflex	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; EYE-MOVEMENTS; EPIDEMIOLOGY; POPULATION; MANAGEMENT; BALANCE	Background: Approximately 90% of athletes with concussion experience a certain degree of visual system dysfunction immediately post-concussion. Of these abnormalities, gaze stability deficits are denoted as among the most common. Little research quantitatively explores these variables post-concussion. As such, the purpose of this study was to investigate and compare gaze stability between a control group of healthy non-injured athletes and a group of athletes with concussions 24-48 hours post-injury. Methods: Ten collegiate NCAA Division I athletes with concussions and ten healthy control collegiate athletes completed two trials of a sport-like antisaccade postural control task, the Wii Fit Soccer Heading Game. During play all participants were instructed to minimize gaze deviations away from a central fixed area. Athletes with concussions were assessed within 24-48 post-concussion while healthy control data were collected during pre-season athletic screening. Raw ocular point of gaze coordinates were tracked with a monocular eye tracking device (240 Hz) and motion capture during the postural task to determine the instantaneous gaze coordinates. This data was exported and analyzed using a custom algorithm. Independent t-tests analyzed gaze resultant distande, prosaccade errors, mean vertical velocity, and mean horizontal velocity. Findings: Athletes with concussions had significantly greater gaze resultant distance (p = 0.006), prosaccade errors (p < 0.001), and horizontal velocity (p = 0.029) when compared to healthy controls. Interpretation: These data suggest that athletes with concussions had less control of gaze during play of the Wii Fit Soccer Heading Game. This could indicate a gaze stability deficit via potentially reduced cortical inhibition that is present within 24-48 hours post-concussion. (C) 2017 Elsevier Ltd. All rights reserved.	[Murray, Nicholas G.; Mormile, Megan E.; Grimes, Katelyn E.; Munkasy, Barry A.] Georgia Southern Univ, Coll Hlth & Human Sci, Sch Hlth & Kinesiol, Statesboro, GA USA; [D'Amico, Nathan R.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Powell, Douglas] Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA; [Gore, Russell K.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Reed-Jones, Rebecca J.] Univ Prince Edward Isl, Fac Sci, Dept Appl Human Sci, Charlottetown, PE, Canada		Murray, NG (corresponding author), Georgia Southern Univ, Sch Hlth & Kinesiol, POB 8076, Statesboro, GA 30460 USA.	nmurray@georgiasouthern.edu	Reed-Jones, Rebecca/L-2021-2019	Murray, Nicholas/0000-0003-3288-2995	Georgia Southern University Office of Research and Economic Development	This work was partially funded by the Graduate Research Investment Award provided by Georgia Southern University Office of Research and Economic Development.	Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson B., 2014, BRAIN IMAGING BEHAV; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; Patla AE, 1997, GAIT POSTURE, V5, P54, DOI 10.1016/S0966-6362(96)01109-5; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmidt M, 2001, J NEUROSCI, V21, P691, DOI 10.1523/JNEUROSCI.21-02-00691.2001; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5	32	3	3	2	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAY	2017	44						21	27		10.1016/j.clinbiomech.2017.03.002			7	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	EV6NH	WOS:000401885600004	28292694				2022-02-06	
J	Orlando, A; Thomas, C; Carrick, M; Slone, DS; Mains, CW; Bar-Or, D				Orlando, Alessandro; Thomas, Christine; Carrick, Matthew; Slone, D. Sue; Mains, Charles W.; Bar-Or, David			Statin discontinuation and mortality in an older adult population with traumatic brain injury: A four-year, multi-centre, observational cohort study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Statins; HMG Co-A reductase inhibitors; Traumatic brain injury; Older adult	ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; ATORVASTATIN REDUCTION; FUNCTIONAL OUTCOMES; NEURONAL SURVIVAL; HEAD-INJURY; SIMVASTATIN; RATS; WITHDRAWAL; INCREASE	Introduction: Statin discontinuation has been investigated in a wide range of diseases and injuries, but there is a paucity of data in the older adult population with traumatic brain injury (TBI). The purpose of this study was to re-examine the extent to which early discontinuation of pre-injury statin (PIS) therapy increases the risk of poor patient outcomes in older adult patients suffering a TBI. Methods: This was a retrospective observational cohort study of adult trauma patients with a blunt TBI across three trauma centres over four years. Patients were excluded because of no PIS use, age < 55 years, or a hospital length of stay (LOS) less than three days. Patients found to be intentionally discontinued from statin therapy within 48 h of hospital admission for injury-related reasons were excluded. The primary and secondary outcomes were in-hospital mortality and a hospital LOS >= 1 week. Outcomes were analysed using logistic regression. Results: There were 266 patients in the continuation group, and 131 in the discontinuation group. The statin discontinuation group had a significantly higher proportion of patients with a moderate or severe head injury, intubation in emergency department (ED), and disposition to the intensive care unit or operating room. Overall, 23 (6%) patients died while in the hospital. After adjusting for ED Glasgow coma scale, the odds of dying in the hospital were not significantly larger for patients having been discontinued from PIS, compared to those who were continued (OR = 1.75, 95% CI = 0.71-4.31, p = 0.22). Among patients who received an in-hospital statin, the median (interquartile range) time between hospital admission and first administration of statin medication did not differ between patients who died and those who survived (22.8 h [10.96-28.91] vs. 22.9 h [11.67-39.80], p = 0.94). There were no significant differences between study groups in the proportion of patients with a hospital length of stay > 1 week (continuation = 29% vs. discontinuation = 36%, p = 0.19). Conclusion: We did not observe a significantly increased odds of in-hospital mortality following PIS discontinuation, compared to PIS continuation, in an older adult population with TBI. It remains to be seen whether statin discontinuation is a proxy variable for injury severity, or whether it exerts deleterious effects after injury. (C) 2016 Elsevier Ltd. All rights reserved.	[Orlando, Alessandro; Thomas, Christine; Slone, D. Sue; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA; [Orlando, Alessandro; Thomas, Christine; Mains, Charles W.; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Orlando, Alessandro; Thomas, Christine; Carrick, Matthew; Bar-Or, David] Med Ctr Plano, Plano, TX USA; [Orlando, Alessandro; Thomas, Christine; Bar-Or, David] Penrose Community Hosp, Colorado Springs, CO USA; [Bar-Or, David] Rocky Vista Univ, Coll Osteopath Med, Parker, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	dbaror@ampiopharma.com	Thomas, Christine/AAP-9643-2021; Bar-Or, David/AAE-9328-2020	Thomas, Christine/0000-0003-2610-6797; 	Swedish Medical Centre; St. Anthony Hospital; Medical Centre of Plano	Funding for this study was provided by Swedish Medical Centre, St. Anthony Hospital, and The Medical Centre of Plano. We would like to thank the hard work of Anita Leyden, BSN, Rachel Aumann, BSN, and Barbara Schaffer, BSN for reviewing the charts of all patients on a pre-injury statin. Their dedication and effort was instrumental to the completion of this study.	Blanco M, 2007, NEUROLOGY, V69, P904, DOI 10.1212/01.wnl.0000269789.09277.47; CDC, 2016, RAT TBI REL EM DEP V; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Dowlatshahi D, 2012, STROKE, V43, P1518, DOI 10.1161/STROKEAHA.111.645978; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; FitzMaurice E, 2008, STROKE, V39, P2151, DOI 10.1161/STROKEAHA.107.508861; Flint AC, 2012, NEUROLOGY, V78, P1678, DOI 10.1212/WNL.0b013e3182575142; Flint AC, 2012, STROKE, V43, P147, DOI 10.1161/STROKEAHA.111.627729; Gu Q, 2014, PRESCRIPTION CHOLEST, P177; Hazer DB, 2010, CLIN HEMORHEOL MICRO, V46, P1, DOI 10.3233/CH-2010-1328; Jung JM, 2015, INT J STROKE, V10, P10, DOI 10.1111/ijs.12624; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; Lai WT, 2005, INT J CARDIOL, V98, P459, DOI 10.1016/j.ijcard.2003.11.023; Laufs U, 2000, CIRCULATION, V102, P3104; Lee KT, 2004, CARDIOLOGY, V102, P166, DOI 10.1159/000080486; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li JJ, 2006, CLIN CHIM ACTA, V366, P269, DOI 10.1016/j.cca.2005.10.021; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mahmood A, 2009, NEUROSURGERY, V65, P91; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Sandoval YHG, 2011, CURR PHARM DESIGN, V17, P3669, DOI 10.2174/138161211798220891; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Singhal AB, 2005, NEUROLOGY, V64, P1008, DOI 10.1212/01.WNL.0000154523.21633.0E; Spencer FA, 2004, ARCH INTERN MED, V164, P2162, DOI 10.1001/archinte.164.19.2162; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; U. S. Department of Health and Human Services, 2013, BRIEF; US Census Bureau, 2012, NAT POP PROJ SUMM TA; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859; Xie CC, 2015, BRAIN RES, V1602, P1, DOI 10.1016/j.brainres.2014.03.021; Xing Yan, 2005, Zhonghua Nei Ke Za Zhi, V44, P22; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z	45	3	3	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2017	48	5					1040	1046		10.1016/j.injury.2016.11.027			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QG	WOS:000402485400014	27914661				2022-02-06	
J	Oyesanya, TO; Bowers, B				Oyesanya, Tolu O.; Bowers, Barbara			Managing Visitors During the Hospital Stay: The Experience of Family Caregivers of Patients With Traumatic Brain Injury	JOURNAL OF FAMILY NURSING			English	Article						traumatic brain injury; patients; family caregivers; visitors	INTENSIVE-CARE-UNIT; COMMUNICATION ABILITY; CENTERED CARE; VISITATION; RESTRICTIONS; MEMBERS; BURDEN; ADULTS; TBI	Family caregivers of patients with moderate-to-severe traumatic brain injury (TBI) regularly visit the patient during the hospital stay and are involved in their care. As impairments caused by the TBI often preclude the patient from stating preferences for visitors, family caregivers often make decisions about visitors on the patient's behalf during the hospital stay. However, limited literature investigates this process. The purpose of this study was to describe family caregivers' experience of visitors while the patient with moderate-to-severe TBI is hospitalized. Authors used grounded theory to conduct 24 interviews with 16 family caregivers. Findings showed family caregivers manage welcome and unwelcome visitors throughout the hospital stay to protect the patient's physical and emotional safety and to conserve their own energy. Staff had limited involvement in management of unwelcome visitors. These findings have practice implications for educating hospital staff about providing family nursing and assisting families to manage unwelcome visitors and about policy implications for improving hospital visiting policies.	[Oyesanya, Tolu O.] Shepherd Ctr, Brain Injury Res, Atlanta, GA USA; [Bowers, Barbara] Univ Wisconsin, Sch Nursing, Nursing, Madison, WI USA; [Bowers, Barbara] Univ Wisconsin, Sch Nursing, Res, Madison, WI USA		Oyesanya, TO (corresponding author), Shepherd Ctr, Crawford Res Inst, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	tolu_oyesanya@shepherd.org		Oyesanya, Tolu/0000-0001-8821-4510	National Institute of Nursing Research (NINR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F31NR015398]; University of Wisconsin-Madison, School of Nursing Eckburg Research and Eckburg Dissertation Research Awards; NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; Clinical and Translational Science Award (CTSA) program through the NIH National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015398] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the National Institute of Nursing Research (NINR) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant F31NR015398 (PI, T. Oyesanya) and by the University of Wisconsin-Madison, School of Nursing Eckburg Research and Eckburg Dissertation Research Awards. This project was partially supported by the NIH/NIGMS Initiative for Maximizing Student Development, Grant R25GM083252 (PI, M. Carnes) and the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000427 (PI, B. Bowers). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agard AS, 2015, J ADV NURS, V71, P1892, DOI 10.1111/jan.12657; Ajay S, 2017, ARCH GERONTOL GERIAT, V68, P143, DOI 10.1016/j.archger.2016.10.003; American Speech-Language-Hearing Association, 2017, TRAUM BRAIN INJ TBI; Bell JM, 2013, J FAM NURS, V19, P411, DOI 10.1177/1074840713512750; Blumer H., 1969, SYMB INTERACT, P1; Bowers B., 2009, DEV GROUNDED THEORY, P88, DOI DOI 10.1111/J.1548-1387.2010.01143.X; Bowers B.J., 1990, PATHS KNOWLEDGE; Cappellini E, 2014, DIMENS CRIT CARE NUR, V33, P181, DOI 10.1097/DCC.0000000000000052; Carlsson E, 2016, INT J NURS STUD, V53, P50, DOI 10.1016/j.ijnurstu.2015.10.004; Carr Jeanine M, 2014, Medsurg Nurs, V23, P251; Centers for Disease Control and Prevention, 2016, TBI DAT STAT; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Chapman DK, 2016, AM J CRIT CARE, V25, P46, DOI 10.4037/ajcc2016789; Charmaz, 2014, CONSTRUCTING GROUNDE; Clay Aaron, 2014, Nursing, V44, P57, DOI 10.1097/01.NURSE.0000445764.18817.d2; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Creswell J.W., 2013, RES DESIGN QUALITATI; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Dionne-Odom JN, 2016, CANCER MED-US, V5, P853, DOI 10.1002/cam4.653; Failla MD, 2016, J HEAD TRAUMA REHAB, V31, pE62, DOI 10.1097/HTR.0000000000000214; Frampton SB, 2017, HARNESSING EVIDENCE; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; Hart A, 2013, DIMENS CRIT CARE NUR, V32, P289, DOI 10.1097/01.DCC.0000434515.58265.7d; Jacob M, 2016, AM J CRIT CARE, V25, P118, DOI 10.4037/ajcc2016258; Kolakowsky-Hayner SA, 2016, NEUROREHABILITATION, V39, P363, DOI 10.3233/NRE-161368; Lor M, 2016, NURS OUTLOOK, V64, P352, DOI 10.1016/j.outlook.2016.02.006; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; Nuss T, 2014, J NURS ADMIN, V44, P403, DOI 10.1097/NNA.0000000000000090; Ostlund U, 2016, J FAM NURS, V22, P148, DOI 10.1177/1074840716642790; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Oyesanya TO, 2017, QUAL HEALTH RES, V27, P1804, DOI 10.1177/1049732317697098; Segaric CA, 2015, J FAM NURS, V21, P35, DOI 10.1177/1074840714564787; Shulkin D, 2014, J HEALTHC QUAL, V36, P54, DOI 10.1111/jhq.12035; Steward KA, 2016, NEUROLOGY, V87, P1052, DOI 10.1212/WNL.0000000000003079; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Turkstra LS, 2013, J HEAD TRAUMA REHAB, V28, P332, DOI 10.1097/HTR.0b013e31828b4f3f; Voncina G, 2016, J PERIANESTH NURS, V31, P415, DOI 10.1016/j.jopan.2014.12.004; Wu C, 2015, WEST J EMERG MED, V16, P707, DOI 10.5811/westjem.2015.7.27458	42	3	3	0	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	MAY	2017	23	2					273	298		10.1177/1074840717697673			26	Family Studies; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Family Studies; Nursing	EV1OX	WOS:000401517000006	28795896	Green Accepted			2022-02-06	
J	Puntis, M; Smith, M				Puntis, Michael; Smith, Martin			Critical care management of adult traumatic brain injury	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						Cerebral perfusion pressure; head injury; intracranial pressure; neurointensive care	INTRACRANIAL HYPERTENSION; THERAPY	Severe traumatic brain injury (TBI) is associated with significant morbidity and mortality. The critical care management of TBI requires a coordinated and comprehensive approach to treatment, including strategies to prevent secondary brain injury by avoidance of systemic physiological disturbances, such as hypotension, hypoxaemia, hypoand hyperglycaemia and hyperthermia, and maintenance of adequate cerebral perfusion and oxygenation. Management protocols have evolved with international consensus, providing guidelines that assist clinicians in delivering optimal care. Those from the Brain Trauma Foundation are continuously updated to incorporate new trial data (https://braintrauma. org/coma/guidelines).	[Puntis, Michael] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neuroanaesthesia & Neurocrit Care, London, England; [Smith, Martin] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neurocrit Care, London, England		Puntis, M (corresponding author), Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neuroanaesthesia & Neurocrit Care, London, England.				National Institute for Health Research via the UCLH/UCL Comprehensive Biomedical Research Centre	MS is part funded by the National Institute for Health Research via the UCLH/UCL Comprehensive Biomedical Research Centre.	Carney N, 2016, NEUROSURGERY    0920; Godoy DA, 2016, CURR OPIN CRIT CARE, V22, P120, DOI 10.1097/MCC.0000000000000292; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; van der Jagt M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1309-2; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4	10	3	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	MAY	2017	18	5					233	238		10.1016/j.mpaic.2017.02.008			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	EZ5FB	WOS:000404737300004		Green Submitted			2022-02-06	
J	Versmee, G; Paez, J; Menegon, P; Jadot, D; Valdenaire, G; Renard, A				Versmee, G.; Paez, J.; Menegon, P.; Jadot, D.; Valdenaire, G.; Renard, A.			Incidence of Delayed Intracranial Hemorrhage in Patients treated by Anticoagulants and Victims of a Head Injury	ANNALES FRANCAISES DE MEDECINE D URGENCE			French	Article						Trauma; Traumatic brain injury; Emergency department; Imaging; Brain CT-scan	TRAUMATIC BRAIN-INJURY; MORTALITY; WARFARIN; CT	Aim: To measure the incidence of delayed intracranial hemorrhage in patients treated by anticoagulants and victims of a head injury. Materials and methods: We conducted a prospective study within two emergency departments. Every patient treated by anticoagulants and victim of a head injury was included. Upon their arrival, they had a physical examination with determination of the Glasgow Coma Scale (GCS), and a blood-test for INR. A CT-scan was carried up in the next hour. In case of an intracranial hemorrhage, an antagonization of the anticoagulant activity was immediately performed. Otherwise, patients were monitored, and a second CT-scan was realized 24 hours after the fall. The primary endpoint was the occurrence of an intracranial hemorrhage at the second CT scan. Results: Between July 2013 and December 2014, 419 patients were included. 334 patients (79.8%) were treated by antivitamin K, 73 (17.4%) by new anticoagulants, and 12 patients by a low-molecular-weight heparin (2.9%). 407 patients (97.1%) had a GCS at 13 or more. 43 patients (10.3%) had an intracranial hemorrhage at the initial CT scan [CI95% 7.4-13.2]. For 7 patients (1.7%), the second CT-scan showed a delayed intracranial hemorrhage, [CI95% 0.4-2.9]. Six were treated by anti-vitamin K, and 1 patient by dabigatran. No patient had required a neurosurgical procedure. Conclusion: The systematic implementation of a control CT-scan 24 hours after the fall allowed the detection of a delayed intracranial hemorrhage for 2% of the patients.	[Versmee, G.; Jadot, D.; Valdenaire, G.] Hop Pellegrin, CHU Bordeaux, Serv Urgences Adultes, Pl Amelie Raba Leon, F-33076 Bordeaux, France; [Paez, J.; Renard, A.] Hop Instruct Armees Laveran, Marseille, France; [Menegon, P.] Hop Pellegrin, CHU Bordeaux, Serv Neuroradiol, Pl Amelie Raba Leon, F-33076 Bordeaux, France		Versmee, G (corresponding author), Hop Pellegrin, CHU Bordeaux, Serv Urgences Adultes, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	gversmee@mail.harvard.edu	VALDENAIRE, GUILLAUME/U-5426-2019				Agence nationale de securite du medicament et des produits de sante, 2012, ANT FRANC 2012 ET LI; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Foerch C, 2012, J NEUROTRAUM, V29, P1150, DOI 10.1089/neu.2011.2104; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kortchinsky T, 2013, ANN FR ANESTH, V32, P37, DOI 10.1016/j.annfar.2012.10.034; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Momo-Boma A, 2014, ANN FR MED URGENCE, V4, P173, DOI 10.1007/s13341-014-0410-x; National Institute for Health and Care Excellence (UK), 2014, HEAD INJ TRIAG ASS I; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Pernod G, 2013, ANN FR ANESTH, V32, P691, DOI 10.1016/j.annfar.2013.04.016; Pernod G, 2010, THROMB RES, V126, pE167, DOI 10.1016/j.thromres.2010.06.017; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tazarourte K, 2014, CRIT CARE, V18, DOI [10.1186/cc13843, 10.1007/s13341-014-0474-7]; Versmee G, 2014, ANN FR MED URGENCE, V4, P288, DOI 10.1007/s13341-014-0454-y; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	21	3	3	0	2	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	2108-6524	2108-6591		ANN FR MED URGENCE	Ann. Fr. Med. Urgence	MAY	2017	7	2					85	91		10.1007/s13341-017-0720-x			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FB0KK	WOS:000405833800003					2022-02-06	
J	Wodushek, TR; Greher, MR				Wodushek, Thomas R.; Greher, Michael R.			Performance Validity Testing in Neuropsychology: Methods for Measurement Development and Maximizing Diagnostic Accuracy	JOURNAL OF PSYCHIATRIC PRACTICE			English	Article						performance validity testing; symptom validity testing; effort testing; malingering; neuropsychology	TRAUMATIC BRAIN-INJURY; MALINGERING DETECTION; MEMORY IMPAIRMENT; AMERICAN ACADEMY; FALSE POSITIVES; TEST FAILURE; DISABILITY; BIAS	In the first column in this 2-part series, Performance Validity Testing in Neuropsychology: Scientific Basis and Clinical Application-A Brief Review, the authors introduced performance validity tests (PVTs) and their function, provided a justification for why they are necessary, traced their ongoing endorsement by neuropsychological organizations, and described how they are used and interpreted by ever increasing numbers of clinical neuropsychologists. To enhance readers' understanding of these measures, this second column briefly describes common detection strategies used in PVTs as well as the typical methods used to validate new PVTs and determine cut scores for valid/invalid determinations. We provide a discussion of the latest research demonstrating how neuropsychologists can combine multiple PVTs in a single battery to improve sensitivity/specificity to invalid responding. Finally, we discuss future directions for the research and application of PVTs.	[Wodushek, Thomas R.; Greher, Michael R.] Univ Colorado, Sch Med, Dept Neurosurg, 12631 E 17th Ave,C307, Aurora, CO 80045 USA; [Wodushek, Thomas R.; Greher, Michael R.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA		Wodushek, TR (corresponding author), Univ Colorado, Sch Med, Dept Neurosurg, 12631 E 17th Ave,C307, Aurora, CO 80045 USA.	thomas.wodushek@ucdenver.edu					Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Committee on Psychological Testing Including Validity Testing for Social Security Administration Disability Determinations; Board on the Health of Select Populations; Institute of Medicine, 2015, PSYCH TEST SERV DIS; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2004, GREENS MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Greher MR, 2017, J PSYCHIATR PRACT, V23, P134, DOI 10.1097/PRA.0000000000000218; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Rickards TA, 2017, APPL NEUROPSYCH-ADUL, V31, P1; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 2008, CLIN ASSESSMENT MALI; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	33	3	3	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1527-4160	1538-1145		J PSYCHIATR PRACT	J. Psychiatr. Pract.	MAY	2017	23	3					214	220		10.1097/PRA.0000000000000233			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EV1RW	WOS:000401525000008	28492460				2022-02-06	
J	Zasler, ND; Bigler, E				Zasler, Nathan D.; Bigler, Erin			Medicolegal Issues in Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Physical medicine and rehabilitation; Physiatry; Independent medical evaluation; Neuropsychology; Neuroimaging; Medicolegal	VALIDITY; HAZARDS; UPDATE	The role of the physiatrist in provision of medicolegal expert testimony in cases involving traumatic brain injury is challenging and complex. This article provides an overview of how such work should be conducted from a practical perspective including discussion of ethical, legal, medical, and business aspects of such activities. Additionally, pointers are provided with regards to how information including preinjury, injury, and postinjury (including neuroimaging and neuropsychological data) should be considered and integrated into medicolegal opinions and testimony.	[Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA; [Bigler, Erin] Brigham Young Univ, 1001 Kimball Tower, Provo, UT 84602 USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com					*AM MED ASS, 1996, COD MED ETH CURR OP; Ameis A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1391; American Academy of Physical Medicine and Rehabilitation, 1992, EXP WITN TEST WHIT P; American Medical Association Policy, 2005, E 10 03 PAT PHYS REL; American Medical Association Policy, 2005, E 5 09 CONF IND EMPL; [Anonymous], 2009, ACT EXP MED P; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; BLAU TH, 1984, PSYCHOL EXPERT WITNE; Brodsky S. L., 1991, TESTIFYING COURT GUI; CMPA General Counsel, 2008, PREP MED REP SUGG PH; Constantinou M, 2003, ARCH CLIN NEUROPSYCH, V18, P788; Department of Consumer & Business Services, 2015, COMM WORK COMP GUID; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Granacher Jr R.P., 2015, TRAUMATIC BRAIN INJU; Howe LLS, 2010, CLIN NEUROPSYCHOL, V24, P518, DOI 10.1080/13854041003775347; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Martelli MF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1415; Meltzer CC, 2014, AM J NEURORADIOL, V35, P632, DOI 10.3174/ajnr.A3711; MORTENSEN EL, 1991, J CLIN EXP NEUROPSYC, V13, P361, DOI 10.1080/01688639108401050; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Rhondinelli RD, 2008, GUIDES EVALUATION PE; Sbordone RJ, 1996, NEUROREHABILITATION, V7, P15, DOI 10.3233/NRE-1996-7103; Sbordone RJ, 2014, APPL NEUROPSYCH-ADUL, V21, P98, DOI 10.1080/09084282.2012.762630; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; Sullivan JD, 2008, MCGILL J MED, V9, P147; Wilde EA, 2012, NEUROREHABILITATION, V31, P227, DOI 10.3233/NRE-2012-0793; Wortzel HS, 2015, J AM ACAD PSYCHIATRY, V43, P499; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Zasler ND, 2015, NEUROREHABILITATION, V36, P401, DOI 10.3233/NRE-151229; Zasler ND, 2008, MOTOR VEHICLE COLLIS, P467	32	3	3	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					379	+		10.1016/j.pmr.2016.12.012			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700014	28390520				2022-02-06	
J	Del Bigio, MR; Phillips, SM				Del Bigio, Marc R.; Phillips, Susan M.			Retroocular and Subdural Hemorrhage or Hemosiderin Deposits in Pediatric Autopsies	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Autopsy; Child Abuse; Forensic Pathology; Head Trauma; Hemorrhage; Optic Nerve; Shaken Baby	ABUSIVE HEAD TRAUMA; RETINAL HEMORRHAGES; INTRACRANIAL HEMORRHAGE; INFANT-DEATH; CARDIOPULMONARY-RESUSCITATION; NATURAL-HISTORY; IRON-METABOLISM; OCULAR FINDINGS; HEME OXYGENASE; BRAIN-INJURY	The presence of hemosiderin in the optic nerve sheath and/or retina is sometimes used to estimate the timing of injury in infants or children with suspected non-accidental head trauma. To determine the prevalence of hemosiderin in deaths not associated with trauma, we performed a prospective study of retroocular orbital tissue, cranial convexity, and cervical spinal cord dura mater in infants and children<2.5 years age. In 53 cases of non-traumatic death, approximately 70% had blood or hemosiderin within the orbital fat, ocular muscles, and parasagittal cranial and/or cervical spinal subdural compartment. This bleeding is likely a consequence of the birth process. None had evidence of hemorrhage within the optic nerve sheath. Premature birth was less likely associated with orbital tissue hemorrhage. Caesarean section birth (mainly nonelective) was not associated with lower prevalence. Residual hemosiderin was identifiable up to 36 weeks postnatal age, suggesting gradual disappearance after birth. Cardiopulmonary resuscitation (performed in the majority of cases) was not associated with acute hemorrhage. In 9 traumatic deaths, 6 had blood and/or hemosiderin within the optic nerve sheath. Knowledge of the potential presence and resolution of hemosiderin in these locations is important for medicolegal interpretation of childhood deaths associated with head or brain injury.	[Del Bigio, Marc R.; Phillips, Susan M.] Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; [Del Bigio, Marc R.; Phillips, Susan M.] Diagnost Serv Manitoba, Winnipeg, MB, Canada; [Del Bigio, Marc R.] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada		Del Bigio, MR (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Pathol, 401 Brodie Ctr,727 McDermot Ave, Winnipeg, MB R3E 3P5, Canada.	marc.delbigio@umanitoba.ca	Shaheen, Ahmed/AAP-4054-2021	Shaheen, Ahmed/0000-0002-2216-1951			Adams G, 2004, EYE, V18, P795, DOI 10.1038/sj.eye.6701643; Anderson RM, 1998, AM J FOREN MED PATH, V19, P1, DOI 10.1097/00000433-199803000-00001; Anderson WAD, 1948, PATHOLOGY, P67; Arredondo JL, 2008, J FORENSIC SCI, V53, P928, DOI 10.1111/j.1556-4029.2008.00757.x; Bais B, 2016, J FORENSIC SCI, V61, P1693, DOI 10.1111/1556-4029.13215; BETZ P, 1994, INT J LEGAL MED, V107, P60, DOI 10.1007/BF01225491; Betz P, 1996, INT J LEGAL MED, V108, P262, DOI 10.1007/BF01369823; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Binenbaum G, 2016, J AAPOS, V20, P131, DOI 10.1016/j.jaapos.2015.12.008; BIZZI A, 1991, AM J NEURORADIOL, V12, P805; Breazzano MP, 2014, AM J OPHTHALMOL, V158, P1146, DOI 10.1016/j.ajo.2014.08.011; BUNN HF, 1968, J BIOL CHEM, V243, P465; Byard RW, 2010, J FORENSIC SCI, V55, P1356, DOI 10.1111/j.1556-4029.2010.01442.x; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Croft PR, 2009, AM J FOREN MED PATH, V30, P10, DOI 10.1097/PAF.0b013e31818737be; De Leeuw M, 2015, J FORENSIC LEG MED, V36, P43, DOI 10.1016/j.jflm.2015.08.009; Emerson MV, 2007, OPHTHALMOLOGY, V114, P1384, DOI 10.1016/j.ophtha.2007.04.015; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Finazzi D, 2014, ARCH TOXICOL, V88, P1787, DOI 10.1007/s00204-014-1329-0; Findley K.A., 2012, HOUSTON J HLTH LAW P, V12, P209; FISCHBACH FA, 1971, J ULTRA MOL STRUCT R, V37, P495, DOI 10.1016/S0022-5320(71)80020-5; Gabaeff SC, 2011, WEST J EMERG MED, V12, P144; Gill JR, 2013, ACAD FORENSIC PATHOL, V4, P206; Gilliland MGF, 2007, AM J FOREN MED PATH, V28, P323, DOI 10.1097/PAF.0b013e31815b4c00; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; Gilliland MGF, 2005, AM J FOREN MED PATH, V26, P1, DOI 10.1097/01.paf.0000154113.38906.12; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; GILLILAND MGF, 1991, ARCH OPHTHALMOL-CHIC, V109, P321; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; GOETTING MG, 1990, PEDIATRICS, V85, P585; Herath JC, 2014, CAN J PUBLIC HEALTH, V105, pE103, DOI 10.17269/cjph.105.4156; Hohnholt MC, 2013, BIOCHEM SOC T, V41, P1588, DOI 10.1042/BST20130114; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Inanir NT, 2015, HIPPOKRATIA, V19, P164; Jayanthi K, 1978, Indian J Ophthalmol, V26, P12; Kelly P, 2014, PEDIATRICS, V134, pE773, DOI 10.1542/peds.2013-3903; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Korolnek T, 2015, BLOOD, V125, P2893, DOI 10.1182/blood-2014-12-567776; Laghmari M, 2014, J FR OPHTALMOL, V37, P313, DOI 10.1016/j.jfo.2013.06.005; Langlois N E I, 2007, Forensic Sci Med Pathol, V3, P241, DOI 10.1007/s12024-007-9019-3; Lavezzi AM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-62; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; LOBERG EM, 1989, MED SCI LAW, V29, P109, DOI 10.1177/002580248902900205; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Mackey M, 2006, ARCH DIS CHILD, V91, P873, DOI 10.1136/adc.2006.100719; Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; MILHORAT TH, 1991, J NEUROSURG, V75, P911, DOI 10.3171/jns.1991.75.6.0911; Miller D, 2015, LAB INVEST, V95, p433A; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Muir R, 1935, J PATHOL BACTERIOL, V41, P183, DOI 10.1002/path.1700410116; Narang SK, 2016, J PEDIATR-US, V177, P273, DOI 10.1016/j.jpeds.2016.06.036; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; OEHMICHEN M, 1980, Z RECHTSMED, V84, P79, DOI 10.1007/BF02114577; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oehmichen M., 2009, Legal Medicine, V11, P118, DOI 10.1016/j.legalmed.2008.11.003; OEHMICHEN M, 1986, FORENSIC SCI INT, V30, P281, DOI 10.1016/0379-0738(86)90136-2; Peterson JEG, 2016, J FORENSIC SCI, V61, P241, DOI 10.1111/1556-4029.12925; Rao MG, 2016, J CLIN DIAGN RES, V10, pHC1, DOI 10.7860/JCDR/2016/19783.8141; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Richman F., 1937, P ROY SOC MED, V30, P277; RICHTER GW, 1978, AM J PATHOL, V91, P361; Rogers CB, 1998, J FORENSIC SCI, V43, P375; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Ross C, 2013, FORENSIC SCI MED PAT, V9, P358, DOI 10.1007/s12024-013-9466-y; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Salvatori MC, 2015, MED SCI LAW, V55, P121, DOI 10.1177/0025802414527077; Sauvageau A, 2008, J FORENSIC SCI, V53, P479, DOI 10.1111/j.1556-4029.2008.00664.x; SEZEN F, 1971, BRIT J OPHTHALMOL, V55, P248, DOI 10.1136/bjo.55.4.248; Shiau T, 2012, ARCH PEDIAT ADOL MED, V166, P623, DOI 10.1001/archpediatrics.2012.46; Sirgiovanni I, 2014, PEDIATR RADIOL, V44, P289, DOI 10.1007/s00247-013-2826-7; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Spies EL, 2016, MMWR-MORBID MORTAL W, V65, P505, DOI 10.15585/mmwr.mm6520a1; STRASSMANN G, 1945, J NEUROPATH EXP NEUR, V4, P393, DOI 10.1097/00005072-194504040-00007; STRASSMANN G, 1949, ARCH PATHOL, V47, P205; Tavani F, 2003, NEURORADIOLOGY, V45, P253, DOI 10.1007/s00234-003-0946-8; Taylor D, 1999, EYE, V13, P3; Thale Andreas, 2002, Orbit, V21, P131, DOI 10.1076/orbi.21.2.131.7187; THORNTON RN, 1986, FORENSIC SCI INT, V31, P225, DOI 10.1016/0379-0738(86)90161-1; TRUMP BF, 1973, AM J PATHOL, V72, P295; Tuerkheimer D, 2011, ALA L REV, V62, P513; Vanezis P, 2001, J CLIN PATHOL, V54, P348, DOI 10.1136/jcp.54.5.348; Vincent AL, 2014, FORENSIC PATHOLOGY I, P455; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Walter Till, 2009, Leg Med (Tokyo), V11 Suppl 1, pS56, DOI 10.1016/j.legalmed.2009.01.112; Watts P, 2013, EYE, V27, P1227, DOI 10.1038/eye.2013.192; Watts P, 2013, ROYAL COLL PAEDIAT C; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; Wixom R L, 1980, Int Rev Exp Pathol, V22, P193; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038	94	3	3	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	APR	2017	76	4					313	322		10.1093/jnen/nlx010			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EW0EP	WOS:000402161700008	28340081	Bronze			2022-02-06	
J	Ekinci, O; Direk, MC; Gunes, S; Teke, H; Ekinci, N; Yildirim, F; Okuyaz, C				Ekinci, Ozalp; Direk, Meltem Cobanogullari; Gunes, Serkan; Teke, Halenur; Ekinci, Nuran; Yildirim, Fatma; Okuyaz, Cetin			Short-term efficacy and tolerability of methylphenidate in children with traumatic brain injury and attention problems	BRAIN & DEVELOPMENT			English	Article						Traumatic brain injury; Children; Methylphenidate	DEFICIT HYPERACTIVITY DISORDER; ONCE-A-DAY; DEFICIT/HYPERACTIVITY DISORDER; ACTING METHYLPHENIDATE; ADOLESCENTS; SECONDARY; BEHAVIOR; STIMULANTS; PREDICTORS; TEACHER	Purpose: This study aims to investigate the short-term efficacy and tolerability of immediate-release methylphenidate (IR-MPH) in children with a history of traumatic brain injury (TBI). Methods: Twenty children with TBI (mean age: 12.7 +/- 3.1 years) who had clinically significant attention deficit and/or hyperactivity-impulsivity symptoms and twenty children with primary Attention Deficit Hyperactivity Disorder (ADHD) (mean age: 12.3 +/- 3.05 years) were included. Study measures, which included the Turgay DSM-IV based ADHD rating Scale (T-DSM-IV-S), Conners' Parent Rating Scale (CPRS), Conners' Teacher Rating Scale (CTRS-R) and Clinical Global Impression Improvement Scale (CGI-I), were completed at the baseline for both of the groups. For the TBI group, study measures and an adverse effect scale developed by the authors were completed 8 weeks after IR-MPH treatment (10 mg dose t.i.d). Results: No significant difference was found regarding the baseline scale scores between the study groups. Among children with TBI, most of the scores on T-DSM-IV-S, CPRS and CTRS-R were found to improve significantly after MPH treatment, (p < 0.05). 70% (N = 14) of the sample were much improved at the endpoint. MPH was generally well-tolerated (95% had either no adverse effect or mild adverse effects). Conclusion: In this preliminary open-label study, IR-MPH was found as a safe and effective treatment option for ADHD symptoms after TBI. However, future controlled studies are needed to confirm our findings. (C) 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Ekinci, Ozalp; Gunes, Serkan; Teke, Halenur; Ekinci, Nuran; Yildirim, Fatma] Mersin Univ, Med Fac, Dept Child & Adolescent Psychiat, Mersin, Turkey; [Direk, Meltem Cobanogullari; Okuyaz, Cetin] Mersin Univ, Med Fac, Dept Pediat Neurol, Mersin, Turkey		Ekinci, O (corresponding author), Mersin Univ, Sch Med, Dept Child & Adolescent Psychiat, Mersin, Turkey.	ozalpekinci@yahoo.com	COBANOGULLARI DIREK, Meltem/ABC-7551-2021	Gunes, Serkan/0000-0002-8247-2145			Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Biederman J, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-49; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Coskun M, 2011, KLIN PSIKOFARMAKOL B, V21, P33; Dereboy C, 2007, TURK PSIKIYATR DERG, V18, P48; Ercan, 2001, COCUK GENCLIK RUH SA, V8, P132, DOI DOI 10.5455/APD.186583; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Karabekiroglu K, 2011, KLIN PSIKOFARMAKOL B, V21, P317, DOI 10.5455/BCP.20110810012912; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Nikles CJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-54; Pelham WE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e105; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Pringsheim T, 2015, CAN J PSYCHIAT, V60, P42, DOI 10.1177/070674371506000202; Punja S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002312; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Schachter HA, 2001, CAN MED ASSOC J, V165, P1475; Sener S., 1995, J CHILD ADOLESCENT M, V2, P131; Sinzig J, 2007, J CHILD ADOL PSYCHOP, V17, P421, DOI 10.1089/cap.2007.0011; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Turgay A, 1994, DISRUPTIVE BEHAV DIS; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Wolraich ML, 2001, PEDIATRICS, V108, P883, DOI 10.1542/peds.108.4.883; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	36	3	3	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	APR	2017	39	4					327	336		10.1016/j.braindev.2016.11.005			10	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	ET3UH	WOS:000400204500007	27903419				2022-02-06	
J	Houston, KE; Paschalis, EI; Angueira, DC; Bronstad, PM; Barrett, AM; Iaccarino, MA				Houston, Kevin E.; Paschalis, Eleftherios I.; Angueira, Danielle C.; Bronstad, P. Matthew; Barrett, Anna M.; Iaccarino, Mary Alexis			Restoration of Vision After Brain Injury Using Magnet Glasses	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injury; Hemianopia; Strabismus; Rehabilitation	QUALITY-OF-LIFE; HOMONYMOUS HEMIANOPIA; VISUAL IMPAIRMENT; STROKE SURVIVORS; STRABISMUS; EXOTROPIA; BIAS	Visual impairments are common after traumatic brain injury (TBI) and negatively affect quality of life. We describe a 39-year-old woman with a severe TBI whowas evaluated by the inpatient optometry and vision rehabilitation service with findings of complete right homonymous hemianopia and right cranial nerve III palsy with 30-degree right exotropia (eye turn out) and complete right ptosis (eyelid will not open). The 30-degree exotropia advantageously generated 30 degrees of right visual field expansion when the right ptosis was treated with a magnetic levator prosthesis, which restores eyelid opening. Once opened, the patient used visual field expansion derived froma right exotropia to overcome functional impairments caused by right hemianopia. Field expansion improved the patient's wheelchair mobility and reaching tasks during inpatient therapy. This is the first report of visual field expansion by strabismus facilitated by correction of ptosis. Strabismus should be considered for its potential field expansion benefits when homonymous visual deficits are present, before considering patching. A multidisciplinary vision rehabilitation team is well suited to make this determination.	[Houston, Kevin E.; Angueira, Danielle C.; Iaccarino, Mary Alexis] Spaulding Rehabil Hosp, Boston, MA USA; [Houston, Kevin E.; Paschalis, Eleftherios I.; Bronstad, P. Matthew] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Iaccarino, Mary Alexis] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Paschalis, Eleftherios I.] Massachusetts Eye & Ear, Keratoprosthesis Lab, Boston, MA USA; [Barrett, Anna M.] Kessler Fdn, W Orange, NJ USA		Iaccarino, MA (corresponding author), 300 First Ave, Charlestown, MA 02129 USA.		Houston, Kevin/ABF-1606-2021; Paschalis, Eleftherios/AAO-4613-2020; Barrett, A.M./ABG-4475-2021	Houston, Kevin/0000-0001-6138-3154; Barrett, A.M./0000-0002-0789-2887; Paschalis, Eleftherios/0000-0002-4544-4452	Kessler Foundation from the NIH [R01NS055808, K02 NS047099, K24HD062647]; NIDILRRUnited States Department of Health & Human Services [901 F0037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD062647] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K12EY016335, R01EY024084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS047099, R01NS055808] Funding Source: NIH RePORTER	A.M. Barrett is employed by the Kessler Foundation, receives honoraria from emedicine, a WebMD company, and receives research funding through the Kessler Foundation from the NIH (R01NS055808, K02 NS047099, K24HD062647), NIDILRR (901 F0037) SPR Therapeutics and DART Neuroscience. Drs. Houston and Paschalis have been involved in the development of the magnetic levator prosthesis, but neither they nor their institution (Mass Eye and Ear-Schepens Eye Research Institute) hold financial interest in this device or other technology discussed in this manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barrett AM, 2001, ARCH PHYS MED REHAB, V82, P516, DOI 10.1053/apmr.2001.21973; Barrett AM, 2006, J REHABIL RES DEV, V43, P337, DOI 10.1682/JRRD.2005.01.0015; Bowers AR, 2014, JAMA OPHTHALMOL, V132, P214, DOI 10.1001/jamaophthalmol.2013.5636; Bowers AR, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/176806; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Chen CS, 2009, TOP STROKE REHABIL, V16, P445, DOI 10.1310/tsr1606-445; Chen P, 2009, NEUROPSYCHOLOGIA, V47, P711, DOI 10.1016/j.neuropsychologia.2008.11.022; Gote H, 1993, BINOCULAR VISION EYE, V8, P129; GRAY CS, 1989, AGE AGEING, V18, P419, DOI 10.1093/ageing/18.6.419; HERZAU V, 1988, GRAEF ARCH CLIN EXP, V226, P148, DOI 10.1007/BF02173304; Houston KE, 2015, OPTOMETRY VISION SCI, V3, P9; Houston KE, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.6.9; HUBEL DH, 1975, BRAIN RES, V96, P25, DOI 10.1016/0006-8993(75)90567-3; Hunter DG, 2003, AM ORTHOPT J, V53, P2; Kerr KE, 1998, OPTOMETRY VISION SCI, V75, P17; Lai Y, 2012, TAIWAN J OPHTHALMOL, V2, P99; Lapid O, 2000, PLAST RECONSTR SURG, V106, P1213, DOI 10.1097/00006534-200010000-00046; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Pollock A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008388.pub2; Rowe F, 2010, EYE, V24, P682, DOI 10.1038/eye.2009.138; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Townend BS, 2007, J CLIN NEUROSCI, V14, P754, DOI 10.1016/j.jocn.2006.02.022; Yates JS, 2002, J REHABIL RES DEV, V39, P385; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	29	3	3	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	2017	96	4					E70	E74		10.1097/PHM.0000000000000592			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EP7UY	WOS:000397583900004	27552350	Green Accepted			2022-02-06	
J	Jiang, Y; Lin, MK; Jicha, GA; Ding, XH; McIlwrath, SL; Fardo, DW; Broster, LS; Schmitt, FA; Kryscio, R; Lipsky, RH				Jiang, Yang; Lin, Ming Kuan; Jicha, Gregory A.; Ding, Xiuhua; McIlwrath, Sabrina L.; Fardo, David W.; Broster, Lucas S.; Schmitt, Frederick A.; Kryscio, Richard; Lipsky, Robert H.			Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults	AGING-US			English	Article						short-term memory; cognitive aging; working memory retrieval; NMDA receptor; GRIN2B gene; functional polymorphism	TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; GENOME-WIDE ANALYSIS; WORKING-MEMORY; NMDA RECEPTOR; ALZHEIMERS-DISEASE; SPATIAL MEMORY; NR2B SUBUNIT; EXPRESSION; HIPPOCAMPUS	We investigated the role of a single nucleotide polymorphism rs3764030 (G>A) within the human GRIN2B promoter in mental processing speed in healthy, cognitively intact, older adults. In vitro DNA-binding and reporter gene assays of different allele combinations in transfected cells showed that the A allele was a gain-of-function variant associated with increasing GRIN2B mRNA levels. We tested the hypothesis that individuals with A allele will have better memory performance (i.e. faster reaction times) in older age. Twenty-eight older adults (ages 6586) from a well-characterized longitudinal cohort were recruited and performed a modified delayed match-to-sample task. The rs3764030 polymorphism was genotyped and participants were grouped based on the presence of the A allele into GG and AA/AG. Carriers of the A allele maintained their speed of memory retrieval over age compared to GG carriers (p = 0.026 slope of the regression line between AA and AG versus GG groups). To validate the results, 12 older adults from the same cohort participated in a different version of the short-term memory task. Reaction times were significantly slower with age in older adults with G allele (p < 0.001). These findings support a role for rs3764030 in maintaining faster mental processing speed over aging.	[Jiang, Yang; McIlwrath, Sabrina L.; Broster, Lucas S.] Univ Kentucky, Dept Behav Sci, Lexington, KY 40536 USA; [Lin, Ming Kuan; Lipsky, Robert H.] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Jiang, Yang; Jicha, Gregory A.; Ding, Xiuhua; Fardo, David W.; Schmitt, Frederick A.; Kryscio, Richard] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Jicha, Gregory A.; Schmitt, Frederick A.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Ding, Xiuhua; Fardo, David W.; Kryscio, Richard] Univ Kentucky, Dept Stat, Lexington, KY 40536 USA; [Ding, Xiuhua; Fardo, David W.; Kryscio, Richard] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Lipsky, Robert H.] Inova Hlth Syst, Inova Neurosci Inst, Dept Neurosci, Falls Church, VA 22042 USA		Lipsky, RH (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA.; Lipsky, RH (corresponding author), Inova Hlth Syst, Inova Neurosci Inst, Dept Neurosci, Falls Church, VA 22042 USA.	robert.lipsky@inova.org		JIANG, Yang/0000-0003-4589-0097; Fardo, David/0000-0002-7207-4696	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG000986, P30AG028383]; Virginia Center on Aging; Inova Research Foundation; George Mason Research Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG000986, P30AG028383] Funding Source: NIH RePORTER	This work was founded by National Institute on Aging K01AG000986; P30AG028383; Virginia Center on Aging (RHL), Inova Research Foundation, George Mason Research Foundation, (RHL, ML)	Andreoli V, 2014, J NEURAL TRANSM, V121, P533, DOI 10.1007/s00702-013-1125-7; Bai L, 2004, NEUROBIOL AGING, V25, P201, DOI 10.1016/S0197-4580(03)00091-5; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brim BL, 2013, BEHAV BRAIN RES, V238, P211, DOI 10.1016/j.bbr.2012.10.026; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Caggiano DM, 2006, AGING NEUROPSYCHOL C, V13, P552, DOI 10.1080/138255890969555; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; ELLISON G, 1995, BRAIN RES REV, V20, P250, DOI 10.1016/0165-0173(94)00014-G; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gupta N, 2011, FEMS IMMUNOL MED MIC, V62, P110, DOI 10.1111/j.1574-695X.2011.00792.x; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hu YZ, 2013, J NEUROSCI, V33, P18566, DOI 10.1523/JNEUROSCI.1973-13.2013; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Jiang Y, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00015; Jiang Y, 2009, AGING NEUROPSYCHOL C, V16, P164, DOI 10.1080/13825580802348588; Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Li J, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0229-3; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; Parasuraman R, 2012, NEUROIMAGE, V59, P70, DOI 10.1016/j.neuroimage.2011.04.040; Pergola G, 2016, PSYCHOL MED, V46, P1135, DOI 10.1017/S0033291715002639; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Ranganath C, 2006, NEUROSCIENCE, V139, P277, DOI 10.1016/j.neuroscience.2005.06.092; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Schmitt FA, 2001, GERONTOLOGIST, V41, P716, DOI 10.1093/geront/41.6.716; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sonntag WE, 2000, BRAIN RES BULL, V51, P331, DOI 10.1016/S0361-9230(99)00259-2; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; VANDERVALK JBF, 1990, EUR J PHARMACOL, V185, P99, DOI 10.1016/0014-2999(90)90215-R; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Zhao X, 2009, NEUROSCIENCE, V162, P933, DOI 10.1016/j.neuroscience.2009.05.018	47	3	3	0	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	APR	2017	9	4					1293	1306		10.18632/aging.101228			14	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	EV9ZA	WOS:000402145300016	28439047	Green Submitted, Green Published, gold			2022-02-06	
J	Marquez, C; Lininger, M; Raab, S				Marquez, Chris; Lininger, Monica; Raab, Scot			ESTABLISHING NORMATIVE CHANGE VALUES IN VISUAL ACUITY LOSS DURING THE DYNAMIC VISUAL ACUITY TEST	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; oculomotor measures; Vestibulo-ocular reflex	VESTIBULAR DYSFUNCTION; GAZE STABILIZATION; HIGH-SCHOOL; CONCUSSION; RELIABILITY; STABILITY; REHABILITATION; DIZZINESS; RECOVERY; REFLEX	Background: Baseline visual acuity (VA) loss from static to dynamic head conditions assessed using the Dynamic Visual Acuity Testing (DVAT) have not been established in NCAA football players. DVAT assesses the Vestibulo-Ocular Reflex (VOR) which is measured in Logarithm of the Minimum Angle of Resolution (logMAR). Decreased VA beyond baseline measures may detect VOR impairment and impact treatment protocols and assist in return to play decisions post-concussion. Hypothesis/Purpose: To establish normative VA mean scores during a static head posture as well as dynamically during the DVAT with a head speed of 150 deg/s in the pitch (vertical) and yaw (horizontal) planes rotating 20 degrees in each direction. Study Design: Descriptive study, Diagnostic Tests. Methods: Sixty-seven, NCAA Division I College football players (age = 19.68 +/- 1.53) completed static VA and DVAT assessment in the pitch and yaw planes during baseline concussion testing at the beginning of the 2014 regular football season. Comparison of VA was evaluated by calculating the difference in players' static and dynamic VA values using the DVAT. Results: Static VA for all participants (n = 67) was -0.232 +/- 0.109 logMAR. Dynamic VA for participants (n = 67) was 0.0845 +/- 0.159 in pitch and -0.007 +/- 0.141 in yaw at 150 deg/sec. Mean losses in VA during pitch and yaw at 150 deg/sec were 0.317 +/- 0.140 and 0.227 +/- 0.133, respectively. Conclusions: VA diminishes during head movement at 150 degrees/sec. Loss of acuity beyond established normative values from baseline may be indicative of VOR dysfunction, especially secondary to head trauma. The assessment of visual acuity function with head movements of 150 deg/sec can potentially identify concussion and subsequent sequelae. Further research is recommended.	[Marquez, Chris; Lininger, Monica; Raab, Scot] No Arizona Univ, Flagstaff, AZ USA		Raab, S (corresponding author), No Arizona Univ, Athlet Training Educ Program, POB 15094, Flagstaff, AZ 86011 USA.	scot.raab@nau.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bloomberg JJ, 2000, J VESTIBUL RES-EQUIL, V10, P75; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Gottshall K, LARYNGOSCOPE; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hazel CA, 2002, OPTOMETRY VISION SCI, V79, P788, DOI 10.1097/00006324-200212000-00011; Herdman SJ, 1998, AM J OTOL, V19, P790; Herdman SJ, 2007, ARCH OTOLARYNGOL, V133, P383, DOI 10.1001/archotol.133.4.383; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mohammad MT, 2011, J VESTIBUL RES-EQUIL, V21, P277, DOI 10.3233/VES-2011-0430; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan I, J ORTHOP SPORTS PHYS; Roberts RA, 2007, J AM ACAD AUDIOL, V18, P236, DOI 10.3766/jaaa.18.3.5; Schubert MC, 2008, ARCH PHYS MED REHAB, V89, P500, DOI 10.1016/j.apmr.2007.11.010; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Whitney SL, 2009, GAIT POSTURE, V29, P194, DOI 10.1016/j.gaitpost.2008.08.002	19	3	5	0	1	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	APR	2017	12	2					227	232					6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	EY6ZP	WOS:000404134600008	28515977				2022-02-06	
J	Ustinova, KI; Langenderfer, JE; Balendra, N				Ustinova, Ksenia I.; Langenderfer, Joseph E.; Balendra, Nilanthy			Enhanced arm swing alters interlimb coordination during overground walking in individuals with traumatic brain injury	HUMAN MOVEMENT SCIENCE			English	Article						Arm-leg coordination; Neurological rehabilitation; Gait	LOCAL DYNAMIC STABILITY; PARKINSONS-DISEASE; GAIT STABILITY; LEG MOVEMENTS; SPEED; LOCOMOTION; STROKE; ADULTS; CLASSIFICATION; STRATEGY	The current study investigated interlimb coordination in individuals with traumatic brain injury (TBI) during overground walking. The study involved 10 participants with coordination, balance, and gait abnormalities post-TBI, as well as 10 sex-and age-matched healthy control individuals. Participants walked 12 m under two experimental conditions: 1) at self-selected comfortable walking speeds; and 2) with instructions to increase the amplitude and out-of-phase coordination of arm swinging. The gait was assessed with a set of spatiotemporal and kinematic parameters including the gait velocity, step length and width, double support time, lateral displacement of the center of mass, the amplitude of horizontal trunk rotation, and angular motions at shoulder and hip joints in sagittal plane. Interlimb coordination (coupling) was analyzed as the relative phase angles between the left and right shoulders, hips, and contralateral shoulders and hips, with an ideal out-of phase coupling of 180 and ideal in-phase coupling of 0 degrees. The TBI group showed much less interlimb coupling of the above pairs of joint motions than the control group. When participants were required to increase and synchronize arm swinging, coupling between shoulder and hip motions was significantly improved in both groups. Enhanced arm swinging was associated with greater hip and shoulder motion amplitudes, and greater step length. No other significant changes in spatiotemporal or kinematic gait characteristics were found in either group. The results suggest that arm swinging may be a gait parameter that, if controlled properly, can improve interlimb coordination during overground walking in patients with TBI. (C) 2017 Elsevier B.V. All rights reserved.	[Ustinova, Ksenia I.; Balendra, Nilanthy] Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA; [Langenderfer, Joseph E.] Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	NSF MRI GrantNational Science Foundation (NSF)NSF - Office of the Director (OD) [CBET-1337511]	Research project was sponsored by NSF MRI Grant CBET-1337511.	Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 1998, J NEUROL NEUROSUR PS, V65, P580, DOI 10.1136/jnnp.65.4.580; BERG K, 1989, Physiotherapy Canada, V41, P304; Bruijn SM, 2008, GAIT POSTURE, V27, P455, DOI 10.1016/j.gaitpost.2007.05.017; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chow JW, 2010, BRAIN INJURY, V24, P1575, DOI 10.3109/02699052.2010.523053; Collins SH, 2009, P ROY SOC B-BIOL SCI, V276, P3679, DOI 10.1098/rspb.2009.0664; Craik R., 1976, HUMAN SOLUTIONS LOCO, P51; Dietz V, 2001, EUR J NEUROSCI, V14, P1906, DOI 10.1046/j.0953-816x.2001.01813.x; Dietz V, 2008, BRAIN, V131, P3421, DOI 10.1093/brain/awn263; Donker SF, 2001, J MOTOR BEHAV, V33, P86, DOI 10.1080/00222890109601905; Farley BG, 2005, EXP BRAIN RES, V167, P462, DOI 10.1007/s00221-005-0179-7; Ford MP, 2007, GAIT POSTURE, V26, P150, DOI 10.1016/j.gaitpost.2006.08.007; Ford MP, 2007, GAIT POSTURE, V26, P135, DOI 10.1016/j.gaitpost.2006.08.008; Ford Matthew P, 2007, J Neurol Phys Ther, V31, P85; Goudriaan M, 2014, GAIT POSTURE, V40, P321, DOI 10.1016/j.gaitpost.2014.04.204; Hu F, 2012, IEEE ENG MED BIO, P4831, DOI 10.1109/EMBC.2012.6347075; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Krasovsky T, 2014, GAIT POSTURE, V39, P378, DOI 10.1016/j.gaitpost.2013.08.011; Krasovsky T, 2013, J NEUROPHYSIOL, V109, P77, DOI 10.1152/jn.00552.2012; Kuhtz-Buschbeck JP, 2012, J ELECTROMYOGR KINES, V22, P199, DOI 10.1016/j.jelekin.2011.08.014; Kwakkel G, 2002, PHYS THER, V82, P432, DOI 10.1093/ptj/82.5.432; Meyns P, 2013, GAIT POSTURE, V38, P555, DOI 10.1016/j.gaitpost.2013.02.006; Meyns P, 2011, RES DEV DISABIL, V32, P1957, DOI 10.1016/j.ridd.2011.03.029; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Nakakubo S, 2014, GAIT POSTURE, V40, P516, DOI 10.1016/j.gaitpost.2014.06.005; Ortega JD, 2008, J BIOMECH, V41, P3303, DOI 10.1016/j.jbiomech.2008.06.039; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Punt M, 2015, GAIT POSTURE, V41, P504, DOI 10.1016/j.gaitpost.2014.12.002; Stenum J, 2014, J BIOMECH, V47, P3776, DOI 10.1016/j.jbiomech.2014.09.020; Stephenson JL, 2010, GAIT POSTURE, V31, P109, DOI 10.1016/j.gaitpost.2009.09.008; Stephenson JL, 2009, GAIT POSTURE, V29, P11, DOI 10.1016/j.gaitpost.2008.05.013; Sterling NW, 2015, J PARKINSON DIS, V5, P141, DOI 10.3233/JPD-140447; Taub E, 1980, BEHAV PSYCHOL REHABI, P371; Tavernese E, 2016, CLIN BIOMECH, V32, P142, DOI 10.1016/j.clinbiomech.2015.11.020; Tester NJ, 2012, GAIT POSTURE, V36, P49, DOI 10.1016/j.gaitpost.2012.01.004; Umberger BR, 2008, J BIOMECH, V41, P2575, DOI 10.1016/j.jbiomech.2008.05.024; Ustinova KI, 2004, MOTOR CONTROL, V8, P139, DOI 10.1123/mcj.8.2.139; USTINOVA KI, 2003, HUM PHYSL, V29, P642, DOI DOI 10.1023/A:1025832420924; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; WAGENAAR RC, 1994, HUM MOVEMENT SCI, V13, P441, DOI 10.1016/0167-9457(94)90049-3; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE13, DOI 10.1097/HTR.0000000000000038; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Winogrodzka A, 2005, ARCH PHYS MED REHAB, V86, P183, DOI 10.1016/j.apmr.2004.09.010; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	46	3	3	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2017	52						45	54		10.1016/j.humov.2017.01.001			10	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	ET4EC	WOS:000400231100005	28110146	Bronze			2022-02-06	
J	Witty, C; Heffernan, T; Riby, L				Witty, Chloe; Heffernan, Thomas; Riby, Leigh			STROKE PATIENTS AND THEIR PARTNER'S PERCEPTIONS OF SURVIVOR FUNCTIONING	ACTA NEUROPSYCHOLOGICA			English	Article						stroke; rehabilitation; couples; incongruence; Self-efficacy; cognition; caregivers	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; SELF-EFFICACY; SPOUSE PERCEPTIONS; IMPACT; CAREGIVERS; CARE; HEALTH; REHABILITATION	Background: Research into stroke survivors and their partners have shown that the partner frequently rates the stroke survivor as less capable than the survivors rate themselves through self-report questionnaires or qualitative interviews; however, no research to date has used cognitive tasks as a method for in vestigation. This paper aims to investigate if the stroke survivor or the partner rate the stroke survivor as worse across all cognitive domains. Material/Methods: This research aimed to observe the incongruence of stroke survivors and their spouse's perception of survivor functioning by rating their confidence on Picture Memory, Verbal Memory, Digit Span, Luria's Three Step Test, NART and Raven's Matrices. Participants, and to compare these score to see if either could predict the actual score. Results: Showed that neither the stroke survivor nor the partner consistently rated functioning as worse, but there was a significant difference between the dyad. Further, the stroke survivor and the partner's confidence had no relationship with raw scores. A thematic analysis was also conducted and themes emerged from the data. These were "Confidence," "Insight into Ability," and "Post-Stroke Changes." Conclusions: These themes were shown to interlink with the scores provided in the qualitative analysis, and implied that low self-efficacy may be crucial in post stroke recovery. Limitations and implications are discussed in full.	[Witty, Chloe; Heffernan, Thomas; Riby, Leigh] Northumbria Univ, Dept Psychol, Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England		Riby, L (corresponding author), Northumbria Univ, Dept Psychol, Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	leigh.riby@northumbria.ac.uk					Allen SM, 1999, GERONTOLOGIST, V39, P150, DOI 10.1093/geront/39.2.150; Anderson C, 2000, STROKE, V31, P1024, DOI 10.1161/01.STR.31.5.1024; Andren S, 2005, SCAND J CARING SCI, V19, P157, DOI 10.1111/j.1471-6712.2005.00328.x; Bakas T, 2009, TOP STROKE REHABIL, V16, P105, DOI 10.1310/tsr1602-105; Bandura A., 1997, SELF EFFICACY EXERCI; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Barry LC, 2003, PAIN, V104, P131, DOI 10.1016/S0304-3959(02)00471-2; Benyamini Y, 2007, PSYCHOL HEALTH, V22, P765, DOI 10.1080/14768320601070639; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cecil R, 2011, J CLIN NURS, V20, P1723, DOI 10.1111/j.1365-2702.2010.03400.x; Cho K, 2012, J PHYS THER SCI, V24, P779, DOI 10.1589/jpts.24.779; CHRISTENSON AL, 1974, LURIAS NEUROPSYCHOLO; Claesson L, 2005, CEREBROVASC DIS, V19, P102, DOI 10.1159/000082787; CRAWFORD JR, 1987, BRIT J CLIN PSYCHOL, V26, P313, DOI 10.1111/j.2044-8260.1987.tb01366.x; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Ezer H, 2011, PSYCHO-ONCOLOGY, V20, P155, DOI 10.1002/pon.1724; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Gainotti G, 2002, CURR OPIN NEUROL, V15, P85, DOI 10.1097/00019052-200202000-00013; Garand L, 2007, WESTERN J NURS RES, V29, P976, DOI 10.1177/0193945907303086; Grant JS, 2014, STROKE, V45, pE151, DOI 10.1161/STROKEAHA.114.005094; Haley WE, 2015, NEUROLOGY, V84, P1323, DOI 10.1212/WNL.0000000000001418; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hurford R, 2013, J NEUROL, V260, P237, DOI 10.1007/s00415-012-6625-0; Jones F, 2008, J CLIN NURS, V17, P244, DOI 10.1111/j.1365-2702.2008.02333.x; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kauhanen ML, 2000, ARCH PHYS MED REHAB, V81, P1541, DOI 10.1053/apmr.2000.9391; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lobchuk MM, 2002, CANCER NURS, V25, P358, DOI 10.1097/00002820-200210000-00005; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lyons KS, 2009, GERONTOLOGIST, V49, P378, DOI 10.1093/geront/gnp046; Makoae MG, 2008, SAHARA J-J SOC ASP H, V5, P36, DOI 10.1080/17290376.2008.9724900; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McCarthy MJ, 2015, AGING MENT HEALTH, V19, P46, DOI 10.1080/13607863.2014.913551; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; Nelson H.E., 1982, NATL ADULT READING T; Northcott S, 2016, CLIN REHABIL, V30, P811, DOI 10.1177/0269215515602136; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Oosterveer DM, 2014, J REHABIL MED, V46, P139, DOI 10.2340/16501977-1250; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Ostwald SK, 2009, TOP STROKE REHABIL, V16, P93, DOI 10.1310/tsr1602-93; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Pachalska M, 2015, ACTA NEUROPSYCHOL, V13, P105, DOI 10.5604/17307503.1162511; Pachalska M, 2015, ACTA NEUROPSYCHOL, V13, P205, DOI 10.5604/17307503.1169396; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Penrose LS, 1936, BRIT J MED PSYCHOL, V16, P97, DOI 10.1111/j.2044-8341.1936.tb00690.x; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Quinn C, 2009, AGING MENT HEALTH, V13, P143, DOI 10.1080/13607860802459799; Quinn K, 2014, DISABIL REHABIL, V36, P1670, DOI 10.3109/09638288.2013.866699; Rasquin SMC, 2004, J NEUROL NEUROSUR PS, V75, P1562, DOI 10.1136/jnnp.2003.024190; Raven JC, 1958, ADV PROGR MATRICES S; Redick TS, 2012, EUR J PSYCHOL ASSESS, V28, P164, DOI 10.1027/1015-5759/a000123; Riby, 2016, HDB GERONTOLOGY RES; Robinson-Smith G, 2002, J NEUROSCIENCE NURSI, V34, P91; Saunders DH, 2013, COCHRANE DB SYST REV, V21; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Shan S. H., 2014, INT J EVID-BASED HEA, V12, P191, DOI DOI 10.1097/01.XEB.0000455183.12101.89; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; Sterba KR, 2008, HEALTH PSYCHOL, V27, P221, DOI 10.1037/0278-6133.27.2.221; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Tsouna-Hadjis E, 2000, ARCH PHYS MED REHAB, V81, P881, DOI 10.1053/apmr.2000.4435; Umegaki H, 2014, ARCH GERONTOL GERIAT, V58, P130, DOI 10.1016/j.archger.2013.08.010; Visser-Meily A, 2005, PATIENT EDUC COUNS, V56, P257, DOI 10.1016/j.pec.2004.02.013; Visser-Meily A, 2006, DISABIL REHABIL, V28, P1557, DOI 10.1080/09638280600648215; Weiner MF, 2011, INT PSYCHOGERIATR, V23, P1602, DOI 10.1017/S1041610211000767; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120; Zell E, 2014, PERSPECT PSYCHOL SCI, V9, P111, DOI 10.1177/1745691613518075; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641; [No title captured]	84	3	3	0	5	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	APR-JUN	2017	15	2					161	180		10.5604/01.3001.0010.2407			20	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	FG0LR	WOS:000409434200005					2022-02-06	
J	Abiko, K; Ikoma, K; Shiga, T; Katoh, C; Hirata, K; Kuge, Y; Kobayashi, K; Tamaki, N				Abiko, Kagari; Ikoma, Katsunori; Shiga, Tohru; Katoh, Chietsugu; Hirata, Kenji; Kuge, Yuji; Kobayashi, Kentaro; Tamaki, Nagara			I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury	EJNMMI RESEARCH			English	Article							TEMPORAL-LOBE EPILEPSY; NONMISSILE HEAD-INJURY; BENZODIAZEPINE-RECEPTORS; AXONAL INJURY; BLOOD-FLOW; RO 15-1788; SPECT; BINDING; PET; HYPOMETABOLISM	Background: Traumatic brain injury (TBI) causes brain dysfunction in many patients. Using C-11 flumazenil (FMZ) positron emission tomography (PET), we have detected and reported the loss of neuronal integrity, leading to brain dysfunction in TBI patients. Similarly to FMZ PET, I-123 iomazenil (IMZ) single photon emission computed tomography (SPECT) is widely used to determine the distribution of the benzodiazepine receptor (BZR) in the brain cortex. The purpose of this study is to examine whether IMZ SPECT is as useful as FMZ PET for evaluating the loss of neuronal integrity in TBI patients. The subjects of this study were seven patients who suffered from neurobehavioral disability. They underwent IMZ SPECT and FMZ PET. Nondisplaceable binding potential (BPND) was calculated from FMZ PET images. The uptake of IMZ was evaluated on the basis of lesion-to-pons ratio (LPR). The locations of low uptake levels were visually evaluated both in IMZ SPECT and FMZ PET images. We compared FMZ BPND and (LPR-1) of IMZ SPECT. Results: In the visual assessment, FMZ BPND decreased in 11 regions. In IMZ SPECT, low uptake levels were observed in eight of the 11 regions. The rate of concordance between FMZ PET and IMZ SPECT was 72.7%. The mean values IMZ (LPR-1) (1.95 +/- 1.01) was significantly lower than that of FMZ BPND (2.95 +/- 0.80 mL/mL). There was good correlation between FMZ BPND and IMZ (LPR-1) (r = 0.80). Conclusions: IMZ SPECT findings were almost the same as FMZ PET findings in TBI patients. The results indicated that IMZ SPECT is useful for evaluating the loss of neuronal integrity. Because IMZ SPECT can be performed in various facilities, IMZ SPECT may become widely adopted for evaluating the loss of neuronal integrity.	[Abiko, Kagari; Ikoma, Katsunori] Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido 0608638, Japan; [Shiga, Tohru; Katoh, Chietsugu; Hirata, Kenji; Kobayashi, Kentaro; Tamaki, Nagara] Hokkaido Univ, Dept Nucl Med, Sch Med, Kita Ku, North 15th,West 7th, Sapporo, Hokkaido 0608638, Japan; [Kuge, Yuji] Hokkaido Univ, Dept Tracer Kinet, Sapporo, Hokkaido 0608638, Japan		Shiga, T (corresponding author), Hokkaido Univ, Dept Nucl Med, Sch Med, Kita Ku, North 15th,West 7th, Sapporo, Hokkaido 0608638, Japan.	tshiga@med.hokudai.ac.jp					ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AXELSSON B, 1984, J NUCL MED, V25, P490; BEER HF, 1990, J NUCL MED, V31, P1007; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cherry S.R., 2012, PHYS NUCL MED, V4th ed.; Debets RMC, 1997, J NEUROL NEUROSUR PS, V62, P141, DOI 10.1136/jnnp.62.2.141; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; HOLTHOFF VA, 1991, J CEREBR BLOOD F MET, V11, P745, DOI 10.1038/jcbfm.1991.131; Hosokawa C, 2015, J NUCL MED, V56, P1910, DOI 10.2967/jnumed.115.156414; ICHISE M, 1994, J NUCL MED, V35, P217; Iida H, 1998, J NUCL MED, V39, P181; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; JOHNSON EW, 1990, LIFE SCI, V47, P1535, DOI 10.1016/0024-3205(90)90182-Q; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kuroda S, 2004, J NUCL MED, V45, P943; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; MEIKLE SR, 1994, J NUCL MED, V35, P360; Millet P, 2000, J CEREBR BLOOD F MET, V20, P1587, DOI 10.1097/00004647-200011000-00009; Morimoto K, 2005, EPILEPSIA, V46, P184, DOI 10.1111/j.1528-1167.2005.01030.x; PERSSON A, 1985, J PSYCHIAT RES, V19, P609, DOI 10.1016/0022-3956(85)90080-9; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; SAMSON Y, 1985, EUR J PHARMACOL, V110, P247, DOI 10.1016/0014-2999(85)90218-3; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sata Y, 2002, EPILEPSIA, V43, P1039, DOI 10.1046/j.1528-1157.2002.137601.x; SAVIC I, 1988, LANCET, V2, P863, DOI 10.1016/S0140-6736(88)92468-3; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Shiga T, 2001, CLIN NUCL MED, V26, P334, DOI 10.1097/00003072-200104000-00011; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	35	3	3	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2191-219X			EJNMMI RES	EJNMMI Res.	MAR 23	2017	7								28	10.1186/s13550-017-0276-1			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EP1SE	WOS:000397163800003	28337724	Green Published, gold			2022-02-06	
J	Koumpan, Y; Murdoch, J; Beyea, JA; Kahn, M; Colbeck, J				Koumpan, Yuri; Murdoch, John; Beyea, Jason A.; Kahn, Michael; Colbeck, Jaime			A Case Report: Establishing a Definitive Airway in a Trauma Patient With a King Laryngeal Tube In Situ in the Presence of a Closed Head Injury and Difficult Airway: "Between the Devil and the Deep Blue Sea"	A & A CASE REPORTS			English	Article							MANAGEMENT	Airway management in trauma is a crucial skill, because patients are at risk of aspiration, hypoxia, and hypoventilation, all of which may be fatal in the setting of increased intracranial pressure. The King Laryngeal Tube reusable supraglottic airway (King Systems, Noblesville, IN) allows for temporary management of a difficult airway but poses a challenge when an attempt is made to exchange the device for an endotracheal tube, often managed by emergency tracheostomy. We describe a novel fiberoptic, video laryngoscope-assisted approach to intubation in a difficult trauma airway with an in situ King Laryngeal Tube.	[Koumpan, Yuri; Murdoch, John; Kahn, Michael; Colbeck, Jaime] Queens Univ, Kingston Gen Hosp, Dept Anesthesiol & Perioperat Med, Kingston, ON, Canada; [Beyea, Jason A.] Queens Univ, Hop Hotel Dieu, Dept Otolaryngol, Kingston, ON, Canada		Murdoch, J (corresponding author), Kingston Gen Hosp, Dept Anesthesiol, Victory 2,76 Stuart St, Kingston, ON K7L 2V7, Canada.	murdochj@kgh.kari.net					Bergold MN, 2016, ANAESTHESIST, V65, P30, DOI 10.1007/s00101-015-0100-0; Galgon RE, 2012, J ANESTHESIOL CLIN S, V1, P15, DOI DOI 10.7243/2049-9752-1-15; Khaja SF, 2010, ARCH OTOLARYNGOL, V136, P979, DOI 10.1001/archoto.2010.172; Klingler W, 2005, NEUROMUSCULAR DISORD, V15, P195, DOI 10.1016/j.nmd.2004.10.017; Lutes M, 2010, J EMERG MED, V38, P222, DOI 10.1016/j.jemermed.2008.08.011; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Subramanian A, 2016, CAN J ANESTH, V63, P275, DOI 10.1007/s12630-015-0493-x	7	3	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2325-7237	2575-3126		A A CASE REP	A A Case Rep.	MAR 15	2017	8	6					139	141		10.1213/XAA.0000000000000446			3	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	ER0VP	WOS:000398506800005	28114156				2022-02-06	
J	Kuwahara, R; Tomita, R; Ogawa, N; Nakajima, K; Takeda, T; Uehara, H; Yamanobe, T				Kuwahara, Ryoko; Tomita, Ryotaro; Ogawa, Natsumi; Nakajima, Kazunori; Takeda, Tomotaka; Uehara, Hiroki; Yamanobe, Takeshi			Crystallization and hardening of poly(ethylene-co-vinyl acetate) mouthguards during routine use	SCIENTIFIC REPORTS			English	Article							ETHYLENE-VINYL-ACETATE; HEAD ACCELERATION; CHAIN-REACTION; POLYETHYLENE; POLYMERASE; NMR; DNA; COPOLYMERS; INJURIES; BEHAVIOR	Mouthguards (MGs) made from poly(ethylene-co-vinyl acetate) (EVA) are widely used in contact sports to prevent injuries such as breaking teeth and lip lacerations and to reduce brain concussion. However, the changes in morphology and the molecular mobility of EVA, which can affect its physical properties during practical usage, have not been precisely examined. Therefore, we attempted to determine the main factors which lead to changes in MG performance after one season of practical use by high school rugby players. Solid-state nuclear magnetic resonance (NMR) and pulse NMR measurements showed the hardening of MGs, which was associated with an increased crystallinity of the EVA resulting from prolonged usage. Furthermore, our data indicated that the increase in the relative amount of the crystalline phase may be primarily attributed to temperature fluctuations and repeated changes in pressure, which could cause the hardening of EVA and eventually diminish the protective ability of MGs.	[Kuwahara, Ryoko; Tomita, Ryotaro; Ogawa, Natsumi; Uehara, Hiroki; Yamanobe, Takeshi] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma, Japan; [Nakajima, Kazunori; Takeda, Tomotaka] Tokyo Dent Coll, Dept Oral Hlth & Clin Sci, Div Sports Dent, Chiyoda Ku, Tokyo, Japan		Yamanobe, T (corresponding author), Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma, Japan.	yamanobe@gunma-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [25463024, 25463025, 26288098]	Financial supports from the Japan Society for the Promotion of Science (Grants 25463024, 25463025 and 26288098) are gratefully acknowledged. The authors thank Katsushi Katano, DDS; and Fumio Yarita, DDS for their generous assistance in dental clinical works.	ADA, 2006, J AM DENT ASSOC, V137, P1712; BISHOP BM, 1985, J PROSTHET DENT, V53, P256, DOI 10.1016/0022-3913(85)90123-4; Bourguignon Cecilia, 2009, Dent Clin North Am, V53, P729, DOI 10.1016/j.cden.2009.06.002; de Wet FA, 1999, J PROSTHET DENT, V82, P301, DOI 10.1016/S0022-3913(99)70084-3; GOING RE, 1974, J AM DENT ASSOC, V89, P132, DOI 10.14219/jada.archive.1974.0354; Gould TE, 2009, DENT MATER, V25, P1593, DOI 10.1016/j.dental.2009.08.003; Gould TE, 2009, DENT MATER, V25, P771, DOI 10.1016/j.dental.2008.12.005; Guerard S, 2014, DENT MATER J, V33, P799, DOI 10.4012/dmj.2014-044; Haaser M, 2013, EUR J PHARM BIOPHARM, V85, P1095, DOI 10.1016/j.ejpb.2013.03.019; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; Hoshina H, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3358146; Johnston T, 1996, ENDOD DENT TRAUMATOL, V12, P277; Kakiage M, 2008, MACROMOL RAPID COMM, V29, P1571, DOI 10.1002/marc.200800316; Kato S, 2015, J PHYS CHEM B, V119, P5062, DOI 10.1021/jp512246d; Kitamura T, 2007, EICE TECH REP, V107, P7; Kuwahara M, 2006, NUCLEIC ACIDS RES, V34, P5383, DOI 10.1093/nar/gkl637; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Marin ML, 1996, J THERM ANAL, V47, P247; Matsuda H, 2001, KOBUNSHI RONBUNSHU, V58, P326, DOI 10.1295/koron.58.326; McNair O. D., 2014, J APPL POLYM SCI; Meng FH, 2007, DENT MATER, V23, P1492, DOI 10.1016/j.dental.2007.01.006; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Narimatsu Keishiro, 2015, General Dentistry, V63, P41; Ozawa T, 2014, DENT TRAUMATOL, V30, P204, DOI 10.1111/edt.12063; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Shi XM, 2008, EXPRESS POLYM LETT, V2, P623, DOI 10.3144/expresspolymlett.2008.75; Sigurdsson A, 2013, PEDIATR DENT, V35, P184; Suzuki H., 2007, INT J ORAL MED SCI, V6, P14; Takahashi M, 2016, DENT TRAUMATOL, V32, P90, DOI 10.1111/edt.12206; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Takeda Tomotaka, 2003, Shikwa Gakuho, V103, P705; Uehara H, 2000, MACROMOLECULES, V33, P4861, DOI 10.1021/ma9918957; Uehara H, 2014, MACROMOL MATER ENG, V299, P669, DOI 10.1002/mame.201300310; Velayudhan S, 2002, J MATER SCI-MATER M, V13, P517, DOI 10.1023/A:1014739326345; Wang LY, 2006, J POLYM SCI POL PHYS, V44, P2864, DOI 10.1002/polb.20917; Warnet L, 2001, BRIT J SPORT MED, V35, P257, DOI 10.1136/bjsm.35.4.257; Winters Jackson, 2014, General Dentistry, V62, P34; Wunderlich B, 1976, MACROMOLECULAR PHYS, V2; Zhang QJ, 2002, J POLYM SCI POL PHYS, V40, P2199, DOI 10.1002/polb.10278	40	3	3	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 15	2017	7								44672	10.1038/srep44672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO4HJ	WOS:000396655700001	28294184	Green Published, gold			2022-02-06	
J	Butlinski, AK; Butt, WW				Butlinski, Anna K.; Butt, Warwick W.			The characteristics, pattern of injury and outcome of children admitted to a paediatric intensive care unit following an inflicted injury	CRITICAL CARE AND RESUSCITATION			English	Article							TRAUMATIC BRAIN-INJURY	Objective: To describe the characteristics, pattern of injury and outcome of children admitted to a paediatric intensive care unit (PICU) following an inflicted injury. Design, setting and participants: A retrospective review of hospital records from a 30-bed PICU in a university teaching hospital, examining data for children admitted to the PICU after an inflicted injury from 1 January 2005 to 31 December 2013. Main outcome measures: The hospital records of 46 children with an inflicted injury were reviewed. Outcome was categorised using the Pediatric Overall Performance Category score. Results: Sixty-one percent of children admitted to the PICU after an inflicted injury were aged under 12 months. Eighty-three percent of children required admission for a head injury. Radiological findings suggestive of pre-existing inflicted injury were evident in 50% of children. Follow-up information was available for 41 children; 76% were alive at follow-up while 24% had died. Among survivors, outcome was evaluated at a median of 11.3 months after admission to the PICU; 74% had a favourable outcome, despite 61% of these children having a disability. The remaining 26% of children had an unfavourable outcome and were likely to live dependent on care. Conclusions: The majority of children admitted to intensive care following an inflicted injury are aged under 12 months. Children most commonly require intensive care for management of a head injury. Many children have radiological findings suggestive of pre-existing inflicted injury. Despite high mortality, the majority of children survive. While most are likely to be independent, many children will have residual disabilities.	[Butlinski, Anna K.; Butt, Warwick W.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Butlinski, Anna K.; Butt, Warwick W.] Royal Childrens Hosp, Paediat Intens Care Unit, Melbourne, Vic, Australia; [Butt, Warwick W.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Butlinski, AK (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Butlinski, AK (corresponding author), Royal Childrens Hosp, Paediat Intens Care Unit, Melbourne, Vic, Australia.	anna.butlinski@rch.org.au					Australian and New Zealand Paediatric Intensive Care Registry, 2015, ANZPIC DIAGN COD TAB; Australian Institute of Family Studies, 2013, RISK PROT FACT CHILD; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Ilves P, 2010, ACTA PAEDIATR, V99, P1329, DOI 10.1111/j.1651-2227.2010.01820.x; Irazuzta JE, 1997, CHILD ABUSE NEGLECT, V21, P751, DOI 10.1016/S0145-2134(97)00036-7; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Pickett TA, 2015, J FORENSIC LEG MED, V33, P105, DOI 10.1016/j.jflm.2015.04.012; Pierce MC, 2010, PEDIATRICS, V125, P67, DOI 10.1542/peds.2008-3632; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Zenel J, 2002, CRIT CARE MED, V30, pS515, DOI 10.1097/00003246-200211001-00016	18	3	3	2	3	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2017	19	1					23	28					6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9DT	WOS:000394920300005	28215128				2022-02-06	
J	Elder, H				Elder, Hinemoa			Te Waka Kuaka and Te Waka Oranga. Working with Whnau to Improve Outcomes	AUSTRALIAN AND NEW ZEALAND JOURNAL OF FAMILY THERAPY			English	Article						whnau; hauora; healing; Maori; cultural practices; traumatic brain injury; recovery; needs assessment		The role of whnau (extended families) is recognised as an essential aspect of hauora (wellbeing) for Maori, who are over represented in populations where there is injury or insult to the brain. Whnau mtauranga (knowledge systems) are a potent resource for enhancing recovery outcomes. This approach, based on Rangahau Kaupapa Maori (research by Maori for Maori) takes the view that by locating the whnau within their own culturally determined knowledge systems and optimising their intergral role in the delivery of culturally required interventions, the recovery experience will be enhanced, and they will feel a greater sense of ease and self-determination in the process of their own healing. Te Waka Oranga describes a process of bringing together whnau knowledge, skills, and feelings, with health workers' knowledge, skills, and feelings in the context of identifying recovery destinations they collectively want to bring forward in order to improve the experience of recovery and to improve outcomes for whnau using the metaphor of a waka. It is also hypothesised that this approach will improve the experience of the health workers. Te Waka Kuaka is a Maori cultural needs assessment tool that has been developed to further guide this work, which uses the metaphor of a flock of godwits. This paper describes the development of a combined approach, using these two tools, with whnau at the centre. This illustrates in both theory and praxis a culturally defined way of bringing whnau resources to the fore to promote whnau healing. While originally designed to address issues in the area of traumatic brain injury, it is likely that this way of working may also have wider application in the areas of insult to the brain such as mental health, addictions, and neurodegenerative disorders.	[Elder, Hinemoa] Child & Adolescent Psychiatrist, Auckland, New Zealand		Elder, H (corresponding author), NZ Hlth Res Council, Auckland, New Zealand.; Elder, H (corresponding author), Ctr Res Excellence Ageing Brain, Auckland, New Zealand.; Elder, H (corresponding author), Univ Auckland, Auckland, New Zealand.	Hinemoa@xtra.co.nz					Barlow C, 2005, TIKANGA WHAKAARO KEY; Durie M., 2001, MAURI ORA DYNAMICS M; Durie M., 2010, WHANAU ORA REPORT TA; Elder H., 2016, ANN PSYCHIAT MENTAL, V4, P1079; Elder H, 2015, RETHINKING REHABILIT, P227; Elder H, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/137402; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Kingi, 1997, FRAMEWORK MEASURING; Lawson-Te Aho K, 2010, DEFINITIONS WHNAU RE; Moko-Mead H., 2003, TIKANGA MORI; Pihama L., 2010, HE KAUPAPA KRERO MOR; Pihama L., 2002, CANADIAN J NATIVE ED, V60, P30; Smith G, 2003, KAUP MOR S NZARE AAR; Smith L. T., 1999, DECOLONIZING METHODO	14	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0814-723X	1467-8438		AUST NZ J FAM THER	Aust. N. Z. J. Fam. Ther.	MAR	2017	38	1			SI		27	42		10.1002/anzf.1206			16	Family Studies	Social Science Citation Index (SSCI)	Family Studies	EQ1KH	WOS:000397828300004					2022-02-06	
J	Eyer, MM; Renier, CM; Woehrle, TA; Vogel, LE; Conway, PG; McCarty, CA				Eyer, Madeline M.; Renier, Colleen M.; Woehrle, Theo A.; Vogel, Linda E.; Conway, Pat G.; McCarty, Catherine A.			Alcohol Use at the Time of Traumatic Brain Injury: Screening and Brief Intervention in a Community Hospital	JOURNAL OF TRAUMA NURSING			English	Article						Alcohol-induced disorders; Brain injuries; CAGE questionnaire	SUBSTANCE MISUSE	The use of screening and brief interventions (SBI) has been proposed to reduce future alcohol misuse and injury in traumatic brain injury (TBI) patients. As a result a SBI protocol for TBI patients was introduced with nursing training at a community hospital. In the 2 years following the implementation of a SBI protocol and nursing training, the number of patients with positive alcohol results decreased. The number of brief interventions increased to 83 (40.1%, 95% confidence limit [CL] = 33.4, 46.8), and CAGE questionnaire screenings decreased to 88 (42.5%, 95% CL = 35.8, 49.2), with 31 (35.2%) having positive results. These results highlight the need to assess processes and training in the emergency department to ensure that SBIs occur.	[Eyer, Madeline M.; Renier, Colleen M.; Woehrle, Theo A.; Conway, Pat G.; McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Woehrle, Theo A.] Essentia Hlth St Marys Med Ctr, 507 E 2nd St,Maildrop 6AV-2, Duluth, MN 55805 USA		Woehrle, TA (corresponding author), Essentia Hlth St Marys Med Ctr, 507 E 2nd St,Maildrop 6AV-2, Duluth, MN 55805 USA.	theo.woehrle@essentiahealth.org		McCarty, Catherine/0000-0003-1089-0142; Renier, Colleen/0000-0001-5083-5282	Essentia Health Duluth Clinic Foundation	The authors acknowledge Heather Royer, registrar, for her assistance in data collection, and the Essentia Health Duluth Clinic Foundation for its funding support.	American College of Surgeons Committee on trauma, 2007, ALC SCREEN BRIEF INT; Bernier RA, 2016, BRAIN INJURY, V30, P414, DOI 10.3109/02699052.2015.1127998; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302	7	3	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAR-APR	2017	24	2					116	124		10.1097/JTN.0000000000000275			9	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	EN3ZR	WOS:000395947100011	28272186	Green Published			2022-02-06	
J	Fisher, F; Philpott, A; Andrews, SC; Maule, R; Douglas, J				Fisher, Fiona; Philpott, April; Andrews, Sophie C.; Maule, Roxanne; Douglas, Jacinta			Characterizing social communication changes in amyotrophic lateral sclerosis	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						motor neuron disease; communication disorder; language test; social cognition; pragmatics; informant report.	TRAUMATIC BRAIN-INJURY; MOTOR-NEURON DISEASE; QUESTIONNAIRE; IMPAIRMENT; CONVERSATION; VALIDITY; DEFICITS; ABILITY; SCALE	Background: Speech and language impairments are well-established in individuals with amyotrophic lateral sclerosis (ALS). However, knowledge about particular aspects of social communication and everyday conversational abilities is limited. Aims: To investigate self- and informant-report ratings of social communicative abilities in ALS participants and matched healthy controls. Methods & Procedures: Thirty-two participants with ALS and 24 controls completed the La Trobe Communication Questionnaire (LCQ). Participants nominated a close other to provide an informant report on the LCQ. Demographic and clinical information was also collected. Outcomes & Results: Informant ratings indicated greater difficulties in conversational initiation, effectiveness and partner sensitivity for ALS participants compared with controls. ALS participants did not rate their social communicative abilities as poorer than controls and self- reports only differed from informant ratings in the control group. LCQ scores were not significantly correlated with clinical/functional variables. Conclusions & Implications: Social communication can be reduced in ALS and individuals may lack insight into these difficulties. In order to understand and provide targeted interventions for such difficulties, clinical speech and language assessment should incorporate social communication assessment, including both a self- and informant report format.	[Fisher, Fiona; Philpott, April; Andrews, Sophie C.; Maule, Roxanne] Calvary Hlth Care Bethlehem, 476 Kooyong Rd, Caulfield, Vic 3162, Australia; [Andrews, Sophie C.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Andrews, Sophie C.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Douglas, Jacinta] La Trobe Univ, Bundoora, Vic, Australia		Fisher, F (corresponding author), Calvary Hlth Care Bethlehem, 476 Kooyong Rd, Caulfield, Vic 3162, Australia.	fiona.fisher@calvarycare.org.au	Andrews, Sophie/L-8031-2019; Andrews, Sophie C/H-8322-2014	Andrews, Sophie C/0000-0002-2103-7748; Douglas, Jacinta/0000-0003-0940-6624	Bethlehem Griffiths Research Foundation; Motor Neurone Disease Research Institute of Australia	The authors thank all the participants who took part in this study. They also thank Jim Howe, Susan Mathers, Katrina Reardon and Renee Lichter for their contributions to data collection and management on this project. Funding for this research was provided by the Bethlehem Griffiths Research Foundation and Motor Neurone Disease Research Institute of Australia.	Ash S, 2015, AMYOTROPH LAT SCL FR, V16, P31, DOI 10.3109/21678421.2014.974617; Ash S, 2014, NEUROLOGY, V83, P520, DOI 10.1212/WNL.0000000000000670; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Bloch S, 2015, INT J SPEECH-LANG PA, V17, P373, DOI 10.3109/17549507.2014.979879; Bloch S, 2011, INT J LANG COMM DIS, V46, P510, DOI 10.1111/j.1460-6984.2011.00076.x; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Clark CN, 2015, CORTEX, V69, P47, DOI 10.1016/j.cortex.2015.03.024; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Gibbons CJ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-82; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Joubert K, 2011, COMMUN DISORD Q, V33, P34, DOI 10.1177/1525740110367824; Staios M, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00178, 10.3389/fnhum.2013.00464]; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tsermentseli S, 2016, AMYOTROPH LAT SCL FR, V17, P69, DOI 10.3109/21678421.2015.1071397	18	3	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAR-APR	2017	52	2					137	142		10.1111/1460-6984.12267			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EQ4PO	WOS:000398060600002	27363686				2022-02-06	
J	Formisano, R; Silvestro, D; Azicnuda, E; Longo, E; Barba, C; Rigon, J; D'Ippolito, M; Giustini, M; Bivona, U				Formisano, Rita; Silvestro, Daniela; Azicnuda, Eva; Longo, Eloise; Barba, Carmen; Rigon, Jessica; D'Ippolito, Mariagrazia; Giustini, Marco; Bivona, Umberto			Quality of life after brain injury (QOLIBRI): Italian validation of the proxy version	INTERNAL AND EMERGENCY MEDICINE			English	Article						Caregiver; Health-related quality of life; Social reintegration; Disability severity; Traumatic brain injury	SELF-AWARENESS; EXECUTIVE FUNCTION; SCALE; CAREGIVERS; DISEASE; INTEGRATION; IMPAIRMENT; OUTCOMES	To validate the proxy version of the Quality of Life after Brain Injury (QOLIBRI) questionnaire to utilize caregivers for comparison and to evaluate the correspondence between patients' self-perceived and caregivers' perception of patients' Health-Related Quality of Life (HRQoL). Ninety-two patients with severe TBI and their main caregivers were enrolled. Patients' and caregivers' HRQoL was assessed by the Patient-QOLIBRI (Pt-QOLIBRI) and the Proxy-QOLIBRI (Pro-QOLIBRI), respectively. The Pro-QOLIBRI is a modified version of the QOLIBRI to investigate caregivers' perception of patients' HRQoL (Pro-QOLIBRIpatient-centered), and their degree of satisfaction and botheredness (Pro-QOLIBRIcaregiver centered). The patients' disability and their social reintegration was investigated by means of Glasgow Outcome Scale Extended and Community Integration Questionnaire. Pro-QOLIBRI has good internal consistency and homogeneity. There was also positive correlation between the level of satisfaction measured by Pro-QOLIBRI but not by Pt-QOLIBRI, and the disability severity and social integration of the patients. The comparison between the Pt-QOLIBRI and Pro-QOLIBRI confirmed the usefulness of the Pro-QOLIBRI, especially the caregiver-centered version, to predict the social reintegration of survivors. To our knowledge this is the first study that correlates the HRQoL of survivors, as self-perceived and as perceived by the caregivers with social reintegration.	[Formisano, Rita; Silvestro, Daniela; Azicnuda, Eva; D'Ippolito, Mariagrazia; Bivona, Umberto] Rehabil Hosp Santa Lucia Fdn, IRCCS, Via Ardeatina 306, I-00142 Rome, Italy; [Silvestro, Daniela; D'Ippolito, Mariagrazia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Longo, Eloise; Giustini, Marco] Natl Inst Hlth, Rome, Italy; [Rigon, Jessica] IRCCS San Camillo Hopsital Fdn, Venice, Italy; [Barba, Carmen] Univ Florence, Pediat Neurol Unit, A Meyer Childrens Hopsital, Florence, Italy		Formisano, R (corresponding author), Rehabil Hosp Santa Lucia Fdn, IRCCS, Via Ardeatina 306, I-00142 Rome, Italy.	r.formisano@hsantalucia.it	Azicnuda, Eva/K-9010-2016; Giustini, Marco/Q-3166-2017; Barba, Carmen/AAB-7162-2022; D'Ippolito, Mariagrazia/K-4010-2016; barba, carmen/K-4942-2016	Giustini, Marco/0000-0003-2691-1956; D'Ippolito, Mariagrazia/0000-0001-7818-7352; barba, carmen/0000-0001-5445-5842			BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Keenan J.P., 2003, FACE MIRROR SEARCH O; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Lule D, 2013, J NEUROL, V260, P2836, DOI 10.1007/s00415-013-7068-y; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Mellon S, 2006, CANCER NURS, V29, P120, DOI 10.1097/00002820-200603000-00007; MOKKEN RJ, 1982, APPL PSYCH MEAS, V6, P417, DOI 10.1177/014662168200600404; Morin A, 2006, CONSCIOUS COGN, V15, P358, DOI 10.1016/j.concog.2005.09.006; Muehlan H, 2016, ASSESSMENT, V23, P124, DOI 10.1177/1073191115569844; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; TEASDALE G, 1974, LANCET, V2, P81; Tramonti F, 2015, PSYCHOL HEALTH MED, V10, P1, DOI DOI 10.1080/13548506.2015.1009380; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zucchella C, 2015, ALZ DIS ASSOC DIS, V29, P50, DOI 10.1097/WAD.0000000000000050	32	3	3	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1828-0447	1970-9366		INTERN EMERG MED	Intern. Emerg. Med.	MAR	2017	12	2					187	198		10.1007/s11739-016-1536-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM6VL	WOS:000395450400007	27686362				2022-02-06	
J	Hacker, D; Jones, CA; Clowes, Z; Belli, A; Su, ZJ; Sitaraman, M; Davies, D; Taylor, R; Flahive, E; Travis, C; O'Neil, N; Pettigrew, Y				Hacker, David; Jones, Christopher A.; Clowes, Zoe; Belli, Antonio; Su, Zhangjie; Sitaraman, Murugan; Davies, David; Taylor, Ross; Flahive, Elizabeth; Travis, Clare; O'Neil, Nicci; Pettigrew, Yvonne			The Development and Psychometric Evaluation of a Supplementary Index Score of the Neuropsychological Assessment Battery Screening Module that is Sensitive to Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment battery; Neuropsychological assessment; Traumatic brain injury; Screening test	ECOLOGICAL VALIDITY; UNCOMPLICATED MILD; COMPLICATED MILD; MODERATE; SAMPLE; NAB; REHABILITATION; RELIABILITY; MEMORY; ADULTS	Objective: This study examines the validity of the NAB Screening Module (screening module of the neuropsychological assessment battery, S-NAB) in an acute traumatic brain injury (TBI) inpatient population and provides psychometric evaluation of an original index sensitive to TBI impairment. Method: The utility of the S-NAB as a TBI screen was examined using a between groups design. One-hundred and four patients with mild complicated to severe TBI were recruited from a consecutive cohort of patients admitted as inpatients to a UK Major Trauma Centre. Ninetyeight control participants were selected from the S-NAB normative sample. All TBI patients completed the S-NAB during their inpatient stay. Results: Control participants scored significantly higher than TBI participants on the Total Screening index (t = 3.626, p < 0.01), The Attention index (t = 7.882, p < 0.01), and the Executive index (t = 5.577, p < 0.01). A briefer TBI Impairment index of six subtests was constructed which accurately discriminated TBI patients from normative controls (t = 9.9, p < 0.01; Cohen's d = 1.54). The TBI index had excellent classification accuracy (AUC = 0.83), superior to that of the standard S-NAB indices. The TBI Index, Attention Index, and Total Screening Index demonstrated increasing impairment with increased severity of injury. Conclusions: The S-NAB TBI index is a robust, reliable screening index for use with acute TBI patients, which is sensitive to the effects of acute TBI. It affords a briefer cognitive screen than the S-NAB and demonstrates a dose response relationship to TBI severity.	[Hacker, David; Jones, Christopher A.; Clowes, Zoe; Taylor, Ross] Univ Hosp Birmingham NHS Fdn Trust, Clin Neuropsychol Dept, Birmingham, W Midlands, England; [Jones, Christopher A.] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Su, Zhangjie] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Su, Zhangjie] Univ Manchester, Inst Brain Behav & Mental Hlth, Clin Neurosci, Manchester, Lancs, England; [Belli, Antonio; Sitaraman, Murugan; Davies, David] Univ Hosp Birmingham NHS Fdn Trust, Dept Neurosurg, Birmingham, W Midlands, England; [Flahive, Elizabeth; Travis, Clare; O'Neil, Nicci; Pettigrew, Yvonne] Univ Hosp Birmingham NHS Fdn Trust, Dept Occupat Therapy, Birmingham, W Midlands, England		Hacker, D (corresponding author), Queen Elizabeth Hosp, Neurosci Ctr, Mindelsohn Way, Birmingham B15 2WB, W Midlands, England.	David.Hacker@uhb.nhs.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933			BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks BL, 2009, ARCH CLIN NEUROPSYCH, V24, P647, DOI 10.1093/arclin/acp061; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crawford JR, 2008, BRIT J CLIN PSYCHOL, V47, P215, DOI 10.1348/014466507X258859; Crawford JR, 2011, PSYCHOL ASSESSMENT, V23, P888, DOI 10.1037/a0023712; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Iverson GL, 2007, APPL NEUROPSYCHOL, V14, P178, DOI 10.1080/09084280701508952; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; White T., 2003, PSYCHOL ASSESSMENT R; Zgaljardic DJ, 2011, REHABIL PSYCHOL, V56, P359, DOI 10.1037/a0025466; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P27, DOI 10.1080/09084280903297909	29	3	3	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2017	32	2					215	227		10.1093/arclin/acw087			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EQ4EG	WOS:000398026400007	28365746	Bronze			2022-02-06	
J	Han, MH; Ryu, JI; Kim, CH; Kim, JM; Cheong, JH; Yi, HJ				Han, Myung-Hoon; Ryu, Je Il; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Yi, Hyeong-Joong			Radiologic Findings and Patient Factors Associated with 30-Day Mortality after Surgical Evacuation of Subdural Hematoma in Patients Less Than 65 Years Old	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Subdural hematoma; Traumatic brain injury; Mortality; Traumatic subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; PREINJURY WARFARIN; SUBARACHNOID HEMORRHAGE; DECOMPRESSIVE CRANIECTOMY; CEREBRAL VASOSPASM; DIABETES-MELLITUS; RISK-FACTORS; HYPERGLYCEMIA; IMPACT	Objective : The purpose of this study is to evaluate the associations between 30-day mortality and various radiological and clinical factors in patients with traumatic acute subdural hematoma (SDH). During the 11-year study period, young patients who underwent surgery for SDH were followed for 30 days. Patients who died due to other medical comorbidities or other organ problems were not included in the study population. Methods : From January 1, 2004 to December 31, 2014, 318 consecutive surgically-treated traumatic acute SDH patients were registered for the study. The Kaplan Meier method was used to analyze 30-day survival rates. We also estimated the hazard ratios of various variables in order to identify the independent predictors of 30-day mortality. Results: We observed a negative correlation between 30-day mortality and Glasgow coma scale score (per 1-point score increase) (hazard ratio [HR], 0.60; 95% confidence interval [Cl], 0.52-0.70; p<0.001). In addition, use of antithrombotics (HR, 2.34; 95% Cl, 1.27-4.33; p=0.008), history of diabetes mellitus (HR, 2.28; 95% Cl, 1.20-4.32; p=0.015), and accompanying traumatic subarachnoid hemorrhage (hazard ratio, 213; 95% Cl, 1.27-3.58; p=0.005) were positively associated with 30-day mortality. Conclusion : We found significant associations between short-term mortality after surgery for traumatic acute SDH and lower Glasgow Coma Scale scores, use of antithrombotics, history of diabetes mellitus, and accompanying traumatic subarachnoid hemorrhage at admission. We expect these findings to be helpful for selecting patients for surgical treatment of traumatic acute SDH, and for making accurate prognoses.	[Han, Myung-Hoon; Ryu, Je Il; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan] Hanyang Univ Guri Hosp, Dept Neurosurg, 153 Gyeongchun Ro, Guri 11923, South Korea; [Yi, Hyeong-Joong] Hanyang Univ Med Ctr, Dept Neurosurg, Seoul, South Korea		Ryu, JI (corresponding author), Hanyang Univ Guri Hosp, Dept Neurosurg, 153 Gyeongchun Ro, Guri 11923, South Korea.	ryujeil@hanmail.net	Yi, Hyeong-Joong/AAR-2685-2020; Ryu, Je Il/E-5511-2018	Ryu, Je Il/0000-0003-2885-5839			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aminmansour B, 2009, J RES MED SCI, V14, P343; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Khoury JC, 2013, STROKE, V44, P1500, DOI 10.1161/STROKEAHA.113.001318; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Lukasiewicz AM, 2015, J NEUROSURG, V124, P1; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Zubkov ZY, 2000, SURG NEUROL, V53, P126	31	3	3	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAR	2017	60	2					239	249		10.3340/jkns.2016.0404.009			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EP6UT	WOS:000397515100016	28264246	Green Published, Green Submitted, gold			2022-02-06	
J	Joshi, S; Dunbar, K; Taylor, P; Sullivan, KL; Afzal, MM; Song, C; Purohit, M; Roy, MJ				Joshi, Shristi; Dunbar, Kerri; Taylor, Patricia; Sullivan, Kelli L.; Afzal, Mariam M.; Song, Christina; Purohit, Maulik; Roy, Michael J.			Streamlining Participant Recruitment for TBI and PTSD Research Studies	MILITARY MEDICINE			English	Article							RETENTION	Objectives: Recruitment of participants for traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) studies is a major challenge, causing delays in study timelines and even study failures. To address this challenge, the Center for Neuroscience and Regenerative Medicine (CNRM) Recruitment Core developed procedures for identification, screening, and referral of participants from screening studies to a broad range of TBI and PTSD studies. Methods: Participants were recruited from civilian hospitals, Military Treatment Facilities, and through various events and presentations. Enrolled participants were referred to other studies during initial enrollment, follow-up visits, or ad hoc as new CNRM studies became active. A centralized online database was used to streamline the eligibility and referral process. Results: As of October 25, 2016, 1,040 enrolled participants from the two screening studies have been assessed for eligibility for active CNRM studies. Referrals have led to 197 total enrollments into other CNRM studies. Common reasons for exclusion from studies included age, date of injury, injury severity, contraindication to Magnetic Resonance Imaging, state of residence, and military status. Conclusion: Collaborative work with multiple disciplines and institutions, and the use of diverse media, was critical to augmenting participant enrollment, and significantly diversified the demographics of the participant population. Streamlining the referral process helps studies meet their timelines and target enrollment.	[Joshi, Shristi; Dunbar, Kerri; Taylor, Patricia; Sullivan, Kelli L.; Afzal, Mariam M.; Song, Christina] Henry M Jackson Fdn, 6720A Rockledge Dr,Suite 100, Bethesda, MD 20817 USA; [Joshi, Shristi; Dunbar, Kerri; Taylor, Patricia; Sullivan, Kelli L.; Afzal, Mariam M.; Song, Christina; Purohit, Maulik; Roy, Michael J.] Ctr Neurosci & Regenerat Med, 12725 Twinbrook Pkwy, Rockville, MD 20852 USA; [Roy, Michael J.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Purohit, Maulik] Ft Belvoir Community Hosp, 9300 DeWitt Loop, Ft Belvoir, VA 22060 USA		Joshi, S (corresponding author), Henry M Jackson Fdn, 6720A Rockledge Dr,Suite 100, Bethesda, MD 20817 USA.; Joshi, S (corresponding author), Ctr Neurosci & Regenerat Med, 12725 Twinbrook Pkwy, Rockville, MD 20852 USA.		Sullivan, Kelli/AAT-8706-2021	Sullivan, Kelli/0000-0002-5144-255X			Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Blanton S, 2006, PHYS THER, V86, P1520, DOI 10.2522/ptj.20060091; Chang Bei-Hung, 2004, BMC Med Res Methodol, V4, P8, DOI 10.1186/1471-2288-4-8; Nathan RA, 1999, J ASTHMA, V36, P213, DOI 10.3109/02770909909075405	4	3	3	0	1	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			124	127		10.7205/MILMED-D-16-00282			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6VN	WOS:000398947100021	28291463	Bronze			2022-02-06	
J	Lane, KS; St Pierre, ME; Lauterbach, MD; Koliatsos, VE				Lane, Kristy S.; St Pierre, Maria E.; Lauterbach, Margo D.; Koliatsos, Vassilis E.			Patient Profiles of Criminal Behavior in the Context of Traumatic Brain Injury	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; traumatic brain injury; frontal lobe; aggression; risk factors; recidivism; incarceration	PSYCHIATRIC-DISORDERS; AGGRESSIVE-BEHAVIOR; MISCONCEPTIONS; POPULATION; PREVALENCE; VIOLENCE	Traumatic brain injury (TBI) can lead to significant post-traumatic disturbances in mood and behavior, with the frontal lobes playing a key role in emotional and behavioral regulation. Injury to the frontal lobe can result in disinhibition and aggression which can result in police intervention and/or incarceration. We highlight four adult cases with a history of severe TBI with frontal lobe injuries and the presence of post-TBI criminal behaviors. There is evidence to support an anatomical basis for aggressive behaviors, yet there are other risk factors to be considered. Behaviors must be investigated thoroughly by obtaining adequate pre- and post-TBI psychiatric and psychosocial histories. By having a comprehensive understanding of aggression while appreciating the complex relationship between TBI, aggression, and premorbid risk factors, clinicians can more adequately treat patients with TBI, with the aim of potentially preventing criminal behaviors and recidivism.	[Lane, Kristy S.; Lauterbach, Margo D.; Koliatsos, Vassilis E.] Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, 6501 North Charles St,POB 6815, Baltimore, MD 21285 USA; [St Pierre, Maria E.] Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21204 USA		Lane, KS (corresponding author), Sheppard Pratt Hlth Syst, Neuropsychiat Program Sheppard Pratt, 6501 North Charles St,POB 6815, Baltimore, MD 21285 USA.	KLane@sheppardpratt.org			Leonard and Helen R. Stulman Charitable Foundation; Women's Hospital Foundation, Inc.	Funding provided by the Leonard and Helen R. Stulman Charitable Foundation and Women's Hospital Foundation, Inc.	Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BIAA, ABOUT BRAIN INJURY; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; CDC, TRAUM BRA INJ US FAC; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; Palijan TZ, 2010, PSYCHIAT DANUB, V22, P253; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Silver JM, 2011, TXB TRAUMATIC BRAIN, P225; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274	24	3	4	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	MAR	2017	62	2					545	548		10.1111/1556-4029.13289			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	EM0UZ	WOS:000395034500038	27864958				2022-02-06	
J	Lefort, R; Hunter, JV; Cruz, AT; Caviness, AC; Luerssen, TG; Adekunle-Ojo, A				Lefort, Roxanna; Hunter, Jill V.; Cruz, Andrea T.; Caviness, A. Chantal; Luerssen, Thomas G.; Adekunle-Ojo, Aderonke			Utility of Emergency Department Observation Units for Neurologically Intact Children With Head CT Abnormalities Secondary to Acute Closed Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						closed head injury; emergency department observation unit; neurologically intact; GCS >= 14; serial head CT	COMPUTED-TOMOGRAPHY; TRAUMA	Objective: The aim of the study was to evaluate the utility of the emergency department observation unit (EDOU) for neurologically intact children with closed head injuries (CHIs) and computed tomography (CT) abnormalities. Methods: A retrospective cohort study of children aged 0 to 18 years with acute CHI, abnormal head CT, and a Glasgow Coma Scales score of 14 or higher admitted to the EDOU of a tertiary care children's hospital from 2007 to 2010. Children with multisystem trauma, nonaccidental trauma, and previous neurosurgical or coagulopathic conditions were excluded. Medical records were abstracted for demographic, clinical, and radiographic findings. Poor outcome was defined as death, intensive care unit admission, or medically/surgically treated increased intracranial pressure. Results: Two hundred two children were included. Median (range) age was 14(4 days-16 years) months; 51% were male. The most common CT findings were nondisplaced (136, 67%) or displaced (46, 23%) as well as skull fractures and subdural hematomas (38, 19%); 54 (27%) had less than 1 CT finding. The most common interventions included repeat CT (42, 21%), antiemetics (26, 13%), and pain medication (29, 14%). Eighty-nine percentwere discharged in less than 24 hours. Inpatient admission from the EDOU occurred in 6 (3%); all were discharged in less than 3 days. One patient required additional intervention (corticosteroid therapy). She had a subdural hematoma, persistent vomiting, intractable headache, and a nonevolving CT. Conclusions: Neurologically intact patients on initial ED evaluation had a very low likelihood of requiring further interventions, irrespective of CT findings. Although prospective evidence is necessary, this supports reliance on clinical findings when evaluating a well-appearing child with an acute CHI.	[Lefort, Roxanna; Cruz, Andrea T.; Caviness, A. Chantal; Adekunle-Ojo, Aderonke] Baylor Coll Med, Sect Emergency Med, Houston, TX 77030 USA; [Lefort, Roxanna; Cruz, Andrea T.; Caviness, A. Chantal; Adekunle-Ojo, Aderonke] Baylor Coll Med, Infect Dis Sect, Houston, TX 77030 USA; [Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Cruz, Andrea T.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Luerssen, Thomas G.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Adekunle-Ojo, A (corresponding author), 6621 Fannin St,Suite A2210, Houston, TX 77030 USA.	aoojo@texaschildrenshospital.org		Lefort, Roxanna/0000-0002-5631-1233			Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074	10	3	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2017	33	3					161	165					5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	EN1XH	WOS:000395803200005	27918377				2022-02-06	
J	Miller, KJ; Kennedy, JE; Schwab, KA				Miller, Kelly J.; Kennedy, Jan E.; Schwab, Karen A.			Long-Term Outcomes and Needs of Military Service Members After Noncombat-Related Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	5th Military Health System Research Symposium	AUG 17-21, 2015	Fort Lauderdale, FL				MILD HEAD-INJURY; MODEL SYSTEMS; UNITED-STATES; HEALTH-CARE; FOLLOW-UP; DISABILITY; TBI; CONSCIOUSNESS; POPULATION; PROGNOSIS	Objectives: Assess the prevalence of self-identified unmet service needs in a military sample an average of 5 years following noncombat traumatic brain injury (TBI). Examine relationships between unmet needs and background, injury-related and outcome variables. Methods: The study sample consisted of 89 veterans and service members who sustained non-combat TBI between 1999 and 2003, selected from enrollees in the Defense and Veterans Brain Injury Center TBI registry. Semistructured telephone interview was used to collect information about participants' self-reported unmet service needs, symptoms, and functional status. Results: Most participants (65%) reported having at least one unmet service need. The most prevalent needs were "getting information about available post-TBI services" (47%) and "improving memory and attention" (45%). Unmet needs were associated with cognitive difficulties, physical and emotional symptoms, mental health diagnosis/treatment, and poorer functional status. Conclusions: Needs for services following TBI are associated with poor symptomatic and functional outcomes and may persist for years after injury in military service members and veterans. The study suggests service members' needs post TBI for improved cognition, support for emotional issues, and resources for vocational skills. Information about available services should be made accessible to those recovering from TBI to reduce the incidence of long-term unmet needs.	[Miller, Kelly J.; Schwab, Karen A.] DVBIC, 1335 East West Hwy Ste 6-100, Silver Spring, MD 20910 USA; [Kennedy, Jan E.] DVBIC, San Antonio Mil Med Ctr MCHE MDU, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Schwab, Karen A.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Miller, KJ (corresponding author), DVBIC, 1335 East West Hwy Ste 6-100, Silver Spring, MD 20910 USA.				Defense Centers of Excellence, Defense and Veterans Brain Injury Center	This study was funded by the Defense Centers of Excellence, Defense and Veterans Brain Injury Center.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Arciniegas D. B., 2013, MANAGEMENT ADULTS TR; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2014, ARCH PHYS MED REH S3, V95; Centers for Disease Control (CDC), 1999, C TRAUM BRAIN INJ US; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cooney R., 2011, RACE GEND CLASS, V18, P360; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; CROAN GM, 1992, 968 US ARM RES I BEH; Defense Medical Surveillance System (DMSS) Theater Medical Data Store (TMDS), DEF VET BRAIN INJ CT; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Enhanced Post-Deployment Health Assessment (PDHA), PROC DD FORM 2796; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lew HL, 2007, J REHABIL RES DEV, V44, P7; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; The CDC NIH DoD and VA Leadership Panel, 2013, C TRAUM BRAIN INJ US; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United States General Accounting Office, 2001, GAO01841 US GOV PRIN; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	46	3	3	0	2	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			137	146		10.7205/MILMED-D-16-00175			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	ER6VN	WOS:000398947100023	28291465	Bronze			2022-02-06	
